PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Vannucci, C; Taniguchi, I; Asatekin, A				Vannucci, Chiara; Taniguchi, Ikuo; Asatekin, Ayse			Nanoconfinement and Chemical Structure Effects on Permeation Selectivity of Self-Assembling Graft Copolymers	ACS MACRO LETTERS			English	Article							TRANSFER RADICAL POLYMERIZATION; MICROPHASE SEPARATION; NANOTUBE MEMBRANES; FILTRATION MEMBRANES; FOULING RESISTANT; BLOCK-COPOLYMERS; COMB COPOLYMERS; POLYMERS; FLUX; TEMPERATURES	Permeation of small molecule solutes through thin films is typically described by the solution-diffusion model, but this model cannot predict the effects of nanostructure due to self-assembly or additives. Other models focusing on diffusion through isolated nanopores indicate that confining permeation to channels slightly larger than the size of the solute can lead to an increased influence of solute pore wall interactions on permeation rate. In this study, we analyze how differences in polymer nanostructure affect the relative contributions of solute size and polymer solute interactions on transport rate. We compared the diffusion rates of several small molecules through two polymer thin films: A cross-linked, homogeneous film of poly(ethylene glycol phenyl ether acrylate) (PEGPEA) and a graft copolymer with a poly(vinylidene fluoride-co-chlorotrifluoroethylene) (P(VDF-co-CTFE)) backbone and PEGPEA side chains that self-assemble into continuous similar to 1-3 nm PEGPEA domains through which transport occurs. We correlated these rates with the size of each solute and its chemical affinity to PEGPEA, as measured by the difference between their solubility parameters. Diffusion rate through the homogeneous polymer film was controlled by solute size, whereas diffusion rate through the copolymer was strongly controlled by the difference between the solubility parameters. Furthermore, permeation selectivity between two selected molecules was 2.5x higher for the nanostructured copolymer, likely enhanced by the nanoconfinement effects. These initial results indicate that polymer self-assembly is a promising tool for designing polymeric membranes that can differentiate between solutes of similar size but differing chemical structures.	[Vannucci, Chiara; Asatekin, Ayse] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA; [Taniguchi, Ikuo] Kyushu Univ Nishi ku, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Asatekin, A (reprint author), Tufts Univ, Dept Chem & Biol Engn, 4 Colby St, Medford, MA 02155 USA.	ayse.asatekin@tufts.edu			Tufts University	The authors thank Prof. Peggy Cebe for access to DSC, David Wilbur for help with GCMS analysis, and Tufts University for funding. SAXS experiments were carried out using the synchrotron X-rays at Kyushu University Beamline (SAGA-LS/BL06) with the proposal No. 2015IK001.	Baxamusa SH, 2008, BIOMACROMOLECULES, V9, P2857, DOI 10.1021/bm800632d; Nedelcu M, 2009, SOFT MATTER, V5, P134, DOI 10.1039/b815166k; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Bengani P, 2015, J MEMBRANE SCI, V493, P755, DOI 10.1016/j.memsci.2015.07.025; Asatekin A, 2011, NANO LETT, V11, P677, DOI 10.1021/nl103799d; Hammouda B, 2010, J APPL CRYSTALLOGR, V43, P716, DOI 10.1107/S0021889810015773; Asatekin A, 2009, J MEMBRANE SCI, V332, P6, DOI 10.1016/j.memsci.2009.01.029; Grozea CM, 2011, MACROMOLECULES, V44, P3901, DOI 10.1021/ma102470v; Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371; Savariar EN, 2008, NAT NANOTECHNOL, V3, P112, DOI 10.1038/nnano.2008.6; Akthakul A, 2005, ADV MATER, V17, P532, DOI 10.1002/adma.200400636; Escobar CA, 2012, ACS APPL MATER INTER, V4, P906, DOI 10.1021/am201565b; Kohli P, 2004, SCIENCE, V305, P984, DOI 10.1126/science.1100024; Lange J, 2003, PACKAG TECHNOL SCI, V16, P149, DOI 10.1002/pts.621; Velleman L, 2009, MICROPOR MESOPOR MAT, V126, P87, DOI 10.1016/j.micromeso.2009.05.024; Chen J, 2014, POLYM CHEM-UK, V5, P2130, DOI 10.1039/c3py01390a; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; BENOIT H, 1993, MACROMOLECULES, V26, P5790, DOI 10.1021/ma00073a037; Pospiech D, 2002, COLLOID POLYM SCI, V280, P1027, DOI 10.1007/s00396-002-0728-6; Matyjaszewski K, 2009, NAT CHEM, V1, P276, DOI [10.1038/nchem.257, 10.1038/NCHEM.257]; Miyata T, 1999, MACROMOLECULES, V32, P3712, DOI 10.1021/ma981949x; Zhang MF, 2006, MACROMOLECULES, V39, P3531, DOI 10.1021/ma060128m; Akthakul A, 2004, MACROMOLECULES, V37, P7663, DOI 10.1021/ma048837s; Luo M, 2013, MACROMOLECULES, V46, P7567, DOI 10.1021/ma401112y; BONARDELLI P, 1986, POLYMER, V27, P905, DOI 10.1016/0032-3861(86)90302-2; Xu JJ, 2012, ADV MATER, V24, P3692, DOI 10.1002/adma.201201197; Freeman B, 1997, TRENDS POLYM SCI, V5, P167; [Anonymous], 1992, J POLYM; Javaid A, 2005, CHEM ENG J, V112, P219, DOI 10.1016/j.cej.2005.07.010; Ahn SH, 2010, CHEM COMMUN, V46, P1935, DOI 10.1039/b919215h; Yang SY, 2006, ADV MATER, V18, P709, DOI 10.1002/adma.200501500; Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g; Hester JF, 2002, J MEMBRANE SCI, V208, P375, DOI 10.1016/S0376-7388(02)00317-4; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Chi WS, 2013, J MEMBRANE SCI, V443, P54, DOI 10.1016/j.memsci.2013.04.049; Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978; Geise GM, 2014, J MEMBRANE SCI, V453, P425, DOI 10.1016/j.memsci.2013.11.004; Kowalczyk SW, 2011, NAT NANOTECHNOL, V6, P433, DOI [10.1038/nnano.2011.88, 10.1038/NNANO.2011.88]; Schacher FH, 2012, ANGEW CHEM INT EDIT, V51, P7898, DOI 10.1002/anie.201200310; BEAUCAGE G, 1994, J NON-CRYST SOLIDS, V172, P797, DOI 10.1016/0022-3093(94)90581-9; Yoshida M, 2006, POLYM REV, V46, P347, DOI 10.1080/15583720600945394; Park C, 2003, POLYMER, V44, P6725, DOI 10.1016/j.polymer.2003.08.011; Berg T, 2003, ANGEW CHEM INT EDIT, V42, P2462, DOI 10.1002/anie.200200558; Geise GM, 2013, J MEMBRANE SCI, V427, P186, DOI 10.1016/j.memsci.2012.09.029; Kumar A, 2007, PROG POLYM SCI, V32, P1205, DOI 10.1016/j.progpolymsci.2007.05.003; SHINOZAKI A, 1994, MACROMOLECULES, V27, P2496, DOI 10.1021/ma00087a018; Wirtz M, 2002, ANALYST, V127, P871, DOI 10.1039/b201939f; LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876; FOSTER DP, 1995, MACROMOLECULES, V28, P3450, DOI 10.1021/ma00113a052; Asatekin A, 2015, NANOSCI NANOTECH LET, V7, P21, DOI 10.1166/nnl.2015.1930; Baker R. W., 2004, MEMBRANE TECHNOLOGY; Friedman M. H., 2008, PRINCIPLES MODELS BI, pxvii; Lovell P., 1991, INTRO POLYM, px; Matyjaszewski K., 2002, ADV POYM SCI, V159, P108; Asatekin A, 2009, SEPAR SCI TECHNOL, V44, P3330, DOI 10.1080/01496390903212516; Park G. S., 1968, DIFFUSION IN POLYMER; Pinnau I., 1999, POLYM MEMBRANES GAS; Ranjan S., 2014, J NANOPART RES, V16; Rodriguez F., 1982, PRINCIPLES POLYM SYS, P157; Roe R., 2000, METHODS OF X RAY AND; Safranski D. L., 2008, EFFECT OF CHEMICAL S; Scott R L., 1950, THE SOLUBILITY OF NO; Te Nijenhuis K., 1972, PROPERTIES OF POLYME; UDDING JH, 1994, J ORG CHEM, V59, P1993, DOI 10.1021/jo00087a011; Zilman A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000804; Zilman A., 2010, PLOS COMPUT BIOL, V6	66	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	SEP	2015	4	9					872	878		10.1021/acsmacrolett.5b00401		7	Polymer Science	Polymer Science	CR5ZX	WOS:000361424000003		
J	Kondo, Y; Osaka, M; Benten, H; Ohkita, H; Ito, S				Kondo, Yuya; Osaka, Miki; Benten, Hiroaki; Ohkita, Hideo; Ito, Shinzaburo			Electron Transport Nanostructures of Conjugated Polymer Films Visualized by Conductive Atomic Force Microscopy	ACS MACRO LETTERS			English	Article							NANOSCALE CHARGE-TRANSPORT; BLEND SOLAR-CELLS; PERFORMANCE; SEMICONDUCTOR; TRANSISTORS; MORPHOLOGY; EFFICIENCY; TEXTURE; DIODES; ORDER	We have successfully measured electron transport nanostructures of conjugated polymer thin films by conductive atomic force microscopy, using an air-stable electron-injecting electrode coated with ethoxylated polyethylenimine. Electron- and hole-transport networks in donor/acceptor polymer blends can be selectively observed by using an appropriately coated electrode. This approach enables us to visualize phase-separated nanostructures of donor/acceptor polymer blends for thin-film electronic devices based on their semiconducting properties.	[Kondo, Yuya; Osaka, Miki; Benten, Hiroaki; Ohkita, Hideo; Ito, Shinzaburo] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan	Benten, H (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	benten@photo.polym.kyoto-u.ac.jp			Japan Science and Technology Agency (JST); JSPS KAKENHI [26288060]	This work was partly supported by the CREST program from the Japan Science and Technology Agency (JST) and JSPS KAKENHI Grant Number 26288060.	Salleo A, 2007, MATER TODAY, V10, P38, DOI 10.1016/S1369-7021(07)70018-4; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Groves C, 2010, ACCOUNTS CHEM RES, V43, P612, DOI 10.1021/ar900231q; Reid OG, 2008, NANO LETT, V8, P1602, DOI [10.1021/nl080155l, 10.1021/nl0801551]; Alexeev A, 2006, ULTRAMICROSCOPY, V106, P191, DOI 10.1016/j.ultramic.2005.07.003; Lee LT, 2012, AMBIO, V41, P135, DOI 10.1007/s13280-012-0269-2; Moerman D, 2014, NANOSCALE, V6, P10596, DOI 10.1039/c4nr02577f; Osaka M, 2013, POLYMER, V54, P3443, DOI 10.1016/j.polymer.2013.04.061; Steyrleuthner R, 2014, J AM CHEM SOC, V136, P4245, DOI 10.1021/ja4118736; Lin HN, 2002, APPL PHYS LETT, V81, P2572, DOI 10.1063/1.1509464; Grimsdale AC, 2009, CHEM REV, V109, P897, DOI 10.1021/cr000013v; McNeill CR, 2012, ENERG ENVIRON SCI, V5, P5653, DOI 10.1039/c2ee03071c; Yan HP, 2012, ACS NANO, V6, P677, DOI 10.1021/nn204150f; Moons E, 2002, J PHYS-CONDENS MAT, V14, P12235, DOI 10.1088/0953-8984/14/47/301; Usta H, 2011, ACCOUNTS CHEM RES, V44, P501, DOI 10.1021/ar200006r; Facchetti A, 2013, MATER TODAY, V16, P123, DOI 10.1016/j.mattod.2013.04.005; Chen MC, 2009, J PHYS CHEM B, V113, P11124, DOI 10.1021/jp901644m; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Chen ZH, 2009, J AM CHEM SOC, V131, P8, DOI 10.1021/ja805407g; Dante M, 2008, J PHYS CHEM C, V112, P7241, DOI 10.1021/jp712086q; Mativetsky JM, 2014, J MATER CHEM C, V2, P3118, DOI 10.1039/c3tc32050b; Facchetti A, 2011, CHEM MATER, V23, P733, DOI 10.1021/cm102419z; Schubert M, 2012, ADV ENERGY MATER, V2, P369, DOI 10.1002/aenm.201100601; Sirringhaus H, 2014, ADV MATER, V26, P1319, DOI 10.1002/adma.201304346; Schuettfort T, 2011, MACROMOLECULES, V44, P1530, DOI 10.1021/ma102451b; Shen YL, 2004, CHEMPHYSCHEM, V5, P16, DOI 10.1002/cphc.200300942; Zhou YH, 2012, SCIENCE, V336, P327, DOI 10.1126/science.1218829; Takacs CJ, 2013, NANO LETT, V13, P2522, DOI 10.1021/nl4005805; Mori D, 2011, ACS APPL MATER INTER, V3, P2924, DOI 10.1021/am200624s; Cheng YJ, 2009, CHEM REV, V109, P5868, DOI 10.1021/cr900182s; Rivnay J, 2011, MACROMOLECULES, V44, P5246, DOI 10.1021/ma200864s; Asadi K, 2009, ADV FUNCT MATER, V19, P3173, DOI 10.1002/adfm.200900383; Douheret O, 2007, MICROELECTRON ENG, V84, P431, DOI 10.1016/j.mee.2006.10.056; Goh C, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1891301; Kline R. J., 2006, J MACROMOL SCI-POL R, V46, P27, DOI DOI 10.1080/15321790500471194; MacDonald GA, 2012, ACS NANO, V6, P9623, DOI 10.1021/nn303043y; Mori D, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500304; Mori D, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301006; Sondergaard R. R., 2013, J POLYM SCI, V51, P16; Rivnay J, 2010, ADV MATER, V22, P4359, DOI 10.1002/adma.201001202	40	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	SEP	2015	4	9					879	885		10.1021/acsmacrolett.5b00352		7	Polymer Science	Polymer Science	CR5ZX	WOS:000361424000004		
J	Suga, T; Aoki, K; Nishide, H				Suga, Takeo; Aoki, Kohei; Nishide, Hiroyuki			Ionic Liquid-Triggered Redox Molecule Placement in Block Copolymer Nanotemplates toward an Organic Resistive Memory	ACS MACRO LETTERS			English	Article							MATERIALS SCIENCE; LITHOGRAPHY; POLYMER; NANOSTRUCTURES; NANOCOMPOSITES; ELECTRONICS; PLATFORM; DEVICES	The integration of functional components such as metal nanoparticles, metal salts, or ionic liquids with well-defined block copolymer (BCP) nanotemplates via non-covalent bond interactions has afforded hybrid functional materials. Here, we designed an ionic liquid (IL)-functionalized redox-active TEMPO (2,2,6,6-tetramethylpiperidine-N-oxy) radical (guest), investigated phase-selective incorporation/placement into host BCP nanostructured matrices, and established a rational approach to functionalize BCP templates. On-demand domain functionalization of poly(styrene-b-ethyl-ene oxide) (PS-b-PEO) was triggered by ion-ionophore interaction, as verified by the suppression of PEO melting transition in DSC, and the swelling behavior of the PEO spherical domain in AFM, TEM, and X-ray scattering characterizations. The obtained BCP layer containing the redox-active TEMPO and IL was utilized as an active layer in the diode-structured memory device, which exhibited on/off resistive switching (on/off ratio >10(3)). Systematic placement of TEMPO and IL in the BCP spherical domain allowed for tuning of the switching characteristics and revealed that the formation of a discontinuous redox-active domain was critical for rewritable resistive switching.	[Suga, Takeo] Waseda Univ, WIAS, Tokyo 1698555, Japan; [Aoki, Kohei; Nishide, Hiroyuki] Waseda Univ, Dept Appl Chem, Tokyo 1698555, Japan	Suga, T (reprint author), Waseda Univ, WIAS, Tokyo 1698555, Japan.	takeosuga@toki.waseda.jp; nishide@waseda.jp			MEXT, Japan [24225003, 23550139]; MEXT/JST tenure-track program [25102541, 15H00766]; MIZUHO Foundation	This work was partially supported by Grants-in Aid for Scientific Research (Nos. 24225003 and 23550139) from MEXT, Japan. T.S. acknowledges the MEXT/JST tenure-track program, Grants-in Aid for Scientific Research on Innovative Areas on New Polymeric Materials Based on Element-Blocks (Nos. 25102541 and 15H00766), and the MIZUHO Foundation.	Suga T, 2009, ADV MATER, V21, P1627, DOI 10.1002/adma.200803073; Bockstaller MR, 2005, ADV MATER, V17, P1331, DOI 10.1002/adma.200500167; De Rosa C, 2010, ADV MATER, V22, P5414, DOI 10.1002/adma.201002649; Kim SH, 2006, MACROMOLECULES, V39, P8473, DOI 10.1021/ma061170k; Nunns A, 2013, POLYMER, V54, P1269, DOI 10.1016/j.polymer.2012.11.057; Son JG, 2009, ACS NANO, V3, P3927, DOI 10.1021/nn900914q; Matsushita Y, 2007, MACROMOLECULES, V40, P771, DOI 10.1021/ma062266h; Zhao Y, 2009, NAT MATER, V8, P979, DOI [10.1038/nmat2565, 10.1038/NMAT2565]; Kim HC, 2010, CHEM REV, V110, P146, DOI 10.1021/cr900159v; Scott JC, 2007, ADV MATER, V19, P1452, DOI 10.1002/adma.200602564; Ling QD, 2008, PROG POLYM SCI, V33, P917, DOI 10.1016/j.progpolymsci.2008.08.001; Tang CB, 2008, SCIENCE, V322, P429, DOI 10.1126/science.1162950; Lin Y, 2011, J AM CHEM SOC, V133, P6513, DOI 10.1021/ja2003632; Young WS, 2009, MACROMOLECULES, V42, P2672, DOI 10.1021/ma802799p; Suga T, 2014, ACS MACRO LETT, V3, P703, DOI 10.1021/mz500273z; Bates CM, 2014, MACROMOLECULES, V47, P2, DOI 10.1021/ma401762n; Suga T, 2011, ADV MATER, V23, P751, DOI 10.1002/adma.201003525; Lin WP, 2014, ADV MATER, V26, P570, DOI 10.1002/adma.201302637; Virgili JM, 2010, MACROMOLECULES, V43, P5417, DOI 10.1021/ma902804e; Nishide H, 2008, SCIENCE, V319, P737, DOI 10.1126/science.1151831; Ueki T, 2008, MACROMOLECULES, V41, P3739, DOI 10.1021/ma800171k; Suga T, 2011, ADV MATER, V23, P5545, DOI 10.1002/adma.201103222; Lodge TP, 2008, SCIENCE, V321, P50, DOI 10.1126/science.1159652; Kurosawa T, 2013, POLYM CHEM-UK, V4, P16, DOI 10.1039/c2py20632c; Bang J, 2009, ADV MATER, V21, P4769, DOI 10.1002/adma.200803302; Leong WL, 2008, ADV MATER, V20, P2325, DOI 10.1002/adma.200702567; Cho JH, 2008, ADV MATER, V20, P686, DOI 10.1002/adma.200701069	27	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	SEP	2015	4	9					892	896		10.1021/acsmacrolett.5b00473		5	Polymer Science	Polymer Science	CR5ZX	WOS:000361424000006		
J	Gudeangadi, PG; Sakamoto, T; Shichibu, Y; Konishi, K; Nakano, T				Gudeangadi, Prashant G.; Sakamoto, Takeshi; Shichibu, Yukatsu; Konishi, Katsuaki; Nakano, Tamaki			Chiral Polyurethane Synthesis Leading to pi-Stacked 2/1-Helical Polymer and Cyclic Compounds	ACS MACRO LETTERS			English	Article							OPTICALLY-ACTIVE POLYURETHANES; BLOCKED ISOCYANATES-III; CRYSTAL-STRUCTURE; CONJUGATED POLYMERS; HELICAL POLYMERS; SYNDIOTACTIC POLYSTYRENE; ASYMMETRIC CATALYSIS; MOLECULAR-COMPOUND; SAMPLE PREPARATION; VINYL POLYMER	(R)-1,1'-Bi(2-naphthol) was reacted with 1,4-phenylene diisocyanate leading to a mixture of linear polyurethane and cyclic compounds including a cyclic dimer and a cyclic trimer. The structure of the cyclic dimer was elucidated by X-ray crystal structure analysis. The polymer was proposed to possess a rather stiff, pi-stacked, 2/1-helical conformation on the basis of NMR, CD, and UV spectra and molecular dynamics simulations. The conformation was stable in the range of temperature of 0-60 degrees C.	[Gudeangadi, Prashant G.; Sakamoto, Takeshi; Nakano, Tamaki] Hokkaido Univ, CRC, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Gudeangadi, Prashant G.; Sakamoto, Takeshi; Nakano, Tamaki] Hokkaido Univ, Grad Sch Chem Sci & Engn, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Shichibu, Yukatsu; Konishi, Katsuaki] Hokkaido Univ, Fac Environm Earth Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Nakano, T (reprint author), Hokkaido Univ, CRC, Kita Ku, N21,W10, Sapporo, Hokkaido 0010021, Japan.	tamaki.nakano@cat.hokudai.ac.jp			Mitsubishi Foundation	We thank Dr. K. Yoza (Bruker AXS) for technical advice on crystallographic analysis. T.N. acknowledges The Mitsubishi Foundation for financial support.	Nakano T, 2014, CHEM REC, V14, P369, DOI 10.1002/tcr.201300042; Nakano T, 2005, MACROMOLECULES, V38, P8140, DOI 10.1021/ma0513564; Yashima E, 1999, NATURE, V399, P449, DOI 10.1038/20900; Pu L, 1998, CHEM REV, V98, P2405, DOI 10.1021/cr970463w; Cappelli A, 2009, MACROMOLECULES, V42, P2368, DOI 10.1021/ma802429g; Takata T, 1998, J AM CHEM SOC, V120, P4530, DOI 10.1021/ja974337l; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; DEMING TJ, 1992, J AM CHEM SOC, V114, P7926, DOI 10.1021/ja00046a057; Morisaki Y, 2008, PROG POLYM SCI, V33, P346, DOI 10.1016/j.progpolymsci.2007.11.003; Nakano T, 2001, J AM CHEM SOC, V123, P9182, DOI 10.1021/ja0111131; Wicks DA, 2001, PROG ORG COAT, V41, P1, DOI 10.1016/S0300-9440(00)00164-8; Petraccone V, 1998, MACROMOLECULES, V31, P5830, DOI 10.1021/ma9718964; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; OKAMOTO Y, 1994, CHEM REV, V94, P349, DOI 10.1021/cr00026a004; Nakano T, 2010, POLYM J, V42, P103, DOI 10.1038/pj.2009.332; CHATANI Y, 1993, POLYMER, V34, P1620, DOI 10.1016/0032-3861(93)90318-5; TINOCO I, 1960, J AM CHEM SOC, V82, P4785, DOI 10.1021/ja01503a007; Delebecq E, 2013, CHEM REV, V113, P80, DOI 10.1021/cr300195n; Cappelli A, 2003, J ORG CHEM, V68, P9473, DOI 10.1021/jo035104h; RHODES W, 1961, J AM CHEM SOC, V83, P3609, DOI 10.1021/ja01478a017; Wicks DA, 1999, PROG ORG COAT, V36, P148, DOI 10.1016/S0300-9440(99)00042-9; Meng B, 2015, MACROMOLECULES, V48, P4357, DOI 10.1021/acs.macromol.5b00702; Knoblock KM, 2006, J AM CHEM SOC, V128, P13680, DOI 10.1021/ja063312w; Krol P, 2007, PROG MATER SCI, V52, P915, DOI 10.1016/j.pmatsci.2006.11.001; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Shimomura K, 2014, NAT CHEM, V6, P429, DOI [10.1038/nchem.1916, 10.1038/NCHEM.1916]; Nakano T, 2003, J AM CHEM SOC, V125, P15474, DOI 10.1021/ja037836x; Hu QS, 1996, J ORG CHEM, V61, P5200, DOI 10.1021/jo9608634; Nakano T, 2004, CHEM LETT, V33, P296, DOI 10.1246/cl.2004.296; Jagtap SP, 2012, J AM CHEM SOC, V134, P7176, DOI 10.1021/ja3019065; CHATANI Y, 1993, POLYMER, V34, P4841, DOI 10.1016/0032-3861(93)90007-W; Nakano T, 2009, J POLYM SCI POL CHEM, V47, P239, DOI 10.1002/pola.23147; De Rosa C, 1999, POLYMER, V40, P2103, DOI 10.1016/S0032-3861(97)10372-X; Nakano T, 2001, J CHROMATOGR A, V906, P205, DOI 10.1016/S0021-9673(00)00944-4; Morisaki Y, 2006, ANGEW CHEM INT EDIT, V45, P6430, DOI 10.1002/anie.200600752; Caraculacu AA, 2001, PROG POLYM SCI, V26, P799, DOI 10.1016/S0079-6700(00)00033-2; Chen J., 2009, FENXI KEXUE XUEBAO, V25, P161; CHEN Y, 1992, J POLYM SCI POL CHEM, V30, P2699, DOI 10.1002/pola.1992.080301305; Green M. M., 1999, Angewandte Chemie (International Edition), V38, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3138::AID-ANIE3138>3.0.CO;2-C; Hu QS, 1996, MACROMOLECULES, V29, P1082, DOI 10.1021/ma951414t; KOBAYASHI T, 1993, POLYM J, V25, P969, DOI 10.1295/polymj.25.969; Ma L, 1997, MACROMOLECULES, V30, P204, DOI 10.1021/ma961192e; Mengerink Y, 2001, J CHROMATOGR A, V914, P131, DOI 10.1016/S0021-9673(01)00622-7; Mengerink Y, 2000, J CHROMATOGR A, V876, P37, DOI 10.1016/S0021-9673(00)00179-5; Mengerink Y, 2002, J CHROMATOGR A, V949, P307, DOI 10.1016/S0021-9673(01)01440-6; Nakano T, 2004, CHEM COMMUN, P144, DOI 10.1039/b312027a; Pirozzi B, 2008, MACROMOL CHEM PHYSIC, V209, P1012, DOI 10.1002/macp.200700643; Pu L, 1999, CHEM-EUR J, V5, P2227, DOI 10.1002/(SICI)1521-3765(19990802)5:8<2227::AID-CHEM2227>3.0.CO;2-Q; Ruddick CL, 2002, J CHEM SOC PERK T 1, P629, DOI 10.1039/b110528k; Sugino H, 2015, RSC ADV, V5, P21310, DOI 10.1039/c4ra16023a; Wang Y, 2014, POLYM CHEM-UK, V5, P718, DOI 10.1039/c3py01492d; Wicks DA, 2001, PROG ORG COAT, V43, P131, DOI 10.1016/S0300-9440(01)00188-6; Wyatt SR, 2001, MACROMOLECULES, V34, P7983, DOI 10.1021/ma011120+; Yu ZN, 2003, CHEM COMMUN, P974, DOI 10.1039/b212916g	54	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	SEP	2015	4	9					901	906		10.1021/acsmacrolett.5b00477		6	Polymer Science	Polymer Science	CR5ZX	WOS:000361424000008		
J	Luo, F; Sun, TL; Nakajima, T; Kurokawa, T; Bin Ihsan, A; Li, XF; Guo, HL; Gong, JP				Luo, Feng; Sun, Tao Lin; Nakajima, Tasuku; Kurokawa, Takayuki; Bin Ihsan, Abu; Li, Xufeng; Guo, Honglei; Gong, Jian Ping			Free Reprocessability of Tough and Self-Healing Hydrogels Based on Polyion Complex	ACS MACRO LETTERS			English	Article							SENSITIVE HYDROGELS; DELIVERY	Tough hydrogels with facile processability to reform into various shapes are required in many practical applications. In this work, we reported that a novel, tough, and self-healing physical hydrogel based on polyion complex (PIC) can be dissolved in 4 M NaCl solution to form a PIC solution. The PIC solution can be easily reprocessed into various shapes, such as thin films, sheets, fibers, and capsules, by using simple methods, such as casting and injection, while maintaining excellent mechanical properties comparable to, or even better than, the original hydrogel. The reprocessability and robust mechanical properties of PIC hydrogels are promising for practical applications in soft materials, especially in 3D/4D printing technology.	[Luo, Feng; Sun, Tao Lin; Nakajima, Tasuku; Kurokawa, Takayuki; Bin Ihsan, Abu; Gong, Jian Ping] Hokkaido Univ, Fac Adv Life Sci, Lab Soft & Wet Matter, Sapporo, Hokkaido 0600810, Japan; [Li, Xufeng; Guo, Honglei] Hokkaido Univ, Grad Sch Life Sci, Lab Soft & Wet Matter, Sapporo, Hokkaido 0600810, Japan	Gong, JP (reprint author), Hokkaido Univ, Fac Adv Life Sci, Lab Soft & Wet Matter, Sapporo, Hokkaido 0600810, Japan.	gong@mail.sci.hokudai.ac.jp	Gong, Jian Ping/B-7019-2009	Gong, Jian Ping/0000-0003-2228-2750	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); JSPS [P12340]	This research was funded by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan) and the Grant-in-Aid for JSPS Fellows relating to JSPS Postdoctoral Fellowships for Foreign Researchers (No. P12340) from JSPS. We also thank Dr. Daniel R. King for checking and editing grammar.	Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001; Tokarev I, 2010, ADV MATER, V22, P3446, DOI 10.1002/adma.201000165; Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156; Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534; Luo F, 2014, MACROMOLECULES, V47, P6037, DOI 10.1021/rna5009447; Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b; Hunt JN, 2011, ADV MATER, V23, P2327, DOI 10.1002/adma.201004230; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Li JY, 2014, ACS MACRO LETT, V3, P520, DOI 10.1021/mz5002355; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Zhao XH, 2014, SOFT MATTER, V10, P672, DOI 10.1039/c3sm52272e; Hao JK, 2011, MACROMOLECULES, V44, P9390, DOI 10.1021/ma202130u; Qiu Y, 2012, ADV DRUG DELIVER REV, V64, P49, DOI 10.1016/j.addr.2012.09.024; Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X; Nakajima T, 2009, CHINESE J POLYM SCI, V27, P1; Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Sun TL, 2013, NAT MATER, V12, P932, DOI [10.1038/nmat3713, 10.1038/NMAT3713]; Luo F, 2015, ADV MATER, V27, P2722, DOI 10.1002/adma.201500140; Burattini S., 2009, CHEM COMMUN, V44, P6717; Gao H, 2013, MACROMOL RAPID COMM, V34, P63, DOI 10.1002/marc.201200548; Hague M. A., 2011, MACROMOLECULES, V44, P8916; Henderson KJ, 2012, MACROMOLECULES, V45, P1631, DOI 10.1021/ma201607m	24	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	SEP	2015	4	9					961	964		10.1021/acsmacrolett.5b00501		4	Polymer Science	Polymer Science	CR5ZX	WOS:000361424000020		
J	Goto, E; Ando, S; Ueda, M; Higashihara, T				Goto, Eisuke; Ando, Shinji; Ueda, Mitsuru; Higashihara, Tomoya			Nonstoichiometric Stills Coupling Polycondensation for Synthesizing Naphthalene-Diimide-Based pi-Conjugated Polymers	ACS MACRO LETTERS			English	Article							REACTION-INDUCED CRYSTALLIZATION; CHAIN-GROWTH POLYMERIZATION; CATALYST-TRANSFER; STEP POLYMERIZATION; COPOLYMERS; OLIGOMERS; MONOMERS; ROUTE; ACID; BOND	A nonstoichiometric Stille coupling polycondensation was first succeeded between 2,5-bis-(trimethylstanny)thiophene (1) and 4,9-dibromo-2,7-bis(2-decyltetradecyl)benzo[lmn][3,8]-phenanthroline-1,3,6,8-tetraone (2) with ratios ranging from 1:1 to 1:10. The model reaction using 2-(tributylstannyl)thiophene (3) and 4,9-dibromo-2,7-bis(2-hexyl)benzo [lmn] [3,8] -phenanthroline-1,3,6,8-tetraone (4) at a 1:1 molar ratio in the presence of catalytic Pd-2(dba)(3)/P(o-toly1)3 indicated that the rate constant of the second substitution reaction (k(2)) is 15 times higher than that of the first one (k(1)). It was found that the selective intramolecular catalyst transfer was promoted by the naphthalene-diimide (NDI) skeleton. The results also provided a new one-pot symmetrical end-functionalization method to synthesize an NDI-based n-type polymer with NDI groups at both alpha,omega-chain ends.	[Goto, Eisuke; Ueda, Mitsuru; Higashihara, Tomoya] Yamagata Univ, Grad Sch Sci & Engn, Dept Organ Device Engn, Yonezawa, Yamagata 9928510, Japan; [Ando, Shinji] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528552, Japan	Higashihara, T (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Organ Device Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	thigashihara@yz.yamagata-u.ac.jp			Japan Society for the Promotion of Science (JSPS) (KAKENHI) [26620172]; JSPS, Research Fellowship for Young Scientists [15J00430]; Innovative Flex Course for Frontier Organic Material Systems (iFront) at Yamagata University	This study was supported by Japan Society for the Promotion of Science (JSPS) (KAKENHI: Proposal No. 26620172). E. Goto appreciates the support by Grant-in-Aid from JSPS, Research Fellowship for Young Scientists (Proposal No. 15J00430), and Innovative Flex Course for Frontier Organic Material Systems (iFront) at Yamagata University. We thank Dr. Masahiko Saito (RIKEN, Japan) and Dr. Itaru Osaka (RIKEN, Japan) for the kind assistance for measuring high-temperature SEC.	Guo XG, 2008, ORG LETT, V10, P5333, DOI 10.1021/ol801918y; Tkachov R, 2014, MACROMOLECULES, V47, P3845, DOI 10.1021/ma5007667; Tkachov R, 2014, MACROMOLECULES, V47, P4994, DOI 10.1021/ma5006588; Yokoyama A, 2007, J AM CHEM SOC, V129, P7236, DOI 10.1021/ja070313v; Matsidik R, 2015, J AM CHEM SOC, V137, P6705, DOI 10.1021/jacs.5b03355; Kang SS, 2013, J AM CHEM SOC, V135, P4984, DOI 10.1021/ja401740m; Sommer M, 2014, J MATER CHEM C, V2, P3088, DOI 10.1039/c3tc31755b; Yokozawa T, 2010, MACROMOLECULES, V43, P7095, DOI 10.1021/ma101073x; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Elmalem E, 2011, MACROMOLECULES, V44, P9057, DOI 10.1021/ma201934q; Nomura N, 2001, ANGEW CHEM INT EDIT, V40, P1932, DOI 10.1002/1521-3773(20010518)40:10<1932::AID-ANIE1932>3.3.CO;2-G; Yokozawa T, 2011, MACROMOL RAPID COMM, V32, P801, DOI 10.1002/marc.201100037; Kiriy A, 2011, MACROMOL RAPID COMM, V32, P1503, DOI 10.1002/marc.201100316; Nojima M, 2015, J AM CHEM SOC, V137, P5682, DOI 10.1021/jacs.5b03113; Flory P. J., 1953, PRINCIPLES POLYM CHE; Hill H., 1972, POLYM PREPR AM CHEM, V13, P603; Iimori H, 2003, MACROMOL SYMP, V199, P23, DOI 10.1002/masy.200350903; Kihara N, 1999, MACROMOLECULES, V32, P4776, DOI 10.1021/ma981835l; Kimura K., 2012, POLYM SCI COMPREHENS, V5, P95; Kimura K, 2002, MACROMOLECULES, V35, P7545, DOI 10.1021/ma0205919; Kohama SI, 2005, J POLYM SCI POL CHEM, V43, P1757, DOI 10.1002/pola.20651; Miyatake K, 2001, MACROMOLECULES, V34, P4288, DOI 10.1021/ma002020r; Nomura N, 2004, J AM CHEM SOC, V126, P5354, DOI 10.1021/ja0492743; Odian G., 1991, PRINCIPLES POLYM; OZIZMIR E, 1980, J POLYM SCI POL CHEM, V18, P1089, DOI 10.1002/pol.1980.170180327; Senkovskyy V, 2012, MACROMOLECULES, V45, P7770, DOI 10.1021/ma301797w; Senkovskyy V, 2011, J AM CHEM SOC, V133, P19966, DOI 10.1021/ja208710x; Wakabayashi K, 2008, MACROMOLECULES, V41, P1168, DOI 10.1021/ma702030u	28	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	SEP	2015	4	9					1004	1007		10.1021/acsmacrolett.5b00532		4	Polymer Science	Polymer Science	CR5ZX	WOS:000361424000029		
J	Ogo, N; Ishikawa, Y; Sawada, J; Matsuno, K; Hashimoto, A; Asai, A				Ogo, Naohisa; Ishikawa, Yoshinobu; Sawada, Jun-ichi; Matsuno, Kenji; Hashimoto, Akihiro; Asai, Akira			Structure-Guided Design of Novel L-Cysteine Derivatives as Potent KSP Inhibitors	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Kinesin spindle protein; L-cysteine derivative; molecular modeling differential scanning fluorimetry; HCT-116 xenograft model	KINESIN SPINDLE PROTEIN; TRITYL-L-CYSTEINE; VIVO ANTITUMOR-ACTIVITY; EG5 INHIBITORS; AGENTS; MICROTUBULES; CANCER; MODELS; TARGET	Kinesin spindle protein (KSP), known as Hs Eg5, a member of the kinesin-5 family, plays an important role in the formation and maintenance of the bipolar spindle. We previously reported S-trityl-L-cysteine derivatives as selective KSP inhibitors. Here, we report further optimizations using docking modeling in the L5 allosteric binding site, which led to the discovery of several high affinity derivatives with two fused phenyl rings in the trityl group giving low nanomolar range KSP ATPase inhibition. The representative derivatives potently inhibited cell growth of HCT116 cells in correlation with KSP inhibitory activities and significantly suppressed tumor growth in the xenograft model in vivo.	[Ogo, Naohisa; Sawada, Jun-ichi; Matsuno, Kenji; Asai, Akira] Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 4228526, Japan; [Ishikawa, Yoshinobu] Univ Shizuoka, Sch Pharmaceut Sci, Dept Phys Biochem, Shizuoka 4228526, Japan; [Hashimoto, Akihiro] Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Tsukuba, Ibaraki 3002611, Japan	Asai, A (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 4228526, Japan.	aasai@u-shizuoka-ken.ac.jp			Drug Discovery Program of the Pharma Valley Center; JSPS KAKENHI [26460150]	This work was supported by the Drug Discovery Program of the Pharma Valley Center and JSPS KAKENHI Grant Number 26460150.	Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Jain S, 2011, CLIN CANCER RES, V17, P6615, DOI 10.1158/1078-0432.CCR-11-1807; Abualhasan MN, 2012, EUR J MED CHEM, V54, P483, DOI 10.1016/j.ejmech.2012.05.034; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Burris HA, 2011, INVEST NEW DRUG, V29, P467, DOI 10.1007/s10637-009-9374-x; El-Nassan HB, 2013, EUR J MED CHEM, V62, P614, DOI 10.1016/j.ejmech.2013.01.031; Good JAD, 2013, J MED CHEM, V56, P1878, DOI 10.1021/jm3014597; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nr1317; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeBonis S, 2008, J MED CHEM, V51, P1115, DOI 10.1021/jm070606z; Dutcher JP, 2000, J CLIN PHARMACOL, V40, P1079; Jackson K W., 2007, NAT REV CANCER, V7, P107; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; Kaan HYK, 2011, J MED CHEM, V54, P1576, DOI 10.1021/jm100991m; Khoury H. J., 2012, CANCER, V14, P3556; Ocio EM, 2014, EXPERT REV HEMATOL, V7, P127, DOI 10.1586/17474086.2014.858595; Ognyanov V. I., 1999, WO, Patent No. [9941227A1, 9941227]; Ogo N, 2007, BIOORG MED CHEM LETT, V17, P3921, DOI 10.1016/j.bmcl.2007.04.101; Shimizu M, 2010, CANCER LETT, V298, P99, DOI 10.1016/j.canlet.2010.06.007; Shimizu M, 2010, BIOORG MED CHEM LETT, V20, P1578, DOI 10.1016/j.bmcl.2010.01.088; Slangy A., 1995, CELL, V83, P1159, DOI DOI 10.1016/0092-8674(95)90142-6; Wang F, 2012, J MED CHEM, V55, P1511, DOI 10.1021/jm201195m; Woessner R, 2009, ANTICANCER RES, V29, P4373; Yokoyama H, 2015, ACS CHEM BIOL, V10, P1128, DOI 10.1021/cb500939x	28	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	SEP	2015	6	9					1004	1009		10.1021/acsmedchemlett.5b00221		6	Chemistry, Medicinal	Pharmacology & Pharmacy	CR3UY	WOS:000361259800012		
J	Sugimoto, H; Chen, TH; Wang, R; Fujii, M; Reinhard, BM; Dal Negro, L				Sugimoto, Hiroshi; Chen, Tianhong; Wang, Ren; Fujii, Minoru; Reinhard, Bjoern M.; Dal Negro, Luca			Plasmon-Enhanced Emission Rate of Silicon Nanocrystals in Gold Nanorod Composites	ACS PHOTONICS			English	Article						silicon nanocrystals; plasmon; nanorod; colloid	SEMICONDUCTOR QUANTUM DOTS; BULK-BAND-GAP; FLUORESCENCE ENHANCEMENT; POLARIZED EMISSION; SI NANOCRYSTALS; LUMINESCENCE; MOLECULES; CELLS; PHOTOLUMINESCENCE; CONFINEMENT	We develop colloidal nanocomposites consisting of coupled light-emitting Si nanocrystals (NCs) and Au nanorods and systematically investigate their structural and photoluminescence (PL) properties, which demonstrate significant enhancement of spontaneous emission rate with suppressed nonradiative quenching. In addition, through a comparison of the polarization dependence of PL and scattering intensities of single nanocomposites, we successfully demonstrate that the emission from Si NCs coupled to Au nanorods is highly polarized along the major axis of nanorods. The experimental results in combination with rigorous simulations of dipolar emission in the vicinity of Au nanorods enable us to demonstrate a 3 times enhancement of the quantum efficiency at the peak of the NC emission. The Si-based active plasmonic-coupled nanocomposites developed in this work provide novel opportunities for biocompatible platforms that leverage nanoscale fluorescent probes for biosensing and bioimaging device applications.	[Sugimoto, Hiroshi; Wang, Ren; Dal Negro, Luca] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Sugimoto, Hiroshi; Wang, Ren; Dal Negro, Luca] Boston Univ, Photon Ctr, Boston, MA 02215 USA; [Sugimoto, Hiroshi; Fujii, Minoru] Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Chen, Tianhong; Reinhard, Bjoern M.] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Chen, Tianhong; Reinhard, Bjoern M.] Boston Univ, Photon Ctr, Boston, MA 02215 USA; [Dal Negro, Luca] Boston Univ, Div Mat Sci & Engn, Brookline, MA 02446 USA	Dal Negro, L (reprint author), Boston Univ, Dept Elect & Comp Engn, 8 St Mary St, Boston, MA 02215 USA.	dalnegro@bu.edu	杉本, 泰/G-3034-2013; Fujii, Minoru/G-3777-2011	Fujii, Minoru/0000-0003-4869-7399	KAKENHI [23310077, 24651143]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering [DOE DE-SC0010679]; U.S. Army Research Laboratory through the Collaborative Research Alliance (CRA) for Multi Scale Multidisciplinary Modeling of Electronic Materials (MSME)	This work was supported by KAKENHI through grants 23310077 and 24651143 (synthesis of silicon quantum dots), the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering, under Award DOE DE-SC0010679 to B.M.R. (nanorod-quantum dot hybrid material assembly), and partly (theoretical modeling) by the U.S. Army Research Laboratory through the Collaborative Research Alliance (CRA) for Multi Scale Multidisciplinary Modeling of Electronic Materials (MSME).	Abadeer NS, 2014, ACS NANO, V8, P8392, DOI 10.1021/nn502887j; Akselrod G. M., 2014, NAT PHOTONICS, V8, P1; Vinciguerra V, 2000, J APPL PHYS, V87, P8165, DOI 10.1063/1.373513; Jin SY, 2013, J PHYS CHEM LETT, V4, P3527, DOI 10.1021/jz401801v; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Nepal D, 2013, ACS NANO, V7, P9064, DOI 10.1021/nn403671q; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Cohen-Hoshen E, 2012, NANO LETT, V12, P4260, DOI 10.1021/nl301917d; Hohenester U, 2012, COMPUT PHYS COMMUN, V183, P370, DOI 10.1016/j.cpc.2011.09.009; Caswell KK, 2003, J AM CHEM SOC, V125, P13914, DOI 10.1021/ja037969i; Govorov AO, 2006, NANO LETT, V6, P984, DOI 10.1021/nl0602140; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; LINDSEY CP, 1980, J CHEM PHYS, V73, P3348, DOI 10.1063/1.440530; Ming T, 2011, NANO LETT, V11, P2296, DOI 10.1021/nl200535y; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI [10.1038/nphoton.2010.237, 10.1038/NPHOTON.2010.237]; Mangolini L, 2007, ADV MATER, V19, P2513, DOI 10.1002/adma.200700595; Takeoka S, 2000, PHYS REV B, V62, P16820, DOI 10.1103/PhysRevB.62.16820; Pi XD, 2014, PART PART SYST CHAR, V31, P751, DOI 10.1002/ppsc.201300346; Bharadwaj P, 2007, OPT EXPRESS, V15, P14266, DOI 10.1364/OE.15.014266; Hu JT, 2001, SCIENCE, V292, P2060, DOI 10.1126/science.1060810; Biteen JS, 2005, NANO LETT, V5, P1768, DOI 10.1021/nl051207z; Peng XG, 2000, NATURE, V404, P59; Munechika K, 2010, NANO LETT, V10, P2598, DOI 10.1021/nl101281a; Lu D, 2014, NAT NANOTECHNOL, V9, P48, DOI [10.1038/nnano.2013.276, 10.1038/NNANO.2013.276]; Takeda E, 2007, J APPL PHYS, V102, DOI 10.1063/1.2753571; Fu Y, 2010, J AM CHEM SOC, V132, P5540, DOI 10.1021/ja9096237; Giannini V, 2011, CHEM REV, V111, P3888, DOI 10.1021/cr1002672; Chang JY, 2005, CHEM COMMUN, P1092, DOI 10.1039/b414059a; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Schubert O, 2008, NANO LETT, V8, P2345, DOI 10.1021/nl801179a; Yao J, 2014, CHEM REV, V114, P6130, DOI 10.1021/cr200359p; Sugimoto H, 2013, J PHYS CHEM C, V117, P11850, DOI 10.1021/jp4027767; Erogbogbo F, 2008, ACS NANO, V2, P873, DOI 10.1021/nn700319z; Pompa PP, 2006, NAT NANOTECHNOL, V1, P126, DOI 10.1038/nnano.2006.93; Ayala-Orozco C, 2014, NANO LETT, V14, P2926, DOI 10.1021/nl501027j; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Sugimoto H, 2014, NANOSCALE, V6, P122, DOI 10.1039/c3nr03863g; Clark RJ, 2010, LANGMUIR, V26, P15657, DOI 10.1021/la102983c; Sugimoto H, 2012, J PHYS CHEM C, V116, P17969, DOI 10.1021/jp305832x; Mastronardi ML, 2012, NANO LETT, V12, P337, DOI 10.1021/nl2036194; Sugimoto H, 2013, J PHYS CHEM C, V117, P6807, DOI 10.1021/jp312788k; Jin YD, 2009, NAT NANOTECHNOL, V4, P571, DOI [10.1038/nnano.2009.193, 10.1038/NNANO.2009.193]; Mertens H, 2006, NANO LETT, V6, P2622, DOI 10.1021/nl061494m; Pi XD, 2012, J PHYS CHEM C, V116, P21240, DOI 10.1021/jp307078g; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Miller JB, 2012, ACS NANO, V6, P7389, DOI 10.1021/nn302524k; Busson MP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1964; Focsan M, 2014, J PHYS CHEM C, V118, P25190, DOI 10.1021/jp501281v; Fujii M, 2014, J APPL PHYS, V115, DOI 10.1063/1.4866497; Fujii M, 2003, J APPL PHYS, V94, P1990, DOI 10.1063/1.1590409; Goffard J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02672; Ion F., 2007, PHYS REV B, V76, P1; Purcell E M E M, 1946, PHYS REV, V69, P674, DOI DOI 10.1103/PHYSREV.69.674.2; Walters It J., 2006, PHYS REV B, V73, P2; Walters R. J., 2009, IEEE INT C GR 4 PHOT, V9, P74	56	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2330-4022			ACS PHOTONICS	ACS Photonics	SEP	2015	2	9					1298	1305		10.1021/acsphotonics.5b00233		8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied; Physics, Condensed Matter	Science & Technology - Other Topics; Materials Science; Optics; Physics	CR7CH	WOS:000361505000012		
J	Sotome, M; Kida, N; Horiuchi, S; Okamoto, H				Sotome, Masato; Kida, Noriaki; Horiuchi, Sachio; Okamoto, Hiroshi			Terahertz Radiation Imaging of Ferroelectric Domain Topography in Room-Temperature Hydrogen-Bonded Supramolecular Ferroelectrics	ACS PHOTONICS			English	Article						organic ferroelectrics; terahertz radiation imaging; ferroelectric domains; nonlinear optical properties	OPTICAL RECTIFICATION; SINGLE-CRYSTALS; WALLS; FILMS; MICROSCOPY; CONDUCTION; GROWTH; LINBO3; LITAO3	We report quasi-three-dimensional imaging of the ferroelectric domains in a hydrogen-bonded supramolecular ferroelectric 1:1 salt of 5,5'-dimethyl-2,2'-bipyridine and deuterated iodanilic acid by mapping out terahertz waves radiated from the crystal upon femtosecond laser irradiation. Polarization dependence of the effective depth radiating the terahertz waves due to the absorption anisotropy for terahertz waves allows us to distinguish domains in the inside and surface regions of the crystals. In an as-grown crystal, a large domain covering almost all the area is discerned in the inside region, while multidomains are discerned in the surface regions. We observed polarization switching via domain boundary motion in the direction perpendicular to the direction of hydrogen-bonded chains in the surface regions under an external electric field. Obtained images suggest that an uncharged 180 degrees domain wall (DW) parallel to the stacking plane of hydrogen-bonded chains covers the whole area at coercive fields. We argue that the DW dynamics stems from the anisotropic crystal structure, i.e., stacking of hydrogen-bonded chains.	[Sotome, Masato; Kida, Noriaki; Okamoto, Hiroshi] Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan; [Horiuchi, Sachio] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Horiuchi, Sachio] Japan Sci & Technol Agcy JST, CREST, Tokyo 1020075, Japan	Kida, N (reprint author), Univ Tokyo, Dept Adv Mat Sci, 5-1-5 Kashiwa No Ha, Chiba 2778561, Japan.	kida@k.u-tokyo.ac.jp			MEXT [25247049, 25600072, 15H03549, 25-3372]; Japan Society for the Promotion of Science (JSPS) through Program for Leading Graduate Schools (MERIT); JSPS Research Fellowships for Young Scientists	This work was partly supported by a Grant-in-Aid by MEXT (No. 25247049, 25600072, 15H03549, and No. 25-3372). M.S. was supported by Japan Society for the Promotion of Science (JSPS) through Program for Leading Graduate Schools (MERIT) and JSPS Research Fellowships for Young Scientists.	FOUSEK J, 1969, J APPL PHYS, V40, P135, DOI 10.1063/1.1657018; Gopalan V, 1998, APPL PHYS LETT, V72, P1981, DOI 10.1063/1.121491; Guyonnet J, 2011, ADV MATER, V23, P5377, DOI 10.1002/adma.201102254; Shin YH, 2007, NATURE, V449, P881, DOI 10.1038/nature06165; Horiuchi S, 2011, ADV MATER, V23, P2098, DOI 10.1002/adma.201100359; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Soergel E, 2005, APPL PHYS B-LASERS O, V81, P729, DOI 10.1007/s00340-005-1989-9; LEBIHAN R, 1989, FERROELECTRICS, V97, P19; Horiuchi S, 2007, ANGEW CHEM INT EDIT, V46, P3497, DOI 10.1002/anie.200700407; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Jia CL, 2008, NAT MATER, V7, P57, DOI 10.1038/nmat2080; Kitamura K, 1998, APPL PHYS LETT, V73, P3073, DOI 10.1063/1.122676; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Takahashi K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.117402; Nahata A, 1996, APPL PHYS LETT, V69, P2321, DOI 10.1063/1.117511; Van Aken BB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.157202; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; Prosandeev S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.172109; Gopalan V, 1999, J APPL PHYS, V85, P2304, DOI 10.1063/1.369542; Seidel J, 2009, NAT MATER, V8, P229, DOI [10.1038/nmat2373, 10.1038/NMAT2373]; Gureev MY, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.184104; Barkhausen H, 1919, PHYS Z, V20, P401; Schroder M, 2012, ADV FUNCT MATER, V22, P3936, DOI 10.1002/adfm.201201174; Schneider A, 2006, J OPT SOC AM B, V23, P1822, DOI 10.1364/JOSAB.23.001822; Kagawa F, 2014, NANO LETT, V14, P239, DOI 10.1021/nl403828u; Bozhevolnyi SI, 1998, APPL PHYS LETT, V73, P1814, DOI 10.1063/1.122291; CANUT M, 1964, ACTA CRYSTALLOGR, V17, P973, DOI 10.1107/S0365110X64002523; Catalan G., 2007, J PHYS CONDENS MATT, V19; DOUGHERTY TP, 1992, J OPT SOC AM B, V9, P2179, DOI 10.1364/JOSAB.9.002179; DVORAK V, 1965, JPN J APPL PHYS, V4, P400; Florsheimer M, 1998, APPL PHYS B-LASERS O, V67, P593, DOI 10.1007/s003400050552; Fujioka J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.125134; Fujioka J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.197601; Gregg JM, 2012, FERROELECTRICS, V433, P74, DOI 10.1080/00150193.2012.678131; Guan W., 2014, JPN J APPL PHYS, V53; Kalinin SV, 2010, SCANNING PROBE MICROSCOPY OF FUNCTIONAL MATERIALS: NANOSCALE IMAGING AND SPECTROSCOPY, P1; Kinoshita Y., 2014, JPN J APPL PHYS, V53; Lines M. E., 1977, PRINCIPLES APPL FERR; Lu YL, 1997, SCIENCE, V276, P2004, DOI 10.1126/science.276.5321.2004; Lulcyanchuk I., 2014, NANO LETT, V14, P6931; Prosandeev S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094102; Scott J. F., 2000, FERROELECTRIC MEMORI; Shur V. Y., 2011, APPL PHYS, V110; Shur V. Ya., 1993, Ferroelectrics, V140, DOI 10.1080/00150199308008301; Sotome M, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.033842; Sotome M., 2014, APPL PHYS LETT, V105; Tagantsev A. K., 2010, DOMAINS FERROIC CRYS; WANG YG, 1995, PHYS REV B, V51, P5311, DOI 10.1103/PhysRevB.51.5311	48	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2330-4022			ACS PHOTONICS	ACS Photonics	SEP	2015	2	9					1373	1383		10.1021/acsphotonics.5b00351		11	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied; Physics, Condensed Matter	Science & Technology - Other Topics; Materials Science; Optics; Physics	CR7CH	WOS:000361505000022		
J	Sabbah, M; Kadota, K; Fuku, Y; Mitsudo, K				Sabbah, Mahmoud; Kadota, Kazushige; Fuku, Yasushi; Mitsudo, Kazuaki			Correction of Stent Distortion and Overhanging Stent Struts during Left Main Bifurcation Stenting by Selective Distal Stent Cell Re-Wiring: A Novel Guidewire Approach	ACTA CARDIOLOGICA SINICA			English	Article						Distal stent strut; Left main bifurcation; Overhanging struts; Side branch re-crossing; Stent optimization	OPTICAL COHERENCE TOMOGRAPHY; CORONARY BIFURCATIONS; KISSING BALLOON; LESIONS	Stent malapposition and overhanging stent struts in front of the side branch (SB) ostium are not uncommon following bifurcation stenting that might lead to stent thrombosis. We herein present 2 cases, in which optical frequency domain imaging and intravascular ultrasound effectively revealed stent malapposition and overhanging struts inside the ostium of the SB following left main coronary artery stenting. Therefore, we introduced a novel technique for rectification of these incidental findings by selective SB re-wiring through the most distal stent cell with the adjunctive help of a double lumen microcatheter.	[Sabbah, Mahmoud] Suez Canal Univ, Fac Med, Dept Cardiol, Ismailia, Egypt; [Sabbah, Mahmoud; Kadota, Kazushige; Fuku, Yasushi; Mitsudo, Kazuaki] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama 7108602, Japan	Sabbah, M (reprint author), Kurashiki Cent Hosp, Dept Cardiol, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	dr1sabbah@yahoo.com					Nakazawa G, 2010, J AM COLL CARDIOL, V55, P1679, DOI 10.1016/j.jacc.2010.01.021; Ormiston JA, 2004, CATHETER CARDIO INTE, V63, P332, DOI 10.1002/ccd.20120; Burzotta F, 2010, EUROINTERVENTION, V6, pJ72, DOI 10.4244/EIJV6SUPJA12; Sgueglia GA, 2012, JACC-CARDIOVASC INTE, V5, P803, DOI 10.1016/j.jcin.2012.06.005; Alegria-Barrero E, 2012, EUROINTERVENTION, V8, P205, DOI 10.4244/EIJV8I2A34; Foin N, 2011, EUROINTERVENTION, V7, P597, DOI 10.4244/EIJV7I5A96; Freixa X, 2013, INT J CARDIOL, V168, P446, DOI 10.1016/j.ijcard.2012.09.130; Okamura T, 2011, EUROINTERVENTION, V7, P886, DOI 10.4244/EIJV7I7A138; Suzuki G, 2013, J INVASIVE CARDIOL, V25, P48; Tyczynski P, 2010, REV ESP CARDIOL, V63, P904, DOI 10.1016/S0300-8932(10)70202-5	10	0	0	TAIWAN SOC CARDIOLOGY	TAIPEI	13F-1, NO. 11, MIN-CHUAN WEST ROAD, TAIPEI, 104, TAIWAN	1011-6842			ACTA CARDIOL SIN	Acta Cardiol. Sin.	SEP	2015	31	5					453	456		10.6515/ACS20150120A		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CR7BZ	WOS:000361504200011		
J	Takagi, H; Umemoto, T				Takagi, Hisato; Umemoto, Takuya		ALICE Grp	Meta-Analysis of Non-O Blood Group as an Independent Risk Factor for Coronary Artery Disease	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							VON-WILLEBRAND-FACTOR; VENOUS THROMBOEMBOLIC DISEASE; MYOCARDIAL-INFARCTION; VASCULAR-DISEASE; HEART-DISEASE; GROUP-B; GROUP-A; ASSOCIATION; CLEARANCE; CONTRIBUTES	To determine whether non-O blood group is an independent risk factor for coronary artery disease (CAD), we performed a meta-analysis of contemporary studies reporting adjusted relative risk estimates using multivariable logistic regression and multivariable Cox proportional hazards regression. MEDLINE and EMBASE were searched from January 2001 to March 2015 using Web-based search engines (Pub Med and OVID). Search terms included blood group/type and coronary (artery/heart) disease, ischemic/ischaemic heart disease, acute coronary syndrome, myocardial infarction, or angina. Eligible were case-control, cross-sectional, or cohort studies reporting adjusted odds ratios (ORs) and hazard ratios (HRs) for CAD in subjects with non-O versus O blood group using multivariable logistic regression/multivariable Cox proportional hazards regression. Study-specific estimates were combined using inverse variance-weighted averages of logarithmic ORs/HRs in the random-effects model. Of 117 potentially relevant articles screened initially, 12 relative risk estimates in 10 eligible studies were identified and included. Pooled analysis of all the 12 ORs/HRs demonstrated that non-O blood group was associated with a statistically significant 14% increase in CAD incidence relative to O blood group (OR/HR 1.14, 95% confidence interval 1.04 to 1.25, p = 0.006). There was no evidence of significant publication bias. Combining 8 studies reporting data regarding (acute) myocardial infarction also generated a statistically significant result unfavoring non-O blood group (OR/HR 1.16, 95% confidence interval 1.02 to 1.31, p = 0.02). In conclusion, we found that based on a meta-analysis of 10 studies enrolling a total of 174,945 participants, non-O blood group appears to be an independent risk factor for CAD and myocardial infarction. (C) 2015 Elsevier Inc. All rights reserved.	[Takagi, Hisato; Umemoto, Takuya; ALICE Grp] Shizuoka Med Ctr, Dept Cardiovasc Surg, Shizuoka, Japan	Takagi, H (reprint author), Shizuoka Med Ctr, Dept Cardiovasc Surg, Shizuoka, Japan.						Davies JA, 2008, J THROMB HAEMOST, V6, P97; Casari C, 2013, J THROMB HAEMOST, V11, P202, DOI 10.1111/jth.12226; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Wu O, 2008, J THROMB HAEMOST, V6, P62; Dentali F, 2012, SEMIN THROMB HEMOST, V38, P535, DOI 10.1055/s-0032-1315758; Franchini M, 2014, THROMB HAEMOSTASIS, V112, P1103, DOI 10.1160/TH14-05-0457; Casari C, 2013, BLOOD, V122, P2893, DOI 10.1182/blood-2013-03-493312; MATSUI T, 1992, J BIOL CHEM, V267, P8723; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; GILL JC, 1987, BLOOD, V69, P1691; Rastegarlari G, 2012, BLOOD, V119, P2126, DOI 10.1182/blood-2011-08-373605; Tanis B, 2006, EUR J HAEMATOL, V77, P67, DOI 10.1111/j.1600-0609.2006.00656.x; Dentali F, 2014, SEMIN THROMB HEMOST, V40, P49, DOI 10.1055/s-0033-1363460; He MA, 2012, ARTERIOSCL THROM VAS, V32, P2314, DOI 10.1161/ATVBAHA.112.248757; Sode BF, 2013, CAN MED ASSOC J, V185, pE229, DOI 10.1503/cmaj.121636; Preston RJS, 2013, BLOOD, V121, P3801, DOI 10.1182/blood-2012-10-415000; Franchini M, 2013, J THROMB THROMBOLYS, V36, P286, DOI 10.1007/s11239-012-0836-1; Biswas S, 2013, BIOMED RES INT, DOI 10.1155/2013/782941; BRONTESTEWART B, 1962, BRIT MED J, P1646; Chen YQ, 2014, CIRC-CARDIOVASC GENE, V7, P43, DOI 10.1161/CIRCGENETICS.113.000299; Franchini M, 2008, SEMIN THROMB HEMOST, V34, P663, DOI 10.1055/s-0028-1104545; Gong P, 2014, INT J CARDIOL, V177, P641, DOI 10.1016/j.ijcard.2014.09.182; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; JICK H, 1969, LANCET, V1, P539; Lee HF, 2012, INTERNAL MED, V51, P1815, DOI 10.2169/internalmedicine.51.7173; MOURANT AE, 1971, LANCET, V1, P223; Nydegger UE, 2003, EUR J IMMUNOGENET, V30, P201, DOI 10.1046/j.1365-2370.2003.00390.x; WESTERHO.B, 1971, LANCET, V2, P664	28	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	SEP 1	2015	116	5					699	704		10.1016/j.amjcard.2015.05.043		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CR3YX	WOS:000361270100005		
J	Fowke, JH; McLerran, DF; Gupta, PC; He, J; Shu, XO; Ramadas, K; Tsugane, S; Inoue, M; Tamakoshi, A; Koh, WP; Nishino, Y; Tsuji, I; Ozasa, K; Yuan, JM; Tanaka, H; Ahn, YO; Chen, CJ; Sugawara, Y; Yoo, KY; Ahsan, H; Pan, WH; Pednekar, M; Gu, DF; Xiang, YB; Sauvaget, C; Sawada, N; Wang, RW; Kakizaki, M; Tomata, Y; Ohishi, W; Butler, LM; Oze, I; Kim, DH; You, SL; Park, SK; Parvez, F; Chuang, SY; Chen, Y; Lee, JE; Grant, E; Rolland, B; Thornquist, M; Feng, ZD; Zheng, W; Boffetta, P; Sinha, R; Kang, D; Potter, JD				Fowke, Jay H.; McLerran, Dale F.; Gupta, Prakash C.; He, Jiang; Shu, Xiao-Ou; Ramadas, Kunnambath; Tsugane, Shoichiro; Inoue, Manami; Tamakoshi, Akiko; Koh, Woon-Puay; Nishino, Yoshikazu; Tsuji, Ichiro; Ozasa, Kotaro; Yuan, Jian-Min; Tanaka, Hideo; Ahn, Yoon-Ok; Chen, Chien-Jen; Sugawara, Yumi; Yoo, Keun-Young; Ahsan, Habibul; Pan, Wen-Harn; Pednekar, Mangesh; Gu, Dongfeng; Xiang, Yong-Bing; Sauvaget, Catherine; Sawada, Norie; Wang, Renwei; Kakizaki, Masako; Tomata, Yasutake; Ohishi, Waka; Butler, Lesley M.; Oze, Isao; Kim, Dong-Hyun; You, San-Lin; Park, Sue K.; Parvez, Faruque; Chuang, Shao-Yuan; Chen, Yu; Lee, Jung Eun; Grant, Eric; Rolland, Betsy; Thornquist, Mark; Feng, Ziding; Zheng, Wei; Boffetta, Paolo; Sinha, Rashmi; Kang, Daehee; Potter, John D.			Associations of Body Mass Index, Smoking, and Alcohol Consumption With Prostate Cancer Mortality in the Asia Cohort Consortium	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						alcohol drinking; Asia; mortality; obesity; prostate cancer; prostate-specific antigen; smoking	RISK-FACTORS; RADICAL PROSTATECTOMY; PREVENTION TRIAL; AFRICAN-AMERICAN; SCREENING TRIAL; CAUCASIAN MEN; OBESITY; CHINA; ANTIGEN; METAANALYSIS	Many potentially modifiable risk factors for prostate cancer are also associated with prostate cancer screening, which may induce a bias in epidemiologic studies. We investigated the associations of body mass index (weight (kg)/height (m)(2)), smoking, and alcohol consumption with risk of fatal prostate cancer in Asian countries where prostate cancer screening is not widely utilized. Analysis included 18 prospective cohort studies conducted during 1963-2006 across 6 countries in southern and eastern Asia that are part of the Asia Cohort Consortium. Body mass index, smoking, and alcohol intake were determined by questionnaire at baseline, and cause of death was ascertained through death certificates. Analysis included 522,736 men aged 54 years, on average, at baseline. During 4.8 million person-years of follow-up, there were 634 prostate cancer deaths (367 prostate cancer deaths across the 11 cohorts with alcohol data). In Cox proportional hazards analyses of all cohorts in the Asia Cohort Consortium, prostate cancer mortality was not significantly associated with obesity (body mass index > 25: hazard ratio (HR) = 1.08, 95% confidence interval (CI): 0.85, 1.36), ever smoking (HR = 1.00, 95% CI: 0.84, 1.21), or heavy alcohol intake (HR = 1.00, 95% CI: 0.74, 1.35). Differences in prostate cancer screening and detection probably contribute to differences in the association of obesity, smoking, or alcohol intake with prostate cancer risk and mortality between Asian and Western populations and thus require further investigation.	[Fowke, Jay H.; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37203 USA; [McLerran, Dale F.; Rolland, Betsy; Thornquist, Mark; Potter, John D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gupta, Prakash C.; Pednekar, Mangesh] Healis Sekhsaria Inst Publ Hlth, Navi Mumbai, India; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Ramadas, Kunnambath] Reg Canc Ctr, Div Radiat Oncol, Trivandrum 695011, Kerala, India; [Tsugane, Shoichiro; Inoue, Manami; Sawada, Norie] Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, AXA Dept Hlth & Human Secur, Tokyo, Japan; [Tamakoshi, Akiko] Hokkaido Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 060, Japan; [Koh, Woon-Puay] Natl Univ Singapore, Duke NUS Grad Med Sch Singapore, Singapore 117548, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Nishino, Yoshikazu] Miyagi Canc Ctr Res Inst, Div Canc Epidemiol & Prevent, Sendai, Miyagi, Japan; [Tsuji, Ichiro; Sugawara, Yumi; Kakizaki, Masako; Tomata, Yasutake] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Ozasa, Kotaro; Ohishi, Waka; Grant, Eric] Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima, Japan; [Yuan, Jian-Min; Wang, Renwei] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Yuan, Jian-Min; Butler, Lesley M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Tanaka, Hideo; Oze, Isao] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Ahn, Yoon-Ok; Yoo, Keun-Young; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Chien-Jen; Pan, Wen-Harn] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Dept Human Genet, Chicago, IL 60637 USA; [Pan, Wen-Harn; Chuang, Shao-Yuan] Natl Hlth Res Inst, Div Prevent Med & Hlth Serv Res, Inst Populat Hlth Sci, Miaoli, Taiwan; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Gu, Dongfeng] Chinese Acad Med Sci, Dept Evidence Based Med, Fu Wai Hosp, Beijing 100730, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Dept Populat Genet & Prevent, Fu Wai Hosp, Beijing 100730, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Sauvaget, Catherine] Int Agcy Res Canc, Screening Grp, F-69372 Lyon, France; [Kim, Dong-Hyun] Hallym Univ, Coll Med, Dept Social & Prevent Med, Seoul, South Korea; [You, San-Lin] Fu Jen Catholic Univ, Dept Publ Hlth, Taipei, Taiwan; [Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Grad Sch, Canc Res Inst, Dept Biomed Sci, Seoul, South Korea; [Parvez, Faruque] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Chen, Yu] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Lee, Jung Eun] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Feng, Ziding] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Sinha, Rashmi] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Potter, John D.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA	Fowke, JH (reprint author), Vanderbilt Univ, Med Ctr, Dept Med, 2525 West End Ave,Suite 1200, Nashville, TN 37203 USA.	jay.fowke@vanderbilt.edu	Chen, Chien-Jen/C-6976-2008; 	Sauvaget, Catherine/0000-0002-8053-4963	National Cancer Institute (US National Institutes of Health) [RO3CA159398]	This research was funded by grant RO3CA159398 (Principal Investigator: J.H.F.) from the National Cancer Institute (US National Institutes of Health).	Andersson SO, 1997, JNCI-J NATL CANCER I, V89, P385, DOI 10.1093/jnci/89.5.385; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Freedland SJ, 2004, J CLIN ONCOL, V22, P446; Gong ZH, 2009, CANCER, V115, P3661, DOI 10.1002/cncr.24423; Hamashima C, 2009, JPN J CLIN ONCOL, V39, P339, DOI 10.1093/jjco/hyp025; Park SK, 2006, PROSTATE, V66, P1285, DOI 10.1002/pros.20419; Dennis LK, 2000, PROSTATE, V42, P56; Boffetta P, 2006, INT J CANCER, V119, P884, DOI 10.1002/ijc.21903; Dean M, 2013, ASIAN J ANDROL, V15, P309, DOI 10.1038/aja.2013.29; Colditz G, 1996, CANCER CAUSE CONTROL, V7, P560, DOI 10.1007/BF00051890; Grubb RL, 2009, CANCER EPIDEM BIOMAR, V18, P748, DOI 10.1158/1055-9965.EPI-08-0938; Parsons JK, 2009, J UROLOGY, V182, P1463, DOI 10.1016/j.juro.2009.06.038; MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P989, DOI 10.1007/s10552-006-0049-z; Zhang L, 2009, ASIAN J ANDROL, V11, P9, DOI 10.1038/aja.2008.21; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; MUIR CS, 1991, ACTA ONCOL, V30, P133; Zuccolo L, 2013, INT J CANCER, V132, P2176, DOI 10.1002/ijc.27877; SNOWDON DA, 1984, AM J EPIDEMIOL, V120, P244; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Zu K, 2009, CANCER CAUSE CONTROL, V20, P1799, DOI 10.1007/s10552-009-9387-y; Huncharek M, 2010, AM J PUBLIC HEALTH, V100, P693, DOI 10.2105/AJPH.2008.150508; Fillmore KM, 2009, MOL NUTR FOOD RES, V53, P240, DOI 10.1002/mnfr.200800122; Fontaine KR, 2005, PUBLIC HEALTH, V119, P694, DOI 10.1016/j.puhe.2004.09.002; Bassett WW, 2005, UROLOGY, V66, P1060, DOI 10.1016/j.urology.2005.05.040; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Kohli S, 2010, OBESITY, V18, P2177, DOI 10.1038/oby.2010.94; Rodriguez C, 2001, CANCER EPIDEM BIOMAR, V10, P345; Barden A, 2007, FREE RADICAL BIO MED, V42, P1730, DOI 10.1016/j.freeradbiomed.2007.03.004; Jemal A, 2006, CA-CANCER J CLIN, V56, P106; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Gong ZH, 2006, CANCER EPIDEM BIOMAR, V15, P1977, DOI 10.1158/1055-9965.EPI-06-0477; Ito K, 2014, NAT REV UROL, V11, P197, DOI 10.1038/nrurol.2014.42; Breslow RA, 1998, NUTR CANCER, V30, P1; Butler LM, 2009, CANCER CAUSE CONTROL, V20, P1967, DOI 10.1007/s10552-009-9391-2; Chao C, 2010, INT J CANCER, V126, P171, DOI 10.1002/ijc.24637; Chia SE, 2010, ANN ACAD MED SINGAP, V39, P466; Naito S, 2010, INT J UROL, V17, P830, DOI 10.1111/j.1442-2042.2010.02613.x; Fagan HB, 2011, J OBES, V2011, DOI DOI 10.1155/2011/218250; Fowke JH, 2006, PROSTATE, V66, P1371, DOI 10.1002/pros.20377; Fowke JH, 2014, EUR UROL, V66, P1133, DOI 10.1016/j.eururo.2014.01.037; Fowke JH, 2010, PROSTATE, V70, P120, DOI 10.1002/pros.21039; Fowke JH, 2006, CANCER, V107, P2361, DOI 10.1002/cncr.22249; Hsing AW, 2000, CANCER EPIDEM BIOMAR, V9, P1335; Hua LX, 2011, MED ONCOL, V28, P357, DOI 10.1007/s12032-009-9409-3; International Agency for Research on Cancer, 2012, GLOB 2012 EST INC MO; Kane CJ, 2005, J UROLOGY, V173, P732, DOI 10.1097/01.ju.0000152408.25738.23; Koh JSB, 2001, ANN ACAD MED SINGAP, V30, P513; Kuwahara M, 2003, UROLOGY, V61, P137, DOI 10.1016/S0090-4295(02)02093-9; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; Neuhouser ML, 2004, UROLOGY, V64, P201, DOI 10.1016/j.urology.2004.04.025; Platz EA, 2009, NAT CLIN PRACT UROL, V6, P70, DOI 10.1038/ncpuro1295; Pu Y S, 2004, Aging Male, V7, P120; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schutze M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1584; Sesso HD, 2001, INT J EPIDEMIOL, V30, P749, DOI 10.1093/ije/30.4.749; Strom SS, 2005, CLIN CANCER RES, V11, P6889, DOI 10.1158/1078-0432.CCR-05-1977; Sung JFC, 1999, CANCER, V86, P484, DOI 10.1002/(SICI)1097-0142(19990801)86:3<484::AID-CNCR17>3.0.CO;2-P; Watters JL, 2009, CANCER EPIDEM BIOMAR, V18, P2427, DOI 10.1158/1055-9965.EPI-09-0252; Werny DM, 2007, CANCER EPIDEM BIOMAR, V16, P70, DOI 10.1158/1055-9965.EPI-06-0588; World Health Organization Western Pacific Region, 2014, CANC SIT CHIN	62	3	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	SEP 1	2015	182	5					381	389		10.1093/aje/kwv089		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CR5NB	WOS:000361388700002		
J	Shibasaki, S; Hoshide, S; Eguchi, K; Ishikawa, J; Kario, K				Shibasaki, Seiichi; Hoshide, Satoshi; Eguchi, Kazuo; Ishikawa, Joji; Kario, Kazuomi		Japan Morning Surge-Home Blood Pre	Increase Trend in Home Blood Pressure on a Single Occasion Is Associated With B-Type Natriuretic Peptide and the Estimated Glomerular Filtration Rate	AMERICAN JOURNAL OF HYPERTENSION			English	Article						home blood pressure; hypertension; multiple measurements on a single occasion; target organ damage	ORGAN DAMAGE; JAPANESE SOCIETY; PROGNOSTIC VALUE; HYPERTENSION; GUIDELINES; VARIABILITY; INTERVAL	BACKGROUND Although obtaining multiple home blood pressure (HBP) measurements on a single occasion was recommended in European and Japanese hypertension guidelines, the clinical implications of the differences in BP measurements on a single occasion have been uncertain. METHODS Here, 4,149 patients with cardiovascular risk factors were enrolled. We asked the patients to measure their HBP 3 times on a single occasion each day over a 2-week period. We evaluated the target organ damage (TOD) indicators left ventricular mass index (LVMI), urinary albumin creatinine ratio, B-type natriuretic peptide (BNP), N-terminal pro-BNP (NT-pro BNP), high-sensitive cardiac troponin, brachial-ankle pulse wave velocity (ba PWV), intima-media thickness, and estimated glomerular filtration rate (eGFR). The associations between TOD and the difference between the first home systolic BP (SBP) value and the average of the second and third home SBP values were assessed by multiple regression analyses with adjustment for covariates. RESULTS Compared to the quintile median, the TOD of the first-quintile patients (i.e., those with elevated the second and third home SBP values compared to the first value) were significantly higher BNP, higher NT-pro BNP, higher ba PWV, and lower eGFR. In a univariate analysis of variance, compared to the median quintile, the first-quintile patients had independently and significantly higher BNP, higher NT-pro BNP, and lower eGFR. CONCLUSION The patients with elevated the second and third home SBP values compared to the first value taken on a single occasion were likely to have deteriorated BNP, NT-pro BNP, and eGFR.	[Shibasaki, Seiichi; Hoshide, Satoshi; Eguchi, Kazuo; Ishikawa, Joji; Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan	Kario, K (reprint author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.	kkario@jichi.ac.jp					Stergiou GS, 1998, J HYPERTENS, V16, P725, DOI 10.1097/00004872-199816060-00002; Hoshide S, 2014, AM J HYPERTENS, V27, P939, DOI 10.1093/ajh/hpt290; Ishikawa J, 2012, HYPERTENSION, V60, P921, DOI 10.1161/HYPERTENSIONAHA.112.198101; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Imai Y, 2013, HYPERTENS RES, V36, P661, DOI 10.1038/hr.2013.38; Wei FF, 2014, HYPERTENSION, V63, P790, DOI 10.1161/HYPERTENSIONAHA.113.02681; Munakata M, 2003, AM J HYPERTENS, V16, P653, DOI 10.1016/S0895-7061(03)00918-X; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Imai Y, 2012, HYPERTENS RES, V35, P777, DOI 10.1038/hr.2012.56; Parati G, 2010, J HUM HYPERTENS, V24, P779, DOI 10.1038/jhh.2010.54; Neumann J, 2007, HYPERTENSION, V49, P506, DOI 10.1161/01.HYP.0000256530.39695.a3; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Imai Y, 2003, HYPERTENS RES, V26, P771, DOI 10.1291/hypres.26.771; Boivin JM, 2014, AM J HYPERTENS, V27, P932, DOI 10.1093/ajh/hpu001; Eguchi K, 2009, J HYPERTENS, V27, P1172, DOI 10.1097/HJH.0b013e32832a6e39; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI 10.1161/HYPERTENSIONAHA.109.140798; Ishikawa J, 2010, J HYPERTENS, V28, P1340, DOI 10.1097/HJH.0b013e328338158b; Johansson JK, 2010, J HYPERTENS, V28, P259, DOI 10.1097/HJH.0b013e328332fa5e; Kawabe H, 2005, CLIN EXP HYPERTENS, V27, P215, DOI 10.1081/CEH-200048854; Koehler NR, 2004, AM J HYPERTENS, V17, P194, DOI 10.1016/j.amjhyper.2003.08.013; Muxfeldt ES, 2014, AM J HYPERTENS; Sakata K, 2009, INTERNAL MED, V48, P393, DOI 10.2169/internalmedicine.48.1599; Stergiou GS, 2014, AM J HYPERTENS, V27, P184, DOI 10.1093/ajh/hpt206; Stergiou GS, 2010, J HUM HYPERTENS, V24, P158, DOI 10.1038/jhh.2009.54; Verberk WJ, 2006, J HYPERTENS, V24, P1541, DOI 10.1097/01.hjh.0000239289.87141.b6; Yarows SA, 2001, BLOOD PRESS MONIT, V6, P145, DOI 10.1097/00126097-200106000-00005	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	SEP	2015	28	9					1098	1105		10.1093/ajh/hpu295		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR5NR	WOS:000361390300005		
J	Takahashi, M; Miyai, N; Nagano, S; Utsumi, M; Oka, M; Yamamoto, M; Shiba, M; Uematsu, Y; Nishimura, Y; Takeshita, T; Arita, M				Takahashi, Maasa; Miyai, Nobuyuki; Nagano, Shiori; Utsumi, Miyoko; Oka, Mayumi; Yamamoto, Mio; Shiba, Mitsuru; Uematsu, Yuji; Nishimura, Yoshiko; Takeshita, Tatsuya; Arita, Mikio			Orthostatic Blood Pressure Changes and Subclinical Markers of Atherosclerosis	AMERICAN JOURNAL OF HYPERTENSION			English	Article						arterial stiffness; arterial wave reflection; blood pressure; hypertension; orthostatic hypotension	PULSE-WAVE VELOCITY; HYPOTENSION PREDICTS MORTALITY; C-REACTIVE PROTEIN; ARTERIAL STIFFNESS; CARDIOVASCULAR RISK; OLDER-ADULTS; ASSOCIATION; COMMUNITIES; HYPERTENSION; SENSITIVITY	BACKGROUND Using a simple standing-up test in normotensive subjects, we evaluated orthostatic upright postural blood pressure (BP) changes and autonomic nervous function, as well as the relationship between orthostatic BP changes and subclinical markers of atherosclerosis. METHODS A total of 515 normotensive subjects aged 35-75 years (58.4 +/- 10.0 years) were enrolled. We measured body mass index (BMI), systolic BP (SBP) and diastolic BP (DBP), serum lipids, hemoglobin A1c (HbA1c), high-sensitivity C-reactive protein (hs-CRP), and urinary albumin-to-creatinine ratio. Brachial to ankle pulse wave velocity (baPWV) and carotid mean intima-media thickness (IMT) were measured. Participants underwent a simple standing-up test involving sitting then standing for 2 minutes each, followed again by sitting. To evaluate autonomic fluctuations, we calculated the coefficient of variation of the R-R interval, the ratio of low to high frequency heart rate variability (LF/HF), and the coefficient of component variance of high frequency. RESULTS SBP and DBP decreased when standing, with a reduction of SBP when changing position of -8.0 +/- 10.2 mm Hg. Orthostatic hypotension (OH) produced a significantly higher SBP than without OH. The baPWV was significantly higher in OH than in without OH. Stepwise regression analysis adjusted for age, sex, BMI, baseline SBP, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, fasting glucose, HbA1c, hs-CRP, IMT, late systolic peak of the pressure wave form (SBP2), and baPWV confirmed that baPWV, SBP2, and triglycerides were independently related to orthostatic BP changes. Multiple regression analyses showed that a decrease in SBP as well as baseline SBP, age, BMI, and fasting glucose were independent determinants of PWV. CONCLUSIONS We have shown that increased arterial stiffness was associated with OH during a standing-up test. Arterial stiffness may contribute to greater BP responses to postural changes from standing.	[Takahashi, Maasa; Miyai, Nobuyuki; Nagano, Shiori; Utsumi, Miyoko; Oka, Mayumi; Yamamoto, Mio; Shiba, Mitsuru; Uematsu, Yuji; Nishimura, Yoshiko; Arita, Mikio] Wakayama Med Univ, Sch Hlth & Nursing Sci, Wakayama, Wakayama, Japan; [Takeshita, Tatsuya] Wakayama Med Univ, Dept Publ Hlth, Wakayama, Wakayama, Japan	Arita, M (reprint author), Wakayama Med Univ, Sch Hlth & Nursing Sci, Wakayama, Wakayama, Japan.	t.hori@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [JSPS25350894]	We thank the staff of the Divisions of Health and Welfare of Minabe, Katsuragi, and Kamitonda towns for their cooperation in this study. We also thank Dr Edward D. Frohlich and Dr Gautam A. Deshpande for their important contributions. This study was supported by a Gran-in Aid for Scientific Research (JSPS25350894 to M.A.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Roberts WL, 2000, CLIN CHEM, V46, P461; RUTAN GH, 1992, HYPERTENSION, V19, P508; Shibao C, 2007, AM J MED, V120, P975, DOI 10.1016/j.amjmed.2007.05.009; Sung SH, 2014, AM J HYPERTENS, V27, P1446, DOI 10.1093/ajh/hpu063; SMITH JJ, 1994, J CLIN PHARMACOL, V34, P375; Mattace-Raso FUS, 2007, J HYPERTENS, V25, P1421, DOI 10.1097/HJH.0b013e32811d6a07; PIGNOLI P, 1986, CIRCULATION, V74, P1399; Fedorowski A, 2010, EUR HEART J, V31, P85, DOI 10.1093/eurheartj/ehp329; Masaki KH, 1998, CIRCULATION, V98, P2290; Zhang Y, 2012, HYPERTENS RES, V35, P399, DOI 10.1038/hr.2011.203; Ravits JM, 1997, MUSCLE NERVE, V20, P919, DOI 10.1002/(SICI)1097-4598(199708)20:8<919::AID-MUS1>3.0.CO;2-9; Takase H, 2013, HYPERTENS RES, V36, P50, DOI 10.1038/hr.2012.122; Rose KM, 2006, CIRCULATION, V114, P630, DOI 10.1161/CIRCULATIONHA.105.598722; Rose KM, 2000, AM J HYPERTENS, V13, P571, DOI 10.1016/S0895-7061(99)00257-5; Eigenbrodt ML, 2000, STROKE, V31, P2307; Kuwahata S, 2011, J CARDIOL, V57, P100, DOI 10.1016/j.jjcc.2010.08.005; Nardo CJ, 1999, HYPERTENSION, V33, P1123; Saji N, 2012, INTERNAL MED, V51, P1003, DOI 10.2169/internalmedicine.51.6852; Libby P, 2004, AM J MED, V116, P9, DOI 10.1016/j.amjmed.2004.02.006; Barochiner J, 2013, AM J HYPERTENS, V26, P872, DOI 10.1093/ajh/hpt036; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Boddaert J, 2004, J AM GERIATR SOC, V52, P568, DOI 10.1111/j.1532-5415.2004.52163.x; Diedrich A, 2004, CLIN AUTON RES, V14, P146, DOI 10.1007/s10286-004-0188-9; Gemignani T, 2012, AM J HYPERTENS, V25, P1083, DOI 10.1038/ajh.2012.101; Im JA, 2007, J PEDIATR-US, V150, P247, DOI 10.1016/j.jpeds2006.11.038; Kario K, 2003, J CARDIOVASC PHARM, V41, pS61; Kawabata A, 2011, PANASONIC TECHNICAL, V57, P10; Miyashita H, 2012, CURR HYPERTENS REV, V8, P80, DOI DOI 10.2174/157340212800840708; Pedrinelli R, 2001, VASC MED, V6, P257, DOI 10.1177/1358836X0100600410; PFEIFER MA, 1982, DIABETES, V31, P339, DOI 10.2337/diabetes.31.4.339; Tabara Y, 2005, HYPERTENS RES, V28, P537, DOI 10.1291/hypres.28.537; Schatz IJ, 1996, NEUROLOGY, V46, P1470	32	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	SEP	2015	28	9					1134	1140		10.1093/ajh/hpu301		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR5NR	WOS:000361390300010		
J	Hirayama, A; Konta, T; Kamei, K; Suzuki, K; Ichikawa, K; Fujimoto, S; Iseki, K; Moriyama, T; Yamagata, K; Tsuruya, K; Kimura, K; Narita, I; Kondo, M; Asahi, K; Kurahashi, I; Ohashi, Y; Watanabe, T				Hirayama, Atsushi; Konta, Tsuneo; Kamei, Keita; Suzuki, Kazuko; Ichikawa, Kazunobu; Fujimoto, Shouichi; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Kimura, Kenjiro; Narita, Ichiei; Kondo, Masahide; Asahi, Koichi; Kurahashi, Issei; Ohashi, Yasuo; Watanabe, Tsuyoshi			Blood Pressure, Proteinuria, and Renal Function Decline: Associations in a Large Community-Based Population	AMERICAN JOURNAL OF HYPERTENSION			English	Article						blood pressure; cohort study; hypertension; renal function	CHRONIC KIDNEY-DISEASE; JAPANESE GENERAL-POPULATION; GLOMERULAR-FILTRATION-RATE; SERUM URIC-ACID; FOLLOW-UP; PROGRESSION; TRIAL; RISK; METAANALYSIS; CREATININE	BACKGROUND Hypertension and proteinuria are risk factors for adverse renal outcomes in patients with chronic kidney disease. This study investigated the associations of blood pressure and proteinuria on renal function in a community-based population. METHODS We analyzed data from a nationwide database of 141,514 subjects who participated in the annual "Specific Health Check and Guidance in Japan" checkup in 2008 and 2010. The study subjects were aged between 29 and 74 years, and the cohort comprised 40% men. We examined relationships between blood pressure levels, proteinuria at baseline, and the 2-year change in the estimated glomerular filtration rate (eGFR), which was determined using the Japanese equation. RESULTS After adjusting for possible confounders, the change in the eGFR was inversely correlated with systolic blood pressure (SBP), but not diastolic blood pressure (DBP), at baseline, irrespective of the presence of proteinuria. Compared with the lowest SBP sixtile (<= 118 mm Hg), eGFRs declined significantly at SBPs >= 134 mm Hg in subjects with proteinuria, while eGFRs declined significantly at SBPs >= 141 mm Hg in those without proteinuria. At the same SBPs, renal function decline was faster and the risk for incident renal insufficiency was higher in subjects with proteinuria compared with those without proteinuria. CONCLUSIONS This study showed that a difference in SBP, but not DBP, is independently associated with a rapid eGFR decline in the general Japanese population, and that the association of SBP on the decline of renal function was greater in subjects with proteinuria compared with those without proteinuria.	[Hirayama, Atsushi; Konta, Tsuneo; Kamei, Keita; Suzuki, Kazuko; Ichikawa, Kazunobu] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Konta, Tsuneo; Fujimoto, Shouichi; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Kimura, Kenjiro; Narita, Ichiei; Kondo, Masahide; Asahi, Koichi; Kurahashi, Issei; Ohashi, Yasuo; Watanabe, Tsuyoshi] Minist Hlth Labour & Welf Japan, Steering Comm Res Design Comprehens Hlth Care Sys, Fukushima, Japan	Konta, T (reprint author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	kkonta@med.id.yamagata-u.ac.jp			Ministry of Health, Labour, and Welfare of Japan	This work was supported by the Health and Labor Sciences Research Grant for "The Study of the Appropriate States of Specific Health Checkups and Specific Health Guidance for the Prevention of CKD Progression, and the Design of a Comprehensive Health Care System for Chronic Kidney Disease (CKD) Based on Individual Risk Assessments by Specific Health Checkups" from the Ministry of Health, Labour, and Welfare of Japan.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kamei K, 2014, NEPHROL DIAL TRANSPL, V29, P2286, DOI 10.1093/ndt/gfu256; Lv JC, 2013, CAN MED ASSOC J, V185, P949, DOI 10.1503/cmaj.121468; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Iseki K, 2013, HYPERTENS RES, V36, P650, DOI 10.1038/hr.2013.11; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Sarnak MJ, 2005, ANN INTERN MED, V142, P342; Yano Y, 2012, KIDNEY INT, V81, P293, DOI 10.1038/ki.2011.346; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; O'Seaghdha CM, 2009, HYPERTENSION, V54, P509, DOI 10.1161/HYPERTENSIONAHA.108.128413; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; PETERSON JC, 1995, ANN INTERN MED, V123, P754; Kronborg J, 2008, NEPHROL DIAL TRANSPL, V23, P2818, DOI 10.1093/ndt/gfn148; Jafar TH, 2003, ANN INTERN MED, V139, P244; Camilla C, 2014, AM J HYPERTENS, V27, P579; Vaughan ED, 2014, AM J HYPERTENS, V27, P1000, DOI 10.1093/ajh/hpu111; Hayashi K, 2010, HYPERTENS RES, V33, P1211, DOI 10.1038/hr.2010.162; Iseki K, 2007, HYPERTENS RES, V30, P167, DOI 10.1291/hypres.30.167; Konta T, 2013, CLIN EXP NEPHROL, V17, P805, DOI 10.1007/s10157-013-0770-3; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; World Health Organization; International Association for the Study of Obesity; International Obesity Task Force, 2000, AS PAC PERSP RED OB, P15	22	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	SEP	2015	28	9					1150	1156		10.1093/ajh/hpv003		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR5NR	WOS:000361390300012		
J	Haruhara, K; Tsuboi, N; Kanzaki, G; Koike, K; Suyama, M; Shimizu, A; Miyazaki, Y; Kawamura, T; Ogura, M; Yokoo, T				Haruhara, Kotaro; Tsuboi, Nobuo; Kanzaki, Go; Koike, Kentaro; Suyama, Masahiro; Shimizu, Akihiro; Miyazaki, Yoichi; Kawamura, Tetsuya; Ogura, Makoto; Yokoo, Takashi			Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis	AMERICAN JOURNAL OF HYPERTENSION			English	Article						blood pressure; glomerular density; glomerular hypertension; hypertension; hypertensive nephrosclerosis; nephron number; proteinuria; renal biopsy	SOUTHEASTERN UNITED-STATES; LONG-TERM PROGNOSIS; LOW-BIRTH-WEIGHT; BENIGN NEPHROSCLEROSIS; AFRICAN-AMERICANS; CLINICOPATHOLOGICAL FEATURES; IGA NEPHROPATHY; KIDNEY-FUNCTION; BLOOD-PRESSURE; RENAL-DISEASE	BACKGROUND Previous autopsy studies suggested that a reduced nephron number is associated with increased risk of hypertension and chronic kidney disease. However, the significance of the nephron number estimated from a renal biopsy in patients with hypertensive nephrosclerosis (HNS) has not yet been elucidated. METHODS In this cross-sectional study, we examined the clinicopathological findings of biopsy-proven HNS patients with preserved renal function (estimated glomerular filtration rate >= 60 ml/min/1.73 m(2)). The glomerular density (GD; the number of glomeruli per total renal cortical area) in biopsy specimens was evaluated as a surrogate of the nephron number. Renal biopsies from kidney transplant donors were used as healthy controls. RESULTS A total of 58 HNS patients were enrolled. The GD value in the HNS patients was low compared with those in the kidney transplant donors (2.0 vs. 3.2/mm(2)). These differences remained significant when globally sclerotic glomeruli were included in the calculation of the GD. Of note, the GD in HNS patients with overt proteinuria (>= 1 g/day) was significantly lower than that of HNS patients with mild proteinuria (< 1 g/day; 1.8 vs. 2.2/mm(2), P = 0.014). In contrast, other histopathological parameters, including the severity of global glomerulosclerosis, interstitial fibrosis/tubular atrophy and arterial and arteriole lesions were comparable between the 2 HNS subgroups. In addition, the GD was identified as a factor that was associated with the amount of urinary protein excretion at biopsy, independent of other clinicopathological factors. CONCLUSIONS These results suggest that a low GD is a renal histological characteristic of HNS patients, especially those with overt proteinuria.	[Haruhara, Kotaro; Tsuboi, Nobuo; Kanzaki, Go; Koike, Kentaro; Suyama, Masahiro; Shimizu, Akihiro; Miyazaki, Yoichi; Kawamura, Tetsuya; Ogura, Makoto; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med,Div Nephrol & Hypertens, Minato Ku, Tokyo, Japan	Tsuboi, N (reprint author), Jikei Univ, Sch Med, Dept Internal Med,Div Nephrol & Hypertens, Minato Ku, Tokyo, Japan.	tsuboi-n@jikei.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Hoy WE, 2003, KIDNEY INT, V63, P31, DOI 10.1046/j.1523-1755.63.s83.8.x; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Tsuboi N, 2011, NEPHROL DIAL TRANSPL, V26, P3555, DOI 10.1093/ndt/gfr399; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Turin TC, 2013, J AM SOC NEPHROL, V24, P1661, DOI 10.1681/ASN.2012111118; Rule AD, 2011, MAYO CLIN PROC, V86, P282, DOI 10.4065/mcp.2010.0821; Kanzaki G, 2013, PATHOL INT, V63, P169, DOI 10.1111/pin.12044; Hughson MD, 2002, AM J KIDNEY DIS, V39, P679, DOI 10.1053/ajkd.2002.31980; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Ikezumi Y, 2013, AM J NEPHROL, V38, P149, DOI 10.1159/000353898; Dasgupta I, 2007, QJM-INT J MED, V100, P113, DOI 10.1093/qjmed/hcl139; Tsuboi N, 2012, CLIN J AM SOC NEPHRO, V7, P735, DOI 10.2215/CJN.07270711; BRENNER BM, 1988, AM J HYPERTENS, V1, P335; Zidar N, 1998, NEPHRON, V80, P97, DOI 10.1159/000045141; Koike K, 2011, AM J NEPHROL, V34, P542, DOI 10.1159/000334360; Hughson MD, 2014, NEPHROL DIAL TRANSPL, V29, P1399, DOI 10.1093/ndt/gft480; Wehrmann M, 1998, PATHOL RES PRACT, V194, P571; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Vikse BE, 2003, NEPHROL DIAL TRANSPL, V18, P517, DOI 10.1093/ndt/18.3.517; McNamara BJ, 2010, NEPHROL DIAL TRANSPL, V25, P1514, DOI 10.1093/ndt/gfq030; Tsuboi N, 2010, CLIN J AM SOC NEPHRO, V5, P39, DOI 10.2215/CJN.04680709; Churgh J, 1982, RENAL DIS CLASSIFICA, P211; Committee of General Countermeasures for Renal Failure Japanese Society for Dialysis Therapy Japan Society for Transplantation Japanese Society for Clinical Renal Transplantation Japanese Society for Pediatric Nephrology Japanese Society of Nephrology, 2013, NIHON JINZO GAKKAI S, V55, P6; Fulladosa X, 2003, J AM SOC NEPHROL, V14, P2662, DOI 10.1097/01.ASN.0000088025.33462.B0; Gilg J, 2013, NEPHRON CLIN PRACT, V123, P1, DOI 10.1159/000353320; Gonzalez SA, 2012, AM J HYPERTENS, V25, P620, DOI 10.1038/ajh.2012.10; Hughson MD, 2007, ARCH PATHOL LAB MED, V131, P1665; Jannette JC, 2007, HEPTINSTALLS PATHOLO, V6th, P943; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Puelles VG, 2012, NEPHROL DIAL TRANSPL, V27, P1880, DOI 10.1093/ndt/gfr539; Takebayashi S, 2001, CLIN NEPHROL, V55, P349; Weibel ER, 1979, STEREOLOGICAL METHOD, V1, p[44, 131]	35	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	SEP	2015	28	9					1164	1171		10.1093/ajh/hpu267		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR5NR	WOS:000361390300014		
J	Li, Q; Tsuneki, M; Krauthammer, M; Couture, R; Schwartz, M; Madri, JA				Li, Qi; Tsuneki, Masayuki; Krauthammer, Michael; Couture, Rachael; Schwartz, Michael; Madri, Joseph A.			Modulation of Sox10, HIF-1 alpha, Survivin, and YAP by Minocycline in the Treatment of Neurodevelopmental Handicaps following Hypoxic Insult	AMERICAN JOURNAL OF PATHOLOGY			English	Article							BIRTH-WEIGHT INFANTS; ROTATIONAL SIDE PREFERENCE; GROWTH-FACTOR RECEPTOR; BLOOD-BRAIN-BARRIER; FRAGILE-X-SYNDROME; NEUROVASCULAR NICHE; PREMATURELY BORN; INTRAVENTRICULAR HEMORRHAGE; STRAIN DIFFERENCES; ENDOTHELIAL-CELLS	Premature infants are at an increased risk of developing cognitive and motor handicaps due to chronic hypoxia. Although the current therapies have reduced the incidence of these handicaps, untoward side effects abound. Using a murine model of sublethal hypoxia, we demonstrated reduction in several transcription factors that modulate expression of genes known to be involved in several neural functions. We demonstrate the induction of these genes by minocycline, a tetracycline antibiotic with noncanonical functions, in both in vitro and in vivo studies. Specifically, there was induction of genes, including Sox10, Hif1a, Hif2a, Birc5, Yap1, Epo, Bdnf, Notch1 (cleaved), Pcna, Mag, Mobp, Plp1, synapsin, Adgra2, Pecam1, and reduction in activation of caspase 3, all known to affect proliferation, apoptosis, synaptic transmission, and nerve transmission. Minocycline treatment of mouse pups reared under sublethal hypoxic conditions resulted in improvement in open field testing parameters. These studies demonstrate beneficial effects of minocycline treatment following hypoxic insult, document up-regulation of several genes associated with improved cognitive function, and support the possibility of minocycline as a potential therapeutic target in the treatment of neurodevelopmental handicaps observed in the very premature newborn population. Additionally, these studies may aid in further interpretation of the effects of minocycline in the treatment trials and animal model studies of fragile X syndrome and multiple sclerosis.	[Li, Qi; Tsuneki, Masayuki; Krauthammer, Michael; Madri, Joseph A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Couture, Rachael; Schwartz, Michael] Yale Univ, Sch Med, Dept Neurosci, New Haven, CT 06520 USA; [Tsuneki, Masayuki] Natl Canc Ctr, Res Inst, Div Canc Biol, Chuo Ku, Tokyo 104, Japan	Madri, JA (reprint author), Yale Univ, Sch Med, Pathol, 310 Cedar St, New Haven, CT 06520 USA.	joseph.madri@yale.edu			US Public Health Service NIH grants [PO1-NS00344738, R01AD062007]; Reed Foundation Fellowship; Japan Society for the Promotion of Science (JSPS) [23-1154]; JSPS postdoctoral fellowship [513]; Uehara Memorial Foundation postdoctoral fellowship [201230024]; Yale University Clinical and Translational Science [BUL1TR000142]	Supported in part by US Public Health Service NIH grants PO1-NS00344738 (J.A.M. and M.S.), R01AD062007, a Reed Foundation Fellowship and an unrestricted gift from Joseph and Lucille Madri (J.A.M.), a grant-in-aid from Japan Society for the Promotion of Science (JSPS) research fellowship for young scientists (No. 23-1154), a JSPS postdoctoral fellowship for research abroad (No. 513) and the Uehara Memorial Foundation postdoctoral fellowship for study abroad (No. 201230024) (M.T.), and a Yale University Clinical and Translational Science award BUL1TR000142 (M.K.).	Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Rotschafer SE, 2012, BRAIN RES, V1439, P7, DOI 10.1016/j.brainres.2011.12.041; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Vose LR, 2013, J NEUROSCI, V33, P17232, DOI 10.1523/JNEUROSCI.2713-13.2013; Flynn KM, 2013, ANGIOGENESIS, V16, P689, DOI 10.1007/s10456-013-9346-9; Schafer RJ, 2009, BRAIN, V132, P661, DOI 10.1093/brain/awn353; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Pytel P, 2010, INT J SURG PATHOL, V18, P449, DOI 10.1177/1066896909351698; Tang JH, 2013, KIDNEY INT, V83, P804, DOI 10.1038/ki.2012.435; Schmitz T, 2012, J NEUROSCI RES, V90, P933, DOI 10.1002/jnr.22824; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Flynn KM, 2013, AM J PATHOL, V182, P1322, DOI 10.1016/j.ajpath.2013.01.003; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Ward NL, 2004, NEUROL RES, V26, P870, DOI 10.1179/016164104X3798; Garrido-Mesa N, 2013, PHARMACOL RES, V67, P18, DOI 10.1016/j.phrs.2012.10.006; Cooke RWI, 2006, ARCH DIS CHILD-FETAL, V91, pF293, DOI 10.1136/adc.2005.080192; ORELLANA SA, 1995, KIDNEY INT, V47, P490, DOI 10.1038/ki.1995.62; Li Q, 2009, AM J PATHOL, V175, P2133, DOI 10.2353/ajpath.2009.090354; Engelhardt B, 2014, CELL TISSUE RES, V355, P687, DOI 10.1007/s00441-014-1811-2; Schmitz T, 2014, EXP NEUROL, V254, P153, DOI 10.1016/j.expneurol.2014.01.017; Khanna S, 2006, FREE RADICAL BIO MED, V40, P2147, DOI 10.1016/j.freeradbiomed.2006.02.010; Sheldon RA, 1998, BRAIN RES, V810, P114, DOI 10.1016/S0006-8993(98)00892-0; Chow J, 2001, DEV BRAIN RES, V130, P123, DOI 10.1016/S0165-3806(01)00220-6; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Griffin MO, 2011, PHARMACOL RES, V63, P102, DOI 10.1016/j.phrs.2010.10.004; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Tsuneki M, 2014, J BIOL CHEM, V289, P5357, DOI 10.1074/jbc.M113.529313; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Zwemer CF, 2007, J APPL PHYSIOL, V102, P286, DOI 10.1152/japplphysiol.00536.2006; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Stenson BJ, 2013, NEONATOLOGY, V103, P341, DOI 10.1159/000349936; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Li Q, 2008, J NEUROSCI RES, V86, P1227, DOI 10.1002/jnr.21597; Wang L, 2012, MED ONCOL, V29, P3484, DOI 10.1007/s12032-012-0267-z; McCrea HL, 2008, CLIN PERINATOL, V35, P777, DOI 10.1016/j.clp.2008.07.014; Bassan H, 2006, PEDIATR NEUROL, V35, P85, DOI 10.1016/j.pediatrneurol.2006.03.005; Bilousova TV, 2013, J MED GENET, V46, P94; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Chen A, 2013, BIOMED REP, V1, P167; Committee for the Update of the Guide for the Care, 2011, GUID CAR US LAB AN; Curristin SM, 2002, P NATL ACAD SCI USA, V99, P15729, DOI 10.1073/pnas.232568799; Filgueiras CC, 2004, BEHAV BRAIN RES, V155, P13, DOI 10.1016/j.bbr.2004.03.028; Jantzie LL, 2014, CEREB CORTEX; Jin Zhuqing, 2015, J Neuroinflammation, V12, P264, DOI 10.1186/s12974-015-0264-1; Karsan A, 2005, CAN J PHYSIOL PHARM, V83, P14, DOI 10.1139/Y04-125; Lee ACC, 2013, PEDIATR RES, V74, P50, DOI 10.1038/pr.2013.206; Li Q, 2011, ANGIOGENESIS, V14, P173, DOI 10.1007/s10456-011-9201-9; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059706; Li Y, 2011, NEUROL RES, V33, P583, DOI 10.1179/1743132810Y.0000000013; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Manhaes AC, 2007, NEUROSCI LETT, V415, P159, DOI 10.1016/j.neulet.2007.01.012; Ment LR, 2007, NAT CLIN PRACT NEURO, V3, P558, DOI 10.1038/ncpneuro0616; Mormile R, 2012, J PEDIATR ENDOCR MET, V25, P1045, DOI 10.1515/jpem-2012-0232; Orsucci D, 2012, CURR NEUROPHARMACOL, V10, P134, DOI 10.2174/157015912800604498; Paribello C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-91; Paul David A, 2006, BMC Pediatr, V6, P2, DOI 10.1186/1471-2431-6-2; Pinter E, 1997, AM J PATHOL, V150, P1523; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Schalomon PM, 2002, BRAIN RES BULL, V57, P27, DOI 10.1016/S0361-9230(01)00633-5; Scheinost D, 2015, CEREB CORTEX, V25, P1858, DOI 10.1093/cercor/bht430; Stolt CC, 2011, INT J BIOCHEM CELL B, V42, P437; Tsuneki M, 2014, MOL CELL BIOL, V34, P4485, DOI 10.1128/MCB.00671-14; Tyson JE, 2005, JAMA-J AM MED ASSOC, V294, P371, DOI 10.1001/jama.294.3.371; Wegner M, 2011, GENE DEV, V25, P2423, DOI 10.1101/gad.181487.111; Yang Yirong, 2015, J Neuroinflammation, V12, P245, DOI 10.1186/s12974-015-0245-4; Zhao Y, 2015, NEUROPSYCH DIS TREAT, V11, P507, DOI 10.2147/NDT.S73836	70	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	SEP	2015	185	9					2364	2378		10.1016/j.ajpath.2015.05.016		15	Pathology	Pathology	CR5ZB	WOS:000361421800004		
J	Iwadate, R; Inoue, J; Tsuda, H; Takano, M; Furuya, K; Hirasawa, A; Aoki, D; Inazawa, J				Iwadate, Reiko; Inoue, Jun; Tsuda, Hitoshi; Takano, Masashi; Furuya, Kenichi; Hirasawa, Akira; Aoki, Daisuke; Inazawa, Johji			High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer	AMERICAN JOURNAL OF PATHOLOGY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; AUTOPHAGY; P62/SQSTM1; ADENOCARCINOMA; NRF2; ACTIVATION; SQSTM1/P62; MECHANISM	High expression of SQSTM1/p62 (p62) protein, which functions as a hub of oncogenic signaling pathways, has been detected in several human cancers. However, the clinicopathological and functional contribution of p62 expression is largely unknown in endometrial cancers (ECs). In this study, we assessed the expression status of p62 in primary ECs (n = 194) by immunohistochemistry and analyzed its clinical significance. Although p62 was expressed in the cytoplasm and/or nucleus in primary ECs, we observed that an expression subtype, high expression of cytoplasmic p62 but Low expression of nuclear p62 (cytoplasm(High)/nucleus(Low)), significantly correlated with nonendometrioid types (P = 0.002), high grade (P < 0.001), deep myometrial invasion (P = 0.025), vascular invasion (P = 0.012), and poor prognosis (P < 0.001), and may be an independent prognostic marker of ECs (P = 0.011). Furthermore, RNA interference mediated inhibition of p62 expression in the HEC-1A EC cell line Led to the reduction of invasiveness and resistance to oxidative stress in vitro, as well as the suppression of in vivo tumor growth in an orthotopic mouse model of ECs. High expression of cytoplasmic p62 is a novel prognostic biomarker of ECs, and excess p62 expression may functionally contribute to the acquirement of malignant phenotypes in EC cells.	[Iwadate, Reiko; Inoue, Jun; Inazawa, Johji] Tokyo Med & Dent Univ, Dept Mol Cytogenet, Hard Tissue Genome Res Ctr, Tokyo 1138510, Japan; [Inoue, Jun; Inazawa, Johji] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Med Res Inst, Tokyo 1138510, Japan; [Inoue, Jun; Inazawa, Johji] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Grad Sch Med & Dent Sci, Bioresource Res Ctr, Tokyo 1138510, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Dept Genome Med, Tokyo 1138510, Japan; [Iwadate, Reiko; Hirasawa, Akira; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Tsuda, Hitoshi] Natl Def Med Coll, Dept Pathol, Saitama, Japan; [Takano, Masashi; Furuya, Kenichi] Natl Def Med Coll, Dept Obstet & Gynecol, Saitama, Japan	Inazawa, J (reprint author), Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	johinaz.cgen@mri.tmd.ac.jp			Japan Society for the Promotion of Science [25250019, 24590372]; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Scientific Research on Priority Areas and Innovative Areas; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Foundation for Promotion of Cancer Research from the Ministry of Health, Labour and Welfare, Japan; Foundation for Promotion of Cancer Research, Tokyo, Japan;  [22134002]	Supported in part by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (A) 25250019 (J.Ina.) and (C) 24590372 (J.Ino.); Grants-in-Aid for Scientific Research on Innovative Areas Integrative Systems Understanding of Cancer for Advanced Diagnosis, Therapy and Prevention 22134002 (J.Ina.), Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Scientific Research on Priority Areas and Innovative Areas (J.Ina.), and the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology (J.Ina.), Japan; Foundation for Promotion of Cancer Research for the 3rd Term Comprehensive 10-Year-Strategy (1124-the 3rd Term-Young-002) (J.Ino.) from the Ministry of Health, Labour and Welfare, Japan; and the Foundation for Promotion of Cancer Research, Tokyo, Japan.	Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Sorosky JI, 2012, OBSTET GYNECOL, V120, P383, DOI 10.1097/AOG.0b013e3182605bf1; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Cai-McRae X, 2015, ONCOGENE, V34, P2968, DOI 10.1038/onc.2014.244; Choi J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3472; Colombo N, 2013, ANN ONCOL SUPPL 6, V24, pvi33, DOI DOI 10.1093/ANN0NC/MDT353; Ferlay J., 2012, IARC CANCERBASE; FUJITA N, 1994, CANCER RES, V54, P3922; Giatromanolaki A, 2014, UROL ONCOL, V32, pe11; Haruki S, 2010, CARCINOGENESIS, V31, P1027, DOI 10.1093/carcin/bgq053; Inui T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074398; ISHIWATA I, 1977, CANCER RES, V37, P1777; ISHIWATA I, 1984, GYNECOL ONCOL, V17, P281, DOI 10.1016/0090-8258(84)90212-9; Iwadate R, 2014, ACTA HISTOCHEM CYTOC, V47, P295, DOI 10.1267/ahc.14048; Kobayashi T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-215; Komatsu M., 2012, PHARM RES, V66, P547; Kuramoto H, 2003, CELL AND MOLECULAR BIOLOGY OF ENDOMETRIAL CARCINOMA, P3; Liu JL, 2014, BRIT J CANCER, V111, P944, DOI 10.1038/bjc.2014.355; Lu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032895; Luo RZ, 2013, ONCO TARGETS THER, V6, P883; Morisawa T, 1987, J JPN SOC CLIN CYTOL, V26, P433; Nishida M, 2003, CELL AND MOLECULAR BIOLOGY OF ENDOMETRIAL CARCINOMA, P35; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Takahashi K, 2011, CANCER SCI, V102, P2272, DOI 10.1111/j.1349-7006.2011.02099.x; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	SEP	2015	185	9					2523	2533		10.1016/j.ajpath.2015.05.008		11	Pathology	Pathology	CR5ZB	WOS:000361421800017		
J	Isayama, T; Mirea, L; Mori, R; Kusuda, S; Fujimura, M; Lee, SK; Shah, PS				Isayama, Tetsuya; Mirea, Lucia; Mori, Rintaro; Kusuda, Satoshi; Fujimura, Masanori; Lee, Shoo K.; Shah, Prakesh S.		Neonatal Res Network Japan; Canadian Neonatal Network	Patent Ductus Arteriosus Management and Outcomes in Japan and Canada: Comparison of Proactive and Selective Approaches	AMERICAN JOURNAL OF PERINATOLOGY			English	Article						patent ductus arteriosus; premature infants; echocardiography; mortality; morbidities	BIRTH-WEIGHT INFANTS; PRETERM INFANTS; INDOMETHACIN PROPHYLAXIS; PREMATURE-INFANTS; GESTATIONAL-AGE; ECHOCARDIOGRAPHY; TRIAL; MORTALITY; CLOSURE	Objective The aim of this study is to compare patent ductus arteriosus (PDA) management strategies and outcomes between the Neonatal Research Network of Japan (NRNJ with proactive functional echocardiography and the Canadian Neonatal Network (CNN) with selective conventional echocardiography practice. Study Design Retrospective analyses examined very low-birth-weight infants admitted to the NRNJ or CNN in 2006 to 2008. Multivariable logistic regression analyses compared a composite outcome indicating a mortality or major morbidity (severe intraventricular hemorrhage, periventricular leukomalacia, severe retinopathy of prematurity, bronchopulmonary dysplasia, or necrotizing enterocolitis) between networks, according to PDA diagnosis and treatment, and tested the association between PDA treatment and the composite outcome within networks. Results PDA treatment (NRNJ:CNN) with conservative management (8%:16%), indomethacin only (77%:59%), ligation only (1%:13%), or indomethacin and ligation (14%:13%) varied significantly between networks. The composite outcome was lower in NRNJ versus CNN only among infants with PDA (odds ratio: 0.70; 95% confidence interval: 0.62-0.80). Surgical ligation was associated with higher composite outcome only in CNN (odds ratio: 1.79; 95% confidence interval: 1.40-2.28). Conclusion Lower composite mortality/morbidity outcome in Japan versus Canada only among infants with PDA, and association of surgical ligation with higher mortality/morbidity only in Canada, suggest differential PDA management and ligation processes contribute to outcome variation.	[Isayama, Tetsuya; Mirea, Lucia; Lee, Shoo K.; Shah, Prakesh S.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Isayama, Tetsuya; Mirea, Lucia; Lee, Shoo K.; Shah, Prakesh S.] Mt Sinai Hosp, Maternal Infant Care MiCare Res Ctr, Toronto, ON M5G 1X6, Canada; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Kusuda, Satoshi] Tokyo Womens Med Univ, Maternal & Perinatal Ctr, Dept Neonatol, Tokyo, Japan; [Fujimura, Masanori] Osaka Med Ctr, Osaka, Japan; [Fujimura, Masanori] Res Inst Maternal & Child Hlth, Osaka, Japan	Mirea, L (reprint author), Mt Sinai Hosp, Maternal Infant Care MiCare Res Ctr, 700 Univ Ave,Suite 8-500, Toronto, ON M5G 1X6, Canada.	LMirea@mtsinai.on.ca			Health Labor Sciences Research Grant from Ministry of Health, Labor and Welfare, Japan; Ministry of Health and Long-Term Care, Ontario	We thank the Tokyo Women's Medical University, Tokyo, Japan and the Canadian Institutes of Health Research Team in Maternal-Infant Care for organizational support to the Neonatal Research Network of Japan (NRNJ), and the Canadian Neonatal Network (CNN), respectively. The NRNJ is supported by a Health Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare, Japan. The Maternal-Infant Care Research Centre is supported by the Ministry of Health and Long-Term Care, Ontario. We thank all site investigators of the NRNJ and the CNN, Mr. Junmin Yang, MSc for statistical support, Dr. Amish Jain, MD, for critical review of the article, and Dr. Ruth Warre, PhD for editorial support.	Schmidt B, 2006, J PEDIATR-US, V148, P730, DOI 10.1016/j.jpeds.2006.01.047; Benitz WE, 2010, J PERINATOL, V30, P241, DOI 10.1038/jp.2010.3; Isayama T, 2012, PEDIATRICS, V130, pE957, DOI 10.1542/peds.2012-0336; Clyman RI, 1996, J PEDIATR-US, V128, P601, DOI 10.1016/S0022-3476(96)80123-5; Loepke AW, 2010, PEDIATR CRIT CARE ME, V11, P217, DOI 10.1097/PCC.0b013e3181b80383; Noori S, 2009, PEDIATRICS, V123, pE138, DOI 10.1542/peds.2008-2418; Su BH, 1999, ARCH DIS CHILD, V81, pF197; SKELTON R, 1994, J PAEDIATR CHILD H, V30, P406, DOI 10.1111/j.1440-1754.1994.tb00689.x; Kabra NS, 2007, J PEDIATR-US, V150, P229, DOI 10.1016/j.jpeds.2006.11.039; Evans N, 1996, ARCH DIS CHILD, V75, pF183, DOI 10.1136/fn.75.3.F183; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Hoellering AB, 2009, J PAEDIATR CHILD H, V45, P204, DOI 10.1111/j.1440-1754.2008.01461.x; KLUCKOW M, 1995, J PEDIATR-US, V127, P774, DOI 10.1016/S0022-3476(95)70172-9; Bancalari E, 2005, BIOL NEONATE, V88, P192, DOI 10.1159/000087582; Evans N, 2011, SEMIN FETAL NEONAT M, V16, P61, DOI 10.1016/j.siny.2010.06.005; Jain A, 2012, J PEDIATR-US, V160, P584, DOI 10.1016/j.jpeds.2011.09.027; Mirea L, 2012, J PEDIATR-US, V161, P689, DOI 10.1016/j.jpeds.2012.05.007; EDWARDS AD, 1990, LANCET, V335, P1491, DOI 10.1016/0140-6736(90)93030-S; CUNNINGHAM S, 1995, LANCET, V346, P1464, DOI 10.1016/S0140-6736(95)92475-2; Kluckow M, 2007, J PEDIATR-US, V150, P125, DOI 10.1016/j.jpeds.2006.10.056; Finan E, 2011, PED AC SOC ANN M DEN; FIRTH J, 1980, LANCET, V2, P144; Kluckow M, 2014, ARCH DIS CHILD-FETAL, V99, pF99, DOI 10.1136/archdischild-2013-304695; Knight D B, 2001, Semin Neonatol, V6, P63, DOI 10.1053/siny.2000.0036; McCurnin D, 2008, PEDIATRICS, V122, pE1262, DOI 10.1542/peds.2008-2045; O'Rourke DJ, 2008, ACTA PAEDIATR, V97, P574, DOI 10.1111/j.1651-2227.2008.00745.x; Statistics Canada, CANSIM LIV BIRTHS BI; Toyoshima K., 2011, 9 ANN M JAP PER CIRC; Uehara R, 2011, J EPIDEMIOL, V21, P217, DOI 10.2188/jea.JE20100123	29	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0735-1631	1098-8785		AM J PERINAT	Am. J. Perinatol.	SEP	2015	32	11					1087	1094		10.1055/s-0035-1548727		8	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CR5UQ	WOS:000361410300013		
J	Shah, MM; Odoyo, E; Larson, PS; Apondi, E; Kathiiko, C; Miringu, G; Nakashima, M; Ichinose, Y				Shah, Mohammad Monir; Odoyo, Erick; Larson, Peter S.; Apondi, Ernest; Kathiiko, Cyrus; Miringu, Gabriel; Nakashima, Masahiro; Ichinose, Yoshio			First Report of a Foodborne Providencia alcalifaciens Outbreak in Kenya	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TRAVELERS DIARRHEA; POTATO PRODUCTS; INVASION; HEP-2	Providencia alcalifaciens is an emerging bacterial pathogen known to cause acute gastroenteritis in children and travelers. In July 2013, P. alcalifaciens was isolated from four children appearing for diarrhea at Kiambu District Hospital (KDH) in Kenya. This study describes the outbreak investigation, which aimed to identify the source and mechanisms of infection. We identified seven primary and four secondary cases. Among primary cases were four mothers who had children and experienced mild diarrhea after eating mashed potatoes. The mothers reported feeding children after visiting the toilet and washing their hands without soap. P. alcalifaciens was detected from all secondary cases, and the isolates were found to be clonal by random amplified polymorphic DNA (RAPD) fingerprinting. Our study suggests that the outbreak was caused by P. alcalifaciens, although no fluid accumulation was observed in rabbit ileal loops. The vehicle of the outbreak was believed to be the mashed potato dish, but the source of P. alcalifaciens could not be confirmed. We found that lack of hygiene, inadequate food storage, and improper hand washing before food preparation was the likely cause of the current outbreak. This is the first report of a foodborne infection caused by P. alcalifaciens in Kenya.	[Shah, Mohammad Monir; Larson, Peter S.; Apondi, Ernest; Ichinose, Yoshio] Nagasaki Univ, Inst Trop Med, Ctr Infect Dis Res Asia & Africa, Nagasaki 8528523, Japan; [Odoyo, Erick; Kathiiko, Cyrus; Miringu, Gabriel] Nagasaki Univ, Inst Trop Med, Kenya Med Res Inst Project, Nairobi, Kenya; [Nakashima, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Tumor & Diagnost Pathol, Nagasaki 852, Japan; [Shah, Mohammad Monir; Larson, Peter S.; Ichinose, Yoshio] Inst Trop Med, Kenya Med Res, Nairobi, Kenya	Shah, MM (reprint author), Nagasaki Univ, Inst Trop Med, Ctr Infect Dis Res Asia & Africa, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	shah@nagasaki-u.ac.jp; e.odoyo@gmail.com; pslarson2@gmail.com; wandesh2000@yahoo.com; ckathiiko@gmail.com; gbm900@yahoo.com; moemoe@nagasaki-u.acjp; ichinose@nagasaki-u.ac.jp			Program for Nurturing Global Leaders in TECD, Nagasaki University, Japan;  [15H05286]	This study was supported in part by Grant-in-Aid for Scientific Research, Japan (Research B: 15H05286) and the Program for Nurturing Global Leaders in TECD, Nagasaki University, Japan.	Albert MJ, 1998, J CLIN MICROBIOL, V36, P1433; ALBERT MJ, 1995, J MED MICROBIOL, V42, P186; ALBERT MJ, 1992, INFECT IMMUN, V60, P5017; Libisch B, 2008, RES MICROBIOL, V159, P162, DOI 10.1016/j.resmic.2007.12.008; Bean N H, 1990, MMWR CDC Surveill Summ, V39, P15; Chlibek R, 2002, J TRAVEL MED, V9, P151; Clinical Laboratory Standards Institute, 2007, M100S17 CLSI; Contzen M, 2014, INT J FOOD MICROBIOL, V174, P19, DOI 10.1016/j.ijfoodmicro.2013.12.024; Doan CH, 2000, J FOOD PROTECT, V63, P668; Ewing WH, 1986, EDWARDS EWINGS IDENT, V4th, P443; FARUQUE ASG, 1994, J DIARRHOEAL DIS RES, V12, P214; Guth BEC, 1996, J MED MICROBIOL, V45, P459; HAYNES J, 1989, BRIT MED J, V299, P94; Janda JM, 1998, CURR MICROBIOL, V37, P159, DOI 10.1007/s002849900357; Lee VJ, 2009, ANN ACAD MED SINGAP, V38, P207; MATHAN MM, 1993, J PATHOL, V171, P67, DOI 10.1002/path.1711710114; Murata T, 2001, J INFECT DIS, V184, P1050, DOI 10.1086/323458; Pham Hong Nhung, 2007, Diagn Microbiol Infect Dis, V58, P153; Yoh M, 2005, J MED MICROBIOL, V54, P1077, DOI 10.1099/jmm.0.45846-0	19	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	SEP	2015	93	3					497	500		10.4269/ajtmh.15-0126		4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CR3TB	WOS:000361254900013		
J	Yoshimura, S; Miyazu, M; Yoshizawa, S; So, M; Kusama, N; Hirate, H; Sobue, K				Yoshimura, S.; Miyazu, M.; Yoshizawa, S.; So, M.; Kusama, N.; Hirate, H.; Sobue, K.			Efficacy of an enteral feeding protocol for providing nutritional support after paediatric cardiac surgery	ANAESTHESIA AND INTENSIVE CARE			English	Article						paediatric intensive care units; enteral nutrition; protocol; cardiac surgery	CRITICALLY-ILL CHILDREN; CONGENITAL HEART-DISEASE; INTENSIVE-CARE-UNIT; NECROTIZING ENTEROCOLITIS; ENERGY-EXPENDITURE; INFANTS; THERAPY; VOLUME; RISK	Enteral nutrition (EN) is considered to be a more appropriate method than parenteral feeding for providing nutrition to critically ill children. However, children who undergo cardiac surgery are at high risk of postoperative gastrointestinal complications during EN. The purpose of this study was to demonstrate the safety and efficacy of our EN feeding protocol after paediatric cardiac surgery through comparison between a single-centre prospective case series and historical cases. Forty-seven children who were admitted to the ICU after cardiac surgery were enrolled ('post group'). Data for these children were compared with a similar cohort of children who were admitted before the implementation of the feeding protocol (n=62; 'pre group'). The incidence of complications including vomiting, necrotising enterocolitis and hypoglycaemia; the time until the initiation of EN; and the changes in calories provided were compared between the groups. The frequency of vomiting was significantly lower in the post group than in the pre group (36.2% versus 58.0%, P=0.038), and necrotising enterocolitis did not occur in either group. The time until the initiation of EN and the total calories provided did not differ significantly; however, in the post group the proportion of energy provided by parenteral nutrition was significantly smaller (P<0.001), and provided by EN was significantly larger (P=0.003), than in the pre group. The frequency of hypoglycaemia was similar in both groups. This study showed that our EN protocol resulted in adjustments to calories provided via EN versus parenteral nutrition after paediatric cardiac surgery, and reduced the frequency of vomiting.	[Yoshimura, S.; Miyazu, M.; Yoshizawa, S.; So, M.; Kusama, N.; Hirate, H.; Sobue, K.] Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Nagoya, Aichi, Japan	Yoshimura, S (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Nagoya, Aichi, Japan.	syoshimura0829@gmail.com					Owens JL, 2009, NUTR CLIN PRACT, V24, P242, DOI 10.1177/0884533609332086; Nydegger A, 2009, EUR J CLIN NUTR, V63, P392, DOI 10.1038/sj.ejcn.1602956; Iannucci GJ, 2013, CARDIOL YOUNG, V23, P553, DOI 10.1017/S1047951112001370; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; Skillman HE, 2008, JPEN-PARENTER ENTER, V32, P520, DOI 10.1177/0148607108322398; Braudis NJ, 2009, PEDIATR CRIT CARE ME, V10, P460, DOI 10.1097/PCC.0b013e318198b167; del Castillo SL, 2010, PEDIATR CRIT CARE ME, V11, P373, DOI 10.1097/PCC.0b013e3181c01475; Meyer R, 2009, J HUM NUTR DIET, V22, P428, DOI 10.1111/j.1365-277X.2009.00994.x; Tume L, 2010, NURS CRIT CARE, V15, P291, DOI 10.1111/j.1478-5153.2010.00420.x; Mikhailov TA, 2014, JPEN-PARENTER ENTER, V38, P459, DOI 10.1177/0148607113517903; Fallon EM, 2012, JPEN-PARENTER ENTER, V36, P506, DOI 10.1177/0148607112449651; Kuppinger DD, 2013, NUTRITION, V29, P1075, DOI 10.1016/j.nut.2013.01.025; Leite HP, 2005, NUTRITION, V21, P553, DOI 10.1016/j.nut.2004.08.026; Li J, 2008, PEDIATR CRIT CARE ME, V9, P55, DOI 10.1097/01.PCC.0000298756.82286.23; Luce WA, 2011, PEDIATR CRIT CARE ME, V12, P46, DOI 10.1097/PCC.0b013e3181e3250c; Mehta NM, 2009, JPEN-PARENTER ENTER, V33, P260, DOI 10.1177/0148607109333114; Petrillo-Albarano T, 2006, PEDIATR CRIT CARE ME, V7, P340, DOI 10.1097/01.PCC.0000225371.10446.8F; Rogers EJ, 2003, NUTRITION, V19, P865, DOI 10.1016/S0899-9007(03)00170-9; Skillman HE, 2012, CURR OPIN CRIT CARE, V18, P192, DOI 10.1097/MCC.0b013e3283514ba7; Zamberlan P, 2011, JPEN-PARENTER ENTER, V35, P523, DOI 10.1177/0148607110386610	20	0	0	AUSTRALIAN SOC ANAESTHETISTS	EDGECLIFF	P O BOX 600, EDGECLIFF, NSW 2027, AUSTRALIA	0310-057X	1448-0271		ANAESTH INTENS CARE	Anaesth. Intensive Care	SEP	2015	43	5					587	593				7	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	CR3YW	WOS:000361270000006		
J	Shibata, S; Morita, T; Yokohama-Tamaki, T; Murakami, G; Cho, BH				Shibata, Shunichi; Morita, Tsuyoshi; Yokohama-Tamaki, Tamaki; Murakami, Gen; Cho, Baik Hwan			An Immunohistochemical Study of Matrix Components in Early-Stage Vascular Canals Within Mandibular Condylar Cartilage in Midterm Human Fetuses	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						vascular canals; condylar cartilage; human fetus; extracellular matrix; immunohistochemistry	HUMAN TEMPOROMANDIBULAR-JOINT; THYROID CARTILAGE; BONE-FORMATION; HISTOCHEMISTRY; OSSIFICATION; LOCALIZATION; PATTERN	Matrix components of vascular canals (VCs) in human fetal mandibular condylar cartilage (15-16 weeks of gestation) were analyzed by immunohistochemistry. Prevascular canals (PVCs), consisting of spindle-shaped cells without capillary invasion, were observed within the cartilage. Intense immunoreactivity for collagen type I, weak immunoreactivity for aggrecan and tenascin-C, weak hyaluronan (HA) staining, and abundant argyrophilic fibers in PVCs indicated that they contain noncartilaginous fibrous connective tissues that was different from those in the perichondrium/periosteum. These structural and immunohistochemical features of PVCs are different from those of previously reported cartilage canals of the long bone. Capillaries entered the VCs from the periosteum and ascended through VCs. Following capillary invasion, loose connective tissue had formed in the lower part of VCs, and immunoreactivity for collagen types I and III, tenascin-C, and HA staining was evident in the matrix of loose connective tissue. No chondroclasts or osteogenic cells were seen at the front of capillary invasion, although small, mononuclear tartrate-resistant acid phosphatase (TRAP)-positive cells were present. Meanwhile, TRAP-positive, multinucleated chondroclasts and flattened, osteoblast-like cells were observed in the loose connective tissue at the lower part of VCs. These results may indicate slow progress of endochondral ossification in human fetal mandibular condyle. Further, unique matrix components in PVCs/VCs, which were different from those in cartilage canals in long bone, may reflect the difference of speed of endochondral ossification in cartilage canals and human fetal mandibular condyles. (C) 2015 Wiley Periodicals, Inc.	[Shibata, Shunichi; Morita, Tsuyoshi; Yokohama-Tamaki, Tamaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Maxillofacial Anat, Tokyo 1138549, Japan; [Murakami, Gen] Iwamizawa Asuka Hosp, Div Internal Med, Iwamizawa, Japan; [Cho, Baik Hwan] Chonbuk Natl Univ Hosp, Dept Surg, Jeonju, South Korea; [Cho, Baik Hwan] Chonbuk Natl Univ Hosp, Res Inst Clin Med, Jeonju, South Korea	Shibata, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Maxillofacial Anat, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	sshibata.mfa@tmd.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22592044]	Grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant number: 22592044.	Shibata S, 2003, ANAT EMBRYOL, V207, P35, DOI 10.1007/s00429-003-0325-6; Shibata S, 1997, J ANAT, V191, P561, DOI 10.1046/j.1469-7580.1997.19140561.x; Blumer MJF, 2008, ANN ANAT, V190, P305, DOI 10.1016/j.aanat.2008.02.004; Shibata S, 2008, J ANAT, V213, P274, DOI 10.1111/j.1469-7580.2008.00934.x; THILANDER B, 1976, ACTA ODONTOL SCAND, V34, P117, DOI 10.3109/00016357609026564; BLACKWOO.HJ, 1965, J ANAT, V99, P551; Blumer MJF, 2005, J ANAT, V206, P359, DOI 10.1111/j.1469-7580.2005.00404.x; CHANDRARAJ S, 1988, J ANAT, V158, P121; Claassen H, 2014, CLIN ANAT, V27, P423, DOI 10.1002/ca.22309; Claassen H, 1996, ANAT EMBRYOL, V194, P147; Craatz S, 1999, ANN ANAT, V181, P359, DOI 10.1016/S0940-9602(99)80128-9; Drury RAB, 1980, CARLETONS HISTOLOGIC, P182; Fritsch H, 2001, J ANAT, V199, P609, DOI 10.1046/j.1469-7580.2001.19950609.x; Gilbert J A, 2001, J Orthop Sci, V6, P519, DOI 10.1007/s007760100007; Hall Brian K., 2005, P149, DOI 10.1016/B978-012319060-4/50014-2; LEGUELLEC D, 1994, HISTOCHEM J, V26, P695; Lieresford WA., 1981, CHONDROID BONE SECON, P23; Linss W, 2007, ANN ANAT, V189, P418, DOI 10.1016/j.aanat.2007.02.017; Merida-Velasco JR, 1999, ANAT REC, V255, P20, DOI 10.1002/(SICI)1097-0185(19990501)255:1<20::AID-AR4>3.0.CO;2-N; Mérida Velasco J R, 2009, J Anat, V214, P56, DOI 10.1111/j.1469-7580.2008.01009.x; MORIMOTO K, 1987, J PROSTHET DENT, V57, P723, DOI 10.1016/0022-3913(87)90372-6; Nanci A, 2008, 10 CATES ORAL HISTOL, V7th, P358; Proffit WR., 2013, CONT ORTHODONTICS, V5th, P20; Rusu MC, 2011, ANN ANAT, V193, P436, DOI 10.1016/j.aanat.2011.03.006; Shibata S, 2013, EUR J HISTOCHEM, V57, P262, DOI 10.4081/ejh.2013.e39; Shibata S, 1997, J ANAT, V191, P65, DOI 10.1046/j.1469-7580.1997.19110065.x; Shibata S, 2013, J ORAL BIOSCI, V55, P208; Shibata S, 2012, Eur J Histochem, V56, pe23, DOI 10.4081/ejh.2012.23; Shibata S, 2001, J ANAT, V198, P129, DOI 10.1046/j.1469-7580.2001.19820129.x; Shibata S, 2006, J ANAT, V208, P269; Shibata S, 2014, ANAT REC, V297, P1208, DOI 10.1002/ar.22911; TAKENOSHITA Y, 1987, CRANIO, V5, P317	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	SEP	2015	298	9					1560	1571		10.1002/ar.23175		12	Anatomy & Morphology	Anatomy & Morphology	CR6TE	WOS:000361479500004		
J	Naito, S; Sakai, H; Hashine, K; Tomita, Y; Shinohara, N; Fujisawa, M; Eto, M; Ozono, S; Akaza, H				Naito, S.; Sakai, H.; Hashine, K.; Tomita, Y.; Shinohara, N.; Fujisawa, M.; Eto, M.; Ozono, S.; Akaza, H.			Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma	ANNALS OF ONCOLOGY			English	Article						S-1; sorafenib; metastatic renal cell carcinoma	II TRIAL; SURVIVAL; CANCER	The potential of S-1 for the treatment of metastatic renal cell carcinoma (mRCC) has been shown in two phase II studies. We aimed to assess the safety, tolerance, pharmacokinetics and clinical activity of S-1 combined with sorafenib in patients with mRCC. In this multicenter, single-arm, open-label, phase I/II study of S-1 plus sorafenib, we recruited patients with clear-cell or papillary renal cell carcinoma who had received a maximum of one prior cytokine-based regimen. The phase I primary end points were the maximum tolerated dose (MTD) and recommended dose (RD). S-1 was administered orally at 60, 80, 100 or 120 mg/day on days 1-28 of a 42-day cycle in combination with sorafenib (400 or 800 mg/day), given daily with dose adjustment. In phase II, the primary end point was to assess the overall response rate (ORR) at the RD. Nine patients were enrolled into phase I and 21 (including 6 patients who received the RD in the phase I portion) were enrolled into phase II. In the phase I portion, the MTD could not be determined, and the RD was defined as S-1 80 mg/m(2)/day on days 1-28 + sorafenib 800 mg/day on days 1-42. In the phase II portion, 21 patients were fully assessable for efficacy and safety. The confirmed ORR was 52% [95% confidence interval (CI) 29.8-74.3], including one complete response (5%) and 10 partial responses (48%). The median progression-free survival was 9.9 (95% CI 6.5-17.1) months. The most frequently reported treatment-related adverse event for all grades was hand-foot skin reaction (100%). The major reasons for dose reduction were hand-foot skin reaction (38%) and rash (14%). Combination therapy with S-1 plus sorafenib is effective and tolerable for patients with mRCC. However, skin events management is important in S-1 plus sorafenib combination therapy.	[Naito, S.] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 8128582, Japan; [Sakai, H.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nephrourol, Nagasaki 852, Japan; [Hashine, K.] Natl Hosp Org, Shikoku Canc Ctr, Dept Urol, Matsuyama, Ehime, Japan; [Tomita, Y.] Yamagata Univ, Fac Med, Dept Urol, Yamagata 990, Japan; [Shinohara, N.] Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan; [Fujisawa, M.] Kobe Univ, Sch Med, Dept Urol, Kobe, Hyogo 650, Japan; [Eto, M.] Kumamoto Univ, Fac Life Sci, Dept Urol, Kumamoto, Japan; [Ozono, S.] Hamamatsu Univ, Sch Med, Dept Urol, Hamamatsu, Shizuoka, Japan; [Akaza, H.] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Strateg Invest, Comprehens Canc Network, Tokyo, Japan	Naito, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Urol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	naito@uro.med.kyushu-u.ac.jp			Taiho Pharmaceuticals	This work was supported by Taiho Pharmaceuticals. No grant number applied.	Albiges L, 2015, EUR UROL, V67, P100, DOI 10.1016/j.eururo.2014.04.006; Ueno H, 2005, ONCOLOGY-BASEL, V68, P171, DOI 10.1159/000086771; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530; [Anonymous], 2006, COMM TERM CRIT ADV E; Naito S, 2010, J CLIN ONCOL, V28, P5022, DOI 10.1200/JCO.2010.29.1203; Naito S, 2011, BJU INT, V108, P1813, DOI 10.1111/j.1464-410X.2011.10281.x; Furuse J, 2010, CANCER SCI, V101, P2606, DOI 10.1111/j.1349-7006.2010.01730.x; Hirata K, 1999, CLIN CANCER RES, V5, P2000; Niwakawa M, 2012, INVEST NEW DRUG, V30, P1046, DOI 10.1007/s10637-010-9630-0; Takeuchi A, 2011, CANCER CHEMOTH PHARM, V68, P1557, DOI 10.1007/s00280-011-1660-6; Ueno H, 2004, BRIT J CANCER, V91, P1769, DOI 10.1038/sj.bjc.6602208	13	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	SEP	2015	26	9					1871	1876		10.1093/annonc/mdv280		6	Oncology	Oncology	CR5ON	WOS:000361392700010		
J	Grenader, T; Nash, S; Plotkin, Y; Furuse, J; Mizuno, N; Okusaka, T; Wasan, H; Valle, J; Bridgewater, J				Grenader, T.; Nash, S.; Plotkin, Y.; Furuse, J.; Mizuno, N.; Okusaka, T.; Wasan, H.; Valle, J.; Bridgewater, J.			Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies	ANNALS OF ONCOLOGY			English	Article						biliary tract cancer; cisplatin and gemcitabine; neutrophil lymphocyte ratio; prognostic; predictive	CELL LUNG-CANCER; INTRAHEPATIC CHOLANGIOCARCINOMA; TRACT CANCER; SYSTEMIC INFLAMMATION; CHEMOTHERAPY; GEMCITABINE; CONTRIBUTES; RESECTION; IMPACT	The superiority of cisplatin and gemcitabine (CisGem) chemotherapy over gemcitabine (Gem) alone in patients with advanced biliary tract cancer (ABC) has been demonstrated in two randomised trials; ABC02 and the Biliary Tract (BT) 22 study. We used a combined dataset from these two trials to investigate the derived neutrophil-to-lymphocyte ratio (dNLR), which is thought to be a prognostic factor associated with clinical outcomes in several solid tumours, including ABC. White blood cell (WBC) and absolute neutrophil count (ANC) were available for 379 of 410 patients from ABC-02 and all 83 patients in BT-22. The dNLR was calculated as ANC/(WBC-ANC), as previously specified. We examined the association between dNLR and overall survival (OS) and progression-free survival (PFS), as well as comparing the treatment effect in two patient groups defined by their dNLR level. A high dNLR was defined as a parts per thousand yen3.0, which was approximately the upper tertile value. A total of 462 individual patient records were analysed, 328 with baseline dNLR < 3 and 134 with dNLR a parts per thousand yen3. There were 443 deaths in the cohort, and all surviving patients had a dNLR < 3. There was strong evidence that dNLR was closely associated with both OS [hazard ratio (HR), 1.62; 95% confidence interval (CI) 1.32-2.01] and PFS (HR, 1.40; 95% CI 1.13-1.72). There was limited evidence (P = 0.10) of a differential effect of CisGem on OS between the two dNLR groups, but this was clearest in the ABC-02 dataset (P = 0.06). There was good evidence (P = 0.008) of an association between low baseline dNLR and long-term survival on a CisGem regimen. There was also good evidence of an association between ECOG performance status (split at 0 and 1 versus 2) on both OS (P < 0.001) and PFS (P = 0.01), but no evidence of a differential treatment effect, with both groups receiving benefit from the addition of cisplatin. These data confirm that high dNLR is associated with worse OS and PFS, and suggests it may also be predictive of benefit for the addition of cisplatin to gemcitabine in European patients with ABC. Incorporating dNLR into the clinical context may better inform prognosis and chemotherapy decisions in ABC patients.	[Grenader, T.; Bridgewater, J.] Shaare Zedek Med Ctr, Jerusalem, Israel; [Nash, S.] UCL, Canc Res UK, London, England; [Nash, S.] UCL, Clin Trials Ctr, London, England; [Plotkin, Y.] Soroka Med Ctr, Dept Oncol, IL-84101 Beer Sheva, Israel; [Furuse, J.] Kyorin Univ, Sch Med, Dept Oncol, Tokyo, Japan; [Mizuno, N.] Aichi Canc Ctr Hosp, Dept Oncol, Nagoya, Aichi 464, Japan; [Okusaka, T.] Natl Canc Ctr, Dept Oncol, Tokyo, Japan; [Wasan, H.] Imperial Healthcare, Dept Oncol, London, England; [Valle, J.] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England	Bridgewater, J (reprint author), UCL, Inst Canc, 72 Huntley St, London WC1E 6DD, England.	j.bridgewater@ucl.ac.uk			CRUK [C444/A15953]; UCL Clinical Trials Unit - Cancer Research UK; Lilly Oncology; Eli Lilly Japan; Ministry of Health, Labour and Welfare	TG is a fellow of the European Society of Medical Oncology. SN was supported by CRUK grant C444/A15953 to the UCL CRUK trials centre. ABC-02 was an investigator-initiated study sponsored by UCL Clinical Trials Unit, funded by Cancer Research UK with gemcitabine provided by Lilly Oncology (unrestricted grant). BT-22 was an Eli Lilly Japan sponsored trial; additional data collection for OS and PFS was investigator-initiated and supported by the Ministry of Health, Labour and Welfare, Health Labour Sciences Research Grant (with data transfer to UCL-CTU under a study-specific agreement for the sole purposes of this meta-analysis).	Leelawat K, 2007, WORLD J GASTROENTERO, V13, P1561; Dumitrascu T, 2013, J GASTROINTEST SURG, V17, P913, DOI 10.1007/s11605-013-2144-2; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Zhou SL, 2014, CARCINOGENESIS, V35, P597, DOI 10.1093/carcin/bgt397; McNamara MG, 2014, EUR J CANCER, V50, P1581, DOI 10.1016/j.ejca.2014.02.015; Suzuki K, 2011, CLIN CANCER RES, V17, P5247, DOI 10.1158/1078-0432.CCR-10-2805; Sato H, 2012, WORLD J SURG, V36, P617, DOI 10.1007/s00268-011-1411-1; Gomez D, 2008, J SURG ONCOL, V97, P513, DOI 10.1002/jso.21001; Wu XS, 2014, ANN SURG ONCOL, V21, P449, DOI 10.1245/s10434-013-3292-z; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; Bridgewater J, 2014, J HEPATOL, V60, P1268, DOI 10.1016/j.jhep.2014.01.021; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Yao YW, 2013, CANCER IMMUNOL IMMUN, V62, P471, DOI 10.1007/s00262-012-1347-9; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Leelawat K, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-3; Valle JW, 2013, ANN ONCOL, V25, P391; Yoon H, 2011, BIOCHEM BIOPH RES CO, V405, P333, DOI 10.1016/j.bbrc.2010.11.130	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	SEP	2015	26	9					1910	1916		10.1093/annonc/mdv253		7	Oncology	Oncology	CR5ON	WOS:000361392700016		
J	Tanabe, K; Fujii, M; Nishikawa, K; Kunisaki, C; Tsuji, A; Matsuhashi, N; Takagane, A; Ohno, T; Kawase, T; Kochi, M; Yoshida, K; Kakeji, Y; Ichikawa, W; Chin, K; Terashima, M; Takeuchi, M; Nakajima, T				Tanabe, K.; Fujii, M.; Nishikawa, K.; Kunisaki, C.; Tsuji, A.; Matsuhashi, N.; Takagane, A.; Ohno, T.; Kawase, T.; Kochi, M.; Yoshida, K.; Kakeji, Y.; Ichikawa, W.; Chin, K.; Terashima, M.; Takeuchi, M.; Nakajima, T.		JACCRO GC-05 Study Grp	Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05)	ANNALS OF ONCOLOGY			English	Article						second-line chemotherapy; gastric cancer; S-1; irinotecan	SUPPORTIVE CARE; OPEN-LABEL; III TRIAL; CISPLATIN; DOCETAXEL; SURVIVAL	In Japan, S-1 plus cisplatin has been used as first-line therapy for advanced gastric cancer (AGC). Patients with no response to first-line treatment with S-1 often receive a taxane-alone or irinotecan-alone as second-line treatment. However, second-line treatment with S-1 plus irinotecan is widely used in patients with AGC resistant to first-line S-1-based chemotherapy. The goal of this trial was to determine whether the consecutive use of S-1 plus irinotecan improves survival when compared with irinotecan-alone as second-line treatment for AGC. Patients who had disease progression during first-line S-1-based chemotherapy were randomly assigned to receive S-1 plus irinotecan or irinotecan-alone. The S-1 plus irinotecan group received oral S-1 (40-60 mg/m(2)) on days 1-14 and intravenous irinotecan (150 mg/m(2)) on day 1 of a 21-day cycle. The irinotecan-alone group received the same dose of irinotecan intravenously on day 1 of a 14-day cycle. The primary end point was overall survival (OS). From February 2008 to May 2011, a total of 304 patients were enrolled. The median OS was 8.8 months in the S-1 plus irinotecan group and 9.5 months in the irinotecan-alone group. This difference was not significant (hazard ratio for death, 0.99; 95% confidence interval 0.78-1.25; P = 0.92). Grade 3 or higher toxicities were more common in the S-1 plus irinotecan group than in the irinotecan-alone group. The consecutive use of S-1 plus irinotecan is not recommended as second-line treatment in patients who are refractory to S-1-based first-line chemotherapy.	[Tanabe, K.] Hiroshima Univ Hosp, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan; [Fujii, M.; Kochi, M.] Nihon Univ, Sch Med, Dept Digest Surg, Tokyo, Japan; [Nishikawa, K.] Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Kunisaki, C.] Yokohama City Univ, Gastroenterol Ctr, Dept Surg, Yokohama, Kanagawa 232, Japan; [Tsuji, A.] Kobe City Med Ctr Gen Hosp, Dept Clin Oncol, Kobe, Hyogo, Japan; [Matsuhashi, N.; Yoshida, K.] Gifu Univ, Sch Med, Dept Surg Oncol, Gifu 500, Japan; [Takagane, A.] Hakodate Goryokaku Hosp, Dept Surg, Hakodate, Hokkaido, Japan; [Ohno, T.] Gunma Univ, Sch Med, Dept Gen Surg Sci, Maebashi, Gumma 371, Japan; [Kawase, T.] Sakai City Hosp, Dept Surg, Sakai, Osaka, Japan; [Kakeji, Y.] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 657, Japan; [Ichikawa, W.] Showa Univ, Sch Med, Dept Med, Devis Med Oncol, Tokyo 142, Japan; [Chin, K.] Canc Inst Hosp JFCR, Div Gastroenterol, Tokyo, Japan; [Terashima, M.] Shizuoka Canc Ctr, Div Gastr Surg, Shizuoka, Japan; [Takeuchi, M.] Kitasato Univ, Sch Pharm, Dept Clin Med Biostat, Tokyo, Japan; [Nakajima, T.] Japan Clin Canc Res Org, Tokyo, Japan	Fujii, M (reprint author), Nihon Univ, Sch Med, Dept Digest Surg, Itabashi Ku, 1-8-13 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	masashi.fujii@gioncology.jp			Japan Clinical Cancer Research Organization [JACCRO GC-05]; Taiho Pharmaceutical Co., Ltd, Japan	This work was supported by the Japan Clinical Cancer Research Organization (JACCRO GC-05) with funding from Taiho Pharmaceutical Co., Ltd, Japan, under a research contract (no grant number).	Narahara H, 2011, GASTRIC CANCER, V14, P72, DOI 10.1007/s10120-011-0009-5; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Hironaka S, 2013, J CLIN ONCOL, V31, P4438, DOI 10.1200/JCO.2012.48.5805; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Fujii M, 2010, SURG TODAY, V40, P295, DOI 10.1007/s00595-009-4148-9; Ichikawa W, 2006, ANN ONCOL, V17, P1665, DOI 10.1093/annonc/mdl174; Ichikawa W, 2004, BRIT J CANCER, V91, P1245, DOI 10.1038/sj.bjc.6602139; Inokuchi M, 2006, BRIT J CANCER, V94, P1130, DOI 10.1038/sj.bjc.6603072; Koizumi W, 2014, J CANCER RES CLIN, V140, P319, DOI 10.1007/s00432-013-1563-5; Shimada S, 2003, ONCOL REP, V10, P687; Sugimoto Naotoshi, 2009, Gan To Kagaku Ryoho, V36, P417; Takiuchi Hiroya, 2007, Gastrointest Cancer Res, V1, P171; Takiuchi Hiroya, 2005, Gan To Kagaku Ryoho, V32, P19; Takiuchi H, 2005, JPN J CLIN ONCOL, V35, P520, DOI 10.1093/jjco/hyi148	17	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	SEP	2015	26	9					1916	1922		10.1093/annonc/mdv265		7	Oncology	Oncology	CR5ON	WOS:000361392700017		
J	Hui, D; Bansal, S; Strasser, F; Morita, T; Caraceni, A; Davis, M; Cherny, N; Kaasa, S; Currow, D; Abernethy, A; Nekolaichuk, C; Bruera, E				Hui, D.; Bansal, S.; Strasser, F.; Morita, T.; Caraceni, A.; Davis, M.; Cherny, N.; Kaasa, S.; Currow, D.; Abernethy, A.; Nekolaichuk, C.; Bruera, E.			Indicators of integration of oncology and palliative care programs: an international consensus	ANNALS OF ONCOLOGY			English	Article						access; indicators; integration; health systems; neoplasms; palliative care	END-OF-LIFE; CANCER CARE; NEAR-DEATH; QUALITY; ASSOCIATIONS; PERFORMANCE; CENTERS; SOCIETY; TRIAL; ESMO	Recently, the concept of integrating oncology and palliative care has gained wide professional and scientific support; however, a global consensus on what constitutes integration is unavailable. We conducted a Delphi Survey to develop a consensus list of indicators on integration of specialty palliative care and oncology programs for advanced cancer patients in hospitals with a parts per thousand yen100 beds. International experts on integration rated a list of indicators on integration over three iterative rounds under five categories: clinical structure, processes, outcomes, education, and research. Consensus was defined a priori by an agreement of a parts per thousand yen70%. Major criteria (i.e. most relevant and important indicators) were subsequently identified. Among 47 experts surveyed, 46 (98%), 45 (96%), and 45 (96%) responded over the three rounds. Nineteen (40%) were female, 24 (51%) were from North America, and 14 (30%) were from Europe. Sixteen (34%), 7 (15%), and 25 (53%) practiced palliative care, oncology, and both specialties, respectively. After three rounds of deliberation, the panelists reached consensus on 13 major and 30 minor indicators. Major indicators included two related to structure (consensus 95%-98%), four on processes (88%-98%), three on outcomes (88%-91%), and four on education (93%-100%). The major indicators were considered to be clearly stated (9.8/10), objective (9.4/10), amenable to accurate coding (9.5/10), and applicable to their own countries (9.4/10). Our international experts reached broad consensus on a list of indicators of integration, which may be used to identify centers with a high level of integration, and facilitate benchmarking, quality improvement, and research.	[Hui, D.; Bansal, S.; Bruera, E.] Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Houston, TX 77030 USA; [Strasser, F.] Cantonal Hosp, Oncol Palliat Med Hematol Oncol, St Gallen, Switzerland; [Morita, T.] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care & Seirei Hosp, Hamamatsu, Shizuoka, Japan; [Caraceni, A.] Fdn IRCCS Ist Nazl Tumori Milano, Palliat Care Pain Therapy & Rehabil, Milan, Italy; [Davis, M.] Taussig Canc Inst, Dept Solid Tumor Oncol, Cleveland, OH USA; [Cherny, N.] Shaare Zedek Med Ctr, Dept Med Oncol, Canc Pain & Palliat Med Serv, Jerusalem, Israel; [Kaasa, S.] Norwegian Univ Sci & Technol, European Palliat Care Res Ctr, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Kaasa, S.] Univ Trondheim Hosp, St Olavs Hosp, Canc Clin, Trondheim, Norway; [Currow, D.] Flinders Univ S Australia, Palliat & Support Serv, Adelaide, SA 5001, Australia; [Abernethy, A.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA; [Nekolaichuk, C.] Univ Alberta, Dept Oncol, Div Palliat Care Med, Edmonton, AB, Canada	Hui, D (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Unit 1414, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dhui@mdanderson.org			University of Texas MD Anderson Cancer Center [CA 016672]; Multinational Association for Supportive Care in Cancer; National Institutes of Health [R21CA186000-01A1]; American Cancer Society Mentored Research Scholar Grant in Applied and Clinical Research [MRSG-14-1418-01-CCE]	This research is supported, in part, by a University of Texas MD Anderson Cancer Center Support Grant (CA 016672). This study is also partly supported by research fund from the Multinational Association for Supportive Care in Cancer. DH is supported, in part, by a National Institutes of Health grant (R21CA186000-01A1) and an American Cancer Society Mentored Research Scholar Grant in Applied and Clinical Research (MRSG-14-1418-01-CCE). The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Agar M, 2008, PALLIATIVE MED, V22, P787, DOI 10.1177/0269216308092287; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Mack JW, 2012, J CLIN ONCOL, V30, P4387, DOI 10.1200/JCO.2012.43.6055; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Abrahm JL, 2012, J NATL COMPR CANC NE, V10, P1192; Buss MK, 2011, CANCER-AM CANCER SOC, V117, P4304, DOI 10.1002/cncr.25952; Davis MP, 2015, SUPPORT CARE CANCER, V23, P2677, DOI 10.1007/s00520-015-2630-z; Abernethy AP, 2013, J PAIN SYMPTOM MANAG, V45, P488, DOI 10.1016/j.jpainsymman.2012.02.024; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Cherny N, 2010, ANN ONCOL, V21, P362, DOI 10.1093/annonc/mdp318; McNiff KK, 2008, J CLIN ONCOL, V26, P3832, DOI 10.1200/JCO.2008.16.8674; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Hui D, 2010, JAMA-J AM MED ASSOC, V303, P1054, DOI 10.1001/jama.2010.258; Hui D, 2015, ONCOLOGIST, V20, P77, DOI 10.1634/theoncologist.2014-0312; Bainbridge Daryl, 2010, BMC Palliat Care, V9, P8, DOI 10.1186/1472-684X-9-8; Bakitas Marie, 2009, Palliat Support Care, V7, P75, DOI 10.1017/S1478951509000108; Blum D, 2014, J PAIN SYMPTOM MANAG, V48, P1160, DOI 10.1016/j.jpainsymman.2014.04.009; Hui D, 2014, CANCER-AM CANCER SOC, V120, P1743, DOI 10.1002/cncr.28628; Kaasa S, 2013, LANCET ONCOL, V14, P571, DOI 10.1016/S1470-2045(13)70202-X; Kamal Arif H, 2014, J Oncol Pract, V10, P281, DOI 10.1200/JOP.2013.001212; National Consensus Project for Quality Palliative Care, 2009, CLIN PRACT GUID QUAL, V2nd; Saarto T, 2014, EUR J PALL CARE, V21, P109; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	23	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	SEP	2015	26	9					1953	1959		10.1093/annonc/mdv269		7	Oncology	Oncology	CR5ON	WOS:000361392700023		
J	Gyawali, B; Shimokata, T; Honda, K; Ando, Y				Gyawali, B.; Shimokata, T.; Honda, K.; Ando, Y.			Flaws in the trial design of IFCT-0802	ANNALS OF ONCOLOGY			English	Letter							CELL LUNG-CANCER		[Gyawali, B.; Shimokata, T.; Honda, K.; Ando, Y.] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan	Gyawali, B (reprint author), Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan.	bg.bishalgyawali@gmail.com					ALBAIN KS, 1990, J CLIN ONCOL, V8, P1563; Chute JP, 1999, J CLIN ONCOL, V17, P1794; Pujol JL, 2015, ANN ONCOL, V26, P908, DOI 10.1093/annonc/mdv065	3	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	SEP	2015	26	9					2003	2003		10.1093/annonc/mdv273		1	Oncology	Oncology	CR5ON	WOS:000361392700031		
J	Senkus, E; Kyriakides, S; Ohno, S; Penault-Llorca, F; Poortmans, P; Rutgers, E; Zackrisson, S; Cardoso, F				Senkus, E.; Kyriakides, S.; Ohno, S.; Penault-Llorca, F.; Poortmans, P.; Rutgers, E.; Zackrisson, S.; Cardoso, F.		ESMO Guidelines Comm	Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(aEuro)	ANNALS OF ONCOLOGY			English	Article							CARCINOMA-IN-SITU; RANDOMIZED CONTROLLED-TRIAL; POSITIVE SENTINEL NODE; ONCOLOGY CONSENSUS GUIDELINE; INDIVIDUAL PATIENT DATA; ADJUVANT CHEMOTHERAPY; AMERICAN-SOCIETY; OPEN-LABEL; POSTMENOPAUSAL WOMEN; PHASE-3 TRIAL		[Senkus, E.] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland; [Kyriakides, S.] Europa Donna Cyprus, Nicosia, Cyprus; [Ohno, S.] Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan; [Penault-Llorca, F.] Ctr Jean Perrin, Dept Pathol, Clermont Ferrand, France; [Penault-Llorca, F.] Univ dAuvergne, EA 4677, Clermont Ferrand, France; [Poortmans, P.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Rutgers, E.] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands; [Zackrisson, S.] Lund Univ, Dept Diagnost Radiol, Malmo, Sweden; [Cardoso, F.] Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal	Senkus, E (reprint author), Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland.				Siemens AG; AstraZeneca; Astellas/Medivation; Celgene; Daiichi-Sankyo; Eisai; GE Oncology; Genentech; GlaxoSmithKline; Merck-Sharp; Merus; Novartis; Pfizer; Roche; Sanofi	SZ has reported travel support from Siemens AG; speaker's fees from Siemens AG and AstraZeneca. FC has reported consultancy/research grants from Astellas/Medivation, AstraZeneca, Celgene, Daiichi-Sankyo, Eisai, GE Oncology, Genentech, GlaxoSmithKline, Merck-Sharp, Merus, Novartis, Pfizer, Roche and Sanofi. The other authors have declared no potential conflicts of interest.	Bentzen SM, 2008, LANCET, V371, P1098; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Koolen BB, 2012, BREAST CANCER RES TR, V131, P117, DOI 10.1007/s10549-011-1767-9; Eidtmann H, 2010, ANN ONCOL, V21, P2188, DOI 10.1093/annonc/mdq217; Adams S, 2010, BREAST CANCER RES TR, V124, P723, DOI 10.1007/s10549-010-1181-8; Bossuyt V, 2015, ANN ONCOL, V26, P1280, DOI 10.1093/annonc/mdv161; Warner E, 2008, ANN INTERN MED, V148, P671; Perrone F, 2015, ANN ONCOL, V26, P675, DOI 10.1093/annonc/mdu564; Mann GB, 2005, J CLIN ONCOL, V23, P5148, DOI 10.1200/JCO.2005.02.076; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bliss JM, 2012, J CLIN ONCOL, V30, P709, DOI 10.1200/JCO.2010.33.7899; Poortmans PM, 2015, NEW ENGL J MED, V373, P317, DOI 10.1056/NEJMoa1415369; Jonat W, 2002, J CLIN ONCOL, V20, P4628, DOI 10.1200/JCO.2002.05.042; Smith IE, 2005, J CLIN ONCOL, V23, P5108, DOI 10.1200/JCO.2005.04.005; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V306, P385, DOI 10.1001/jama.2011.1034; von Minckwitz G, 2011, BREAST CANCER RES TR, V125, P145, DOI 10.1007/s10549-010-1228-x; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Risch HA, 2006, J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JCO.2009.26.3756; Vaidya JS, 2014, LANCET, V383, P603, DOI 10.1016/S0140-6736(13)61950-9; Allemani C, 2013, INT J CANCER, V132, P2404, DOI 10.1002/ijc.27895; Azim HA, 2013, ANN ONCOL, V24, P647, DOI 10.1093/annonc/mds645; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; Ravdin PM, 2001, J CLIN ONCOL, V19, P980; Donker M, 2014, LANCET ONCOL, V15, P1303, DOI 10.1016/S1470-2045(14)70460-7; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI [10.1016/S1470-2045(10)70257-6, 10.1016/S1470.2045(10)70257.6]; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Boughey JC, 2013, JAMA-J AM MED ASSOC, V310, P1455, DOI 10.1001/jama.2013.278932; Houssami N, 2010, EUR J CANCER, V46, P3219, DOI 10.1016/j.ejca.2010.07.043; Chatterjee JS, 2009, BRIT J SURG, V96, P1135, DOI 10.1002/bjs.6693; Pivot X, 2013, LANCET ONCOL, V14, P741, DOI 10.1016/S1470-2045(13)70225-0; Davidson NE, 2005, J CLIN ONCOL, V23, P5973, DOI 10.1200/JCO.2005.05.551; Colleoni M, 2006, J CLIN ONCOL, V24, P1332, DOI 10.1200/JCO.2005.03.0783; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Sideras K, 2010, J CLIN ONCOL, V28, P2768, DOI 10.1200/JCO.2009.23.8931; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Del Turco MR, 2010, EUR J CANCER, V46, P2344, DOI 10.1016/j.ejca.2010.06.119; McTiernan A, 2003, ONCOLOGIST, V8, P326, DOI 10.1634/theoncologist.8-4-326; Wilson ARM, 2013, EUR J CANCER, V49, P3579, DOI 10.1016/j.ejca.2013.07.017; Di Leo A, 2011, LANCET ONCOL, V12, P1134, DOI 10.1016/S1470-2045(11)70231-5; Whelan TJ, 2015, NEW ENGL J MED, V373, P307, DOI 10.1056/NEJMoa1415340; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Coleman R, 2014, LANCET ONCOL, V15, P997, DOI 10.1016/S1470-2045(14)70302-X; Cataliotti L, 2006, CANCER, V106, P2095, DOI 10.1002/cncr.21872; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI 10.1016/S1470-2045(08)60348-7; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Guarneri V, 2012, J CLIN ONCOL, V30, P1989, DOI 10.1200/JCO.2011.39.0823; Goss PE, 2008, J CLIN ONCOL, V26, P1948, DOI 10.1200/JCO.2007.11.6798; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Chlebowski RT, 2002, J CLIN ONCOL, V20, P1128, DOI 10.1200/JCO.20.4.1128; Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Leidenius M, 2006, J SURG ONCOL, V94, P380, DOI 10.1002/jso.20581; Regan MM, 2012, J NATL CANCER I, V104, P441, DOI 10.1093/jnci/djs125; Regan MM, 2011, LANCET ONCOL, V12, P1101, DOI 10.1016/S1470-2045(11)70270-4; Liebens FP, 2007, EUR J CANCER, V43, P238, DOI 10.1016/j.ejca.2006.07.019; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Korde LA, 2010, J CLIN ONCOL, V28, P2114, DOI 10.1200/JCO.2009.25.5729; Goldhirsch A, 2013, LANCET, V382, P1021, DOI 10.1016/S0140-6736(13)61094-6; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Pagani O, 1998, EUR J CANCER, V34, P632, DOI 10.1016/S0959-8049(97)10036-3; Poortmans P, 2012, SEMIN RADIAT ONCOL, V22, P29, DOI 10.1016/j.semradonc.2011.09.007; Muss HB, 2009, NEW ENGL J MED, V360, P2055, DOI 10.1056/NEJMoa0810266; Yen TWF, 2005, J AM COLL SURGEONS, V200, P516, DOI 10.1016/j.jamcollsurg.2004.11.012; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Gianni L, 2009, J CLIN ONCOL, V27, P2474, DOI 10.1200/JCO.2008.19.2567; Kuehn T, 2013, LANCET ONCOL, V14, P609, DOI 10.1016/S1470-2045(13)70166-9; Gonzalez-Angulo AM, 2009, J CLIN ONCOL, V27, P5700, DOI 10.1200/JCO.2009.23.2025; Dykewicz CA, 2001, CLIN INFECT DIS, V33, P139, DOI 10.1086/321805; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Pruthi S, 2010, MAYO CLIN PROC, V85, P1111, DOI 10.4065/mcp.2010.0414; Bartelink H, 2015, LANCET ONCOL, V16, P47, DOI 10.1016/S1470-2045(14)71156-8; Chen XS, 2012, BREAST CANCER RES TR, V134, P957, DOI 10.1007/s10549-012-1990-z; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Holmberg L, 2008, J NATL CANCER I, V100, P475, DOI 10.1093/jnci/djn058; Morrow M, 2015, NAT REV CLIN ONCOL, V12, P227, DOI 10.1038/nrclinonc.2015.8; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Giordano L, 2012, J MED SCREEN, V19, P72, DOI 10.1258/jms.2012.012085; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Partridge AH, 2014, BREAST, V23, P209, DOI 10.1016/j.breast.2014.03.011; Eiermann W, 2001, ANN ONCOL, V12, P1527, DOI 10.1023/A:1013128213451; Hwang ES, 2013, CANCER-AM CANCER SOC, V119, P1402, DOI 10.1002/cncr.27795; Guiu S, 2012, ANN ONCOL, V23, P2997, DOI 10.1093/annonc/mds586; Veronesi U, 2013, LANCET ONCOL, V14, P1269, DOI 10.1016/S1470-2045(13)70497-2; Poortmans P, 2014, LANCET, V383, P2104, DOI 10.1016/S0140-6736(14)60192-6; Harbeck N, 2014, CANCER TREAT REV, V40, P434, DOI 10.1016/j.ctrv.2013.09.014; Drukker CA, 2013, INT J CANCER, V133, P929, DOI 10.1002/ijc.28082; Moran MS, 2014, J CLIN ONCOL, V32, P1507, DOI 10.1200/JCO.2013.53.3935; Weaver DL, 2010, MODERN PATHOL, V23, pS26, DOI 10.1038/modpathol.2010.36; von Minckwitz G, 2014, LANCET ONCOL, V15, P747, DOI 10.1016/S1470-2045(14)70160-3; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Dubsky P, 2013, BRIT J CANCER, V109, P2959, DOI 10.1038/bjc.2013.671; Blamey R, 2000, EUR J CANCER, V36, P2288; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Crivellari D, 2013, BREAST, V22, P130, DOI 10.1016/j.breast.2013.01.015; Jones S, 2009, J CLIN ONCOL, V27, P1177, DOI 10.1200/JCO.2008.18.4028; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Cardoso F, 2012, EUR J CANCER, V48, P3355, DOI 10.1016/j.ejca.2012.10.004; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; Robertson IJ, 2011, BREAST, V20, P491, DOI 10.1016/j.breast.2011.07.002; Association of Breast Surgery at BASO, 2009, EUR J SURG ONCOL S1, V35, P1, DOI [10.1016/j.ejso.2009.01.008, DOI 10.1016/J.EJS0.2009.01.008)]; Association of European Cancer Leagues, EUR UN COUNC REC CAN; Autier P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3620; Blamey RW, 2007, EUR J CANCER, V43, P1545, DOI 10.1016/j.ejca.2007.01.003; Cardoso F, 2014, SABCS, pS6; Clarke M, 2008, LANCET, V371, P29; Coates AS, 2015, ANN ONCOL, P1533; Coleman R, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-S4-07; Cuzick J, 2007, LANCET, V369, P1711; Darby S, 2011, LANCET, V378, P1707, DOI DOI 10.1016/S0140-6736(11)61629-2; Earl HM, 2014, LANCET ONCOL, V15, P201, DOI 10.1016/S1470-2045(13)70554-0; Abe O, 2005, LANCET, V365, P1687; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Edge SB, 2010, AJCC CANC STAGING HD; Eggemann H, 2013, BREAST CANCER RES TR, V137, P465, DOI 10.1007/s10549-012-2355-3; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Gebruers N, 2015, ARCH PHYS MED REHAB, V96, P1131, DOI 10.1016/j.apmr.2015.01.014; Geyer Jr CE, 2014, SABCS, pS3; Goodwin A, 2009, BREAST, V18, P143, DOI 10.1016/j.breast.2009.04.003; Gotzsche PC, 2011, COCHRANE DB SYST REV, V19, P1, DOI DOI 10.1002/14651858.CD001877.PUB4; Hammond M Elizabeth Hale, 2011, Appl Immunohistochem Mol Morphol, V19, P499, DOI 10.1097/PAI.0b013e31822a8eac; Harbeck N, 2002, CANCER RES, V62, P4617; Independent UK, 2012, LANCET, V380, P1778, DOI DOI 10.1016/S0140-6736(12)61611-0; Kaufmann M, 2010, CANCER-AM CANCER SOC, V116, P1184, DOI 10.1002/cncr.24874; Kyndi M, 2009, RADIOTHER ONCOL, V90, P74, DOI 10.1016/j.radonc.2008.04.014; Lakhani SR, 2012, WHO CLASSIFICATION T; Meijnen P, 2007, BRIT J SURG, V94, P952, DOI 10.1002/bjs.5735; Moore HCF, 2015, NEW ENGL J MED, V372, P923, DOI 10.1056/NEJMoa1413204; Moore KH, 2007, ANN SURG ONCOL, V14, P2911, DOI 10.1245/s10434-007-9414-8; Offersen BV, 2015, RADIOTHER ONCOL, V114, P3, DOI 10.1016/j.radonc.2014.11.030; Ottini L, 2010, CRIT REV ONCOL HEMAT, V73, P141, DOI 10.1016/j.critrevonc.2009.04.003; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Perry N, 2006, EUROPEAN GUIDELINES; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Piccart-Gebhart MJ, 2014, J CLIN ONCOL S5S, V32; Polgár Csaba, 2010, Radiother Oncol, V94, P264, DOI 10.1016/j.radonc.2010.01.014; Reid DM, 2008, CANCER TREAT REV, V34, pS3, DOI 10.1016/j.ctrv.2008.03.007; Rugo HS, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-S5-02; Schnitt SJ, 2015, ARCH PATHOL LAB MED, V139, P575, DOI 10.5858/arpa.2014-0384-ED; Senkus E, 2014, PSYCHO-ONCOLOGY, V23, P173, DOI 10.1002/pon.3384; Senkus-Konefka E, 2004, CANCER TREAT REV, V30, P671, DOI 10.1016/j.ctrv.2004.06.008; Shao N, 2012, BREAST, V21, P389, DOI 10.1016/j.breast.2012.03.011; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Sousa Berta, 2013, Eur J Pharmacol, V717, P71, DOI 10.1016/j.ejphar.2013.03.037; Staley H, 2012, COCHRANE DB SYST REV, V10; Swain SM, 2010, NEW ENGL J MED, V363, P2268, DOI 10.1056/NEJMc1009616; Thorsen LBJ, 2014, RADIOTHER ONCOL S1; Wazir Umar, 2014, World J Clin Oncol, V5, P795, DOI 10.5306/wjco.v5.i5.795; Werkhoven E, 2011, RADIOTHER ONCOL, V100, P101; Wishart GC, 2011, EJSO-EUR J SURG ONC, V37, P411, DOI 10.1016/j.ejso.2011.02.001	160	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	SEP	2015	26			5			V8	V30		10.1093/annonc/mdv298		23	Oncology	Oncology	CR5PD	WOS:000361394500002		
J	Tashiro, E; Imoto, M				Tashiro, Estu; Imoto, Masaya			Chemical biology of compounds obtained from screening using disease models	ARCHIVES OF PHARMACAL RESEARCH			English	Review						Cell migration; Apoptosis; Parkinson's disease; MEK; beta-Catenin; Androgen	DEPENDENT PROSTATE-CANCER; CELL-MIGRATION; PARKINSONS-DISEASE; STREPTOMYCES-SPECTABILIS; ANDROGEN RECEPTOR; RAC1 ACTIVATION; BETA-CATENIN; PROTEIN; GROWTH; BCL-2	Bioactive compounds are extremely powerful tools for studying biological systems because they can rapidly, conditionally, often reversibly, and dose-dependently modulate the biological function of living cells. Moreover, they are expected to be drug seeds for chemotherapy of several diseases. Two approaches are used to find and obtain bioactive compounds, namely, molecular-target-based screening and phenotypic screening. Through phenotypic screening that mimics tumor metastasis, multi-drug resistance, and Parkinson's disease, we identified several compounds that inhibit cancer cell migration, anti-apoptotic function of Bcl-2/Bcl-xL, and neuronal cell death. By using MEK inhibitor that was developed by target-based screening, we discovered that MEK inhibitor selectively induces apoptosis in tumor cells with beta-catenin mutation. Using target-based screening, we identified arabilin, a novel androgen antagonist. In this review, we introduce our recent studies on the identification of bioactive compounds by phenotypic screening and by target-based screening for drug-seed discovery.	[Tashiro, Estu; Imoto, Masaya] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Imoto, M (reprint author), Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	imoto@bio.keio.ac.jp					Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; BOS JL, 1989, CANCER RES, V49, P4682; Miyanaga S, 2010, BIOORG MED CHEM LETT, V20, P963, DOI 10.1016/j.bmcl.2009.12.055; Deakin NO, 2009, J CELL SCI, V122, P1654, DOI 10.1242/jcs.049130; Igarashi Y, 2005, J ANTIBIOT, V58, P350; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; KINO T, 1987, J ANTIBIOT, V40, P1249; Eberhardt O, 2003, TOXICOL LETT, V139, P135, DOI 10.1016/S0378-4274(02)00428-9; HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Hara T, 2003, CANCER RES, V63, P149; Futamura Y, 2008, J AM CHEM SOC, V130, P1822, DOI [10.1021/ja710124p, 10.1021/ja710124pS0002-7863(71)00124-0]; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; SCHER HI, 1995, UROLOGY, V46, P142, DOI 10.1016/S0090-4295(99)80182-4; Sawada M, 2011, BIOORG MED CHEM LETT, V21, P1385, DOI 10.1016/j.bmcl.2011.01.028; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Kobayashi H, 2011, J BIOL CHEM, V286, P39259, DOI 10.1074/jbc.M111.255489; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Wang SM, 2003, SEMIN ONCOL, V30, P133, DOI 10.1053/S0093-7754(03)00488-2; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Polakis P, 2000, GENE DEV, V14, P1837; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Nagamine N, 2007, BIOINFORMATICS, V23, P2004, DOI 10.1093/bioinformatics/btm266; Kurosawa K, 2001, J ANTIBIOT, V54, P541; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; BINDOFF LA, 1989, LANCET, V2, P49; Cohen Yoram, 2003, Journal of the National Cancer Institute (Bethesda), V95, P625; Druker BJ, 2002, TRENDS MOL MED, V8, pS14, DOI 10.1016/S1471-4914(02)02305-5; HATANO T, 1989, CHEM PHARM BULL, V37, P3005; JONES TR, 1989, CAN J PHYSIOL PHARM, V67, P17; KAKINUMA K, 1976, TETRAHEDRON, V32, P217, DOI 10.1016/0040-4020(76)87004-4; Kawamura T, 2010, J ANTIBIOT, V63, P601, DOI 10.1038/ja.2010.98; Kiga M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08155; Kiga M, 2012, ANTI-CANCER DRUG, V23, P119, DOI 10.1097/CAD.0b013e32834c6a33; Kobayashi Hiroki, 2012, BMC Chemical Biology, V12, P2, DOI 10.1186/1472-6769-12-2; Magi S, 2014, CANCER SCI, V105, P290, DOI 10.1111/cas.12340; RodriguezViciana P, 1996, EMBO J, V15, P2442; Singh SB, 1996, J ORG CHEM, V61, P7727, DOI 10.1021/jo961074p; Steketee K., 2002, J INT CANC, V100, P309; Takemoto Y, 2005, CHEM BIOL, V12, P1337, DOI 10.1016/j.chembiol.2005.09.017; Tanimura S, 2002, J BIOL CHEM, V277, P28256, DOI 10.1074/jbc.M202866200; Tao WW, 2012, FITOTERAPIA, V83, P422, DOI 10.1016/j.fitote.2011.12.010; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; TATE KM, 1995, INT IMMUNOL, V7, P747, DOI 10.1093/intimm/7.5.747; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470	54	0	0	PHARMACEUTICAL SOC KOREA	SEOUL	1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA	0253-6269	1976-3786		ARCH PHARM RES	Arch. Pharm. Res.	SEP	2015	38	9			SI		1651	1660		10.1007/s12272-015-0633-4		10	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CR6HC	WOS:000361445000010		
J	Kwon, HJ; Kim, Y; Sugihara, Y; Baldetorp, B; Welinder, C; Watanabe, K; Nishimura, T; Malm, J; Torok, S; Dome, B; Vegvari, A; Gustavsson, L; Fehniger, TE; Marko-Varga, G				Kwon, Ho Jeong; Kim, Yonghyo; Sugihara, Yutaka; Baldetorp, Bo; Welinder, Charlotte; Watanabe, Ken-ichi; Nishimura, Toshihide; Malm, Johan; Toeroek, Szilvia; Doeme, Balazs; Vegvari, Akos; Gustavsson, Lena; Fehniger, Thomas E.; Marko-Varga, Gyorgy			Drug compound characterization by mass spectrometry imaging in cancer tissue	ARCHIVES OF PHARMACAL RESEARCH			English	Review						Mass spectrometry imaging; Protein sequence; Drug compound; Cancer; Malignant melanoma	HUMAN PROTEOME PROJECT; ANTIANGIOGENIC THERAPY; MALDI-MS; MELANOMA; PROTEINS; METABOLITES; VEMURAFENIB; RESOURCES; SURVIVAL	MALDI mass spectrometry imaging (MSI) provides a technology platform that allows the accurate visualization of unlabeled small molecules within the two-dimensional spaces of tissue samples. MSI has proven to be a powerful tool-box concept in the development of new drugs. MSI allows unlabeled drug compounds and drug metabolites to be detected and identified and quantified according to their mass-to-charge ratios (m/z) at high resolution in complex tissue environments. Such drug characterization in situ, by both spatial and temporal behaviors within tissue compartments, provide new understandings of the dynamic processes impacting drug uptake and metabolism at the local sites targeted by therapy. Further, MSI in combination with histology and immunohistochemistry, provides the added value of defining the context of cell biology present at the sites of drug localization thus providing invaluable information relating to treatment efficacy. In this report we provide mass spectrometry imaging data within various cancers such as malignant melanoma in patients administered with vemurafenib, a protein kinase inhibitor that is targeting BRAF mutated proteins and that has shown significant efficacy in restraining disease progression. We also provide an overview of other examples of the new generation of targeted drugs, and demonstrate the data on personalized medicine drugs localization within tumor compartments within in vivo models. In these cancer models we provide detailed data on drug and target protein co-localization of YCG185 and sunitinib. These drugs are targeting VEGFR2 within the angiogenesis mechanism. Our ability to resolve drug uptake at targeted sites of directed therapy provides important opportunities for increasing our understanding about the mode of action of drug activity within the environment of disease.	[Kwon, Ho Jeong; Kim, Yonghyo] Yonsei Univ, Chem Genom Natl Res Lab, Translat Res Ctr Funct Control, Dept Biotechnol,Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Sugihara, Yutaka; Baldetorp, Bo; Welinder, Charlotte] Lund Univ, Dept Clin Sci Lund, Oncol & Pathol, Lund, Sweden; [Watanabe, Ken-ichi] Sumitomo Dainippon Pharma Co Ltd, Preclin Res Labs, Osaka, Japan; [Watanabe, Ken-ichi; Nishimura, Toshihide; Vegvari, Akos; Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Dept Biomed Engn, Biomed Ctr, Clin Prot Sci & Imaging,BMC D13, Lund, Sweden; [Nishimura, Toshihide; Malm, Johan; Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry CEBMM, Biomed Ctr D13, Lund, Sweden; [Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Shinjuku Ku, Tokyo 1608402, Japan; [Malm, Johan] Lund Univ, Skane Univ Hosp Malmo, Dept Translat Med, Sect Clin Chem, Malmo, Sweden; [Toeroek, Szilvia; Doeme, Balazs] Natl Koranyi Inst Pulmonol, Budapest, Hungary; [Doeme, Balazs] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Vegvari, Akos] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Gustavsson, Lena] H Lundbeck & Co AS, Dept Drug Metab, Copenhagen, Denmark	Malm, J (reprint author), Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry CEBMM, Biomed Ctr D13, Lund, Sweden.	johan.malm@med.lu.se	Welinder, Charlotte/G-1144-2014; 	Welinder, Charlotte/0000-0001-9626-0576; Vegvari, Akos/0000-0002-1287-0906	Mrs. Berta Kamprad Foundation; Swedish Academy of Pharmaceutical Sciences; Swedish Research Council; Swedish Foundation for Strategic Research; Vinnova; Ingabritt & Arne Lundbergs forskningsstiftelse; Fundacion Federico SA; Crafoord Foundation; National Research Foundation of Korea (NRF) - Korean Government [2009-0083522, 2012M3A9D1054520]; Brain Korea 21 Plus Project, Republic of Korea	This work was supported by grants from Mrs. Berta Kamprad Foundation, Swedish Academy of Pharmaceutical Sciences, Swedish Research Council, the Swedish Foundation for Strategic Research, Vinnova, Ingabritt & Arne Lundbergs forskningsstiftelse, Fundacion Federico SA, the Crafoord Foundation and from the National Research Foundation of Korea (NRF) funded by the Korean Government (2009-0083522 and 2012M3A9D1054520), and the Brain Korea 21 Plus Project, Republic of Korea.	Abe H, 2013, INT J UROL, V20, P944, DOI 10.1111/iju.12187; Amir E, 2009, EXPERT OPIN INV DRUG, V18, P1667, DOI 10.1517/13543780903336050; Fehniger TE, 2011, ANAL CHEM, V83, P8329, DOI 10.1021/ac2014349; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Pellegatti M, 2011, EXPERT OPIN DRUG MET, V7, P137, DOI 10.1517/17425255.2011.545053; Jayson GC, 2012, NAT REV CLIN ONCOL, V9, P297, DOI 10.1038/nrclinonc.2012.8; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Paik YK, 2012, J PROTEOME RES, V11, P2005, DOI 10.1021/pr200824a; Solon EG, 2010, AAPS J, V12, P11, DOI 10.1208/s12248-009-9158-4; Swales JG, 2014, ANAL CHEM, V86, P8473, DOI 10.1021/ac502217r; Cobice DF, 2013, ANAL CHEM, V85, P11576, DOI 10.1021/ac402777k; Nilsson CL, 2015, J PROTEOME RES, V14, P603, DOI 10.1021/pr500564q; Paik YK, 2014, J PROTEOME RES, V13, P1, DOI 10.1021/pr4011958; Lazova R, 2012, AM J DERMATOPATH, V34, P82, DOI 10.1097/DAD.0b013e31823df1e2; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Langer O, 2004, CURR DRUG METAB, V5, P463, DOI 10.2174/1389200043335379; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; Baker M, 2012, NATURE, V486, P141, DOI 10.1038/486141a; Lietz CB, 2013, ADV DRUG DELIVER REV, V65, P1074, DOI 10.1016/j.addr.2013.04.009; Takai N, 2012, RAPID COMMUN MASS SP, V26, P1549, DOI 10.1002/rcm.6256; Castellino S, 2013, CHEM RES TOXICOL, V26, P241, DOI 10.1021/tx3004196; Garcia VM, 2012, CLIN CANCER RES, V18, P3750, DOI 10.1158/1078-0432.CCR-11-1275; Koeniger SL, 2011, RAPID COMMUN MASS SP, V25, P503, DOI 10.1002/rcm.4891; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Marko-Varga G, 2013, J PROTEOME RES, V12, P1, DOI [10.1021/pr301183a, 10.1021/pr301183aIJ]; Willems SM, 2010, J PATHOL, V222, P400, DOI 10.1002/path.2771; Buck A, 2015, ANAL BIOANAL CHEM, V407, P2107, DOI 10.1007/s00216-014-8237-2; Chaurand P, 2008, MOL CELL PROTEOMICS, V7, P411, DOI 10.1074/mcp.M700190-MCP200; Dwyer Drew, 2011, Int J Evid Based Healthc, V9, P388, DOI 10.1111/j.1744-1609.2011.00239.x; Fehniger TE, 2014, J PROTEOME RES, V13, P5310, DOI 10.1021/pr500472d; Fu YL, 2010, J CARDIOVASC TRANSL, V3, P24, DOI 10.1007/s12265-009-9158-x; Goto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090242; Harbst K, 2014, J PATHOL, V233, P39, DOI 10.1002/path.4318; Hardesty WM, 2008, ANAL BIOANAL CHEM, V391, P899, DOI 10.1007/s00216-008-1972-5; Jirasko R, 2014, ANAL BIOANAL CHEM, V406, P4601, DOI 10.1007/s00216-014-7880-y; Kato H, 2011, J PROTEOMICS, V74, P759, DOI 10.1016/j.jprot.2010.12.006; Lanao JM, 2005, CURR PHARM DESIGN, V11, P3829, DOI 10.2174/138161205774580679; Legrain P., 2011, MOL CELL PROTEOMICS, V10; Liu XH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02859; Loges Sonja, 2010, Genes Cancer, V1, P12, DOI 10.1177/1947601909356574; Marko-Varga G, 2014, J PROTEOME RES, V13, P5319, DOI 10.1021/pr500475q; Marko-Varga György, 2012, Clin Transl Med, V1, P8, DOI 10.1186/2001-1326-1-8; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Nishimura T., 2014, CLIN TRANSLATIONAL M, V3, P61; Shariatgorji M, 2014, NEURON, V84, P697, DOI 10.1016/j.neuron.2014.10.011; Sugihara Y, 2014, PROTEOMICS, V14, P1963, DOI 10.1002/pmic.201300476; Torok S, 2015, BRIT J PHARMACOL, V172, P1148, DOI 10.1111/bph.12990; Welinder Charlotte, 2013, Clin Transl Med, V2, P7, DOI 10.1186/2001-1326-2-7; Yasunaga M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03050; Ye H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092831; Young T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086706	54	0	0	PHARMACEUTICAL SOC KOREA	SEOUL	1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA	0253-6269	1976-3786		ARCH PHARM RES	Arch. Pharm. Res.	SEP	2015	38	9			SI		1718	1727		10.1007/s12272-015-0627-2		10	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CR6HC	WOS:000361445000014		
J	Wang, YT; Zhang, Y; Zhang, CD; Weng, HL; Li, Y; Cai, W; Xie, MY; Long, YJ; Ai, Q; Liu, Z; Du, G; Wang, S; Niu, YL; Song, FZ; Ozaki, T; Bu, YQ				Wang, Yitao; Zhang, Ying; Zhang, Chundong; Weng, Huali; Li, Yi; Cai, Wei; Xie, Mengyu; Long, Yinjiang; Ai, Qing; Liu, Zhu; Du, Gang; Wang, Sen; Niu, Yulong; Song, Fangzhou; Ozaki, Toshinori; Bu, Youquan			The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						Bidirectional promoter; PRR11; SKA2; NF-Y; Cell cycle; Lung cancer	CELL-CYCLE PROGRESSION; HUMAN GENOME; TRANSCRIPTIONAL REGULATION; MRPS12/SARSM PROMOTER; EXPRESSION; ORGANIZATION; SEQUENCE; COMPLEX; PROLIFERATION; MOUSE	Head-to-head gene pairs represent a unique feature of gene organization in eukaryotes, accounting for >10% of genes in the human genome. Identification and functional analysis of such gene pairs is only in its infancy. Recently, we identified PRR11 as a novel cancer-related gene that is implicated in cell cycle and lung cancer. Here we demonstrate that PRR11 is oriented in a head-to-head configuration with its neighboring gene, SKA2. 5'-RACE assay revealed that the intergenic spacer region between the two genes is <500 bp. Serial luciferase reporter assays demonstrated that a minimal 80-bp intergenic region functions as a core bidirectional promoter to drive basal transcription in both the PRR11 and SKA2 orientations. EMSA and ChIP assays demonstrated that NF-Y binds to and directly transactivates the PRR11-SKA2 bidirectional promoter. SiRNA-mediated NF-Y depletion significantly downregulated PRR11 and SKA2 expression. Expression of both PRR11 and SKA2 was significantly upregulated in lung cancer. Expression of the two genes was highly correlated with each other and with NF-Y expression. Remarkably, high expression of both PRR11 and SKA2 was associated with poorer prognosis in lung cancer patients compared with high expression of one gene or low expression of both genes. Knockdown of PRR11 and/or SKA2 remarkably reduced cell proliferation, migration, and invasion in lung cancer cells. Thus, the PRR11-SKA2 bidirectional transcription unit, which is a novel direct target of NF-Y, is essential for the accelerated proliferation and motility of lung cancer cells and may represent a potential target in the diagnosis and/or treatment of human lung cancer. (C) 2015 Elsevier B.V. All rights reserved.	[Wang, Yitao; Zhang, Ying; Zhang, Chundong; Weng, Huali; Li, Yi; Cai, Wei; Xie, Mengyu; Long, Yinjiang; Ai, Qing; Liu, Zhu; Du, Gang; Wang, Sen; Song, Fangzhou; Bu, Youquan] Chongqing Med Univ, Dept Biochem & Mol Biol, Chongqing 400016, Peoples R China; [Wang, Yitao; Zhang, Ying; Zhang, Chundong; Weng, Huali; Li, Yi; Cai, Wei; Xie, Mengyu; Long, Yinjiang; Ai, Qing; Liu, Zhu; Du, Gang; Wang, Sen; Niu, Yulong; Song, Fangzhou; Bu, Youquan] Chongqing Med Univ, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China; [Ozaki, Toshinori] Chiba Canc Ctr, Res Inst, Lab DNA Damage Signaling, Chuoh Ku, Chiba 2608717, Japan	Bu, YQ (reprint author), ChongQing Med Univ, Dept Biochem & Mol Biol, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	buyqcn@cqmu.edu.cn			National Natural Science Foundation of China [30801356, 81001097, 81302263, 81401889]	This work was supported by the National Natural Science Foundation of China (No. 30801356 and No. 81001097 to YB, No. 81302263 to YZ, and No. 81401889 to HZ).	Imbriano C, 2012, BBA-REV CANCER, V1825, P131, DOI 10.1016/j.bbcan.2011.11.001; Orekhova AS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P335, DOI 10.1134/S0006297913040020; Benatti P, 2011, NUCLEIC ACIDS RES, V39, P5356, DOI 10.1093/nar/gkr128; Chen Z, 2012, J CELL BIOCHEM, V113, P3229, DOI 10.1002/jcb.24200; Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Dolfini D, 2013, CELL DEATH DIFFER, V20, P676, DOI 10.1038/cdd.2013.13; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Wakano C, 2012, BBA-GENE REGUL MECH, V1819, P688, DOI 10.1016/j.bbagrm.2012.02.006; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Jeyaprakash AA, 2012, MOL CELL, V46, P274, DOI 10.1016/j.molcel.2012.03.005; Mycko MP, 2012, P NATL ACAD SCI USA, V109, pE1248, DOI 10.1073/pnas.1114325109; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Chen PY, 2009, MOL CELL NEUROSCI, V42, P23, DOI 10.1016/j.mcn.2009.05.001; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Liu ZY, 2012, HEAD NECK-J SCI SPEC, V34, P1789, DOI 10.1002/hed.22013; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Bu YQ, 2008, GENES CELLS, V13, P53, DOI 10.1111/j.1365-2443.2007.01144.x; Chen P.Y., 2007, BMC MOL BIOL, V9, P2; Guarguaglini G, 1997, BIOCHEM J, V325, P277; Ji Y, 2013, INT J BIOCHEM CELL B, V45, P645, DOI 10.1016/j.biocel.2012.12.002; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055532; Malumbres Marcos, 2003, Prog Cell Cycle Res, V5, P5; Rice L, 2008, J ENDOCRINOL, V198, P499, DOI 10.1677/JOE-08-0019; Sturgill TW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-104; Suen TC, 2005, BBA-GENE STRUCT EXPR, V1728, P126, DOI 10.1016/j.bbaexp.2005.01.014; Voth H, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-28; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Xu CF, 1997, J BIOL CHEM, V272, P20994, DOI 10.1074/jbc.272.34.20994; Yang MQ, 2007, PLOS COMPUT BIOL, V3, P733, DOI 10.1371/journal.pcbi.0030072; Zanotto E, 2009, BBA-GENE REGUL MECH, V1789, P432, DOI 10.1016/j.bbagrm.2009.05.001; Zanotto E, 2008, BBA-MOL CELL RES, V1783, P2352, DOI 10.1016/j.bbamcr.2008.08.001; Zanotto E, 2007, NUCLEIC ACIDS RES, V35, P664, DOI 10.1093/nar/gkl1037; Zhang CD, 2015, BIOCHEM BIOPH RES CO, V458, P501, DOI 10.1016/j.bbrc.2015.01.139	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	SEP	2015	1849	9					1133	1144		10.1016/j.bbagrm.2015.07.002		12	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CR5TW	WOS:000361408200001		
J	Shintani, H				Shintani, Hideharu			Validation Studies for Microbial Contamination and Control of Contaminants	BIOCONTROL SCIENCE			English	Review						Microbial contamination; Disinfectant; Contaminant		Microbiological control is a regulatory requirement and one that can be defined as the continued interaction of science and applied technology with products, processes, materials, equipment, and personnel entering the manufacturing areas. In the ISO 14644-1, control of microbial contamination is addressed. A good microbiological control program starts with understanding the risks for microbial contamination in the manufacturing process and identification of possible types of contaminants. The results obtained from such risk assessment can be used in the design of facilities and equipment as well as when establishing protocols regarding equipment and personnel. Once possible sources of contamination have been identified, control and preventative measures can be implemented and qualified/validated.	Chuo Univ, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan	Shintani, H (reprint author), Chuo Univ, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	hshintani@jcom.zaq.ne.jp					[Anonymous], 1999, OFFICIAL METHODS ANA; [Anonymous], USP31NF26A; [Anonymous], USP31NF26B; Ayorinde J O., 2005, PHARM TECHNOLOGY; Block S. S., 1990, DISINFECTION STERILI, V4th; Cundell A. M., 2002, PHARMACOPEIAL FORUM, V28; EC, 2003, GUID GOOD MAN PRACT; EU, 2001, QUAL VAL FIN VERS AN; FDA, 2004, PHARM CGMPS 21 CENT; FDA Guidance for Industry, 2004, STER DRUG PROD PROD; Hugo W. B., 1992, PHARM MICROBIOLOGY, V5th; Obuekwe I. F., 2002, Pakistan Journal of Scientific and Industrial Research, V45, P341; Van Schothorst M., 2004, SIMPLE GUIDE UNDERST; WHO, 2003, WHO TECHN REP SER, V908	14	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					161	170				10	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400001		
J	Poapolathep, S; Imsilp, K; Machii, K; Kumagai, S; Poapolathep, A				Poapolathep, Saranya; Imsilp, Kanjana; Machii, Kenji; Kumagai, Susumu; Poapolathep, Amnart			The Effects of Curcumin on Aflatoxin B1-Induced Toxicity in Rats	BIOCONTROL SCIENCE			English	Article						Curcumin; Aflatoxin B1; Toxicity; Hepatocarcinogenicity; Rats	CHEMOPREVENTIVE AGENTS; PENTACYCLIC TRITERPENE; LIPID-PEROXIDATION; OXIDATIVE STRESS; B-1; ANTIOXIDANT; CANCER; INHIBITION; METABOLISM; LUPEOL	To evaluate the potential of curcumin on toxic and carcinogenic effects of Aflatoxin B1 (AFB1) in relation to AFB1 metabolism, we studied the effects of curcumin on hepatic AFB1-DNA adduct formation and glutathione S-transferase (GST) activity, and the toxic effects of AFB1 in male Fischer 344 rats. Oral administration of curcumin to 5-week-old male rats at a dose of 8 or 80 mg/kg for five consecutive days for three weeks resulted in reduction of AFB1-DNA adduct formation mediated by both liver microsomal and postmitochondrial fractions. The activity of liver GST toward a universal substrate, CDNB, was increased in curcumin-administered rats. As for the acute toxicity of AFB1, curcumin was orally administered to rats for 3 weeks and then AFB1 was given by intragastric intubation. The result showed a decrease of plasma AST and ALT activities in curcumin-treated rats compared with those which received AFB1 alone. Moreover, we have observed that curcumin also reduced glutathione S-transferase placental form positive single cells and foci caused by AFB1 treatment. These results demonstrate the potential of curcumin to reduce the toxic and carcinogenic effects of AFB1 by modulating hepatic drug metabolizing enzymes responsible for AFB1 metabolism.	[Poapolathep, Saranya; Imsilp, Kanjana; Poapolathep, Amnart] Kasetsart Univ, Dept Pharmacol, Fac Vet Med, Bangkok 10900, Thailand; [Kumagai, Susumu] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo 1138657, Japan; [Machii, Kenji] Natl Inst Hlth Sci, Div Biomed Food Res, Tokyo 1588501, Japan	Poapolathep, A (reprint author), Kasetsart Univ, Dept Pharmacol, Fac Vet Med, Bangkok 10900, Thailand.	fvetamp@ku.ac.th			University of Tokyo, Japan	This study was supported by the University of Tokyo, Japan.	Reddy ACP, 1996, TOXICOLOGY, V107, P39, DOI 10.1016/0300-483X(95)03199-P; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; SATOSKAR RR, 1986, INT J CLIN PHARM TH, V24, P651; Preetha SP, 2006, COMP BIOCHEM PHYS C, V143, P333, DOI 10.1016/j.cbpc.2006.03.008; Iqbal M, 2003, PHARMACOL TOXICOL, V92, P33, DOI 10.1034/j.1600-0773.2003.920106.x; El-Agamy DS, 2010, ARCH TOXICOL, V84, P389, DOI 10.1007/s00204-010-0511-2; Wogan GN, 1999, HEPATOLOGY, V30, P573, DOI 10.1002/hep.510300231; MCLEAN M, 1995, PHARMACOL THERAPEUT, V65, P163, DOI 10.1016/0163-7258(94)00054-7; Guengerich FP, 1998, MUTAT RES-FUND MOL M, V402, P121, DOI 10.1016/S0027-5107(97)00289-3; Hayes JD, 1998, CHEM-BIOL INTERACT, V112, P51; Nagaraj M, 2000, J APPL TOXICOL, V20, P413, DOI 10.1002/1099-1263(200009/10)20:5<413::AID-JAT706>3.0.CO;2-Y; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Kaur G, 2006, CLIN EXP IMMUNOL, V145, P313, DOI 10.1111/j.1365-2249.2006.03108.x; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; RAO CV, 1993, CARCINOGENESIS, V14, P2219, DOI 10.1093/carcin/14.11.2219; Soto C, 2003, COMP BIOCHEM PHYS C, V136, P205, DOI 10.1016/S1532-0456(03)00214-X; AZUINE MA, 1992, NUTR CANCER, V17, P77; Bammler TK, 2000, TOXICOL SCI, V54, P30, DOI 10.1093/toxsci/54.1.30; Bannasch P., 1992, IARC SCI PUBL, P389; Chin D, 2013, CURR MED CHEM, V20, P3955; CHOY WN, 1993, MUTAT RES, V296, P181, DOI 10.1016/0165-1110(93)90010-K; DOLL R, 1981, J NATL CANCER I, V66, P1191; Ellis EM, 2009, TOXICOL SCI, V109, P1, DOI 10.1093/toxsci/kfp052; Esaki H, 2002, TOXICON, V40, P941, DOI 10.1016/S0041-0101(02)00090-9; Franschini F., 2002, CLIN DRUG INVEST, V22, P51; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; International Agency for Research on Cancer (IARC), 1993, IARC MON EV CARC RIS, V56, P245; JECFA, 1998, WHO FOOD ADDITIVES S, V40, P361; KALENGAYI MMR, 1975, CANCER RES, V35, P2845; Kaul S, 1997, MOL CELL BIOCHEM, V175, P43, DOI 10.1023/A:1006829010327; KELLOFF GJ, 1992, CANCER CHEMOPREVENTION, P41; KELLOFF GJ, 1994, J CELL BIOCHEM, P1; Kono M, 1995, MYCOPATHOLOGIA, V132, P117, DOI 10.1007/BF01103784; LARSSON P, 1994, CARCINOGENESIS, V15, P947, DOI 10.1093/carcin/15.5.947; Murakami Teruo, 2004, Drug Metab Pharmacokinet, V19, P96, DOI 10.2133/dmpk.19.96; Plaa G.L., 1986, PRINCIPLES METHODS T, P401; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; Smith WA, 2001, MUTAT RES-FUND MOL M, V480, P97, DOI 10.1016/S0027-5107(01)00173-7; Sudharsan PT, 2005, HUM EXP TOXICOL, V24, P313, DOI 10.1191/0960327105ht530oa; TATEMATSU M, 1987, TOXICOL PATHOL, V15, P60; YIN SJ, 1980, BRIT J CANCER, V42, P319, DOI 10.1038/bjc.1980.233	41	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					171	177				7	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400002		
J	Kojima, C; Kishimoto, M; Ezaki, T				Kojima, Chiaki; Kishimoto, Michiru; Ezaki, Takayuki			Distribution of Antimicrobial Resistance in Campylobacter Strains Isolated from Poultry at a Slaughterhouse and Supermarkets in Japan	BIOCONTROL SCIENCE			English	Article						Campylobacter; Fluoroquinolone; Erythromycin; Antimicrobial resistance	FOOD-PRODUCING ANIMALS; MACROLIDE RESISTANCE; JEJUNI; FARMS; COLI; PREVALENCE; TRENDS	Fifty strains of Campylobacter jejuni/coli were detected in 108 specimens of chicken meat and organs sampled at six supermarkets and one poultry slaughterhouse (large scale) between April and October 2013 (isolation rates: 84.8% from the slaughterhouse, 29.3% from the supermarkets). 46/50 strains were successfully recovered and subjected to the E-test to examine their susceptibility to three fluoroquinolone antibacterial agents authorized for use in poultry in Japan: enrofloxacin (ERFX), ofloxacin (OFLX), and norfloxacin (NLFX). 29 isolates (63%) were resistant to all three agents and 2 isolates (4.3%) were resistant to two agents (ERFX and OFLX). The resistance rates of strains isolated fom the supermarkets and slaughterhouse were 61.9% and 72.0%, respectively. Because the chickens processed at the slaughterhouse were raised without the use of fluoroquinolone, the results did not suggest a positive relationship between the use of these agents and the distribution of antimicrobial-resistant bacteria. Susceptibility to macrolide antibiotics (erythromycin [EM]) was also tested in 42 strains, and one strain (2.4%), C. coil from a retailer sample, showed resistance. Previous studies have detected high rates of fluoroquinolone-resistant strains, suggesting an expanding distribution of resistant bacteria. The detection of EM-resistant bacteria downstream in the food distribution chain (i.e., closer to consumers) is a concern for human health.	[Kojima, Chiaki; Ezaki, Takayuki] Gifu Univ, Sch Med, Dept Microbiol, Gifu 5011194, Japan; [Kishimoto, Michiru] Nagoya Univ Arts & Sci, Nisshin, Aichi 4700196, Japan	Kojima, C (reprint author), Gifu Univ, Sch Med, Dept Microbiol, 1-1 Yanagido, Gifu 5011194, Japan.	r2801002@edu.gifu-u.ac.jp					Aiba M., 2012, J JAPAN VET MED ASS, V65, P147; Gupta A, 2004, EMERG INFECT DIS, V10, P1102; Gibreel A, 2006, J ANTIMICROB CHEMOTH, V58, P243, DOI 10.1093/jac/dkl210; Nelson JM, 2007, CLIN INFECT DIS, V44, P977, DOI 10.1086/512369; Haruna M, 2012, ZOONOSES PUBLIC HLTH, V59, P241, DOI 10.1111/j.1863-2378.2011.01441.x; Engberg J, 2001, EMERG INFECT DIS, V7, P24; Asai T., 2009, LIVESTOCK TECHNOLOGY, V651, P6; Asai T, 2007, JPN J INFECT DIS, V60, P290; Clinical and Laboratory Standards Institute, 2010, M45A2 CLSI; Food Safety Commission of Japan, 2007, REP JAP FOOD PROD AN; Harada K, 2006, J VET MED SCI, V68, P1109, DOI 10.1292/jvms.68.1109; Hayashi M, 2013, INT J FOOD MICROBIOL, V163, P41, DOI 10.1016/j.ijfoodmicro.2013.02.007; Igimi S., 2012, JAPANESE J CLIN MED, V70, P1298; Igimi S, 2008, FOOD ADDIT CONTAM A, V25, P1080, DOI 10.1080/02652030802093900; Ishihara K, 2006, J VET MED SCI, V68, P515, DOI 10.1292/jvms.68.515; Kakimoto S., 2007, J JAPANESE ASS INFEC, V81, P363; Kawakami S., 2009, CLIN MICROBIOLOGY, V36, P536; Kawanishi M., 2012, ALL SWINE, V41, P44; Misawa N., 2012, J JAPAN VET MED ASS, V65, P617; National Antimicrobial Resistance Monitoring System, 2012, RET MEAT ANN REP 201; Ono K., 2002, Journal of the Japan Veterinary Medical Association, V55, P447; Sakagami S., 1998, J PRACTICAL PHARM, V49, P1157; Tsunematsu S., 2012, JAPANESE J CLIN MED, V70, P1352	23	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					179	184				6	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400003		
J	Sabike, II; Fujikawa, H; Edris, AM				Sabike, Islam I.; Fujikawa, Hiroshi; Edris, Abobakr M.			The Growth Kinetics of Salmonella Enteritidis in Raw Ground Beef	BIOCONTROL SCIENCE			English	Article						Salmonella; Ground beef; Logistic model; Polynomial model; Growth kinetics	LIQUID EGG PRODUCTS; LOGISTIC MODEL; MICROBIAL-GROWTH; TEMPERATURE; OUTBREAK; CULTURE	The growth kinetics of Salmonella Enteritidis in raw beef has been little studied so far. Thus, this study aimed to clarify the growth kinetics of the pathogen in ground beef using a growth model. When Salmonella cells inoculated at various initial doses into ground beef were incubated at a given temperature (24 degrees C), the maximum population (N-max) of the microbe at the stationary phase varied with the doses. This relationship was expressed with a polynomial equation for Nmax using the initial dose. The combination of the growth model and the polynomial equation successfully predicted Salmonella growth at a given initial dose. When Salmonella cells inoculated in ground beef were incubated at various constant temperatures, the growth curves of the pathogen and natural microflora (NM) were well described with the growth model. The rate constant of growth and the N-max values for Salmonella and NM were then analyzed kinetically. From these results, growth curves of Salmonella and NM in ground beef stored at dynamic temperatures were successfully predicted. Competition between Salmonella and NM in ground beef was also found during the storage. This study could give usable information on the growth of Salmonella and NM in ground beef at various temperatures.	[Sabike, Islam I.; Fujikawa, Hiroshi] Tokyo Univ Agr & Technol, Fac Agr, Lab Vet Publ Hlth, Fuchu, Tokyo 183, Japan; [Sabike, Islam I.; Edris, Abobakr M.] Benha Univ, Dept Food control, Fac Vet Med, Banha, Egypt	Fujikawa, H (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Lab Vet Publ Hlth, Fuchu, Tokyo 183, Japan.	fujik@cc.tuat.ac.jp					Moller COA, 2013, FOOD MICROBIOL, V34, P284, DOI 10.1016/j.fm.2012.10.010; Juneja VK, 2009, INT J FOOD MICROBIOL, V131, P106, DOI 10.1016/j.ijfoodmicro.2009.01.034; Zaher SM, 2011, J FOOD PROTECT, V74, P735, DOI 10.4315/0362-028X.JFP-10-334; Breidt F, 1998, APPL ENVIRON MICROB, V64, P3159; Jackson BR, 2013, EMERG INFECT DIS, V19, P1239, DOI 10.3201/eid1908.121511; Fujikawa H, 2004, FOOD MICROBIOL, V21, P501, DOI 10.1016/j.fm.2004.01.007; Roels TH, 1997, EPIDEMIOL INFECT, V119, P127, DOI 10.1017/S0950268897007851; RATKOWSKY DA, 1982, J BACTERIOL, V149, P1; Le Marc Y, 2009, INT J FOOD MICROBIOL, V129, P306, DOI 10.1016/j.ijfoodmicro.2008.12.015; [Anonymous], 2004, STANDARD METHOD ANAL; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Gimenez B, 2004, J APPL MICROBIOL, V96, P96, DOI 10.1046/j.1365-2672.2003.02137.x; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Arthur TM, 2008, J FOOD PROTECT, V71, P1685; Ayres J. C., 1955, ADV FOOD RES, V6, P109; CDC (Centers for Disease Control and Prevention), 1995, MMWR WEEKLY, V44, P905; CDC (Centers for Disease Control and Prevention), 2012, MULT OUTBR SALM ENT; CDC (Centers for Disease Control and Prevention), 2013, MULT OUTBR HUM SALM; CDC (Centers for Disease Control and Prevention), 2006, MMWR-MORBID MORTAL W, V55, P180; DAOUST JY, 1991, INT J FOOD MICROBIOL, V13, P207, DOI 10.1016/0168-1605(91)90004-9; Dens EJ, 1999, J THEOR BIOL, V201, P159, DOI 10.1006/jtbi.1999.1021; Fujikawa H, 2009, BIOCONTROL SCI, V14, P83; Fujikawa H, 2003, J FOOD HYG SOC JPN, V44, P155; Fujikawa H, 2014, BIOCONTROL SCI, V19, P61; IDSC (Infectious Disease Surveillance center), 2014, 15 MOST COMM SALM SE; MACKEY BM, 1988, INT J FOOD MICROBIOL, V6, P57, DOI 10.1016/S0168-1605(00)00357-3; McMeekin T.A., 1993, PREDICTIVE MICROBIOL; Sakha MZ, 2012, BIOCONTROL SCI, V17, P183, DOI 10.4265/bio.17.183; Sakha MZ, 2013, BIOCONTROL SCI, V18, P89; USDA (US Department of Agriculture) and FSIS (Food Safety and Inspection Service), 2012, PROGR REP SALM CAMP; Vandermeer J. H., 2003, POPULATION ECOLOGY 1	31	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					185	192				8	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400004		
J	Kawakami, H; Nishikubo, H; Hirayama, K; Suzuki, S; Sato, Y; Kikuchi, Y				Kawakami, Hiroshi; Nishikubo, Hideyuki; Hirayama, Kenta; Suzuki, Satoshi; Sato, Yoshihiro; Kikuchi, Yasushi			Effects of NaOCl Aqueous Solutions and Ethyl Alcohol Solutions on Removing Protein Surface Contaminants and Re-establishing Antibacterial Activities of Copper-Alloyed Stainless Steel	BIOCONTROL SCIENCE			English	Article						Sodium hypochlorite; Ethyl alcohol; Antibacterial stainless steel; Protein surface contaminant; Environmental surfaces	ENVIRONMENTAL SURFACES; CROSS-CONTAMINATION; SURVIVAL; PATHOGENS	Effects of wiping copper-alloyed stainless steel surfaces with disinfectants to remove protein surface contaminants and re-establish their antibacterial activities were quantitatively studied. Disinfectants used were sodium hypochlorite aqueous solutions and ethyl alcohol aqueous solutions. Wiping with NaOCl aqueous solutions effectively removed protein surface contaminants. Ethyl alcohol aqueous solutions were also effective for cleaning, but their efficiency was less than that of NaOCl aqueous solutions. When the amount of residual surface contaminants was reduced to 0.4 ng/mm(2), the surfaces of the copper-alloyed stainless steel regained antibacterial activities to the same level as those in a clean surface condition.	[Kawakami, Hiroshi; Nishikubo, Hideyuki; Hirayama, Kenta; Suzuki, Satoshi; Sato, Yoshihiro; Kikuchi, Yasushi] Osaka City Univ, Grad Sch Engn, Sumiyoshi Ku, Osaka 558, Japan; [Suzuki, Satoshi] Nisshin Steel Co Ltd, Stainless Steel & High Alloy R&D Dept, Shunan, Yamaguchi, Japan	Kawakami, H (reprint author), Osaka City Univ, Grad Sch Engn, Sumiyoshi Ku, Sugimoto 3-3-138, Osaka 558, Japan.	hkawakam@mech.eng.osaka-cu.ac.jp					Rose LJ, 2003, APPL ENVIRON MICROB, V69, P2166, DOI 10.1128/AEM.69.4.2166-2171.2003; Hong IT, 2005, MAT SCI ENG A-STRUCT, V393, P213, DOI 10.1016/j.msea.2004.10.032; Kusumaningrum HD, 2003, INT J FOOD MICROBIOL, V85, P227, DOI 10.1016/S0168-1605(02)00540-8; Noyce JO, 2006, APPL ENVIRON MICROB, V72, P4239, DOI 10.1128/AEM.02532-05; Dietze B, 2001, J HOSP INFECT, V49, P255, DOI 10.1053/jhin.2001.1094; Fukuzaki S., 2014, J ANTIBACT ANTIFUNG, V42, P475; Fukuzaki S., 2007, J SURFACE FINISH SOC, V58, P465, DOI [10.4139/sfj.58.465, DOI 10.4139/SFJ.58.465]; Higashino T., 2011, MED MICROBIOLOGY, V155, P456; Kawakami H, 2010, ISIJ INT, V50, P133, DOI 10.2355/isijinternational.50.133; Kawakami H, 2014, BIOCONTROL SCI, V19, P73; Kielemoes J, 2001, LETT APPL MICROBIOL, V33, P148, DOI 10.1046/j.1472-765X.2001.00967.x; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Shams AM, 2007, APPL ENVIRON MICROB, V73, P8001, DOI 10.1128/AEM.00936-07; Suzuki S, 2014, TETSU TO HAGANE, V100, P1021, DOI 10.2355/tetsutohagane.100.1021; Suzuki S., 2001, BOKIN BOBAI, V29, P433; Urano Hiromi, 2005, Biocontrol Science, V10, P21; Urano H., 2010, Bokin Bobai - Journal of Antibacterial and Antifungal Agents, V38, P211	17	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					193	198				6	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400005		
J	Elgaml, A; Miyoshi, SI				Elgaml, Abdelaziz; Miyoshi, Shin-ichi			Presence of Nitric Oxide-Sensing Systems in the Human Pathogen Vibrio vulnificus	BIOCONTROL SCIENCE			English	Article						Vibrio vulnificus; Nitric oxide; Oxidative stress; Detoxification	ENTERICA SEROVAR TYPHIMURIUM; NEISSERIA-MENINGITIDIS; BACTERIAL RESPONSES; PROTEASE PRODUCTION; HUMAN MACROPHAGES; BIOFILM FORMATION; METALLOPROTEASE; DETOXIFICATION; FLAVORUBREDOXIN; DISCOVERY	Vibrio vulnificus is a halophilic estuarine bacterium, but this species causes fatal septicemia in humans. V. vulnificus may encounter many kinds of stresses either in the natural environment or in the human body. One of the striking stresses is the exposure to the reactive oxygen species including nitric oxide (NO). The present study revealed that NO could participate in the regulation of the V. vulnificus community behavior. When the bacterium was cultivated in the presence of sub-lethal doses of an NO donor, the expression of the genes encoding NO-detoxifying enzymes was significantly increased. The NO donor was also found to cause significant increase in production of a metalloprotease, a putative virulence factor, by the bacterium.	[Elgaml, Abdelaziz; Miyoshi, Shin-ichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Okayama 7008530, Japan; [Elgaml, Abdelaziz] Mansoura Univ, Fac Pharm, Microbiol & Immunol Dept, Mansoura 35516, Egypt	Miyoshi, SI (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 1-1-1 Tsushima Naka, Okayama, Okayama 7008530, Japan.	miyos-s@cc.okayama-u.ac.jp			Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), the Ministry of Education, Culture, Sports, Science and Technology in Japan	This study was supported by a grant from the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Nowakowska J, 2013, FEMS MICROBIOL ECOL, V84, P213, DOI 10.1111/1574-6941.12052; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Kawase T, 2004, FEMS MICROBIOL LETT, V240, P55, DOI 10.1016/j.femsle.2004.09.023; MIYOSHI N, 1987, MICROBIOL IMMUNOL, V31, P13; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Stevanin TM, 2005, INFECT IMMUN, V73, P3322, DOI 10.1128/IAI.73.6.3322-3329.2005; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Heurlier K, 2008, J BACTERIOL, V190, P2488, DOI 10.1128/JB.01869-07; Wang YL, 2010, P NATL ACAD SCI USA, V107, P8375, DOI 10.1073/pnas.1003571107; Henares BM, 2012, ACS CHEM BIOL, V7, P1331, DOI 10.1021/cb300215t; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Plate L, 2013, TRENDS BIOCHEM SCI, V38, P566, DOI 10.1016/j.tibs.2013.08.008; Carlson HK, 2010, MOL MICROBIOL, V77, P930, DOI 10.1111/j.1365-2958.2010.07259.x; Mills PC, 2008, MICROBIOL-SGM, V154, P1218, DOI 10.1099/mic.0.2007/014290-0; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Elgaml A, 2014, WORLD J MICROB BIOT, V30, P681, DOI 10.1007/s11274-013-1501-3; Miyoshi S, 2006, J DERMATOL, V33, P589, DOI 10.1111/j.1346-8138.2006.00139.x; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Derbyshire Emily R., 2009, V191, P17; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Elgaml A, 2013, AQUACULTURE, V416, P315, DOI 10.1016/j.aquaculture.2013.09.041; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Miyoshi S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00339; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; Stern AM, 2012, MBIO, V3, DOI 10.1128/mBio.00013-12; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Wang J, 2008, MICROB PATHOGENESIS, V44, P494, DOI 10.1016/j.micpath.2008.01.001	28	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					199	203				5	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400006		
J	Harada, Y; Lekcharoensuk, P; Furuta, T; Taniguchi, T				Harada, Yu; Lekcharoensuk, Porntippa; Furuta, Taro; Taniguchi, Tooru			Inactivation of Foot-and-Mouth Disease Virus by Commercially Available Disinfectants and Cleaners	BIOCONTROL SCIENCE			English	Article						Foot-and-mouth disease virus; Virucidal effect; Alcohol-based disinfectant; Alkaline cleaner; Chlorine disinfectant	JAPAN	Foot-and-mouth disease virus (FMDV) is an animal pathogen of great concern. It is contagious to cloven-hoofed animals and affects animals in extensive areas worldwide. In general, the primary eradication strategies for foot-and-mouth disease (FMD) in Japan are stamping out the disease and restriction of movement. It is also important to completely disinfect the infected area to prevent the spread of FMDV, including vehicles and people as well. However, there is no report on the effect of commercially available disinfectants against FMDV in a short contact time. In this study, we evaluated the virucidal effect of thirteen commercially available products, and got the following results: acidic ethanol disinfectants, alkaline cleaners and sodium hypochlorite had great effect (>3.0 log(10) reduction in titer) against FMDV. On the other hand, neutral ethanol disinfectants, hand soaps, and quaternary ammonium compound sanitizers did not show great effect against FMDV. Therefore, it is presumed that acidic ethanol disinfectants are effective for human use and alkaline cleaners are effective for use in the infected environment for the control of a FMD outbreak.	[Harada, Yu; Taniguchi, Tooru] Saraya Co Ltd, Biochem Lab, Satellite Lab, Ibaraki, Osaka 5670085, Japan; [Lekcharoensuk, Porntippa] Kasetsart Univ, Dept Microbiol & Immunol, Fac Vet Med, Bangkok 10900, Thailand; [Furuta, Taro] Saraya Co Ltd, Biochem Lab, Kashiwara, Osaka 5820028, Japan	Harada, Y (reprint author), Saraya Co Ltd, Biochem Lab, Satellite Lab, 309 Saito Bioincubator,7-7-15 Saitoasagi, Ibaraki, Osaka 5670085, Japan.	harada-y@saraya.com					Muroga N, 2012, J VET MED SCI, V74, P399, DOI 10.1292/jvms.11-0271; Farez S, 1997, REV SCI TECH OIE, V16, P65; Rutala WA, 1996, AM J INFECT CONTROL, V24, P313, DOI 10.1016/S0196-6553(96)90066-8; Denyer SP, 1998, INT BIODETER BIODEGR, V41, P261, DOI 10.1016/S0964-8305(98)00023-7; Chen HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-510; SELLERS RF, 1969, J HYG-CAMB, V67, P671; MARIS P, 1995, REV SCI TECH OIE, V14, P47; European Committee for Standardization, 2005, 14476 EN EUR COMM ST; Furuta T., 2009, Bokin Bobai - Journal of Antibacterial and Antifungal Agents, V37, P659; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480; Muroga N, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-150; Owen J. M., 1995, REV SCI TECH OIE, V14, P382; Sanchez-Aparicio MT, 2009, CLIN VACCINE IMMUNOL, V16, P1228, DOI 10.1128/CVI.00139-09; U.S. Environmental Protection Agency Antimicrobials Division, 2005, CONF VIR EFF TEST US	14	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					205	208				4	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400007		
J	Masuda, M; Era, M; Kawahara, T; Kanyama, T; Morita, H				Masuda, Manami; Era, Mariko; Kawahara, Takayoshi; Kanyama, Takahide; Morita, Hiroshi			Antibacterial Effect of Fatty Acid Salts on Oral Bacteria	BIOCONTROL SCIENCE			English	Article						Antibacterial activity; Fatty acid salt; Oral bacteria	STAPHYLOCOCCUS-AUREUS; INHIBITION	Fatty acid salts are a type of surfactant known to have potent antibacterial activity. We therefore examined the antibacterial activities of fatty acid salts against Streptococcus mutans. Potassium caprylate (C10K), potassium laurate (C12K), potassium myristate (C14K), potassium oleate (C18:1K), potassium linoleate (C18:2K), and potassium linolenate (C18:3K), used at a concentration of 175 mM, resulted in a 7 log-unit reduction of S. mutans after a 10-min incubation. The minimum inhibitory concentration (MIC) of C18:2K and C18:3K was 5.5 mM. C12K also demonstrated high antibacterial activity (MIC of 21.9 mM). These results indicate that C12K, C18:2K, and C18:3K have high antibacterial activity against S. mutans, and possess great potential as antibacterial agents.	[Masuda, Manami; Era, Mariko] Univ Kitakyushu, Grad Sch Environm Engn, Wakamatsu Ku, Kitakyushu 8080135, Japan; [Kawahara, Takayoshi; Kanyama, Takahide] Shabondama Soap Co Ltd, Wakamatsu Ku, Kitakyushu, Fukuoka 8080195, Japan; [Morita, Hiroshi] Univ Kitakyushu, Fac Environm Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080135, Japan	Morita, H (reprint author), Univ Kitakyushu, Fac Environm Engn, Wakamatsu Ku, 1-1 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.	morita@kitakyu-u.ac.jp					ABABOUCH L, 1992, J FOOD PROTECT, V55, P980; Altieri C, 2007, J FOOD PROTECT, V70, P1206; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Desbois AP, 2013, MAR DRUGS, V11, P4544, DOI 10.3390/md11114544; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23; Chen CH, 2011, J MICROBIOL BIOTECHN, V21, P391, DOI 10.4014/jmb.1011.11014; EISLER DM, 1968, J BACTERIOL, V95, P1767; Hirasawa T., 2000, WATER AND OIL, P114; KNAPP HR, 1986, J INFECT DIS, V154, P84; Shapiro S, 1996, ORAL MICROBIOL IMMUN, V11, P350, DOI 10.1111/j.1399-302X.1996.tb00193.x; Suido H., 2011, Bokin Bobai - Journal of Antibacterial and Antifungal Agents, V39, P57	13	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					209	213				5	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400008		
J	Fujikawa, H; Sabike, II; Edris, AM				Fujikawa, Hiroshi; Sabike, Islam I.; Edris, Abobakr M.			Prediction of the Growth of Salmonella Enteritidis in Raw Ground Beef at Various Combinations of the Initial Concentration of the Pathogen and Temperature	BIOCONTROL SCIENCE			English	Article						Salmonella; Ground beef; Growth prediction; Logistic model; Polynomial model	LIQUID EGG PRODUCTS; LOGISTIC MODEL; INOCULUM SIZE; CHICKEN SKIN; NETWORK	Recently we clarified the growth kinetics of Salmonella Enteritidis in raw ground beef at various temperatures with our growth model. Based on those results, this study aimed to build a new methodology to predict the growth of Salmonella in ground beef at given initial concentrations of the pathogen and temperatures. Namely, the maximum cell population of Salmonella at various combinations of its initial concentration and temperature was developed with a polynomial equation. The rate constants of Salmonella growth at various temperatures were estimated with the square root model studied in our recent study. A new system consisting of our growth model, the polynomial equation, and the square root model successfully predicted the growth of Salmonella inoculated at given concentrations in beef at constant and dynamic temperatures. The growth of natural microflora in beef at those temperature patterns were also successfully predicted with the growth model.	[Fujikawa, Hiroshi; Sabike, Islam I.] Tokyo Univ Agr & Technol, Fac Agr, Lab Vet Publ Hlth, Fuchu, Tokyo 183, Japan; [Sabike, Islam I.; Edris, Abobakr M.] Benha Univ, Fac Vet Med, Dept Food Control, Banha, Egypt	Fujikawa, H (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Lab Vet Publ Hlth, Fuchu, Tokyo 183, Japan.	fujik@cc.tuat.ac.jp					Juneja VK, 2009, INT J FOOD MICROBIOL, V131, P106, DOI 10.1016/j.ijfoodmicro.2009.01.034; Fujikawa H, 2005, APPL ENVIRON MICROB, V71, P7920, DOI 10.1128/AEM.71.12.7920-7926.2005; Zaher SM, 2011, J FOOD PROTECT, V74, P735, DOI 10.4315/0362-028X.JFP-10-334; Jackson BR, 2013, EMERG INFECT DIS, V19, P1239, DOI 10.3201/eid1908.121511; Oscar TP, 2009, J FOOD PROTECT, V72, P2078; [Anonymous], 2004, STANDARD METHOD ANAL; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Fujikawa H, 2009, BIOCONTROL SCI, V14, P83; Fujikawa H, 2003, J FOOD HYG SOC JPN, V44, P155; IDSC (Infectious Disease Surveillance center), 2014, 15 MOST COMM SALM SE; Koseki S, 2011, J FOOD PROTECT, V74, P176, DOI 10.4315/0362-028X.JFP-10-258; MACKEY BM, 1988, INT J FOOD MICROBIOL, V6, P57, DOI 10.1016/S0168-1605(00)00357-3; Oscar TP, 2011, J FOOD PROTECT, V74, P1630, DOI 10.4315/0362-028X.JFP-11-127; Sabike I.I., 2015, BIOCONTROL SCI, V20, P183; Sakha MZ, 2012, BIOCONTROL SCI, V17, P183, DOI 10.4265/bio.17.183; Sakha MZ, 2013, BIOCONTROL SCI, V18, P89	16	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					215	220				6	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400009		
J	Nakano, M				Nakano, Miyo			Development of a Quantitative PCR Assay for Thermophilic Spore-Forming Geobacillus stearothermophilus in Canned Food	BIOCONTROL SCIENCE			English	Article						Geobacillus stearothermophilus; Flat sour spoilage; Real-time PCR; Spore-forming thermophilic bacteria	REAL-TIME PCR; BACTERIA; INTERFACE; PRODUCTS	The thermophilic spore forming bacteria Geobacillus stearothermophilus is recognized as a major cause of spoilage in canned food. A quantitative real-time PCR assay was developed to specifically detect and quantify the species G. stearothermophilus in samples from canned food. The selected primer pairs amplified a 163-bp fragment of the 16S rRNA gene in a specific PCR assay with a detection limit of 12.5 fg of pure culture DNA, corresponding to DNA extracted from approximately 0.7 CFU/mL of G. stearothermophilus. Analysis showed that the bacterial species G. stearothermophilus was not detected in any canned food sample. Our approach presented here will be useful for tracking or quantifying species G. stearotethermophilus in canned food and ingredients.	Toyo Inst Food Technol, Div Food Sci, Kawanishi, Hyogo 6660026, Japan	Nakano, M (reprint author), Toyo Inst Food Technol, Div Food Sci, 23-2,4 Chome, Kawanishi, Hyogo 6660026, Japan.	miyo_nakano@shokuken.orjp					Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Membre JM, 2011, INT J FOOD MICROBIOL, V144, P413, DOI 10.1016/j.ijfoodmicro.2010.10.028; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Ruckert A, 2004, INT J FOOD MICROBIOL, V96, P263, DOI 10.1016/j.ijfoodmicro.2004.03.020; Oomes SJCM, 2007, INT J FOOD MICROBIOL, V120, P85, DOI 10.1016/j.ijfoodmicro.2007.06.013; Andre S, 2013, INT J FOOD MICROBIOL, V165, P134, DOI 10.1016/j.ijfoodmicro.2013.04.019; Prevost S, 2010, CURR MICROBIOL, V61, P525, DOI 10.1007/s00284-010-9648-8; Le Drean G, 2010, INT J FOOD MICROBIOL, V138, P100, DOI 10.1016/j.ijfoodmicro.2009.12.013; Burgess SA, 2010, INT J FOOD MICROBIOL, V144, P215, DOI 10.1016/j.ijfoodmicro.2010.09.027; Cooper RM, 2006, J BASIC MICROB, V46, P358, DOI 10.1002/jobm.200510132; Logan N. A., 2009, BERGEYS MANUAL SYSTE, V3, P21; Malorny B, 2008, APPL ENVIRON MICROB, V74, P1299, DOI 10.1128/AEM.02489-07; Postollec F., 2011, FOOD MICROBIOL, P1; Rose HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022668	14	0	0	SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN	OSAKA	NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA, 550-0005, JAPAN	1342-4815	1884-0205		BIOCONTROL SCI	Biocontrol Sci.	SEP	2015	20	3					221	227				7	Biology; Biotechnology & Applied Microbiology	Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied Microbiology	CR5YX	WOS:000361421400010		
J	Kamijo, K; Takeda, Y; Takai, Y; Haramura, M				Kamijo, Keita; Takeda, Yuji; Takai, Yohei; Haramura, Miki			Greater aerobic fitness is associated with more efficient inhibition of task-irrelevant information in preadolescent children	BIOLOGICAL PSYCHOLOGY			English	Article						Childhood fitness; Attentional orientation; P3a; Task-irrelevant information; Event-related brain potentials (ERPs)	ERROR-DETECTION; PHYSICAL-ACTIVITY; ERP COMPONENTS; VISUAL-STIMULI; NEURAL SYSTEM; BRAIN; EXERCISE; P3A; PERFORMANCE; ATTENTION	A growing number of neuroelectric studies using event-related brain potentials have demonstrated that greater aerobic fitness is associated with superior cognitive functioning across the lifespan. However, empirical data regarding the association between fitness and attentional orienting is scarce, with no evidence in children, and the findings are inconclusive. We designed the present study to examine the relationship between aerobic fitness and involuntary attentional orientation to task-irrelevant information in preadolescent children. Lower-fit and higher-fit children performed a visual oddball task in which irregular (i.e., rule-violating) stimuli appeared as a task-irrelevant dimension, while measures of task performance and the P3a component elicited by the irregular stimuli were assessed. Analyses revealed that higher-fit children exhibited lower miss rates and smaller P3a amplitude relative to lower-fit children. These findings suggest that greater childhood fitness is associated with more efficient inhibition of task-irrelevant information. (C) 2015 Elsevier B.V. All rights reserved.	[Kamijo, Keita] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan; [Takeda, Yuji] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; [Takai, Yohei; Haramura, Miki] Natl Inst Fitness & Sports Kanoya, Kanoya, Kagoshima 8932311, Japan	Kamijo, K (reprint author), Waseda Univ, Fac Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.	k-kamijo@aoni.waseda.jp			NIFS	This study was supported by a NIFS project for designing school-based exercise training for promoting fitness and cognitive functioning in children.	Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Hillman CH, 2005, MED SCI SPORT EXER, V37, P1967, DOI 10.1249/01.mss.0000176680.79702.ce; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Carro E, 2001, J NEUROSCI, V21, P5678; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Hillman CH, 2009, DEV PSYCHOL, V45, P114, DOI 10.1037/a0014437; Freitas D, 2007, ANN HUM BIOL, V34, P107, DOI 10.1080/03014460501080983; Pontifex MB, 2009, PSYCHOPHYSIOLOGY, V46, P379, DOI 10.1111/j.1469-8986.2008.00782.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Guthold R, 2010, J PEDIATR-US, V157, P43, DOI 10.1016/j.jpeds.2010.01.019; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Mezzacappa E, 2004, CHILD DEV, V75, P1373, DOI 10.1111/j.1467-8624.2004.00746.x; Bruin KJ, 2001, CLIN NEUROPHYSIOL, V112, P1660, DOI 10.1016/S1388-2457(01)00601-0; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; Dien J, 2004, PSYCHOPHYSIOLOGY, V41, P665, DOI 10.1111/j.1469-8986.2004.00193.x; DuPaul GJ, 1998, ADHD RATING SCALE 4; Erickson K. I., 2015, CURRENT OPINION BEHA, V4, P27; Getzmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074539; Hillman C. H., 2012, FUNCTIONAL NEUROIMAG, P419, DOI DOI 10.1007/978-1-4614-3293-7_18; Japanese Ministry of Education Culture Sports Science and Technology, 2013, REP 2012 SCH HLTH EX; Japanese Ministry of Education Culture Sports Science and Technology, 1981, REP 1980 2001 NAT GR; Kamijo K., 2015, EXERCISE CO IN PRESS; Kimura M., 2015, BRAIN RES; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	SEP	2015	110						68	74		10.1016/j.biopsycho.2015.07.007		7	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Psychology; Behavioral Sciences	CR2KV	WOS:000361159200008		
J	Li, YM; Osada, K; Chen, QX; Tockary, TA; Dirisala, A; Takeda, KM; Uchida, S; Nagata, K; Itaka, K; Kataoka, K				Li, Yanmin; Osada, Kensuke; Chen, Qixian; Tockary, Theofilus A.; Dirisala, Anjaneyulu; Takeda, Kaori M.; Uchida, Satoshi; Nagata, Kazuya; Itaka, Keiji; Kataoka, Kazunori			Toroidal Packaging of pDNA into Block Ionomer Micelles Exerting Promoted in Vivo Gene Expression	BIOMACROMOLECULES			English	Article							POLYPLEX MICELLES; PANCREATIC TUMORS; SKELETAL-MUSCLE; DNA; THERAPY; DELIVERY; COMPLEXES; CATIOMER; CONDENSATION; TRANSFECTION	Selectively spooling single plasmid DNA (pDNA), as a giant polyelectrolyte, into a nanosized toroidal structure or folding it into a rodlike structure has been accomplished by polyion complexation with block catiomers to form polymeric micelles in varying NaCl concentrations. The interactive potency between the pDNA and block catiomers was determined to play a critical role in defining the ultimate structure of the pDNA; the formation of toroidal or rod-like structures was achieved by complexation in 600 or 0 nM NaCl solutions, respectively. Compared with the rod-like structure, the toroidal structure possessed superior biological functions capable not only of elevating in vitro transcription but also of elevating in vivo gene transduction efficiency. This demonstrated the great utility of the toroidal pDNA packaging as a distinct structured gene carrier. Furthermore, the fact that the NaCl concentration at which the toroidal structure was specifically formed corresponds to seawater stimulates interest in this ordered nanostructure as a possible inherent structure for DNA.	[Li, Yanmin; Osada, Kensuke; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan; [Chen, Qixian; Tockary, Theofilus A.; Dirisala, Anjaneyulu; Takeda, Kaori M.; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Uchida, Satoshi; Nagata, Kazuya; Itaka, Keiji; Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Clin Biotechnol,Bunkyo Ku, Tokyo 1130033, Japan; [Osada, Kensuke] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Osada, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	osada@bmw.t.u-tolcyo.ac.jp; kataoka@bmw.t.u-tokyo.ac.jp			Precursory Research for Embryonic Science and Technology (PRESTO) from the Japan Science and Technology Corporation (JST); Center of Innovation (COI) program from the Japan Science and Technology Corporation (JST); Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through "Nanotechnology Platform"; MEXT	This work was financially supported by Precursory Research for Embryonic Science and Technology (PRESTO) and the Center of Innovation (COI) program from the Japan Science and Technology Corporation (JST), KAKENHI Grant-in-Aid for Specially Promoted Research and Core to Core Program for A. Advanced Research Networks from the Japan Society for the Promotion of Science (JSPS), and Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through "Nanotechnology Platform". Y. Li acknowledges a fellowship from the MEXT. The authors are grateful to Dr. S. Fukuda from the University of Tokyo Hospital and Mr. H. Hoshi for their valuable assistance in conducting TEM and to Dr. Y. Mochida from the Graduate School of Medicine at the University of Tokyo for technical support and assistance.	Annunziato AT, 2008, NAT ED, V1, P26; Hagstrom JE, 2004, MOL THER, V10, P386, DOI 10.1016/j.ymthe.2004.05.004; Dirisala A, 2014, BIOMATERIALS, V35, P5359, DOI 10.1016/j.biomaterials.2014.03.037; Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Golan R, 1999, BIOCHEMISTRY-US, V38, P14069, DOI 10.1021/bi990901o; Schaffert D, 2008, GENE THER, V15, P1131, DOI 10.1038/gt.2008.105; MINAGAWA K, 1994, BIOPOLYMERS, V34, P555, DOI 10.1002/bip.360340410; Kanayama N, 2006, CHEMMEDCHEM, V1, P439, DOI 10.1002/cmdc.200600008; Chen QX, 2012, BIOMATERIALS, V33, P4722, DOI 10.1016/j.biomaterials.2012.03.017; Miyata K, 2008, J AM CHEM SOC, V130, P16287, DOI 10.1021/ja804561g; Leforestier A, 2009, P NATL ACAD SCI USA, V106, P9157, DOI 10.1073/pnas.0901240106; LIFSHITZ IM, 1978, REV MOD PHYS, V50, P683, DOI 10.1103/RevModPhys.50.683; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; IVANOV VI, 1974, J MOL BIOL, V87, P817, DOI 10.1016/0022-2836(74)90086-2; Osada K, 2010, J AM CHEM SOC, V132, P12343, DOI 10.1021/ja102739b; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; EICKBUSH TH, 1978, CELL, V13, P295, DOI 10.1016/0092-8674(78)90198-8; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Itaka K, 2010, J CONTROL RELEASE, V143, P112, DOI 10.1016/j.jconrel.2009.12.014; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495; Itaka K, 2010, BIOMATERIALS, V31, P3707, DOI 10.1016/j.biomaterials.2009.11.072; POHL FM, 1972, J MOL BIOL, V67, P375, DOI 10.1016/0022-2836(72)90457-3; Kabanov VA, 2000, MACROMOLECULES, V33, P9587, DOI 10.1021/ma000674u; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Arsuaga J, 2008, COMPUT MATH METHOD M, V9, P303, DOI 10.1080/17486700802167801; Carnerup AM, 2011, SOFT MATTER, V7, P760, DOI 10.1039/c0sm00644k; Cerritelli ME, 1997, CELL, V91, P271, DOI 10.1016/S0092-8674(00)80409-2; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Dore K, 2007, LANGMUIR, V23, P258, DOI 10.1021/la061699a; HUD NV, 1995, P NATL ACAD SCI USA, V92, P3581, DOI 10.1073/pnas.92.8.3581; Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306; MARX KA, 1982, P NATL ACAD SCI-BIOL, V79, P6484, DOI 10.1073/pnas.79.21.6484; NAMORK E, 1980, MICRON, V11, P85, DOI 10.1016/0047-7206(80)90142-9; Oba M, 2011, BIOMATERIALS, V32, P652, DOI 10.1016/j.biomaterials.2010.09.022; Osada K, 2014, POLYM J, V46, P469, DOI 10.1038/pj.2014.49; Osada K, 2012, BIOMATERIALS, V33, P325, DOI 10.1016/j.biomaterials.2011.09.046; Osada K., 2005, ANGEW CHEM, V117, P3610, DOI 10.1002/ange.200500201; Park SY, 1998, BIOPHYS J, V75, P714; Tockary TA, 2013, MACROMOLECULES, V46, P6585, DOI 10.1021/ma401093z	43	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	SEP	2015	16	9					2664	2671		10.1021/acs.biomac.5b00491		8	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CR4WV	WOS:000361341700012		
J	Chan, MN; Lux, J; Nishimura, T; Akiyoshi, K; Almutairi, A				Chan, Minnie; Lux, Jacques; Nishimura, Tomoki; Akiyoshi, Kazunari; Almutairi, Adah			Long-Lasting and Efficient Tumor Imaging Using a High Relaxivity Polysaccharide Nanogel Magnetic Resonance Imaging Contrast Agent	BIOMACROMOLECULES			English	Article							MOLECULAR-WEIGHT; BEARING PULLULAN; DRUG-DELIVERY; GADOLINIUM; NANOPARTICLES; CANCER; LIVER; PHARMACOKINETICS; LIPOSOMES; HYDROGELS	Clinically approved small-molecule magnetic resonance imaging (MRI) contrast agents are all rapidly cleared from the body and offer weak signal enhancement. To avoid repeated administration of contrast agent and improve signal-to-noise ratios, agents with stronger signal enhancement and better retention in tumors are needed. Therefore, we focused on hydrogels because of their excellent water accessibility and biodegradability. Gadolinium (Gd)-chelating cross-linkers were incorporated into self-assembled pullulan nanogels to both impart magnetic properties and to stabilize this material that has been extensively studied for medical applications. We show that these Gd-chelating pullulan nanogels (Gd-CHPOA) have the highest reported relaxivity for any hydrogel-based particles and accumulate in the 4T1 tumors in mice at high levels 4 h after injection. This combination offers high signal enhancement and lasts up to 7 days to delineate the tumor clearly for longer imaging time scales. Importantly, this long-term accumulation does not cause any damage or toxicity in major organs up to three months after injection. Our work highlights the clinical potential of Gd-CHPOA as a tumor-imaging MRI contrast agent, permitting tumor identification and assessment with a high signal-to-background ratio.	[Chan, Minnie] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Lux, Jacques; Almutairi, Adah] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, KACST UCSD Ctr Excellence Nanomed, Lab Biorespons Mat, La Jolla, CA 92093 USA; [Nishimura, Tomoki; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Nishimura, Tomoki; Akiyoshi, Kazunari] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Bionanotransporter Project, Nishikyo Ku,Katsura Inttech Ctr, Kyoto 6158530, Japan	Almutairi, A (reprint author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, KACST UCSD Ctr Excellence Nanomed, Lab Biorespons Mat, La Jolla, CA 92093 USA.	aalmutairi@ucsd.edu	Nishimura, Tomoki/E-5189-2010		NIH New Innovator Award [DP 2OD006499]; King Abdulaziz City for Science and Technology (through the KACST-UCSD Center for Excellence in Nanomedicine and Engineering); NIH [5R01EY024134-02]	The authors gratefully acknowledge the NIH New Innovator Award (DP 2OD006499), King Abdulaziz City for Science and Technology (through the KACST-UCSD Center for Excellence in Nanomedicine and Engineering), and NIH (5R01EY024134-02) for funding. We gratefully acknowledge the assistance of staff at the Center for Functional MRI, especially Dr. Robert Bussell. We would also like to thank Dr. Nissi Varki for assessment and evaluation of histology slides.	AKIYOSHI K, 1993, MACROMOLECULES, V26, P3062, DOI 10.1021/ma00064a011; KABALKA GW, 1991, MAGNET RESON MED, V19, P406, DOI 10.1002/mrm.1910190231; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Soleimani A, 2013, J MATER CHEM B, V1, P1027, DOI 10.1039/c2tb00352j; Caravan P, 2006, CHEM SOC REV, V35, P512, DOI 10.1039/b510982p; Shimizu T, 2008, BIOCHEM BIOPH RES CO, V367, P330, DOI 10.1016/j.bbrc.2007.12.112; Hashim Z, 2014, NANOSCALE, V6, P8376, DOI 10.1039/c4nr01491j; Barrett T, 2006, EUR J RADIOL, V60, P353, DOI 10.1016/j.ejrad.2006.06.025; Lux J, 2013, J MATER CHEM B, V1, P6359, DOI 10.1039/c3tb21104e; Cheng ZL, 2014, CHEM COMMUN, V50, P2502, DOI 10.1039/c3cc48939f; Aime S, 2009, J MAGN RESON IMAGING, V30, P1259, DOI 10.1002/jmri.21969; Hosseinkhani H, 2002, J CONTROL RELEASE, V83, P287, DOI 10.1016/S0168-3659(02)00201-8; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Turner JL, 2005, ADV FUNCT MATER, V15, P1248, DOI 10.1002/adfm.200500005; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Fass L, 2008, MOL ONCOL, V2, P115, DOI 10.1016/j.molonc.2008.04.001; Laurent S, 2010, CONTRAST MEDIA MOL I, V5, P305, DOI 10.1002/cmmi.388; Li Y, 2012, MACROMOLECULES, V45, P4196, DOI 10.1021/ma300521c; Lim CK, 2013, BIOMATERIALS, V34, P6846, DOI 10.1016/j.biomaterials.2013.05.069; Forsyth PAJ, 1997, J CLIN ONCOL, V15, P2076; ALBERT FK, 1994, NEUROSURGERY, V34, P45; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Liu YJ, 2011, BIOMATERIALS, V32, P5167, DOI 10.1016/j.biomaterials.2011.03.077; Huang CH, 2012, ACS NANO, V6, P9416, DOI 10.1021/nn304160p; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/nmat2784, 10.1038/NMAT2784]; Grobner T, 2007, KIDNEY INT, V72, P260, DOI 10.1038/sj.ki5002338; Kobayashi H, 2005, ADV DRUG DELIVER REV, V57, P2271, DOI 10.1016/j.addr.2005.09.016; Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001; Kang JH, 2010, BIOORGAN MED CHEM, V18, P3946, DOI 10.1016/j.bmc.2010.04.031; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; Lee DE, 2012, CHEM SOC REV, V41, P2656, DOI 10.1039/c2cs15261d; Schopf E, 2012, MOL PHARMACEUT, V9, P1911, DOI 10.1021/mp2005998; Akiyoshi K, 1998, J CONTROL RELEASE, V54, P313, DOI 10.1016/S0168-3659(98)00017-0; Laurent S, 2006, CONTRAST MEDIA MOL I, V1, P128, DOI 10.1002/cmmi.100; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; VEXLER VS, 1994, JMRI-J MAGN RESON IM, V4, P381, DOI 10.1002/jmri.1880040325; Ekinci G, 2003, EUR J RADIOL, V45, P99, DOI 10.1016/S0720-048X(02)00027-X; Caravan P., 2007, ANGEW CHEM, p[8319, 119], DOI 10.1002/ange.200700700; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Fujioka-Kobayashi M, 2012, BIOMATERIALS, V33, P7613, DOI 10.1016/j.biomaterials.2012.06.075; Kojima C, 2011, NANOMED-NANOTECHNOL, V7, P1001, DOI 10.1016/j.nano.2011.03.007; Lescher S, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.9.FOCUS14479; Lux J, 2015, THERANOSTICS, V5, P277, DOI 10.7150/thno.10904; Robic Caroline, 2011, Biometals, V24, P759, DOI 10.1007/s10534-011-9422-9; Sasaki Y., 2010, CHEM REC, P366; Savla R, 2014, PHARM RES-DORDR, V31, P3487, DOI 10.1007/s11095-014-1436-x; Suginoshita O., 2002, J CONTROL RELEASE, V83, P75	49	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	SEP	2015	16	9					2964	2971		10.1021/acs.biomac.5b00867		8	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CR4WV	WOS:000361341700043		
J	Kanamori, T; Fujisawa, H				Kanamori, Takafumi; Fujisawa, Hironori			Robust estimation under heavy contamination using unnormalized models	BIOMETRIKA			English	Article						Contamination ratio; Heterogeneous contamination; Regression; Scoring rule; Unnormalized model	SCORING RULES; DIVERGENCE; PARAMETER	Contamination caused by outliers is inevitable in data analysis, and robust statistical methods are often needed. In this paper we develop a new approach for robust data analysis on the basis of scoring rules. A scoring rule is a discrepancy measure to assess the quality of probabilistic forecasts. We propose a simple method of estimating not only parameters in the statistical model but also the contamination ratio, i.e., the ratio of outliers. The outliers are detected based on the estimated contamination ratio. For this purpose, we use scoring rules with extended statistical models called unnormalized models. Regression problems are also considered. We study complex heterogeneous contamination wherein the contamination ratio in a response variable may depend on covariate variables, and propose a simple method to estimate a robust regression function and expected contamination ratio. Simulation studies demonstrate the effectiveness of our method.	[Kanamori, Takafumi] Nagoya Univ, Dept Comp Sci & Math Informat, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Fujisawa, Hironori] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan	Kanamori, T (reprint author), Nagoya Univ, Dept Comp Sci & Math Informat, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	kanamori@is.nagoya-u.ac.jp; fujisawa@ism.ac.jp			Japan Society for the Promotion of Science	We are grateful to the editor, associate editor, and referees for their helpful suggestions. Research support from the Japan Society for the Promotion of Science is gratefully acknowledged.	SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Rousseeuw PJ, 2006, DATA MIN KNOWL DISC, V12, P29, DOI 10.1007/s10618-005-0024-4; Jones MC, 2001, BIOMETRIKA, V88, P865, DOI 10.1093/biomet/88.3.865; Murata N, 2004, NEURAL COMPUT, V16, P1437, DOI 10.1162/089976604323057452; WINDHAM MP, 1995, J ROY STAT SOC B MET, V57, P599; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Basu A, 1998, BIOMETRIKA, V85, P549, DOI 10.1093/biomet/85.3.549; Fujisawa H, 2008, J MULTIVARIATE ANAL, V99, P2053, DOI 10.1016/j.jmva.2008.02.004; Black MJ, 1996, INT J COMPUT VISION, V19, P57, DOI 10.1007/BF00131148; BASU A., 2010, STAT INFERENCE MINIU; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Dawid A.P., 2014, METRON, V72, P169; GOOD I. J., 1971, FDN STAT INFERENCE; Hampel FR, 1986, ROBUST STAT APPROACH; Kanamori T, 2014, BERNOULLI, V20, P2278, DOI 10.3150/13-BEJ557; Luenberger DG, 2008, INT SER OPER RES MAN, V116, P1; Maronna RA, 2006, ROBUST STAT THEORY M; Parry M, 2012, ANN STAT, V40, P561, DOI 10.1214/12-AOS971; R Development Core Team, 2015, R LANG ENV STAT COMP; RASMUSSEN C. E., 1996, THE DELVE MANUAL	21	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-3444	1464-3510		BIOMETRIKA	Biometrika	SEP	2015	102	3					559	572		10.1093/biomet/asv014		14	Biology; Mathematical & Computational Biology; Statistics & Probability	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology; Mathematics	CR6LB	WOS:000361457200005		
J	Ghosh, M; Kubokawa, T; Kawakubo, Y				Ghosh, M.; Kubokawa, T.; Kawakubo, Y.			Benchmarked empirical Bayes methods in multiplicative area-level models with risk evaluation	BIOMETRIKA			English	Article						Constrained Bayes procedure; Empirical Bayes estimator; Fay-Herriot model; Hierarchical Bayes estimator; Kullback-Leibler divergence; Parametric bootstrap; Second-order approximation; Small area estimation	MEAN-SQUARED ERROR; SURVEY WEIGHTS; ESTIMATORS; UNCERTAINTY	The paper develops hierarchical empirical Bayes and benchmarked hierarchical empirical Bayes estimators of positive small area means under multiplicative models. The usual benchmarking requirement is that the small area estimates, when aggregated, should equal the direct estimates for the larger geographical areas. However, while estimating positive small area parameters, the conventional squared error or weighted squared error loss subject to the usual benchmark constraint may not produce positive estimators, so it is necessary to seek other loss functions. We consider a multiplicative model for the original data for estimating positive small area means, and suggest a variant of the Kullback-Leibler divergence as a loss function. The prediction errors of the suggested hierarchical empirical Bayes estimators are investigated asymptotically, and their second-order unbiased estimators are provided. Bootstrapped estimators of these prediction errors for both hierarchical empirical Bayes and benchmarked hierarchical empirical Bayes estimators are also given. The performance of the suggested procedures is investigated through simulation as well as with an example.	[Ghosh, M.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Kubokawa, T.] Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan; [Kawakubo, Y.] Univ Tokyo, Grad Sch Econ, Bunkyo Ku, Tokyo 1130033, Japan	Ghosh, M (reprint author), Univ Florida, Dept Stat, Box 118545, Gainesville, FL 32611 USA.	ghoshm@stat.ufl.edu; tatsuya@e.u-tokyo.ac.jp; y.k.5.58.2010@gmail.com			U.S. National Science Foundation; Japan Society for the Promotion of Science	We thank the editor, associate editor and two reviewers for many valuable comments and helpful suggestions which led to an improved version of this paper. The first author was supported by the U.S. National Science Foundation. The second and third authors were supported by the Japan Society for the Promotion of Science.	Banerjee A, 2005, J MACH LEARN RES, V6, P1705; Datta GS, 2000, STAT SINICA, V10, P613; FAY RE, 1979, J AM STAT ASSOC, V74, P269; DEELY JJ, 1981, J AM STAT ASSOC, V76, P833, DOI 10.2307/2287578; Datta GS, 2011, TEST-SPAIN, V20, P574, DOI 10.1007/s11749-010-0218-y; PRASAD NGN, 1990, J AM STAT ASSOC, V85, P163, DOI 10.2307/2289539; You Y, 2002, CAN J STAT, V30, P431, DOI 10.2307/3316146; MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098; Bell WR, 2013, BIOMETRIKA, V100, P189, DOI 10.1093/biomet/ass063; Butar FB, 2003, J STAT PLAN INFER, V112, P63, DOI 10.1016/S0378-3758(02)00323-3; Datta GS, 2005, BIOMETRIKA, V92, P183, DOI 10.1093/biomet/92.1.183; DEVILLE JC, 1992, J AM STAT ASSOC, V87, P376, DOI 10.2307/2290268; Ghosh M, 2013, TEST-SPAIN, V22, P670, DOI 10.1007/s11749-013-0338-2; Isaki CT, 2000, SURV METHODOL, V26, P31; James W., 1961, P 4 BERK S MATH STAT, V1, P361; Slud EV, 2011, J STAT PLAN INFER, V141, P3520, DOI 10.1016/j.jspi.2011.05.005; PFEFFERMANN D, 1991, J BUS ECON STAT, V9, P73, DOI 10.2307/1391941; Pfeffermann D, 2014, TEST-SPAIN, V23, P631, DOI 10.1007/s11749-014-0398-y; Rao J.N.K., 2003, SMALL AREA ESTIMATIO; Slud EV, 2006, J ROY STAT SOC B, V68, P239, DOI 10.1111/j.1467-9868.2006.00542.x; Steorts RC, 2013, STAT SINICA, V23, P749, DOI 10.5705/ss.2012.053; Wange JY, 2008, SURV METHODOL, V34, P29; You Y, 2003, J STAT PLAN INFER, V111, P197, DOI 10.1016/S0378-3758(02)00301-4	23	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-3444	1464-3510		BIOMETRIKA	Biometrika	SEP	2015	102	3					647	659		10.1093/biomet/asv010		13	Biology; Mathematical & Computational Biology; Statistics & Probability	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology; Mathematics	CR6LB	WOS:000361457200011		
J	Shiga, T; Shimbo, T; Yoshizawa, A				Shiga, Tomoko; Shimbo, Takuro; Yoshizawa, Atsuto			Multicenter investigation of lifestyle-related diseases and visceral disorders in thalidomide embryopathy at around 50 years of age	BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY			English	Article						thalidomide embryopathy; lifestyle-related disease; visceral disorders; gallbladder aplasia; block vertebra	FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; RISK-FACTORS; INSULIN-RESISTANCE; PREVALENCE; ASSOCIATION; JAPAN; TERATOGEN; ADULTS	BackgroundIn utero exposure to thalidomide causes a wide range of birth defects, including phocomelia, hearing loss and visceral disorders, known as thalidomide embryopathy (TE). Fifty years after the first report of TE, we conducted the first cross-sectional multicenter study to investigate the development of lifestyle-related diseases and identify risk factors for visceral disorders in subjects with TE. MethodsSeventy-six cases with TE (31 men, 45 women) underwent medical examinations between 2011 and 2014 to determine the types of TE-related anomalies (limbs, auditory organs, or visceral organs) and lifestyle-related diseases present. Logistic multiple regression analyses, adjusted for gender and age, were conducted between TE and lifestyle-related diseases and to evaluate association between block vertebra and gallbladder aplasia. ResultsFatty liver (FL), nonalcoholic FL disease and dyslipidemia were detected in 52.6%, 35.0%, and 23.7% of subjects, respectively, with higher incidences among men. Dyslipidemia was detected in 40.0% of subjects with FL and was significantly associated with FL (odds ratio=8.86; p=0.008). Block vertebrae were detected in 44.4% of subjects with gallbladder aplasia, and this association was significant (odds ratio=9.96; p=0.006). ConclusionSubjects with TE have also a risk for lifestyle-related disease as well as the general Japanese population. In addition, cervical spine radiography and magnetic resonance imaging are recommended to assess block vertebrae in subjects with TE with gallbladder aplasia who develop shoulder pain. Birth Defects Research (Part A) 103:787-793, 2015. (c) 2015 Wiley Periodicals, Inc.	[Shiga, Tomoko] Natl Ctr Global Hlth & Med, Dept Gen Med, Div Med Check Up, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Dept Clin Study, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Informat Ctr Clin Sci, Tokyo 1628655, Japan; [Yoshizawa, Atsuto] Natl Ctr Global Hlth & Med, Gen Internal Med, Tokyo 1628655, Japan	Shiga, T (reprint author), Natl Ctr Global Hlth & Med, Dept Gen Med, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	toshiga@hosp.ncgm.go.jp			Ministry of Health, Labour, and Welfare of Japan [H23-Iyaku-Shitei-023]; National Center for Global Health and Medicine [26A-201]	This study was funded by a Grant-in-Aid for Research on Regulatory Science of Pharmaceuticals and Medical Devices (grant no.: H23-Iyaku-Shitei-023) from the Ministry of Health, Labour, and Welfare of Japan. This work was supported in part by Grants-in-Aid for Research from the National Center for Global Health and Medicine (grant no.: 26A-201).	Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; Akahoshi M, 2001, HYPERTENS RES, V24, P337, DOI 10.1291/hypres.24.337; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Schuler-Faccini L, 2007, BIRTH DEFECTS RES A, V79, P671, DOI 10.1002/bdra.20384; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Fu JF, 2011, WORLD J GASTROENTERO, V17, P735, DOI 10.3748/wjg.v17.i6.735; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Matsuzawa Y, 2005, J ATHEROSCLER THROMB, V12, P301; Stephens TD, 2000, BIOCHEM PHARMACOL, V59, P1489, DOI 10.1016/S0006-2952(99)00388-3; Reid AE, 2001, GASTROENTEROLOGY, V121, P710, DOI 10.1053/gast.2001.27126; Donati G, 2004, GUT, V53, P1020, DOI 10.1136/gut.2003.027086; Tanaka H, 2005, J ATHEROSCLER THROMB, V12, P284; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Castilla EE, 1996, TERATOLOGY, V54, P273, DOI 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#; Friedman J M, 1999, Teratology, V59, P120, DOI 10.1002/(SICI)1096-9926(199902)59:2<120::AID-TERA6>3.0.CO;2-X; Hashimoto E, 2009, J GASTROEN HEPATOL, V24, P501, DOI 10.1111/j.1440-1746.2009.05806.x; Hashimoto E, 2015, HEPATOL RES, V45, P20, DOI 10.1111/hepr.12333; IKAI E, 1995, J HUM HYPERTENS, V9, P101; Kayamori R., 2014, PRINCIPAL INVESTIGAT, P46; Kayamori R., 2013, JPN J REHAB MED, V50, P957; Kayamori R., 2013, THALIDOMIDE MED TRAJ, P64; Lary JM, 1999, DRUG SAFETY, V21, P161, DOI 10.2165/00002018-199921030-00002; Ministry of Health Labour and Welfare of Japan., 2013, RES SURV PHYS COND 2, P107; Shimbo T, 2014, PRINCIPAL INVESTIGAT, P38; Siddiqui MS, 2013, GASTROENTEROLOGY, V145, P1271, DOI 10.1053/j.gastro.2013.08.036; Yasui K, 2005, CURR PHARM DESIGN, V11, P395, DOI 10.2174/1381612053382179; YOSHIDA S, 1991, INT J OBESITY, V15, P37; Yoshizawa A, 2012, PRINCIPAL INVESTIGAT, P1	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1542-0752	1542-0760		BIRTH DEFECTS RES A	Birth Defects Res. Part A-Clin. Mol. Teratol.	SEP	2015	103	9					787	793		10.1002/bdra.23363		7	Developmental Biology; Toxicology	Developmental Biology; Toxicology	CR3PQ	WOS:000361245800007		
J	Matsukawa, H; Fujii, M; Murakata, A; Shinoda, M; Takahashi, O				Matsukawa, Hidetoshi; Fujii, Motoharu; Murakata, Atsushi; Shinoda, Masaki; Takahashi, Osamu			Foramen spinosum and middle meningeal artery in moyamoya disease: Preliminary results of a pilot study	BRAIN INJURY			English	Article						Collateral circulation; moyamoya disease; skull base foramina	MAGNETIC-RESONANCE ANGIOGRAPHY; REVASCULARIZATION SURGERY; CEREBRAL ANEURYSMS; CLINICAL ARTICLE; TECHNICAL NOTE; SKULL-BASE; DIAGNOSIS; CHILDREN; ADULTS; SYNANGIOSIS	Object: This study investigated whether the size of the middle cranial fossa foramina reflects the severity of moyamoya disease (MMD). Methods: It compared 20 adult patients managed without surgical revascularization with 2 age-and sex-matched controls. MR angiography scores were assigned by the severity of occlusive changes of the internal carotid artery, the middle cerebral artery, the anterior and the posterior cerebral arteries and the signals of the distal branches of these arteries. These scores were stratified into MR angiography grades (Houkin's grade: 1-4). The relationships between the Houkin's grade and the size of the foramen spinosum (FS), foramen ovale, carotid canal and middle meningeal artery (MMA) were evaluated. Results: Simple regression analysis showed the correlation between the Houkin's grade and the bilateral FS (right, r=0.56, p=0.010; left, r=0.46, p=0.044) and MMA (right, r=0.89, p=0.0050; left, r=0.47, p=0.036). It also showed the correlation between the FS and MMA (right, r=0.53, p=0.018; left, r=0.55, p=0.013). There were no significant differences between the Houkin's grade, the size of the carotid canal and the foramen ovale. Conclusions: The larger FS and MMA on brain CT, which might be performed for patients suspected of intracranial lesions, could aid the diagnosis of MMD.	[Matsukawa, Hidetoshi; Fujii, Motoharu; Murakata, Atsushi; Shinoda, Masaki] St Lukes Int Hosp, Dept Neurosurg, Tokyo 1048560, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Dept Med, Div Gen Internal Med, Tokyo 1048560, Japan	Matsukawa, H (reprint author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	nowornever1982@gmail.com			Japan Heart Foundation; St Luke's Life Science Institute Research Grant for Clinical Epidemiology Research; Smoking Research Foundation	This study was supported by the Japan Heart Foundation Young Investigator's Research Grant 2012, St Luke's Life Science Institute Research Grant for Clinical Epidemiology Research 2012 and Smoking Research Foundation.	SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; SATOH T, 1983, J NEUROSURG, V58, P949, DOI 10.3171/jns.1983.58.6.0949; Houkin K, 2000, ACTA NEUROCHIR, V142, P269, DOI 10.1007/s007010050035; Hallemeier CL, 2006, STROKE, V37, P1490, DOI 10.1161/01.STR.0000221787.70503.ca; Houkin K, 2005, CEREBROVASC DIS, V20, P347, DOI 10.1159/000087935; SUZUKI J, 1983, STROKE, V14, P104; Dusick JR, 2011, NEUROSURGERY, V68, P34, DOI 10.1227/NEU.0b013e3181fc5ec2; ENDO M, 1989, J NEUROSURG, V71, P180, DOI 10.3171/jns.1989.71.2.0180; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; KONISHI Y, 1985, NEUROSURGERY, V16, P484; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; GINSBERG LE, 1994, AM J NEURORADIOL, V15, P283; Watanabe A, 2010, J NEUROSURG-PEDIATR, V5, P591, DOI 10.3171/2010.3.PEDS09417; BERLIS A, 1992, BRIT J RADIOL, V65, P653; Dauser RC, 1997, J NEUROSURG, V86, P719, DOI 10.3171/jns.1997.86.4.0719; Kawaguchi S, 1996, ACTA NEUROCHIR, V138, P1287, DOI 10.1007/BF01411057; Jo KI, 2014, CEREBROVASC DIS, V37, P94, DOI 10.1159/000356350; Berge JK, 2001, CLIN ANAT, V14, P406, DOI 10.1002/ca.1075; Czabanka M, 2011, CEREBROVASC DIS, V32, P41, DOI 10.1159/000326077; Fishpool SJC, 2007, CLIN ANAT, V20, P371, DOI 10.1002/ca.20377; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; HAN DH, 2000, ZNG, V142, P1263; Han DH, 1997, CLIN NEUROL NEUROSUR, V99, pS151; HOUKIN K, 1994, STROKE, V25, P2159; Houkin K, 2001, NEUROSURG CLIN N AM, V12, P575; Kashiwagi S, 1996, J NEUROSURG, V85, P380, DOI 10.3171/jns.1996.85.3.0380; King JAJ, 2010, J NEUROS-PEDIATR, V5, P184, DOI 10.3171/2009.9.PEDS0932; Koebbe CJ, 2004, AM J NEURORADIOL, V25, P574; Kuroda S, 2007, STROKE, V38, P1430, DOI 10.1161/STROKEAHA.106.478297; Kurokawa T, 1985, Pediatr Neurol, V1, P274, DOI 10.1016/0887-8994(85)90027-X; Lindblom K, 1936, ROENTGENOGRAPHIC STU; McLaughlin N, 2013, J NEUROSURG, V118, P104, DOI 10.3171/2012.9.JNS112354; Motoshima Shigenobu, 2012, Fukuoka Acta Medica, V103, P206; Park YS, 2010, J NEUROSURG, V113, P749, DOI 10.3171/2009.11.JNS09895; Sainte-Rose C, 2006, J NEUROSURG, V105, P437, DOI 10.3171/ped.2006.105.6.437; SHAPIRO R, 1967, AMER J ROENTGENOL RA, V101, P779; TAKAHASHI M, 1980, AM J NEURORADIOL, V1, P547; TAKEUCHI S, 1992, Neurologia Medico-Chirurgica, V32, P80, DOI 10.2176/nmc.32.80; Ushikoshi S, 1996, J NEUROSURG, V84, P269, DOI 10.3171/jns.1996.84.2.0269; YAMADA I, 1992, NEURORADIOLOGY, V34, P318	40	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1246	1251		10.3109/02699052.2015.1035333		6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400015		
J	Iwanaga, M; Kato, N; Okazaki, T; Hachisuka, K				Iwanaga, Masaru; Kato, Noriaki; Okazaki, Tetsuya; Hachisuka, Kenji			Effects of low-dose milnacipran on event-related potentials and neuropsychological tests in persons with traumatic brain injury: A preliminary study	BRAIN INJURY			English	Article						Cognition; event-related potential; milnacipran; neuropsychological test; trauasatic brain injury	COGNITIVE DYSFUNCTION; DEPRESSION SCALE; HEAD-INJURY; ERP; ATTENTION; EFFICACY; ANTIDEPRESSANT; DONEPEZIL	Introduction: Psychostimulants are among the most commonly used pharmacological agents for countering cognitive dysfunction and/or enhancing rehabilitation in persons with brain injury. It was postulated that milnacipran, a serotonin-norepinephrine reuptake inhibitor, would be effective against cognitive dysfunction in non-depressed persons with brain injury. Methods: Eighteen patients were recruited with at least moderate disability more than 4 months after a traumatic brain injury (TBI) and they were randomized to an 8-week, placebo-controlled, double-blind trial. Cognitive dysfunction was assessed at baseline with the Trail Making Test, the Wechsler Adult Intelligence Scale-Revised (WAIS-R), the Wechsler Memory Scale-Revised (WMS-R) and measurement of event-related potentials (ERPs) both before randomization and after an 8-week administration of milnacipran or placebo. Results: N2 and P3 latencies in the milnacipran group were significantly shortened by the intervention. Moreover, the Verbal Intelligence Quotient and Full Intelligence Quotient scores of the WAIS-R and the delayed recall score of the WMS-R were significantly higher than baseline after milnacipran intervention. Conclusion: Milnacipran administration improved ERP measures of attention and information processing in non-depressed persons with brain injury and also improved scores on three sub-scales of standard neuropsychological tests of cognitive dysfunction. Therefore, this intervention merits validation by additional, larger studies.	[Iwanaga, Masaru; Kato, Noriaki; Okazaki, Tetsuya; Hachisuka, Kenji] Univ Occupat & Environm Hlth, Dept Rehabil Med, Kitakyushu, Fukuoka 0878555, Japan	Iwanaga, M (reprint author), Univ Occupat & Environm Hlth, Dept Rehabil Med, 1-1 Iseigaoka, Kitakyushu, Fukuoka 0878555, Japan.	i-masaru@med.uoeh-u.ac.jp			Research Committee for Promotion of Community Life Support for Persons with Higher Brain Dysfunction, Ministry of Health, Labour, and Welfare, Japan	We express our gratitude to Ms. Yoko Nakayama for the ERP measurements and data formatting. This study was partly supported by a Grant-in-Aid from the Research Committee for Promotion of Community Life Support for Persons with Higher Brain Dysfunction, Ministry of Health, Labour, and Welfare, Japan.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63; Sato S, 2006, PSYCHIAT CLIN NEUROS, V60, P584, DOI 10.1111/j.1440-1819.2006.01562.x; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; GOODIN D, 1994, ELECTROEN CLIN NEURO, V91, P18, DOI 10.1016/0013-4694(94)90014-0; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr2003.10.014; Kok A, 2000, BIOL PSYCHOL, V54, P107, DOI 10.1016/S0301-0511(00)00054-5; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; NESHIGE R, 1988, J NEUROL NEUROSUR PS, V51, P1120, DOI 10.1136/jnnp.51.9.1120; Donchin E., 1988, BEHAVIORAL BRAIN SCI, V11, P355, DOI 10.1017/S0140525X00058027; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; Kanetani Kouichi, 2003, Journal of Nippon Medical School, V70, P313; Kaye Neil S, 2003, J Neuropsychiatry Clin Neurosci, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LEWIS GW, 1984, INT J NEUROSCI, V25, P131, DOI 10.3109/00207458408985595; Pae CU, 2009, CLIN NEUROPHARMACOL, V32, P355, DOI 10.1097/WNF.0b013e3181ac155b; Pehrson AL, 2015, EUR J PHARMACOL, V753, P19, DOI 10.1016/j.ejphar.2014.07.044; Shinha R, 1992, BIOL PSYCHIAT, V32, P992; Spikman JM, 2004, J INT NEUROPSYCH SOC, V10, P851, DOI 10.1017/S1355617704106061; Tignol J, 1998, ACTA PSYCHIAT SCAND, V97, P157, DOI 10.1111/j.1600-0447.1998.tb09980.x; Zang L, 2004, ARCH PHYS MED REHAB, V85, P1050; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	27	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1252	1257		10.3109/02699052.2015.1035332		6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400016		
J	Serizawa, M; Yokota, T; Hosokawa, A; Kusafuka, K; Sugiyama, T; Tsubosa, Y; Yasui, H; Nakajima, T; Koh, Y				Serizawa, Masakuni; Yokota, Tomoya; Hosokawa, Ayumu; Kusafuka, Kimihide; Sugiyama, Toshiro; Tsubosa, Yasuhiro; Yasui, Hirofumi; Nakajima, Takashi; Koh, Yasuhiro			The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues	CANCER GENETICS			English	Article						Amplicon-based massively parallel sequencing; Formalin-fixed paraffin-embedded samples; Cytosine deamination; Uracil DNA glycosylase; Molecular cancer diagnostics	NUCLEIC-ACIDS; ARTIFACTS; MUTATIONS; SPECIMENS; FIXATION; GENOMICS; BIOPSIES; TUMORS	Advances in mutation testing for molecular-targeted cancer therapies have led to the increased use of archived formalin-fixed paraffin-embedded (FFPE) tumors. However, DNA extracted from FFPE tumors (FFPE DNA) is problematic for mutation testing, especially for amplicon-based massively parallel sequencing (MPS), owing to DNA fragmentation and artificial C:G > T:A single nucleotide variants (SNVs) caused by deamination of cytosine to uracil. Therefore, to reduce artificial C:G > T:A SNVs in amplicon-based MPS using FFPE DNA, we evaluated the efficacy of uracil DNA glycosylase (UDG) pretreatment, which can eliminate uracil-containing DNA molecules, with 126 archived FFPE esophageal cancer specimens. We also examined the association between the frequency of C:G > T:A SNVs and DNA quality, as assessed by a quantitative PCR (qPCR)-based assay. UDG pretreatment significantly lowered the frequency of C:G > T:A SNVs in highly fragmented DNA (by approximately 60%). This effect was not observed for good- to moderate-quality DNA, suggesting that a predictive assay (i.e., DNA quality assessment) needs to be performed prior to UDG pretreatment. These results suggest that UDG pretreatment is efficacious for mutation testing by amplicon-based MPS with fragmented DNA from FFPE samples.	[Serizawa, Masakuni; Yokota, Tomoya; Koh, Yasuhiro] Shizuoka Canc Ctr, Res Inst, Drug Discovery & Dev Div, Shizuoka, Japan; [Yokota, Tomoya; Yasui, Hirofumi] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; [Hosokawa, Ayumu; Sugiyama, Toshiro] Toyama Univ, Fac Med, Dept Gastroenterol & Hematol, Toyama 930, Japan; [Kusafuka, Kimihide; Nakajima, Takashi] Shizuoka Canc Ctr, Div Pathol, Shizuoka, Japan; [Tsubosa, Yasuhiro] Shizuoka Canc Ctr, Div Esophageal Surg, Shizuoka, Japan; [Koh, Yasuhiro] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan	Koh, Y (reprint author), Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan.	ykoh@wakayama-med.ac.jp					Wong SQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03494; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Luthra R, 2014, HAEMATOLOGICA, V99, P465, DOI 10.3324/haematol.2013.093765; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Arteaga CL, 2012, CLIN CANCER RES, V18, P612, DOI 10.1158/1078-0432.CCR-11-2019; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Do HD, 2012, ONCOTARGET, V3, P546; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; BENEZRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P351; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Chang FQ, 2013, CANCER GENET-NY, V206, P413, DOI 10.1016/j.cancergen.2013.10.003; Fairley JA, 2012, CURR DRUG TARGETS, V13, P1475; Koh Y, 2013, J CLIN ONCOL S, V31; Sah S, 2013, GENOME MED, V5, DOI 10.1186/gm481; Sedlackova T, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-5; Simbolo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062692; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Yokota T, 2010, TRANSL RES, V156, P98, DOI 10.1016/j.trsl.2010.05.007	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2210-7762	2210-7770		CANCER GENET-NY	Cancer Genet.	SEP	2015	208	9					415	427		10.1016/j.cancergen.2015.05.001		13	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CR5YB	WOS:000361419200001		
J	Khalili, H; Gong, J; Brenner, H; Austin, TR; Hutter, CM; Baba, Y; Baron, JA; Berndt, SI; Bezieau, S; Caan, B; Campbell, PT; Chang-Claude, J; Chanock, SJ; Chen, C; Hsu, L; Jiao, S; Conti, DV; Duggan, D; Fuchs, CS; Gala, M; Gallinger, S; Haile, RW; Harrison, TA; Hayes, R; Hazra, A; Henderson, B; Haiman, C; Hoffmeister, M; Hopper, JL; Jenkins, MA; Kolonel, LN; Kury, S; LaCroix, A; Le Marchand, L; Lemire, M; Lindor, NM; Ma, J; Manson, JE; Morikawa, T; Nan, H; Ng, K; Newcomb, PA; Nishihara, R; Potter, JD; Qu, CH; Schoen, RE; Schumacher, FR; Seminara, D; Taverna, D; Thibodeau, S; Wactawski-Wende, J; White, E; Wu, K; Zanke, BW; Casey, G; Hudson, TJ; Kraft, P; Peters, U; Slattery, ML; Ogino, S; Chan, AT				Khalili, Hamed; Gong, Jian; Brenner, Hermann; Austin, Thomas R.; Hutter, Carolyn M.; Baba, Yoshifumi; Baron, John A.; Berndt, Sonja I.; Bezieau, Stephane; Caan, Bette; Campbell, Peter T.; Chang-Claude, Jenny; Chanock, Stephen J.; Chen, Constance; Hsu, Li; Jiao, Shuo; Conti, David V.; Duggan, David; Fuchs, Charles S.; Gala, Manish; Gallinger, Steven; Haile, Robert W.; Harrison, Tabitha A.; Hayes, Richard; Hazra, Aditi; Henderson, Brian; Haiman, Chris; Hoffmeister, Michael; Hopper, John L.; Jenkins, Mark A.; Kolonel, Laurence N.; Kuery, Sebastien; LaCroix, Andrea; Le Marchand, Loic; Lemire, Mathieu; Lindor, Noralane M.; Ma, Jing; Manson, Joann E.; Morikawa, Teppei; Nan, Hongmei; Ng, Kimmie; Newcomb, Polly A.; Nishihara, Reiko; Potter, John D.; Qu, Conghui; Schoen, Robert E.; Schumacher, Fredrick R.; Seminara, Daniela; Taverna, Darin; Thibodeau, Stephen; Wactawski-Wende, Jean; White, Emily; Wu, Kana; Zanke, Brent W.; Casey, Graham; Hudson, Thomas J.; Kraft, Peter; Peters, Ulrike; Slattery, Martha L.; Ogino, Shuji; Chan, Andrew T.		GECCO; CGFR	Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer	CARCINOGENESIS			English	Article							ISLAND METHYLATOR PHENOTYPE; GENOME-WIDE ASSOCIATION; POPULATION-BASED SAMPLE; MICROSATELLITE INSTABILITY; ULCERATIVE-COLITIS; COLON-CANCER; SUSCEPTIBILITY LOCI; MOLECULAR-FEATURES; CROHNS-DISEASE; MAIT CELLS	We identified the minor allele (T) in SNP rs11676348 to have pleiotropic effect on risk of UC and CRC, particularly in tumors with an inflammatory component. Our findings offer the promise of risk stratification of UC patients for developing CRC.Although genome-wide association studies (GWAS) have separately identified many genetic susceptibility loci for ulcerative colitis (UC), Crohn's disease (CD) and colorectal cancer (CRC), there has been no large-scale examination for pleiotropy, or shared genetic susceptibility, for these conditions. We used logistic regression modeling to examine the associations of 181 UC and CD susceptibility variants previously identified by GWAS with risk of CRC using data from the Genetics and Epidemiology of Colorectal Cancer Consortium and the Colon Cancer Family Registry. We also examined associations of significant variants with clinical and molecular characteristics in a subset of the studies. Among 11794 CRC cases and 14190 controls, rs11676348, the susceptibility single nucleotide polymorphism (SNP) for UC, was significantly associated with reduced risk of CRC (P = 7E-05). The multivariate-adjusted odds ratio of CRC with each copy of the T allele was 0.93 (95% CI 0.89-0.96). The association of the SNP with risk of CRC differed according to mucinous histological features (P (heterogeneity) = 0.008). In addition, the (T) allele was associated with lower risk of tumors with Crohn's-like reaction but not tumors without such immune infiltrate (P (heterogeneity) = 0.02) and microsatellite instability-high (MSI-high) but not microsatellite stable or MSI-low tumors (P (heterogeneity) = 0.03). The minor allele (T) in SNP rs11676348, located downstream from CXCR2 that has been implicated in CRC progression, is associated with a lower risk of CRC, particularly tumors with a mucinous component, Crohn's-like reaction and MSI-high. Our findings offer the promise of risk stratification of inflammatory bowel disease patients for complications such as CRC.	[Khalili, Hamed; Gala, Manish; Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Gong, Jian; Hsu, Li; Jiao, Shuo; Harrison, Tabitha A.; LaCroix, Andrea; Newcomb, Polly A.; Potter, John D.; Qu, Conghui; White, Emily; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Seattle, WA 98104 USA; [Brenner, Hermann; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Cosortium DKTK, Heidelberg, Germany; [Austin, Thomas R.] Whitman Coll, Walla Walla, WA 99362 USA; [Hutter, Carolyn M.; Seminara, Daniela] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Baba, Yoshifumi] Kumamoto Univ, Dept Surg Gastroenterol, Kumamoto, Japan; [Baron, John A.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Berndt, Sonja I.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Bezieau, Stephane; Kuery, Sebastien] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Caan, Bette] Univ Ottawa, Fac Med, Div Hematol, Ottawa, ON, Canada; [Campbell, Peter T.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chen, Constance; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA USA; [Conti, David V.; Henderson, Brian; Haiman, Chris; Schumacher, Fredrick R.; Casey, Graham] Univ So Calif, Keck Sch Med, Los Angeles, CA USA; [Duggan, David; Taverna, Darin] Syst Imaginat, Computat Biol, Phoenix, AZ USA; [Fuchs, Charles S.; Ng, Kimmie; Nishihara, Reiko; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fuchs, Charles S.; Hazra, Aditi; Ma, Jing; Nan, Hongmei; Kraft, Peter; Chan, Andrew T.] Indiana Univ, Dept Epidemiol, Sch Publ Hlth, Indianapolis, IN 46204 USA; [Gallinger, Steven] Toronto Gen Hosp, Dept Surg, Univ Hlth Network, Toronto, ON, Canada; [Haile, Robert W.] Stanford Canc Inst, Palo Alto, CA USA; [Hayes, Richard; Jenkins, Mark A.] NYU, Div Epidemiol, Sch Med, New York, NY USA; [Hopper, John L.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Australia; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Epidemiol Program, Ctr Canc, Honolulu, HI 96822 USA; [Lemire, Mathieu; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Serv, Scottsdale, AZ USA; [Manson, Joann E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Nishihara, Reiko; Wu, Kana] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Potter, John D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Schoen, Robert E.] Univ Pittsburgh, Dept Med & Epidemiol, Med Ctr, Pittsburgh, PA USA; [Thibodeau, Stephen] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Zanke, Brent W.] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, OK USA; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, OK USA; [Slattery, Martha L.] Univ Utah, Dept Internal Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Chan, AT (reprint author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.	shuji_ogino@dfci.harvard.edu; achan@mgh.harvard.edu	Gallinger, Steven/E-4575-2013; Bezieau, stephane/G-5621-2015; Jenkins, Mark/P-7803-2015; KURY, Sebastien/G-5971-2015	Bezieau, stephane/0000-0003-0095-1319; Jenkins, Mark/0000-0002-8964-6160; KURY, Sebastien/0000-0001-5497-0465	Crohn's and Colitis Foundation of America (CCFA); American Gastroenterological Association (AGA); National Institute of Diabetes and Digestive and Kidney Diseases [K23 DK099681]; National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services [U01 CA137088, R01 CA059045]; Regional Council of Pays de la Loire; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Institutes of Health [R01 CA60987, UM1 CA167551, R01 CA48998, CA61757, U01 CA074783, CA42182, R01 CA076366, K05 CA154337]; National Cancer Institute, National Institutes of Health [U01 CA122839, R01 CA143237]; National Institutes of Health: Australasian Colorectal Cancer Family Registry [U01/U24 CA097735]; National Institutes of Health: Familial Colorectal Neoplasia Collaborative Group [U01/U24 CA074799]; National Institutes of Health: Mayo Clinic Cooperative Family Registry for Colon Cancer Studies [U01/U24 CA074800]; National Institutes of Health: Ontario Registry for Studies of Familial Colorectal Cancer [U01/U24 CA074783]; National Institutes of Health: Seattle Colorectal Cancer Family Registry [U01/U24 CA074794]; National Institutes of Health: University of Hawaii Colorectal Cancer Family Registry [U01/U24 CA074806]; German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; National Institutes of Health; Ontario Research Fund; Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation; Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) [Z01 CP 010200]; NIH [U01 HG004446]; NIH GEI [U01 HG 004438]; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C];  [R01 CA137178];  [R01 CA050385];  [R01 CA151993];  [P01 CA87969];  [P30 DK043351];  [P50 CA127003];  [UM1 CA 167552];  [UM1 CA186107];  [K24 [DK]098311];  [K07 CA190673];  [K07 CA148894]	Funded by R01 CA137178, R01 CA050385, R01 CA151993, P01 CA87969, P30 DK043351, P50 CA127003, UM1 CA 167552, UM1 CA186107, K23 DK099681, K24 [DK]098311, K07 CA190673 and K07 CA148894. Senior investigator grant from the Crohn's and Colitis Foundation of America (CCFA) to A.T.C. A career development award from the American Gastroenterological Association (AGA) and by National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK099681 to H.K.).; GECCO: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CA137088; R01 CA059045).; ASTERISK: a Hospital Clinical Research Program (PHRC) and supported by the Regional Council of Pays de la Loire, the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), the Association Anne de Bretagne Genetique and the Ligue Regionale Contre le Cancer (LRCC).; COLO2&3: National Institutes of Health (R01 CA60987).; CCFR: National Institutes of Health (UM1 CA167551) and through cooperative agreements with members of the Colon Cancer Family Registry and P.I.s. This genome wide scan was supported by the National Cancer Institute, National Institutes of Health by U01 CA122839 and R01 CA143237 to G.C. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government or the CFR. The following CFR centers contributed data to this manuscript and were supported by National Institutes of Health: Australasian Colorectal Cancer Family Registry (U01/U24 CA097735), Familial Colorectal Neoplasia Collaborative Group (U01/U24 CA074799), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01/U24 CA074800), Ontario Registry for Studies of Familial Colorectal Cancer (U01/U24 CA074783), Seattle Colorectal Cancer Family Registry (U01/U24 CA074794) and the University of Hawaii Colorectal Cancer Family Registry (U01/U24 CA074806).; DACHS: German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4 and CH 117/1-1), and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814).; DALS: National Institutes of Health (R01 CA48998 and CA61757 to M.L.S.);; OFCCR: National Institutes of Health, through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783); see CCFR section. Additional funding toward genetic analyses of OFCCR includes the Ontario Research Fund, the Canadian Institutes of Health Research and the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation.; PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. Additionally, a subset of control samples were genotyped as part of the Cancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer GWAS (Yeager,M. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39, 645-649), Colon CGEMS pancreatic cancer scan (PanScan) (Amundadottir, L et al. (2009) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat. Genet., 41, 986-990, and Petersen, G.M. et al. (2010) A genome-wide association study identifies pancreatic cancer susceptibility locion chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet., 42, 224-228), and the Lung Cancer and Smoking study (Landi,M.T. et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet., 85, 679-691). The prostate and PanScan study datasets were accessed with appropriate approval through the dbGaP online resource (http://cgems.cancer.gov/data/) accession numbers phs000207v.1p1 and phs000206.v3.p2, respectively, and the lung datasets were accessed from the dbGaP website (http://www.ncbi.nlm.nih.gov/gap) through accession number phs000093 v2.p2. Funding for the Lung Cancer and Smoking study was provided by National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) Z01 CP 010200, NIH U01 HG004446 and NIH GEI U01 HG 004438. For the lung study, the GENEVA Coordinating Center provided assistance with genotype cleaning and general study coordination, and the Johns Hopkins University Center for Inherited Disease Research conducted genotyping.; PHS: National Institutes of Health (CA42182).; PMH: National Institutes of Health (R01 CA076366 to P.A.N.).; VITAL: National Institutes of Health (K05 CA154337).; WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C and HHSN271201100004C.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Brentnall TA, 1996, CANCER RES, V56, P1237; Itzkowitz SH, 2005, INFLAMM BOWEL DIS, V11, P314, DOI 10.1097/01.MIB.0000160811.76729.d5; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Morikawa T, 2012, INT J CANCER, V131, P1169, DOI 10.1002/ijc.26495; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Phipps AI, 2012, GASTROENTEROLOGY, V143, P51, DOI 10.1053/j.gastro.2012.04.052; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Samowitz WS, 2002, INT J CANCER, V99, P597, DOI 10.1002/ijc.10405; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Aust DE, 2002, CANCER, V94, P1421, DOI 10.1002/cncr.10334; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Cravo ML, 1998, AM J GASTROENTEROL, V93, P2060; Elliott M, 2009, ANN NY ACAD SCI, V1182, P97, DOI 10.1111/j.1749-6632.2009.05070.x; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ishitsuka T, 2001, J CLIN PATHOL, V54, P526, DOI 10.1136/jcp.54.7.526; Jiao S, 2011, GENET EPIDEMIOL, V35, P597, DOI 10.1002/gepi.20608; Lion J, 2013, EUR J IMMUNOL, V43, P1363, DOI 10.1002/eji.201242461; Lyda MH, 1998, GASTROENTEROLOGY, V115, P1566, DOI 10.1016/S0016-5085(98)70037-X; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Mogoanta SS, 2014, ROM J MORPHOL EMBRYO, V55, P1429; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Young MH, 2013, CELL RES, V23, P460, DOI 10.1038/cr.2012.168; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	50	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334	1460-2180		CARCINOGENESIS	Carcinogenesis	SEP	2015	36	9					999	1007		10.1093/carcin/bgv086		9	Oncology	Oncology	CR5QA	WOS:000361397000008		
J	Shimizu, C; Sood, A; Lau, HD; Oharaseki, T; Takahashi, K; Krous, HF; Campman, S; Burns, JC				Shimizu, Chisato; Sood, Alka; Lau, Hubert D.; Oharaseki, Toshiaki; Takahashi, Kei; Krous, Henry F.; Campman, Steven; Burns, Jane C.			Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood	CARDIOVASCULAR PATHOLOGY			English	Article						Kawasaki disease; Sudden death; Coronary artery aneurysm; Myocardial fibrosis; Autopsy; Transforming growth factor beta	ARTERY ANEURYSMS; UNITED-STATES; SEQUELAE; BIOPSY	Purpose: Coronary artery aneurysms (CAA) may remain silent after Kawasaki disease (KD) until adulthood when myocardial ischemia can lead to sudden death. We postulated that there would be young adults with sudden, unexpected death due to CAA from KD who would have a state-mandated autopsy performed by the San Diego County Medical Examiner's Office (SDCMEO). Methods: We reviewed all autopsy cases <35 years of age from 1997 to 2012 at the SDCMEO with a cardiovascular cause of death (n=154). Results: We found 2 cases meeting inclusion criteria. Case 1 was a 22-year-old Korean male with chronic ischemic changes due to a partially occluded and diffusely calcified 15 mm aneurysm at the bifurcation of the left main coronary artery. Interview of the mother revealed that this patient had been diagnosed with KD complicated by giant aneurysms at age two years. Case 2 was a 30-year-old Hispanic male with myocardial infarction due to thrombosis of a calcified left anterior descending artery aneurysm. Histologic findings included diffuse myocardial fibrosis and a recanalized aneurysm in the right coronary artery. Interview of the family revealed a KD-compatible illness in childhood. Immunohistochemical staining showed expression of transforming growth factor beta pathway molecules in the aneurysmal arterial wall. Conclusions: In a medical examiner's office serving a population of approximately 3 million people, 2 of 154 (1.3%) cardiovascular deaths in persons <35 years were attributed to cardiovascular complications of KD in childhood. Antecedent KD should be considered in the evaluation of all cases of sudden, unexpected death in young adults. (C) 2015 Elsevier Inc. All rights reserved.	[Shimizu, Chisato; Sood, Alka; Lau, Hubert D.; Burns, Jane C.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Oharaseki, Toshiaki; Takahashi, Kei] Toho Univ, Ohashi Med Ctr, Tokyo, Japan; [Krous, Henry F.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Campman, Steven] San Diego Cty Med Examiners Off, San Diego, CA USA	Shimizu, C (reprint author), Univ Calif San Diego, Sch Med, Dept Pediat 0641, 9500 Gilman Dr, La Jolla, CA 92093 USA.	c1shimizu@ucsd.edu			National Institutes of Health, National Heart, Lung, Blood Institute [HL69413]; iDASH grant [U54HL108460]; NIH through UCSD Neuroscience Microscopy Shared Facility Grant [P30 NS047101]; Biorepository of the UCSD Clinical and Translational Research Institute Grant [1UL1RR031980]; National Institutes of Health through NIH Roadmap for Medical Research [U54HL108460]	This work supported in part by grants from the National Institutes of Health, National Heart, Lung, Blood Institute (HL69413) awarded to JCB and the iDASH grant U54HL108460. We also acknowledge NIH support through the UCSD Neuroscience Microscopy Shared Facility Grant P30 NS047101 and the Biorepository of the UCSD Clinical and Translational Research Institute Grant 1UL1RR031980. The dataset used in this project can be downloaded from the iDASH repository (https://idash-data.ucsd.edu/) by making a request to the authors for access. Database supported by the National Institutes of Health through the NIH Roadmap for Medical Research, Grant U54HL108460.	Holman RC, 2003, PEDIATRICS, V112, P495, DOI 10.1542/peds.112.3.495; YUTANI C, 1981, ARCH PATHOL LAB MED, V105, P470; Shimizu C, 2013, HUM PATHOL, V44, P189, DOI 10.1016/j.humpath.2012.05.004; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Daniels LB, 2012, CIRCULATION, V125, P2447, DOI 10.1161/CIRCULATIONAHA.111.082107; KATO H, 1982, AM J CARDIOL, V49, P1758, DOI 10.1016/0002-9149(82)90256-9; Gordon JB, 2009, J AM COLL CARDIOL, V54, P1911, DOI 10.1016/j.jacc.2009.04.102; Kato H, 1996, CIRCULATION, V94, P1379; Byard RW, 2002, AM J FOREN MED PATH, V23, P364, DOI 10.1097/00000433-200212000-00013; Fineschi V, 1999, INT J LEGAL MED, V112, P120, DOI 10.1007/s004140050213; Harada M, 2012, HISTOPATHOLOGY, V61, P1156, DOI 10.1111/j.1365-2559.2012.04332.x; Kojimahara M, 2000, NIHON IJI SHINPO, V3974, P33; KONECKE LL, 1971, AM J CARDIOL, V27, P221, DOI 10.1016/0002-9149(71)90262-1; Mandal R, 2012, AM J FOREN MED PATH, V33, P382, DOI 10.1097/PAF.0b013e3182518e5f; Molina DK, 2012, AM J FOREN MED PATH, V33, P362, DOI 10.1097/PAF.0b013e31823d298b; Nakamura Y, 2013, J EPIDEMIOL, V23, P429, DOI 10.2188/jea.JE20130048; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Nobrega TP, 1996, CATHETER CARDIO DIAG, V39, P75, DOI 10.1002/(SICI)1097-0304(199609)39:1<75::AID-CCD16>3.0.CO;2-N; Okura N, 2013, FORENSIC SCI INT, V225, P85, DOI 10.1016/j.forsciint.2012.04.036; Orenstein JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038998; POUNDER DJ, 1985, ARCH PATHOL LAB MED, V109, P874; QUAM JP, 1986, J FORENSIC SCI, V31, P1135; Rajs J, 2001, AM J FOREN MED PATH, V22, P58, DOI 10.1097/00000433-200103000-00011; Rozin L, 2003, AM J FOREN MED PATH, V24, P45, DOI 10.1097/00000433-200303000-00009; Takahashi K, 2001, PEDIATR CARDIOL, V22, P138, DOI 10.1007/s002460010180; Takahashi K, 2002, PROG MED, V22, P1676; Williams JA, 2007, ANN THORAC SURG, V83, pS757, DOI 10.1016/j.athoracsur.2006.10.091; Williams JA, 2007, ANN THORAC SURG, V83, pS785; WREFORD FS, 1991, J FORENSIC SCI, V36, P51; Wreford FS, 1989, AM J FOREN MED PATH, V10, P264, DOI 10.1097/00000433-198909000-00021; YONESAKA S, 1989, Acta Paediatrica Japonica, V31, P706; Yonesaka S, 2010, CARDIOL YOUNG, V20, P602, DOI 10.1017/S1047951109991132	32	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-8807	1879-1336		CARDIOVASC PATHOL	Cardiovasc. Pathol.	SEP-OCT	2015	24	5					310	316		10.1016/j.carpath.2015.02.006		7	Cardiac & Cardiovascular Systems; Pathology	Cardiovascular System & Cardiology; Pathology	CR2TL	WOS:000361183400007		
J	Hattori, K; Dupuis, B; Fu, BX; Edwards, NM				Hattori, Kazuki; Dupuis, Brigitte; Fu, Bin Xiao; Edwards, Nancy M.			Effects of Monoglycerides of Varying Fatty Acid Chain Length and Mixtures Thereof on Sponge-and-Dough Breadmaking Quality	CEREAL CHEMISTRY			English	Article							SURFACE-ACTIVE AGENTS; BREAD QUALITY; MODEL SYSTEM; WHEAT-STARCH; BAKING; FLOUR; AMYLOPECTIN; EMULSIFIERS; COMPLEXES; FIRMNESS	Monoglycerides are widely used in the baking industry because of their antistaling effects, mainly suppressing crumb firming. Commercial monoglycerides are normally prepared from hydrogenated fats, with stearate being the most common fatty acid. In a previous study, monoglycerides such as monopalmitate (C16) and monostearate (C18) had positive effects on Canadian short process bread but no improvements on sponge-and-dough process (SDP) bread. The objective of this study was to investigate the effects of saturated monoglycerides of varying fatty acid chain length (C14-C22) on SDP breadmaking quality by using volume judgment, crumb image analysis, and texture measurements. Higher levels (1.00-1.50%) of all monoglycerides (C14, C16, and C18) significantly (P < 0.05) increased loaf volume and cell diameter. The larger cell diameter with increasing levels of these monoglycerides may have resulted from softer, more extensible dough handling properties and greater gas cell stability during baking. Addition of C16 and C18 caused the largest increase in crumb softness with increasing monoglyceride levels but showed relatively low resilience, which might be related to larger loaf volume (i.e., lower density of bread). However, addition of blended monoglycerides C14+C16 increased crumb softness and loaf volume while partially retaining resilience. Each monoglyceride had a different function in breadmaking quality and somewhat positive effects on SDP.	[Hattori, Kazuki] Yamazaki Baking Co Ltd, Sumida Ku, Tokyo, Japan; [Dupuis, Brigitte; Fu, Bin Xiao; Edwards, Nancy M.] Grain Res Lab, Canadian Grain Commiss, Winnipeg, MB R3C3G8, Canada	Hattori, K (reprint author), Yamazaki Baking Co Ltd, Sumida Ku, 3-15-6 Chitose, Tokyo, Japan.	hattori@yamazakipan.com					Ahmad A, 2014, CRIT REV FOOD SCI, V54, P208, DOI 10.1080/10408398.2011.579697; Tufvesson F, 2003, STARCH-STARKE, V55, P61, DOI 10.1002/star.200390018; Pareyt B, 2011, J CEREAL SCI, V54, P266, DOI 10.1016/j.jcs.2011.08.011; RIISOM T, 1984, J CEREAL SCI, V2, P105; Ribotta PD, 2004, FOOD HYDROCOLLOID, V18, P305, DOI 10.1016/S0268-005X(03)00086-9; BATRES LV, 1986, J AM OIL CHEM SOC, V63, P1537, DOI 10.1007/BF02553079; Turabi E, 2008, FOOD HYDROCOLLOID, V22, P305, DOI 10.1016/j.foodhyd.2006.11.016; ELIASSON AC, 1988, J SCI FOOD AGR, V44, P353, DOI 10.1002/jsfa.2740440408; ELIASSON AC, 1985, J CEREAL SCI, V3, P239; Raphaelides SN, 2008, FOOD RES INT, V41, P75, DOI 10.1016/j.foodres.2007.10.004; HUANG JJ, 1993, CEREAL CHEM, V70, P42; STAMPFLI L, 1995, FOOD CHEM, V52, P353, DOI 10.1016/0308-8146(95)93281-U; Blazek J, 2011, J CEREAL SCI, V54, P151, DOI 10.1016/j.jcs.2011.02.014; BAJWA U, 1990, J SCI FOOD AGR, V52, P97, DOI 10.1002/jsfa.2740520111; BELL BM, 1977, FOOD CHEM, V2, P57, DOI 10.1016/0308-8146(77)90008-5; Gomez AV, 2012, FOOD RES INT, V46, P62, DOI 10.1016/j.foodres.2011.12.007; INOUE S, 1995, J JPN SOC FOOD SCI, V42, P634; Keetels CJAM, 1996, J CEREAL SCI, V24, P33, DOI 10.1006/jcrs.1996.0035; KILBORN RH, 1990, CEREAL CHEM, V67, P443; KNIGHTLY WH, 1988, CEREAL FOOD WORLD, V33, P405; LUTTON ES, 1971, J AM OIL CHEM SOC, V48, P778, DOI 10.1007/BF02609279; Mira I, 2007, CARBOHYD POLYM, V68, P665, DOI 10.1016/j.carbpol.2006.07.032; PISESOOKBUNTERNG W, 1983, CEREAL CHEM, V60, P298; PRESTON KR, 1982, CAN I FOOD SC TECH J, V15, P29; ROACH RR, 1995, CEREAL CHEM, V72, P578; Sawa K, 2009, FOOD CHEM, V115, P884, DOI 10.1016/j.foodchem.2009.01.010; Stauffer C. E, 1999, EMULSIFIERS, P25; TSEN CC, 1981, CEREAL CHEM, V58, P180; Van Steertegem B, 2013, FOOD CHEM, V141, P4179, DOI 10.1016/j.foodchem.2013.07.017; YAMADA Y, 1994, CEREAL CHEM, V71, P297	30	0	0	AACC INTERNATIONAL	ST PAUL	3340 PILOT KNOB RD, ST PAUL, MN 55121-2097 USA	0009-0352	1943-3638		CEREAL CHEM	Cereal Chem.	SEP-OCT	2015	92	5					481	486		10.1094/CCHEM-12-14-0267-R		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CQ7XM	WOS:000360819700009		
J	Matsuki, J; Okunishi, T; Okadome, H; Suzuki, K; Yoza, K; Tokuyasu, K				Matsuki, Junko; Okunishi, Tomoya; Okadome, Hiroshi; Suzuki, Keitaro; Yoza, Koichi; Tokuyasu, Ken			Development of a Simple Method for Evaluation of Water Absorption Rate and Capacity of Rice Flour Samples	CEREAL CHEMISTRY			English	Article							PARTICLE-SIZE; HYDRATION PROPERTIES; FOOD POWDERS; WHEAT-FLOUR; BREAD; QUALITY; GLUTEN; FRACTIONS; STARCH	A simple method employing a commercially available canister was developed for the determination of mode of water absorption of rice flour samples. The samples prepared by four different grinding methods were used to analyze water absorption. The total amount of water in a flour sample was described by using an exponential model. Capacity and rate of water absorption of the samples were determined, and the relationship to baking quality of partially substituted rice bread was investigated. The water absorption was highly dependent on the method of grinding. Flours produced by wet jet-milling of the grains, which absorbed a small amount of water at high speed, were most suitable for rice bread. The method was applicable to other food powders, provided that flour particles do not stick together or swell immediately upon contact with water.	[Matsuki, Junko; Okunishi, Tomoya; Okadome, Hiroshi; Yoza, Koichi; Tokuyasu, Ken] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Suzuki, Keitaro] Natl Agr & Food Res Org, Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	Matsuki, J (reprint author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan.	matsuki@affrc.go.jp			MAFF, Japan	This study was partly supported by the grant for "Development of technology for stable production and supply of agricultural products with low cost and good qualities for food processing industries: 4. Rice," from MAFF, Japan. We are grateful to Nobuko Yoshii for her excellent technical assistance.	AACC International, 1975, APPR METH AN; de la Hera E, 2013, LWT-FOOD SCI TECHNOL, V54, P199, DOI 10.1016/j.lwt.2013.04.019; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; de la Hera E, 2014, FOOD CHEM, V151, P526, DOI 10.1016/j.foodchem.2013.11.115; Xiao ZS, 2006, CEREAL CHEM, V83, P465, DOI 10.1094/CC-83-0465; Shoji N, 2012, J JPN SOC FOOD SCI, V59, P192; PILOSOF AMR, 1985, J FOOD SCI, V50, P278, DOI 10.1111/j.1365-2621.1985.tb13334.x; de la Hera E, 2013, CARBOHYD POLYM, V98, P421, DOI 10.1016/j.carbpol.2013.06.002; Araki E, 2009, FOOD SCI TECHNOL RES, V15, P439; Baumann H., 1966, FETT SEIFEN ANSTR, V68, P741, DOI 10.1002/lipi.19660680905; Berton B, 2002, POWDER TECHNOL, V128, P326, DOI 10.1016/S0032-5910(02)00168-7; Bushuk W., 1964, BAKERS DIG, V38, P43; Bushuk W., 1966, BAKERS DIG, V40, P38; CHEN JY, 1984, J FOOD SCI, V49, P59, DOI 10.1111/j.1365-2621.1984.tb13668.x; Eliasson A. C., 1993, CEREALS BREADMAKING, P261; Elizalde BE, 1996, J FOOD SCI, V61, P407, DOI 10.1111/j.1365-2621.1996.tb14204.x; FINNEY KF, 1946, CEREAL CHEM, V23, P416; Greer EN, 1959, J SCI FOOD AGR, V10, P248, DOI 10.1002/jsfa.2740100409; Kuno H., 1958, KOGYO KAGAKU ZASSHI, V61, P1445; NISHITA KD, 1982, CEREAL CHEM, V59, P46; Sasaki T, 2014, CEREAL CHEM, V91, P146, DOI 10.1094/CCHEM-08-13-0150-R; Shishido K., 1992, REPORT FOOD RES I NI, V27, P21; SOLLARS WF, 1973, CEREAL CHEM, V50, P717; TESTER RF, 1994, J CEREAL SCI, V20, P175, DOI 10.1006/jcrs.1994.1057; TORGERSEN H, 1977, J FOOD SCI, V42, P1615, DOI 10.1111/j.1365-2621.1977.tb08440.x	25	0	0	AACC INTERNATIONAL	ST PAUL	3340 PILOT KNOB RD, ST PAUL, MN 55121-2097 USA	0009-0352	1943-3638		CEREAL CHEM	Cereal Chem.	SEP-OCT	2015	92	5					487	490		10.1094/CCHEM-01-15-0004-N		4	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CQ7XM	WOS:000360819700010		
J	Nakamura, H				Nakamura, H.			Specific Median Flour Particle Size Distribution of Japanese Common Wheats; Comparison with Chinese Common Wheats	CEREAL RESEARCH COMMUNICATIONS			English	Article						median flour particle size; soft type; breeding material; bottleneck effect; Chinese common wheat	QUALITY; HARDNESS; PROTEIN; NOODLES; BREAK	Flour particle size distribution is a major factor affecting the milling behavior in common wheats (Triticum aestivum L.). Also, a previous study has revealed a relationship between flour yield and median flour particle size of Japanese wheats. However, the genetic base of Japanese common wheat is narrow and will need to be broadened. Therefore, in order to help develop the genetic resource for higher flour yields in Japanese wheat breeding, the flour yield of one hundred and seventy Chinese common wheats were investigated in relation to the median flour particle size and the flour particle size distribution patterns as determined by laser diffraction. The results showed significant differences in the median flour particle size and distribution patterns of Chinese wheats and the Japanese wheats that had been analyzed in a previous study. In particular, 45% of Chinese wheats were categorized as hard wheats, but only 4% as soft wheats. In contrast, the previously analyzed Japanese wheat proportions were 20% and 25%, respectively. The results show that analysis of median flour particle size distribution by laser diffraction is a simple but effective tool for measuring and selecting the good flour milling quality in Chinese wheat genetic resources. In addition, the major differences between the Japanese and Chinese wheats highlighted in this study occurred despite the fact that it is well known that Chinese common wheats contributed to modern Japanese wheat varieties. The differences may be explained by either the founder effect or by a selective bottleneck in Japanese wheat genetic resources.	NARO Inst Crop Sci, Tsukuba, Ibaraki, Japan	Nakamura, H (reprint author), NARO Inst Crop Sci, Tsukuba, Ibaraki, Japan.	hiro@affrc.go.jp					Greffeuille V, 2006, THEOR APPL GENET, V114, P1, DOI 10.1007/s00122-006-0403-2; Devaux MF, 1998, J SCI FOOD AGR, V78, P237, DOI 10.1002/(SICI)1097-0010(199810)78:2<237::AID-JSFA110>3.0.CO;2-M; Kim W, 2004, J CEREAL SCI, V40, P9, DOI 10.1016/j.jcs.2004.04.005; TEMPLETON AR, 1980, GENETICS, V94, P1011; DONELSON DH, 1972, CEREAL CHEM, V49, P641; Fang CY, 2003, J CEREAL SCI, V37, P21, DOI 10.1006/jers.2002.0475; GAINES CS, 1985, CEREAL CHEM, V62, P290; Ikeda R, 1961, B TOKAI KINKI NATL A, P1; MCDONALD CE, 1994, CEREAL FOOD WORLD, V39, P29; Ministry of Agriculture and Forestry, 1968, EV METH JAP HEX WHEA, P10; Nakamura H, 2014, CEREAL RES COMMUN, V42, P668, DOI 10.1556/CRC.2014.0016; NAKAMURA H, 1990, JPN J BREED, V40, P485; Nakamura H, 2008, CROP SCI, V48, P1117, DOI 10.2135/cropsci2007.05.0305; Nakamura H, 2002, CEREAL CHEM, V79, P486, DOI 10.1094/CCHEM.2002.79.4.486; ODA M, 1980, CEREAL CHEM, V57, P253; OH NH, 1985, CEREAL CHEM, V62, P441; Posner E.S., 1997, WHEAT FLOUR MILLING, P219; WU YV, 1990, CEREAL CHEM, V67, P421; Yamashita A, 1994, DISCUSSION JAPANESE, P1	19	0	0	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	0133-3720	1788-9170		CEREAL RES COMMUN	Cereal Res. Commun.	SEP	2015	43	3					459	469		10.1556/0806.43.2015.008		11	Agronomy	Agriculture	CR2OS	WOS:000361170500011		
J	El-Hendawy, S; Sone, C; Ito, O; Sakagami, JI				El-Hendawy, S.; Sone, C.; Ito, O.; Sakagami, J-I.			Traits Associated with the Escape Strategy are Responsible for Flash Flooding Tolerance of Rice during the Emergence and Seedling Stages	CEREAL RESEARCH COMMUNICATIONS			English	Article						coleoptile elongation; crop establishment; early flooding; quiescence strategy; seedling vigour	ORYZA-SATIVA-L.; SUBMERGENCE TOLERANCE; CARBOHYDRATE-LEVELS; GENE-EXPRESSION; ELONGATION; GERMINATION; COLEOPTILE; ABILITY; GROWTH; SUB1A	To identify the adaptive traits responsible for flooding tolerance during the initial growth stages of rice, dry seeds of 53 contrasting genotypes were sown in soil and watered normally (control) or submerged with 10 cm of water for 17 days. Subsequently, the plants were kept under normal rice cultivation conditions for a further 7 days. Cluster analysis showed that 53 genotypes were divided into three groups based on emergence date, percentage of plants reaching the water's surface, maximum coleoptile length, shoot elongation rate during submergence and increases in shoot dry weight after de-submergence. Twelve genotypes were placed in cluster 1 and characterized by fast emergence, rapid coleoptile elongation, and vigorous shoot growth under control and submergence conditions. The genotypes in cluster 1 attained also a higher increase in shoot dry weight at different time of submergence and de-submergence than the genotypes in clusters 2 and 3. A significant correlation was observed between the increase in shoot dry weight and traits related with fast and vigorous shoot elongation and coleoptile. In conclusion, flooding tolerance during initial growth stages were mainly due to major submergence avoidance or escape mechanisms, and crop establishment of direct-seeded rice in flood-prone areas is accomplished by harnessing reserves for fast shoot elongation.	[El-Hendawy, S.] King Saud Univ, Coll Food & Agr Sci, Plant Prod Dept, Riyadh 11451, Saudi Arabia; [El-Hendawy, S.] Suez Canal Univ, Dept Agron, Fac Agr, Ismailia 41522, Egypt; [Sone, C.; Ito, O.; Sakagami, J-I.] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki 3058686, Japan	El-Hendawy, S (reprint author), King Saud Univ, Coll Food & Agr Sci, Plant Prod Dept, Riyadh 11451, Saudi Arabia.	shendawy@yahoo.com			Deanship of Scientific Research at King Saud University [RG-1435-032]	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding this Research Group No. (RG-1435-032).	Alibu S, 2011, AFR J AGR RES, V6, P6463, DOI 10.5897/AJAR11.1506; Das KK, 2005, PLANT SCI, V168, P131, DOI 10.1016/j.plantsci.2004.07.023; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Ismail AM, 2009, ANN BOT-LONDON, V103, P197, DOI 10.1093/aob/mcn211; Angaji SA, 2010, EUPHYTICA, V172, P159, DOI 10.1007/s10681-009-0014-5; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Biswas JK, 2002, PAK J BIOL SCI, V5, P413; Chung NJ, 2010, CROP PASTURE SCI, V61, P911, DOI 10.1071/CP10099; El-Hendawy S., 2012, Australian Journal of Crop Science, V6, P1587; El-Hendawy S. E., 2011, Research Journal of Seed Science, V4, P82, DOI 10.3923/rjss.2011.82.93; Ella ES, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr007; Huang SB, 2003, J EXP BOT, V54, P2363, DOI 10.1093/jxb/erg252; Magneschi L, 2009, PLANT BIOLOGY, V11, P561, DOI 10.1111/j.1438-8677.2008.00150.x; Nishiuchi S., 2012, RICE, V5, P1; Perata P, 2007, TRENDS PLANT SCI, V12, P43, DOI 10.1016/j.tplants.2006.12.005; Romersburg H.C., 1988, CLUSTER ANAL RES; Sarkar RK, 2011, RICE, V5, P1; SAS, 2004, SAS SYST WIND VERS 9; Vu HTT, 2010, AUST J CROP SCI, V4, P264	19	0	0	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	0133-3720	1788-9170		CEREAL RES COMMUN	Cereal Res. Commun.	SEP	2015	43	3					525	536		10.1556/0806.43.2015.005		12	Agronomy	Agriculture	CR2OS	WOS:000361170500017		
J	Volz, LJ; Hamada, M; Rothwell, JC; Grefkes, C				Volz, Lukas J.; Hamada, Masashi; Rothwell, John C.; Grefkes, Christian			What Makes the Muscle Twitch: Motor System Connectivity and TMS-Induced Activity	CEREBRAL CORTEX			English	Article						fMRI; functional connectivity; I-waves; TMS	TRANSCRANIAL MAGNETIC STIMULATION; DORSAL PREMOTOR CORTEX; FUNCTIONAL CONNECTIVITY; CORTICOSPINAL VOLLEYS; CORTICAL PLASTICITY; BRAIN-STIMULATION; VENTRAL PREMOTOR; CONSCIOUS HUMANS; UNIT RESPONSES; SURFACE EMG	Transcranial magnetic stimulation (TMS) of the primary motor cortex (M1) evokes several volleys of corticospinal activity. While the earliest wave (D-wave) originates from axonal activation of corticospinal neurons (CSN), later waves (I-waves) result from activation of mono-and polysynaptic inputs to CSNs. Different coil orientations preferentially stimulate cortical elements evoking different outputs: latero-medial-induced current (LM) elicits D-waves and short-latency electromyographic responses (MEPs); posterior-anterior current (PA) evokes early I-waves. Anterior-posterior current (AP) is more variable and tends to recruit later I-waves, featuring longer onset latencies compared with PA-TMS. We tested whether the variability in response to AP-TMS was related to functional connectivity of the stimulated M1 in 20 right-handed healthy subjects who underwent functional magnetic resonance imaging while performing an isometric contraction task. The MEP-latency after AP-TMS (relative to LM-TMS) was strongly correlated with functional connectivity between the stimulated M1 and a network involving cortical premotor areas. This indicates that stronger premotor-M1 connectivity increases the probability that AP-TMS recruits shorter latency input to CSNs. In conclusion, our data strongly support the hypothesis that TMS of M1 activates distinct neuronal pathways depending on the orientation of the stimulation coil. Particularly, AP currents seem to recruit short latency cortico-cortical projections from premotor areas.	[Volz, Lukas J.; Grefkes, Christian] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Volz, Lukas J.; Grefkes, Christian] Univ Hosp Cologne, Dept Neurol, D-50937 Cologne, Germany; [Hamada, Masashi; Rothwell, John C.] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Hamada, Masashi] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1130033, Japan; [Grefkes, Christian] INM 3, Juelich Res Ctr, Cologne, Germany	Grefkes, C (reprint author), Univ Cologne, Dept Neurol, Kerpener St 62, D-50937 Cologne, Germany.	christian.grefkes@uk-koeln.de		Grefkes, Christian/0000-0002-1656-720X	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG GR 3285/2-1, GR 3285/5-1]; Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad; European Union [222918]	LJV and CG are supported by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG GR 3285/2-1 and GR 3285/5-1). MH was supported by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad. JCR has been supported by: the European Union (REPLACES, an FP7 collaborative project - 222918).	Koch G, 2013, J NEUROSCI, V33, P9725, DOI 10.1523/JNEUROSCI.4988-12.2013; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Esser SK, 2005, J NEUROPHYSIOL, V94, P622, DOI 10.1152/jn.01230.2004; BURKE D, 1993, J PHYSIOL-LONDON, V470, P383; Boudrias MH, 2012, NEUROIMAGE, V59, P3398, DOI 10.1016/j.neuroimage.2011.11.025; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Arai N, 2005, CLIN NEUROPHYSIOL, V116, P605, DOI 10.1016/j.clinph.2004.09.020; Groppa S, 2012, NEUROIMAGE, V62, P500, DOI 10.1016/j.neuroimage.2012.05.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Di Lazzaro V, 2012, BRAIN STIMUL, V5, P512, DOI 10.1016/j.brs.2011.07.008; Cardenas-Morales L, 2014, CEREB CORTEX, V24, P1697, DOI 10.1093/cercor/bht023; Maccabee PJ, 1998, J PHYSIOL-LONDON, V513, P571, DOI 10.1111/j.1469-7793.1998.571bb.x; Bzdok D, 2011, BRAIN STRUCT FUNCT, V215, P209, DOI 10.1007/s00429-010-0287-4; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Moisa M, 2012, J NEUROSCI, V32, P7244, DOI 10.1523/JNEUROSCI.2757-11.2012; Baumer T, 2009, CLIN NEUROPHYSIOL, V120, P1724, DOI 10.1016/j.clinph.2009.07.035; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Ni Z, 2011, J NEUROPHYSIOL, V105, P749, DOI 10.1152/jn.00640.2010; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Di Lazzaro V, 2001, EXP BRAIN RES, V138, P268; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; BARKER AT, 1985, LANCET, V1, P1106; BERARDELLI A, 1990, NEUROSCI LETT, V112, P54, DOI 10.1016/0304-3940(90)90321-Y; Di Lazzaro V, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00018; Diekhoff S, 2011, HUM BRAIN MAPP, V32, P341, DOI 10.1002/hbm.21024; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Koch G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052660; Maier MA, 2013, J NEUROPHYSIOL, V109, P2982, DOI 10.1152/jn.01080.2012; Passingham RE, 2004, HUMAN BRAIN FUNCTION, V2nd, P5; Peterchev AV, 2013, CLIN NEUROPHYSIOL, V124, P1364, DOI 10.1016/j.clinph.2013.01.011; Rehme AK, 2013, NEUROIMAGE, V67, P237, DOI 10.1016/j.neuroimage.2012.11.027; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Veniero D, 2013, J NEUROSCI, V33, P13773, DOI 10.1523/JNEUROSCI.1777-13.2013; WERHAHN KJ, 1994, ELECTROEN CLIN NEURO, V93, P138, DOI 10.1016/0168-5597(94)90077-9; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032	41	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	SEP	2015	25	9					2346	2353		10.1093/cercor/bhu032		8	Neurosciences	Neurosciences & Neurology	CR6NK	WOS:000361464000002		
J	Uematsu, A; Kitamura, A; Iwatsuki, K; Uneyama, H; Tsurugizawa, T				Uematsu, Akira; Kitamura, Akihiko; Iwatsuki, Ken; Uneyama, Hisayuki; Tsurugizawa, Tomokazu			Correlation Between Activation of the Prelimbic Cortex, Basolateral Amygdala, and Agranular Insular Cortex During Taste Memory Formation	CEREBRAL CORTEX			English	Article						basolateral amygdala; fMRI; learning and memory; prelimbic cortex; taste aversion	MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; IN-VIVO; ORBITOFRONTAL CORTEX; MESOCRICETUS-AURATUS; STIMULUS CONVERGENCE; MOLECULAR-MECHANISMS; AVERSION; RAT; BRAIN	Conditioned taste aversion (CTA) is a well-established learning paradigm, whereby animals associate tastes with subsequent visceral illness. The prelimbic cortex (PL) has been shown to be involved in the association of events separated by time. However, the nature of PL activity and its functional network in the whole brain during CTA learning remain unknown. Here, using awake functional magnetic resonance imaging and fiber tracking, we analyzed functional brain connectivity during the association of tastes and visceral illness. The blood oxygen level-dependent (BOLD) signal significantly increased in the PL after tastant and lithium chloride (LiCl) infusions. The BOLD signal in the PL significantly correlated with those in the amygdala and agranular insular cortex (IC), which we found were also structurally connected to the PL by fiber tracking. To precisely examine these data, we then performed double immunofluorescence with a neuronal activity marker (c-Fos) and an inhibitory neuron marker (GAD67) combined with a fluorescent retrograde tracer in the PL. During CTA learning, we found an increase in the activity of excitatory neurons in the basolateral amygdala (BLA) or agranular IC that project to the PL. Taken together, these findings clearly identify a role of synchronized PL, agranular IC, and BLA activity in CTA learning.	[Uematsu, Akira; Kitamura, Akihiko; Iwatsuki, Ken; Uneyama, Hisayuki; Tsurugizawa, Tomokazu] Ajinomoto Co Inc, Inst Innovat, Frontier Res Labs, Kawasaki, Kanagawa 2108681, Japan	Uematsu, A (reprint author), RIKEN, Brain Sci Inst, Lab Neural Circuitry Memory, Saitama 3510198, Japan.	akirauematsu0104@gmail.com					Abdel-Zaher AO, 1999, PHARMACOL RES, V39, P275, DOI 10.1006/phrs.1998.0445; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; St Andre J, 2007, BRAIN RES, V1135, P122, DOI 10.1016/j.brainres.2006.12.010; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; Akirav I, 2006, LEARN MEMORY, V13, P254, DOI 10.1101/lm.191706; KOSTEN T, 1989, BEHAV BRAIN RES, V35, P9, DOI 10.1016/S0166-4328(89)80003-8; Ethofer T, 2011, NEUROIMAGE, V55, P411, DOI 10.1016/j.neuroimage.2010.11.033; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; Mickley GA, 2005, BRAIN RES, V1051, P176, DOI 10.1016/j.brainres.2005.05.033; Reyes-Lopez J, 2010, NEUROSCIENCE, V169, P195, DOI 10.1016/j.neuroscience.2010.04.054; Tsurugizawa T, 2010, NEUROSCIENCE, V165, P244, DOI 10.1016/j.neuroscience.2009.10.006; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Gilmartin MR, 2010, LEARN MEMORY, V17, P289, DOI 10.1101/lm.1597410; Uematsu A, 2011, PHYSIOL BEHAV, V102, P553, DOI 10.1016/j.physbeh.2011.01.005; Reilly S, 2005, NEUROSCI BIOBEHAV R, V29, P1067, DOI 10.1016/j.neubiorev.2005.03.025; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI 10.1073/pnas.1200506109; Gallagher M, 1999, J NEUROSCI, V19, P6610; Fox AS, 2010, J NEUROSCI, V30, P7023, DOI 10.1523/JNEUROSCI.5952-09.2010; Hernadi I, 2000, BRAIN RES BULL, V53, P751, DOI 10.1016/S0361-9230(00)00361-0; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.bps.2004.08.019; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Tsurugizawa T, 2009, GASTROENTEROLOGY, V137, P262, DOI 10.1053/j.gastro.2009.02.057; Schafe GE, 1998, BRAIN RES, V800, P40, DOI 10.1016/S0006-8993(98)00492-2; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Tabbert K, 2005, INT J PSYCHOPHYSIOL, V57, P15, DOI 10.1016/j.ijpsycho.2005.01.007; Gilmartin MR, 2013, J NEUROSCI, V33, P10910, DOI 10.1523/JNEUROSCI.0144-13.2013; Barot SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006156; Barot SK, 2008, P NATL ACAD SCI USA, V105, P20959, DOI 10.1073/pnas.0808996106; Clark EW, 2009, BEHAV BRAIN RES, V197, P356, DOI 10.1016/j.bbr.2008.09.030; Escobar ML, 1998, BRAIN RES, V779, P314, DOI 10.1016/S0006-8993(97)01175-X; GALLO M, 1992, BEHAV BRAIN RES, V52, P91, DOI 10.1016/S0166-4328(05)80328-6; Gannon RL, 2007, PSYCHOPHARMACOLOGY, V195, P325, DOI 10.1007/s00213-007-0903-z; Jones MW, 1999, J NEUROSCI, V19, part. no.; Koh MT, 2009, PHYSIOL BEHAV, V98, P103, DOI 10.1016/j.physbeh.2009.04.017; Koh MT, 2005, BEHAV NEUROSCI, V119, P388, DOI 10.1037/0735-7044.119.2.388; LeBlanc J, 2007, PHYSIOL BEHAV, V91, P208, DOI 10.1016/j.physbeh.2007.02.011; Maroun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035853; Nunez-Jaramillo L, 2010, BEHAV BRAIN RES, V207, P232, DOI 10.1016/j.bbr.2009.10.040; REEP RL, 1982, NEUROSCIENCE, V7, P2609, DOI 10.1016/0306-4522(82)90087-2; REEP RL, 1982, NEUROSCIENCE, V7, P1265, DOI 10.1016/0306-4522(82)91133-2; Rodriguez-Duran LF, 2011, NEUROBIOL LEARN MEM, V95, P519, DOI 10.1016/j.nlm.2011.03.003; SCHALOMON PM, 1994, BEHAV BRAIN RES, V65, P57, DOI 10.1016/0166-4328(94)90073-6; Silvagni A, 2008, EUR J NEUROSCI, V28, P744, DOI 10.1111/j.1460-9568.2008.06364.x; Uematsu A, 2010, EUR J NEUROSCI, V31, P1136, DOI 10.1111/j.1460-9568.2010.07136.x; Watson C, 2007, RAT BRAIN STEREOTAXI; Zhao G, 2007, J ETHNOPHARMACOL, V112, P498, DOI 10.1016/j.jep.2007.04.013	51	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	SEP	2015	25	9					2719	2728		10.1093/cercor/bhu069		10	Neurosciences	Neurosciences & Neurology	CR6NK	WOS:000361464000033		
J	Sugiura, M; Miyauchi, CM; Kotozaki, Y; Akimoto, Y; Nozawa, T; Yomogida, Y; Hanawa, S; Yamamoto, Y; Sakuma, A; Nakagawa, S; Kawashima, R				Sugiura, Motoaki; Miyauchi, Carlos Makoto; Kotozaki, Yuka; Akimoto, Yoritaka; Nozawa, Takayuki; Yomogida, Yukihito; Hanawa, Sugiko; Yamamoto, Yuki; Sakuma, Atsushi; Nakagawa, Seishu; Kawashima, Ryuta			Neural Mechanism for Mirrored Self-face Recognition	CEREBRAL CORTEX			English	Article						contingency; face; fMRI; recognition; self	FRONTAL-CORTEX; VISUAL-CORTEX; FMRI; EXPERIENCE; AWARENESS; MOTION; MISIDENTIFICATION; CONSEQUENCES; CONVERGENCE; VARIABILITY	Self-face recognition in the mirror is considered to involve multiple processes that integrate 2 perceptual cues: temporal contingency of the visual feedback on one's action (contingency cue) and matching with self-face representation in long-term memory (figurative cue). The aim of this study was to examine the neural bases of these processes by manipulating 2 perceptual cues using a "virtual mirror" system. This system allowed online dynamic presentations of real-time and delayed self-or other facial actions. Perception-level processes were identified as responses to only a single perceptual cue. The effect of the contingency cue was identified in the cuneus. The regions sensitive to the figurative cue were subdivided by the response to a static self-face, which was identified in the right temporal, parietal, and frontal regions, but not in the bilateral occipitoparietal regions. Semantic-or integration-level processes, including amodal self-representation and belief validation, which allow modality-independent self-recognition and the resolution of potential conflicts between perceptual cues, respectively, were identified in distinct regions in the right frontal and insular cortices. The results are supportive of the multicomponent notion of self-recognition and suggest a critical role for contingency detection in the co-emergence of self-recognition and empathy in infants.	[Sugiura, Motoaki; Miyauchi, Carlos Makoto; Kotozaki, Yuka; Akimoto, Yoritaka; Nozawa, Takayuki; Hanawa, Sugiko; Yamamoto, Yuki; Sakuma, Atsushi; Nakagawa, Seishu; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Sugiura, Motoaki] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 9808575, Japan; [Miyauchi, Carlos Makoto] Univ Tokyo, Grad Sch Law, Tokyo 1130033, Japan; [Miyauchi, Carlos Makoto] Univ Tokyo, Grad Sch Polit, Tokyo 1130033, Japan; [Yomogida, Yukihito] Japan Soc Promot Sci, Tokyo 1028472, Japan; [Yomogida, Yukihito] Tamagawa Univ, Brain Sci Inst, Tokyo 1948610, Japan	Sugiura, M (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Aoba Ku, Seiryo Machi 4-1, Sendai, Miyagi 9808575, Japan.	motoaki@idac.tohoku.ac.jp			MEXT KAKENHI [23119702, 25560347]	This study was supported by MEXT KAKENHI 23119702 and 25560347. Funding to pay the Open Access publication charges for this article was provided by MEXT KAKENHI 25560347.	Smith AT, 2012, CEREB CORTEX, V22, P1068, DOI 10.1093/cercor/bhr179; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Marino L, 2002, BRAIN BEHAV EVOLUT, V59, P21, DOI 10.1159/000063731; BROOKSGUNN J, 1984, DEV REV, V4, P215, DOI 10.1016/S0273-2297(84)80006-4; Schnell K, 2007, NEUROIMAGE, V34, P332, DOI 10.1016/j.neuroimage.2006.08.027; Coltheart M, 2010, ANN NY ACAD SCI, V1191, P16, DOI 10.1111/j.1749-6632.2010.05496.x; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126; Oikawa H, 2012, NEUROIMAGE, V59, P3668, DOI 10.1016/j.neuroimage.2011.10.098; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Nadel J, 1999, DEVELOPMENTAL SCI, V2, P164, DOI 10.1111/1467-7687.00065; David N, 2007, NEUROIMAGE, V36, P1004, DOI 10.1016/j.neuroimage.2007.03.030; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Morita T, 2008, J COGNITIVE NEUROSCI, V20, P342, DOI 10.1162/jocn.2008.20024; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; Reddy V, 2007, INFANT BEHAV DEV, V30, P195, DOI 10.1016/j.infbeh.2007.02.009; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; ANDERSON JR, 1984, DEV PSYCHOBIOL, V17, P35, DOI 10.1002/dev.420170104; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Connors MH, 2011, NEUROPSYCHOLOGIA, V49, P1679, DOI 10.1016/j.neuropsychologia.2011.02.041; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; Wegner DM, 1999, AM PSYCHOL, V54, P480, DOI 10.1037/0003-066X.54.7.480; Kaplan JT, 2008, SOC COGN AFFECT NEUR, V3, P218, DOI 10.1093/scan/nsn014; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Breen N, 2001, NEUROCASE, V7, P239, DOI 10.1093/neucas/7.3.239; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Courage ML, 2004, INFANT BEHAV DEV, V27, P509, DOI 10.1016/j.infbeh.2004.06.001; Hart BL, 2008, NEUROSCI BIOBEHAV R, V32, P86, DOI 10.1016/j.neubiorev.2007.05.012; Villarejo A, 2011, NEUROCASE, V17, P276, DOI 10.1080/13554794.2010.498427; Sugiura M, 2008, NEUROIMAGE, V42, P414, DOI 10.1016/j.neuroimage.2008.03.054; Inoue K, 2000, NEUROIMAGE, V11, P505, DOI 10.1006/nimg.2000.0554; BIGELOW AE, 1981, J GENET PSYCHOL, V139, P11; BISCHOFKOHLER D, 1988, SCHWEIZ Z PSYCHOL, V47, P147; EPSTEIN R, 1981, SCIENCE, V212, P695, DOI 10.1126/science.212.4495.695; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; Gergely G, 1999, EARLY SOCIAL COGNITION, P101; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; LOVELAND KA, 1986, DEV REV, V6, P1, DOI 10.1016/0273-2297(86)90001-8; Suddendorf T, 2009, P R SOC B, V276, P1671, DOI 10.1098/rspb.2008.1754; Sugiura M, 2012, HUM BRAIN MAPP, V33, P1364, DOI 10.1002/hbm.21290; Sugiura M, 2006, NEUROIMAGE, V32, P1905, DOI 10.1016/j.neuroimage.2006.05.026; Sugiura M, 2007, HUM BRAIN MAPP, V28, P49, DOI 10.1002/hbm.20256; Sugiura M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00535; Turner DC, 2004, CEREB CORTEX, V14, P872, DOI 10.1093/cercor/bhh046; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032	55	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	SEP	2015	25	9					2806	2814		10.1093/cercor/bhu077		9	Neurosciences	Neurosciences & Neurology	CR6NK	WOS:000361464000041		
J	Liu, X; Yanagawa, T; Leopold, DA; Fujii, N; Duyn, JH				Liu, Xiao; Yanagawa, Toru; Leopold, David A.; Fujii, Naotaka; Duyn, Jeff H.			Robust Long-Range Coordination of Spontaneous Neural Activity in Waking, Sleep and Anesthesia	CEREBRAL CORTEX			English	Article						anesthesia; electrocorticography; resting-state networks; sleep; spontaneous activity	RESTING STATE NETWORKS; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; NEURONAL AVALANCHES; BOLD CONNECTIVITY; CLUSTER-ANALYSIS; AROUSAL SYSTEMS; MOTOR CORTEX; DEFAULT MODE; TOP-DOWN	Although the emerging field of functional connectomics relies increasingly on the analysis of spontaneous fMRI signal covariation to infer the spatial fingerprint of the brain's large-scale functional networks, the nature of the underlying neuro-electrical activity remains incompletely understood. In part, this lack in understanding owes to the invasiveness of electrophysiological acquisition, the difficulty in their simultaneous recording over large cortical areas, and the absence of fully established methods for unbiased extraction of network information from these data. Here, we demonstrate a novel, data-driven approach to analyze spontaneous signal variations in electrocorticographic (ECoG) recordings from nearly entire hemispheres of macaque monkeys. Based on both broadband analysis and analysis of specific frequency bands, the ECoG signals were found to co-vary in patterns that resembled the fMRI networks reported in previous studies. The extracted patterns were robust against changes in consciousness associated with sleep and anesthesia, despite profound changes in intrinsic characteristics of the raw signals, including their spectral signatures. These results suggest that the spatial organization of large-scale brain networks results from neural activity with a broadband spectral feature and is a core aspect of the brain's physiology that does not depend on the state of consciousness.	[Liu, Xiao; Duyn, Jeff H.] NINDS, Adv MRI Sect, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Yanagawa, Toru; Fujii, Naotaka] RIKEN, Brain Sci Inst, Lab Adapt Intelligence, Saitama, Japan; [Leopold, David A.] NIMH, Sect Cognit Neurophysiol & Imaging, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA	Liu, X (reprint author), 10 Ctr Dr,Bldg 10,Rm B1D-723A-MSC 1065, Bethesda, MD 20892 USA.	liux15@ninds.nih.gov			National Institute of Neurological Disorders and Stroke at the National Institutes of Health	This research was supported (in part) by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.	Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Wang L, 2012, NEURON, V76, P1010, DOI 10.1016/j.neuron.2012.09.033; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Jones BE, 2003, FRONT BIOSCI, V8, pS438, DOI 10.2741/1074; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; MARROCCO RT, 1994, CURR OPIN NEUROBIOL, V4, P166, DOI 10.1016/0959-4388(94)90067-1; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Breshears JD, 2010, P NATL ACAD SCI USA, V107, P21170, DOI 10.1073/pnas.1011949107; Petridou N, 2013, HUM BRAIN MAPP, V34, P1319, DOI 10.1002/hbm.21513; Adachi Y, 2012, CEREB CORTEX, V22, P1586, DOI 10.1093/cercor/bhr234; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; STERIADE M, 1993, J NEUROSCI, V13, P3252; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Liu X, 2012, J NEUROSCI METH, V211, P94, DOI 10.1016/j.jneumeth.2012.08.016; Liu X, 2013, P NATL ACAD SCI USA, V110, P4392, DOI 10.1073/pnas.1216856110; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; John ER, 2001, CONSCIOUS COGN, V10, P165, DOI 10.1006/ccog.2001.0507; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Leopold DA, 2012, NEUROIMAGE, V62, P2190, DOI 10.1016/j.neuroimage.2011.10.059; Moeller S, 2009, J NEUROSCI, V29, P5897, DOI 10.1523/JNEUROSCI.0220-09.2009; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Rack-Gomer AL, 2012, NEUROIMAGE, V59, P2994, DOI 10.1016/j.neuroimage.2011.10.001; FORGY EW, 1965, BIOMETRICS, V21, P768; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Hutchison RM, 2012, FRONT NEUROANAT, V6, P1, DOI 10.3389/fnana.2012.00029; Hutchison RM, 2011, NEUROIMAGE, V56, P1546, DOI 10.1016/j.neuroimage.2011.02.063; Liu Xiao, 2013, Front Syst Neurosci, V7, P101, DOI 10.3389/fnsys.2013.00101; Liu ZM, 2010, NEUROIMAGE, V51, P102, DOI 10.1016/j.neuroimage.2010.01.092; Mitra P., 2008, OBSERVED BRAIN DYNAM; Nagasaka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022561; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Thiagarajan TC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000278; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Wey HY, 2014, BRAIN STRUCT FUNCT, V219, P2187, DOI 10.1007/s00429-013-0620-9	56	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	SEP	2015	25	9					2929	2938		10.1093/cercor/bhu089		10	Neurosciences	Neurosciences & Neurology	CR6NK	WOS:000361464000052		
J	Zhang, HY				Zhang, Hongyong			How does agglomeration promote the product innovation of Chinese firms?	CHINA ECONOMIC REVIEW			English	Article						Agglomeration economies; Localization economies; Urbanization economies; Product innovation; New product	INDUSTRY; CITIES; GROWTH; DIVERSITY; IMPACT; SIZE	This study empirically analyzes the effect of agglomeration economies on firm-level product innovation (new products), using Chinese firm-level data from 1998 to 2007. In terms of new product introduction and new product output, I find that Chinese firms benefit from urbanization economies (as measured by the number of workers in other industries in the same city and by the diversity of industries in the same city). Conversely, I find no positive effects of localization economies (as measured by the number of other workers working for neighboring firms in the same industry and in the same city). These results suggest that in China, urbanization economies play an important role in fostering product innovation by urban size and diversity. (C) 2015 Elsevier Inc. All rights reserved.	RIETI, Chiyoda Ku, Tokyo 1000013, Japan	Zhang, HY (reprint author), RIETI, Chiyoda Ku, 1-3-1 Kasumigaseki, Tokyo 1000013, Japan.	zhang-hong-yong@rieti.go.jp					Hu AGZ, 2002, WORLD ECON, V25, P1063, DOI 10.1111/1467-9701.00481; Wen M, 2004, J DEV ECON, V73, P329, DOI 10.1016/j.jdeveco.2003.04.001; Henderson JV, 2003, J URBAN ECON, V53, P1, DOI 10.1016/S0094-1190(02)00505-3; Feldman MP, 1999, EUR ECON REV, V43, P409, DOI 10.1016/S0014-2921(98)00047-6; Martin P, 2011, J URBAN ECON, V69, P182, DOI 10.1016/j.jue.2010.09.002; Duranton G, 2001, AM ECON REV, V91, P1454, DOI 10.1257/aer.91.5.1454; Long C, 2011, J INT ECON, V84, P112, DOI 10.1016/j.jinteco.2011.03.002; Girma S, 2009, SCAND J ECON, V111, P863, DOI 10.1111/j.1467-9442.2009.01586.x; Lin HL, 2011, CHINA ECON REV, V22, P313, DOI 10.1016/j.chieco.2011.03.003; Hu AG, 2009, J DEV ECON, V90, P57, DOI 10.1016/j.jdeveco.2008.11.004; Levinsohn J, 2003, REV ECON STUD, V70, P317, DOI 10.1111/1467-937X.00246; Lu JY, 2009, J URBAN ECON, V65, P167, DOI 10.1016/j.jue.2008.10.003; Au CC, 2006, J DEV ECON, V80, P350, DOI 10.1016/j.jdeveco.2005.04.002; Melitz MJ, 2008, REV ECON STUD, V75, P295, DOI 10.1111/j.1467-937X.2007.00463.x; Brandt L, 2012, J DEV ECON, V97, P339, DOI 10.1016/j.jdeveco.2011.02.002; Au CC, 2006, REV ECON STUD, V73, P549, DOI 10.1111/j.1467-937X.2006.00387.x; Wang J, 2013, J DEV ECON, V101, P133, DOI 10.1016/j.jdeveco.2012.10.009; Lu Y, 2013, CHINA ECON REV, V27, P135, DOI 10.1016/j.chieco.2013.08.004; Ge Y, 2009, WORLD DEV, V37, P550, DOI 10.1016/j.worlddev.2008.07.005; Chen J., 1993, DEV POLICY REV, V11, P261, DOI 10.1111/j.1467-7679.1993.tb00041.x; Ellison G, 1997, J POLIT ECON, V105, P889, DOI 10.1086/262098; Fujita M., 2004, HDB REGIONAL URBAN E, V4, P2911; GLAESER EL, 1992, J POLIT ECON, V100, P1126, DOI 10.1086/261856; GRILICHES Z, 1990, J ECON LIT, V28, P1661; Ito B., 2013, RIETI DISCUSSION PAP, P1; Jacobs J, 1969, EC CITIES; Jefferson G., 2008, J CHINESE EC BUSINES, V6, P120; Jefferson G. H., 2004, CHINA ECON REV, V14, P89; Li DY, 2012, REG SCI URBAN ECON, V42, P135, DOI 10.1016/j.regsciurbeco.2011.07.003; Marshall A., 1890, PRINCIPLES EC; MOFCOM, 2013, IND REP CHIN NAT EC; Okubo T., 2006, J ECON GEOGR, V6, P323; Porter M., 1998, CLUSTERS NEW EC COMP, P77; Kuchiki A, 2009, IDE-JETRO SER, P1, DOI 10.1057/9780230251014; Van Beveren I., 2010, 14 KU LEUVEN VIVES, P1, DOI 10.1109/ICELMACH.2010.5608300; Yang CH, 2013, CHINA ECON REV, V27, P162, DOI 10.1016/j.chieco.2013.09.005	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1043-951X	1873-7781		CHINA ECON REV	China Econ. Rev.	SEP	2015	35						105	120		10.1016/j.chieco.2015.06.003		16	Economics	Business & Economics	CR5XF	WOS:000361417000007		
J	Dang, JW; Motohashi, K				Dang, Jianwei; Motohashi, Kanyuki			Patent statistics: A good indicator for innovation in China? Patent subsidy program impacts on patent quality	CHINA ECONOMIC REVIEW			English	Article						Patent; Subsidy; Quality; Innovation; China	INVENTION PATENTS; PRODUCTIVITY; PERFORMANCE; REFORM; SURGE; SIZE	Using a merged dataset of Chinese patent data and industrial survey data, we make a bibliometric analysis of patenting activities of Chinese large and medium-sized enterprises under local patent subsidy programs and test whether patent statistics are a good indicator of innovation in China. Our empirical results show that patent count is correlated with R&D input and financial output which suggests that patent statistics are meaningful indicators. However, patent subsidy programs increase patent counts more than 30%. We emphasize the necessity of adjustments and provide a novel method of using the number of nouns in claims to quantify the claim scope, thereby overcoming the shortcomings of Chinese patent data that have no citations or lack well-documented patent claim information. We extend prior studies on patent subsidy programs by providing a detailed clarification of policy designs and their impacts and by evaluating policy impacts on both the quantity and quality of patent applications. (C) 2015 Elsevier Inc. All rights reserved.	[Dang, Jianwei; Motohashi, Kanyuki] Univ Tokyo, Sch Engn, Dept Technol Management Innovat, Bunkyo Ku, Tokyo 1138656, Japan	Dang, JW (reprint author), Univ Tokyo, Sch Engn, Dept Technol Management Innovat, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.	dangjw@gmail.com; motohashi@tmi.t.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [257268]	The authors would like to thank a guest editor and two anonymous reviewers for their constructive comments and suggestions, which helped significantly in the revision of this paper. The first author would also like to gratefully acknowledge the financial assistance provided by the Japan Society for the Promotion of Science (JSPS) Grant in Aid for Young Scientists, number 257268.	HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Harhoff D, 1999, REV ECON STAT, V81, P511, DOI 10.1162/003465399558265; Goto A, 2007, RES POLICY, V36, P1431, DOI 10.1016/j.respol.2007.06.005; Lanjouw JO, 2004, ECON J, V114, P441, DOI 10.1111/j.1468-0297.2004.00216.x; Hu AG, 2009, J DEV ECON, V90, P57, DOI 10.1016/j.jdeveco.2008.11.004; Harhoff D, 2003, RES POLICY, V32, P1343, DOI 10.1016/S0048-7333(02)00124-5; Li XB, 2012, RES POLICY, V41, P236, DOI 10.1016/j.respol.2011.07.003; ALBERT MB, 1991, RES POLICY, V20, P251, DOI 10.1016/0048-7333(91)90055-U; Nagaoka S, 2010, HBK ECON, V2, P1083, DOI 10.1016/S0169-7218(10)02009-5; Motohashi K, 2007, RES POLICY, V36, P1251, DOI 10.1016/j.respol.2007.02.023; Jefferson G, 2003, CHINA ECON REV, V14, P89, DOI 10.1016/S1043-951X(03)00003-8; Hu AG, 2010, RES POLICY, V39, P985, DOI 10.1016/j.respol.2010.04.006; Liu FC, 2011, RES POLICY, V40, P917, DOI 10.1016/j.respol.2011.05.005; Arora A., 2001, MARKETS TECHNOLOGY E; Barney JA, 2008, NOUVELLES, P123; Bloom N, 2002, ECON J, V112, pC97, DOI 10.1111/1468-0297.00022; Cal H., 2009, ECON J, V119, P764; Eberhardt M., 2011, IS DRAGON LEARNING F, P2011; Eldering CA, 2010, NW J TECHNOLOGY INTE, V9; Griliches Z., 1984, R D PATENTS PRODUCTI, VI, P55; Griliches Z., 1998, ECONOMETRICS EVIDENC, VI, P287; Hagedoorn J., 2014, RES POLICY, DOI [http://dx.doi.org/10.1016/j.respol.2014.03.010, DOI 10.1016/J.RESP0L.2014.03.010]; Hall B, 2005, RAND J ECON, P1; Hall B. H., 1986, ECON REV, V27, P265; Hall Bronwyn H., 2007, ACAD MGMT ANN M P, V8, P1, DOI DOI 10.5465/AMBPP.2007.26530853; Motohashi Kazuyuki, 2008, World Patent Information, V30, DOI 10.1016/j.wpi.2007.10.006; Motohashi K., 2009, CHINA EC J, V2, P1, DOI [http://dx.doi.org/10.1080/17538960902860055, DOI 10.1080/17538960902860055]; Nie H, 2012, WORLD ECON, V5, P142; Thoma G., 2013, SEOUL J EC, V26; Tong SY, 2009, CHINA ECON REV, V20, P402, DOI 10.1016/j.chieco.2009.06.008; Trajtenberg M., 1990, J ECON, V21, P172, DOI DOI 10.2307/2555502; WIPO, 2009, GLOB EC SLOWD IMP 20; Xu XP, 2012, WORLD DEV, V40, P62, DOI 10.1016/j.worlddev.2011.05.006; Xue L., 2010, INT J TECHNOLOGY MAN, P51; Yang DL, 2008, RES POLICY, V37, P1035, DOI 10.1016/j.respol.2008.03.008; Zhang GP, 2012, CHINA ECON REV, V23, P357, DOI 10.1016/j.chieco.2012.02.002	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1043-951X	1873-7781		CHINA ECON REV	China Econ. Rev.	SEP	2015	35						137	155		10.1016/j.chieco.2015.03.012		19	Economics	Business & Economics	CR5XF	WOS:000361417000009		
J	Kuriyama, A; Urushidani, S				Kuriyama, Akira; Urushidani, Seigo			Pneumonia Prevention to Decrease Mortality in Intensive Care Units	CLINICAL INFECTIOUS DISEASES			English	Letter									[Kuriyama, Akira] Kurashiki Cent Hosp, Dept Gen Med, Kurashiki, Okayama 7108602, Japan; [Urushidani, Seigo] Kurashiki Cent Hosp, Dept Emergency Med, Kurashiki, Okayama 7108602, Japan	Kuriyama, A (reprint author), Kurashiki Cent Hosp, Dept Gen Med, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	nrk40448@nifty.com					Bender R, 2008, J CLIN EPIDEMIOL, V61, P857, DOI 10.1016/j.jclinepi.2008.03.004; Roquilly A, 2015, CLIN INFECT DIS, V60, P64, DOI 10.1093/cid/ciu740	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1058-4838	1537-6591		CLIN INFECT DIS	Clin. Infect. Dis.	SEP 1	2015	61	5								10.1093/cid/civ410		1	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CR6PD	WOS:000361468700032		
J	Kusumoto, S; Tanaka, Y; Suzuki, R; Watanabe, T; Nakata, M; Takasaki, H; Fukushima, N; Fukushima, T; Moriuchi, Y; Itoh, K; Nosaka, K; Choi, I; Sawa, M; Okamoto, R; Tsujimura, H; Uchida, T; Suzuki, S; Okamoto, M; Takahashi, T; Sugiura, I; Onishi, Y; Kohri, M; Yoshida, S; Sakai, R; Kojima, M; Takahashi, H; Tomita, A; Maruyama, D; Atsuta, Y; Tanaka, E; Suzuki, T; Kinoshita, T; Ogura, M; Mizokami, M; Ueda, R				Kusumoto, Shigeru; Tanaka, Yasuhito; Suzuki, Ritsuro; Watanabe, Takashi; Nakata, Masanobu; Takasaki, Hirotaka; Fukushima, Noriyasu; Fukushima, Takuya; Moriuchi, Yukiyoshi; Itoh, Kuniaki; Nosaka, Kisato; Choi, Ilseung; Sawa, Masashi; Okamoto, Rumiko; Tsujimura, Hideki; Uchida, Toshiki; Suzuki, Sachiko; Okamoto, Masataka; Takahashi, Tsutomu; Sugiura, Isamu; Onishi, Yasushi; Kohri, Mika; Yoshida, Shinichiro; Sakai, Rika; Kojima, Minoru; Takahashi, Hiroyuki; Tomita, Akihiro; Maruyama, Dai; Atsuta, Yoshiko; Tanaka, Eiji; Suzuki, Takayo; Kinoshita, Tomohiro; Ogura, Michinori; Mizokami, Masashi; Ueda, Ryuzo			Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study	CLINICAL INFECTIOUS DISEASES			English	Article						HBV DNA monitoring; HBV reactivation; resolved HBV infection; rituximab; preemptive antiviral therapy	RANDOMIZED CONTROLLED-TRIAL; CYTOTOXIC CHEMOTHERAPY; RECEIVING RITUXIMAB; MALIGNANT-LYMPHOMA; INFECTION; LAMIVUDINE; THERAPY; PATIENT; IMMUNOGENICITY; PROPHYLAXIS	Background. There is no standard management of reactivation of hepatitis B virus (HBV) infection in HBV-resolved patients without hepatitis B surface antigen (HBsAg), but with antibodies against hepatitis B core antigen and/or antibodies against HBsAg (anti-HBs). Methods. We conducted a prospective observational study to evaluate the occurrence of HBV reactivation by serial monthly monitoring of HBV DNA and to establish preemptive therapy guided by this monitoring in B-cell non-Hodgkin lymphoma (B-NHL) treated with rituximab plus corticosteroid-containing chemotherapy (R-steroid-chemo). The primary endpoint was the incidence of HBV reactivation defined as quantifiable HBV DNA levels of >= 11 IU/mL. Results. With a median HBV DNA follow-up of 562 days, HBV reactivation was observed in 21 of the 269 analyzed patients. The incidence of HBV reactivation at 1.5 years was 8.3% (95% confidence interval, 5.5-12.4). No hepatitis due to HBV reactivation was observed in patients who received antiviral treatment when HBV DNA levels were between 11 and 432 IU/mL. An anti-HBs titer of <10 mIU/mL and detectable HBV DNA remaining below the level of quantification at baseline were independent risk factors for HBV reactivation (hazard ratio, 20.6 and 56.2, respectively; P < .001). Even in 6 patients with a rapid increase of HBV due to mutations, the monthly HBV DNA monitoring was effective at preventing HBV-related hepatitis. Conclusions. Monthly monitoring of HBV DNA is useful for preventing HBV reactivation-related hepatitis among B-NHL patients with resolved HBV infection following R-steroid-chemo (UMIN000001299).	[Kusumoto, Shigeru] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Suzuki, Ritsuro; Atsuta, Yoshiko] Nagoya City Univ, Grad Sch Med Sci, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi, Japan; [Watanabe, Takashi; Maruyama, Dai] Natl Canc Ctr, Dept Hematol, Tokyo, Japan; [Nakata, Masanobu] Sapporo Hokuyu Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan; [Takasaki, Hirotaka] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa 2410815, Japan; [Fukushima, Takuya] Nagasaki Univ, Atom Bomb Dis Inst, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, Nagasaki, Japan; [Moriuchi, Yukiyoshi] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan; [Itoh, Kuniaki] Natl Canc Ctr Hosp East, Div Hematol & Oncol, Kashiwa, Chiba, Japan; [Nosaka, Kisato] Kumamoto Univ, Sch Med, Dept Hematol & Infect Dis, Kumamoto 860, Japan; [Choi, Ilseung] Natl Hosp Org, Kyushu Canc Ctr, Div Hematol, Fukuoka, Japan; [Sawa, Masashi] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Aichi, Japan; [Okamoto, Rumiko] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Chemotherapy, Tokyo, Japan; [Tsujimura, Hideki] Chiba Canc Ctr, Div Hematol Oncol, Chiba, Japan; [Uchida, Toshiki; Ogura, Michinori] Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Suzuki, Sachiko] Natl Hosp Org, Hokkaido Canc Ctr, Dept Hematol, Sapporo, Hokkaido, Japan; [Okamoto, Masataka] Fujita Hlth Univ, Sch Med, Dept Hematol & Med Oncol, Toyoake, Aichi 47011, Japan; [Takahashi, Tsutomu] Shimane Univ Hosp, Dept Oncol Hematol, Izumo, Shimane, Japan; [Sugiura, Isamu] Toyohashi Municipal Hosp, Div Hematol & Oncol, Toyohashi, Aichi, Japan; [Onishi, Yasushi] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan; [Kohri, Mika] Saitama Med Univ, Int Med Ctr, Dept Hematol, Hidaka, Japan; [Yoshida, Shinichiro] Natl Hosp Org, Nagasaki Med Ctr, Dept Hematol, Ohmura, Japan; [Sakai, Rika] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa, Japan; [Kojima, Minoru] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Takahashi, Hiroyuki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa, Japan; [Tomita, Akihiro] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 390, Japan; [Suzuki, Takayo] Shiga Med Ctr Adults, Dept Hematol & Oncol, Moriyama, Japan; [Kinoshita, Tomohiro] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan; [Ueda, Ryuzo] Aichi Med Univ, Sch Med, Dept Tumor Immunol, Nagoya, Aichi, Japan	Mizokami, M (reprint author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, 1-7-1 Kounodai, Ichikawa 2728516, Japan.	mmizokami@hospk.ncgm.go.jp			Ministry of Health, Labour and Welfare of Japan [H20-kanen-014, H23-kanen-008, H24-kanen-004]	This work was supported by the Ministry of Health, Labour and Welfare of Japan (grant-in-aid H20-kanen-014 to S. K., H23-kanen-008 to S. K., and H24-kanen-004 to M.M.].	Byrd KK, 2012, VACCINE, V30, P3376, DOI 10.1016/j.vaccine.2012.03.055; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Artz AS, 2010, J CLIN ONCOL, V28, P3199, DOI 10.1200/JCO.2010.30.0673; Hsu C, 2014, HEPATOLOGY, V59, P2092, DOI 10.1002/hep.26718; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P1664, DOI 10.1001/jama.2013.281115; HADLER SC, 1986, NEW ENGL J MED, V315, P209, DOI 10.1056/NEJM198607243150401; Loomba R, 2008, ANN INTERN MED, V148, P519; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Yeo W, 2004, J CLIN ONCOL, V22, P927, DOI 10.1200/JCO.2004.05.161; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Dervite I, 2001, NEW ENGL J MED, V344, P68, DOI 10.1056/NEJM200101043440120; OMATA M, 1991, NEW ENGL J MED, V324, P1699, DOI 10.1056/NEJM199106133242404; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lau GKK, 2003, GASTROENTEROLOGY, V125, P1742, DOI 10.1053/S0016-5085(03)01518-X; Fukushima N, 2009, ANN ONCOL, V20, P2013, DOI 10.1093/annonc/mdp230; Kusumoto S, 2009, INT J HEMATOL, V90, P13, DOI 10.1007/s12185-009-0359-5; Hammond SP, 2009, BIOL BLOOD MARROW TR, V15, P1049, DOI 10.1016/j.bbmt.2009.05.001; Hui CK, 2006, GASTROENTEROLOGY, V131, P59, DOI 10.1053/j.gastro.2006.04.015; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Awerkiew S, 2007, J CLIN VIROL, V38, P83, DOI 10.1016/j.jcv.2006.10.006; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1; Ferreira R, 2012, SAUDI J GASTROENTERO, V18, P277, DOI 10.4103/1319-3767.98436; Goedel S, 2009, J CLIN VIROL, V45, P232, DOI 10.1016/j.jcv.2009.05.021; Hochberger S, 2006, J CLIN VIROL, V35, P373, DOI 10.1016/j.jcv.2006.01.003; Kinn S, 2011, J CLIN VIROL, V50, P297, DOI 10.1016/j.jcv.2011.01.009; Kusumoto S, 2013, J CLIN ONCOL, V31, P4480, DOI 10.1200/JCO.2013.52.1278; Launay O, 2011, JAMA-J AM MED ASSOC, V305, P1432, DOI 10.1001/jama.2011.351; Shin IT, 2008, HEPATOL RES, V38, P234, DOI DOI 10.1111/J.1872-034X.2007.00262.X; Yoshida T, 2010, INT J HEMATOL, V91, P844, DOI 10.1007/s12185-010-0592-y	32	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1058-4838	1537-6591		CLIN INFECT DIS	Clin. Infect. Dis.	SEP 1	2015	61	5					719	729		10.1093/cid/civ344		11	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CR6PD	WOS:000361468700009		
J	Yen, NY; Nguyen, UT; Park, JH				Yen, Neil Y.; Uyen Trang Nguyen; Park, Jong Hyuk			Mining Social Media for Knowledge Discovery	COMPUTER JOURNAL			English	Article						social network; knowledge discovery; recommender system; social media		With ever-rising popularity of social media, some sort of on-the-fly experiences are being learned and obtained by daily users. Despite a wide spectrum of research development efforts, how to facilitate knowledge discovery from an open environment and provide corresponding services remains an open challenge. In this special issue, we aim to foster the dissemination of high-quality research in methods, theories and techniques concerning the knowledge discovery from the next generation social media. Original and research articles include all aspects of theoretical studies, practical applications and experimental prototypes.	[Yen, Neil Y.] Univ Aizu, Sch Engn & Comp Sci, Aizu Wakamatsu, Fukushima, Japan; [Uyen Trang Nguyen] York Univ, Dept Comp Sci & Engn, Toronto, ON M3J 2R7, Canada; [Park, Jong Hyuk] Seoul Natl Univ Sci & Technol, Dept Comp Sci & Engn, Seoul, South Korea	Park, JH (reprint author), Seoul Natl Univ Sci & Technol, Dept Comp Sci & Engn, Seoul, South Korea.	jhpark1@seoultech.ac.kr						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0010-4620	1460-2067		COMPUT J	Comput. J.	SEP	2015	58	9					1859	1860		10.1093/comjnl/bxv018		2	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CR6PO	WOS:000361469800001		
J	Chen, SH; Zang, MY; Xu, W				Chen, Shunhua; Zang, Mengyan; Xu, Wei			A three-dimensional computational framework for impact fracture analysis of automotive laminated glass	COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING			English	Article						Laminated glass; Cohesive model; Contact algorithm; Impact fracture; Coupling model	FINITE-ELEMENT-ANALYSIS; CONTACT SEARCH ALGORITHM; COMBINED DE/FE ALGORITHM; CRACK-PROPAGATION; NUMERICAL-SIMULATION; DYNAMIC FRACTURE; BRITTLE-FRACTURE; INDUCED DELAMINATION; NONSMOOTH CONTACT; COHESIVE ELEMENTS	This work is concerned with a three-dimensional modelling of impact fracture behaviours of laminated glass. A cohesive model that is able to account for path-dependent behaviours is extended to three dimensions to predict the onset and evolution of fracture. A compact and efficient adjacency-based topological data structure termed TopS is utilized to store and manipulate mesh information. In view of contact characteristics, a global contact search algorithm is developed, which includes a regular search and an adaptive search. The regular search is performed by recourse to a linear contact algorithm named LC-Grid. The adaptive search algorithm is proposed to efficiently update new contacts during fracture. Additionally, a local contact search algorithm is developed, which facilitates the judgements of node-face and edge-edge contacts with a unified inside-outside approach. Afterwards, the cohesive model is coupled with the frictional contact algorithm to account for the unilateral and frictional sliding effects of cohesive elements under mixed mode loading. Finally, the impact fracture behaviours of a laminated glass plate are simulated. The simulation results compare well with the experimental outcomes, which validates the capability of the proposed method in the impact fracture analysis of laminated glass. (C) 2015 Elsevier B.V. All rights reserved.	[Chen, Shunhua; Zang, Mengyan; Xu, Wei] S China Univ Technol, Sch Mech & Automot Engn, Guangzhou 510641, Guangdong, Peoples R China; [Xu, Wei] Kanazawa Univ, Sch Mech Engn, Kanazawa, Ishikawa 9201192, Japan	Zang, MY (reprint author), 381 Wushan RD, Guangzhou 510641, Guangdong, Peoples R China.	chenshunhuascut@126.com; myzang@scut.edu.cn; xwteamobj007@gmail.com			National Natural Science Foundation of China [10972079, 11172104]; International S&T Cooperation Program of Guangdong Province [2013B051000012]	This work is supported by the National Natural Science Foundation of China (Nos. 10972079 and 11172104) and the International S&T Cooperation Program of Guangdong Province (No. 2013B051000012).	Camanho PP, 2003, J COMPOS MATER, V37, P1415, DOI 10.1177/002199803034505; DUGDALE DS, 1960, J MECH PHYS SOLIDS, V8, P100, DOI 10.1016/0022-5096(60)90013-2; OLDENBURG M, 1994, INT J NUMER METH ENG, V37, P359, DOI 10.1002/nme.1620370302; Munjiza A, 2013, INT J NUMER METH ENG, V95, P478, DOI 10.1002/nme.4511; Park K, 2009, J MECH PHYS SOLIDS, V57, P891, DOI 10.1016/j.jmps.2008.10.003; Paggi M, 2013, COMPUT STRUCT, V122, P230, DOI 10.1016/j.compstruc.2013.03.006; Zhang ZYJ, 2005, INT J PLASTICITY, V21, P1195, DOI 10.1016/j.ijplas.2004.06.009; Agwai A, 2011, INT J FRACTURE, V171, P65, DOI 10.1007/s10704-011-9628-4; Toti J, 2013, COMPUT METHOD APPL M, V260, P1, DOI 10.1016/j.cma.2013.03.010; Hidallana-Gamage HD, 2014, ENG FAIL ANAL, V36, P14, DOI 10.1016/j.engfailanal.2013.09.018; Du Bois PA, 2003, COMP MATER SCI, V28, P675, DOI 10.1016/j.commatsci.2003.08.023; Zhang ZY, 2007, INT J NUMER METH ENG, V72, P893, DOI 10.1002/nme.2030; Zhao SM, 2006, ENG FAIL ANAL, V13, P582, DOI 10.1016/j.engfailanal.2004.12.038; Ruiz G, 2001, INT J NUMER METH ENG, V52, P97, DOI 10.1002/nme.273; Xu W, 2014, COMPUT MECH, V54, P535, DOI 10.1007/s00466-014-1004-6; Peng Y, 2013, INT J IMPACT ENG, V57, P27, DOI 10.1016/j.ijimpeng.2013.01.010; Zheng JW, 2012, COMPUT STRUCT, V112, P193, DOI 10.1016/j.compstruc.2012.08.003; Marfia S, 2012, COMPUT METHOD APPL M, V205, P189, DOI 10.1016/j.cma.2010.12.024; Alfano G, 2001, INT J NUMER METH ENG, V50, P1701, DOI 10.1002/nme.93; Espinosa HD, 2000, COMPUT METHOD APPL M, V183, P259, DOI 10.1016/S0045-7825(99)00222-4; Alfano G, 2006, INT J NUMER METH ENG, V68, P542, DOI 10.1002/nme.1728; Xu J, 2011, COMPOS PART B-ENG, V42, P302, DOI 10.1016/j.compositesb.2010.10.009; Benedetti I, 2013, COMPUT METHOD APPL M, V265, P36, DOI 10.1016/j.cma.2013.05.023; Lei Z, 2010, COMPUT MECH, V46, P609, DOI 10.1007/s00466-010-0502-4; Timmel M, 2007, INT J IMPACT ENG, V34, P1465, DOI 10.1016/j.ijimpeng.2006.07.008; Xu J, 2010, COMP MATER SCI, V48, P582, DOI 10.1016/j.commatsci.2010.02.026; Geubelle PH, 1998, COMPOS PART B-ENG, V29, P589, DOI 10.1016/S1359-8368(98)00013-4; Zang MY, 2007, COMPUT MECH, V41, P73, DOI 10.1007/s00466-007-0170-1; Alfano G, 2006, COMPUT METHOD APPL M, V196, P192, DOI 10.1016/j.cma.2006.03.001; Wang SP, 1997, INT J NUMER METH ENG, V40, P3665, DOI 10.1002/(SICI)1097-0207(19971015)40:19<3665::AID-NME234>3.0.CO;2-K; Maiti S, 2006, ENG FRACT MECH, V73, P22, DOI 10.1016/j.engfracmech.2005.07.005; Pandolfi A, 2012, INT J NUMER METH ENG, V92, P694, DOI 10.1002/nme.4352; Mota A, 2008, INT J NUMER METH ENG, V73, P1547, DOI 10.1002/nme.2135; Ortiz M, 1999, INT J NUMER METH ENG, V44, P1267, DOI 10.1002/(SICI)1097-0207(19990330)44:9<1267::AID-NME486>3.3.CO;2-Z; Camacho GT, 1996, INT J SOLIDS STRUCT, V33, P2899, DOI 10.1016/0020-7683(95)00255-3; Larcher M, 2012, INT J IMPACT ENG, V39, P42, DOI 10.1016/j.ijimpeng.2011.09.006; Cirak F, 2005, INT J NUMER METH ENG, V64, P1078, DOI 10.1002/nme.1400; van den Bosch MJ, 2006, ENG FRACT MECH, V73, P1220, DOI 10.1016/j.engfracmech.2005.12.006; Song JH, 2008, COMPUT MECH, V42, P239, DOI 10.1007/s00466-007-0210-x; XU XP, 1994, J MECH PHYS SOLIDS, V42, P1397, DOI 10.1016/0022-5096(94)90003-5; Barenblatt G. I., 1962, ADV APPL MECH, V7, P55, DOI DOI 10.1016/S0065-2156(08)70121-2; Barenblatt GI, 1959, PMM-J APPL MATH MEC, V23, P622, DOI DOI 10.1016/0021-8928(59)90157-1); BENSON DJ, 1990, COMPUT METHOD APPL M, V78, P141, DOI 10.1016/0045-7825(90)90098-7; Celes W, 2005, J COMPUT INF SCI ENG, V5, P348, DOI 10.1115/1.2052830; Celes W, 2005, INT J NUMER METH ENG, V64, P1529, DOI 10.1002/nme.1440; Chen H, 2014, COMPUT MECH, V54, P1285, DOI 10.1007/s00466-014-1058-5; Chen JJ, 2013, ENG FRACT MECH, V112, P26, DOI 10.1016/j.engfracmech.2013.09.010; Geissler G, 2010, ENG FRACT MECH, V77, P3541, DOI 10.1016/j.engfracmech.2010.04.029; Guiamatsia I, 2014, INT J SOLIDS STRUCT, V51, P647, DOI 10.1016/j.ijsolstr.2013.10.032; Haikal G, 2007, COMPUT METHOD APPL M, V196, P4690, DOI 10.1016/j.cma.2007.06.002; Johnson G, 2012, COMPUT METHOD APPL M, V233, P49, DOI 10.1016/j.cma.2012.04.006; Kane C, 1999, COMPUT METHOD APPL M, V180, P1, DOI 10.1016/S0045-7825(99)00034-1; Paggi M, 2006, LECT NOTES APPL COMP, V27, P297; Pandolfi A, 2013, INT J FRACTURE, V184, P3, DOI 10.1007/s10704-012-9788-x; Park K, 2011, APPL MECH REV, V64, DOI 10.1115/1.4023110; Paulino GH, 2008, ENG COMPUT-GERMANY, V24, P59, DOI 10.1007/s00366-007-0069-7; Pyttel T, 2011, INT J IMPACT ENG, V38, P252, DOI 10.1016/j.ijimpeng.2010.10.035; Raous M, 1999, COMPUT METHOD APPL M, V177, P383, DOI 10.1016/S0045-7825(98)00389-2; Repetto EA, 2000, COMPUT METHOD APPL M, V183, P3, DOI 10.1016/S0045-7825(99)00208-X; SCHELLEKENS JCJ, 1993, INT J NUMER METH ENG, V36, P43, DOI 10.1002/nme.1620360104; Snozzi L, 2013, INT J NUMER METH ENG, V93, P510, DOI 10.1002/nme.4398; van den Bosch MJ, 2008, COMPUT MECH, V42, P171, DOI 10.1007/s00466-007-0184-8; Wang FJ, 2000, ACTA MECH SINICA, V16, P374; Xu J, 2009, INT J IMPACT ENG, V36, P783, DOI 10.1016/j.ijimpeng.2008.11.008; Xu J, 2009, INT J CRASHWORTHINES, V14, P63, DOI 10.1080/13588260802462427; Xu J, 2009, P I MECH ENG D-J AUT, V223, P77, DOI 10.1243/09544070JAUTO974; Xu W, 2014, INT J SOLIDS STRUCT, V51, P1890, DOI 10.1016/j.ijsolstr.2014.01.026; Zang Mengyan, 2009, Chinese Journal of Mechanical Engineering, V45, DOI 10.3901/JME.2009.02.268; Zhang XH, 2013, INT J IMPACT ENG, V55, P49, DOI 10.1016/j.ijimpeng.2013.01.002	69	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0045-7825	1879-2138		COMPUT METHOD APPL M	Comput. Meth. Appl. Mech. Eng.	SEP 1	2015	294						72	99		10.1016/j.cma.2015.06.005		28	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications; Mechanics	Engineering; Mathematics; Mechanics	CR6YD	WOS:000361493600004		
J	Igasaki, FMT; Igasaki, T; Murayama, N				Mahananto, Faizal; Igasaki, Tomohiko; Murayama, Nobuki			Potential force dynamics of heart rate variability reflect cardiac autonomic modulation with respect to posture, age, and breathing pattern	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Potential force dynamics; Non-linear analysis; Heart rate variability; Autonomic nervous system; Breathing pattern	LOW-FREQUENCY POWER; PERIOD VARIABILITY; SYMBOLIC DYNAMICS; NERVOUS-SYSTEM; TIME-SERIES; FAILURE; DISEASE; TONE; MORTALITY; PRESSURE	Rationale: Various physiological and pathological conditions are correlated with cardiac autonomic function. Heart rate variability is a marker of cardiac autonomic modulation and can be measured by several methods. However, the available methods are sensitive to breathing patterns. Objectives: To quantify cardiac autonomic modulation by observing the potential force dynamics of the R-R interval time series in healthy individuals. Methods: We propose two "potentials of unbalanced complex kinetic" (PUCK) parameters to quantify the characteristics of the potential force dynamics of R-R interval time series: potential strength (slope) and fluctuation size (slope standard deviations [SSD1, SSD2]). We applied this method to the series of R-R intervals obtained from 30 healthy subjects in an experimental condition that elicited cardiac autonomic (i.e., sympathetic and vagal) activation (in supine, sitting, and standing positions). Subjects were categorized into three groups by decade (i.e., 20 s, 30 s, and 40 s) to verify the cardiac autonomic differences by age. Two respiration patterns were introduced to check the influence of the pattern into the analytical results. Measurements and main results: Sympathetic modulation activation significantly increased the slope and reduced SSD1 and SSD2; these trends were confirmed in all groups. The slope is concordant with the result of the low frequency/high frequency (LF/HF) ratio in frequency components as an indicator of sympathetic modulation. No trend was observed in slope among age groups. However, SSD1 and SSD2 in the 40 s group were significantly decreased in the supine and sitting positions. The results with respect to respiration frequency showed lower sympathetic modulation as shown in the LF/HF ratio and slope, whereas higher vagal modulation as shown in the HF appeared with a longer breathing rate. Conclusions: PUCK can quantify the cardiac autonomic modulation in the experimental conditions of different postures. SSD1 and SSD2 are more sensitive to age than frequency components and are unaffected by breathing patterns. This method may be an alternative method for observing cardiac autonomic modulation in clinical practice. (C) 2015 Elsevier Ltd. All rights reserved.	[Mahananto, Faizal; Igasaki, Tomohiko; Murayama, Nobuki] Kumamoto Univ, Grad Sch Sci & Technol, Dept Informat Technol Human & Environm Sci, Kumamoto 8608555, Japan	Igasaki, T (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Informat Technol Human & Environm Sci, 2-39-1 Kurokami,Chuo Ward, Kumamoto 8608555, Japan.	iga@cs.kumamoto-u.ac.jp					Abounooria E, 2012, PHYSICA A, V391, P3170, DOI 10.1016/j.physa.2011.12.045; Furlan R, 2000, CIRCULATION, V101, P886; HUIKURI HV, 1994, CIRCULATION, V90, P121; Mourot L, 2004, EUR J APPL PHYSIOL, V91, P79, DOI 10.1007/s00421-003-0917-0; Moak JP, 2007, HEART RHYTHM, V4, P1523, DOI 10.1016/j.hrthm.2007.07.019; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; Cysarz D, 2012, COMPUT BIOL MED, V42, P313, DOI 10.1016/j.compbiomed.2011.04.013; Voss A, 2009, PHILOS T R SOC A, V367, P277, DOI 10.1098/rsta.2008.0232; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Huikuri HV, 2000, CIRCULATION, V101, P47; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; Takayasu M, 2006, PHYSICA A, V370, P91, DOI 10.1016/j.physa.2006.04.041; Cheng ST, 2014, HEART LUNG, V43, P249, DOI 10.1016/j.hrtlng.2014.03.002; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; Ponnusamy A, 2011, EPILEPSY BEHAV, V22, P685, DOI 10.1016/j.yebeh.2011.08.020; FURLAN R, 1990, CIRCULATION, V81, P537; Berntson GG, 2005, PSYCHOPHYSIOLOGY, V42, P246, DOI 10.1111/j.1469-8986.2005.00277.x; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Hillebrand S, 2013, EUROPACE, V15, P742, DOI 10.1093/europace/eus341; vandeBorne P, 1997, CIRCULATION, V95, P1449; Avbelj V, 2003, COMPUT BIOL MED, V33, P259, DOI 10.1016/S0010-4825(02)00092-6; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Chen WL, 2008, AM J EMERG MED, V26, P395, DOI 10.1016/j.ajem.2007.06.016; Chiarugi F, 2007, COMPUT CARDIOL, V34, P157; Clifford GD, 2005, IEEE T BIO-MED ENG, V52, P630, DOI 10.1109/TBME.2005.844028; Garcia-Gonzalez MA, 2000, PHYSIOL MEAS, V21, P417, DOI 10.1088/0967-3334/21/3/307; GOLDBERGER A L, 1990, Scientific American, V262, P42; Liu LZ, 2010, PHYSICA A, V389, P4785, DOI 10.1016/j.physa.2010.06.013; Milicevic G, 2005, COLLEGIUM ANTROPOL, V29, P295; Mizuno T, 2007, PHYSICA A, V382, P187, DOI 10.1016/j.physa.2007.02.049; PFEIFER MA, 1983, AM J MED, V75, P249, DOI 10.1016/0002-9343(83)91201-9; Porta A, 2007, IEEE T BIO-MED ENG, V54, P94, DOI 10.1109/TBME.2006.883789; Porta A, 2008, AM J PHYSIOL-REG I, V295, pR550, DOI 10.1152/ajpregu.00129.2008; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Roberts J., 1993, AGING AUTONOMIC NERV, P140; Sanderson JE, 1996, CLIN SCI, V91, P35; Seyd PTA, 2008, INT J BIOL LIFE SCI, V4, P24; Camm AJ, 1996, CIRCULATION, V93, P1043; Wang G.-J., 2012, SYSTEMS ENG PROCEDIA, V3, P201, DOI DOI 10.1016/J.SEPR0.2011.10.030; Yukishita T., 2010, J ANTI-AGING MED, V7, P94; Zamaklar-Trifunović Danijela, 2007, Srp Arh Celok Lek, V135, P135	45	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	SEP 1	2015	64						197	207		10.1016/j.compbiomed.2015.07.005		11	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	CR5VM	WOS:000361412500019		
J	Soen, S; Fujiwara, S; Takayanagi, R; Sato, M; Tsujimoto, M; Yamamoto, T; Enomoto, H; Krege, JH				Soen, Satoshi; Fujiwara, Saeko; Takayanagi, Ryoichi; Sato, Masayo; Tsujimoto, Mika; Yamamoto, Takanori; Enomoto, Hiroyuki; Krege, John H.			Japan Fracture Observational Study (JFOS): patient characteristics and interim data on the use of daily teriparatide in Japanese patients with osteoporosis	CURRENT MEDICAL RESEARCH AND OPINION			English	Article						Daily teriparatide; Fracture; Japanese population; Observational study; Osteoporosis; Quality of life	BONE-MINERAL DENSITY; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; COMMUNITY EXPERIENCE DANCE; PARATHYROID-HORMONE 1-34; QUALITY-OF-LIFE; POSTMENOPAUSAL OSTEOPOROSIS; NONVERTEBRAL FRACTURES; DOUBLE-BLIND; BACK-PAIN; HIGH-RISK	Objectives: This report from the Japan Fracture Observational Study (JFOS) describes the design of the study, baseline characteristics of the patients, and interim results. Research design and methods: This is an interim analysis from an ongoing observational study of male and female patients with osteoporosis initiating daily teriparatide treatment observed at baseline, 3, 6 and 12 months. There was no control group. Baseline data were collected on demographic characteristics, medical and osteoporosis history, prior use of medications and health-related quality of life (HRQoL). This interim analysis includes preliminary information concerning incidence of clinical fractures, bone mineral density (BMD), procollagen type 1 aminoterminal propeptide (P1NP), back pain, HRQoL, and adverse events. Results: Baseline observations were completed for 1810 patients; 90.1% were female. Compared with osteoporotic patients treated with teriparatide in other observational studies, those in JFOS were older but had fewer osteoporosis risk factors. The incidence of clinical fractures was 2.9% at 6 months and 3.7% at 12 months. At 12 months, mean BMD was 8.9% higher at the lumbar spine and 0.8% higher at the total hip compared to baseline. At 6 months, the median serum concentration of P1NP was 187.7% higher than at baseline. At 12 months, back pain scores assessed by visual analog scale (VAS) were lower and HRQoL scores were higher than at baseline. No new safety signals were observed. Conclusions: This is the first report from an observational study of daily teriparatide in Japanese osteoporotic patients at high risk of fractures. Patients in JFOS were older but had fewer osteoporosis risk factors than those treated with teriparatide in other observational studies. The interim analysis suggests that the clinical profile of teriparatide in the real world is similar to that observed in clinical trials and observational studies conducted in Europe and the United States.	[Soen, Satoshi] Kinki Univ, Fac Med, Nara Hosp, Dept Orthoped Surg & Rheumatol, Ikoma City, Japan; [Fujiwara, Saeko] Hiroshima Atom Bomb Casualty Council, Hlth Management & Promot Ctr, Hiroshima, Japan; [Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Sato, Masayo; Tsujimoto, Mika; Yamamoto, Takanori; Enomoto, Hiroyuki] Eli Lilly Japan KK, Med Dev Unit Japan, Kobe, Hyogo, Japan; [Krege, John H.] Eli Lilly & Co, Biomed Core Team, Indianapolis, IN 46285 USA	Sato, M (reprint author), 7-1-5 Isogamidori,Chuo Ku, Kobe, Hyogo 6510086, Japan.	sato_masayo@lilly.com			Eli Lilly Japan K.K.	The study was sponsored by Eli Lilly Japan K.K.	Aloumanis K, 2011, J OSTEOPOROS, V2011, DOI DOI 10.4061/2011/510398; Nomura Y, 2013, J BONE MINER METAB, V31, P644, DOI 10.1007/s00774-013-0460-y; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Miyauchi A, 2010, BONE, V47, P493, DOI 10.1016/j.bone.2010.05.022; Kumamoto K, 2010, J BONE MINER METAB, V28, P1, DOI 10.1007/s00774-009-0125-z; Lindsay R, 2009, OSTEOPOROSIS INT, V20, P943, DOI 10.1007/s00198-008-0766-0; Krege JH, 2014, OSTEOPOROSIS INT, V25, P2159, DOI 10.1007/s00198-014-2646-0; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Silverman SL, 2010, CALCIFIED TISSUE INT, V87, P375, DOI 10.1007/s00223-010-9400-1; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Misof BM, 2010, J BONE MINER RES, V25, P2297, DOI 10.1002/jbmr.198; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Nishizawa Y, 2013, J BONE MINER METAB, V31, P1, DOI 10.1007/s00774-012-0392-y; Jiang YB, 2003, J BONE MINER RES, V18, P1932, DOI 10.1359/jbmr.2003.18.11.1932; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; Fahrleitner-Pammer A, 2011, OSTEOPOROSIS INT, V22, P2709, DOI 10.1007/s00198-010-1498-5; Hagino H, 2009, BONE, V23, P47; International Osteoporosis Foundation, 2013, AS PAC REG AD EP COS; Krege JH, 2012, BONE, V50, P161, DOI 10.1016/j.bone.2011.10.018; Langdahl BL, 2009, CALCIFIED TISSUE INT, V85, P484, DOI 10.1007/s00223-009-9299-6; Lips P, 2005, OSTEOPOROSIS INT, V16, P447, DOI 10.1007/s00198-004-1762-7; Ljunggren O, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-251; Lyritis G, 2010, CURR MED RES OPIN, V26, P1799, DOI 10.1185/03007995.2010.488516; McClung MR, 2005, ARCH INTERN MED, V165, P1762, DOI 10.1001/archinte.165.15.1762; Miller PD, 2006, OSTEOPOROSIS INT, V17, P85, DOI 10.1007/s00198-005-1915-3; Miyauchi A, 2008, J BONE MINER METAB, V26, P624, DOI 10.1007/s00774-008-0871-3; Orimo Hajime, 2012, Arch Osteoporos, V7, P3; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Prevrhal S, 2009, CURR MED RES OPIN, V25, P921, DOI 10.1185/03007990902790993 ; Sakamoto K, 2006, J ORTHOP SCI, V11, P127, DOI 10.1007/s00776-005-0998-1; Silverman S, 2013, OSTEOPOROSIS INT, V24, P2309, DOI 10.1007/s00198-013-2284-y; Tajeu GS, 2014, J GERONTOL A-BIOL, V69, P346, DOI 10.1093/gerona/glt105; Tsujimoto M, 2011, BONE, V48, P798, DOI 10.1016/j.bone.2010.12.006; Yamamoto T, 2014, J BONE MINER METAB, V32, P699, DOI 10.1007/s00774-013-0546-6	39	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0300-7995	1473-4877		CURR MED RES OPIN	Curr. Med. Res. Opin.	SEP	2015	31	9					1771	1779		10.1185/03007995.2015.1074063		9	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CR4SH	WOS:000361328000016		
J	Kikuchi, M; Omori, A; Kurokawa, D; Akasaka, K				Kikuchi, Mani; Omori, Akihito; Kurokawa, Daisuke; Akasaka, Koji			Patterning of anteroposterior body axis displayed in the expression of Hox genes in sea cucumber Apostichopus japonicus	DEVELOPMENT GENES AND EVOLUTION			English	Article						Anteroposterior axis; Echinoderm; Hox; Sea cucumber	PERONELLA-JAPONICA; DIGESTIVE-TRACT; GUT DEVELOPMENT; URCHIN EMBRYOS; HOMEOBOX GENES; EVOLUTION; ECHINODERM; CLUSTER; ORGANIZATION; DROSOPHILA	The presence of an anteroposterior body axis is a fundamental feature of bilateria. Within this group, echinoderms have secondarily evolved pentameral symmetric body plans. Although all echinoderms present bilaterally symmetric larval stages, they dramatically rearrange their body axis and develop a pentaradial body plan during metamorphosis. Therefore, the location of their anteroposterior body axis in adult forms remains a contentious issue. Unlike other echinoderms, sea cucumbers present an obvious anteroposterior axis not rearranged during metamorphosis, thus representing an interesting group to study their anteroposterior axis patterning. Hox genes are known to play a broadly conserved role in anteroposterior axis patterning in deuterostomes. Here, we report the expression patterns of Hox genes from early development to pentactula stage in sea cucumber. In early larval stages, five Hox genes (AjHox1, AjHox7, AjHox8, AjHox11/13a, and AjHox11/13b) were expressed sequentially along the archenteron, suggesting that the role of anteroposterior patterning of the Hox genes is conserved in bilateral larvae of echinoderms. In doliolaria and pentactula stages, eight Hox genes (AjHox1, AjHox5, AjHox7, AjHox8, AjHox9/10, AjHox11/13a, AjHox11/13b, and AjHox11/13c) were expressed sequentially along the digestive tract, following a similar expression pattern to that found in the visceral mesoderm of other bilateria. Unlike other echinoderms, pentameral expression patterns of AjHox genes were not observed in sea cucumber. Altogether, we concluded that AjHox genes are involved in the patterning of the digestive tract in both larvae and metamorphosis of sea cucumbers. In addition, the anteroposterior axis in sea cucumbers might be patterned like that of other bilateria.	[Kikuchi, Mani; Omori, Akihito; Kurokawa, Daisuke; Akasaka, Koji] Univ Tokyo, Misaki Marine Biol Stn, Grad Sch Sci, Miura, Kanagawa 2380225, Japan	Kikuchi, M (reprint author), Univ Tokyo, Misaki Marine Biol Stn, Grad Sch Sci, 1024 Koajiro, Miura, Kanagawa 2380225, Japan.	mkikuchi@mmbs.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports and Technology of Japan [23570248]	The authors express their thanks to Dr. Michiyasu Yoshikuni for generously providing cubifrin. We also thank Dr. Fred H. Wilt for his advice in preparation and critical reading of the manuscript. This work was supported in part by Grants-in-Aid for Scientific Research (No. 23570248) to Koji Akasaka from the Ministry of Education, Culture, Sports and Technology of Japan.	ANGERER LM, 1989, GENE DEV, V3, P370, DOI 10.1101/gad.3.3.370; Kawazoe Y, 2002, DEV GROWTH DIFFER, V44, P77; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Beck F, 2000, BIOESSAYS, V22, P431, DOI 10.1002/(SICI)1521-1878(200005)22:5<431::AID-BIES5>3.0.CO;2-X; Peterson KJ, 1997, BIOESSAYS, V19, P623, DOI 10.1002/bies.950190713; Bromham LD, 1999, EVOL DEV, V1, P166, DOI 10.1046/j.1525-142x.1999.99026.x; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; YOKOUCHI Y, 1995, DEV BIOL, V169, P76, DOI 10.1006/dbio.1995.1128; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; Omori A, 2011, GENE EXPR PATTERNS, V11, P48, DOI 10.1016/j.gep.2010.09.002; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Aronowicz J, 2006, INTEGR COMP BIOL, V46, P890, DOI 10.1093/icb/icl045; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Hara Y, 2006, DEV GENES EVOL, V216, P797, DOI 10.1007/s00427-006-0108-1; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Arenas-Mena C, 1998, P NATL ACAD SCI USA, V95, P13062, DOI 10.1073/pnas.95.22.13062; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Peterson KJ, 2000, EVOL DEV, V2, P93, DOI 10.1046/j.1525-142x.2000.00042.x; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Arenas-Mena C, 2006, DEV GROWTH DIFFER, V48, P463, DOI 10.1111/j.1440-169x.2006.00883.x; Baughman KW, 2014, GENESIS, V52, P952, DOI 10.1002/dvg.22840; BIENZ M, 1994, TRENDS GENET, V10, P22, DOI 10.1016/0168-9525(94)90015-9; Cisternas P, 2009, DEV GENES EVOL, V219, P613, DOI 10.1007/s00427-010-0318-4; Hano Y, 2001, ZOOL SCI, V18, P353, DOI 10.2108/zsj.18.353; Ikuta T, 2005, DEV DYNAM, V233, P382, DOI 10.1002/dvdy.20374; Irvine SQ, 2000, DEV BIOL, V217, P333, DOI 10.1006/dbio.1999.9541; Ishii M, 1999, DEV GROWTH DIFFER, V41, P241; Kato S, 2009, DEV BIOL, V326, P169, DOI 10.1016/j.ydbio.2008.11.003; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; Mendez AT, 2000, MAR BIOTECHNOL, V2, P231, DOI 10.1007/s101269900027; Morris VB, 2014, DEV GENES EVOL, V224, P1, DOI 10.1007/s00427-013-0457-5; Morris VB, 2005, J EXP ZOOL PART B, V304B, P456, DOI 10.1002/jez.b.21065; Peterson KJ, 2004, MOL PHYLOGENET EVOL, V31, P1208, DOI 10.1016/j.ympev.2003.10.007; Popodi E, 1996, MOL BIOL EVOL, V13, P1078; Sakiyama J, 2001, MECH DEVELOP, V101, P233, DOI 10.1016/S0925-4773(00)00564-5; Sharkey M, 1997, TRENDS GENET, V13, P145, DOI 10.1016/S0168-9525(97)01096-2; Shoguchi E, 2000, GENESIS, V27, P58, DOI 10.1002/1526-968X(200006)27:2<58::AID-GENE20>3.0.CO;2-8; Tsuchimoto J, 2014, DEV DYNAM, V243, P1020, DOI [10.1002/dvdy.24135, 10.1002/DVDY.24135]; Wada H, 1999, DEV BIOL, V213, P131, DOI 10.1006/dbio.1999.9369; Wilson KA, 2005, EVOL DEV, V7, P401, DOI 10.1111/j.1525-142X.2005.05045.x; Yoshida W, 2001, B FAC AGR LIFE SCI H, V4, P16; Zakany J, 1999, NATURE, V401, P761	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-944X	1432-041X		DEV GENES EVOL	Dev. Genes Evol.	SEP	2015	225	5					275	286		10.1007/s00427-015-0510-7		12	Cell Biology; Evolutionary Biology; Developmental Biology	Cell Biology; Evolutionary Biology; Developmental Biology	CR6PU	WOS:000361470400002		
J	Maruyama, K; Wang, B; Ishikawa, Y; Yasumasu, S; Iuchi, I				Maruyama, Kouichi; Wang, Bing; Ishikawa, Yuji; Yasumasu, Shigeki; Iuchi, Ichiro			Evolutionary pathway of pseudogenization of globin genes, alpha 5 and beta 5, in genus Oryzias	DEVELOPMENT GENES AND EVOLUTION			English	Article						Hemoglobin; Pseudogene; Medaka; Oryzias	LATIPES; MEDAKA; EXPRESSION; ORGANIZATION; BELONIFORMES	Hemoglobin transports oxygen in many organisms and consists of alpha- and beta-globin chains. Previously, using molecular phylogenetic analysis, we proposed that both alpha- and beta-globins of teleost could be classified into four groups. We also showed that the Hd-rR strain of medaka (Oryzias latipes) inhabiting southern Japan had all four groups of globin genes but that the alpha- and beta-globin genes of group III were pseudogenized (alpha 5(psi alpha), beta 5(psi beta)). Based on the small degree of nucleotide variations, the pseudogenization of beta 5 was assumed to have occurred at a relatively late stage of evolution. Here, we compared the alpha 5(psi alpha)-beta 5(psi beta) of two other strains of O. latipes and found that both alpha 5(psi alpha) and beta 5(psi beta) of the northern Japanese and Korean strains were pseudogenized similar to those of Hd-rR. In a Philippine population (Oryzias luzonensis), alpha 5(psi alpha) was also pseudogenized, but the structure was different from that of O. latipes, and beta 5(psi beta) was almost deleted. Interestingly, an Indonesian population (Oryzias celebensis) had alpha 5 and beta 5 genes that were deduced to be functional. Indeed, they were expressed from the young to adult development stages, and this expression pattern was consistent with the expression of alpha 2 and ad.alpha 1 in Hd-rR. Because alpha 2 and ad.alpha 1 in Hd-rR were assigned to groups I and II, respectively, we speculate that their expression patterns might be altered by pseudogenization of group III genes. These results provide a basis for further investigations of recruiting and changing expression patterns of one globin gene after pseudogenization of other globin genes during evolution.	[Maruyama, Kouichi] Natl Inst Radiol Sci, Fukushima Project Headquarters, Inage Ku, Chiba 2638555, Japan; [Maruyama, Kouichi; Wang, Bing; Ishikawa, Yuji] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, Chiba 2638555, Japan; [Yasumasu, Shigeki; Iuchi, Ichiro] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1028554, Japan	Maruyama, K (reprint author), Natl Inst Radiol Sci, Fukushima Project Headquarters, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	k_maruya@nirs.go.jp					Hardison R, 1998, J EXP BIOL, V201, P1099; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494; Maruyama K, 2004, MECH DEVELOP, V121, P753, DOI 10.1016/j.mod.2004.03.035; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Setiamarga DHE, 2009, BIOL LETTERS, V5, P812, DOI 10.1098/rsbl.2009.0419; Chan FY, 1997, BLOOD, V89, P688; Maruyama K, 2002, J BIOCHEM, V132, P581; Maruyama K, 2012, GENE, V492, P212, DOI 10.1016/j.gene.2011.10.026; Maruyama K, 2004, GENE, V335, P89, DOI 10.1016/j.gene.2004.03.007; McMorrow T, 1996, DNA CELL BIOL, V15, P407, DOI 10.1089/dna.1996.15.407; Thein S.L., 2009, HUM MOL GENET, V18, P216; Wawrowski A, 2011, J COMP PHYSIOL B, V181, P199, DOI 10.1007/s00360-010-0518-2	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-944X	1432-041X		DEV GENES EVOL	Dev. Genes Evol.	SEP	2015	225	5					305	311		10.1007/s00427-015-0509-0		7	Cell Biology; Evolutionary Biology; Developmental Biology	Cell Biology; Evolutionary Biology; Developmental Biology	CR6PU	WOS:000361470400004		
J	Nakagaki, Y; Sakuma, M; Machida, R				Nakagaki, Yasutaka; Sakuma, Masashi; Machida, Ryuichiro			Expression of engrailed-family genes in the jumping bristletail and discussion on the primitive pattern of insect segmentation	DEVELOPMENT GENES AND EVOLUTION			English	Article						Segmentation; Short-germ; Engrailed; Archaeognatha; Apterygote insects; In situ hybridization	PHYLOGENETIC ANALYSIS; DROSOPHILA; THYSANURA; COCKROACH; EVOLUTION; CLONING	It has been shown that segmentation in the short-germ insects proceeds by a two-step mechanism. The anterior region is simultaneously segmented in a manner similar to that in Drosophila, which is apparently unique to insects, and the rest of the posterior region is segmented sequentially by a mechanism involving a segmentation clock, which is derived from the common ancestor of arthropods. In order to propose the evolutionary scenario of insect segmentation, we examined segmentation in the jumping bristletail, the basalmost extant insect. Using probes for engrailed-family genes for in situ hybridization, we found no sign of simultaneous segmentation in the anterior region of the jumping bristletail embryos. All segments except the anteriormost segment are formed sequentially. This condition shown in the jumping bristletail embryos may represent the primitive pattern of insect segmentation. The intercalating formation of the intercalary segment is assumed to be a synapomorphic trait shared among all insects after the branching of the jumping bristletail.	[Nakagaki, Yasutaka] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Nakagaki, Yasutaka; Sakuma, Masashi; Machida, Ryuichiro] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano 3862204, Japan	Nakagaki, Y (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	grayishbird@gmail.com			JSPS [17370030, 21570089];  [20.6763]	We wish to express our sincerest thanks to Dr. Shigeo Hayashi and Dr. Nao Niwa of RIKEN CDB for their valuable support and advice for the experimentation and critical reading of the manuscript. Thanks are also due to Prof. Tetsuo Hashimoto of the University of Tsukuba for his helpful advice, constant encouragement, and critical reading of the manuscript. We also thank Dr. Kaoru Sekiya for her helpful advice and constant encouragement. This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows Grant Number 20.6763 to YN, and Grants-in-Aid for Scientific Research from JSPS (Scientific Research (B) 17370030 and (C) 21570089) to RM. This work is a contribution from the Sugadaira Montane Research Center, University of Tsukuba.	KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Rogers BT, 1996, DEVELOPMENT, V122, P3419; LARINK O, 1969, HELGOLAND WISS MEER, V19, P111, DOI 10.1007/BF01625861; LOGAN C, 1992, DEV GENET, V13, P345, DOI 10.1002/dvg.1020130505; MACHIDA R, 1981, J MORPHOL, V168, P339, DOI 10.1002/jmor.1051680310; Marie B, 2000, DEV GENES EVOL, V210, P436, DOI 10.1007/s004270000082; Peel A, 2003, CURR BIOL, V13, P708; Peel AD, 2006, P ROY SOC B-BIOL SCI, V273, P1733, DOI 10.1098/rspb.2006.3497; Peterson MD, 1998, DEV GENES EVOL, V208, P547, DOI 10.1007/s004270050214; Pueyo JI, 2008, P NATL ACAD SCI USA, V105, P16614, DOI 10.1073/pnas.0804093105; REMPEL J G, 1975, Quaestiones Entomologicae, V11, P7; Sander K, 1976, ADV INSECT PHYSIOL, V12, P125, DOI DOI 10.1016/S0065-2806(08)60255-6; Siegler MVS, 1999, NEURON, V22, P265, DOI 10.1016/S0896-6273(00)81088-0	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-944X	1432-041X		DEV GENES EVOL	Dev. Genes Evol.	SEP	2015	225	5					313	318		10.1007/s00427-015-0512-5		6	Cell Biology; Evolutionary Biology; Developmental Biology	Cell Biology; Evolutionary Biology; Developmental Biology	CR6PU	WOS:000361470400005		
J	Ono, S; Fujishiro, M; Ikeda, Y; Komuro, I; Koike, K				Ono, Satoshi; Fujishiro, Mitsuhiro; Ikeda, Yuichi; Komuro, Issei; Koike, Kazuhiko			Recent clinical management of antithrombotic agents for gastrointestinal endoscopy after revision of guidelines in Japan	DIGESTIVE ENDOSCOPY			English	Review						antithrombotic agent; bleeding; endoscopy; guidelines; thromboembolism	EARLY GASTRIC-CANCER; BAND IMAGING-SYSTEM; LOW-DOSE ASPIRIN; SUBMUCOSAL DISSECTION; ANTIPLATELET THERAPY; CONTINUED USE; RISK-FACTORS; ANTICOAGULATION; POLYPECTOMY; DIAGNOSIS	In 2012, the Japan Gastroenterological Endoscopy Society (JGES) revised guidelines for the management of gastrointestinal endoscopy for patients using antithrombotic agents. The conventional guidelines emphasized reducing the bleeding risk that accompanies gastrointestinal endoscopy, but the present guidelines prioritize reduction of thromboembolism risk during discontinuation of antithrombotic agents, which is consistent with Western guidelines. When the advantages outweigh the disadvantages, the guidelines permit endoscopic biopsy and high-bleeding-risk procedures without discontinuation of selected antithrombotic agents. These guidelines created a paradigm shift that has slowly, but surely, changed clinical daily practice in Japan. As a result, endoscopic biopsy without discontinuation of antithrombotic agents has been widely accepted, although solid evidence for its support is still lacking. Additionally, feasibility of high-bleeding-risk procedures without discontinuation of selected antithrombotic agents is also controversial because evidence newly acquired after publication of the present guidelines is low in evidence level. Consequently, clinical studies with a high evidence level, including randomized controlled studies, are mandatory to establish reliable upcoming guidelines. At the same time, under the present guidelines, the accomplishment of such studies in Japan is expected.	[Ono, Satoshi; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Tokyo 1138655, Japan; [Ikeda, Yuichi; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiol, Tokyo 1138655, Japan	Ono, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	satoshi-tky@umin.ac.jp			Eisai, Co. Ltd; Takeda Pharmaceutical Co. Ltd/Nippon Boehringer Ingelheim Co. Ltd; MSD K.K.; Astellas Pharma Inc.; Dainippon Sumitomo Pharma Co. Ltd; DAIICHI SANKYO Co. Ltd; Genzyme Japan K.K.; Mitsubishi Tanabe Pharma Corp.	M.F RECEIVED LECTURE fees from Eisai, Co. Ltd. I.K. received lecture fees or commercial research funding from Takeda Pharmaceutical Co. Ltd/Nippon Boehringer Ingelheim Co. Ltd, MSD K.K., Astellas Pharma Inc., Dainippon Sumitomo Pharma Co. Ltd, DAIICHI SANKYO Co. Ltd, Genzyme Japan K.K. and Mitsubishi Tanabe Pharma Corp.	Nakayoshi T, 2004, ENDOSCOPY, V36, P1080, DOI 10.1055/s-2004-825961; Manocha D, 2012, AM J MED, V125, P1222, DOI 10.1016/j.amjmed.2012.05.030; Hallas J, 2006, BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Boustiere C, 2011, ENDOSCOPY, V43, P445, DOI 10.1055/s-0030-1256317; Sanomura Y, 2014, GASTRIC CANCER, V17, P489, DOI 10.1007/s10120-013-0305-3; Tsuji Y, 2014, GASTROINTEST ENDOSC, V79, P151, DOI 10.1016/j.gie.2013.08.041; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Kodashima S, 2010, WORLD J GASTROENTERO, V16, P1043, DOI 10.3748/wjg.v16.i9.1043; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Desai J, 2013, GASTROINTEST ENDOSC, V78, P227, DOI 10.1016/j.gie.2013.04.179; Anderson MA, 2009, GASTROINTEST ENDOSC, V70, P1060, DOI 10.1016/j.gie.2009.09.040; Rubboli A, 2005, CARDIOLOGY, V104, P101, DOI 10.1159/000086918; Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183; Aras N, 2015, DIGEST ENDOSC, V27, P458; Chos SJ, 2012, ENDOSCOPY, V44, P114; Feagins LA, 2013, CLIN GASTROENTEROL H, V11, P1325, DOI 10.1016/j.cgh.2013.02.003; Fujishiro M, 2009, J GASTROEN HEPATOL, V24, P214, DOI 10.1111/j.1440-1746.2008.05604.x; Fujita M, 2015, DIGEST ENDOSC, V27, P25, DOI 10.1111/den.12303; Hayashis T, 2013, GASTROENTEROL ENDOSC, V55, P1806; Idos K, 2004, GASTROENTEROL ENDOSC, V46, P2079; Inoue T, 2014, DIGEST ENDOSC, V26, P243, DOI 10.1111/den.12123; Ishikawas S, 2013, GASTROENTEROL ENDOSC, V55, P3357; Kaise M, 2014, ENDOSCOPY, V46, P827, DOI 10.1055/s-0034-1377524; Kohs R, 2013, GASTROINTEST ENDOSC, V78, P476; Lims JH, 2012, GASTROINTEST ENDOSC, V75, P719; Mabes K, 2010, GASTROENTEROL ENDOSC, V52, P2976; Matsumura T, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-172; Neumann H, 2010, GASTROENTEROLOGY, V139, P388, DOI 10.1053/j.gastro.2010.06.029; Ninomiyas Y, 2015, J GASTROENTEROL, DOI [10.1007/s00535-015-1053-4, DOI 10.1007/S00535-015-1053-4]; Ogoshi K, 2005, GASTROENTEROL ENDOSC, V47, P2691; Onos S, 2011, J GASTROEN HEPATOL, V26, P1434; Onos S, 2015, ENDOSCOPY, DOI [10.1055/s-0034-1391354, DOI 10.1055/S-0034-1391354]; Onos S, 2012, J GASTROENTEROL, V47, P770; Takeuchi T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-136; Takimoto K, 2012, Endoscopy, V44 Suppl 2 UCTN, pE414, DOI 10.1055/s-0032-1325739; Tomodas T, 2014, GASTROENTEROL ENDOSC, V56, P2150; Tounous S, 2011, GASTROENTEROL ENDOSC, V53, P3326; Yoshizawa M, 2009, GASTROINTEST ENDOSC, V69, P19, DOI 10.1016/j.gie.2008.09.007	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					649	656		10.1111/den.12498		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900002		
J	Saito, Y; Nakajima, T; Sakamoto, T; Yamada, M; Matsuda, T; Monkemuller, K				Saito, Yutaka; Nakajima, Takeshi; Sakamoto, Taku; Yamada, Masayoshi; Matsuda, Takahisa; Moenkemueller, Klaus			Clinical pathway to discharge three days after colorectal endoscopic submucosal dissection: For whom and for what purpose?	DIGESTIVE ENDOSCOPY			English	Editorial Material							CARE PATHWAY		[Saito, Yutaka; Nakajima, Takeshi; Sakamoto, Taku; Yamada, Masayoshi; Matsuda, Takahisa] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Matsuda, Takahisa] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Canc Screening Div, Tokyo 104, Japan; [Moenkemueller, Klaus] Univ Alabama Birmingham, Basil I Hirschowitz Endoscop Ctr Excellence, Div Gastroenterol & Hepatol, Birmingham, AL USA	Saito, Y (reprint author), Natl Canc Ctr, Endoscopy Div, Tokyo, Japan.						al-Shaqha W M, 2000, Int J Health Care Qual Assur Inc Leadersh Health Serv, V13, P208, DOI 10.1108/09526860010342707; Tomiki Y, 2015, DIGEST ENDOSC, V27, P679, DOI 10.1111/den.12468; Aoki T, 2012, WORLD J GASTROENTERO, V18, P3721, DOI 10.3748/wjg.v18.i28.3721; Falconer J A, 1993, QRB Qual Rev Bull, V19, P8; Hoffman PA, 1993, JOINT COMM J QUAL IM, V19, P235; Ono H, 2010, GASTROENTEROLOGICAL; Pfau PR, 2004, AM J GASTROENTEROL, V99, P425, DOI 10.1111/j.1572-0241.2004.04090.x; Podila PV, 2001, AM J GASTROENTEROL, V96, P208	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					662	664		10.1111/den.12512		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900004		
J	Nonaka, S; Kawaguchi, Y; Oda, I; Nakamura, J; Sato, C; Kinjo, Y; Abe, S; Suzuki, H; Yoshinaga, S; Sato, T; Saito, Y				Nonaka, Satoru; Kawaguchi, Yosuke; Oda, Ichiro; Nakamura, Jun; Sato, Chiko; Kinjo, Yuzuru; Abe, Seiichiro; Suzuki, Haruhisa; Yoshinaga, Shigetaka; Sato, Tetsufumi; Saito, Yutaka			Safety and effectiveness of propofol-based monitored anesthesia care without intubation during endoscopic submucosal dissection for early gastric and esophageal cancers	DIGESTIVE ENDOSCOPY			English	Article						body movements; endoscopic submucosal dissection; monitored anesthesia care; propofol	GI ENDOSCOPY; SEDATION; RESECTION	Background and AimEndoscopic submucosal dissection (ESD) becomes more difficult with an increased risk of complications if patient sedation is insufficient. We assessed the safety and effectiveness of propofol-based monitored anesthesia care (MAC) without intubation during ESD for early esophageal cancer (EEC) or early gastric cancer (EGC) in the endoscopy room. MethodsWe investigated 1013 consecutive patients with 1126 lesions who underwent ESD for EGC/EEC with either MAC or regular sedation by endoscopists (control group) between July 2010 and March 2013. Patient characteristics, endoscopic findings, technical results, body movement, oxygen saturation (SpO(2)), and drug dosages were then examined. ResultsMAC was carried out in 137 EGC (16%) and 82 EEC patients (57%), whereas regular sedation was used in 731 EGC (84%) and 63 EEC patients (43%). MAC was conducted in 21% of all ESD procedures. In the MAC and control groups, body movement requiring a third person for control occurred in 30 (22%) and 533 (72%) cases during gastric ESD (P<0.0001) and in 36 (44%) and 53 (84%) cases during esophageal ESD (P<0.0001), respectively. The median minimum SpO(2) was significantly lower in the MAC group than in the control group during both gastric and esophageal ESD (96% vs 98%, P<0.0001; 96% vs 98%, P<0.0004, respectively). MAC did not cause any adverse effects requiring prolongation of hospitalization. ConclusionsPropofol-based MAC without intubation provided a safer treatment environment by significantly reduced body movement and was very effective for difficult cases requiring longer procedure times or more powerful sedation.	[Nonaka, Satoru; Oda, Ichiro; Nakamura, Jun; Sato, Chiko; Kinjo, Yuzuru; Abe, Seiichiro; Suzuki, Haruhisa; Yoshinaga, Shigetaka; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo 1040045, Japan; [Kawaguchi, Yosuke; Sato, Tetsufumi] Natl Canc Ctr, Dept Anesthesiol, Tokyo 1040045, Japan; [Kawaguchi, Yosuke; Sato, Tetsufumi] Natl Canc Ctr, Dept Crit Care Med, Tokyo 1040045, Japan	Nonaka, S (reprint author), Natl Canc Ctr, Endoscopy Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	snonaka@ncc.go.jp					Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Sasaki T, 2013, DIGEST ENDOSC, V25, P79, DOI 10.1111/den.12024; Saito Y, 2012, DIGEST ENDOSC, V24, P67, DOI 10.1111/j.1443-1661.2012.01282.x; Imagawa A, 2008, ENDOSCOPY, V40, P905, DOI 10.1055/s-2008-1077641; Gillham MJ, 2001, GASTROINTEST ENDOSC, V54, P14, DOI 10.1067/mge.2001.116358; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Lichtenstein DR, 2008, GASTROINTEST ENDOSC, V68, P815, DOI 10.1016/j.gie.2008.09.029; Fujishiro M, 2009, DIGEST ENDOSC, V21, P109, DOI 10.1111/j.1443-1661.2009.00837.x; Isomoto H, 2013, DIGEST ENDOSC, V25, P29, DOI 10.1111/j.1443-1661.2012.01388.x; Gotoda T, 2010, BRIT J SURG, V97, P868, DOI 10.1002/bjs.7033; Vargo JJ, 2009, GASTROENTEROLOGY, V137, P2161, DOI 10.1053/j.gastro.2009.09.050; Sasaki T, 2012, ENDOSCOPY, V44, P584, DOI 10.1055/s-0032-1306776; Nonaka S, 2011, GASTRIC CANCER, V14, P56, DOI 10.1007/s10120-011-0008-6; Gambus PL, 2011, ANESTH ANALG, V112, P331, DOI 10.1213/ANE.0b013e3182025a70; Japanese Classification of Esophageal Cancer, 2008, JAP CLASS ESOPH CANC; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kiriyama S, 2010, J GASTROENTEROL, V45, P831, DOI 10.1007/s00535-010-0222-8; Kuwano H, 2008, ESOPHAGUS, V5, P61, DOI [10.1007/s10388-008-0151-2, DOI 10.1007/S10388-008-0151-2]; Odas I, 2005, DIGEST ENDOSC, V17, P54; Odas I, 2013, DIG ENDOSC S1, V25, P71	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					665	673		10.1111/den.12457		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900005		
J	Tsujikawa, T; Bamba, S; Inatomi, O; Hasegawa, H; Ban, H; Nishida, A; Imaeda, H; Itoh, A; Saotome, T; Sasaki, M; Andoh, A				Tsujikawa, Tomoyuki; Bamba, Shigeki; Inatomi, Osamu; Hasegawa, Hiroshi; Ban, Hiromitsu; Nishida, Atsushi; Imaeda, Hirotsugu; Itoh, Akihiko; Saotome, Takao; Sasaki, Masaya; Andoh, Akira			Factors affecting pancreatic hyperamylasemia in patients undergoing peroral single-balloon enteroscopy	DIGESTIVE ENDOSCOPY			English	Article						acute pancreatitis; hyperamylasemia; oral insertion; risk factors; single-balloon enteroscopy	COMPLICATIONS; ENDOSCOPY; MANAGEMENT; DISEASE	Background and AimAcute pancreatitis following balloon-assisted enteroscopy is a rare but serious complication. The causative mechanism is uncertain and prevention strategies are not established. We conducted a retrospective study to clarify the risk factors for pancreatic hyperamylasemia. MethodsEighty-four patients undergoing peroral single-balloon enteroscopy (SBE) were enrolled in this study. Serum pancreatic and salivary amylase levels were measured 2h after endoscopic examination. ResultsWe experienced three patients with post-SBE pancreatitis. Factors predicting pancreatic hyperamylasemia were: (i) elderly patients; (ii) deeper insertion; and (iii) clockwise insertion. In contrast, younger age at examination was a significant factor observed in salivary hyperamylasemia. ConclusionsIt is important to measure pancreatic amylase and not total amylase after SBE. When carrying out peroral SBE, the distance of insertion should be reduced especially if the scope traces a clockwise loop or the subject is elderly.	[Tsujikawa, Tomoyuki; Itoh, Akihiko; Saotome, Takao] Shiga Univ Med Sci, Comprehens Internal Med, Otsu, Shiga 5202192, Japan; [Bamba, Shigeki; Inatomi, Osamu; Hasegawa, Hiroshi; Nishida, Atsushi; Imaeda, Hirotsugu; Andoh, Akira] Shiga Univ Med Sci, Dept Gastroenterol, Otsu, Shiga 5202192, Japan; [Ban, Hiromitsu] Shiga Univ Med Sci, Div Endoscopy, Otsu, Shiga 5202192, Japan; [Sasaki, Masaya] Shiga Univ, Med Sci Hosp, Dept Clin Nutr, Otsu, Shiga, Japan	Tsujikawa, T (reprint author), Shiga Univ Med Sci, Comprehens Internal Med, Otsu, Shiga 5202192, Japan.	tujikawa@belle.shiga-med.ac.jp					COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Honda K, 2006, ENDOSCOPY, V38, P1040, DOI 10.1055/s-2006-944831; Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; Kopacova M, 2010, WORLD J GASTROENTERO, V16, P2331, DOI 10.3748/wjg.v16.i19.2331; Moschler O, 2008, Z GASTROENTEROL, V46, P266, DOI 10.1055/s-2007-963719; Tsujikawa T, 2008, ENDOSCOPY, V40, P11, DOI 10.1055/s-2007-966976; Heine GDN, 2006, ENDOSCOPY, V38, P42, DOI 10.1055/s-2005-921188; Kawamura T, 2008, GASTROINTEST ENDOSC, V68, P1112, DOI 10.1016/j.gie.2008.03.1063; Aktas H, 2010, ENDOSCOPY, V42, P365, DOI 10.1055/s-0029-1243931; Mensink PBF, 2007, ENDOSCOPY, V39, P613, DOI 10.1055/s-2007-966444; Sunada K, 2009, J GASTROENTEROL, V44, P1, DOI 10.1007/s00535-008-2292-4; Groenen MJM, 2006, ENDOSCOPY, V38, P82, DOI 10.1055/s-2005-921179; Eisen GM, 2007, ENDOSCOPY, V39, P113, DOI 10.1055/s-2007-966141; Honda K, 2006, WORLD J GASTROENTERO, V12, P1802; Jarbandhan SVA, 2008, WORLD J GASTROENTERO, V14, P720, DOI 10.3748/wjg.14.720; Matsushita M, 2007, ENDOSCOPY, V39, P480, DOI 10.1055/s-2007-966258; Matsushita M, 2007, ENDOSCOPY, V39, P1; Mays A, 2006, DIGEST LIVER DIS, V38, P932; Mensink PBF, 2010, SCAND J GASTROENTERO, V45, P483, DOI 10.3109/00365520903563774; Nakamura Masamoto, 2009, Nihon Shokakibyo Gakkai Zasshi, V106, P1744; Ohtsuka Y, 2007, J PEDIATR GASTR NUTR, V44, P501, DOI 10.1097/01.mpg.0000252194.06955.18	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					674	678		10.1111/den.12449		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900006		
J	Tomiki, Y; Kawai, M; Takehara, K; Tashiro, Y; Munakata, S; Kure, K; Ishiyama, S; Sugimoto, K; Kamiyama, H; Takahashi, M; Sakamoto, K				Tomiki, Yuichi; Kawai, Masaya; Takehara, Kazuhiro; Tashiro, Yoshihiko; Munakata, Shinya; Kure, Kazumasa; Ishiyama, Shun; Sugimoto, Kiichi; Kamiyama, Hirohiko; Takahashi, Makoto; Sakamoto, Kazuhiro			Clinical pathway to discharge 3 days after colorectal endoscopic submucosal dissection	DIGESTIVE ENDOSCOPY			English	Article						clinical pathway; colorectal endoscopic submucosal dissection (ESD); hospital stay; incident; medical fee point	RISK-FACTORS; PERFORATION; NEOPLASMS; FEASIBILITY; MULTICENTER; TUMORS; JAPAN	Background and AimColorectal endoscopic submucosal dissection (ESD) is a useful treatment method; however, no index has been established for time for patient to start food ingestion or be discharged after ESD. We investigated the potential of a clinical pathway in which patients started food ingestion on day 2 after ESD and were discharged on day 3. MethodsA total of 382 patients underwent colorectal ESD between 2006 and 2012. A flow chart of a clinical pathway was prepared based on the data obtained, with the aim of shortening hospital stay after ESD. ResultsMean duration of postoperative hospital stay in the 382 patients was 5.31.8 days. The most common cause of extended hospital stay was abnormal blood test finding, as detected in 50 patients in group C (n=131; 38.2%), followed by careful course observations, as noted in 48 patients in group C (n=131; 36.6%). Regarding procedural accidents as a result of ESD, intraoperative perforation occurred in 15 patients (3.9%) and post-ESD bleeding in seven patients (1.8%), which extended the hospital stay. Food ingestion was started on day 2 when no abnormality was noted during ESD or in physical and imaging findings or blood tests on day 1. In the 86 patients who underwent the prepared clinical pathway as a validation study, 68 (79.0%) were discharged on day 3. Duration of postoperative hospital stay was 3.4 +/- 1.2 days. ConclusionDischarge may be possible 3 days after ESD when no abnormalities are noted during ESD or on post-ESD day 1.	[Tomiki, Yuichi; Kawai, Masaya; Takehara, Kazuhiro; Tashiro, Yoshihiko; Munakata, Shinya; Kure, Kazumasa; Ishiyama, Shun; Sugimoto, Kiichi; Kamiyama, Hirohiko; Takahashi, Makoto; Sakamoto, Kazuhiro] Juntendo Univ, Fac Med, Dept Coloproctol Surg, Tokyo 1138421, Japan	Tomiki, Y (reprint author), Juntendo Univ, Fac Med, Dept Coloproctol Surg, Bunkyo Ku, 2-1-1 Hongou, Tokyo 1138421, Japan.	tomiki@juntendo.ac.jp					Saito Y, 2007, GASTROINTEST ENDOSC, V66, P966, DOI 10.1016/j.gie.2007.02.053; Suzuki S, 2014, WORLD J GASTROENTERO, V20, P1839, DOI 10.3748/wjg.v20.i7.1839; Farhat S, 2011, ENDOSCOPY, V43, P664, DOI 10.1055/s-0030-1256413; Saito Y, 2010, SURG ENDOSC, V24, P343, DOI 10.1007/s00464-009-0562-8; Kantsevoy SV, 2014, GASTROINTEST ENDOSC, V79, P503, DOI 10.1016/j.gie.2013.10.051; Taku K, 2007, J GASTROEN HEPATOL, V22, P1409, DOI 10.1111/j.1440-1746.2007.05022.x; Fujishiro M, 2006, ENDOSCOPY, V38, P1001, DOI 10.1055/s-2006-944775; Yoshida N, 2009, ENDOSCOPY, V41, P758, DOI 10.1055/s-0029-1215028; Terasaki M, 2014, INT J COLORECTAL DIS, V29, P877, DOI 10.1007/s00384-014-1901-3; Aoki T, 2012, WORLD J GASTROENTERO, V18, P3721, DOI 10.3748/wjg.v18.i28.3721; Iacucci M, 2013, CAN J GASTROENTEROL, V27, P689; Ishikawas H, 1999, J INFECT CHEMOTHER, V5, P86, DOI 10.1007/s101560050014; Jungs D, 2013, ENDOSCOPY, V45, P714; Kawakamis Y., 2014, DIAGNOSIS PROCEDURE, V7th, P374; Lees E-J, 2013, SURG ENDOSC, V27, P31; Santos JOM, 2013, CLINICS, V68, P141, DOI [10.6061/clinics/2013(02)OA04, 10.6061/CLINICS/2013(02)OA04]; Spychalski M, 2015, DIGEST ENDOSC, V27, P368, DOI 10.1111/den.12353; Tanaka S, 2010, DIGEST ENDOSC, V22, pS2, DOI 10.1111/j.1443-1661.2010.00952.x; Waye J D, 1996, Gastrointest Endosc Clin N Am, V6, P343; Yoshida N, 2013, GASTROENT RES PRACT, DOI 10.1155/2013/287173	20	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					679	686		10.1111/den.12468		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900007		
J	Wang, MH; Dy, F; Vu, V; Lim, LG; Tayyab, GUN; Ratanachu-ek, T; Samarasekera, DN; Dhir, V; Jin, ZD; Kida, M; Seo, DW; Wang, HP; Teoh, A; Hawes, R; Varadarajulu, S; Yasuda, K; Ho, KY				Wang, Myrna Huixian; Dy, Frederick; Van Khien Vu; Lim, Lee Guan; Tayyab, Ghias Un Nabi; Ratanachu-ek, Thawee; Samarasekera, Dharmabandhu N.; Dhir, Vinay; Jin, Zheng-Dong; Kida, Mitsuhiro; Seo, Dong Wang; Wang, Hsiu-Po; Teoh, Anthony; Hawes, Robert; Varadarajulu, Shyam; Yasuda, Ken; Ho, Khek Yu			Structured endoscopic ultrasonography (EUS) training program improved knowledge and skills of trainees: Results from the Asian EUS Group	DIGESTIVE ENDOSCOPY			English	Article						education; endoscopic ultrasonography; endoscopy; gastrointestinal; training		Background and AimA major reason impeding the growth of endoscopic ultrasound (EUS) in Asia is the lack of training availability. We aimed to prospectively evaluate the effectiveness of a short-term structured EUS training program in improving the knowledge and skill of EUS among trainees. MethodsThe study was conducted in six workshops in six countries including Sri Lanka, Pakistan, Thailand, Vietnam, Singapore and Philippines, within a year. Trainees were evaluated using written and skill tests before and after completion of the training. ResultsPre- and post-workshop written tests from a total of 62 trainees were analyzed. Compared with pre-training, the trainees improved significantly in the overall mean (SD) scores after the training (66.0 +/- 0.3% to 77.5 +/- 0.2%, P<0.0001). Thirty-one trainees were randomly selected to undergo a skill test before and after the course. Compared with pre-training, the proportions of trainees who succeeded in locating each structure post-training were: celiac axis (36-80.5%), pancreatic body (51.5-80.5%), pancreatic body and tail (42-77.5%), splenic vein and artery (48.5-84%), left kidney (60-83%), and spleen (47-83%). Overall, there was a significant improvement in the proportion of trainees' successful localization of structures post-training compared to before training (P<0.0001). ConclusionFollowing a structured training program, trainees' knowledge and skills in EUS improved significantly. Structured training courses appear to be an effective way of imparting EUS knowledge and skills to aspiring endosonographers in the Asian region.	[Wang, Myrna Huixian] Natl Univ Singapore Hosp, Dept Gastroenterol & Hepatol, Singapore 117548, Singapore; [Lim, Lee Guan] Raffles Hosp, Singapore, Singapore; [Ho, Khek Yu] Natl Univ Hlth Syst Univ, Med Cluster, Dept Med, Singapore 119228, Singapore; [Dy, Frederick] Univ Santo Tomas Hosp, Manila, Philippines; [Van Khien Vu] 108 Mil Hosp, Hanoi, Vietnam; [Tayyab, Ghias Un Nabi] Lahore Gen Hosp, Lahore, Pakistan; [Ratanachu-ek, Thawee] Rajavithi Hosp, Dept Surg, Bangkok, Thailand; [Samarasekera, Dharmabandhu N.] Univ Colombo, Dept Surg, Colombo, Sri Lanka; [Dhir, Vinay] Inst Adv Endoscopy, Mumbai, Maharashtra, India; [Jin, Zheng-Dong] Shanghai Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Teoh, Anthony] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kida, Mitsuhiro] Kitasato Univ, East Hosp, Tokyo, Japan; [Yasuda, Ken] Kyoto Second Red Cross Hosp, Dept Gastroenterol, Kyoto, Japan; [Seo, Dong Wang] Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Wang, Hsiu-Po] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hawes, Robert; Varadarajulu, Shyam] Florida Hosp, Ctr Intervent Endoscopy, Orlando, FL USA	Ho, KY (reprint author), Natl Univ Hlth Syst Univ, Med Cluster, Dept Med, Level 10,NUHS Tower Block 1E,Kent Ridge Rd, Singapore 119228, Singapore.	khek_yu_ho@nuhs.edu.sg					DIMAGNO EP, 1980, LANCET, V1, P629; Barthet M, 2007, ENDOSCOPY, V39, P535, DOI 10.1055/s-2007-966336; Hos KY, 2004, DIG ENDOSC S, V16, pS144; Hos KY, 2006, J GASTROEN HEPATOL, V21, P1231; Kongkam P, 2013, J GASTROEN HEPATOL, V28, P924, DOI 10.1111/jgh.12198; Lims LG, 2011, J GASTROEN HEPATOL, V26, P1702; Lims LG, 2013, DIGEST DIS SCI, V58, P1751; Meenan J, 2003, ENDOSCOPY, V35, P1020; Sanderss MK, 2006, ENDOSONOGRAPHY TRAIN, P35; STROHM WD, 1980, ENDOSCOPY, V12, P241, DOI 10.1055/s-2007-1021752	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					687	691		10.1111/den.12458		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900008		
J	Yamamoto, Y; Nishisaki, H; Koma, Y; Sawai, H; Sakai, A; Mimura, T; Kushida, S; Tsumura, H; Sakamoto, T; Tobimatsu, K; Miki, I; Sakuma, T; Tsuda, M; Mano, M; Hirose, T; Inokuchi, H				Yamamoto, Yoshinobu; Nishisaki, Hogara; Koma, Yu-ichiro; Sawai, Hiroaki; Sakai, Aya; Mimura, Takuya; Kushida, Saeko; Tsumura, Hidetaka; Sakamoto, Takeshi; Tobimatsu, Kazutoshi; Miki, Ikuya; Sakuma, Toshiko; Tsuda, Masahiro; Mano, Masayuki; Hirose, Takanori; Inokuchi, Hideto			Polypoid leiomyosarcoma of the esophagus treated by endoscopic submucosal dissection	DIGESTIVE ENDOSCOPY			English	Article						dissection; endoscopic; esophagus; leiomyosarcoma; submucosal	SURGICAL-TREATMENT	We report a rare case of polypoid leiomyosarcoma of the esophagus that was treated by endoscopic submucosal dissection (ESD). A 63-year-old man with complaints of progressive dysphagia was referred to Hyogo Cancer Center for treatment of esophageal tumor. Esophagoscopy revealed a polypoid tumor 25mm in diameter on the left side of the upper esophagus. Despite several biopsy specimens, the diagnosis could not be confirmed. Computed tomography showed a protruded, homogeneously enhancing mass in the upper esophagus, but no lymph node enlargement or metastasis. After 1.5 months, the esophagogram showed a filling defect 47mm in diameter in the upper esophagus. Given this rapid tumor growth, en bloc resection was done by ESD for therapeutic diagnosis. After this treatment, the tumor seemed to grow larger, showing a short stalk and occupying the esophageal lumen. Histopathologically, the tumor comprised pleomorphic spindle cells with mitosis. Tumor invasion involved the lumina propria mucosae and contact with the muscularis mucosae, but not involving the submucosa. Immunohistochemical examination showed positive staining for smooth muscle actin and HHF35, but negative for desmin, caldesmon, CD34, c-kit, DOG1, ALK, S-100 protein and cytokeratin. These histopathological findings were compatible with a diagnosis of esophageal leiomyosarcoma derived from the muscularis mucosae.	[Yamamoto, Yoshinobu; Sawai, Hiroaki; Sakai, Aya; Mimura, Takuya; Kushida, Saeko; Tsumura, Hidetaka; Sakamoto, Takeshi; Tobimatsu, Kazutoshi; Miki, Ikuya; Tsuda, Masahiro; Inokuchi, Hideto] Hyogo Canc Ctr, Dept Gastroenterol, Akashi, Hyogo 6738558, Japan; [Sakuma, Toshiko; Hirose, Takanori] Hyogo Canc Ctr, Dept Diagnost Pathol, Akashi, Hyogo 6738558, Japan; [Nishisaki, Hogara] Kaibara Hosp, Dept Internal Med, Kobe, Hyogo, Japan; [Koma, Yu-ichiro] Kobe Univ, Grad Sch Med, Dept Pathol, Kobe, Hyogo, Japan; [Mano, Masayuki] Osaka Med Ctr, Dept Clin Lab, Osaka, Japan	Yamamoto, Y (reprint author), Hyogo Canc Ctr, Dept Gastroenterol, Kitaoji 13-70, Akashi, Hyogo 6738558, Japan.	yoppi@hp.pref.hyogo.jp					AIMOTO T, 1992, GASTROENTEROL JPN, V27, P773; ALMEIDA JMM, 1982, CHEST, V81, P761, DOI 10.1378/chest.81.6.761; Toyonaga T, 2010, ALIMENT PHARM THER, V32, P908, DOI 10.1111/j.1365-2036.2010.04425.x; Howard WT, 1902, J AMER MED ASSOC, V38, P392; PATEL SR, 1990, NEW YORK STATE J MED, V90, P371; Pramesh CS, 2003, DIS ESOPHAGUS, V16, P142, DOI 10.1046/j.1442-2050.2003.00298.x; Ferguson MK, 1998, ANN THORAC SURG, V66, P897; Rocco G, 1998, ANN THORAC SURG, V66, P894, DOI 10.1016/S0003-4975(98)00684-5; Stelow EB, 2007, DIAGN CYTOPATHOL, V35, P167, DOI 10.1002/dc.20606; Suwas T, 2008, ESOPHAGUS, V5, P105, DOI 10.1007/s10388-008-0155-y; Zhang BH, 2014, DIS ESOPHAGUS, V27, P547, DOI 10.1111/j.1442-2050.2012.01444.x	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					700	703		10.1111/den.12437		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900010		
J	Kobayashi, Y; Komazawa, Y; Kusunoki, M; Takahashi, Y; Uno, G; Yuki, M; Sugiyama, A; Shizuku, T; Kinoshita, Y				Kobayashi, Yoshiya; Komazawa, Yoshinori; Kusunoki, Maho; Takahashi, Yoshiko; Uno, Goichi; Yuki, Mika; Sugiyama, Akira; Shizuku, Toshihiro; Kinoshita, Yoshikazu			Novel stenting method for malignant right colonic stenosis using ultra-thin endoscopy: Report of four cases	DIGESTIVE ENDOSCOPY			English	Article						contrast agent marking; double balloon endoscopy; malignant colonic stenosis; self-expandable metallic stent; ultra-thin endoscopy	EXPANDING METALLIC STENTS; PROXIMAL COLON; COLORECTAL OBSTRUCTION	Placement of a self-expandable metallic stent (SEMS) is recognized as a safe and effective procedure for patients with malignant severe colonic stenosis. However, reports of this stent for right-sided colonic stenosis are limited, possibly as a result of technical difficulties. We report a new method for delivering SEMS to the site of right-sided colonic stenosis in four patients with malignant right-sided colonic stenosis. Technical success was obtained with sequential use of a double-balloon endoscope and ultrathin endoscope, while we also injected non-ionic contrast agent into the submucosal layer as a marker for stenting under fluoroscopy. There were no adverse events noted during the procedure and clinical improvement was seen in all four cases. In conclusion, SEMS placement for right-sided malignant colonic stenosis with our newly developed method appears to be safe and effective, and can be used for decompression of the right colon.	[Kobayashi, Yoshiya; Komazawa, Yoshinori; Kusunoki, Maho; Takahashi, Yoshiko; Uno, Goichi; Yuki, Mika; Shizuku, Toshihiro] Shimane Univ, Div Internal Med, Matsue, Shimane, Japan; [Sugiyama, Akira] Shimane Univ, Surg, Izumo City Gen Med Ctr, Matsue, Shimane, Japan; [Kinoshita, Yoshikazu] Shimane Univ, Dept Gastroenterol & Hepatol, Matsue, Shimane, Japan	Kobayashi, Y (reprint author), Izumo City Gen Med Ctr, Div Internal Med, 613 Nadabun, Izumo, Shimane 6910003, Japan.	yoshiya_kobayashi@hotmail.com					Watt AM, 2007, ANN SURG, V246, P24, DOI 10.1097/01.sla.0000261124.72687.72; Dronamraju SS, 2009, DIS COLON RECTUM, V52, P1657, DOI 10.1007/DCR.0b013e3181a8f4af; Repici A, 2007, GASTROINTEST ENDOSC, V66, P940, DOI 10.1016/j.gie.2007.04.032; Baron TH, 2001, NEW ENGL J MED, V344, P1681, DOI 10.1056/NEJM200105313442206; Chos YK, 2011, GUT LIVER, V5, P165; Fahndrich M, 2011, ENDOSCOPY, V43, pE23, DOI 10.1055/s-0030-1255895; Kobayashis Y, 2013, SURG ONCOL, V22, P14; Pasha SF, 2007, GASTROINTEST ENDOSC, V65, P848, DOI 10.1016/j.gie.2006.08.046; Ptok H, 2006, SURG ENDOSC, V20, P909, DOI 10.1007/s00464-005-0594-7	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					704	707		10.1111/den.12450		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900011		
J	Tsutsumi, K; Kato, H; Okada, H				Tsutsumi, Koichiro; Kato, Hironari; Okada, Hiroyuki			Side-to-side jejunojejunostomy is favorable for scope insertion during endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y hepaticojejunostomy	DIGESTIVE ENDOSCOPY			English	Letter									[Tsutsumi, Koichiro; Kato, Hironari; Okada, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan	Tsutsumi, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan.						Shimatani M, 2009, ENDOSCOPY, V41, P849, DOI 10.1055/s-0029-1215108; Tsutsumi K, 2015, SURG ENDOSC, V29, P1944, DOI 10.1007/s00464-014-3889-8; Fukuba Nobuhiko, 2014, Endoscopy, V46 Suppl 1 UCTN, pE587, DOI 10.1055/s-0034-1377943; Sakakihara I, 2015, DIGEST ENDOSC, V27, P146, DOI 10.1111/den.12332; Yano T, 2012, ENDOSCOPY, V44, pE340, DOI 10.1055/s-0032-1309865	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					708	708		10.1111/den.12487		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900012		
J	Nakahara, K; Itoh, F				Nakahara, Kazunari; Itoh, Fumio			Endoscopic retrieval of a migrated esophageal stent using another anchored esophageal stent and an enteroscopy overtube: A novel technique	DIGESTIVE ENDOSCOPY			English	Letter									[Nakahara, Kazunari; Itoh, Fumio] St Marianna Univ, Sch Med, Dept Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan	Nakahara, K (reprint author), St Marianna Univ, Sch Med, Dept Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan.						Tsujikawa T, 2008, ENDOSCOPY, V40, P11, DOI 10.1055/s-2007-966976; Vanbiervliet G, 2012, SURG ENDOSC, V26, P53, DOI 10.1007/s00464-011-1827-6; Kato H, 2007, HEPATO-GASTROENTEROL, V54, P1388; Kims ID, 2010, SCAND J GASTROENTERO, V45, P100	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					709	709		10.1111/den.12488		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900013		
J	Nakachi, K; Iguchi, M; Kato, J				Nakachi, Kenichiro; Iguchi, Mikitaka; Kato, Jun			Following JGES guidelines for patients with antiplatelet agents might increase bleeding after gastric endoscopic submucosal dissection	DIGESTIVE ENDOSCOPY			English	Letter									[Nakachi, Kenichiro; Iguchi, Mikitaka; Kato, Jun] Wakayama Med Univ, Dept Internal Med 2, Wakayama, Japan	Nakachi, K (reprint author), Wakayama Med Univ, Dept Internal Med 2, Wakayama, Japan.						Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					711	711		10.1111/den.12493		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900015		
J	Yasuda, I				Yasuda, Ichiro			Novel retrieval basket for small bile duct stones	DIGESTIVE ENDOSCOPY			English	Letter									Teikyo Univ, Mizonokuchi Hosp, Dept Gastroenterol, Kawasaki, Kanagawa, Japan	Yasuda, I (reprint author), Teikyo Univ, Mizonokuchi Hosp, Dept Gastroenterol, Kawasaki, Kanagawa, Japan.						Yasuda I, 2013, DIGEST ENDOSC, V25, P376, DOI 10.1111/den.12118	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					712	712		10.1111/den.12496		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900016		
J	Waseda, Y; Hayashi, T; Kaneko, S				Waseda, Yohei; Hayashi, Tomoyuki; Kaneko, Shuichi			Gastric metastasis from breast cancer visualized by magnifying endoscopy with narrow-band imaging	DIGESTIVE ENDOSCOPY			English	Letter							CARCINOMA		[Waseda, Yohei; Hayashi, Tomoyuki; Kaneko, Shuichi] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	Waseda, Y (reprint author), Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan.						Abids A, 2013, J CLIN ONCOL, V31, P106; Taal BG, 2000, CANCER, V89, P2214, DOI 10.1002/1097-0142(20001201)89:11<2214::AID-CNCR9>3.0.CO;2-D; Almubarak MM, 2011, DIGEST LIVER DIS, V43, P823, DOI 10.1016/j.dld.2011.04.009; Kudo T, 2005, GASTROINTEST ENDOSC, V62, P139, DOI 10.1016/S0016-5107(05)00514-6; RAJU U, 1993, MODERN PATHOL, V6, P516	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	SEP	2015	27	6					713	713		10.1111/den.12499		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CR6MH	WOS:000361460900017		
J	Ko, JH; Lee, CM				Ko, Jun-Hyung; Lee, Chang-Min			International economic policy uncertainty and stock prices: Wavelet approach	ECONOMICS LETTERS			English	Article						Policy uncertainty; Stock price; International spillover; Wavelet analysis		This paper examines the link between economic policy uncertainty and stock price in both a time and frequency domain. Wavelet analysis reveals that the relationship is generally negative but changes over time exhibiting low to high frequency cycles. Moreover, the timing of frequency changes overlaps when US policy uncertainty comoves with other countries' policy uncertainty. (C) 2015 Elsevier B.V. All rights reserved.	[Ko, Jun-Hyung] Aoyama Gakuin Univ, Shibuya Ku, Tokyo 1508366, Japan; [Lee, Chang-Min] Hankuk Univ Foreign Studies, Seoul 130791, South Korea	Ko, JH (reprint author), Aoyama Gakuin Univ, Shibuya Ku, Shibuya 4-4-25, Tokyo 1508366, Japan.	kojunhyung@aoyamagakuin.jp; changminlee@hufs.ac.kr			Kikawada Foundation; JSPS [15K17095]; Hankuk University of Foreign Studies Research Fund	The authors are grateful for the financial support provided by the Kikawada Foundation. Ko acknowledges financial support from Grant-in-Aid for Young Scientists (B) (Grant Number 15K17095) from JSPS. This work is also supported by Hankuk University of Foreign Studies Research Fund and the Kikawada Foundation.	Aguiar-Conraria L, 2014, J ECON SURV, V28, P344, DOI 10.1111/joes.12012; Pastor L, 2012, J FINANC, V67, P1219, DOI 10.1111/j.1540-6261.2012.01746.x; Antonakakis N, 2013, ECON LETT, V120, P87, DOI 10.1016/j.econlet.2013.04.004; Colombo V, 2013, ECON LETT, V121, P39, DOI 10.1016/j.econlet.2013.06.024; Baker S. R., 2013, MEASURING EC POLICY; Bijsterbosch M, 2013, ECON LETT, V121, P239, DOI 10.1016/j.econlet.2013.08.005; Brogaard J, 2015, MANAGE SCI, V61, P3, DOI 10.1287/mnsc.2014.2044; Klobner S., 2014, ECON LETT, V124, P508; Pastor L, 2013, J FINANC ECON, V110, P520, DOI 10.1016/j.jfineco.2013.08.007	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	SEP	2015	134						118	122		10.1016/j.econlet.2015.07.012		5	Economics	Business & Economics	CR3UA	WOS:000361257400030		
J	Itaya, K				Itaya, Kingo			Recent Progresses of Electrochemical Surface Science similar to Importance of Surface Imaging with Atomic Scale similar to	ELECTROCHEMISTRY			English	Article						Electrochemical Surface Science; STM; AFM; LCM-DIM; Single Crystals	SCANNING-TUNNELING-MICROSCOPY; IN-SITU STM; SINGLE-CRYSTAL SURFACES; SULFURIC-ACID-SOLUTION; DIFFERENTIAL OPTICAL MICROSCOPY; ULTRAHIGH-VACUUM ENVIRONMENT; IODINE-MODIFIED AU(111); METAL PHTHALOCYANINES; ELECTRODE SURFACES; AQUEOUS-SOLUTIONS	In the electrochemical surface science during the past 20 years, in-situ electrochemical scanning tunneling microscopy (EC-STM) and atomic force microscopy (AFM) have made significant contribution to understand various electrochemical processes with atomic scale. For examples, the underpotential deposition of copper, silver, and other metal ions; the specific adsorption of anions such as iodine and sulfate/bisulfate ions; electrochemical etching processes of metals and semiconductors and the molecular assembly of many organic molecules, such as metalloporphyrins, and metallophthalocyanines. Furthermore, we have recently developed a high resolution laser confocal microscope, combined with a differential interference contrast microscope, which enables to follows fast dynamic electrochemical processes at atomic height resolution in relatively large areas. It has been shown for the first time that single atomic steps of metals can be successfully seen by the newly developed optical microscope. Surface imaging techniques provide local pictures of electrode processes on the atomic scale, not averaged information in large areas. (C) The Electrochemical Society of Japan, All rights reserved.	Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Itaya, K (reprint author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	itaya@atom.che.tohoku.ac.jp			NEDO; JSPS	The author thank Dr. M. Azhagurajan (Tohoku University) and Prof. T. Ito (Tohoku University) for useful discussions in writing the manuscript. It is my great pleasure to thank all my previous students and colleagues. Particularly, my colleagues for their contributions to ITAYA-Electrochemiscopy Project (ERATO) organized by Japan Science and Technology Corporation (JST) during the period of 1992-1997. This work was also supported in part by funds from NEDO and JSPS.	Abruna H. D., 1991, ELECTROCHEMICAL INTE; Andersen JET, 1996, J APPL ELECTROCHEM, V26, P161, DOI 10.1007/BF00364066; Shingaya Y, 1999, J ELECTROANAL CHEM, V467, P299, DOI 10.1016/S0022-0728(99)00085-6; Cuesta A, 2000, PHYS CHEM CHEM PHYS, V2, P5684, DOI 10.1039/b006464p; Wan LJ, 1999, J PHYS CHEM B, V103, P6978, DOI 10.1021/jp991112j; Magnussen OM, 2002, CHEM REV, V102, P679, DOI 10.1021/cr000069p; TAO NJ, 1995, LANGMUIR, V11, P4445, DOI 10.1021/la00011a043; He Y, 2002, J AM CHEM SOC, V124, P11964, DOI 10.1021/ja026115f; Gewirth AA, 1997, CHEM REV, V97, P1129, DOI 10.1021/cr960067y; Yoshimoto S, 2013, ANNU REV ANAL CHEM, V6, P213, DOI 10.1146/annurev-anchem-062012-092559; Itaya K, 1998, PROG SURF SCI, V58, P121, DOI 10.1016/S0079-6816(98)00022-7; Ye S, 2009, ELECTROCHEMISTRY, V77, P2; Ataka K, 1998, LANGMUIR, V14, P951, DOI 10.1021/la971110v; MANNE S, 1991, SCIENCE, V251, P183, DOI 10.1126/science.251.4990.183; Hipps KW, 1996, J PHYS CHEM-US, V100, P11207, DOI 10.1021/jp960422o; CLAVILIER J, 1980, J ELECTROANAL CHEM, V107, P205, DOI 10.1016/0368-1874(80)80076-1; Lennartz M, 1999, SURF SCI, V442, P215, DOI 10.1016/S0039-6028(99)00918-8; Barlow DE, 2000, J PHYS CHEM B, V104, P5993, DOI 10.1021/jp0004462; Wen R, 2010, J AM CHEM SOC, V132, P13657, DOI 10.1021/ja106231x; SIMMONS JG, 1963, J APPL PHYS, V34, P2581, DOI 10.1063/1.1729774; De Feyter S, 2003, CHEM SOC REV, V32, P139, DOI 10.1039/b206566p; Lu X, 1996, J AM CHEM SOC, V118, P7197, DOI 10.1021/ja960874e; Hamelin A, 1996, J ELECTROANAL CHEM, V407, P1, DOI 10.1016/0022-0728(95)04499-X; CLAVILIER J, 1991, J CHIM PHYS PCB, V88, P1291; Sato K, 2006, ELECTROCHEM COMMUN, V8, P725, DOI 10.1016/j.elecom.2006.03.001; Lu X, 1997, J PHYS CHEM B, V101, P5391, DOI 10.1021/jp9707448; Hipps KW, 2002, J AM CHEM SOC, V124, P2126, DOI 10.1021/ja017561q; Yoshimoto S, 2005, CHEM PHYS, V319, P147, DOI 10.1016/j.chemphys.2005.04.038; Azhagurajan M, 2015, SURF SCI, V631, P57, DOI 10.1016/j.susc.2014.07.031; Azhagurajan M, 2013, J ELECTROCHEM SOC, V160, pD361, DOI 10.1149/2.057309jes; Batina N, 1996, J ELECTROANAL CHEM, V405, P245, DOI 10.1016/0022-0728(95)04480-9; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Chiang S, 1997, CHEM REV, V97, P1083, DOI 10.1021/cr940555a; Depeursinge C., 2006, DIGITAL HOLOGRAPHY 3; Driessche A. E. S. V., 2007, CRYST GROWTH DES, V7, P1980; Driessche A. E. S. V., 2008, J CRYST GROWTH DES, V8, P4316; FELIU JM, 1994, J ELECTROANAL CHEM, V372, P265, DOI 10.1016/0022-0728(93)03259-R; Funtikov A. M., 1997, J ELECTROANAL CHEM, V428, P143; Funtilcov A. M., 1995, SURF SCI, V324, P343; HACHIYA T, 1991, J ELECTROANAL CHEM, V315, P275, DOI 10.1016/0022-0728(91)80076-3; Hai NTM, 2008, J PHYS CHEM C, V112, P10176, DOI 10.1021/jp711376c; Hamelin A., 1985, MOD ASPECT ELECTROC, P1; He Y, 2007, ANGEW CHEM INT EDIT, V46, P6098, DOI 10.1002/anie.200603822; HONBO H, 1990, ANAL CHEM, V62, P2424, DOI 10.1021/ac00221a003; HOTTENHUIS MHJ, 1988, ELECTROCHIM ACTA, V33, P1519, DOI 10.1016/0013-4686(88)80222-6; HUBBARD AT, 1988, CHEM REV, V88, P633, DOI 10.1021/cr00086a004; HUCKABY DA, 1991, J ELECTROANAL CHEM, V315, P255, DOI 10.1016/0022-0728(91)80074-Z; Jerkiewicz G., 1997, SOLID LIQUID ELECTRO; KAJI K, 1995, J APPL PHYS, V78, P5727, DOI 10.1063/1.359633; Kobayashi SI, 2011, ELECTROCHEM SOLID ST, V14, pH351, DOI 10.1149/1.3597657; Kolb DM, 2001, ANGEW CHEM INT EDIT, V40, P1162, DOI 10.1002/1521-3773(20010401)40:7<1162::AID-ANIE1162>3.3.CO;2-6; Kunitake M, 1997, LANGMUIR, V13, P1607, DOI 10.1021/la9620216; Lu PC, 2002, LANGMUIR, V18, P754, DOI 10.1021/la0107493; MAGNUSSEN OM, 1990, PHYS REV LETT, V64, P2929, DOI 10.1103/PhysRevLett.64.2929; MOTOO S, 1984, J ELECTROANAL CHEM, V167, P309, DOI 10.1016/0368-1874(84)87078-1; NICHOLS RJ, 1991, J ELECTROANAL CHEM, V313, P109, DOI 10.1016/0022-0728(91)85174-N; NISHIZAWA J, 1981, J CRYST GROWTH, V55, P402, DOI 10.1016/0022-0248(81)90044-0; Ogaki K, 1996, J PHYS CHEM-US, V100, P7185, DOI 10.1021/jp953517j; OGAKI K, 1995, ELECTROCHIM ACTA, V40, P1249, DOI 10.1016/0013-4686(95)99706-2; Okada J, 2001, PHYS CHEM CHEM PHYS, V3, P3297, DOI 10.1039/b101093j; Popescu G, 2008, METHOD CELL BIOL, V90, P87, DOI 10.1016/S0091-679X(08)00805-4; Raya K., 1988, SURF SCI, V201, P507; Safarowsky C, 2004, LANGMUIR, V20, P8261, DOI 10.1021/la048940a; Safarowsky C, 2004, ANGEW CHEM INT EDIT, V43, P1291, DOI 10.1002/anie.200352968; Sakaguchi H, 2004, NAT MATER, V3, P551, DOI 10.1038/nmat1176; Sashikata K, 1998, LANGMUIR, V14, P2896, DOI 10.1021/la971410c; ITAYA K, 1990, J VAC SCI TECHNOL A, V8, P515, DOI 10.1116/1.576378; Sazaki G, 2004, J CRYST GROWTH, V262, P536, DOI 10.1016/j.jcrysgro.2003.10.049; Shi Z., 1995, J ELECTROANAL CHEM, V396, P317; SHI ZC, 1994, J ELECTROANAL CHEM, V365, P303, DOI 10.1016/0022-0728(93)03207-6; Shingaya Y, 1998, ELECTROCHIM ACTA, V44, P745, DOI 10.1016/S0013-4686(98)00191-1; Siegenthaler H., 1992, SCANNING TUNNELING M, VII, P7; Sin Z., 1994, J ELECTROANAL CHEM, V366, P317; SONNENFELD R, 1986, SCIENCE, V232, P211, DOI 10.1126/science.232.4747.211; Soriaga M. P., 1988, ELECTROCHEMICAL SURF; SORIAGA MP, 1992, PROG SURF SCI, V39, P325, DOI 10.1016/0079-6816(92)90016-B; Suto K, 2003, J AM CHEM SOC, V125, P14976, DOI 10.1021/ja038857u; TANAKA S, 1995, J ELECTROANAL CHEM, V396, P125, DOI 10.1016/0022-0728(95)04062-S; Tansel T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.026101; Taranovskyy A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.106101; Thorgaard SN, 2010, LANGMUIR, V26, P7133, DOI 10.1021/la904182p; TONEY MF, 1995, PHYS REV LETT, V75, P4472, DOI 10.1103/PhysRevLett.75.4472; Tsukamoto K, 2007, AIP CONF PROC, V916, P329; Wan LJ, 2000, LANGMUIR, V16, P2164, DOI 10.1021/1a991069r; WAN LJ, 1995, J PHYS CHEM-US, V99, P9507, DOI 10.1021/j100023a031; Wandlowski T, 2004, ELECTROCHIM ACTA, V49, P1233, DOI 10.1016/j.electacta.2003.06.002; Wen R, 2010, J ELECTROANAL CHEM, V649, P257, DOI 10.1016/j.jelechem.2010.06.009; Wieckowski A, 1999, INTERFACIAL ELECTROC; Yoshimoto S, 2008, J AM CHEM SOC, V130, P15944, DOI 10.1021/ja804564f; Yoshimoto S, 2004, LANGMUIR, V20, P3159, DOI 10.1021/la0359474	90	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	SEP	2015	83	9					670	679		10.5796/electrochemistry.83.670		10	Electrochemistry	Electrochemistry	CR4YD	WOS:000361345100001		
J	Homma, T				Homma, Takayuki			Electrochemical Processes for the Fabrication of Functional Micro-nano Structures and Devices: Mechanistic Understanding and Process Development	ELECTROCHEMISTRY			English	Article						Electrodeposition; Electroless Deposition; Micro-nano Fabrication Process; Ab Initio Calculation	ELECTROLESS DEPOSITION PROCESS; LATERALLY-ENHANCED GROWTH; BIT-PATTERNED MEDIA; SI WAFER SURFACES; HYPOPHOSPHITE IONS; METAL-SURFACES; ELECTRODEPOSITION PROCESS; AU ELECTRODEPOSITION; DIMETHYLAMINE BORANE; THEORETICAL-ANALYSIS	Electrochemical approaches for the fabrication of functional micro-nano structures and devices were comprehensively described primarily on the basis of the results obtained from previous studies conducted by the author's group with the aim of demonstrating the potential for achieving further precise controllability. First, a theoretical study was conducted for investigating the processes, mainly focusing upon electroless deposition to present an approach for analyzing its reaction mechanism from the molecular level. These approaches could be powerful tools for elucidating the overall process and could contribute toward achieving the precise design of processes. Second, some experimental approaches for achieving the precise control of micro-nano fabrication of functional structures, such as maskless and electroless fabrication of metal nano-patterns, lateral enhanced electrodeposition to form ultrathin layers, as well as the nanostructures for various devices by through-mask electrochemical deposition, were introduced to demonstrate high capability of the processes for nanoscale fabrication in various applications. (C) The Electrochemical Society of Japan, All rights reserved.	Waseda Univ, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan	Homma, T (reprint author), Waseda Univ, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan.	t.homma@waseda.jp			MEXT; JST; JSPS; SRC	The results described herein were obtained by collaboration and discussions with a number of collaborators, and the author would like to sincerely thank Prof. T. Osaka, Prof. Y Yamazaki, Prof. S. Shoji, Prof. H. Nakai, Prof. C. E. D. Chidsey, Prof. M. Chemla, Prof. Y. Fukunaka, Prof. M. Yanagisawa, Prof. M. Saito, Prof. H. Sato, Dr. N. Kubo, Dr. T. Shimada, Dr. K. Sakata, Dr. T. Ouchi, Dr. M. Kunimoto, Dr. C. Kobayashi, Dr. B. Jiang, Dr. C. P. Lin, and many colleagues for their cooperation, continuous encouragement as well as help with experiments. The financial support from MEXT, JST, JSPS, and SRC, as well as several organizations, is also greatly acknowledged.	Abrantes LM, 1997, J CHEM SOC FARADAY T, V93, P1119, DOI 10.1039/a606732h; Uda K, 2015, ELECTROCHIM ACTA, V153, P515, DOI 10.1016/j.electacta.2014.12.019; Schultze JW, 2005, ELECTROCHIM ACTA, V51, P775, DOI 10.1016/j.electacta.2005.04.073; DECKERT CA, 1995, PLAT SURF FINISH, V82, P58; Kervennic YV, 2002, APPL PHYS LETT, V80, P321, DOI 10.1063/1.1433914; White RL, 1997, IEEE T MAGN, V33, P990, DOI 10.1109/20.560144; LEHMANN V, 1993, J ELECTROCHEM SOC, V140, P2836, DOI 10.1149/1.2220919; Richter HJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209179; Andricacos PC, 1998, IBM J RES DEV, V42, P567; Niwa D, 2004, J PHYS CHEM B, V108, P9900, DOI 10.1021/jp037159t; VANDENMEERAKKER JEAM, 1981, J APPL ELECTROCHEM, V11, P395; Romankiw LT, 1997, ELECTROCHIM ACTA, V42, P2985, DOI 10.1016/S0013-4686(97)00146-1; OHNO I, 1985, J ELECTROCHEM SOC, V132, P2323, DOI 10.1149/1.2113572; Chik H, 2004, MAT SCI ENG R, V43, P103, DOI 10.1016/j.mser.2003.12.001; Chemla M, 2003, J ELECTROANAL CHEM, V559, P111, DOI 10.1016/S0022-0728(02)01280-9; Choeng W. J., 2004, APPL SURF SCI, V229, P282; Homma T, 1999, J PHYS CHEM B, V103, P1774, DOI 10.1021/jp982116b; Homma T, 2003, J ELECTROANAL CHEM, V559, P131, DOI 10.1016/S0022-0728(03)00042-1; Homma T, 2009, J ELECTROCHEM SOC, V156, pH475, DOI 10.1149/1.3106085; Homma T, 2005, J PHYS CHEM B, V109, P5724, DOI 10.1021/jp045822n; Homma T, 1998, J PHYS CHEM B, V102, P7919, DOI 10.1021/jp982109n; Homma T, 2003, ELECTROCHIM ACTA, V48, P3115, DOI 10.1016/S0013-4686(03)00339-6; Homma T., 2015, ECS T, V64, P1; Homma T, 2003, J ELECTROANAL CHEM, V559, P143, DOI 10.1016/S0022-0728(02)01282-2; Jiang B, 2013, ELECTROCHIM ACTA, V100, P317, DOI 10.1016/j.electacta.2012.09.074; Jiang B, 2013, ELECTROCHEMISTRY, V81, P674, DOI 10.5796/electrochemistry.81.674; Jiang B, 2013, J ELECTROCHEM SOC, V160, pD366, DOI 10.1149/2.073309jes; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KIVEL J, 1965, J ELECTROCHEM SOC, V112, P1201, DOI 10.1149/1.2423399; Kobayashi C, 2013, ELECTROCHEMISTRY, V81, P236, DOI 10.5796/electrochemistry.81.236; Kobayashi C, 2012, ELECTROCHIM ACTA, V74, P235, DOI 10.1016/j.electacta.2012.04.071; Kobayashi C, 2011, ECS TRANSACTIONS, V33, P1, DOI 10.1149/1.3576071; Kubo N, 2005, ELECTROCHIM ACTA, V51, P834, DOI 10.1016/j.electacta.2005.04.058; Kunimoto M, 2012, ELECTROCHEMISTRY, V80, P222, DOI 10.5796/electrochemistry.80.222; Kunimoto M, 2011, J ELECTROCHEM SOC, V158, pD585, DOI 10.1149/1.3609000; Kunimoto M, 2012, ELECTROCHEMISTRY, V80, P126, DOI 10.5796/electrochemistry.80.126; Kunimoto M, 2013, ELECTROCHIM ACTA, V100, P311, DOI 10.1016/j.electacta.2012.09.070; Kunimoto M, 2011, J ELECTROCHEM SOC, V158, pD626, DOI 10.1149/1.3623782; Li J, 2002, J ELECTROCHEM SOC, V149, pC631, DOI 10.1149/1.1517582; LI J, 1992, MATER SCI REP, V9, P1, DOI 10.1016/0920-2307(92)90011-O; Liu B, 2005, ELECTROCHIM ACTA, V50, P3041, DOI 10.1016/j.electacta.2004.12.041; Mallory G. O., 1990, ELECTROLESS PLATING; MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466; OHNO I, 1991, MAT SCI ENG A-STRUCT, V146, P33, DOI 10.1016/0921-5093(91)90266-P; Ouchi T, 2011, ELECTROCHIM ACTA, V56, P9575, DOI 10.1016/j.electacta.2011.04.085; Ouchi T, 2010, ELECTROCHIM ACTA, V55, P8081, DOI 10.1016/j.electacta.2010.02.073; Ouchi T, 2010, IEEE T MAGN, V46, P2224, DOI 10.1109/TMAG.2010.2040068; Ouchi T, 2008, J MAGN MAGN MATER, V320, P3104, DOI 10.1016/j.jmmm.2008.08.022; Paunovic M., 2006, FUNDAMENTALS ELECTRO, V2nd; Sakata K, 2005, ELECTROCHIM ACTA, V51, P1000, DOI 10.1016/j.electacta.2005.05.061; Sakata K, 2012, ELECTROCHEM COMMUN, V25, P144, DOI 10.1016/j.elecom.2012.08.030; Sato H, 2010, ELECTROCHEM COMMUN, V12, P765, DOI 10.1016/j.elecom.2010.03.028; Sato H, 2005, ELECTROCHIM ACTA, V51, P844, DOI 10.1016/j.electacta.2005.04.067; Sato H, 2005, J ELECTROANAL CHEM, V584, P28, DOI 10.1016/j.jelechem.2004.11.001; Sato H, 2005, ELECTROCHEMISTRY, V73, P275; Shimada T, 2005, ELECTROCHIM ACTA, V51, P906, DOI 10.1016/j.electacta.2005.04.051; VANDENMEERAKKER JEAM, 1990, J APPL ELECTROCHEM, V20, P85; VANDENMEERAKKER JEAM, 1981, J APPL ELECTROCHEM, V11, P387; Wodarz S., 2015, ECS T, V64, P99; Zeng Y, 2005, J MOL STRUC-THEOCHEM, V724, P81, DOI 10.1016/j.theochem.2005.03.014	60	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	SEP	2015	83	9					680	687		10.5796/electrochemistry.83.680		8	Electrochemistry	Electrochemistry	CR4YD	WOS:000361345100002		
J	Ino, K				Ino, Kosuke			Microchemistry- and MEMS-based Integrated Electrochemical Devices for Bioassay Applications	ELECTROCHEMISTRY			English	Article						Electrochemical Device; Analytical Electrochemistry; Microchemistry; BioMEMS	INTERDIGITATED ARRAY ELECTRODES; EC CHIP DEVICE; SECRETED ALKALINE-PHOSPHATASE; MAGNETITE CATIONIC LIPOSOMES; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; VOLTAMMETRIC DETECTION; AMPEROMETRIC SENSOR; SINGLE CELLS; NEGATIVE DIELECTROPHORESIS	Here, we present an overview of our recent research progress in development of electrochemical devices/systems for bioassays. These devices/systems are based on microchemistry and micro-electromechanical systems (MEMS) for sophisticated analytical and electrochemical measurements. In particular, we exploit the unique chemical reactions occurring in micrometer-size spaces and/or involving micrometer-size structures for bioassays, including cell analyses. This paper addresses five topics: probe-, chip-, large-scale-integration chip-, and dielectrophoresisbased devices, and electrodeposition of hydrogels for bioassays. (C) The Electrochemical Society of Japan, All rights reserved.	Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Ino, K (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-11-604 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	ino.kosuke@bioinfo.che.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [20860017, 22245011, 23760745, 25248032, 26600057, 15H05415]; Asahi Glass Foundation; Murata Science Foundation; Yazaki Memorial Foundation for Science and Technology; Kato Memorial Bioscience Foundation; Casio Science Promotion Foundation; Nakatani Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, from the Japan Science and Technology Agency	I want to thank members of the Matsue Laboratory (Tohoku University) and research collaborators. This work was supported in part by grants from the Japan Society for the Promotion of Science (JSPS) (Nos. 20860017, 22245011, 23760745, 25248032, 26600057, and 15H05415). This work was also supported by the Asahi Glass Foundation, the Murata Science Foundation, the Yazaki Memorial Foundation for Science and Technology, the Kato Memorial Bioscience Foundation, the Casio Science Promotion Foundation, the Nakatani Foundation, and the Mitsui Sumitomo Insurance Welfare Foundation. Additional support was provided by Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, from the Japan Science and Technology Agency.	Ino K, 2014, LAB CHIP, V14, P787, DOI 10.1039/c3lc51156a; Lin ZY, 2010, CHEM COMMUN, V46, P559, DOI 10.1039/b915212a; Inoue KY, 2012, LAB CHIP, V12, P3481, DOI 10.1039/c2lc40323d; Cui HF, 2006, ANAL CHEM, V78, P6347, DOI 10.1021/ac060018d; Ferguson BS, 2009, ANAL CHEM, V81, P6503, DOI 10.1021/ac900923e; Berdondini L, 2009, LAB CHIP, V9, P2644, DOI 10.1039/b907394a; Mittal N, 2007, LAB CHIP, V7, P1146, DOI 10.1039/b706342c; BARD AJ, 1989, ANAL CHEM, V61, P132, DOI 10.1021/ac00177a011; Kanno Y, 2015, J ELECTROANAL CHEM, V741, P109, DOI 10.1016/j.jelechem.2015.01.020; Barker AL, 1999, ANAL CHIM ACTA, V385, P223, DOI 10.1016/S0003-2670(98)00588-1; AOKI K, 1988, J ELECTROANAL CHEM, V256, P269, DOI 10.1016/0022-0728(88)87003-7; Kranz C, 2014, ANALYST, V139, P336, DOI 10.1039/c3an01651j; Pedrero M, 2009, SENSORS-BASEL, V9, P5503, DOI 10.3390/s90705503; Albrecht DR, 2004, BIOPHYS J, V87, P2131, DOI 10.1529/biophysj.104.039511; Yamamura S, 2005, ANAL CHEM, V77, P8050, DOI 10.1021/ac051632; Ino K, 2012, CHEM COMMUN, V48, P8505, DOI 10.1039/c2cc34264b; Sen M, 2012, BIOTECHNOL BIOENG, V109, P2163, DOI 10.1002/bit.24461; Doh I, 2005, SENSOR ACTUAT A-PHYS, V121, P59, DOI 10.1016/j.sna.2005.01.030; Metz S, 2004, BIOSENS BIOELECTRON, V19, P1309, DOI 10.1016/j.bios.2003.11.021; Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2; Sen M, 2012, LAB CHIP, V12, P4328, DOI 10.1039/c2lc40674h; Jones IL, 2011, ANAL BIOANAL CHEM, V399, P2313, DOI 10.1007/s00216-010-3968-1; Pamme N, 2007, LAB CHIP, V7, P1644, DOI 10.1039/b712784g; Cheng Y, 2011, LAB CHIP, V11, P2316, DOI 10.1039/c1lc20306a; Ozawa F, 2013, J BIOSCI BIOENG, V115, P459, DOI 10.1016/j.jbiosc.2012.10.014; POHL HA, 1951, J APPL PHYS, V22, P869, DOI 10.1063/1.1700065; Sen M, 2013, BIOSENS BIOELECTRON, V48, P12, DOI 10.1016/j.bios.2013.03.069; Ino K, 2012, ANGEW CHEM INT EDIT, V51, P6648, DOI 10.1002/anie.201201602; MEYER H, 1995, ANAL CHEM, V67, P1164, DOI 10.1021/ac00103a005; Kim BN, 2013, BIOSENS BIOELECTRON, V41, P736, DOI 10.1016/j.bios.2012.09.058; Sen M, 2013, LAB CHIP, V13, P3650, DOI 10.1039/c3lc50561h; Eyer K, 2012, LAB CHIP, V12, P765, DOI 10.1039/c2lc20876h; Zhu X, 2011, SENSOR ACTUAT B-CHEM, V160, P923, DOI 10.1016/j.snb.2011.09.004; Shiku H, 2013, MOL BIOSYST, V9, P2701, DOI 10.1039/c3mb70223e; Arrigan DWM, 2004, ANALYST, V129, P1157, DOI 10.1039/b415395m; Ozawa F, 2013, LAB CHIP, V13, P3128, DOI 10.1039/c3lc50455g; Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Lin ZY, 2009, ANGEW CHEM INT EDIT, V48, P2044, DOI 10.1002/anie.200805743; Ramon-Azcon J, 2013, ADV MATER, V25, P4028, DOI 10.1002/adma.201301300; Ndieyira JW, 2008, NAT NANOTECHNOL, V3, P691, DOI 10.1038/nnano.2008.275; NIWA O, 1993, ANAL CHEM, V65, P1559, DOI 10.1021/ac00059a013; Ino K, 2012, ANAL CHEM, V84, P7593, DOI 10.1021/ac301429n; Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; Yasukawa T, 2012, ANAL CHEM, V84, P8830, DOI 10.1021/ac302239k; Kruppa P, 2010, BIOSENS BIOELECTRON, V26, P1414, DOI 10.1016/j.bios.2010.07.070; Cira NJ, 2012, LAB CHIP, V12, P1052, DOI 10.1039/c2lc20887c; Ito A, 2005, BIOMATERIALS, V26, P6185, DOI 10.1016/j.biomaterials.2005.03.039; Arai T, 2013, ANAL CHEM, V85, P9647, DOI 10.1021/ac401824q; Sun P, 2007, PHYS CHEM CHEM PHYS, V9, P802, DOI 10.1039/b612259k; Ino K, 2011, LAB CHIP, V11, P385, DOI 10.1039/c0lc00437e; Schulte A, 2010, ANNU REV ANAL CHEM, V3, P299, DOI 10.1146/annurev.anchem.111808.073651; Ito A, 2005, TISSUE ENG, V11, P1553, DOI 10.1089/ten.2005.11.1553; Wang YF, 2011, ADV MATER, V23, P5817, DOI 10.1002/adma.201103726; Sato K, 2003, ADV DRUG DELIVER REV, V55, P379, DOI 10.1016/S0169-409X(02)00225-9; Ino K, 2009, ELECTROPHORESIS, V30, P3406, DOI 10.1002/elps.200900244; Ino K, 2009, BIOTECHNOL BIOENG, V104, P709, DOI 10.1002/bit.22445; Ino K, 2014, ANAL CHEM, V86, P4016, DOI 10.1021/ac500435d; Kozminski KD, 1998, ANAL CHEM, V70, P3123, DOI 10.1021/ac980129f; Wang J, 2013, ANAL CHEM, V85, P5600, DOI 10.1021/ac4009385; Matsumae Y, 2013, CHEM COMMUN, V49, P6498, DOI 10.1039/c3cc43126f; Cheung KC, 2007, BIOSENS BIOELECTRON, V22, P1783, DOI 10.1016/j.bios.2006.08.035; Yang LJ, 2006, LAB CHIP, V6, P896, DOI 10.1039/b607061m; KWAK J, 1989, ANAL CHEM, V61, P1221, DOI 10.1021/ac00186a009; Ho CT, 2006, LAB CHIP, V6, P724, DOI 10.1039/b60203d; NIWA O, 1989, J ELECTROANAL CHEM, V267, P291, DOI 10.1016/0022-0728(89)80257-8; Patel AN, 2013, ANAL CHEM, V85, P11755, DOI 10.1021/ac401969q; Takeda M, 2011, ANALYST, V136, P4991, DOI 10.1039/c1an15620a; Xu XL, 2009, TALANTA, V80, P8, DOI 10.1016/j.talanta.2009.06.039; Ino K, 2008, LAB CHIP, V8, P134, DOI 10.1039/b712330b; Sen M, 2014, ANAL METHODS-UK, V6, P6337, DOI 10.1039/c4ay00791c; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Ino K, 2013, ELECTROCHEMISTRY, V81, P682, DOI 10.5796/electrochemistry.81.682; MATSUMOTO N, 1994, BIOELECTROCH BIOENER, V34, P199, DOI 10.1016/0302-4598(94)80037-5; Bertoncello P, 2010, ENERG ENVIRON SCI, V3, P1620, DOI 10.1039/c0ee00046a; BOND AM, 1994, ANALYST, V119, pR1, DOI 10.1039/an994190001r; Cox JT, 2012, ANNU REV ANAL CHEM, V5, P253, DOI 10.1146/annurev-anchem-062011-143124; Ino K, 2011, SENSOR ACTUAT B-CHEM, V153, P468, DOI 10.1016/j.snb.2010.11.012; Ino K, 2008, BIOTECHNOL BIOENG, V100, P168, DOI 10.1002/bit.21738; Ino K, 2007, BIOTECHNOL BIOENG, V97, P1309, DOI 10.1002/bit.21322; Ino K, 2009, BIOTECHNOL BIOENG, V102, P882, DOI 10.1002/bit.22104; Ino K, 2013, ANAL CHEM, V85, P3832, DOI 10.1021/ac303569t; Ino K, 2007, J CHEM ENG JPN, V40, P51, DOI 10.1252/jcej.40.51; Kanno Y, 2014, ANAL SCI, V30, P305; Kuno T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EL01; Lai SCS, 2012, MRS BULL, V37, P668, DOI 10.1557/mrs.2012.146; Lin ZY, 2010, CHEM COMMUN, V46, P243, DOI 10.1039/b915871e; Matsue T, 2012, B CHEM SOC JPN, V85, P545, DOI 10.1246/bcsj.20110249; MATSUE T, 1993, TRAC-TREND ANAL CHEM, V12, P100, DOI 10.1016/0165-9936(93)88009-T; RELLER H, 1984, J ELECTROANAL CHEM, V161, P247, DOI 10.1016/S0022-0728(84)80184-9; Rothe J, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054010; Shiku H, 2010, ELECTROCHIM ACTA, V55, P8263, DOI 10.1016/j.electacta.2010.04.011; Shiku H, 2010, FEBS LETT, V584, P4000, DOI 10.1016/j.febslet.2010.08.008; Zhou Y, 2013, ANAL BIOCHEM, V439, P187, DOI 10.1016/j.ab.2013.04.020	95	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	SEP	2015	83	9					688	694		10.5796/electrochemistry.83.688		7	Electrochemistry	Electrochemistry	CR4YD	WOS:000361345100003		
J	Orikasa, Y				Orikasa, Yuki			Hierarchical Spatiotemporal Analyses of Reactions Using Synchrotron Radiation and the Design of Next-Generation Energy Conversion Devices	ELECTROCHEMISTRY			English	Article						Operando Analysis; Synchrotron Radiation; Lithium Ion Battery	RAY-ABSORPTION SPECTROSCOPY; LITHIUM-ION BATTERIES; THIN-FILM ELECTRODE; CATHODE/ELECTROLYTE INTERFACE; ELECTROCHEMICAL PROPERTIES; SOLID-SOLUTION; CATHODE; TEMPERATURE; LIXFEPO4; LIFEPO4	To improve the performance of electrochemical devices such as batteries and fuel cells, it is essential to understand reaction hierarchies over wide temporal and spatial ranges. To this end, operando measurement techniques have been developed that enable analysis of the electrode/electrolyte interface of the reaction site, phase transitions of active materials, and macro reactions within real electrodes over various spatial and temporal scales. These analytic techniques pioneer a new way of performing kinetic analysis by introducing axes of space and time into reaction analyses, and are applicable to various types of electrochemical devices. Moreover, a magnesium rechargeable battery featuring the merits of high theoretical energy density, high safety, and easily acquirable raw materials was developed by employing these operando analytic techniques. (C) The Electrochemical Society of Japan, All rights reserved.	Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Orikasa, Y (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan.	orikasa.yuuki.2a@kyoto-u.ac.jp					Takamatsu D, 2015, J PHYS CHEM C, V119, P9791, DOI 10.1021/jp511405g; Orikasa Y, 2013, J AM CHEM SOC, V135, P5497, DOI 10.1021/ja312527x; Chang CC, 2011, J ELECTROCHEM SOC, V158, pA481, DOI 10.1149/1.3560222; Takamatsu D, 2013, J ELECTROCHEM SOC, V160, pA3054, DOI 10.1149/2.006305jes; Delmas C, 2008, NAT MATER, V7, P665, DOI 10.1038/nmat2230; Delacourt C, 2005, NAT MATER, V4, P254, DOI 10.1038/nmat1335; Aurbach D, 2002, ELECTROCHIM ACTA, V47, P4291, DOI 10.1016/S0013-4686(02)00417-6; Zheng HH, 2012, J POWER SOURCES, V208, P52, DOI 10.1016/j.jpowsour.2012.02.001; Yamamoto K, 2014, J PHYS CHEM C, V118, P9538, DOI 10.1021/jp5011132; Edstrom K, 2004, ELECTROCHIM ACTA, V50, P397, DOI 10.1016/j.electacta.2004.03.049; Yamada A, 2006, NAT MATER, V5, P357, DOI 10.1038/nmat1634; Siroma Z, 2010, J ELECTROANAL CHEM, V648, P92, DOI 10.1016/j.jelechem.2010.08.010; Cho KY, 2013, MATER RES BULL, V48, P2922, DOI 10.1016/j.materresbull.2013.04.026; REIMERS JN, 1992, J ELECTROCHEM SOC, V139, P2091, DOI 10.1149/1.2221184; Ma XH, 2010, J ELECTROCHEM SOC, V157, pA925, DOI 10.1149/1.3439678; Aurbach D, 2000, NATURE, V407, P724, DOI 10.1038/35037553; Yoon WS, 2000, J ELECTROCHEM SOC, V147, P2023, DOI 10.1149/1.1393479; Ogumi Z, 2010, ELECTROCHEMISTRY, V78, P319; Xu K, 2011, J MATER CHEM, V21, P9849, DOI 10.1039/c0jm04309e; Aurbach D, 2007, J POWER SOURCES, V165, P491, DOI 10.1016/j.jpowsour.2006.10.025; Orikasa Y, 2013, CHEM MATER, V25, P1032, DOI 10.1021/cm303411t; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Chen GY, 2009, J ELECTROCHEM SOC, V156, pA756, DOI 10.1149/1.3167389; Koyama Y, 2012, CHEM MATER, V24, P3886, DOI 10.1021/cm3018314; Lu WQ, 2010, J MATER RES, V25, P1656, DOI 10.1557/JMR.2010.0214; Orikasa Y., 2014, ADV MAT INTERFACES, V1; Orikasa Yuki, 2014, Sci Rep, V4, P5622, DOI 10.1038/srep05622; Ouyang CY, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.104303; Saisho H., 1996, APPL SYNCHROTRON RAD; Takamatsu D, 2012, ANGEW CHEM INT EDIT, V51, P11597, DOI 10.1002/anie.201203910; Takamatsu D, 2011, J PHYS CHEM LETT, V2, P2511, DOI 10.1021/jz2011226; Van der Ven A, 2000, ELECTROCHEM SOLID ST, V3, P301, DOI 10.1149/1.1391130; Yamamoto K, 2014, ELECTROCHEMISTRY, V82, P891, DOI 10.5796/electrochemistry.82.891	33	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	SEP	2015	83	9					695	700		10.5796/electrochemistry.83.695		6	Electrochemistry	Electrochemistry	CR4YD	WOS:000361345100004		
J	Hirayama, M				Hirayama, Masaaki			Interfacial Reactions of Intercalation Electrodes in Lithium Ion Batteries	ELECTROCHEMISTRY			English	Article						Surface Diffraction; Reflectometry; Epitaxial Film Electrode; Interfacial Structure	X-RAY REFLECTOMETRY; EPITAXIAL FILM ELECTRODES; ELECTRODE/ELECTROLYTE INTERFACE; ELECTROCHEMICAL PROPERTIES; ELEVATED-TEMPERATURE; LIMN2O4 ELECTRODE; SOLID-ELECTROLYTE; CATHODE MATERIAL; THIN-FILMS; SURFACE	Gaining a thorough understanding of the electrochemical interface in lithium ion batteries is essential for the development of a common strategy for the material design. This comprehensive paper presents the interfacial reaction analyses between intercalation electrodes and organic electrolytes using an epitaxial-film model electrode and in situ surface scattering techniques. The crystal structures of the intercalation electrodes drastically change in 10 nm-regions from the top of the electrode surface when soaked to the electrolyte and are reconstructed during the initial electrochemical reaction, which is accompanied with formation of a solid electrolyte interface layer. The reconstructed interfaces have a pronounced effect on the power characteristics and the stability at the subsequent electrochemical cycles. (C) The Electrochemical Society of Japan, All rights reserved.	Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Hirayama, M (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	hitrayama@echem.titech.ac.jp	Hirayama, Masaaki/B-5781-2011	Hirayama, Masaaki/0000-0003-4804-4208	JSPS	The author is grateful to Prof. Ryoji Kanno (Tokyo Institute of Technology), Prof Kota Suzuki (Tokyo Institute of Technology), Dr. Sou Taminato (Tokyo Institute of Technology), Prof Masao Yonemura (High Energy Accelerator Research Organization), and Dr. Kazuhisa Tamura (Japan Atomic Energy Agency), and many collaborators for the experiments, discussions, supervisions, and the fruitful joint research. This work was supported in part by a Grant-in-Aid for Scientific Research (A) (C) and a Grant-in-Aid for Young Scientists (B) from JSPS.	Albina JM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165103; Sun WW, 2012, J MATER CHEM, V22, P20952, DOI 10.1039/c2jm32658b; Hirayama M, 2007, J POWER SOURCES, V168, P493, DOI 10.1016/j.jpowsour.2007.03.034; Cho Y, 2010, J ELECTROCHEM SOC, V157, pA617, DOI 10.1149/1.3332676; Komo M, 2012, ELECTROCHEMISTRY, V80, P834, DOI 10.5796/electrochemistry.80.834; Todorov YM, 2004, ELECTROCHIM ACTA, V50, P495, DOI 10.1016/j.electacta.2004.05.050; Hirayama M, 2011, DALTON T, V40, P2882, DOI 10.1039/c0dt01477j; Lu ZH, 2002, J ELECTROCHEM SOC, V149, pA778, DOI 10.1149/1.1471541; Sakamoto K, 2009, CHEM MATER, V21, P2632, DOI 10.1021/cm8033559; Sakamoto K, 2010, PHYS CHEM CHEM PHYS, V12, P3815, DOI 10.1039/b920271d; PELED E, 1979, J ELECTROCHEM SOC, V126, P2047, DOI 10.1149/1.2128859; Shizuka K, 2005, J POWER SOURCES, V146, P589, DOI 10.1016/j.jpowsour.2005.03.046; Zheng YM, 2012, THIN SOLID FILMS, V520, P4889, DOI 10.1016/j.tsf.2012.03.029; Mitamura K, 2013, POLYM J, V45, P100, DOI 10.1038/pj.2012.156; Thackeray MM, 2006, ELECTROCHEM COMMUN, V8, P1531, DOI 10.1016/j.elecom.2006.06.030; THACKERAY MM, 1983, MATER RES BULL, V18, P461, DOI 10.1016/0025-5408(83)90138-1; Suzuki K, 2013, J POWER SOURCES, V226, P340, DOI 10.1016/j.jpowsour.2012.11.008; Schechter A, 1999, LANGMUIR, V15, P3334, DOI 10.1021/la981048h; Croguennec L, 2001, J MATER CHEM, V11, P131, DOI 10.1039/b003377o; Aurbach D, 1998, J ELECTROCHEM SOC, V145, P3024, DOI 10.1149/1.1838758; Thackeray MM, 1997, PROG SOLID STATE CH, V25, P1, DOI 10.1016/S0079-6786(97)81003-5; Asakura K, 1999, J POWER SOURCES, V81, P388, DOI 10.1016/S0378-7753(99)00113-5; Hirayama M, 2007, ELECTROCHIM ACTA, V53, P871, DOI 10.1016/j.electacta.2007.07.074; Hirayama M, 2010, ELECTROCHEMISTRY, V78, P413; Amatucci G, 1999, ELECTROCHIM ACTA, V45, P255, DOI 10.1016/S0013-4686(99)00209-1; Kim K, 2012, ELECTROCHEMISTRY, V80, P800, DOI 10.5796/electrochemistry.80.800; Matsuo Y, 2001, J ELECTROCHEM SOC, V148, pA687, DOI 10.1149/1.1373658; Hirayama M, 2007, J ELECTROCHEM SOC, V154, pA1065, DOI 10.1149/1.2778853; Taminato S, 2014, J MATER CHEM A, V2, P17875, DOI 10.1039/c4ta02795g; Bar-Tow D, 1999, J ELECTROCHEM SOC, V146, P824, DOI 10.1149/1.1391688; Hirayama M, 2010, J AM CHEM SOC, V132, P15268, DOI 10.1021/ja105389t; Kim S, 2014, SOLID STATE IONICS, V262, P578, DOI 10.1016/j.ssi.2013.09.040; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; KOBAYASHI H, 1995, SOLID STATE IONICS, V82, P25, DOI 10.1016/0167-2738(95)00135-S; Aurbach D, 2000, J ELECTROCHEM SOC, V147, P1322, DOI 10.1149/1.1393357; Lei JL, 2005, J ELECTROCHEM SOC, V152, pA774, DOI 10.1149/1.1867652; Lin HB, 2014, J MATER CHEM A, V2, P11987, DOI 10.1039/c4ta01810a; Araki K, 2003, J POWER SOURCES, V124, P124, DOI 10.1016/S0378-7753(03)00593-7; Cho J, 1999, ELECTROCHEM SOLID ST, V2, P607, DOI 10.1149/1.1390922; Fujii T, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.165101; Kannan AM, 2003, ELECTROCHEM SOLID ST, V6, pA16, DOI 10.1149/1.1526782; Kim S, 2014, CRYSTENGCOMM, V16, P1044, DOI 10.1039/c3ce42003e; Kim S, 2013, DALTON T, V42, P13112, DOI 10.1039/c3dt51795k; McBreen J, 2009, J SOLID STATE ELECTR, V13, P1051, DOI 10.1007/s10008-008-0685-1; Menetrier M, 2004, ELECTROCHEM SOLID ST, V7, pA140, DOI 10.1149/1.1697905; Taminato S, 2015, CHEM COMMUN, V51, P1673, DOI 10.1039/c4cc07758j; Wu MS, 2005, J ELECTROCHEM SOC, V152, pA1041, DOI 10.1149/1.1896325; Yamada N. L., 2011, EUR PHYS J PLUS, V126, P1; Yonemura M, 2014, J PHYS CONF SER, V502, DOI 10.1088/1742-6596/502/1/012054	49	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	SEP	2015	83	9					701	706		10.5796/electrochemistry.83.701		6	Electrochemistry	Electrochemistry	CR4YD	WOS:000361345100005		
J	Nakagawa, H				Nakagawa, Hiroe			Electrolytes Containing Ionic Liquids for Improved Safety of Lithium-ion Batteries	ELECTROCHEMISTRY			English	Article						Lithium-ion Cell; Ionic Liquid; Non-flammable Electrolyte	TEMPERATURE MOLTEN-SALT; SOLAR-CELL; GRAPHITE; RTILS	Ionic liquids are of interest for application in electrolytes of lithium-ion batteries, because of their non-flammability, thermal stability, and non-volatility. Electrolytes containing ionic liquids have therefore been used to improve the safety of lithium-ion cells. Both the liquid electrolyte and the gelled electrolyte, which was composed of 1-ethyl-3-methyl-imidazolium tetrafluoroborate and LiBF4, were shown to have good thermal and electrochemical stability and to be applicable for use in lithium-ion cells with Li[Li1/3Ti5/3]O-4 as the negative electrode active material. Electrolytes containing a mixture of organic solvents and N-methyl-N-propylpiperidinium bis (trifluoromethanesulfonyl) imide were also found to exhibit good discharge performance for use in lithium-ion cells and nonflammability for use as an electrolyte. Furthermore, it was found that graphite was able to perform in the electrolyte containing the ionic liquid. (C) The Electrochemical Society of Japan, All rights reserved.	GS Yuasa Int, Minami Ku, Kyoto 6018520, Japan	Nakagawa, H (reprint author), GS Yuasa Int, Minami Ku, Kyoto 6018520, Japan.	hiroe.nakagawa@jp.gs-yuasa.com			New Energy and Industrial Technology Development Organization (NEDO), Japan	The second section of this work forms part of collaborative research with National Institute of Advanced Industrial Science and Technology (AIST), and supported by New Energy and Industrial Technology Development Organization (NEDO), Japan.	Chagnes A, 2005, J POWER SOURCES, V145, P82, DOI 10.1016/j.jpowsour.2004.12.035; Bonhote P, 1996, INORG CHEM, V35, P1168, DOI 10.1021/ic951325x; Doyle M, 2000, J ELECTROCHEM SOC, V147, P34, DOI 10.1149/1.1393153; Nanjundiah C, 1997, J ELECTROCHEM SOC, V144, P3392, DOI 10.1149/1.1838024; Sakaebe H, 2005, J POWER SOURCES, V146, P693, DOI 10.1016/j.jpowsour.2005.03.071; Sakaebe H, 2003, ELECTROCHEM COMMUN, V5, P594, DOI 10.1016/S1388-2481(03)00137-1; Holzapfel M, 2005, CARBON, V43, P1488, DOI 10.1016/j.carbon.2005.01.030; Fuller J, 1997, J ELECTROCHEM SOC, V144, P3881, DOI 10.1149/1.1838106; Nakagawa H, 2007, J POWER SOURCES, V174, P1021, DOI 10.1016/j.jpowsour.2007.06.133; Matsumoto H, 2005, J POWER SOURCES, V146, P45, DOI 10.1016/j.jpowsour.2005.03.103; Nakagawa H, 2003, J ELECTROCHEM SOC, V150, pA695, DOI 10.1149/1.1568939; Papageorgiou N, 1996, J ELECTROCHEM SOC, V143, P3099, DOI 10.1149/1.1837171; CARLIN RT, 1994, J ELECTROCHEM SOC, V141, pL73, DOI 10.1149/1.2055041; Diaw M, 2005, J POWER SOURCES, V146, P682, DOI 10.1016/j.jpowsour.2005.03.068; Fung YS, 1999, J POWER SOURCES, V81, P891, DOI 10.1016/S0378-7753(99)00127-5; Katayama Y, 2003, ELECTROCHEM SOLID ST, V6, pA96, DOI 10.1149/1.1566213; Matsumoto H, 2001, CHEM LETT, P26, DOI 10.1246/cl.2001.26; Ui K, 1997, DENKI KAGAKU, V65, P161; Wilkes J. S., 1992, CHEM COMMUN, V965	19	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	SEP	2015	83	9					707	710		10.5796/electrochemistry.83.707		4	Electrochemistry	Electrochemistry	CR4YD	WOS:000361345100006		
J	Kikuchi, R; Kouzaki, T; Kuftabuchi, T; Hato, K				Kikuchi, Ryosuke; Kouzaki, Takashi; Kuftabuchi, Takahiro; Hato, Kazuhito			Characterization of Baddeleyite-structure NbON Films Deposited by RF Reactive Sputtering for Solar Hydrogen Production Devices	ELECTROCHEMISTRY			English	Article						NbON; Photocatalyst; Sputtering; Water Splitting	VISIBLE-LIGHT IRRADIATION; OXYNITRIDE TAON PHOTOANODE; WATER; CATALYSTS; TA3N5	In this study, baddeleyite-structure NbON was investigated as new photocatalysts for solar hydrogen production devices. We deposited pure 90-nm-thick NbON films on quartz substrates under a fixed O-2 and N-2 ambient mixture by RF reactive sputtering. The NbON films showed semiconductive characteristics and a narrower band gap than that of Ta0N. The band gap of NbON was estimated to be 2.1 eV. We confirmed that the NbON film was very dense without distinct cracks and had an approximately stoichiometric and uniform composition. We prepared an NbON photoelectrode on a conducting substrate and clearly observed the photocurrent by 436-nm monochromatic light. NbON has potential as a photocatalyst for direct water splitting. (C) The Electrochemical Society of Japan, All rights reserved.	[Kikuchi, Ryosuke; Kuftabuchi, Takahiro; Hato, Kazuhito] Panasonic Corp, Adv Res Div, Energy Res Lab, Moriguchi, Osaka 5708501, Japan; [Kouzaki, Takashi] Panasonic Corp, Adv Res Div, Mat Res Lab, Moriguchi, Osaka 5708501, Japan	Hato, K (reprint author), Panasonic Corp, Adv Res Div, Energy Res Lab, 3-1-1 Yagumo Naka Machi, Moriguchi, Osaka 5708501, Japan.	hatoh.kazuhito@jp.panasonic.com			 [P-Hf-16]	This paper is the revised version based on the proceeding at Grand Renewable Energy 2014 International Conference and Exhibition (program number: P-Hf-16).	Osterloh FE, 2008, CHEM MATER, V20, P35, DOI 10.1021/cm7024203; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Abe R, 2010, J AM CHEM SOC, V132, P11828, DOI 10.1021/ja1016552; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Chen SY, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3664346; Hara M, 2003, CATAL TODAY, V78, P555, DOI 10.1016/S0920-5861(02)00354-1; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Chun WJ, 2003, J PHYS CHEM B, V107, P1798, DOI 10.1021/jp027593f; Higashi M, 2012, J AM CHEM SOC, V134, P6968, DOI 10.1021/ja302059g; Abe R, 2005, CHEM LETT, V34, P1162, DOI 10.1246/cl.2005.1162; Domen K, 2000, B CHEM SOC JPN, V73, P1307, DOI 10.1246/bcsj.73.1307; Hitoki G, 2002, CHEM COMMUN, P1698, DOI 10.1039/b202393h; Kato K, 2008, VACUUM, V83, P592, DOI 10.1016/j.vacuum.2008.04.045; Weishaupt V. M., 1977, Z ANORG ALLG CHEM, V429, P261	14	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	SEP	2015	83	9					711	714		10.5796/electrochemistry.83.711		4	Electrochemistry	Electrochemistry	CR4YD	WOS:000361345100007		
J	Matsuo, K; Takatsuji, Y; Kohno, M; Kamachi, T; Nakada, H; Haruyama, T				Matsuo, Keishi; Takatsuji, Yoshiyuki; Kohno, Masahiro; Kamachi, Toshiaki; Nakada, Hideo; Haruyama, Tetsuya			Dispersed-phase Interfaces between Mist Water Particles and Oxygen Plasma Efficiently Produce Singlet Oxygen (O-1(2)) and Hydroxyl Radical (center dot OH)	ELECTROCHEMISTRY			English	Article						Reactive Oxygen; Spin Trapping ESR; Ozone; Chemical Process	REEVALUATION	Efficient generation of oxygen radicals and reactive oxygen was successfully performed at the dispersed-phasic interface between vapor-water and oxygen plasma in a reaction chamber having an internal atmosphere with a normal-pressure and temperature. In the space of the reactor chamber (radical vapor reactor [RVR]), the gas phase was strictly controlled in terms of vaporized water (small water mist), temperature, plasma conditions, and UV irradiation. According to spin-trapping electron spin resonance analysis, the RVR efficiently and quantitatively yielded two types of reactive oxygen species (O-1(2) and OH radical) with the atmosphere of the RVR chamber. This is the report of the efficient, quantitative production of reactive oxygen in an atmosphere. The reactivity of the produced O-1(2) and OH radical may be applicable for various chemical processes, such as oxidation and electron absorption. (C) The Electrochemical Society of Japan, All rights reserved.	[Matsuo, Keishi; Takatsuji, Yoshiyuki; Haruyama, Tetsuya] Kyushu Inst Technol, Dept Biol Funct & Engn, Div Funct Interface Engn, Fukuoka 8080196, Japan; [Haruyama, Tetsuya] Res Ctr Ecofitting Technol, Fukuoka 8080196, Japan; [Takatsuji, Yoshiyuki; Haruyama, Tetsuya] Japan Sci & Technol Agcy JST, Adv Catalyt Transformat Program Carbon Utilizat A, Tokyo 1020076, Japan; [Kohno, Masahiro; Kamachi, Toshiaki] Tokyo Inst Technol, Dept Bioengn, Meguro Ku, Tokyo 1528550, Japan; [Nakada, Hideo] Ebara Jitsugyo Co Ltd, Chuo Ku, Tokyo 1048174, Japan	Haruyama, T (reprint author), Kyushu Inst Technol, Dept Biol Funct & Engn, Div Funct Interface Engn, Kitakyushu Sci & Res Pk, Fukuoka 8080196, Japan.	haruyama@life.kyutech.ac.jp					Anglada JM, 2010, J CHEM THEORY COMPUT, V6, P2743, DOI 10.1021/ct100358e; KERN W, 1990, J ELECTROCHEM SOC, V137, P1887, DOI 10.1149/1.2086825; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; VIG JR, 1985, J VAC SCI TECHNOL A, V3, P1027, DOI 10.1116/1.573115; Tasaki T, 2009, J HAZARD MATER, V162, P1103, DOI 10.1016/j.jhazmat.2008.05.162; Nakamura K, 2011, J CLIN BIOCHEM NUTR, V49, P87, DOI 10.3164/jcbn.10-125; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Nakamura K, 2010, B CHEM SOC JPN, V83, P1037, DOI 10.1246/bcsj.20100078; Cerkovnik J, 2002, J AM CHEM SOC, V124, P404, DOI 10.1021/ja017320l; Madden KP, 2001, FREE RADICAL BIO MED, V30, P1374, DOI 10.1016/S0891-5849(01)00540-8	10	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	SEP	2015	83	9					721	724		10.5796/electrochemistry.83.721		4	Electrochemistry	Electrochemistry	CR4YD	WOS:000361345100009		
J	Teramoto, K; Nishide, T; Ikeda, Y				Teramoto, Kazunori; Nishide, Toshikazu; Ikeda, Yasuhisa			Studies on Metal Complexes as Active Materials in Redox-flow Battery Using Ionic Liquids as Electrolyte: Cyclic Voltammetry of Betainium Bis(Trifluoromethylsulfonyl)Imide Solution Dissolving Na[Fe-III(edta)(H2O)] as an Anode Active Material	ELECTROCHEMISTRY			English	Article						Redox-flow Battery; Ionic Liquid; Iron(III) Complex; Cyclic Voltammetry	ELECTROCHEMICAL-BEHAVIOR; IRON COMPLEXES; EQUILIBRIA; SOLVENTS; LIGANDS; FUTURE; OXIDES; EDTA	As a part of studies for finding metal complexes as an active material in the redox-flow battery system using ionic liquids (ILs) as an electrolyte, we have measured cyclic voltammograms (CVs) of betainium bis(trifluoromethylsulfonyl)imide ([Hbet][Tf2N]) (H2O content: 11 wt%) dissolving Na[Fe-III(edta)(H2O)] (edta = ethylenediamine-N,N,N',N'-tetraacetate). Two peaks corresponding to one redox couple were observed around 50 and 220 mV vs. Ag/AgCl and assigned as a quasi-reversible redox reaction based on electrochemical data. Furthermore, the CVs were found to be cycled stably. From these results, the Na[Fe-III(edta)(H2O)] is expected to be used as anode active material for the redox-flow batteries using [Hbet][Tf2N] containing 11 wt% H2O as the electrolyte. (C) The Electrochemical Society of Japan, All rights reserved.	[Teramoto, Kazunori; Nishide, Toshikazu] Nihon Univ, Dept Chem Biol & Appl Chem, Coll Engn, Koriyama, Fukushima 9638642, Japan; [Ikeda, Yasuhisa] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan	Ikeda, Y (reprint author), Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, 2-12-1-N1-34 Ookayama, Tokyo 1528550, Japan.	yikeda@nr.titech.ac.jp					Yamamura T, 2005, J ELECTROCHEM SOC, V152, pA830, DOI 10.1149/1.1870794; Barrosse-Antle LE, 2010, CHEM-ASIAN J, V5, P202, DOI 10.1002/asia.200900191; Shimizu K, 2007, J ELECTROANAL CHEM, V603, P44, DOI 10.1016/j.jelechem.2007.01.027; Szilagyi PA, 2008, THERMOCHIM ACTA, V479, P53, DOI 10.1016/j.tca.2008.09.009; Teramoto K, 2014, ELECTROCHEMISTRY, V82, P566, DOI 10.5796/electrochemistry.82.566; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Earle MJ, 2000, PURE APPL CHEM, V72, P1391, DOI 10.1351/pac200072071391; Nockemann P, 2006, J PHYS CHEM B, V110, P20978, DOI 10.1021/jp0642995; Nockemann P, 2008, INORG CHEM, V47, P9987, DOI 10.1021/ic801213z; LEVER ABP, 1990, INORG CHEM, V29, P1271, DOI 10.1021/ic00331a030; Skyllas-Kazacos M, 2010, INT J ENERG RES, V34, P182, DOI 10.1002/er.1658; Chakrabarti M. H., 2007, ELECTROCHIM ACTA, V52, P2189; de Leon C. Ponce, 2006, J POWER SOURCES, V160, P716, DOI DOI 10.1016/J.JPOWSOUR.2006.02.095; Gomathi H, 2000, B ELECTROCHEM, V16, P459; GONZALEZ I, 1990, ELECTROCHIM ACTA, V35, P1325, DOI 10.1016/0013-4686(90)85002-5; Hamot P., 2008, CHEM REV, V108, P2238; Kobayashi H., 1990, CHEM SOC JAPAN, V2, P163; Kokorin A., 2011, IONIC LIQUIDS APPL P; MAYER U, 1979, J ELECTROANAL CHEM, V103, P409, DOI 10.1016/S0022-0728(79)80364-2; MIZUTA T, 1990, INORG CHIM ACTA, V175, P121, DOI 10.1016/S0020-1693(00)83206-5; MIZUTA T, 1993, B CHEM SOC JPN, V66, P2547, DOI 10.1246/bcsj.66.2547; MIZUTA T, 1995, INORG CHIM ACTA, V230, P119, DOI 10.1016/0020-1693(94)04311-I; Ohno H, 2005, ELECTROCHEMICAL ASPECTS OF IONIC LIQUIDS, P1, DOI 10.1002/0471762512; Rogers R. D., 2002, ASC S SERIES, V818; SCHWARZENBACH G, 1951, HELV CHIM ACTA, V34, P1492, DOI 10.1002/hlca.19510340533; SKOCHDOPOLE R, 1959, J INORG NUCL CHEM, V11, P222, DOI 10.1016/0022-1902(59)80248-7; Takahashi A, 1997, CAN J CHEM, V75, P1084, DOI 10.1139/v97-128; Wasserscheid P., 2008, IONIC LIQUIDS SYNTHE; Yamagata M, 2007, ELECTROCHIM ACTA, V52, P3317, DOI 10.1016/j.electacta.2006.10.008; Zanello P., 2003, INORGANIC ELECTROCHE	30	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	SEP	2015	83	9					730	732		10.5796/electrochemistry.83.730		3	Electrochemistry	Electrochemistry	CR4YD	WOS:000361345100011		
J	Hirayama, A; Sugimoto, M; Suzuki, A; Hatakeyama, Y; Enomoto, A; Harada, S; Soga, T; Tomita, M; Takebayashi, T				Hirayama, Akiyoshi; Sugimoto, Masahiro; Suzuki, Asako; Hatakeyama, Yoko; Enomoto, Ayame; Harada, Sei; Soga, Tomoyoshi; Tomita, Masaru; Takebayashi, Toru			Effects of processing and storage conditions on charged metabolomic profiles in blood	ELECTROPHORESIS			English	Article						Capillary electrophoresis-mass spectrometry; Metabolomics; Plasma; Serum	ELECTROPHORESIS-MASS SPECTROMETRY; PLASMA; SERUM; CHROMATOGRAPHY; PLATFORM	The development of high-throughput metabolite measurement technologies has enabled the use of metabolomics for epidemiologic studies by profiling metabolite concentrations in large cohorts of human blood samples. Standard protocols are necessary to obtain unbiased profiles through multiple runs over long periods of time and to allow reliable statistical analyses. This study assessed the effects of sampling procedures and storage conditions on the stability of metabolomic profiles in plasma and serum. Charged metabolomic profiles were determined by capillary electrophoresis-mass spectrometry (CE-MS) and compared by multivariate analyses. The effects of pre-analytical procedures, including times for clotting and incubation of serum and plasma, respectively; incubation temperatures; and number of freeze-thaw cycles, were assessed. Overall, inter-individual differences in profiles were larger than intra-individual differences, and profiles in plasma showed better stability than those in serum. These quantified datasets of metabolites, along with their stability and variation, may help in interpreting data from long-term cohort studies.	[Hirayama, Akiyoshi; Sugimoto, Masahiro; Suzuki, Asako; Hatakeyama, Yoko; Enomoto, Ayame; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Harada, Sei; Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo, Japan	Sugimoto, M (reprint author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan.	msugi@sfc.keio.ac.jp			Yamagata prefecture; Tsuruoka City; Japan Society for the Promotion of Science [24390168]	The authors would like to thank the study participants and the members of the Tsuruoka metabolomics cohort study team. This work was supported by grants from Yamagata prefecture and Tsuruoka City, and a Grant-in-Aid for Scientific Research (grant number 24390168) from the Japan Society for the Promotion of Science.	Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; David A, 2014, J CHROMATOGR A, V1365, P72, DOI 10.1016/j.chroma.2014.09.001; Yin PY, 2013, CLIN CHEM, V59, P833, DOI 10.1373/clinchem.2012.199257; Sugimoto M, 2012, CURR BIOINFORM, V7, P96; Robledo VR, 2014, ELECTROPHORESIS, V35, P2292, DOI 10.1002/elps.201300561; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Kamlage B, 2014, CLIN CHEM, V60, P399, DOI 10.1373/clinchem.2013.211979; Barri T, 2013, ANAL CHIM ACTA, V768, P118, DOI 10.1016/j.aca.2013.01.015; Chalcraft KR, 2009, ANAL CHEM, V81, P2506, DOI 10.1021/ac802272u; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; D'Agostino LA, 2011, J PROTEOME RES, V10, P592, DOI 10.1021/pr100771g; Wedge DC, 2011, ANAL CHEM, V83, P6689, DOI 10.1021/ac2012224; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Sukumaran DK, 2009, MAGN RESON CHEM, V47, pS81, DOI 10.1002/mrc.2469; Breier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089728; Kuehnbaum NL, 2013, ANAL CHEM, V85, P10664, DOI 10.1021/ac403171u; Lindenburg PW, 2014, ELECTROPHORESIS, V35, P1308, DOI 10.1002/elps.201300357; Liu LS, 2010, ANAL BIOCHEM, V406, P105, DOI 10.1016/j.ab.2010.07.015; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	SEP	2015	36	18					2148	2155		10.1002/elps.201400600		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CR2UK	WOS:000361185900003		
J	Hiyama, K; Glicksman, L				Hiyama, Kyosuke; Glicksman, Leon			Preliminary design method for naturally ventilated buildings using target air change rate and natural ventilation potential maps in the United States	ENERGY			English	Article						Natural ventilation; Air change rate; Adaptive comfort model; Mixed-mode; Map; Preliminary evaluation	RESIDENTIAL BUILDINGS; THERMAL COMFORT; ENERGY; OPTIMIZATION; PERFORMANCE	Natural ventilation design is one of the most effective strategies for designing green buildings. The cost-effectiveness of this strategy should be considered to balance its benefits with its higher initial costs. In addition, it is becoming increasingly important to discuss the potential energy savings. For this purpose, quantitative evaluations are valued during the early stages of building planning and design because a building's shape can have large impacts on the performance of natural ventilation. However, few studies have fully examined the criteria for this type of evaluation. In this paper, a target air change rate is proposed as a desired criterion. The target air change rate is defined as the point where the gradient of the increase in the cooling effect from natural ventilation reaches a maximum. Above this point the rate of improvement in building comfort is more modest. In addition, this paper provides maps of indices for the United States. The maps help architects obtain a clear understanding of their design directions, e.g., a carefully designed natural ventilation strategy is highly recommended for building projects in warm-dry climates, where the internal gains are moderate, and for building projects in cold climates, where the internal gains are very high. (C) 2015 Elsevier Ltd. All rights reserved.	[Hiyama, Kyosuke] Yamaguchi Univ, Fac Engn, Ube, Yamaguchi 7558611, Japan; [Glicksman, Leon] MIT, Dept Architecture, Cambridge, MA 02139 USA	Hiyama, K (reprint author), 4-2-201 Gojumeyama Cho, Ube, Yamaguchi 7550005, Japan.	hiyama@yamaguchi-u.ac.jp; glicks@mit.edu			JSPS KAKENHI [25709051]	This work was supported by JSPS KAKENHI Grant Number 25709051.	AIA, 2012, ARCH GUID INT EN MOD, P8; Allard F, 1998, NATURAL VENTILATION; Hu JJ, 2014, BUILD ENVIRON, V71, P233, DOI 10.1016/j.buildenv.2013.09.005; Sartori I, 2012, ENERG BUILDINGS, V48, P220, DOI 10.1016/j.enbuild.2012.01.032; Crawley DB, 2001, ENERG BUILDINGS, V33, P319, DOI 10.1016/S0378-7788(00)00114-6; Allocca C, 2003, ENERG BUILDINGS, V35, P785, DOI 10.1016/S0378-7788(02)00239-6; de Dear RJ, 2002, ENERG BUILDINGS, V34, P549, DOI 10.1016/S0378-7788(02)00005-1; Hamdy M, 2013, ENERG BUILDINGS, V56, P189, DOI 10.1016/j.enbuild.2012.08.023; Marszal AJ, 2011, ENERG BUILDINGS, V43, P971, DOI 10.1016/j.enbuild.2010.12.022; Roetzel A, 2014, BUILD ENVIRON, V71, P165, DOI 10.1016/j.buildenv.2013.10.001; Zhou CB, 2014, ENERG BUILDINGS, V82, P457, DOI 10.1016/j.enbuild.2014.06.036; ASHRAE, 2009, ASHRAE HDB FUND; ASHRAE, 2010, NORM APP B BUILD ENV, P134; Axley JW, 2001, GCR01820 NAT I STAND; Center for the Built Environment University of California Berkeley, AB MIX MOD; Emmerich SJ, 2011, ENERG BUILDINGS, V43, P2101, DOI 10.1016/j.enbuild.2011.04.016; Grinberg M., 2013, 13 C INT BUILD PERF, P121; Hiyama K, 2014, AS 2014 NAG JAP, P107; Hiyama K, 2014, ENERG BUILDINGS, V73, P83, DOI 10.1016/j.enbuild.2014.01.025; Holford JM, 2003, BUILD ENVIRON, V38, P409, DOI 10.1016/S0360-1323(02)00019-7; Menchaca- B M-A, 2008, SIMBUILD 2008 3 NAT, P132; Oropeza-Perez I, 2014, ENERGY, V64, P1080, DOI 10.1016/j.energy.2013.11.009; Oropeza-Perez I, 2014, APPL ENERG, V130, P20, DOI 10.1016/j.apenergy.2014.05.035; Oropeza-Perez I, 2014, APPL ENERG, V114, P520, DOI 10.1016/j.apenergy.2013.10.008; Rupp RF, 2014, RENEW SUST ENERG REV, V29, P449, DOI 10.1016/j.rser.2013.08.102; Turner WJN, 2013, BUILD ENVIRON, V70, P20, DOI 10.1016/j.buildenv.2013.08.004; Wang LP, 2007, ENERG BUILDINGS, V39, P954, DOI 10.1016/j.enbuild.2006.10.011	27	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-5442	1873-6785		ENERGY	Energy	SEP	2015	89						655	666		10.1016/j.energy.2015.06.026		12	Thermodynamics; Energy & Fuels	Thermodynamics; Energy & Fuels	CR3SD	WOS:000361252500060		
J	Wada, K; Miyashin, M				Wada, K.; Miyashin, M.			New techniques for producing aesthetic, direct full-crown composite resin restorations for primary molars: a 24-month follow-up study of eight cases	EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY			English	Article						Aesthetic restorations; Clear matrix; Composite resin; Direct full-crown; Primary molar; Resin bloc	CLINICAL-PERFORMANCE	Aim Although the demand for aesthetic restoration of primary molars has increased, techniques for producing aesthetic, direct full-crown restorations using light-cured composite resin for primary molars and the associated clinical outcome are not well established. The aim of this study was to describe the use of new techniques to produce aesthetic, direct full-crown restorations using light-cured composite resin for primary molars. The authors evaluate the clinical outcomes of the restoration method and investigate whether this technique could be used as an alternative to conventional methods. Materials and Methods Two new techniques, the resin block and the clear matrix, were studied by treating 8 teeth. The occlusal surface of stainless steel crowns Was used for impression-taking to facilitate accurate reproduction of the anatomic structure, and the aesthetic restoration was obtained simply and consistently. Results At the 24-month follow-up evaluation, these new direct techniques were completely satisfactory Marginal discoloration was observed in one tooth treated with the clear matrix technique, and a small partial wear was observed in another tooth treated with the resin block. Conclusion The new techniques for restoration resulted in functional and aesthetic reproduction of occlusal morphology Therefore, these techniques could be considered a practical alternative to conventional methods.	[Wada, K.; Miyashin, M.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Pediat Dent, Tokyo, Japan	Wada, K (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Pediat Dent, Tokyo, Japan.	wadadohs@tmd.ac.jp					Hickel R, 2005, AM J DENT, V18, P198; Baratieri L N, 1996, Quintessence Int, V27, P733; Castro J J, 1997, J Esthet Dent, V9, P311, DOI 10.1111/j.1708-8240.1997.tb00958.x; Cehreli ZC, 2006, AM J DENT, V19, P262; CHECCHIO LM, 1983, J DENT CHILD, V50, P205; Conte Gabriele, 2008, Dent Today, V27, P126; Croll T P, 1999, Compend Contin Educ Dent, V20, P89; Fuks A B, 1999, Pediatr Dent, V21, P445; Goracci G, 1999, Compend Contin Educ Dent, V20, P643; Guelmann M, 2005, PEDIATR DENT, V27, P24; Liebenberg W H, 1996, Quintessence Int, V27, P81; Martos Josu, 2010, Indian J Dent Res, V21, P596, DOI 10.4103/0970-9290.74231; Puppin-Rontani RM, 2006, AM J DENT, V19, P255; Rabêlo Rita Tereza Serra, 2005, J Clin Pediatr Dent, V29, P277; Ram Diana, 2003, Pediatr Dent, V25, P582; Villalta Patricia, 2006, J Clin Pediatr Dent, V31, P17; Wada K, 2011, AM J DENT, V24, P67	17	0	0	ARIESDUE SRL	CARIMATE	VIA AIROLDI, CARIMATE, 11-22060, ITALY	1591-996X	2035-648X		EUR J PAEDIATR DENT	Eur. J. Paediatr. Dent.	SEP	2015	16	3					205	209				5	Dentistry, Oral Surgery & Medicine; Pediatrics	Dentistry, Oral Surgery & Medicine; Pediatrics	CR3ZZ	WOS:000361272900011		
J	Nakagawa, S; Marubayashi, H; Nojima, S				Nakagawa, Shintaro; Marubayashi, Hironori; Nojima, Shuichi			Crystallization of polymer chains confined in nanodomains	EUROPEAN POLYMER JOURNAL			English	Article						Confined crystallization; Microdomain structure; Space confinement; Chain confinement	SEMICRYSTALLINE BLOCK-COPOLYMERS; AMORPHOUS DIBLOCK COPOLYMER; ATOMIC-FORCE MICROSCOPY; CRYSTAL ORIENTATION; POLY(EPSILON-CAPROLACTONE)-BLOCK-POLYETHYLENE COPOLYMERS; ISOTHERMAL CRYSTALLIZATION; SURFACE CRYSTALLIZATION; POLY(ETHYLENE OXIDE); LAMELLAR MORPHOLOGY; POLY(BETA-PROPIOLACTONE)-BLOCK-POLYETHYLENE COPOLYMERS	Recent experimental studies are extensively reviewed on the crystallization of polymer chains spatially confined in small domains with their dimension on the order of 10 nm (nanodomains), with a particular emphasis on unique features of crystallization behavior and crystal orientation of confined chains. The nanodomains employed here (such as nanospheres, nanocylinders, or nanolamellae) are mainly provided by the microphase separation of diblock copolymers, and therefore we introduce the crystallization of block chains (i.e., polymer chains with one of chain-ends always tethered at nanodomain interfaces). The crystallization of confined blocks is very complicated and hence interesting as compared with that of bulk homopolymers, because it depends significantly on the shape, size, and hardness of nanodomains as well as the crystalline nature of block chains. Furthermore, we discuss a substantial difference in the crystallization behavior and crystal orientation between block chains and homopolymers (i.e., polymer chains with both chain-ends free) spatially confined in identical nanodomains. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakagawa, Shintaro; Marubayashi, Hironori; Nojima, Shuichi] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan	Nojima, S (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Meguro Ku, H-125,2-12-1 Ookayama, Tokyo 1528552, Japan.	snojima@polymer.titech.ac.jp	Nojima, Shuichi/D-4245-2015				Wu H, 2012, SOFT MATTER, V8, P3180, DOI 10.1039/c2sm06896f; Gondo S, 2013, POLYMER, V54, P6768, DOI 10.1016/j.polymer.2013.10.021; Castillo RV, 2009, PROG POLYM SCI, V34, P516, DOI 10.1016/j.progpolymsci.2009.03.002; Loo YL, 2000, PHYS REV LETT, V84, P4120, DOI 10.1103/PhysRevLett.84.4120; Sun JR, 2006, MACROMOLECULES, V39, P3717, DOI 10.1021/ma0603074; Suzuki Y, 2013, SOFT MATTER, V9, P9189, DOI 10.1039/c3sm50907a; Nakagawa S, 2013, MACROMOLECULES, V46, P2199, DOI 10.1021/ma400071f; Takeshita H, 2013, POLYMER, V54, P4776, DOI 10.1016/j.polymer.2013.06.031; Hamley IW, 2006, MACROMOL CHEM PHYS, V207, P941, DOI 10.1002/macp.200600085; He WN, 2012, PROG POLYM SCI, V37, P1350, DOI 10.1016/j.progpolymsci.2012.05.002; Jukes PC, 2005, MACROMOLECULES, V38, P2315, DOI 10.1021/ma0490606; Zhang Q, 2005, CURR ORG CHEM, V9, P1053, DOI 10.2174/1385272054368466; Takeshita H, 2006, POLYMER, V47, P8210, DOI 10.1016/j.polymer.2006.09.043; Lin MC, 2011, J PHYS CHEM B, V115, P2494, DOI 10.1021/jp1103565; Sun L, 2004, POLYMER, V45, P8181, DOI 10.1016/j.polymer.2004.09.063; Michell RM, 2013, POLYMER, V54, P4059, DOI 10.1016/j.polymer.2013.05.029; Sun YS, 2007, MACROMOLECULES, V40, P6778, DOI 10.1021/ma0709708; Nojima S, 2009, MACROMOLECULES, V42, P9515, DOI 10.1021/ma901964a; Li S, 2011, MACROMOLECULES, V44, P8835, DOI 10.1021/ma201951j; Shin K, 2007, MACROMOLECULES, V40, P6617, DOI 10.1021/ma070994e; Jiang Q, 2014, CHEM SOC REV, V43, P2066, DOI 10.1039/c3cs60234f; Zhu L, 2001, MACROMOLECULES, V34, P1244, DOI 10.1021/ma001882p; Chiang YW, 2014, J PHYS CHEM C, V118, P19402, DOI 10.1021/jp504976s; Huber P, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/10/103102; Nakagawa S, 2014, POLYMER, V55, P4394, DOI 10.1016/j.polymer.2014.06.049; Maiz J, 2012, LANGMUIR, V28, P12296, DOI 10.1021/la302675k; Huang CL, 2013, J PHYS CHEM B, V117, P10665, DOI 10.1021/jp4059966; Nojima S, 2008, MACROMOLECULES, V41, P1915, DOI 10.1021/ma7027903; Huang P, 2001, MACROMOLECULES, V34, P6649, DOI 10.1021/ma010671x; Loo YL, 2002, MACROMOLECULES, V35, P2365, DOI 10.1021/ma011824j; Lin MC, 2012, SOFT MATTER, V8, P7306, DOI 10.1039/c2sm25583a; Nojima S, 2002, POLYMER, V43, P4087, DOI 10.1016/S0032-3861(02)00217-3; Nojima S, 2010, MACROMOLECULES, V43, P3916, DOI 10.1021/ma100236u; Bertoldo M, 2010, POLYMER, V51, P3660, DOI 10.1016/j.polymer.2010.05.040; Chen LL, 2015, MACROMOLECULES, V48, P1804, DOI 10.1021/ma5025945; Steinhart M, 2008, ADV POLYM SCI, V220, P123, DOI 10.1007/12_2008_142; Huang P, 2006, POLYMER, V47, P5457, DOI 10.1016/j.polymer.2005.06.129; Cai T, 2009, MACROMOLECULES, V42, P3381, DOI 10.1021/ma900069m; Kim JK, 2010, PROG POLYM SCI, V35, P1325, DOI 10.1016/j.progpolymsci.2010.06.002; Chung TM, 2010, MACROMOLECULES, V43, P6237, DOI 10.1021/ma100998k; Huang SY, 2014, RSC ADV, V4, P24566, DOI 10.1039/c4ra03043e; Wang XH, 2014, MACROMOLECULES, V47, P668, DOI 10.1021/ma4012208; Su YL, 2014, ACCOUNTS CHEM RES, V47, P192, DOI 10.1021/ar400116c; Carr JM, 2012, J MATER RES, V27, P1326, DOI 10.1557/jmr.2012.17; He CL, 2006, BIOMACROMOLECULES, V7, P252, DOI 10.1021/bm050627f; Vasilev C, 2006, POLYMER, V47, P330, DOI 10.1016/j.polymer.2005.11.040; Muller AJ, 2005, ADV POLYM SCI, V190, P1, DOI 10.1007/12_001; Zhao H, 2012, MACROMOLECULES, V45, P1723, DOI 10.1021/ma201924h; Martin-Fabiani I, 2013, ACS APPL MATER INTER, V5, P5324, DOI 10.1021/am401194p; Shiomi T, 2001, POLYMER, V42, P4997, DOI 10.1016/S0032-3861(00)00894-6; Chen HL, 2002, MACROMOLECULES, V35, P2417, DOI 10.1021/ma011748k; Wu H, 2007, MACROMOLECULES, V40, P4244, DOI 10.1021/ma070564o; Lin MC, 2012, MACROMOLECULES, V45, P5114, DOI 10.1021/ma300711k; Castillo RV, 2008, MACROMOLECULES, V41, P6154, DOI 10.1021/ma800859y; Nakagawa S, 2012, MACROMOLECULES, V45, P1892, DOI 10.1021/ma202566f; Asada M, 2014, SOFT MATTER, V10, P6392, DOI 10.1039/c4sm00683f; Carvalho JL, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.237801; Carvalho JL, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11006-y; Liu YX, 2010, COORDIN CHEM REV, V254, P1011, DOI 10.1016/j.ccr.2010.02.017; De Cupere VM, 2002, POLYMER, V43, P5571, DOI 10.1016/S0032-3861(02)00394-4; Du ZX, 2007, J APPL POLYM SCI, V104, P2986, DOI 10.1002/app.25932; Gitsas A, 2010, MACROMOLECULES, V43, P2453, DOI 10.1021/ma902639g; Guan Y, 2013, ACS MACRO LETT, V2, P181, DOI 10.1021/mz300592v; Higa T, 2010, POLYMER, V51, P5576, DOI 10.1016/j.polymer.2010.09.039; Hijikawa R, 2014, POLYMER, V55, P6960, DOI 10.1016/j.polymer.2014.10.079; Ho RM, 2004, MACROMOLECULES, V37, P5985, DOI 10.1021/ma0492869; Huang L, 2012, POLYMER, V53, P5856, DOI 10.1016/j.polymer.2012.10.013; Ikeda H, 2008, POLYM J, V40, P241, DOI 10.1295/polymj.PJ2007150; Jiang SC, 2008, EUR PHYS J E, V27, P357, DOI 10.1140/epje/i2008-10385-4; Kalloudis M, 2013, LANGMUIR, V29, P2339, DOI 10.1021/la400041x; Kim YY, 2013, MACROMOLECULES, V46, P8235, DOI 10.1021/ma401440y; Li LB, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2405357; Lin MC, 2012, J PHYS CHEM B, V116, P12357, DOI 10.1021/jp306410j; Liu XB, 2013, CHINESE J POLYM SCI, V31, P946, DOI 10.1007/s10118-013-1285-9; Loo Y. L., 2004, DEV BLOCK COPOLYMER, DOI DOI 10.1002/0470093943.ch6; Maiz J, 2013, MACROMOLECULES, V46, P403, DOI 10.1021/ma3023876; Malek A, 2013, EUR POLYM J, V49, P2704, DOI 10.1016/j.eurpolymj.2013.05.031; Massa CA, 2014, EUR POLYM J, V60, P286, DOI 10.1016/j.eurpolymj.2014.08.012; Michell RM, 2014, J POLYM SCI POL PHYS, V52, P1179, DOI 10.1002/polb.23553; Michell RM, 2012, MACROMOLECULES, V45, P1517, DOI 10.1021/ma202327f; Muller A., 2007, PROGR UNDERSTANDING, V714, P229, DOI 10.1007/3-540-47307-6_13; Myers SB, 2010, MACROMOLECULES, V43, P393, DOI 10.1021/ma9019587; Nandan B, 2006, POLYM REV, V46, P143, DOI 10.1080/15321790600646802; Nojima S, 2007, POLYMER, V48, P3607, DOI 10.1016/j.polymer.2007.04.053; Nojima S, 2008, POLYM J, V40, P986, DOI 10.1295/polymj.PJ2008139; Nojima S, 2005, POLYMER, V46, P4060, DOI 10.1016/j.polymer.2005.02.075; Nojima S, 2004, POLYMER, V45, P7317, DOI 10.1016/j.polymer.2004.08.044; Sakurai T, 2008, POLYM J, V40, P971, DOI 10.1295/polymj.PJ2008092; Sakurai T, 2013, POLYM J, V45, P436, DOI 10.1038/pj.2012.164; Shinotsuka K, 2012, POLYMER, V53, P5554, DOI 10.1016/j.polymer.2012.09.048; Shiomi T, 2001, POLYMER, V42, P3233, DOI 10.1016/S0032-3861(00)00597-8; Steinhart M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.027801; Weiyu Cao, 2009, J Phys Chem B, V113, P2338, DOI 10.1021/jp8092435; Xue FF, 2012, POLYM INT, V61, P909, DOI 10.1002/pi.4158; Yang JL, 2006, J POLYM SCI POL PHYS, V44, P3215, DOI 10.1002/polb.20886; Yu SH, 2006, CURR NANOSCI, V2, P81, DOI 10.2174/157341306776875767; Yuryev Y, 2011, POLYMER, V52, P708, DOI 10.1016/j.polymer.2010.12.043; Zhang XY, 2014, RSC ADV, V4, P7900, DOI 10.1039/c3ra47499b	98	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0014-3057	1873-1945		EUR POLYM J	Eur. Polym. J.	SEP	2015	70						262	275		10.1016/j.eurpolymj.2015.07.018		14	Polymer Science	Polymer Science	CR5SH	WOS:000361403800026		
J	Katsuyama, H; Fushimi, S; Yamane, K; Watanabe, Y; Shimoya, K; Okuyama, T; Katsuyama, M; Saijoh, K; Tomita, M				Katsuyama, Hironobu; Fushimi, Shigeko; Yamane, Kunikazu; Watanabe, Yoko; Shimoya, Koichiro; Okuyama, Toshiko; Katsuyama, Midori; Saijoh, Kiyofumi; Tomita, Masafumi			Effect of vitamin K2 on the development of stress-induced osteopenia in a growing senescence-accelerated mouse prone 6 strain	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						senescence-accelerated mouse prone 6; water-immersion restraint stress; vitamin K2; bone histomorphometry; bone resorption; bone formation	IMMERSION RESTRAINT STRESS; WATER-IMMERSION; BONE LOSS; CONTROLLED-TRIALS; TRABECULAR BONE; MURINE MODEL; NITRIC-OXIDE; RATS; MICE; RECEPTOR	Vitamin K2 (VK2) has been used as a therapeutic agent for osteoporosis, since it has been suggested to be able to reduce the frequency of fractures by improving bone quality; however, bone turnover is strictly regulated by various cytokines and hormones. In the present study, the effect of menaquinone-4 (MK-4) on bone turnover was investigated using the senescence-accelerated mouse prone 6 (SAMP6) strain. Since water-immersion restraint stress (WRS) causes a significant decrease in bone mineral density (BMD), WRS was used as the bone resorption model in the SAMP6 strain. Six-week-old SAMP6 male mice were divided into the following three groups: Control, WRS and WRS + MK-4. WRS was performed for 6 h per day, 5 times a week, for 4 weeks. Following WRS, MK-4 (30 mg/kg) was injected subcutaneously 3 times a week for 4 weeks. No growth retardation was observed in the WRS groups as compared with the control group. In the WRS groups, the BMD was significantly lower than that in the control group. The levels of bone formation and resorption markers were increased in the WRS groups, indicating that WRS reduced the BMD by promoting high bone turnover. A bone histomorphometrical examination showed that the trabecular (Tb) bone mass in the secondary spongiosa at the distal femur was significantly reduced in the WRS mice, and this reduction was abrogated by MK-4 treatment. Specifically, the Tb bone reduction was caused by the activation of osteoclasts (Ocs), and Oc activity was suppressed by MK-4. The number of osteoblasts and the mineral apposition rate were significantly increased in the WRS and WRS + MK-4 mice, suggesting that WRS triggered a significantly higher mineral apposition rate. These results indicate that MK-4 can induce recovery from the bone mineral loss caused by WRS treatment. Further studies are required to clarify the association between bone quality and MK-4.	[Katsuyama, Hironobu; Fushimi, Shigeko; Yamane, Kunikazu] Kawasaki Med Univ, Dept Publ Hlth, Kurashiki, Okayama 7010192, Japan; [Fushimi, Shigeko] Okayama Univ, Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Okayama 7008525, Japan; [Watanabe, Yoko] Kawasaki Med Univ, Dept Nat Sci, Kurashiki, Okayama 7010192, Japan; [Shimoya, Koichiro] Kawasaki Med Univ, Dept Obstet & Gynecol, Kurashiki, Okayama 7010192, Japan; [Okuyama, Toshiko; Tomita, Masafumi] Kawasaki Med Univ, Dept Med Toxicol, Kurashiki, Okayama 7010192, Japan; [Katsuyama, Midori; Saijoh, Kiyofumi] Kanazawa Univ, Sch Med, Dept Hyg, Kanazawa, Ishikawa 9208640, Japan	Katsuyama, H (reprint author), Kawasaki Med Univ, Dept Publ Hlth, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	katsu@med.kawasaki-m.ac.jp			KAKENHI [22500684]	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI; grant no. 22500684). The authors would like to acknowledge Editage for their English editing service.	Katsuyama H, 2007, INT J MOL MED, V19, P279; Cockayne S, 2006, ARCH INTERN MED, V166, P1256, DOI 10.1001/archinte.166.12.1256; Koshihara Y, 2003, J ENDOCRINOL, V176, P339, DOI 10.1677/joe.0.1760339; Akiyama Y, 1999, JPN J PHARMACOL, V80, P67, DOI 10.1254/jjp.80.67; Ohta Y, 2012, J CLIN BIOCHEM NUTR, V51, P136, DOI 10.3164/jcbn.11-14; Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/jbmr.090217, 10.1359/JBMR.090217]; TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1; Knapen MHJ, 2013, OSTEOPOROSIS INT, V24, P2499, DOI 10.1007/s00198-013-2325-6; MATSUSHITA M, 1986, AM J PATHOL, V125, P276; Atkins GJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1358, DOI 10.1152/ajpcell.00216.2009; Azuma K, 2010, J ENDOCRINOL, V207, P257, DOI 10.1677/JOE-10-0208; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Duque G, 2005, AM J PHYSIOL-ENDOC M, V288, pE723, DOI 10.1152/ajpendo.00180.2004; Fu XY, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-12; Huang P, 2012, GENET MOL RES, V11, P4775, DOI 10.4238/2012.September.19.2; Ichikawa T, 2007, J MOL ENDOCRINOL, V39, P239, DOI 10.1677/JME-07-0048; Iwamoto J, 2009, YONSEI MED J, V50, P189, DOI 10.3349/ymj.2009.50.2.189; Iwamoto J, 2009, CLIN DRUG INVEST, V29, P471, DOI 10.2165/00044011-200929070-00005; Kawamori Y, 2010, BLOOD, V116, P5528, DOI 10.1182/blood-2010-04-279216; Koshihara Y, 1996, CALCIFIED TISSUE INT, V59, P466, DOI 10.1007/BF00369212; Landeira-Fernandez J, 2004, PHYSIOL BEHAV, V82, P827, DOI 10.1016/j.physbeh.2004.06.016; Magierowski M, 2013, J PHARMACOL EXP THER, V347, P717, DOI 10.1124/jpet.113.207233; Nur Azlina MF, 2013, EVID-BASED COMPL ALT, V2013; OHNISHI K, 1995, ACTA NEUROPATHOL, V90, P11; Ohsaki Y, 2010, J NUTR BIOCHEM, V21, P1120, DOI 10.1016/j.jnutbio.2009.09.011; Parfitt A. M, 1984, CALCIF TISSUE INT S, V36, pS37; Sakata T, 1999, J BONE MINER RES, V14, P1596, DOI 10.1359/jbmr.1999.14.9.1596; Sasaki H, 2010, J BONE MINER METAB, V28, P403, DOI 10.1007/s00774-009-0148-5; Szlachcic A, 2013, PEPTIDES, V49, P9, DOI 10.1016/j.peptides.2013.07.017; TAKAGI K, 1968, JPN J PHARMACOL, V18, P9, DOI 10.1254/jjp.18.9; Tomita M, 2010, INT J MOL MED, V25, P415, DOI 10.3892/ijmm_00000360; Washimi Y, 2010, J ENDOCRINOL INVEST, V33, P395, DOI 10.3275/6623	33	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2015	10	3					843	850		10.3892/etm.2015.2621		8	Medicine, Research & Experimental	Research & Experimental Medicine	CR2HR	WOS:000361148800001		
J	Aisu, N; Tanimura, S; Yamashita, Y; Yamashita, K; Maki, K; Yoshida, Y; Sasaki, T; Takeno, S; Hoshino, S				Aisu, Naoya; Tanimura, Shu; Yamashita, Yuichi; Yamashita, Kanefumi; Maki, Kenji; Yoshida, Yoichiro; Sasaki, Takamitsu; Takeno, Shinsuke; Hoshino, Seiichiro			Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						probiotics; surgical site infections; colorectal cancer surgery; terminal-restriction fragment length polymorphism; ImmuKnow	RANDOMIZED CONTROLLED-TRIAL; SYNBIOTIC TREATMENT; SURGERY; COMPLICATIONS; BACTERIA; REDUCE	The aim of the present study was to estimate the effect of the perioperative administration of probiotics in patients undergoing colorectal cancer (CRC) surgery. The study focused on a total of 156 consecutive surgeries carried out from among all the elective CRC surgeries performed between April 2009 and March 2013. The patients involved in surgeries undertaken between April 2009 and October 2011 were placed in the non-probiotic group (group A, 81 patients) and those involved in surgeries between November 2011 and March 2013 were placed in the probiotic group (group B, 75 patients). Postoperative infectious complications were recorded, and the immune responses and fecal microbiota were determined. A breakdown of infectious complications showed that 21 (13.5%) patients experienced superficial incisional surgical site infections (SSIs), of which 16 patients were from group A (19.8%), and five patients from group B (6.7%) (P=0.016). The ImmuKnow (R) adenosine triphosphate values peaked on the first postoperative day (POD) in both groups. In group A, the ImmuKnow value of the first POD was increased significantly compared with the preoperative value (P=0.022). In group B, the value of the first POD did not increase compared with the preoperative value (P=0.28). In conclusion, probiotic treatment can reduce superficial incisional SSIs in patients undergoing CRC surgery. Perioperative probiotic treatment can enhance immune responses and improve the intestinal microbial environment.	[Aisu, Naoya; Tanimura, Shu; Yamashita, Yuichi; Yamashita, Kanefumi; Maki, Kenji; Yoshida, Yoichiro; Sasaki, Takamitsu; Takeno, Shinsuke; Hoshino, Seiichiro] Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Fukuoka 8140180, Japan	Aisu, N (reprint author), Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Jonan Ku, Nanakuma 7-45-1, Fukuoka 8140180, Japan.	ice13man1978@yahoo.co.jp			Toa Pharmaceutical Co., Ltd. (Tokyo, Japan)	The study was partially supported by Toa Pharmaceutical Co., Ltd. (Tokyo, Japan).	Bartosch S, 2005, CLIN INFECT DIS, V40, P28, DOI 10.1086/426027; Matsuzaki T, 2000, IMMUNOL CELL BIOL, V78, P67, DOI 10.1046/j.1440-1711.2000.00887.x; Duc LH, 2004, APPL ENVIRON MICROB, V70, P2161, DOI 10.1128/AEM.70.4.2161-2171.2004; Kowalski RJ, 2006, TRANSPLANTATION, V82, P663, DOI 10.1097/01.tp.0000234837.02126.70; Sheeran P, 1997, BRIT J ANAESTH, V78, P201; Eguchi S, 2011, AM J SURG, V201, P498, DOI 10.1016/j.amjsurg.2010.02.013; Itani KMF, 2006, NEW ENGL J MED, V355, P2640, DOI 10.1056/NEJMoa054408; Sugawara G, 2006, ANN SURG, V244, P706, DOI 10.1097/01.sla.0000219039.20924.88; Serra-Aracil X, 2011, ARCH SURG-CHICAGO, V146, P606, DOI 10.1001/archsurg.2011.90; Sheih YH, 2001, J AM COLL NUTR, V20, P149; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Rafter J, 2004, NUTR RES REV, V17, P277, DOI 10.1079/NRR200484; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Zhang JW, 2012, AM J MED SCI, V343, P199, DOI 10.1097/MAJ.0b013e31823aace6; Willemsen LEM, 2003, GUT, V52, P1442, DOI 10.1136/gut.52.10.1442; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Nakamura T, 2013, SURGERY, V153, P576, DOI 10.1016/j.surg.2012.11.018; Young H, 2012, J AM COLL SURGEONS, V214, P852, DOI 10.1016/j.jamcollsurg.2012.01.041; Huang YF, 2014, J CLIN GASTROENTEROL, V48, P37, DOI 10.1097/MCG.0b013e31828f1c6e; Kanazawa H, 2005, LANGENBECK ARCH SURG, V390, P104, DOI 10.1007/s00423-004-0536-1; Kowalski R, 2003, CLIN TRANSPLANT, V17, P77, DOI 10.1034/j.1399-0012.2003.00013.x; Kusachi S, 2012, SURG INFECT, V13, P257, DOI 10.1089/sur.2011.007; Mitsuoka T., 2000, Bioscience and Microflora, V19, P15; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Takesue Y, 2006, NIHON GEKA KANSENSHO, V3, P471; Tanaka K, 2012, SURGERY, V152, P832, DOI 10.1016/j.surg.2012.02.021	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2015	10	3					966	972		10.3892/etm.2015.2640		7	Medicine, Research & Experimental	Research & Experimental Medicine	CR2HR	WOS:000361148800021		
J	Suzuki, Y; Shimizu, T; Ota, M; Hirata, R; Sato, K; Tamura, Y; Imanishi, A; Watanabe, M; Sakuraba, K				Suzuki, Yoshio; Shimizu, Tomomi; Ota, Makoto; Hirata, Ryuzo; Sato, Kenji; Tamura, Yoshifumi; Imanishi, Akio; Watanabe, Masayuki; Sakuraba, Keishoku			Different training status may alter the continuous blood glucose kinetics in self-paced endurance running	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						glucose; continuous glucose monitoring system; prolonged exercise; running	FUEL SELECTION; SKELETAL-MUSCLE; EXERCISE; METABOLISM; INTENSITY; RACE; MEN	The main purpose of the systemic energy metabolism is to provide a source of energy, mainly glucose, for the brain; therefore, blood glucose levels would be expected to correlate with exercise performance. The individual training status may also affect the blood glucose levels. The aim of the present study was to assess the association between blood glucose levels and running velocity during prolonged running in athletes with different training statuses. Two female college athletes, a triathlete and a tennis player, ran a course that was 247.4 m in circumference for 5 h while wearing a continuous glucose monitoring system. Blood was obtained at time-points of -1, 1, 3 and 5 h. The athletes had free access to food and fluids throughout the run. The athletes ran at almost the same pace without a sudden decrease in pace. The blood glucose levels increased and remained high in the triathlete, whereas the tennis player remained hypoglycemic throughout the run. Carbohydrate ingestion did not affect the blood glucose levels. The magnitude of hormonal changes, e.g. insulin, adrenaline and cortisol, was greater in the tennis player. The blood glucose concentration did not correlate with the running velocity or the carbohydrate ingestion; however, a discrepancy in blood glucose transition was observed between the triathlete and the tennis player, indicating a possible association between the adaptation to endurance exercise and the blood glucose kinetics during prolonged running.	[Suzuki, Yoshio; Sakuraba, Keishoku] Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai, Chiba 2701695, Japan; [Shimizu, Tomomi] Univ Yokohama, Fac Biomed Engn, Aoba Ku, Yokohama, Kanagawa 2258503, Japan; [Ota, Makoto] Daito Bunka Univ, Grad Sch Hlth & Sports Sci, Matsuyama, Saitama 3558501, Japan; [Hirata, Ryuzo] Jikei Univ, Katsushika Med Ctr, Tokyo 1258506, Japan; [Sato, Kenji] Kyoto Prefectural Univ, Div Appl Sci, Kyoto 6068522, Japan; [Tamura, Yoshifumi] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Tokyo 1138421, Japan; [Imanishi, Akio] Daito Bunka Univ, Fac Sports & Hlth Sci, Matsuyama, Saitama 3558501, Japan; [Watanabe, Masayuki] Tokyo Gakugei Univ, Tokyo 1840015, Japan	Suzuki, Y (reprint author), Juntendo Univ, Grad Sch Hlth & Sports Sci, 1-1 Hiraga Gakuendai, Inzai, Chiba 2701695, Japan.	yssuzuki@juntendo.ac.jp			Juntendo University [1508-048]	The authors would like to thank Mr. T. Kawana of Juntendo University Urayasu Hospital for his assistance in specimen collection. Part of this study was presented at the 67th Annual Meeting of the Japanese Society of Physical Fitness and Sports Medicine, September 14-16, 2012 in Gifu, Japan. The present study was funded by Juntendo University (grant no. 1508-048).	AMIEL SA, 1995, P NUTR SOC, V54, P151, DOI 10.1079/PNS19950044; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Iwai K, 2005, J AGR FOOD CHEM, V53, P6531, DOI 10.1021/jf050206p; COGGAN AR, 1990, J APPL PHYSIOL, V68, P990; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; HENRIKSSON J, 1995, P NUTR SOC, V54, P125, DOI 10.1079/PNS19950042; JANSSON E, 1987, J APPL PHYSIOL, V62, P999; Japanese Ministry of Education, FOOD COMP DAT; LINDHOLM A, 1995, P NUTR SOC, V54, P275, DOI 10.1079/PNS19950054; Newsholm E, 1994, KEEP RUNNING SCI TRA; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380; Sengoku Y, 2008, JPN J PHYS FIT SPORT, V57, P285; Sengoku Y, 2015, INT J SPORT PHYSIOL, V10, P124, DOI 10.1123/ijspp.2013-0493	15	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2015	10	3					978	982		10.3892/etm.2015.2587		5	Medicine, Research & Experimental	Research & Experimental Medicine	CR2HR	WOS:000361148800023		
J	Akashi, K				Akashi, Koichi			TIM-3 AND ITS LIGAND, GALECTIN-9 CONSTITUTE AN AUTOCRINE LOOP TO MAINTAIN STEM CELLS IN MOST HUMAN MYELOID MALIGNANCIES	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Akashi, Koichi] Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 812, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		1010	S29	S29				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400011		
J	Alam, MM; Kariya, R; Matsuda, K; Okada, S				Alam, Md Masud; Kariya, Ryusho; Matsuda, Kouki; Okada, Seiji			CHLOROQUINE INHIBITS AUTOPHAGY AND INDUCES THE APOPTOSIS OF PRIMARY EFFUSION LYMPHOMA VIA ER STRESS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Alam, Md Masud; Kariya, Ryusho; Matsuda, Kouki; Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3142	S86	S86				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400199		
J	Bueno, C; Sardina, JL; Romero-Moya, D; Munoz-Lopez, A; Di Stefano, B; Quintana-Bustamante, O; Segovia, JC; Nakanishi, M; Graf, T; Menendez, P				Bueno, Clara; Luis Sardina, Jose; Romero-Moya, Damia; Munoz-Lopez, Alvaro; Di Stefano, Bruno; Quintana-Bustamante, Oscar; Carlos Segovia, Jose; Nakanishi, Mahito; Graf, Thomas; Menendez, Pablo			REPROGRAMMING PRIMARY HUMAN MATURE B-CELLS INTO INDUCED PLURIPOTENT STEM CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Bueno, Clara; Romero-Moya, Damia; Munoz-Lopez, Alvaro; Menendez, Pablo] Josep Carreras Leukemia Res Inst, Barcelona, Spain; [Luis Sardina, Jose; Di Stefano, Bruno; Graf, Thomas] Ctr Genom Regulat, Barcelona, Spain; [Quintana-Bustamante, Oscar; Carlos Segovia, Jose] CIEMAT, Madrid, Spain; [Nakanishi, Mahito] Res Ctr Stem Cell Engn, Tsukuba, Ibaraki, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3116	S80	S80				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400173		
J	Chamnanchanunt, S; Okada, K; Desakorn, V; Koga, M; Nakamura, Y; Shiotsu, H; Fucharoen, S; Umemura, T				Chamnanchanunt, Supat; Okada, Kazuhiro; Desakorn, Varunee; Koga, Misaki; Nakamura, Yuuri; Shiotsu, Hiromichi; Fucharoen, Suthat; Umemura, Tsukuru			DOWN-REGULATED MICRORNAS IN PLASMA AND RED BLOOD CELLS OF PATIENTS WITH MALARIA INFECTION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Okada, Kazuhiro; Koga, Misaki; Nakamura, Yuuri; Shiotsu, Hiromichi; Umemura, Tsukuru] Kyushu Univ, Fukuoka 812, Japan; [Umemura, Tsukuru] Int Univ Hlth & Sci, Ohkawa, Japan; [Chamnanchanunt, Supat; Desakorn, Varunee; Fucharoen, Suthat] Mahidol Univ, Bangkok 10700, Thailand								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3022	S56	S56				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400079		
J	Chanda, B; Kotani, A				Chanda, B.; Kotani, Ai			MICRORNA CAN COMPLETELY RESCUE B LINEAGE COMMITMENT ARREST DUE TO EARLY B CELL FACTOR 1 DEFICIENCY plus CAN MICRORNAS CONTROL CELL FATE AS AN ALTERNATIVE TO TRANSCRIPTION FACTORS?	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Chanda, B.; Kotani, Ai] Tokai Univ, Isehara, Kanagawa, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3092	S74	S74				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400149		
J	Chen, FL; Ishikawa, Y; Kihara, R; Naoe, T; Kiyoi, H				Chen, Fangli; Ishikawa, Yuichi; Kihara, Rika; Naoe, Tomoki; Kiyoi, Hitoshi			MECHANISM OF FLT3 LIGAND DEPENDENT RESISTANCE TO FLT3 INHIBITORS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Chen, Fangli; Ishikawa, Yuichi; Kihara, Rika; Kiyoi, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Naoe, Tomoki] Natl Hosp Org Nagoya Med Ctr, Nagoya, Aichi, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3024	S57	S57				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400081		
J	Chen, YF; Li, B; Yokoyama, A; Ernst, P				Chen, Yufei; Li, Bin; Yokoyama, Akihiko; Ernst, Patricia			ENDOGENOUS MLL1 IS DISPENSABLE FOR MLL-REARRANGED LEUKEMIA, BUT PROMOTES ACUTE LEUKEMIA DRIVEN BY OTHER ONCOPROTEINS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Ernst, Patricia] Univ Colorado, Aurora, CO USA; [Chen, Yufei; Li, Bin] Geisel Sch Med, Hanover, NH USA; [Yokoyama, Akihiko] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3043	S61	S61				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400100		
J	Fukuda, S; Abe, M; Hirade, T; Yamaguchi, S				Fukuda, Seiji; Abe, Mariko; Hirade, Tomohiro; Yamaguchi, Seiji			DISRUPTING CDKN1A SECONDARY TO FLT3/ITD INHIBITION IS RESPONSIBLE FOR RESISTANCE TO FLT3/ITD INHIBITOR AC220 IN FLT3/ITD+ CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Fukuda, Seiji; Abe, Mariko; Hirade, Tomohiro; Yamaguchi, Seiji] Shimane Univ, Sch Med, Izumo, Shimane, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3049	S63	S63				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400106		
J	Hosokawa, K; MacArthur, BD; Hanazawa, S; Suda, T; Arai, F				Hosokawa, Kentaro; MacArthur, Ben D.; Hanazawa, Shigemasa; Suda, Toshio; Arai, Fumio			PROTECTION OF TELOMERES 1 (POT1) REGULATES HEMATOPOIETIC STEM CELL ACTIVITY DURING AGEING	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Hosokawa, Kentaro; Arai, Fumio] Kyushu Univ, Fukuoka 812, Japan; [MacArthur, Ben D.] Univ Southampton, Southampton, Hants, England; [Suda, Toshio] Natl Univ Singapore, Singapore 117548, Singapore; [Hanazawa, Shigemasa] Nihon Univ, Kanagawa, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3068	S68	S68				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400125		
J	Ieyasu, A; Yamazaki, S; Nakauchi, H				Ieyasu, Aki; Yamazaki, Satoshi; Nakauchi, Hiromitsu			HOMEOSTATIC REGULATION OF HEMATOPOIETIC STEM CELLS BY THE INTERACTION OF NICHE FACTORS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Ieyasu, Aki; Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3070	S68	S68				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400127		
J	Iida, R; Garrett, K; Alberola-Ila, J; Kohara, A; Kincade, P				Iida, Ryuji; Garrett, Karla; Alberola-Ila, Jose; Kohara, Arihiro; Kincade, Paul			DYNAMIC EXPRESSION OF B7 FAMILY MOLECULES ON HEMATOPOIETIC STEM CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Iida, Ryuji; Garrett, Karla; Alberola-Ila, Jose; Kincade, Paul] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Iida, Ryuji; Kohara, Arihiro] Natl Inst Biomed Innovat Hlth & Nutr, Ibaraki, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3071	S68	S68				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400128		
J	Inoue, D; Horikawa, S; Matsui, H; Nagase, R; Saika, M; Kawabata, KC; Goyama, S; Kitamura, T				Inoue, Daichi; Horikawa, Sayuri; Matsui, Hirotaka; Nagase, Reina; Saika, Makoto; Kawabata, Kimihito C.; Goyama, Susumu; Kitamura, Toshio			NOVEL ROLES OF ASXL1 IN EPIGENETIC REGULATION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Inoue, Daichi; Horikawa, Sayuri; Nagase, Reina; Saika, Makoto; Kawabata, Kimihito C.; Goyama, Susumu; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan; [Matsui, Hirotaka] Kumamoto Univ, Fac Life Sci, Dept Mol Lab Med, Kumamoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3072	S69	S69				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400129		
J	Iriguchi, S; Kikuchi, N; Noguchi, E; Morishima, Y; Matsuyama, M; Yoh, K; Takahashi, S; Nakauchi, H; Ishii, Y; Kaneko, S				Iriguchi, Shoichi; Kikuchi, Norihiro; Noguchi, Emiko; Morishima, Yuko; Matsuyama, Masashi; Yoh, Keigyou; Takahashi, Satoru; Nakauchi, Hiromitsu; Ishii, Yukio; Kaneko, Shin			T CELL-RESTRICTED T-BET OVEREXPRESSION INDUCES ABERRANT HEMATOPOIESIS OF MYELOID CELLS AND IMPAIRS FUNCTION OF LUNG MACROPHAGES IN THE LUNG	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Iriguchi, Shoichi; Kaneko, Shin] Kyoto Univ, Kyoto, Japan; [Kikuchi, Norihiro; Noguchi, Emiko; Morishima, Yuko; Matsuyama, Masashi; Yoh, Keigyou; Takahashi, Satoru; Ishii, Yukio] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Iriguchi, Shoichi; Nakauchi, Hiromitsu; Kaneko, Shin] Univ Tokyo, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3073	S69	S69				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400130		
J	Ishibashi, T; Yokota, T; Tanaka, H; Ichii, M; Sudo, T; Satoh, Y; Doi, Y; Tanimura, A; Hamanaka, Y; Ezoe, S; Shibayama, H; Oritani, K; Kanakura, Y				Ishibashi, Tomohiko; Yokota, Takafumi; Tanaka, Hirokazu; Ichii, Michiko; Sudo, Takao; Satoh, Yusuke; Doi, Yukiko; Tanimura, Akira; Hamanaka, Yuri; Ezoe, Sachiko; Shibayama, Hirohiko; Oritani, Kenji; Kanakura, Yuzuru			ENDOTHELIAL CELL-SELECTIVE ADHESION MOLECULE IS A NOVEL HUMAN HEMATOPOIETIC STEM CELL MARKER ASSOCIATED WITH A SUBSET OF HUMAN LEUKEMIAS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Ishibashi, Tomohiko; Yokota, Takafumi; Ichii, Michiko; Sudo, Takao; Doi, Yukiko; Tanimura, Akira; Hamanaka, Yuri; Ezoe, Sachiko; Shibayama, Hirohiko; Oritani, Kenji; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Tanaka, Hirokazu] Kinki Univ, Sch Med, Osaka 589, Japan; [Satoh, Yusuke] Kobe Shoin Womens Univ, Kobe, Hyogo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3074	S69	S69				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400131		
J	Ishikawa, F				Ishikawa, Fumihiko			DEVELOPING THERAPEUTIC STRATEGIES TARGETING POOR PROGNOSIS ACUTE MYELOID LEUKEMIA	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Ishikawa, Fumihiko] RIKEN, IMS, Yokohama, Kanagawa, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		1036	S42	S42				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400035		
J	Iwama, A				Iwama, Atsushi			ROLE OF NON-CANONICAL POLYCOMB REPRESSIVE COMPLEX 1 IN HEMATOPOIESIS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Iwama, Atsushi] Chiba Univ, Grad Sch Med, Chiba, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		1004	S26	S26				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400006		
J	Kaneda, KN; Saito, Y; Suekane, A; Shimosaki, S; Morishita, K				Kaneda, Kazuko N.; Saito, Yusuke; Suekane, Akira; Shimosaki, Shunsuke; Morishita, Kazuhiro			INHIBITION OF GPR56 BY PI-POLYAMIDE TARGETING THE EVI1-BINDING SITE WITH SUPPRESSION OF LEUKEMIA	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kaneda, Kazuko N.; Saito, Yusuke; Suekane, Akira; Shimosaki, Shunsuke; Morishita, Kazuhiro] Miyazaki Univ, Fac Med, Miyazaki, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3125	S82	S82				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400182		
J	Kanehira, M; Fujiwara, T; Nakajima, S; Okitsu, Y; Onishi, Y; Fukuhara, N; Ichinohasama, R; Harigae, H				Kanehira, Masahiko; Fujiwara, Tohru; Nakajima, Shinji; Okitsu, Yoko; Onishi, Yasushi; Fukuhara, Noriko; Ichinohasama, Ryo; Harigae, Hideo			THE SIGNALING BALANCE BETWEEN LYSOPHOSPHATIDIC ACID RECEPTOR 1 AND 3 IN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS DETERMINES PROGRESSION OF MULTIPLE MYELOMA	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kanehira, Masahiko; Fujiwara, Tohru; Nakajima, Shinji; Okitsu, Yoko; Onishi, Yasushi; Fukuhara, Noriko; Ichinohasama, Ryo; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3080	S71	S71				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400137		
J	Katayama, Y				Katayama, Yoshio			LYMPHO-HEMATOPOIETIC MICROENVIRONMENT REGULATED BY INTER-ORGAN COMMUNICATION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Katayama, Yoshio] Kobe Univ Hosp, Kobe, Hyogo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		1013	S31	S31				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400014		
J	Kawabata, KC; Inoue, D; Goyama, S; Harada, H; Kitaura, J; Kitamura, T				Kawabata, Kimihito Cojin; Inoue, Daichi; Goyama, Susumu; Harada, Hironori; Kitaura, Jiro; Kitamura, Toshio			INACTIVATION OF EZH2 BY TRANCATED FORM MUTAION DE-REPRESSES NOVEL TARGET GENES TO PROMOTE TUMOR-INITIATING CAPACITY	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kawabata, Kimihito Cojin; Inoue, Daichi; Goyama, Susumu; Kitaura, Jiro; Kitamura, Toshio] Univ Tokyo, Tokyo 1138654, Japan; [Harada, Hironori] Juntendo Univ, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3000	S51	S51				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400057		
J	Kawaguchi, M; Kitajima, K; Kanokoda, M; Suzuki, H; Nakajima, M; Kasahara, K; Hara, T				Kawaguchi, Manami; Kitajima, Kenji; Kanokoda, Mai; Suzuki, Hidenori; Nakajima, Marino; Kasahara, Kohji; Hara, Takahiko			MEGAKARYOCYTE-PLATELET INDUCTION FROM MOUSE EMBRYONIC STEM CELLS BY ENFORCED EXPRESSION OF GATA2 IN LATE HEMOGENIC ENDOTHELIAL CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kawaguchi, Manami; Kitajima, Kenji; Kanokoda, Mai; Nakajima, Marino; Kasahara, Kohji; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Kawaguchi, Manami; Kanokoda, Mai; Nakajima, Marino; Hara, Takahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan; [Suzuki, Hidenori] Nippon Med Sch, Div Morphol & Biomol Res, Tokyo 113, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3060	S66	S66				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400117		
J	Kawamura, S; Onai, N; Takenaka, K; Akashi, K; Ohteki, T				Kawamura, Shunsuke; Onai, Nobuyuki; Takenaka, Katsuto; Akashi, Koichi; Ohteki, Toshiaki			IDENTIFICATION OF COMMON MONOCYTE PROGENITORS, PRE-MONOCYTES, AND GRANULOCYTE MONOCYTE PROGENITORS IN HUMAN UMBILICAL CORD BLOOD	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kawamura, Shunsuke; Onai, Nobuyuki; Ohteki, Toshiaki] Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan; [Kawamura, Shunsuke] Japan Soc Promot Sci, Tokyo, Japan; [Takenaka, Katsuto; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3085	S72	S72				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400142		
J	Kawanishi, S; Takata, K; Takada, T; Kitamura, Y; Ashihara, E				Kawanishi, Shohei; Takata, Kazuyuki; Takada, Tetsuya; Kitamura, Yoshihisa; Ashihara, Eishi			CHARACTERIZATION OF MICROGLIA-LIKE CELLS DERIVED FROM MOUSE BONE MARROW CELLS FOR NEW THERAPEUTIC STRATEGY OF ALZHEIMER'S DISEASE	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kawanishi, Shohei; Takata, Kazuyuki; Takada, Tetsuya; Ashihara, Eishi] Kyoto Pharmaceut Univ, Kyoto 607, Japan; [Kitamura, Yoshihisa] Ritsumeikan Univ, Kusatsu, Shiga, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3084	S72	S72				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400141		
J	Kikuchi, J; Koyama, D; Wada, T; Izumi, T; Hofgaard, PO; Bogen, B; Furukawa, Y				Kikuchi, Jiro; Koyama, Daisuke; Wada, Taeko; Izumi, Tohru; Hofgaard, Peter O.; Bogen, Bjarne; Furukawa, Yusuke			PHOSPHORYLATION-MEDIATED EZH2 INACTIVATION PROMOTES DRUG RESISTANCE IN MULTIPLE MYELOMA	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kikuchi, Jiro; Koyama, Daisuke; Wada, Taeko; Furukawa, Yusuke] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Izumi, Tohru] Tochigi Canc Ctr, Utsunomiya, Tochigi, Japan; [Hofgaard, Peter O.; Bogen, Bjarne] Oslo Univ Hosp, Oslo, Norway; [Hofgaard, Peter O.; Bogen, Bjarne] Univ Oslo, Oslo, Norway								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3052	S64	S64				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400109		
J	Koide, S; Takubo, K; Oshima, M; Miyagi, S; Saraya, A; Wang, CS; Matsui, H; Kimura, H; Shinkai, Y; Suda, T; Iwama, A				Koide, Shuhei; Takubo, Keiyo; Oshima, Motohiko; Miyagi, Satoru; Saraya, Atsunori; Wang, Changshan; Matsui, Hirotaka; Kimura, Hiroshi; Shinkai, Yoichi; Suda, Toshio; Iwama, Atsushi			HISTONE METHYLTRANSFERASE SETDB1 REGULATES ENERGY METABOLISM IN HEMATOPOIETIC STEM AND PROGENITOR CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Koide, Shuhei; Oshima, Motohiko; Miyagi, Satoru; Saraya, Atsunori; Wang, Changshan; Iwama, Atsushi] Chiba Univ, Chiba, Japan; [Takubo, Keiyo; Suda, Toshio] Keio Univ, Tokyo, Japan; [Matsui, Hirotaka] Hiroshima Univ, Hiroshima, Japan; [Kimura, Hiroshi] Tokyo Inst Technol, Tokyo 152, Japan; [Shinkai, Yoichi] RIKEN, Wako, Saitama, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3089	S73	S73				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400146		
J	Kon, A; Yamazaki, S; Kataoka, K; Yoshizato, T; Shiozawa, Y; Sanada, M; Yoshida, K; Nagata, Y; Shiraishi, Y; Miyano, S; Haferlach, T; Nakayama, M; Koseki, H; Nakauchi, H; Ogawa, S				Kon, Ayana; Yamazaki, Satoshi; Kataoka, Keisuke; Yoshizato, Tetsuichi; Shiozawa, Yusuke; Sanada, Masashi; Yoshida, Kenichi; Nagata, Yasunobu; Shiraishi, Yuichi; Miyano, Satoru; Haferlach, Torsten; Nakayama, Manabu; Koseki, Haruhiko; Nakauchi, Hiromitsu; Ogawa, Seishi			BIOLOGICAL AND GENETIC CHARACTERIZATION OF THE ROLE OF SRSF2 MUTATIONS IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kon, Ayana; Kataoka, Keisuke; Yoshizato, Tetsuichi; Shiozawa, Yusuke; Sanada, Masashi; Yoshida, Kenichi; Nagata, Yasunobu; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Med, Div Stem Cell Therapy, Tokyo, Japan; [Shiraishi, Yuichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Haferlach, Torsten] Munich Leukemia Lab, Munich, Germany; [Nakayama, Manabu] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba, Japan; [Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Nakauchi, Hiromitsu] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3090	S73	S73				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400147		
J	Kunisaki, Y				Kunisaki, Yuya			THE IMAGING OF THE BONE MARROW AND HEMATOPOIETIC STEM CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kunisaki, Yuya] Kyushu Univ Hosp, Fukuoka, Fukuoka 812, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		1008	S28	S28				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400009		
J	Kuribayashi, W; Mizukami, T; Takizawa, K; Sugata, K; Kuramitsu, M; Momose, H; Iwama, A; Hamaguchi, I				Kuribayashi, Wakako; Mizukami, Takuo; Takizawa, Kazuya; Sugata, Kenji; Kuramitsu, Madoka; Momose, Haruka; Iwama, Atsushi; Hamaguchi, Isao			IDENTIFICATION OF ATL STEM CELLS IN AN ATL MODEL HBZ TRANSGENIC MOUSE	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kuribayashi, Wakako; Mizukami, Takuo; Takizawa, Kazuya; Kuramitsu, Madoka; Momose, Haruka; Hamaguchi, Isao] Natl Inst Infect Dis, Tokyo, Japan; [Kuribayashi, Wakako; Iwama, Atsushi] Chiba Univ, Chiba, Japan; [Sugata, Kenji] Kyoto Univ, Kyoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3094	S74	S74				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400151		
J	Kurotaki, D; Nakabayashi, J; Nishiyama, A; Sasaki, H; Kaneko, N; Koizumi, S; Ozato, K; Suzuki, Y; Tamura, T				Kurotaki, Daisuke; Nakabayashi, Jun; Nishiyama, Akira; Sasaki, Haruka; Kaneko, Naofumi; Koizumi, Shin-ichi; Ozato, Keiko; Suzuki, Yutaka; Tamura, Tomohiko			ENHANCER LANDSCAPE DYNAMICS DURING MONOCYTE AND DENDRITIC CELL DEVELOPMENT AND THE ROLE OF THE TRANSCRIPTION FACTOR IRF8	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kurotaki, Daisuke; Nishiyama, Akira; Sasaki, Haruka; Kaneko, Naofumi; Koizumi, Shin-ichi; Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 232, Japan; [Ozato, Keiko] NICHD, NIH, Bethesda, MD USA; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Comp Biol, Tokyo, Japan; [Nakabayashi, Jun; Tamura, Tomohiko] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 232, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3189	S98	S98				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400245		
J	Kurotaki, D; Yamamoto, M; Nishiyama, A; Uno, K; Ban, T; Ichino, M; Sasaki, H; Matsunaga, S; Yoshinari, M; Ryo, A; Nakazawa, M; Ozato, K; Tamura, T				Kurotaki, Daisuke; Yamamoto, Michio; Nishiyama, Akira; Uno, Kazuhiro; Ban, Tatsuma; Ichino, Motohide; Sasaki, Haruka; Matsunaga, Satoko; Yoshinari, Masahiro; Ryo, Akihide; Nakazawa, Masatoshi; Ozato, Keiko; Tamura, Tomohiko			IRF8 INHIBITS THE ACTIVITY OF C/EBP alpha TO RESTRAIN MONONUCLEAR PHAGOCYTE PROGENITORS FROM DIFFERENTIATING INTO NEUTROPHILS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kurotaki, Daisuke; Yamamoto, Michio; Nishiyama, Akira; Uno, Kazuhiro; Ban, Tatsuma; Ichino, Motohide; Sasaki, Haruka; Yoshinari, Masahiro; Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 232, Japan; [Matsunaga, Satoko; Ryo, Akihide] Yokohama City Univ, Grad Sch Med, Dept Microbiol, Yokohama, Kanagawa 232, Japan; [Nakazawa, Masatoshi] Yokohama City Univ, Grad Sch Med, Dept Expt Anim Sci, Yokohama, Kanagawa 232, Japan; [Ozato, Keiko] NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3097	S75	S75				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400154		
J	Matsui, H; Kanai, A; Nagamachi, A; Okuno, M; Inaba, T				Matsui, Hirotaka; Kanai, Akinori; Nagamachi, Akiko; Okuno, Moe; Inaba, Toshiya			DEFECT IN PRE-RIBOSOMAL RNA PROCESSING IS INVOLVED IN MYELOID LEUKEMOGENESIS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kanai, Akinori; Nagamachi, Akiko; Okuno, Moe; Inaba, Toshiya] Hiroshima Univ, Hiroshima, Japan; [Matsui, Hirotaka] Kumamoto Univ, Dept Mol Lab Med, Kumamoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3110	S78	S78				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400167		
J	Matsuo, T; Sumiyoshi, R; Shirasaki, R; Yamamoto, T; Oka-Miura, Y; Matsumoto, K; Ooi, J; Shirafuji, N				Matsuo, Takuji; Sumiyoshi, Rhitsu; Shirasaki, Ryosuke; Yamamoto, Tadashi; Oka-Miura, Yoko; Matsumoto, Kennsuke; Ooi, Jun; Shirafuji, Naoki			HEMOGENIC ENDOTHELIUM-LIKE CHANGES WERE OBSERVED IN AN ADULT HUMAN DERMAL FIBROBLAST WITH POLY (I:C) AND AN ELECTRICAL STIMULATION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Matsuo, Takuji; Sumiyoshi, Rhitsu; Shirasaki, Ryosuke; Yamamoto, Tadashi; Oka-Miura, Yoko; Matsumoto, Kennsuke; Ooi, Jun; Shirafuji, Naoki] Teikyo Univ, Sch Med, Tokyo 173, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3113	S79	S79				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400170		
J	Matsuoka, Y; Sumide, K; Kawamura, H; Nakatsuka, R; Sasaki, Y; Sonoda, Y				Matsuoka, Yoshikazu; Sumide, Keisuke; Kawamura, Hiroshi; Nakatsuka, Ryusuke; Sasaki, Yutaka; Sonoda, Yoshiaki			FUNCTIONAL SIGNIFICANCE OF MPL EXPRESSION IN THE HUMAN HEMATOPOLETIC STEM CELL COMPARTMENT	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Matsuoka, Yoshikazu; Sumide, Keisuke; Kawamura, Hiroshi; Nakatsuka, Ryusuke; Sasaki, Yutaka; Sonoda, Yoshiaki] Kansai Med Univ, Dept Stem Cell Biol & Regenerat Med, Hirakata, Osaka, Japan; [Kawamura, Hiroshi] Kansai Med Univ, Dept Orthoped Surg, Hirakata, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3115	S79	S79				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400172		
J	Matsuoka, Y; Sumide, K; Kawamura, H; Nakatsuka, R; Fujioka, T; Sasaki, Y; Sonoda, Y				Matsuoka, Yoshikazu; Sumide, Keisuke; Kawamura, Hiroshi; Nakatsuka, Ryusuke; Fujioka, Tatsuya; Sasaki, Yutaka; Sonoda, Yoshiaki			HUMAN CORD BLOOD-DERIVED PRIMITIVE CD34-NEGATIVE HEMATOPOIETIC STEM CELLS (HSCS) ARE MYELOID-BIASED LONG-TERM HSCS RESIDING AT THE APEX OF HUMAN HSC HIERARCHY	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Matsuoka, Yoshikazu; Sumide, Keisuke; Kawamura, Hiroshi; Nakatsuka, Ryusuke; Fujioka, Tatsuya; Sasaki, Yutaka; Sonoda, Yoshiaki] Kansai Med Univ, Dept Stem Cell Biol & Regenerat Med, Hirakata, Osaka, Japan; [Kawamura, Hiroshi] Kansai Med Univ, Dept Orthoped Surg, Hirakata, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3112	S79	S79				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400169		
J	Matsuoka, Y; Sumide, K; Kawamura, H; Nakatsuka, R; Fujioka, T; Sasaki, Y; Sonoda, Y				Matsuoka, Yoshikazu; Sumide, Keisuke; Kawamura, Hiroshi; Nakatsuka, Ryusuke; Fujioka, Tatsuya; Sasaki, Yutaka; Sonoda, Yoshiaki			PROSPECTIVE ISOLATION OF HUMAN HEMATOPOIETIC STEM CELL-SUPPORTIVE MESENCHYMAL STEM/STROMAL CELLS FROM HUMAN BONE MARROW	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Matsuoka, Yoshikazu; Sumide, Keisuke; Kawamura, Hiroshi; Nakatsuka, Ryusuke; Fujioka, Tatsuya; Sasaki, Yutaka; Sonoda, Yoshiaki] Kansai Med Univ, Dept Stem Cell Biol & Regenerat Med, Hirakata, Osaka, Japan; [Kawamura, Hiroshi] Kansai Med Univ, Dept Orthoped Surg, Hirakata, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3114	S79	S79				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400171		
J	Matsuo-Tezuka, Y; Noguchi-Sasaki, M; Sasaki, Y; Kondo, K; Kihara, M; Kurasawa, M; Yorozu, K; Shimonaka, Y				Matsuo-Tezuka, Yukari; Noguchi-Sasaki, Mariko; Sasaki, Yusuke; Kondo, Kumiko; Kihara, Makoto; Kurasawa, Mitsue; Yorozu, Keigo; Shimonaka, Yasushi			QUANTIFICATION AND VISUALIZATION OF DIETARY IRON UTILIZATION UNDER ERYTHROPOTETIC STIMULATION BY USING STABLE IRON ISOTOPE (FE)-F-57 AND MASS SPECTROMETRY	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Matsuo-Tezuka, Yukari; Noguchi-Sasaki, Mariko; Sasaki, Yusuke; Kondo, Kumiko; Kihara, Makoto; Kurasawa, Mitsue; Yorozu, Keigo; Shimonaka, Yasushi] Chugai Pharmaceut Co Ltd, Kamakura, Kanagawa, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3117	S80	S80				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400174		
J	Mitsui, T; Koiso, H; Namahashi, H; Saito, A; Ishizaki, T; TAakizawa, M; Yokohama, A; Saito, T; Jinbo, T; Ogura, H; Handa, H; Sawamura, M; Sakura, T; Karasawa, M; Murakami, H; Nojima, Y; Tsukamoto, N				Mitsui, Takeki; Koiso, Hiromi; Namahashi, Hirotaka; Saito, Akio; Ishizaki, Takuma; TAakizawa, Makiko; Yokohama, Akihiko; Saito, Takayuki; Jinbo, Takahiro; Ogura, Hidemi; Handa, Hiroshi; Sawamura, Morio; Sakura, Tohru; Karasawa, Masamitsu; Murakami, Hirokazu; Nojima, Yoshihisa; Tsukamoto, Norifumi			MUTATION OF THE SF3B1 PREDICT A POOR PROGNOSIS IN JAPANESE CLL PATIENTS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Mitsui, Takeki; Namahashi, Hirotaka; Ishizaki, Takuma; TAakizawa, Makiko; Saito, Takayuki; Handa, Hiroshi; Murakami, Hirokazu; Nojima, Yoshihisa] Gunma Univ, Grad Sch Med, Maebashi, Gumma 371, Japan; [Koiso, Hiromi; Yokohama, Akihiko; Tsukamoto, Norifumi] Gunma Univ Hosp, Maebashi, Gumma, Japan; [Saito, Akio; Jinbo, Takahiro] Fujioka Gen Hosp, Fujioka, Japan; [Ogura, Hidemi] Maebashi Red Cross Hosp, Maebashi, Gumma, Japan; [Sawamura, Morio] Nishigunma Natl Hosp, Natl Hosp Org, Shibukawa, Japan; [Sakura, Tohru] Saiseikai Maebashi Hosp, Maebashi, Gumma, Japan; [Karasawa, Masamitsu] Usui Hosp, Annaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3121	S81	S81				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400178		
J	Miyawaki, K; Iwasaki, H; Akashi, K				Miyawaki, Kohta; Iwasaki, Hiromi; Akashi, Koichi			IDENTIFICATION OF THE HUMAN UNIPOTENT MEGAKARYOCYTE PROGENITOR, AND ITS PATHOPHYSIOLOGICAL ROLES IN HUMAN THROMBOPOIETIC DISORDERS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Miyawaki, Kohta; Akashi, Koichi] Kyushu Univ, Fukuoka 812, Japan; [Iwasaki, Hiromi] Kyushu Univ Hosp, Fukuoka 812, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3120	S81	S81				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400177		
J	Mochizuki-Kashio, M; Sashida, G; Aoyama, K; Wang, CS; Tomioka, T; Oshima, M; Iwama, A				Mochizuki-Kashio, Makiko; Sashida, Goro; Aoyama, Kazumasa; Wang, Changshan; Tomioka, Takahisa; Oshima, Motohiko; Iwama, Atsushi			EZH2 LOSS IN HEMATOPOIETIC STEM CELLS PREDISPOSES MICE TO DEVELOP HETEROGENEOUS MALIGNANCIES IN AN EZH1-DEPENEDENT MANNER	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Mochizuki-Kashio, Makiko; Aoyama, Kazumasa; Wang, Changshan; Tomioka, Takahisa; Oshima, Motohiko; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan; [Sashida, Goro] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3123	S81	S81				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400180		
J	Murakami, S; Yamantoto, M; Motohashi, H				Murakami, Shohei; Yamantoto, Masayuki; Motohashi, Hozumi			A STRESS-RESPONSIVE TRANSCRIPTIONAL FACTOR NRF2 ACTIVATES HEMATOPOIETIC STEM CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Murakami, Shohei; Motohashi, Hozumi] Tohoku Univ, IDAC, Sendai, Miyagi 980, Japan; [Yamantoto, Masayuki] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3127	S82	S82				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400184		
J	Murase, A; Kashiwase, N; Tanizaki, Y; Otani, T; Mochizuki, Y; Kato, T				Murase, Ayaka; Kashiwase, Nao; Tanizaki, Yuta; Otani, Takato; Mochizuki, Yoko; Kato, Takashi			MIGRATION AND CHARACTERISTICS OF THROMBOCYTES DURING COLD-EXPOSURE IN XENOPUS LAEVIS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Murase, Ayaka; Kashiwase, Nao; Otani, Takato; Mochizuki, Yoko; Kato, Takashi] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Tanizaki, Yuta; Kato, Takashi] Waseda Univ, Sch Educ, Dept Biol, Shinjuku Ku, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3126	S82	S82				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400183		
J	Nagasawa, T				Nagasawa, Takashi			THE MICROENVIRONMENTAL NICHES FOR HEMATOPOIETIC STEM AND PROGENITOR CELLS IN BONE MARROW	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Nagasawa, Takashi] Kyoto Univ, Kyoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		1012	S30	S30				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400013		
J	Nakahata, S; Ichikawa, T; Yusuke, S; Arai, Y; Taki, T; Taniwaki, M; Morishita, K				Nakahata, Shingo; Ichikawa, Tomonaga; Yusuke, Saito; Arai, Yasuhito; Taki, Tomohiko; Taniwaki, Masafumi; Morishita, Kazuhiro			DOWN-REGULATION OF NDRG2 PLAYS AN IMPORTANT ROLE IN ATLL LEUKEMOGENESIS VIA THE PTEN-MEDIATED PI3K/AKT SIGNALING PATHWAY	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Nakahata, Shingo; Ichikawa, Tomonaga; Yusuke, Saito; Morishita, Kazuhiro] Miyazaki Univ, Miyazaki, Japan; [Arai, Yasuhito] Natl Canc Ctr, Tokyo, Japan; [Taki, Tomohiko; Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Kyoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3128	S83	S83				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400185		
J	Nakatsuka, R; Matsuoka, Y; Sumide, K; Kawamura, H; Fujioka, T; Sasaki, Y; Sonoda, Y				Nakatsuka, Ryusuke; Matsuoka, Yoshikazu; Sumide, Keisuke; Kawamura, Hiroshi; Fujioka, Tatsuya; Sasaki, Yutaka; Sonoda, Yoshiaki			EVALUATION OF STEM CELL CHARACTERISTICS OF ADULT MOUSE BONE-DERIVED SMALL CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Nakatsuka, Ryusuke; Matsuoka, Yoshikazu; Sumide, Keisuke; Kawamura, Hiroshi; Fujioka, Tatsuya; Sasaki, Yutaka; Sonoda, Yoshiaki] Kansai Med Univ, Dept Stem Cell Biol & Regenerat Med, Hirakata, Osaka, Japan; [Kawamura, Hiroshi] Kansai Med Univ, Dept Orthoped Surg, Hirakata, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3130	S83	S83				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400187		
J	Nakauchi, H				Nakauchi, Hiromitsu			DIETARY CREATED NICHE FOR NON-MYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTATION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Tokyo, Japan; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo 1138654, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		1021	S35	S35				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400022		
J	Niimi, G				Niimi, Gen			DELAYED ADDITION OF EPOETIN BETA DURING STORAGE: EFFECT ON PERIPHERAL ERYTHROCYTE DIVISION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Niimi, Gen] Fujita Hlth Univ, Joint Res Lab, Toyoake, Aichi, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3135	S84	S84				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400192		
J	Nishikii, H; Umemoto, T; Goltsev, Y; Matsuzaki, Y; Yamato, M; Nolan, G; Negrin, R; Chiba, S				Nishikii, Hidekazu; Umemoto, Terumasa; Goltsev, Yury; Matsuzaki, Yu; Yamato, Masayuki; Nolan, Garry; Negrin, Robert; Chiba, Shigeru			UNIPOTENT MEGAKARYOPOIETIC PATHWAY BRIDGING HEMATOPOIETIC STEM CELLS AND MATURE MEGAKARYOCYTES	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Nishikii, Hidekazu; Chiba, Shigeru] Univ Tsukuba, Dept Hematol, Tsukuba, Ibaraki, Japan; [Goltsev, Yury; Nolan, Garry] Stanford Univ, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Umemoto, Terumasa; Matsuzaki, Yu; Yamato, Masayuki] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Nishikii, Hidekazu; Negrin, Robert] Stanford Univ, Div BMT, Stanford, CA 94305 USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3136	S85	S85				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400193		
J	Nitta, E; Yamashita, M; Oshima, M; Iwama, A; Suda, T				Nitta, Eriko; Yamashita, Masayuki; Oshima, Motohiko; Iwama, Atsushi; Suda, Toshio			CHROMATIN REMODELING FACTOR BRM IS ESSENTIAL FOR THE MAINTENANCE OF HSC QUIESCENCE	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Nitta, Eriko; Oshima, Motohiko; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Chiba, Japan; [Nitta, Eriko; Yamashita, Masayuki; Suda, Toshio] Keio Univ, Sch Med, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3139	S85	S85				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400196		
J	Nobuhisa, I; Osawa, M; Uemura, M; Harada, K; Anani, M; Saito, K; Takagi, H; Takahashi, S; Kanai-Azuma, M; Kanai, Y; Iwama, A; Taga, T				Nobuhisa, Ikuo; Osawa, Mitsujiro; Uemura, Mami; Harada, Kaho; Anani, Maha; Saito, Kiyoka; Takagi, Haruna; Takahashi, Satomi; Kanai-Azuma, Masami; Kanai, Yoshiakira; Iwama, Atsushi; Taga, Tetsuya			SOX17 IS CRITICAL FOR THE MAINTENANCE OF STEM CELL PHENOTYPE OF INTRA-AORTIC HEMATOPOIETIC CLUSTERS OF CELLS IN THE AORTA-GONAD-MESONEPHROS REGION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Nobuhisa, Ikuo; Harada, Kaho; Anani, Maha; Saito, Kiyoka; Takahashi, Satomi; Taga, Tetsuya] Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Regulat, Tokyo, Japan; [Osawa, Mitsujiro] Kyoto Univ, Clin Applicat Dept, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Osawa, Mitsujiro; Takagi, Haruna; Iwama, Atsushi] Chiba Univ, Dept Cellular & Mol Med, Grad Sch Med, Chiba, Japan; [Uemura, Mami; Kanai, Yoshiakira] Univ Tokyo, Dept Vet Anat, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kanai-Azuma, Masami] TMDU, Ctr Expt Anim, Dept Expt Anim Model Human Dis, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3138	S85	S85				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400195		
J	Obara, N; Chiba, S; Kato, T; Sakamoto, T; Cao, L; Suzuki, S; Kurita, N; Yokoyama, Y; Sakata, M; Hasegawa, Y				Obara, Naoshi; Chiba, Shigeru; Kato, Takayasu; Sakamoto, Tatsuhiro; Cao, Luan; Suzuki, Sachie; Kurita, Naoki; Yokoyama, Yasuhisa; Sakata, Mamiko; Hasegawa, Yuichi			ABNORMALITIES IN NESTIN-EXPRESSING BONE MARROW STROMAL CELLS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Obara, Naoshi; Chiba, Shigeru; Kato, Takayasu; Sakamoto, Tatsuhiro; Cao, Luan; Suzuki, Sachie; Kurita, Naoki; Yokoyama, Yasuhisa; Sakata, Mamiko; Hasegawa, Yuichi] Univ Tsukuba, Tsukuba, Ibaraki, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3143	S86	S86				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400200		
J	Onai, N; Kurosaki-Nakamura, R; Ohteki, T				Onai, Nobuyuki; Kurosaki-Nakamura, Rumiko; Ohteki, Toshiaki			IDENTIFICATION OF FLT3-LIGAND PRODUCING CELLS BY GENERATING FLT3-LIGAND MCHERRY REPORTER MOUSE	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Onai, Nobuyuki; Kurosaki-Nakamura, Rumiko; Ohteki, Toshiaki] Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3145	S87	S87				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400202		
J	Rai, S; Tanaka, H; Watanabe, T; Kanakura, Y; Matsumura, I				Rai, Shinya; Tanaka, Hirokazu; Watanabe, Toshio; Kanakura, Yuzuru; Matsumura, Itaru			TARGETING INTRACELLULAR TRAFFICKING OF FLT3-ITD AND KIT D816V BY CHLORPROMAZINE SHOWS PROMISING PRECLINICAL ACTIVITY AGAINST ACUTE MYELOID LEUKEMIA CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Rai, Shinya; Tanaka, Hirokazu; Matsumura, Itaru] Kinki Univ, Fac Med, Osaka, Japan; [Watanabe, Toshio] Nara Womens Univ, Nara 630, Japan; [Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Suita, Osaka 565, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3156	S90	S90				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400213		
J	Saiki, N; Oshima, K; Hirayama, A; Soga, T; Tomita, M; Nakahata, T; Saito, MK				Saiki, Norikazu; Oshima, Koichi; Hirayama, Akiyoshi; Soga, Tomoyoshi; Tomita, Masaru; Nakahata, Tatsutoshi; Saito, Megumu K.			PLURIPOTENT STEM CELL MODELS OF RETICULAR DYSGENESIS AS A TOOL FOR ELUCIDATING THE POTENTIAL ROLE OF INTRACELLULAR BIOENERGETIC SYSTEMS ON CONTROLLING THE FATE OF HEMATOPOIETIC PROGENITORS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Saiki, Norikazu; Oshima, Koichi; Nakahata, Tatsutoshi; Saito, Megumu K.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Saiki, Norikazu] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Hirayama, Akiyoshi; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3164	S92	S92				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400221		
J	Saito, K; Nobuhisa, I; Anani, M; Harada, K; Takahashi, S; Taga, T				Saito, Kiyoka; Nobuhisa, Ikuo; Anani, Maha; Harada, Kaho; Takahashi, Satomi; Taga, Tetsuya			MAINTENANCE OF HEMATOPOIETIC STEM AND PROGENITOR CELL PHENOTYPE OF INTRA-AORTIC CELL CLUSTERS IN THE AGM REGION THROUGH THE SOX17-NOTCH1-HES1 AXIS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Saito, Kiyoka; Nobuhisa, Ikuo; Anani, Maha; Harada, Kaho; Takahashi, Satomi; Taga, Tetsuya] Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3167	S92	S92				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400224		
J	Saito, Y; Ellegast, JM; Kull, D; Heikenwalder, M; Flavell, RA; Manz, MG				Saito, Yasuyuki; Ellegast, Jana M.; Kull, Daniel; Heikenwaelder, Mathias; Flavell, Richard A.; Manz, Markus G.			DEVELOPMENT OF HUMAN HEMATO-LYMPHOID SYSTEM IN HUMAN CYTOKINE KNOCK-IN RAG2(-/-)IL2RG(-/-) MICE ENGRAFTED WITH PERIPHERAL BLOOD MOBILIZED CD34(+) CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Saito, Yasuyuki] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan; [Saito, Yasuyuki; Ellegast, Jana M.; Manz, Markus G.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Kull, Daniel; Heikenwaelder, Mathias] Tech Univ Munich, D-80290 Munich, Germany; [Kull, Daniel; Heikenwaelder, Mathias] Helmholtz Zentrum Munchen, Munich, Germany; [Flavell, Richard A.] Yale Univ, New Haven, CT USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3166	S92	S92				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400223		
J	Sakamoto, A; Shimada, K; Katayama, M; Hayakawa, F; Tomita, A; Kiyoi, H				Sakamoto, Akihiko; Shimada, Kazuyuki; Katayama, Miyuki; Hayakawa, Fumihiko; Tomita, Akihiro; Kiyoi, Hitoshi			LYMPH NODE-ASSOCIATED STROMAL FIBROBLASTS AS A POTENTIAL SOURCE OF HUMORAL FACTORS TO SUPPORT B-CELL LYMPHOMA CELLS VIA THE PHOSPHATIDYLINOSITOL 3-KINASE PATHWAY	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Sakamoto, Akihiko; Shimada, Kazuyuki; Hayakawa, Fumihiko; Tomita, Akihiro; Kiyoi, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Shimada, Kazuyuki] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Katayama, Miyuki] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3169	S93	S93				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400226		
J	Sakurai, H; Harada, Y; Matsui, H; Nakajima, H; Kitamura, T; Komatsu, N; Harada, H				Sakurai, Hiroko; Harada, Yuka; Matsui, Hirotaka; Nakajima, Hideaki; Kitamura, Toshio; Komatsu, Norio; Harada, Hironori			OVEREXPRESSION OF RUNX1 SHORT ISOFORM PLAYS A PIVOTAL ROLE IN THE DEVELOPMENT OF MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Sakurai, Hiroko; Harada, Yuka; Komatsu, Norio; Harada, Hironori] Juntendo Univ, Sch Med, Tokyo 113, Japan; [Matsui, Hirotaka] Kumamoto Univ, Kumamoto, Japan; [Nakajima, Hideaki] Keio Univ, Sch Med, Tokyo, Japan; [Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Harada, Yuka] Bunkyo Gakuin Univ, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3168	S93	S93				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400225		
J	Sasaki, H; Kurotaki, D; Osato, N; Sato, H; Sasaki, I; Koizumi, S; Wang, HS; Kaneda, C; Nishiyama, A; Kaisho, T; Aburatani, H; Morse, HC; Ozato, K; Tamura, T				Sasaki, Haruka; Kurotaki, Daisuke; Osato, Naoki; Sato, Hideaki; Sasaki, Izumi; Koizumi, Shin-ichi; Wang, Hongsheng; Kaneda, Chika; Nishiyama, Akira; Kaisho, Tsuneyasu; Aburatani, Hiroyuki; Morse, Herbert C., III; Ozato, Keiko; Tamura, Tomohiko			A ROLE OF THE TRANSCRIPTION FACTOR IRF8 IN BASOPHIL AND MAST CELL DEVELOPMENT	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Sasaki, Haruka; Kurotaki, Daisuke; Sato, Hideaki; Koizumi, Shin-ichi; Kaneda, Chika; Nishiyama, Akira; Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 232, Japan; [Osato, Naoki; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Div Genome Sci, Tokyo, Japan; [Sasaki, Izumi; Kaisho, Tsuneyasu] Osaka Univ, IFReC, Lab Immune Reg, Osaka, Japan; [Wang, Hongsheng; Morse, Herbert C., III] NIAID, NIH, Rockville, MD USA; [Ozato, Keiko] NICHD, NIH, Bethesda, MD USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3170	S93	S93				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400227		
J	Sasaki, Y; Matsuoka, Y; Nakatsuka, R; Sumide, K; Kawamura, H; Fujioka, T; Sonoda, Y				Sasaki, Yutaka; Matsuoka, Yoshikazu; Nakatsuka, Ryusuke; Sumide, Keisuke; Kawamura, Hiroshi; Fujioka, Tatsuya; Sonoda, Yoshiaki			FACS-SEGREGATED C-KITHIGH AND C-KITLOW CELLS IN THE MURINE HEMATOPOIETIC STEM CELL COMPARTMENT ARE FUNCTIONALLY DISTINCT	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Sasaki, Yutaka; Matsuoka, Yoshikazu; Nakatsuka, Ryusuke; Sumide, Keisuke; Kawamura, Hiroshi; Fujioka, Tatsuya; Sonoda, Yoshiaki] Kansai Med Univ, Hirakata, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3173	S94	S94				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400230		
J	Sigurdsson, V; Takei, H; Soboleva, S; Siva, K; Galeev, R; Leeb-Lundberg, F; Iida, T; Nittono, H; Miharada, K				Sigurdsson, Valgardur; Takei, Hajime; Soboleva, Svetlana; Siva, Kavitha; Galeev, Roman; Leeb-Lundberg, Fredrik; Iida, Takashi; Nittono, Hiroshi; Miharada, Kenichi			BILE ACIDS SUPPORT EXPANDING HEMATOPOIETIC STEM/PROGENITOR CELLS IN THE FETAL LIVER	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Sigurdsson, Valgardur; Soboleva, Svetlana; Siva, Kavitha; Galeev, Roman; Miharada, Kenichi] Lund Univ, Lund Stem Cell Ctr, Div Mol Med & Gene Therapy, Lund, Sweden; [Takei, Hajime; Nittono, Hiroshi] Bile Acid Inst, Junshin Clin, Tokyo, Japan; [Leeb-Lundberg, Fredrik] Lund Univ, Dept Drug Target Discovery, Lund, Sweden; [Iida, Takashi] Nihon Univ, Dept Chem, Coll Humanities & Sci, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3176	S95	S95				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400233		
J	Sudo, K; Yamazaki, S; Nakauchi, H; Nakamura, Y				Sudo, Kazuhiro; Yamazaki, Satoshi; Nakauchi, Hiromitsu; Nakamura, Yukio			MAINTENANCE AND EXPANSION OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS IN THE PRESENCE OF DEFINED FACTORS ALONE	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Sudo, Kazuhiro; Nakamura, Yukio] RIKEN BRC, Tsukuba, Ibaraki, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3180	S96	S96				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400237		
J	Tadokoro, Y; Yoshimura, A; Nakauchi, H; Hirao, A				Tadokoro, Yuko; Yoshimura, Akihiko; Nakauchi, Hiromitsu; Hirao, Atsushi			ROLE OF SPRED1 IN THE REGULATION OF SELF-RENEWAL AND AGING OF HEMATOPOIETIC STEM CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Tadokoro, Yuko; Hirao, Atsushi] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 920, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Shinjyuku Ku, Tokyo, Japan; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3182	S96	S96				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400238		
J	Tajima, Y; Yamazaki, S; Nakauchi, H				Tajima, Yoko; Yamazaki, Satoshi; Nakauchi, Hiromitsu			A NEW GENE TRANSFER SYSTEM FOR HEMATOPOIETIC STEM CELLS UNDER PHYSIOLOGICAL CONDITION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Tajima, Yoko; Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3185	S97	S97				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400241		
J	Takada, T; Takata, K; Ashihara, E				Takada, Tetsuya; Takata, Kazuyuki; Ashihara, Eishi			ION TRANSPORT-ASSOCIATED MOLECULES AS THERAPEUTIC TARGETS AGAINST GLIOBLASTOMA STEM CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Takada, Tetsuya; Takata, Kazuyuki; Ashihara, Eishi] Kyoto Pharmaceut Univ, Kyoto 607, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3184	S96	S96				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400240		
J	Takihara, Y; Ohno, Y; Suzuki-Takedachi, K; Kurogi, T; Santo, M; Naka, K; Yasunaga, S				Takihara, Yoshihiro; Ohno, Yoshinori; Suzuki-Takedachi, Kyoko; Kurogi, Toshiaki; Santo, Mimoko; Naka, Kazuhito; Yasunaga, Shin'ichiro			A NEW STRATEGY FOR MANIPULATING EXPRESSION AND ACTIVITY OF GEMININ COULD MAKE IT POSSIBLE TO REGULATE CELL FATES OF HSCS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Takihara, Yoshihiro; Ohno, Yoshinori; Suzuki-Takedachi, Kyoko; Kurogi, Toshiaki; Santo, Mimoko; Naka, Kazuhito; Yasunaga, Shin'ichiro] Hiroshima Univ, RIRBM, Hiroshima, Japan; [Yasunaga, Shin'ichiro] Fukuoka Univ, Fac Med, Dept Biochem, Fukuoka 81401, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3187	S97	S97				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400243		
J	Takubo, K				Takubo, Keiyo			DECLINED PRESENTATION P38 alpha-ACTIVATED PURINE METABOLISM PLAYS A CRUCIAL ROLE IN PROLIFERATION OF TRANSPLANTED HEMATOPOIETIC STEM CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Takubo, Keiyo] Natl Ctr Global Hlth & Med, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3186	S97	S97				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400242		
J	Tan, J; Watanabe, T				Tan, Jon; Watanabe, Takeshi			A STROMAL ORGANISER CELL THAT DIRECTS NEONATAL SPLEEN REGENERATION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Tan, Jon] Australian Natl Univ, Acton, ACT, Australia; [Tan, Jon; Watanabe, Takeshi] Kyoto Univ, Sakyo Ku, Kyoto, Japan; [Watanabe, Takeshi] Kitano Hosp, Tazuke Kofukai Med Res Inst, Kita Ku, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3188	S97	S97				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400244		
J	Tanaka, H; Rai, S; Watazzabe, T; Kanakura, Y; Matsumura, I				Tanaka, Hirokazu; Rai, Shinya; Watazzabe, Toshio; Kanakura, Yuzuru; Matsumura, Itaru			CALM PLAYS A CRITICAL ROLE FOR ONCOGENIC ACTIVITY OF RTK MUTANTS AND WOULD BE A PROMISING THERAPEUTIC TARGET	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Kanakura, Yuzuru] Dept Hematol & Oncol, Suita, Osaka, Japan; [Watazzabe, Toshio] Grad Sch Humanities & Sci, Dept Biol Sci, Nara, Japan; [Tanaka, Hirokazu; Rai, Shinya; Matsumura, Itaru] Kinki Univ, Fac Med, Dept Hematol & Rheumatol, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3191	S98	S98				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400247		
J	Tanaka, Y; Moignard, V; Wilkinson, AC; Hannah, R; Ladopoulos, V; Gottgens, B				Tanaka, Yosuke; Moignard, Victoria; Wilkinson, Adam C.; Hannah, Rebecca; Ladopoulos, Vasileios; Gottgens, Bertie			IDENTIFICATION OF RUNX1-DIRECT TARGETS IMPORTANT FOR DEFINITIVE HEMATOPOIESIS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Tanaka, Yosuke] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, Tokyo, Japan; [Tanaka, Yosuke; Moignard, Victoria; Wilkinson, Adam C.; Hannah, Rebecca; Ladopoulos, Vasileios; Gottgens, Bertie] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Tanaka, Yosuke; Moignard, Victoria; Wilkinson, Adam C.; Ladopoulos, Vasileios; Gottgens, Bertie] Univ Cambridge, Cambridge Stem Cell Inst, MRC, Wellcome Trust, Cambridge, England								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3190	S98	S98				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400246		
J	Tanakai, T; Nakajima-Takagi, Y; Oshima, M; Saraya, A; Tara, S; Si, S; Sone, H; Koseki, H; Iwama, A				Tanakai, Tomoyuki; Nakajima-Takagi, Yeako; Oshima, Motohiko; Saraya, Atsunori; Tara, Shiro; Si, Sha; Sone, Hirohito; Koseki, Haruhiko; Iwama, Atsushi			ROLE OF THE POLYCOMB GENE BCOR IN HEMATOPOIESIS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Tanakai, Tomoyuki; Nakajima-Takagi, Yeako; Oshima, Motohiko; Saraya, Atsunori; Tara, Shiro; Si, Sha; Iwama, Atsushi] Chiba Univ, Chiba, Japan; [Tanakai, Tomoyuki; Sone, Hirohito] Niigata Univ, Niigata, Japan; [Koseki, Haruhiko] RIKEN, Yokohama, Kanagawa, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3131	S83	S83				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400188		
J	Tanimura, N; Miller, E; Igarashi, K; Burstyn, JN; Dewey, CN; Bresnick, EH				Tanimura, Nobuyuki; Miller, Eli; Igarashi, Kazuhiko; Burstyn, Judith N.; Dewey, Colin N.; Bresnick, Emery H.			LINKING HEME BIOSYNTHESIS WITH A GATA FACTOR-REGULATED GENETIC NETWORK THAT CONTROLS CELLULAR DIFFERENTIATION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Miller, Eli; Burstyn, Judith N.] UW Madison, Dept Chem, Madison, WI USA; [Igarashi, Kazuhiko] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan; [Tanimura, Nobuyuki; Bresnick, Emery H.] Univ Wisconsin, Sch Med & Publ Hlth, UW Madison Blood Res Program, Dept Cell & Regenerat Biol, Madison, WI USA; [Dewey, Colin N.] UW Madison, Dept Biostat & Med Informat, Madison, WI USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3193	S99	S99				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400249		
J	Tanizaki, Y; Murase, A; Mochizuki, Y; Otani, T; Kato, T				Tanizaki, Yuta; Murase, Ayaka; Mochizuki, Yoko; Otani, Takato; Kato, Takashi			DEVELOPMENT OF THROMBOCYTES FROM THE MEGAKARYOCYTE INDUCED BY THROMBOPOIETIN IN FROG	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Tanizaki, Yuta; Kato, Takashi] Waseda Univ, Sch Educ, Dept Biol, Shinjuku Ku, Tokyo, Japan; [Murase, Ayaka; Mochizuki, Yoko; Otani, Takato; Kato, Takashi] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3192	S98	S98				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400248		
J	Wada, T; Koyama, D; Kikuchi, J; Honda, H; Furukawa, Y				Wada, Taeko; Koyama, Daisuke; Kikuchi, Jiro; Honda, Hiroaki; Furukawa, Yusuke			OVEREXPRESSION OF THE SHORTEST ISOFORM OF HISTONE DEMETHYLASE LSD1 PRIMES HEMATOPOIETIC STEM/PROGENITOR CELLS FOR MALIGNANT TRANSFORMATION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Wada, Taeko; Koyama, Daisuke; Kikuchi, Jiro; Furukawa, Yusuke] Fichi Med Univ, Shimotsuke, Tochigi, Japan; [Honda, Hiroaki] Hiroshima Univ, Hiroshima, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3051	S63	S63				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400108		
J	Yamakawa, N; Imadome, KI; Yahata, T; Kotani, A				Yamakawa, Natsuko; Imadome, Ken-Ichi; Yahata, Takashi; Kotani, Ai			MODULATION OF MACROPHAGES BY TUMOR-DERIVED SECRETARY SMALL RNAS IS CRITICAL FOR EBV POSITIVE LYMPHOMA FORMATION	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Yamakawa, Natsuko; Yahata, Takashi; Kotani, Ai] Tokai Univ, Isehara, Kanagawa, Japan; [Imadome, Ken-Ichi] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3207	S102	S102				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400263		
J	Yamazaki, S; Nakauchi, H				Yamazaki, Satoshi; Nakauchi, Hiromitsu			SPECIFIC AMINO ACID ENVIRONMENTS OF BONE MARROW ARE CRUCIAL FOR THE MAINTENANCE OF HEMATOPOIETIC STEM CELLS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3206	S102	S102				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400262		
J	Yokota, A; Hirai, H; Hayashi, Y; Tamura, A; Sato, A; Iwasa, M; Fujishiro, A; Shoji, T; Miura, Y; Maekawa, T				Yokota, Asumi; Hirai, Hideyo; Hayashi, Yoshihiro; Tamura, Akihiro; Sato, Atsushi; Iwasa, Masaki; Fujishiro, Aya; Shoji, Tsukimi; Miura, Yasuo; Maekawa, Taira			IFN alpha PROMOTES DIFFERENTIATION OF BCR-ABL(+) LEUKEMIC CELLS THROUGH UPREGULATING C/EBP beta	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Yokota, Asumi; Hirai, Hideyo; Tamura, Akihiro; Sato, Atsushi; Iwasa, Masaki; Fujishiro, Aya; Shoji, Tsukimi; Miura, Yasuo; Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med Cell Therapy, Kyoto 606, Japan; [Hayashi, Yoshihiro] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Hayashi, Yoshihiro; Iwasa, Masaki; Fujishiro, Aya] Shiga Univ Med Sci, Div Gastroenterol & Hematol, Otsu, Shiga 52021, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3213	S104	S104				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400269		
J	Yoshihara, S; Li, YY; Xia, JX; Li, W; Fujimori, Y; Yang, YG				Yoshihara, Satoshi; Li, Yuying; Xia, Jinxing; Li, Wei; Fujimori, Yoshihiro; Yang, Yong-Guang			STEM CELL FACTOR, GM-CSF, AND IL-3-TRANSGENIC HUMANIZED MICE DEVELOP FATAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Yoshihara, Satoshi; Fujimori, Yoshihiro] Hyogo Coll Med, Dept Transfus Med & Cellular Therapy, Nishinomiya, Hyogo 6638501, Japan; [Yoshihara, Satoshi; Li, Yuying; Xia, Jinxing; Yang, Yong-Guang] Columbia Univ Coll Phys & Surg, Dept Med, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Li, Yuying; Li, Wei; Yang, Yong-Guang] Jilin Univ, Hosp 1, Changchun 130023, Jilin, Peoples R China			Xia, Jinxing/E-5658-2015					0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		2018	S48	S48				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400050		
J	Yuda, J; Miyamoto, T; Odawara, J; Ohkawa, Y; Akashi, K				Yuda, Junichiro; Miyamoto, Toshihiro; Odawara, Jun; Ohkawa, Yasuyuki; Akashi, Koichi			THE CLINICAL IMPACT OF BOTH POINT MUTATED AND ALTERNATIVELY SPLICED BCR-ABL IN CML PATIENTS: RESULT OF HIGHLY-SENSITIVE, DEEP SEQUENCING STUDY	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract	44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH)	SEP 17-19, 2015	Kyoto, JAPAN	Int Soc Expt Hematol					[Yuda, Junichiro; Miyamoto, Toshihiro; Odawara, Jun; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Dept Adv Med Initiat, Fukuoka 812, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	SEP	2015	43	9		1		3215	S104	S104				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CR5XJ	WOS:000361417400271		
J	Hashizume, H; Nishitani, T; Konishi, S; Ueda, Y; Fukada, S; Sagara, A				Hashizume, H.; Nishitani, T.; Konishi, S.; Ueda, Y.; Fukada, S.; Sagara, A.			OVERVIEW OF FUSION ENGINEERING IN JAPAN	FUSION SCIENCE AND TECHNOLOGY			English	Article							LARGE HELICAL DEVICE; BROADER APPROACH; SUPERCONDUCTING MAGNET; REACTOR DESIGN; TUNGSTEN; BLANKET; DEMO; DIVERTOR; FFHR-D1; PROJECT	Based on long-term research activities on fusion engineering, eleven key technologies for future fusion reactors, especially for demo reactor, were selected in the Working Group of fusion research under the Council for Science and Technology, MEXT. In this paper, the recent achievement on the following key technologies will be summarized, which are strongly related to the Working Group proposal, 1) Fusion engineering research project in National Institute for Fusion Science, 2) High T-c superconducting magnets, 3) LiPb blanket system 4) Tungsten divertor and 5) Fusion engineering activities under the Broader Approach (BA) framework.	[Hashizume, H.] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Nishitani, T.] Japan Atom Energy Agcy, Rokkasho, Japan; [Konishi, S.] Kyoto Univ, Inst Adv Energy, Uji, Kyoto, Japan; [Ueda, Y.] Osaka Univ, Grad Sch Engn, Osaka, Japan; [Fukada, S.] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 812, Japan; [Sagara, A.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Hashizume, H (reprint author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan.	hidetoshi.hashizume@qse.tohoku.ac.jp					Tanaka T, 2014, FUSION ENG DES, V89, P1939, DOI 10.1016/j.fusengdes.2014.02.071; Sagara A, 2014, FUSION ENG DES, V89, P2114, DOI 10.1016/j.fusengdes.2014.02.076; Tamura H, 2014, FUSION ENG DES, V89, P2336, DOI 10.1016/j.fusengdes.2014.02.058; Ito S, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2244197; Masuzaki S, 2002, NUCL FUSION, V42, P750, DOI 10.1088/0029-5515/42/6/313; Kwon S, 2013, FUSION SCI TECHNOL, V64, P599; Ibano K, 2011, FUSION ENG DES, V86, P2779, DOI 10.1016/j.fusengdes.2010.12.011; Ueda Y, 2014, FUSION ENG DES, V89, P901, DOI 10.1016/j.fusengdes.2014.02.078; Tobita K, 2014, FUSION ENG DES, V89, P1870, DOI 10.1016/j.fusengdes.2014.02.077; Fukada S, 2013, MATER TRANS, V54, P425, DOI 10.2320/matertrans.MG201203; GOTO T., 2014, 25 FUS EN C OCT 13 1; Hashimoto N, 2013, MATER TRANS, V54, P442, DOI 10.2320/matertrans.MG201207; Hashizume H, 2014, FUSION ENG DES, V89, P2241, DOI 10.1016/j.fusengdes.2013.12.014; Hashizume H., 2002, J PLASMA FUSION RES, V5, P532; Ito S, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2176290; Ito S, 2004, INT J APPL ELECTROM, V19, P467; Ito S, 2001, INT J APPL ELECTROM, V14, P85; Ito S, 2006, FUSION ENG DES, V81, P2527, DOI 10.1016/j.fusengdes.2006.07.005; ITO S., 2014, PLASMA FUSION RES, V9; Ito S, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2291157; Kawai K, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2239335; Kikuchi Y, 2013, J NUCL MATER, V438, pS715, DOI 10.1016/j.jnucmat.2013.01.151; Komori A, 2010, FUSION SCI TECHNOL, V58, P1; Matsuda S, 2007, FUSION ENG DES, V82, P435, DOI 10.1016/j.fusengdes.2007.03.038; Mori D, 2014, FUSION ENG DES, V89, P1086, DOI 10.1016/j.fusengdes.2013.12.038; Nishitani T, 2014, FUSION ENG DES, V89, P1699, DOI 10.1016/j.fusengdes.2014.01.075; Noborio K, 2011, FUSION SCI TECHNOL, V60, P298; Okino F, 2013, FUSION SCI TECHNOL, V64, P543; Oya Y, 2013, MATER TRANS, V54, P430, DOI 10.2320/matertrans.MG201205; Sagara A, 2013, MATER TRANS, V54, P477, DOI 10.2320/matertrans.MG201210; SAGARA A., 21 TOFE NOV 10 AN US; TANAKA Y., 2015, FUSION SCI TECHNOL, V68, DOI [http://dx.doi.org/10.13182/FST15-109, DOI 10.13182/FST15-109]; TOKITANI M., 2014, 24 INT TOK C NOV 4 7; UO K., 1985, P IAEA TECHN COMM M, V687; YAGI J., 29 SOFT2014 SEPT 29; YANAGI N., 2014, P IAEA FUS EN C 2014; YANAGI N., 2014, 25 FUS EN C OCT 13 1; Yanagi N, 2011, FUSION SCI TECHNOL, V60, P648	38	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					201	210				10	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800002		
J	Mutoh, T; Nagaoka, K; Takahashi, H; Kasahara, H; Osakabe, M; Kubo, S; Shimozuma, T; Yoshimura, Y; Tsumori, K; Seki, T; Saito, K; Igami, H; Nakano, H; Ikeda, K; Kisaki, M; Seki, R; Kamio, S; Ii, T; Nakamura, Y; Takeiri, Y; Kaneko, O				Mutoh, T.; Nagaoka, K.; Takahashi, H.; Kasahara, H.; Osakabe, M.; Kubo, S.; Shimozuma, T.; Yoshimura, Y.; Tsumori, K.; Seki, T.; Saito, K.; Igami, H.; Nakano, H.; Ikeda, K.; Kisaki, M.; Seki, R.; Kamio, S.; Ii, T.; Nakamura, Y.; Takeiri, Y.; Kaneko, O.		LHD Expt Grp	HIGH POWER HEATING AND STEADY STATE OPERATION IN THE LARGE HELICAL DEVICE	FUSION SCIENCE AND TECHNOLOGY			English	Article							NEUTRAL BEAM INJECTION; LHD; IMPROVEMENT; PLASMAS; ENERGY	Recent advances in the high power and steady state heating system and experiment results of the Large Helical Device (LHD) are reviewed in this paper. Plasma performance is extended largely through high power NBI, ECH and steady state ICRF heating devices, and improved operation techniques. The NBI of a 28 MW has extended the plasma parameter regime such as ion ITB plasmas, has a central ion temperature of more than 8 keV, and the extremely high-density plasmas ten times higher than the tokamak limit. An ECH system with seven gyrotrons (total power of 4.6MW) has been operated for pre-ionization and plasma heating. The high electron temperature regime was extended toward a higher density regime and a central electron temperature of 13.5 keV was achieved with a line-averaged electron density of n(e) = 1 x 10(19) m(-3). Steady state operation plasma with n(e) = 1.2 x 10(19) m(-3), ion and electron temperature of 2 keV, and plasma sustainment time of 48 min was achieved with ICH and ECH heating power of 1.2 MW for majority helium with minority hydrogen.	[Mutoh, T.; Nagaoka, K.; Takahashi, H.; Kasahara, H.; Osakabe, M.; Kubo, S.; Shimozuma, T.; Yoshimura, Y.; Tsumori, K.; Seki, T.; Saito, K.; Igami, H.; Nakano, H.; Ikeda, K.; Kisaki, M.; Seki, R.; Kamio, S.; Ii, T.; Nakamura, Y.; Takeiri, Y.; Kaneko, O.; LHD Expt Grp] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Mutoh, T (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	mutoh@nifs.ac.jp			LHD project [NIFSULRR 701, NIFSULRR 702, NIFSULRR 703]	The authors thank the LHD project and technical team for their excellent support. This work is supported by the LHD project budget (NIFSULRR 701,702,703).	Takahashi H, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4884365; Yoshimura Y, 2010, FUSION SCI TECHNOL, V58, P551; Nakamura Y, 2006, NUCL FUSION, V46, P714, DOI 10.1088/0029-5515/46/7/004; Nagaoka K, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083022; Miyazawa J, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/4/043010; Shimozuma T, 2010, FUSION SCI TECHNOL, V58, P530; Nakano H, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3298843; Mutoh T, 2007, NUCL FUSION, V47, P1250, DOI 10.1088/0029-5515/47/9/023; Kaneko O, 2002, NUCL FUSION, V42, P441, DOI 10.1088/0029-5515/42/4/308; van Houtte D, 2004, NUCL FUSION, V44, pL11, DOI 10.1088/0029-5515/44/5/L01; Saito K, 2013, FUSION ENG DES, V88, P1025, DOI 10.1016/j.fusengdes.2013.02.100; Yokoyama M, 2007, NUCL FUSION, V47, P1213, DOI 10.1088/0029-5515/47/9/018; Yamada H, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/9/094021; Ii T, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4907355; AZUMI M., FRONTIER FU IN PRESS; IGAMI H., 2012, PLASMA FUSION RES, V7, P1, DOI [http://dx.doi.org/10.1585/pfr.7.2402110, DOI 10.1585/PFR.7.240211]; Ikeda K., 2013, NEW J PHYS, V15, DOI DOI 10.1088/1367-2630/15/10/103026; KAMIO S., 2015, FUSION ENG DESIGN; Kaneko O, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104015; Kasahara H, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4884363; Kasahara H., 2014, P 25 IAEA FUS EN C S; KISAKI M., 2013, PLASMA FUSION RES, V8, DOI [http://dx.doi.org/10.1585/pfr.8.2405060, DOI 10.1585/PFR.8.2405060]; Komori A, 2010, FUSION SCI TECHNOL, V58, P1; Kubo S, 2005, PLASMA PHYS CONTR F, V47, pA81, DOI 10.1088/0741-3335/47/5A/008; Mutoh T, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063017; Mutoh T, 2010, FUSION SCI TECHNOL, V58, P504; Nagaoka K., 2014, P 25 IAEA FUS EN C S; Nagaoka K, 2010, FUSION SCI TECHNOL, V58, P46; Osakabe Masaki, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S2042; Osakabe M., 2006, Nuclear Fusion, V46, DOI 10.1088/0029-5515/46/10/S07; Seki T., 2014, P 25 IAEA FUS EN C S; Shimozuma Takashi, 2009, J Microw Power Electromagn Energy, V43, P60; Takahashi H., 2014, PLASMA FUSION RES, V9, DOI DOI 10.1585/PFR.9.1402050; Takahashi H., 2012, PLASMA FUSION RES, V7; TAKEIRI Y., 2015, PLASMA FUSION RES; Takeiri Y, 2007, NUCL FUSION, V47, P1078, DOI 10.1088/0029-5515/47/9/002; Tsumori K, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2822111; Tsumori K, 2006, PLASMA SCI TECHNOL, V8, P24, DOI 10.1088/1009-0630/8/1/6	38	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					216	224				9	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800004		
J	Higashijima, S; Kamada, Y; Barabaschi, P; Shirai, H				Higashijima, Satoru; Kamada, Yutaka; Barabaschi, Pietro; Shirai, Hiroshi		JT-60SA Team	PRESENT STATUS OF MANUFACTURING AND R&Ds FOR THE JT-60SA TOKAMAK	FUSION SCIENCE AND TECHNOLOGY			English	Article							DESIGN	The JT-60SA superconducting tokamak is now under construction toward the first plasma in March 2019 as a joint project between the Broader Approach (BA) Satellite Tokamak Programme between Japan and Europe, and the Japanese national programme. The JT-60SA mission is to contribute to early realization of fusion energy by supporting ITER and by complementing ITER in resolving key physics and engineering issues for DEMO reactors. Before procurements of the major components, some R&Ds for key techniques were performed. By November 2014, 25 procurement arrangements (PAs) have been launched (JA: 14 PAs, EU: 11 PAs) covering 88% of the total cost of the BA Satellite Tokamak Programme, and the main components have entered the manufacturing stage. In addition, the JT-60SA tokamak assembly started since January 2013. This paper summarizes the recent progress of the JT-60SA project.	[Higashijima, Satoru; Kamada, Yutaka] Japan Atom Energy Agcy, JT JA Home Team 60SA, Naka, Ibaraki 3110193, Japan; [Barabaschi, Pietro] JT 60SA EU Home Team Fus Energy, D-85748 Garching, Germany; [Shirai, Hiroshi] Japan Atom Energy Agcy, JT Project Team 60SA, Naka, Ibaraki 3110193, Japan	Higashijima, S (reprint author), Japan Atom Energy Agcy, JT JA Home Team 60SA, 801-1 Mukoyama, Naka, Ibaraki 3110193, Japan.	higashijima.satoru@jaea.go.jp					Medrano M, 2013, FUSION ENG DES, V88, P711, DOI 10.1016/j.fusengdes.2013.01.028; Di Pietro E, 2014, FUSION ENG DES, V89, P2128, DOI 10.1016/j.fusengdes.2013.11.015; Kamada Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104010; Ikeda Y, 2014, FUSION ENG DES, V89, P2018, DOI 10.1016/j.fusengdes.2013.12.017; ISAYAMA A., 2012, P 24 IAEA FUS EN C S; Lamaison V, 2014, AIP CONF PROC, V1573, P337, DOI 10.1063/1.4860720; Shibama YK, 2013, FUSION ENG DES, V88, P1916, DOI 10.1016/j.fusengdes.2013.01.100	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					259	266				8	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800009		
J	Sagara, A; Tanaka, T; Yagi, J; Takahashi, M; Miura, K; Yokomine, T; Fukada, S; Ishiyama, S				Sagara, Akio; Tanaka, Teruya; Yagi, Juro; Takahashi, Mitsutoshi; Miura, Kuniaki; Yokomine, Takehiko; Fukada, Satoshi; Ishiyama, Shintaro			FIRST OPERATION OF THE FLINAK/LiPb TWIN LOOP (OROSHI)-I-2-2 WITH A 3T SC MAGNET FOR R&D OF LIQUID BLANKET FOR FUSION REACTOR	FUSION SCIENCE AND TECHNOLOGY			English	Article							PRESSURE-DROP; LITHIUM FLOW; TECHNOLOGY; STEEL	A Flinak/LiPb twin-loop Orosh(2)i-2 was constructed in the Fusion Engineering Research Project of NIFS to establish an engineering basis for the "real function" of a liquid blanket for fusion energy reactors. It was constructed with a 3 T superconducting magnet, which is the strongest in the world for these purposes. In this study, 120 litter Flinak and LiPb were successfully prepared in-situ in a purified glove-box. Designed flow velocity up to 1.5 m/sec was achieved for both. The magnetic field and velocity dependence on pressure drop agreed well with theoretical predictions. Tentative plans for phased experiments within the next few years have been presented, including operation of Supercritical-CO2 Turbine (SCOT) power generation system in the Flinak loop.	[Sagara, Akio; Tanaka, Teruya; Yagi, Juro] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Takahashi, Mitsutoshi; Miura, Kuniaki] Sukegawa Elect Co Ltd, Takahagi, Ibaraki 3180004, Japan; [Yokomine, Takehiko] Kyoto Univ, Nishikyo Ku, Kyoto 6158540, Japan; [Fukada, Satoshi] Kyushyu Univ, Kasuga, Fukuoka 8168580, Japan; [Ishiyama, Shintaro] Okayama Univ, Kita Ku, Okayama 7008530, Japan	Sagara, A (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	sagara.akio@LHD.nifs.ac.jp			JSPS KAKENHI [25249133]; NIFS [NIFS612002007]	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (A)25249133 and NIFS budget code NIFS612002007.	Ishiyama S, 2008, PROG NUCL ENERG, V50, P325, DOI 10.1016/j.pnucene.2007.11.078; Smolentsev S, 2010, FUSION ENG DES, V85, P1196, DOI 10.1016/j.fusengdes.2010.02.038; Sagara A, 2014, FUSION ENG DES, V89, P2114, DOI 10.1016/j.fusengdes.2014.02.076; Cheng WJ, 2015, SOL ENERG MAT SOL C, V132, P563, DOI 10.1016/j.solmat.2014.10.007; MIYAZAKI K, 1986, FUSION TECHNOL, V10, P830; LANE J. A., 1958, FLUID FUEL REACTORS; MIYAZAKI K, 1983, NUCL TECHNOL-FUSION, V4, P447; Nygren RE, 2005, FUSION SCI TECHNOL, V47, P549; Sagara A, 2011, FUSION SCI TECHNOL, V60, P3; Satake S, 2006, FUSION ENG DES, V81, P367, DOI 10.1016/j.fusengdes.2005.09.069; Ueki Y, 2014, FUSION ENG DES, V89, P77, DOI 10.1016/j.fusengdes.2013.12.011; Valls EM, 2008, J NUCL MATER, V376, P353, DOI 10.1016/j.jnucmat.2008.02.016; WRIGHT S., 2009, P ICAPP, V9152; YAGI J., 2014, 29 SOFT SPAIN	14	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					303	307				5	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800016		
J	Nishitani, T; Kondo, K; Ohira, S; Yamanishi, T; Sugimoto, M; Hayashi, T; Ochiai, K				Nishitani, T.; Kondo, K.; Ohira, S.; Yamanishi, T.; Sugimoto, M.; Hayashi, T.; Ochiai, K.			NEUTRON SOURCE FOR MATERIAL AND COMPONENT TESTS BY USING IFMIF/EVEDA PROTOTYPE ACCELERATOR	FUSION SCIENCE AND TECHNOLOGY			English	Article							IFMIF	A neutron source for material and component tests is an essential tool for the DEMO reactor development. An accelerator-based neutron source such as IFMIF is regarded as the most promising one in Japan and the EU. The construction plan of IFMIF is still open due to the influence of the large cost overrun of ITER procurements. Japan Atomic Energy Agency (JAEA) has a plan of a neutron source for material and component tests using an IFMIF/EVEDA prototype accelerator and a lithium test loop for the IFMIF target facility. Expected performances of three options; 9 MeV and upgrading to 26 or 40 MeV of deuteron beam, are discussed. At the back plate position of the target, 1.5, 14, and 25 dpa/fpy are expected for 9, 26, and 40 MeV case, respectively. The option of 40 MeV is desirable, however, the option of 26 MeV is acceptable for blanket functional tests and material tests.	[Nishitani, T.; Kondo, K.; Ohira, S.; Yamanishi, T.; Sugimoto, M.; Hayashi, T.; Ochiai, K.] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan	Nishitani, T (reprint author), Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan.	nishitani.takeo@jaea.go.jp					Knaster J, 2014, FUSION ENG DES, V89, P1709, DOI 10.1016/j.fusengdes.2014.01.011; Fischer U, 2007, J NUCL MATER, V367, P1531, DOI 10.1016/j.jnucmat.2007.04.038; Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Simakov SP, 2012, FUSION SCI TECHNOL, V62, P233; Kondo H, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/12/123008; Giancarli L, 2006, FUSION ENG DES, V81, P393, DOI 10.1016/j.fusengdes.2005.08.096; Garin P, 2009, FUSION ENG DES, V84, P259, DOI 10.1016/j.fusengdes.2008.12.040; HElDlNGER R., 2014, FUSION ENG DES, V89, DOI [http://dx.doi.org/10.1016/j.fusengdes.2014.03.085, DOI 10.1016/J.FUSENGDES.2014.03.085]; Matsuda S, 2007, FUSION ENG DES, V82, P435, DOI 10.1016/j.fusengdes.2007.03.038	9	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					326	330				5	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800020		
J	Takeda, S; Konishi, S; Yamamoto, Y; Kasada, R; Sakurai, S				Takeda, Shutaro; Konishi, Satoshi; Yamamoto, Yasushi; Kasada, Ryuta; Sakurai, Shigeki			DYNAMIC SIMULATION-BASED CASE STUDY OF FUSION ON SMALL-SCALE ELECTRICAL GRIDS	FUSION SCIENCE AND TECHNOLOGY			English	Article								This study analyzed adverse effects of fusion plants on the stability of small-scale grids through simulation-based case studies. Major frequency fluctuations were observed in the event of a plant start-up and a sudden interruption of fusion electric output power, as represented by plasma disruption, suggesting difficulties in fusion plant installation to majority of countries in the future. To mitigate the adverse effects, a fusion plant combined with an energy storage was proposed and evaluated. The results indicated that large energy storage like pumped-hydro storage could successfully reduce the frequency deviations to the acceptable range. An innovative offshore pumped-hydro storage, marine inverse dam, is also discussed in this paper.	[Takeda, Shutaro; Sakurai, Shigeki] Kyoto Univ Yoshidakonoe, Grad Sch Adv Integrated Studies Human Survivabil, Sakyo Ward, Kyoto 6068501, Japan; [Konishi, Satoshi; Kasada, Ryuta] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Yamamoto, Yasushi] Kansai Univ, Fac Engn Sci, Suita, Osaka 5648680, Japan	Takeda, S (reprint author), Kyoto Univ Yoshidakonoe, Grad Sch Adv Integrated Studies Human Survivabil, Sakyo Ward, 69 Yoshidakonoe, Kyoto 6068501, Japan.	takeda.shutarou.55r@st.kyoto-u.ac.jp					[Anonymous], 2003, FREQ REG INT COORD E; [Anonymous], 2013, WORLD EN OUTL, P169, DOI [http://dx.doi.org/10.1787/weo-2013-8-en, DOI 10.1787/WE0-2013-8-EN]; [Anonymous], 2001, ITER FEAT FIN DES RE; Chen HS, 2009, PROG NAT SCI, V19, P291, DOI 10.1016/j.pnsc.2008.07.014; Fraile-Ardanuy J, 2006, IEEE T ENERGY CONVER, V21, P569, DOI 10.1109/TEC.2005.858084; [Anonymous], 2002, EM NORM TIM FREQ CON, P55; [Anonymous], 2014, INT EN STAT; HUE H., 2008, POWERCON2008 POW C I; Konishi S, 2002, FUSION ENG DES, V63-64, P11, DOI 10.1016/S0920-3796(02)00264-8; SHIMADA R, 1987, FUSION ENG DES, V5, P47, DOI 10.1016/S0920-3796(87)90556-4	10	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					341	345				5	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800023		
J	Oya, Y; Sato, M; Yuyama, K; Hara, M; Hatano, Y; Matsuyama, M; Chikada, T				Oya, Yasuhisa; Sato, Misaki; Yuyama, Kenta; Hara, Masanori; Hatano, Yuji; Matsuyama, Masao; Chikada, Takumi			DYNAMICS FOR HT AND HTO RECOVERY THROUGH WATER BUBBLER AND CuO CATALYST	FUSION SCIENCE AND TECHNOLOGY			English	Article							SEPARATION; GAS	Dynamics of tritium recovery using CuO catalyst and water bubbler was studied as a function of gas flow rate and CuO temperature. The rate constant of tritiated water formation by CuO catalyst at the temperature above 500 K was determined to be k [s(-1)] = 5.4x10(5) exp (-0.65 eV / k(B)T). For the flow rate less than 50 sccm, it was found that the reaction rate will be controlled by the desorption rate of HTO on the surface of CuO. These results were applied for the design of tritium removal system at radiation-controlled area. It was concluded that the reactor tubing with 1.0 meter length at 600 K will be suitable to reduce the tritium concentration less than 1/1000 and the longer reactor tubing will be required if the operation temperature will be lower than 600 K	[Oya, Yasuhisa; Sato, Misaki; Yuyama, Kenta; Chikada, Takumi] Shizuoka Univ, Grad Sch Sci, Suruga Ku, Shizuoka 4228529, Japan; [Hara, Masanori; Hatano, Yuji; Matsuyama, Masao] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan	Oya, Y (reprint author), Shizuoka Univ, Grad Sch Sci, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	oya.yasuhisa@shizuoka.ac.jp			University of Toyama collaboration program [HRC2014-01]	This study is supported by University of Toyama collaboration program, HRC2014-01.	NISHIKAWA M, 1983, J NUCL SCI TECHNOL, V20, P145; CLARK W. E., ORNL2815; Hara M, 2013, J PHYS CHEM SOLIDS, V74, P1174, DOI 10.1016/j.jpcs.2013.03.023; Kawabata H, 1979, Radioisotopes, V28, P542; MANNONE F., 1993, SAFETY TRITIUM HANDL, DOI [http://dx.doi.org/10.1007/978-94-011-1910-8, DOI 10.1007/978-94-011-1910-8]; MATSUYAMA M., 1981, DESIGN CONSTRUCTION, V1, P15; Morimoto Y, 2006, FUSION ENG DES, V81, P821, DOI 10.1016/j.fusengdes.2005.07.026; OKAMOTO M, 1995, FUSION TECHNOL, V28, P460; Watanabe K, 1997, J ALLOY COMPD, V257, P278, DOI 10.1016/S0925-8388(96)03133-7	9	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					358	361				4	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800026		
J	Moriyama, Y; Kunugi, T; Yokomine, T; Kawara, Z; Norimatsu, T				Moriyama, Yuji; Kunugi, Tomoaki; Yokomine, Takehiko; Kawara, Zensaku; Norimatsu, Takayoshi			FUNDAMENTAL STUDY OF WAVE PROPAGATION ON LIQUID SURFACE RELATED IFE MIRROR	FUSION SCIENCE AND TECHNOLOGY			English	Article							METAL MIRRORS; FUSION	A laser fusion reactor needs an optical mirror in its final optical system. This optical mirror is exposed to the neutron produced with fusion reaction. It is pointed out that the exposure to neutron will produce hydrogen gas in the mirror and cause swelling deformation of mirror. To avoid this swelling of mirror, a liquid-metal mirror is promising. High energy laser shots on the liquid mirror will cause the surface wave. These waves must be damped to under 1/10 of the laser wavelength in 250 ms or less. In this study, the hydrodynamic behavior of the liquid surface was investigated by experiment with water as surrogate liquid, the computational evaluation for the wave propagation with the MARS (Multi-interface Advection and Reconstruction Solver, 2001) was carried out, and the design window for the optical mirror based on the water experiment was discussed.	[Moriyama, Yuji; Kunugi, Tomoaki; Yokomine, Takehiko; Kawara, Zensaku; Norimatsu, Takayoshi] Kyoto Daigaku Katsura, Nishikyo Ku, Kyoto 6158540, Japan	Kunugi, T (reprint author), Kyoto Daigaku Katsura, Nishikyo Ku, Kyoto 6158540, Japan.	kunugi@nucleng.kyoto-u.ac.jp			National Institute for Fusion Science;  [25420887]	The authors would like to thank for the support provided by the National Institute for Fusion Science and Grants-in-Aid for Scientific Research C, 25420887.	Snead LL, 2009, FUSION SCI TECHNOL, V56, P1069; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; Tillack MS, 2009, FUSION SCI TECHNOL, V56, P446; KOZAK Y., 2006, J PLASMA FUSION RES, V82, P817, DOI http://dx.doi.org/10.1051/jp4:2006133168; KUNUGI T., 2001, COMPUT FLUID DYN J, V9, P563; MIZUMURA K., 1992, KAIGAN KAIYO KOGAKU; Moir RW, 2000, FUSION ENG DES, V51-52, P1121, DOI 10.1016/S0920-3796(00)00224-6	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					392	396				5	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800033		
J	Kawamoto, Y; Nakaya, H; Matsuura, H; Katayama, K; Goto, M; Nakagawa, S				Kawamoto, Yasuko; Nakaya, Hiroyuki; Matsuura, Hideaki; Katayama, Kazunari; Goto, Minoru; Nakagawa, Shigeaki			STUDY ON OPERATION SCENARIO OF TRITIUM PRODUCTION FOR A FUSION REACTOR USING A HIGH TEMPERATURE GAS-COOLED REACTOR	FUSION SCIENCE AND TECHNOLOGY			English	Article							PRODUCTION DEVICE; PERFORMANCE; DESIGN	To start up a fusion reactor, it is necessary to provide a sufficient amount of tritium from an external device. The fusion DEMO reactor is planned to start up in the 2030s. Herein, methods for supplying the reactor with tritium are discussed. For the initial startup of the fusion reactor, use of a high temperature gas-cooled reactor (HTGR) as a tritium production device has been proposed So far, the analyses have been focused only on the operation in which fuel is exchanged at stated periods (batch) using the block type HTGR. In this paper, to improve the performance of tritium production, properties of the HTGR are studied from the viewpoint of continuous operation for several conditions. In continuous operation, for example, in the pebble bed type HTGR, it is possible to design an operation that has no time loss for refueling. The pebble bed modular reactor (PBMR) and the gas turbine high temperature reactor of 300 MWe nominal capacity (GTHTR300) are assumed as the calculation and comparison targets, and simulation is made using the continuous-energy Monte Carlo transport code MVP-BURN. It is shown that the continuous operation using the pebble bed type HTGR has almost the same tritium productivity compared with the batch operation using the block type HGTR. The issues for pebble bed type HTGR as a tritium production device are discussed.	[Kawamoto, Yasuko; Nakaya, Hiroyuki; Matsuura, Hideaki] Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 8190395, Japan; [Katayama, Kazunari] Kyushu Univ, Dept Adv Energy Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Goto, Minoru; Nakagawa, Shigeaki] Japan Atom Energy Agcy, Higashiibaraki, Ibaraki 3111313, Japan	Kawamoto, Y (reprint author), Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, 744 Motooka, Fukuoka 8190395, Japan.	kawamoto@nucl.kyushu-u.ac.jp			JSPS KAKENHI [25630421]	This work is supported by JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research 25630421.	Acir A, 2015, PROG NUCL ENERG, V78, P380, DOI 10.1016/j.pnucene.2013.11.009; Matsuura H, 2013, FUSION ENG DES, V88, P2219, DOI 10.1016/j.fusengdes.2013.05.022; Matsuura H, 2012, NUCL ENG DES, V243, P95, DOI 10.1016/j.nucengdes.2011.12.008; Koster A, 2003, NUCL ENG DES, V222, P231, DOI 10.1016/S0029-5493(03)00029-3; Nakaya H, 2014, NUCL ENG DES, V271, P505, DOI 10.1016/j.nucengdes.2013.12.023; Nishikawa M, 2012, FUSION ENG DES, V87, P466, DOI 10.1016/j.fusengdes.2011.12.022; Powers JJ, 2010, J NUCL MATER, V405, P74, DOI 10.1016/j.jnucmat.2010.07.030; Ni MY, 2013, FUSION ENG DES, V88, P2422, DOI 10.1016/j.fusengdes.2013.05.043; Asaoka Y, 1996, FUSION TECHNOL, V30, P853; BAUMER R, 1990, NUCL ENG DES, V121, P155, DOI 10.1016/0029-5493(90)90100-C; Katayama K, 2015, FUSION SCI TECHNOL, V68, P662, DOI 10.13182/FST14-968; KATAYAMA K., 2011, J PLASMA FUSION RES, V87, P503; NAGAYA Y., 2005, JAERI, V1348; Reed MD, 2005, J CRYST GROWTH, V274, P14, DOI 10.1016/j.jcrysgro.2004.09.079; Yan X, 2003, NUCL ENG DES, V222, P247, DOI 10.1016/S0029-5493(03)00030-X	15	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					397	401				5	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800034		
J	Someya, Y; Tobita, K; Utoh, H; Asakura, N; Sakamoto, Y; Hoshino, K; Nakamura, M; Tokunaga, S				Someya, Youji; Tobita, Kenji; Utoh, Hiroyasu; Asakura, Nobuyuki; Sakamoto, Yoshiteru; Hoshino, Kazuo; Nakamura, Makoto; Tokunaga, Shinsuke			MANAGEMENT STRATEGY FOR RADIOACTIVE WASTE IN THE FUSION DEMO REACTOR	FUSION SCIENCE AND TECHNOLOGY			English	Article							POWER-PLANTS; CLEARANCE	We have considered a strategy for reducing the radioactive waste generated by the replacement of in-vessel components, such as blanket segments and divertor cassettes, for the fusion DEMO reactor. In the basic case, the main parameters of the DEMO reactor are a major radius of 8.2 m and a fusion power of 1.35 GW. Blanket segments and divertor cassettes should be replaced independently, as their lifetimes differ. A blanket segment comprises several blanket modules mounted to a back-plate. The total weight of an in-vessel component is estimated to be about 6,648 ton (1,575, 3,777, 372, and 924 ton of blanket module, back-plate, conducting shell, and divertor cassette, respectively). The lifetimes of a blanket segment and a divertor cassette are assumed to be 2.2 years and 0.6 years, respectively, and 52,487 tons of waste is generated over a plant life of 20 years. Therefore, there is a concern that the contamination-control area for radioactive waste may need to increase due to the amount of waste generated from every replacement. This paper proposes a management scenario to reduce radioactive waste. When feasible and relevant, back-plates of blanket segment and divertor cassette bodies (628 ton) should be reused. Using the three-dimensional neutron transportation code MCNP, the displacement per atom (DPA) of the SUS316LN back-plates is 0.2 DPA/year and that of the F82H cassette bodies is 0.6 DPA/year. Therefore, the reuse of back-plates and cassette bodies would be possible if re-welding points are arranged under neutron shielding. We found that radioactive waste could be reduced to 20 % when tritium breeding materials are recycled. Finally, we propose a design for the DEMO building that uses a hot cell and temporary storage.	[Someya, Youji; Tobita, Kenji; Utoh, Hiroyasu; Asakura, Nobuyuki; Sakamoto, Yoshiteru; Hoshino, Kazuo; Nakamura, Makoto; Tokunaga, Shinsuke] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan	Someya, Y (reprint author), Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan.	someya.yoji@jaea.go.jp					Al-dama D. Lopez, 2004, INDCNDS46 IAEA; Crofts O, 2014, FUSION ENG DES, V89, P2383, DOI 10.1016/j.fusengdes.2014.01.038; Someya Y, 2011, FUSION ENG DES, V86, P2269, DOI 10.1016/j.fusengdes.2011.01.141; El-Guebaly L, 2006, FUSION SCI TECHNOL, V49, P62; Nagy D, 2008, FUSION ENG DES, V83, P1870, DOI 10.1016/j.fusengdes.2008.05.033; El-Guebaly L, 2008, FUSION ENG DES, V83, P928, DOI 10.1016/j.fusengdes.2008.05.025; EL-GUEBALY L. A., 2005, UWFDM1285; SEKI Y., 1986, JAERI, V1301; Tobita K, 2006, FUSION ENG DES, V81, P1151, DOI 10.1016/j.fusengdes.2005.08.058; X-5 Monte Carlo Team, 2005, LACP030245 LANL; Zucchetti M, 2007, J NUCL MATER, V367, P1355, DOI 10.1016/j.jnucmat.2007.03.248	11	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					423	427				5	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800039		
J	Ito, S; Hashizume, H				Ito, Satoshi; Hashizume, Hidetoshi			STEADY AND TRANSIENT THERMAL ANALYSES ON A SEGMENTED HIGH-TEMPERATURE SUPERCONDUCTING MAGNET WITH POROUS MEDIA-INSERTED CRYOGENIC COOLING	FUSION SCIENCE AND TECHNOLOGY			English	Article							DESIGN; FIELD; HEAT	This paper discusses thermal design of a segmented high-temperature superconducting (HTS) magnet depending on geometry of HTS conductors, cooling system (indirect cooling or partial forced flow cooling), cooling techniques and joint resistance. For the purpose, three-dimensional heat conduction analysis was carried out with a finite element code, modeling geometry and operating condition of helical coils. in a helical fusion reactor, FFHR as an example. In this analysis, liquid neon was assumed to be used as a coolant at an operating temperature of 25 K. As a heat removal technique for the joint, cooling system of a cryogenic liquid coolant with metal porous media has been proposed and it was also modeled in the heat conduction analysis. The numerical results showed that stainless steel jacket and a low thermal conductivity insulator determine temperature distribution and any cooling techniques cannot contribute to prevent the temperature rise when joint resistance increases in the case of the indirect cooling system. On the other hand, a high performance cooling technique such as metal porous media-inserted channel is effective to reduce temperature rise in the partial force cooling system.	[Ito, Satoshi; Hashizume, Hidetoshi] Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Ito, S (reprint author), Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy Engn, Aoba Ku, Aramaki Aza Aoba 6-6-01-2, Sendai, Miyagi 9808579, Japan.	satoshi.ito@qse.tohoku.ac.jp			JSPS [26220913]	This work was partially supported by JSPS, Grant-in-Aid for Scientific Research (S), 26220913, 2014. S. Ito and H. Hashizume appreciate Y. Tanno, S. Sasaki and D. Issiki for their technical supports.	Sagara A, 2014, FUSION ENG DES, V89, P2114, DOI 10.1016/j.fusengdes.2014.02.076; Ito S, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2244197; Bromberg L, 2001, FUSION ENG DES, V54, P167, DOI 10.1016/S0920-3796(00)00432-4; ACHENBACH E, 1995, EXP THERM FLUID SCI, V10, P17, DOI 10.1016/0894-1777(94)00077-L; Hartwig ZS, 2012, FUSION ENG DES, V87, P201, DOI 10.1016/j.fusengdes.2011.10.002; Jiang PX, 2004, INT J HEAT MASS TRAN, V47, P2085, DOI 10.1016/j.ijheatmasstransfer.2003.12.004; BANSAL G., 2008, PLASMA FUSION RES, V3, pS1049, DOI [http://dx.doi.org/10.1585/pfr.3.51049, DOI 10.1585/PFR.3.51049]; Hashizume H, 2014, FUSION ENG DES, V89, P2241, DOI 10.1016/j.fusengdes.2013.12.014; Hashizume H., 2002, J PLASMA FUSION RES, V5, P532; Inoue M, 2003, PHYSICA C, V392, P1078, DOI 10.1016/S0921-4534(03)00831-1; ITO S., 2014, PLASMA FUSION RES, V9; MONIWA K., 2008, P 22 INT CRYON ENG C, P329; Tanno Y, 2014, AIP CONF PROC, V1573, P597, DOI 10.1063/1.4860756; Yanagi N, 2011, FUSION SCI TECHNOL, V60, P648; YUKI K., 2009, AM SOC MECH ENG	15	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					428	432				5	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800040		
J	Tanaka, Y; Lee, HT; Ueda, Y; Nagata, M; Kikuchi, Y; Suzuki, S; Seki, Y				Tanaka, Yasufumi; Lee, Heun Tae; Ueda, Yoshio; Nagata, Masayoshi; Kikuchi, Yusuke; Suzuki, Satoshi; Seki, Yohji			EFFECT OF SURFACE DAMAGE ON THERMAL RESPONSE OF TUNGSTEN MONOBLOCKS	FUSION SCIENCE AND TECHNOLOGY			English	Article							HEAT; ITER; DIVERTOR; LOADS	In this study, surface damaged W monoblocks (melting and cracking) by a pulsed plasma gun and an e-beam devices were exposed to cyclic heat loads (simulating normal heat loads and slow transients) and pulsed heat loads (simulating ELMs) to observe the effects of surface damage on surface erosion and heat removal capability. Heat load tests simulating the normal heat load (10 MW/m(2), 10 sec, 300 cycles) and the slow transient (similar to 20 MW/m(2), 10 sec, 300 cycles) were performed by the e-beam. The surface morphology changes after the heat load tests were observed using laser sccaning microscopy and FE-SEM After e-beam irradiation of similar to 20 MW/m(2), the longitudinal cracks crossing over entire mono blocks appeared on the surfaces of all monoblocks. Recrystallization and additional crack formation were also observed on the surface. However, there was no significant change of heat removal capability. In the additional pulsed heat load test, the energy fluence of 0.042-0.30MJ/m(2) was applied with pulse numbers of 10(3) and 10(4).The surface morphology changes after laser irradiation were observed using laser scanning microscope. After laser irradiation, the grain ejection occurred above a certain energy fluence (similar to 25 % of melting threshold).	[Tanaka, Yasufumi; Lee, Heun Tae; Ueda, Yoshio] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan; [Nagata, Masayoshi; Kikuchi, Yusuke] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712201, Japan; [Suzuki, Satoshi; Seki, Yohji] Japan Atom Energy Agcy, Naka, Ibaraki, Japan	Tanaka, Y (reprint author), Osaka Univ, Grad Sch Engn, 2-2 Yamadaoka, Suita, Osaka, Japan.	yueda@eei.eng.osaka-u.ac.jp					Nagata M, 2009, IEEJ T ELECTR ELECTR, V4, P518, DOI 10.1002/tee.20438; Pintsuk G, 2013, FUSION ENG DES, V88, P1858, DOI 10.1016/j.fusengdes.2013.05.091; Masaki K, 2002, FUSION ENG DES, V61-62, P171, DOI 10.1016/S0920-3796(02)00115-1; Pitts RA, 2011, J NUCL MATER, V415, pS957, DOI 10.1016/j.jnucmat.2011.01.114; Hirai T, 2013, FUSION ENG DES, V88, P1798, DOI 10.1016/j.fusengdes.2013.05.010; Garkusha IE, 2014, FUSION SCI TECHNOL, V65, P186; Ueda Y, 2014, FUSION ENG DES, V89, P901, DOI 10.1016/j.fusengdes.2014.02.078; Wirtz M, 2013, FUSION ENG DES, V88, P1768, DOI 10.1016/j.fusengdes.2013.05.077; Ueda Y, 2007, FUSION ENG DES, V82, P1904, DOI 10.1016/j.fusengdes.2006.12.002; Gavila P, 2011, FUSION ENG DES, V86, P1652, DOI 10.1016/j.fusengdes.2011.02.012; Kikuchi Y, 2013, J NUCL MATER, V438, pS715, DOI 10.1016/j.jnucmat.2013.01.151; Klimov NS, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014064; LOEWENHOFF T., 2012, THESIS RWTH AACHEN G	13	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					433	437				5	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800041		
J	Muneoka, T; Fukada, S; Yoshimura, R; Katayama, K; Edao, Y; Hayashi, T				Muneoka, Taiki; Fukada, S.; Yoshimura, R.; Katayama, K.; Edao, Y.; Hayashi, T.			EXPERIMENT ON RECOVERY OF HYDROGEN FROM FLUIDIZED Li17Pb83 BLANKET	FUSION SCIENCE AND TECHNOLOGY			English	Article							ISOTOPIC EXCHANGE; EUTECTIC ALLOY; LITHIUM; LI0.17PB0.83; PERMEATION; DIFFUSION	Development of an efficient tritium recovery method is indispensable in order to compose a liquid blanket system of a D-T fusion reactor in the near future. Here, tritium recovery using a bubbling tower is focused on, and the behavior of H transfer between fluidized lithium-lead (Li-Pb) and gas bubbles of Ar-H-2 or pure Ar is examined analytically and experimentally under isothermal conditions. Gas of Ar-H-2 or pure Ar is injected into fluidized Li-Pb through an I-shape nozzle made from SS-316. Time variations of the H-2 concentration in gas bubbles that come out from fluidized Li-Pb are measured by gas chromatography. Mass-transfer coefficients to correlate rates of H atom transfer between Li-Pb and gas bubbles are obtained by fitting analytical equations to experimental results. The solution is derived under conditions where H transfer between bubbles and liquid Li-Pb is limited by diffusion in the Li-Pb boundary layer. The parameters such as bubble diameter and terminal rising velocity which are used in order to derive analytic formula are estimated from balance among several forces such as gravity, surface tension, inertia force and so on. The behavior of hydrogen transfer at gas-liquid interfaces in liquid blanket is investigated in terms of the mass-transfer coefficient obtained under various conditions.	[Muneoka, Taiki; Fukada, S.; Yoshimura, R.; Katayama, K.] Kyushu Univ, Dept Adv Energy Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Edao, Y.; Hayashi, T.] Japan Atom Energy Agcy, Tritium Proc Lab, Tokai, Ibaraki 3191184, Japan	Muneoka, T (reprint author), Kyushu Univ, Dept Adv Energy Engn Sci, Kasuga Koen 6-1, Kasuga, Fukuoka 8168580, Japan.	sfukada@nucl.kyushu-u.ac.jp					SIEMES W, 1956, CHEM ENG SCI, V5, P127, DOI 10.1016/0009-2509(56)80028-6; Edao Y, 2009, FUSION SCI TECHNOL, V56, P831; TERAI T, 1992, J NUCL MATER, V191, P272; Edao Y, 2011, FUSION SCI TECHNOL, V60, P1163; Kondo M, 2012, FUSION ENG DES, V87, P1788, DOI 10.1016/j.fusengdes.2012.02.097; Okitsu H, 2012, FUSION ENG DES, V87, P1324, DOI 10.1016/j.fusengdes.2012.03.004; Maeda Y, 2008, FUSION SCI TECHNOL, V54, P131; Edao Y, 2011, J NUCL MATER, V417, P723, DOI 10.1016/j.jnucmat.2010.12.126; Edao Y, 2010, FUSION ENG DES, V85, P1225, DOI 10.1016/j.fusengdes.2010.03.010; Hadamard J.S., 1911, CR HEBD ACAD SCI, V152, P1735; MAEDA S., 1963, KAGAKU KOGAKU, V27, P147	11	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					443	447				5	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800043		
J	Furuichi, K; Katayama, K; Date, H; Takeishi, T; Fukada, S				Furuichi, Kazuya; Katayama, Kazunari; Date, Hiroyuki; Takeishi, Toshiharu; Fukada, Satoshi			TRITIUM DESORPTION BEHAVIOR FROM SOIL EXPOSED TO TRITIATED WATER	FUSION SCIENCE AND TECHNOLOGY			English	Article								In this study, tritiated water was poured in a packed bed of natural soil and subsequently distilled water was poured in the bed to recover tritium retained in the soil at room temperature. From tritium balance, 22.5 % (7.1 MBq) of input tritium (31.5 MBq) was retained in the soil bed. By distilled water purge, 70 % (5 MBq) of retained tritium was recovered but 30% (2.1 MBq) was left. To recover residual tritium, the soil was immersed in distilled water for 531 days but the amount of tritium released to distilled water was slight (0.04 MBq). A part of the soil immersed in the water was taken out and heated up to 300 degrees C under humid oxygen atmosphere. Tritium release terminated at about 50 hours. 11 % (0.23 MBq) of retained tritium was released. By heating to 1000 degrees C, the release amount of tritium increased proportionally to the time and additional 4% (0.09 MBq) was released at 5 hours. The desorption rates of tritium in each process was quantified. Tritium is quite slowly released from the natural soil exposed to tritiated water in water at room temperature. However, a long time heating by 1000 degrees C would be required to try to recover all tritium from the contaminated soil positively, although tritium recovery was not completed in this work.	[Furuichi, Kazuya; Katayama, Kazunari; Date, Hiroyuki; Fukada, Satoshi] Kyushu Univ, Dept Adv Energy Engn, Kasuga, Fukuoka 8168580, Japan; [Takeishi, Toshiharu] Kyushu Univ, Fac Engn, Nishi Ku, Fukuoka 8190395, Japan	Furuichi, K (reprint author), Kyushu Univ, Dept Adv Energy Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	kfuruichi@aees.kyushu-u.ac.jp			KAKENHI [25709087]	This work is supported by KAKENHI Grant-in-Aid for Young Scientists (A) 25709087.	Furuichi K, 2007, J NUCL MATER, V367, P1243, DOI 10.1016/j.jnucmat.2007.03.227; HONDA T., 2014, FUSION SCI TECHNOL, V67, P382, DOI [http://dx.doi.org/10.13182/FST14-T34, DOI 10.13182/FST14-T34]; Jackson D. G., 2013, WAST MAN S 2013; Kalinichenko EA, 2002, CLAY MINER, V37, P497, DOI 10.1180/0009855023730048; Nakashio N, 1998, FUSION TECHNOL, V33, P287; The Clay Sci. Soc. Japan, 2009, NENDO HDB, V3rd	6	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	SEP	2015	68	2					458	464				7	Nuclear Science & Technology	Nuclear Science & Technology	CR5YR	WOS:000361420800046		
J	Surbhi; Kumari, Y; Rani, S; Tsutsui, K; Kumar, V				Surbhi; Kumari, Yatinesh; Rani, Sangeeta; Tsutsui, Kazuyoshi; Kumar, Vinod			Duration of melatonin regulates seasonal plasticity in subtropical Indian weaver bird, Ploceus philippinus	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						GnIH; GnRH I; HVC; Indian weaver bird; Melatonin; RA	GONADOTROPIN-INHIBITORY HORMONE; QUAIL COTURNIX-COTURNIX; SONG CONTROL-SYSTEM; BUNTING EMBERIZA-MELANOCEPHALA; PHOTOPERIODIC TIME MEASUREMENT; SPARROWS PASSER-DOMESTICUS; HOUSE SPARROW; CIRCADIAN-RHYTHMS; JAPANESE-QUAIL; ZEBRA FINCH	Day length regulates seasonal plasticity connected with reproduction in birds. Rhythmic pineal melatonin secretion is a reliable indicator of the night length, hence day length. Removal of rhythmic melatonin secretion by exposure to constant bright light (LLbright) or by pinealectomy renders several species of songbirds including Indian weaver bird (Ploceus philippinus) arrhythmic. Present study investigated whether rhythmic melatonin is involved in the regulation of key reproductive neuropeptides (GnRH I and GnIH) and reproduction linked neural changes, viz, song control nuclei, in Indian weaver birds. Two experiments were performed using birds in an arrhythmic condition with low (under LLbright) or no (in the absence of pineal gland) endogenous melatonin. In experiment I, three groups of birds (n = 5 each) entrained to 12L:12D were exposed to LLbright (25 lux) for two weeks. Beginning on day 15 of LLbright, a control group received vehicle for 16 h and two treatment groups were given melatonin in drinking water for 8 h or 16 h. In experiment II, one group of sham-operated and three groups of pinealectomized birds (n = 5 each) entrained to 12L:12D were exposed to constant dim light (LLdim 0.5 lux). Beginning on day 15 of LLdim, three groups received similar treatment as in experiment I. Birds were perfused after thirty cycles of the melatonin treatment, and brain sections were immunohistochemically double-labeled for GnRH I and GnIH or Nissl stained. Activity was recorded throughout the experiments, while body mass and testes were measured at the beginning and end of the experiment. Birds were synchronized with melatonin cycles and measured the duration of melatonin as "night". Pinealectomized birds that received 16 h of melatonin had significantly higher GnIH-ir cells than those received 8 h melatonin; there was no difference in the GnRH I immunoreactivity between two treatment groups however. Intact birds that received long duration melatonin cycles exhibited small song control nuclei, specifically the high vocal center (HVC) and the robust nucleus of the arcopallium (RA), while birds that received short duration melatonin or no melatonin exhibited large HVC and RA. Thus, melatonin possibly regulates seasonal reproduction via GnIH secretion, and also controls seasonal neuroplasticity in the song control system in songbirds. (C) 2014 Elsevier Inc. All rights reserved.	[Surbhi; Kumar, Vinod] Univ Delhi, Dept Zool, DST IRHPA Ctr Excellence Biol Rhythms Res, Delhi 110007, India; [Kumari, Yatinesh; Rani, Sangeeta] Univ Lucknow, Dept Zool, DST IRHPA Ctr Excellence Biol Rhythms Res, Lucknow 226007, Uttar Pradesh, India; [Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Tokyo 1628480, Japan	Kumar, V (reprint author), Univ Delhi, Dept Zool, DST IRHPA Ctr Excellence Biol Rhythms Res, Delhi 110007, India.	drvkumar11@yahoo.com			Department of Science and Technology, New Delhi, India, under IRHPA (Intensification of Research in High Priority Area) scheme; Department of Biotechnology, New Delhi, India; DST-INSPIRE Fellowship	We are grateful to Dr. Henryk Urbanski, Oregon Health and Sciences University, USA, for kindly gifting GnRH antibody used in this study. Financial support for the study was given by a generous research grant by the Department of Science and Technology, New Delhi, India, under IRHPA (Intensification of Research in High Priority Area) scheme is acknowledged. The current financial support is given by the Department of Biotechnology, New Delhi, India. Surbhi receives a DST-INSPIRE Fellowship.	Ali S., 1974, HDB BIRDS INDIA PAKI, V10, P288; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Chowdhury VS, 2010, ENDOCRINOLOGY, V151, P271, DOI 10.1210/en.2009-0908; GASTON S, 1968, SCIENCE, V160, P1125, DOI 10.1126/science.160.3832.1125; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; WhitfieldRucker MG, 1996, HORM BEHAV, V30, P528, DOI 10.1006/hbeh.1996.0056; Tobari Y, 2005, ZOOL SCI, V22, P1089, DOI 10.2108/zsj.22.1089; ZIMMERMAN NH, 1979, P NATL ACAD SCI USA, V76, P999, DOI 10.1073/pnas.76.2.999; Wang G, 2012, J BIOL RHYTHM, V27, P145, DOI 10.1177/0748730411435965; Ball GF, 2004, ANN NY ACAD SCI, V1016, P586, DOI 10.1196/annals.1298.043; Bentley GE, 2000, J NEUROENDOCRINOL, V12, P745, DOI 10.1046/j.1365-2826.2000.00523.x; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Bentley GE, 1999, P NATL ACAD SCI USA, V96, P4674, DOI 10.1073/pnas.96.8.4674; Bentley GE, 2001, MICROSC RES TECHNIQ, V53, P63, DOI 10.1002/jemt.1069; Kumar V, 2004, BIOL RHYTHM RES, V35, P121, DOI 10.1080/09291010412331313287; Kumar V, 2002, J EXP ZOOL, V292, P277, DOI 10.1002/jez.10079; Gahr M, 1996, J COMP NEUROL, V367, P308; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; Gwinner E, 1997, BRAIN RES BULL, V44, P439, DOI 10.1016/S0361-9230(97)00224-4; Chowdhury VS, 2013, GEN COMP ENDOCR, V181, P175, DOI 10.1016/j.ygcen.2012.08.005; WILSON FE, 1991, J EXP ZOOL, V259, P117, DOI 10.1002/jez.1402590114; Bentley GE, 2003, J NEUROENDOCRINOL, V15, P794; HEIGL S, 1994, NATURWISSENSCHAFTEN, V81, P83; KUMAR V, 1993, J PINEAL RES, V14, P192, DOI 10.1111/j.1600-079X.1993.tb00502.x; Cassone VM, 2008, J BIOL RHYTHM, V23, P49, DOI 10.1177/0748730407311110; McGuire NL, 2011, ENDOCRINOLOGY, V152, P3461, DOI 10.1210/en.2011-1053; LU J, 1993, J COMP PHYSIOL A, V173, P775, DOI 10.1007/BF02451908; Ukena K, 2003, CELL TISSUE RES, V312, P73, DOI 10.1007/s00441-003-0700-x; Rani S, 2009, CHRONOBIOL INT, V26, P653, DOI 10.1080/07420520902926009; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Brandstatter R, 2001, J PINEAL RES, V31, P120, DOI 10.1034/j.1600-079x.2001.310205.x; CASSONE VM, 1995, BRAIN BEHAV EVOLUT, V45, P241, DOI 10.1159/000113553; REPPERT SM, 1995, NEURON, V15, P1003, DOI 10.1016/0896-6273(95)90090-X; CHABOT CC, 1992, J COMP PHYSIOL A, V170, P615; Deregnaucourt S, 2012, J PINEAL RES, V53, P245, DOI 10.1111/j.1600-079X.2012.00993.x; Gore A.C., 2002, GNRH1 MASTER MOL REP; Guyomarc'h C, 2001, BEHAV PROCESS, V53, P121, DOI 10.1016/S0376-6357(01)00133-4; HAHN TP, 1995, GEN COMP ENDOCR, V99, P349, DOI 10.1006/gcen.1995.1119; JUSS TS, 1993, P ROY SOC B-BIOL SCI, V254, P21, DOI 10.1098/rspb.1993.0121; Kliiver H., 1953, J NEUROPATH EXP NEUR, V12, P400; KUMAR V, 1993, INT CONGR SER, V1017, P163; Kumar V, 2001, J EXP BIOL, V204, P2843; Malik S, 2004, CHRONOBIOL INT, V21, P367, DOI 10.1081/CBI-120038742; OHTA M, 1989, BIOL REPROD, V40, P935, DOI 10.1095/biolreprod40.5.935; Pandey K.R., 2011, CHRONOBIOL INT, V28, P758; Rani S, 2007, J ORNITHOL, V148, pS601, DOI 10.1007/s10336-007-0236-z; Rastogi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070065; SAIOVICI M S, 1987, Journal of Biological Rhythms, V2, P139, DOI 10.1177/074873048700200205; Singh J, 2012, HORM BEHAV, V61, P527, DOI 10.1016/j.yhbeh.2012.01.015; URBANSKI HF, 1990, J REPROD FERTIL, V90, P157; URBANSKI HF, 1992, ENDOCRINOLOGY, V131, P1665, DOI 10.1210/en.131.4.1665	51	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	SEP 1	2015	220				SI		46	54		10.1016/j.ygcen.2014.06.004		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CR3UW	WOS:000361259600007		
J	Biswas, S; Jadhao, AG; Pinelli, C; Palande, NV; Tsutsui, K				Biswas, Saikat; Jadhao, Arun G.; Pinelli, Claudia; Palande, Nikhil V.; Tsutsui, Kazuyoshi			GnIH and GnRH expressions in the central nervous system and pituitary of Indian major carp, Labeo rohita during ontogeny: An immunocytochemical study	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						GnIH; GnRH; Pituitary; Ontogeny; Carp	GONADOTROPIN-RELEASING-HORMONE; LPXRF-AMIDE PEPTIDES; INHIBITORY HORMONE; GOLDFISH; BRAIN; IDENTIFICATION; LOCALIZATION; DISCOVERY; NEURONS	Gonadotropin-releasing hormone (GnRH) is the major hypothalamic neuropeptide stimulating gonadotropin secretion in vertebrates. In 2000, gonadotropin-inhibitory hormone (GnIH) was discovered as a hypothalamic neuropeptide that inhibits gonadotropin secretion in birds. Subsequent studies have shown that GnIH is present in the brain of other vertebrates. We show for the first time GnIH immunoreactivity in the central nervous system and pituitary during development of Indian major carp, Labeo rohita and compare it with the localization of GnRH. GnIH and GnRH immunoreactivities were observed from the olfactory system to spinal cord throughout development. In the brain, both neuropeptides were localized in the telencephalon, diencephalon including the preoptic area and rhombencephalon. The localization of GnIH and GnRH in the pituitary suggests that these neuropeptides are involved in the regulation of pituitary hormones by an autocrine manner during development. In addition, the presence of GnIH and GnRH in several other brain regions including the olfactory system suggests their involvement in the regulation of other physiological functions. (C) 2014 Elsevier Inc. All rights reserved.	[Biswas, Saikat; Jadhao, Arun G.; Palande, Nikhil V.] RTM Nagpur Univ, Dept Zool, Nagpur 440033, Maharashtra, India; [Pinelli, Claudia] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, I-81100 Caserta, Italy; [Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Lab Integrat Brain Sci, Tokyo 1628480, Japan; [Tsutsui, Kazuyoshi] Waseda Univ, Ctr Med Life Sci, Tokyo 1628480, Japan	Jadhao, AG (reprint author), RTM Nagpur Univ, Dept Zool, Nagpur 440033, Maharashtra, India.	agj213@hotmail.com		Pinelli, Claudia/0000-0002-1845-9886	DBT [BT/PR4688/AAQ/03/585/2012]; UGC [41-22/2012 (SR)]; DST, Govt. of India [SR/SO/AS/-09/2006]; CSIR	This study was supported by Grants from DBT [BT/PR4688/AAQ/03/585/2012], UGC [41-22/2012 (SR)], DST [SR/SO/AS/-09/2006] Govt. of India to A.G.J. and by CSIR, senior research fellowship to S.B. A donation of Axio Imager A<INF>2</INF> (Zeiss) microscope by Alexander von Humboldt Foundation, Germany to A.G.J. used for the photomicrography is acknowledged.	Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Tsutsui K, 2012, GEN COMP ENDOCR, V177, P305, DOI 10.1016/j.ygcen.2012.02.013; Amano M, 2006, J ENDOCRINOL, V188, P417, DOI 10.1677/joe.1.06494; Kah O, 2007, GEN COMP ENDOCR, V153, P346, DOI 10.1016/j.ygcen.2007.01.030; Moussavi M, 2013, J NEUROENDOCRINOL, V25, P506, DOI 10.1111/jne.12024; Shahjahan M, 2011, J NEUROENDOCRINOL, V23, P39, DOI 10.1111/j.1365-2826.2010.02081.x; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Tsutsui K, 2009, PROG NEUROBIOL, V88, P76, DOI 10.1016/j.pneurobio.2009.02.003; Palevitch O, 2009, DEV DYNAM, V238, P66, DOI 10.1002/dvdy.21823; Ukena K, 2005, MASS SPECTROM REV, V24, P469, DOI 10.1002/mas.20031; Parhar IS, 2001, NEUROSCIENCE, V104, P1099, DOI 10.1016/S0306-4522(01)00153-1; Tsutsui K, 2006, PEPTIDES, V27, P1121, DOI 10.1016/j.peptides.2005.06.036; MIYAMOTO K, 1982, BIOCHEM BIOPH RES CO, V107, P820, DOI 10.1016/0006-291X(82)90596-4; Moussavi M, 2012, MOL CELL ENDOCRINOL, V350, P53, DOI 10.1016/j.mce.2011.11.020; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; Qi X, 2013, MOL CELL ENDOCRINOL, V366, P9, DOI 10.1016/j.mce.2012.11.001; Tsutsui K, 2010, J NEUROENDOCRINOL, V22, P716, DOI 10.1111/j.1365-2826.2010.02018.x; BURGUS R, 1972, P NATL ACAD SCI USA, V69, P278, DOI 10.1073/pnas.69.1.278; Sawada K, 2002, EUR J BIOCHEM, V269, P6000, DOI 10.1046/j.1432-1033.2002.03351.x; Pandolfi M, 2002, ANAT EMBRYOL, V205, P271, DOI 10.1007/s00429-002-0253-x; Zhang Y, 2010, PEPTIDES, V31, P1034, DOI 10.1016/j.peptides.2010.03.003; Biju K.C., 2005, GEN COMP ENDOCR, V141, P61; HALPERNSEBOLD LR, 1983, CELL TISSUE RES, V229, P75; KING JA, 1982, J BIOL CHEM, V257, P722; MIYAMOTO K, 1984, P NATL ACAD SCI-BIOL, V81, P3874, DOI 10.1073/pnas.81.12.3874; Norris D.O., 2011, HORMONES REPROD VERT, V1, P1; SHERWOOD NM, 1986, J BIOL CHEM, V261, P4812; Tsutsui K, 2006, J EXP ZOOL PART A, V305A, P801, DOI 10.1002/jez.a.306; Tsutsui K, 2007, GEN COMP ENDOCR, V153, P365, DOI 10.1016/j.gcen.2006.10.005; Tsutsui K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00060	30	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	SEP 1	2015	220				SI		88	92		10.1016/j.ygcen.2014.06.005		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CR3UW	WOS:000361259600012		
J	Poursarebani, N; Seidensticker, T; Koppolu, R; Trautewig, C; Gawronski, P; Bini, F; Govind, G; Rutten, T; Sakuma, S; Tagiri, A; Wolde, GM; Youssef, HM; Battal, A; Ciannamea, S; Fusca, T; Nussbaumer, T; Pozzi, C; Borner, A; Lundqvist, U; Komatsuda, T; Salvi, S; Tuberosa, R; Uauy, C; Sreenivasulu, N; Rossini, L; Schnurbusch, T				Poursarebani, Naser; Seidensticker, Tina; Koppolu, Ravi; Trautewig, Corinna; Gawronski, Piotr; Bini, Federica; Govind, Geetha; Rutten, Twan; Sakuma, Shun; Tagiri, Akemi; Wolde, Gizaw M.; Youssef, Helmy M.; Battal, Abdulhamit; Ciannamea, Stefano; Fusca, Tiziana; Nussbaumer, Thomas; Pozzi, Carlo; Boerner, Andreas; Lundqvist, Udda; Komatsuda, Takao; Salvi, Silvio; Tuberosa, Roberto; Uauy, Cristobal; Sreenivasulu, Nese; Rossini, Laura; Schnurbusch, Thorsten			The Genetic Basis of Composite Spike Form in Barley and 'Miracle-Wheat'	GENETICS			English	Article						'Miracle-Wheat'; 'Wunder-Weizen'; 'Compositum-Barley'; inflorescence branching; yield potential	REPRODUCTIVE DEVELOPMENT; SUPERNUMERARY SPIKELETS; MERISTEM IDENTITY; GRAIN PRODUCTION; FLORAL MERISTEM; FRIZZY-PANICLE; ZINC-FINGER; RICE; DOMESTICATION; ARABIDOPSIS	Inflorescences of the tribe Triticeae, which includes wheat (Triticum sp. L.) and barley (Hordeum vulgare L.) are characterized by sessile spikelets directly borne on the main axis, thus forming a branchless spike. 'Compositum-Barley' and tetraploid 'Miracle-Wheat' (T. turgidum convar. compositum (L.f.) Filat.) display noncanonical spike-branching in which spikelets are replaced by lateral branch-like structures resembling small-sized secondary spikes. As a result of this branch formation 'Miracle-Wheat' produces significantly more grains per spike, leading to higher spike yield. In this study, we first isolated the gene underlying spike-branching in 'Compositum-Barley,' i.e., compositum 2 (com2). Moreover, we found that COM2 is orthologous to the branched head(t) (bh(t)) locus regulating spike branching in tetraploid 'Miracle-Wheat.' Both genes possess orthologs with similar functions in maize BRANCHED SILKLESS 1 (BD1) and rice FRIZZY PANICLE/BRANCHED FLORETLESS 1 (FZP/BFL1) encoding AP2/ERF transcription factors. Sequence analysis of the bht locus in a collection of mutant and wild-type tetraploid wheat accessions revealed that a single amino acid substitution in the DNA-binding domain gave rise to the domestication of 'Miracle-Wheat.' mRNA in situ hybridization, microarray experiments, and independent qRT-PCR validation analyses revealed that the branch repression pathway in barley is governed through the spike architecture gene Six-rowed spike 4 regulating COM2 expression, while HvIDS1 (barley ortholog of maize INDETERMINATE SPIKELET 1) is a putative downstream target of COM2. These findings presented here provide new insights into the genetic basis of spike architecture in Triticeae, and have disclosed new targets for genetic manipulations aiming at boosting wheat's yield potential.	[Poursarebani, Naser; Seidensticker, Tina; Koppolu, Ravi; Trautewig, Corinna; Gawronski, Piotr; Bini, Federica; Govind, Geetha; Rutten, Twan; Wolde, Gizaw M.; Youssef, Helmy M.; Boerner, Andreas; Sreenivasulu, Nese; Schnurbusch, Thorsten] Leibniz Inst Plant Genet & Crop Plant Res, D-06466 Ot Gatersleben, Stadt Seeland, Germany; [Sakuma, Shun; Tagiri, Akemi; Komatsuda, Takao] Natl Inst Agrobiol Sci, Plant Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Youssef, Helmy M.] Cairo Univ, Fac Agr, Giza 12613, Egypt; [Battal, Abdulhamit] John Innes Ctr, Dept Crop Genet, Norwich NR4 7UH, Norfolk, England; [Battal, Abdulhamit; Uauy, Cristobal] Middle E Tech Univ, Biol Sci, TR-06800 Ankara, Turkey; [Ciannamea, Stefano; Fusca, Tiziana; Pozzi, Carlo; Rossini, Laura] Parco Tecnol Padano, I-26900 Lodi, Italy; [Nussbaumer, Thomas] Helmholtz Ctr Munich, Plant Genome & Syst Biol, D-85764 Neuherberg, Germany; [Lundqvist, Udda] Nord Genet Resource Ctr, SE-23053 Alnarp, Sweden; [Salvi, Silvio; Tuberosa, Roberto] Univ Bologna, Dipartimento Sci Agr, I-40127 Bologna, Italy; [Rossini, Laura] Univ Milan, DiSAA, I-20133 Milan, Italy	Schnurbusch, T (reprint author), Leibniz Inst Plant Genet & Crop Plant Res, Corrensstr 3, D-06466 Ot Gatersleben, Stadt Seeland, Germany.	thor@ipk-gatersleben.de	Sreenivasulu, Nese/E-8600-2011; Rossini, Laura/J-7873-2012; Schnurbusch, Thorsten/B-2249-2009; 	Sreenivasulu, Nese/0000-0002-3998-038X; Rossini, Laura/0000-0001-6509-9177; Schnurbusch, Thorsten/0000-0002-5267-0677; Pozzi, Carlo Massimo/0000-0002-2899-177X	Scientific and Technological Research Council of Turkey [2214/A]; IPK Gatersleben; German Federal Ministry of Education and Research, GABI-FUTURE Start Young Investigator Program [0315071]	We thank H. Bockelman (US Department of Agriculture-Agricultural Research Service) and M. Grau [Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) gene bank] for providing initial mutant germplasm; M. van Slageren (Royal Botanic Gardens, Kew, UK) for useful discussion on the Lobel reference; the International Barley Sequencing Consortium for prepublication access to sequence information of chromosome 2H; H. Ernst for taking photographs; and M. Purschel, A. Marlow, E. Miatton, V. Talame, J. Simmonds, R. Voss, and C. Weissleder for excellent technical support. A.B. was supported by the Scientific and Technological Research Council of Turkey 2214/A International Research Fellowship Programme as a visiting scholar in the John Innes Centre. This work was partly supported by grants from the IPK Gatersleben and the German Federal Ministry of Education and Research, GABI-FUTURE Start Young Investigator Program grant 0315071 to T.S.	Amagai Y, 2014, GENET RESOUR CROP EV, V61, P465, DOI 10.1007/s10722-013-0050-9; Schmutzer T, 2014, CYTOGENET GENOME RES, V142, P66, DOI 10.1159/000356460; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Komatsu M, 2003, DEVELOPMENT, V130, P3841, DOI 10.1242/dev.00564; Roder MS, 1998, GENETICS, V149, P2007; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Li SY, 2013, P NATL ACAD SCI USA, V110, P3167, DOI 10.1073/pnas.1300359110; Zhang DB, 2014, ANNU REV PLANT BIOL, V65, P553, DOI 10.1146/annurev-arplant-050213-040104; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Lolas IB, 2010, PLANT J, V61, P686, DOI 10.1111/j.1365-313X.2009.04096.x; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Sharman BC, 1944, NATURE, V153, P497, DOI 10.1038/153497a0; Zhu JY, 2013, DEVELOPMENT, V140, P1615, DOI 10.1242/dev.060590; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Liu FQ, 2004, PLANT CELL, V16, P5, DOI 10.1105/tpc.017772; Sotelo-Silveira M, 2013, PLANT PHYSIOL, V162, P779, DOI 10.1104/pp.113.218214; Miralles DJ, 2007, J AGR SCI, V145, P139, DOI 10.1017/S0021859607006752; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Faris JD, 2003, GENETICS, V164, P311; Le Signor C, 2009, PLANT BIOTECHNOL J, V7, P430, DOI 10.1111/j.1467-7652.2009.00410.x; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; PENNELL AL, 1983, EUPHYTICA, V32, P767, DOI 10.1007/BF00042157; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Ball C. R., 1916, BULLETIN, V357; Boden SA, 2015, NAT PLANTS, V1, P1, DOI 10.1038/NPLANTS.2014.16; Castiglioni P, 1998, GENETICS, V149, P2039; Colombo L, 1998, PLANT J, V16, P355, DOI 10.1046/j.1365-313x.1998.00300.x; Derbyshire P, 2013, PLANT PHYSIOL, V161, P1291, DOI 10.1104/pp.112.212340; DEVRIES JN, 1984, Z PFLANZENZUCHT, V92, P117; Dobrovolskaya O, 2015, PLANT PHYSIOL, V167, P189, DOI 10.1104/pp.114.250043; Druka A, 2010, BIOCHEM SOC T, V38, P683, DOI 10.1042/BST0380683; Echeverry-Solarte M, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.03.0013; Gawronski P, 2014, GENETICS, V196, P1253, DOI 10.1534/genetics.113.158444; Klindworth DL, 1997, J HERED, V88, P229; L'Obel M. de, ICONES STIRPIUM; Lawlor DW, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00418; Mascher M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r78; Rossini L, 2006, THEOR APPL GENET, V112, P1073, DOI 10.1007/s00122-006-0209-2; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Tschermak E., 1914, VERERBUNGSWEISE ART; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Zalewski W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-206; Zhu Q H, 2003, BMC PLANT BIOL, V3, P1	51	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	SEP	2015	201	1					155	+		10.1534/genetics.115.176628		39	Genetics & Heredity	Genetics & Heredity	CR3BX	WOS:000361206400013		
J	Tabe, K				Tabe, Kazunori			Transparent Aquabeads to Model LNAPL Ganglia Migration Through Surfactant Flushing	GEOTECHNICAL TESTING JOURNAL			English	Article						LNAPL; tank test; multiphase flow; transparent synthetic soil; surfactant flushing	NONAQUEOUS PHASE LIQUID; PARTICLE IMAGE VELOCIMETRY; MACROHETEROGENEOUS POROUS-MEDIA; PORE-SCALE FLOW; SOLUTE TRANSPORT; MULTIPHASE FLOW; DISSOLUTION KINETICS; DNAPL REMEDIATION; PIV MEASUREMENTS; FLUORESCENT DYE	Light nonaqueous phase liquids (LNAPLs) represent potential long-term sources for continuing groundwater contamination. Their movement in the subsurface is controlled by several complex multiphase conditions because of soil heterogeneity and fluid saturations. The first part of this paper reviews previous experimental studies on LNAPL transport. For developing numerical models and remediation technologies, these studies reproduce the transport parameters, such as density, viscosity, capillary pressure, saturation and residual saturation, and relative permeability found in the subsurface environment. The second part presents 2D tank experiments of LNAPL ganglia migration using transparent synthetic soils. The main contribution of this part is to demonstrate the possibility for the transparent Aquabeads model for better simulation of macroscopic flow properties of natural soils. Transparent synthetic soil can visualize flow problems in the subsurface environment by an optical system and digital image processing. A water-based transparent material called Aquabeads is suitable for modeling flow properties of natural soils. Advantages of Aquabeads over available transparent synthetic soils include such features as their being a water-based material, having similar macroscopic hydraulic characteristics to natural soils, and compatibility with water- and oil-selected surfactants/alcohols used for simulating multiphase flow. Therefore, this transparent material is suitable for visualizing 2D flow and soil-contamination problems. Surfactant-flushing tests were conducted to model LNAPL ganglia transport through a multilayer Aquabeads model. This model visualized the concentration profile and upward migration of motor oil ganglia during surfactant flushing. The results showed the feasibility of surfactant flushing on multilayer soils using the Aquabeads model.	TAO, Hayama, Kanagawa 2400111, Japan	Tabe, K (reprint author), TAO, 1793 Issiki, Hayama, Kanagawa 2400111, Japan.	kazunoritabe@gmail.com			Civil Engineering Department at Polytechnic Institute of New York University	This study had been financially supported by the Civil Engineering Department at Polytechnic Institute of New York University. Aquabeads materials were freely provided for this research by Mr. Hiroaki Yoshino, former president of Kuraray America Inc. (then located in New York, currently located at 2625 Bay Area Blvd., #600, Houston, TX 77058, United States of America) and Mr. Hiromasa Doi, former vice president of SEPTON Inc. (then located in Texas, currently located in Massachusetts, United States).	ALAHYARI A, 1994, EXP FLUIDS, V17, P434, DOI 10.1007/BF01877047; America Kuraray, 1998, WAT ABS RES KI GEL 2; Meinhart CD, 1999, EXP FLUIDS, V27, P414, DOI 10.1007/s003480050366; ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fluid.23.1.261; Jones EH, 2005, WATER RES, V39, P5099, DOI 10.1016/j.watres.2005.09.044; WAN JM, 1994, WATER RESOUR RES, V30, P11, DOI 10.1029/93WR02403; Iskander MG, 2002, J GEOTECH GEOENVIRON, V128, P262, DOI 10.1061/(ASCE)1090-0241(2002)128:3(262); Conrad SH, 2002, J CONTAM HYDROL, V58, P13, DOI 10.1016/S0169-7722(02)00024-4; Glass RJ, 2001, WATER RESOUR RES, V37, P1197, DOI 10.1029/2000WR900294; Willingham TW, 2008, ENVIRON SCI TECHNOL, V42, P3185, DOI 10.1021/es7022835; Johns ML, 1999, J COLLOID INTERF SCI, V210, P261, DOI 10.1006/jcis.1998.5950; Cenedese A, 1996, WATER RESOUR RES, V32, P2329, DOI 10.1029/96WR00605; Al-Raoush RI, 2005, J HYDROL, V300, P44, DOI 10.1016/j.jhydrol.2004.05.005; Kashuk S, 2014, J CONTAM HYDROL, V162, P1, DOI 10.1016/j.jconhyd.2014.04.001; Stohr M, 2003, EXP FLUIDS, V35, P159, DOI 10.1007/s00348-003-0641-x; [Anonymous], 2008, D561394 ASTM; Chu YJ, 2004, J CONTAM HYDROL, V73, P15, DOI 10.1016/j.jconhyd.2003.12.003; ANDERSON WG, 1986, J PETROL TECHNOL, V38, P1125, DOI 10.2118/13932-PA; Wildenschild D, 2013, ADV WATER RESOUR, V51, P217, DOI 10.1016/j.advwatres.2012.07.018; Fontenot MM, 2002, J COLLOID INTERF SCI, V247, P481, DOI 10.1006/jcis.2001.8158; NORTHRUP MA, 1993, CHEM ENG SCI, V48, P13, DOI 10.1016/0009-2509(93)80279-Y; Lo HC, 2010, GEOTECH TEST J, V33, P1; Sahloul NA, 2002, ADV WATER RESOUR, V25, P33, DOI 10.1016/S0309-1708(01)00025-2; Glass RJ, 2000, WATER RESOUR RES, V36, P3121, DOI 10.1029/2000WR900152; Zinn B, 2004, ENVIRON SCI TECHNOL, V38, P3916, DOI 10.1021/es034958g; Baumann T, 2004, VADOSE ZONE J, V3, P434; Koptyug IV, 2012, PROG NUCL MAG RES SP, V65, P1, DOI 10.1016/j.pnmrs.2011.12.001; Werth CJ, 2010, J CONTAM HYDROL, V113, P1, DOI 10.1016/j.jconhyd.2010.01.001; Chomsurin C, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001643; Huang WE, 2003, ENVIRON SCI TECHNOL, V37, P1905, DOI 10.1021/es020128b; LIU CH, 1990, EXP FLUIDS, V10, P50, DOI 10.1007/BF00187872; Duffield AR, 2003, WATER AIR SOIL POLL, V143, P111, DOI 10.1023/A:1022829204883; Barth GR, 2001, WATER RESOUR RES, V37, P2503, DOI 10.1029/2001WR000242; Bear J., 1972, DYNAMICS FLUIDS PORO; Bear J, 2010, THEOR APPL TRANS POR, V23, P1, DOI 10.1007/978-1-4020-6682-5; Betson M, 2004, TRANSPORT POROUS MED, V57, P203, DOI 10.1023/B:TIPM.0000038264.33451.4a; Bridge JW, 2007, ENVIRON SCI TECHNOL, V41, P8288, DOI 10.1021/es071155a; Brock D. C., 1991, SPE ANN TECHN C EXH; CHEN JD, 1986, EXP FLUIDS, V4, P336; Chevalier LR, 2003, ENVIRON MONIT ASSESS, V84, P19, DOI 10.1023/A:1022870626617; Corapcioglu MY, 1999, J CONTAM HYDROL, V36, P209, DOI 10.1016/S0169-7722(98)00145-4; Corapcioglu MY, 1997, WATER RESOUR RES, V33, P2547; Cui MM, 1997, EXP FLUIDS, V22, P261, DOI 10.1007/s003480050045; Davis E. L., 1993, EPA600R93021 RS KERR; DEMOND AH, 1991, WATER RESOUR RES, V27, P423, DOI 10.1029/90WR02408; Dwarakanath V, 1999, ENVIRON SCI TECHNOL, V33, P3829, DOI 10.1021/es990082v; Elango L., 2005, NUMERICAL SIMULATION; Fernandez S. R., 2011, GEOTECH LETT, V1, P71; Ferre TPA, 2005, WTR SCI TEC LIBR, V50, P441; Flores G, 2011, SOILS FOUND, V51, P835, DOI 10.3208/sandf.51.835; Huang WE, 2002, WATER RES, V36, P1843, DOI 10.1016/S0043-1354(01)00393-1; Huling S. G., 1991, EPA540491002; Jeong SW, 2003, AICHE J, V49, P782, DOI 10.1002/aic.690490321; Jia C, 1999, J CONTAM HYDROL, V35, P363, DOI 10.1016/S0169-7722(98)00102-8; Jose SC, 2004, ENVIRON SCI TECHNOL, V38, P2089, DOI 10.1021/es034586b; Kamaruddin S. A., 2011, NETW COD NETCOD 2011, P1; Kashuk S., 2015, GEOTECH TEST J, V38; Kostarelos K, 1998, J CONTAM HYDROL, V34, P383, DOI 10.1016/S0169-7722(98)00091-6; Liu J., 2005, P 16 INT C SOIL MECH, V4, P2411; MANNHEIMER RJ, 1993, GROUND WATER, V31, P781, DOI 10.1111/j.1745-6584.1993.tb00851.x; Matsubayashi U, 1997, J HYDROL, V192, P51, DOI 10.1016/S0022-1694(96)03120-4; MCDOUGALL TJ, 1979, J FLUID MECH, V93, P83, DOI 10.1017/S0022112079001798; MERCER J W, 1990, Journal of Contaminant Hydrology, V6, P107, DOI 10.1016/0169-7722(90)90043-G; MONTEMAGNO CD, 1995, GEOPHYS RES LETT, V22, P425, DOI 10.1029/94GL02697; Newell C. J., 1995, EPA540S95500; Rahman MA, 2005, J CONTAM HYDROL, V80, P130, DOI 10.1016/j.conhyd.2005.06.010; Rashidi M, 1996, ADV WATER RESOUR, V19, P163, DOI 10.1016/0309-1708(95)00048-8; Reddi LN, 1996, J ENVIRON ENG-ASCE, V122, P1115, DOI 10.1061/(ASCE)0733-9372(1996)122:12(1115); Reddi LN, 1998, J HAZARD MATER, V62, P211, DOI 10.1016/S0304-3894(98)00164-2; Slavik J., 1994, FLUORESCENT PROVES C; Tabe K., 2011, P SCH ENG TOKAI U E, P7; Tabe K., 2009, THESIS POLYTECHNIC I; Theodoropoulou MA, 2003, J HYDROL, V274, P176, DOI 10.1016/S0022-1694(02)00421-3; Wang D. C., 2002, OPTICAL TECHNOLOGY I; Wick LY, 2004, ENVIRON SCI TECHNOL, V38, P4596, DOI 10.1021/es0354420; WILLIAMS D E, 1971, Ground Water, V9, P50, DOI 10.1111/j.1745-6584.1971.tb03577.x; Wilson J. L., 1990, EPA600690004; Yoon S., 2006, THESIS POLYTECHNIC U; Zachos A, 1996, EXP FLUIDS, V20, P229, DOI 10.1007/BF00190280; Zhang CY, 2007, ENVIRON SCI TECHNOL, V41, P3672, DOI 10.1021/es061675q; Zhong LR, 2001, WATER RESOUR RES, V37, P523, DOI 10.1029/2000WR900300	81	0	0	AMER SOC TESTING MATERIALS	W CONSHOHOCKEN	100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959 USA	0149-6115	1945-7545		GEOTECH TEST J	Geotech. Test. J.	SEP	2015	38	5					787	804		10.1520/GTJ20140221		18	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CR6DX	WOS:000361434600017		
J	Suzuki, A; Niibori, Y; Fomin, S; Chugunov, V; Hashida, T				Suzuki, Anna; Niibori, Yuichi; Fomin, Sergei; Chugunov, Vladimir; Hashida, Toshiyuki			Prediction of reinjection effects in fault-related subsidiary structures by using fractional derivative-based mathematical models for sustainable design of geothermal reservoirs	GEOTHERMICS			English	Article						Reinjection; Fault zone; Fractal; Tracer test; Fractional advection-dispersion equation (fADE)	ADVECTION-DISPERSION EQUATION; CONTAMINANT TRANSPORT; THERMAL BREAKTHROUGH; ZONE ARCHITECTURE; FLUID-FLOW; MEDIA; INJECTION; AQUIFER; ROCKS	This study provides a method to evaluate the effects of cold-water injection into an advection-dominated geothermal reservoir. A fractional advection-dispersion equation (fADE) and a fractional heat transfer equation (fHTE) are applied to fault-related structures in geothermal areas where the fracture density is described by a power-law model. Synthetic production data generated by a numerical reservoir simulator reveal that the fADE and the fHTE are in reasonable agreement with the tracer responses and temperature change in a fault zone. Tracer analysis based on the fADE has potential to elucidate fault-related structures and to predict premature thermal breakthroughs quickly and efficiently. (C) 2015 Elsevier Ltd. All rights reserved.	[Suzuki, Anna] Stanford Univ, Stanford, CA 94305 USA; [Niibori, Yuichi; Hashida, Toshiyuki] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Fomin, Sergei] Calif State Univ Chico, Chico, CA 95929 USA; [Chugunov, Vladimir] Kazan Fed Univ, Kazan 420008, Russia	Suzuki, A (reprint author), Stanford Univ, 367 Panama St,Green Earth Sci Bldg 080C, Stanford, CA 94305 USA.	anna3@stanford.edu			Japan Society for the Promotion of Science under JSPS [H26-416]	This work was supported by the Japan Society for the Promotion of Science, under JSPS Postdoctoral Fellowships for Research Abroad (H26-416), whose support is gratefully acknowledged. Comments by two anonymous reviewers, Joseph N. Moore, Roland N. Horne, and Audrey P. Fan greatly helped to improve an earlier version of this article.	Agosta F., 2003, J GEOPHYS RES SOLID, V108; Aksoy N, 2008, GEOTHERMICS, V37, P444, DOI 10.1016/j.geothermics.2007.12.003; Huang QZ, 2008, ADV WATER RESOUR, V31, P1578, DOI 10.1016/j.advwatres.2008.07.002; CHESTER FM, 1986, PURE APPL GEOPHYS, V124, P79, DOI 10.1007/BF00875720; Baeumer B, 2001, WATER RESOUR RES, V37, P1543, DOI 10.1029/2000WR900409; Fomin SA, 2011, ADV WATER RESOUR, V34, P205, DOI 10.1016/j.advwatres.2010.11.002; Benson DA, 2000, WATER RESOUR RES, V36, P1403, DOI 10.1029/2000WR900031; Kocabas I, 2005, GEOTHERMICS, V34, P27, DOI 10.1016/j.geothermics.2004.09.003; Faulkner DR, 2010, J STRUCT GEOL, V32, P1557, DOI 10.1016/j.jsg.2010.06.009; De Joussineau G, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004711; Shook GM, 2001, GEOTHERMICS, V30, P573, DOI 10.1016/S0375-6505(01)00015-3; GRINGARTEN AC, 1975, J GEOPHYS RES, V80, P4956, DOI 10.1029/JB080i035p04956; Zhang Y, 2009, ADV WATER RESOUR, V32, P561, DOI 10.1016/j.advwatres.2009.01.008; Caine JS, 1996, GEOLOGY, V24, P1025, DOI 10.1130/0091-7613(1996)024<1025:FZAAPS>2.3.CO;2; Bonnet E, 2001, REV GEOPHYS, V39, P347, DOI 10.1029/1999RG000074; VANGENUCHTEN MT, 1976, SOIL SCI SOC AM J, V40, P473; Kaya E, 2011, RENEW SUST ENERG REV, V15, P47, DOI 10.1016/j.rser.2010.07.032; Savage HM, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007665; LOPEZ DL, 1995, WATER RESOUR RES, V31, P1489, DOI 10.1029/95WR00422; ADAMS EE, 1992, WATER RESOUR RES, V28, P3293, DOI 10.1029/92WR01757; Axelsson G., 2010, Geothermics, V39, P283, DOI 10.1016/j.geothermics.2010.08.001; Bear J., 1972, DYNAMICS FLUIDS PORO; Bodvarsson G., 1972, GEOTHERMICS, V1, P63, DOI DOI 10.1016/0375-6505(72)90013-2; BODVARSSON GS, 1982, J GEOPHYS RES, V87, P1031, DOI 10.1029/JB087iB02p01031; BROCK WG, 1977, GEOL SOC AM BULL, V88, P1667, DOI 10.1130/0016-7606(1977)88<1667:DAWTMO>2.0.CO;2; Brogi A, 2008, J STRUCT GEOL, V30, P237, DOI 10.1016/j.jsg.2007.10.004; Burnecki K, 2008, ACTA PHYS POL B, V39, P1043; Fomin S, 2005, P ROY SOC A-MATH PHY, V461, P2923, DOI 10.1098/rspa.2005.1487; Gudmundsson A., 2011, ROCK FRACTURES GEOLO; Lauwerier H.A., 1955, APPL SCI RES       A, V5, P145, DOI DOI 10.1007/8F03184614; Le Garzic E, 2011, J STRUCT GEOL, V33, P519, DOI 10.1016/j.jsg.2011.01.012; Massart B., 2010, WORLD GEOTH C, P2010; PRUESS K, 1984, J PETROL TECHNOL, V36, P1567; Pruess K., 1999, LBNL43134; Samko S., 1993, FRACTIONAL INTEGRALS; Sanjuan B, 2006, GEOTHERMICS, V35, P622, DOI 10.1016/j.geothermics.2006.09.007; Schumer R, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002141; Shook G.M., 2003, GEOTHERMAL RESOURCES, V27, P407; Suzuki A, 2015, GEOTHERMICS, V53, P125, DOI 10.1016/j.geothermics.2014.05.003; Suzuki A., 2014, MATH GEOSCI, V47, P31; Welty J. R., 2009, FUNDAMENTALS MOMENTU; WOODS AW, 1993, J FLUID MECH, V251, P563, DOI 10.1017/S0022112093003520; Zhang XX, 2007, ADV WATER RESOUR, V30, P1205, DOI 10.1016/j.advwatres.2006.11.002	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0375-6505	1879-3576		GEOTHERMICS	Geothermics	SEP	2015	57						196	204		10.1016/j.geothermics.2015.04.001		9	Energy & Fuels; Geosciences, Multidisciplinary	Energy & Fuels; Geology	CR3UC	WOS:000361257600017		
J	Bonneterre, J; Hutt, E; Bosq, J; Graham, JD; Powell, MA; Leblanc, E; Fujiwara, K; Herzog, TJ; Coleman, RL; Clarke, CL; Gilles, EM; Zukiwski, AA; Monk, BJ				Bonneterre, Jacques; Hutt, Emilie; Bosq, Jacques; Graham, J. Dinny; Powell, Matthew A.; Leblanc, Eric; Fujiwara, Keiichi; Herzog, Thomas J.; Coleman, Robert L.; Clarke, Christine L.; Gilles, Erard M.; Zukiwski, Alexander A.; Monk, Bradley J.			Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus	GYNECOLOGIC ONCOLOGY			English	Article						Endometrial cancer; Activated progesterone receptor; Onapristone; Progestin; Anti-progestin	BREAST-CANCER CELLS; SUBNUCLEAR DISTRIBUTION; THERAPY; PR	Objective. Hormonal therapy is generally reserved for patients with endometrial cancers that fail cytotoxic chemotherapy, but there is a lack of sufficiently sensitive diagnostics to identify potential responders. We sought to develop a diagnostic technique to detect activated progesterone receptors (APR) in endometrial cancers using routine immunohistochemistry (IHC) and to correlate the presence of APR with other histopathological features and clinical disease stage. Methods. Seventy-two tumor block specimens from patients with endometrial cancer were processed with conventional IHC methods for estrogen receptor-alpha. (ER alpha), progesterone receptor (PR) and Ki67, a marker of proliferation. Tumor specimens were analyzed for the PR nuclear distribution patterns in individual tumor cells: APR positive (APR(pos)) tumors were prospectively defined as any tumor with >5% countable malignant cells with an aggregated nuclear pattern. Tumor APR status was analyzed against other biomarkers including ER alpha. expression, Ki67 and tumor grade. Results. Fifty-six of 72 samples were endometrioid. Twenty-six of 49 PR-positive endometrioid tumors (53%; 95% CI 39-67%) were APR(pos). Percent of ERpos cells correlated with % PRpos malignant cells (p = 0.001, rho = 0.44). APR positivity did not correlate with % PRpos cells in a given tumor, nor did it correlate with % Ki67 positivity; APR positivity was independent of disease stage and tumor grade (p = NS). Conclusions. In this study, approximately half of endometrioid tumors were APR(pos). APR is independent of histopathological and other known risk factors. Refining conventional PR detection has the potential to prospectively identify patients with endometrial cancer who may benefit from anti-progestin therapy. (C) 2015 Elsevier Inc. All rights reserved.	[Bonneterre, Jacques; Hutt, Emilie; Leblanc, Eric] Ctr Oscar Lambret, F-59000 Lille, France; [Bosq, Jacques] Inst Gustave Roussy, F-94805 Villejuif, France; [Graham, J. Dinny; Clarke, Christine L.] Univ Sydney, Westmead Millennium Inst Sydney, Med Sch Westmead, Ctr Canc Res, New South Wales, Australia; [Powell, Matthew A.] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Hidaka Shi, Saitama 3501241, Japan; [Herzog, Thomas J.] Univ Cincinnati, Inst Canc, Cincinnati, OH 45267 USA; [Coleman, Robert L.] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Gilles, Erard M.] Invivis Pharmaceut, Bridgewater, NJ 08807 USA; [Gilles, Erard M.; Zukiwski, Alexander A.] Arno Therapeut, Flemington, NJ 08822 USA; [Monk, Bradley J.] Univ Arizona, Canc Ctr Phoenix, Creighton Uni,Sch Med, St Josephs Hosp & Med Ctr, Phoenix, AZ 85013 USA	Bonneterre, J (reprint author), Ctr Oscar Lambret, 3 Rue Freder Combemale, F-59000 Lille, France.	j-bonneterre@o-lambret.fr			Arno Therapeutics, Flemington, NJ, USA; Arno Therapeutics	This research was funded by Arno Therapeutics, 200 Route 31 Flemington, NJ 08822, USA. Philippe Jamme reviewed the patients' clinical files. Dr. Alice S Bexon and Mr Matthew F Reid of Bexon Clinical Consulting LLC provided medical writing services, which were funded by Arno Therapeutics.	Hagan CR, 2011, MOL CELL BIOL, V31, P2439, DOI 10.1128/MCB.01246-10; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Ramondetta LM, 2009, CANCER, V115, P1867, DOI 10.1002/cncr.24197; Arnett-Mansfield RL, 2004, J CLIN ENDOCR METAB, V89, P1429, DOI 10.1210/jc.2003-031111; Lange CA, 2008, ADV EXP MED BIOL, V630, P94; Arnett-Mansfield RL, 2007, MOL ENDOCRINOL, V21, P14, DOI 10.1210/me.2006-0041; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84; Wright JD, 2012, LANCET, V379, P1352, DOI 10.1016/S0140-6736(12)60442-5; Bonneterre J., 2012, CANCER RES, V72, pA723; Clarke CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035859; Edge S., 2010, AJCC CANC STAGING MA, P1; Edwards D. P., 2004, ENCY HORMONES, P249; Ferlay J., 2013, 11 IARC; Janzen DM, 2013, CANCER RES, V73, P4697, DOI 10.1158/0008-5472.CAN-13-0930; Jonat W, 2013, ANN ONCOL, V24, P2543, DOI 10.1093/annonc/mdt216; KASTNER P, 1990, EMBO J, V9, P1603; Plataniotis G, 2010, ANN ONCOL, V21, pv41, DOI 10.1093/annonc/mdq245; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Scarpin K. M., 2009, NUCL RECEPT SIGNAL, V7, P1; Serin G, 2012, EUR J CANCER, V48, P146	21	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	SEP	2015	138	3					663	667		10.1016/j.ygyno.2015.06.037		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CR3YP	WOS:000361269300029		
J	Furuya, Y; Kondo, N; Yamagata, Z; Hashimoto, H				Furuya, Yoko; Kondo, Naoki; Yamagata, Zentaro; Hashimoto, Hideki			Health literacy, socioeconomic status and self-rated health in Japan	HEALTH PROMOTION INTERNATIONAL			English	Article						Japan; health literacy; socioeconomic status; perceived health	MANAGED CARE ORGANIZATION; OLDER-ADULTS; PUBLIC-HEALTH; MEDICARE ENROLLEES; MORTALITY; KNOWLEDGE; BEHAVIORS; RISK; COMMUNICATION; ASSOCIATION	Health literacy (HL) is a key determinant of health in a contemporary society characterized by abundant information. Previous studies have suggested that basic or functional HL is positively associated with health, whereas evidences on the association between health and communicative/critical HL are scarce. Furthermore, confounding by socioeconomic status on HL-health association has been poorly tested. Using cross-sectional data from a nationally representative community-based survey in Japan, we investigated whether communicative/critical HL is associated with self-rated health independent of socioeconomic status. A total of 1237 subjects participated in this study; the response rate was 62%. To measure communicative/critical HL, we used three questions assessing the respondents' ability to select, to communicate to others and to evaluate specific health-related information. Potential confounders included demographic factors, household income, employment status, and educational attainment. A multivariate model revealed that good self-reported health was significantly associated with younger age [odds ratio (OR), 0.99; 95% confidence interval (CI), 0.97-0.99], employment (OR, 2.89; 95% CI, 1.06-7.88) and higher communicative/critical HL scores (OR 2.75; 95%CI, 1.93-3.90). Respondents with lower education were likely to have poorer communicative/critical HL. These results imply that to close the health gap, policy interventions should focus on the promotion of HL among deprived sociodemographic groups.	[Furuya, Yoko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Fundamental & Clin Nursing, Chuo Ku, Yamanashi, Japan; [Kondo, Naoki; Hashimoto, Hideki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, Tokyo, Japan; [Yamagata, Zentaro] Univ Yamanashi, Dept Hlth Sci, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan	Furuya, Y (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Fundamental & Clin Nursing, Chuo Ku, Yamanashi, Japan.	yohkof@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21792204]; Japan Ministry of Health, Labor and Welfare [H17-TOKEI-IPPAN-002]	This work was supported partly by funds from the Grant-in-Aid for Young Scientists (B) (Grant No. 21792204) of Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and by the grant-in-aid by Japan Ministry of Health, Labor and Welfare (H17-TOKEI-IPPAN-002).	Steckelberg A, 2009, ADV HEALTH SCI EDUC, V14, P11, DOI 10.1007/s10459-007-9083-1; von Wagner C, 2007, J EPIDEMIOL COMMUN H, V61, P1086, DOI 10.1136/jech.2006.053967; Howard DH, 2005, AM J MED, V118, P371, DOI 10.1016/j.amjmed.2005.01.010; Chaudhry SI, 2011, J CARD FAIL, V17, P122, DOI 10.1016/j.cardfail.2010.09.016; Scott TL, 2002, MED CARE, V40, P395, DOI 10.1097/00005650-200205000-00005; Davis TC, 2006, ANN INTERN MED, V145, P887; Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; Tokuda Y, 2009, PATIENT EDUC COUNS, V75, P411, DOI 10.1016/j.pec.2009.03.031; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Ishikawa H, 2008, HEALTH EXPECT, V11, P113, DOI 10.1111/j.1369-7625.2008.00497.x; Wolf MS, 2007, AM J PREV MED, V32, P19, DOI 10.1016/j.amepre.2006.08.024; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI [10.7326/0003-4819-155-2-201107190-00005, 10.1059/0003-4819-155-2-201107190-00005]; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Pleasant A, 2008, HEALTH PROMOT INT, V23, P152, DOI 10.1093/heapro/dan001; Chinn D, 2011, SOC SCI MED, V73, P60, DOI 10.1016/j.socscimed.2011.04.004; Bennett IM, 2009, ANN FAM MED, V7, P204, DOI 10.1370/afm.940; Sakurai K, 2010, SOC SCI MED, V70, P1832, DOI 10.1016/j.socscimed.2010.01.019; Albert C, 2011, HEALTH PROMOT INT, V26, P163, DOI 10.1093/heapro/daq059; Ishikawa H, 2009, FAM PRACT, V26, P517, DOI 10.1093/fampra/cmp060; Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Sudore RL, 2006, J GEN INTERN MED, V21, P806, DOI 10.1111/j.1525-1497.2006.00539.x; Ishikawa H, 2008, DIABETES CARE, V31, P874, DOI 10.2337/dc07-1932; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Williams MV, 1998, CHEST, V114, P1008, DOI 10.1378/chest.114.4.1008; Kalichman SC, 2000, AM J PREV MED, V18, P325, DOI 10.1016/S0749-3797(00)00121-5; Ratzan SC, 2001, HEALTH PROMOT INT, V16, P207, DOI 10.1093/heapro/16.2.207; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Peerson A, 2009, HEALTH PROMOT INT, V24, P285, DOI 10.1093/heapro/dap014; Lee SYD, 2004, SOC SCI MED, V58, P1309, DOI 10.1016/S0277-9536(03)00329-0; Berkman ND, 2011, EVID REP TECHNOL ASS, V199, P1; Bostock S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1602; Calnan M., 1986, HLTH PROMOTION, V1, P167, DOI 10.1093/heapro/1.2.167; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Guerra CE, 2008, FAM PRACT, V25, P49, DOI 10.1093/fampra/cmn005; Ishikawa H, 2008, HEALTH PROMOT INT, V23, P269, DOI 10.1093/heapro/dan017; Ishikawa H, 2011, PATIENT EDUC COUNS, V84, P393, DOI 10.1016/j.pec.2011.01.029; JACKSON C, 1991, AM J PREV MED, V7, P82; Kish L., 1965, SURVEY SAMPLING; Kurodas Y., 1986, APPL STOCH MODEL BUS, V2, P43, DOI 10.1002/asm.3150020105; Kutner M, 2006, 2006483 NCES US DEP; Lai AY, 2013, PATIENT EDUC COUNS, V91, P221, DOI 10.1016/j.pec.2012.12.018; Laramee AS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-98; Levin-Zamir D, 2001, HEALTH PROMOT INT, V16, P87, DOI 10.1093/heapro/16.1.87; Lorenc T, 2012, J EPIDEMIOL COMMUNIT, V67, P190; Ministry of Internal Affairs and Communications Statistics Bureau, 2012, 2010 JAP CENS; Ministry of Internal Affairs and Communications Statistics Bureau, 2010, COMM US TREND SURV 2; Organization for Economic Co-operation and Development, 2010, ED GLANC 2010; Ratzan S., 2000, CURRENT BIBLIO MED H; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Sorensen K., 2013, HLTH PROMOTION INT; Wolf MS, 2004, INT J STD AIDS, V15, P747, DOI 10.1258/0956462042395131; Wolf MS, 2010, SOC SCI MED, V70, P1335, DOI 10.1016/j.socscimed.2009.12.013; World Health Organization, 2008, CLOS GAP GEN HLTH EQ; World Health Organization, 2010, URB HLTH EQ ASS RESP	56	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0957-4824	1460-2245		HEALTH PROMOT INT	Health Promot. Int.	SEP	2015	30	3					505	513		10.1093/heapro/dat071		9	Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CR3EC	WOS:000361212400010		
J	Itoh, K; Nejime, M; Konoike, N; Nakada, T; Nakamura, K				Itoh, Kosuke; Nejime, Masafumi; Konoike, Naho; Nakada, Tsutomu; Nakamura, Katsuki			Noninvasive scalp recording of cortical auditory evoked potentials in the alert macaque monkey	HEARING RESEARCH			English	Article						Nonhuman primates; Old world monkey; Event-related potential (ERP); Auditory evoked potential (AEP); Auditory late response (ALR); Electroencephalogram (EEG)	EVENT-RELATED POTENTIALS; BRAIN-STEM; MISMATCH NEGATIVITY; GAP DETECTION; MATURATION; CORTEX; NOISE; CHIMPANZEE; ATTENTION; COMPONENT	Scalp-recorded evoked potentials (EP) provide researchers and clinicians with irreplaceable means for recording stimulus-related neural activities in the human brain, due to its high temporal resolution, handiness, and, perhaps more importantly, non-invasiveness. This work recorded the scalp cortical auditory EP (CAEP) in unanesthetized monkeys by using methods that are essentially identical to those applied to humans. Young adult rhesus monkeys (Macaca mulatto, 5-7 years old) were seated in a monkey chair, and their head movements were partially restricted by polystyrene blocks and tension poles placed around their head. Individual electrodes were fixated on their scalp using collodion according to the 10-20 system. Pure tone stimuli were presented while electroencephalograms were recorded from up to nineteen channels, including an electrooculogram channel. In all monkeys (n = 3), the recorded CAEP comprised a series of positive and negative deflections, labeled here as macaque P1 (mP1), macaque N1 (mN1), macaque P2 (mP2), and macaque N2 (mN2), and these transient responses to sound onset were followed by a sustained potential that continued for the duration of the sound, labeled the macaque sustained potential (mSP). mPl, mN2 and mSP were the prominent responses, and they had maximal amplitudes over frontal/central midline electrode sites, consistent with generators in auditory cortices. The study represents the first noninvasive scalp recording of CAEP in alert rhesus monkeys, to our knowledge. (C) 2015 Elsevier B.V. All rights reserved.	[Itoh, Kosuke; Nakada, Tsutomu] Niigata Univ, Brain Res Inst, Ctr Integrated Human Brain Sci, Niigata 9518585, Japan; [Nejime, Masafumi; Konoike, Naho; Nakamura, Katsuki] Kyoto Univ, Primate Res Inst, Cognit Neurosci Sect, Inuyama, Aichi 4848506, Japan	Itoh, K (reprint author), Niigata Univ, Brain Res Inst, Ctr Integrated Human Brain Sci, 1-757 Asahimachi, Niigata 9518585, Japan.	itoh@bri.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (Japan), JSPS KAKENHI [25540052]; Cooperative Research Program of the Primate Research Institute, Kyoto University	The work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (Japan), JSPS KAKENHI Grant Number 25540052, and the Cooperative Research Program of the Primate Research Institute, Kyoto University.	Alegre M, 2001, HEARING RES, V151, P115, DOI 10.1016/S0378-5955(00)00215-X; Alho K, 2012, EUR J NEUROSCI, V36, P2972, DOI 10.1111/j.1460-9568.2012.08219.x; Pratt H, 2005, CLIN NEUROPHYSIOL, V116, P2648, DOI 10.1016/j.clinch.2005.08.001; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Eggermont JJ, 2003, ACTA OTO-LARYNGOL, V123, P249, DOI 10.1080/0036554021000028098; Harris KC, 2012, EAR HEARING, V33, P330, DOI 10.1097/AUD.0b013e31823fb585; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; Fishman YI, 2012, J NEUROSCI, V32, P15747, DOI 10.1523/JNEUROSCI.2835-12.2012; Shi YD, 2013, CEREB CORTEX, V23, P36, DOI 10.1093/cercor/bhr372; Sussman E, 2008, HEARING RES, V236, P61, DOI 10.1016/j.heares.2007.12.001; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Gil-Da-Costa R, 2013, P NATL ACAD SCI USA, V110, P15425, DOI 10.1073/pnas.1312264110; JAVITT DC, 1992, ELECTROEN CLIN NEURO, V83, P87, DOI 10.1016/0013-4694(92)90137-7; Wunderlich JL, 2006, HEARING RES, V212, P185, DOI 10.1016/j.heares.2005.11.010; Ueno A, 2010, BIOL LETTERS, V6, P311, DOI 10.1098/rsbl.2009.0864; ALLEN AR, 1978, ELECTROEN CLIN NEURO, V45, P53, DOI 10.1016/0013-4694(78)90341-3; Pratt H, 2007, CLIN NEUROPHYSIOL, V118, P1078, DOI 10.1016/j.clinph.2007.01.005; Reinhart RMG, 2012, J NEUROSCI, V32, P7711, DOI 10.1523/JNEUROSCI.0215-12.2012; DAVIS H, 1966, ELECTROEN CLIN NEURO, V21, P105, DOI 10.1016/0013-4694(66)90118-0; Ceponiene R, 2002, CLIN NEUROPHYSIOL, V113, P870, DOI 10.1016/S1388-2457(02)00078-0; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; ARTHUR DL, 1984, SCIENCE, V223, P186, DOI 10.1126/science.6691145; Fontanarosa JB, 2004, BRAIN TOPOGR, V17, P99, DOI 10.1007/s10548-004-1007-2; FRUHSTOR.H, 1970, ELECTROEN CLIN NEURO, V28, P153, DOI 10.1016/0013-4694(70)90183-5; Fukushima H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013366; Glover A., 1991, CLIN NEUROPHYSIOL, V90, P65; Godlove DC, 2011, J NEUROSCI, V31, P15640, DOI 10.1523/JNEUROSCI.3349-11.2011; Hirata S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01342; Honing H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051369; Knickmeyer RC, 2010, CEREB CORTEX, V20, P1053, DOI 10.1093/cercor/bhp166; LEGATT AD, 1986, ELECTROEN CLIN NEURO, V64, P41, DOI 10.1016/0013-4694(86)90042-8; LOW MD, 1966, PERCEPT MOTOR SKILL, V22, P443; Mitsudo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00763; PALLER KA, 1992, ELECTROEN CLIN NEURO, V84, P269, DOI 10.1016/0168-5597(92)90008-Y; PICTON TW, 1978, ELECTROEN CLIN NEURO, V45, P186, DOI 10.1016/0013-4694(78)90003-2; PINEDA JA, 1993, BEHAV BRAIN RES, V53, P177, DOI 10.1016/S0166-4328(05)80277-3; Rupp A, 2002, NEUROREPORT, V13, P2203, DOI 10.1097/01.wnr.0000045007.30898.39; Rupp A, 2004, J NEUROPHYSIOL, V92, P2239, DOI 10.1152/jn.00163.2004; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; VANDERMAREL EH, 1984, ELECTROEN CLIN NEURO, V57, P354; Woodman GF, 2007, P NATL ACAD SCI USA, V104, P15111, DOI 10.1073/pnas.0703477104; Woodman G.F, 2012, OXFORD HDB EVENT REL	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	SEP	2015	327						117	125		10.1016/j.heares.2015.05.007		9	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	CR3RX	WOS:000361251900013		
J	Tateya, T; Sakamoto, S; Imayoshi, I; Kageyama, R				Tateya, Tomoko; Sakamoto, Susumu; Imayoshi, Itaru; Kageyama, Ryoichiro			In vivo overactivation of the Notch signaling pathway in the developing cochlear epithelium	HEARING RESEARCH			English	Article						NICD overexpression; Cochlea; Prosensory; Hair cells; Supporting cells	MAMMALIAN INNER-EAR; HAIR-CELL-DIFFERENTIATION; NEURAL STEM-CELLS; PROSENSORY DOMAIN; FATE; SPECIFICATION; JAGGED1; ROLES; INHIBITION; INDUCTION	Notch signaling is thought to play important roles in both prosensory domain specification and cell fate determination during inner ear development. Inhibition of the Notch signaling pathway in prosensory cells results in excessive hair cell formation, while activation of the Notch signaling pathway by overexpression of activated Notchl (Notchl -intercellular domain, NICD) in the cochlear epithelium results in ectopic sensory patches where NICD is expressed. However, the effect of Notch activation on the prosensory domain is not fully understood. To elucidate the precise roles of Notch signaling in cochlear prosensory epithelium we examined the effects of Notch overactivation on cochlear prosensory cells of transgenic mice with conditional NICD expression. The histology of the cochlear epithelium was investigated in these mice. The cochlear duct of conditional NICD embryos was wide and short, and the epithelium formed an abnormal tubular structure. Hair cell numbers were reduced though some hair cells developed where NICD was overexpressed. The decrease in hair cells was not accompanied by Hes5-positive and Proxl-positive supporting cell overproduction. Ectopic expression of early prosensory markers, such as Jag1 and Hes/Hey genes, was observed but no expression of Hes5 was found. Our data shows that NICD overexpression disrupts the extension of cochlear epithelium, and reduces the total numbers of hair cells and supporting cells in the sensory epithelium. Thus, an appropriate level of Notch signaling is needed for the normal extension of the cochlear epithelium and for differentiation of both hair cells and supporting cells. (C) 2015 Elsevier B.V. All rights reserved.	[Tateya, Tomoko; Sakamoto, Susumu; Imayoshi, Itaru; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Tateya, Tomoko; Imayoshi, Itaru] Kyoto Univ, Hakubi Ctr, Kyoto 6068302, Japan; [Sakamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068507, Japan; [Imayoshi, Itaru] Japan Sci & Technol Agcy, PRESTO, Kyoto 6068507, Japan; [Kageyama, Ryoichiro] Kyoto Univ, World Premier Int Res Initiat, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068501, Japan; [Kageyama, Ryoichiro] Japan Sci & Technol Agcy, CREST, Sakyo Ku, Kyoto 6068507, Japan	Tateya, T (reprint author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	t_tateya@ent.kuhp.kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [25462635]	We thank Dr. Shinichi Aizawa for the Emx<SUP>2+/Cre</SUP> mice. We also thank Shinya Sohmiya, Kentaro Goto and Shinya Kuwata for providing assistance in animal care and genotyping. This work was supported by The Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant number 25462635).	Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Tateya T, 2013, DEVELOPMENT, V140, P3848, DOI 10.1242/dev.095398; Tsai H, 2001, HUM MOL GENET, V10, P507, DOI 10.1093/hmg/10.5.507; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Zine A, 2000, DEVELOPMENT, V127, P3373; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Driver EC, 2009, BIRTH DEFECTS RES C, V87, P212, DOI 10.1002/bdrc.20154; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Lanford PJ, 1999, NAT GENET, V21, P289; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Zheng JL, 2000, DEVELOPMENT, V127, P4551; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Zine A, 2001, J NEUROSCI, V21, P4712; Yamamoto N, 2006, J MOL MED-JMM, V84, P37, DOI 10.1007/s00109-005-0706-9; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Kiernan AE, 2013, SEMIN CELL DEV BIOL, V24, P470, DOI 10.1016/j.semcdb.2013.04.002; Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Pan W, 2010, P NATL ACAD SCI USA, V107, P15798, DOI 10.1073/pnas.1003089107; Liu ZY, 2012, DEV DYNAM, V241, P684, DOI 10.1002/dvdy.23754; Bermingham-McDonogh O, 2011, NEURON, V71, P389, DOI 10.1016/j.neuron.2011.07.015; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kimura J, 2005, J NEUROSCI, V25, P5097, DOI 10.1523/JNEUROSCI.0239-05.2005; Liu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034123; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Ono K., 2003, MOL CELL NEUROSCI, V42, P391; Savoy-Burke G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108160; Yamamoto N, 2009, DEVELOPMENT, V136, P1977, DOI 10.1242/dev.030718; Zhang N, 2000, CURR BIOL, V10, P659, DOI 10.1016/S0960-9822(00)00522-4	39	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	SEP	2015	327						209	217		10.1016/j.heares.2015.07.012		9	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	CR3RX	WOS:000361251900022		
J	Aikawa, T; Mogushi, K; Iijima-Tsutsui, K; Ishikawa, K; Sakurai, M; Tanaka, H; Mizusawa, H; Watase, K				Aikawa, Tomonori; Mogushi, Kaoru; Iijima-Tsutsui, Kumiko; Ishikawa, Kinya; Sakurai, Miyano; Tanaka, Hiroshi; Mizusawa, Hidehiro; Watase, Kei			Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model	HUMAN MOLECULAR GENETICS			English	Article							INNATE IMMUNE ACTIVATION; CALCIUM-CHANNEL; SPINAL-CORD; EXPRESSION; DISEASE; SCA6; GENE; POLARIZATION; RECEPTOR; BETA	Spinocerebellar ataxia type 6 (SCA6) is dominantly inherited neurodegenerative disease, caused by an expansion of CAG repeat encoding a polyglutamine (PolyQ) tract in the Ca(v)2.1 voltage-gated calcium channel. Its key pathological features include selective degeneration of the cerebellar Purkinje cells (PCs), a common target for PolyQ-induced toxicity in various SCAs. Mutant Ca(v)2.1 confers toxicity primarily through a toxic gain-of-function mechanism; however, its molecular basis remains elusive. Here, we studied the cerebellar gene expression patterns of young Sca6-MPI118Q/118Q knockin (KI) mice, which expressed mutant Ca(v)2.1 from an endogenous locus and recapitulated many phenotypic features of human SCA6. Transcriptional signatures in the MPI118Q/118Q mice were distinct from those in the Sca(1154Q/2Q) mice, a faithful SCA1 KI mouse model. Temporal expression profiles of the candidate genes revealed that the up-regulation of genes associated with microglial activation was initiated before PC degeneration and was augmented as the disease progressed. Histological analysis of the MPI118Q/118Q cerebellum showed the predominance of M1-like pro-inflammatory microglia and it was concomitant with elevated expression levels of tumor necrosis factor, interleukin-6, Toll-like receptor (TLR) 2 and 7. Genetic ablation of MyD88, a major adaptor protein conveying TLR signaling, altered expression patterns of M1/M2 microglial phenotypic markers in the MPI118Q/118Q cerebellum. More importantly, it ameliorated PC loss and partially rescued motor impairments in the early disease phase. These results suggest that early neuroinflammatory response may play an important role in the pathogenesis of SCA6 and its modulation could pave the way for slowing the disease progression during the early stage of the disease.	[Aikawa, Tomonori; Sakurai, Miyano; Mizusawa, Hidehiro; Watase, Kei] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo 1138510, Japan; [Mogushi, Kaoru; Iijima-Tsutsui, Kumiko; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Dept Bioinformat, Med Res Inst, Tokyo 1138510, Japan; [Ishikawa, Kinya; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Dept Neurol & Neur Sci, Tokyo 1138510, Japan; [Aikawa, Tomonori; Mogushi, Kaoru; Iijima-Tsutsui, Kumiko; Ishikawa, Kinya; Tanaka, Hiroshi; Mizusawa, Hidehiro; Watase, Kei] JST, CREST, Tokyo 1028666, Japan; [Mogushi, Kaoru] Juntendo Univ, Ctr Genom & Regenerat Med, Tokyo 1130033, Japan; [Iijima-Tsutsui, Kumiko] Int Univ Hlth & Welf, Dept Social Serv & Healthcare Management, Ohtawara, Tochigi 3248501, Japan; [Mizusawa, Hidehiro] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Tokyo 1878551, Japan	Watase, K (reprint author), Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	keinuro@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25282241, 26860661]; Foundation of Synapse and Neurocircuit Pathology from the Ministry of Education, Culture, Sports, Science and Technology of Japan [25110712]; Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency; Japan Science and Technology Agency	This work was supported by the following: Grants-in-Aid for Scientific Research (grant number '25282241') (to H.M. and K.W.), a Grant-in-Aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology, grant number '25110712') (to K.W.) and a Grant-in-Aid for Young Scientists (grant number '26860661') (to T.A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a grant from the Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (to H.T. and H.M.). Funding to pay the Open Access publication charges for this article was provided by the Japan Science and Technology Agency.	Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Panaro MA, 2008, IMMUNOPHARM IMMUNOT, V30, P729, DOI 10.1080/08923970802278557 ; Wirths O, 2010, NEUROBIOL AGING, V31, P747, DOI 10.1016/j.neurobiolaging.2008.06.011; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Takahashi H, 2004, J HUM GENET, V49, P256, DOI 10.1007/s10038-004-0142-7; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Du XF, 2013, CELL, V154, P118, DOI 10.1016/j.cell.2013.05.059; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Taylor PR, 2002, J IMMUNOL, V169, P3876; Willment JA, 2003, J IMMUNOL, V171, P4569; Rub U, 2013, PROG NEUROBIOL, V104, P38, DOI 10.1016/j.pneurobio.2013.01.001; Snook ER, 2014, AM J PATHOL, V184, P382, DOI 10.1016/j.ajpath.2013.10.011; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Cvetanovic M, 2015, NEUROSCIENCE, V289, P289, DOI 10.1016/j.neuroscience.2015.01.003; Gatchel JR, 2008, P NATL ACAD SCI USA, V105, P1291, DOI 10.1073/pnas.0711257105; Hanke ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042476; Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0; Ishikawa K, 1999, AM J HUM GENET, V65, pA276; Ishikawa K, 1997, AM J HUM GENET, V61, P336, DOI 10.1086/514867; Kahle JJ, 2011, HUM MOL GENET, V20, P510, DOI 10.1093/hmg/ddq496; O'Halloran S, 2014, IMMUNOL LETT, V162, P109, DOI 10.1016/j.imlet.2014.08.001; Smyth GK, 2005, LIMMA LINEAR MODELS; Unno T, 2012, P NATL ACAD SCI USA, V109, P17693, DOI 10.1073/pnas.1212786109; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182	41	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	SEP 1	2015	24	17					4780	4791		10.1093/hmg/ddv202		12	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CR4OY	WOS:000361316300002		
J	Ohta, E; Nihira, T; Uchino, A; Imaizumi, Y; Okada, Y; Akamatsu, W; Takahashi, K; Hayakawa, H; Nagai, M; Ohyama, M; Ryo, M; Ogino, M; Murayama, S; Takashima, A; Nishiyama, K; Mizuno, Y; Mochizuki, H; Obata, F; Okano, H				Ohta, Etsuro; Nihira, Tomoko; Uchino, Akiko; Imaizumi, Yoichi; Okada, Yohei; Akamatsu, Wado; Takahashi, Kayoko; Hayakawa, Hideki; Nagai, Makiko; Ohyama, Manabu; Ryo, Masafuchi; Ogino, Mieko; Murayama, Shigeo; Takashima, Akihiko; Nishiyama, Kazutoshi; Mizuno, Yoshikuni; Mochizuki, Hideki; Obata, Fumiya; Okano, Hideyuki			I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3 beta signaling pathway	HUMAN MOLECULAR GENETICS			English	Article							REPEAT KINASE 2; DISEASE-ASSOCIATED MUTATIONS; PLURIPOTENT STEM-CELLS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GENE; NEURODEGENERATION; EXPRESSION; PATHOLOGY	Leucine-rich repeat kinase 2 (LRRK2) is the causative molecule of the autosomal dominant hereditary form of Parkinson's disease (PD), PARK8, which was originally defined in a study of a Japanese family (the Sagamihara family) harboring the I2020T mutation in the kinase domain. Although a number of reported studies have focused on cell death mediated by mutant LRRK2, details of the pathogenetic effect of LRRK2 still remain to be elucidated. In the present study, to elucidate the mechanism of neurodegeneration in PD caused by LRRK2, we generated induced pluripotent stem cells (iPSC) derived from fibroblasts of PD patients with I2020T LRRK2 in the Sagamihara family. We found that I2020T mutant LRRK2 iPSC-derived neurons released less dopamine than control-iPSC-derived neurons. Furthermore, we demonstrated that patient iPSC-derived neurons had a lower phospho-AKT level than control-iPSC-derived neurons, and that the former showed an increased incidence of apoptosis relative to the controls. Interestingly, patient iPSC-derived neurons exhibited activation of glycogen synthase kinase-3 beta (GSK-3 beta) and high Tau phosphorylation. In addition, the postmortem brain of the patient from whom the iPSC had been established exhibited deposition of neurofibrillary tangles as well as increased Tau phosphorylation in neurons. These results suggest that I2020T LRRK2-iPSC could be a promising new tool for reproducing the pathology of PD in the brain caused by the I2020T mutation, and applicable as a model in studies of targeted therapeutics.	[Ohta, Etsuro; Obata, Fumiya] Kitasato Univ, Sch Allied Hlth Sci, Inst Regenerat Med & Cell Design, R&D Ctr Cell Design, Sagamihara, Kanagawa, Japan; [Ohta, Etsuro; Obata, Fumiya] Kitasato Univ, Grad Sch Med Sci, Div Clin Immunol, Sagamihara, Kanagawa, Japan; [Nihira, Tomoko; Hayakawa, Hideki; Mizuno, Yoshikuni] Kitasato Univ, Grad Sch Med Sci, Dept Neuroregenerat Med, Sagamihara, Kanagawa, Japan; [Uchino, Akiko; Nishiyama, Kazutoshi] Kitasato Univ, Grad Sch Med Sci, Dept Neurol, Sagamihara, Kanagawa, Japan; [Ohta, Etsuro; Nihira, Tomoko; Imaizumi, Yoichi; Okada, Yohei; Akamatsu, Wado; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Ohyama, Manabu] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Uchino, Akiko; Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Brain Bank Aging Res, Tokyo 173, Japan; [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo 173, Japan; [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Bioresource Ctr, Brain Bank Aging Res, Tokyo 173, Japan; [Murayama, Shigeo] Inst Gerontol, Tokyo, Japan; [Okada, Yohei] Aichi Med Univ, Sch Med, Dept Neurol, Aichi, Japan; [Akamatsu, Wado] Juntendo Univ, Sch Med, Ctr Genom & Regenerat Med, Tokyo 113, Japan; [Takahashi, Kayoko] Kitasato Univ Hosp, Dept Med Lab, Sagamihara, Kanagawa, Japan; [Ogino, Mieko; Nishiyama, Kazutoshi] Kitasato Univ, Sch Med, Dept Neurol, Sagamihara, Kanagawa, Japan; [Takashima, Akihiko] Natl Ctr Geriatr & Gerontol, Dept Neurobiol, Obu, Japan; [Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan	Okano, H (reprint author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hidokano@a2.keio.jp	Okano, Hideyuki/J-5973-2013		Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST); Japan Agency for Medical Research and Development (AMED); Brain Science Foundation; MEXT [15H01565]; Kitasato University School of Allied Health Sciences [2012-1006, 2013-1005, 2014-1007]; Kitasato University;  [15K06777]	This work was supported by the Project for the Realization of Regenerative Medicine and Support for the Core Institutes for iPS cell research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), by the Program for Intractable Disease Research utilizing disease-specific iPS Cells from the Japan Science and Technology Agency (JST) and Japan Agency for Medical Research and Development (AMED), by Brain Science Foundation (Grant-in-Aid 2012), by Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) (Grant Number 15H01565) from MEXT, by Grant-in-Aid for Scientific Research (C) (Grant Number 15K06777), by Kitasato University School of Allied Health Sciences (Grant-in-Aid for Research Project, No. 2012-1006, No. 2013-1005 and No. 2014-1007) and by Kitasato University (Research Grant for Young Researchers).	Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Paisan-Ruiz C, 2004, NEURON, V44, P595; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Kawakami F, 2014, FEBS J, V281, P3, DOI 10.1111/febs.12579; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Belluzzi E, 2012, BIOCHEM SOC T, V40, P1111, DOI 10.1042/BST20120124; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Cheng KKY, 2012, P NATL ACAD SCI USA, V109, P8919, DOI 10.1073/pnas.1202435109; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Hasegawa K, 2009, PARKINSONISM RELAT D, V15, P300, DOI 10.1016/j.parkreldis.2008.07.010; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Ohnishi H, 2001, P NATL ACAD SCI USA, V98, P10930, DOI 10.1073/pnas.191368198; Attems J, 2012, BIOCHEM SOC T, V40, P711, DOI 10.1042/BST20120034; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Bardien S, 2011, PARKINSONISM RELAT D, V17, P501, DOI 10.1016/j.parkreldis.2010.11.008; Cooper O, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003985; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Funayama M, 2005, ANN NEUROL, V57, P918, DOI 10.1002/ana.20484; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greene ID, 2014, J NEUROSCI RES, V92, P506, DOI 10.1002/jnr.23331; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Higurashi N, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-19; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Kataoka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025158; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Lobbestael E, 2012, BIOCHEM SOC T, V40, P1102, DOI 10.1042/BST20120128; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Medina M., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/479249.EPUB; Migheli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077198; Milosevic J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-25; Nguyen Ha Nam, 2011, Cell Stem Cell, V8, P267, DOI 10.1016/j.stem.2011.01.013; Nishiki T, 1997, BIOCHEM BIOPH RES CO, V239, P57, DOI 10.1006/bbrc.1997.7427; Ohta E, 2011, FEBS LETT, V585, P2165, DOI 10.1016/j.febslet.2011.05.044; Ohta E, 2009, BIOCHEM BIOPH RES CO, V390, P710, DOI 10.1016/j.bbrc.2009.10.034; Ohta E, 2007, NEUROSCI LETT, V417, P21, DOI 10.1016/j.neulet.2007.02.086; Ohta E, 2010, BIOCHEM BIOPH RES CO, V391, P242, DOI 10.1016/j.bbrc.2009.11.043; Ohta E, 2013, BIOCHEM BIOPH RES CO, V430, P560, DOI 10.1016/j.bbrc.2012.11.113; Ohta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016182; Rojo L, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/73976; Ujiie S, 2012, PARKINSONISM RELAT D, V18, P819, DOI 10.1016/j.parkreldis.2012.03.024; Yagi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041572; Yamamori S, 2011, J COMP NEUROL, V519, P916, DOI 10.1002/cne.22558; Yun HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.68	62	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	SEP 1	2015	24	17					4879	4900		10.1093/hmg/ddv212		22	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CR4OY	WOS:000361316300009		
J	Zhong, N; Yau, SS; Ma, JH; Shimojo, S; Just, M; Hu, B; Wang, GY; Oiwa, K; Anzai, Y				Zhong, Ning; Yau, Stephen S.; Ma, Jianhua; Shimojo, Shinsuke; Just, Marcel; Hu, Bin; Wang, Guoyin; Oiwa, Kazuhiro; Anzai, Yuichiro			Brain Informatics-Based Big Data and the Wisdom Web of Things	IEEE INTELLIGENT SYSTEMS			English	Article							NETWORKS		[Zhong, Ning] Maebashi Inst Technol, Dept Life Sci & Informat, Maebashi, Gumma, Japan; [Zhong, Ning] Beijing Univ Technol, Int Web Intelligence Consortium WIC Inst, Beijing, Peoples R China; [Yau, Stephen S.] Arizona State Univ, Informat Assurance Ctr, Tempe, AZ 85287 USA; [Ma, Jianhua] Hosei Univ, Fac Comp & Informat Sci, Tokyo, Japan; [Shimojo, Shinsuke] CALTECH, Expt Psychol, Pasadena, CA 91125 USA; [Just, Marcel] Carnegie Mellon Univ, Sci Imaging & Brain Res Ctr, Pittsburgh, PA 15213 USA; [Hu, Bin] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China; [Wang, Guoyin] Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Chongqing, Peoples R China; [Oiwa, Kazuhiro] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Tokyo, Japan; [Anzai, Yuichiro] Japan Soc Promot Sci, Tokyo, Japan	Zhong, N (reprint author), Maebashi Inst Technol, Dept Life Sci & Informat, Maebashi, Gumma, Japan.	zhong@maebashi-it.ac.jp; yau@asu.edu; jianhua@hosei.ac.jp; sshimojo@caltech.edu; just@cmu.edu; bh@lzu.edu.cn; wanggy@cqupt.edu.cn; oiwa@nict.go.jp; anzai@jsps.go.jp			National Basic Research Program of China [2014CB744600]; International Science & Technology Cooperation Program of China [2013DFA32180]; National Natural Science Foundation of China [61420106005, 61272345]; Beijing Natural Science Foundation [4132023]; JSPS [26350994]	This work was supported by grants from the National Basic Research Program of China (2014CB744600), the International Science & Technology Cooperation Program of China (2013DFA32180), the National Natural Science Foundation of China (61420106005 and 61272345), the Beijing Natural Science Foundation (4132023), and the JSPS Grants-in-Aid for Scientific Research of Japan (26350994).	Hu B, 2011, IEEE INTELL SYST, V26, P46, DOI 10.1109/MIS.2011.58; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Zhong N, 2011, IEEE INTELL SYST, V26, P16, DOI 10.1109/MIS.2011.83; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Cukur T, 2013, NAT NEUROSCI, V16, P763, DOI 10.1038/nn.3381; Turk-Browne NB, 2013, SCIENCE, V342, P580, DOI 10.1126/science.1238409; Keller TA, 2009, NEURON, V64, P624, DOI 10.1016/j.neuron.2009.10.018; Lindsen JP, 2010, NEUROIMAGE, V50, P1626, DOI 10.1016/j.neuroimage.2010.01.079; Zhong N, 2013, J SUPERCOMPUT, V64, P862, DOI 10.1007/s11227-010-0518-8; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Sporns O, 2013, NAT METHODS, V10, P491, DOI 10.1038/nmeth.2485; Horikawa T, 2013, SCIENCE, V340, P639, DOI 10.1126/science.1234330; Anzai Y, 2013, ACMIEEE INT CONF HUM, P65, DOI 10.1109/HRI.2013.6483503; Chen JH, 2014, IEEE INTELL SYST, V29, P40; Douglas D., 2011, SCI AM, P37; Fensel D., 2008, IEEE INT C SEM COMP, V12, P524; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Haruno M, 2010, NAT NEUROSCI, V13, P160, DOI 10.1038/nn.2468; Heylighen F., 2007, SOCIAL EVOLUTION HIS, V6, P58; Lee VK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00259; Ma JH, 2011, IEEE INTELL SYST, V26, P30, DOI 10.1109/MIS.2011.55; Murakami I, 2006, VISION RES, V46, P2421, DOI 10.1016/j.visres.2006.01.030; Murata T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115658; Shimojo S., 2003, NAT NEUROSCI, V6, P13; Wang G. Y., 2014, BRAIN INFORM, DOI [10.1007/s40708-014-0001-z, DOI 10.1007/S40708-014-0001-Z]; Zhong N, 2012, IEEE T KNOWL DATA EN, V24, P2127, DOI 10.1109/TKDE.2011.139	26	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1541-1672	1941-1294		IEEE INTELL SYST	IEEE Intell. Syst.	SEP-OCT	2015	30	5					2	7				6	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	CR4OW	WOS:000361315900001		
J	Watanabe, T				Watanabe, Taro			Modeling Translation	IEEE INTELLIGENT SYSTEMS			English	Article									Google Japan, Tokyo, Japan	Watanabe, T (reprint author), Google Japan, Tokyo, Japan.	tarow@google.com					Chiang D, 2007, COMPUT LINGUIST, V33, P201, DOI 10.1162/coli.2007.33.2.201; [Anonymous], 2003, P 2003 C N AM CHAPT, DOI DOI 10.3115/1073445.1073462; Brown P. F., 1993, COMPUTATIONAL LINGUI, V19; Chiang D., 2009, P HUM LANG TECHN 200, P218, DOI 10.3115/1620754.1620786; Galley M., 2004, P HLT NAACL, P273; Hopkins M., 2011, P 2011 C EMP METH NA, P1352; Ney H., 2003, COMPUTATIONAL LINGUI, V29, P2003; Och F. J., 2003, P 41 ANN M ASS COMP, P160; Papineni K., 2002, P 40 ANN M ASS COMP, P311, DOI DOI 10.3115/1073083.1073135; Wu D, 1997, COMPUT LINGUIST, V23, P377	10	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1541-1672	1941-1294		IEEE INTELL SYST	IEEE Intell. Syst.	SEP-OCT	2015	30	5					36	44				9	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	CR4OW	WOS:000361315900005		
J	Verbruggen, B; Tsouhlarakis, J; Yamamoto, T; Iriguchi, M; Martens, E; Craninckx, J				Verbruggen, Bob; Tsouhlarakis, Jorgo; Yamamoto, Takaya; Iriguchi, Masao; Martens, Ewout; Craninckx, Jan			A 60 dB SNDR 35 MS/s SAR ADC With Comparator-Noise-Based Stochastic Residue Estimation	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Analog-digital converter (ADC); comparator noise; power efficiency; stochastic quantization; successive approximation	CMOS	We present a SAR ADC with comparator-noise-based stochastic residue estimation. The circuit uses a 9 cycle SAR converter to generate a residue, which is then quantized by clocking 16 noisy comparators four times each and digitally calculating the most likely input voltage for the obtained distribution of zeros and ones. The ADC achieves a 60.9 dB SNDR for a near-Nyquist input at 35 MS/s for a purely dynamic power consumption of 12 mu W/MHz.	[Verbruggen, Bob; Tsouhlarakis, Jorgo; Martens, Ewout; Craninckx, Jan] IMEC, B-3001 Louvain, Belgium; [Yamamoto, Takaya] Renesas Elect, Takasaki, Gumma, Japan; [Iriguchi, Masao] Renesas Elect, Kawasaki, Kanagawa 2150006, Japan	Verbruggen, B (reprint author), Xilinx, Saggart, County Dublin, Ireland.	bverbrug@gmail.com			European Union [248277]	This work was supported in part by the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant 248277.	KOBAYASHI T, 1993, IEEE J SOLID-ST CIRC, V28, P523, DOI 10.1109/4.210039; Abo AM, 1999, IEEE J SOLID-ST CIRC, V34, P599, DOI 10.1109/4.760369; Weaver S, 2010, IEEE T CIRCUITS-I, V57, P2825, DOI 10.1109/TCSI.2010.2050225; Nuzzo P, 2008, IEEE T CIRCUITS-I, V55, P1441, DOI 10.1109/TCSI.2008.917991; PELGROM MJM, 1989, IEEE J SOLID-ST CIRC, V24, P1433, DOI 10.1109/JSSC.1989.572629; Brooks L, 2008, IEEE T CIRCUITS-I, V55, P2969, DOI 10.1109/TCSI.2008.925373; Verbruggen B, 2012, IEEE J SOLID-ST CIRC, V47, P2880, DOI 10.1109/JSSC.2012.2217873; Berger R. L., 2001, LEARNING, V2nd, P312; Berger R. L., 2001, STAT INFERENCE, V2nd, P91; Figueiredo P. M., 2006, IEEE INT SOL STAT CI, P568; Giannini V., 2008, IEEE ISSCC, P238; Harpe P., 2013, IEEE ISSCC, P270; Lee MJE, 2000, IEEE J SOLID-ST CIRC, V35, P1591, DOI 10.1109/4.881204; Li J., 2002, EL CIRC SYST 2002 9, V1, P17; Miyahara M., 2008, P AS SOL STAT CIRC C, P554; Morie T., 2013, IEEE ISSCC, P272; Murmann B., ADC PERMANCE SURV; Okada H., 2003, P 29 EUR SOL STAT CI, P711; van der Goes F., 2014, IEEE INT SOL STAT CI, P200; Van der Plas G., 2006, IEEE ISSCC FEB, P566; Weaver S, 2014, IEEE T CIRCUITS-I, V61, P84, DOI 10.1109/TCSI.2013.2268571	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	SEP	2015	50	9					2002	2011		10.1109/JSSC.2015.2422781		10	Engineering, Electrical & Electronic	Engineering	CQ8VZ	WOS:000360889300004		
J	Jalali, MS; Sheikholeslami, A; Kibune, M; Tamura, H				Jalali, Mohammad Sadegh; Sheikholeslami, Ali; Kibune, Masaya; Tamura, Hirotaka			A Reference-Less Single-Loop Half-Rate Binary CDR	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Burst-mode CDR; clock and data recovery; cycle-slipping; frequency detection; gated VCO	DATA RECOVERY CIRCUIT; 10-GB/S CMOS CLOCK; TRANSCEIVER; DETECTOR	This paper proposes a half-rate single-loop reference-less binary CDR that operates from 8.5 Gb/s to 12.1 Gb/s (36% capture range). The high capture range is made possible by adding a novel frequency detection mechanism which limits the magnitude of the phase error between the input data and the VCO clock. The proposed frequency detector produces three phases of the data, and feeds into the phase detector the data phase that minimizes the CDR phase error. This frequency detector, implemented within a 10 Gb/s CDR in Fujitsu's 65 nm CMOS, consumes 11 mW and improves the capture range by up to 6x when it is activated.	[Jalali, Mohammad Sadegh; Sheikholeslami, Ali] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Kibune, Masaya; Tamura, Hirotaka] Fujitsu Labs Ltd, Kawasaki, Kanagawa 2118588, Japan	Jalali, MS (reprint author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.				NSERC	This work was supported by NSERC.	Yang RJ, 2004, IEEE J SOLID-ST CIRC, V39, P1356, DOI 10.1109/JSSC.2004.831809; Savoj J, 2001, IEEE J SOLID-ST CIRC, V36, P761, DOI 10.1109/4.918913; Hsieh MT, 2008, IEEE CIRC SYST MAG, V8, P45, DOI 10.1109/MCAS.2008.930152; Kromer C, 2006, IEEE J SOLID-ST CIRC, V41, P2921, DOI 10.1109/JSSC.2006.884389; Chan M, 2009, IET CIRC DEVICE SYST, V3, P76, DOI 10.1049/iet-cds.2008.0119; Choi W., 2013, IEEE VLSI S, pC280; Guanghua S., 2014, IEEE ISSCC, P150; Henrickson L, 2003, IEEE J SOLID-ST CIRC, V38, P1595, DOI 10.1109/JSSC.2003.817586; Hsiao KJ, 2008, 2008 INTERNATIONAL SYMPOSIUM ON VLSI DESIGN, AUTOMATION AND TEST (VLSI-DAT), PROCEEDINGS OF TECHNICAL PROGRAM, P121; Huang S., 2014, IEEE ISSCC, P152; Jalali M., 2013, P CICC SEP, P1; Kalantari N, 2013, IEEE T CIRCUITS-I, V60, P2920, DOI 10.1109/TCSI.2013.2256172; Kocaman N., 2013, IEEE J SOLID-ST CIRC, P1875; Liang J, 2015, IEEE J SOLID-ST CIRC, V50, P845, DOI 10.1109/JSSC.2014.2378280; Muthali HS, 2004, IEEE J SOLID-ST CIRC, V39, P1026, DOI 10.1109/JSSC.2004.829935; Nogawa M., 2005, IEEE INT SOL STAT CI, P228, DOI 10.1109/ISSCC.2005.1493952; Rezayee A., 2004, P IEEE ESSCIRC, P683; RICHMAN D, 1954, P IRE, V42, P106, DOI 10.1109/JRPROC.1954.274618; Savoj J, 2003, IEEE J SOLID-ST CIRC, V38, P13, DOI 10.1109/JSSC.2002.806284; Shivnaraine R., 2013, IEEE T CIRCUITS-I, V61, P2129; Zhang B., 2013, IEEE ISSCC, P34	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	SEP	2015	50	9					2037	2047		10.1109/JSSC.2015.2429714		11	Engineering, Electrical & Electronic	Engineering	CQ8VZ	WOS:000360889300007		
J	Aoki, T; Okamoto, Y; Nakagawa, T; Kozuma, M; Kurokawa, Y; Ikeda, T; Yamade, N; Okazaki, Y; Miyairi, H; Fujita, M; Koyama, J; Yamazaki, S				Aoki, Takeshi; Okamoto, Yuki; Nakagawa, Takashi; Kozuma, Munehiro; Kurokawa, Yoshiyuki; Ikeda, Takayuki; Yamade, Naoto; Okazaki, Yutaka; Miyairi, Hidekazu; Fujita, Masahiro; Koyama, Jun; Yamazaki, Shunpei			Normally-Off Computing for Crystalline Oxide Semiconductor-Based Multicontext FPGA Capable of Fine-Grained Power Gating on Programmable Logic Element With Nonvolatile Shadow Register	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						CAAC-IGZO; crystalline IGZO; crystalline oxide semiconductor; field programmable gate array; multicontext; nonvolatile memory; normally-off computing; oxide semiconductor; power gating; shadow register	MEMORY; TECHNOLOGY; TRANSISTOR; GATE	Normally-off computing (Noff computing) using a multicontext field programmable gate array (MC-FPGA) consisting of crystalline oxide semiconductor FETs has been developed. The Noff computing discussed in this paper is a control architecture for an MC-FPGA capable of performing fine-grained power gating on each programmable logic element (PLE) whose registers include a volatile register and also a nonvolatile shadow register for storing and loading data in the volatile register. The MC-FPGA performs fine-grained control of power supplied only to PLEs contributing to effective calculation, when context switching happens. With an MC-FPGA fabricated with a hybrid process of a 1.0 mu m crystalline oxide semiconductor FET on a 0.5 mu m CMOS FET, it has been confirmed that the proposed Noff computing can resume the previous task when a context switches back to it, increases PLE use efficiency, and reduces the power consumption by 27.7% at operating frequencies of 20 MHz with a driving voltage of 2.5 V.	[Aoki, Takeshi; Okamoto, Yuki; Nakagawa, Takashi; Kozuma, Munehiro; Kurokawa, Yoshiyuki; Ikeda, Takayuki; Yamade, Naoto; Okazaki, Yutaka; Miyairi, Hidekazu; Koyama, Jun; Yamazaki, Shunpei] Semicond Energy Lab Co Ltd, Atsugi, Kanagawa 2430036, Japan; [Fujita, Masahiro] Univ Tokyo, VDEC, Tokyo 1130032, Japan	Aoki, T (reprint author), Semicond Energy Lab Co Ltd, Atsugi, Kanagawa 2430036, Japan.	ta1107@sel.co.jp					Amano S., 2010, P SID 11, P626; Inoue H, 2012, IEEE J SOLID-ST CIRC, V47, P2258, DOI 10.1109/JSSC.2012.2198969; Sekine Y, 2011, ECS TRANSACTIONS, V37, P77, DOI 10.1149/1.3600726; [Anonymous], 2006, STRAT DEV HDB; [Anonymous], 2013, P 5 IEEE INT MEM WOR; Choi D, 2008, IEEE T VLSI SYST, V16, P874, DOI 10.1109/TVLSI.2008.2000461; Masui S, 2003, IEEE J SOLID-ST CIRC, V38, P715, DOI 10.1109/JSSC.2003.810034; Aoki T, 2014, ISSCC DIG TECH PAP I, V57, P502, DOI 10.1109/ISSCC.2014.6757531; Sakimura N, 2008, IEEE CUST INTEGR CIR, P355; [Anonymous], 2008, P IEEE AS SOL STAT C; Kato K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.021201; Rahman A, 2006, IEEE CUST INTEGR CIR, P9, DOI 10.1109/CICC.2006.320938; Okamoto Y, 2013, ECS TRANSACTIONS, V54, P141, DOI 10.1149/05401.0141ecst; Aoki T., 2011, P VLSI TECHN S, P174; Ishizu T., 2012, SOL STAT DEV MAT, P590; Isobe A., 2014, P VLSI CIRC S, P49; Kobayashi H., 2013, COOL CHIPS 16 SESS 6; Kobayashi Y., 2014, P VLSI TECHN S, P170; Kozuma M., 2013, SOL STAT DEV MAT, P1096; Kozuma M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EE12; Kuon I., 2008, FPGA ARCHITECTURE SU; Kurokawa Y., 2013, P AS S QUAL EL DES, P66; Liauw Young Yang, 2012, IEEE INT C SOL STAT, P406; Matsuzaki T., 2015, IEEE ISSCC, P306; Matsuzaki T., 2011, P 3 IEEE INT MEM WOR, P185; Miyamura M., 2011, INT SOLID STATE CIRC, V11, P228; Ohmaru T., 2012, SOL STAT DEV MAT, P1144; Ohshima K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EE02; Okamoto Y, 2015, IEEE T VLSI SYST, V23, P422, DOI 10.1109/TVLSI.2014.2316871; Rabaey J. M., 2001, LOW ENERGY FPGAS ARC; Sjokvist N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EE10; Suzuki D., 2006, P VLSI CIRC S, P80; Suzuki D., 2010, 2010 INT C SOL STAT, P1146; Tada M., 2011, IEDM, P689; Tamura H., 2014, COOL CHIPS 17 SESS 7; Tamura H., 2011, P SID11 DIG, P729; Tanabe T., 2012, P SID, P88; Trimberger S., 1994, FIELD PROGRAMMABLE G; Trimberger S, 1997, 5TH ANNUAL IEEE SYMPOSIUM ON FIELD-PROGRAMMABLE CUSTOM COMPUTING MACHINES, P22, DOI 10.1109/FPGA.1997.624601; Yamazaki S., 2012, SID S, V43, P183	40	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	SEP	2015	50	9					2199	2211		10.1109/JSSC.2015.2438824		13	Engineering, Electrical & Electronic	Engineering	CQ8VZ	WOS:000360889300020		
J	Ohata, T; Saito, T				Ohata, Toshiyasu; Saito, Toshimichi			Stability Analysis of Multi-Phase Synchronization in Paralleled Buck Converters With Winner-Take-All and Loser-Take-All Switching Rules	IEEE JOURNAL ON EMERGING AND SELECTED TOPICS IN CIRCUITS AND SYSTEMS			English	Article						Current sharing; multi-phase synchronization; paralleled power converters; ripple reduction; switched dynamical systems; switching power converters	DC-DC CONVERTERS; CURRENT-SHARING CONTROL; DYNAMICAL-SYSTEMS; POWER CONVERTERS; VOLTAGE	This paper studies paralleled systems of buck converters with two kinds of switching rules. First, the system is controlled by the winner-take-all and current threshold switching rules. The system can generate stable multi-phase synchronization of inductor currents. As parameters vary, the multi-phase synchronization loses stability and the system exhibits a chaotic phenomenon in which unstable multi-phase synchronization is embedded. Second, the system is controlled by winner-take-all and loser-take-all switching rules. The system can generate stable multi-phase synchronization in a wide range of parameters: it is suitable to realize current-sharing and ripple reduction for low-voltage-high-current capabilities. In order to analyze the dynamics, we present simple piecewise linear models. Using the piecewise exact solutions, we prove stability of the synchronization phenomena and give a condition of parameters for the stability. We can also investigate the ripple characteristics precisely. Presenting simple test circuits, the stable synchronization phenomena are confirmed experimentally.	[Ohata, Toshiyasu] Yokogawa Elect Corp, Tokyo 1808570, Japan; [Saito, Toshimichi] Hosei Univ, Dept Elect & Elect Engn, Tokyo 1848584, Japan	Saito, T (reprint author), Hosei Univ, Dept Elect & Elect Engn, Tokyo 1848584, Japan.	tsaito@hosei.ac.jp					Tse CK, 2002, P IEEE, V90, P768, DOI 10.1109/JPROC.2002.1015006; Renaudineau H, 2014, IEEE T POWER ELECTR, V29, P759, DOI 10.1109/TPEL.2013.2256369; Rodriguez P, 2011, IEEE T IND ELECTRON, V58, P127, DOI 10.1109/TIE.2010.2042420; Giaouris D, 2012, IEEE T CIRCUITS-I, V59, P207, DOI 10.1109/TCSI.2011.2161371; Wang JP, 2013, IEEE T IND ELECTRON, V60, P1759, DOI 10.1109/TIE.2012.2190956; Giral R, 1999, IEEE T POWER ELECTR, V14, P643, DOI 10.1109/63.774201; Kapat S, 2011, IEEE T CIRCUITS-I, V58, P1958, DOI 10.1109/TCSI.2011.2106052; Rodriguez E, 2012, IEEE T CIRCUITS-I, V59, P215, DOI 10.1109/TCSI.2011.2161396; Chae S, 2012, IEEE T IND INFORM, V8, P536, DOI 10.1109/TII.2012.2193405; Zhou XW, 2000, IEEE T POWER ELECTR, V15, P1153, DOI 10.1109/63.892830; Abu-Qahouq J, 2004, IEEE T POWER ELECTR, V19, P1397, DOI 10.1109/TPEL.2004.836639; Mandal K, 2013, IEEE T CIRCUITS-I, V60, P778, DOI 10.1109/TCSI.2012.2209732; Aroudi A. E., 2010, IEEE T CIRCUITS-II, V57, P218; Banerjee S., 2001, NONLINEAR PHENOMENA; Deane JHB, 1999, IEEE T CIRCUITS-I, V46, P1313, DOI 10.1109/81.802818; Deivasundari P, 2014, IET POWER ELECTRON, V7, P1235, DOI 10.1049/iet-pel.2013.0313; Anand S, 2012, IET POWER ELECTRON, V5, P782, DOI 10.1049/iet-pel.2011.0346; Ishikawa Y., 2008, IEICE T FUND ELECTR, V8, P2076; Kapat S., 2009, IEEE T CIRCUITS-I, V57, P1793; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Saito T., 2007, IEICE T FUND ELECTR, V6, P1162; Saito T, 2005, IEEE T CIRCUITS-I, V52, P1666, DOI 10.1109/TCSI.2005.851676; Saito T, 2007, INT J BIFURCAT CHAOS, V17, P3373, DOI 10.1142/S021812740701910X; Saito T, 2000, IEEE T CIRCUITS-I, V47, P1038, DOI 10.1109/81.855459; Saito T., 2013, P IEEE IECON, P8389; Wang JB, 2012, IET POWER ELECTRON, V5, P1569, DOI 10.1049/iet-pel.2012.0216; Xie F., 2013, P IEEE IECON, P8354; Zhang LD, 2010, IEEE T POWER SYST, V25, P809, DOI 10.1109/TPWRS.2009.2032231	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3357			IEEE J EM SEL TOP C		SEP	2015	5	3					345	353		10.1109/JETCAS.2015.2462191		9	Engineering, Electrical & Electronic	Engineering	CR5MF	WOS:000361386400006		
J	Yamada, Y; Nagashima, T; Ibuki, Y; Fukumoto, Y; Ikenari, T; Sekiya, H				Yamada, Yuta; Nagashima, Tomoharu; Ibuki, Yoshifumi; Fukumoto, Yoshiki; Ikenari, Tatsuya; Sekiya, Hiroo			Design of a DC-DC Converter With Phase-Controlled Class-D ZVS Inverter	IEEE JOURNAL ON EMERGING AND SELECTED TOPICS IN CIRCUITS AND SYSTEMS			English	Article						Computation algorithm; phase control; resonant power converter; soft switching; zero-voltage switching (ZVS)	SWITCHED DYNAMICAL-SYSTEMS; BIFURCATION-ANALYSIS; POWER TRANSFER; EQUATIONS; COMPUTATION; EFFICIENCY; CIRCUITS; VALUES	This paper presents a design methodology of switching power converters with visualizations of converter characteristics on a system-parameter space. The computation techniques of the bifurcation parameter derivations are used for the characteristics visualizations directly. This paper shows a design of the resonant converter with the class-D zero-voltage-switching (ZVS) inverter as a design example. By drawing the ZVS region and the output-power contour map on the two-dimensional system parameter space, it is possible to obtain the component values that satisfy the ZVS condition at any phase shift. The validity and effectiveness of the proposed design strategy was confirmed by showing the quantitative agreements between PSpice-simulation and experimental results.	[Yamada, Yuta; Nagashima, Tomoharu; Sekiya, Hiroo] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2638522, Japan; [Ibuki, Yoshifumi; Fukumoto, Yoshiki; Ikenari, Tatsuya] DAIHEN Corp, Osaka 5320028, Japan	Sekiya, H (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2638522, Japan.	sekiya@faculty.chiba-u.jp			JSPS, Japan [26289115]	This research was supported in part by Grant-in-Aid for scientific research (Grant 26289115) of JSPS, Japan.	Angulo F, 2008, IEEE T CIRCUITS-I, V55, P2392, DOI 10.1109/TCSI.2008.918226; Xue RF, 2013, IEEE T CIRCUITS-I, V60, P867, DOI 10.1109/TCSI.2012.2209297; Kendir GA, 2005, IEEE T CIRCUITS-I, V52, P857, DOI 10.1109/TCSI.2005.846208; Thota P, 2008, SIAM J APPL DYN SYST, V7, P1283, DOI 10.1137/070703028; Musavi F, 2013, IEEE T POWER ELECTR, V28, P5437, DOI 10.1109/TPEL.2013.2241792; Huang M, 2013, IEEE T CIRCUITS-I, V60, P3328, DOI 10.1109/TCSI.2013.2264698; Ji C, 2014, IEEE T IND APPL, V50, P2660, DOI 10.1109/TIA.2013.2292997; KAWAKAMI H, 1984, IEEE T CIRCUITS SYST, V31, P248, DOI 10.1109/TCS.1984.1085495; Wu XK, 2015, IEEE T POWER ELECTR, V30, P780, DOI 10.1109/TPEL.2014.2309605; Robert B, 2002, INT J CONTROL, V75, P1356, DOI 10.1080/0020717021000023771; Wang H, 2012, IET POWER ELECTRON, V5, P401, DOI 10.1049/iet-pel.2010.0400; Ma Y, 2004, IEEE T CIRCUITS-I, V51, P1184, DOI 10.1109/TCSI.2004.829240; Xu DH, 2004, IEEE T POWER ELECTR, V19, P666, DOI 10.1109/TPEL.2004.826485; Nagashima T, 2014, IEEE T CIRCUITS-I, V61, P2904, DOI 10.1109/TCSI.2014.2327276; Mandal K, 2013, IEEE T CIRCUITS-I, V60, P778, DOI 10.1109/TCSI.2012.2209732; Pinuela M, 2013, IEEE T POWER ELECTR, V28, P2437, DOI 10.1109/TPEL.2012.2215887; Yadav GNB, 2014, IEEE T POWER ELECTR, V29, P4538, DOI 10.1109/TPEL.2013.2284780; Fang X, 2012, IEEE T POWER ELECTR, V27, P1985, DOI 10.1109/TPEL.2011.2168545; Aroudi A.E., 1999, IEEE T CIRCUITS SYST, V146, P1374; Donde V, 2006, INT J BIFURCAT CHAOS, V16, P671, DOI 10.1142/S0218127406015040; Giaouris D., 2008, IEEE T CIRCUITS-I, V21, P985; Kawakami H., 1995, INT J APPL ELECT MAT, V69, P293; Kousaka T., 2011, INT J BIFURCAT CHAOS, V55, P1084; Kousaka T, 1999, IEEE T CIRCUITS-II, V46, P878, DOI 10.1109/82.775383; Ma Y, 2006, INT J BIFURCAT CHAOS, V16, P693, DOI 10.1142/S0218127406015052; Robert B, 2006, MATH COMPUT SIMULAT, V71, P310, DOI 10.1016/j.matcom.2006.02.022; Sekiya H, 2006, IEEE T CIRCUITS-I, V53, P254, DOI 10.1109/TCSI.2005.855741; Sekiya H, 2002, IEEE T CIRCUITS-I, V49, P966, DOI 10.1109/TCSI.2002.800474; Sekiya H, 2008, IEEE T CIRCUITS-I, V55, P3688, DOI 10.1109/TCSI.2008.926288; Taralova I, 2002, IEEE T CIRCUITS-I, V49, P1592, DOI 10.1109/TCSI.2002.804592; Yamada Y., 2014, P IEEE IECON NOV, P4338; Ye ZM, 2007, IEEE T IND ELECTRON, V54, P2831, DOI 10.1109/TIE.2007.896030; YOSHINAGA T, 1991, IEICE TRANS COMMUN, V74, P1420	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3357			IEEE J EM SEL TOP C		SEP	2015	5	3					354	363		10.1109/JETCAS.2015.2467071		10	Engineering, Electrical & Electronic	Engineering	CR5MF	WOS:000361386400007		
J	Zhang, QF; Guo, TF; Khan, BA; Kodera, T; Caloz, C				Zhang, Qingfeng; Guo, Tongfeng; Khan, Bakhtiar Ali; Kodera, Toshiro; Caloz, Christophe			Coupling Matrix Synthesis of Nonreciprocal Lossless Two-Port Networks Using Gyrators and Inverters	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Complex inverter; coupling matrix; gyrator; lossless; nonreciprocal network; similarity transformation; synthesis	FILTERS	A coupling matrix technique is presented for the synthesis of nonreciprocal lossless two-port networks. This technique introduces complex inverters to build the nonreciprocal transversal network corresponding to the nonreciprocal coupling matrix. It subsequently transforms this matrix into canonical topologies through complex similarity transformations. The complex inverters in the final topology are transformed into real inverters and gyrators for implementation simplicity. A second-order network example and a fourth-order network example, as well as an experimental validation, are then provided to illustrate the proposed technique. Finally, other possible implementations of the nonreciprocal gyrators are discussed.	[Zhang, Qingfeng; Guo, Tongfeng] South Univ Sci & Technol China, Dept Elect & Elect Engn, Shenzhen 518055, Guangdong, Peoples R China; [Khan, Bakhtiar Ali; Caloz, Christophe] Ecole Polytech, Polygrames Res Ctr, Dept Elect Engn, Montreal, PQ H3T 1J4, Canada; [Kodera, Toshiro] Meisei Univ, Dept Interdisciplinary Sci & Engn, Tokyo 1918506, Japan; [Caloz, Christophe] King Abdulaziz Univ, Dept Elect Engn, Jeddah 22254, Saudi Arabia	Zhang, QF (reprint author), South Univ Sci & Technol China, Dept Elect & Elect Engn, Shenzhen 518055, Guangdong, Peoples R China.	zhang.qf@sustc.edu.cn; toshiro.kodera@meisei-u.ac.jp; christophe.caloz@polymtl.ca			National Natural Science Foundation of China [61401191]	Manuscript received August 11, 2014; revised January 15, 2015, May 09, 2015, and June 17, 2015; accepted June 19, 2015. Date of publication July 14, 2015; date of current version September 01, 2015. This work was supported by the National Natural Science Foundation of China under Grant 61401191.	Macchiarella G, 2006, IEEE T MICROW THEORY, V54, P4281, DOI 10.1109/TMTT.2006.885909; Shmilovitz D, 1998, IEEE T CIRCUITS-I, V45, P428, DOI 10.1109/81.669066; Kodera T, 2013, IEEE T MICROW THEORY, V61, P1030, DOI 10.1109/TMTT.2013.2238246; Zhao LY, 2014, IEEE T ANTENN PROPAG, V62, P2767, DOI 10.1109/TAP.2014.2308547; Caloz C, 2013, IEEE MICROW MAG, V14, P87, DOI 10.1109/MMM.2013.2269862; ATIA AE, 1972, IEEE T MICROW THEORY, VMT20, P258, DOI 10.1109/TMTT.1972.1127732; Skaik TF, 2011, IET MICROW ANTENNA P, V5, P1081, DOI 10.1049/iet-map.2010.0447; TELLEGEN BDH, 1948, PHILIPS RES REP, V3, P81; Cameron RJ, 1999, IEEE T MICROW THEORY, V47, P433, DOI 10.1109/22.754877; Zhang QF, 2013, IEEE T MICROW THEORY, V61, P1043, DOI 10.1109/TMTT.2013.2241785; Cameron RJ, 2003, IEEE T MICROW THEORY, V51, P1, DOI 10.1109/TMTT.2002.806937; Atia A., 1971, COMSAT TECH REV, V1, P20; Barazarte RY, 2010, IEEE T POWER ELECTR, V25, P1832, DOI 10.1109/TPEL.2010.2042820; Cameron R., 2007, MICROWAVE FILTERS CO; CHUA HT, 1967, ELECTRON LETT, V3, P182, DOI 10.1049/el:19670144; Chung SJ, 2012, EUR MICROW CONF, P1331; HOGAN CL, 1952, AT&T TECH J, V31, P1; Hong J. S., 2001, MICROSTRIP FILTERS R; Pozar D. M., 2011, MICROWAVE ENG; RUBIN WL, 1962, IRE T CIRCUIT THEORY, VCT 9, P48; SHENOI BA, 1965, IEEE T CIRCUITS SYST, VCT12, P374	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	SEP	2015	63	9					2782	2792		10.1109/TMTT.2015.2450733		11	Engineering, Electrical & Electronic	Engineering	CR3OL	WOS:000361242500010		
J	Zhou, JF; Morris, KA; Watkins, GT; Yamaguchi, K				Zhou, Jiafeng; Morris, Kevin A.; Watkins, Gavin T.; Yamaguchi, Keiichi			Improved Reactance-Compensation Technique for the Design of Wideband Suboptimum Class-E Power Amplifiers	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Class-E; impedance transforming; matching networks; power amplifier (PA); reactance compensation; switching mode; wideband	EFFICIENCY; MODEL	A reactance-compensation technique has been introduced recently for the design of wideband class-E power amplifiers (PAs). With this technique, the load resistance can be transformed to an optimal complex drain impedance in a broad frequency band. One potential problem of this technique is that an additional network is often needed to transform 50 to the optimum load resistance, which is typically at a lower value. This paper proposes a method to improve the reactance compensation technique. By using the proposed method, the required low-value load resistance is up to four times the original value. This is achieved not by adding more components, but by simply changing the order and values of them. With the proposed method, the additional resistance matching network is no longer needed in many cases, or can be significantly simplified in other cases. To validate the theory, two broadband class-E amplifiers were designed using the original technique and the proposed method, respectively. The performances of the two amplifiers are compared. By using similar complexity of matching networks, the PA designed using the original method can achieve better than 70% power-added efficiency for a fractional bandwidth of 42%. The PA designed using the proposed method can achieve above 70% efficiency for a bandwidth of 51%. The proposed method can be used in the design of many other types of amplifiers.	[Zhou, Jiafeng; Morris, Kevin A.] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UB, Avon, England; [Watkins, Gavin T.] Toshiba Res Europe Ltd, Bristol BS1 4ND, Avon, England; [Yamaguchi, Keiichi] Toshiba Co Ltd, Corp Res & Dev Ctr, Wireless Syst Lab, Kawasaki, Kanagawa 2128582, Japan	Zhou, JF (reprint author), Univ Liverpool, Dept Elect Engn & Elect, Liverpool L69 3GJ, Merseyside, England.	Jiafeng.zhou@liverpool.ac.uk			Toshiba Research Europe Limited; Toshiba Mobile Communications Laboratory	Manuscript received August 31, 2014; revised December 05, 2014, January 26, 2015, and May 29, 2015; accepted June 15, 2015. Date of publication July 27, 2015; date of current version September 01, 2015. This work was supported by Toshiba Research Europe Limited and by the Toshiba Mobile Communications Laboratory.	AITCHISO.CS, 1967, IEEE T MICROW THEORY, VMT15, P22, DOI 10.1109/TMTT.1967.1126364; SOKAL NO, 1975, IEEE J SOLID-ST CIRC, VSC10, P168, DOI 10.1109/JSSC.1975.1050582; Al Tanany A, 2009, IEEE MTT S INT MICR, P761, DOI 10.1109/MWSYM.2009.5165808; Chen K, 2011, IEEE T MICROW THEORY, V59, P3162, DOI 10.1109/TMTT.2011.2169080; Bahl I. J., 2009, FUNDAMENTALS RF MICR; Carrubba V., 2011, IEEE MTT S INT MICR, P1; Cripps SC, 2002, ADV TECHNIQUES RF PO; EVERARD JKA, 1987, J I ELECTRON RAD ENG, V57, P52; Grebennikov A., 2007, SWITCHMODE RF POWER; Hong J. S., 2001, MICROSTRIP FILTERS R; Matthaei G. L., 1980, MICROWAVE FILTER IMP; Minnis B. J., 1996, DESIGNING MICROWAVE; Narendra K., 2008, IEEE T MICROW THEORY, V56, P604; Ortega-Gonzalez FJ, 2010, IEEE MICROW WIREL CO, V20, P569, DOI 10.1109/LMWC.2010.2064760; Ortega-Gonzalez FJ, 2013, IEEE T MICROW THEORY, V61, P3712, DOI 10.1109/TMTT.2013.2279366; Ozen M, 2012, IEEE T CIRCUITS-II, V59, P731, DOI 10.1109/TCSII.2012.2228392; Paynter M, 2012, EUR MICROW INTEGRAT, P76; Paynter M., 2011, IEEE EUR MICR C OCT, P152; Raab F. H., 1989, Proceedings RF Technology Expo 89; Raab FH, 2006, IEEE MTT-S, P902, DOI 10.1109/MWSYM.2006.249839; Shi K., 2011, EUR MICR C MANCH UK, P542; Tee Y. K., 2014, IET CIRCUITS DEVICES, V60, P1; Ui N, 2006, EUR MICROW INTEGRAT, P72, DOI 10.1109/EMICC.2006.282753; Wei MD, 2012, IEEE T MICROW THEORY, V60, P1916, DOI 10.1109/TMTT.2012.2191304; Zhou JF, 2013, MICROW OPT TECHN LET, V55, P323, DOI 10.1002/mop.27305; Zhou JF, 2013, EUR MICROW CONF, P1307	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	SEP	2015	63	9					2793	2801		10.1109/TMTT.2015.2455505		9	Engineering, Electrical & Electronic	Engineering	CR3OL	WOS:000361242500011		
J	Gao, F; Zhang, FS; Wakatsuchi, H; Sievenpiper, DF				Gao, Fei; Zhang, Fushun; Wakatsuchi, Hiroki; Sievenpiper, Daniel F.			Synthesis and Design of Programmable Subwavelength Coil Array for Near-Field Manipulation	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Electrically small; near-field; subwavelength array; synthesis; transcranial magnetic stimulation (TMS)	MAGNETIC-STIMULATION; ANTENNA-ARRAYS; RESOLUTION; BRAIN; PATTERNS	We present the design and experimental demonstration of a programmable subwavelength coil array, which can manipulate the evanescent magnetic field leading to a precisely controlled electric-field pattern at an image plane in the near-field zone. A synthesis methodology is outlined for 2-D near-field manipulations. Simulation based on a full-wave electromagnetic solver clearly demonstrates the focused electric-field pattern, and its implementation is discussed. An example of a three-layer subwavelength coil array with 48 units is fabricated and measured. The consensus of the measured results with the simulated and synthesized results verified the presented synthesis method. Such a device, capable of producing a programmable magnetic field and electric field, respectively, in orthogonal planes, will find applications in biomedical devices such as neural stimulation, and potentially other areas such as noncontact charging.	[Gao, Fei; Zhang, Fushun] Xidian Univ, Natl Key Lab Antennas & Microwave Technol, Xian 710071, Shaanxi, Peoples R China; [Gao, Fei; Sievenpiper, Daniel F.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Wakatsuchi, Hiroki] Nagoya Inst Technol, Ctr Innovat Young Researchers, Dept Elect & Elect Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Gao, F (reprint author), Xidian Univ, Natl Key Lab Antennas & Microwave Technol, Xian 710071, Shaanxi, Peoples R China.	saltfeig@eng.ucsd.edu			University of California at San Diego Center for Brain Activity Mapping [2013-008CBAM]; China Scholarship Council (CSC)	Manuscript received September 19, 2014; revised December 09, 2014, March 24, 2015, and May 09, 2015; accepted June 12, 2015. Date of publication July 15, 2015; date of current version September 01, 2015. This work was supported by the University of California at San Diego Center for Brain Activity Mapping (2013-008CBAM). This work was supported in part by the China Scholarship Council (CSC).	Grbic A, 2008, SCIENCE, V320, P511, DOI 10.1126/science.1154753; Merlin R, 2007, SCIENCE, V317, P927, DOI 10.1126/science.1143884; UENO S, 1990, IEEE T MAGN, V26, P1539, DOI 10.1109/20.104438; Ludwig A, 2014, IEEE T ANTENN PROPAG, V62, P3543, DOI 10.1109/TAP.2014.2316297; Rao KVS, 2005, IEEE T ANTENN PROPAG, V53, P3870, DOI 10.1109/TAP.2005.859919; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; Chou HT, 2011, IEEE T ANTENN PROPAG, V59, P4342, DOI 10.1109/TAP.2011.2164221; ASH EA, 1972, NATURE, V237, P510, DOI 10.1038/237510a0; Synge EH, 1928, PHILOS MAG, V6, P356; Hui SYR, 2005, IEEE T POWER ELECTR, V20, P620, DOI 10.1109/TPEL.2005.846550; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Chou HT, 2011, IEEE T ANTENN PROPAG, V59, P3224, DOI 10.1109/TAP.2011.2161554; Gao F, 2014, IEEE T MICROW THEORY, V62, P481, DOI 10.1109/TMTT.2014.2299763; Stephan KD, 2007, IEEE T ANTENN PROPAG, V55, P1199, DOI 10.1109/TAP.2007.893429; Sentenac A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.013901; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Rossini PM, 2010, IEEE ENG MED BIOL, V29, P84, DOI 10.1109/MEMB.2009.935474; Balanis C. A., 2012, ANTENNA THEORY ANAL; Banerjee D., 2011, APPL PHYS LETT, V99; Chou HT, 2011, IEEE T ANTENN PROPAG, V59, P1013, DOI 10.1109/TAP.2010.2103030; Dede E. M., 2012, APPL PHYS LETT, V101; Finkenzeller K., 1999, RFID HDB RADIO FREQU; Fraleigh J., 1995, LINEAR ALGEBRA, V3rd; Gadh R, 2010, P IEEE, V98, P1546, DOI 10.1109/JPROC.2010.2053871; Grbic A, 2011, P IEEE, V99, P1806, DOI 10.1109/JPROC.2011.2106191; Hansen R. C., 2006, ELECT SMALL SUPERDIR; Imani MF, 2010, IEEE T MICROW THEORY, V58, P3982, DOI 10.1109/TMTT.2010.2088136; Jiang RL, 2013, IEEE T NEUR SYS REH, V21, P370, DOI 10.1109/TNSRE.2012.2226914; Lin J., 2007, P 19 AS PAC MICR C, V1, P1; Markley L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.113901; Mittra R., 2000, FRONTIERS ELECTROMAG, P474; Overfelt PL, 1996, IEEE T ANTENN PROPAG, V44, P166, DOI 10.1109/8.481643; Ruohonen J, 1998, MED BIOL ENG COMPUT, V36, P297, DOI 10.1007/BF02522474; Verslegers L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.033902; Werner DH, 1996, IEEE T ANTENN PROPAG, V44, P157, DOI 10.1109/8.481642; Yang S, 2010, IEEE T APPL SUPERCON, V20, P829, DOI 10.1109/TASC.2010.2040379	36	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	SEP	2015	63	9					2971	2982		10.1109/TMTT.2015.2450711		12	Engineering, Electrical & Electronic	Engineering	CR3OL	WOS:000361242500029		
J	Shimizu, T; Fukuda, H; Toyoda, K; Cho, M				Shimizu, Tatsuo; Fukuda, Hiroshi; Toyoda, Kazuhiro; Cho, Mengu			Development of an In-Orbit High-Voltage Experimental Platform: HORYU-4	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						High-voltage technology demonstration; in-orbit ESD experiment; instrument development; nanosatellite	SOLAR-ARRAY; DEGRADATION; ENVIRONMENT	HORYU-4 is a 12-kg satellite currently under development at the Kyushu Institute of Technology. Its main mission is to perform an in-orbit high-voltage technology demonstration to evaluate state-of-the-art arc mitigation technologies in real space environments. The main objective is to perform a similar experiment as those on the ground for the validation of existing test methods. The obtained data (arc current waveforms, in particular) will be utilized to evaluate testing methods, as the waveforms on the ground must have some resemblance to those in space. To perform such an experiment in orbit, we have outfitted this satellite with typical laboratory equipment, such as oscilloscopes and video cameras and a high-voltage source (i.e., Sphelar solar cells, also used on HORYU-2). In fact, this satellite is a miniaturized in-orbit laboratory for high-voltage experiments. An oscilloscope and video camera have been designed and developed using commercial off-the-shelf components that provide sufficient measurement capabilities with a limited size and power range.	[Shimizu, Tatsuo; Fukuda, Hiroshi; Toyoda, Kazuhiro; Cho, Mengu] Kyushu Inst Technol, Lab Spacecraft Environm Interact Engn, Kitakyushu, Fukuoka 8048550, Japan	Shimizu, T (reprint author), Kyushu Inst Technol, Lab Spacecraft Environm Interact Engn, Kitakyushu, Fukuoka 8048550, Japan.	shimizu.tatsuo363@mail.kyutech.jp; o349523h@mail.kyutech.jp; toyoda@ele.kyutech.ac.jp; cho@ele.kyutech.ac.jp					[Anonymous], 2014, TOP 10 THINGS CONS S; Toyoda K, 2004, J SPACECRAFT ROCKETS, V41, P854, DOI 10.2514/1.13103; [Anonymous], 2011, 11221 ISO; Okumura T, 2010, J SPACECRAFT ROCKETS, V47, P533, DOI 10.2514/1.47929; [Anonymous], 2012, 10 THINGS CONS SEL Y; Ferguson D. C., 1986, TM87259 NASA; Ferguson DC, 2001, ESA SP PUBL, V476, P83; Fuchikami S., 2014, P 13 SPAC CHARG TECH; Fukuda H., 2014, P 13 SPAC CHARG TECH; Hastings D., 1996, SPACECRAFT ENV INTER, P142, DOI 10.1017/CBO9780511525032.006; HILLARD GB, 1993, J SPACECRAFT ROCKETS, V30, P488, DOI 10.2514/3.25555; Iwai S., 2013, P 4 INT ASTR C BEIJ; Katz I., 1998, P 36 AER SCI M REST, DOI [10.2514/6.1998-1002, DOI 10.2514/6.1998-1002]; KUNINAKA H, 1995, J SPACECRAFT ROCKETS, V32, P894, DOI 10.2514/3.26702; Okumura T., 2011, P 9 EUR SPAC POW C S; Soldi JD, 1997, J SPACECRAFT ROCKETS, V34, P92, DOI 10.2514/2.3177; Takahashi A., 2014, P 13 SPAC CHARG C PA; Toyoda K, 2005, J SPACECRAFT ROCKETS, V42, P947, DOI 10.2514/1.11602; Yoke T, 2013, IEEE T PLASMA SCI, V41, P3477, DOI 10.1109/TPS.2013.2276439	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	SEP	2015	43	9	1		SI		3027	3040		10.1109/TPS.2015.2453330		14	Physics, Fluids & Plasmas	Physics	CR3FE	WOS:000361215200034		
J	Toyoda, K; Kawano, A; Miyazaki, S; Cho, M				Toyoda, Kazuhiro; Kawano, Anna; Miyazaki, Satoshi; Cho, Mengu			Flashover Discharge Measurement With Uniform Surface Charging and Modeling of Current Waveform	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Flashover discharge; simulation; vacuum ultraviolet (VUV)		Flashover discharge occurs on spacecraft solar array with inverted potential gradient. The flashover discharges have been measured with an electron beam. However, it is difficult to charge the coupon surface uniformly. In this paper, ultraviolet light was used to achieve a uniform surface charging. The discharge current waveforms and surface potentials were measured with changing uniform surface potential. From these test results, the current waveform was calculated with a ladder circuit model. This model shows that the surface potential neutralization pattern is the same as that obtained with the experimental results.	[Toyoda, Kazuhiro; Kawano, Anna; Miyazaki, Satoshi; Cho, Mengu] Kyushu Inst Technol, Kitakyushu, Fukuoka 8040015, Japan	Toyoda, K (reprint author), Kyushu Inst Technol, Kitakyushu, Fukuoka 8040015, Japan.	toyoda@ele.kyutech.ac.jp; n108308a@mail.kyutech.jp; m349539s@tobata.isc.kyutech.ac.jp; cho@ele.kyutech.ac.jp					Amorin E., 2005, P 9 SPAC CHARG TECHN; Masui H, 2008, IEEE T PLASMA SCI, V36, P2387, DOI 10.1109/TPS.2008.2003191; Leung P., P 8 SCTC LEUN; Okumura T., 2010, P 11 SPAC CHARG TECH; Siguier J.-M., 2007, P 10 SPAC CHARG TECH; Suzuki T., 2012, P 12 SPAC CHARG TECH; Vayner B., 2010, P 11 SPAC CHARG TECH	7	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	SEP	2015	43	9	1		SI		3064	3069		10.1109/TPS.2015.2404853		6	Physics, Fluids & Plasmas	Physics	CR3FE	WOS:000361215200038		
J	Lyczko, K; Lyczko, M; Wozniak, K; Stachowicz, M; Oziminski, WP; Kubo, K				Lyczko, Krzysztof; Lyczko, Monika; Wozniak, Krzysztof; Stachowicz, Marcin; Oziminski, Wojciech P.; Kubo, Kanji			Influence of pH and type of counterion on the formation of bismuth(III) complexes with tropolonato and 5-methyltropolonato ligands: Synthesis, structure, spectroscopic characterization and calculation studies	INORGANICA CHIMICA ACTA			English	Article						Bismuth(III) complexes; Tropolone; 5-Methyltropolone; Crystal structure; DFT calculations	MOLECULAR-ORBITAL METHODS; GAUSSIAN-TYPE BASIS; X-RAY CRYSTAL; LONE-PAIR; COORDINATION-COMPLEXES; MAIN-GROUP; ANTIMICROBIAL ACTIVITIES; BIOLOGICAL EVALUATION; HELICOBACTER-PYLORI; ORGANIC-MOLECULES	Reactions of tropolone (Htrop) and 5-methyltropolone (5-meHtrop) with bismuth(III) triflate, perchlorate and nitrate in methanol solution at pH below 0 lead to the formation of different complexes with monomeric (Bi(5-metrop)(2)(NO3) (7)), dimeric ([Bi(trop)(2)(CF3SO3)](2) (1)) or polymeric structures ([Bi-2(trop)(4)(ClO4)(2)](n) (2), [Bi-2(trop)(4)(NO3)(2)](n) (3), [Bi-2(5-metrop)(4)(CF3SO3)(2)](n) (5) and {[Bi-2(5-metrop)(4)(ClO4) MeOH]ClO4}(n) (6)). On the other hand, if the syntheses are performed at higher pH the simple homoleptic Bi(trop) 3 (4) and Bi(5-metrop) 3 (8) compounds are obtained independently of the bismuth(III) salt used. The crystal structures of studied compounds have been determined by single-crystal X-ray diffraction. The molecular structure of 7 has been compared with its geometry received from DFT calculations giving a good correlation. The structures of 4 and 8 have been also simulated by means of the DFT method because it was not possible to obtain sufficiently large single crystals. The total coordination number of the bismuth(III) ion is six in 7, seven in 1, eight in 2, 5 and 6 and nine in 3. The optimized geometry for 4 and 8 shows a distorted triangle antiprism of oxygen atoms around metal center with three shorter and three longer Bi-O bond lengths. The compounds were characterized by FT-IR, NMR and UV-Vis techniques. IR and UV-Vis spectra of 4, 7 and 8 were also simulated by DFT methods. TD-DFT predictions demonstrate the frontier HOMOs and LUMOs cover the ligands giving LLCT character of the lowest-lying electronic transitions. NBOs analysis for these three complexes shows low p character of 5.6% (4 and 8) or 7.3% (7) for the 6s(2) lone electron pair on the bismuth(III) ion. (C) 2015 Elsevier B.V. All rights reserved.	[Lyczko, Krzysztof; Lyczko, Monika] Inst Nucl Chem & Technol, PL-03195 Warsaw, Poland; [Wozniak, Krzysztof; Stachowicz, Marcin] Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, PL-02089 Warsaw, Poland; [Oziminski, Wojciech P.] Natl Med Inst, PL-00725 Warsaw, Poland; [Kubo, Kanji] Hokkai Gakuen Univ, Fac Engn, Toyohira Ku, Sapporo, Hokkaido 0628605, Japan	Lyczko, K (reprint author), Inst Nucl Chem & Technol, Dorodna 16, PL-03195 Warsaw, Poland.	k.lyczko@ichtj.waw.pl			Institute of Nuclear Chemistry and Technology; Interdisciplinary Centre for Mathematical and Computational Modelling at Warsaw University (ICM UW) [G36-9]	The authors gratefully acknowledge the Institute of Nuclear Chemistry and Technology for financial support. Computational Grant G36-9 from the Interdisciplinary Centre for Mathematical and Computational Modelling at Warsaw University (ICM UW) is gratefully acknowledged.	ANDERSON TJ, 1974, INORG CHEM, V13, P158, DOI 10.1021/ic50131a030; Andrews P. C., 2003, CHEM COMMUN, V49, P2870; Andrews PC, 2002, J CHEM SOC DALTON, P4634, DOI 10.1039/b209347b; Andrews PC, 2013, CHEM COMMUN, V49, P2870, DOI 10.1039/c3cc40645h; Anjaneyulu O, 2012, DALTON T, V41, P1004, DOI 10.1039/c1dt11207d; Williams PA, 2001, CHEM VAPOR DEPOS, V7, P205, DOI 10.1002/1521-3862(200109)7:5<205::AID-CVDE205>3.0.CO;2-9; WADT WR, 1985, J CHEM PHYS, V82, P284, DOI 10.1063/1.448800; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1021/cr00088a005; Carolan AN, 2013, INORG CHEM, V52, P15, DOI 10.1021/ic3002509; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Thurston JH, 2004, INORG CHEM, V43, P3299, DOI 10.1021/ic035284d; Chandrasekhar V, 2013, DALTON T, V42, P8709, DOI 10.1039/c3dt50537e; Mahony DE, 1999, ANTIMICROB AGENTS CH, V43, P582; Dittes U, 1997, COORDIN CHEM REV, V163, P345, DOI 10.1016/S0010-8545(97)00042-8; Luqman A, 2014, CHEM-EUR J, V20, P14362, DOI 10.1002/chem.201404109; Mantina M, 2009, J PHYS CHEM A, V113, P5806, DOI 10.1021/jp8111556; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Fridrichova A, 2009, ORGANOMETALLICS, V28, P5522, DOI 10.1021/om900607n; Briand GG, 1999, CHEM REV, V99, P2601, DOI 10.1021/cr980425s; Beckmann J, 2012, INORG CHEM, V51, P12395, DOI 10.1021/ic3017722; Zhang N, 2014, DALTON T, V43, P5182, DOI 10.1039/c4dt00077c; Dikarev EV, 2005, J AM CHEM SOC, V127, P6156, DOI 10.1021/ja051265m; Shimoni-Livny L, 1998, INORG CHEM, V37, P1853, DOI 10.1021/ic970909r; Li MX, 2012, BIOORG MED CHEM LETT, V22, P2418, DOI 10.1016/j.bmcl.2012.02.024; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Armelao L, 1998, INORG CHIM ACTA, V276, P340; AVDEEF A, 1974, INORG CHEM, V13, P1854, DOI 10.1021/ic50138a015; Balaban AT, 1996, MAIN GROUP MET CHEM, V19, P385; Bao M, 2007, ORGANOMETALLICS, V26, P1816, DOI 10.1021/om0611453; Barret MC, 2001, INORG CHEM, V40, P4384, DOI 10.1021/ic0100368; BENSCH W, 1987, ACTA CRYSTALLOGR C, V43, P1699, DOI 10.1107/S0108270187090498; Boitrel B, 2003, DALTON T, P1803, DOI 10.1039/b210318d; BURDEN KJ, 1989, SPECTROCHIM ACTA A, V45, P1179, DOI 10.1016/0584-8539(89)80198-9; BURGESS J, 1994, ACTA CRYSTALLOGR C, V50, P1911, DOI 10.1107/S0108270194006463; Busse M., 2013, DALTON T, V43, P17980; Chitnis SS, 2013, INORG CHEM, V52, P7242, DOI 10.1021/ic400875a; CHOW YM, 1975, ACTA CRYSTALLOGR B, V31, P1929, DOI 10.1107/S0567740875006498; Conrad E, 2010, CHEM COMMUN, V46, P4598, DOI 10.1039/c0cc00111b; Deak A, 2007, DALTON T, P234, DOI 10.1039/b613692c; DIEMER R, 1995, CHEM BER, V128, P335, DOI 10.1002/cber.19951280404; DITCHFIE.R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Dittes U, 1996, ANGEW CHEM INT EDIT, V35, P67, DOI 10.1002/anie.199600671; DODDRELL DM, 1979, AUST J CHEM, V32, P1219; Dostal L, 2011, DALTON T, V40, P8922, DOI 10.1039/c1dt10234f; Dostal L, 2007, ORGANOMETALLICS, V26, P2911, DOI 10.1021/om070186b; ERRINGTON RJ, 1993, J CHEM SOC DALTON, P1201, DOI 10.1039/dt9930001201; Frisch M J, 2010, GAUSSIAN 09 REVISION; FUKIN GK, 1993, ZH NEORG KHIM+, V38, P1205; GarciaMontalvo V, 1996, INORG CHEM, V35, P3948, DOI 10.1021/ic9512082; Glendening J.E.D., 2001, NBO 5 0; GRIFFIN RT, 1980, J CHEM SOC DALTON, P1550, DOI 10.1039/dt9800001550; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Imam SK, 2001, INT J RADIAT ONCOL, V51, P271, DOI 10.1016/S0360-3016(01)01585-1; Johnson AM, 2013, DALTON T, V42, P8394, DOI 10.1039/c3dt50578b; Kira M, 1998, ORGANOMETALLICS, V17, P887, DOI 10.1021/om970937h; KIRA M, 1995, CHEM LETT, P659, DOI 10.1246/cl.1995.659; Kubo K, 2007, ACTA CRYSTALLOGR E, V63, pO1063, DOI 10.1107/S1600536807004035; Kuechle W., 1991, MOL PHYS, V74, P1245; Lehmann M, 2012, ANGEW CHEM INT EDIT, V51, P8087, DOI 10.1002/anie.201203267; Lewinski J, 1997, ORGANOMETALLICS, V16, P4597, DOI 10.1021/om961054d; Luckay R, 1997, J CHEM SOC DALTON, P901, DOI 10.1039/a605068i; Lyczko K, 2007, INORG CHEM, V46, P4402, DOI 10.1021/ic061561f; Mahjoub A.R., 2003, J COORD CHEM, V57, P571; Mazieres S, 2004, EUR J INORG CHEM, P2823, DOI 10.1002/ejic.200400281; Michaudet L, 2000, J PORPHYR PHTHALOCYA, V4, P261, DOI 10.1002/(SICI)1099-1409(200004/05)4:3<261::AID-JPP203>3.0.CO;2-B; Miersch L, 2010, EUR J INORG CHEM, P4763, DOI 10.1002/ejic.201000753; Moniz SJA, 2012, INORG CHIM ACTA, V380, P328, DOI 10.1016/j.ica.2011.09.029; Morsali A, 2005, Z NATURFORSCH B, V60, P389; Mudring AV, 2005, INORG CHEM, V44, P6240, DOI 10.1021/ic050547k; MUETTERT.EL, 1966, J AM CHEM SOC, V88, P4856, DOI 10.1021/ja00973a019; MUETTERT.EL, 1972, J AM CHEM SOC, V94, P8046, DOI 10.1021/ja00778a019; MUETTERTIES EL, 1964, J AM CHEM SOC, V86, P5132, DOI 10.1021/ja01077a017; Nakamoto K., 1986, INFRARED RAMAN SPECT; NEPVEU F, 1993, INORG CHIM ACTA, V211, P141, DOI 10.1016/S0020-1693(00)85593-0; Nomiya K, 2009, INORG CHIM ACTA, V362, P43, DOI 10.1016/j.ica.2008.02.061; PARK JJ, 1970, J AM CHEM SOC, V92, P3636, DOI 10.1021/ja00715a016; Reith LM, 2011, INORG CHEM, V50, P6788, DOI 10.1021/ic200840m; RETTIG SJ, 1984, CAN J CHEM, V62, P1705, DOI 10.1139/v84-293; ROGERS RD, 1992, J AM CHEM SOC, V114, P2967, DOI 10.1021/ja00034a032; Rostkowska H, 2002, INT J QUANTUM CHEM, V90, P1163, DOI 10.1002/qua.10327; Schiwon R, 2013, Z NATURFORSCH B, V68, P561, DOI 10.5560/ZNB.2013-3081; Sharutin VV, 2004, RUSS J COORD CHEM+, V30, P309, DOI 10.1023/B:RUCO.0000025998.92519.0e; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; SMITH G, 1994, AUST J CHEM, V47, P1413; Su FM, 2005, NUCL MED BIOL, V32, P741, DOI 10.1016/j.nucmedbio.2005.06.009; Sukhov BG, 2008, ARKIVOC, P139; Suresh P, 2012, Z ANORG ALLG CHEM, V638, P617, DOI 10.1002/zaac.201100463; Tan NY, 2011, ACTA CRYSTALLOGR E, V67, pM252, DOI 10.1107/S1600536811002510; Thirumurugan A, 2012, DALTON T, V41, P4126, DOI [10.1039/c2dt12330d, 10.1039/12dt12330d]; Thurston JH, 2002, CHEM COMMUN, P2834, DOI 10.1039/b209188g; Uhl W, 2002, Z NATURFORSCH B, V57, P141; Yang SP, 2012, ACTA CHIM SINICA, V70, P519; Yin HD, 2006, INDIAN J CHEM A, V45, P365; Yoshida J, 2014, J ORGANOMET CHEM, V756, P19, DOI 10.1016/j.jorganchem.2014.01.018; Yu L, 2004, INORG CHEM COMMUN, V7, P410, DOI 10.1016/j.inoche.2003.12.025; Zhang XW, 2011, ACTA CRYSTALLOGR E, V67, pM875, DOI 10.1107/S1600536811021039	96	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	SEP 1	2015	436						57	68		10.1016/j.ica.2015.07.011		12	Chemistry, Inorganic & Nuclear	Chemistry	CR2VB	WOS:000361187700009		
J	Masuoka, Y; Yaguchi, H; Suzuki, R; Maekawa, K				Masuoka, Yudai; Yaguchi, Hajime; Suzuki, Ryutaro; Maekawa, Kiyoto			Knockdown of the juvenile hormone receptor gene inhibits soldier-specific morphogenesis in the damp-wood termite Zootermopsis nevadensis (Isoptera: Archotermopsidae)	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Juvenile hormone; Methoprene-tolerant; Termites; Soldier differentiation	HODOTERMOPSIS-SJOSTEDTI ISOPTERA; BEETLE TRIBOLIUM-CASTANEUM; BHLH-PAS FAMILY; METHOPRENE-TOLERANT; NASUTE TERMITE; NASUTITERMES-TAKASAGOENSIS; RETICULITERMES-SPERATUS; CASTE DIFFERENTIATION; PCR DATA; TERMOPSIDAE	The Methoprene-tolerant (Met) protein has been established as a juvenile hormone (JH) receptor. Knockdown of the Met gene caused precocious metamorphosis and suppression of ovarian development. However, the function of Met in caste development of social insects is unclear. In termites, JH acts as a central factor for caste development, especially for soldier differentiation, which involves two molts from workers via a presoldier stage. Increased JH titer in workers is needed for the presoldier molt, and the high JH titer is maintained throughout the presoldier period. Although presoldiers have the fundamental morphological features of soldiers, the nature of the cuticle is completely different from that of soldiers. We expected that JH signals via Met are involved in soldier-specific morphogenesis of the head and mandibles during soldier differentiation, especially in the presoldier period, in natural conditions. To test this hypothesis, we focused on soldier differentiation in an incipient colony of the damp-wood termite Zootermopsis nevadensis. Met homolog (ZnMet) expression in heads increased just after the presoldier molt. This high expression was reduced by ZnMet double stranded (dsRNA) injection before the presoldier molt. Although this treatment did not cause any morphological changes in presoldiers, it caused strong effects on soldiers, their mandibles being significantly shorter and head capsules smaller than those of control soldiers. Injection of ZnMet dsRNA throughout the presoldier stage did not affect the formation of soldier morphology, including cuticle formation. These results suggested that the rapid increase in ZnMet expression and subsequent activation of JH signaling just after the presoldier molt are needed for the formation of soldier-specific weapons. Therefore, besides its established role in insect metamorphosis, the JH receptor signaling also underlies soldier development in termites. (C) 2015 Elsevier Ltd. All rights reserved.	[Masuoka, Yudai; Yaguchi, Hajime; Suzuki, Ryutaro; Maekawa, Kiyoto] Toyama Univ, Grad Sch Sci & Engn, Toyama 930, Japan	Maekawa, K (reprint author), Toyama Univ, Grad Sch Sci & Engn, Toyama 930, Japan.				Japan Society for the Promotion of Science [24570022, 25128705]	We are grateful to Tsutomu Tsuchida (University of Toyama) who helped for qPCR and bioanalyzer experiments. Thanks are also due to Akiko Fujiwara, Takashi Sugimoto, Kouhei Toga, Ryota Saiki, Takaya Inoue, Syutaro Hanmoto and Souichiro Kawamura for their help during both field and laboratory work This study was supported in part by Grant-in-Aids for Scientific Research (Nos. 24570022 and 25128705 to KM) from the Japan Society for the Promotion of Science.	Zhou XF, 2002, DEVELOPMENT, V129, P2259; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Koshikawa S, 2002, INSECT SOC, V49, P245, DOI 10.1007/s00040-002-8309-8; Miura T, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P211, DOI 10.1007/978-90-481-3977-4_9; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Tsuchiya M, 2008, APPL ENTOMOL ZOOL, V43, P307, DOI 10.1303/aez.2008.307; Cornette R, 2006, INSECT MOL BIOL, V15, P235, DOI 10.1111/j.1365-2583.2006.00632.x; Miura T, 2000, P ROY SOC B-BIOL SCI, V267, P1185, DOI 10.1098/rspb.2000.1127; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Toga K, 2012, EVOL DEV, V14, P286, DOI 10.1111/j.1525-142X.2012.00545.x; Scharf ME, 2003, INSECT SOC, V50, P346, DOI 10.1007/s00040-003-0690-4; Saiki R, 2014, ZOOL SCI, V31, P573, DOI 10.2108/zs140083; Cornette R, 2008, INSECT SOC, V55, P407, DOI 10.1007/s00040-008-1031-4; Miura T, 2001, INSECT SOC, V48, P216, DOI 10.1007/PL00001769; Itano H, 2008, SOCIOBIOLOGY, V51, P151; Futahashi R, 2007, INSECT BIOCHEM MOLEC, V37, P855, DOI 10.1016/j.ibmb.2007.02.014; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Roisin Y, 1996, INSECT SOC, V43, P375, DOI 10.1007/BF01258410; Masuoka Y, 2013, ARTHROPOD STRUCT DEV, V42, P469, DOI 10.1016/j.asd.2013.08.003; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Maekawa K, 2012, ZOOL SCI, V29, P213, DOI 10.2108/zsj.29.213; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Maekawa K, 2014, AUSTRAL ENTOMOL, V53, P138, DOI 10.1111/aen.12060; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Saiki R, 2015, INSECT MOL BIOL, V24, P432, DOI 10.1111/imb.12169; Toga K, 2009, ZOOL SCI, V26, P382, DOI 10.2108/zsj.26.382; Elias-Neto M, 2010, INSECT BIOCHEM MOLEC, V40, P241, DOI 10.1016/j.ibmb.2010.02.004; Heath H, 1927, J MORPHOL PHYSIOL, V43, P387, DOI 10.1002/jmor.1050430206; Hattori A, 2013, J EXP ZOOL PART B, V320B, P295, DOI 10.1002/jez.b.22501; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Castle G.B., 1934, TERMITES TERMITE CON, P273; Emlen J.D., 2006, HEREDITY, V97, P179; Howard J.K., 2011, BIOL TERMITES MODERN, P97; Ishikawa Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002617; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Korb J., 2015, ADV INSECT PHYSL GEN, V48, P131; Lozano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103614; Marchal E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106737; Moczek P.A., 2002, EVOL DEV, V4, P252; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; Nalepa A.C, 2011, BIOL TERMITES MODERN, P69; Nijhout HF, 1994, INSECT HORMONES; Noirot C, 1985, CASTE DIFFERENTIATIO, P75; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Riddiford M.L, 2008, J INSECT PHYSL, V54, P895; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Untergasser A., 2007, NUCLEIC ACIDS RES, V35, P71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00127	54	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	SEP	2015	64						25	31		10.1016/j.ibmb.2015.07.013		7	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	CR5RY	WOS:000361402900003		
J	Kikuta, S; Nakamura, Y; Hattori, M; Sato, R; Kikawada, T; Noda, H				Kikuta, Shingo; Nakamura, Yuki; Hattori, Makoto; Sato, Ryoichi; Kikawada, Takahiro; Noda, Hiroaki			Herbivory-induced glucose transporter gene expression in the brown planthopper, Nilaparvata lugens	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Glucose transporter; Midgut; Gene expression; Xenopus oocyte; Laser stylectomy; Microarray; Brown planthopper; Nilaparvata lugens	RICE PHLOEM SAP; TREHALOSE TRANSPORTER; ACYRTHOSIPHON-PISUM; SUGAR TRANSPORTERS; PEA APHID; INSECTS; PLANT; METABOLISM; PREDICTION; DROSOPHILA	Nilaparvata lugens, the brown planthopper (BPH) feeds on rice phloem sap, containing high amounts of sucrose as a carbon source. Nutrients such as sugars in the digestive tract are incorporated into the body cavity via transporters with substrate selectivity. Eighteen sugar transporter genes of BPH (Nlst) were reported and three transporters have been functionally characterized. However, individual characteristics of NlST members associated with sugar transport remain poorly understood. Comparative gene expression analyses using oligo-microarray and quantitative RT-PCR revealed that the sugar transporter gene Nlst16 was markedly up-regulated during BPH feeding. Expression of Nlst16 was induced 2 h after BPH feeding on rice plants. Nlst16, mainly expressed in the midgut, appears to be involved in carbohydrate incorporation from the gut cavity into the hemolymph. Nlst1 (NlHT1), the most highly expressed sugar transporter gene in the midgut was not up-regulated during BPH feeding. The biochemical function of NlST16 was shown as facilitative glucose transport along gradients. Glucose uptake activity by NlST16 was higher than that of NlST1 in the Xenopus oocyte expression system. At least two NlST members are responsible for glucose uptake in the BPH midgut, suggesting that the midgut of BPH is equipped with various types of transporters having diversified manner for sugar uptake. (C) 2015 Elsevier Ltd. All rights reserved.	[Kikuta, Shingo; Nakamura, Yuki; Hattori, Makoto; Kikawada, Takahiro; Noda, Hiroaki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Kikuta, Shingo; Kikawada, Takahiro; Noda, Hiroaki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Kikuta, Shingo; Sato, Ryoichi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan	Kikuta, S (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan.	singo@cc.tuat.ac.jp; hnada@affrc.go.jp	Kikuta, Shingo/J-5219-2013; Kikawada, Takahiro/A-1289-2010	Kikuta, Shingo/0000-0002-3925-576X; Kikawada, Takahiro/0000-0002-2329-9282	integrated Research Project of Insects Using Genome Technology of Ministry of Agriculture, Forestry, and Fisheries of Japan;  [12J110839];  [26850216]	This work was supported in part by the integrated Research Project of Insects Using Genome Technology of Ministry of Agriculture, Forestry, and Fisheries of Japan (for H. N). S. K. was financially supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Numbers 12J110839 and 26850216). We would like to thank Dr. Nobuhiko Nakashima at National Institute of Agrobiological Sciences (Ibaraki, Japan) in radioactive isotope analyses.	BLAKEMORE SJ, 1995, BIOCHEM J, V309, P7; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600; Watanabe M, 2002, J EXP BIOL, V205, P2799; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; WYATT GR, 1961, ANNU REV ENTOMOL, V6, P75, DOI 10.1146/annurev.en.06.010161.000451; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; HAYASHI H, 1990, PLANT CELL PHYSIOL, V31, P247; KAWABE S, 1980, PLANT CELL PHYSIOL, V21, P1319; Stergiopoulos K, 2009, PHYSIOL GENOMICS, V37, P1, DOI 10.1152/physiolgenomics.90360.2008; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Kikuta S, 2010, INSECT BIOCHEM MOLEC, V40, P805, DOI 10.1016/j.ibmb.2010.07.008; THORSTEINSON AJ, 1960, ANNU REV ENTOMOL, V5, P193, DOI 10.1146/annurev.en.05.010160.001205; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; Kellett GL, 2001, J PHYSIOL-LONDON, V531, P585, DOI 10.1111/j.1469-7793.2001.0585h.x; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; AUCLAIR JL, 1969, ENTOMOL EXP APPL, V12, P623; BECK SD, 1965, ANNU REV ENTOMOL, V10, P207, DOI 10.1146/annurev.en.10.010165.001231; FUKUMORITA T, 1982, PLANT CELL PHYSIOL, V23, P273; Price DRG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-647; Ghaffar MBAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022137; HSIAO TH, 1969, J INSECT PHYSIOL, V15, P1785, DOI 10.1016/0022-1910(69)90010-9; Kikuta S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00290; Moriwaki N, 2003, APPL ENTOMOL ZOOL, V38, P359, DOI 10.1303/aez.2003.359; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; Price DRG, 2010, INSECT MOL BIOL, V19, P97, DOI 10.1111/j.1365-2583.2009.00918.x; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P307, DOI 10.1016/j.ibmb.2006.12.005; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P1138, DOI 10.1016/j.ibmb.2007.07.001; Rhodes JD, 1997, PHYSIOL ENTOMOL, V22, P373, DOI 10.1046/j.1365-3032.1997.d01-4.x; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	SEP	2015	64						60	67		10.1016/j.ibmb.2015.07.015		8	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	CR5RY	WOS:000361402900007		
J	Zhu, L; Tatsuke, T; Xu, J; Li, ZQ; Mon, H; Lee, JM; Kusakabe, T				Zhu, Li; Tatsuke, Tsuneyuki; Xu, Jian; Li, Zhiqing; Mon, Hiroaki; Lee, Jae Man; Kusakabe, Takahiro			Logs depends on R2D2 to localize in D2 body-like granules and functions in RNAi pathways in silkworm cells	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Silkworm; RNAi; P-bodies; D2 bodies; R2D2; Loqs	BOMBYX-MORI; ENDOGENOUS SIRNAS; GENE-EXPRESSION; DISTINCT ROLES; MESSENGER-RNAS; MOUSE OOCYTES; DROSOPHILA; COMPLEXES; TRANSPOSONS; MICRORNAS	The phenomenon of RNA interference (RNAi) has been found in various organisms. However, the proteins implicated in RNAi pathway in different species show distinct roles. Knowledge on the underlying mechanism of lepidopteron RNAi is quite lacking such as the roles of Loquacious (Loqs) and R2D2, the dsRNA-binding proteins in silkworm RNAi pathway. Here, we report that Logs and R2D2 protein depletion affected efficiency of dsRNA-mediated RNAi pathway. Besides, Logs was found to co-localize with Dicer2 to some specific cytoplasmic foci, which were looked like D2-bodies marked by R2D2 and Dicer2 in Fly cells, thereby calling the foci as D2 body-like granules. Using RNAi methods, Logs was found to be the key protein in these granules, although R2D2 determined the localization of Logs in D2 body-like granules. Interestingly, in the R2D2-depeted silkworm cells, the formation of processing bodies, another cytoplasmic foci, was affected. These data indicated R2D2 regulated these two kinds of cytoplasmic foci. Domain deletion analysis demonstrated that dsRBD 1 and 2 were required for Logs in D2 body-like granules and dsRBD 2 and 3 were required for Logs to interact with R2D2 and Ago1, respectively. Altogether, our observations provide important information for further study on D2 body-like granules, the newly found cytoplasmic foci in silkworm cells. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhu, Li; Tatsuke, Tsuneyuki; Xu, Jian; Mon, Hiroaki; Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Lab Silkworm Sci, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan; [Li, Zhiqing] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China	Kusakabe, T (reprint author), Kyushu Univ, Lab Silkworm Sci, Grad Sch Bioresource & Bioenvironm Sci, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	kusakabe@agr.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22248004, 23580077]; JSPS Postdoctoral Fellowship [25-03387]	We thank the editor and the reviewers for the constructive suggestions. This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) Nos. 22248004 and 23580077 from the Japan Society for the Promotion of Science (JSPS) to T.K. L.Z. was supported by a JSPS Postdoctoral Fellowship (25-03387). The authors have declared that no conflict of interest exists.	Aizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049783; Mon H, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.15501; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Mitsunobu Hitoshi, 2006, Journal of Insect Biotechnology and Sericology, V75, P141; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Okamura K, 2011, MOL CELL BIOL, V31, P884, DOI 10.1128/MCB.01141-10; Tatsuke T, 2010, CELL MOL BIOL LETT, V15, P118, DOI 10.2478/s11658-009-0038-9; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Zhu L, 2013, INSECT MOL BIOL, V22, P320, DOI 10.1111/imb.12023; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Zhu L, 2012, APPL ENTOMOL ZOOL, V47, P207, DOI 10.1007/s13355-012-0109-7; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Zhou R, 2009, RNA, V15, P1886, DOI 10.1261/rna.1611309; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Zhu L, 2013, INSECT BIOCHEM MOLEC, V43, P664, DOI 10.1016/j.ibmb.2013.04.004; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Nishida KM, 2013, MOL CELL, V49, P680, DOI 10.1016/j.molcel.2012.12.024; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Kolliopoulou A, 2013, INSECT BIOCHEM MOLEC, V43, P654, DOI 10.1016/j.ibmb.2013.05.001; Li ZQ, 2014, INSECT BIOCHEM MOLEC, V51, P71, DOI 10.1016/j.ibmb.2014.05.008; Mon H, 2009, ANAL BIOCHEM, V392, P180, DOI 10.1016/j.ab.2009.05.033; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Swevers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020250; Terenius O., 2011, J INSECT PHYSL, V57, P231; Zhu L, 2013, CHINESE HOSP, V2, P1	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	SEP	2015	64						78	90		10.1016/j.ibmb.2015.07.011		13	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	CR5RY	WOS:000361402900009		
J	Kato, Y; Takanashi, S; Fukui, T; Naruko, T; Shibata, T; Shimizu, Y				Kato, Yasuyuki; Takanashi, Shuichiro; Fukui, Toshihiro; Naruko, Takahiko; Shibata, Toshihiko; Shimizu, Yoshihiro			Does the complexity of coronary artery disease affect outcomes after complete revascularization with long segmental reconstruction of the left anterior descending artery using the left internal thoracic artery?	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Complex coronary artery disease; Coronary artery bypass; Complete revascularization	BYPASS GRAFT-SURGERY; FOLLOW-UP; SURGICAL REVASCULARIZATION; MAMMARY-ARTERY; TERM SURVIVAL; SYNTAX SCORE; ENDARTERECTOMY; ANGIOPLASTY; IMPACT; TRIAL	We evaluated the influence of the complexity of coronary artery disease stratified by the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score on early or late outcomes after complete revascularization with long segmental reconstruction of the left anterior descending artery using the left internal thoracic artery. From March 1995 to December 2003, a total of 102 patients with triple-vessel and/or left main disease underwent complete revascularization with long segmental left anterior descending artery reconstruction (a parts per thousand yen2 cm) with or without endarterectomy using the left internal thoracic artery. The patients were divided into two groups according to the median SYNTAX score: the low group (SYNTAX score of < 32, n = 50) and the high group (SYNTAX score of a parts per thousand yen32, n = 52). Outcomes were compared between the two groups, and predictors of follow-up death and major adverse cardiac and cerebrovascular events were determined. The mean number of distal anastomoses was 4.2 +/- 1.1, and complete revascularization was achieved in 96% of patients. The early mortality rate was 2.9%, and no significant differences in the perioperative results were observed between groups. There were no significant differences in overall survival or major adverse cardiac and cerebrovascular event-free survival between the two groups. The hazard ratio of SYNTAX score for early mortality was 0.94 (95% confidence interval: 0.88-1.01) and for major adverse cardiac and cerebrovascular events was 0.97 (95% confidence interval: 0.92-1.02). The complexity of coronary artery disease had no impact on early or late outcomes after complete revascularization with long segmental left anterior descending artery reconstruction using the left internal thoracic artery.	[Kato, Yasuyuki] Osaka City Gen Hosp, Dept Cardiovasc Surg, Osaka 5340021, Japan; [Takanashi, Shuichiro; Fukui, Toshihiro] Sakakibara Heart Inst, Dept Cardiovasc Surg, Tokyo, Japan; [Naruko, Takahiko] Osaka City Gen Hosp, Dept Cardiol, Osaka 5340021, Japan; [Shibata, Toshihiko] Osaka City Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka 558, Japan; [Shimizu, Yoshihiro] Ishikiriseiki Hosp, Dept Cardiovasc Surg, Osaka, Japan	Kato, Y (reprint author), Osaka City Gen Hosp, Dept Cardiovasc Surg, Miyakojima Ku, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.	kato20001224@gmail.com					Mohr FW, 2011, J THORAC CARDIOV SUR, V141, P130, DOI 10.1016/j.jtcvs.2010.07.094; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; LAWRIE GM, 1982, CIRCULATION, V66, P717; Kleisli T, 2005, J THORAC CARDIOV SUR, V129, P1283, DOI 10.1016/j.jtcvs.2004.12.034; Tasdemir O, 1996, J THORAC CARDIOV SUR, V112, P745, DOI 10.1016/S0022-5223(96)70061-2; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Barra JA, 2000, EUR J CARDIO-THORAC, V17, P509, DOI 10.1016/S1010-7940(00)00403-6; Birim O, 2009, ANN THORAC SURG, V87, P1097, DOI 10.1016/j.athoracsur.2008.11.079; Byrne JG, 2004, ANN THORAC SURG, V78, P867, DOI 10.1016/j.athoracsur.2004.03.046; Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402; Carnero-Alcazar M, 2011, J THORAC CARDIOV SUR, V142, pE123, DOI 10.1016/j.jtcvs.2010.10.036; Fukui T, 2005, ANN THORAC SURG, V80, P2098, DOI 10.1016/j.athoracsur.2005.06.047; Gill IS, 1998, ANN THORAC SURG, V65, P659, DOI 10.1016/S0003-4975(97)01301-5; Girerd N, 2012, ANN THORAC SURG, V94, P1166, DOI 10.1016/j.athoracsur.2012.05.023; Holzhey DM, 2010, HEART SURG FORUM, V13, pE143, DOI 10.1532/HSF98.20091157; Kato Y, 2012, ANN THORAC SURG, V93, P1195, DOI 10.1016/j.athoracsur.2011.12.059; Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI 10.1093/ejcts/ezu366; Lemesle G, 2009, CATHETER CARDIO INTE, V73, P612, DOI 10.1002/ccd.21883; Melina G, 2013, J THORAC CARDIOV SUR, V146, P656, DOI 10.1016/j.jtcvs.2012.08.058; MINALE C, 1989, ANN THORAC SURG, V48, P235; Ngaage DL, 2010, J THORAC CARDIOV SUR, V140, P66, DOI 10.1016/j.jtcvs.2009.09.029; Ogus TN, 2007, ANN THORAC SURG, V83, P496, DOI 10.1016/j.athoracsur.2006.09.073; Rastan AJ, 2009, CIRCULATION, V120, pS70, DOI 10.1161/CIRCULATIONAHA.108.842005; Vander Salm TJ, 2002, J AM COLL CARDIOL, V39, P565, DOI 10.1016/S0735-1097(01)01806-X	25	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	SEP	2015	21	3					308	314		10.1093/icvts/ivv146		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CR3FZ	WOS:000361217800010		
J	Yamashiro, S; Arakaki, R; Kise, Y; Inafuku, H; Kuniyoshi, Y				Yamashiro, Satoshi; Arakaki, Ryoko; Kise, Yuya; Inafuku, Hitoshi; Kuniyoshi, Yukio			Management of visceral malperfusion complicated with acute type A aortic dissection	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Visceral malperfusion; Aortic dissection; Superior mesenteric artery ischaemia	FENESTRATION	The extent of visceral malperfusion due to acute type A aortic dissection remains difficult to assess in view of the clinical signs that typically present at a late stage. We suspected that visceral malperfusion can persist after proximal aortic graft replacement despite redirecting blood flow into the true lumen. We therefore evaluated the operative outcomes of visceral malperfusion complicated with acute type A aortic dissection. Among 121 patients with acute type A aortic dissection treated at our hospital between January 2000 and December 2014, 10 (8.2%) were preoperatively complicated with visceral malperfusion. Eight of them had been treated by visceral arterial branch bypass followed by central repair, and 2 with circulatory instability had undergone central repair followed by laparotomy. The 2 patients who underwent initial central repair required extensive intestinal resection due to necrosis and died of multiple organ failure related to visceral necrosis in hospital (hospital mortality rate, 20.0%). The ischaemic time (interval between the onset of dissection and visceral arterial revascularization) was significantly longer for patients who initially underwent central repair compared with those who were initially treated by visceral arterial revascularization. However, base excess and lactate levels did not significantly differ between the two groups. We believe that if visceral ischaemia is severe and extensive in patients with type A aortic dissection, abdominal surgery should proceed before the aorta is surgically approached to avoid further irreversible ischaemic damage caused by circulatory arrest in organs with compromised perfusion.	[Yamashiro, Satoshi; Arakaki, Ryoko; Kise, Yuya; Inafuku, Hitoshi; Kuniyoshi, Yukio] Univ Ryukyus, Dept Thorac & Cardiovasc Surg, Grad Sch Med, Nishihara, Okinawa 9030215, Japan	Yamashiro, S (reprint author), Univ Ryukyus, Dept Thorac & Cardiovasc Surg, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	y3104@med.u-ryukyu.ac.jp					Demir IE, 2012, DIGEST SURG, V29, P226, DOI 10.1159/000338086; FANN JI, 1990, ANN SURG, V212, P705, DOI 10.1097/00000658-199012000-00009; Geirsson A, 2007, EUR J CARDIO-THORAC, V32, P255, DOI 10.1016/j.ejcts.2007.04.012; Di Eusanio M, 2013, J THORAC CARDIOV SUR, V145, P385, DOI 10.1016/j.jtcvs.2012.01.042; Firstenberg MS, 2007, ANN THORAC SURG, V84, P8; Guel E, 1998, PEDIAT SURG INT, V14, P59; Panneton JM, 2000, J VASC SURG, V32, P711, DOI 10.1067/mva.2000.110054; Shimamoto Takeshi, 2014, Gen Thorac Cardiovasc Surg, V62, P398, DOI 10.1007/s11748-014-0406-x; Slonim SM, 1996, J VASC SURG, V23, P241, DOI 10.1016/S0741-5214(96)70268-9; Uchida Naomichi, 2009, Interact Cardiovasc Thorac Surg, V8, P75, DOI 10.1510/icvts.2008.186247; Yamashiro S, 2014, JPN J VASC SURG, V23, P687	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	SEP	2015	21	3					346	351		10.1093/icvts/ivv159		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CR3FZ	WOS:000361217800019		
J	Kitahara, H; Yoshitake, A; Hachiya, T; Shimizu, H				Kitahara, Hiroto; Yoshitake, Akihiro; Hachiya, Takashi; Shimizu, Hideyuki			Emergency endovascular graft repair of computed tomography-detected disruption of bilateral aorto-bi-iliac graft legs	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Dacron graft disruption; Aorto-bi-iliac graft replacement; Endovascular therapy; Emergency surgery		We report a case of endovascular repair of disruption of an aorto-bi-iliac graft detected by 4D computed tomography. An 83-year old man with previous aorto-bi-iliac graft replacement was admitted to our institution with severe epigastric pain. A 4D computed tomography detected disruption within the fabric of both graft legs, and we performed emergency endovascular repair. The graft legs' disruption sites were completely covered by stent grafts. On the 12th postoperative day, a balloon-expandable stent was added to diminish Type I endoleak. The patient was discharged in an ambulatory state on the 34th postoperative day.	[Kitahara, Hiroto; Yoshitake, Akihiro; Hachiya, Takashi; Shimizu, Hideyuki] Keio Univ Hosp, Dept Cardiovasc Surg, Tokyo 1608582, Japan	Kitahara, H (reprint author), Keio Univ Hosp, Dept Cardiovasc Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kthrhrt11@gmail.com					BERGER K, 1981, ANN SURG, V193, P477; Matsumura JS, 1999, CARDIOVASC SURG, V7, P614, DOI 10.1016/S0967-2109(99)00030-7; Ofer A, 2001, CARDIOVASC INTER RAD, V24, P60, DOI 10.1007/s002700001722; Shingu Yasushige, 2005, Ann Thorac Cardiovasc Surg, V11, P343; Sultan Sherif, 2005, Vasc Endovascular Surg, V39, P183, DOI 10.1177/153857440503900208	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	SEP	2015	21	3					391	392		10.1093/icvts/ivv152		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CR3FZ	WOS:000361217800031		
J	Ito, T; Tokoro, M; Yanagisawa, J				Ito, Toshiaki; Tokoro, Masayoshi; Yanagisawa, Jyunji			Mitral valve plasty for a hammock mitral valve in an adult patient	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Hammock mitral valve; Mitral valve plasty; Pericardium; Congenital mitral valve stenosis		A 50-year old woman presented with arterial thrombosis in the right leg. Echocardiography revealed a mobile left atrial thrombus and severe mitral stenosis. She underwent a left atrial thrombectomy, the maze procedure and mitral valve plasty. Anterior and posterior mitral leaflets arose directly from the anterior papillary muscle, and from the posterior papillary muscle intervened by short chordae. This suggested a hammock mitral valve. A posterior papillary muscle division and commissurotomy were performed. The anterior leaflet was divided off the anterior papillary muscle, then extended by a triangular-shaped autologous pericardial patch and apically reattached. The postoperative mean pressure gradient of the mitral valve was 2.2 mmHg, and there was no regurgitation. The patient was in NYHA Class 1 and in sinus rhythm, 14 months after the operation.	[Ito, Toshiaki; Tokoro, Masayoshi; Yanagisawa, Jyunji] Japanese Red Cross Nagoya First Hosp, Dept Cardiovasc Surg, Nakamura Ku, Nagoya, Aichi 4538511, Japan	Ito, T (reprint author), Japanese Red Cross Nagoya First Hosp, Dept Cardiovasc Surg, 3-35 Michishita Cho, Nagoya, Aichi 4538511, Japan.	cvs1@nagoya-1st.jrc.or.jp					Ito Toshiaki, 2013, Gen Thorac Cardiovasc Surg, V61, P571, DOI 10.1007/s11748-012-0195-z; Kato Takayoshi, 2012, Gen Thorac Cardiovasc Surg, V60, P53, DOI 10.1007/s11748-011-0776-2; LAYMAN TE, 1967, CIRCULATION, V35, P389; Remenyi Bo, 2012, Ann Pediatr Cardiol, V5, P3, DOI 10.4103/0974-2069.93703; Zedgi R, 2005, J THORAC CARDIOVASC, V130, P217	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	SEP	2015	21	3					393	395		10.1093/icvts/ivv147		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CR3FZ	WOS:000361217800032		
J	Miyamoto, E; Sato, M; Yamada, T; Date, H				Miyamoto, Ei; Sato, Msasaaki; Yamada, Tetsu; Date, Hiroshi			Successful bilateral lung transplantation from a deceased donor with a ruptured main bronchus	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Lung transplantation; Post-traumatic donor; Ruptured main bronchus	TRACHEOBRONCHIAL INJURIES; MANAGEMENT	Major tracheobronchial trauma may lead to underestimation of the potential for lung donation due to insufficient alveolar ventilation and resulting poor oxygenation, bronchoscopic findings and radiographic findings (e.g. atelectasis). Here, we report a case of successful bilateral lung transplantation from a deceased donor whose right bronchus was ruptured by a trauma from the main bronchus to the bronchus intermedius. Although poor oxygenation and a collapsed right lung detected by computed tomography scanning precluded the use of the donor lungs by multiple transplant centres, careful bronchoscopic evaluation and intraoperative assessment convinced us that the parenchyma of the donor lungs was preserved sufficiently well for transplantation. Upon transplantation, the donor right bronchus was anastomosed at two levels, the upper lobe bronchus and the bronchus intermedius, and the lacerated portion was removed. The recipient's postoperative course was uneventful and the bronchial anastomoses healed excellently. Careful preoperative evaluation and appropriate surgical techniques might enable successful lung transplantation, using seemingly suboptimal donor lungs with major airway trauma.	[Miyamoto, Ei; Sato, Msasaaki; Yamada, Tetsu; Date, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan	Date, H (reprint author), 54 Shogoin Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	hdate@kuhp.kyoto-u.ac.jp					Gomez-Caro A, 2006, J TRAUMA, V61, P1426, DOI 10.1097/01.ta.0000196801.52594.b5; Kiser AC, 2001, ANN THORAC SURG, V71, P2059, DOI 10.1016/S0003-4975(00)02453-X; Gomez-Caro A, 2006, J TRAUMA, V61, P34; Hendriks JMH, 2009, J THORAC CARDIOV SUR, V137, P771, DOI 10.1016/j.jtcvs.2007.12.083; Schmidt F, 2001, ANN THORAC SURG, V72, P935, DOI 10.1016/S0003-4975(00)02432-2; SUNDARESAN S, 1993, ANN THORAC SURG, V56, P1409	6	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	SEP	2015	21	3					396	398		10.1093/icvts/ivv161		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CR3FZ	WOS:000361217800033		
J	Date, H; Miyamoto, E; Sato, M; Yamada, T				Date, Hiroshi; Miyamoto, Ei; Sato, Masaaki; Yamada, Tetsu			eReply. Re: Tracheobronchial trauma in lung transplantation: ethical considerations	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Letter									[Date, Hiroshi; Miyamoto, Ei; Sato, Masaaki; Yamada, Tetsu] Kyoto Univ, Kyoto, Japan	Date, H (reprint author), Kyoto Univ, Kyoto, Japan.						Burnell P, 2015, INTERACT CARDIOV TH, V21, P398, DOI 10.1093/icvts/ivv199; Miyamoto E, 2015, INTERACT CARDIOV TH, V21, P396, DOI 10.1093/icvts/ivv161	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	SEP	2015	21	3					398	398		10.1093/icvts/ivv208		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CR3FZ	WOS:000361217800035		
J	Karuppagounder, V; Arumugam, S; Thandavarayan, RA; Pitchaimani, V; Sreedhar, R; Afrin, R; Harima, M; Suzuki, H; Suzuki, K; Nakamura, M; Ueno, K; Watanabe, K				Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Thandavarayan, Rajarajan Amirthalingam; Pitchaimani, Vigneshwaran; Sreedhar, Remya; Afrin, Rejina; Harima, Meilei; Suzuki, Hiroshi; Suzuki, Kenji; Nakamura, Masahiko; Ueno, Kazuyuki; Watanabe, Kenichi			Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NF kappa B p65 mediated inflammation	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Inflammation; Angiotensin II type I receptor; Nephrotoxicity; Extracellular signal-regulated kinase; Endoplasmic reticulum stress	RECEPTOR-GAMMA AGONISTS; CHRONIC KIDNEY-DISEASE; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; ANGIOTENSIN-II; OXIDATIVE STRESS; DIABETIC MICE; UP-REGULATION; RATS; PROGRESSION	Inflammation and oxidative stress play important roles in the progression of renal damage. The natural polyphenol naringenin is known to exert potent antioxidant and anti-inflammatory effects. In this study, we have investigated the effect of naringenin on kidney dysfunction, fibrosis, endoplasmic reticulum (ER) stress, angiotensin II type I receptor (AT1R) expression and inflammation in daunorubicin (DNR) induced nephrotoxicity model. Nephrotoxicity was induced in rats by intravenous injection of DNR at a cumulative dose of 9 mg/kg. After 1 week, naringenin (20 mg/kg/day. p.o) was administered daily for 6 weeks. Biochemical studies were performed to evaluate renal function. Western blotting was performed to measure the protein levels of AT1R, endothelin (ET)1, ET receptor type A (ETAR), extracellular signal-regulated kinase (ERK)1/2, nuclear factor (NF)KB p65, peroxisome proliferator activated receptor (PPAR)gamma, oxidative/ER stress, apoptosis, and inflammatory markers in the kidney of DNR treated rats. Histopathological analysis was done using hemotoxylin eosin and Masson trichrome stained renal sections to investigate the structural abnormalities and fibrosis. DNR treated rats suffered from nephrotoxicity as evidenced by worsened renal function, increased blood urea nitrogen, serum creatinine levels in renal tissues and histopathogical abnormalities. Treatment with naringenin mitigated these changes. Furthermore, naringenin up regulated PPAR gamma and down regulated AT1R, ET1, ETAR, p-ERK1/2, p-NFKB p65, ER stress, apoptosis, and inflammatory markers. Our results suggest that naringenin has an ability to improve renal function and attenuates AT1R, ERK1/2-NRIB p65 signaling pathway in DNR induced nephrotoxicity in rats. (C) 2015 Elsevier B.V. All rights reserved.	[Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Thandavarayan, Rajarajan Amirthalingam; Pitchaimani, Vigneshwaran; Sreedhar, Remya; Afrin, Rejina; Harima, Meilei; Suzuki, Hiroshi; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata 9568603, Japan; [Thandavarayan, Rajarajan Amirthalingam] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Suzuki, Kenji] Niigata Univ, Dept Gastroenterol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Nakamura, Masahiko] Yamanashi Prefectural Cent Hosp, Dept Cardiol, Yamanashi 4008506, Japan; [Ueno, Kazuyuki] Niigata Univ Pharm & Appl Life Sci, Dept Pharmaceut Sci, Niigata 9568603, Japan	Watanabe, K (reprint author), Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Akiha Ku, 265-1 Higashijima, Niigata 9568603, Japan.	watanabe@nupals.ac.jp			Ministry of Education, Culture, Sports and Technology of Japan [23602012]; Promotion and Mutual Aid Corporation for Private Schools, Japan [26460239]	This research was supported by the Ministry of Education, Culture, Sports and Technology of Japan (23602012) and by a grant from the Promotion and Mutual Aid Corporation for Private Schools, Japan (26460239).	Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; Tsai SJ, 2012, J AGR FOOD CHEM, V60, P514, DOI 10.1021/jf203259h; Karuppagounder V, 2014, INT IMMUNOPHARMACOL, V23, P617, DOI 10.1016/j.intimp.2014.10.014; Iglesias P, 2006, EUR J ENDOCRINOL, V154, P613, DOI 10.1530/eje.1.02134; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Arozal W, 2010, FREE RADICAL RES, V44, P1369, DOI 10.3109/10715762.2010.509399; Arumugam S, 2013, CARDIOVASC THER, V31, P352, DOI 10.1111/1755-5922.12029; Hoffmann S, 2004, J AM SOC NEPHROL, V15, P1475, DOI 10.1097/01.ASN.0000127988; Lorz C, 2004, J AM SOC NEPHROL, V15, P380, DOI 10.1097/01.ASN.0000111289.9120.B0; Badary OA, 2005, LIFE SCI, V76, P2125, DOI 10.1016/j.lfs.2004.11.005; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Morikawa K, 2008, J AGR FOOD CHEM, V56, P11030, DOI 10.1021/jf801965n; Arozal W, 2010, TOXICOLOGY, V274, P18, DOI 10.1016/j.tox.2010.05.003; Henriksson M, 2004, BRIT J PHARMACOL, V142, P1155, DOI 10.1038/sj.bjp.0705803; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Gounder VK, 2014, INT IMMUNOPHARMACOL, V18, P282, DOI 10.1016/j.intimp.2013.11.018; Xu CW, 2013, BIOL PHARM BULL, V36, P1549; Orsolic N, 2011, EUR J PHARMACOL, V656, P110, DOI 10.1016/j.ejphar.2011.01.021; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Liu HR, 2008, J ETHNOPHARMACOL, V118, P466, DOI 10.1016/j.jep.2008.05.015; Ibrahim MA, 2014, IMMUNOPHARM IMMUNOT, V36, P130, DOI 10.3109/08923973.2014.884135; Arozal W, 2011, TOXICOLOGY, V279, P91, DOI 10.1016/j.tox.2010.09.013; Cassidy H., 2012, J SIGNAL TRANSDUCT, V2012; Cernuda-Morollon E, 2002, J AM SOC NEPHROL, V13, P2223, DOI 10.1097/01.ASN.0000025786.87646.B1; Cianfrocca R, 2014, LIFE SCI, V118, P179, DOI 10.1016/j.lfs.2014.01.078; Feliers D, 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/768512, DOI 10.1155/2011/768512]; Fougeray S, 2011, Cell Death Dis, V2, pe143, DOI 10.1038/cddis.2011.26; GARVIN J, 1991, J AM SOC NEPHROL, V2, P976; Gonzalez AA, 2013, HYPERTENSION, V61, P443, DOI 10.1161/HYPERTENSIONAHA.112.196303; Mao ZG, 2009, NEPHRON CLIN PRACT, V112, pC230, DOI 10.1159/000224789; Mershiba SD, 2013, MOL BIOL REP, V40, P3681, DOI 10.1007/s11033-012-2444-8; Nakamura T, 2010, EUR J CLIN INVEST, V40, P790, DOI 10.1111/j.1365-2362.2010.02319.x; Ozbek E, 2009, RENAL FAILURE, V31, P382, DOI 10.1080/08860220902835863; Peng CC, 2012, MOL NUTR FOOD RES, V56, P1541, DOI 10.1002/mnfr.201200178; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Skinner R, 2011, J PEDIAT HEMATOL ONC, V33, P128, DOI 10.1097/MPH.0b013e3181f8cac0; Soetikno V, 2013, MOL NUTR FOOD RES, V57, P1649, DOI 10.1002/mnfr.201200540; Vidotti DB, 2004, AM J PHYSIOL-RENAL, V286, pF1039, DOI 10.1152/ajprenal.00371.2003	40	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	SEP	2015	28	1					154	159		10.1016/j.intimp.2015.05.050		6	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CR5VW	WOS:000361413500019		
J	Tokunaga, Y; Matsumoto, M; Sugimoto, Y				Tokunaga, Yuhei; Matsumoto, Mitsuharu; Sugimoto, Yasushi			Amyloid fibril formation from a 9 amino acid peptide, 55th-63rd residues of human lysozyme	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						Human lysozyme; Hen egg white lysozyme; Amyloid fibril; Core peptide; Acid hydrolysis; beta-Structure	HEREDITARY RENAL AMYLOIDOSIS; HEN LYSOZYME; PROTEIN; AGGREGATION; MUTATIONS; DISEASE; FAMILY; REGION; STATE	Hen egg white lysozyme (HEWL) readily forms amyloid fibrils in vitro. We have previously identified a core structure, termed HEWL K-peptide, involved in fibril formation. Two major peptides, peptide #3 (50th-102nd residues of human lysozyme (hLZ)) and peptide #5 (54th-102nd residues), were isolated from the hLZ amyloid fibrils that had been exposed to pH 2.0 and 58 degrees C, and precipitated by ultra-centrifugation. These peptides cover most of the beta-domain and C-helix of hLZ including a 9 residues sequence corresponds to a human counterpart of HEWL K-peptide, GIFQINSRY (55th-63rd residues of hLZ, thus named "human K-peptide"). Chemically synthesized human K-peptide readily formed amyloid fibrils, as in HEWL K-peptide. It was demonstrated that both at least 9 residue length and Phe residue at 3rd position of the human K-peptide were crucial for amyloidogenesis in vitro. Short peptides covering COOH-terminal region of peptides #3 and #5 did not form amyloid fibrils. These data suggested that human K-peptide region with high propensity of amyloidogenesis plays a key role as a fibril-forming core sequence of hLZ. Interestingly, human K-peptide region is flanked by two predicted semi-disordered regions (39th-52nd and 67th-75th residues). We discuss the possible role of these regions. (C) 2015 Elsevier B.V. All rights reserved.	[Tokunaga, Yuhei; Sugimoto, Yasushi] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan; [Matsumoto, Mitsuharu] Kagoshima Univ, Joint Fac Vet Med, Kagoshima 8900065, Japan	Tokunaga, Y (reprint author), Kagoshima Univ, United Grad Sch Agr Sci, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	k0085039@kadai.jp; yasushi@chem.agri.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	We are grateful to Dr. T. Arakawa and Mr. M. Sogawa for technical suggestion and helpful discussion. This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Yazaki M, 2003, KIDNEY INT, V63, P1652, DOI 10.1046/j.1523-1755.2003.00904.x; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Zhang T, 2013, CELL BIOCHEM BIOPHYS, V67, P1193, DOI 10.1007/s12013-013-9638-0; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.imb.2006.06.055; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sattianayagam PT, 2012, J INTERN MED, V272, P36, DOI 10.1111/j.1365-2796.2011.02470.x; Mossuto ME, 2011, ANGEW CHEM INT EDIT, V50, P7048, DOI 10.1002/anie.201100986; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Valleix S, 2002, KIDNEY INT, V61, P907, DOI 10.1046/j.1523-1755.2002.00205.x; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Frare E, 2004, J MOL BIOL, V340, P1153, DOI 10.1016/j.jmb.2004.05.056; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Tokunaga Y, 2013, INT J BIOL SCI, V9, P219, DOI 10.7150/ijbs.5380; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Chen HF, 2009, COMPUT BIOL CHEM, V33, P41, DOI 10.1016/j.compbiolchem.2008.07.023; Funahashi J, 1996, J BIOCHEM, V120, P1216; Girnius S, 2012, AMYLOID, V19, P182, DOI 10.3109/13506129.2012.723074; Kamada Y, 2015, BBA-GEN SUBJECTS, V1850, P1107, DOI 10.1016/j.bbagen.2015.01.018; Mishima T, 2007, BIOCHEM BIOPH RES CO, V356, P769, DOI 10.1016/j.bbrc.2007.03.043; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Röcken Christoph, 2006, Hum Mutat, V27, P119, DOI 10.1002/humu.9393; Schmid FX, 1997, PROTEIN STRUCTURE PR, P261; Sugimoto Y, 2011, BIOCHEM CELL BIOL, V89, P533, DOI [10.1139/o11-041, 10.1139/O11-041]	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	SEP	2015	80						208	216		10.1016/j.ijbiomac.2015.06.015		9	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CR3RO	WOS:000361251000023		
J	Akazawa, Y; Matsuda, K; Isomoto, H; Matsushima, K; Kido, Y; Urabe, S; Yamaghchi, N; Ohnita, K; Takeshima, F; Kondo, H; Tsugawa, H; Suzuki, H; Moss, J; Nakao, K; Nakashima, M				Akazawa, Yuko; Matsuda, Katsuya; Isomoto, Hajime; Matsushima, Kayoko; Kido, Yoko; Urabe, Shigetoshi; Yamaghchi, Naoyuki; Ohnita, Ken; Takeshima, Fuminao; Kondo, Hisayoshi; Tsugawa, Hitoshi; Suzuki, Hidekazu; Moss, Joel; Nakao, Kazuhiko; Nakashima, Masahiro			BH3-only protein Bim is associated with the degree of Helicobacter pylori-induced gastritis and is localized to the mitochondria of inflammatory cells in the gastric mucosa	INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY			English	Article						BH3-only protein; Bim; Bcl-2; Bax; Apoptosis; Gastritis; Mitochondria; Helicobacter pylori	APOPTOSIS	BH3-only protein, Bim, is a pro-apoptotic protein that mediates mitochondria-dependent cell death. However, the role of Bim in Helicobacter pylori-associated gastritis remains unclear. This study aimed to assess the cellular localization of Bim and its possible role in H. pylori-induced gastritis. The study was conducted on biopsy specimens obtained from 80 patients who underwent upper gastrointestinal endoscopy (H. pylori-negative: n = 30, positive: n = 50). Association between Bim mRNA expression and severity of gastritis was evaluated and the localization of Bim was examined by immunofluorescence. Bim mRNA expression was positively correlated with the degree of gastritis, as defined by the Sydney system. Immunohistochemical analysis confirmed increased Bim expression in H. pylori-infected gastric mucosa compared with uninfected mucosa in both humans and mice. Bim localized in myeloperoxidase-and CD138-positive cells of H. pylori-infected lamina propria and submucosa of the gastric tract, indicating that this protein is predominantly expressed in neutrophils and plasma cells. In contrast, Bim did not localize in CD20-, CD3-, or CD68-positive cells. Bim was expressed in the mitochondria, where it was partially co-localized with activated Bax and cleaved-PARP. In conclusion, Bim is expressed in neutrophils and plasma cells in H. pylori-associated gastritis, where it may participate in the termination of inflammatory response by causing mitochondria-mediated apoptosis in specific leucocytes. (C) 2015 Elsevier GmbH. All rights reserved.	[Akazawa, Yuko; Isomoto, Hajime; Matsushima, Kayoko; Kido, Yoko; Urabe, Shigetoshi; Yamaghchi, Naoyuki; Ohnita, Ken; Takeshima, Fuminao; Nakao, Kazuhiko] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Nagasaki 8528501, Japan; [Akazawa, Yuko; Matsuda, Katsuya; Nakashima, Masahiro] Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki, Nagasaki 8528523, Japan; [Kondo, Hisayoshi] Atom Bomb Dis Inst, Dept Radioisotope Med, Div Sci Data Registry, Biostat Sect, Nagasaki, Nagasaki 8528523, Japan; [Tsugawa, Hitoshi; Suzuki, Hidekazu] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1600000, Japan; [Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	Akazawa, Y (reprint author), Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan.	akazaway@nagasaki-u.ac.jp	Suzuki, Hidekazu/J-4396-2013		Japan Society for the Promotion of Science (JSPS) Kakenhi [24790709, 2646097]; National Institutes of Health, National Heart, Lung, and Blood Institute	We thank Mr. Tsutomu Kanda for his excellent experimental support. We thank Dr. Hitoshi Hirayama for his academic suggestions. This study was supported by the Japan Society for the Promotion of Science (JSPS) Kakenhi [grant numbers 24790709 and 2646097 to YA and FT, respectively]. JM was supported by the Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute.	Aguilo N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.313; Akazawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082322; Alfredsson J., 2005, CELL DEATH DIFFER, V12; Andina N., 2009, CELL DEATH DIFFER, V16; Cid TP, 2013, HELICOBACTER, V18, P12, DOI 10.1111/hel.12076; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Aebischer T, 2010, HELICOBACTER, V15, P21, DOI 10.1111/j.1523-5378.2010.00777.x; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; Blaser M.J., 2004, J CLIN INVEST, V113; Dijkers P.F., 2000, CURR BIOL, V10; Dyugovskaya L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-211; Hansen P.S., 1999, INFECT IMMUN, V67; Hart S.P., 2000, CELL DEATH DIFFER, V7; Kim J.S., 2001, HELICOBACTER, V6; Kirschnek S., 2011, CELL DEATH DIFFER, V18; Kottakis F., 2008, FEBS J, V275; Luo H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.3; Mika D., 2011, J EXP THER ONCOL, V9, P93100; Miller-Podraza H., 1999, INFECT IMMUN, V67; Murao S., 1988, P NATL ACAD SCI USA, V85; Pierzchalski P., 2009, J PHYSIOL PHARMACOL, V60; Plas D.R., 2002, NAT IMMUNOL, V3; Puthalakath H., 2002, CELL DEATH DIFFER, V9; Saito Y., 2011, GASTROENTEROLOGY, V140; Strasser A., 2000, ANN NY ACAD SCI, V917; Strasser A., 2005, NAT REV IMMUNOL, V5; Suzuki H., 2009, GUT LIVER, V3, P8187; Villunger A., 2003, BLOOD, V101; Villunger A., 2000, J EXP MED, V192; Wang C.A., 2008, BIOCHEM BIOPH RES CO, V377, P5256; Wei M.C., 2001, SCIENCE, V292; Wen S., 2009, CANC LETT, V282, P18; Willis S.N., 2005, CURR OPIN CELL BIOL, V17; Winter J., 2014, INFECT IMMUN, V82; Xia H.H., 2001, AM J GASTROENTEROL, V96, P1626; Xie B., 2011, J NEUROSCI, V31; Youle RJ, 2008, NATURE REV, V9, P4759; Zhao J., 2009, GROWTH HORM IGF RES, V19; Zullo A, 2014, ANN GASTROENTEROL, V27, P27	39	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1438-4221	1618-0607		INT J MED MICROBIOL	Int. J. Med. Microbiol.	SEP	2015	305	6					553	562		10.1016/j.ijmm.2015.07.002		10	Microbiology; Virology	Microbiology; Virology	CR3UM	WOS:000361258600008		
J	Watanabe, Y; Yoshida, M; Yamanishi, K; Yamamoto, H; Okuzaki, D; Nojima, H; Yasunaga, T; Okamura, H; Matsunaga, H; Yamanishi, H				Watanabe, Yuko; Yoshida, Momoko; Yamanishi, Kyosuke; Yamamoto, Hideyuki; Okuzaki, Daisuke; Nojima, Hiroshi; Yasunaga, Teruo; Okamura, Haruki; Matsunaga, Hisato; Yamanishi, Hiromichi			Genetic analysis of genes causing hypertension and stroke in spontaneously hypertensive rats: Gene expression profiles in the kidneys	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						attention-deficit hyperactivity disorder; kidney; gene expression profiles; hypertension; spontaneously hypertensive rats; stroke-prone spontaneously hypertensive rats	EPIDERMAL-GROWTH-FACTOR; II TYPE-1 RECEPTOR; HUNTINGTONS-DISEASE; BINDING PROTEIN; CYSTIC-FIBROSIS; THYROID-HORMONE; IN-VITRO; C-JUN; CELLS; TRANSCRIPTION	Spontaneously hypertensive rats (SHRs) and stroke-prone SHRs (SHRSP) are frequently used as models not only of essential hypertension and stroke, but also of attention-deficit hyperactivity disorder (ADHD). Normotensive Wistar-Kyoto (WKY) rats are normally used as controls in these studies. In the present study, we aimed to identify the genes causing hypertension and stroke, as well as the genes involved in ADHD using these rats. We previously analyzed gene expression profiles in the adrenal glands and brain. Since the kidneys can directly influence the functions of the cardiovascular, endocrine and sympathetic nervous systems, gene expression profiles in the kidneys of the 3 rat strains were examined using genome-wide microarray technology when the rats were 3 and 6 weeks old, a period in which rats are considered to be in a pre-hypertensive state. Gene expression profiles were compared between the SHRs and WKY rats and also between the SHRSP and SHRs. A total of 232 unique genes showing more than a 4-fold increase or less than a 4-fold decrease in expression were isolated as SHR- and SHRSP-specific genes. Candidate genes were then selected using two different web tools: the 1st tool was the Database for Annotation, Visualization and Integrated Discovery (DAVID), which was used to search for significantly enriched genes and categorized them using Gene Ontology (GO) terms, and the 2nd was Ingenuity Pathway Analysis (IPA), which was used to search for interactions among SHR-and also SHRSP-specific genes. The analyses of SHR-specific genes using IPA revealed that B-cell CLL/lymphoma 6 (Bcl6) and SRY (sex determining region Y)-box 2 (Sox2) were possible candidate genes responsible for causing hypertension in SHRs. Similar analyses of SHRSP-specific genes revealed that angiotensinogen (Agt), angiotensin II receptor-associated protein (Agtrap) and apolipoprotein H (Apoh) were possible candidate genes responsible for triggering strokes. Since our results revealed that SHRSP-specific genes isolated from the kidneys of rats at 6 weeks of age, included 6 genes related to Huntington's disease, we discussed the genetic association between ADHD and Huntington's disease.	[Watanabe, Yuko; Yoshida, Momoko; Yamanishi, Hiromichi] Hirakata Gen Hosp Dev Disorders, Hirakata, Osaka 5730122, Japan; [Watanabe, Yuko; Yoshida, Momoko; Yasunaga, Teruo] Osaka Univ, Microbial Dis Res Inst, Dept Genome Informat, Suita, Osaka 5650871, Japan; [Okuzaki, Daisuke; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 5650871, Japan; [Matsunaga, Hisato] Hyogo Coll Med, Dept Neuropsychiat, Nishinomiya, Hyogo 6638501, Japan; [Yamanishi, Kyosuke; Yamamoto, Hideyuki; Okamura, Haruki] Hyogo Coll Med, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan	Yamanishi, H (reprint author), Hirakata Gen Hosp Dev Disorders, 2-1-1 Tsudahigashi, Hirakata, Osaka 5730122, Japan.	hirochan@hirakataryoiku-med.or.jp					Kyriakis JM, 2001, PHYSIOL REV, V81, P807; Dhordain P, 2000, ONCOGENE, V19, P6240, DOI 10.1038/sj.onc.1203976; Vasanwala FH, 2002, J IMMUNOL, V169, P1922; Rao S, 1999, J BIOL CHEM, V274, P11115, DOI 10.1074/jbc.274.16.11115; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Simpkins AN, 2009, AM J PATHOL, V174, P2086, DOI 10.2353/ajpath.2009.080544; Delbosc S, 2002, HYPERTENSION, V40, P142, DOI 10.1161/01.HYP.0000024348.87637.6F; Thulin A, 2009, MOL CANCER RES, V7, P1792, DOI 10.1158/1541-7786.MCR-09-0094; Miles RR, 2005, MOL CELL PROTEOMICS, V4, P1898, DOI 10.1074/mcp.M500112-MCP200; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; Wei F, 2009, MOL CELL BIOL, V29, P4612, DOI 10.1128/MCB.00234-09; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Ueno K, 2002, BEHAV PHARMACOL, V13, P1; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Fukuyama K, 2003, HYPERTENSION, V41, P598, DOI 10.1161/01.HYP.0000056524.35294.80; Canettieri G, 2008, ENDOCRINOLOGY, V149, P695, DOI 10.1210/en.2007-0779; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Bellomo D, 2000, CIRC RES, V86, pE29; Liu QJ, 2009, TOXICOL LETT, V191, P314, DOI 10.1016/j.toxlet.2009.09.015; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Seo E, 2011, MOL CELL BIOL, V31, P4593, DOI 10.1128/MCB.05798-11; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Azuma K, 2007, HYPERTENSION, V50, P926, DOI 10.1161/HYPERTENSIONAHA.107.096115; Cox JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062857; El-Shewy HM, 2012, MOL ENDOCRINOL, V26, P833, DOI 10.1210/me.2011-1261; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Gonzalez-Villalobos RA, 2013, J CLIN INVEST, V123, P2011, DOI 10.1172/JCI65460; Gumieniak O, 2007, HYPERTENSION, V49, P461, DOI 10.1161/01.HYP.0000256295.72185.fd; Guyton AC., 1991, HYPERTENSION S5, V18, pIII49; Horisawa K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh167; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Izzotti A, 2004, CANCER RES, V64, P8566, DOI 10.1158/0008-5472.CAN-04-1420; Jahan A, 2005, AM J PHYSIOL-GASTR L, V288, pG685, DOI 10.1152/ajpgi.00207.2004; Kephart DD, 1996, MOL ENDOCRINOL, V10, P408, DOI 10.1210/me.10.4.408; Kinoshita I, 2003, ONCOGENE, V22, P2710, DOI 10.1038/sj.onc.1206371; Lempinen M, 2005, SCAND J GASTROENTERO, V40, P225, DOI 10.1080/00365520510011560; Loset M, 2011, AM J OBSTET GYNECOL, V204, pe1, DOI [10.1016/j.ajog.2010.08.043, DOI 10.1016/J.AJOG.2010.08.043]; Morris JB, 2004, J BIOL CHEM, V279, P8740, DOI 10.1074/jbc.M310012200; Okamoto K, 1974, CIRC RES S1, V34-35; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; O-Uchi J, 2013, AM J PHYSIOL-HEART C, V305, pH1736, DOI 10.1152/ajpheart.00094.2013; Sakai T, 2007, AM J PATHOL, V171, P1659, DOI 10.2353/ajpath.2007.070146; Scotet V, 2001, CLIN GENET, V59, P42, DOI 10.1034/j.1399-0004.2001.590107.x; Thomas EA, 2006, J NEUROSCI RES, V84, P1151, DOI 10.1002/jnr.21046; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; Yamamoto H, 2013, INT J MOL MED, V31, P1057, DOI 10.3892/ijmm.2013.1304; Yoshida M, 2014, INT J MOL MED, V33, P887, DOI 10.3892/ijmm.2014.1631; Pike JW, 2008, ENDOCRINOLOGY, V149, P3656, DOI 10.1210/en.2008-0042	53	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	SEP	2015	36	3					712	724		10.3892/ijmm.2015.2281		13	Medicine, Research & Experimental	Research & Experimental Medicine	CR2DH	WOS:000361134700012		
J	Kuroyanagi, G; Tokuda, H; Yamamoto, N; Matsushima-Nishiwaki, R; Kozawa, O; Otsuka, T				Kuroyanagi, Gen; Tokuda, Haruhiko; Yamamoto, Naohiro; Matsushima-Nishiwaki, Rie; Kozawa, Osamu; Otsuka, Takanobu			Unphosphorylated HSP27 (HSPB1) regulates the translation initiation process via a direct association with eIF4E in osteoblasts	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						heat-shock protein; eukaryotic translation initiation factor 4E; translation regulation; osteoblast	SHOCK-PROTEIN 27; HEAT-SHOCK; GROWTH-FACTOR; HEAT-SHOCK-PROTEIN-27; KINASE; DIFFERENTIATION; CELLS; IMMUNOLOCALIZATION; OVEREXPRESSION; ACTIVATION	Heat-shock protein 27 (HSP27/HSPB1) and its phosphorylation are implicated in multiple physiological and pathophysiological cell functions. Our previous study reported that unphosphorylated HSP27 has an inhibitory role in triiodothyronine (T-3)-induced osteocalcin (OC) synthesis in osteoblasts. However, the mechanisms behind the HSP27-mediated effects on osteoblasts remain to be clarified. In the present study, to investigate the exact mechanism of HSP27 and its phosphorylation in osteoblasts, the molecular targets of HSP27 were explored using osteoblast-like MC3T3-E1 cells. The levels of OC mRNA induced by T3 in the HSP27-overexpressing cells did not show any significant differences compared with those in the control empty vector-transfected cells. Therefore, the interactions between HSP27 and translational molecules were focused on, including eukaryotic translation initiation factor 4E (eIF4E), eIF4G and 4E-binding protein 1 (4E-BP1). The HSP27 protein in the unstimulated cells co-immunoprecipitated with eIF4E, but not eIF4G or 4E-BP1. In addition, the association of eIF4E with 4E-BP1 was observed in the HSP27-overexpressing cells, as well as in the control cells. Under T3 stimulation, the binding of eIF4E to eIF4G was markedly attenuated in the HSP27-overexpressing cells compared with the control cells. In addition, the binding of HSP27 to eIF4E in the unstimulated cells was diminished by the phosphorylation of HSP27. In response to T3 stimulation, the association of eIF4E with eIF4G in the unphosphorylatable HSP27-overexpressing cells was markedly reduced compared with the phospho-mimic HSP27-overexpressing cells. Taken together, these findings strongly suggest that unphosphorylated HSP27 associates with eIF4E in osteoblasts and suppresses the translation initiation process.	[Kuroyanagi, Gen; Yamamoto, Naohiro; Matsushima-Nishiwaki, Rie; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi 4678601, Japan; [Kuroyanagi, Gen; Tokuda, Haruhiko; Yamamoto, Naohiro; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Tokuda, Haruhiko] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi 4748511, Japan	Kozawa, O (reprint author), Gifu Univ, Grad Sch Med, Dept Pharmacol, 1-1 Yanagido, Gifu 5011194, Japan.	okkasugai@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19591042]; National Center for Geriatrics and Gerontology (NCGG) of Japan [23-9, 25-4]	The authors are grateful to Dr Yumiko Kurokawa for her skillful technical assistance. The present study was supported in part by a Grant-in-Aid for Scientific Research (no. 19591042) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Research Funding for Longevity Sciences (nos. 23-9 and 25-4) from the National Center for Geriatrics and Gerontology (NCGG) of Japan.	Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Tiffee JC, 2000, TISSUE CELL, V32, P141, DOI 10.1054/tice.2000.0097; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Leonardi R, 2004, CALCIFIED TISSUE INT, V75, P509, DOI 10.1007/s00223-004-0077-1; Simpson D, 2000, MOL VIS, V6, P178; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; Kato K, 2011, ENDOCRINOLOGY, V152, P1872, DOI 10.1210/en.2010-1062; Andrieu C, 2010, ONCOGENE, V29, P1883, DOI 10.1038/onc.2009.479; Jia Y, 2012, MED RES REV, V32, P786, DOI 10.1002/med.21260; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; LANDRY J, 1992, J BIOL CHEM, V267, P794; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; KOZAWA O, 1992, EXP CELL RES, V198, P130, DOI 10.1016/0014-4827(92)90158-5; Cuesta R, 2000, GENE DEV, V14, P1460; Arrigo André-Patrick, 2014, Cancers (Basel), V6, P333, DOI 10.3390/cancers6010333; Barutta F, 2008, AM J PHYSIOL-RENAL, V295, pF1817, DOI 10.1152/ajprenal.90234.2008; Dubinska-Magiera M, 2014, FEBS LETT, V588, P517, DOI 10.1016/j.febslet.2014.01.005; Gibert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029719; Gilbertt RJC, 2007, P NATL ACAD SCI USA, V104, P5788, DOI 10.1073/pnas.0606880104; Kato K, 2011, INT J MOL MED, V27, P423, DOI 10.3892/ijmm.2011.595; Kozawa O, 2001, ARCH BIOCHEM BIOPHYS, V388, P237, DOI 10.1006/abbi.2000.2290; Kozawa O, 1999, J BONE MINER RES, V14, P1761, DOI 10.1359/jbmr.1999.14.10.1761; Kubisch C, 2004, GASTROENTEROLOGY, V127, P275, DOI 10.1053/j.gastro.2004.04.005; Matsushima-Nishiwaki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078440; Matsushima-Nishiwaki R, 2008, J BIOL CHEM, V283, P18852, DOI 10.1074/jbc.M801301200; SHAKOORI AR, 1992, J CELL BIOCHEM, V48, P277, DOI 10.1002/jcb.240480308; Singh D, 2007, AM J PHYSIOL-LUNG C, V293, pL436, DOI 10.1152/ajplung.00097.2007; Uozaki H, 1997, CANCER, V79, P2336, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2336::AID-CNCR7>3.0.CO;2-J	35	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	SEP	2015	36	3					881	889		10.3892/ijmm.2015.2274		9	Medicine, Research & Experimental	Research & Experimental Medicine	CR2DH	WOS:000361134700033		
J	Tsuchiya, T; Synodinos, NE				Tsuchiya, Takahiro; Synodinos, Nicolaos E.			Searching for Alternatives: Comparisons Between Two Sample Selection Methods in Japan	INTERNATIONAL JOURNAL OF PUBLIC OPINION RESEARCH			English	Article							RESPONDENT SELECTION; NONRESPONSE; TRENDS; RDD	This study compared answers of Japanese respondents to two self-administered conditions. For the mail condition, individuals (aged 20-79 years) were randomly selected from government registers, and questionnaires were mailed to them. For the drop condition, questionnaires were inserted in the mailboxes of households selected via area sampling and could be completed by any member 20-79 years old. Drop and mail respondents had similar demographic characteristics (e.g., gender, age, occupation, education), and the two samples exhibited similar biases in representing the population. Respondents were mostly similar in expressed opinions, nonsubstantive responses, and other responses. However, some differences were found, and the response rate of the drop (18.0%) was substantially lower than for mail (28.7%). Reasons for the observed differences are discussed.	[Tsuchiya, Takahiro] Inst Stat Math, Dept Data Sci, Tokyo, Japan; [Synodinos, Nicolaos E.] Univ Hawaii Manoa, Shidler Coll Business, Honolulu, HI 96822 USA	Synodinos, NE (reprint author), Univ Hawaii Manoa, Shidler Coll Business, Dept Mkt, Honolulu, HI 96822 USA.	nick@hawaii.edu					AAPOR, 2004, STAND DEF FIN DISP C; Ando M., 2006, SHIN JOHO, V94, P27; Ando N., 2009, SHAKAI TO CHOSA, V3, P65; Link MW, 2008, PUBLIC OPIN QUART, V72, P6, DOI 10.1093/poq/nfn003; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; SALMON CT, 1983, PUBLIC OPIN QUART, V47, P270, DOI 10.1086/268785; Gaziano C, 2005, PUBLIC OPIN QUART, V69, P124, DOI 10.1093/poq/nfi006; Aquilino WS, 1996, PUBLIC OPIN QUART, V60, P563, DOI 10.1086/297773; Asakura M., 2006, P 34 C BEH SOC JAP S, P290; Battaglia MP, 2008, PUBLIC OPIN QUART, V72, P459, DOI 10.1093/poq/nfn026; Dillman D. A., 2009, INTERNET MAIL MIXED; Dillman D. A., 2007, MAIL INTERNET SURVEY; Groves R., 1998, NONRESPONSE HOUSEHOL; Groves R., 1989, SURVEY ERRORS SURVEY; Kamimura S., 2008, YORON, V101, P28; Kanamori Y., 1987, SHIIO CHOSA, V191, P2; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; LELE C, 1994, AM J EPIDEMIOL, V140, P643; Link MW, 2006, AM J EPIDEMIOL, V164, P1019, DOI 10.1093/aje/kwj310; Link MW, 2011, PUBLIC OPIN QUART, V75, P613, DOI 10.1093/poq/nfr040; Matsuda E., 2008, KODO KEIRYO GAKU, V35, P17; Matsuda E., 2006, SHIN JOHO, V94, P8; Ministry of Internal Affairs and Communications, 2011, 2010 COMM US TREND S; Ministry of Internal Affairs and Communications, 2013, COMM US TREND SURV 2; Nemoto R., 1984, MAKETTINGU RISACHA, V33, P26; Sakamoto Y., 2007, STUDY JAPANESE NATL; SMITH TW, 1983, PUBLIC OPIN QUART, V47, P386, DOI 10.1086/268797; Statistics Bureau, 2006, TABL 6 PRIV HOUS HOU; Statistics Bureau, 2005, 2005 POP CENS SMALL; STEEH CG, 1981, PUBLIC OPIN QUART, V45, P40, DOI 10.1086/268633; Suzuki T., 2006, P 34 C BEH SOC JAP S, P286; Synodinos N. E., 2008, ELECT EXIT POLLING, P161; Synodinos NE, 2000, INT J PUBLIC OPIN R, V12, P48, DOI 10.1093/ijpor/12.1.48; Tourangeau R., 2013, SCI WEB SURVEYS; Tourangeau R., 2000, PSYCHOL SURVEY RESPO; YAMADA S, 1994, INT J PUBLIC OPIN R, V6, P118, DOI 10.1093/ijpor/6.2.118; Zheng Y., 2006, P 34 C BEH SOC JAP S, P224	37	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0954-2892	1471-6909		INT J PUBLIC OPIN R	Int. J. Public Opin. Res.	FAL	2015	27	3					383	405		10.1093/ijpor/edu034		23	Communication	Communication	CR3HB	WOS:000361221500005		
J	Nakanishi, M; Nakashima, T; Shindo, Y; Miyamoto, Y; Gove, D; Radbruch, L; van der Steen, JT				Nakanishi, Miharu; Nakashima, Taeko; Shindo, Yumi; Miyamoto, Yuki; Gove, Dianne; Radbruch, Lukas; van der Steen, Jenny T.			An evaluation of palliative care contents in national dementia strategies in reference to the European Association for Palliative Care white paper	INTERNATIONAL PSYCHOGERIATRICS			English	Article						dementia; end-of-life; national health policy; palliative care		Background: Dementia involves a progressive decline in many functional areas. Policy and practice guidelines should cover the entire course of the disease from early detection to the end-of-life. The present study aimed to evaluate the contents of national dementia strategies with a focus on palliative care content. Methods: We employed qualitative content analyses. Sixteen national dementia strategies from 14 countries were reviewed. Using open coding, the contents were compared to the domains and recommendations of the palliative care in dementia white paper of the European Association for Palliative Care (EAPC). Results: Although palliative care was not explicitly referred to in eight of the 14 countries and only to a limited extent in three countries, a number of domains from the EAPC white paper were well represented, including "person-centered care, communication, and shared decision making"; "continuity of care"; and "family care and involvement." Three countries that referred to palliative care did so explicitly, with two domains being well represented: "education of the health care team"; and "societal and ethical issues." The strategies all lacked reference to the domain of "prognostication and timely recognition of dying" and to spiritual caregiving. Conclusions: National dementia strategies cover part of the recent definition of palliative care in dementia, although they do not frequently label these references as "palliative care." In view of the growing numbers of people dying with dementia, preparation for the last phase of life should be added to national strategies.	[Nakanishi, Miharu] Tokyo Metropolitan Inst Med Sci, Mental Hlth & Nursing Res Team, Setagaya Ku, Tokyo 1568506, Japan; [Nakashima, Taeko] Rutgers State Univ, Dept Econ, Camden, NJ 08102 USA; [Shindo, Yumi] Tokyo Dementia Care Res & Training Ctr, Div Res, Suginami Ku, Tokyo 1680071, Japan; [Miyamoto, Yuki] Univ Tokyo, Grad Sch Med, Dept Psychiat Nursing, Bunkyo Ku, Tokyo 1130033, Japan; [Gove, Dianne] Alzheimer Europe, L-1417 Luxembourg, Luxembourg; [Radbruch, Lukas] Univ Hosp Bonn, Dept Palliat Med, D-53127 Bonn, Germany; [Radbruch, Lukas] Malteser Hosp Bonn Rhein Sieg, Palliat Care Ctr, D-53123 Bonn, Germany; [van der Steen, Jenny T.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice & Elderly Care Med, NL-1081 BT Amsterdam, Netherlands	Nakanishi, M (reprint author), Tokyo Metropolitan Inst Med Sci, Mental Hlth & Nursing Res Team, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	mnakanishi-tky@umin.ac.jp		Nakanishi, Miharu/0000-0001-6200-9279			Alzheimer Europe, 2008, ALZH EUR REP END OF; Alzheimers Disease International, 2014, GOV ALZH PLANS; Alzheimers Disease International, 2012, NAT ALZH DEM PLANS P; Gusmano M, 2012, HEALTH ECON POLICY L, V7, P485, DOI 10.1017/S1744133112000266; Nakanishi M, 2014, ALZHEIMERS DEMENT, V10, P468, DOI 10.1016/j.jalz.2013.06.005; Pastrana T, 2008, PALLIATIVE MED, V22, P222, DOI 10.1177/0269216308089803; Yaguchi A, 2005, ARCH INTERN MED, V165, P1970, DOI 10.1001/archinte.165.17.1970; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; van der Steen JT, 2010, J ALZHEIMERS DIS, V22, P37, DOI 10.3233/JAD-2010-100744; van der Steen JT, 2013, J MED ETHICS, V39, P104, DOI 10.1136/medethics-2012-100903; Arcand Marcel, 2013, Int J Palliat Nurs, V19, P67; Australian Health Ministers Conference, 2006, NAT FRAM ACT DEM 200; Commonwealth of Australia, 2000, NAT PALL CAR STRAT N; Dementia stakeholder groups, 2010, PRIOR AR 2 ACT; Dementia stakeholder groups, 2010, PRIOR AR 3 AT; Dementia stakeholder groups, 2010, PRIOR AR 1 ACT; Dementia stakeholder groups, 2010, PRIOR AR 4 ACT; Department of Health, 2008, END LIF CAR STRAT PR; Department of Health, 2013, CONS PAP NAT FRAM AC; Department of Health Social Services and Public Safety., 2011, IMPR DEM SERV NO IR; Department of Health Social Services and Public Safety, 2010, LIV MATT DYING MATT; DH, 2009, LIV WELL DEM NAT DEM; Helse- og omsorgsdepartementet, 2007, DEM 2015 GOD DAG; LEquipe de la Mission Plan Alzheimer, 2008, PLAN ALZH MAL APP 20; LEquipe de la Mission Plan Alzheimer, 2012, NAT PLAN ALZH REL DI; Ministerie van Volksgezondheid Welzijn en Sport Zorgverzekeraars Nederland Alzheimer Nederland ActiZ, 2009, LEIDR KET DEM HULPM; Ministry of Health and Welfare, 2012, 2 NAT DEM MAN COMPR; Ministry of Health and Welfare, 2008, DEM COMPR MAN MEAS; Ministry of Health Labour and Welfare, 2012, REP DIR FUT POL DEM; Ministry of Health Labour and Welfare, 2012, 5 YEAR PLAN PROM MEA; Ministry of Health Welfare and Sport Zorgverzekeraars Nederland Alzheimer Nederland ActiZ, 2009, GUID INT DEM CAR EXC; Ministry of Social Affairs and Health, 2013, NAT MEM PROGR 2012 2; Nederlandse Federatie van Universitair Medische Centra Alzheimer Nederland VUmc Alzheimercentrum ZonMw, 2012, DELT DEM 2012 2020; Norwegian Ministry of Health and Care Services, 2008, SUBPL CAR PLAN 2015; Scottish Government, 2008, LIV DYING WELL NAT A; Scottish Government, 2010, SCOTL NAT DEM STRAT; Socialministreriet og Indenrigs- og Sundhedsministeriet, 2010, NAT HANDL DEM; Socialstyrelsen, 2010, NAT RIKTL VARD OMS V; Socialstyrelsen, 2013, NAT KUNSK GOD PALL V; Sosiaali- ja terveysministerio, 2012, KANS MUIST 2012 2020; Sosiaali- ja terveysministerio, 2010, HYV SAATT SUOM AS PE; The Scottish Government, 2013, SCOTL NAT DEM STRAT; U. S. Department of Health and Human Services, 2013, NAT PLAN ADDR ALZH D; Welsh Assembly Government, 2011, NAT DEM VIS WAL DEM; World Health Assembly, 2014, STRENGTH PALL CAR CO; Worldwide Palliative Care Alliance, 2014, WHO GLOB ATL PALL CA; ZonMw, 2013, MEM PROGR OND INN DE	47	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1041-6102	1741-203X		INT PSYCHOGERIATR	Int. Psychogeriatr.	SEP	2015	27	9					1551	1561		10.1017/S1041610215000150		11	Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry; Psychology	Psychology; Geriatrics & Gerontology; Psychiatry	CR5LS	WOS:000361384600015		
J	Kim, JY				Kim, Ji Young			Rethinking the role of identity factors: the history problem and the Japan-South Korea security relationship in the post-Cold War period	INTERNATIONAL RELATIONS OF THE ASIA-PACIFIC			English	Article							POLITICS	What explains the Japan-South Korea security relationship in the post-Cold War period? This article highlights the impact of the conflict and convergence of identity factors vis-A -vis external factors (such as the North Korean military threat, the regional presence of US forces, and growing Chinese power) to offer a more comprehensive explanation of the ebb and flow of security cooperation between Japan and South Korea. This article argues that in some cases, the identity factors affect security cooperation more than external strategic factors. Based on three in-depth case studies, the article provides an empirical examination of how identity factors have affected the overall pattern of Japan-South Korea security relations since the 1990s. The analysis will have important implications for our understanding of the role of identity factors between Japan and South Korea, as well as envisioning the possibilities of regional security cooperation in the future.	Univ Tokyo, Dept Area Studies, Grad Sch Arts & Sci, Tokyo, Japan	Kim, JY (reprint author), Univ Tokyo, Dept Area Studies, Grad Sch Arts & Sci, Tokyo, Japan.	jykim@ask.c.u-tokyo.ac.jp					[Anonymous], 1993, GUKHOE BONHOEUI HOEU, V160-165; Kang DC, 2009, J EAST ASIAN STUD, V9, P1; Bae J., 2006, ILBONUI GUKGAJEONRYA; Berger TU, 2012, WAR, GUILT, AND WORLD POLITICS AFTER WORLD WAR II, P1, DOI 10.1017/CBO9781139109437; Bridges B., 1993, JAPAN KOREA 1990S AN; Cha Victor, 1999, ALIGNMENT DESPITE AN; [Cheong Wa Dae The Republic of Korea], 2005, BLUE HOUS BRIEF; Christensen T. J., 2003, INT RELATIONS THEORY, P25; Dudden A., 2008, TROUBLED APOLOGIES J; Gong KY, 2012, ASIAN PERSPECT-SEOUL, V36, P309; Green M. J., 2001, JAPANS RELUCTANT REA; Grimes W. W., 2005, INT RELATIONS THEORY, P353; Hasegawa Tsuyoshi, 2008, E ASIAS HAUNTED PRES; Hughes C. W., 2009, JAPANS REMILITARIZAT; Berger T, 2003, REINVENTING THE ALLIANCE: U.S.-JAPAN SECURITY PARTNERSHIP IN AN ERA OF CHANGE, P63; Institute for Advanced Studies on Asia, 2009, ACT PLAN NEW JAP REP; Japan Ministry of Defense, 2009, NIH NO BOEI; Japan Ministry of Defense, 2007, NIH NO BOEI; Japan Ministry of Defense, 1994, NIH NO BOEI; Japan Ministry of Defense, 2006, NIH NO BOEI; JapanMinistry of Defense, 2010, NIH NO BOEI; Kang D. C., 2003, NUCL N KOREA DEBATE; Kaseda Y, 2010, PEACE REGIME BUILDING ON THE KOREAN PENINSULA AND NORTHEAST ASIAN SECURITY COOPERATION, P151; Kaseda Y., 2003, KOREAN PEACE PROCESS, P119; Katzenstein P. J., 1996, E ASIAN SECURITY, P265; Katzenstein P. J., 1996, CULTURE NATL SECURIT, P317; Kim J. S., 2005, ILBON YEONGU NONCHON, V21, P261; Kim JY, 2014, ASIAN PERSPECT-SEOUL, V38, P31; Kim S. T., 2009, GUKJE JEONGCHI NONCH, V49, P61; Lee C., 1985, JAPAN KOREA POLITICA; Lee M., 2011, HYUNDAE ILBONUI OEGY; Lee W., 2002, OEGYO, V60, P116; Glaser CL, 2009, J EAST ASIAN STUD, V9, P337; Manosevitz JU, 2003, ASIAN SURV, V43, P801, DOI 10.1525/as.2003.43.5.801; Michishita N, 2010, ROUTL SECUR ASIA-PAC, P1; Midford P, 2000, PAC REV, V13, P367, DOI 10.1080/09512740050147924; Ministry of Foreign Affairs and Trade, 2004, DAEHANMINGUK OEGYO Y; Ministry of Foreign Affairs Republic of Korea ( ROK), 1992, DAEHANMINGUK OEGYO Y; Ministry of Foreign Affairs ROK, 1993, DAEHANMINGUK OEGYO Y; Ohhata H., 2007, HANIL GUKJAE JEONGCH, P170; Park CH, 2009, JPN J POLIT SCI, V10, P247, DOI 10.1017/S1468109909990089; Park H, 1998, KOREAN J DEF ANAL, V10, P95; Pyle K. B., 2007, PUBLIC AFFAIRS; Samuels Richard J., 2007, SECURING JAPAN TOKYO; Shin Y., 2001, YOU DECEIVE HIST YOU; Park CH, 2011, EUR I JPN STUD E ASI, V11, P39; Song H., 2007, GUKBANG JEONGCHAEK Y, V75, P45; Swenson-Wright J., 2011, JAPAN NORMAL COUNTRY, P146; Tadokoro M., 2011, JAPAN NORMAL COUNTRY, P38; Togo K., 2005, JAPANS FOREIGN POLIC; Chen ZM, 2012, ASIAN PERSPECT-SEOUL, V36, P195	51	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1470-482X	1470-4838		INT RELAT ASIA-PAC	Int. Relat. Asia-Pac.	SEP	2015	15	3					477	503		10.1093/irap/lcv007		27	International Relations	International Relations	CR3HE	WOS:000361221800003		
J	Jetschke, A; Acharya, A; De Lombaerde, P; Katsumata, H; Pempel, TJ				Jetschke, Anja; Acharya, Amitav; De Lombaerde, Philippe; Katsumata, Hiro; Pempel, T. J.			Studying Asian and comparative regionalism through Amitav Acharya's work	INTERNATIONAL RELATIONS OF THE ASIA-PACIFIC			English	Article							INTEGRATION; IDEAS; POWER; EU	The field of regionalism has been flourishing for some time. Amitav Acharya has been a persistent and powerful voice in the field, and he has contributed to and actively shaped paradigmatic debates within it. His theoretically sophisticated and contextually grounded approach to Southeast Asia's regional order and beyond has inspired countless scholars and better informed generations of students. A group of scholars, therefore, decided to discuss Acharya's contribution to the field of Asian and comparative regionalism more systematically with a view of the balance between disciplinary and area studies, ideas and institutions and non-Western international relations theorizing.	[Jetschke, Anja] Univ Gottingen, Dept Polit Sci, Hamburg, Germany; [Jetschke, Anja] GIGA German Inst Global & Area Studies, Hamburg, Germany; [Acharya, Amitav] Amer Univ, UNESCO Chair Transnat Challenges & Governance, Washington, DC 20016 USA; [De Lombaerde, Philippe] United Nations Univ, Inst Comparat Reg Integrat Studies UNU CRIS, Brugge, Belgium; [Katsumata, Hiro] Tohoku Univ, Grad Sch Int Cultural Studies, Sendai, Miyagi 980, Japan; [Pempel, T. J.] Univ Calif Berkeley, Dept Polit Sci, Berkeley, CA 94720 USA	Jetschke, A (reprint author), Univ Gottingen, Dept Polit Sci, Hamburg, Germany.	anja.jetschke@sowi.uni-goettingen.de					Acharya A, 2007, J EAST ASIAN STUD, V7, P370; Acharya A, 2007, INT RELAT ASIA-PAC, V7, P427, DOI 10.1093/irap/lcm017; Acharya A, 2012, INT SPECTATOR, V47, P3, DOI DOI 10.1080/03932729.2012.655004; Acharya Amitav, 2007, CRAFTING COOPERATION; Acharya A, 2007, INT RELAT ASIA-PAC, V7, P287, DOI 10.1093/irap/lcm012; Acharya A, 1997, PAC REV, V10, P319, DOI 10.1080/09512749708719226; Acharya Amitav, 2001, CONSTRUCTING SECURIT; Acharya Amitav, 2009, WHOSE IDEAS MATTER A; Alagappa M., 2003, ASIAN SECURITY ORDER, P210; Johnson T, 2013, J POLIT, V75, P183, DOI 10.1017/S0022381612000953; Shaw TM, 2011, INT POLIT ECON NEW, P3; Jetschke A, 2012, WEST EUR POLIT, V35, P174, DOI 10.1080/01402382.2012.631320; Acharya A, 2003, INT SECURITY, V28, P149; Mansfield ED, 1999, INT ORGAN, V53, P589, DOI 10.1162/002081899551002; Solingen E, 2007, AM POLIT SCI REV, V101, P757; De Lombaerde P, 2010, REV INT STUD, V36, P731, DOI 10.1017/S0260210510000707; Lenz T, 2013, COOP CONFL, V48, P211, DOI 10.1177/0010836713485539; Acharya A, 2007, WORLD POLIT, V59, P629, DOI 10.1353/wp.2008.0000; Acharya A, 2004, INT ORGAN, V58, P239, DOI 10.1017/S0020818304582024; Sbragia A, 2008, JCMS-J COMMON MARK S, V46, P29, DOI 10.1111/j.1468-5965.2008.00809.x; Acharya A, 2011, INT STUD QUART, V55, P95, DOI 10.1111/j.1468-2478.2010.00637.x; Checkel JT, 1998, WORLD POLIT, V50, P324; Breslin S., 2000, NEW POLIT ECON, V5, P333, DOI 10.1080/713687784; De Lombaerde P, 2011, INT POLIT ECON NEW, P31; De Lombaerde P, 2011, JCMS-J COMMON MARK S, V49, P675, DOI 10.1111/j.1468-5965.2010.02151.x; Fawn R, 2009, REV INT STUD, V35, P5, DOI 10.1017/S0260210509008419; Genna G.M., 2010, J EUROPEAN INTEGRATI, V32, P583, DOI 10.1080/07036337.2010.518717; Goh Evelyn, 2013, STRUGGLE ORDER HEGEM; Hameiri S, 2013, REV INT STUD, V39, P313, DOI 10.1017/S026021051100074X; Jetschke A, 2013, J EUR PUBLIC POLICY, V20, P626, DOI 10.1080/13501763.2012.762186; Katzenstein Peter, 2005, WORLD REGIONS ASIA E; Lake D. A., 2007, REV INT ORGAN, V2, P219, DOI 10.1007/s11558-007-9012-3; Leifer M., 1996, ASEAN REGIONAL FORUM; LINDBERG LN, 1970, INT ORGAN, V24, P649; MacIntyre A., 2013, INTEGRATING REGIONS; Marks G., 2013, AUTHORITY INT ORG EF; Munakata N., 2006, JAPAN DYNAMICS E ASI, P130; Pempel T. J., 2012, EC SECURITY NEXUS NE; Pempel T. J., 2014, International Journal of Korean Unification Studies, V23, P65; Powers K, 2011, REV INT STUD, V37, P2387, DOI 10.1017/S0260210510001762; Ramo JC, 2004, BEIJING CONSENSUS; Sil Rudra, 2010, PERSPECTIVES POLITIC, V8, P411	42	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1470-482X	1470-4838		INT RELAT ASIA-PAC	Int. Relat. Asia-Pac.	SEP	2015	15	3					537	566		10.1093/irap/lcv005		30	International Relations	International Relations	CR3HE	WOS:000361221800005		
J	Oba, M				Oba, Mie			The Struggle for Order: Hegemony, Hierarchy, and Transition in Post-Cold War East Asia	INTERNATIONAL RELATIONS OF THE ASIA-PACIFIC			English	Book Review									[Oba, Mie] Tokyo Univ Sci, Tokyo 162, Japan	Oba, M (reprint author), Tokyo Univ Sci, Tokyo 162, Japan.	obamie@rs.kagu.tus.ac.jp					Goh Evelyn, 2013, STRUGGLE ORDER HEGEM	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1470-482X	1470-4838		INT RELAT ASIA-PAC	Int. Relat. Asia-Pac.	SEP	2015	15	3					567	571		10.1093/irap/lcv017		5	International Relations	International Relations	CR3HE	WOS:000361221800006		
J	Takeda, O				Takeda, Okiyoshi			Asia in Washington: Exploring the Penumbra of Transnational Power	INTERNATIONAL RELATIONS OF THE ASIA-PACIFIC			English	Book Review									[Takeda, Okiyoshi] Aoyama Gakuin Univ, Tokyo, Japan	Takeda, O (reprint author), Aoyama Gakuin Univ, Tokyo, Japan.	otakeda@sipeb.aoyama.ac.jp					CALDER KE, 2014, ASIA INWASHINGTON EX	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1470-482X	1470-4838		INT RELAT ASIA-PAC	Int. Relat. Asia-Pac.	SEP	2015	15	3					571	574		10.1093/irap/lcv016		4	International Relations	International Relations	CR3HE	WOS:000361221800007		
J	Miyamoto, S; Okada, R; Ando, K				Miyamoto, Shingo; Okada, Rika; Ando, Kazumichi			Platinum hypersensitivity and desensitization	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Review						platinum; hypersensitivity; desensitization	PHASE-III TRIAL; ADVANCED COLORECTAL-CANCER; RECURRENT OVARIAN-CANCER; CELL LUNG-CANCER; CARBOPLATIN HYPERSENSITIVITY; MAST-CELLS; RISK-FACTORS; RAPID DESENSITIZATION; CLINICAL-FEATURES; CHEMOTHERAPY AGENTS	Platinum agents are drugs used for various types of cancer. With increased frequency of administration of platinum agents, hypersensitivity reactions appear more frequently, occurring in over 25% of cases from the seventh cycle or second line onward. It then becomes difficult to conduct treatment using these agents. Various approaches have been investigated to address hypersensitivity reactions to platinum agents. Desensitization, which gradually increases the concentration of the anticancer drug considered to be the antigen until the target dosage, has been reported as being particularly effective, with a success rate of 80-100%. The aims of this paper are to present the current findings regarding hypersensitivity reactions to platinum agents and to discuss attempts of using desensitization against hypersensitivity reactions worldwide.	[Miyamoto, Shingo] Japanese Red Cross Med Ctr, Dept Med Oncol, Shibuya Ku, Tokyo 1508935, Japan; [Okada, Rika] Japanese Red Cross Med Ctr, Dept Allergy & Rheumatol, Shibuya Ku, Tokyo 1508935, Japan; [Ando, Kazumichi] Japanese Red Cross Med Ctr, Dept Gynecol, Shibuya Ku, Tokyo 1508935, Japan	Miyamoto, S (reprint author), Japanese Red Cross Med Ctr, Dept Med Oncol, Shibuya Ku, 4-1-22 Hiroo, Tokyo 1508935, Japan.	aaa17580@pop06.odn.ne.jp					Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Lee CW, 2005, GYNECOL ONCOL, V99, P393, DOI 10.1016/j.ygyno.2005.06.028; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Sancho-Serra MD, 2011, EUR J IMMUNOL, V41, P1004, DOI 10.1002/eji.201040810; Sliesoraitis S, 2005, INT J GYNECOL CANCER, V15, P13, DOI 10.1111/j.1048-891x.2005.14401.x; Thomas RR, 2003, CANCER, V97, P2301, DOI 10.1002/cncr.11379; Oka T, 2013, J ALLERGY CLIN IMMUN, V132, P922, DOI 10.1016/j.jaci.2013.05.004; Robinson JB, 2001, GYNECOL ONCOL, V82, P550, DOI 10.1006/gyno.2001.6331; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Leguy-Seguin V, 2007, J ALLERGY CLIN IMMUN, V119, P726, DOI 10.1016/j.jaci.2006.11.640; Lenz HJ, 2007, ONCOLOGIST, V12, P601, DOI 10.1634/theoncologist.12-5-601; Gomez R, 2009, INT J GYNECOL CANCER, V19, P1284, DOI 10.1111/IGC.0b013e3181a418ff; Mori Y, 2010, ONCOLOGY-BASEL, V79, P136, DOI 10.1159/000320613; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Shepherd GM, 2003, CLIN REV ALLERG IMMU, V24, P253, DOI 10.1385/CRIAI:24:3:253; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Pagani M, 2010, MED CLIN N AM, V94, P835, DOI 10.1016/j.mcna.2010.03.002; Markman M, 2010, GYNECOL ONCOL, V116, P323, DOI 10.1016/j.ygyno.2009.11.026; Rothenberg ML, 2003, J CLIN ONCOL, V21, P2059, DOI 10.1200/JCO.2003.11.126; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Caiado J, 2013, J ALLER CL IMM-PRACT, V1, P494, DOI 10.1016/j.jaip.2013.06.002; Ichikawa Y, 2009, JPN J CLIN ONCOL, V39, P616, DOI 10.1093/jjco/hyp070; Kidera Y, 2011, INT J CLIN ONCOL, V16, P244, DOI 10.1007/s10147-010-0170-6; Zanotti KM, 2001, DRUG SAFETY, V24, P767, DOI 10.2165/00002018-200124100-00005; Markman M, 2003, J CLIN ONCOL, V21, P4611, DOI 10.1200/JCO.2003.05.539; Breslow RG, 2009, ANN ALLERG ASTHMA IM, V102, P155, DOI 10.1016/S1081-1206(10)60247-5; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033; Pfisterer J, 2005, INT J GYNECOL CANCER, V15, P36, DOI 10.1111/j.1525-1438.2005.15355.x; Pujade-Lauraine E, 2010, J CLIN ONCOL, V28, P3323, DOI 10.1200/JCO.2009.25.7519; Siu SWK, 2006, ANN ONCOL, V17, P259, DOI 10.1093/annonc/mdj042; Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; Brockow K, 2008, CURR PHARM DESIGN, V14, P2778, DOI 10.2174/138161208786369821; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Tonini G, 2002, J BIOL REG HOMEOS AG, V16, P105; Park JO, 2007, J CLIN ONCOL, V25, P5233, DOI 10.1200/JCO.2007.10.8134; Simons FER, 2010, J ALLERGY CLIN IMMUN, V125, pS161, DOI 10.1016/j.jaci.2009.12.981; Shao YY, 2010, J FORMOS MED ASSOC, V109, P362, DOI 10.1016/S0929-6646(10)60064-2; Polyzos A, 2001, ONCOLOGY-BASEL, V61, P129, DOI 10.1159/000055363; Rose PG, 2003, GYNECOL ONCOL, V89, P429, DOI 10.1016/S0090-8258(03)00178-1; Liu A, 2011, CLIN EXP ALLERGY, V41, P1679, DOI 10.1111/j.1365-2222.2011.03825.x; Kim MY, 2012, ASIAN PAC J CANCER P, V13, P1209, DOI 10.7314/APJCP.2012.13.4.1209; Gaeta TJ, 2007, ANN ALLERG ASTHMA IM, V98, P360; Brandi G, 2003, BRIT J CANCER, V89, P477, DOI 10.1038/sj.bjc.6601155; Castells M, 2006, CURR OPIN ALLERGY CL, V6, P271, DOI 10.1097/01.all.0000235900.57182.15; Zanotti KM, 2001, J CLIN ONCOL, V19, P3126; Seki K, 2011, INT J MED SCI, V8, P210; Confino-Cohen R, 2005, CANCER, V104, P640, DOI 10.1002/cncr.21168; Markman M, 1999, J CLIN ONCOL, V17, P1141; Kim BH, 2009, ONCOLOGY-BASEL, V76, P231, DOI 10.1159/000205263; Polyzos A, 2009, ONCOLOGY-BASEL, V76, P36, DOI 10.1159/000178163; Iwamoto T, 2012, BIOL PHARM BULL, V35, P1487; Confino-Cohen R, 2010, ANN ALLERG ASTHMA IM, V104, P73, DOI 10.1016/j.anai.2009.11.001; Shibata Y, 2009, INT J CLIN ONCOL, V14, P397, DOI 10.1007/s10147-009-0883-6; CLEARE MJ, 1976, CLIN ALLERGY, V6, P183, DOI 10.1111/j.1365-2222.1976.tb01897.x; Hesterberg PE, 2009, J ALLERGY CLIN IMMUN, V123, P1262, DOI 10.1016/j.jaci.2009.02.042; Parmar MKB, 2003, LANCET, V361, P2099; Lieberman Phillip, 2010, J Allergy Clin Immunol, V126, P477, DOI 10.1016/j.jaci.2010.06.022; Patil SU, 2012, J ALLERGY CLIN IMMUN, V129, P443, DOI 10.1016/j.jaci.2011.10.010; Arimoto T, 2013, J OBSTET GYNAECOL RE, V39, P336, DOI 10.1111/j.1447-0756.2012.01917.x; Boulanger J, 2014, CURR ONCOL, V21, P630; Caiado J, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0451-7; Callahan MB, 2007, AM J OBSTET GYNECOL, V197, P199; Castells MC, 2008, J ALLERGY CLIN IMMUN, V30, P1160; CHENG E, 1978, CANCER, V42, P2162, DOI 10.1002/1097-0142(197811)42:5<2162::AID-CNCR2820420512>3.0.CO;2-I; Cortijo-Cascajares S, 2013, CLIN TRANSL ONCOL, V15, P219, DOI 10.1007/s12094-012-0909-9; de Vries R S, 2006, Ann Oncol, V17, P1723, DOI 10.1093/annonc/mdl116; Demoly P, 2002, ALLERGY, V57, P37, DOI 10.1034/j.1398-9995.57.s72.7.x; Dillman Robert O, 2003, Support Cancer Ther, V1, P38, DOI 10.3816/SCT.2003.n.003; Dizon DS, 2002, GYNECOL ONCOL, V84, P378, DOI 10.1006/gyno.2001.6519; Gadducci A, 2008, INT J GYNECOL CANCER, V18, P615, DOI 10.1111/j.1525-1438.2007.01063.x; Garufi C, 2000, ANN ONCOL, V11, P497, DOI 10.1023/A:1008336108007; GETAZ EP, 1980, NEW ENGL J MED, V302, P334, DOI 10.1056/NEJM198002073020607; GRALLA RJ, 1981, ANN INTERN MED, V95, P414; Joly F, 2011, GYNECOL ONCOL, V122, P226, DOI 10.1016/j.ygyno.2011.04.019; Kandel MJ, 2005, INT J GYNECOL CANCER, V15, P780, DOI 10.1111/j.1525-1438.2005.00136.x; Koren C, 2002, AM J CLIN ONCOL-CANC, V25, P625, DOI 10.1097/00000421-200212000-00020; Lee SY, 2014, CANCER CHEMOTH PHARM, V73, P1021, DOI 10.1007/s00280-014-2437-5; MacGlashan D, 2012, CLIN EXP ALLERGY, V42, P1060, DOI 10.1111/j.1365-2222.2012.04013.x; Madrigal-Burgaleta R, 2013, ALLERGY, V68, P853, DOI 10.1111/all.12105; Maindrault-Goebel F, 2005, EUR J CANCER, V41, P2262, DOI 10.1016/j.ejca.2005.06.021; Makrilia Nektaria, 2010, Metal-Based Drugs, P207084, DOI 10.1155/2010/207084; Marani TM, 1996, TRANSFUSION, V36, P1016, DOI 10.1046/j.1537-2995.1996.36111297091748.x; Masse MS, 2012, J INVEST ALLERG CLIN, V22, P372; Michikami H, 2013, J OBSTET GYNAECOL RE, V39, P330, DOI 10.1111/j.1447-0756.2012.01893.x; Moon DH, 2013, BRIT J CANCER, V109, P1072, DOI 10.1038/bjc.2013.389; Morales AR, 2005, ANN ALLERG ASTHMA IM, V94, P575; MORGAN JS, 1994, EUR J CANCER, V30A, P1205, DOI 10.1016/0959-8049(94)90489-8; O'Cearbhaill R, 2010, GYNECOL ONCOL, V116, P326, DOI 10.1016/j.ygyno.2009.10.070; Pagani M, 2008, INT ARCH ALLERGY IMM, V145, P54, DOI 10.1159/000107467; Parel M, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-1; ROSENBER.B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Santini D, 2001, ANN ONCOL, V12, P132, DOI 10.1023/A:1008366223918; Schwartz JR, 2007, GYNECOL ONCOL, V105, P81, DOI 10.1016/j.ygyno.2006.10.047; SHALIT M, 1995, CLIN EXP ALLERGY, V25, P896, DOI 10.1111/j.1365-2222.1995.tb00033.x; SHALIT M, 1993, IMMUNOLOGY, V79, P319; Shukunami K, 1999, GYNECOL ONCOL, V72, P431, DOI 10.1006/gyno.1998.5273; Simons F Estelle R, 2011, World Allergy Organ J, V4, P13, DOI 10.1097/WOX.0b013e318211496c; Smith IE, 2001, J CLIN ONCOL, V19, P1336; Sugimoto H, 2011, CANCER CHEMOTH PHARM, V67, P415, DOI 10.1007/s00280-010-1338-5; SULLIVAN TJ, 1982, J ALLERGY CLIN IMMUN, V69, P500, DOI 10.1016/0091-6749(82)90174-9; Syrigou Ekaterini, 2010, Inflammation & Allergy Drug Targets, V9, P206; Takase N, 2014, INT J CLIN ONCOL; Ulrich-Pur H, 2000, ONCOLOGY-BASEL, V59, P187, DOI 10.1159/000012159; Vyas N, 2013, J ONCOL PHARM PRACT, V20, P278; Wang JH, 2012, WORLD J GASTROENTERO, V18, P5427, DOI 10.3748/wjg.v18.i38.5427; WENDEL GD, 1985, NEW ENGL J MED, V312, P1229, DOI 10.1056/NEJM198505093121905; WILLIAMS CJ, 1979, BRIT MED J, V1, P1689; ZWEIZIG S, 1994, GYNECOL ONCOL, V53, P121, DOI 10.1006/gyno.1994.1098	108	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	SEP	2015	45	9					795	804		10.1093/jjco/hyv081		10	Oncology	Oncology	CR4FE	WOS:000361286500001		
J	Saito, Y; Yoshida, M; Omura, G; Kobayashi, K; Fujimoto, C; Ando, M; Sakamoto, T; Asakage, T; Yamasoba, T				Saito, Yuki; Yoshida, Masafumi; Omura, Go; Kobayashi, Kenya; Fujimoto, Chisato; Ando, Mizuo; Sakamoto, Takashi; Asakage, Takahiro; Yamasoba, Tatsuya			Prognostic value of p16 expression irrespective of human papillomavirus status in patients with oropharyngeal carcinoma	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						oropharyngeal carcinoma; p16; HPV; prognosis; Japanese	SQUAMOUS-CELL CARCINOMA; JAPANESE PATIENTS; IMPROVED SURVIVAL; HPV INFECTION; NECK CANCERS; HEAD; DNA	In a previous study, we reported the value of p16 expression and alcohol consumption in oropharyngeal carcinoma in Japan. We now report the clinical significance of human papillomavirus status and p16 expression in oropharyngeal carcinoma in Japan. Over a 9-year period, a retrospective case comparison study of the pathology database was conducted at the University of Tokyo to identify tumor samples of oropharyngeal carcinoma. We performed immunohistochemistry for the p16 protein, in situ hybridization for human papillomavirus-deoxyribonucleic acid and polymerase chain reaction for the human papillomavirus-deoxyribonucleic acid oncogene E6 in oropharyngeal carcinoma in Japanese patients. We evaluated the human papillomavirus status in patients with oropharyngeal carcinoma to determine its prevalence and association with prognosis. We defined human papillomavirus(+) and human papillomavirus(-) oropharyngeal carcinoma cohorts as those with and without polymerase chain reaction for the human papillomavirus-deoxyribonucleic acid oncogene E6 or in situ hybridization-human papillomavirus. In oropharyngeal carcinoma, the prevalences of p16(+)human papillomavirus(+), p16(+)human papillomavirus(-), p16(-)human papillomavirus(+) and p16(-)human papillomavirus(-) were 32% (48/150), 7% (10/150), 2% (3/150) and 59% (89/150), respectively. Low tobacco and alcohol consumption, tonsil or base of tongue localization, but not age, were associated with p16(+)human papillomavirus(+). Low alcohol consumption was associated with p16(+)human papillomavirus(-). There was a significant difference in overall survival between p16(+)human papillomavirus(-) and p16(-)human papillomavirus(-) (P = 0.03). In multivariate Cox regression models, p16 was the independent prognostic factor, regardless of human papillomavirus status. p16 expression was a reliable prognostic biomarker regardless of human papillomavirus status.	[Saito, Yuki; Yoshida, Masafumi; Omura, Go; Kobayashi, Kenya; Fujimoto, Chisato; Ando, Mizuo; Sakamoto, Takashi; Asakage, Takahiro; Yamasoba, Tatsuya] Univ Tokyo, Dept Otolaryngol Head & Neck Surg, Tokyo 1138655, Japan	Saito, Y (reprint author), Univ Tokyo, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	saitou-tky@umin.ac.jp			JSPS KAKENHI [25861531]	This study was supported by JSPS KAKENHI grant number 25861531.	Schache AG, 2011, CLIN CANCER RES, V17, P6262, DOI 10.1158/1078-0432.CCR-11-0388; Bogina GS, 2014, MODERN PATHOL, V27, P204, DOI 10.1038/modpathol.2013.137; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Dok R, 2014, CANCER RES, V74, P1739, DOI 10.1158/0008-5472.CAN-13-2479; Tong JL, 2011, LUNG CANCER, V74, P155, DOI 10.1016/j.lungcan.2011.04.019; Dreyer JH, 2013, VIRCHOWS ARCH, V462, P381, DOI 10.1007/s00428-013-1393-5; Al-Swiahb JN, 2010, ARCH OTOLARYNGOL, V136, P502, DOI 10.1001/archoto.2010.47; Saito Y, 2013, CANCER-AM CANCER SOC, V119, P2005, DOI 10.1002/cncr.28015; Mizumachi T, 2013, INT J CLIN ONCOL, V18, P824, DOI 10.1007/s10147-012-0469-6; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Gillison ML, 2008, J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Huang H, 2012, ASIAN PAC J CANCER P, V13, P891, DOI 10.7314/APJCP.2012.13.3.891; Kawakami H, 2013, CANCER MED-US, V2, P933, DOI 10.1002/cam4.151; Gillison ML, 2006, J CLIN ONCOL, V24, P5623, DOI 10.1200/JCO.2006.07.1829; Weinberger PM, 2010, LARYNGOSCOPE, V120, P1531, DOI 10.1002/lary.20984; Worsham MJ, 2013, CLIN CANCER RES, V19, P2486, DOI 10.1158/1078-0432.CCR-12-3003; Park K, 2013, ACTA OTO-LARYNGOL, V133, P297, DOI 10.3109/00016489.2012.741327; Klingenberg B, 2010, HISTOPATHOLOGY, V56, P957, DOI 10.1111/j.1365-2559.2010.03576.x; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Thavaraj S, 2011, J CLIN PATHOL, V64, P308, DOI 10.1136/jcp.2010.088450; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; Evans Mark Francis, 2011, Head Neck Pathol, V5, P344, DOI 10.1007/s12105-011-0282-y; Joo YH, 2012, HEAD NECK-J SCI SPEC, V34, P10, DOI 10.1002/hed.21697; Simard EP, 2014, ORAL ONCOL, DOI [10.1016/j.oraloncology, DOI 10.1016/J.0RAL0NC0L0GY]; Ueda Y, 2004, AM J CLIN PATHOL, V122, P266, DOI 10.1309/65MKPQT3E2BDM67E; Zandberg DP, 2013, CA-CANCER J CLIN, V63, P57, DOI 10.3322/caac.21167	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	SEP	2015	45	9					828	836		10.1093/jjco/hyv085		9	Oncology	Oncology	CR4FE	WOS:000361286500005		
J	Ichioka, D; Miyazaki, J; Inoue, T; Kageyama, S; Sugimoto, M; Mitsuzuka, K; Matsui, Y; Shiraishi, Y; Kinoshita, H; Wakeda, H; Nomoto, T; Kikuchi, E; Nishiyama, H				Ichioka, Daishi; Miyazaki, Jun; Inoue, Takamitsu; Kageyama, Susumu; Sugimoto, Mikio; Mitsuzuka, Koji; Matsui, Yoshiyuki; Shiraishi, Yusuke; Kinoshita, Hidefumi; Wakeda, Hironobu; Nomoto, Takeshi; Kikuchi, Eiji; Nishiyama, Hiroyuki			Impact of renal function of patients with advanced urothelial cancer on eligibility for first-line chemotherapy and treatment outcomes	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						urothelial cancer; gemcitabine; cisplatin; renal function; chemotherapy; eGFR	CISPLATIN-BASED CHEMOTHERAPY; TRANSITIONAL-CELL-CARCINOMA; METASTATIC BLADDER-CANCER; GEMCITABINE; CARBOPLATIN; UNFIT; METHOTREXATE; VINBLASTINE; DOXORUBICIN; PREVALENCE	The aim of the study is to clarify the clinical effects of first-line chemotherapy regimens for advanced urothelial cancer on clinical responses and survival of patients grouped by renal function. In this multicenter retrospective cohort study, 345 urothelial cancer patients received systemic chemotherapy for metastatic or unresectable disease in 17 centers (2004-10). Two hundred and forty-one patients were treated with methotrexate, vinblastine, doxorubicin and cisplatin/methotrexate, epirubicin and cisplatin (n = 136) or gemcitabine and cisplatin (n = 105) followed by carboplatin-based treatments, non-platinum treatments or other regimens. After 2008, gemcitabine and cisplatin was the most frequently used regimen in patients with an estimated glomerular filtration rate < 60 ml/min/1.73 m(2) and in those with estimated glomerular filtration rate a parts per thousand yen60 ml/min/1.73 m(2). The gemcitabine and cisplatin patients' complete response rate was 10.5% and their response rate was 52.4%, which was highest among all regimens. Gemcitabine and cisplatin demonstrated a better 3-year overall survival when the estimated glomerular filtration rate was a parts per thousand yen60 ml/min/1.73 m(2) (31.4%), but it tended to be worse when the estimated glomerular filtration rate was < 60 ml/min/1.73 m(2) (14.1%). In the latter cases, the dose reduction rate of gemcitabine and cisplatin was high (43.9%). Among the patients with estimated glomerular filtration rate < 60 ml/min/1.73 m(2), the 1-year overall survival of the patients treated with a reduced dose of gemcitabine and cisplatin was significantly lower than that of those treated with standard-dose gemcitabine and cisplatin (26.2 vs. 60.3%, respectively, P = 0.0108). Gemcitabine and cisplatin provided favorable responses and survival in patients with estimated glomerular filtration rate a parts per thousand yen60 ml/min/1.73 m(2) but unsatisfactory oncological outcomes in patients with estimated glomerular filtration rate < 60 ml/min/1.73 m(2), especially when treated with a reduced dose. Alternative regimens might be optimal rather than reduced-dose gemcitabine and cisplatin in patients with estimated glomerular filtration rate < 60 ml/min/1.73 m(2).	[Ichioka, Daishi; Miyazaki, Jun; Nishiyama, Hiroyuki] Univ Tsukuba, Fac Med, Dept Urol, Tsukuba, Ibaraki 305, Japan; [Inoue, Takamitsu] Akita Univ, Grad Sch Med, Dept Urol, Akita 010, Japan; [Kageyama, Susumu] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga 52021, Japan; [Sugimoto, Mikio] Kagawa Univ, Fac Med, Dept Urol, Takamatsu, Kagawa 760, Japan; [Mitsuzuka, Koji] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan; [Matsui, Yoshiyuki] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Shiraishi, Yusuke] Hyogo Coll Med, Dept Urol, Kobe, Hyogo, Japan; [Kinoshita, Hidefumi] Kansai Med Univ, Dept Urol & Androl, Hirakata, Osaka, Japan; [Wakeda, Hironobu] Miyazaki Univ, Dept Urol, Fac Med, Miyazaki, Japan; [Nomoto, Takeshi] Tokai Univ Sch Med, Dept Urol, Isehara, Kanagawa, Japan; [Kikuchi, Eiji] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan	Nishiyama, H (reprint author), Univ Tsukuba, Fac Med, Dept Urol, 1-1-1 Tennodai, Tsukuba, Ibaraki 305, Japan.	nishiuro@md.tsukuba.ac.jp		Kageyama, Susumu/0000-0001-7150-647X	 [26462397];  [26293349]	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (26462397) and a Grant-in-Aid for Scientific Research (B) (26293349).	Nogue-Aliguer M, 2003, CANCER, V97, P2180, DOI 10.1002/cncr.10990; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Linardou H, 2004, UROLOGY, V64, P479, DOI 10.1016/j.urology.2004.04.024; De Santis M, 2012, J CLIN ONCOL, V30, P191, DOI 10.1200/JCO.2011.37.3571; STERNBERG CN, 1988, J UROLOGY, V139, P461; von der Maase H, 2000, J CLIN ONCOL, V18, P3068; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Dogliotti L, 2007, EUR UROL, V52, P134, DOI 10.1016/j.eururo.2006.12.029; Dash A, 2006, CANCER, V107, P506, DOI 10.1002/cncr.22031; Bellmunt J, 2001, EUR J CANCER, V37, P2212, DOI 10.1016/S0959-8049(01)00295-7; Canter D, 2011, UROLOGY, V77, P160, DOI 10.1016/j.urology.2010.03.091; Carles J, 2000, ONCOLOGY-BASEL, V59, P24, DOI 10.1159/000012132; Hussain SA, 2004, BRIT J CANCER, V91, P844, DOI 10.1038/sj.bjc.6602112; Launay-Vacher V, 2009, CLIN GENITOURIN CANC, V7, pE83, DOI 10.3816/CGC.2009.n.029; Morales-Barrera R, 2012, EUR J CANCER, V48, P1816, DOI 10.1016/j.ejca.2012.04.002; Tsao CK, 2012, CLIN GENITOURIN CANC, V10, P15, DOI 10.1016/j.clgc.2011.10.004; Vaughn DJ, 2008, CANCER TREAT REV, V34, P328, DOI 10.1016/j.ctrv.2007.12.006	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	SEP	2015	45	9					867	873		10.1093/jjco/hyv082		7	Oncology	Oncology	CR4FE	WOS:000361286500010		
J	Matsumoto, R; Takada, N; Abe, T; Minami, K; Harabayashi, T; Nagamori, S; Hatanaka, KC; Miyajima, N; Tsuchiya, K; Maruyama, S; Murai, S; Shinohara, N				Matsumoto, Ryuji; Takada, Norikata; Abe, Takashige; Minami, Keita; Harabayashi, Toru; Nagamori, Satoshi; Hatanaka, Kanako C.; Miyajima, Naoto; Tsuchiya, Kunihiko; Maruyama, Satoru; Murai, Sachiyo; Shinohara, Nobuo			Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						bladder cancer; extended lymph node dissection; prospective study; micrometastasis; laparoscopic radical cystectomy	DISSECTION; LYMPHADENECTOMY; CARCINOMA; IMPACT; SURVIVAL; OUTCOMES; NUMBER; EXTENT	To investigate node-disease prevalence including micrometastases and its survival impact on bladder cancer patients. A total of 60 patients participated in this study, in which extended lymph node dissection was carried out according to the prospective rule (below aortic bifurcation). Radical cystectomy and extended lymph node dissection were performed by open surgery (n = 23) or laparoscopically (n = 37). Perioperative, pathological and follow-up data were collected. Micrometastasis in lymph nodes was investigated by pan-cytokeratin immunohistochemistry. Recurrence-free survival was estimated with the Kaplan-Meier method. The median number of lymph nodes removed was 29 (range: 10-103) and there was no significant difference between the two groups (open group: median 30, laparoscopic group: median 29). Routine pathological examination revealed that 10 patients had lymph node metastases. Immunohistochemistry revealed micrometastases in four additional patients (pNmicro+), who had been diagnosed with pN0 on routine pathological examination. After excluding the three patients with pure nonurothelial carcinoma on the final pathology (small cell carcinoma: n = 2, adenocarcinoma: n = 1), 10 out of the 57 urothelial carcinoma patients (17.5%) had node metastasis, and an additional 4 out of the 47 pN0 patients (4/47, 8.5%) had micrometastasis. The 2-year recurrence-free survival rates divided by pN stage were 82.4% for pN0, 66.7% for pNmicro+ and 12.5% for pN+ (three-sample log-rank test, P < 0.0001). Three out of the four patients with pNmicro+ were disease free at the last follow-up. We confirmed under extended lymph node dissection that a substantial proportion of the patients had node metastasis (pN+: n = 10 and pNmicro+: n = 4), and the pN stage influenced patient survival. Our observations of micrometastasis yielded additional evidence for the potential survival benefit of extended lymphadenectomy by eliminating microdisease.	[Matsumoto, Ryuji; Takada, Norikata; Abe, Takashige; Miyajima, Naoto; Tsuchiya, Kunihiko; Maruyama, Satoru; Murai, Sachiyo; Shinohara, Nobuo] Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido 0608638, Japan; [Matsumoto, Ryuji; Minami, Keita; Harabayashi, Toru; Nagamori, Satoshi] Hokkaido Canc Ctr, Dept Urol, Sapporo, Hokkaido, Japan; [Hatanaka, Kanako C.] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan	Abe, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Urol, North Ward, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	takataka@rf6.so-net.ne.jp					Abe T, 2015, J ENDOUROL, V29, P304, DOI [10.1089/end.2014.0369, 10.1089/end.2014.0381]; Abe T, 2010, EJSO-EUR J SURG ONC, V36, P1085, DOI 10.1016/j.ejso.2010.08.134; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Kurahashi T, 2005, CLIN CANCER RES, V11, P3773, DOI 10.1158/1078-0432.CCR-04-2297; Lopez-Beltran A, 2004, EUR UROL, V45, P257, DOI 10.1016/j.eururo.2003.09.018; Simone G, 2013, INT J UROL, V20, P390, DOI 10.1111/j.1442-2042.2012.03148.x; Dhar NB, 2008, J UROLOGY, V179, P873, DOI 10.1016/j.juro.2007.10.076; Abaza R, 2012, J UROLOGY, V187, P1200, DOI 10.1016/j.juro.2011.11.092; Koppie TM, 2006, CANCER, V107, P2368, DOI 10.1002/cncr.22250; Zehnder P, 2011, J UROLOGY, V186, P1261, DOI 10.1016/j.juro.2011.06.004; Poulsen AL, 1998, J UROLOGY, V160, P2015, DOI 10.1016/S0022-5347(01)62229-8; Leissner J, 2004, J UROLOGY, V171, P139, DOI 10.1097/01.ju.0000102302.26806.fb; Abol-Enein H, 2011, EUR UROL, V60, P572, DOI 10.1016/j.eururo.2011.05.062; Bruins HM, 2014, EUR UROL, V66, P1065, DOI 10.1016/j.eururo.2014.05.031; Desai MM, 2012, EUR UROL, V61, P350, DOI 10.1016/j.eururo.2011.09.011; Dorin RP, 2011, EUR UROL, V60, P946, DOI 10.1016/j.eururo.2011.07.012; Herr HW, 2002, J UROLOGY, V167, P1295, DOI 10.1016/S0022-5347(05)65284-6; Holmer M, 2009, WORLD J UROL, V27, P521, DOI 10.1007/s00345-008-0366-9; Jensen JB, 2011, SCAND J UROL NEPHROL, V45, P419, DOI 10.3109/00365599.2011.599336; Jensen JB, 2010, BJU INT, V106, P199, DOI 10.1111/j.1464-410X.2009.09118.x; Kitamura H, 2011, INT J CLIN ONCOL, V16, P179, DOI 10.1007/s10147-011-0235-1; Marin-Aguilera M, 2008, EUR UROL, V54, P1363; Ost MC, 2008, J ENDOUROL, V22, P105, DOI 10.1089/end.2007.9858; Sobin L, 2009, CLASSIFICATION MALIG, P258	24	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	SEP	2015	45	9					874	880		10.1093/jjco/hyv091		7	Oncology	Oncology	CR4FE	WOS:000361286500011		
J	Hori, M; Matsuda, T; Shibata, A; Katanoda, K; Sobue, T; Nishimoto, H				Hori, Megumi; Matsuda, Tomohiro; Shibata, Akiko; Katanoda, Kota; Sobue, Tomotaka; Nishimoto, Hiroshi		Japan Canc Surveillance Res Grp	Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Article						cancer incidence; incidence estimates; extent of disease; cancer registry; Japan	UPDATED REPORT; MORTALITY; TRENDS	The Japan Cancer Surveillance Research Group aimed to estimate the cancer incidence in Japan in 2009 based on data collected from 32 of 37 population-based cancer registries, as part of the Monitoring of Cancer Incidence in Japan (MCIJ) project. The incidence of only primary invasive cancer in Japan for 2009 was estimated to be 775 601. Stomach cancer and breast cancer were the leading types of cancer in males and females, respectively.	[Hori, Megumi; Matsuda, Tomohiro; Shibata, Akiko; Katanoda, Kota; Nishimoto, Hiroshi] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Canc Informat Serv & Surveillance Div, Chuo Ku, Tokyo 1040045, Japan; [Sobue, Tomotaka] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan	Hori, M (reprint author), Natl Canc Ctr, Ctr Canc Control & Informat, Surveillance Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	mhori@ncc.go.jp			Third-Term Comprehensive 10-Year Strategy for Cancer Control	The study was supported by the Third-Term Comprehensive 10-Year Strategy for Cancer Control.	Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P139, DOI 10.1093/jjco/hyq169; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P850, DOI 10.1093/jjco/hyp106; Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002; Marugame T, 2007, JPN J CLIN ONCOL, V37, P884, DOI 10.1093/jjco/hym112; Marugame T, 2006, JPN J CLIN ONCOL, V36, P668, DOI 10.1093/jjco/hyl084; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Matsuda T, 2008, JPN J CLIN ONCOL, V38, P641, DOI 10.1093/jjco/hyn074; Matsuda T, 2010, JPN J CLIN ONCOL, V40, P1192, DOI 10.1093/jjco/hyq109; Tajima K, 2004, CANC MORT MORB STAT, P95; Hanai A, 1998, JPN J CLIN ONCOL, V28, P54; HANAI A, 1994, JPN J CLIN ONCOL, V24, P299; U. S National Institutes of Health, 2000, SEER SUMM STAG MAN	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	SEP	2015	45	9					884	891		10.1093/jjco/hyv088		8	Oncology	Oncology	CR4FE	WOS:000361286500013		
J	Kitamura, S; Kataoka, Y; Fukutomi, H; Nakajima, N				Kitamura, Satoru; Kataoka, Yuki; Fukutomi, Hikaru; Nakajima, Naoki			Tracheal obstruction caused by cervical malignant peripheral nerve sheath tumor	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Kitamura, Satoru] Hyogo Canc Ctr, Dept Digest Med, Kobe, Hyogo, Japan; [Kataoka, Yuki] Hyogo Kenritsu Amagasaki Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Fukutomi, Hikaru] Hyogo Kenritsu Amagasaki Hosp, Dept Radiol, Kobe, Hyogo, Japan; [Nakajima, Naoki] Hyogo Kenritsu Amagasaki Hosp, Dept Pathol, Kobe, Hyogo, Japan	Kitamura, S (reprint author), Hyogo Canc Ctr, Dept Digest Med, Kobe, Hyogo, Japan.							0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	SEP	2015	45	9					892	893		10.1093/jjco/hyv090		2	Oncology	Oncology	CR4FE	WOS:000361286500014		
J	Matsuda, T; Niino, M				Matsuda, Tomohiro; Niino, Mariko			Morphological distribution of testis cancer from Cancer Incidence in Five Continents Vol. X	JAPANESE JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									[Matsuda, Tomohiro; Niino, Mariko] Natl Canc Ctr, Div Surveillance, Ctr Canc Control & Informat Serv, Tokyo, Japan	Matsuda, T (reprint author), Natl Canc Ctr, Div Surveillance, Ctr Canc Control & Informat Serv, Tokyo, Japan.							0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0368-2811	1465-3621		JPN J CLIN ONCOL	Jpn. J. Clin. Oncol.	SEP	2015	45	9					894	894		10.1093/jjco/hyv133		1	Oncology	Oncology	CR4FE	WOS:000361286500015		
J	Matsuda, S; Iguchi, H; Tada, T; Hosono, M; Osawa, M; Kuwae, Y; Morimoto, H; Okazaki, E; Amano, K; Miki, Y; Tsutsumi, S; Shimatani, Y; Miki, Y				Matsuda, Shogo; Iguchi, Hiroyoshi; Tada, Takuhito; Hosono, Masako; Osawa, Masahiko; Kuwae, Yuuko; Morimoto, Hideyuki; Okazaki, Eiichiro; Amano, Kosuke; Miki, Yoshitaka; Tsutsumi, Shinichi; Shimatani, Yasuhiko; Miki, Yukio			Results of surgery plus postoperative radiotherapy for patients with malignant parotid tumor	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Malignant parotid tumor; Surgery; Postoperative radiotherapy; WHO classification	SALIVARY-GLAND TUMORS; PROGNOSTIC-FACTORS; RADIATION-THERAPY; PHASE-II; CARCINOMA; OUTCOMES; CISPLATIN; CANCER	The latest version of the World Health Organization (WHO) histologic classification of salivary gland malignancies was published in 2005. To contribute to data accumulation on the basis of this latest version, a retrospective study was performed. Participants comprised 27 patients who underwent postoperative radiotherapy between 2000 and 2013. Two, eight, and 17 patients were allocated to low, intermediate, and high-grade groups, respectively, in accordance with the latest WHO classification. The radiation field included the tumor bed and ipsilateral regional lymph nodes for 25 patients. The radiation dose was 46-60 Gy (median 56 Gy). Median duration of follow-up was 41 months. Five-year locoregional control was 89 %. Two patients experienced local recurrence and 7 patients developed distant metastases. No patients in the low or intermediate-grade groups developed distant metastases. Overall 3 and 5-year survival for all patients were 81 and 75 %, respectively. Five-year overall survival for patients in the low and intermediate-grade groups was 100 %, compared with 59 % for patients in the high-grade group (p = 0.03). Favorable locoregional control was achieved for patients with malignant parotid tumors who underwent surgery plus postoperative radiotherapy. Patients with high-grade tumors frequently experienced distant metastases and prognosis was poor.	[Matsuda, Shogo; Hosono, Masako; Morimoto, Hideyuki; Okazaki, Eiichiro; Amano, Kosuke; Miki, Yoshitaka; Tsutsumi, Shinichi; Shimatani, Yasuhiko; Miki, Yukio] Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Abeno Ku, Osaka 5458585, Japan; [Matsuda, Shogo; Osawa, Masahiko; Morimoto, Hideyuki; Okazaki, Eiichiro; Amano, Kosuke; Miki, Yoshitaka; Tsutsumi, Shinichi; Shimatani, Yasuhiko; Miki, Yukio] Osaka City Univ, Grad Sch Med, Dept Radiat Oncol, Abeno Ku, Osaka 5458585, Japan; [Iguchi, Hiroyoshi] Osaka City Univ, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Abeno Ku, Osaka 5458585, Japan; [Tada, Takuhito] Izumi Municipal Hosp, Dept Radiol, Izumi 5940071, Japan; [Osawa, Masahiko; Kuwae, Yuuko] Osaka City Univ, Dept Diagnost Pathol, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan	Matsuda, S (reprint author), Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	shogo313@gmail.com					Agulnik M, 2008, ONCOL REV, V2, P86, DOI 10.1007/s12156-008-0062-4; Mendenhall WM, 2005, CANCER, V103, P2544, DOI 10.1002/cncr.21083; HARRISON LB, 1990, J SURG ONCOL, V45, P52, DOI 10.1002/jso.2930450112; LICITRA L, 1991, CANCER, V68, P1874, DOI 10.1002/1097-0142(19911101)68:9<1874::AID-CNCR2820680904>3.0.CO;2-S; Chen AM, 2006, INT J RADIAT ONCOL, V66, P152, DOI 10.1016/j.ijrobp.2006.04.014; TRAN L, 1986, LARYNGOSCOPE, V96, P1139; Pohar S, 2005, INT J RADIAT ONCOL, V61, P112, DOI 10.1016/j.ijrobp.2004.04.052; Terhaard CHJ, 2005, INT J RADIAT ONCOL, V61, P103, DOI 10.1016/j.ijrobp.2004.03.018; Vander Poorten VLM, 1999, CANCER, V85, P2057, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2057::AID-CNCR24>3.0.CO;2-F; Airoldi M, 2001, CANCER, V91, P541, DOI 10.1002/1097-0142(20010201)91:3<541::AID-CNCR1032>3.0.CO;2-Y; Al-Mamgani A, 2012, INT J RADIAT ONCOL, V84, P189, DOI 10.1016/j.ijrobp.2011.11.045; FRANKENTHALER RA, 1991, ARCH OTOLARYNGOL, V117, P1251; ARMSTRONG JG, 1990, ARCH OTOLARYNGOL, V116, P290; Arrangoiz R, 2013, J CAN TREAT RES, V1, P8; Barnes L, 2005, WHO CLASSIFICATION T, P221; Brandwein MS, 2002, ACTA OTO-LARYNGOL, V122, P758, DOI 10.1080/003655402/000028047; FITZPATRICK PJ, 1986, INT J RADIAT ONCOL, V12, P1743; FU KK, 1977, CANCER, V40, P2882, DOI 10.1002/1097-0142(197712)40:6<2882::AID-CNCR2820400618>3.0.CO;2-I; KANE WJ, 1991, ARCH OTOLARYNGOL, V117, P307	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	SEP	2015	33	9					533	537		10.1007/s11604-015-0450-1		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CR6FS	WOS:000361440600002		
J	Ohta, T; Nakata, N; Nishioka, M; Igarashi, T; Fukuda, K				Ohta, Tomoyuki; Nakata, Norio; Nishioka, Makiko; Igarashi, Takao; Fukuda, Kunihiko			Quantitative differentiation of benign and malignant mammographic circumscribed masses using intensity histograms	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Mammography; Intensity histogram; Hardness	BREAST	To investigate the usefulness of density gradient of mammographic masses for differentiating benign from malignant lesions, particularly circumscribed masses, which are difficult to diagnose by shape. Phantom experiments were performed and diagnostic mammography examinations were reviewed. Mammograms of three acrylic resin globes differing in hardness were acquired with/without applied pressure, and density gradients were examined on intensity histograms with standard deviation (SD) as a hardness index. Similar analyses were performed using clinical mammographic examinations of circumscribed mass lesions. The usefulness of SD for differentiating between benign and malignant lesions was investigated by ROC curve analysis and minimum/maximum values of malignant and benign lesions, respectively. For circumscribed masses (n = 196, benign, n = 176; malignant, n = 20), ROC analysis showed AUC = 0.786, with sensitivity = 70.0 %, specificity = 70.5 %, accuracy = 70.4 %, positive predictive value = 21.1 %, and negative predictive value = 95.4 % at SD = 64.46. Minimum and maximum SD of malignant and benign masses were 39.1 and 241.7, respectively. On mammography, circumscribed masses can be diagnosed with moderate accuracy using the intensity histogram SD. Masses with SD below the minimum of breast cancer can be roughly diagnosed as clinically benign.	[Ohta, Tomoyuki; Nakata, Norio; Nishioka, Makiko; Igarashi, Takao; Fukuda, Kunihiko] Jikei Univ, Dept Radiol, Sch Med, Minato Ku, Tokyo 1058461, Japan	Ohta, T (reprint author), Jikei Univ, Dept Radiol, Sch Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	ohta.kent@nifty.com; nakata@jikei.ac.jp; n-makiko@jikei.ac.jp; igarashi-t@jikei.ac.jp; fukuda@jikei.ac.jp					American College of Radiology (ACR), 2013, BREAST IM REP DAT SY, P136; Baker JA, 1996, AM J ROENTGENOL, V166, P773; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260; Brant WE, 2012, FUNDAMENTALS DIAGNOS, P546; Joe BN, 2014, RADIOLOGY, V273, pS23, DOI 10.1148/radiol.14141233; Marsteller L P, 1989, Radiographics, V9, P13; Okafuji Takashi, 2008, Magn Reson Med Sci, V7, P195; OSTRUM BJ, 1973, RADIOLOGY, V109, P323; SICKLES EA, 1989, RADIOLOGY, V173, P297	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	SEP	2015	33	9					559	565		10.1007/s11604-015-0456-8		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CR6FS	WOS:000361440600005		
J	Nakaura, T; Nagayama, Y; Kidoh, M; Nakamura, S; Namimoto, T; Awai, K; Harada, K; Yamashita, Y				Nakaura, Takeshi; Nagayama, Yasunori; Kidoh, Masafumi; Nakamura, Shinichi; Namimoto, Tomohiro; Awai, Kazuo; Harada, Kazunori; Yamashita, Yasuyuki			Low contrast dose protocol involving a 100 kVp tube voltage for hypervascular hepatocellular carcinoma in patients with renal dysfunction	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Low kilo voltage CT; 100 kVp; Contrast induced nephropathy; Renal dysfunction; Hypervascular hepatocellular carcinoma	MULTIDETECTOR ROW CT; ITERATIVE RECONSTRUCTION ALGORITHM; IMAGE QUALITY; ARTERIAL PHASE; DYNAMIC CT; ABDOMINAL CT; HEPATIC ARTERIOGRAPHY; LIVER-TUMORS; THIN ADULTS; HELICAL CT	To evaluate the feasibility of a 20 % reduced contrast dose hepatic arterial phase (HAP) CT for hypervascular hepatocellular carcinoma (HCC) with 100 kVp. The study included 97 patients with hypervascular HCC who underwent dynamic CT, including HAP scanning. The 54 patients had an estimated glomerular filtration rate (eGFR) of a parts per thousand yen60 were scanned with our conventional 120 kVp protocol. The other 43 patients (eGFR < 60) underwent scans using a tube voltage of 100 kVp and a 20 % reduced contrast dose. We compared the estimated effective dose, image noise, tumor-liver contrast (TLC), and contrast-to-noise ratio (CNR) in the hepatic arterial phase between the two groups using the Student's t test. Estimated effective dose and image noise were not significantly different between these groups (p = 0.67 and p = 0.20, respectively). The TLC and CNR were significantly higher for the 100 kVp protocol than for the 120 kVp protocol (52.2 HU +/- 17.4 vs 40.8 HU +/- 18.6, p < 0.01 and 6.8 +/- 2.6 vs 5.5 +/- 2.4, p = 0.01, respectively). For hepatic arterial phase CT of hypervascular HCC, 100 kVp scan allows a 20 % reduction in the contrast dose without reduction in image quality compared with a standard 120 kVp CT protocol.	[Nakaura, Takeshi; Nagayama, Yasunori; Kidoh, Masafumi; Nakamura, Shinichi] Amakusa Med Ctr, Diagnost Radiol, Amakusa, Kumamoto 8630046, Japan; [Nakaura, Takeshi; Nagayama, Yasunori; Kidoh, Masafumi; Nakamura, Shinichi; Namimoto, Tomohiro; Yamashita, Yasuyuki] Kumamoto Univ, Dept Diagnost Radiol, Grad Sch Med Sci, Kumamoto, Japan; [Awai, Kazuo] Hiroshima Univ, Grad Sch Med Sci, Dept Diagnost Radiol, Hiroshima, Japan; [Harada, Kazunori] Amakusa Med Ctr, Dept Surg, Amakusa, Japan	Nakaura, T (reprint author), Amakusa Med Ctr, Diagnost Radiol, Kameba 854-1, Amakusa, Kumamoto 8630046, Japan.	kff00712@gmail.com					Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Ertl-Wagner BB, 2004, RADIOLOGY, V231, P528, DOI 10.1148/radiol.2312030543; Guimaraes LS, 2010, RADIOLOGY, V257, P732, DOI 10.1148/radiol.10092016; Nakaura T, 2011, AM J ROENTGENOL, V196, P1332, DOI 10.2214/AJR.10.5698; Christner JA, 2010, AM J ROENTGENOL, V194, P881, DOI 10.2214/AJR.09.3462; Utsunomiya D, 2010, EUR RADIOL, V20, P2758, DOI 10.1007/s00330-010-1841-4; From AM, 2008, MAYO CLIN PROC, V83, P1095, DOI 10.4065/83.10.1095; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; Ueda K, 1998, RADIOLOGY, V206, P161; Yanaga Y, 2011, AM J ROENTGENOL, V196, P1324, DOI 10.2214/AJR.10.4545; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; Bae KT, 2010, RADIOLOGY, V256, P32, DOI 10.1148/radiol.10090908; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; [Anonymous], 2006, KIDNEY INT S, DOI DOI 10.1038/SJ.KI.5000366; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Huda W, 2000, RADIOLOGY, V217, P430; Schindera ST, 2008, RADIOLOGY, V246, P125, DOI 10.1148/radiol.2461070307; Bischoff B, 2009, JACC-CARDIOVASC IMAG, V2, P940, DOI 10.1016/j.jcmg.2009.02.015; Yamashita Y, 2000, RADIOLOGY, V216, P718; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; HOLLETT MD, 1995, AM J ROENTGENOL, V164, P879; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Schindera ST, 2011, RADIOLOGY, V260, P454, DOI 10.1148/radiol.11102217; Sultana S, 2007, RADIOLOGY, V243, P140, DOI 10.1148/radiol.2431060069; Nakaura T, 2012, RADIOLOGY, V264, P445, DOI 10.1148/radiol.12111082; BARON RL, 1994, AM J ROENTGENOL, V163, P323; Nakayama Yoshiharu, 2006, AJR Am J Roentgenol, V187, pW490, DOI 10.2214/AJR.05.0471; Hausleiter J, 2010, JACC-CARDIOVASC IMAG, V3, P1113, DOI 10.1016/j.jcmg.2010.08.016; Huda W, 2004, P SOC PHOTO-OPT INS, V5368, P499, DOI 10.1117/12.535608; Kim T, 1998, AM J ROENTGENOL, V171, P429; Kitao A, 2009, RADIOLOGY, V252, P605, DOI 10.1148/radiol.2522081414; Kojiro Masamichi, 2004, Liver Transpl, V10, pS3, DOI 10.1002/lt.20042; Nakaura T, 2011, RADIOLOGY, V261, P467, DOI 10.1148/radiol.11110021; OHASHI I, 1993, RADIOLOGY, V189, P851; Sherman M, 2005, HEPATOLOGY, V42, P14, DOI 10.1002/hep.20790; Suzuki H, 2004, EUR RADIOL, V14, P2099, DOI 10.1007/s00330-004-2439-5	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	SEP	2015	33	9					566	576		10.1007/s11604-015-0457-7		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CR6FS	WOS:000361440600006		
J	Harada, M; Karasawa, K; Yasuda, S; Kamada, T; Nemoto, K				Harada, Mayumi; Karasawa, Kumiko; Yasuda, Shigeo; Kamada, Tadashi; Nemoto, Kenji			One shot of carbon-ion radiotherapy cured a 6-cm chemo-resistant metastatic liver tumor: a case of breast cancer	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Carbon-ion radiotherapy; Metastatic liver tumor; Breast cancer	STEREOTACTIC BODY RADIOTHERAPY; HEPATOCELLULAR-CARCINOMA; EXPERIENCE; THERAPY; LESIONS	The standard treatment for metastatic liver tumor from breast cancer is systemic medical treatment, and there is controversy regarding the value of local treatment. However, there are some exceptional cases that do benefit from local therapy. We describe the case of a 54-year-old woman with systemic therapy-resistant liver metastasis from breast cancer successfully treated with a single shot of 36-GyE carbon-ion radiotherapy and surviving more than 8 years without local recurrence. This case represents a good example of the usefulness and safety of carbon-ion radiotherapy, and who might benefit from local therapy.	[Harada, Mayumi; Nemoto, Kenji] Yamagata Univ, Sch Med, Dept Radiat Oncol, Yamagata, Yamagata 9909585, Japan; [Harada, Mayumi; Karasawa, Kumiko; Yasuda, Shigeo; Kamada, Tadashi] Res Ctr Hosp Charged Particle Therapy, Natl Inst Radiol Sci, Inage Ku, Chiba, Chiba 2638555, Japan	Harada, M (reprint author), Yamagata Univ, Sch Med, Dept Radiat Oncol, 2-2-2 Iida Nishi, Yamagata, Yamagata 9909585, Japan.	ideal.fullmoon@gmail.com					Akamatsu H, 2014, JPN J RADIOL, V32, P288, DOI 10.1007/s11604-014-0300-6; Atalay G, 2003, EUR J CANCER, V39, P2439, DOI 10.1016/S0959-8049(03)00601-4; Milano MT, 2012, INT J RADIAT ONCOL, V83, P878, DOI 10.1016/j.ijrobp.2011.08.036; Yuan ZY, 2014, ONCOTARGETS THER, V7, P915, DOI 10.2147/OTT.S58409; Elsberger B, 2014, HEPATO-GASTROENTEROL, V61, P181, DOI 10.5754/hge12405; Habermehl D, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-175; Imada H, 2010, RADIOTHER ONCOL, V96, P231, DOI 10.1016/j.radonc.2010.05.019; Kamada T, 2015, LANCET ONCOL, V16, pE93, DOI 10.1016/S1470-2045(14)70412-7; Kumler I, 2015, RADIOL MED, V120, P536, DOI 10.1007/s11547-014-0489-6; Makita M, 2014, BREAST CANC, DOI [10.1007/s12282-014-0571-x, DOI 10.1007/S12282-014-0571-X]; Milano MT, 2008, INT J RADIAT ONCOL, V72, P1516, DOI 10.1016/j.ijrobp.2008.03.044; Skinner HD, 2011, SEMIN RADIAT ONCOL, V21, P278, DOI 10.1016/j.semradonc.2011.05.007	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	SEP	2015	33	9					598	602		10.1007/s11604-015-0462-x		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CR6FS	WOS:000361440600010		
J	Kobayashi, F; Kuroki, M				Kobayashi, Fumiaki; Kuroki, Manabu			Causal Measures of the Treatment Effect Captured by Candidate Surrogate Endpoints	JOURNAL OF AGRICULTURAL BIOLOGICAL AND ENVIRONMENTAL STATISTICS			English	Article						Mediation proportion; Potential outcome approach; Proportion indirect	MEDIATION ANALYSIS; OVERT NEPHROPATHY; CARDIOVASCULAR OUTCOMES; COVARIATE SELECTION; PROPORTION; INFERENCE; MARKER; SURVIVAL; ORIENT; MODELS	In randomized clinical trials, true clinical endpoints that are rare or difficult to measure can be costly and time consuming. Therefore, there is an increasing need to substitute true clinical endpoints with surrogate endpoints. However, candidate surrogate endpoints require appropriate validation. To evaluate the extent of a treatment effect (TE) captured by candidate surrogate endpoints, various surrogacy measures have been proposed by biostatisticians and medical professionals. Although many researchers stated that it is desirable that surrogacy measures should take values between zero to one, those often fall outside a range [0, 1] without suitable assumptions. To overcome this problem, we propose two types of surrogacy measures based on the causal association (CA) paradigm and the causal effect (CE) paradigm. These operate by decomposing the TE into those parts that are and are not captured by candidate surrogate endpoints. The surrogacy measures based on the CA paradigm mainly consider how much of the TE of the treatment on the true clinical endpoint can be predicted through the TE on the candidate surrogate endpoints, while the surrogacy measures based on the CE paradigm are concerned with how much of the TE on the true clinical endpoint is a result of the candidate surrogate endpoints. In addition, we demonstrate some properties of the proposed surrogacy measures, and show that they always fall inside the range [0, 1]. Furthermore, they can be considered as improved and extended versions of existing surrogacy measures. Based on simulation experiments and applications of the proposed surrogacy measures to a case study of the Olmesartan Reducing Incidence of End-stage Renal Disease in Diabetic Nephropathy Trial, we show that the proposed surrogacy measures solve the problems encountered by the existing surrogacy measures. This paper presents new quantitative surrogacy measures that reliably evaluate the proportion of the TE captured by candidate surrogate endpoints. Supplementary materials accompanying this paper appear online.	[Kobayashi, Fumiaki] Daiichi Sankyo Co Ltd, Clin Data & Biostat, Shinagawa Ku, Tokyo 1408710, Japan; [Kuroki, Manabu] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan	Kobayashi, F (reprint author), Daiichi Sankyo Co Ltd, Clin Data & Biostat, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	FKobayashi@dsd-eu.com; mkuroki@ism.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We would like to thank the ORIENT group for allowing the use of their data. This research was funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	De Luna X, 2011, BIOMETRIKA, V98, P861, DOI 10.1093/biomet/asr041; Albert JM, 2008, STAT MED, V27, P1282, DOI 10.1002/sim.3016; Weir CJ, 2006, STAT MED, V25, P183, DOI 10.1002/sim.2319; Qu Y, 2007, BIOMETRICS, V63, P958, DOI 10.1111/j.1541-0420.2007.00852_1.x; TSIATIS AA, 1995, J AM STAT ASSOC, V90, P27, DOI 10.2307/2291126; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Imai E, 2013, HYPERTENS RES, V36, P1051, DOI 10.1038/hr.2013.86; VanderWeele TJ, 2010, AM J EPIDEMIOL, V172, P1339, DOI 10.1093/aje/kwq332; FREEDMAN LS, 1992, STAT MED, V11, P167, DOI 10.1002/sim.4780110204; Imai E, 2011, DIABETOLOGIA, V54, P2978, DOI 10.1007/s00125-011-2325-z; Taylor JMG, 2005, BIOMETRICS, V61, P1102, DOI 10.1111/j.1541-0420.2005.00350.x; Imai E, 2013, NEPHROL DIAL TRANSPL, V28, P2526, DOI 10.1093/ndt/gft249; RUBIN DB, 1978, ANN STAT, V6, P34, DOI 10.1214/aos/1176344064; Wang Y, 2002, BIOMETRICS, V58, P803, DOI 10.1111/j.0006-341X.2002.00803.x; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P582, DOI 10.1097/EDE.0b013e31821db37e; Joffe MM, 2009, BIOMETRICS, V65, P530, DOI 10.1111/j.1541-0420.2008.01106.x; Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P18, DOI 10.1097/EDE.0b013e31818f69ce; Cai ZH, 2008, BIOMETRICS, V64, P695, DOI 10.1111/j.1541-0420.2007.00949.x; Bickel DR, 2002, COMPUT STAT DATA AN, V39, P153, DOI 10.1016/S0167-9473(01)00057-3; Burzykowski T, 2006, EVALUATION SURROGATE; DeGruttola V, 1997, J INFECT DIS, V175, P237; Imbens G. W., 2015, CAUSAL INFERENCE STA; Kobayashi F, 2014, STAT MED, V33, P3338, DOI 10.1002/sim.6180; Kuroki M., 2014, BERNULLI IN PRESS; Kuroki M., 2004, 20 C UNC ART INT, P333; Kuroki M, 2003, J ROY STAT SOC B, V65, P209, DOI 10.1111/1467-9868.00381; Li ZQ, 2001, STAT MED, V20, P3175, DOI 10.1002/sim.984.abs; Pearl J., 2014, PSYCHOL MET IN PRESS; Pearl J., 2001, P 17 C UNC ART INT, P411; Pearl J., 1988, PROBABILISTIC REASON; Pearl J., 2009, CAUSALITY MODELS REA; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Ramsahai R. R., 2012, CAUSALITY STAT PERSP, P218; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; Robins J. M., 1989, HLTH SERVICE RES MET, P113; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; RUBIN DB, 1986, J AM STAT ASSOC, V81, P961, DOI 10.2307/2289065; VanderWeele TJ, 2013, BIOMETRICS, V69, P561, DOI 10.1111/biom.12071; Yusuf S, 2008, NEW ENGL J MED, V358, P1547	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1085-7117	1537-2693		J AGR BIOL ENVIR ST	J. Agric. Biol. Environ. Stat.	SEP	2015	20	3					409	430		10.1007/s13253-015-0215-4		22	Biology; Mathematical & Computational Biology; Statistics & Probability	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology; Mathematics	CR6MX	WOS:000361462700007		
J	Kobayashi, K				Kobayashi, Kazuhiko			FACE-ing the challenges of increasing surface ozone concentration in Asia Foreword	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Editorial Material							CO2 ENRICHMENT FACE; AIR; WHEAT; EXPOSURE; SYSTEM; FLUX; CROPS; CHINA; PHOTOSYNTHESIS; ECOSYSTEMS		Univ Tokyo, Bunkyo Ku, Tokyo 1138657, Japan	Kobayashi, K (reprint author), Univ Tokyo, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aclasman@mail.ecc.u-tokyo.ac.jp					Agathokleous E, 2015, J AGRIC METEOROL, V71, P185, DOI 10.2480/agrmet.D-14-00017; Avnery S, 2011, ATMOS ENVIRON, V45, P2284, DOI 10.1016/j.atmosenv.2010.11.045; [Anonymous], 2008, 1508 ROYAL SOC; Pleijel H, 2007, ATMOS ENVIRON, V41, P3022, DOI 10.1016/j.atmosenv.2006.12.002; Tang HY, 2011, ATMOS ENVIRON, V45, P6276, DOI 10.1016/j.atmosenv.2011.08.059; Pinter PJ, 2000, AGR FOREST METEOROL, V103, P319, DOI 10.1016/S0168-1923(00)00150-7; Feng ZZ, 2014, ENVIRON POLLUT, V193, P296, DOI 10.1016/j.envpol.2014.06.004; Mills G, 2011, GLOBAL CHANGE BIOL, V17, P592, DOI 10.1111/j.1365-2486.2010.02217.x; Mills G, 2007, ATMOS ENVIRON, V41, P2630, DOI 10.1016/j.atmosenv.2006.11.016; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Karnosky DF, 2007, ENVIRON POLLUT, V147, P489, DOI 10.1016/j.envpol.2006.08.043; Avnery S, 2011, ATMOS ENVIRON, V45, P2297, DOI 10.1016/j.atmosenv.2011.01.002; Zhu XK, 2011, GLOBAL CHANGE BIOL, V17, P2697, DOI 10.1111/j.1365-2486.2011.02400.x; Feng ZZ, 2012, ENVIRON POLLUT, V164, P16, DOI 10.1016/j.envpol.2012.01.014; Feng ZZ, 2009, ATMOS ENVIRON, V43, P1510, DOI 10.1016/j.atmosenv.2008.11.033; Tang HY, 2013, GLOBAL CHANGE BIOL, V19, P2739, DOI 10.1111/gcb.12252; ALLEN LH, 1992, CRIT REV PLANT SCI, V11, P85, DOI 10.1080/07352689209382333; HEGGESTAD HE, 1959, SCIENCE, V129, P208, DOI 10.1126/science.129.3343.208; Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Grueters U., 1995, Environmental Pollution, V87, P141; HEAGLE A S, 1973, Journal of Environmental Quality, V2, P365; Hoshika Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09871; Hoshika Y, 2015, J AGRIC METEOROL, V71, P218, DOI 10.2480/agrmet.D-14-00013; Ji DH, 2015, J AGRIC METEOROL, V71, P232, DOI 10.2480/agrmet.D-14-00027; Kam D. -G., 2015, J AGROMETEOROL, V71, P239; Kobayashi K, 2001, JPN J CROP SCI, V70, P1; Kobayashi K., 1999, J JPN SOC ATMOS ENV, V34, P162; Kobayashi K., 1996, ATMOS ENVIRON, V31, P703; Koike T, 2015, J AGRIC METEOROL, V71, P174, DOI 10.2480/agrmet.D-14-00020; Komatsu M, 2015, J AGRIC METEOROL, V71, P202, DOI 10.2480/agrmet.D-14-00024; Matsuoka Y., 1976, Proceedings of the Crop Science Society of Japan, V45, P124; MCLEOD AR, 1995, PLANT CELL ENVIRON, V18, P215, DOI 10.1111/j.1365-3040.1995.tb00357.x; Morgan PB, 2004, PLANT PHYSIOL, V135, P2348, DOI 10.1104/pp.104.043968; Norby RJ, 2001, NEW PHYTOL, V150, P215, DOI 10.1046/j.1469-8137.2001.00118.x; Nussbaum S, 2000, ENVIRON POLLUT, V109, P463, DOI 10.1016/S0269-7491(00)00049-X; Okada M, 2001, NEW PHYTOL, V150, P251, DOI 10.1046/j.1469-8137.2001.00097.x; Oksanen E, 2003, PLANT CELL ENVIRON, V26, P875, DOI 10.1046/j.1365-3040.2003.01020.x; Oue Hiroki, 2008, Journal of Agricultural Meteorology, V64, P223; Oue Hiroki, 2009, Journal of Agricultural Meteorology, V65, P239; Richards B. L., 1958, AGRON J, V50, P559; Watanabe M, 2015, J AGRIC METEOROL, V71, P227, DOI 10.2480/agrmet.D-14-00012; Watanabe Y, 2015, J AGRIC METEOROL, V71, P167, DOI 10.2480/agrmet.D-14-00011; Werner H, 2002, ENVIRON SCI POLLUT R, V9, P117, DOI 10.1007/BF02987458; Yamaguchi M, 2015, J AGRIC METEOROL, V71, P211, DOI 10.2480/agrmet.D-14-00014; Yamaguchi T, 2015, J AGRIC METEOROL, V71, P196, DOI 10.2480/agrmet.D-14-00056	45	0	0	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					161	166		10.2480/agrmet.D-15-00100		6	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000001		
J	Watanabe, Y				Watanabe, Yoko			Canopy, leaf surface structure and tree phenology: Arboreal factors influencing aerosol deposition in forests	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Review						Aerosol deposition; Forest; Leaf surface structure; SEM-EDX	EPICUTICULAR WAX; ATMOSPHERIC PARTICLES; PARTICULATE POLLUTION; ENVIRONMENTAL-FACTORS; DECIDUOUS FOREST; FINE PARTICLES; TRACE-ELEMENT; AIR-POLLUTION; URBAN TREES; LEAVES	In determining the effect of aerosols on forest trees, it is necessary to estimate the deposition of aerosols to forests. To this end we must consider the arboreal factors that influence the deposition of aerosols on forest trees. This paper examines such relevant factors as canopy shape, shoot structure, and leaf surface structures. Laboratory and field experiments in urban areas show that these factors play an important role in the deposition of aerosols on trees. SEM-EDX analyses have determined the chemical composition of particles deposited on the surfaces of tree leaves in urban areas. In forests, however, details of aerosol particles deposited on leaf surfaces is not known, and the effect of abiotic factors such as rainfall, fog and wind has not been determined. Further information is needed, including experimental data about the aerosols deposited on leaf surfaces of trees in a forest, taking into account canopy shape, leaf surface structures and tree phenology.	[Watanabe, Yoko] Hokkaido Univ Forests, FSC, Sapporo, Hokkaido 0600809, Japan; [Watanabe, Yoko] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan	Watanabe, Y (reprint author), Hokkaido Univ Forests, FSC, Sapporo, Hokkaido 0600809, Japan.	youko@for.agr.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21120501, 23120701]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan (21120501, 23120701)	Bargel H, 2006, FUNCT PLANT BIOL, V33, P893, DOI 10.1071/FP06139; Burkhardt J, 2012, NEW PHYTOL, V196, P774, DOI 10.1111/j.1469-8137.2012.04307.x; Eichert T, 2008, PHYSIOL PLANTARUM, V134, P151, DOI 10.1111/j.1399-3054.2008.01135.x; Rasanen JV, 2013, ENVIRON POLLUT, V183, P64, DOI 10.1016/j.envpol.2013.05.015; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; COE JM, 1987, JAPCA J AIR WASTE MA, V37, P237; HIRANO T, 1995, ENVIRON POLLUT, V89, P255, DOI 10.1016/0269-7491(94)00075-O; Freer-Smith PH, 2004, WATER AIR SOIL POLL, V155, P173, DOI 10.1023/B:WATE.0000026521.99552.fd; Smith W. H., 1977, Environmental Management, V1, P317, DOI 10.1007/BF01865859; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; Koch K, 2008, MICRON, V39, P759, DOI 10.1016/j.micron.2007.11.010; Burkhardt J, 2010, ECOL MONOGR, V80, P369, DOI 10.1890/09-1988.1; Markert B, 1995, SCI TOTAL ENVIRON, V176, P45, DOI 10.1016/0048-9697(95)04829-4; Pryor SC, 2008, TELLUS B, V60, P42, DOI 10.1111/j.1600-0889.2007.00298.x; YOSHIE F, 1985, CAN J BOT, V63, P2150; Tomasevic M, 2005, CHEMOSPHERE, V61, P753, DOI 10.1016/j.chemosphere.2005.03.077; Whang SS, 2004, BOT J LINN SOC, V144, P303, DOI 10.1111/j.1095-8339.2003.00245.x; Sawidis T, 2012, BIOL TRACE ELEM RES, V148, P396, DOI 10.1007/s12011-012-9378-9; Freer-Smith PH, 2005, ENVIRON POLLUT, V133, P157, DOI 10.1016/j.envpol.2004.03.031; Lorenzini G, 2006, ATMOS ENVIRON, V40, P4025, DOI 10.1016/j.atmosenv.2006.03.032; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Neinhuis C, 1998, NEW PHYTOL, V138, P91, DOI 10.1046/j.1469-8137.1998.00882.x; Beckett KP, 2000, GLOB CHANGE BIOL, V6, P995, DOI 10.1046/j.1365-2486.2000.00376.x; Vollenweider P, 2005, ENVIRON POLLUT, V137, P455, DOI 10.1016/j.envpol.2005.01.032; Beckett K. Paul, 2000, Journal of Arboriculture, V26, P12; Burkhardt J, 2014, ENVIRON POLLUT, V184, P659, DOI 10.1016/j.envpol.2013.04.041; BURKHARDT J, 1995, J EXP BOT, V46, P823, DOI 10.1093/jxb/46.7.823; CROSSLEY A, 1986, NEW PHYTOL, V103, P207, DOI 10.1111/j.1469-8137.1986.tb00609.x; eburnis D., 2000, ATMOS ENVIRON, V34, P4265; Evert R. F., 2006, ESAUS PLANT ANATOMY, P601; Gronholm T., 2009, J GEOPHYS RES, V114; Gunthardt-Goerg M. S., 2007, ENVIRON POLLUT, V147, P467; Igawa M., 2009, SCI REPORTS RES I EN, V32, P67; Izuta T, 1998, J PLANT RES, V111, P471, DOI 10.1007/BF02507781; Kardel F, 2012, ENVIRON EXP BOT, V75, P277, DOI 10.1016/j.envexpbot.2011.07.011; Katata G., 2011, PROG NUCL SCI TECHNO, V2, P530; Katul GG, 2011, ATMOS ENVIRON, V45, P1203, DOI 10.1016/j.atmosenv.2010.06.032; Koike T., 2006, Eurasian Journal of Forest Research, V9-2, P69; KRAUSE CR, 1982, PHYTOPATHOLOGY, V72, P382; Kume A, 2010, ECOL RES, V25, P233, DOI 10.1007/s11284-009-0647-9; Landis JD, 2014, ENVIRON SCI TECHNOL, V48, P12022, DOI 10.1021/es503351u; Lequy E, 2014, SCI TOTAL ENVIRON, V487, P206, DOI 10.1016/j.scitotenv.2014.04.028; LINDBERG SE, 1982, SCIENCE, V215, P1609, DOI 10.1126/science.215.4540.1609; LITTLE P, 1977, ENVIRON POLLUT, V12, P293, DOI 10.1016/0013-9327(77)90023-4; Matsuda K, 2010, ATMOS ENVIRON, V44, P4582, DOI 10.1016/j.atmosenv.2010.08.015; Oliva SR, 2003, BOREAL ENVIRON RES, V8, P263; Puxbaum H, 1998, ATMOS ENVIRON, V32, P3557, DOI 10.1016/S1352-2310(98)00073-9; Ram S. S., 2012, MITIGATION ADAPTATIO, P1; Sase H, 1998, CAN J FOREST RES, V28, P546, DOI 10.1139/cjfr-28-4-546; Swbo A., 2012, SCI TOTAL ENVIRON, V427-428, P347; TURUNEN M, 1990, J ENVIRON QUAL, V19, P35; Viskari EL, 2000, WATER AIR SOIL POLL, V121, P327, DOI 10.1023/A:1005204323073; Watanabe Yoko, 2013, Asian Journal of Atmospheric Environment, V7, P1, DOI 10.5572/ajae.2013.7.1.001; Watanabe Y., 2014, EAROZORU KENKYU, V29, P176; WEDDING JB, 1977, WATER AIR SOIL POLL, V7, P545; Yamaguchi Masahiro, 2012, Asian Journal of Atmospheric Environment, V6, P259, DOI 10.5572/ajae.2012.6.4.259; Yamaguchi M, 2014, ATMOS ENVIRON, V97, P493, DOI 10.1016/j.atmosenv.2014.01.023; Yamane Kenichi, 2012, Asian Journal of Atmospheric Environment, V6, P275, DOI 10.5572/ajae.2012.6.4.275; ZOBEL A, 1991, NEW PHYTOL, V117, P565, DOI 10.1111/j.1469-8137.1991.tb00961.x	59	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					167	173		10.2480/agrmet.D-14-00011		7	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000002		
J	Koike, T; Watanabe, M; Watanabe, Y; Agathokleous, E; Eguchi, N; Takagi, K; Satoh, F; Kitaoka, S; Funada, R				Koike, Takayoshi; Watanabe, Makoto; Watanabe, Yoko; Agathokleous, Evgenios; Eguchi, Norikazu; Takagi, Kentaro; Satoh, Fuyuki; Kitaoka, Satoshi; Funada, Ryo			Ecophysiology of deciduous trees native to Northeast Asia grown under FACE (Free Air CO2 Enrichment)	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Review						Deciduous trees; FACE; LAI; Photosynthetic adjustment; Xylem structure	ELEVATED ATMOSPHERIC CO2; ANNUAL RING STRUCTURE; CARBON-DIOXIDE; WOOD PROPERTIES; PHOTOSYNTHETIC RESPONSES; CO2-ENRICHED ATMOSPHERE; ECTOMYCORRHIZAL FUNGI; FOREST ECOSYSTEMS; SOIL FERTILITY; CLIMATE-CHANGE	We examined the effects of elevated CO2 (eCO(2)) on the growth and photosynthetic responses of deciduous trees using a Free Air CO2 Enrichment (FACE). In the FACE, photosynthesis was down-regulated in several trees but not in alder. Except alder, the leaf nitrogen concentration decreased in eCO(2). Alder underwent symbiosis with N-fixing microorganisms (Frankia sp.) in roots, which act as a sink of photosynthates. Leaves of alder had intensively been grazed by leaf beetles in eCO(2), due to the enhanced leaf N concentration; grazed leaves died later. The leaf area index was initially increased by eCO(2), but this increment minimized over time, as it was found in other FACE systems in global. The light compensation point of the light-photosynthetic curves declined, with an increase in the initial slope of the curve. In eCO(2), the stomatal conductance of most species decreased and the photosynthetic water use efficiency (PWUE) increased. We expected the eCO(2)-induced increase in the PWUE being accompanied by smaller size and density of the vessels. However, in eCO(2), the vessel size of petioles and current shoots decreased without evident anatomical changes. We conclude that the whole plant physiology must be studied in order to provide insight into further changes.	[Koike, Takayoshi; Watanabe, Yoko; Agathokleous, Evgenios; Eguchi, Norikazu; Kitaoka, Satoshi; Funada, Ryo] Hokkaido Univ, Grp Forest Resources Sci, Sapporo, Hokkaido 0608589, Japan; [Watanabe, Makoto; Funada, Ryo] Tokyo Univ Agr & Technol, Tokyo 1838509, Japan; [Watanabe, Yoko; Takagi, Kentaro; Satoh, Fuyuki; Kitaoka, Satoshi] Hokkaido Univ Forests, Sapporo, Hokkaido 0600809, Japan; [Eguchi, Norikazu] Forest Res Inst Aichi Prefecture, Shinjyo, Yamagata 4411622, Japan	Koike, T (reprint author), Hokkaido Univ, Grp Forest Resources Sci, Sapporo, Hokkaido 0608589, Japan.	tkoike@for.agr.hokudai.ac.jp	Funada, Ryo/C-2020-2013; Watanabe, Makoto/B-7464-2015	Watanabe, Makoto/0000-0003-2328-3990	JSPS [21114008, 26 292075]	Financial support was in part by Grant-in-Aid of the JSPS (Innovation Research: 21114008, Type B: 26 292075). We thank Mr. T. Ueda of DALTON Co. Ltd., for planning and maintaining FACE, Prof. Emeritus K. Sasa, Mr. K. Ichikawa of Hokkaido University Forests and Mr. T. Hayashi of Daltec. CO. Ltd. for maintaining FACE from 2002. Finally, we thank Prof. R. Oren of Duke University, Prof. Ch. Korner of The University of Basel and Dr. R. Hasler of WSL for providing us the frame idea of the FACE system. Thanks are also due to all members of our research group for their great contribution.	Agari T., 2007, T M HOKKAIDO BRANCH, V55, P56; Kobayashi T, 2006, PHYTOPATHOLOGY, V96, P425, DOI 10.1094/PHYTO-96-0425; Kostiainen K, 2014, PLANT CELL ENVIRON, V37, P1452, DOI 10.1111/pce.12261; Watanabe Y, 2010, PLANT CELL ENVIRON, V33, P1101, DOI 10.1111/j.1365-3040.2010.02132.x; Tissue DT, 1997, PLANT CELL ENVIRON, V20, P1123, DOI 10.1046/j.1365-3040.1997.d01-140.x; Hamilton JG, 2004, OECOLOGIA, V138, P566, DOI 10.1007/s00442-003-1463-5; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; TYREE MT, 1993, VEGETATIO, V104, P47, DOI 10.1007/BF00048144; Yazaki K, 2001, TREE PHYSIOL, V21, P1223; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Makino A, 1999, PLANT CELL PHYSIOL, V40, P999; Usuda H, 1998, PLANT CELL PHYSIOL, V39, P1; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Matsuki S, 2006, ANN BOT-LONDON, V97, P813, DOI 10.1093/aob/mc1041; Mccarthy HR, 2007, GLOBAL CHANGE BIOL, V13, P2479, DOI 10.1111/j.1365-2486.2007.01455.x; MCCONNAUGHAY KDM, 1993, OECOLOGIA, V94, P550, DOI 10.1007/BF00566971; ARP WJ, 1991, PLANT CELL ENVIRON, V14, P869, DOI 10.1111/j.1365-3040.1991.tb01450.x; Saxe H, 1998, NEW PHYTOL, V139, P395, DOI 10.1046/j.1469-8137.1998.00221.x; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pinkard EA, 2010, FOREST ECOL MANAG, V260, P1251, DOI 10.1016/j.foreco.2010.07.018; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Lukac M, 2010, TREE PHYSIOL, V30, P1209, DOI 10.1093/treephys/tpq040; Kostiainen K, 2008, TREE PHYSIOL, V28, P805; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Drigo B, 2008, BIOL FERT SOILS, V44, P667, DOI 10.1007/s00374-008-0277-3; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; TISSUE DT, 1987, ECOLOGY, V68, P401, DOI 10.2307/1939271; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Kostiainen K, 2009, GLOBAL CHANGE BIOL, V15, P368, DOI 10.1111/j.1365-2486.2008.01755.x; Hendrey GR, 1999, GLOB CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Wang D, 2012, OECOLOGIA, V169, P1, DOI 10.1007/s00442-011-2172-0; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; COLEMAN JS, 1993, OECOLOGIA, V93, P195, DOI 10.1007/BF00317671; Norby RJ, 2001, NEW PHYTOL, V150, P477, DOI 10.1046/j.1469-8137.2001.00099.x; ARNONE JA, 1990, NEW PHYTOL, V116, P55, DOI 10.1111/j.1469-8137.1990.tb00510.x; Bardgett R. D., 2010, OXFORD SERIES ECOLOG; Bazzaz FA, 1996, PLANTS CHANGING ENV; Choi DS, 2005, PHOTOSYNTHETICA, V43, P223, DOI 10.1007/s11099-005-0037-7; Choi DongSu, 2008, Eurasian Journal of Forest Research, V11-1, P1; Dickson R. E., 2000, NC214 USDA FOR SERV; Eguchi N, 2005, PHYTON-ANN REI BOT A, V45, P133; Eguchi N, 2008, TREE PHYSIOL, V28, P287; Eguchi N, 2008, TREES-STRUCT FUNCT, V22, P437, DOI 10.1007/s00468-007-0204-5; Eguchi N., 2008, THESIS AGR HOKK U SA; Ferreira V, 2010, GLOBAL CHANGE BIOL, V16, P3284, DOI 10.1111/j.1365-2486.2009.02153.x; Fitter A. H., 2001, ENV PHYSL PLANTS, V3rd, P367; Gartner BL, 2003, TREE PHYSIOL, V23, P387; Gough CM, 2010, FOREST ECOL MANAG, V260, P36, DOI 10.1016/j.foreco.2010.03.027; Hara Y., 2014, BOREAL FOREST RES, V62, P57; Hattenschwiler S, 2002, NEW PHYTOL, V156, P363, DOI 10.1046/j.1469-8137.2002.00537.x; Hattenschwiler S, 1996, GLOB CHANGE BIOL, V2, P377, DOI 10.1111/j.1365-2486.1996.tb00088.x; Hida T., 2006, T M HOKK BRANCH JAP, V54, P58; Hoosbeek MR, 2011, BIOGEOSCIENCES, V8, P353, DOI 10.5194/bg-8-353-2011; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; Kim Y. S., 2011, J JAPAN SOC ATMOSPHE, V46, P30; Kitao M., 2015, PLANT BIOL IN PRESS; Knepp RG, 2005, NEW PHYTOL, V167, P207, DOI 10.1111/j.1469-8137.2005.01399.x; Kobayashi K, 2001, JPN J CROP SCI, V70, P1; Koike T, 2010, ECOL STUD-ANAL SYNTH, V209, P447, DOI 10.1007/978-1-4020-9693-8_23; KOIKE T, 1995, CAN J BOT, V73, P149; Koike T, 1996, TREE PHYSIOL, V16, P381; Koike T., 1991, RES REPORT FORESTRY, V25, P1; Koike T., 2003, Eurasian Journal of Forest Research, V6-2, P177; Koike T, 2006, POPUL ECOL, V48, P23, DOI 10.1007/s10144-005-0236-x; Koike T., 1997, PLANT NUTR SUSTAINAB, P887; Koike Takayoshi, 1995, Plant Species Biology, V10, P95, DOI 10.1111/j.1442-1984.1995.tb00127.x; Koike T., 2002, EURASIAN J FOREST RE, V5, P132; Koike T, 2005, PHYTON-ANN REI BOT A, V45, P163; Koike T., 1993, 1 IGBP S JAP PROM SC, P425; Koike T., 1988, PLANT SPEC BIOL, V3, P7; KORNER C, 1992, SCIENCE, V257, P1672, DOI 10.1126/science.257.5077.1672; Kubiske ME, 2006, GLOBAL CHANGE BIOL, V12, P1054, DOI 10.1111/j.1365-2486.2006.01152.x; Lieberloo M., 2006, GLOBAL CHANGE BIOL, V12, P1094; Lindroth Richard L., 1996, P347, DOI 10.1016/B978-012420870-4/50055-4; MAKINO A, 1994, J PLANT RES, V107, P79, DOI 10.1007/BF02344533; Makino A, 1997, PLANT PHYSIOL, V115, P199; Matsuki S, 2004, ANN BOT-LONDON, V93, P141, DOI 10.1093/aob/mch022; Millett J, 2012, OECOLOGIA, V169, P541, DOI 10.1007/s00442-011-2197-4; Morii N., 2007, T M HOKK BRANCH JAPA, V55, P53; Nakamura T, 1999, PHOTOSYNTHETICA, V37, P61, DOI 10.1023/A:1007018929795; Nosberger J., 2006, MANAGED ECOSYSTEMS C; OIKAWA T, 1986, BOT MAG TOKYO, V99, P419, DOI 10.1007/BF02488720; Onoda Y, 2005, PHYTON-ANN REI BOT A, V45, P389; Osada N, 2010, OECOLOGIA, V164, P41, DOI 10.1007/s00442-010-1635-z; Osawa A, 2010, ECOL STUD-ANAL SYNTH, V209, P1, DOI 10.1007/978-1-4020-9693-8; Pepin S, 2002, OECOLOGIA, V133, P1, DOI 10.1007/s00442-002-1008-3; Qu L. Y., 2015, EURASIAN J IN PRESS; Qu LY, 2004, TREE PHYSIOL, V24, P1369; Schlesinger WH, 2006, ECOL STU AN, V187, P197; Schoonhoven L. M., 1998, PLANT INSECT BIOL PH; Schulze E., 2005, PLANT ECOLOGY; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Takeda H., 1999, DECOMPOSITION PROCES; Tatewaki M, 1958, J FAC AGR HOKKAIDO U, V50, P371; Tobita H, 2011, FUNCT PLANT BIOL, V38, P702, DOI 10.1071/FP11024; Wang X., 2014, ENVIRON POLLUT, V197, P116; Watanabe M, 2014, EUR J FOREST RES, V133, P725, DOI 10.1007/s10342-013-0744-8; Watanabe Y, 2008, TREES-STRUCT FUNCT, V22, P403, DOI 10.1007/s00468-007-0201-8; Wullschleger S. D., 2010, SCI AM, V302, P32; Yazaki K, 2005, Plant Responses to Air Pollution and Global Change, P89, DOI 10.1007/4-431-31014-2_11; Yazaki K, 2004, TREE PHYSIOL, V24, P951	111	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					174	184		10.2480/agrmet.D-14-00020		11	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000003		
J	Agathokleous, E; Koike, T; Watanabe, M; Hoshika, Y; Saitanis, CJ				Agathokleous, Evgenios; Koike, Takayoshi; Watanabe, Makoto; Hoshika, Yasutomo; Saitanis, Costas J.			Ethylene-di-urea (EDU), an effective phytoproctectant against O-3 deleterious effects and a Valuable research tool	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Review						Antiozonant; Biomonitoring tool; Ethylene-di-urea (EDU); Plant protection; Tropospheric ozone	PHASEOLUS-VULGARIS L; ELEVATED TROPOSPHERIC OZONE; POTATO SOLANUM-TUBEROSUM; LOBLOLLY-PINE SEEDLINGS; TRITICUM-AESTIVUM L.; GROUND-LEVEL OZONE; FIELD-GROWN CROPS; AMBIENT OZONE; DIUREA EDU; SODIUM ERYTHORBATE	Ground-surface ozone (O-3) has been increasing over the last decades, and it is now well known that crop and forestry plants suffer from elevated O-3 levels. Ethylene-di-urea (EDU) is considered a chemical that offers protection to the treated plants against O-3. Increasing evidence on the antiozonate efficacy of EDU against the phytotoxic action of O-3 is becoming more readily available. We aimed to review the current literatures on the EDU effects on plants, summarize the findings, note any problems, and formulate conclusions from the existing researches. EDU is a very promising antiozonant with its antiozonate action being observed when applied to roots in the concentrations of 275.7 to 374.3 mg L-1, or on leaves in the concentrations of 365.1 to 519.5 mg L-1. There is an evidence that EDU was more effective in some cultivars compared with others although this remains inexplicable. Additionally; the biochemical mechanism Of its antiozonate activity is not well understood and requires parallel toxicological studies. In summary, EDU must play an important role in O-3 research in the future.	[Agathokleous, Evgenios; Koike, Takayoshi] Hokkaido Univ, Silviculture & Forest Ecol Studies, Sapporo, Hokkaido 0608589, Japan; [Watanabe, Makoto] Tokyo Univ Agr & Technol, Inst Agr, Tokyo 1838509, Japan; [Hoshika, Yasutomo] CNR, Natl Res Council, Inst Sustainable Plant Protect IPSP, I-50019 Florence, Italy; [Saitanis, Costas J.] Agr Univ Athens, Lab Ecol & Environm Sci, GR-11855 Athens, Greece	Koike, T (reprint author), Hokkaido Univ, Silviculture & Forest Ecol Studies, Sapporo, Hokkaido 0608589, Japan.	tkoike@for.agr.hokudai.ac.jp	Watanabe, Makoto/B-7464-2015	Watanabe, Makoto/0000-0003-2328-3990	JSPS [140539, 26292075, 26660119, 24710027, 24780239]	We thank Dr. E. Paoletti of the Institute of Sustainable Plant Protection, CNR, Italy and Prof. W. J. Manning of the University of Massachusetts, MA, U.S.A. for their encouragement in the synthesis of this review. We are indebted to Dr. Rhett Loban of the Queensland University of Technology, Australia, for proofreading the manuscript. E.A. thanks the JSPS for funding (scholarship no: 140539). This study was funded by JSPS through Grant-in-Aid to T.K. (Type B: 26292075; Exploratory Research 26660119), M.W. (Young Scientists B 24710027) and Y.H. (Young Scientists B 24780239 and Postdoctoral fellowship for research abroad).	Agathokleous E, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2139-y; Agathokleous E, 2015, J AGRIC METEOROL, V71, P142, DOI 10.2480/agrmet.D-14-00008; Ahmad MN, 2013, ENVIRON POLLUT, V174, P244, DOI 10.1016/j.envpol.2012.11.029; AINSWORTH N, 1992, FOREST ECOL MANAG, V51, P129, DOI 10.1016/0378-1127(92)90479-S; Ainsworth N, 1996, AGR ECOSYST ENVIRON, V59, P33, DOI 10.1016/0167-8809(96)01043-2; Akhtar N, 2010, ENVIRON POLLUT, V158, P1763, DOI 10.1016/j.envpol.2009.11.011; Akimoto H, 2015, ATMOS ENVIRON, V102, P302, DOI 10.1016/j.atmosenv.2014.12.001; ASTORINO G, 1995, PLANT SCI, V111, P237, DOI 10.1016/0168-9452(95)04234-L; HASSAN IA, 1995, ENVIRON POLLUT, V89, P107, DOI 10.1016/0269-7491(94)00023-7; BRUNSCHONHARTI S, 1995, ENVIRON POLLUT, V90, P95, DOI 10.1016/0269-7491(94)00084-Q; Feng ZZ, 2010, ENVIRON POLLUT, V158, P3236, DOI 10.1016/j.envpol.2010.07.009; Tiwari S, 2009, CHEMOSPHERE, V75, P1492, DOI 10.1016/j.chemosphere.2009.02.034; LONG RP, 1991, ENVIRON POLLUT, V70, P241, DOI 10.1016/0269-7491(91)90012-L; Tanimoto H, 2009, ATMOS ENVIRON, V43, P1358, DOI 10.1016/j.atmosenv.2008.12.006; Agrawal SB, 2005, CHEMOSPHERE, V61, P218, DOI 10.1016/j.chemosphere.2005.01.087; Singh S, 2009, ENVIRON POLLUT, V157, P2359, DOI 10.1016/j.envpol.2009.03.029; Sachs JD, 2009, SCIENCE, V325, P1502, DOI 10.1126/science.1175035; Szantoi Z, 2007, ENVIRON POLLUT, V150, P200, DOI 10.1016/j.envpol.2007.01.020; Oksanen E, 2013, ENVIRON POLLUT, V177, P189, DOI 10.1016/j.envpol.2013.02.010; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Hoshika Y, 2013, ENVIRON POLLUT, V180, P299, DOI 10.1016/j.envpol.2013.05.041; Nagashima T, 2010, ATMOS CHEM PHYS, V10, P11305, DOI 10.5194/acp-10-11305-2010; Manning WJ, 2011, ENVIRON POLLUT, V159, P3283, DOI 10.1016/j.envpol.2011.07.005; Gatta L, 1997, ENVIRON POLLUT, V96, P445, DOI 10.1016/S0269-7491(97)00035-3; Chou CCK, 2006, ATMOS ENVIRON, V40, P3898, DOI 10.1016/j.atmosenv.2006.02.018; Manning WJ, 2003, ENVIRON POLLUT, V126, P73, DOI 10.1016/S0269-7491(03)00141-6; Paoletti E, 2008, ENVIRON POLLUT, V155, P464, DOI 10.1016/j.envpol.2008.01.040; Lee EH, 1997, ENVIRON EXP BOT, V38, P199, DOI 10.1016/S0098-8472(97)00016-6; Lal DM, 2012, ATMOS RES, V116, P82, DOI 10.1016/j.atmosres.2012.02.014; Wang XK, 2007, ENVIRON POLLUT, V148, P390, DOI 10.1016/j.envpol.2006.12.014; Emberson LD, 2001, WATER AIR SOIL POLL, V130, P107, DOI 10.1023/A:1012251503358; Paoletti E, 2009, ENVIRON POLLUT, V157, P1453, DOI 10.1016/j.envpol.2008.09.021; Potvin C, 1988, FUNCT ECOL, V2, P123, DOI 10.2307/2389472; Kleanthous S, 2014, SCI TOTAL ENVIRON, V476, P677, DOI 10.1016/j.scitotenv.2013.12.101; Baldantoni D, 2011, SCI TOTAL ENVIRON, V409, P979, DOI 10.1016/j.scitotenv.2010.11.022; BAMBAWALE OM, 1986, ATMOS ENVIRON, V20, P1501, DOI 10.1016/0004-6981(86)90022-3; BISESSAR S, 1984, ATMOS ENVIRON, V18, P1025, DOI 10.1016/0004-6981(84)90080-5; Bortier K, 2001, ENVIRON POLLUT, V111, P199, DOI 10.1016/S0269-7491(00)00075-0; BRENNAN EG, 1990, ENVIRON POLLUT, V66, P361, DOI 10.1016/0269-7491(90)90151-2; BYTNEROWICZ A, 1993, ENVIRON POLLUT, V80, P301, DOI 10.1016/0269-7491(93)90052-P; CANNON WN, 1993, FOREST ECOL MANAG, V61, P61, DOI 10.1016/0378-1127(93)90190-X; CARNAHAN JE, 1978, PHYTOPATHOLOGY, V68, P1225; CHANWAY CP, 1984, ENVIRON POLLUT A, V35, P49, DOI 10.1016/0143-1471(84)90129-6; Chen Z, 2008, J ENVIRON SCI-CHINA, V20, P320, DOI 10.1016/S1001-0742(08)60050-9; CLARKE BB, 1990, ENVIRON POLLUT, V66, P351, DOI 10.1016/0269-7491(90)90150-B; DUGGER WM, 1962, PLANT PHYSIOL, V37, P487, DOI 10.1104/pp.37.4.487; Eckardt NA, 1996, ENVIRON POLLUT, V92, P299, DOI 10.1016/0269-7491(95)00111-5; Elagoz V, 2005, ENVIRON POLLUT, V136, P385, DOI 10.1016/j.envpol.2005.01.022; ELFVING DC, 1976, B ENVIRON CONTAM TOX, V15, P336; ELLIOTT CL, 1987, ENVIRON POLLUT, V44, P61, DOI 10.1016/0269-7491(87)90129-1; Emberson LD, 2009, ATMOS ENVIRON, V43, P1945, DOI 10.1016/j.atmosenv.2009.01.005; FREEBAIRN H T, 1960, J Air Pollut Control Assoc, V10, P314; Fumagalli I, 1997, AGRONOMIE, V17, P271, DOI 10.1051/agro:19970502; Godzik B, 1998, ENVIRON POLLUT, V103, P1, DOI 10.1016/S0269-7491(98)00151-1; Izuta T., 2006, PLANTS ENV STRESSES; Kim H. J., 2008, ASIAN J ATMOSPHERIC, V2-1, P47; Kim Soyoung, 2013, Asian Journal of Atmospheric Environment, V7, P139, DOI 10.5572/ajae.2013.7.3.139; Koike T, 2013, DEV ENVIRONM SCI, V13, P371, DOI 10.1016/B978-0-08-098349-3.00017-7; Koike Takayoshi, 2012, Asian Journal of Atmospheric Environment, V6, P104; KOSTKARICK R, 1993, ENVIRON POLLUT, V82, P63, DOI 10.1016/0269-7491(93)90163-I; KOSTKARICK R, 1993, AGR ECOSYST ENVIRON, V47, P195, DOI 10.1016/0167-8809(93)90122-6; KOSTKARICK R, 1993, ENVIRON POLLUT, V80, P133, DOI 10.1016/0269-7491(93)90139-F; KOSTKARICK R, 1993, ENVIRON POLLUT, V79, P249, DOI 10.1016/0269-7491(93)90097-8; Kuehler EA, 1999, ENVIRON POLLUT, V105, P25, DOI 10.1016/S0269-7491(98)00211-5; Larcher W, 2003, PHYSL PLANT ECOLOGY; LEE EH, 1981, CHEMOSPHERE, V10, P889, DOI 10.1016/0045-6535(81)90088-6; MERSIE W, 1994, ENVIRON EXP BOT, V34, P379, DOI 10.1016/0098-8472(94)90020-5; Middleton J. T., 1950, PLANT DIS, V32, P9; MIDDLETON JT, 1953, PHYTOPATHOLOGY, V43, P588; Nakaji T., 2004, WATER AIR SOIL POLL, V4, P277, DOI 10.1023/B:WAFO.0000028360.61672.8d; Paoletti E, 2007, ENVIRON POLLUT, V145, P869, DOI 10.1016/j.envpol.2006.05.005; Pleijel H, 1999, ENVIRON POLLUT, V106, P143, DOI 10.1016/S0269-7491(99)00057-3; Rai R, 2010, ATMOS ENVIRON, V44, P4272, DOI 10.1016/j.atmosenv.2010.06.022; ROBERTS BR, 1987, ENVIRON POLLUT, V45, P81, DOI 10.1016/0269-7491(87)90050-9; Saitanis CJ, 2015, ENVIRON POLLUT, V197, P247, DOI 10.1016/j.envpol.2014.11.013; Scheepers CCW, 2010, S AFR J BOT, V76, P403, DOI 10.1016/j.sajb.2010.02.045; Singh S, 2010, J ENVIRON SCI-CHINA, V22, P1096, DOI 10.1016/S1001-0742(09)60223-0; Singh S, 2010, AGR ECOSYST ENVIRON, V138, P214, DOI 10.1016/j.agee.2010.04.020; Singh S, 2010, ECOTOX ENVIRON SAFE, V73, P1765, DOI 10.1016/j.ecoenv.2010.05.001; Szantoi Z, 2009, ENVIRON POLLUT, V157, P840, DOI 10.1016/j.envpol.2008.11.014; Tiwari S, 2005, ENVIRON POLLUT, V138, P153, DOI 10.1016/j.envpol.2005.02.008; Tiwari S, 2010, ECOTOX ENVIRON SAFE, V73, P1018, DOI 10.1016/j.ecoenv.2010.03.008; Tonneijck AEG, 1997, AGR ECOSYST ENVIRON, V65, P79, DOI 10.1016/S0167-8809(97)00058-3; Tonneijck AEG, 2002, ENVIRON EXP BOT, V48, P33, DOI 10.1016/S0098-8472(02)00007-2; Varshney CK, 1998, B ENVIRON CONTAM TOX, V61, P188; Wahid A, 2012, PAK J BOT, V44, P99; Wang YX, 2012, AGR ECOSYST ENVIRON, V150, P63, DOI 10.1016/j.agee.2012.01.016; Wang YX, 2012, FIELD CROP RES, V129, P81, DOI 10.1016/j.fcr.2012.01.019; Wat E. K. W., 1975, UREA DERIVATIVES 2 I; WEIDENSAUL TC, 1980, PHYTOPATHOLOGY, V70, P42, DOI 10.1094/Phyto-70-42; Yamaguchi Masahiro, 2011, Asian Journal of Atmospheric Environment, V5, P65; ZILINSKAS BA, 1990, ENVIRON POLLUT, V65, P241, DOI 10.1016/0269-7491(90)90086-R	92	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					185	195		10.2480/agrmet.D-14-00017		11	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000004		
J	Yamaguchi, T; Noguchi, I				Yamaguchi, Takashi; Noguchi, Izumi			Long-term trends for nitrate and sulfate ions in snowcover on Hokkaido, northern Japan	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Review						East Asia; Long range transported air pollution; Nitrogen deposition; NO3-/nss-SO42- ratio; Snowcover	NITROGEN DEPOSITION; SPECIES RICHNESS; CHINA; EMISSIONS; SULFUR; CHEMISTRY; FOG	On the island of Hokkaido in northern Japan, a survey of air pollutants in snowpack has been carried out every four years from 1988 to 2012. In this report Hokkaido was divided into four areas, and we determined the concentration and deposition of non-sea salt (nss) sulfate, ammonium and nitrate ions in each. Transported air pollution was found to have accumulated in the snowcover, especially on the Sea of Japan side (JS). The amount of nss-sulfate decreased continuously after 1988, but nitrate increased after 2000, especially in JS, from 3.7 meq m(-2) (2000) to 5.3 meq m(-2) (2012). Nitrogen deposition (nitrogen in ammonium and nitrate) was estimated at 8.9 meq m(-2) (1.2 kg N ha(-1)) in JS in 2012. The nitrate/nss-sulfate concentration ratio shows a clear increasing trend. Previous studies have found that sulfur emission in China decreased after 2006. The present result appears to reflect the change in winter emissions in northern/northeastern China.	[Yamaguchi, Takashi; Noguchi, Izumi] Hokkaido Res Org, Inst Environm Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan	Yamaguchi, T (reprint author), Hokkaido Res Org, Inst Environm Sci, Kita Ku, Kita19 Jo Nishi12 Chome, Sapporo, Hokkaido 0600819, Japan.	t-yamaguchi@hro.or.jp					Aikawa M, 2010, ATMOS ENVIRON, V44, P381, DOI 10.1016/j.atmosenv.2009.10.025; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI 10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2; Morino Y, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015205; Zhao B, 2013, ATMOS CHEM PHYS, V13, P9869, DOI 10.5194/acp-13-9869-2013; Stevens CJ, 2011, ENVIRON POLLUT, V159, P665, DOI 10.1016/j.envpol.2010.12.008; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Gu DS, 2013, ENVIRON SCI TECHNOL, V47, P12912, DOI 10.1021/es401727e; Brooks PD, 1999, HYDROL PROCESS, V13, P2177, DOI 10.1002/(SICI)1099-1085(199910)13:14/15<2177::AID-HYP850>3.3.CO;2-M; Lu Z, 2011, ATMOS CHEM PHYS, V11, P9839, DOI 10.5194/acp-11-9839-2011; Kuribayashi M, 2012, ATMOS ENVIRON, V59, P461, DOI 10.1016/j.atmosenv.2012.04.060; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Xing J, 2011, ATMOS CHEM PHYS, V11, P3119, DOI 10.5194/acp-11-3119-2011; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Itahashi S, 2014, ATMOS ENVIRON, V92, P171, DOI 10.1016/j.atmosenv.2014.04.022; Williams MW, 1996, ENVIRON SCI TECHNOL, V30, P640, DOI 10.1021/es950383e; BARRIE LA, 1985, J GEOPHYS RES-ATMOS, V90, P5789, DOI 10.1029/JD090iD03p05789; Fujita S., 2013, J JAPAN SOC ATMOSPHE, V48, P12; Igawa M, 2002, ENVIRON SCI TECHNOL, V36, P1, DOI 10.1021/es0105358; Inoue M., 2005, J AEROSOL RES, V20, P333; JOHANNESSEN M, 1978, WATER RESOUR RES, V14, P615, DOI 10.1029/WR014i004p00615; Lepori F, 2003, FRESHWATER BIOL, V48, P1873, DOI 10.1046/j.1365-2427.2003.01121.x; Nagafuchi O, 2001, WATER AIR SOIL POLL, V130, P1565, DOI 10.1023/A:1013930929517; Network Center for EANET, 2013, DAT REP AC DEP E AS; Noguchi I., 2007, WATER AIR SOIL POLL, V7, P67, DOI DOI 10.1007/S11267-006-9095-5; Noguchi I., 2005, REPORT HOKKAIDO I EN, V31, P65; Noguchi I, 2001, WATER AIR SOIL POLL, V130, P421, DOI 10.1023/A:1013893403804; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, DOI 10.1080/02693799008941549; Roth T, 2013, AGR ECOSYST ENVIRON, V178, P121, DOI 10.1016/j.agee.2013.07.002; Satoh F., 1999, Research Bulletin of the Hokkaido University Forests, V56, P1; Tomoyose N., 2009, J JAPAN SOC ATMOSPHE, V44, P117; Var F, 2000, ATMOS ENVIRON, V34, P2755, DOI 10.1016/S1352-2310(99)00353-2; Yamaguchi T, 2015, ATMOS RES, V151, P82, DOI 10.1016/j.atmosres.2014.01.023; Yamaguchi T., 2009, REPORT HOKKAIDO I EN, V35, P61	33	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					196	201		10.2480/agrmet.D-14-00056		6	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000005		
J	Komatsu, M; Yoshimura, K; Fujii, S; Yazaki, K; Tobita, H; Mizoguchi, Y; Miyama, T; Kominami, Y; Yasuda, Y; Yamanoi, K; Kitao, M				Komatsu, Masabumi; Yoshimura, Kenichi; Fujii, Saori; Yazaki, Kenichi; Tobita, Hiroyuki; Mizoguchi, Yasuko; Miyama, Takafumi; Kominami, Yuji; Yasuda, Yukio; Yamanoi, Katsumi; Kitao, Mitsutoshi			Estimation of ozone concentrations above forests using atmospheric observations at urban air pollution monitoring stations	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Air pollution monitoring station; Forests; Multiple linear regression model; NOX titration; O-3	TROPOSPHERIC OZONE; SURFACE OZONE; EAST-ASIA; IMPACT; TREES; JAPAN; NOX; SIMULATIONS; MOUNTAIN; EXPOSURE	As tropospheric ozone (O-3) concentrations over Japan are increasing, there is concern over its potential adverse effects on forest trees induced by stomatal uptake in the daytime. Although atmospheric data, including O-3 levels, have been frequently collected at air pollution monitoring stations in urban areas since the 1970s, continuous recording of O-3 concentration data above forests has been less frequent. Therefore, O-3 concentrations above forests were monitored at three flux towers in Sapporo, Appi, and Yamashiro from 2012 onwards. Furthermore, past daytime O-3 concentrations in the forests were estimated by a multiple regression model using atmospheric and meteorological data of the forests and nearby monitoring stations. The obtained daytime (sunrise to sunset) forest O-3 concentrations were positively correlated with urban O-3 concentrations, although less correlated early in the morning. In the multiple regression analysis, the model with the minimum Akaike information criterion was employed using data from 2012 and validated using data from 2013. To assess past O-3 risk, we estimated O-3 concentrations over the forests from 2000 to 2011 and calculated the cumulative exposure index AOT40 during daylight hours (>= 50 Wm(-2) global radiation). Among the three sites, AOT40 was lowest in the Sapporo forest site and did not exceed the critical level for the dominant canopy species (Betula platyphylla var. japonica and Quercus mongolica var. crispula) from 2000 to 2011. Conversely, since the dominant canopy species of the Appi forest site is Fagus crenata, categorized as a highly O-3-sensitive species, the forest of Appi was subject to AOT40 above the critical level throughout the period from 2001 to 2011. As AOT40 of Yamashiro has increased and exceeded the critical level of the dominant canopy species, Q. serrata (a moderately O-3-sensitive species), since 2006, the forest of Yamashiro might have suffered some adverse effects of O-3 exposure.	[Komatsu, Masabumi; Yoshimura, Kenichi; Yazaki, Kenichi; Tobita, Hiroyuki; Mizoguchi, Yasuko; Miyama, Takafumi; Kominami, Yuji; Yasuda, Yukio; Yamanoi, Katsumi; Kitao, Mitsutoshi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Fujii, Saori] Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan	Komatsu, M (reprint author), Forestry & Forest Prod Res Inst, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	kopine@ffpri.affrc.go.jp			Japan's Ministry of the Environment [5B-1105]	This study was conducted as part of a program of the Environment Research and Technology Development Fund (5B-1105, 2011-2013) supported by Japan's Ministry of the Environment. We greatly appreciate the provision of hourly atmospheric data by Sapporo city, Morioka city, and Kyoto prefecture.	Matyssek R, 2010, ENVIRON POLLUT, V158, P1990, DOI 10.1016/j.envpol.2009.11.033; Fares S, 2013, GLOBAL CHANGE BIOL, V19, P2427, DOI 10.1111/gcb.12222; Gerosa G, 2004, ATMOS ENVIRON, V38, P2421, DOI 10.1016/j.atmosenv.2003.12.040; Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8; Velasco E, 2008, ATMOS CHEM PHYS, V8, P3061; Kume A, 2009, ECOL RES, V24, P821, DOI 10.1007/s11284-008-0557-2; Wittig VE, 2009, GLOBAL CHANGE BIOL, V15, P396, DOI 10.1111/j.1365-2486.2008.01774.x; Pretzsch H, 2010, ENVIRON POLLUT, V158, P1061, DOI 10.1016/j.envpol.2009.07.035; Matyssek R, 2003, PROG BOT, V64, P349; Chen CL, 2002, ATMOS ENVIRON, V36, P2049, DOI 10.1016/S1352-2310(02)00086-9; Tanimoto H, 2009, ATMOS ENVIRON, V43, P1358, DOI 10.1016/j.atmosenv.2008.12.006; Stockwell WR, 1997, J GEOPHYS RES-ATMOS, V102, P25847, DOI 10.1029/97JD00849; Yasuda Y, 2012, J FOREST RES-JPN, V17, P253, DOI 10.1007/s10310-011-0298-x; Itano Y, 2007, SCI TOTAL ENVIRON, V379, P46, DOI 10.1016/j.scitotenv.2007.01.079; Nagashima T, 2010, ATMOS CHEM PHYS, V10, P11305, DOI 10.5194/acp-10-11305-2010; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Kominami Y, 2008, AGR FOREST METEOROL, V148, P723, DOI 10.1016/j.agrformet.2008.01.017; Gelman A, 2011, CH CRC HANDB MOD STA, P163; Tanimoto H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023514; Matyssek R, 2008, ENVIRON POLLUT, V156, P567, DOI 10.1016/j.envpol.2008.04.017; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; Zhang J, 1999, J APPL METEOROL, V38, P1674, DOI 10.1175/1520-0450(1999)038<1674:TROVMI>2.0.CO;2; Kitamura K, 2012, J FOREST RES-JPN, V17, P323, DOI 10.1007/s10310-012-0335-4; Aso T., 2006, J ENV LAB ASS, V31, P85; GARLAND JA, 1979, Q J ROY METEOR SOC, V105, P169; Gerosa G, 2007, ENVIRON POLLUT, V145, P629, DOI 10.1016/j.envpol.2006.02.030; Gerosa G, 2009, ENVIRON POLLUT, V157, P1737, DOI 10.1016/j.envpol.2007.11.025; Houghton J T, 2001, CLIM CHANG 2001 SCI; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Kimura F., 1991, TENKI, V38, P315; Kitao M, 2014, ENVIRON POLLUT, V184, P457, DOI 10.1016/j.envpol.2013.09.023; Kohno Y, 2005, Plant Responses to Air Pollution and Global Change, P243, DOI 10.1007/4-431-31014-2_27; Ministry of the Environment Japan, 2010, MAN CONT MON AIR POL; Mori H., 1998, ANN REPORT ENV RES C, V28, P53; Noguchi I., 2010, J JPN SOC ATMOS ENV, V45, P153; Ohara T, 2008, NATO SCI PEACE SECUR, P136, DOI 10.1007/978-1-4020-8453-9_15; Ohtani Y., 2001, P INT WORKSH ADV FLU, P129; Piikki K, 2009, ENVIRON POLLUT, V157, P3051, DOI 10.1016/j.envpol.2009.05.038; Tanighchi N., 2010, ANN REPORT KYOTO PRE, V55, P67; UNECE, 2004, MAN METH CRIT MOD MA, P266; Uno I., 2007, J DISASTER RES, V2, P163; US EPA, 1991, EPA450491013 RES TRI; US EPA, 2007, EPA454B07002 RES TRI; Wada R., 2014, MOUNT FUJI RES, V8, P33; Wakamatsu S., 1990, J JAPANESE SOC AIR P, V25, P97; WOLFF GT, 1987, JAPCA J AIR WASTE MA, V37, P45; Yamada E, 2012, BUNSEKI KAGAKU, V61, P319; Yamaji K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008663	48	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					202	210		10.2480/agrmet.D-14-00024		9	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000006		
J	Yamaguchi, M; Hoshino, D; Kondo, T; Satoh, R; Inada, H; Izuta, T				Yamaguchi, Masahiro; Hoshino, Daiki; Kondo, Taisuke; Satoh, Ryohei; Inada, Hidetoshi; Izuta, Takeshi			Evaluation of O-3 effect on net photosynthetic rate in flag leaves of rice (Oryza sativa L.) by stomatal O-3 flux and radical scavenging enzyme activities	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Net photosynthetic rate; Ozone; Radical scavenging enzymes; Rice; Stomatal ozone flux	GAS-EXCHANGE RATES; BANGLADESHI CULTIVARS; SUPEROXIDE-DISMUTASE; SPINACH-CHLOROPLASTS; HYDROGEN-PEROXIDE; OZONE RISK; REDUCTASE; YIELD; CONDUCTANCE; ASCORBATE	To evaluate the effects of O-3 on the net photosynthetic rate in flag leaves of rice (Oryza sativa L.) based on stomatal O-3 flux and reactive oxygen species (ROS) scavenging enzyme activities, the Japanese rice cultivar Koshihikari was exposed to O-3 for 1 month after heading in O-3-exposure chambers. During the exposure period, rice plants were exposed to charcoal-filtered air or O-3 at 60 or 100 nl l(-1) (ppb) daily (10:00-17:00). Light-saturated net photosynthetic rate (A(sat)) and ROS scavenging enzyme activities in the flag leaves were periodically measured during the exposure period. The O-3 exposure significantly reduced A(sat) on the 20th and 31st days after the beginning of O-3 exposure (DAB). The degree of O-3-induced reduction in A(sat) was explained by the cumulative flux of O-3 compared with concentration-based O-3 indices. The activities of ROS scavenging enzymes such as ascorbate peroxidase and catalase at 32 DAE were lower than at 1 DAB. During the latter half of the O-3 exposure period (21-31 DAE), the daily average stomatal O-3 flux was also lower than that during the first half of the period (1-20 DAB), which was mainly caused by lower photosynthetic photon flux density, lower air temperature and leaf senescence. These results suggest that the balance between stomatal O-3 flux and leaf cellular detoxification capacity in the flag leaves of rice, which determines the degree of O-3 damage, might have been similar between the first half and latter half of the O-3 exposure period.	[Yamaguchi, Masahiro; Hoshino, Daiki; Kondo, Taisuke; Satoh, Ryohei; Inada, Hidetoshi] Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo 1838509, Japan; [Izuta, Takeshi] Tokyo Univ Agr & Technol, Inst Agr, Tokyo 1838509, Japan	Izuta, T (reprint author), Tokyo Univ Agr & Technol, Inst Agr, 3-5-8 Saiwai Cho, Tokyo 1838509, Japan.	izuta@cc.tuat.ac.jp			Ministry of the Environment, Japan [C-062]	The authors acknowledge Prof. Kazuhiko Kobayashi, Dr. Isamu Nouchi and Dr. Haruto Sasaki (The University of Tokyo) for their valuable suggestions and technical support. The authors are greatly indebted to Prof. Hiroshi Hara (Tokyo University of Agriculture and Technology) for his comprehensive guidance. The authors also acknowledge Mr. Masayoshi Uchida (Tokyo University of Agriculture and Technology) for his technical support. This study was financially supported by the program of the Global Environment Research Fund (C-062) from the Ministry of the Environment, Japan.	Aebi H, 1984, METHOD ENZYMOL, V6, P105, DOI DOI 10.1016/S0076-6879(84)05016-3; Akhtar N, 2010, ENVIRON POLLUT, V158, P2970, DOI 10.1016/j.envpol.2010.05.026; Akhtar N, 2010, ENVIRON POLLUT, V158, P1763, DOI 10.1016/j.envpol.2009.11.011; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; LAISK A, 1989, PLANT PHYSIOL, V90, P1163, DOI 10.1104/pp.90.3.1163; Ryan A, 2009, PLANT CELL ENVIRON, V32, P31, DOI 10.1111/j.1365-3040.2008.01897.x; Emberson LD, 2000, ENVIRON POLLUT, V109, P393, DOI 10.1016/S0269-7491(00)00042-7; Fuhrer J, 2009, NATURWISSENSCHAFTEN, V96, P173, DOI 10.1007/s00114-008-0468-7; BARNES JD, 1992, ENVIRON EXP BOT, V32, P85, DOI 10.1016/0098-8472(92)90034-Y; Musselman RC, 2006, ATMOS ENVIRON, V40, P1869, DOI 10.1016/j.atmosenv.2005.10.064; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; ASADA K, 1973, EUR J BIOCHEM, V36, P257, DOI 10.1111/j.1432-1033.1973.tb02908.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Matyssek R, 2008, ENVIRON POLLUT, V156, P567, DOI 10.1016/j.envpol.2008.04.017; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P85; Emberson LD, 2013, ATMOS CHEM PHYS, V13, P6741, DOI 10.5194/acp-13-6741-2013; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Dizengremel P, 2009, PLANT BIOLOGY, V11, P35, DOI 10.1111/j.1438-8677.2009.00261.x; Inada Hidetoshi, 2008, Journal of Agricultural Meteorology, V64, P243; Ishihara K., 1995, SCI RICE PLANT, V2, P491; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Mills G., 2010, MAPPING MANUAL 2004; Nouchi I, 2002, AIR POLLUTION AND PLANT BIOTECHNOLOGY: PROSPECTS FOR PHYTOMONITORING AND PHYTOREMEDIATION, P3; Yamaguchi M, 2014, ENVIRON POLLUT, V184, P472, DOI 10.1016/j.envpol.2013.09.024	26	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					211	217		10.2480/agrmet.D-14-00014		7	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000007		
J	Hoshika, Y; Watanabe, M; Inada, N; Koike, T				Hoshika, Yasutomo; Watanabe, Makoto; Inada, Naoki; Koike, Takayoshi			Effects of ozone-induced stomatal closure on ozone uptake and its changes due to leaf age in sun and shade leaves of Siebold's beech	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Free-air ozone exposure; Siebold's beech; Stomatal conductance model; Stomatal ozone uptake; Sun and shade leaves	ADULT FAGUS-SYLVATICA; FREE-AIR FUMIGATION; O-3 EXPOSURE; PHOTOSYNTHETIC RESPONSES; SPRING WHEAT; CONDUCTANCE; CRENATA; CANOPY; STRESS; MODEL	An estimation of stomatal ozone uptake for the assessment of ozone risks in forest trees can be modified by ozone-induced stomatal closure. We thus examined a seasonal course of stomatal conductance in sun and shade leaves of Siebold's beech native to northern Japan (Fagus crenata) grown under free-air ozone exposure. A performance of multiplicative stomatal conductance model was also tested, when considering ozone-induced stomatal closure into the model. Ozone caused stomatal closure in both sun and shade leaves (20% and 30-40% reduction of stomatal conductance in sun and shade leaves, respectively) during early summer. However, in autumn, stomatal closure was diminished regardless of canopy positions (approximately 7% and 6% reduction of stomatal conductance in sun and shade leaves, respectively). When observed seasonal course of stomatal closure was taken into account in stomatal conductance model, the model provided a good agreement with measurements even under conditions of elevated ozone. As a result, ozone-induced stomatal closure limited stomatal ozone uptake by 11% and 17% in sun and shade leaves of Siebold's beech, respectively. In addition, stomatal ozone uptake in shade leaves under elevated ozone was much less than that in sun leaves (35% of the value in sun leaves), indicating better avoidance of ozone stress in shade leaves. Our results suggest that a loss of ozone-induced stomatal closure after ozone exposure in the late growing season should be considered in modeling stomatal ozone uptake for the assessment of ozone impacts on Siebold's beech.	[Hoshika, Yasutomo; Inada, Naoki; Koike, Takayoshi] Hokkaido Univ, Silviculture & Forest Ecol Studies, Sapporo, Hokkaido 0608589, Japan; [Watanabe, Makoto] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838509, Japan	Koike, T (reprint author), Hokkaido Univ, Silviculture & Forest Ecol Studies, Sapporo, Hokkaido 0608589, Japan.	tkoike@for.agr.hokudai.ac.jp	Watanabe, Makoto/B-7464-2015; 	Watanabe, Makoto/0000-0003-2328-3990; Hoshika, Yasutomo/0000-0002-5263-2945	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [B-1105]; Japan Society for the Promotion of Science [23380078, 26292075, 15K16136, 24780239]	This study was supported partly by the Environment Research and Technology Development Fund (B-1105) of the Ministry of the Environment, Japan, and a Grant in Aid from the Japan Society for the Promotion of Science through its Type B program (to T. Koike, 23380078 and 26292075), Young Scientists B (to M. Watanabe, 15K16136 and to Y. Hoshika, 24780239) and Young Scientists for research abroad (to Y. Hoshika).	Emberson LD, 2000, ENVIRON POLLUT, V109, P403, DOI 10.1016/S0269-7491(00)00043-9; Kitao M, 2009, ENVIRON POLLUT, V157, P537, DOI 10.1016/j.envpol.2008.09.016; Paoletti E, 2005, ENVIRON POLLUT, V134, P439, DOI 10.1016/j.envpol.2004.09.011; Hoshika Y, 2015, ENVIRON POLLUT, V196, P527, DOI 10.1016/j.envpol.2014.07.034; Danielsson H, 2003, ATMOS ENVIRON, V37, P475, DOI 10.1016/S1352-2310(02)00924-X; Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Reich PB, 1987, TREE PHYSIOL, V3, P63; Watanabe M, 2013, ENVIRON POLLUT, V174, P50, DOI 10.1016/j.envpol.2012.11.006; GRUTERS U, 1995, ENVIRON POLLUT, V87, P141, DOI 10.1016/0269-7491(94)P2600-E; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Pleijel H, 2002, EUR J AGRON, V17, P303, DOI 10.1016/S1161-0301(02)00068-0; Low M, 2007, PLANT BIOLOGY, V9, P197, DOI 10.1055/s-2006-924656; Matyssek R, 2003, PROG BOT, V64, P349; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Elvira S, 2007, ENVIRON POLLUT, V146, P617, DOI 10.1016/j.envpol.2006.08.008; Alonso R, 2008, ENVIRON POLLUT, V155, P473, DOI 10.1016/j.envpol.2008.01.032; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Matyssek R, 2015, ENVIRON POLLUT, V196, P518, DOI 10.1016/j.envpol.2014.06.029; Hoshika Y, 2012, ENVIRON POLLUT, V166, P152, DOI 10.1016/j.envpol.2012.03.013; Kitao M, 2012, ENVIRON POLLUT, V166, P108, DOI 10.1016/j.envpol.2012.03.014; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; Matyssek R, 2010, ENVIRON POLLUT, V158, P2527, DOI 10.1016/j.envpol.2010.05.009; ASADA K., 1996, PHOTOSYNTHESIS ENV, V5, P123, DOI [10.1007/0-306-48135-9_5, DOI 10.1007/0-306-48135-9_5]; FARAGE PK, 1995, PHOTOSYNTH RES, V43, P11, DOI 10.1007/BF00029457; Haberer K, 2007, PLANT BIOLOGY, V9, P215, DOI 10.1055/s-2007-964824; Hoshika Y, 2013, ANN BOT-LONDON, V112, P1149, DOI 10.1093/aob/mct166; Hoshika Y, 2012, WATER AIR SOIL POLL, V223, P3893, DOI 10.1007/s11270-012-1158-9; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Karriosky D., 2003, AIR POLLUTION GLOBAL; Kohno Y, 2005, Plant Responses to Air Pollution and Global Change, P243, DOI 10.1007/4-431-31014-2_27; Koike T., 1988, PLANT SPEC BIOL, V3, P77, DOI 10.1111/j.1442-1984.1988.tb00173.x; MCNAUGHTON KG, 1995, BOUND-LAY METEOROL, V74, P261, DOI 10.1007/BF00712121; Mills G, 2009, GLOBAL CHANGE BIOL, V15, P1522, DOI 10.1111/j.1365-2486.2008.01798.x; Mills G., 2010, MAPPING MANUAL 2004; Ohara Toshimasa, 2011, Japanese Journal of Ecology (Otsu), V61, P77; Oksanen E, 2003, PLANT CELL ENVIRON, V26, P875, DOI 10.1046/j.1365-3040.2003.01020.x; Omasa K., 2002, AIR POLLUTION PLANT; Onandia G, 2011, ENVIRON POLLUT, V159, P2350, DOI 10.1016/j.envpol.2011.06.001; Oue Hiroki, 2008, Journal of Agricultural Meteorology, V64, P223; Oue Hiroki, 2009, Journal of Agricultural Meteorology, V65, P239; Paoletti E, 2005, ENVIRON POLLUT, V137, P483, DOI 10.1016/j.envpol.2005.01.035; Pons T. L., 2008, PLANT PHYSL ECOLOGY; REICH PB, 1984, PLANT CELL ENVIRON, V7, P661; Watanabe M, 2014, ENVIRON POLLUT, V184, P682, DOI 10.1016/j.envpol.2013.04.018; Watanabe M, 2012, EUR J FOREST RES, V131, P475, DOI 10.1007/s10342-011-0521-5; Watanabe M, 2014, J PLANT RES, V127, P339, DOI 10.1007/s10265-013-0622-y; Watanabe M, 2010, EUR J FOREST RES, V129, P421, DOI 10.1007/s10342-009-0316-0; Werner H, 2002, ENVIRON SCI POLLUT R, V9, P117, DOI 10.1007/BF02987458; Yamaguchi M, 2007, TREES-STRUCT FUNCT, V21, P707, DOI 10.1007/s00468-007-0163-x; Yamaji K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008663	51	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					218	226		10.2480/agrmet.D-14-00013		9	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000008		
J	Watanabe, M; Hoshika, Y; Inada, N; Koike, T				Watanabe, Makoto; Hoshika, Yasutomo; Inada, Naoki; Koike, Takayoshi			Difference in photosynthetic responses to free air ozone fumigation between upper and lower canopy leaves of Japanese oak (Quercus mongolica var. crispula) saplings	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Free air ozone exposure; Japanese Oak; Light condition; Photosynthesis; Sensitivity to ozone	BEECH FAGUS-CRENATA; SIEBOLDS BEECH; STOMATAL SLUGGISHNESS; EXPOSURE; TREES; STRESS	To clarify the difference of ozone (O-3) sensitivity of photosynthesis in leaves located different canopy positions, we investigated photosynthetic responses of Japanese oak saplings to free air O-3 exposure, and compared the results with Siebold's beech saplings reported previously. The O-3 at 60 nmol mol(-1) during daytime was fumigated for two growing seasons, from 6 August to 11 November 2011 and from 17 May to 10 November 2012. In June, August and October of 2012, we determined photosynthetic activity of upper and lower canopy leaves. The exposure to O-3 increased the ratio of intercellular CO2 concentration to ambient CO2 concentration in October, indicating stomatal sluggishness. We observed an O-3-induced, significant decrease in light-saturated net photosynthetic rate (A(sat)) with no significant interaction between O-3 effect and canopy position for A(sat). Therefore, we conclude that the O-3 sensitivity of photosynthesis in upper and lower canopy leaves was similar in Japanese oak, while our previous study reported that the upper canopy leaves of Siebold's beech have a higher O-3 sensitivity than lower canopy leaves.	[Watanabe, Makoto] Tokyo Univ Agr & Technol, Inst Agr, Tokyo 1838509, Japan; [Hoshika, Yasutomo; Inada, Naoki; Koike, Takayoshi] Hokkaido Univ, Silviculture & Forest Ecol Studies, Sapporo, Hokkaido 0608589, Japan; [Hoshika, Yasutomo] Natl Res Council Italy, Inst Sustainable Plant Protect, I-50019 Sesto Fiorentino, Italy	Koike, T (reprint author), Hokkaido Univ, Silviculture & Forest Ecol Studies, Sapporo, Hokkaido 0608589, Japan.	tkoike@for.agr.hokudai.ac.jp	Watanabe, Makoto/B-7464-2015; 	Watanabe, Makoto/0000-0003-2328-3990; Hoshika, Yasutomo/0000-0002-5263-2945	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [B-1105]; Japan Society for the Promotion of Science [23380078, 26292075, 24710027, 15K16136, 24780239]	This study was supported by the Environment Research and Technology Development Fund (B-1105) of the Ministry of the Environment, Japan (grant to T. Koike), and a Grant-in-Aid from the Japan Society for the Promotion of Science through its Type B program (to T. Koike, 23380078 and 26292075), Young Scientists B (to M. Watanabe, 24710027 and 15K16136, and to Y. Hoshika, 24780239) and Young Scientists for research abroad (to Y. Hoshika). We appriciate for relevant suggestions and comments from the editor and anonymous two reviewers, which helped us to improve the manuscript.	Kitao M, 2009, ENVIRON POLLUT, V157, P537, DOI 10.1016/j.envpol.2008.09.016; Watanabe M, 2013, ENVIRON POLLUT, V174, P50, DOI 10.1016/j.envpol.2012.11.006; Matyssek R, 2003, PROG BOT, V64, P349; TJOELKER MG, 1995, PLANT CELL ENVIRON, V18, P895, DOI 10.1111/j.1365-3040.1995.tb00598.x; Paoletti E, 2010, ENVIRON POLLUT, V158, P2664, DOI 10.1016/j.envpol.2010.04.024; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Hoshika Y, 2012, ENVIRON POLLUT, V166, P152, DOI 10.1016/j.envpol.2012.03.013; Erzyzanowski J., 2004, ATMOS ENVIRON, V38, P5957; Hoshika Y, 2013, ANN BOT-LONDON, V112, P1149, DOI 10.1093/aob/mct166; Hoshika Y, 2012, WATER AIR SOIL POLL, V223, P3893, DOI 10.1007/s11270-012-1158-9; Kitaoka S, 2009, LANDSC ECOL ENG, V5, P137, DOI 10.1007/s11355-009-0070-y; Kohno Y, 2005, Plant Responses to Air Pollution and Global Change, P243, DOI 10.1007/4-431-31014-2_27; Koike T, 2013, DEV ENVIRONM SCI, V13, P371, DOI 10.1016/B978-0-08-098349-3.00017-7; Koike T., 1988, PLANT SPEC BIOL, V3, P77, DOI 10.1111/j.1442-1984.1988.tb00173.x; Patterson MC, 2000, ENVIRON POLLUT, V110, P225, DOI 10.1016/S0269-7491(99)00303-6; Pons T. L., 2008, PLANT PHYSL ECOLOGY; R Development Core Team, 2012, R LANG ENV STAT COMP; The Royal Society, 2008, 1508 ROYAL SOC; TJOELKER MG, 1993, NEW PHYTOL, V124, P627, DOI 10.1111/j.1469-8137.1993.tb03852.x; Watanabe M, 2014, ENVIRON POLLUT, V184, P682, DOI 10.1016/j.envpol.2013.04.018; Watanabe M, 2010, EUR J FOREST RES, V129, P421, DOI 10.1007/s10342-009-0316-0; Watanabe S., 1994, TREES SOCIOLOGY NATU; Yamaji K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008663	24	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					227	231		10.2480/agrmet.D-14-00012		5	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000009		
J	Ji, DH; Mao, QZ; Watanabe, Y; Kitao, M; Kitaoka, S				Ji, Dong Hun; Mao, QiaoZhi; Watanabe, Yoko; Kitao, Mitsutoshi; Kitaoka, Satoshi			Effect of nitrogen loading on the growth and photosynthetic responses of Japanese larch seedlings grown under different light regimes	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Light demanding conifer; Nitrogen allocation; Needle anatomy	LEAF NITROGEN; GAS-EXCHANGE; C-3 PLANTS; LEAVES; ACCLIMATION; FOREST; CO2; LIMITATIONS; ANATOMY; PLANTATIONS	We determined the effects of nitrogen (N) loading (35 kg N ha(-1) y(-1)) on the needle morphological and photosynthetic traits of 4-year-old seedlings of Japanese larch (Larix kaempferi) under different three light intensities (open, 50% and 20% light) to evaluate how they adjust to low light conditions. Nitrogen deposition in forests has been increasing in East Asia. Although Japanese larch is not native to Hokkaido, northern Japan, this light demanding tree species is now a promising forestation species and reaches to the age of bearing cones for regeneration. Forest gaps affects the success in regeneration. This light-demanding tree is a promising reforestation species, but its success at natural regeneration depends on the availability of light. The net photosynthetic rate at light saturation (P-sat) decreased with increasing shading. Nitrogen addition increased P-sat in unshaded seedlings but not in 50% and 20% light seedlings. Independent of added N, photosynthetic adjustment to the light environment was regulated by the allocation of N between rubisco and light-harvesting proteins. P-sat in full sun was higher with N than without; the difference would be related to changes of stomatal limitation (Ls). With added N, larch seedlings in shade may store extra N in rubisco. Therefore, though Japanese larch is light demanding conifer, at the N level used in this study, shaded Japanese larch seedlings can regenerate in forest floor.	[Ji, Dong Hun; Mao, QiaoZhi; Watanabe, Yoko] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Kitao, Mitsutoshi; Kitaoka, Satoshi] FFPRI, Hokkaido Branch Ctr, Sapporo, Hokkaido 0620045, Japan; [Kitao, Mitsutoshi; Kitaoka, Satoshi] FFPRI, Tsukuba, Ibaraki 3508687, Japan	Kitaoka, S (reprint author), FFPRI, Hokkaido Branch Ctr, Sapporo, Hokkaido 0620045, Japan.	skitaoka3104@gmail.com			Japan Society of Promotion Science [21114008, 06J00993]; Environment Research and Technology Development Fund of the Ministry of the Environment [1-1401]	The Authors are grateful to Professor T. Koike (Hokkaido University), Professor J.S. Yi (Kangwon National University) and Dr. H. Utsugi (FFPRI) for their support and suggestions in this study. S.K. is also grateful to Drs. K. Okabe and T. Sato (FFPRI) for their kind support. Financial support in the form of a Grant-in-Aid from Japan Society of Promotion Science (Innovation research: 21114008 to T. Koike, Hokkaido University, and Research fellowship for young scientist: 06J00993 to S.K.) and by the Environment Research and Technology Development Fund of the Ministry of the Environment (1-1401 to K. Okabe, FFPRI) is gratefully acknowledged.	Onoda Y, 2005, J EXP BOT, V56, P755, DOI 10.1093/jxb/eri052; HIKOSAKA K, 1995, PLANT CELL ENVIRON, V18, P605, DOI 10.1111/j.1365-3040.1995.tb00562.x; Wilson KB, 2000, TREE PHYSIOL, V20, P565; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Kitaoka S, 2005, TREE PHYSIOL, V25, P467; Evans JR, 1999, NEW PHYTOL, V143, P93, DOI 10.1046/j.1469-8137.1999.00440.x; FANGMEIER A, 1994, ENVIRON POLLUT, V86, P43, DOI 10.1016/0269-7491(94)90008-6; Warren CR, 2001, PLANT CELL ENVIRON, V24, P597, DOI 10.1046/j.1365-3040.2001.00711.x; Takashima T, 2004, PLANT CELL ENVIRON, V27, P1047, DOI 10.1111/j.1365-3040.2004.01209.x; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; KOIKE T, 1990, TREE PHYSIOL, V7, P21; Son Y, 2000, J PLANT NUTR, V23, P697, DOI 10.1080/01904160009382051; SHARKEY TD, 1985, BOT REV, V51, P53, DOI 10.1007/BF02861058; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Niinemets U, 2007, TREE PHYSIOL, V27, P1137; Sase H, 2008, ENVIRON POLLUT, V152, P1, DOI 10.1016/j.envpol.2007.06.023; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; Bondada BR, 2003, TREE PHYSIOL, V23, P553; Eguchi N, 2004, PHOTOSYNTHETICA, V42, P173, DOI 10.1023/B:PHOT.0000040587.99518.a8; estak Z., 1985, PHOTOSYNTHESIS LEAF, P352; Evans JR, 1989, PHOTOSYNTHESIS, P183; Frak E, 2001, PLANT CELL ENVIRON, V24, P1279, DOI 10.1046/j.0016-8025.2001.00784.x; Igarashi T., 1987, Research Bulletins of the College Experiment Forests, Hokkaido University, V44, P1019; Izuta T., 2006, PLANTS ENV STRESSES, P232; Ji D. H., 2004, IUFRO WORKSH GROWTH, P41; Kitaoka S., 2001, P INT WORKSH ADV FLU, P109; Kitaoka S, 2004, PHYSIOL PLANTARUM, V121, P604, DOI 10.1111/j.1399-3054.2004.00359.x; Koike T., 1993, RES REPORT FFPRI SAP, V25, P1; Koike T., 2000, RES NOTE FAC FORESTR, V92, P49; Lambers H., 1998, PLANT PHYSL ECOLOGY, P540; Larcher W, 2003, PHYSL PLANT ECOLOGY, P513; MAKINO A, 1994, PLANT PHYSIOL, V105, P173; Makoto K, 2007, PHOTOSYNTHETICA, V45, P99, DOI 10.1007/s11099-007-0015-3; Mao QZ, 2014, LANDSC ECOL ENG, V10, P1, DOI 10.1007/s11355-012-0207-2; Niinemets U., 1997, PLANT CELL ENVIRON, V20, P845; Ogawa A, 2006, HYDROL PROCESS, V20, P251, DOI 10.1002/hyp.5901; Qu L. Y., 2005, EURASIAN J FOR RES, V8, P43; Ryu K, 2009, LANDSC ECOL ENG, V5, P99, DOI 10.1007/s11355-009-0063-x; SAS Institute Inc, 2003, STAT GRAPH GUID VER; Schulze E. D., 2005, PLANT ECOL, P700; Shinano T, 1996, PHOTOSYNTHETICA, V32, P409; Slaton MR, 2002, INT J PLANT SCI, V163, P937, DOI 10.1086/342517; TERASHIMA I, 1992, PHOTOSYNTH RES, V31, P195, DOI 10.1007/BF00035537; Tissue DT, 2005, TREE PHYSIOL, V25, P447; Wang WJ, 2009, LANDSC ECOL ENG, V5, P147, DOI 10.1007/s11355-009-0066-7	46	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					232	238		10.2480/agrmet.D-14-00027		7	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000010		
J	Dong-Gyu, K; Shi, C; Watanabe, M; Kita, K; Satoh, F; Koike, T				Dong-Gyu, Kam; Shi, Cong; Watanabe, Makoto; Kita, Kazuhito; Satoh, Fuyuki; Koike, Takayoshi			Growth of Japanese and hybrid larch seedlings grown under free-air O-3 fumigation-an initial assessment of the effects of adequate and excessive nitrogen	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Ground surface ozone; Hybrid larch F-1; Japanese larch; Nitrogen deposition; Re-translocation	PHOTOSYNTHETIC TRAITS; SIEBOLDS BEECH; ELEVATED CO2; OZONE; DEPOSITION; KAEMPFERI; TRENDS; IMPACT; LEAVES	Ground-surface ozone (O-3) and nitrogen (N) deposition in forests are increasing rapidly in East Asia. The Japanese larch (JL) has been transplanted from central Japan to northern areas. Because the JL suffers from shoot blight disease and grazing by voles, the hybrid larch (F-1) was developed to overcome these weak points. For sustainable use of these larches, we should know the growth responses of larches to elevated O-3 (eO(3)) and excessive N deposition in northern Japan. Two-year-old JL and F-1 seedlings were potted in well-weathered immature volcanic ash soil with basal dressing of balanced fertilizer containing 47 kgN ha(-1) yr(-1), due to a lack of nutrients in the soil. To simulate eO(3), seedlings were grown in a free-air O-3 fumigation system (60 nmol mol(-1) in daytime). Also, to simulate acid rain, NH4NO3 (50 kgN ha(-1) yr(-1) in total) was applied to the plants. Independent of the N loading, the dry mass of needle litter in both JL and F-1 was less at eO(3) than at ambient O-3. Re-translocation of N before the needle shedding of both larches was lower under eO(3). As a result, the aboveground biomass per needle (i.e. productive efficiency) was higher at eO(3).	[Dong-Gyu, Kam; Shi, Cong] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Watanabe, Makoto] Tokyo Univ Agr & Technol, Tokyo 1838509, Japan; [Kita, Kazuhito] Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan; [Satoh, Fuyuki] Hokkaido Univ Forests, Sapporo, Hokkaido 0600809, Japan; [Koike, Takayoshi] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Koike, T (reprint author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan.	tkoike@for.agr.hokudai.ac.jp	Watanabe, Makoto/B-7464-2015	Watanabe, Makoto/0000-0003-2328-3990	Earth Environmental Research Fund of the Ministry of Environment of Japan [B1105]; JSPS fund [26292075, 15K16136]	This study was partly supported by the Earth Environmental Research Fund of the Ministry of Environment (B1105) of Japan, and a Grant-in-aid from the JSPS fund (Type B: 26292075, Young Scientists B: 15K16136). We thank to Mr. T. Ueda of DALTON Co. LTD for planning and maintaining our free air O<INF>3</INF> fumigation system and Dr. T. Nakaji in FSC Hokkaido University for NC analysis in the needles. Thanks are also due to Dr. Anthony Garrett of SCITEXT of Cambridge, UK for the intensive English proofreading, and Mr. E. Agatholdeous of JSPS fellow for discussion.	ADORC (Acid Deposition and Oxidant Research Center), 2006, TROP OZ GROW THREAT; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Watanabe M, 2013, ENVIRON POLLUT, V174, P50, DOI 10.1016/j.envpol.2012.11.006; Matyssek R, 2003, PROG BOT, V64, P349; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Karnosky DF, 2003, FUNCT ECOL, V17, P289, DOI 10.1046/j.1365-2435.2003.00733.x; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Hoshika Y, 2013, ANN BOT-LONDON, V112, P1149, DOI 10.1093/aob/mct166; Izuta T., 2006, PLANTS ENV STRESSES; Izuta Takeshi, 2005, Journal of Agricultural Meteorology, V60, P1125; Japanese Forestry Agency, 2010, FOR WHIT PAP; Kikuzawa K, 2011, ECOL RES MONOGR, P1; Kimura SD, 2009, WATER AIR SOIL POLL, V202, P369, DOI 10.1007/s11270-009-9983-1; Kita K, 2009, J WOOD SCI, V55, P425, DOI 10.1007/s10086-009-1064-y; Koike Takayoshi, 2012, Asian Journal of Atmospheric Environment, V6, P104; Koike T., 1992, RES PHOTOSYNTHESIS, V4, P703; Lambers H., 2008, PLANT PHYSL ECOLOGY, V2nd, P321, DOI 10.1007/978-0-387-78341-3_10; Mao QZ, 2012, PHOTOSYNTHETICA, V50, P422, DOI 10.1007/s11099-012-0049-z; Mao QZ, 2014, LANDSC ECOL ENG, V10, P1, DOI 10.1007/s11355-012-0207-2; Ryu K, 2009, LANDSC ECOL ENG, V5, P99, DOI 10.1007/s11355-009-0063-x; Schluze E-D., 2005, PLANT ECOL, P438; Uddling J, 2006, TREE PHYSIOL, V26, P113; Watanabe M, 2012, ENVIRON EXP BOT, V83, P73, DOI 10.1016/j.envexpbot.2012.04.011; Watanabe Makoto, 2011, Japanese Journal of Ecology (Otsu), V61, P89; Watanabe M, 2011, TREE PHYSIOL, V31, P965, DOI 10.1093/treephys/tpr059; Watanabe M, 2006, J JPN SOC ATMOS ENV, V41, P320	30	0	0	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	SEP	2015	71	3					239	244		10.2480/agrmet.D-14-00029		6	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	CR5WL	WOS:000361415000011		
J	Tanaka, Y				Tanaka, Yoshiya			Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside	JOURNAL OF BIOCHEMISTRY			English	Review						DMARD; JAK inhibitor; remission; rheumatoid arthritis	MODIFYING ANTIRHEUMATIC DRUGS; TOFACITINIB CP-690,550; INADEQUATE RESPONSE; ALLOGRAFT-REJECTION; AUTOIMMUNE-DISEASES; KINASE INHIBITORS; TYROSINE KINASE; JANUS KINASES; METHOTREXATE; ADALIMUMAB	Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by synovial inflammation and joint destruction. However, the combined use of synthetic disease-modifying anti-rheumatic drug (DMARD) such as methotrexate and a biological DMARD targeting tumour necrosis factor (TNF) has revolutionized treatment of RA. Clinical remission is a realistic target to treat and the maintenance of remission has produced significant improvements in structural and function outcomes. However, biological DMARDs are limited to intravenous or subcutaneous uses and orally available small but strong products have been developed. The multiple cytokines and cell surface molecules bind to receptors, resulting in the activation of various signalling, including phosphorylation of kinase proteins. Among multiple kinases, Janus kinase (JAK) plays pivotal roles in the pathological processes of RA. Tofacitinib, a small product targeting JAK, inhibits phosphorylation of JAK1 and JAK3, subsequent Stat1 and expression of Stat1-inducible genes, which contribute to efficient propagation of its anti-inflammatory effects for the treatment of RA. The primary targets of tofacitinib are dendritic cells, CD4(+) T cells such as Th1 and Th17 and activated B cells which leads to multi-cytokine targeting. Six global phase 3 studies revealed that oral administration of 5 or 10 mg tofacitinib was significantly effective than placebo with or without methotrexate in active RA patients with methotrexate-na < ve, inadequately responsive to methotrexate or TNF-inhibitors. Therapeutic efficacy of tofacitinib was observed in a short term after administration and was as strong as adalimumab, a TNF-inhibitor. The most commonly observed adverse events were related to infection, hematologic, hepatic and renal disorders and association of tofacitinib with carcinogenicity and infections remains debated. Further investigation on post-marketing survey would help us understand the positioning of this drug.	Univ Occupat & Environm Hlth Japan, Dept Internal Med 1, Sch Med, Kitakyushu, Fukuoka 8078555, Japan	Tanaka, Y (reprint author), Univ Occupat & Environm Hlth Japan, Dept Internal Med 1, Sch Med, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; University of Occupational and Environmental Health, Japan through UOEH	This work was supported in part by a Grant-In-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the University of Occupational and Environmental Health, Japan, through UOEH Grant for Advanced Research.	Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; Keystone EC, 2015, ANN RHEUM DIS, V74, P333, DOI 10.1136/annrheumdis-2014-206478; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Williams NK, 2009, J MOL BIOL, V387, P219, DOI 10.1016/j.jmb.2009.01.041; Borie DC, 2005, TRANSPLANTATION, V80, P1756, DOI 10.1097/01.tp.0000184634.25042.ea; Tanaka Y, 2011, ARTHRIT CARE RES, V63, P1150, DOI 10.1002/acr.20494; Kontzias A, 2012, CURR OPIN PHARMACOL, V12, P464, DOI 10.1016/j.coph.2012.06.008; O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576; Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006; Burmester GR, 2015, ANN RHEUM DIS, V74, P1037, DOI 10.1136/annrheumdis-2013-204769; Furst DE, 2014, RHEUMATOLOGY, V53, P1560, DOI 10.1093/rheumatology/ket414; Kubo S, 2014, ANN RHEUM DIS, V73, P2192, DOI 10.1136/annrheumdis-2013-203756; Maeshima K, 2012, ARTHRITIS RHEUM-US, V64, P1790, DOI 10.1002/art.34329; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Rousvoal G, 2006, TRANSPLANT INT, V19, P1014, DOI 10.1111/j.1432-2277.2006.00387.x; Sonomoto K, 2014, RHEUMATOLOGY, V53, P914, DOI 10.1093/rheumatology/ket466; Swanson CD, 2009, NAT REV RHEUMATOL, V5, P317, DOI 10.1038/nrrheum.2009.82; Tanaka Y, 2013, MOD RHEUMATOL, V23, P415, DOI 10.1007/s10165-012-0799-2; Walker JG, 2007, ANN RHEUM DIS, V66, P992, DOI 10.1136/ard.2006.060822; Wang SP, 2015, RHEUMATOLOGY, V54, P1488, DOI 10.1093/rheumatology/keu532	31	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					173	179		10.1093/jb/mvv069		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900001		
J	Song, J; Hong, HR; Yamashita, E; Park, IY; Lee, SJ				Song, Jinsue; Hong, Hye Rim; Yamashita, Eiki; Park, Il Yeong; Lee, Soo Jae			Low pH-driven folding of WW45-SARAH domain leads to stabilization of the WW45-Mst2 complex	JOURNAL OF BIOCHEMISTRY			English	Article						Hippo pathway; low-pH stabilization; refolding; SARAH domain; WW45	HIPPO SIGNALING PATHWAY; MST2 SARAH DOMAIN; COILED-COIL; CELL-PROLIFERATION; STRUCTURAL BASIS; DROSOPHILA; CRYSTALLIZATION; STABILITY; APOPTOSIS; PROTEINS	The scaffolding protein Salvador (Sav) plays a key role in the Hippo (Hpo) signalling pathway, which controls tissue growth by inhibiting cell proliferation and promoting apoptosis. Dysregulation of the Hippo pathway contributes to cancer development. Since the identification of the first Sav gene in 2002, very little is known regarding the molecular basis of Sav-SARAH mediating interactions due to its insolubility. In this study, refolding of the first Sav (known as WW45)-SARAH provided insight into the biochemical and biophysical properties, indicating that WW45-SARAH exhibits properties of a disordered protein, when the domain was refolded at a neutral pH. Interestingly, WW45-SARAH shows folded and rigid conformations relative to the decrease in pH. Further, diffracting crystals were obtained from protein refolded under acidic pH, suggesting that the refolded WW45 protein at low pH has a homogeneous and stable conformation. A comparative analysis of molecular properties found that the acidic-stable fold of WW45-SARAH enhances a heterotypic interaction with Mst2-SARAH. In addition, using an Mst2 mutation that disrupts homotypic dimerization, we showed that the monomeric Mst2-SARAH domain could form a stable complex of 1:1 stoichiometric ratio with WW45 refolded under acidic pH.	[Song, Jinsue; Hong, Hye Rim; Park, Il Yeong; Lee, Soo Jae] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, Chungbuk, South Korea; [Yamashita, Eiki] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Lee, SJ (reprint author), Chungbuk Natl Univ, Coll Pharm, 410 Seungbong, Cheongju 361763, Chungbuk, South Korea.	sjlee@chungbuk.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MEST) [2008-0062275, 2011-0017405]; Chungbuk National University	This research was supported by a National Research Foundation of Korea (NRF) grant, funded by the Korea government (MEST) (2008-0062275, 2011-0017405), and research grant from Chungbuk National University in 2011 to L.S.J.	Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801; Liu GG, 2014, J STRUCT BIOL, V185, P366, DOI 10.1016/j.jsb.2014.01.008; Ni LS, 2013, STRUCTURE, V21, P1757, DOI 10.1016/j.str.2013.07.008; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Hwang E, 2014, ACTA CRYSTALLOGR D, V70, P1944, DOI 10.1107/S139900471400947X; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Peteranderl R, 1999, BIOCHEMISTRY-US, V38, P3559, DOI 10.1021/bi981774j; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Park SY, 2012, J BIOL CHEM, V287, P11261, DOI 10.1074/jbc.M111.310953; Makbul C, 2013, BIOCHEMISTRY-US, V52, P1045, DOI 10.1021/bi3014642; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Bonnete F, 2002, ACTA CRYSTALLOGR D, V58, P1571, DOI 10.1107/S090744490201418X; Di Russo NV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002761; Guthrie C., 1991, GUIDE YEAST GENETICS; Hauri S, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304750; Michielsen ECHJ, 2006, CLIN CHEM LAB MED, V44, P1422, DOI 10.1515/CCLM.2006.265; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pfeifer GP, 2010, CURR BIOL, V20, pR344, DOI 10.1016/j.cub.2010.02.019; Picotti P, 2009, FEBS J, V276, P7027, DOI 10.1111/j.1742-4658.2009.07416.x; Schmitz K., 1990, INTRO DYNAMIC LIGHT; Song J, 2011, ACTA CRYSTALLOGR F, V67, P1403, DOI 10.1107/S1744309111033823; Wu D, 2013, BIOCHEM BIOPH RES CO, V433, P538, DOI 10.1016/j.bbrc.2013.03.023	31	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					181	188		10.1093/jb/mvv031		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900002		
J	Tsutsui, S; Yamamura, N; Yoshida, T; Nakamura, O				Tsutsui, Shigeyuki; Yamamura, Nozomi; Yoshida, Takaya; Nakamura, Osamu			Fugu (Takifugu rubripes) serum GlcNAc-binding lectin is a kalliklectin but has different properties from those of a reported homologue	JOURNAL OF BIOCHEMISTRY			English	Article						Fugu Takifugu rubripes; GlcNAc; lectin	SPERM-EGG BINDING; CARBOHYDRATE-RECOGNITION; PURIFICATION; FISH	A 40-kDa lectin with N-acetyl-d-glucosamine-binding ability was purified from the sera of fugu (Takifugu rubripes) by affinity chromatography and subsequent gel filtration. N-terminal amino acid sequencing, in silico cloning using the fugu genome database and cDNA cloning demonstrated that this lectin is a homologue of kalliklectin, a novel lectin that was previously found in the flathead teleost Platycephalus indicus and has structural similarity to mammalian plasma kallikreins and coagulation factor XI. This is the second report of a kalliklectin, but the fugu kalliklectin differs in its sugar-binding spectra, intersubunit association and tissue distribution from the previously identified flathead kalliklectin. These findings indicate that kalliklectins vary in properties among fish species.	[Tsutsui, Shigeyuki; Yamamura, Nozomi; Yoshida, Takaya; Nakamura, Osamu] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan	Tsutsui, S (reprint author), Kitasato Univ, Sch Marine Biosci, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	tsutsui@kitasato-u.ac.jp					Watanabe Y, 2008, DEV COMP IMMUNOL, V32, P487, DOI 10.1016/j.dci.2007.08.007; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949; Clark GF, 2014, BIOCHEM BIOPH RES CO, V450, P1195, DOI 10.1016/j.bbrc.2014.06.051; DELPECH B, 1981, J NEUROCHEM, V36, P855, DOI 10.1111/j.1471-4159.1981.tb01672.x; Clark GF, 2013, HUM REPROD, V28, P566, DOI 10.1093/humrep/des447; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Blather D., 1991, NEUROCHEM INT, V18, P275; Dan H., 2013, BIOCHEM J, V453, P261; Hosono M, 2005, BBA-GEN SUBJECTS, V1725, P160, DOI 10.1016/j.bbagen.2005.07.009; Hosono M., BIOCH BIOPHYS ACTA, V1472, P668; KAWAI Y, 1991, J PHARMACOBIO-DYNAM, V14, P244; KUBO T, 1990, INSECT BIOCHEM, V20, P585, DOI 10.1016/0020-1790(90)90070-B; Ni Y, 1996, VET IMMUNOL IMMUNOP, V55, P205, DOI 10.1016/S0165-2427(96)05718-2; Springer SA, 2008, INT J DEV BIOL, V52, P759, DOI 10.1387/ijdb.082581ss; Tateno H, 1998, J BIOL CHEM, V273, P19190, DOI 10.1074/jbc.273.30.19190; Tsutsui S, 2011, GLYCOBIOLOGY, V21, P1580, DOI 10.1093/glycob/cwr070; Tsutsui S, 2013, DEV COMP IMMUNOL, V41, P20, DOI 10.1016/j.dci.2013.03.018; Zanetta J. P., 1992, TRENDS GLYCOSCI GLYC, V4, P415; Zhang H, 2012, FISH SHELLFISH IMMUN, V32, P598, DOI 10.1016/j.fsi.2011.12.009	20	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					189	195		10.1093/jb/mvv033		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900003		
J	Ueyama, H; Muraki, S; Tanabe, S; Yamade, S; Ogita, H				Ueyama, Hisao; Muraki, Sanae; Tanabe, Shoko; Yamade, Shinichi; Ogita, Hisakazu			A new subset of deutan colour vision defect associated with an L/M visual pigment gene array of normal order and-71C substitution in the Japanese population	JOURNAL OF BIOCHEMISTRY			English	Article						deutan; gene; opsin; promoter; thyroid hormone	CONE DYSFUNCTION SYNDROME; THYROID-HORMONE; MOLECULAR-GENETICS; HYBRID PIGMENTS; GREEN; MUTATIONS; RED; DEFICIENCY; PHENOTYPE; MALES	In 524 Japanese individuals with deutan colour vision defect, 76 had a normal-order pigment gene array, where the L gene is at the first position and the M gene(s) is located downstream. Of these 76 individuals, 69 had a -71A > C substitution in the M gene without any other mutation. Because the expression of L/M genes is up-regulated by thyroid hormone (T-3) in human retinoblastoma WERI cells, we examined the effects of T-3 on promoter activity; T-3 increased the activity of the -71A promoter 2-fold, but it had no effect on the -71C promoter. Similarly, the -71C promoter was much less activated by T-3 than the -71A promoter in HEK293 cells expressing thyroid hormone receptor isoform beta 2. Such a weak response of the -71C promoter to T-3 may cause a decrease in the number of M cones and/or the density of M pigment during the differentiation of M cones. The average Rayleigh match midpoint was 18.9 +/- 4.1 in 162 ordinary deuteranomaly individuals, but was 37.3 +/- 9.1 in 63 deuteranomaly individuals with -71C. The -71A > C substitution was found to be specific to eastern Asia. These results suggest that there may be a new subset of deuteranomaly associated with -71C in the Japanese (and probably eastern Asian) population(s).	[Ueyama, Hisao; Ogita, Hisakazu] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Otsu, Shiga 5202192, Japan; [Muraki, Sanae; Yamade, Shinichi] Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga 5202192, Japan; [Tanabe, Shoko] Inst Vis Res, Atsuta Ku, Nagoya, Aichi 4568502, Japan	Ueyama, H (reprint author), Shiga Univ Med Sci, Dept Biochem & Mol Biol, Otsu, Shiga 5202192, Japan.	datt@belle.shiga-med.ad.jp			Japan Society for the Promotion of Science [22591940, 25462711, 25462712]	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant numbers 22591940 and 25462711 to H.U., and 25462712 to S.M.).	Carroll J, 2012, INVEST OPHTH VIS SCI, V53, P8006, DOI 10.1167/iovs.12-11087; NATHANS J, 1993, AM J HUM GENET, V53, P987; Jagla WM, 2002, HUM MOL GENET, V11, P23, DOI 10.1093/hmg/11.1.23; Neitz M, 2004, VISUAL NEUROSCI, V21, P205, DOI 10.1017/S0952523804213293; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Ueyama H, 2002, BIOCHEM BIOPH RES CO, V294, P205, DOI 10.1016/S0006-291X(02)00458-8; Ng L, 2001, NAT GENET, V27, P94; Ueyama H, 2012, BIOCHEM BIOPH RES CO, V424, P152, DOI 10.1016/j.bbrc.2012.06.094; WINDERICKX J, 1992, NAT GENET, V1, P251, DOI 10.1038/ng0792-251; Sharpe LT, 1998, J NEUROSCI, V18, P10053; Gardner JC, 2009, MOL VIS, V15, P876; DEEB SS, 1992, AM J HUM GENET, V51, P687; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; Crognale MA, 2004, VISUAL NEUROSCI, V21, P197, DOI 10.1017/S0952523804213384; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1448, DOI 10.1016/j.ophtha.2005.02.021; McClements M, 2013, INVEST OPHTH VIS SCI, V54, P1361, DOI 10.1167/iovs.12-11156; Gardner JC, 2014, HUM MUTAT, V35, P1354, DOI 10.1002/humu.22679; Hayashi T, 1999, NAT GENET, V22, P90; Iwagawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072065; Ostrer H, 1997, Mol Vis, V3, P16; Kazmi MA, 1997, INVEST OPHTH VIS SCI, V38, P1074; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; Mizrahi-Meissonnier L, 2010, INVEST OPHTH VIS SCI, V51, P3884, DOI 10.1167/iovs.09-4592; Oda S, 2003, VISION RES, V43, P489, DOI 10.1016/S0042-6989(02)00679-X; Shevell SK, 1998, VISION RES, V38, P3371, DOI 10.1016/S0042-6989(97)00434-3; Ueyama H, 2004, VISION RES, V44, P2241, DOI 10.1016/j.visres.2004.04.011; Ueyama H, 2009, J HUM GENET, V54, P525, DOI 10.1038/jhg.2009.73; Ueyama H, 2003, P NATL ACAD SCI USA, V100, P3357, DOI 10.1073/pnas.0637437100; Weiss AH, 2012, OPHTHALMIC GENET, V33, P187, DOI 10.3109/13816810.2012.681096	33	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					197	204		10.1093/jb/mvv034		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900004		
J	Miyazaki, N; Kiyose, N; Akazawa, Y; Takashima, M; Hagihara, Y; Inoue, N; Matsuda, T; Ogawa, R; Inoue, S; Ito, Y				Miyazaki, Nobuo; Kiyose, Norihiko; Akazawa, Yoko; Takashima, Mizuki; Hagihara, Yosihisa; Inoue, Naokazu; Matsuda, Tomonari; Ogawa, Ryu; Inoue, Seiya; Ito, Yuji			Isolation and characterization of antigen-specific alpaca (Lama pacos) VHH antibodies by biopanning followed by high-throughput sequencing	JOURNAL OF BIOCHEMISTRY			English	Article						alpaca; antibody; domain; folding; VHH	HEAVY-CHAIN ANTIBODIES; SINGLE-DOMAIN ANTIBODIES; PHAGE DISPLAY; GENE REPERTOIRE; LIGHT-CHAINS; FRAGMENTS; BINDING; PROTECTION; DISCOVERY; LIBRARIES	The antigen-binding domain of camelid dimeric heavy chain antibodies, known as VHH or Nanobody, has much potential in pharmaceutical and industrial applications. To establish the isolation process of antigen-specific VHH, a VHH phage library was constructed with a diversity of 8.4 x 10(7) from cDNA of peripheral blood mononuclear cells of an alpaca (Lama pacos) immunized with a fragment of IZUMO1 (IZUMO1(PFF)) as a model antigen. By conventional biopanning, 13 antigen-specific VHHs were isolated. The amino acid sequences of these VHHs, designated as N-group VHHs, were very similar to each other (> 93% identity). To find more diverse antibodies, we performed high-throughput sequencing (HTS) of VHH genes. By comparing the frequencies of each sequence between before and after biopanning, we found the sequences whose frequencies were increased by biopanning. The top 100 sequences of them were supplied for phylogenic tree analysis. In total 75% of them belonged to N-group VHHs, but the other were phylogenically apart from N-group VHHs (Non N-group). Two of three VHHs selected from non N-group VHHs showed sufficient antigen binding ability. These results suggested that biopanning followed by HTS provided a useful method for finding minor and diverse antigen-specific clones that could not be identified by conventional biopanning.	[Miyazaki, Nobuo; Kiyose, Norihiko; Ito, Yuji] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Miyazaki, Nobuo; Inoue, Seiya] ARK Resource Co Ltd, Nishi Ku, Kumamoto 8615271, Japan; [Akazawa, Yoko; Takashima, Mizuki; Hagihara, Yosihisa] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan; [Inoue, Naokazu] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima 9601295, Japan; [Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga 5200811, Japan; [Ogawa, Ryu] MOLCURE Inc, Taito Ku, Tokyo, Japan	Ito, Y (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, 1-21-35 Korimoto, Kagoshima 8900065, Japan.	yito@sci.kagoshima-u.ac.jp			JSPS [25460151]; Health and Labour Sciences Research Grants	This work was partially supported by JSPS Grant-in-Aid for Scientific Research (C) (25460151), and Health and Labour Sciences Research Grants.	GRIFFITHS AD, 1994, EMBO J, V13, P3245; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Ravn U, 2013, METHODS, V60, P99, DOI 10.1016/j.ymeth.2013.03.001; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Saggy I, 2012, PROTEIN ENG DES SEL, V25, P539, DOI 10.1093/protein/gzs060; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Monegal A, 2012, DEV COMP IMMUNOL, V36, P150, DOI 10.1016/j.dci.2011.06.016; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Achour I, 2008, J IMMUNOL, V181, P2001; Daley LP, 2010, CLIN VACCINE IMMUNOL, V17, P239, DOI 10.1128/CVI.00421-09; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Deschacht N, 2010, J IMMUNOL, V184, P5696, DOI 10.4049/jimmunol.0903722; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j/jim.2007.04.008; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Daley-Bauer LP, 2010, CLIN VACCINE IMMUNOL, V17, P2007, DOI 10.1128/CVI.00287-10; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Inoue N, 2014, DEVELOPMENT, V140, P3221; Muraoka Junko, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P42, DOI 10.1089/mab.2013.0068; Muraoka S, 2009, J BIOCHEM, V145, P799, DOI 10.1093/jb/mvp039; Muyldermans S, 2001, J Biotechnol, V74, P277; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Primakoff P, 2007, FEBS LETT, V581, P2174, DOI 10.1016/j.febslet.2007.02.021; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Stone E, 2007, J IMMUNOL METHODS, V318, P88, DOI 10.1016/j.jim.2006.10.006; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; KABAT EA, 1991, J IMMUNOL, V147, P1709; Yang JP, 2010, J BIOCHEM, V148, P507, DOI 10.1093/jb/mvq084	37	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					205	215		10.1093/jb/mvv038		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900005		
J	Okuda, K; Ito, T; Goto, M; Takenaka, T; Hemmi, H; Yoshimura, T				Okuda, Keita; Ito, Tomokazu; Goto, Masaru; Takenaka, Takashi; Hemmi, Hisashi; Yoshimura, Tohru			Domain characterization of Bacillus subtilis GabR, a pyridoxal 5 '-phosphate-dependent transcriptional regulator	JOURNAL OF BIOCHEMISTRY			English	Article						aminotransferase; domain; GabR; pyridoxal 5'-phosphate; transcriptional regulator	ALPHA-AMINOADIPATE AMINOTRANSFERASE; EFFECTOR-BINDING DOMAIN; THERMUS-THERMOPHILUS; FUNCTIONAL DOMAINS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ARAC PROTEIN; GNTR FAMILY; DNA-BINDING; FADR	Bacillus subtilis GabR is a transcriptional regulator consisting of a helix-turn-helix N-terminal DNA-binding domain, a pyridoxal 5'-phosphate (PLP)-binding C-terminal domain that has a structure homologous to aminotransferases, and a linker of 29 amino acid residues. In the presence of gamma-aminobutyrate (GABA), GabR activates the transcription of gabT and gabD, which encode GABA aminotransferase and succinate semialdehyde dehydrogenase, respectively. We expressed N-terminal and C-terminal domain fragments (named N'-GabR and C'-GabR) in Escherichia coli cells, and obtained N'-GabR as a soluble monomer and C'-GabR as a soluble dimer. Spectroscopic studies suggested that C'-GabR contains PLP and binds to d-Ala, beta-Ala, d-Asn and d-Gln, as well as GABA, although the intact GabR binds only to GABA. N'-GabR does not bind to the DNA fragment containing the GabR-binding sequence regardless of the presence or absence of C'-GabR. A fusion protein consisting of N'-GabR and 2-aminoadipate aminotransferase of Thermus thermophilus bound to the DNA fragment. These results suggested that each domain of GabR could be an independent folding unit. The C-terminal domain provides the N-terminal domain with DNA-binding ability via dimerization. The N-terminal domain controls the ligand specificity of the C-terminal domain. Connection by the linker is indispensable for the mutual interaction of the domains.	[Okuda, Keita; Ito, Tomokazu; Takenaka, Takashi; Hemmi, Hisashi; Yoshimura, Tohru] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Goto, Masaru] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 2748510, Japan	Yoshimura, T (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan.	yosimura@agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [25292059, 24780098]	This work was supported in part by the Grant-in-Aid for Research 25292059 (to T.Y.) and Grant-in-Aid for Young Scientists (B) 24780098 (to T.I.) from the Ministry of Education, Culture, Sports, Science, and Technology.	Okuda K, 2015, MOL MICROBIOL, V95, P245, DOI 10.1111/mmi.12861; Resch M, 2010, NUCLEIC ACIDS RES, V38, P2485, DOI 10.1093/nar/gkp1191; BUSTOS SA, 1993, P NATL ACAD SCI USA, V90, P5638, DOI 10.1073/pnas.90.12.5638; Tomita T, 2009, PROTEINS, V75, P348, DOI 10.1002/prot.22245; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Bramucci E, 2011, BIOCHEM BIOPH RES CO, V415, P88, DOI 10.1016/j.bbrc.2011.10.017; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Miyazaki T, 2004, MICROBIOL-SGM, V150, P2327, DOI 10.1099/mic.0.27037-0; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Gorelik M, 2006, PROTEIN SCI, V15, P1506, DOI 10.1110/ps062146906; Belitsky BR, 2004, J MOL BIOL, V340, P655, DOI 10.1016/j.jmb.2004.05.020; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; Belitsky BR, 2002, MOL MICROBIOL, V45, P569, DOI 10.1046/j.1365-2958.2002.03036.x; Edayathumangalam R, 2013, P NATL ACAD SCI USA, V110, P17820, DOI 10.1073/pnas.1315887110; Franco IS, 2006, J BACTERIOL, V188, P3024, DOI 10.1128/JB.188.8.3024-3036.2006; Hoskisson PA, 2006, J BACTERIOL, V188, P5014, DOI 10.1128/JB.00307-06; Ito T, 2012, AMINO ACIDS, V43, P1567, DOI 10.1007/s00726-012-1232-z; Kataoka M, 2008, J BACTERIOL, V190, P7164, DOI 10.1128/JB.00843-08; Lee MH, 2003, J BACTERIOL, V185, P4315, DOI 10.1128/JB.185.15.4315-4325.2003; LOBELL RB, 1990, SCIENCE, V250, P528, DOI 10.1126/science.2237403; MAITRE M, 1975, EUR J BIOCHEM, V52, P157, DOI 10.1111/j.1432-1033.1975.tb03983.x; POWELL JT, 1978, EUR J BIOCHEM, V87, P391, DOI 10.1111/j.1432-1033.1978.tb12388.x; Rezacova P, 2007, PROTEINS, V69, P679, DOI 10.1002/prot.21516; Wickstrum JR, 2007, J BACTERIOL, V189, P4984, DOI 10.1128/JB.00530-07	25	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					225	234		10.1093/jb/mvv040		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900007		
J	Shintani, T; Higashi, S; Takeuchi, Y; Gaudio, E; Trapasso, F; Fusco, A; Noda, M				Shintani, Takafumi; Higashi, Satoru; Takeuchi, Yasushi; Gaudio, Eugenio; Trapasso, Francesco; Fusco, Alfredo; Noda, Masaharu			The R3 receptor-like protein tyrosine phosphatase subfamily inhibits insulin signalling by dephosphorylating the insulin receptor at specific sites	JOURNAL OF BIOCHEMISTRY			English	Article						diabetes; insulin receptor; insulin signalling; protein tyrosine phosphatase; Ptprj-deficient mice	SUBSTRATE-TRAPPING MUTANTS; METABOLISM; RESISTANCE; GLUCOSE; GENE; MICE; TUMORIGENESIS; SENSITIVITY; EXPRESSION; 1B	The autophosphorylation of specific tyrosine residues occurs in the cytoplasmic region of the insulin receptor (IR) upon insulin binding, and this in turn initiates signal transduction. The R3 subfamily (Ptprb, Ptprh, Ptprj and Ptpro) of receptor-like protein tyrosine phosphatases (RPTPs) is characterized by an extracellular region with 6-17 fibronectin type III-like repeats and a cytoplasmic region with a single phosphatase domain. We herein identified the IR as a substrate for R3 RPTPs by using the substrate-trapping mutants of R3 RPTPs. The co-expression of R3 RPTPs with the IR in HEK293T cells suppressed insulin-induced tyrosine phosphorylation of the IR. In vitro assays using synthetic phosphopeptides revealed that R3 RPTPs preferentially dephosphorylated a particular phosphorylation site of the IR: Y960 in the juxtamembrane region and Y1146 in the activation loop. Among four R3 members, only Ptprj was co-expressed with the IR in major insulin target tissues, such as the skeletal muscle, liver and adipose tissue. Importantly, the activation of IR and Akt by insulin was enhanced, and glucose and insulin tolerance was improved in Ptprj-deficient mice. These results demonstrated Ptprj as a physiological enzyme that attenuates insulin signalling in vivo, and indicate that an inhibitor of Ptprj may be an insulin-sensitizing agent.	[Shintani, Takafumi; Higashi, Satoru; Takeuchi, Yasushi; Noda, Masaharu] Natl Inst Basic Biol, Dept Neurobiol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Shintani, Takafumi; Higashi, Satoru; Noda, Masaharu] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Gaudio, Eugenio; Trapasso, Francesco] Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, I-88100 Catanzaro, Italy; [Fusco, Alfredo] Univ Naples Federico II, Scuola Med & Chirurg Napoli, Dipartimento Med Mol & Biotecnol Med, Ist Endocrinol & Oncol Sperimentale CNR, I-80138 Naples, Italy	Gaudio, E (reprint author), IOR Inst Oncol Res, Lymphoma & Genom Res Program, CH-6500 Bellinzona, Switzerland.	madon@nibb.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; WHITE MF, 1988, J BIOL CHEM, V263, P2969; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Drake PG, 1998, MOL CELL BIOCHEM, V182, P79, DOI 10.1023/A:1006808100755; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Bevan P, 2001, J CELL SCI, V114, P1429; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Shintani T, 2009, J NEUROSCI, V29, P11628, DOI 10.1523/JNEUROSCI.2394-09.2009; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Kubota T, 2013, REV ENDOCR METAB DIS, V14, P207, DOI 10.1007/s11154-013-9242-z; Trapasso F, 2006, DNA CELL BIOL, V25, P376, DOI 10.1089/dna.2006.25.376; Manrique C, 2014, ANN NY ACAD SCI, V1311, P138, DOI 10.1111/nyas.12395; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; Ottensmeyer FP, 2000, BIOCHEMISTRY-US, V39, P12103, DOI 10.1021/bi0015921; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639; Beltran PJ, 2003, J COMP NEUROL, V456, P384, DOI 10.1002/cne.10532; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Gaya A, 1999, LEUKEMIA LYMPHOMA, V35, P237, DOI 10.3109/10428199909145726; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; Kruger J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-49; KUHNE MR, 1994, J BIOL CHEM, V269, P15833; Norris K, 1997, FEBS LETT, V415, P243, DOI 10.1016/S0014-5793(97)01133-2; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; Sakuraba J, 2013, J BIOL CHEM, V288, P23421, DOI 10.1074/jbc.M113.458489	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					235	243		10.1093/jb/mvv045		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900008		
J	Takeuchi, S; Katoh, H; Negishi, M				Takeuchi, Shingo; Katoh, Hironori; Negishi, Manabu			Eph/ephrin reverse signalling induces axonal retraction through RhoA/ROCK pathway	JOURNAL OF BIOCHEMISTRY			English	Article						axonal retraction; Eph; ephrin reverse signalling; hippocampal neuron; RhoA; ROCK	EPH RECEPTORS; RHO-GTPASES; KINASE; GUIDANCE; EPHRINS; BINDING; PHOSPHORYLATION; MORPHOGENESIS; REPULSION; SYNAPSES	Eph/ephrin signalling plays essential roles in various tissue developments, such as axon guidance, angiogenesis and tissue separation. Interaction between Ephs and ephrins upon cell-cell contact results in forward (towards Eph-expressing cells) and reverse (towards ephrin-expressing cells) signalling. Although the molecular mechanisms downstream of Eph/ephrin forward signalling have been extensively studied, the functions and intracellular molecular mechanisms of Eph/ephrin reverse signalling are not fully understood. Rho GTPases are key regulators of the actin cytoskeleton to regulate cell morphology. In this study, we revealed that stimulation with the extracellular domain of EphB2 to activate Eph/ephrin reverse signalling induced axonal retraction in hippocampal neurons. The reduction of axonal length and branching by Eph/ephrin reverse signalling was blocked by inhibition of RhoA or Rho-associated coiled-coil-containing protein kinase (ROCK). These results suggest that Eph/ephrin reverse signalling negatively regulates axonal outgrowth and branching through RhoA/ROCK pathway in hippocampal neurons.	[Takeuchi, Shingo; Katoh, Hironori; Negishi, Manabu] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan	Negishi, M (reprint author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	mnegishi@pharm.kyoto-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [23390019]	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (23390019).	Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; LEUNG T, 1995, J BIOL CHEM, V270, P29051; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Mellitzer G, 1999, NATURE, V400, P77; Amano M, 1996, J BIOL CHEM, V271, P20246; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Flanagan JG, 1997, CELL, V90, P403; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Tanaka M, 2004, EMBO J, V23, P1075, DOI 10.1038/sj.emboj.7600128; Thakar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1445; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	32	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					245	252		10.1093/jb/mvv042		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900009		
J	Nomata, J; Maeda, M; Isu, A; Inoue, K; Hisabori, T				Nomata, Jiro; Maeda, Maki; Isu, Atsuko; Inoue, Kazuhito; Hisabori, Toru			Involvement of thioredoxin on the scaffold activity of NifU in heterocyst cells of the diazotrophic cyanobacterium Anabaena sp strain PCC 7120	JOURNAL OF BIOCHEMISTRY			English	Article						cyanobacteria; heterocyst; nitrogen fixation; redox regulation; thioredoxin	IRON-BINDING; NITROGENASE; PROTEIN; CLUSTER; EXPRESSION; INSERTION; SYSTEMS	The diazotrophic cyanobacteriumAnabaena sp. strain PCC 7120 (A.7120) differentiates into specialized heterocyst cells that fix nitrogen under nitrogen starvation conditions. Although reducing equivalents are essential for nitrogen fixation, little is known about redox systems in heterocyst cells. In this study, we investigated thioredoxin (Trx) networks in Anabaena using TrxM, and identified 16 and 38 candidate target proteins in heterocysts and vegetative cells, respectively, by Trx affinity chromatography (Motohashi et al. (Comprehensive survey of proteins targeted by chloroplast thioredoxin. Proc Natl Acad Sci USA, 2001;98, 11224-11229)). Among these, the Fe-S cluster scaffold protein NifU that facilitates functional expression of nitrogenase in heterocysts was found to be a potential TrxM target. Subsequently, we observed that the scaffold activity of N-terminal catalytic domain of NifU is enhanced in the presence of Trx-system, suggesting that TrxM is involved in the Fe-S cluster biogenesis.	[Nomata, Jiro; Maeda, Maki; Isu, Atsuko; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Nomata, Jiro; Isu, Atsuko; Hisabori, Toru] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan; [Inoue, Kazuhito] Kanagawa Univ, Dept Biol Sci, Hiratsuka, Kanagawa 2591293, Japan	Nomata, J (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Nomata, Jiro/D-1813-2015	Nomata, Jiro/0000-0001-9849-2426	Core Research of Evolutional Science & Technology programme (CREST) from Japan Science and Technology Agency (JST); Network Joint Research Center for Materials and Devices, MEXT, Japan; JSPS KAKENHI [24770040]; MEXT, Japan;  [24107004]	This work was supported by the Core Research of Evolutional Science & Technology programme (CREST) from the Japan Science and Technology Agency (JST), and was supported in part by the Network Joint Research Center for Materials and Devices, MEXT, Japan, in part by JSPS KAKENHI (24770040) (to J.N.), and in part by grant-in aid for Scientific Research on Innovative Areas (24107004) and Strategic Research Base Development Program for Private Universities from MEXT, Japan (to K.I.).	Achebach S, 2004, FEBS LETT, V565, P203, DOI 10.1016/j.febslet.2004.01.007; Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Cardona T, 2009, BBA-BIOENERGETICS, V1787, P252, DOI 10.1016/j.bbabio.2009.01.015; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Buchanan BB, 2012, BBA-GEN SUBJECTS, V1820, P1822, DOI 10.1016/j.bbagen.2012.07.006; Ding HG, 2005, J BIOL CHEM, V280, P30432, DOI 10.1074/jbc.M504638200; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; Ow SY, 2008, J PROTEOME RES, V7, P1615, DOI 10.1021/pr700604v; Hu YL, 2011, COORDIN CHEM REV, V255, P1218, DOI 10.1016/j.ccr.2010.11.018; Yoshida K, 2013, PLANT CELL PHYSIOL, V54, P875, DOI 10.1093/pcp/pct037; Ehira S, 2012, J BIOL CHEM, V287, P40433, DOI 10.1074/jbc.M112.384206; ELHAI J, 1990, EMBO J, V9, P3379; Florencio FJ, 2006, PHOTOSYNTH RES, V89, P157, DOI 10.1007/s11120-006-9093-5; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; Gleason FK, 1996, ARCH BIOCHEM BIOPHYS, V334, P277, DOI 10.1006/abbi.1996.0456; Hisabori T, 2005, J EXP BOT, V56, P1463, DOI 10.1093/jxb/eri170; Hosoya-Matsuda N, 2009, MOL PLANT, V2, P336, DOI 10.1093/mp/ssn077; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; MURRY MA, 1989, CAN J MICROBIOL, V35, P636; WOOD NB, 1980, J BACTERIOL, V141, P1375; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					253	261		10.1093/jb/mvv046		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900010		
J	Takahashi, D; Sato, K; Hirayama, E; Takata, M; Kurumizaka, H				Takahashi, Daisuke; Sato, Koichi; Hirayama, Emiko; Takata, Minoru; Kurumizaka, Hitoshi			Human FAN1 promotes strand incision in 5 '-flapped DNA complexed with RPA	JOURNAL OF BIOCHEMISTRY			English	Article						DNA interstrand crosslinking repair; Fanconi anaemia; Fanconi anaemia-associated nuclease 1 (FAN1); replication protein A (RPA); structure-specific endonuclease	CROSS-LINK REPAIR; FANCONI-ANEMIA PATHWAY; CORE-COMPLEX; MONOUBIQUITINATED FANCD2; IDENTIFIES FAN1; BINDING-PROTEIN; NUCLEASE; KIAA1018/FAN1; MECHANISM; DAMAGE	Fanconi anaemia (FA) is a human infantile recessive disorder. Seventeen FA causal proteins cooperatively function in the DNA interstrand crosslink (ICL) repair pathway. Dual DNA strand incisions around the crosslink are critical steps in ICL repair. FA-associated nuclease 1 (FAN1) is a DNA structure-specific endonuclease that is considered to be involved in DNA incision at the stalled replication fork. Replication protein A (RPA) rapidly assembles on the single-stranded DNA region of the stalled fork. However, the effect of RPA on the FAN1-mediated DNA incision has not been determined. In this study, we purified human FAN1, as a bacterially expressed recombinant protein. FAN1 exhibited robust endonuclease activity with 5'-flapped DNA, which is formed at the stalled replication fork. We found that FAN1 efficiently promoted DNA incision at the proper site of RPA-coated 5'-flapped DNA. Therefore, FAN1 possesses the ability to promote the ICL repair of 5'-flapped DNA covered by RPA.	[Takahashi, Daisuke; Sato, Koichi; Hirayama, Emiko; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan; [Takata, Minoru] Kyoto Univ, Ctr Radiat Biol, Dept Late Effects Studies,Lab DNA Damage Signalin, Sakyo Ku, Kyoto 6068501, Japan	Kurumizaka, H (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	kurumizaka@waseda.jp			JSPS KAKENHI [25250023, 24310042, 26830128]; MEXT KAKENHI [25116002, 23114010]	This work was supported in part by JSPS KAKENHI Grant Numbers 25250023 [to H.K.], 24310042 [to M.T.] and 26830128 [to K.S.] and by MEXT KAKENHI Grant Numbers 25116002 [to H.K.] and 23114010 [to M.T.].	Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; Ionita-Laza I, 2014, P NATL ACAD SCI USA, V111, P343, DOI 10.1073/pnas.1309475110; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Huang J, 2013, MOL CELL, V52, P434, DOI 10.1016/j.molcel.2013.09.021; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Shigechi T, 2012, CANCER RES, V72, P1149, DOI 10.1158/0008-5472.CAN-11-2904; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Unno J, 2014, CELL REP, V7, P1039, DOI 10.1016/j.celrep.2014.04.005; Medhurst AL, 2006, BLOOD, V108, P2072, DOI 10.1182/blood-2005-11-008151; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Leveille F, 2004, J BIOL CHEM, V279, P39421, DOI 10.1074/jbc.M407034200; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; SASAKI MS, 1975, NATURE, V257, P501, DOI 10.1038/257501a0; Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Murina O, 2014, CELL REP, V7, P1030, DOI 10.1016/j.celrep.2014.03.069; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Longerich S, 2014, NUCLEIC ACIDS RES, V42, P5657, DOI 10.1093/nar/gku198; Wang R, 2014, SCIENCE, V346, P1127, DOI 10.1126/science.1258973; Blom E, 2004, DNA REPAIR, V3, P77, DOI 10.1016/j.dnarep.2003.09.007; Gwon GH, 2014, GENE DEV, V28, P2276, DOI 10.1101/gad.248492.114; Kook H, 2005, HEMATOLOGY, V10, P108, DOI 10.1080/10245330512331390096; Kruyt FAE, 1999, J BIOL CHEM, V274, P34212, DOI 10.1074/jbc.274.48.34212; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Longerich S, 2014, BLOOD, V124, P2812, DOI 10.1182/blood-2014-04-526293; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Mouw KW, 2014, DNA REPAIR, V19, P130, DOI 10.1016/j.dnarep.2014.03.019; Pennell S, 2014, CELL REP, V8, P84, DOI 10.1016/j.celrep.2014.06.001; Reuter T, 2000, BLOOD, V95, P719; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Sawyer SL, 2015, CANCER DISCOV, V5, P135, DOI 10.1158/2159-8290.CD-14-1156; Shereda RD, 2010, CELL CYCLE, V9, P3977, DOI 10.4161/cc.9.19.13207; Tomida J, 2013, NUCLEIC ACIDS RES, V41, P6930, DOI 10.1093/nar/gkt467; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320	61	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	SEP	2015	158	3					263	270		10.1093/jb/mvv043		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CR4DV	WOS:000361282900011		
J	Higashimoto, S; Nishi, T; Yasukawa, M; Azuma, M; Sakata, Y; Kobayashi, H				Higashimoto, Shinya; Nishi, Takuya; Yasukawa, Miki; Azuma, Masashi; Sakata, Yoshihisa; Kobayashi, Hisayoshi			Photocatalysis of titanium dioxide modified by catechol-type interfacial surface complexes (ISC) with different substituted groups	JOURNAL OF CATALYSIS			English	Article						Photocatalytic H-2 production; Titanium dioxide; Interfacial surface complex; Catechol; Visible light; DFT calculation	VISIBLE-LIGHT IRRADIATION; SELECTIVE ORGANIC TRANSFORMATIONS; DYE-SENSITIZED TIO2; BENZYL ALCOHOL; AEROBIC OXIDATION; DOPED TIO2; CORRESPONDING ALDEHYDES; ANATASE NANOPARTICLES; AQUEOUS SUSPENSION; ELECTRON-TRANSFER	Visible-light responsive TiO2 photocatalyst modified by catechol-type interfacial surface complexes (ISC) was designed by the reaction of Ti-OH moieties with catechol and such derivatives as 3-methoxycatechol involving electron-donating groups (EDG) and 3,4-dihydroxybenzonitrile involving electron-withdrawing groups (EWG). The visible-light response of the ISC is attributed to excitation from the donor levels created in the TiO2 midband. The phenyl-ring-substituted groups strongly influence the electronic structures of the ISC: the catechols with substituted EWG induce an anodic shift of the donor levels accompanied by an enlargement of the energy gaps, compared with catechol without substituted groups. The photocatalytic activities for H-2 evolution from triethanolamine aqueous solutions were systematically investigated. It was confirmed that the more anodic the oxidative potentials of photoinduced holes in the ISC are, the higher the photocatalytic activities they exhibit. (C) 2015 Elsevier Inc. All rights reserved.	[Higashimoto, Shinya; Nishi, Takuya; Yasukawa, Miki; Azuma, Masashi] Osaka Inst Technol, Coll Engn, Asahi Ku, Osaka 5358585, Japan; [Sakata, Yoshihisa] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan; [Kobayashi, Hisayoshi] Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan	Higashimoto, S (reprint author), Osaka Inst Technol, Coll Engn, Asahi Ku, 5-16-1 Omiya, Osaka 5358585, Japan.	higashimoto@chem.oit.ac.jp					Kim S, 2005, J PHYS CHEM B, V109, P5143, DOI 10.1021/jp045806q; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Tanaka A, 2013, CHEM COMMUN, V49, P2551, DOI 10.1039/c3cc39096a; Higashimoto S, 2010, J CATAL, V274, P76, DOI 10.1016/j.jcat.2010.06.006; Kamegawa T, 2012, ACS APPL MATER INTER, V4, P6635, DOI 10.1021/am3017762; Liu Y, 1999, J PHYS CHEM B, V103, P2480, DOI 10.1021/jp984288e; Zhang MA, 2008, ANGEW CHEM INT EDIT, V47, P9730, DOI 10.1002/anie.200803630; Persson P, 2000, J PHYS CHEM B, V104, P10348, DOI 10.1021/jp002550p; Naya S, 2013, ACS CATAL, V3, P10, DOI 10.1021/cs300682d; Shiraishi Y, 2008, J PHOTOCH PHOTOBIO C, V9, P157, DOI 10.1016/j.jphotochemrev.2008.05.001; Lana-Villarreal T, 2005, J AM CHEM SOC, V127, P12601, DOI 10.1021/ja052798y; Higashimoto S, 2014, J CATAL, V311, P137, DOI 10.1016/j.jcat.2013.11.013; Higashimoto S, 2009, J CATAL, V266, P279, DOI 10.1016/j.jcat.2009.06.018; Palmisano G, 2010, CHEM COMMUN, V46, P7074, DOI 10.1039/c0cc02087g; Higashimoto S, 2008, APPL CATAL A-GEN, V340, P98, DOI 10.1016/j.apcata.2008.02.003; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Ikeda S, 2003, J PHOTOCH PHOTOBIO A, V160, P61, DOI 10.1016/S1010-6030(03)00222-3; Ohno T, 2004, APPL CATAL A-GEN, V265, P115, DOI 10.1016/j.apcata.2004.01.007; Lang XJ, 2014, CHEM SOC REV, V43, P473, DOI 10.1039/c3cs60188a; FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016; Jankovic IA, 2009, J PHYS CHEM C, V113, P12645, DOI 10.1021/jp9013338; Asahi R, 2014, CHEM REV, V114, P9824, DOI 10.1021/cr5000738; Sakthivel S, 2003, ANGEW CHEM INT EDIT, V42, P4908, DOI 10.1002/anie.200351577; Lang XJ, 2012, CHEM-EUR J, V18, P2624, DOI 10.1002/chem.201102779; Savic TD, 2012, NANOSCALE, V4, P1612, DOI 10.1039/c2nr11501h; Ma Y, 2014, CHEM REV, V114, P9987, DOI 10.1021/cr500008u; MOSER J, 1991, LANGMUIR, V7, P3012, DOI 10.1021/la00060a018; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Jankovic IA, 2010, NANOSCALE RES LETT, V5, P81, DOI 10.1007/s11671-009-9447-y; Tian Y, 2005, J AM CHEM SOC, V127, P7632, DOI 10.1021/ja042192u; Sakthivel S, 2004, J PHYS CHEM B, V108, P19384, DOI 10.1021/jp046857q; Park Y, 2009, CHEM-EUR J, V15, P10843, DOI 10.1002/chem.200901704; Araujo PZ, 2005, LANGMUIR, V21, P3470, DOI 10.1021/la0476985; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Higashimoto S, 2013, CURR ORG CHEM, V17, P2374; Higashimoto S, 2010, TOP CATAL, V53, P578, DOI 10.1007/s11244-010-9490-z; Higashimoto S, 2012, RSC ADV, V2, P669, DOI 10.1039/c1ra00417d; Kobayashi H, 2015, APPL CATAL B-ENVIRON, V170, P135, DOI 10.1016/j.apcatb.2015.01.035; Kowalska E, 2009, CHEM COMMUN, P241, DOI 10.1039/b815679d; Silverstein R. M., 1991, SPECTROMETRIC IDENTI	40	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	SEP	2015	329						286	290		10.1016/j.jcat.2015.05.010		5	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CR3RM	WOS:000361250800027		
J	Al-Azri, ZHN; Chen, WT; Chan, A; Jovic, V; Ina, T; Idriss, H; Waterhouse, GIN				Al-Azri, Zakiya H. N.; Chen, Wan-Ting; Chan, Andrew; Jovic, Vedran; Ina, Toshiaki; Idriss, Hicham; Waterhouse, Geoffrey I. N.			The roles of metal co-catalysts and reaction media in photocatalytic hydrogen production: Performance evaluation of M/TiO2 photocatalysts (M = Pd, Pt, Au) in different alcohol-water mixtures	JOURNAL OF CATALYSIS			English	Article						Hydrogen production; Photocatalysis; TiO2; Co-catalyst; Alcohols; Polarity	ELECTRON-TRANSFER REACTIONS; H-2 PRODUCTION; AU/TIO2 PHOTOCATALYSTS; PT/TIO2 PHOTOCATALYSTS; METHANOL OXIDATION; TIO2 NANOPARTICLES; PD/TIO2 CATALYSTS; RUTILE TIO2(110); VISIBLE-LIGHT; PARTICLE-SIZE	M/TiO2 photocatalyst activity for H-2 production depends on both the metal co-catalyst (M) and the reaction medium. To quantify such effects, we compared the performance of M/TiO2 photocatalysts (M = Pd, Pt, Au) for H-2 production in different alcohol-water mixtures under UV excitation. Photocatalysts were prepared using Degussa P25 TiO2 at metal loadings of 0.5 and 1 wt.% for Pd, 1 wt.% for Pt and 1 wt.% for Au. TEM, UV-Vis, XPS and EXAFS analyses confirmed the presence of supported metal nanoparticles of size similar to 2, 1.3 and 5.4 nm for Pd/TiO2, Pt/TiO2 and Au/TiO2, respectively. Photoluminescence data established that the metal co-catalysts effectively suppressed electron-hole pair recombination in TiO2 following photo-excitation. The activities of the M/TiO2 photocatalysts for Hy production were evaluated in a wide range of alcohol-water mixtures (alcohol concentration 10 vol.%) under UV (365 nm, 5 mW cm(-2)). H-2 production rates in the alcohol-water mixtures were dependent on (i) the metal co-catalyst; (ii) the co-catalyst loading; and (iii) the alcohol type. Co-catalyst activity followed the order Pd > Pt approximate to Au. The highest Hy production rates were achieved for the 1 wt.% Pd/TiO2 photocatalyst in glycerol-water mixtures (47.5 mmol g(-1)h(-1)) and 1,2-ethanediol-water mixtures (44.5 mmol g(-1) h(-1)). H2 production rates decreased in the order glycerol > 1,2-ethanediol > 1,2-propanediol > methanol > ethanol > 2-propanol > tert-butanol >> water. For each M/TiO2 photocatalyst, correlations were established between the rate of H2 production and specific alcohol properties, especially alcohol polarity and the exponential of the alcohol oxidation potential. (C) 2015 Elsevier Inc. All rights reserved.	[Al-Azri, Zakiya H. N.; Chen, Wan-Ting; Chan, Andrew; Jovic, Vedran; Waterhouse, Geoffrey I. N.] Univ Auckland, Sch Chem Sci, Auckland 1, New Zealand; [Al-Azri, Zakiya H. N.; Waterhouse, Geoffrey I. N.] MacDiarmid Inst Adv Mat & Nanotechnol, Auckland, New Zealand; [Ina, Toshiaki] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan; [Idriss, Hicham] KAUST, SABIC, Corp Res & Innovat CRI Ctr, Thuwal, Saudi Arabia; [Idriss, Hicham] UCL, Dept Chem, London, England	Idriss, H (reprint author), KAUST, SABIC, Corp Res & Innovat CRI Ctr, Thuwal, Saudi Arabia.	IdrissH@SABIC.com; g.waterhouse@auckland.ac.nz			Saudi Basic Industries Corporation (SABIC); MacDiarmid Institute for Advanced Materials and Nanotechnology; Australian Institute of Nuclear Science and Technology (AINSE); Ministry of Higher Education at the Sultanate of Oman; Energy Education Trust of New Zealand	EXAFS experiments were performed at the BL01B1 (XAFS) of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 201481065). The authors gratefully acknowledge funding support from the Saudi Basic Industries Corporation (SABIC), the MacDiarmid Institute for Advanced Materials and Nanotechnology, the Australian Institute of Nuclear Science and Technology (AINSE) and the Ministry of Higher Education at the Sultanate of Oman (PhD scholarship for Zakiya Al-Azri). Zakiya Al-Azri and Wan-Ting Chen also acknowledge the Energy Education Trust of New Zealand for the award of PhD scholarships.	Al-Azri ZHN, 2014, INT J NANOTECHNOL, V11, P695, DOI 10.1504/IJNT.2014.060592; Alonso F, 2008, J CATAL, V260, P113, DOI 10.1016/j.jcat.2008.09.009; MARCUS RA, 1956, J CHEM PHYS, V24, P966, DOI 10.1063/1.1742723; Crabtree GW, 2004, PHYS TODAY, V57, P39, DOI 10.1063/1.1878333; Ruban A, 1997, J MOL CATAL A-CHEM, V115, P421, DOI 10.1016/S1381-1169(96)00348-2; Iwasita T, 2002, ELECTROCHIM ACTA, V47, P3663, DOI 10.1016/S0013-4686(02)00336-5; Muir JN, 2012, PHYS CHEM CHEM PHYS, V14, P11910, DOI 10.1039/c2cp40641a; Bowker M, 2014, J CATAL, V310, P10, DOI 10.1016/j.jcat.2013.04.005; ROTHENBERGER G, 1985, J AM CHEM SOC, V107, P8054, DOI 10.1021/ja00312a043; Tanaka A, 2013, ACS CATAL, V3, P79, DOI 10.1021/cs3006499; Chen WT, 2013, INT J HYDROGEN ENERG, V38, P15036, DOI 10.1016/j.ijhydene.2013.09.101; Di Valentin C, 2013, J PHYS CHEM LETT, V4, P1901, DOI 10.1021/jz400624w; Zanella R, 2002, J PHYS CHEM B, V106, P7634, DOI 10.1021/jp0144810; Wood A, 2001, J PHYS CHEM B, V105, P8810, DOI 10.1021/jp011576t; Naldoni A, 2013, APPL CATAL B-ENVIRON, V130, P239, DOI 10.1016/j.apcatb.2012.11.006; Maeda K, 2010, J PHYS CHEM LETT, V1, P2655, DOI 10.1021/jz1007966; Zhu GA, 2010, NANOSCALE RES LETT, V5, P1749, DOI 10.1007/s11671-010-9705-z; Shimura K, 2011, ENERG ENVIRON SCI, V4, P2467, DOI 10.1039/c1ee01120k; Chen XB, 2012, CHEM SOC REV, V41, P7909, DOI 10.1039/c2cs35230c; MARCUS RA, 1965, J CHEM PHYS, V43, P679, DOI 10.1063/1.1696792; Bahruji H, 2013, APPL CATAL A-GEN, V454, P66, DOI 10.1016/j.apcata.2013.01.005; Farfan-Arribas E, 2002, J PHYS CHEM B, V106, P10680, DOI 10.1021/jp020729p; Chen T, 2007, J PHYS CHEM C, V111, P8005, DOI 10.1021/jp071022b; Navarro RM, 2007, CHEM REV, V107, P3952, DOI 10.1021/cr0501994; SERPONE N, 1995, J PHYS CHEM-US, V99, P16646, DOI 10.1021/j100045a026; MARCUS RA, 1957, J CHEM PHYS, V26, P867, DOI 10.1063/1.1743423; Al-Mazroai LS, 2007, CATAL TODAY, V122, P46, DOI 10.1016/j.cattod.2007.01.022; Gallo A, 2012, GREEN CHEM, V14, P330, DOI 10.1039/c2gc16112e; MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599; Bowker M, 2015, CATAL LETT, V145, P214, DOI 10.1007/s10562-014-1443-x; Jovic V, 2013, J CATAL, V305, P307, DOI 10.1016/j.jcat.2013.05.031; Colmenares JC, 2011, CATAL COMMUN, V16, P1, DOI 10.1016/j.catcom.2011.09.003; Murdoch M, 2011, NAT CHEM, V3, P489, DOI [10.1038/nchem.1048, 10.1038/NCHEM.1048]; Fu XZ, 1996, ENVIRON SCI TECHNOL, V30, P647, DOI 10.1021/es950391v; Waterhouse GIN, 2012, INT J NANOTECHNOL, V9, P113, DOI 10.1504/IJNT.2012.044832; Bowker M, 2011, GREEN CHEM, V13, P2235, DOI 10.1039/c1gc00022e; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Balat M, 2008, INT J HYDROGEN ENERG, V33, P4013, DOI 10.1016/j.ijhydene.2008.05.047; Bahruji H, 2011, APPL CATAL B-ENVIRON, V107, P205, DOI 10.1016/j.apcatb.2011.07.015; Miller JT, 2006, J CATAL, V240, P222, DOI 10.1016/j.jcat.2006.04.004; Jovic V, 2013, TOP CATAL, V56, P1139, DOI 10.1007/s11244-013-0080-8; Ismail AA, 2013, CATAL TODAY, V209, P2, DOI 10.1016/j.cattod.2012.09.027; Kabra K, 2004, IND ENG CHEM RES, V43, P7683, DOI 10.1021/ie0498551; Zhang XM, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046401; Behar D, 2006, J PHYS CHEM B, V110, P8750, DOI 10.1021/jp060971m; Ohyama J, 2011, ACS CATAL, V1, P187, DOI 10.1021/cs100072k; Yang YZ, 2006, APPL CATAL B-ENVIRON, V67, P217, DOI 10.1016/j.apcatb.2006.05.007; Rodriguez JA, 2013, PHYS CHEM CHEM PHYS, V15, P12004, DOI 10.1039/c3cp50416f; Ohtani B, 1997, J PHYS CHEM B, V101, P3349, DOI 10.1021/jp962060q; Balzani V., 1983, ENERGY RESOURCES PHO, P2; BAMWENDA GR, 1995, J PHOTOCH PHOTOBIO A, V89, P177, DOI 10.1016/1010-6030(95)04039-I; Chen JJ, 2010, J PHYS CHEM C, V115, P210, DOI DOI 10.1021/JP1074048; Connelly KA, 2012, GREEN CHEM, V14, P260, DOI 10.1039/c1gc15992e; Golikand AN, 2006, ELECTROANAL, V18, P911, DOI 10.1002/elan.200503476; Huang BS, 2010, INT J HYDROGEN ENERG, V35, P7699, DOI 10.1016/j.ijhydene.2010.05.103; KAISE M, 1994, LANGMUIR, V10, P1345, DOI 10.1021/la00017a005; Kieu L, 2002, J MOL CATAL A-CHEM, V188, P153, DOI 10.1016/S1381-1169(02)00210-8; Kim YK, 2007, J PHYS CHEM C, V111, P18236, DOI 10.1021/jp075608+; Lide D, 2009, CRC HDB CHEM PHYS; MARCUS RA, 1957, J CHEM PHYS, V26, P872, DOI 10.1063/1.1743424; Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711; Nadeem AM, 2011, PHYS CHEM CHEM PHYS, V13, P7637, DOI 10.1039/c0cp01896a; Nakajima H, 2006, PHYSICA B, V376, P820, DOI 10.1016/j.physb.2005.12.205; Okumura K, 2009, J CATAL, V265, P89, DOI 10.1016/j.jcat.2009.04.016; Ouyang L, 2015, J CATAL, V321, P70, DOI 10.1016/j.jcat.2014.10.003; Panayotov DA, 2012, J PHYS CHEM C, V116, P6623, DOI 10.1021/jp209215c; Waterhouse GIN, 2013, SCI REP-UK, V3, DOI 10.1038/srep02849; Zhu SY, 2012, APPL CATAL B-ENVIRON, V119, P146, DOI 10.1016/j.apcatb.2012.02.020	68	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	SEP	2015	329						355	367		10.1016/j.jcat.2015.06.005		13	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CR3RM	WOS:000361250800034		
J	Hibi, Y; Tomigashi, A				Hibi, Yoshihiko; Tomigashi, Akira			Evaluation of a coupled model for numerical simulation of a multiphase flow system in a porous medium and a surface fluid	JOURNAL OF CONTAMINANT HYDROLOGY			English	Article						Multiphase flow; Darcy equation; Porous medium; Surface fluid; Coupling; Numerical simulation	BOUNDARY-CONDITIONS; SOLUTE TRANSPORT; 2-PHASE FLOW; GROUNDWATER; INTERPOLATION; FORMULATION; EQUATIONS; SEEPAGE; BEACH	Numerical simulations that couple flow in a surface fluid with that in a porous medium are useful for examining problems of pollution that involve interactions among atmosphere, water, and groundwater, including saltwater intrusion along coasts. Coupled numerical simulations of such problems must consider both vertical flow between the surface fluid and the porous medium and complicated boundary conditions at their interface. In this study, a numerical simulation method coupling Navier-Stokes equations for surface fluid flow and Darcy equations for flow in a porous medium was developed. Then, the basic ability of the coupled model to reproduce (1) the drawdown of a surface fluid observed in square-pillar experiments, using pillars filled with only fluid or with fluid and a porous medium and (2) the migration of saltwater (salt concentration 0.5%) in the porous medium using the pillar filled with fluid and a porous medium was evaluated. Simulations that assumed slippery walls reproduced well the results with drawdowns of 10-30 cm when the pillars were filled with packed sand, gas, and water. Moreover, in the simulation of saltwater infiltration by the method developed in this study, velocity was precisely reproduced because the experimental salt concentration in the porous medium after saltwater infiltration was similar to that obtained in the simulation. Furthermore, conditions across the boundary between the porous medium and the surface fluid were satisfied in these numerical simulations of square-pillar experiments in which vertical flow predominated. Similarly, the velocity obtained by the simulation for a system coupling flow in surface fluid with that in a porous medium when horizontal flow predominated satisfied the conditions across the boundary. Finally, it was confirmed that the present simulation method was able to simulate a practical-scale surface fluid and porous medium system. All of these numerical simulations, however, required a great deal of computational effort, because time was incremented in 0.05- to 0.10-s steps. Hereafter, the present simulation method needs to be improved so that the simulations can be conducted with less computational effort. (C) 2015 Elsevier B.V. All rights reserved.	[Hibi, Yoshihiko] Meijo Univ, Fac Sci & Technol, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; [Tomigashi, Akira] Yachiyo Engn Co LTD, Engn Management & Coordinat Div, Tech Dev Dept, Shinjuku Ku, Tokyo 1618575, Japan	Hibi, Y (reprint author), Meijo Univ, Fac Sci & Technol, Tenpaku Ku, 1-501 Shiogamaguchi, Nagoya, Aichi 4688502, Japan.	hibiy@meijo-u.ac.jp					Amsden A. A., 1970, Journal of Computational Physics, V6, DOI 10.1016/0021-9991(70)90029-X; Groen J, 2000, J HYDROL, V234, P1, DOI 10.1016/S0022-1694(00)00235-3; HARLOW FH, 1965, PHYS FLUIDS, V8, P2182, DOI 10.1063/1.1761178; Discacciati M, 2002, APPL NUMER MATH, V43, P57, DOI 10.1016/S0168-9274(02)00125-3; YABE T, 1991, COMPUT PHYS COMMUN, V66, P233, DOI 10.1016/0010-4655(91)90072-S; SMOLARKIEWICZ PK, 1992, J ATMOS SCI, V49, P2082, DOI 10.1175/1520-0469(1992)049<2082:ACOSLA>2.0.CO;2; Yabe T, 2001, J COMPUT PHYS, V169, P556, DOI 10.1006/jcph.2000.6625; Chen ZX, 1997, J COMPUT PHYS, V132, P362, DOI 10.1006/jcph.1996.5641; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Boufadel MC, 2000, WATER RESOUR RES, V36, P2549, DOI 10.1029/2000WR900159; Hill AA, 2009, ADV WATER RESOUR, V32, P1609, DOI 10.1016/j.advwatres.2009.08.007; Chang YC, 1996, J COMPUT PHYS, V124, P449, DOI 10.1006/jcph.1996.0072; BEAVERS GS, 1967, J FLUID MECH, V30, P197, DOI 10.1017/S0022112067001375; BROCK TD, 1982, WATER RES, V16, P1255, DOI 10.1016/0043-1354(82)90144-0; CHORIN AJ, 1968, MATH COMPUT, V22, P745, DOI 10.2307/2004575; Hill AA, 2013, ADV WATER RESOUR, V60, P1, DOI 10.1016/j.advwatres.2013.07.005; BELANGER TV, 1985, WATER RESOUR BULL, V21, P265; Chavent G., 1986, MATH MODELS FINITE E; CHEN Z, 1994, WATER TRANS, V12, P925; Dahle HK, 2002, DEV WATER SCI, V47, P1067; Geng XL, 2014, J CONTAM HYDROL, V165, P37, DOI 10.1016/j.jconhyd.2014.07.001; Geng XL, 2015, J GEOPHYS RES-OCEANS, V120, P1409, DOI 10.1002/2014JC010539; Hibi Y., 2010, J GROUNDW HYDROL, V52, P169; Hill AA, 2008, J FLUID MECH, V603, P137, DOI 10.1017/S0022112008000852; Li H, 2008, J HYDROL, V352, P211, DOI 10.1016/j.jhydrol.2008.01.013; SUSSMAN M, 1994, J COMPUT PHYS, V114, P146, DOI 10.1006/jcph.1994.1155	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-7722	1873-6009		J CONTAM HYDROL	J. Contam. Hydrol.	SEP	2015	180						34	55		10.1016/j.jconhyd.2015.07.005		22	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CR5VI	WOS:000361412100004		
J	Hsiao, CN; Ko, EC; Shieh, TY; Chen, HS				Hsiao, Chun-Nan; Ko, Edward Chengchuan; Shieh, Tien-Yu; Chen, Hong-Sen			Relationship between areca nut chewing and periodontal status of people in a typical aboriginal community in Southern Taiwan	JOURNAL OF DENTAL SCIENCES			English	Article						areca; oral hygiene; periodontal attachment loss; tooth toss	CALCIUM HYDROXIDE SUSPENSION; ORAL-HEALTH-CARE; NATURAL-HISTORY; TOWER-HAMLETS; RISK-FACTORS; BETEL NUT; EXTRACTS; EPIDEMIOLOGY; PHAGOCYTOSIS; ASSOCIATION	Background/purpose: Although the clinical impact of areca nut chewing on periodontal status had been reported, the results of epidemiological studies on areca nut or betel quid chewing did not show the same influence on periodontitis. This study assessed the influence of variables such as areca nut chewing, sociodemographic variables, lifestyle, and oral hygiene behavior on the periodontal status of people in a typical aboriginal community in Southern Taiwan. Materials and methods: A survey was conducted on an aboriginal community in Taiwan, because nonsmoking chewers are rare in cities. In total, 114 aboriginal residents, 30-60 years old, were recruited for this study. Clinical measurements included bleeding on probing, pocket depth, clinical attachment loss (CAL), and tooth loss. Adjusted means were estimated by least-squares means. Multiple regression analysis was used to assess the relationship between potential risk factors and CAL. Results: Age- and sex-adjusted means showed that the CAL of chewers was significantly higher than that of the control group. The chewing of more than 33,000 pieces of areca nut resulted in significant CAL. Multiple regression showed that areca nut chewing led to 0.16 mm (P = 0.0298) total CAL for every thousand pieces, and plaque index was a significantly strong contributing factor. Conclusion: The results indicated that areca nut chewing might significantly enhance CAL in the population. Improved oral hygiene, fewer additives, and reduced use of areca nut would significantly reduce CAL, which should be encouraged for chewers. Copyright (C) 2015, Association for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.	[Hsiao, Chun-Nan; Ko, Edward Chengchuan] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung 80787, Taiwan; [Ko, Edward Chengchuan] Kaohsiung Med Univ Hosp, Div Oral & Maxillofacial Surg, Kaohsiung, Taiwan; [Ko, Edward Chengchuan] Univ Tokyo, Grad Sch Med, Dept Cartilage & Bone Regenerat Fujisoft, Tokyo, Japan; [Shieh, Tien-Yu; Chen, Hong-Sen] Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, Kaohsiung 80787, Taiwan; [Chen, Hong-Sen] Kaohsiung Med Univ, Chun Ho Mem Hosp, Dept Pediat Dent, Kaohsiung 80787, Taiwan	Chen, HS (reprint author), Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, 100 Shih Chuan 1st Rd, Kaohsiung 80787, Taiwan.	hosech@kmu.edu.tw					Amarasena N, 2003, J CLIN PERIODONTOL, V30, P403, DOI 10.1034/j.1600-051X.2003.20010.x; Gupta PC, 2004, ANN ACAD MED SINGAP, V33, P31; Neely AL, 2005, J CLIN PERIODONTOL, V32, P984, DOI 10.1111/j.1600-051X.2005.00797.x; Wen CP, 2010, CANCER CAUSE CONTROL, V21, P1427, DOI 10.1007/s10552-010-9570-1; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Ling LJ, 2001, ORAL MICROBIOL IMMUN, V16, P364, DOI 10.1034/j.1399-302X.2001.160608.x; Akhter R, 2008, J CLIN PERIODONTOL, V35, P9, DOI 10.1111/j.1600-051X.2007.01164.x; Nelson BS, 1999, ANN EMERG MED, V34, P238, DOI 10.1016/S0196-0644(99)70239-8; KO YC, 1992, J ORAL PATHOL MED, V21, P261, DOI 10.1111/j.1600-0714.1992.tb01007.x; Chang LY, 2009, J PERIODONTAL RES, V44, P175, DOI 10.1111/j.1600-0765.2008.01104.x; Aziz SR, 2010, J AM DENT ASSOC, V141, P423; Chang Y C, 1999, Clin Oral Investig, V3, P25, DOI 10.1007/s007840050074; Chatrchaiwiwatana Supaporn, 2006, Journal of the Medical Association of Thailand, V89, P1004; Chatrchaiwiwatana S, 2007, PUBLIC HEALTH, V121, P106, DOI 10.1016/j.puhe.2006.06.010; Dalla VCF, 2005, J PERIODONTOL, V76, P1721; Deurenberg P, 1999, BEST PRACT RES CL EN, V13, P1, DOI 10.1053/beem.1999.0003; Farrand P, 2006, COMMUNITY DENT HLTH, V23, P58; Hung SL, 2006, J PERIODONTOL, V77, P579, DOI 10.1902/jop.2006.050217; Hung SL, 2005, J PERIODONTOL, V76, P373, DOI 10.1902/jop.2005.76.3.373; Kasaj A, 2006, CLIN ORAL INVEST, V10, P72, DOI 10.1007/s00784-005-0029-9; Lai YL, 2007, J PERIODONTAL RES, V42, P69, DOI 10.1111/j.1600-0765.2006.00917.x; Ling LJ, 2005, J CLIN PERIODONTOL, V32, P353, DOI 10.1111/j.1600-051X.2005.00687.x; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Machtei E E, 1992, J Periodontol, V63, P206; MEHTA F S, 1955, J Am Dent Assoc, V50, P531; Neely AL, 2001, J PERIODONTOL, V72, P1006, DOI 10.1902/jop.2001.72.8.1006; Parmar Girish, 2008, J Oral Sci, V50, P57, DOI 10.2334/josnusd.50.57; Pearson N, 2001, INT DENT J, V51, P23; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Stratul SI, 2006, CLIN ORAL INVEST, V10, P55, DOI 10.1007/s00784-005-0024-1; Teng HC, 2003, J PERIODONTOL, V74, P1169, DOI 10.1902/jop.2003.74.8.1169; Tseng YH, 2008, J PERIODONTAL RES, V43, P490, DOI 10.1111/j.1600-0765.2007.01035.x; Yang YH, 2002, TAIWAN J ORAL MED HL, V18, P1	33	0	0	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1991-7902			J DENT SCI	J. Dental Sci.	SEP	2015	10	3					300	308		10.1016/j.jds.2014.06.006		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CR3TW	WOS:000361257000012		
J	Hartana; Murakami, K				Hartana; Murakami, Keisuke			Numerical and Experimental Simulation of Two-Phase Tsunami Flow Through Buildings with Openings	JOURNAL OF EARTHQUAKE AND TSUNAMI			English	Article						Two-phase flow; bore type tsunami; tsunami pressure; uplift force; building with openings	WAVE IMPACT; VERTICAL WALL; PRESSURES; SURGES; FORCES; BORES; AIR	During tsunami action on a structure, the structure is subjected to heavy loads with complex phenomena which include the interactions among tsunami, structure and air. In order to mitigate tsunami damages on structures, it is important to understand the characteristics of tsunami hydraulic loads acting on the structures with taking into account the above interactions. In the present study, the characteristics of tsunami forces on a building structure are investigated using a two-phase flow model. Two types of building models, a building without openings and with openings, were dealt with; and the effects of openings on the building under the tsunami hydraulic loads are examined. The simulation results were compared with the results obtained from one-phase flow simulation, and also verified with experimental data. The numerical results show good agreement with the measured ones. Furthermore, the effects of air taken into the flow and opening configuration on the characteristics of pressures and uplift forces were also discussed.	[Hartana] Univ Mataram, Fac Engn, Dept Civil Engn, Mataram 83125, Indonesia; [Murakami, Keisuke] Miyazaki Univ, Dept Civil & Environm Engn, Miyazaki 8892192, Japan	Hartana (reprint author), Univ Mataram, Fac Engn, Dept Civil Engn, Jl Majapahit 62, Mataram 83125, Indonesia.	hartana@unram.ac.id; keisuke@cc.miyazaki-u.ac.jp					HATTORI M, 1994, COAST ENG, V22, P79, DOI 10.1016/0378-3839(94)90049-3; Wood DJ, 2000, J WATERW PORT C-ASCE, V126, P182, DOI 10.1061/(ASCE)0733-950X(2000)126:4(182); Chanson H, 2006, COAST ENG J, V48, P355, DOI 10.1142/S0578563406001477; CHAN ES, 1988, PROC R SOC LON SER-A, V417, P95, DOI 10.1098/rspa.1988.0053; Nouri Y, 2010, COAST ENG J, V52, P43, DOI 10.1142/S0578563410002117; YEH HH, 1989, J FLUID MECH, V206, P563, DOI 10.1017/S0022112089002417; Bullock GN, 2001, COAST ENG, V42, P291, DOI 10.1016/S0378-3839(00)00065-X; Arnasson H, 2009, J DISASTER RES, V4, P391; Bagnold RA, 1939, J I CIVIL ENG, V12, P202, DOI 10.1680/ijoti.1939.14539; Bozorgnia M., 2012, COAST ENG J, V33, P1; Bozorgnia M., 2010, P 32 C COAST ENG SHA, V5, P3264; Bricker J., 2013, P 2013 IAHR WORLD C, P1; Chanson H., 1996, AIR BUBBLE ENTRAINME; Coastal Development Institute of Technology, 2010, CADMAS SURF 3D RES D; Cross R. H, 1967, J WATERWAYS HARBORS, V93, P201; Federal Emergency Management Agency, 2008, GUID DES STRUCT VERT; Fukui Y., 1962, ANN J COASTAL ENG JA, V9, P44; Hartana, 2014, P 24 INT OFFSH POL E, V22, P52; Hartana, 2013, J JPN SOC CIVIL E B3, V69, P347; Hartana, 2013, P INT SESS C COAST E, V4, P55; Lubin P., 2012, P 33 INT C COAST ENG, V33, P1; Lukkunaprasit P., 2009, SCI TSUNAMI HAZARDS, V28, P1; OpenFOAM, 2012, OPENCFD OPENFOAM 2 1; Peregrine D. H., 2004, P 29 INT C COAST ENG, V4, P4005; Pimanmas A., 2010, J EARTHQ TSUNAMI, V4, P69; Plumerault L.-R, 2009, THESIS U PAU PAYS AD; RAMSDEN JD, 1990, J WATERW PORT C-ASCE, V116, P592, DOI 10.1061/(ASCE)0733-950X(1990)116:5(592); Ramsden JD, 1996, J WATERW PORT C-ASCE, V122, P134, DOI 10.1061/(ASCE)0733-950X(1996)122:3(134); Rao P. K. R., 2010, INT J ENG SCI TECH, V2, P195; Santo J., 2010, UHMCEE1002 COLL ENG, P1; Triatmadja R., 2012, J EARTHQ TSUNAMI, V06, P1; Wemmenhove R., 2008, THESIS U GRONINGEN N; Wemmenhove R., 2006, P ECOMAS CFD 2006 DE, P1; Wijatmiko I., 2010, ANN J CIVIL ENG OCEA, V26, P273	34	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-4311	1793-7116		J EARTHQ TSUNAMI	J. Earthq. Tsunami	SEP	2015	9	3							1550007	10.1142/S1793431115500074		15	Geochemistry & Geophysics	Geochemistry & Geophysics	CR7IR	WOS:000361523300001		
J	Tubuxin, B; Rahimzadeh-Bajgiran, P; Ginnan, Y; Hosoi, F; Omasa, K				Tubuxin, Bayaer; Rahimzadeh-Bajgiran, Parinaz; Ginnan, Yusaku; Hosoi, Fumiki; Omasa, Kenji			Estimating chlorophyll content and photochemical yield of photosystem II (I broken vertical bar(PSII)) using solar-induced chlorophyll fluorescence measurements at different growing stages of attached leaves	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Chlorophyll content; different leaf age; Fraunhofer line depth principle; photochemical yield of photosystem II (I broken vertical bar PSII); solar-induced chlorophyll fluorescence	A FLUORESCENCE; IN-VIVO; REFLECTANCE INDEX; XANTHOPHYLL CYCLE; PLANT-LEAVES; PHOTOSYNTHESIS; VEGETATION; PARAMETERS; EMISSION; STRESS	An estimation and comparison of chlorophyll content and photochemical yield of photosystem II obtained from solar and artificially induced chlorophyll fluorescence is presented here, along with a new technique to estimate photochemical yield from the solar-induced method.This paper illustrates the possibility of measuring chlorophyll (Chl) content and Chl fluorescence parameters by the solar-induced Chl fluorescence (SIF) method using the Fraunhofer line depth (FLD) principle, and compares the results with the standard measurement methods. A high-spectral resolution HR2000+ and an ordinary USB4000 spectrometer were used to measure leaf reflectance under solar and artificial light, respectively, to estimate Chl fluorescence. Using leaves of <italic toggle="yes">Capsicum annuum cv. 'Sven' (paprika), the relationships between the Chl content and the steady-state Chl fluorescence near oxygen absorption bands of O2B (686nm) and O(2)A (760nm), measured under artificial and solar light at different growing stages of leaves, were evaluated. The Chl fluorescence yields of I broken vertical bar F 686nm/I broken vertical bar F 760nm ratios obtained from both methods correlated well with the Chl content (steady-state solar light: R-2 = 0.73; artificial light: R-2 = 0.94). The SIF method was less accurate for Chl content estimation when Chl content was high. The steady-state solar-induced Chl fluorescence yield ratio correlated very well with the artificial-light-induced one (R-2 = 0.84). A new methodology is then presented to estimate photochemical yield of photosystem II (I broken vertical bar(PSII)) from the SIF measurements, which was verified against the standard Chl fluorescence measurement method (pulse-amplitude modulated method). The high coefficient of determination (R-2 = 0.74) between the I broken vertical bar(PSII) of the two methods shows that photosynthesis process parameters can be successfully estimated using the presented methodology.	[Tubuxin, Bayaer; Rahimzadeh-Bajgiran, Parinaz; Ginnan, Yusaku; Hosoi, Fumiki; Omasa, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Rahimzadeh-Bajgiran, Parinaz] Univ Maine, Sch Forest Resources, Orono, ME 04469 USA	Omasa, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aomasa@mail.ecc.u-tokyo.ac.jp					Konishi A, 2009, FUNCT PLANT BIOL, V36, P874, DOI 10.1071/FP09108; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Liu LY, 2010, IEEE J-STARS, V3, P306, DOI 10.1109/JSTARS.2010.2048200; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Zarco-Tejada PJ, 2012, REMOTE SENS ENVIRON, V117, P322, DOI 10.1016/j.rse.2011.10.007; Omasa K, 2009, PLANT CELL PHYSIOL, V50, P90, DOI 10.1093/pcp/pcn174; Omasa K, 2007, J EXP BOT, V58, P881, DOI 10.1093/jxb/erl142; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Gitelson AA, 2003, J PLANT PHYSIOL, V160, P271, DOI 10.1078/0176-1617-00887; Joiner J, 2011, BIOGEOSCIENCES, V8, P637, DOI 10.5194/bg-8-637-2011; Malenovsky Z, 2009, J EXP BOT, V60, P2987, DOI 10.1093/jxb/erp156; Kolber Z, 2005, PHOTOSYNTH RES, V84, P121, DOI 10.1007/s11120-005-5092-1; Meroni M, 2008, SENSORS-BASEL, V8, P1740, DOI 10.3390/s8031740; Meroni M, 2008, INT J REMOTE SENS, V29, P5409, DOI 10.1080/01431160802036292; Baker NR, 2004, ADV PHOTO RESPIRAT, V19, P65; Meroni M, 2009, REMOTE SENS ENVIRON, V113, P2037, DOI 10.1016/j.rse.2009.05.003; PLASCYK JA, 1975, IEEE T INSTRUM MEAS, V24, P306, DOI 10.1109/TIM.1975.4314448; Kim MS, 2001, APPL OPTICS, V40, P157, DOI 10.1364/AO.40.000157; GAMON JA, 1990, OECOLOGIA, V85, P1, DOI 10.1007/BF00317336; Buschmann C, 2007, PHOTOSYNTH RES, V92, P261, DOI 10.1007/s11120-007-9187-8; Moya I, 2004, REMOTE SENS ENVIRON, V91, P186, DOI 10.1016/j.rse.2004.02.012; Kalaji HM, 2012, PHOTOSYNTH RES, V114, P69, DOI 10.1007/s11120-012-9780-3; Gitelson AA, 1998, J PLANT PHYSIOL, V152, P283; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; AGATI G, 1995, J PLANT PHYSIOL, V145, P228; Daumard F, 2012, IEEE T GEOSCI REMOTE, V50, P4292, DOI 10.1109/TGRS.2012.2193131; Corp LA, 2006, APPL OPTICS, V45, P1023, DOI 10.1364/AO.45.001023; Zarco-Tejada PJ, 2003, REMOTE SENS ENVIRON, V84, P283, DOI 10.1016/S0034-4257(02)00113-X; LICHTENTHALER HK, 1988, CRIT REV ANAL CHEM, V19, pS29; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87; Pieruschka R, 2014, TREE PHYSIOL, V34, P674, DOI 10.1093/treephys/tpu035; Porcar-Castell A, 2014, J EXP BOT, V65, P4065, DOI 10.1093/jxb/eru191; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BUSCHMANN C, 1994, REMOTE SENS ENVIRON, V48, P18, DOI 10.1016/0034-4257(94)90110-4; WINTERMA.JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Campbell PKE, 2008, SCI TOTAL ENVIRON, V404, P433, DOI 10.1016/j.scitotenv.2007.11.004; Frankenberg C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048738; Govindjee, 1995, J PLANT PHYSL, V22, P131; LICHTENTHALER HK, 1986, RADIAT ENVIRON BIOPH, V25, P297, DOI 10.1007/BF01214643; Lichtenthaler HK, 1992, EARSEL ADV REMOTE SE, V1, P20; Liu LY, 2005, IEEE T GEOSCI REMOTE, V43, P827, DOI 10.1109/TGRS.2005.843320; Meroni M, 2006, REMOTE SENS ENVIRON, V103, P438, DOI 10.1016/j.rse.2006.03.016; MOYA I, 1992, ISPRS J PHOTOGRAMM, V47, P205, DOI 10.1016/0924-2716(92)90033-6; Omasa K, 2003, PLANT CELL PHYSIOL, V44, P1290, DOI 10.1093/pcp/pcg165; Omasa K, 1998, P SOC PHOTO-OPT INS, V3382, P91, DOI 10.1117/12.312614; OMASA K, 1987, PLANT PHYSIOL, V84, P748, DOI 10.1104/pp.84.3.748; Papageorgiou GC, 2004, ADV PHOTOSYNTHESIS R, V19; Pieruschka Roland, 2012, Methods Mol Biol, V918, P51, DOI 10.1007/978-1-61779-995-2_5; Rahimzadeh-Bajgiran P, 2012, PHOTOSYNTH RES, V113, P261, DOI 10.1007/s11120-012-9747-4; Rascher U, 2008, 14 INT C PHOT, P1387; Rascher U., 2009, BIOGEOSCIENCES DISCU, V6, P2217, DOI DOI 10.5194/BGD-6-2217-2009; van der Tol C, 2014, J GEOPHYS RES-BIOGEO, V119, P2312, DOI 10.1002/2014JG002713	52	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	SEP	2015	66	18			SI		5595	5603		10.1093/jxb/erv272		9	Plant Sciences	Plant Sciences	CR3CL	WOS:000361208000018		
J	Lu, S; Lu, XT; Zhao, WL; Liu, Y; Wang, ZY; Omasa, K				Lu, Shan; Lu, Xingtong; Zhao, Wenli; Liu, Yu; Wang, Zheyi; Omasa, Kenji			Comparing vegetation indices for remote chlorophyll measurement of white poplar and Chinese elm leaves with different adaxial and abaxial surfaces	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Adaxial and abaxial leaf surfaces; chlorophyll; phenotyping; reflectance; remote sensing; vegetation index	SPECTRAL REFLECTANCE; EUCALYPTUS LEAVES; RED EDGE; OPTICAL-PROPERTIES; LEAF REFLECTANCE; PLANT-LEAVES; CANOPIES; FLUORESCENCE; CAROTENOIDS; ABSORPTION	Quick non-destructive assessment of leaf chlorophyll content (LCC) is important for studying phenotypes related to plant growth and stress resistance. This study was undertaken to investigate the quantitative relationship between LCC and different vegetation indices (VIs) on both adaxial and abaxial surfaces of white poplar (Populus alba), which has dense tubular hairs on its abaxial surface, and Chinese elm (Ulmus pumila var. pendula), which does not show obvious superficial differences except for lighter colour on the abaxial surface. Some published and newly developed VIs were tested to relate them to LCC. The results showed that most of the published VIs had strong relationships with LCC on the one-surface dataset, but did not show a clear relationship with LCC when both adaxial and abaxial surface reflectance data were included. Among the reflectance indices tested, the modified Datt index, (R719-R726)/(R719-R743), performed best and is proposed as a new index for remote estimation of chlorophyll content in plants with varying leaf surface structures. It explained 92% of LCC variation in this research, and the root mean square error of the LCC prediction was 5.23 mu g/cm2. This new index is insensitive to the effects of adaxial and abaxial leaf surface structures and is strongly related to the variation in reflectance caused by chlorophyll content.	[Lu, Shan; Lu, Xingtong; Zhao, Wenli; Liu, Yu; Wang, Zheyi] NE Normal Univ, Sch Geog Sci, Changchun 130024, Peoples R China; [Omasa, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Omasa, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	aomasa@mail.ecc.u-tokyo.ac.jp			National Natural Science Foundation of China [41001258]; Science and Technology Planning Project of '12th Five-Year Plan' in the Department of Education of Jilin province; Japan Society for the Promotion of Science [24248043]	This work was supported by the National Natural Science Foundation of China (grant no: 41001258), Science and Technology Planning Project of '12th Five-Year Plan' in the Department of Education of Jilin province and the Japan Society for the Promotion of Science (grant no: 24248043).	Ainsworth EA, 2014, PHOTOSYNTH RES, V119, P65, DOI 10.1007/s11120-013-9837-y; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Blackburn GA, 1998, INT J REMOTE SENS, V19, P657, DOI 10.1080/014311698215919; Maccioni A, 2001, J PHOTOCH PHOTOBIO B, V61, P52, DOI 10.1016/S1011-1344(01)00145-2; CHAPPELLE EW, 1992, REMOTE SENS ENVIRON, V39, P239, DOI 10.1016/0034-4257(92)90089-3; Serrano L, 2008, INT J REMOTE SENS, V29, P5265, DOI 10.1080/01431160802036359; Gitelson AA, 2003, J PLANT PHYSIOL, V160, P271, DOI 10.1078/0176-1617-00887; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Lichtenthaler HK, 1996, J PLANT PHYSIOL, V148, P483; Adams ML, 1999, INT J REMOTE SENS, V20, P3663, DOI 10.1080/014311699211264; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; Chelle M, 2006, ECOL MODEL, V198, P219, DOI 10.1016/j.ecolmodel.2006.04.010; TAKEBE M, 1989, JARQ-JPN AGR RES Q, V23, P86; Verrelst J, 2012, IEEE T GEOSCI REMOTE, V50, P1832, DOI 10.1109/TGRS.2011.2168962; Levizou E, 2005, NEW PHYTOL, V165, P463, DOI 10.1111/j.1469-8137.2004.01250.x; Datt B, 1998, REMOTE SENS ENVIRON, V66, P111, DOI 10.1016/S0034-4257(98)00046-7; Datt B, 1999, J PLANT PHYSIOL, V154, P30; Slaton MR, 2001, AM J BOT, V88, P278, DOI 10.2307/2657019; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Zarco-Tejada PJ, 2001, IEEE T GEOSCI REMOTE, V39, P1491, DOI 10.1109/36.934080; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; Penuelas J, 1997, INT J REMOTE SENS, V18, P2869, DOI 10.1080/014311697217396; Gitelson AA, 1996, J PLANT PHYSIOL, V148, P494; Tian YC, 2011, FIELD CROP RES, V120, P299, DOI 10.1016/j.fcr.2010.11.002; Campbell PKE, 2007, J ENVIRON QUAL, V36, P832, DOI 10.2134/jeq2005.0396; GITELSON A, 1994, J PLANT PHYSIOL, V143, P286; Smith WK, 1997, BIOSCIENCE, V47, P785, DOI 10.2307/1313100; Demarez V, 1999, INT J REMOTE SENS, V20, P879, DOI 10.1080/014311699212975; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Mutanga O, 2007, ISPRS J PHOTOGRAMM, V62, P34, DOI 10.1016/j.isprsjprs.2007.02.001; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Sadras VO, 2000, ANN BOT-LONDON, V85, P187, DOI 10.1006/anbo.1999.1013; Datt B, 1999, INT J REMOTE SENS, V20, P2741, DOI 10.1080/014311699211778; Baret F, 1988, APPL CHLOROPHYLL FLU, P345; Blackburn GA, 1998, REMOTE SENS ENVIRON, V66, P273, DOI 10.1016/S0034-4257(98)00059-5; Cordon GB, 2007, PHOTOCH PHOTOBIO SCI, V6, P873, DOI 10.1039/b617685b; CURRAN PJ, 1995, TREE PHYSIOL, V15, P203; WINTERMA.JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Kim M.S., 1994, P 6 S PHYS MEAS SIGN, P299; Lu XT, 2015, INT J REMOTE SENS, V36, P1447, DOI 10.1080/01431161.2015.1012277; Main R, 2011, ISPRS J PHOTOGRAMM, V66, P751, DOI 10.1016/j.isprsjprs.2011.08.001; PENUELAS J, 1994, REMOTE SENS ENVIRON, V48, P135, DOI 10.1016/0034-4257(94)90136-8; Rautiainen M, 2010, SCAND J FOREST RES, V25, P325, DOI 10.1080/02827581.2010.497159; Steele M, 2008, AM J ENOL VITICULT, V59, P299; VOGELMANN JE, 1993, INT J REMOTE SENS, V14, P1563; Zhu Y, 2007, AUST J AGR RES, V58, P1077, DOI 10.1071/AR06413	47	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	SEP	2015	66	18			SI		5625	5637		10.1093/jxb/erv270		13	Plant Sciences	Plant Sciences	CR3CL	WOS:000361208000021		
J	Oikawa, Y; Saito, T; Idomukai, S; Tanaka, T; Nishida, M; Sawada, H				Oikawa, Yuri; Saito, Tomoya; Idomukai, Satsuki; Tanaka, Tomoko; Nishida, Masakazu; Sawada, Hideo			Preparation of magnesium carbonate nanoparticles encapsulated by nanocomposite material derived from fluoroalkyl end-capped vinyltrimethoxysilane oligomer - Application to the surface modification of glass and poly(methyl methacrylate)	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Fluorinated oligomer; Silica; Magnesium carbonate; Nanocomposites; Magnesium fluoride; Calcination	OPTICAL THIN-FILMS; 800 DEGREES-C; INORGANIC MATERIALS; FLAME RETARDANTS; AUTOCLAVED SOLS; HYBRID; COATINGS; SILICA; PEROXIDES; POLYMERIZATION	Sol-gel reactions of fluoroalkyl end-capped vinyltrimethoxysilane oligomer in the presence of magnesium carbonate fine particles were found to proceed smoothly under alkaline conditions at room temperature to give the corresponding fluorinated oligomeric silica nanocomposites-encapsulated magnesium carbonate nanoparticles [R-F-(VM-SiO2)(n)-R-F/MgCO3]. The obtained composites have good dispersibility in traditional organic media, and these composites are nanoparticles without agglomeration or coagulation before and even after calcination at 800 degrees C. Parent magnesium carbonate undergoes the decarboxylation at around 400 degrees C to afford magnesium oxide; however, the more smooth pyrolysis of the R-F-(VM-SiO2)(n)-R-F/MgCO3 nanocomposites can be observed at around 300 degrees C to cause the selective formation of not magnesium oxide but magnesium fluoride. The modified glass surfaces treated with the R-F-(VM-SiO2)(n)-R-F/MgCO3 nanocomposites after calcination from 200 to 460 degrees C were found to exhibit the same superhydrophobic (water contact angle value: 180 degrees) characteristic with good oleophobicity as that of the corresponding nanocomposites before calcination. The transparent colorless modified poly(methyl methacrylate) (PMMA) film was prepared by the treatment of the R-F-(VM-SiO2)(n)-R-F/MgCO3 nanocomposites to give the good oleophobicity imparted by fluorine in the composites on the modified surface. R-F-(VM-SiO2)(n)-R-F/MgCO3 nanocomposites after calcination at 200-800 degrees C were also applied to the surface modification of PMMA films, and refractive indices of the obtained transparent colorless PMMA films were found to decrease with increasing the calcination temperatures of the nanocomposites, indicating that magnesium fluoride is likely to form in the composites by increasing the calcination temperatures. (C) 2015 Elsevier B.V. All rights reserved.	[Oikawa, Yuri; Saito, Tomoya; Idomukai, Satsuki; Sawada, Hideo] Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan; [Tanaka, Tomoko; Nishida, Masakazu] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Sawada, H (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan.	hideosaw@hirosaki-u.ac.jp			Ministry of Education, Science, Sports, and Culture, Japan [24550220]	This work was partially supported by a Grant-in-Aid for Scientific Research No. 24550220 from the Ministry of Education, Science, Sports, and Culture, Japan.	Ameduri B, 2004, WELL ARCHITECTURED F; Kruger H, 2008, THIN SOLID FILMS, V516, P4175, DOI 10.1016/j.tsf.2007.10.126; Goto Y, 2011, J COLLOID INTERF SCI, V362, P375, DOI 10.1016/j.jcis.2011.06.045; Boschet F, 2014, CHEM REV, V114, P927, DOI 10.1021/cr2002933; Murata T, 2004, J SOL-GEL SCI TECHN, V32, P161, DOI 10.1007/s10971-004-5782-8; Waltz F, 2012, J MATER SCI, V47, P176, DOI 10.1007/s10853-011-5785-0; Dolbier WR, 2005, J FLUORINE CHEM, V126, P157, DOI 10.1016/j.jfluchem.2004.09.033; Girard E, 2012, ACS MACRO LETT, V1, P270, DOI 10.1021/mz2001143; Harmer MA, 1996, J AM CHEM SOC, V118, P7708, DOI 10.1021/ja9541950; Johns K, 2000, J FLUORINE CHEM, V104, P5, DOI 10.1016/S0022-1139(00)00251-7; David G, 2006, CHEM REV, V106, P3936, DOI 10.1021/cr0509612; Kemnitz E, 2011, EUR J INORG CHEM, P4773, DOI 10.1002/ejic.201100539; Kim DS, 2004, J APPL POLYM SCI, V93, P209, DOI 10.1002/app.20451; Ameduri B, 2009, CHEM REV, V109, P6632, DOI 10.1021/cr800187m; Ogoshi T, 2005, J POLYM SCI POL CHEM, V43, P3543, DOI 10.1002/pola.20833; Yao L, 2010, J APPL POLYM SCI, V115, P3500, DOI 10.1002/app.30526; Sel O, 2010, ADV FUNCT MATER, V20, P1090, DOI 10.1002/adfm.200902210; Guo SJ, 2012, J COLLOID INTERF SCI, V387, P141, DOI 10.1016/j.jcis.2012.08.005; Puts GJ, 2014, J FLUORINE CHEM, V168, P9, DOI 10.1016/j.jfluchem.2014.08.012; Chen YC, 2004, J POLYM SCI POL CHEM, V42, P1789, DOI 10.1002/pola.20033; Cho J. W., 2001, FIBER POLYM, V2, P135, DOI 10.1007/BF02875326; Cornelius CJ, 2002, POLYMER, V43, P2385, DOI 10.1016/S0032-3861(01)00803-5; Cui XJ, 2010, COLLOID SURFACE A, V360, P41, DOI 10.1016/j.colsurfa.2010.02.006; Durand N, 2011, LANGMUIR, V27, P4057, DOI 10.1021/la1048826; Fabbri P, 2006, POLYMER, V47, P1055, DOI 10.1016/j.polymer.2005.12.028; Goto Y, 2012, COLLOID POLYM SCI, V290, P11, DOI 10.1007/s00396-011-2509-6; Hsuan Chang T., 2008, EUR POLYM J, V44, P3482; Ishizawa H, 2008, APPL OPTICS, V47, pC200, DOI 10.1364/AO.47.00C200; Koch EC, 2012, METAL-FLUOROCARBON BASED ENERGETIC MATERIALS, P1, DOI 10.1002/9783527644186; Messori M, 2002, EUR POLYM J, V38, P1129, DOI 10.1016/S0014-3057(01)00295-6; Morganl AB, 2007, FIRE MATER, V31, P387, DOI 10.1002/fam.950; Murata T, 2006, APPL OPTICS, V45, P1465, DOI 10.1364/AO.45.001465; Murata T, 2008, APPL OPTICS, V47, pC246, DOI 10.1364/AO.47.00C246; Murata T, 2011, J SOL-GEL SCI TECHN, V60, P125, DOI 10.1007/s10971-011-2566-9; Murata T, 2012, APPL OPTICS, V51, P2298, DOI 10.1364/AO.51.002298; Pantoya M.L., 2009, THERMOCHIM ACTA, V494, P109; Pardal F, 2009, J POLYM SCI POL CHEM, V47, P4617, DOI 10.1002/pola.23513; Puts GJ, 2014, J FLUORINE CHEM, V168, P260, DOI 10.1016/j.jfluchem.2014.05.004; Qui P.S., 2008, J APPL POLYM SCI, V110, P2763; RIGOLO M, 1992, POLYM ENG SCI, V32, P327, DOI 10.1002/pen.760320505; Sawada E, 2010, COMPOS PART B-ENG, V41, P498, DOI 10.1016/j.compositesb.2010.04.002; Sawada H, 2003, J FLUORINE CHEM, V121, P111, DOI 10.1016/S0022-1139(03)00040-X; Sawada H, 2010, B CHEM SOC JPN, V83, P75, DOI 10.1246/bcsj.20090204; Sawada H, 2007, PROG POLYM SCI, V32, P509, DOI 10.1016/j.progpolymsci.2007.02.002; SAWADA H, 1991, J CHEM SOC CHEM COMM, P677, DOI 10.1039/c39910000677; Sawada H, 2007, POLYM J, V39, P637, DOI 10.1295/polymj.PJ2006242; Sawada H, 2008, COLLOID POLYM SCI, V286, P1569, DOI 10.1007/s00396-008-1926-7; Sawada H, 2000, J FLUORINE CHEM, V105, P219, DOI 10.1016/S0022-1139(00)00279-7; Sawada H, 2001, EUR POLYM J, V37, P1433, DOI 10.1016/S0014-3057(01)00005-2; Sawada H, 2001, KOBUNSHI RONBUNSHU, V58, P255; Sawada H, 2001, KOBUNSHI RONBUNSHU, V58, P147; Sawada H, 2012, POLYM CHEM-UK, V3, P46, DOI 10.1039/c1py00325a; Sawada H, 2010, POLYM J, V42, P167, DOI 10.1038/pj.2009.316; Sawada H, 1996, CHEM REV, V96, P1779, DOI 10.1021/cr9411482; Shin J, 2010, COLLOID POLYM SCI, V288, P63, DOI 10.1007/s00396-009-2129-6; Smith jr Dennisw, 2014, HDB FLUOROPOLYMER SC; Wang FY, 2011, J SOL-GEL SCI TECHN, V58, P587, DOI 10.1007/s10971-011-2431-x; Yano S, 1996, MACROMOL SYMP, V108, P279, DOI 10.1002/masy.19961080123	58	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	SEP	2015	177				SI		70	79		10.1016/j.jfluchem.2015.02.003		10	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	CR3SB	WOS:000361252300010		
J	Murakami, A; Nesumi, A; Maeda-Yamamoto, M; Yamaguchi, H; Yashima, K; Miura, M; Nakano, T; Nekoshima, K				Murakami, Akira; Nesumi, Atsushi; Maeda-Yamamoto, Mari; Yamaguchi, Hidekazu; Yashima, Koji; Miura, Masahiro; Nakano, Tsuyoshi; Nekoshima, Kazunori			Anthocyanin-rich tea Sunrouge upregulates expressions of heat shock proteins in the gastrointestinal tract of ICR mice: A comparison with the conventional tea cultivar Yabukita	JOURNAL OF FOOD AND DRUG ANALYSIS			English	Article						anthocyanins; green tea; heat shock protein; self-defense; Sunrouge	CAENORHABDITIS-ELEGANS; GASTRIC-MUCOSA; GREEN TEA; HEME OXYGENASE-1; CARBON-MONOXIDE; STRESS-RESPONSE; IN-VIVO; HEAT-SHOCK-PROTEIN-70; POLYPHENOLS; ACTIVATION	Sunrouge is an anthocyanin-rich, new tea cultivar that contains similar levels of catechins as Yabukita, the most popular tea cultivar consumed in Japan. Interestingly, Sunrouge preparations have previously been shown to have more pronounced acetylcholinesterase inhibitory and anticolitis activities than those of Yabukita. In this study, we examined their effects on expressions of self-defensive molecules, including heat shock proteins (HSPs), which are molecular chaperones involved in homeostasis and longevity. Hot water extract from freeze-dried Sunrouge significantly upregulated messenger RNA (mRNA) expressions of HSP40, HSP70, and HSP32 (heme oxygenase-1), with grades greater than those shown by Yabukita. Oral administration of freeze-dried preparation of Sunrouge to male ICR mice at a dose of 1% in the basal diet for 1 month resulted in marked upregulations of several HSP mRNA expressions in mucosa from the gastrointestinal tract, especially the upper small intestine. Again, its efficacy was remarkably higher than that of Yabukita. Moreover, exposure of Caenorhabditis elegans to Sunrouge conferred thermoresistant phenotype, and also resulted in a significant life-span elongation. Taken together, our results suggest that Sunrouge is a unique and promising tea cultivar for regulating self-defense systems. Copyright (c) 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC. All rights reserved.	[Murakami, Akira] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan; [Nesumi, Atsushi] Natl Agr & Food Res Org, Natl Inst Vegetable & Tea Sci, Kagoshima 8980087, Japan; [Maeda-Yamamoto, Mari] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Yamaguchi, Hidekazu; Yashima, Koji; Miura, Masahiro; Nakano, Tsuyoshi; Nekoshima, Kazunori] Nepuree Corp, Chuo Ku, Tokyo 1040031, Japan	Murakami, A (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan.	cancer@kais.kyoto-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [23005];  [26450156]	This work was supported by Research and Development Projects for Application in Promoting New Policy of Agriculture Forestry and Fisheries, from the Ministry of Agriculture, Forestry and Fisheries of Japan (Grant No. 23005, to all authors), and by a Grant-in-aid for Scientific Research (C) (No. 26450156 to A.M.).	Ahmed K, 2012, INT J HYPERTHER, V28, P1, DOI 10.3109/02656736.2011.627408; Akiyama S, 2012, BIOFACTORS, V38, P226, DOI 10.1002/biof.1008; Maeda-Yamamoto M, 2007, CYTOTECHNOLOGY, V55, P135, DOI 10.1007/s10616-007-9112-1; Mollapour M, 2010, CELL CYCLE, V9, P2310; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Barbagallo I, 2012, CURR PHARM BIOTECHNO, V13, P787; Karlsen A, 2007, J NUTR, V137, P1951; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377; Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013; Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a; Fagone P, 2012, CLIN EXP IMMUNOL, V167, P179, DOI 10.1111/j.1365-2249.2011.04491.x; Renis M, 2008, BRIT J NUTR, V100, P27, DOI 10.1017/S0007114507876239; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Walker GA, 2003, FASEB J, V17, P1960, DOI 10.1096/fj.03-0164fje; Kakuda T, 2002, BIOL PHARM BULL, V25, P1513, DOI 10.1248/bpb.25.1513; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Wu DQ, 2009, EXP GERONTOL, V44, P607, DOI 10.1016/j.exger.2009.06.007; BRENNER S, 1974, GENETICS, V77, P71; Cornelius C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00120; Cox D, 2014, BBA-MOL BASIS DIS, V1842, P1830, DOI 10.1016/j.bbadis.2014.06.024; Dongo E, ACTA PHYSL HUNG; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Frei B, 2003, J NUTR, V133, p3275S; Fujimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023426; Inoue H, 2012, NUTR RES, V32, P357, DOI 10.1016/j.nutres.2012.04.001; Sorensen JG, 2007, EXP GERONTOL, V42, P1123, DOI 10.1016/j.exger.2007.09.001; Maeda-Yamamoto M, 2012, J SCI FOOD AGR, V92, P2379, DOI 10.1002/jsfa.5644; MCALISTER L, 1980, BIOCHEM BIOPH RES CO, V93, P819, DOI 10.1016/0006-291X(80)91150-X; Murakami A, 2013, J CLIN BIOCHEM NUTR, V52, P215, DOI 10.3164/jcbn.12-126; Ohnishi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058641; Ohnishi K, 2013, BIOCHEM BIOPH RES CO, V430, P616, DOI 10.1016/j.bbrc.2012.11.104; Otaka M, 2007, BIOCHEM BIOPH RES CO, V353, P399, DOI 10.1016/j.bbrc.2006.12.031; Saito T, 2011, J AGR FOOD CHEM, V59, P4779, DOI 10.1021/jf200250g; Smid SD, 2012, FOOD FUNCT, V3, P1242, DOI 10.1039/c2fo30075c; Solis GM, 2011, JOVE-J VIS EXP, DOI 10.3791/2496; Subarnas A, 2000, PHYTOMEDICINE, V7, P401; Tachibana H, 2012, J FOOD DRUG ANAL, V20, P313; Yanaka A, 2007, DIGESTION, V75, P148, DOI 10.1159/000106756	39	0	0	FOOD & DRUG ADMINSTRATION	TAIPEI	161-2 KUNYANG STREET, NANGANG, TAIPEI, 00000, TAIWAN	1021-9498			J FOOD DRUG ANAL	J. Food Drug Anal.	SEP	2015	23	3					407	416		10.1016/j.jfda.2014.11.004		10	Food Science & Technology; Pharmacology & Pharmacy	Food Science & Technology; Pharmacology & Pharmacy	CR3TV	WOS:000361256900008		
J	Teramura, H; Iwasaki, M; Ogihara, H				Teramura, Hajime; Iwasaki, Mihoko; Ogihara, Hirokazu			Development of a Novel Chromogenic Medium for Improved Campylobacter Detection from Poultry Samples	JOURNAL OF FOOD PROTECTION			English	Article							SPECTRUM BETA-LACTAMASES; SPP.; CHICKEN; ENUMERATION; IDENTIFICATION; ENRICHMENT; INFECTION; JEJUNI; AGAR; MEAT	The presence of expanded-spectrum beta-lactamase (ESBL)-producing Escherichia coli is a common problem in the isolation of Campylobacter from poultry samples using conventional cefoperazone-based selective media. A novel chromogenic medium (CM-HT), based on modified charcoal cefoperazone deoxycholate agar (mCCDA), has been developed as a solution for improved Campylobacter detection from poultry samples. Although the basic components of CM-HT are the same as mCCDA, CM-HT uses both granular charcoal and sodium cefoxitin to enhance viewability and inhibit ESBL-producing bacteria. All tested Campylobacter jejuni (n = 31) and Campylobacter coli (n = 6) strains grew and formed purple-colored colonies on CM-HT. In contrast, the growth of all other tested microorganisms, including ESBL-producing E. coli strains, was suppressed by this medium. Additionally, 84 poultry samples were examined for the presence of Campylobacter using the ISO 10272-1 method (enrichment with Bolton broth) and the NIHSJ-02 method (enrichment with Preston broth) with mCCDA and CM-HT media for the isolation. The numbers of samples from which Camplylobacter was detected on CM-HT using Preston and Bolton broth were 22 and 18, whereas the numbers on mCCDA were 22 and 13, respectively. Only Campylobacter was detected on CM-HT using both enrichment broths; however, there were 5 and 19 samples from which ESBL-producing E. coli was detected on mCCDA using Preston and Bolton broth, respectively. Thus, there was a significant difference between CM-HT and mCCDA in selectivity for ESBL-producing E. coli regardless of which enrichment broth was used. The results obtained demonstrated that CM-HT is a possible solution for the improved isolation of Campylobacter from poultry samples.	[Teramura, Hajime; Iwasaki, Mihoko] JNC Corp, Yokohama Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 2368605, Japan; [Teramura, Hajime; Ogihara, Hirokazu] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa 2520880, Japan	Teramura, H (reprint author), JNC Corp, Yokohama Res Ctr, Kanazawa Ku, 5-1 Ookawa, Yokohama, Kanagawa 2368605, Japan.	h.teramura@jnc-corp.co.jp					Ahmed R, 2012, J MICROBIOL METH, V88, P304, DOI 10.1016/j.mimet.2011.12.011; Paterson DL, 2001, J CLIN MICROBIOL, V39, P2206, DOI 10.1128/JCM.39.6.2206-2212.2001; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; Taylor EV, 2013, EPIDEMIOL INFECT, V141, P987, DOI 10.1017/S0950268812001744; [Anonymous], 2010, AGENTS SURVEILL REP, V31, P1; Gharst G, 2013, J MICROBIOL METH, V95, P84, DOI 10.1016/j.mimet.2013.07.014; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/jlijfoodmicro.2007.01.006; BOLTON FJ, 1984, J CLIN MICROBIOL, V19, P169; Chon J. W., 2014, J FOOD SCI, V79, P923; Chon JW, 2013, INT J FOOD MICROBIOL, V165, P7, DOI 10.1016/j.ijfoodmicro.2013.04.006; Habib I, 2011, FOOD MICROBIOL, V28, P1117, DOI 10.1016/j.fm.2011.03.001; Hanaki H, 2005, J ANTIBIOT, V58, P69; HOLMES B, 1978, J CLIN PATHOL, V31, P22, DOI 10.1136/jcp.31.1.22; International Organization for Standardization, 2006, 102721 ISO; International Organization for Standardization, 2003, 16140 ISO; Jasson V, 2009, INT J FOOD MICROBIOL, V135, P248, DOI 10.1016/j.ijfoodmicro.2009.09.007; Momose Y., 2006, J AOAC INT, V96, P991; Moran L, 2011, LETT APPL MICROBIOL, V52, P614, DOI 10.1111/j.1472-765X.2011.03046.x; Seliwiorstow T, 2014, J FOOD PROTECT, V77, P2111, DOI 10.4315/0362-028X.JFP-14-237; Shih DYC, 2000, J FOOD PROTECT, V63, P304; SPEED B, 1984, J INFECTION, V8, P85, DOI 10.1016/S0163-4453(84)93516-3; U.S. Food and Drug Administration, 2015, BACT AN MAN ONL; Yoo JH, 2014, INT J FOOD MICROBIOL, V189, P67, DOI 10.1016/j.ijfoodmicro.2014.07.032	23	0	0	INT ASSOC FOOD PROTECTION	DES MOINES	6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA	0362-028X	1944-9097		J FOOD PROTECT	J. Food Prot.	SEP	2015	78	9					1750	1755		10.4315/0362-028X.JFP-15-115		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CR2JE	WOS:000361154300017		
J	Obata, S; Ieiri, S; Uemura, M; Jimbo, T; Souzaki, R; Matsuoka, N; Katayama, T; Hashizume, M; Taguchi, T				Obata, Satoshi; Ieiri, Satoshi; Uemura, Munenori; Jimbo, Takahiro; Souzaki, Ryota; Matsuoka, Noriyuki; Katayama, Tamotsu; Hashizume, Makoto; Taguchi, Tomoaki			An Endoscopic Surgical Skill Validation System for Pediatric Surgeons Using a Model of Congenital Diaphragmatic Hernia Repair	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							LAPAROSCOPIC SURGERY; FUNDAMENTALS; PROGRAM	Purpose: We developed a system to objectively verify the endoscopic surgical skills of pediatric surgeons. Materials and Methods: We developed a thoracoscopic model of congenital diaphragmatic hernia mimicking a newborn's size. The examinees were divided into Experts (n=10) and Trainees (n=19), and each group performed two tasks (Task 1, reduction of a herniated intestine from the thoracic space to the abdomen; Task 2, perform three suture ligatures of a diaphragm defect using intracorporeal knot-tying). The end points were the time required to complete Task 1, time score calculated using the residual time from the time limit for Task 2, number of complete full-thickness sutures, maximum air-pressure tolerance, degree of diaphragm deformation, and the residual defect areas after suturing. We also evaluated the total path length and velocity of the forceps tips using a three-dimensional position measurement instrument. Results: The Experts had significantly superior results for the time for Task 1, time score, number of complete full-thickness sutures, maximum air-pressure tolerance, and degree of diaphragm deformation in Task 2 (all P<.05). We found that the total path length and average velocities for the left forceps were inferior to those of the right forceps in both tasks in the Trainees (both P<.05, respectively), whereas the Expert group showed no significant laterality in these tasks. Conclusions: Our model could validate the quality of endoscopic surgical skills and could differentiate between Expert and Trainee pediatric surgeons. The Experts could use their forceps equally well to perform tasks even in a small working space.	[Obata, Satoshi; Ieiri, Satoshi; Jimbo, Takahiro; Souzaki, Ryota; Taguchi, Tomoaki] Kyushu Univ, Fac Med Sci, Dept Pediat Surg Reprod & Dev Med, Fukuoka 8128582, Japan; [Ieiri, Satoshi; Uemura, Munenori; Souzaki, Ryota; Hashizume, Makoto] Kyushu Univ Hosp, Dept Adv Med & Innovat Technol, Fukuoka 812, Japan; [Matsuoka, Noriyuki; Katayama, Tamotsu] Kyoto Kagaku Co Ltd, Kyoto, Japan	Taguchi, T (reprint author), Kyushu Univ, Fac Med Sci, Dept Pediat Surg Reprod & Dev Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	taguchi@pedsurg.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [25293360]; Japanese Foundation for Research and Promotion of Endoscopy	We thank Brian Quinn for his comments and help with the manuscript. This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI grant 25293360) and a grant from The Japanese Foundation for Research and Promotion of Endoscopy.	Alain JL, 1996, J LAPAROENDOSC SURG, V6, pS41; Peters JH, 2004, SURGERY, V135, P21, DOI 10.1016/S0039-6060(03)00156-9; Scott DJ, 2008, SURG ENDOSC, V22, P1887, DOI 10.1007/s00464-008-9745-y; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; Becmeur François, 2007, Semin Pediatr Surg, V16, P238, DOI 10.1053/j.sempedsurg.2007.06.005; Cho A, 2013, J PEDIATR SURG, V48, P404, DOI 10.1016/j.jpedsurg.2012.11.022; Diao M, 2013, PEDIATR SURG INT, V29, P317, DOI 10.1007/s00383-013-3266-z; HOLCOMB GW, 1991, J PEDIATR SURG, V26, P1186, DOI 10.1016/0022-3468(91)90330-V; Ieiri S, 2010, PEDIATR SURG INT, V26, P947, DOI 10.1007/s00383-010-2665-7; Ieiri S, 2013, PEDIATR SURG INT, V29, P501, DOI 10.1007/s00383-013-3276-x; Iwanaka T, 2011, PEDIATR SURG INT, V27, P727, DOI 10.1007/s00383-011-2871-y; Rothenberg Steven S, 2005, Semin Pediatr Surg, V14, P2, DOI 10.1053/j.sempedsurg.2004.10.020; Uemura M, 2015, SURG ENDOSC, V29, P444, DOI 10.1007/s00464-014-3681-9	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	SEP 1	2015	25	9					775	781		10.1089/lap.2014.0259		7	Surgery	Surgery	CR5IY	WOS:000361375800016		
J	Pashchenko, S; Porapakkarm, P				Pashchenko, Svetlana; Porapakkarm, Ponpoje			Welfare costs of reclassification risk in the health insurance market	JOURNAL OF MACROECONOMICS			English	Article						Health insurance; Reclassification risk; Dynamic insurance; Guaranteed renewable contracts; General equilibrium	REFORM	We assess the quantitative importance of reclassification risk in the US health insurance market. Reclassification risk arises because the health conditions of individuals evolve over time, while a typical health insurance contract only lasts for one year. Thus, a change in the health status can lead to a significant change in the health insurance premium. We measure welfare gains from introducing explicit insurance against this risk in the form of guaranteed renewable health insurance contracts. We find that in the current institutional environment individuals are well-sheltered against reclassification risk and they only moderately gain from having access to these contracts. More specifically, we show that employer-sponsored health insurance and public means-tested transfers play an important role in providing implicit insurance against reclassification risk. If these institutions are removed, the average welfare gains from having access to guaranteed renewable contracts exceed 4% of the annual consumption. (C) 2015 Elsevier Inc. All rights reserved.	[Pashchenko, Svetlana] Univ Surrey, Guildford GU2 7XH, Surrey, England; [Porapakkarm, Ponpoje] Natl Grad Inst Policy Studies GRIPS, Tokyo, Japan	Pashchenko, S (reprint author), Univ Surrey, Fac Business Econ & Law, Sch Econ, Guildford GU2 7XH, Surrey, England.	svetlanap.econ@gmail.com; p-porapakkarm@grips.ac.jp			Research and Development Administration Office at the University of Macau	We thank all seminar participants at the University of Virginia, Federal Reserve Bank of Richmond, QSPS Summer Workshop, PET Meeting in Bloomington, SED Meeting in Ghent, GRIPS, Asian Meeting of the Econometric Society in Seoul, Uppsala University, and especially, Huberto Ennis, John Jones, Ping Wang, Eric Young, and the anonymous referee for their comments and suggestions. The authors acknowledge financial support from the Research and Development Administration Office at the University of Macau. All errors are our own.	French E, 2004, J APPL ECONOMET, V19, P705, DOI 10.1002/jae.790; De Nardi M, 2010, J POLIT ECON, V118, P39; Hansen GD, 2014, J ECON DYN CONTROL, V45, P315, DOI 10.1016/j.jedc.2014.06.006; Hsu MC, 2013, REV ECON DYNAM, V16, P511, DOI 10.1016/j.red.2012.09.001; Jeske K, 2009, J MONETARY ECON, V56, P210, DOI 10.1016/j.jmoneco.2008.12.004; GOUVEIA M, 1994, NATL TAX J, V47, P317; COCHRANE JH, 1995, J POLIT ECON, V103, P445, DOI 10.1086/261991; De Santis M, 2007, AM ECON REV, V97, P1488, DOI 10.1257/aer.97.4.1488; DIAMOND P, 1992, ECONOMETRICA, V60, P1233, DOI 10.2307/2951520; Finkelstein A, 2005, AM ECON REV, V95, P224, DOI 10.1257/000282805774669808; Hendel I, 2003, Q J ECON, V118, P299, DOI 10.1162/00335530360535216; Kahn J., 2005, HEALTH AFFAIR, P24; Kennickell A., 2003, WORKING PAPER; Kiffman M., 2002, INSURING PREMIUM RIS; Pashchenko S, 2013, REV ECON DYNAM, V16, P383, DOI 10.1016/j.red.2012.09.002; PAULY MV, 1995, J RISK UNCERTAINTY, V10, P143, DOI 10.1007/BF01083557; Sommers J., 2002, 14 MEPS AG HEALTHC R	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0164-0704	1873-152X		J MACROECON	J. Macroecon.	SEP	2015	45						21	44		10.1016/j.jmacro.2015.04.003		24	Economics	Business & Economics	CR5SQ	WOS:000361404700002		
J	Ganelli, G; Tervala, J				Ganelli, Giovanni; Tervala, Juha			Value of WTO trade agreements in a New Keynesian model	JOURNAL OF MACROECONOMICS			English	Article						Tariffs; Terms of trade theory; Trade agreement; Trade liberalization; WTO	EXCHANGE-RATE; INTERNATIONAL-TRADE; WORLD-TRADE; TARIFFS; GROWTH; MONETARY; WELFARE; RETALIATION; FRAMEWORK; RETURNS	We revisit the question of the quantitative benefits of WTO trade agreements in a setup that is non-standard from the traditional trade policy point of view. We show that in a New Keynesian model, unilateral trade liberalization reduces welfare due to terms-of-trade deterioration, creating an incentive for a trade agreement. For realistic parameter values, the value of an agreement, which cuts tariffs by one percentage point, is 0.5-2% of consumption, much larger than in trade models. The intuition for this result hinges on endogenous labor supply. (C) 2015 International Monetary Fund. Published by Elsevier Inc. All rights reserved.	[Ganelli, Giovanni] Int Monetary Fund, IMF Reg Off Asia & Pacific, Chiyoda Ku, Tokyo 1000011, Japan; [Tervala, Juha] Univ Helsinki, FIN-00014 Helsinki, Finland	Ganelli, G (reprint author), Int Monetary Fund, IMF Reg Off Asia & Pacific, Chiyoda Ku, Fukoku Seimei Bldg,2-2-2 Uchisaiwai Cho, Tokyo 1000011, Japan.	gganelli@imf.org; juha.tervala@helsinki.fi					Broda C, 2008, AM ECON REV, V98, P2032, DOI 10.1257/aer.98.5.2032; Bagwell K, 1999, AM ECON REV, V89, P215, DOI 10.1257/aer.89.1.215; Melitz MJ, 2012, J ECON PERSPECT, V26, P91, DOI 10.1257/jep.26.2.91; Eaton J, 2002, ECONOMETRICA, V70, P1741, DOI 10.1111/1468-0262.00352; Johnson HG, 1953, REV ECON STUD, V21, P142, DOI 10.2307/2296006; Singh T, 2010, WORLD ECON, V33, P1517, DOI 10.1111/j.1467-9701.2010.01243.x; Bagwell K, 2011, AM ECON REV, V101, P1238, DOI 10.1257/aer.101.4.1238; MANKIW NG, 1986, J MONEY CREDIT BANK, V18, P415, DOI 10.2307/1992462; Keane M, 2012, J ECON LIT, V50, P464, DOI 10.1257/jel.50.2.464; Yi KM, 2003, J POLIT ECON, V111, P52, DOI 10.1086/344805; Bergin PR, 2006, J INT MONEY FINANC, V25, P675, DOI 10.1016/j.jimonfin.2006.04.001; Ossa R, 2011, J POLIT ECON, V119, P122, DOI 10.1086/659371; Head K, 2001, AM ECON REV, V91, P858, DOI 10.1257/aer.91.4.858; Romalis J, 2007, REV ECON STAT, V89, P416, DOI 10.1162/rest.89.3.416; Basu S, 1997, J POLIT ECON, V105, P249, DOI 10.1086/262073; Schmitt-Grohe S, 2007, J MONETARY ECON, V54, P1702, DOI 10.1016/j.jmoneco.2006.07.002; Bagwell K., 2002, EC WORLD TRADING SYS; Caliendo L, 2015, REV ECON STUD, V82, P1, DOI 10.1093/restud/rdu035; CALVO GA, 1983, J MONETARY ECON, V12, P383, DOI 10.1016/0304-3932(83)90060-0; Chetty R., 2013, NBER MACROECON ANNU, V2012, P1; Cirera X., 2013, J EC SURV, V28, P449; Deardorff A.V., 1984, STRUCTURE EVOLUTION; Dollar D, 2004, ECON J, V114, pF22, DOI 10.1111/j.0013-0133.2004.00186.x; Feenstra R., 2014, 20063 NBER; Fender J, 2000, J INT MONEY FINANC, V19, P633, DOI 10.1016/S0261-5606(00)00027-9; Gopinath G, 2008, Q J ECON, V123, P531, DOI 10.1162/qjec.2008.123.2.531; GROS D, 1987, J INT ECON, V23, P357, DOI 10.1016/0022-1996(87)90061-4; Hooper P., 2000, PRINCETON STUDIES IN; Hwang YN, 2013, J INT MONEY FINANC, V33, P81, DOI 10.1016/j.jimonfin.2012.10.004; Ju J., 2012, 18653 NBER; KING RG, 1988, J MONETARY ECON, V21, P195, DOI 10.1016/0304-3932(88)90030-X; Klein P., 2000, J ECON DYN CONTROL, V24, P1223; McCallum B., 2001, SOFTWARE RE ANAL; Obstfeld M., 2007, G7 CURRENT ACCOUNT I; Ossa R, 2014, AM ECON REV, V104, P4104, DOI 10.1257/aer.104.12.4104; Raza W., 2014, ASSESS TIPP ASSESSIN; Reitz S., 2005, SWISS J EC STAT, V141, P285; SVENSSON LEO, 1989, ECON J, V99, P785, DOI 10.2307/2233771; Tervala J, 2012, J INT MONEY FINANC, V31, P356, DOI 10.1016/j.jimonfin.2011.11.019; Tille C., 2001, J INT ECON, V53, P421, DOI 10.1016/S0022-1996(00)00071-4; World Bank, 2014, DATA; WTO, 2014, TAR	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0164-0704	1873-152X		J MACROECON	J. Macroecon.	SEP	2015	45						347	362		10.1016/j.jmacro.2015.06.001		16	Economics	Business & Economics	CR5SQ	WOS:000361404700022		
J	Nunokawa, M; Sokol, J				Nunokawa, Mamoru; Sokol, Janusz			ON AN EXTENSION OF SAKAGUCHI'S RESULT	JOURNAL OF MATHEMATICAL INEQUALITIES			English	Article						Analytic functions; convex functions; univalent functions; Jack's Lemma; Nunokawa's Lemma	CONVEX-FUNCTIONS; ORDER	We improve Pommerenke's result [15] by using a generalized lemma from [11]. It gives an extension of Sakaguchi's result too, [18]. Several applications of main theorems are presented. A part of them improves the previous results of this type. We consider also Sakaguchi's result under different type of the assumptions.	[Nunokawa, Mamoru] Gunma Univ, Chuou Ward, Chiba 2600808, Japan; [Sokol, Janusz] Rzeszow Univ Technol, Dept Math, PL-35959 Rzeszow, Poland	Nunokawa, M (reprint author), Gunma Univ, Chuou Ward, Hoshikuki Cho 798-8, Chiba 2600808, Japan.	mamoru_nuno@doctor.nifty.jp; jsokol@prz.edu.pl					LIBERA RJ, 1965, P AM MATH SOC, V16, P755, DOI 10.2307/2033917; Fukui S., 1980, B FAC ED WAKAYAMA U, V29, P1; Goodman A. W., 1983, UNIVALENT FUNCTIONS, VII; JACK IS, 1971, J LOND MATH SOC, V3, P469; Kaplan W., 1952, MICH MATH J, V1, P169; LEWANDOWSKI Z., 1958, ANN U M CURIESKLOD A, V12, P131; LEWANDOWSKI Z., 1960, ANN U M CURIESKLODOW, V14, P19; MACGREGOR TH, 1975, J LOND MATH SOC, V9, P530; Mocanu P.T., 2000, SERIES MONOGRAPHS TX, V225; Mocanu PT, 1986, PREPRINT, V5, P91; NUNOKAWA M, 1993, P JPN ACAD A-MATH, V69, P234; Nunokawa M, 2011, COMPUT MATH APPL, V61, P1291, DOI 10.1016/j.camwa.2010.12.050; NUNOKAWA M, 1992, P JPN ACAD A-MATH, V68, P152; OZAKI S., 1935, SCI REP TOKYO BUNR A, V2, P167; POMMERENKE CH., 1969, T AM MATH SOC, V114, P176; PONNUSMY S., 1989, COMPLEX VAR THEORY A, V11, P79, DOI 10.1080/17476938908814326; READE MO, 1956, DUKE MATH J, V23, P459, DOI 10.1215/S0012-7094-56-02342-0; SAKAGUCHI K., 1959, J MATH SOC JAPAN, V11, P72, DOI DOI 10.2969/JMSJ/01110072; Sokol J., 2007, Applied Mathematics and Computation, V190, DOI 10.1016/j.amc.2007.01.034; Sokol J, 2011, MATH NACHR, V284, P1547, DOI 10.1002/mana.200910074; Sokol J, 2008, APPL MATH COMPUT, V203, P273, DOI 10.1016/j.amc.2008.04.036; STUDY E., 1913, KONFORME ABBILDUNG E; UMEZAWA T., 1955, TOHOKU MATH J, V7, P212, DOI 10.2748/tmj/1178245060; UMEZAWA T., 1957, P AM MATH SOC, V8, P869, DOI 10.2307/2033681	24	0	0	ELEMENT	ZAGREB	R AUSTRIJE 11, 10000 ZAGREB, CROATIA	1846-579X			J MATH INEQUAL	J. Math. Inequal.	SEP	2015	9	3					683	697		10.7153/jmi-09-57		15	Mathematics, Applied; Mathematics	Mathematics	CR4OG	WOS:000361313300004		
J	Okayasu, M; Fukui, H				Okayasu, Mitsuhiro; Fukui, Hironobu			Effects of cyclic loading on fatigue properties of austenite stainless steel	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						A stainless steel; Fatigue strength; Failure characteristic; Frequency; Stress ratio	STRENGTH; LIFE	Fatigue properties of stainless steels have been investigated by various researchers. The present work examined fatigue properties under various cyclic loading conditions to determine the significant factors of loading condition to fatigue strength (sigma(e)). From this approach, no clear frequency effects on the S-N (f) relation were detected, but clear R-ratio effects were identified on fatigue strength. A higher R-ratio yielded higher sigma(e), and a clear correlation was observed between R-ratio and endurance limit. A different trend was observed for the S-N (f) curve when the stress value on the ordinate of the S-N f relation was plotted using the maximum tensile stress (sigma(max)). However, the S-N (f) curves obtained overlaid each other when using stress amplitude (sigma(a)) instead of sigma(max). Fatigue properties were analyzed further using several relations proposed previously, such as modified Goodman relation. In this case, the fatigue data obtained were clearly approximated by an elliptical relation. Severe microstructural damage arising from plastic deformation was observed in the sample fractured under the R = -1 condition, where striation was a main failure mode. In contrast, no clear microstructural damages were observed in the samples fractured at R = 0.1 even when a higher maximum tensile stress was applied (e.g., sigma(max) = 60% sigma(UTS)), where ripple-like failure was the dominant feature.	[Okayasu, Mitsuhiro; Fukui, Hironobu] Ehime Univ, Dept Mat Sci & Engn, Matsuyama, Ehime 7908577, Japan	Okayasu, M (reprint author), Ehime Univ, Dept Mat Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	mitsuhiro.okayasu@utoronto.ca					Akai A., 2012, J SOC MAT SCI JPN, V61, P953; Liaw PK, 2000, SCRIPTA MATER, V42, P389, DOI 10.1016/S1359-6462(99)00358-9; Morrissey RJ, 1999, INT J FATIGUE, V21, P679, DOI 10.1016/S0142-1123(99)00030-4; Strizak JP, 2005, J NUCL MATER, V343, P134, DOI 10.1016/j.jnucmat.2005.03.019; ASM International, 2008, EL MET ENG ALL 5224G, P224; Dieter G. E., 1986, MECHANICAL METALLURG, V3<SUP>rd</SUP>, P383; Hasunuma S., 2011, T JPN SOC MECH ENG, V77, P843; Hertzberg R. W., 1996, DEFORMATION FRACTURE, V4<SUP>th</SUP>, p[276, 535]; Kwofie S, 2001, INT J FATIGUE, V23, P829, DOI 10.1016/S0142-1123(01)00044-5; Pereira H. F. S. G., 2008, CIENCIA TECNOLOGIA M, V20, P60; Sines G., 1959, METAL FATIGUE, P298; Suresh S., 2004, FATIGUE MAT, V2<SUP>nd</SUP>, P242; Susmel L, 2005, INT J FATIGUE, V27, P928, DOI 10.1016/j.ijfatigue.2004.11.012; Tokaji K., 1985, Journal of the Society of Materials Science, Japan, V34; Underhill PR, 2006, INT J ADHES ADHES, V26, P62, DOI 10.1016/j.ijadhadh.2005.03.006	15	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	SEP	2015	29	9					3663	3668		10.1007/s12206-015-0810-x		6	Engineering, Mechanical	Engineering	CR6JW	WOS:000361453800012		
J	Ohnishi, T; Suzuki, M; Kobayashi, T; Naomoto, S; Sukegawa, T; Nawata, A; Haneishil, H				Ohnishi, Takashi; Suzuki, Masahiko; Kobayashi, Tatsuya; Naomoto, Shinji; Sukegawa, Tomoyuki; Nawata, Atsushi; Haneishi, Hideaki			Motion Analysis of the Femorotibial and Patellofemoral Joints Using a 2D/3D Registration Technique	JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS			English	Article						Knee Joint; 2D/3D Registration; Bi-Plane Fluoroscopic Images; Computed Tomography; Kinetics; Knee Osteoarthritis	IN-VIVO; TIBIOFEMORAL KINEMATICS; KNEE KINEMATICS; PATELLA; MODELS; MRI; FLUOROSCOPY; TRACKING; FLEXION	The in vivo kinematics of the knee joint has been analyzed by multiple approaches. In order to obtain the knee potion with the weight-bearing characteristic, a 2D/3D registration technique has been used. Whereas many studies have analyzed the femorotibial (FT) joint, only a few studies have reported a motion analysis for the patellofemoral (PF) joint. This paper focuses on the motions of both the FT and PF joints with the weight-bearing characteristic. An image acquisition test is conducted with weight-bearing for healthy subjects (n = 10) and patients with knee osteoarthritis (OA) (n = 10). The knee motions of the FT and PF joints are analyzed using the distribution area (DA) of a facet space map, percentage of short facet space (PS), weighted center position of the facet space map and average space distance (ASD) at 10 degree intervals of the flexion angle. In the case of knee OA patients, most ASDs of the PF joint were over 1 mm shorter than those of the healthy subjects. DAs of the PF facet space maps of the patient group were twice as large as those of the healthy group at 20 and 30 degree flexion angles. PSs of the PF joint of the patient group were over 2.5% from 10 to 40 degree flexion angles. This paper shows that the knee OA narrows the facet spaces of both FT and PF joints. In particular, the short facet space appears for the PF joint in knee OA patients.	[Ohnishi, Takashi; Suzuki, Masahiko; Haneishi, Hideaki] Chiba Univ, Ctr Frontier Med Engn, Inage Ku, Chiba 2638522, Japan; [Kobayashi, Tatsuya] Chiba Univ, Grad Sch Med, Chuo Ku, Chiba 260877, Japan; [Naomoto, Shinji; Sukegawa, Tomoyuki; Nawata, Atsushi] Alcare Co Ltd, Sumida Ku, Tokyo 1310046, Japan	Ohnishi, T (reprint author), Chiba Univ, Ctr Frontier Med Engn, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.				Japan Science and Technology Agency; Japan Society for the Promotion of Science	This paper was partly supported by the Japan Science and Technology Agency and the Japan Society for the Promotion of Science.	Li GA, 2006, J BONE JOINT SURG AM, V88A, P1826, DOI 10.2106/JBJS.E.00539; Moro-Oka T, 2007, J ORTHOP RES, V25, P867, DOI 10.1002/jor.20355; Hamai S, 2009, J ORTHOP RES, V27, P1555, DOI 10.1002/jor.20928; Seisler AR, 2007, IEEE T BIO-MED ENG, V54, P1333, DOI 10.1109/TBME.2007.890735; Nha KW, 2008, J ORTHOP RES, V26, P1067, DOI 10.1002/jor.20554; Tennant S, 2001, KNEE SURG SPORT TR A, V9, P155; Penney GP, 1998, IEEE T MED IMAGING, V17, P586, DOI 10.1109/42.730403; Hinterwimmer S, 2004, CLIN BIOMECH, V19, P704, DOI 10.1016/j.clinbiomech.2004.04.011; Li GA, 2005, AM J SPORT MED, V33, P102, DOI 10.1177/036354650235577; Komistek RD, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000062384.79828.3b; Kozanek M, 2009, J BIOMECH, V42, P1877, DOI 10.1016/j.jbiomech.2009.05.003; Moro-Oka TA, 2008, J ORTHOP RES, V26, P428, DOI 10.1002/jor.20488; DeFrate LE, 2004, J BIOMECH, V37, P1499, DOI 10.1016/j.jbiomech.2004.01.012; Ariumi A, 2010, J ORTHOP SCI, V15, P64, DOI 10.1007/s00776-009-1414-z; ASANO T, 2001, CLINORTHOPAEDICS REL, V388, P157, DOI 10.1097/00003086-200107000-00023; Eisenhart-Rothe R., 2004, J BIOMECH, V37, P927; Eisenhart-Rothe R, 2004, J ORTHOP RES, V22, P275; Gonzalez R. C., 2002, DIGITAL IMAGE PROCES, P613; Grood W. E., 1983, J BIOMECHANICAL ENG, V105, P136; Hill PF, 2000, J BONE JOINT SURG BR, V82B, P1196, DOI 10.1302/0301-620X.82B8.10716; KUJALA UM, 1989, ACTA ORTHOP SCAND, V60, P13, DOI 10.3109/17453678909150081; Lacroute P, 1994, COMPUTER GRAPHICS, V28, P451; Li G, 2007, J BIOMECH ENG-T ASME, V129, P937, DOI 10.1115/1.2803267; Mori Shinichiro, 2009, Radiol Phys Technol, V2, P40, DOI 10.1007/s12194-008-0040-3; Nakagawa S, 2000, J BONE JOINT SURG BR, V82B, P1199, DOI 10.1302/0301-620X.82B8.10718; Press W. H., 1992, NUMERICAL RECIPES C, P412; Yamada Y, 2007, J BONE JOINT SURG BR, V89B, P752, DOI 10.1302/0301-620X.89B6.18515; Yamazaki T, 2007, IFMBE PROC, V14, P2793	28	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2156-7018	2156-7026		J MED IMAG HEALTH IN	J. Med. Imaging Health Inform.	SEP	2015	5	5					918	925		10.1166/jmihi.2015.1477		8	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	CR3ZP	WOS:000361271900005		
J	Kwoh, CK; Li, XL; Zheng, J; Cho, SB				Kwoh, Chee Keong; Li, Xiaoli; Zheng, Jie; Cho, Sung-Bae			A Special Section on Computational Systems for Medical and Health Informatics	JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS			English	Editorial Material									[Kwoh, Chee Keong] Nanyang Technol Univ, Sch Comp Engn, Singapore, Singapore; [Kwoh, Chee Keong] Nanyang Technol Univ, Biomed Engrg Res Ctr, Singapore, Singapore; [Li, Xiaoli] Inst Infocomm Res, Machine Learning Lab, Singapore, Singapore; [Li, Xiaoli] Natl Univ Singapore, Singapore 117548, Singapore; [Li, Xiaoli] Nanyang Technol Univ, Singapore, Singapore; [Zheng, Jie] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [Cho, Sung-Bae] Yonsei Univ, Seoul 120749, South Korea; [Cho, Sung-Bae] Adv Telecommun Res ATR Inst, Human Informat Proc Res Labs, Kyoto, Japan; [Cho, Sung-Bae] Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea							Fong S, 2015, J MED IMAG HEALTH IN, V5, P1093, DOI 10.1166/jmihi.2015.1501; Okada M, 2015, J MED IMAG HEALTH IN, V5, P1104, DOI 10.1166/jmihi.2015.1503; Paul M, 2015, J MED IMAG HEALTH IN, V5, P1099, DOI 10.1166/jmihi.2015.1502; Verma TN, 2015, J MED IMAG HEALTH IN, V5, P1088, DOI 10.1166/jmihi.2015.1500	4	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2156-7018	2156-7026		J MED IMAG HEALTH IN	J. Med. Imaging Health Inform.	SEP	2015	5	5					1084	1087		10.1166/jmihi.2015.1499		4	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	CR3ZP	WOS:000361271900027		
J	Okada, M; Ito, T; Ohwada, H; Aoki, S				Okada, Masato; Ito, Tadasuke; Ohwada, Hayato; Aoki, Shin			Docking Score Calculation Using Machine Learning with an Enhanced Inhibitor Database	JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS			English	Article						Drug Discovery; In Silico Screening; Machine Learning; SVM	SUPPORT-VECTOR-MACHINE	This paper describes a machine-learning method for docking score calculation with the Database of Useful Decoys: Enhanced (DUD-E). This database includes both good inhibitors (ligands) and poor inhibitors (decoys), allowing machine learning to predict appropriate docking scores of a ligand and the associated decoys. This property enables us to find new inhibitor candidates with high accuracy and to screen many compounds with excellent performance. The proposed method can also be applied to any enzymes without the use of the molecular structure of an enzyme, outperforming a number of traditional docking software tools in both predictive accuracy and generality. We selected 10 enzymes from DUD-E and conducted a comparative study using two docking software tools. The classification performance was obtained from an experiment where 2869 ligands were predicted from 2985 actual ligands, and 8923 decoys were predicted from 8955 registered decoys. Such excellent performance is visualized by Receiver Operating Characteristic (ROC) curves at various threshold settings.	[Okada, Masato; Ito, Tadasuke; Ohwada, Hayato] Tokyo Univ Sci, Dept Ind Adm, Chiba 2788510, Japan; [Aoki, Shin] Tokyo Univ Sci, Dept Med & Life Sci, Chiba 2788510, Japan	Ohwada, H (reprint author), Tokyo Univ Sci, Dept Ind Adm, Chiba 2788510, Japan.						Springer C, 2005, J MED CHEM, V48, P6821, DOI 10.1021/jm0493360; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Okamoto M, 2010, BIOORGAN MED CHEM, V18, P2728, DOI 10.1016/j.bmc.2010.02.018; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Jorissen RN, 2005, J CHEM INF MODEL, V45, P549, DOI 10.1021/ci049641u; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Borman S, 2005, CHEM ENG NEWS, V83, P28; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Gaulton A., 2012, NUCLEIC ACIDS RES, V40, P1100, DOI DOI 10.1093/NAR/GKR777; Geppert H, 2008, J CHEM INF MODEL, V48, P742, DOI 10.1021/ci700461s; Hanaya K, 2012, J BIOL INORG CHEM, V17, P517, DOI 10.1007/s00775-012-0873-4; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Okada M., 2011, P 2 INT C ENG MET EN, P94; Okada M., 2013, 5 INT C BIOINF COMP, P125; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334	16	1	1	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2156-7018	2156-7026		J MED IMAG HEALTH IN	J. Med. Imaging Health Inform.	SEP	2015	5	5					1104	1107		10.1166/jmihi.2015.1503		4	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	CR3ZP	WOS:000361271900031		
J	Kanno, K; Suzuki, K; Owada, M; Suzuki, H				Kanno, Kiyoshi; Suzuki, Kazuo; Owada, Makoto; Suzuki, Hiroshi			Minimally Invasive Laparoscopic Surgery in a Patient With Wunderlich Syndrome	JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY			English	Editorial Material									[Kanno, Kiyoshi] Fukushima Med Univ, Dept Obstet & Gynecol, Fukushima, Fukushima 9601295, Japan; [Suzuki, Kazuo; Owada, Makoto; Suzuki, Hiroshi] Jusendo Gen Hosp Yuasa Fdn, Dept Obstet & Gynecol, Fukushima, Japan	Kanno, K (reprint author), Fukushima Med Univ, Dept Obstet & Gynecol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	less_is_more71@yahoo.co.jp					Tong JL, 2013, INT J GYNECOL OBSTET, V121, P173, DOI 10.1016/j.ijgo.2012.11.023; Fedele L, 2005, FERTIL STERIL, V83, P432, DOI 10.1016/j.fertnstert.2004.07.966; Falcone T, 1997, HUM REPROD, V12, P263, DOI 10.1093/humrep/12.2.263	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1553-4650	1553-4669		J MINIM INVAS GYN	J. Mimim. Invasive Gynecol.	SEP-OCT	2015	22	6					925	926		10.1016/j.jmig.2015.01.024		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CR5ZN	WOS:000361423000003		
J	Hirata, T; Nakazawa, A; Fukuda, S; Hirota, Y; Izumi, G; Takamura, M; Harada, M; Koga, K; Wada-Hiraike, O; Fujii, T; Osuga, Y				Hirata, Tetsuya; Nakazawa, Akari; Fukuda, Shinya; Hirota, Yasushi; Izumi, Gentaro; Takamura, Masashi; Harada, Miyuki; Koga, Kaori; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka			Four Cases of Postoperative Pneumothorax Among 2814 Consecutive Laparoscopic Gynecologic Surgeries: A Possible Correlation Between Postoperative Pneumothorax and Endometriosis	JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY			English	Article						Endometriosis; Laparoscopic surgery; Postoperative pneumothorax	THORACIC ENDOMETRIOSIS; CATAMENIAL PNEUMOTHORAX; MAJOR COMPLICATIONS; BILATERAL PNEUMOTHORAX; RISK-FACTORS	Study Objectives: To evaluate the frequency of pneumothorax after laparoscopic surgery and to identify possible correlations to endometriosis. Design: Retrospective review. Setting: Tokyo University Hospital between 2006 and 2013. Patients: Four patients among a total of 2814 patients with a postoperative pneumothorax. Intervention: Laparoscopic surgery for gynecologic benign disease. The main outcome was the clinical frequency and characteristics of the patients with postoperative pneumothorax. Measurements and Main Results: We observed 4(0.14%) cases of postoperative pneumothorax after laparoscopic surgery, all of whom were diagnosed with endometriomas and developed a right-sided pneumothorax. The incidence of postoperative pneumothorax in 1097 patients with endometriomas was 0.36%, which was significantly higher than those without endometriomas. Conclusion: The presence of endometrioma should be considered a risk factor for postoperative pneumothorax in gynecologic laparoscopic surgery. (C) 2015 AAGL. All rights reserved.	[Hirata, Tetsuya; Nakazawa, Akari; Fukuda, Shinya; Hirota, Yasushi; Izumi, Gentaro; Takamura, Masashi; Harada, Miyuki; Koga, Kaori; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 1138655, Japan	Hirata, T (reprint author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	thira-tky@umin.ac.jp			Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science, and Technology [26462477]; Takeda Science Foundation; Kanae Foundation for the promotion of medical science; Terumo Life Science Foundation; Uehara Memorial Foundation; Kanzawa Medical Research Foundation	The authors would like to thank Enago (www.enago.jp) for the English language review. This study was partly supported by grants from the Ministry of Health, Labour and Welfare, the Ministry of Education, Culture, Sports, Science, and Technology (26462477), Takeda Science Foundation, Kanae Foundation for the promotion of medical science, Terumo Life Science Foundation, the Uehara Memorial Foundation, and the Kanzawa Medical Research Foundation.	Korom S, 2004, J THORAC CARDIOV SUR, V128, P502, DOI 10.1016/j.jtcvs.2004.04.039; Johnston K, 2007, J MINIM INVAS GYN, V14, P339, DOI 10.1016/j.jmig.2006.12.003; Joseph J, 1996, AM J MED, V100, P164, DOI 10.1016/S0002-9343(97)89454-5; Chapron C, 1998, HUM REPROD, V13, P867, DOI 10.1093/humrep/13.4.867; Murdock CM, 2000, OBSTET GYNECOL, V95, P704, DOI 10.1016/S0029-7844(00)00781-X; Alifano M, 2003, CHEST, V124, P1004, DOI 10.1378/chest.124.3.1004; Jansen FW, 1997, BRIT J OBSTET GYNAEC, V104, P595, DOI 10.1111/j.1471-0528.1997.tb11539.x; Haga T, 2014, LUNG, V192, P583, DOI 10.1007/s00408-014-9598-1; HarkkiSiren P, 1997, OBSTET GYNECOL, V89, P108, DOI 10.1016/S0029-7844(96)00390-0; de Tayrac R, 2001, J AM ASSOC GYN LAP, V8, P291, DOI 10.1016/S1074-3804(05)60593-2; GARCIAPADIAL J, 1994, J AM ASSOC GYN LAP, V2, P97, DOI 10.1016/S1074-3804(05)80840-0; Graybill WS, 2012, GYNECOL ONCOL, V125, P556, DOI 10.1016/j.ygyno.2012.03.020; Gueret G, 1999, ANESTHESIOLOGY, V91, P1179, DOI 10.1097/00000542-199910000-00044; Kumakiri J, 2010, J MINIM INVAS GYN, V17, P593, DOI 10.1016/j.jmig.2010.04.011; Kumakiri J, 2008, FERTIL STERIL, V90; Kyo S, 2012, ARCH GYNECOL OBSTET, V286, P411, DOI 10.1007/s00404-012-2313-7; Mekaru K, 2009, ARCH GYNECOL OBSTET, V280, P157, DOI 10.1007/s00404-008-0866-2; Nezhat C, 2009, J MINIM INVAS GYN, V16, P573, DOI 10.1016/j.jmig.2009.06.012; Nezhat C, 2014, JSLS, V18; Rousset-Jablonski C, 2011, HUM REPROD, V26, P2322, DOI 10.1093/humrep/der189; Solomon ER, 2013, AM J OBSTET GYNECOL, V208; Soriano D, 2012, J MINIM INVAS GYN, V19, P742, DOI 10.1016/j.jmig.2012.08.773; Tian YF, 2007, J MINIM INVAS GYN, V14, P284, DOI 10.1016/j.jmig.2006.10.011; VS Y, 2014, J CLIN DIAGN RES, V8, pGD01; Wang PH, 2001, J AM ASSOC GYN LAP, V8, P68, DOI 10.1016/S1074-3804(05)60551-8; Weerasekera DS, 2010, SRI LANKA J OBSTET G, V32, P67	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1553-4650	1553-4669		J MINIM INVAS GYN	J. Mimim. Invasive Gynecol.	SEP-OCT	2015	22	6					980	984		10.1016/j.jmig.2015.04.023		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CR5ZN	WOS:000361423000015		
J	Shigetomi, H; Oka, K; Seki, T; Kobayashi, H				Shigetomi, Hiroshi; Oka, Kiyoshi; Seki, Takeshi; Kobayashi, Hiroshi			Design and Preclinical Validation of the Composite-Type Optical Fiberscope for Minimally Invasive Procedures of Intrauterine Disease	JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY			English	Article						Composite-type optical fiberscope; Ablation; Fiberscope; Laser; Minimally invasive procedure	HYSTEROSCOPIC MYOMECTOMY; CANCER; MINIHYSTEROSCOPY; METAANALYSIS	Study Objective: Because of the rapid growth of minimally invasive surgical procedures, we developed an ultrathin fiberscopic imaging system for laser surgery that could be an important instrument for clinical use in an office setting. Methods and Main Results: A new device, consisting of a custom 1.1-mm diameter flexible fiberscope and ytterbium laser-supported ablation system (composite-type optical fiberscope), has been developed to achieve accurate laser irradiation for minimally invasive procedures of intrauterine disease. This system was validated ex vivo with successful laser ablation under observation. This study provides the design, characterization, performance, and preclinical validation of an optimized composite-type optical fiberscope system. The validation of this fiberscope for endometrial ablation was performed in 12 hysterectomy samples. The irradiated spot diameter and depth were (mean +/- SD) 2.80 +/- 0.28 mm and 1.53 +/- 0.58 mm, respectively, in the range of 185 to 400 J. The effects of the laser on endometrial tissue depended strongly on the combined effects of the output power density and duration of irradiation. The new device makes it possible to perform accurate ablation, because our technology concentrated on combining the 2 subsystems into a single prototype capable of simultaneously observing both the endometrial lesion and the laser spot on a monitor. Conclusions: In conclusion, the feasibility and performance of the composite-type fiberscope system were demonstrated in preclinical studies. (C) 2015 AAGL. All rights reserved.	[Shigetomi, Hiroshi; Oka, Kiyoshi; Kobayashi, Hiroshi] Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 6348522, Japan; [Seki, Takeshi] Akita Univ, Grad Sch Engn & Resource Sci, Dept Mech Engn, Akita 010, Japan	Kobayashi, H (reprint author), Nara Med Univ, Dept Obstet & Gynecol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	hirokoba@naramed-u.ac.jp			Ministry of Education, Science, and Culture of Japan [23390391]; Ministry of Economy, Trade, and Industry, Japan	The present study was supported by grant-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan to the Department of Obstetrics and Gynecology, Nara Medical University (to H.K., No. 23390391). This study was also funded by Ministry of Economy, Trade, and Industry, Japan as a part of "Program to support collaboration between hospitals and businesses for development and improvement of medical equipment and devices to solve unmet medical needs (supplementary budget, 2010FY)."	Keane MG, 2014, WORLD J GASTROENTERO, V20, P2267, DOI 10.3748/wjg.v20.i9.2267; Cicinelli E, 2003, J AM ASSOC GYN LAP, V10, P399, DOI 10.1016/S1074-3804(05)60272-1; Cicinelli E, 2010, J MINIM INVAS GYN, V17, P703, DOI 10.1016/j.jmig.2010.07.003; van Dongen H, 2007, BJOG-INT J OBSTET GY, V114, P664, DOI 10.1111/j.1471-0528.2007.01326.x; Ubaldi F, 1995, HUM REPROD UPDATE, V1, P81, DOI 10.1093/humupd/1.1.81; Sardo ADS, 2008, HUM REPROD UPDATE, V14, P101, DOI 10.1093/humupd/dmm041; Bai YJ, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-301; Brian MM, 2014, JSLS, V18; Jacobs VR, 2005, J MINIM INVAS GYN L, V12, P426, DOI 10.1016/j.jmig.2005.06.013; Knavel Erica M, 2013, Tech Vasc Interv Radiol, V16, P192, DOI 10.1053/j.tvir.2013.08.002; Sandulache Vlad C, 2014, Rambam Maimonides Med J, V5, pe0012, DOI 10.5041/RMMJ.10146; Lee Ted, 2014, Rev Urol, V16, P55; Li CH, 2014, MICROMACHINES-BASEL, V5, P432, DOI 10.3390/mi5030432; Luyten A, 2014, GYNECOL ONCOL, V135, P217, DOI 10.1016/j.ygyno.2014.08.019; Oka K, 2011, SURG ENDOSC, V25, P2368, DOI 10.1007/s00464-010-1540-x; PINION SB, 1994, BRIT MED J, V309, P979; Ross JW, 2000, J AM ASSOC GYN LAP, V7, P221, DOI 10.1016/S1074-3804(00)80044-4; Seibold Leonard K, 2015, Middle East Afr J Ophthalmol, V22, P18, DOI 10.4103/0974-9233.148344; Venugopal V, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126018	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1553-4650	1553-4669		J MINIM INVAS GYN	J. Mimim. Invasive Gynecol.	SEP-OCT	2015	22	6					985	991		10.1016/j.jmig.2015.04.024		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CR5ZN	WOS:000361423000016		
J	Ikutomi, M; Sahara, M; Nakajima, T; Minami, Y; Morita, T; Hirata, Y; Komuro, I; Nakamura, F; Sata, M				Ikutomi, Masayasu; Sahara, Makoto; Nakajima, Toshiaki; Minami, Yoshiyasu; Morita, Toshihiro; Hirata, Yasunobu; Komuro, Issei; Nakamura, Fumitaka; Sata, Masataka			Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Endothelial progenitor cell; Monocrotaline; Post-angioplasty restenosis; Pulmonary arterial hypertension; Vascular disease	GROWTH-FACTOR; MONOCROTALINE PYRROLE; ANGIOGENIC PROPERTIES; GENE-THERAPY; TRANSPLANTATION; INSIGHTS; INJURY; RATS; SUBPOPULATIONS; TRANSFUSION	Aims: It is still controversial whether bone marrow (BM)-derived endothelial progenitor cells (EPCs) can contribute to vascular repair and prevent the progression of vascular diseases. We aimed to characterize BM-derived EPC subpopulations and to evaluate their therapeutic efficacies to repair injured vascular endothelium of systemic and pulmonary arteries. Methods and results: BM mononuclear cells of Fisher-344 rats were cultured under endothelial cell-conditions. Early EPCs appeared on days 3-6. Late-outgrowth and very late-outgrowth EPCs (LOCs and VLOCs) were defined as cells forming cobblestone colonies on days 9-14 and 17-21, respectively. Among EPC subpopulations, LOCs showed the highest angiogenic capability with enhanced proliferation potential and secretion of proangiogenic proteins. To investigate the therapeutic effects of these EPCs, Fisher-344 rats underwent wire-mediated endovascular injury in femoral artery (FA) and were concurrently injected intraperitoneally with 60 mg/kg monocrotaline (MCI). Injured rats were then treated with six injections of one of three EPCs (1 x 10(6) per time). After 4 weeks, transplanted LOCs, but not early EPCs or VLOCs, significantly attenuated neointimal lesion formation in injured FAs. Some of CD31(+) LOCs directly replaced the injured FA endothelium (replacement ratio: 11.7 +/- 7.0%). In contrast, any EPC treatment could neither replace MCT-injured endothelium of pulmonary arterioles nor prevent the progression of pulmonary arterial hypertension (PAH). LOCs modified protectively the expression profile of angiogenic and inflammatory genes in injured FAs, but not in MCT-injured lungs. Conclusion: BM-derived LOCs can contribute to vascular repair of injured systemic artery; however, even they cannot rescue injured pulmonary vasculature under MCT-induced PAH. (C) 2015 Elsevier Ltd. All rights reserved.	[Ikutomi, Masayasu; Sahara, Makoto; Nakajima, Toshiaki; Minami, Yoshiyasu; Morita, Toshihiro; Hirata, Yasunobu; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Ikutomi, Masayasu; Nakamura, Fumitaka] Teikyo Univ, Chiba Med Ctr, Dept Cardiol, Chiba 2990111, Japan; [Sahara, Makoto] Karolinska Inst, Dept Med Cardiol Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Sata, Masataka] Univ Tokushima, Grad Sch Med, Inst Hlth Biosci, Dept Cardiovasc Med, Tokushima 7708503, Japan	Sahara, M (reprint author), Karolinska Inst, Dept Med Cardiol Cell & Mol Biol, SE-17177 Stockholm, Sweden.	makoto.sahara@ki.se			Ministry of Education, Culture, Sports, Science and Technology of Japan [19390207]; Japan Heart Foundation; Japan Research Promotion Society for Cardiovascular Disease; Public Trust Cardiovascular Research Fund	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan [#19390207 to M. Sata] and by a research fellowship from Japan Heart Foundation, Japan Research Promotion Society for Cardiovascular Disease, and Public Trust Cardiovascular Research Fund to M. Sahara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Zhu JH, 2008, PEDIATR TRANSPLANT, V12, P650, DOI 10.1111/j.1399-3046.2007.00863.x; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Yang NN, 2011, CYTOTECHNOLOGY, V63, P217, DOI 10.1007/s10616-010-9329-2; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; CORY AH, 1991, CANCER COMMUN, V3, P207; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Wang SH, 2009, ARTERIOSCL THROM VAS, V29, P816, DOI 10.1161/ATVBAHA.109.184739; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Sahara M, 2007, CIRCULATION, V115, P509, DOI 10.1161/CIRCULATIONAHA.106.655837; Santhanam AVR, 2007, CIRC RES, V100, P1379, DOI 10.1161/01.RES.0000265848.55035.5d; Wang XG, 2007, J AM COLL CARDIOL, V49, P1566, DOI 10.1016/j.jacc.2006.12.037; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Shantsila E, 2008, J AM COLL CARDIOL, V51, P669, DOI [10.1016/j.jacc.2007.09.057, 10.1016/j.jacc.2007.09.OS7]; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157572.70560.7b; Sahara M, 2010, ARTERIOSCL THROM VAS, V30, P1315, DOI 10.1161/ATVBAHA.109.201327; Takahashi M, 2004, TISSUE ENG, V10, P771, DOI 10.1089/1076327041348563; Sahara M, 2014, CELL RES, V24, P820, DOI 10.1038/cr.2014.59; YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313; Hagensen MK, 2010, CIRCULATION, V121, P898, DOI 10.1161/CIRCULATIONAHA.109.885459; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Partovian C, 2000, AM J RESP CELL MOL, V23, P762; Kong D, 2004, CIRCULATION, V109, P1769, DOI 10.1161/01.CIR.0000121732.85572.6F; Lame MW, 2000, J BIOL CHEM, V275, P29091, DOI 10.1074/jbc.M001372200; Liu SQ, 2011, CARDIOVASC RES, V90, P171, DOI 10.1093/cvr/cvq395; Marsboom G, 2008, STEM CELLS, V26, P1017, DOI 10.1634/stemcells.2007-0562; Mirsky R, 2011, AM J PHYSIOL-LUNG C, V301, pL12, DOI 10.1152/ajplung.00215.2010; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Nagaya N, 2003, CIRCULATION, V108, P889, DOI 10.1161/01.CIR.0000079161.56080.22; Raoul W, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-8; Sun CK, 2012, INT J CARDIOL, V162, P45, DOI 10.1016/j.ijcard.2011.05.002; WAGNER JG, 1993, AM J PHYSIOL, V264, pL517; Watanabe H, 2007, BIOCHEM BIOPH RES CO, V354, P841, DOI 10.1016/j.bbrc.2006.12.236; Xia L, 2009, CYTOTHERAPY, V11, P492, DOI 10.1080/14653240902960460	43	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	SEP	2015	86						121	135		10.1016/j.yjmcc.2015.07.019		15	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CR5YA	WOS:000361419100015		
J	Li, PL; Kurata, Y; Maharani, N; Mahati, E; Higaki, K; Hasegawa, A; Shirayoshi, Y; Yoshida, A; Kondo, T; Kurozawa, Y; Yamamoto, K; Ninomiya, H; Hisatome, I				Li, Peili; Kurata, Yasutaka; Maharani, Nani; Mahati, Endang; Higaki, Katsumi; Hasegawa, Akira; Shirayoshi, Yasuaki; Yoshida, Akio; Kondo, Tatehito; Kurozawa, Youichi; Yamamoto, Kazuhiro; Ninomiya, Haruaki; Hisatome, Ichiro			E3 ligase CHIP and Hsc70 regulate Kv1.5 protein expression and function in mammalian cells	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Kv1.5 protein; CHIP E3 ligase; Hsc70; Ubiquitination; Proteasome	ATRIAL-FIBRILLATION; PROTEASOMAL DEGRADATION; MOLECULAR CHAPERONES; UBIQUITIN LIGASE; QUALITY-CONTROL; CHANNEL; HSP70; HSP40; PATHWAY	Kv1.5 confers ultra-rapid delayed-rectifier potassium channel current (I-Kur) which contributes to repolarization of the atrial action potential. Kv1.5 proteins, degraded via the ubiquitin-proteasome pathway, decreased in some atrial fibrillation patients. Carboxyl-terminus heat shock cognate 70-interacting protein (CHIP), an E3 ubiquitin ligase, is known to ubiquitinate short-lived proteins. Here, we investigated the roles of CHIP in Kv1.5 degradation to provide insights into the mechanisms of Kv1.5 decreases and treatments targeting Kv15 for atrial fibrillation. Coexpression of CHIP with Kv1.5 in HEK293 cells increased Kv1.5 protein ubiquitination and decreased the protein level. Immunofluorescence revealed decreases of Kvl 5 proteins in the endoplasmic reticulum and on the cell membrane. A siRNA against CHIP suppressed Kv15 protein ubiquitination and increased its protein level. CHIP mutants, lacking either the N-terminal tetratricopeptide region domain or the C-terminal U-box domain, failed to exert these effects on Kv1.5 proteins. Immunoprecipitation showed that CHIP formed complexes with Kv15 proteins and heat shock cognate protein 70 (Hsc70). Effects of Hsc70 on Kv1.5 were similar to CHIP by altering interaction of CHIP with Kv1.5 protein. Coexpression of CHIP and Hsc70 with Kv1.5 additionally enhanced Kv1.5 ubiquitination. Kv1.5 currents were decreased by overexpression of CHIP or Hsc70 but were increased by knockdown of CHIP or Hsc70 in HEK 293 cells stably expressing Kv1.5. These effects of CHIP and Hsc70 were also observed on endogenous Kv1.5 in HL-1 mouse cardiomyocytes, decreasing 'Cur and prolonging action potential duration. These results indicate that CHIP decreases the Kv15 protein level and functional channel by facilitating its degradation in concert with chaperone Hsc70. (C) 2015 Elsevier Ltd. All rights reserved.	[Li, Peili; Maharani, Nani; Mahati, Endang; Hasegawa, Akira; Shirayoshi, Yasuaki; Yoshida, Akio] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Genet Med & Regenerat Therapeut, Yonago, Tottori, Japan; [Kurata, Yasutaka] Kanazawa Med Univ, Dept Physiol, Kanazawa, Ishikawa 9200293, Japan; [Higaki, Katsumi] Tottori Univ, Fac Med, Dept Human Genome Sci, Yonago, Tottori 683, Japan; [Kondo, Tatehito; Yamamoto, Kazuhiro] Tottori Univ, Fac Med, Dept Cardiovasc Med, Yonago, Tottori 683, Japan; [Kurozawa, Youichi] Tottori Univ, Fac Med, Div Hlth Adm & Promot, Yonago, Tottori 683, Japan; [Ninomiya, Haruaki] Tottori Univ, Fac Med, Dept Regulat Biol, Yonago, Tottori 683, Japan	Li, PL (reprint author), Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Genet Med & Regenerat Therapeut, Nishimachi 36, Yonago, Tottori, Japan.	peili-li@med.tottori-u.ac.jp					Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Kato M, 2005, BIOCHEM BIOPH RES CO, V337, P343, DOI 10.1016/j.bbrc.2005.09.053; Brundel BJJM, 2006, CIRC RES, V99, P1394, DOI 10.1161/01.RES.0000252323.83137.fe; Meacham GC, 2001, NAT CELL BIOL, V3, P100; Narayan V, 2011, J BIOL CHEM, V286, P607, DOI 10.1074/jbc.M110.153122; Connell P, 2001, NAT CELL BIOL, V3, P93; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Ting YK, 2011, BRIT J PHARMACOL, V162, P1832, DOI 10.1111/j.1476-5381.2011.01204.x; Tanabe Y, 2006, BIOCHEM BIOPH RES CO, V345, P1116, DOI 10.1016/j.bbrc.2006.05.030; Brundel BJJM, 2001, CIRCULATION, V103, P684; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Cintron NS, 2006, J BIOL CHEM, V281, P26235, DOI 10.1074/jbc.M605417200; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Yang YQ, 2009, J HUM GENET, V54, P277, DOI 10.1038/jhg.2009.26; Zhao J, 2012, J BIOL CHEM, V287, P19105, DOI 10.1074/jbc.M112.339507; Matsumura Y, 2013, J BIOL CHEM, V288, P31069, DOI 10.1074/jbc.M113.479345; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Hirota Y, 2008, BIOCHEM BIOPH RES CO, V372, P469, DOI 10.1016/j.bbrc.2008.05.068; Iwai C, 2013, CARDIOVASC RES, V100, P520, DOI 10.1093/cvr/cvt200; Li PL, 2011, CIRC RES, V108, P458, DOI 10.1161/CIRCRESAHA.110.227835; Schumacher SM, 2009, CIRC RES, V104, P1390, DOI 10.1161/CIRCRESAHA.108.192773; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065	26	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	SEP	2015	86						138	146		10.1016/j.yjmcc.2015.07.018		9	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CR5YA	WOS:000361419100017		
J	Matsumoto, K; Vongsa, S; Nakajima, I; Ejima, K; Kohinata, K; Suzuki, T; Hosono, S; Aboshi, H; Kuwata, F; Otsuka, K				Matsumoto, Kunihito; Vongsa, Souksavanh; Nakajima, Ichiro; Ejima, Ken-ichiro; Kohinata, Kiyomi; Suzuki, Toshihiro; Hosono, Shigeharu; Aboshi, Hirofumi; Kuwata, Fumiyuki; Otsuka, Kichibee			Assessment of quality and interpretation of panoramic radiographs obtained in the Lao People's Democratic Republic as part of a teleradiology collaboration with Japan	JOURNAL OF ORAL SCIENCE			English	Article						teleradiology; panoramic radiography; quality assessment; temporomandibular joint	RELIABILITY	As part of quality assessment of a teleradiology program we evaluated the validity of patient information received, the quality of panoramic radiography imaging in Laos, and the ability of a Laotian radiologist to detect temporomandibular joint abnormalities. The amount of patient information gathered from 2,021 scans of panoramic radiographs was evaluated by triage before image diagnosis. Among the radiographs from 2,021 patients, primary triage indicated that there was insufficient information for 794 (39.3%) patients. Secondary triage to assess imaging failure included 1,227 radiographs, four of which were excluded from imaging diagnosis because of unacceptable image flaws. In total, 2,446 joints from 1,223 radiographs were evaluated for temporomandibular joint abnormalities in order to compare the image interpretation abilities of Laotian and Japanese radiologists. The kappa coefficient was 0.836 (P < 0.01) for the agreement between the two observers in detecting temporomandibular joint abnormalities on radiographs. We conclude that additional efforts are needed in order to overcome the challenges of maintaining quality in imaging techniques and diagnoses in Laos.	[Matsumoto, Kunihito; Ejima, Ken-ichiro; Kohinata, Kiyomi; Suzuki, Toshihiro] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Tokyo 1018310, Japan; [Matsumoto, Kunihito; Ejima, Ken-ichiro] Nihon Univ, Sch Dent, Dent Res Ctr, Div Adv Dent Treatment, Tokyo 1018310, Japan; [Vongsa, Souksavanh] Univ Hlth Sci, Fac Dent, Viangchan, Laos; [Nakajima, Ichiro] Nihon Univ, Sch Dent, Dept Community Dent, Tokyo 1018310, Japan; [Nakajima, Ichiro; Kuwata, Fumiyuki] Nihon Univ, Sch Dent, Dent Res Ctr, Div Dent Educ, Tokyo 1018310, Japan; [Hosono, Shigeharu] Nihon Univ, Sch Med, Dept Pediat, Tokyo 1018310, Japan; [Aboshi, Hirofumi] Nihon Univ, Sch Dent, Dept Legal Med, Tokyo 1018310, Japan; [Aboshi, Hirofumi] Nihon Univ, Sch Dent, Dent Res Ctr, Div Social Dent, Tokyo 1018310, Japan; [Kuwata, Fumiyuki] Nihon Univ, Sch Dent, Dept Chem, Tokyo 1018310, Japan; [Otsuka, Kichibee] Nihon Univ, Sch Dent, Dept Biochem, Tokyo 1018310, Japan	Matsumoto, K (reprint author), Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	matsumoto.kunihito@nihon-u.ac.jp			Nihon University President Grant Initiative; Sato Fund; Nihon University School of Dentistry Dental Research Center	This study was supported by the Nihon University President Grant Initiative (2012-2014), the Sato Fund (2014), and a grant from the Nihon University School of Dentistry Dental Research Center (2014).	LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Ahmad M, 2009, ORAL SURG ORAL MED O, V107, P844, DOI 10.1016/j.tripleo.2009.02.023; Besseling Sjobbe, 2013, J Investig Clin Dent, V4, P44, DOI 10.1111/j.2041-1626.2012.00136.x; Chuckpaiwong S, 2000, Southeast Asian J Trop Med Public Health, V31, P775; Dahlstrom L, 1996, DENTOMAXILLOFAC RAD, V25, P197; Jiirgensen N, 2009, BMC ORAL HEALTH, V9, P29; Kahn CE, 2011, RADIOGRAPHICS, V31, P295, DOI 10.1148/rg.311105085; Martí-Bonmatí L, 2012, Radiologia, V54, P115, DOI 10.1016/j.rx.2011.05.020; Matsumoto K, 2013, PRACTICE PROSTHODONT, P69; Motohashi Masafumi, 2009, J Oral Sci, V51, P131; Sisounthone J, 2015, ORAL RADIOL IN PRESS; United Nations Development Programme, 2013, HUM DEV REP 2013 RIS, P143	12	0	0	NIHON UNIV, SCHOOL DENTISTRY	TOYKO	1--13 KANDA-SURUGADAI, CHIYODA-KU, TOYKO, 101-8310, JAPAN	1343-4934	1880-4926		J ORAL SCI	J. Oral Sci.	SEP	2015	57	3					235	239		10.2334/josnusd.57.235		5	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	CR5YO	WOS:000361420500011		
J	Takayasu, H; Masumoto, K; Hagiwara, K; Sasaki, T; Ono, K; Jimbo, T; Uesugi, T; Gotoh, C; Urita, Y; Shinkai, T; Tanaka, H				Takayasu, Hajime; Masumoto, Kouji; Hagiwara, Koki; Sasaki, Takato; Ono, Kentaro; Jimbo, Takahiro; Uesugi, Toru; Gotoh, Chikashi; Urita, Yasuhisa; Shinkai, Toko; Tanaka, Hideaki			Increased pulmonary RhoA expression in the nitrofen-induced congenital diaphragmatic hernia rat model	JOURNAL OF PEDIATRIC SURGERY			English	Article						Congenital diaphragmatic hernia; Pulmonary hypertension; Nitrofen; RhoA/Rho-kinase; Vasoconstrictor	INDUCED HYPOPLASTIC LUNG; RECEPTOR EXPRESSION; GENE-EXPRESSION; KINASE PATHWAY; WNT PATHWAY; HYPERTENSION; VASOCONSTRICTION; VASCULATURE; INVOLVEMENT; INHIBITION	Purpose: Persistent pulmonary hypertension remains a major cause of mortality and morbidity in cases of congenital diaphragmatic hernia (CDH). Recently, RhoA/Rho-kinase-mediated vasoconstriction has been reported to be important in the pathogenesis of pulmonary hypertension (PH). Several recent reports have described that fasudil, a potent Rho-kinase inhibitor and vasodilator, could represent a potential therapeutic option for PH. We designed this study to investigate the hypothesis that the expression level of RhoA is increased in the nitrofen-induced CDH rat model. The expression level of Wnt11, an activator of RhoA, was also evaluated. Methods: Pregnant rats were treated with or without nitrofen on gestational day 9 (D9). Fetuses were sacrificed on D17, D19 and D21 and were divided into control and CDH groups. Quantitative real-time polymerase chain reaction was performed to determine the pulmonary gene expression levels of both Wnt11 and RhoA. An immunofluorescence study was also performed to evaluate the expression and localization of RhoA. Results: The relative mRNA expression levels of pulmonary Wnt11 and RhoA on D21 were significantly increased in the CDH group compared with the control group (p=0.016 and p=0.008, respectively). The immunofluorescence study confirmed the overexpression of RhoA in the pulmonary vessels of CDH rats on D21. Conclusions: Our results provide evidence that the RhoA/Rho-kinase-mediated pathway is involved in the pathogenesis of PH in the nitrofen-induced CDH rat model. Our data also suggest that the fasudil, a Rho-kinase inhibitor, could represent a therapeutic option for the treatment of PH in CDH. (C) 2015 Elsevier Inc. All rights reserved.	[Takayasu, Hajime; Masumoto, Kouji; Hagiwara, Koki; Sasaki, Takato; Ono, Kentaro; Jimbo, Takahiro; Uesugi, Toru; Gotoh, Chikashi; Urita, Yasuhisa; Shinkai, Toko; Tanaka, Hideaki] Univ Tsukuba, Fac Med, Dept Pediat Surg, Tsukuba, Ibaraki 3058575, Japan	Takayasu, H (reprint author), Univ Tsukuba, Fac Med, Dept Pediat Surg, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	hajimeta@md.tsukuba.ac.jp					Takayasu H, 2007, J PEDIATR SURG, V42, P426, DOI 10.1016/j.jpedsurg.2006.10.018; Nakazawa N, 2007, J PEDIATR SURG, V42, P345, DOI 10.1016/j.jpedsurg.2006.10.028; Coppola CP, 1998, J SURG RES, V76, P74, DOI 10.1006/jsre.1997.5293; Sbragia L, 2014, BRAZ J MED BIOL RES, V47, P171, DOI 10.1590/1414-431X20133221; Dingemann J, 2010, PEDIATR SURG INT, V26, P65, DOI 10.1007/s00383-009-2514-8; Dong M, 2010, DRUG DISCOV TODAY, V15, P622, DOI 10.1016/j.drudis.2010.06.011; Lally KP, 2013, J PEDIATR SURG, V48, P2408, DOI 10.1016/j.jpedsurg.2013.08.014; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Nagaoka T, 2006, J APPL PHYSIOL, V100, P996, DOI 10.1152/japplphysiol.01028.2005; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Mey J, 2003, AM J PATHOL, V162, P673, DOI 10.1016/S0002-9440(10)63861-8; Abe K, 2004, CIRC RES, V94, P385, DOI 10.1161/01.RES.0000111804.34509.94; Bejsovec A, 2005, CELL, V120, P11, DOI 10.1016/S0092-8674(04)01246-2; Taira Y, 1998, PEDIATR SURG INT, V14, P30, DOI 10.1007/s003830050429; Kotsinas A, 2002, AM J PATHOL, V161, P1619, DOI 10.1016/S0002-9440(10)64440-9; Garriboli M, 2012, PEDIATR SURG INT, V28, P1177, DOI 10.1007/s00383-012-3184-5; NORTH AJ, 1995, AM J RESP CELL MOL, V13, P676; Oka M, 2008, METHOD ENZYMOL, V439, P191, DOI 10.1016/S0076-6879(07)00415-6; Leeuwen L, 2014, J PAEDIATR CHILD H, V50, P667, DOI 10.1111/jpc.12508; Hofmann AD, 2014, PEDIATR SURG INT, V30, P197, DOI 10.1007/s00383-013-3450-1; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Vijfhuize S, 2012, EUR J PEDIATR SURG, V22, P374, DOI 10.1055/s-0032-1329531; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Laumanns IP, 2009, AM J RESP CELL MOL, V40, P683, DOI 10.1165/rcmb.2008-0153OC; Sluiter I, 2013, EXP MOL PATHOL, V94, P195, DOI 10.1016/j.yexmp.2012.09.010; Jernigan NL, 2008, AM J PHYSIOL-LUNG C, V295, pL515, DOI 10.1152/ajplung.00355.2007; Badejo AM, 2008, AM J PHYSIOL-LUNG C, V295, pL828, DOI 10.1152/ajplung.00042.2008; Luong C, 2011, CIRCULATION, V123, P2120, DOI 10.1161/CIRCULATIONAHA.108.845909; Li FH, 2009, PEDIATR CARDIOL, V30, P363, DOI 10.1007/s00246-008-9315-z; Homma N, 2008, AM J PHYSIOL-LUNG C, V295, pL71, DOI 10.1152/ajplung.90251.2008; Guilluy C, 2005, BRIT J PHARMACOL, V146, P1010, DOI 10.1038/sj.bjp.0706408; Sugimoto M, 2009, SURG TODAY, V39, P459, DOI 10.1007/s00595-008-3912-6; Doi T, 2009, J PEDIATR SURG, V44, P2302, DOI 10.1016/j.jpedsurg.2009.07.069; Doe Z, 2008, CIRCULATION, V118, pS446; Nagaoka T, 2004, AM J PHYSIOL-LUNG C, V287, pL665, DOI 10.1152/ajplung.00050.2003	35	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	SEP	2015	50	9					1467	1471		10.1016/j.jpedsurg.2015.02.063		5	Pediatrics; Surgery	Pediatrics; Surgery	CR7AK	WOS:000361499500005		
J	Ikeda, H; Nakamura, Y				Ikeda, Hitoshi; Nakamura, Yosikazu			Trends in incidence of childhood malignant solid tumors in Japan: Estimation based on hospital-based registration	JOURNAL OF PEDIATRIC SURGERY			English	Article						Hepatoblastoma; Hepatocellular carcinoma; Neuroblastoma; Wilms tumor	LOW-BIRTH-WEIGHT; CANCER INCIDENCE; HEPATOBLASTOMA; CHILDREN; NEUROBLASTOMA; RISK; AGE; EPIDEMIOLOGY; MORTALITY; COHORT	Background/Purpose: In Japan, an increase in hepatoblastoma with low birth weight has become evident since the 1990s, and there is concern about a possible increase in unfavorable neuroblastomas after the cessation of mass screening in 2004. Methods: The trends in incidence of malignant solid tumors in children younger than 15 years of age were inferred by evaluating registration incidence in the registry of the Japanese Society of Pediatric Surgeons. Results: A significant trend toward an increase in the registration incidence for hepatoblastoma was observed (p < 0.001). Hepatoblastomas with low birth weight (<1500 g) represented as many as 16% of hepatoblastomas. In hepatocellular carcinoma, there was a significant trend toward a decrease (p = 0.042). The registration incidence of nonmass screening-detected neuroblastoma remained unchanged until 2003, but the registration incidence in the period from 2004 to 2012 was significantly higher than that in the period from 1996 to 2003 (p = 0.021). There was an increase in the relative incidence of favorable stages after the cessation of mass screening. Conclusions: The notable increase in hepatoblastoma during the last three decades is partly attributed to an increase in hepatoblastoma in children of low birth weight, but this alone is not sufficient to explain the increase in hepatoblastoma. The increase in neuroblastoma after the halt of mass screening is so minimal that it is not recommended to consider reimplementation of mass screening. (C) 2015 Elsevier Inc. All rights reserved.	[Ikeda, Hitoshi] Dokkyo Med Univ, Dept Pediat Surg, Koshigaya Hosp, Koshigaya, Saitama 3438555, Japan; [Nakamura, Yosikazu] Jichi Med Univ, Dept Publ Hlth, Shimotsuke, Tochigi, Japan	Ikeda, H (reprint author), Dokkyo Med Univ, Dept Pediat Surg, Koshigaya Hosp, 2-1-50 Minami Koshigaya, Koshigaya, Saitama 3438555, Japan.	hike@dokkyomed.ac.jp			Health Labour Sciences Research grant from the Ministry of Health, Labour and Welfare of Japan [H25-Jisedai-Ippan-003]	This work was partly supported by a Health Labour Sciences Research grant (H25-Jisedai-Ippan-003) from the Ministry of Health, Labour and Welfare of Japan.	Schilling FH, 2002, NEW ENGL J MED, V346, P1047, DOI 10.1056/NEJMoa012277; Kaatsch P, 2006, EUR J CANCER, V42, P1961, DOI 10.1016/j.ejca.2006.05.014; Darbari A, 2003, HEPATOLOGY, V38, P560, DOI 10.1053/jhep.2003.50375; Ansell P, 2005, EUR J CANCER, V41, P741, DOI 10.1016/j.ejca.2004.10.024; Maruyama K, 2000, PEDIATR INT, V42, P492, DOI 10.1046/j.1442-200x.2000.01287.x; Tajiri H, 2011, CANCER CAUSE CONTROL, V22, P523, DOI 10.1007/s10552-010-9721-4; Spector LG, 2012, PEDIATR BLOOD CANCER, V59, P776, DOI 10.1002/pbc.24215; Takahashi K, 2012, J PUBLIC HEALTH POL, V33, P136, DOI 10.1057/jphp.2011.53; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Baade PD, 2010, BRIT J CANCER, V102, P620, DOI 10.1038/sj.bjc.6605503; Yamamoto K, 2002, J CLIN ONCOL, V20, P1209, DOI 10.1200/JCO.20.5.1209; Ikeda H, 2001, MED PEDIATR ONCOL, V37, P505, DOI 10.1002/mpo.1243; Ikeda H, 1997, J PEDIATR-US, V130, P557, DOI 10.1016/S0022-3476(97)70239-7; Hiyama E, 2008, LANCET, V371, P1173, DOI 10.1016/S0140-6736(08)60523-1; Reynolds P, 2004, CANCER, V100, P1070, DOI 10.1002/cncr.20061; Williams CL, 2013, NEW ENGL J MED, V369, P1819, DOI 10.1056/NEJMoa1301675; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; Tanimura M, 1998, CANCER RES, V58, P3032; Licht SD, 2012, INT J CANCER, V131, pE555, DOI 10.1002/ijc.27351; Hisashige Akinori, 2014, Glob J Health Sci, V6, P94, DOI 10.5539/gjhs.v6n4p94; Ikeda H, 2010, J JPN SOC PEDIAT, V114, P1497; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V10, P437; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V33, P99; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V28, P119; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V21, P117; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V23, P163; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V24, P129; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V9, P436; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V29, P907; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V48, P92; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V42, P61; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V31, P76; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V25, P123; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V15, P139; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V41, P51; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V34, P75; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V16, P117; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V26, P143; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V19, P759; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V47, P90; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V38, P69; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V35, P67; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V50, P114; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V33, P906; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V14, P161; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V44, P38; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V45, P90; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V43, P62; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V46, P63; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V37, P95; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V36, P86; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V39, P83; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V11, P875; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V20, P245; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V49, P70; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V27, P136; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V32, P88; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V18, P239; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V38, P732; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V30, P144; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V10, P809; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V13, P479; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V40, P71; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V22, P125; The Committee on Malignant Tumors of the Japanese Society of Pediatric Surgeons, 1973, J JPN SOC PEDIAT SUR, V17, P137; Watanabe S, 1995, CANC TREATM SURV, P203; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387	67	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	SEP	2015	50	9					1506	1512		10.1016/j.jpedsurg.2014.12.010		7	Pediatrics; Surgery	Pediatrics; Surgery	CR7AK	WOS:000361499500013		
J	Horvatovich, P; Lundberg, EK; Chen, YJ; Sung, TY; He, FC; Nice, EC; Goode, RJ; Yu, S; Ranganathan, S; Baker, MS; Domont, GB; Velasquez, E; Li, D; Liu, SQ; Wang, QH; He, QY; Menon, R; Guan, YF; Corrales, FJ; Segura, V; Casal, JI; Pascual-Montano, A; Albar, JP; Fuentes, M; Gonzalez-Gonzalez, M; Diez, P; Ibarrola, N; Degano, RM; Mohammed, Y; Borchers, CH; Urbani, A; Soggiu, A; Yamamoto, T; Salekdeh, GH; Archakov, A; Ponomarenko, E; Lisitsa, A; Lichti, CF; Mostovenko, E; Kroes, RA; Rezeli, M; Vegvari, A; Fehniger, TE; Bischoff, R; Vizcaino, JA; Deutsch, EW; Lane, L; Nilsson, CL; Marko-Varga, G; Omenn, GS; Jeong, SK; Lim, JS; Paik, YK; Hancock, WS				Horvatovich, Peter; Lundberg, Emma K.; Chen, Yu-Ju; Sung, Ting-Yi; He, Fuchu; Nice, Edouard C.; Goode, Robert J.; Yu, Simon; Ranganathan, Shoba; Baker, Mark S.; Domont, Gilberto B.; Velasquez, Erika; Li, Dong; Liu, Siqi; Wang, Quanhui; He, Qing-Yu; Menon, Rajasree; Guan, Yuanfang; Corrales, Fernando J.; Segura, Victor; Casal, J. Ignacio; Pascual-Montano, Alberto; Albar, Juan P.; Fuentes, Manuel; Gonzalez-Gonzalez, Maria; Diez, Paula; Ibarrola, Nieves; Degano, Rosa M.; Mohammed, Yassene; Borchers, Christoph H.; Urbani, Andrea; Soggiu, Alessio; Yamamoto, Tadashi; Salekdeh, Ghasem Hosseini; Archakov, Alexander; Ponomarenko, Elena; Lisitsa, Andrey; Lichti, Cheryl F.; Mostovenko, Ekaterina; Kroes, Roger A.; Rezeli, Melinda; Vegvari, Akos; Fehniger, Thomas E.; Bischoff, Rainer; Vizcaino, Juan Antonio; Deutsch, Eric W.; Lane, Lydie; Nilsson, Carol L.; Marko-Varga, Gyorgy; Omenn, Gilbert S.; Jeong, Seul-Ki; Lim, Jong-Sun; Paik, Young-Ki; Hancock, William S.			Quest for Missing Proteins: Update 2015 on Chromosome-Centric Human Proteome Project	JOURNAL OF PROTEOME RESEARCH			English	Editorial Material						missing proteins; Chromosome-Centric Human Proteome Project; LC-MS; antibody enrichment; proteomics; bioinformatics	TANDEM MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; DATA SETS; FUNCTIONAL ANNOTATION; INTERNATIONAL-SOCIETY; ANTIBODY PROTEOMICS; CEREBROSPINAL-FLUID; DISSOCIATION ETHCD; STATISTICAL-MODEL; GENOME ANNOTATION	This paper summarizes the recent activities of the Chromosome-Centric Human Proteome Project (C-HPP) consortium, which develops new technologies to identify yet-to-be annotated proteins (termed "missing proteins") in biological samples that lack sufficient experimental evidence at the protein level for confident protein identification. The C-HPP also aims to identify new protein forms that may be caused by genetic variability, post-translational modifications, and alternative splicing. Proteogenomic data integration forms the basis of the C-HPP's activities; therefore, we have summarized some of the key approaches and their roles in the project. We present new analytical technologies that improve the chemical space and lower detection limits coupled to bioinformatics tools and some publicly available resources that can be used to improve data analysis or support the development of analytical assays. Most of this paper's content has been compiled from posters, slides, and discussions presented in the series of C-HPP workshops held during 2014. All data (posters, presentations) used are available at the C-HPP Wild (http://c-hpp.webhosting.rug.nl/) and in the Supporting Information.	[Horvatovich, Peter; Bischoff, Rainer] Univ Groningen, Dept Pharm, Analyt Biochem, NL-9713 AV Groningen, Netherlands; [Lundberg, Emma K.] KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden; [Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei 115, Taiwan; [Sung, Ting-Yi] Acad Sinica, Inst Informat Sci, Taipei 115, Taiwan; [He, Fuchu; Li, Dong] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Nice, Edouard C.; Goode, Robert J.; Yu, Simon] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Ranganathan, Shoba] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Ranganathan, Shoba] Macquarie Univ, ARC Ctr Excellence Bioinformat, Sydney, NSW 2109, Australia; [Baker, Mark S.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Domont, Gilberto B.; Velasquez, Erika] Univ Fed Rio de Janeiro, Inst Chem, Prote Unit, BR-21941909 Rio De Janeiro, RJ, Brazil; [Liu, Siqi; Wang, Quanhui] Beijing Inst Genom, Beijing 100101, Peoples R China; [Liu, Siqi; Wang, Quanhui] BGI Shenzhen, Beijing 100101, Peoples R China; [He, Qing-Yu] Jinan Univ, Coll Life Sci & Technol, Guangdong Higher Educ Inst, Key Lab Funct Prot Res, Guangzhou 510632, Guangdong, Peoples R China; [Menon, Rajasree] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Guan, Yuanfang] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Guan, Yuanfang] Univ Michigan, Dept Comp Sci, Ann Arbor, MI 48109 USA; [Corrales, Fernando J.; Segura, Victor] Univ Navarra, ProteoRed ISCIII, Spanish Consortium CHPP Chr 16, CIMA,Biomol & Bioinformat Resources PRB2, Pamplona 31008, Spain; [Corrales, Fernando J.; Segura, Victor] Univ Navarra, CIMA, Chr16 SpHPP Consortium, Pamplona 31008, Spain; [Casal, J. Ignacio] CSIC, CIB, Dept Cellular & Mol Med, E-28040 Madrid, Spain; [Pascual-Montano, Alberto; Albar, Juan P.] CSIC, CNB, E-28049 Madrid, Spain; [Fuentes, Manuel; Gonzalez-Gonzalez, Maria; Diez, Paula; Ibarrola, Nieves; Degano, Rosa M.] Univ Salamanca, CSIC, IBSAL, Ctr Canc Res,Prote Unit, Salamanca 37007, Spain; [Fuentes, Manuel; Gonzalez-Gonzalez, Maria; Diez, Paula; Ibarrola, Nieves; Degano, Rosa M.] Univ Salamanca, CSIC, IBSAL, Ctr Canc Res,Gen Serv Cytometry,Dept Med, Salamanca 37007, Spain; [Mohammed, Yassene; Borchers, Christoph H.] Univ Victoria, Genome British Columbia Prote Ctr, Victoria, BC V8Z 7X8, Canada; [Mohammed, Yassene] Leiden Univ, Med Ctr, Ctr Prote & Metabol, NL-2333 ZA Leiden, Netherlands; [Urbani, Andrea] Fdn Santa Lucia, Prote & Metabon Lab, Rome, Italy; [Urbani, Andrea] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Soggiu, Alessio] Univ Milan, Dept Vet Sci & Publ Hlth DIVET, I-20133 Milan, Italy; [Yamamoto, Tadashi] Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Niigata, Japan; [Salekdeh, Ghasem Hosseini] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran; [Archakov, Alexander; Ponomarenko, Elena; Lisitsa, Andrey] Orechovich Inst Biomed Chem, Moscow, Russia; [Lichti, Cheryl F.; Mostovenko, Ekaterina; Nilsson, Carol L.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Kroes, Roger A.] Northwestern Univ, Dept Biomed Engn, Falk Ctr Mol Therapeut, Evanston, IL 60201 USA; [Rezeli, Melinda; Vegvari, Akos; Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Dept Biomed Engn, Clin Prot Sci & Imaging, S-22184 Lund, Sweden; [Vizcaino, Juan Antonio] EMBL EBI, Cambridge CB10 1SD, England; [Deutsch, Eric W.] Inst Syst Biol, Seattle, WA 98109 USA; [Lane, Lydie] SIB Swiss Inst Bioinformat, Geneva, Switzerland; [Lane, Lydie] Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland; [Omenn, Gilbert S.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Jeong, Seul-Ki; Lim, Jong-Sun; Paik, Young-Ki] Yonsei Univ, Yonsei Proteome Res Ctr, Coll Life Sci & Technol, Dept Integrated Omics Biomed Sci, Seoul 120749, South Korea; [Jeong, Seul-Ki; Lim, Jong-Sun] Yonsei Univ, Yonsei Proteome Res Ctr, Coll Life Sci & Technol, Dept Biochem, Seoul 120749, South Korea; [Hancock, William S.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Liu, Siqi] BGI Shenzhen, Shenzhen 518083, Peoples R China	Horvatovich, P (reprint author), Univ Groningen, Dept Pharm, Analyt Biochem, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	p.l.horvatovich@rug.nl	Bischoff, Rainer/H-5404-2011; 	Diez, Paula/0000-0003-2150-6898; Omenn, Gilbert S./0000-0002-8976-6074; Ranganathan, Shoba/0000-0002-8290-813X			Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Zhao YM, 2009, PROTEOMICS, V9, P4632, DOI 10.1002/pmic.200900398; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Rost HL, 2014, NAT BIOTECHNOL, V32, P219, DOI 10.1038/nbt.2841; Rosenling T, 2009, J PROTEOME RES, V8, P5511, DOI 10.1021/pr9005876; Righetti PG, 2008, MASS SPECTROM REV, V27, P596, DOI 10.1002/mas.20178; Larsson K, 2006, J IMMUNOL METHODS, V315, P110, DOI 10.1016/j.jim.2006.07.014; Boschetti E, 2008, J PROTEOMICS, V71, P255, DOI 10.1016/j.jprot.2008.05.002; Keller A, 2011, METHODS MOL BIOL, V694, P169, DOI 10.1007/978-1-60761-977-2_12; Mohammed Y, 2014, J PROTEOMICS, V106, P151, DOI 10.1016/j.jprot.2014.04.018; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Kroksveen AC, 2012, ACTA NEUROL SCAND, V126, P90, DOI 10.1111/ane.12029; Edfors F, 2014, MOL CELL PROTEOMICS, V13, P1611, DOI 10.1074/mcp.M113.034140; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/nmeth.1584, 10.1038/NMETH.1584]; Perez-Riverol Y, 2014, BBA-PROTEINS PROTEOM, V1844, P63, DOI 10.1016/j.bbapap.2013.02.032; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Islam MT, 2014, J PROTEOME RES, V13, P76, DOI 10.1021/pr400794x; Sheynkman GM, 2014, J PROTEOME RES, V13, P228, DOI 10.1021/pr4009207; Persson A, 2006, CURR OPIN MOL THER, V8, P185; Mayer G, 2014, BBA-PROTEINS PROTEOM, V1844, P98, DOI 10.1016/j.bbapap.2013.02.017; Marx H, 2013, NAT BIOTECHNOL, V31, P557, DOI 10.1038/nbt.2585; Govorukhina NI, 2009, J CHROMATOGR B, V877, P1281, DOI 10.1016/j.jchromb.2008.10.029; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Rosenling T, 2011, CLIN CHEM, V57, P1703, DOI 10.1373/clinchem.2011.167601; Goode RJA, 2013, J PROTEOME RES, V12, P172, DOI 10.1021/pr3010056; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Wang QH, 2014, J PROTEOME RES, V13, P200, DOI 10.1021/pr400899b; Guo FF, 2013, J PROTEOME RES, V12, P179, DOI [10.1021/pr300831z, 10.1021/pr300831zl]; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Mommen GPM, 2014, P NATL ACAD SCI USA, V111, P4507, DOI 10.1073/pnas.1321458111; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Imanishi T, 2013, J PROTEOME RES, V12, P62, DOI 10.1021/pr300861a; Omenn GS, 2014, J PROTEOMICS, V100, P3, DOI 10.1016/j.jprot.2013.10.012; Frese CK, 2012, ANAL CHEM, V84, P9668, DOI 10.1021/ac3025366; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; Paik YK, 2012, J PROTEOME RES, V11, P2005, DOI 10.1021/pr200824a; Gaudet P, 2013, J PROTEOME RES, V12, P293, DOI 10.1021/pr300830v; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Bastian F, 2008, LECT N BIOINFORMAT, V5109, P124, DOI 10.1007/978-3-540-69828-9_12; Wang D, 2014, J PROTEOME RES, V13, P99, DOI 10.1021/pr400795c; Jeong SK, 2013, J PROTEOME RES, V12, P106, DOI 10.1021/pr3009447; Duncan DT, 2005, J PROTEOME RES, V4, P1842, DOI 10.1021/pr050058i; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Shargunov AV, 2014, J PROTEOME RES, V13, P173, DOI 10.1021/pr400808u; Mathivanan S, 2008, NAT BIOTECHNOL, V26, P164, DOI 10.1038/nbt0208-164; Zgoda VG, 2013, J PROTEOME RES, V12, P123, DOI [10.1021/pr300821n, 10.1021/pr300821n1]; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Farrah T, 2012, PROTEOMICS, V12, P1170, DOI 10.1002/pmic.201100515; Farrah T, 2014, J PROTEOME RES, V13, P60, DOI 10.1021/pr4010037; Guruceaga E, 2015, J PROTEOME RES, V14, P1350, DOI 10.1021/pr500850u; Tang W, 2012, MOL BIOTECHNOL, V52, P91, DOI 10.1007/s12033-012-9498-7; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Bjornson RD, 2008, J PROTEOME RES, V7, P293, DOI 10.1021/pr0701198; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Guo XF, 2014, MOL CELL PROTEOMICS, V13, P1573, DOI 10.1074/mcp.M113.035170; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Betsou F, 2013, J MOL DIAGN, V15, P3, DOI 10.1016/j.jmoldx.2012.06.008; Chepelev I, 2012, METHODS MOL BIOL, V815, P91, DOI 10.1007/978-1-61779-424-7_8; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Baczek T, 2009, PROTEOMICS, V9, P835, DOI 10.1002/pmic.200800544; Lichti CF, 2015, J PROTEOME RES, V14, P778, DOI [10.1021/pr500810g, 10.1021/pr5008109]; Wang K, 2014, BIOMED CHROMATOGR, V28, P848, DOI 10.1002/bmc.3157; Whiteaker JR, 2014, NAT METHODS, V11, P703, DOI 10.1038/nmeth.3002; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Lambert JP, 2013, NAT METHODS, V10, P1239, DOI [10.1038/nmeth.2702, 10.1038/NMETH.2702]; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Farrah T, 2013, J PROTEOME RES, V12, P162, DOI [10.1021/pr301012j, 10.1021/Pr301012j]; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Chang C, 2014, J PROTEOME RES, V13, P38, DOI 10.1021/pr4009018; Zhang CC, 2011, J PROTEOME RES, V10, P656, DOI 10.1021/pr1008652; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Sheng QH, 2011, J BIOINFORM COMPUT B, V9, P51, DOI 10.1142/S0219720011005756; Picotti P, 2008, NAT METHODS, V5, P913, DOI 10.1038/nmeth1108-913; Sherwood CA, 2009, J PROTEOME RES, V8, P4396, DOI 10.1021/pr900010h; Zhong JY, 2014, J PROTEOME RES, V13, P50, DOI 10.1021/pr4007409; Menon R, 2014, J PROTEOME RES, V13, P212, DOI 10.1021/pr400773v; Catherman AD, 2014, BIOCHEM BIOPH RES CO, V445, P683, DOI 10.1016/j.bbrc.2014.02.041; Razavi M, 2012, J PROTEOME RES, V11, P5642, DOI 10.1021/pr300652v; Ranganathan S, 2013, J PROTEOME RES, V12, P2504, DOI 10.1021/pr301082p; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Wang T, 2013, NUCLEIC ACIDS RES, V41, P4743, DOI 10.1093/nar/gkt178; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Kandasamy K, 2009, NUCLEIC ACIDS RES, V37, pD773, DOI 10.1093/nar/gkn701; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/nmeth.1607, 10.1038/NMETH.1607]; Deutsch EW, 2010, METHODS MOL BIOL, V604, P285, DOI 10.1007/978-1-60761-444-9_19; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Horvatovich P, 2014, J PROTEOME RES, V13, P5, DOI 10.1021/pr400765y; Lisitsa A, 2014, EXPERT REV PROTEOMIC, V11, P121, DOI 10.1586/14789450.2014.878652; Marko-Varga G, 2013, J PROTEOME RES, V12, P1, DOI [10.1021/pr301183a, 10.1021/pr301183aIJ]; Lane L, 2014, J PROTEOME RES, V13, P15, DOI 10.1021/pr401144x; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Gremse M, 2011, NUCLEIC ACIDS RES, V39, pD507, DOI 10.1093/nar/gkq968; Bischoff R, 2012, J PROTEOMICS, V75, P2275, DOI 10.1016/j.jprot.2012.01.041; Marko-Varga G, 2012, J PROTEOME RES, V11, P5124, DOI 10.1021/pr300185k; Ezkurdia I, 2014, J PROTEOME RES, V13, P3854, DOI 10.1021/pr500572z; Apweiler K, 2004, CURR OPIN CHEM BIOL, V8, P76; Beavis K C, 2006, METHOD MOL BIOL, V328, P217; Pitt Karen, 2012, Biopreserv Biobank, V10, P548, DOI 10.1089/bio.2012.1064; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/nmeth.2732, 10.1038/NMETH.2732]; Brusniak MYK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-78; Chang A., 2014, NUCLEIC ACIDS RES, V43, pD439; Consortium EP, 2004, SCIENCE, V306, P636, DOI DOI 10.1126/SCIENCE.1105136; Consortium U., 2014, NUCLEIC ACIDS RES, V42, pD191, DOI DOI 10.1093/NAR/GKT1140; Cote R, 2010, NUCLEIC ACIDS RES, V38, pW155, DOI 10.1093/nar/gkq331; Eksi R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003314; Farrah T., 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/mcp.m110.006353; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Gaudet P., 2012, J PROTEOME RES, V12, P293; Gaudet P., 2015, NUCLEIC ACIDS RES, V43, pD746; Harte RA, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas008; Jeong K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S2; Kali L., 2008, BIOINFORMATICS, V24, pi42; Kelleher N. L., 2014, EXPERT REV PROTEOMIC, P1; Kusebauch U., 2014, CURR PROTOC BIOINF, V46; Layton Daniel, 2013, Biophysical Reviews, V5, DOI 10.1007/s12551-012-0095-6; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.M111.009993; Liu F, 2014, MOL CELL PROTEOMICS, V13, P2776, DOI 10.1074/mcp.O114.039057; Magrane M, 2011, DATABASE-OXFORD, V2011, DOI [DOI 10.1093/DATABASE/BAR009, 10.1093/database/bar009]; Marko-Varga György, 2013, Clin Transl Med, V2, P4, DOI 10.1186/2001-1326-2-4; Muthusamy B, 2013, CURR PROTOC BIOINFOR; Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/nmeth.3144, 10.1038/NMETH.3144]; Nilsson C. L., 2014, J PROTEOME RES, V14, P603; Nilsson CL, 2013, J PROTEOME RES, V12, P135, DOI 10.1021/pr3008607; Omenn G. S., 2015, J PROTEOME RES, DOI [10.1021/acs.jproteome.5b00499, DOI 10.1021/ACS.JPR0TE0ME.5B00499]; Pugh RS, 2014, BIOPRESERV BIOBANK, V12, P358, DOI 10.1089/bio.2014.1252; Rosenberger G., 2014, SCI DATA, V1, P1, DOI DOI 10.1038/SDATA.2014.31; Sarntivijai S, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-37; Savitski MM, 2015, MOL CELL PROTEOMICS, DOI [10.1074/mcp.M114.046995, DOI 10.1074/MCP.M114.046995]; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI 10.1093/nar/gkr1184; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2015, SCIENCE, V347, P394, DOI 10.1126/science.1260419; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Végvári Akos, 2011, J Clin Bioinforma, V1, P24, DOI 10.1186/2043-9113-1-24; Verhaak RG, 2010, CANCER CELL, V17, P98; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Welinder Charlotte, 2013, Clin Transl Med, V2, P7, DOI 10.1186/2001-1326-2-7; Zeiler M, 2012, MOL CELL PROTEOMICS, V11; Zhao L., 2011, JOVE-J VIS EXP, V53, P2812	154	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	SEP	2015	14	9					3415	3431		10.1021/pr5013009		17	Biochemical Research Methods	Biochemistry & Molecular Biology	CR1LU	WOS:000361087100002		
J	Horvatovich, P; Vegvari, A; Saul, J; Park, JG; Qiu, J; Syring, M; Pirrotte, P; Petritis, K; Tegeler, TJ; Aziz, M; Fuentes, M; Diez, P; Gonzalez-Gonzalez, M; Ibarrola, N; Droste, C; De Las Rivas, J; Gil, C; Clemente, F; Hernaez, ML; Corrales, FJ; Nilsson, CL; Berven, FS; Bischoff, R; Fehniger, TE; LaBaer, J; Marko-Varga, G				Horvatovich, Peter; Vegvari, Akos; Saul, Justin; Park, Jin G.; Qiu, Ji; Syring, Michael; Pirrotte, Patrick; Petritis, Konstantinos; Tegeler, Tony J.; Aziz, Meraj; Fuentes, Manuel; Diez, Paula; Gonzalez-Gonzalez, Maria; Ibarrola, Nieves; Droste, Conrad; De Las Rivas, Javier; Gil, Concha; Clemente, Felipe; Luisa Hernaez, Maria; Corrales, Fernando J.; Nilsson, Carol L.; Berven, Frode S.; Bischoff, Rainer; Fehniger, Thomas E.; LaBaer, Joshua; Marko-Varga, Gyorgy			In Vitro Transcription/Translation System: A Versatile Tool in the Search for Missing Proteins	JOURNAL OF PROTEOME RESEARCH			English	Editorial Material						Missing proteins; Chromosome-Centric Human Proteome Project; LC-MS; in vitro transcription/translation system; proteomics; bioinformatics	HUMAN PROTEOME PROJECT; MASS-SPECTROMETRY; ELECTRON-TRANSFER; LIQUID-CHROMATOGRAPHY; DISSOCIATION ETHCD; ENRICHMENT; PEPTIDES; STRATEGIES; SEPARATION; COVERAGE	Approximately 18% of all human genes purported to encode proteins have not been directly evidenced at the protein level, according to the validation criteria established by neXtProt, and are considered to be "missing" proteins. One of the goals of the Chromosome-Centric Human Proteome Project (C-HPP) is to identify as many of these missing proteins as possible in human samples using mass spectrometry-based methods. To further this goal, a consortium of C-HPP teams (chromosomes 5, 10, 16, and 19) has joined forces to devise new strategies to identify missing proteins by use of a cell-free in vitro transcription/translation system (IVTT). The proposed strategy employs LC-MS/MS data-dependent acquisition (DDA) and targeted selective reaction monitoring (SRM) methods to scrutinize low-complexity samples derived from IVTT. The optimized assays are then applied to identify missing proteins in human cells and tissues. We describe the approach and show proof-of-concept results for development of LC SRM assays for identification of 18 missing proteins. We believe that the IVTT system, when coupled with downstream mass spectrometric identification, can be applied to identify proteins that have eluded more traditional methods of detection.	[Horvatovich, Peter; Bischoff, Rainer] Univ Groningen, Dept Pharm, Analyt Biochem, NL-9713 AV Groningen, Netherlands; [Vegvari, Akos; Nilsson, Carol L.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Vegvari, Akos; Nilsson, Carol L.; Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Dept Biomed Engn, Biomed Ctr, Clin Prot Sci & Imaging, S-22184 Lund, Sweden; [Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, S-22184 Lund, Sweden; [Saul, Justin; Park, Jin G.; Qiu, Ji; LaBaer, Joshua] Arizona State Univ, Biodesign Inst, Ctr Personalized Diagnost, Tempe, AZ 85287 USA; [Syring, Michael; Pirrotte, Patrick; Petritis, Konstantinos; Tegeler, Tony J.; Aziz, Meraj] Translat Genom Res Inst, Ctr Prote, Phoenix, AZ 85004 USA; [Petritis, Konstantinos] Phoenix Childrens Hosp, Pathol Res, Phoenix, AZ 85016 USA; [Fuentes, Manuel; Diez, Paula; Gonzalez-Gonzalez, Maria] Canc Res Ctr CSIC USAL IBSAL, Dept Med & Gen Cytometry Serv Nucleus, Salamanca 37007, Spain; [Fuentes, Manuel; Diez, Paula; Gonzalez-Gonzalez, Maria; Ibarrola, Nieves] Canc Res Ctr CSIC USAL IBSAL, Prote Unit, Salamanca 37007, Spain; [Droste, Conrad; De Las Rivas, Javier] Canc Res Ctr CSIC USAL IBSAL, Bioinformat & Funct Genom Res Grp, Salamanca 37007, Spain; [Gil, Concha; Clemente, Felipe; Luisa Hernaez, Maria] Univ Complutense Madrid, Dept Microbiol, E-28040 Madrid, Spain; [Gil, Concha; Clemente, Felipe; Luisa Hernaez, Maria] Univ Complutense Madrid, Prote Unit, E-28040 Madrid, Spain; [Corrales, Fernando J.] Univ Navarra, Ctr Appl Med Res CIMA, MISNA, ProteoRed ISCIII PRB2, Pamplona 31008, Spain; [Berven, Frode S.] Univ Bergen, Dept Biomed, Prote Unit PROBE, N-5009 Bergen, Norway; [Berven, Frode S.] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway; [Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Shinjuku Ku, Tokyo 1600023, Japan	Horvatovich, P (reprint author), Univ Groningen, Dept Pharm, Analyt Biochem, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	p.l.horvatovich@rug.nl	Bischoff, Rainer/H-5404-2011; Gil, Concha/F-6470-2015; De Las Rivas, Javier/G-5936-2014; 	Gil, Concha/0000-0003-3137-2600; De Las Rivas, Javier/0000-0002-0984-9946; Diez, Paula/0000-0003-2150-6898			Fang Y, 2010, J PROTEOME RES, V9, P1902, DOI 10.1021/pr901063t; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Mommen GPM, 2014, P NATL ACAD SCI USA, V111, P4507, DOI 10.1073/pnas.1321458111; Ongay S, 2012, J SEP SCI, V35, P2341, DOI 10.1002/jssc.201200434; Frese CK, 2012, ANAL CHEM, V84, P9668, DOI 10.1021/ac3025366; Paik YK, 2012, J PROTEOME RES, V11, P2005, DOI 10.1021/pr200824a; Saul J, 2014, PROTEIN SCI, V23, P1123, DOI 10.1002/pro.2484; Gaudet P, 2013, J PROTEOME RES, V12, P293, DOI 10.1021/pr300830v; Yang CX, 2014, ELECTROPHORESIS, V35, P3418, DOI 10.1002/elps.201400017; Fusaro VA, 2009, NAT BIOTECHNOL, V27, P190, DOI 10.1038/nbt.1524; Zhang K, 2013, ANALYST, V138, P1628, DOI 10.1039/c3an36837h; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Nilsson CL, 2015, J PROTEOME RES, V14, P603, DOI 10.1021/pr500564q; Paulo JA, 2013, BBA-PROTEINS PROTEOM, V1834, P791, DOI 10.1016/j.bbapap.2013.01.011; Drissi R, 2013, FEBS J, V280, P5626, DOI 10.1111/febs.12502; Beltran L, 2012, AMINO ACIDS, V43, P1009, DOI 10.1007/s00726-012-1288-9; Festa F, 2013, PROTEOM CLIN APPL, V7, P372, DOI 10.1002/prca.201200063; Escher C, 2012, PROTEOMICS, V12, P1111, DOI 10.1002/pmic.201100463; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ito Shigeyasu, 2009, V534, P195, DOI 10.1007/978-1-59745-022-5_14; Lichti CF, 2014, J PROTEOME RES, V13, P191, DOI 10.1021/pr400786s; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Li HM, 2013, J PROTEOMICS, V81, P173, DOI 10.1016/j.jprot.2013.01.026; Fila J, 2012, AMINO ACIDS, V43, P1025, DOI 10.1007/s00726-011-1111-z; Di Palma S, 2012, J PROTEOMICS, V75, P3791, DOI 10.1016/j.jprot.2012.04.033; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Xie F, 2012, J CHROMATOGR A, V1261, P78, DOI 10.1016/j.chroma.2012.06.098; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Horvatovich P, 2010, J SEP SCI, V33, P1421, DOI 10.1002/jssc.201000050; Canterbury JD, 2014, J AM SOC MASS SPECTR, V25, P2048, DOI 10.1007/s13361-014-0981-1; Huang BY, 2014, ELECTROPHORESIS, V35, P2091, DOI 10.1002/elps.201400034; Lawless C, 2012, OMICS, V16, P449, DOI 10.1089/omi.2011.0156; Chong S., 2014, CURR PROTOC MOL BIOL, V108; Eyers C.E., 2011, MOL CELL PROTEOMICS, V10; Lam H., 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.R111.008565; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.M111.009993; Liu F, 2014, MOL CELL PROTEOMICS, V13, P2776, DOI 10.1074/mcp.O114.039057	38	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	SEP	2015	14	9					3441	3451		10.1021/acs.jproteome.5b00486		11	Biochemical Research Methods	Biochemistry & Molecular Biology	CR1LU	WOS:000361087100004		
J	Komatsu, S; Tougou, M; Nanjo, Y				Komatsu, Setsuko; Tougou, Makoto; Nanjo, Yohei			Proteomic Techniques and Management of Flooding Tolerance in Soybean	JOURNAL OF PROTEOME RESEARCH			English	Review						proteomics; soybean; flooding; tolerance; review	STRESS-RESPONSE MECHANISM; LOW-ABUNDANCE PROTEINS; QUANTITATIVE PROTEOMICS; ABSCISIC-ACID; ROOT-TIPS; GEL-FREE; COMPREHENSIVE ANALYSIS; SUBMERGENCE TOLERANCE; MEMBRANE-PROTEINS; NUCLEAR PROTEOME	Climate change is considered a major threat to world agriculture and food security. To improve the agricultural productivity and sustainability, the development of high-yielding stress-tolerant, and climate-resilient crops is essential. Of the abiotic stresses, flooding stress is a very serious hazard because it markedly reduces plant growth and grain yield. Proteomic analyses indicate that the effects of flooding stress are not limited to oxygen deprivation but include many other factors. Although many flooding response mechanisms have been reported, flooding tolerance mechanisms have not been fully clarified for soybean. There were limitations in soybean materials, such as mutants and varieties, while they were abundant in rice and Arabidopsis. In this review, plant proteomic technologies are introduced and flooding tolerance mechanisms of soybeans are summarized to assist in the improvement of flooding tolerance in soybeans. This work will expedite transgenic or marker-assisted genetic enhancement studies in crops for developing high-yielding stress-tolerant lines or varieties under abiotic stress.	[Komatsu, Setsuko; Tougou, Makoto; Nanjo, Yohei] Natl Agr & Food Res Org, Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	Komatsu, S (reprint author), Natl Agr & Food Res Org, Natl Inst Crop Sci, Kannondai 2-1-18, Tsukuba, Ibaraki 3058518, Japan.	skomatsu@affrc.go.jp					Ahsan N, 2007, PLANT SOIL, V295, P37, DOI 10.1007/s11104-007-9258-9; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; HOFFMANNBENNING S, 1992, PLANT PHYSIOL, V99, P1156, DOI 10.1104/pp.99.3.1156; Nagai K, 2010, J PLANT RES, V123, P303, DOI 10.1007/s10265-010-0332-7; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Hossain Z, 2013, J PROTEOME RES, V12, P4670, DOI 10.1021/pr400604b; Zhu JM, 2007, PLANT PHYSIOL, V145, P1533, DOI 10.1104/pp.107.107250; Taylor NL, 2005, MOL CELL PROTEOMICS, V4, P1122, DOI 10.1074/mcp.M400210-MCP200; Nanjo Y, 2010, J PROTEOME RES, V9, P3989, DOI 10.1021/pr100179f; Komatsu S, 2011, PLANT MOL BIOL, V77, P309, DOI 10.1007/s11103-011-9812-y; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Komatsu S, 2013, J PROTEOME RES, V12, P4769, DOI 10.1021/pr4001898; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Khan MN, 2014, J PROTEOME RES, V13, P5812, DOI 10.1021/pr5007476; Hashiguchi A, 2010, FOOD RES INT, V43, P1803, DOI 10.1016/j.foodres.2009.07.033; Ahsan N, 2007, PHYSIOL PLANTARUM, V131, P555, DOI 10.1111/j.1399-3054.2007.00980.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Rockstrom J, 2000, CRIT REV PLANT SCI, V19, P319, DOI 10.1016/S0735-2689(00)80007-6; Nanjo Y, 2011, PLANT MOL BIOL, V77, P129, DOI 10.1007/s11103-011-9799-4; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Jacoby RP, 2010, J PROTEOME RES, V9, P6595, DOI 10.1021/pr1007834; Ahsan N, 2010, PROTEOMICS, V10, P2605, DOI 10.1002/pmic.201000180; Nanjo Y, 2014, PHYTOCHEMISTRY, V106, P25, DOI 10.1016/j.phytochem.2014.06.017; Yang CY, 2014, PLANTA, V239, P877, DOI 10.1007/s00425-013-2020-z; Choudhary MK, 2009, MOL CELL PROTEOMICS, V8, P1579, DOI 10.1074/mcp.M800601-MCP200; Yin X, 2014, J PROTEOMICS, V106, P1, DOI 10.1016/j.jprot.2014.04.004; Komatsu S, 2009, J PROTEOME RES, V8, P4487, DOI 10.1021/pr9002883; Komatsu S, 2010, AMINO ACIDS, V38, P729, DOI 10.1007/s00726-009-0277-0; Fukao T, 2008, P NATL ACAD SCI USA, V105, P16814, DOI 10.1073/pnas.0807821105; Komatsu S, 2010, AMINO ACIDS, V39, P1435, DOI 10.1007/s00726-010-0608-1; Shi F, 2008, PHYTOCHEMISTRY, V69, P1295, DOI 10.1016/j.phytochem.2008.01.007; Oh M, 2015, J PROTEOMICS, V114, P161, DOI 10.1016/j.jprot.2014.11.008; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Kong FJ, 2010, BBA-PROTEINS PROTEOM, V1804, P124, DOI 10.1016/j.bbapap.2009.09.023; Sauter M, 2013, CURR OPIN PLANT BIOL, V16, P282, DOI 10.1016/j.pbi.2013.03.013; Khatoon A, 2012, J PROTEOMICS, V75, P5706, DOI 10.1016/j.jprot.2012.07.031; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Stecker KE, 2014, PLANT PHYSIOL, V165, P1171, DOI 10.1104/pp.114.238816; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Dat JF, 2004, PLANT PHYSIOL BIOCH, V42, P273, DOI 10.1016/j.plaphy.2004.02.003; Pandey A, 2010, J PROTEOME RES, V9, P3443, DOI 10.1021/pr901098p; Steffens B, 2005, PLANT PHYSIOL, V139, P713, DOI 10.1104/pp.105.064469; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Ahsan N, 2010, J PROTEOME RES, V9, P4189, DOI 10.1021/pr100504j; Salavati A, 2012, J PROTEOMICS, V75, P878, DOI 10.1016/j.jprot.2011.10.002; Nanjo Y, 2013, J PROTEOME RES, V12, P4785, DOI 10.1021/pr4002349; Hashiguchi A, 2009, J PROTEOME RES, V8, P2058, DOI 10.1021/pr801051m; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Frohlich A, 2012, PLANT PHYSIOL, V159, P902, DOI 10.1104/pp.112.198077; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Zhang YX, 2013, MOL CELL PROTEOMICS, V12, P3431, DOI 10.1074/mcp.M112.025213; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Krishnan HB, 2009, PHYTOCHEMISTRY, V70, P1958, DOI 10.1016/j.phytochem.2009.08.020; Miller MJ, 2013, MOL CELL PROTEOMICS, V12, P449, DOI 10.1074/mcp.M112.025056; Komatsu S, 2012, J PROTEOMICS, V77, P531, DOI 10.1016/j.jprot.2012.09.032; Komatsu S, 2013, J PROTEOMICS, V79, P231, DOI 10.1016/j.jprot.2012.12.023; Widjaja I, 2009, PROTEOMICS, V9, P138, DOI 10.1002/pmic.200800293; Yanagawa Y, 2012, PLANT SCI, V185, P250, DOI 10.1016/j.plantsci.2011.11.014; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; van Veen H, 2013, PLANT CELL, V25, P4691, DOI 10.1105/tpc.113.119016; Tan YF, 2010, PLANT PHYSIOL, V152, P747, DOI 10.1104/pp.109.147942; Kim DY, 2013, PLANT CELL, V25, P1523, DOI 10.1105/tpc.112.108613; Komatsu S, 2011, J PROTEOME RES, V10, P3993, DOI 10.1021/pr2001918; Nanjo Y, 2012, J PROTEOME RES, V11, P372, DOI 10.1021/pr200701y; Armstrong W., 1979, Advances in Botanical Research, V7, P225; Ashraf M. A., 2012, African Journal of Agricultural Research, V7, P1976; Benschop JJ, 2006, PLANT PHYSIOL, V141, P1644, DOI 10.1104/pp.106.082636; Bertolde FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108705; Bohler S, 2011, J PROTEOME RES, V10, P3003, DOI 10.1021/pr1012009; Bray E, 2000, BIOCH MOL BIOL PLANT, P1158; Chen Y, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-33; Duque Paula, 2011, Plant Signal Behav, V6, P49; Easterling W. E., 2007, CLIMATE CHANGE 2007, P273; Fukao T, 2008, PLANT SCI, V175, P43, DOI 10.1016/j.plantsci.2007.12.002; Gong A., 2004, PROTEOMICS, V4, P3665; Hague M. E., 2011, PROTEIN PEPTIDE LETT, V18, P912; He LZ, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-42; Kamal AHM, 2015, J PROTEOMICS, V112, P1, DOI 10.1016/j.jprot.2014.08.014; Kamal AM, 2015, J PROTEOME RES, V14, P2219, DOI 10.1021/acs.jproteome.5b00007; Khan K. W., 2015, J PROTEOMICS, V121, P15; Khatoon A, 2012, AMINO ACIDS, V43, P2513, DOI 10.1007/s00726-012-1333-8; Khatoon A, 2012, MOL BIOL REP, V39, P10581, DOI 10.1007/s11033-012-1946-8; Kim YJ, 2013, PROTEOMICS, V13, P2176, DOI 10.1002/pmic.201200555; Komatsu S, 2014, PROTEIN PEPTIDE LETT, V21, P865, DOI 10.2174/0929866521666140320110521; Komatsu S, 2012, J PROTEOME RES, V11, P68, DOI 10.1021/pr2008863; Komatsu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065301; Komatsui S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00071; Komatsu S, 2014, MOL BIOL REP, V41, P1127, DOI 10.1007/s11033-013-2959-7; Komatsu S., 2015, J ANAL SCI TECHNOL, V6, P9; Komatsu S, 2013, J PROTEOMICS, V93, P169, DOI 10.1016/j.jprot.2012.12.016; Komatsu S., 2010, PROTEOMICS, V10, P1930; Mustafa G, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00627; Nanjo Y, 2011, PHYTOCHEMISTRY, V72, P1263, DOI 10.1016/j.phytochem.2010.10.017; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Oh M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00559; Oh MW, 2014, PROTEIN PEPTIDE LETT, V21, P458, DOI 10.2174/09298665113206660120; Oh MW, 2014, PROTEIN PEPTIDE LETT, V21, P911, DOI 10.2174/0929866521666140403122602; Pandey A., 2007, MOL CELL PROTEOMICS, V7, P88, DOI 10.1074/mcp.M700314-MCP200; SAGLIO PH, 1988, PLANT PHYSIOL, V86, P61, DOI 10.1104/pp.86.1.61; Sakagami J.-I., 2012, NIPPON SAKUMOTSU GAK, V81, P1; Stoychev V, 2013, ACTA PHYSIOL PLANT, V35, P1925, DOI 10.1007/s11738-013-1231-z; Tougou M, 2012, PLANT BIOTECHNOL-NAR, V29, P301, DOI 10.5511/plantbiotechnology.12.0301a; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yin XJ, 2015, J PROTEOMICS, V119, P183, DOI 10.1016/j.jprot.2015.02.004; Yin XJ, 2014, J PROTEOME RES, V13, P5618, DOI 10.1021/pr500621c; Zhu W, 2015, J PROTEOME RES, V14, P2669, DOI 10.1021/acs.jproteome.5b00208	111	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	SEP	2015	14	9					3768	3778		10.1021/acs.jproteome.5b00389		11	Biochemical Research Methods	Biochemistry & Molecular Biology	CR1LU	WOS:000361087100032		
J	Noro, E; Togayachi, A; Sato, T; Tomioka, A; Fujita, M; Sukegawa, M; Suzuki, N; Kaji, H; Narimatsu, H				Noro, Erika; Togayachi, Akira; Sato, Takashi; Tomioka, Azusa; Fujita, Mika; Sukegawa, Masako; Suzuki, Nami; Kaji, Hiroyuki; Narimatsu, Hisashi			Large-Scale Identification of N-Glycan Glycoproteins Carrying Lewis x and Site-Specific N-Glycan Alterations in Fut9 Knockout Mice	JOURNAL OF PROTEOME RESEARCH			English	Article						alpha 1,3-fucosyltransferase 9 (Fut9); knockout mouse; kidney; Lewis x; glycoproteomics; IGOT-LC-MS; xsite-specific N-glycome analysis	ALPHA-1,3-FUCOSYL-TRANSFERASE-IX FUT9; HELICOBACTER-PYLORI; LE(X) CARBOHYDRATE; MASS-SPECTROMETRY; AFFINITY CAPTURE; SIALIC-ACID; FUC-TIX; MOUSE; EXPRESSION; ANTIBODY	The Lewis x (Le(x)) structure (Gal beta 1-4(Fuc alpha 1-3)GlcNAc-R) is a carbohydrate epitope comprising the stage-specific embryonic antigen-1 (SSEA-1) and CD15, and it is synthesized by alpha 1,3-fucosyltransferase 9 (Fut9). Fut9 is expressed specifically in the stomach, kidney, brain, and in leukocytes, suggesting a specific function in these tissues. In this study, the N-linked glycan mass spectrometry profile of wild-type mouse kidney glycoproteins revealed the presence of abundant terminal fucoses, which were lost following knockout of the Fut9 gene; the terminal fucose was therefore concluded to be Le(x). These results suggested that Le(x) presence is widespread rather than being limited to specific proteins. We endeavored to comprehensively identify the Le(x) carriers in the mouse kidney. Glycopeptides carrying fucosylated glycans were collected by Aleuria aurantia lectin (AAL) affinity chromatography from kidney homogenates of wild-type and Fut9 knockout mice. The site-specific N-glycomes on the glycopeptides were subsequently analyzed by adopting a new glycoproteomic technology composed of dissociation-independent assignment of glycopeptide signals and accurate mass-based prediction of the N-glycome on the glycopeptides. Our analyses demonstrated that 24/32 glycoproteins contained the Le(x) N-glycan structure in wild-type kidney; of these, Le(x) was lost from 21 in the knockout mice. This is the first report of large-scale identification of Le(x)-carrying glycoproteins from a native sample based on the site-specific glycome analysis.	[Noro, Erika; Togayachi, Akira; Sato, Takashi; Tomioka, Azusa; Fujita, Mika; Sukegawa, Masako; Suzuki, Nami; Kaji, Hiroyuki; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, RCMG, Tsukuba, Ibaraki 3058568, Japan; [Noro, Erika; Narimatsu, Hisashi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Life Syst Med Sci, Dept Biomol Funct, Tsukuba, Ibaraki 3058572, Japan	Narimatsu, H (reprint author), Natl Inst Adv Ind Sci & Technol, RCMG, Tsukuba, Ibaraki 3058568, Japan.	h.narimatsu@aist.go.jp			JSPS KAKENHI [13313213, 15641201]	This work was partially supported by JSPS KAKENHI (Grant-in-Aid for Scientific Research (A)) Grant Number 13313213, 15641201. Acknowledged to all members of the Research Center for Medical Glycoscience of the National Institute of Advanced Industrial Science and Technology, AIST.	Gelberg H, 1996, LAB INVEST, V74, P907; DEKAN G, 1991, P NATL ACAD SCI USA, V88, P5398, DOI 10.1073/pnas.88.12.5398; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Quaggin SE, 2007, J CLIN INVEST, V117, P1480, DOI 10.1172/JCI32482; Kaneko M, 1999, FEBS LETT, V452, P237, DOI 10.1016/S0014-5793(99)00640-7; Ito H, 2009, J PROTEOME RES, V8, P1358, DOI 10.1021/pr800735j; Sheu SM, 2007, INFECT IMMUN, V75, P2661, DOI 10.1128/IAI.01689-06; Kaji H, 2006, NAT PROTOC, V1, P3019, DOI 10.1038/nprot.2006.444; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Warren HS, 1996, J IMMUNOL, V156, P2866; ALLENDOERFER KL, 1995, MOL CELL NEUROSCI, V6, P381, DOI 10.1006/mcne.1995.1029; Hakansson K, 2001, ANAL CHEM, V73, P4530, DOI 10.1021/ac0103470; Streit A, 1996, J NEUROCHEM, V66, P834; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Shimoda Y, 2002, J BIOL CHEM, V277, P2033, DOI 10.1074/jbc.M108495200; Kaji H, 2012, J PROTEOME RES, V11, P4553, DOI 10.1021/pr300346c; Edwards NJ, 2000, MOL MICROBIOL, V35, P1530, DOI 10.1046/j.1365-2958.2000.01823.x; Kudo T, 1998, J BIOL CHEM, V273, P26729, DOI 10.1074/jbc.273.41.26729; Kakani S, 2012, AM J PATHOL, V180, P1431, DOI 10.1016/j.ajpath.2011.12.023; MELNICK DA, 1986, BLOOD, V67, P1388; Wu SW, 2014, ANAL CHEM, V86, P5478, DOI 10.1021/ac500945m; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Allendoerfer KL, 1999, DEV BIOL, V211, P208, DOI 10.1006/dbio.1999.9308; Hashii N, 2009, J PROTEOME RES, V8, P3415, DOI 10.1021/pr9000527; MOHOS SC, 1969, SCIENCE, V164, P1519, DOI 10.1126/science.164.3887.1519; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Kudo T, 2004, MOL CELL BIOL, V24, P4221, DOI 10.1128/MCB.24.10.4221-4228.2004; Kudo T, 2007, GLYCOBIOLOGY, V17, P1, DOI 10.1093/glycob/cwl047; Liu TW, 2012, GLYCOBIOLOGY, V22, P630, DOI 10.1093/glycob/cwr189; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Macauley MS, 2014, J BIOL CHEM, V289, P35149, DOI 10.1074/jbc.M114.606517; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Sugahara D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00680	35	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	SEP	2015	14	9					3823	3834		10.1021/acs.jproteome.5b00178		12	Biochemical Research Methods	Biochemistry & Molecular Biology	CR1LU	WOS:000361087100036		
J	Nakamura, K; Kitamura, K; Kim, Y; Someya, T				Nakamura, Kazutoshi; Kitamura, Kaori; Kim, Yoshiharu; Someya, Toshiyuki			Property damage and long-term psychological distress after the 2004 Niigata-Chuetsu earthquake in Ojiya, Japan: a community-based study	JOURNAL OF PUBLIC HEALTH			English	Article						earthquakes; epidemiological studies; mental health; property damage; psychological distress	POSTTRAUMATIC-STRESS-DISORDER; SURVIVORS; RECOVERY; DEPRESSION; SYMPTOMS; TAIWAN; TURKEY	Background This study aimed to assess psychological distress (PD) in earthquake-stricken communities with regard to the extent of property damage for 3 years following the 2004 Niigata-Chuetsu earthquake in Japan. Methods Subjects were participants of health check examinations in a community near the epicentre, and included 7097 residents (a parts per thousand yen18 years) in 2005, 6586 in 2006 and 6698 in 2007. Interviews assessed PD symptoms and lifestyles. The Kessler Psychological Distress Scale (K10) was used, with scores a parts per thousand yen20 considered as PD. The 137 subdistricts were divided into quartiles according to the proportion of half-completely destroyed houses at cut-offs of 18.9, 30.5 and 66.7%. Results The PD prevalence was 17.0% in 2005, 13.2% in 2006 and 11.8% in 2007. In 2005, the more and most heavily damaged groups had significantly higher PD prevalence (OR = 1.5 and 1.4, respectively) than that of the least damaged group with a dose-dependent relationship (P = 0.0005). This association was weaker in 2006 (P = 0.0413) and in 2007 (P = 0.1816). Conclusions Psychological distress prevalence was high in highly damaged areas, and the prevalence difference between areas with high versus low damage decreases with time. Extensive mental health care in communities with substantial damage should be expected to last 2 years after an earthquake.	[Nakamura, Kazutoshi; Kitamura, Kaori] Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Med, Chuo Ku, Niigata 9518510, Japan; [Kim, Yoshiharu] Natl Inst Mental Hlth, Natl Ctr Neurol & Psychiat, Dept Adult Mental Hlth, Tokyo, Japan; [Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan; [Someya, Toshiyuki] Niigata Inst Traumat Stress Mental Hlth & Welf As, Niigata, Japan	Nakamura, K (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Med, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	kazun@med.niigata-u.ac.jp			Niigata Institute for Traumatic Stress (Mental Health and Welfare Association in Niigata Prefecture), Japan	This work was supported in part by the Niigata Institute for Traumatic Stress (Mental Health and Welfare Association in Niigata Prefecture), Japan.	Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Chen CH, 2007, COMPR PSYCHIAT, V48, P269, DOI 10.1016/j.comppsych.2006.12.003; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; Oyama Mari, 2012, Environmental Health and Preventive Medicine, V17, P118, DOI 10.1007/s12199-011-0225-y; Cerda M, 2013, DEPRESS ANXIETY, V30, P413, DOI 10.1002/da.22007; Slade T, 2011, AUST NZ J PSYCHIAT, V45, P308, DOI 10.3109/00048674.2010.543653; Byles JE, 2014, DEPRESS ANXIETY, V31, P524, DOI 10.1002/da.22162; Cabinet Office Government of Japan, AUTH HOUS DAM REL DI; Chan CLW, 2011, J TRAUMA STRESS, V24, P295, DOI 10.1002/jts.20645; Chen CC, 2001, PSYCHIAT RES, V105, P13, DOI 10.1016/S0165-1781(01)00334-1; Honda R, 2005, EARTH PLANETS SPACE, V57, P527; Kilic C, 2003, ACTA PSYCHIAT SCAND, V108, P232, DOI 10.1034/j.1600-0447.2003.00119.x; Kuwabara H, 2008, PSYCHIAT CLIN NEUROS, V62, P503, DOI 10.1111/j.1440-1819.2008.01842.x; Nakamura K, 2014, J EPIDEMIOL, V24, P125, DOI 10.2188/jea.JE20130097; Niigata Prefectural Government, 2009, NIIG PREF REP DAM 20; Ojiya City Government Niigata Institute for Traumatic Stress, 2012, NIIG CHUETS EARTHQ R; Ojiya City Government Niigata Institute for Traumatic Stress, 2013, SURV DEM OJ CIT; Osaki Y, 2001, AM J EPIDEMIOL, V153, P153, DOI 10.1093/aje/153.2.153; Toyabe S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-230	20	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1741-3842	1741-3850		J PUBLIC HEALTH-UK	J. Public Health	SEP	2015	37	3					398	405		10.1093/pubmed/fdu052		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CR4PC	WOS:000361316900005		
J	Kuriyama, A; Takahashi, Y; Tsujimura, Y; Miyazaki, K; Satoh, T; Ikeda, S; Nakayama, T				Kuriyama, Akira; Takahashi, Yoshimitsu; Tsujimura, Yuka; Miyazaki, Kikuko; Satoh, Toshihiko; Ikeda, Shunya; Nakayama, Takeo			Predicting failure to follow-up screened high blood pressure in Japan: a cohort study	JOURNAL OF PUBLIC HEALTH			English	Article						circulatory disease; health services; secondary and tertiary services	HYPERTENSION GUIDELINES; MANAGEMENT; AWARENESS; SOCIETY	Background This study aimed to determine the prevalence and predictors of working-age individuals who did not follow-up for possible hypertension that was detected in the population-based screening. Methods We conducted a retrospective cohort study, using the database of health insurance claims and health checkups from several health insurance societies for employees in Japan. Screened participants aged a parts per thousand yen20 years, with possible hypertension (systolic blood pressure a parts per thousand yen140 mmHg and/or diastolic blood pressure a parts per thousand yen90 mmHg) and without known antihypertensive treatment, were included. The outcome was lack of clinical follow-up for possible hypertension within 6 months of the latest screening. Multivariate logistic regression analysis was performed to identify predictors. Results Among 17 173 participants (15 793 males and 1380 females) who were identified as possible hypertensives, 89.7 and 82.3% of them, respectively, did not consult physicians for screened possible hypertension. Predictors of no clinical follow-up for males included younger age, lower body mass index (BMI), lower hemoglobin A1c and milder hypertension. Predictors for females included younger age, lower BMI and being insured. Conclusions Approximately 80% of participants failed to consult physicians even with positive screening results. Younger individuals with lower BMI are at high risk of no clinical follow-up.	[Kuriyama, Akira; Takahashi, Yoshimitsu; Tsujimura, Yuka; Miyazaki, Kikuko; Nakayama, Takeo] Kyoto Univ, Dept Hlth Informat, Sch Publ Hlth, Kyoto 6068501, Japan; [Satoh, Toshihiko] Aoyama Gakuin Univ, Sch Social Informat, Sagamihara, Kanagawa 2525258, Japan; [Ikeda, Shunya] Int Univ & Hlth Welf, Sch Pharm, Dept Pharmaceut Sci, Ohtawara 3248501, Japan	Kuriyama, A (reprint author), Kyoto Univ, Dept Hlth Informat, Sch Publ Hlth, Kyoto 6068501, Japan.	nrk40448@nifty.com			Ministry of Education, Culture, Sports, Science, and Technology	This study was partly supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology.	Sheridan S, 2003, AM J PREV MED, V25, P151, DOI 10.1016/S0749-3797(03)00121-1; Chalmers J, 1999, J HYPERTENS, V17, P151; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)17741-1; Zanchetti A, 2005, J HYPERTENS, V23, P1113, DOI 10.1097/01.hjh.0000170370.41387.1b; Horton NJ, 2001, AM STAT, V55, P244, DOI 10.1198/000313001317098266; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Japan Atherosclerosis S, 2007, J ATHEROSCLER THROMB, P5; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Schmitz N, 2006, PSYCHOSOM MED, V68, P246, DOI 10.1097/01.psy.0000204883.77284.6b; Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, 2002, 5 NAT SURV CARD DIS; Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, 2011, EST NAT MED CAR EXP; The Commitee of Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, 2010, DIABETOL INT, V1, P2; The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, 2010, J JAPAN DIAB SOC, V53, P450; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV; WHO Collaborating Centre for Drug Statistics Methodology, ATC DDD IND 2013; World Health Organization, INT CLASS DIS ICD	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1741-3842	1741-3850		J PUBLIC HEALTH-UK	J. Public Health	SEP	2015	37	3					498	505		10.1093/pubmed/fdu056		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CR4PC	WOS:000361316900017		
J	Yamaguchi, H; Hirade, N; Higashizono, K; Tada, K; Kishimoto, K; Oyama, K; Ichimi, K				Yamaguchi, Hitomi; Hirade, Naoto; Higashizono, Keigo; Tada, Kuninao; Kishimoto, Koji; Oyama, Kenichi; Ichimi, Kazuhiko			Light and nutrient limitation on phytoplankton production in the strait of an enclosed coastal sea (Bisan Strait, eastern Seto Inland Sea, Japan)	JOURNAL OF SEA RESEARCH			English	Article						Photosynthetic-irradiance curve; Production; Nutrient; Light; Phytoplankton		The Bisan Strait is a vertically well-mixed, shallow area (mean depth 13.9 m) in the Seto Inland Sea. The strait has the lowest Secchi transparency (mean 4.5 m) within the Inland Sea because of active sediment re-suspension. Therefore, in comparison with adjacent areas, phytoplankton production in the strait may be strongly affected by light availability in addition to nutrient availability. In this study, we examined environmental variables, photosynthesis-irradiance (P-I) curves and phytoplankton production in the Bisan Strait over 1 year. There were temporal variations in the light-saturated photosynthesis rate (P-m(B)) and initial slope of P-I curve (alpha(B)), with maxima in autumn and minima in spring. Most of the variability in P-m(B) and alpha(B) was explained by variations in nutrient concentrations (dissolved inorganic nitrogen) and water temperature. Meanwhile, phytoplankton production reached a peak in summer and a nadir in spring, but an autumn peak in production was not observed. Diagnostic analysis suggested that, for almost all of the year, nutrients were more important for phytoplankton growth than light limitation. However, light limitation became more important in autumn when underwater irradiance reached low levels. Therefore, the lack of an autumn peak in production is likely to be related to light limitation. We suggest that low light availability during the autumn depresses the annual rate of phytoplankton production in the Bisan Strait, in comparison with adjacent areas where seasonal stratification is established and phytoplankton blooms frequently occur in early autumn. (C) 2015 Elsevier B.V. All rights reserved.	[Yamaguchi, Hitomi; Hirade, Naoto; Higashizono, Keigo; Tada, Kuninao] Kagawa Univ, Fac Agr, Miki, Kita 7610795, Japan; [Kishimoto, Koji; Ichimi, Kazuhiko] Kagawa Univ, Seto Inland Sea Reg Res Ctr, Takamatsu, Kagawa 7610130, Japan; [Oyama, Kenichi] Akashiwo Res Inst Kagawa Prefecture, Takamatsu, Kagawa 7610111, Japan	Yamaguchi, H (reprint author), Kagawa Univ, Fac Agr, 2393 IkeNobe, Miki, Kita 7610795, Japan.	hitomiyjp@yahoo.co.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	We thank the members of the Marine Environmental Laboratory, Kagawa University, for sampling assistance. We would also like to express our appreciation to Dr. T. Asashi and Ms. Y. Takigawa for their advisory comments, and Dr. J. van Beusekom and two anonymous reviewers for improving the quality of the manuscript. This work was partly supported by the grant "Coastal Ecosystem Complex", from the Japanese Ministry of Education, Culture, Sports, Science and Technology.		0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1385-1101	1873-1414		J SEA RES	J. Sea Res.	SEP	2015	103						75	83		10.1016/j.seares.2015.06.006		9	Marine & Freshwater Biology; Oceanography	Marine & Freshwater Biology; Oceanography	CR2LH	WOS:000361160600008		
J	Kida, S; Yamamoto, M; Tada, K; Kawata, H; Hirai, Y; Yasuda, M				Kida, Shogo; Yamamoto, Masaya; Tada, Kazuhiro; Kawata, Hiroaki; Hirai, Yoshihiko; Yasuda, Masaaki			Correlation between electron-irradiation defects and applied stress in graphene: A molecular dynamics study	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							CARBON NANOTUBES; BEAM; TEMPERATURE; ENERGETICS; RIBBONS; ADATOMS; SYSTEMS; STATE	Molecular dynamics (MD) simulations are performed to study the correlation between electron irradiation defects and applied stress in graphene. The electron irradiation effect is introduced by the binary collision model in the MD simulation. By applying a tensile stress to graphene, the number of adatom-vacancy (AV) and Stone-Wales (SW) defects increase under electron irradiation, while the number of single-vacancy defects is not noticeably affected by the applied stress. Both the activation and formation energies of an AV defect and the activation energy of an SW defect decrease when a tensile stress is applied to graphene. Applying tensile stress also relaxes the compression stress associated with SW defect formation. These effects induced by the applied stress cause the increase in AV and SW defect formation under electron irradiation. (C) 2015 American Vacuum Society.	[Kida, Shogo; Yamamoto, Masaya; Kawata, Hiroaki; Hirai, Yoshihiko; Yasuda, Masaaki] Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan; [Tada, Kazuhiro] Toyama Coll, Natl Inst Technol, Dept Elect & Control Syst Engn, Toyama 9398630, Japan	Kida, S (reprint author), Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan.	yasuda@pe.osakafu-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25249052]	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant No. 25249052.	Krasheninnikov AV, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125428; Banhart F, 2011, ACS NANO, V5, P26, DOI 10.1021/nn102598m; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Skowron ST, 2015, CHEM SOC REV, V44, P3143, DOI 10.1039/c4cs00499j; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Zobelli A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245402; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Mott NF, 1929, P R SOC LOND A-CONTA, V124, P425, DOI 10.1098/rspa.1929.0127; Li L, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.184109; BRENNER DW, 1990, PHYS REV B, V42, P9458, DOI 10.1103/PhysRevB.42.9458; Lehtinen PO, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.187202; Lusk MT, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.175503; Krasheninnikov AV, 2004, CARBON, V42, P1021, DOI [10.1016/j.carbon.2003.12.025, 10.1016/j.carbon.2003.12.055]; Leyssale JM, 2014, J PHYS CHEM C, V118, P8200, DOI 10.1021/jp501028n; Lu Y, 2011, NANO LETT, V11, P5184, DOI 10.1021/nl2023756; Song B, 2011, NANO LETT, V11, P2247, DOI 10.1021/nl200369r; Zhao RQ, 2015, NANOSCALE, V7, P8315, DOI 10.1039/c5nr00552c; BRENNER DW, 1993, PHYS REV LETT, V70, P2174, DOI 10.1103/PhysRevLett.70.2174; Ewels CP, 2002, CHEM PHYS LETT, V351, P178, DOI 10.1016/S0009-2614(01)01371-9; TERSOFF J, 1988, PHYS REV B, V37, P6991, DOI 10.1103/PhysRevB.37.6991; Samsonidze GG, 2002, COMP MATER SCI, V23, P62, DOI 10.1016/S0927-0256(01)00220-8; STONE AJ, 1986, CHEM PHYS LETT, V128, P501, DOI 10.1016/0009-2614(86)80661-3; Dumitrica T, 2004, APPL PHYS LETT, V84, P2775, DOI 10.1063/1.1695630; Ma J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.033407; Krasheninnikov AV, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.245405; Lemme MC, 2009, ACS NANO, V3, P2674, DOI 10.1021/nn900744z; TERSOFF J, 1989, PHYS REV B, V39, P5566, DOI 10.1103/PhysRevB.39.5566; Girifalco LA, 2000, PHYS REV B, V62, P13104, DOI 10.1103/PhysRevB.62.13104; Asayama Y, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4765630; Bell DC, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455301; Chihara Y, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3662409; El-Barbary AA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.144107; Krasheninnikov AV, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.073402; Lehtinen PO, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.017202; Oeiras RY, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.073405; Ohishi M, 2007, JPN J APPL PHYS 2, V46, pL605, DOI 10.1143/JJAP.46.L605; Pregler SK, 2007, NUCL INSTRUM METH B, V262, P240, DOI 10.1016/j.nimb.2007.05.030; Samsonidze GG, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.065501; Tsetseris L, 2009, CARBON, V47, P901, DOI 10.1016/j.carbon.2008.12.002; Wakabayashi K, 1999, PHYS REV B, V59, P8271, DOI 10.1103/PhysRevB.59.8271; Yamamoto M, 2014, J VAC SCI TECHNOL B, V32, DOI 10.1116/1.4897304; Yasuda M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3549728; Yasuda M, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4823760; Yasuda M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205406	44	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	SEP	2015	33	5							05E127	10.1116/1.4928414		6	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CR3JP	WOS:000361229000027		
J	Kubota, Y; Lee, J				Kubota, Yusuke; Lee, Jungmee			THE COORDINATE STRUCTURE CONSTRAINT AS A DISCOURSE-ORIENTED PRINCIPLE: FURTHER EVIDENCE FROM JAPANESE AND KOREAN	LANGUAGE			English	Article						coordinate structure constraint; Japanese; Korean; coordination; subordination; island constraints; discourse relation	CATEGORIES; SEMANTICS; GRAMMAR	We reexamine the status of the COORDINATE STRUCTURE CONSTRAINT (CSC; Ross 1967) by drawing on evidence from Japanese and Korean. Contrary to the standard view that the CSC is a syntactic constraint, the empirical patterns from the two languages show that it should instead be viewed as a pragmatic principle. We propose a pragmatic analysis by building on and extending a previous proposal by Kehler (2002). Examining the Japanese and Korean data turns out to be vital in the comparison of the syntactic and pragmatic approaches, since the syntactic differences between the relevant constructions in the two languages and their counterparts in English crucially distinguish the predictions of the two approaches.	[Kubota, Yusuke] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan; [Kubota, Yusuke] Ohio State Univ, Columbus, OH 43210 USA; [Lee, Jungmee] Seoul Natl Univ Sci & Technol, Seoul, South Korea	Kubota, Y (reprint author), 108A Ohio Stadium East 1961 Tuttle Pk Pl, Columbus, OH 43210 USA.	kubota.7@osu.edu; jungmeelee@seoultech.ac.kr			Japan Society for Promotion of Science (JSPS); Japan Society for the Promotion of Science (Postdoctoral Fellowship for Research Abroad)	We would like to thank Bob Levine for his continued encouragement and numerous inputs (of various sorts) on this work throughout its long gestation. Earlier versions of this article were presented at the 15th International Conference on Head-Driven Phrase Structure Grammar (Keihanna, Japan, 2008) and the 83rd annual meeting of the Linguistic Society of America (San Francisco, 2009); we would like to thank the participants of these conferences for feedback. Thanks are also due to the members of the syntax-semantics discussion group 'Synners' at the OSU Linguistics Department. We would also like to thank four anonymous Language referees for their comments, which helped improve both the content and presentation of the article greatly. Last but not least, we would like to thank Language editor Greg Carlson for his very thoughtful editorial guidance and various useful remarks on this work. The first author was supported by the Japan Society for the Promotion of Science (JSPS; PD 2010-2013 and Postdoctoral Fellowship for Research Abroad 2013-2014) when he worked on the revisions of this article, and would like to thank the JSPS for its financial support.	Chaves RP, 2012, NAT LANG LINGUIST TH, V30, P465, DOI 10.1007/s11049-011-9164-y; Steedman M, 2011, NON-TRANSFORMATIONAL SYNTAX: FORMAL AND EXPLICIT MODELS OF GRAMMAR, P181; Bayer S, 1996, LANGUAGE, V72, P579, DOI 10.2307/416279; Kennedy C, 2007, LINGUIST PHILOS, V30, P1, DOI 10.1007/s10988-006-9008-0; Kennedy C, 2005, LANGUAGE, V81, P345, DOI 10.1353/lan.2005.0071; SAG IA, 1985, NAT LANG LINGUIST TH, V3, P117, DOI 10.1007/BF00133839; Hofmeister P, 2010, LANGUAGE, V86, P366; Campbell J., 1982, GRAMMATICAL MAN INFO; CHAVES RUI PEDRO, 2007, THESIS U LISBON PORT; CHO SAE-YOUN, 2005, LANGUAGE INFORM, V9, P35; Deane P., 1991, Cognitive Linguistics, V2, DOI 10.1515/cogl.1991.2.1.1; Fox Danny, 2000, EC SEMANTIC INTERPRE; Goldsmith John A., 1985, CHICAGO LINGUISTIC S, V21, P133; Kehler A., 2002, COHERENCE REFERENCE; Kluender R., 1992, ISLAND CONSTRAINTS T, P223; KLUENDER ROBERT, 1998, THE LIMITS OF SYNTAX, P241; Kuno Susumu, 1973, STRUCTURE JAPANESE L; Kuroda Sige-Yuki, 1986, ISSUES JAPANESE LING, P229; Lakoff George, 1986, CHICAGO LINGUISTIC S, V22, P152; LEWIS D., 1973, COUNTERFACTUALS; MATSUMOTO YOSHIKO, 1997, NOUN MODIFYING CONST; Partee Barbara H., 1983, MEANING USE INTERPRE, P361; Pollard Carl, 1994, HEAD DRIVEN PHRASE S; PRINCE ELLEN F., 1986, PAP LINGUIST, V19, P351; Pustejovsky J., 1995, GENERATIVE LEXICON; Roberts C, 1996, OSU WORKING PAPERS L, V49, P91; Ross John Robert, 1967, THESIS MIT CAMBRIDGE; Sag I. A., 2003, SYNTACTIC THEORY FOR; SAG IVAN A., 2000, ANOTHER ARGUMENT WH; SCHMERLING SUSAN, 1972, STUDIES LINGUISTIC S, V2, P91104; SCHMERLING SUSAN F., 1975, SYNTAX SEMANTICS, V3, P211; Shopin T., 2007, LANGUAGE TYPOLOGY SY, VII, P1; Steedman M, 2012, TAKING SCOPE: THE NATURAL SEMANTICS OF QUANTIFIERS, P1; TOKASHIKI KYOKO, 1989, THESIS OHIO STATE U; Lee J, 2010, J SEMANT, V27, P307, DOI 10.1093/jos/ffq005; YATABE SHUICHI, 2003, NIHON GENGOGAKKAI DA, P262; YOON JAE-HAK, 1993, OHIO STATE U WORKING; YOON JAMES HYE SUX, 1997, HARVARD STUDIES KORE, V7, P3; YOUNGHEE NA, 1992, JOY GRAMMAR FESTSCHR, P251	39	0	0	LINGUISTIC SOC AMER	WASHINGTON	1325 18TH ST NW, SUITE 211, WASHINGTON, DC 20036-6501 USA	0097-8507	1535-0665		LANGUAGE	Language	SEP	2015	91	3					642	675				34	Linguistics; Language & Linguistics	Linguistics	CR5WK	WOS:000361414900005		
J	Sanfilippo, A; Morishita, T; Kumagai, H; Nakamura, K; Okino, K; Hara, K; Tamura, A; Arai, S				Sanfilippo, Alessio; Morishita, Tomoaki; Kumagai, Hidenori; Nakamura, Kentaro; Okino, Kyoko; Hara, Kaori; Tamura, Akihiro; Arai, Shoji			Hybrid troctolites from mid-ocean ridges: inherited mantle in the lower crust	LITHOS			English	Article							LOWER OCEANIC-CRUST; CENTRAL INDIAN RIDGE; MELT-ROCK REACTION; SPREADING CENTER; REACTIVE CRYSTALLIZATION; ABYSSAL PERIDOTITES; PETROLOGY; ELEMENTS; OLIVINE; GABBROS	Studies on olivine-rich troctolites from oceanic ridges propose that hybridized mantle rocks may locally constitute small portions of the lower oceanic crust. The exact reaction process by which they originate is still debated and their hybrid nature is controversial. We show that textural and chemical inheritances of the pre-existing mantle are preserved in olivine-rich troctolites recently sampled at the Central Indian Ridge. The occurrence of a large orthopyroxene of a probable mantle origin suggests that these rocks formed through the reactive overprint of a mantle peridotite. Combining our data with those of olivine-rich troctolites worldwide, we show that the clinopyroxenes from these rocks follow chemical trends slightly distinct to those of the oceanic gabbros. These chemical trends can be ascribed to crystallization from melts assimilating mantle peridotites, suggesting that a "mantle flavor" can be locally retained in these hybrid rocks. The present distribution of Ol-rich troctolites suggests that melt-mantle reaction processes by which these rocks originate is likely to be more diffuse at slower spreading environments, where extensive melt-rock reactions within a thick thermal boundary layer enhances the conversion of the shallow oceanic mantle into hybrid crustal rocks. (C) 2015 Elsevier B.V. All rights reserved.	[Sanfilippo, Alessio] Univ Pavia, Dipartimento Sci Ambiente & Terr, I-27100 Pavia, Italy; [Sanfilippo, Alessio; Morishita, Tomoaki; Hara, Kaori; Tamura, Akihiro; Arai, Shoji] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan; [Kumagai, Hidenori] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Nakamura, Kentaro; Okino, Kyoko] Univ Tokyo, Tokyo 1648639, Japan	Sanfilippo, A (reprint author), Univ Pavia, Dipartimento Sci Ambiente & Terr, Via Ferrata 1A, I-27100 Pavia, Italy.	alessio.sanfilippo@unipv.it		Sanfilippo, Alessio/0000-0002-4112-3643	Ministry of Education, Culture, Sports and Technology of Japan [N 26287134]; Japan Society for Promotion of Science	We thank the captain of R/V Yokosuka, the Shinkai team, and YK05-16 scientific team for the successful cruise. Constructive reviews by Y. Liang and J. Natland and the editorial work of N. Eby greatly enhanced the quality of the manuscript. This work was supported by a Grant-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports and Technology of Japan (N 26287134) to T.M. A.S was partly supported by Japan Society for Promotion of Science with a JSPS Postdoctoral fellowship.	Abily B, 2013, GEOLOGY, V41, P67, DOI 10.1130/G33351.1; ANDERS E, 1982, GEOCHIM COSMOCHIM AC, V46, P2363, DOI 10.1016/0016-7037(82)90208-3; Drouin M, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002995; Hellebrand E, 2005, CONTRIB MINERAL PETR, V150, P486, DOI 10.1007/s00410-005-0036-5; Sanfilippo A, 2014, GEOCHIM COSMOCHIM AC, V141, P423, DOI 10.1016/j.gca.2014.06.012; BREY GP, 1990, J PETROL, V31, P1353; Cherniak DJ, 2010, REV MINERAL GEOCHEM, V72, P641, DOI 10.2138/rmg.2010.72.14; Kelemen PB, 1998, GEOPH MONOG SERIES, V106, P267; Gao Y, 2007, CONTRIB MINERAL PETR, V153, P429, DOI 10.1007/s00410-006-0158-4; Dick HJB, 2000, EARTH PLANET SC LETT, V179, P31, DOI 10.1016/S0012-821X(00)00102-3; Suhr G, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002012; Lissenberg CJ, 2013, EARTH PLANET SC LETT, V361, P436, DOI 10.1016/j.epsl.2012.11.012; Liang Y, 2013, GEOCHIM COSMOCHIM AC, V102, P246, DOI 10.1016/j.gca.2012.10.035; Borghini G, 2007, CONTRIB MINERAL PETR, V154, P619, DOI 10.1007/s00410-007-0217-5; Godard M, 2009, EARTH PLANET SC LETT, V279, P110, DOI 10.1016/j.epsl.2008.12.034; Nakamura K, 2009, EARTH PLANET SC LETT, V280, P128, DOI 10.1016/j.epsl.2009.01.024; KELEMEN PB, 1990, J PETROL, V31, P51; Sanfilippo A, 2013, CONTRIB MINERAL PETR, V165, P705, DOI 10.1007/s00410-012-0831-8; Collier ML, 2010, J PETROL, V51, P1913, DOI 10.1093/petrology/egq043; Sanfilippo A, 2013, J PETROL, V54, P861, DOI 10.1093/petrology/egs089; Niu YL, 2004, J PETROL, V45, P2423, DOI 10.1093/petrology/egh068; Drouin M, 2009, CHEM GEOL, V264, P71, DOI 10.1016/j.chemgeo.2009.02.013; Gillis KM, 2014, NATURE, V505, P204, DOI 10.1038/nature12778; Adam J, 2006, CONTRIB MINERAL PETR, V152, P1, DOI 10.1007/s00410-006-0085-4; Lissenberg CJ, 2008, EARTH PLANET SC LETT, V271, P311, DOI 10.1016/j.epsl.2008.04.023; Hellebrand E, 2002, J PETROL, V43, P2305, DOI 10.1093/petrology/43.12.2305; Arai S, 1997, GEOCHIM COSMOCHIM AC, V61, P671, DOI 10.1016/S0016-7037(96)00389-4; Blackman D. K., 2006, P INTEGRATED OCEAN D, P304, DOI [10.2204/iodp.proc.304305103, DOI 10.2204/IODP.PROC.304305.2006, 10.2204/iodp.proc.304305.2006]; Coogan L. A., 2007, TREATISE GEOCHEMISTR, V3, P1, DOI DOI 10.1016/B978-008043751-4/00230-3; Coogan LA, 2000, EARTH PLANET SC LETT, V176, P245, DOI 10.1016/S0012-821X(00)00006-6; DEPAOLO DJ, 1981, J GEOPHYS RES, V86, P470, DOI 10.1029/JB086iB11p10470; Dick H. J. B., 1996, P ODP SCI RES, V147, P103, DOI DOI 10.2973/ODP.PROC.SR.147.007.1996; Dick HJB, 2010, J PETROL, V51, P425, DOI 10.1093/petrology/egp088; ELTHON D, 1987, J GEOPHYS RES-SOLID, V92, P658, DOI 10.1029/JB092iB01p00658; GROVE TL, 1992, MANTLE FLOW MELT GEN, V71, P281, DOI DOI 10.1029/GM071P0281; Kelemen P.B., 2007, P OCEAN DRILLING PRO, V209, P1, DOI DOI 10.2973/ODP.PROC.SR.209.001.2007; Koepke J, 2007, CONTRIB MINERAL PETR, V153, P67, DOI 10.1007/s00410-006-0135-y; Morishita T, 2009, J PETROL, V50, P1299, DOI 10.1093/petrology/egp025; Morishita T., 2014, SUBSEAFLOOR BIOSPHER; Perk NW, 2007, CONTRIB MINERAL PETR, V154, P575, DOI 10.1007/s00410-007-0210-z; Saper L, 2014, CONTRIB MINERAL PETR, V167, DOI 10.1007/s00410-014-0985-7; Tamura A., 2014, CONTRIBUTION MINERAL, V164, P974; Tamura A, 2008, CONTRIB MINERAL PETR, V155, P491, DOI 10.1007/s00410-007-0254-0; Tartarotti P, 2002, LITHOS, V63, P125, DOI 10.1016/S0024-4937(02)00116-0; Renna MR, 2011, J PETROL, V52, P1763, DOI 10.1093/petrology/egr029; Von der Handt A., 2012, EUR MIN C 2012 1, V1	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	SEP 1	2015	232						124	130		10.1016/j.lithos.2015.06.025		7	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CR5TX	WOS:000361408400010		
J	Arai, S; Miura, M				Arai, Shoji; Miura, Makoto			Podiform chromitites do form beneath mid-ocean ridges	LITHOS			English	Article						Podiform chromitite; Mid-ocean ridge; Off-ridge magmatism; Harzburgite; Peridotite-melt reaction; Ridge segment center	NORTHERN OMAN OPHIOLITE; EAST PACIFIC RISE; SOUTHWEST INDIAN RIDGE; ULTRAHIGH-PRESSURE CHROMITITES; SPREADING-RATE DEPENDENCE; MID-ATLANTIC RIDGE; CHROMIAN SPINEL; EQUATORIAL PACIFIC; MANTLE SECTION; ALKALI-BASALT	Podiform chromitites are commonly found within the Moho transition zone to mantle section of ophiolites, as well as in non-ophiolitic peridotite massifs. However, they have rarely been observed in the present-day ocean floor, even though some ophiolites are considered slices of oceanic lithosphere. One of the factors controlling podiform chromitite formation is the chemistry of the host mantle peridotite. A moderately refractory harzburgite that contains chromite with an intermediate Cr# (Cr/(Cr + Al)) of 0.4-0.6 is the optimum host for chromitites. Such a harzburgite represents the most typical lithology of oceanic lithosphere where peridotite-melt reactions, another requirement for chromitite formation, are possibly common. Thus, the oceanic upper mantle is potentially a suitable host for podiform chromitites. In particular, off-ridge magmatism may lead to the formation of podiform chromitite. The apparent rarity of chromitites in the present-day ocean floor is simply a reflection of the under-sampling of mantle material from fast-spreading ridges and the center segment of slow-spreading ridges. However, in addition to ophiolitic chromitites forming at ordinary mid-ocean ridges from genuine MORB, they also form in the typical ophiolite tectonic setting, at supra-subduction zone spreading centers, from wet MORB. Future mantle drilling as an active way of sampling, on the ocean floor will possibly reveal the occurrence of podiform chromitite in present-day oceanic lithosphere, analogous to ophiolitic chromitite. (C) 2015 Elsevier B.V. All rights reserved.	[Arai, Shoji; Miura, Makoto] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan	Arai, S (reprint author), Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan.	ultrasa@staff.kanazawa-u.ac.jp					Abe N, 2011, J MINER PETROL SCI, V106, P97, DOI 10.2465/jmps.101022; Ahmed AH, 2002, CONTRIB MINERAL PETR, V143, P263, DOI 10.1007/s00410-002-0347-8; Ishii T, 2014, AM MINERAL, V99, P1788, DOI 10.2138/am.2014.4736; TUCHOLKE BE, 1994, J GEOPHYS RES-SOL EA, V99, P11937, DOI 10.1029/94JB00338; BATIZA R, 1990, GEOLOGY, V18, P1122, DOI 10.1130/0091-7613(1990)018<1122:COSNTE>2.3.CO;2; ARAI S, 1994, CHEM GEOL, V113, P191, DOI 10.1016/0009-2541(94)90066-3; ARAI S, 1994, ECON GEOL BULL SOC, V89, P1279; ALABASTER T, 1982, CONTRIB MINERAL PETR, V81, P168, DOI 10.1007/BF00371294; Cannat M, 1996, J GEOPHYS RES-SOL EA, V101, P2847, DOI 10.1029/95JB03116; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; Niu YL, 1997, NATURE, V385, P326, DOI 10.1038/385326a0; Rollinson H, 2013, LITHOS, V177, P314, DOI 10.1016/j.lithos.2013.07.004; LAGO BL, 1982, J PETROL, V23, P103; ZHOU MF, 1994, MINER DEPOSITA, V29, P98; Gonzalez-Jimenez JM, 2014, LITHOS, V189, P140, DOI 10.1016/j.lithos.2013.09.008; Yang JS, 2007, GEOLOGY, V35, P875, DOI 10.1130/G23766A.1; Arai S, 2006, J GEOL SOC LONDON, V163, P869, DOI 10.1144/0016-76492005-057; DICK HJB, 1984, CONTRIB MINERAL PETR, V86, P54, DOI 10.1007/BF00373711; LIN J, 1992, GEOPHYS RES LETT, V19, P13, DOI 10.1029/91GL03041; ALLAN JF, 1989, J PETROL, V30, P1245; KELEMEN PB, 1990, J PETROL, V31, P99; Arai S, 2004, CONTRIB MINERAL PETR, V147, P145, DOI 10.1007/s00410-004-0552-8; DICK HJB, 1984, EARTH PLANET SC LETT, V69, P88, DOI 10.1016/0012-821X(84)90076-1; MacLeod CJ, 2013, GEOLOGY, V41, P459, DOI 10.1130/G33904.1; Gonzalez-Jimenez JM, 2011, LITHOS, V125, P101, DOI 10.1016/j.lithos.2011.01.016; Arai S, 1998, EARTH PLANET SC LETT, V156, P117, DOI 10.1016/S0012-821X(97)00210-0; ARAI S, 1992, MINERAL MAG, V56, P173, DOI 10.1180/minmag.1992.056.383.04; ARAI S, 1994, MINER DEPOSITA, V29, P434, DOI 10.1007/BF01886963; Arai S., 1995, ISL ARC, V4, P104, DOI 10.1111/j.1440-1738.1995.tb00135.x; Arai S, 1997, RESOUR GEOL, V47, P177; Arai S, 1997, GEOCHIM COSMOCHIM AC, V61, P671, DOI 10.1016/S0016-7037(96)00389-4; ARAI S, 1995, AM MINERAL, V80, P1041; Arai S, 2013, EARTH PLANET SC LETT, V379, P81, DOI 10.1016/j.epsl.2013.08.006; Arai S, 1996, P ODP SCI RESULTS, V147, P135, DOI DOI 10.2973/ODP.PROC.SR.147.008.1996; Arai S, 1998, LITHOS, V43, P1, DOI 10.1016/S0024-4937(98)00003-6; Arai S, 2005, P JPN ACAD B-PHYS, V81, P14, DOI 10.2183/pjab.81.14; AUGE T, 1987, MINER DEPOSITA, V22, P1; BELL RE, 1992, NATURE, V357, P583, DOI 10.1038/357583a0; BONATTI E, 1992, J GEOPHYS RES-SOL EA, V97, P4461, DOI 10.1029/91JB02838; Borisova AY, 2012, J PETROL, V53, P2411, DOI 10.1093/petrology/egs054; Brown J. R., 1988, Marine Geophysical Researches, V10, DOI 10.1007/BF02424663; CASSARD D, 1981, ECON GEOL, V76, P805; Christie D.M., 2006, EOS T AGU, V87, P539, DOI DOI 10.1029/2006EO480005; Dick H.J.B., 1996, SCI RESULTS, V147, P103; Geshi N, 2007, EARTH PLANET SC LETT, V258, P61, DOI 10.1016/j.epsl.2007.03.019; HEBERT R, 1983, EARTH PLANET SC LETT, V65, P107, DOI 10.1016/0012-821X(83)90193-0; IRVINE TN, 1977, GEOLOGY, V5, P273, DOI 10.1130/0091-7613(1977)5<273:OOCLIT>2.0.CO;2; Ishii T, 2015, AM MINERAL, V100, P59, DOI 10.2138/am-2015-4818; Jackson E.D., 1972, P 24 INT GEOL C MONT, P289; KEITH ML, 1954, J AM CERAM SOC, V37, P490, DOI 10.1111/j.1151-2916.1954.tb13981.x; KUSHIRO I, 1969, AM J SCI, V267, P269; LORAND JP, 1989, LITHOS, V22, P173, DOI 10.1016/0024-4937(89)90054-6; Matsukage K, 1998, CONTRIB MINERAL PETR, V131, P111, DOI 10.1007/s004100050382; Matsumoto I, 1997, J ASIAN EARTH SCI, V15, P295; Miura M, 2014, J MINER PETROL SCI, V109, P38, DOI 10.2465/jmps.131006; Miura M, 2012, J ASIAN EARTH SCI, V59, P52, DOI 10.1016/j.jseaes.2012.05.008; Morishita T, 2007, EUR J MINERAL, V19, P871, DOI 10.1127/0935-1221/2007/0019-1773; Morishita T., 2006, ISLAND ARCS, V15, P80; Noller J.S., 1986, METALLOGENY BASIC UL, P151; Payot BD, 2014, MINER PETROL, V108, P533, DOI 10.1007/s00710-013-0317-z; Robinson PT, 2004, GEOL SOC SPEC PUBL, V226, P247, DOI 10.1144/GSL.SP.2004.226.01.14; Rollinson H., 2013, GONDWANA RES; Rollinson H, 2008, CONTRIB MINERAL PETR, V156, P273, DOI 10.1007/s00410-008-0284-2; Schiano P, 1997, EARTH PLANET SC LETT, V146, P489, DOI 10.1016/S0012-821X(96)00254-3; Sims KWW, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000443; Standish JJ, 2010, NAT GEOSCI, V3, P286, DOI 10.1038/NGEO824; Sturm ME, 2000, EARTH PLANET SC LETT, V181, P61, DOI 10.1016/S0012-821X(00)00177-1; TAKAZAWA E, 2007, P OC DRILL PROGR SCI, V0209; Tamura A., 2004, SCI REPORTS KANAZAWA, V48, P9; Umino S., 2008, J GEOGR, V117, P190, DOI DOI 10.5026/JGEOGRAPHY.117.190	70	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	SEP 1	2015	232						143	149		10.1016/j.lithos.2015.06.015		7	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CR5TX	WOS:000361408400012		
J	Sugita, T; Yamazaki, T; Yamada, S; Takeoka, H; Cho, O; Tanaka, T; Ohno, G; Watanabe, K; Makimura, K; Ohshima, H; Ishioka, N; Mukai, C				Sugita, Takashi; Yamazaki, Takashi; Yamada, Shin; Takeoka, Hajime; Cho, Otomi; Tanaka, Takafumi; Ohno, Giichiro; Watanabe, Kentaro; Makimura, Koichi; Ohshima, Hiroshi; Ishioka, Noriaki; Mukai, Chiaki			Temporal changes in the skin Malassezia microbiota of members of the Japanese Antarctic Research Expedition (JARE): A case study in Antarctica as a pseudo-space environment	MEDICAL MYCOLOGY			English	Article						Antarctica; international space station; Malassezia; skin	ATOPIC-DERMATITIS PATIENTS; SEBORRHEIC DERMATITIS; MOLECULAR ANALYSIS; HEALTHY-SUBJECTS; MICROFLORA; BACTERIAL; DANDRUFF; DISEASES; FUNGAL	The International Space Station (ISS) is located approximately 400 km above the Earth. Astronauts staying at the ISS are under microgravity and are thus unable to bathe or shower; instead, they wash their bodies using wet tissues. For astronauts, skin hygiene management is important to maintain the quality of life during long-term stays on the ISS. In Antarctica, members of a Japanese geological investigation team negotiate their way over land using snowmobiles. During their 3-month stay, they are subject to a "pseudo-space" environment similar to that experienced by ISS astronauts, including the inability to bathe or shower. In this study, temporal changes in the colonization levels of skin lipophilic fungi, Malassezia were investigated in 16 team members. Compared to the levels before their trip to Antarctica, the fold changes in Malassezia colonization levels during the researchers' stay in Antarctica were in the range of 3.0 +/- 1.9 to 5.3 +/- 7.5 in cheek samples, 8.9 +/- 10.6 to 22.2 +/- 40.0 in anterior chest samples, 6.2 +/- 5.4 to 16.9 +/- 25.5 in behind-the-ear samples, and 1.7 +/- 0.9 to 17.4 +/- 33.4 in sole-of-the-foot samples. On the scalp, the level of Malassezia colonization increased dramatically, by 96.7 +/- 113.8 to 916.9 +/- 1251.5 fold. During their stay in Antarctica, the team members experienced itchy scalps and produced a large number of scales. The relative proportions of Malassezia globosa and M. restricta shifted to seborrheic dermatitis/dandruff types. These results provide useful information for the development of skin hygiene management plans for astronauts staying at the ISS.	[Sugita, Takashi; Cho, Otomi; Tanaka, Takafumi] Meiji Pharmaceut Univ, Dept Microbiol, Kiyose, Tokyo 2048588, Japan; [Yamazaki, Takashi; Ishioka, Noriaki] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, ISS Sci Project Off, Tsukuba, Ibaraki, Japan; [Yamazaki, Takashi; Makimura, Koichi] Teikyo Univ, Grad Sch Med, Lab Space & Environm Med, Tokyo 173, Japan; [Yamazaki, Takashi; Makimura, Koichi] Teikyo Univ, Inst Med Mycol, Hachioji, Tokyo, Japan; [Yamazaki, Takashi; Makimura, Koichi] Teikyo Univ, Genome Res Ctr, Hachioji, Tokyo, Japan; [Yamada, Shin; Takeoka, Hajime; Ohshima, Hiroshi; Mukai, Chiaki] Japan Aerosp Explorat Agcy JAXA, Space Biomed Res Off, Tsukuba, Ibaraki, Japan; [Ohno, Giichiro; Watanabe, Kentaro] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Ohno, Giichiro] Toukatsu Hosp, Nagareyama, Chiba, Japan	Sugita, T (reprint author), Meiji Pharmaceut Univ, Dept Microbiol, Kiyose, Tokyo 2048588, Japan.	sugita@my-pharm.ac.jp					Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gao Z, 2010, J CLIN MICROBIOL, V48, P3575, DOI 10.1128/JCM.00597-10; Dawson TL, 2007, J INVEST DERM SYMP P, V12, P15, DOI 10.1038/sj.jidsymp.5650049; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; DeAngelis YM, 2005, J INVEST DERM SYMP P, V10, P295, DOI 10.1111/j.1087-0024.2005.10119.x; Gaitanis G, 2013, CLIN DERMATOL, V31, P455, DOI 10.1016/j.clindermatol.2013.01.012; Christensen GJM, 2014, BENEF MICROBES, V5, P201, DOI 10.3920/BM2012.0062; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Morishita N, 2006, MYCOPATHOLOGIA, V161, P61, DOI 10.1007/s11046-005-0149-4; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Sugita T, 2006, MICROBIOL IMMUNOL, V50, P549; Sugita Takashi, 2013, Med Mycol J, V54, P39, DOI 10.3314/mmj.54.39; Sugita T, 2001, J CLIN MICROBIOL, V39, P3486, DOI 10.1128/JCM.39.10.3486-3490.2001; Tajima M, 2008, J INVEST DERMATOL, V128, P345, DOI 10.1038/sj.jid.5701017	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1369-3786	1460-2709		MED MYCOL	Med. Mycol.	SEP	2015	53	7					717	724		10.1093/mmy/myv041		8	Infectious Diseases; Mycology; Veterinary Sciences	Infectious Diseases; Mycology; Veterinary Sciences	CR4JV	WOS:000361299100009		
J	Yao, MQ; Tang, B; Sato, KZ; Su, W				Yao, Mingqiu; Tang, Bin; Sato, Kazuo; Su, Wei			Silicon anisotropic etching in Triton-mixed and isopropyl alcohol-mixed tetramethyl ammonium hydroxide solution	MICRO & NANO LETTERS			English	Article						silicon; etching; elemental semiconductors; surface roughness; surface finishing; silicon anisotropic etching; triton-mixed tetramethyl ammonium hydroxide solution; isopropyl alcohol-mixed tetramethyl ammonium hydroxide solution; Triton X-100; etch rate; convex corners; etched surface roughness; mirror-like surface finish; microstructure fabrication; Si	TMAH; SURFACE	The anisotropic silicon (Si) etching characteristics of Si (100) in 25 wt.% tetramethyl ammonium hydroxide (TMAH) solutions containing Triton X-100 and isopropyl alcohol (IPA) were studied. The etch rate, convex corners and roughness of the etched surface were investigated. In this reported work two central goals, a mirror-like surface finish and a high reduction of undercutting, have been achieved. The best etched result was obtained in 25 wt.% TMAH + 0.25%v/v Triton + 16%v/v IPA, which has minimum convex corner undercutting and a smooth etched surface (R-a = 1 nm). This study is useful for engineering applications where the fabrication of microstructures for high-quality devices should simultaneously contain smooth surfaces on a large area and less convex corner undercutting.	[Yao, Mingqiu; Tang, Bin; Su, Wei] China Acad Engn Phys, Inst Elect Engn, Mianyang 621999, Peoples R China; [Yao, Mingqiu] Nanjing Univ Sci & Technol, Nanjing 210094, Jiangsu, Peoples R China; [Sato, Kazuo] Aichi Inst Technol, Dept Mech Engn, Toyota 4700392, Japan	Yao, MQ (reprint author), China Acad Engn Phys, Inst Elect Engn, Mianyang 621999, Peoples R China.	ivykaiser@163.com			Natural Science Foundation of China (NSFC) [51305412]; Laboratory of Ultra Precision Manufacturing Technology (CAEP) [2012CJMZZ00003]	This work was supported by the Natural Science Foundation of China (NSFC) project (no. 51305412) and by the Funding Support by Laboratory of Ultra Precision Manufacturing Technology (CAEP) project (no. 2012CJMZZ00003).	Gosalvez MA, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/12/125011; Sundaram KB, 2005, MICROELECTRON ENG, V77, P230, DOI 10.1016/j.mee.2004.11.004; Zubel I, 2012, SENSOR ACTUAT A-PHYS, V178, P126, DOI 10.1016/j.sna.2012.02.018; Tang B, 2009, SENSOR ACTUAT A-PHYS, V156, P334, DOI 10.1016/j.sna.2009.10.017; MERLOS A, 1993, SENSOR ACTUAT A-PHYS, V37-8, P737, DOI 10.1016/0924-4247(93)80125-Z; Zubel I, 2001, SENSOR ACTUAT A-PHYS, V93, P138, DOI 10.1016/S0924-4247(01)00648-3; Pal P, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/6/065013; Pal P, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/5/055003; Tang B, 2014, SENSOR ACTUAT A-PHYS, V217, P105, DOI 10.1016/j.sna.2014.05.011; Tang B, 2014, MICRO NANO LETT, V9, P582, DOI 10.1049/mnl.2014.0214; Yang MZ, 2011, SENSORS-BASEL, V11, P9798, DOI 10.3390/s111009798; ZANA R, 1995, ADV COLLOID INTERFAC, V57, P1, DOI 10.1016/0001-8686(95)00235-I	12	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1750-0443			MICRO NANO LETT	Micro Nano Lett.	SEP	2015	10	9					469	471		10.1049/mnl.2015.0104		3	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CR5LA	WOS:000361382300011		
J	Norimatsu, Y; Kawashima, J; Takano-Yamamoto, T; Takahashi, N				Norimatsu, Yuka; Kawashima, Junko; Takano-Yamamoto, Teruko; Takahashi, Nobuhiro			Nitrogenous compounds stimulate glucose-derived acid production by oral Streptococcus and Actinomyces	MICROBIOLOGY AND IMMUNOLOGY			English	Article						acids production; nitrogen compounds; oral Streptococcus; oral Actinomyces	ROOT-SURFACE CARIES; DENTAL PLAQUE; NAESLUNDII; MUTANS; METABOLISM; BACTERIA; PHOSPHOENOLPYRUVATE; FERMENTATION; VISCOSUS; PROTEINS	Both Streptococcus and Actinomyces can produce acids from dietary sugars and are frequently found in caries lesions. In the oral cavity, nitrogenous compounds, such as peptides and amino acids, are provided continuously by saliva and crevicular gingival fluid. Given that these bacteria can also utilize nitrogen compounds for their growth, it was hypothesized that nitrogenous compounds may influence their acid production; however, no previous studies have examined this topic. Therefore, the present study aimed to assess the effects of nitrogenous compounds (tryptone and glutamate) on glucose-derived acid production by Streptococcus and Actinomyces. Acid production was evaluated using a pH-stat method under anaerobic conditions, whereas the amounts of metabolic end-products were quantified using high performance liquid chromatography. Tryptone enhanced glucose-derived acid production by up to 2.68-fold, whereas glutamate enhanced Streptococcus species only. However, neither tryptone nor glutamate altered the end-product profiles, indicating that the nitrogenous compounds stimulate the whole metabolic pathways involving in acid production from glucose, but are not actively metabolized, nor do they alter metabolic pathways. These results suggest that nitrogenous compounds in the oral cavity promote acid production by Streptococcus and Actinomyces in vivo.	[Norimatsu, Yuka; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Div Orthodont & Dentofacial Orthoped, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Norimatsu, Yuka; Kawashima, Junko; Takahashi, Nobuhiro] Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kawashima, Junko] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Community Oral Hlth Sci,Aoba Ku, Sendai, Miyagi 9808573, Japan	Norimatsu, Y (reprint author), Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	nobu-t@dent.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26293439, 25861783]	This study was supported in part by Grants-in-Aid for Scientific Research B (No. 26293439) and Young Scientists (B) (No. 25861783) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABBE K, 1991, Proceedings of the Finnish Dental Society, V87, P477; DILLS SS, 1980, MICROBIOL REV, V44, P385; POSTMA PW, 1985, MICROBIOL REV, V49, P232; VANHOUTE J, 1994, J DENT RES, V73, P1727; Chen PM, 2010, APPL ENVIRON MICROB, V76, P2478, DOI 10.1128/AEM.02622-09; Takahashi N, 2003, ORAL MICROBIOL IMMUN, V18, P109, DOI 10.1034/j.1399-302X.2003.00054.x; Takahashi N, 1999, CRIT REV ORAL BIOL M, V10, P487; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P60, DOI 10.1034/j.1399-302X.1999.140108.x; Kido J, 2012, J PERIODONTAL RES, V47, P488, DOI 10.1111/j.1600-0765.2011.01458.x; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Struzycka I, 2014, POL J MICROBIOL, V63, P127; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161; HAMADA S, 1980, MICROBIOL REV, V44, P331; BUCHANAN BB, 1967, J GEN MICROBIOL, V46, P225; Cvitkovitch DG, 1997, J BACTERIOL, V179, P650; ELLEN RP, 1978, J DENT RES, V57, P550, DOI 10.1177/00220345780570040201; ELLEN RP, 1985, J DENT RES, V64, P1377, DOI 10.1177/00220345850640121001; JORDAN HV, 1973, J PERIODONTOL, V44, P158; Kawashima J, 2013, MICROBIOL IMMUNOL, V57, P797, DOI 10.1111/1348-0421.12098; Marsh P. D., 1992, ORAL MICROBIOL IMMUN, V4th, P5; Marsh P. D., 1992, ORAL MICROBIOL IMMUN, V4th, P58; Peter H. A. S., 1986, BERGEYS MANUAL SYSTE, V1st, P1383; Peter H. A. S., 1986, BERGEYS MANUAL SYSTE, V2, P1054; SCHUPBACH P, 1995, CARIES RES, V29, P382; TAKAHASHI N, 1992, ORAL MICROBIOL IMMUN, V7, P165, DOI 10.1111/j.1399-302X.1992.tb00530.x; TAKAHASHI N, 1995, J BACTERIOL, V177, P5806; VANHOUTE J, 1990, J DENT RES, V69, P1463, DOI 10.1177/00220345900690080301; van Ruyven FOJ, 2000, J DENT RES, V79, P778; YAMADA T, 1973, ARCH ORAL BIOL, V18, P799, DOI 10.1016/0003-9969(73)90051-4	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	SEP	2015	59	9					501	506		10.1111/1348-0421.12283		6	Immunology; Microbiology	Immunology; Microbiology	CR3DS	WOS:000361211300001		
J	Kabeya, H; Sato, S; Maruyama, S				Kabeya, Hidenori; Sato, Shingo; Maruyama, Soichi			Prevalence and characterization of Chlamydia DNA in zoo animals in Japan	MICROBIOLOGY AND IMMUNOLOGY			English	Article						Chlamydia pneumonia; Chlamydia psittaci; zoo animals; zoonosis	POLYMERASE-CHAIN-REACTION; PNEUMONIAE STRAIN TWAR; CHLAMYDOPHILA-PNEUMONIAE; TRACHOMATIS STRAINS; GENETIC DIVERSITY; OMPA-GENE; PSITTACI; DIFFERENTIATION; BIRDS; INFECTIONS	Because many people visit zoos, prevention of zoonoses is important from the standpoint of public health. This study examined the prevalence of Chlamydia among zoo animals in Japan by PCR and characterized these bacteria by performing phylogenetic analyses of the sequences of the variable domain (VD) 2 and VD4 regions of the ompA gene, which encodes the Chlamydia major outer membrane protein. Fecal samples were collected from 1150 zoo animals in five zoos and examined for Chlamydia DNA. Chlamydia psittaci DNA was found in 3.9% of mammals, 7.2% of birds and 8.1% of reptiles. The prevalence of Chlamydia pneumoniae DNA was significantly higher in reptiles (5.8%) than in mammals (0.3%) and birds (0.3%). Phylogenetic analysis of the ompA VD2 region from 18 samples showed that nine were in three different clusters containing C. psittaci strains, six were in a cluster containing C. pneumoniae strains and three each formed a distinct branch. Furthermore, phylogenetic analysis of the ompA VD4 region showed that C. pneumoniae DNAs from reptiles were close to those from human patients. The C. pneumoniae DNAs from the European glass lizard, Emerald tree boa, and Panther chameleon were classified in clusters that were distinct from other strains, suggesting that these reptiles had each been infected with a specific C. pneumoniae genotype. This study showed that diverse Chlamydia strains have been prevalent among a variety of zoo animals.	[Kabeya, Hidenori; Sato, Shingo; Maruyama, Soichi] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Publ Hlth, Fujisawa, Kanagawa 2520880, Japan	Kabeya, H (reprint author), Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Publ Hlth, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	kabeya.hidenori@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [S1491007]	The authors are grateful to Fumika Ohnishi, Yumiko Kato, Rikiya Ishikawa, Mamiko Sakai, Mihoko Kimura, Toru Ogishima and Risa Hatakeyama, graduated students of the Laboratory of Veterinary Public Health, Department of Veterinary Medicine, College of Bioresource Sciences, Nihon University, Japan for their assistance with this work. We also thank Dr Fukushi and Dr Ohya, Gifu University, Japan for generously providing the Chlamydia strains. This work was supported in part by a grant from the Strategic Research Foundation Grant-aided Project for Private Universities, Academic Frontier Project "International joint research and training of young researchers for zoonosis control in the globalized world. (S1491007)" from the Ministry of Education, Culture, Sports, Science and Technology.	Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; GRAYSTON JT, 1990, J INFECT DIS, V161, P618; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451; Yoshida H, 1998, MICROBIOL IMMUNOL, V42, P411; KALTENBOECK B, 1991, J CLIN MICROBIOL, V29, P1969; Cochrane M, 2005, MICROBIOL-SGM, V151, P2285, DOI 10.1099/mic.0.27781-0; Chahota R, 2006, MICROBIOL IMMUNOL, V50, P663; Reed KD, 2000, EMERG INFECT DIS, V6, P196; Geens T, 2005, J CLIN MICROBIOL, V43, P2456, DOI 10.1128/JCM.43.5.2456-2461.2005; Bodetti TJ, 2002, SYST APPL MICROBIOL, V25, P146, DOI 10.1078/0723-2020-00086; Myers GSA, 2009, J BACTERIOL, V191, P7225, DOI 10.1128/JB.00746-09; Frutos MC, 2015, AVIAN PATHOL, V44, P50, DOI 10.1080/03079457.2014.993593; GAYDOS CA, 1994, J CLIN MICROBIOL, V32, P903; GRAYSTON JT, 1992, CLIN INFECT DIS, V15, P757; GRAYSTON JT, 1989, INT J SYST BACTERIOL, V39, P88; Herrmann B, 2015, J CLIN MICROBIOL, V53, P2172, DOI 10.1128/JCM.00249-15; Jackson Michael, 1999, Veterinary Microbiology, V65, P255, DOI 10.1016/S0378-1135(98)00302-2; Jacobson ER, 2004, J VET DIAGN INVEST, V16, P153; KALTENBOECK B, 1993, J BACTERIOL, V175, P487; Matsui T, 2008, EPIDEMIOL INFECT, V136, P492, DOI 10.1017/S0950268807008783; Messmer TO, 1997, J CLIN MICROBIOL, V35, P2043; Mitchell CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000903; National Institute of Infectious Diseases, 2002, INFECT AGENTS SURVEI, V23, P245; Pineiro L, 2014, INFECTION, V42, P905, DOI 10.1007/s15010-014-0665-6; SAYADA C, 1995, RES MICROBIOL, V146, P155, DOI 10.1016/0923-2508(96)80893-X; Steinhoff D, 1996, CLIN INFECT DIS, V22, P958; Stenzel T, 2014, POULTRY SCI, V93, P3009, DOI 10.3382/ps.2014-04219; Sudler C, 2004, VET MICROBIOL, V98, P235, DOI 10.1016/j.vetmic.2003.07.008; Vanrompay D, 1997, RES MICROBIOL, V148, P327, DOI 10.1016/S0923-2508(97)81588-4; Wardrop S, 1999, SYST APPL MICROBIOL, V22, P22; WILLS JM, 1990, VET MICROBIOL, V24, P11, DOI 10.1016/0378-1135(90)90046-X	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	SEP	2015	59	9					507	515		10.1111/1348-0421.12287		9	Immunology; Microbiology	Immunology; Microbiology	CR3DS	WOS:000361211300002		
J	Okamoto, M; Imai, S; Miyanohara, M; Saito, W; Momoi, Y; Nomura, Y; Ikawa, T; Ogawa, T; Miyabe-Nishiwaki, T; Kaneko, A; Watanabe, A; Watanabe, S; Hayashi, M; Tomonaga, M; Hanada, N				Okamoto, Masaaki; Imai, Susumu; Miyanohara, Mayu; Saito, Wataru; Momoi, Yasuko; Nomura, Yoshiaki; Ikawa, Tomoko; Ogawa, Takumi; Miyabe-Nishiwaki, Takako; Kaneko, Akihisa; Watanabe, Akino; Watanabe, Shohei; Hayashi, Misato; Tomonaga, Masaki; Hanada, Nobuhiro			Streptococcus panodentis sp nov from the oral cavities of chimpanzees	MICROBIOLOGY AND IMMUNOLOGY			English	Article						chimpanzee; oral cavity; taxonomy	GENUS STREPTOCOCCUS; PAN-TROGLODYTES; MITIS; IDENTIFICATION; SEQUENCES; GORDONII; PATIENT; THROAT	Three strains TKU9, TKU49 and TKU50(T), were isolated from the oral cavities of chimpanzees (Pan troglodytes). The isolates were all gram-positive, facultative anaerobic cocci that lacked catalase activity. Analysis of partial 16S rRNA gene sequences showed that the most closely related species was Streptococcus infantis (96.7%). The next most closely related species to the isolates were S. rubneri, S. mitis, S. peroris and S. australis (96.6 to 96.4%). Based on the rpoB and gyrB gene sequences, TKU50(T) was clustered with other member of the mitis group. Enzyme activity and sugar fermentation patterns differentiated this novel bacterium from other members of the mitis group streptococci. The DNA G+C content of strain TKU50(T) was 46.7 mol%, which is the highest reported value for members of the mitis group (40-46 mol%). On the basis of the phenotypic characterization, partial 16S rRNA gene and sequences data for two housekeeping gene (gyrB and rpoB), we propose a novel taxa, S. panodentis for TKU 50(T) (type strain=CM 30579(T)=DSM 29921(T)), for these newly described isolates.	[Okamoto, Masaaki; Imai, Susumu; Miyanohara, Mayu; Nomura, Yoshiaki; Hanada, Nobuhiro] Tsurumi Univ, Sch Dent Med, Dept Translat Res, Tsurumi ku, Yokohama, Kanagawa 2308501, Japan; [Saito, Wataru; Momoi, Yasuko] Tsurumi Univ, Sch Dent Med, Dept Operat Dent, Tsurumi ku, Yokohama, Kanagawa 2308501, Japan; [Ikawa, Tomoko; Ogawa, Takumi] Tsurumi Univ, Sch Dent Med, Dept Fixed Prosthodont, Tsurumi ku, Yokohama, Kanagawa 2308501, Japan; [Miyabe-Nishiwaki, Takako; Kaneko, Akihisa; Watanabe, Akino; Watanabe, Shohei] Kyoto Univ, Ctr Human Evolut Modeling Res, Inuyama, Aichi 4848506, Japan; [Hayashi, Misato; Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Language & Intelligence Sect, Inuyama, Aichi 4848506, Japan	Okamoto, M (reprint author), Tsurumi Univ, Sch Dent Med, Dept Translat Res, Tsurumi ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	okamoto-m@tsurumi-u.ac.jp			JSPS [26861847, 24000001, 23220006, 22592350, 20002001, 15H05709]; Primate Research Institute, Kyoto University [2014-A10, 2013-A5, 2012-A7, 2011-B-63, 2010-B-54, 2009-C-20]	We are grateful thank to Dr. Hans G. Truper for help with the deviation of the species epithet. This study was supported in part by Grants-in-Aid from JSPS (26861847, 24000001, 23220006, 22592350, 20002001 and 15H05709), and by the Cooperative Research Program of the Primate Research Institute, Kyoto University (2014-A10, 2013-A5, 2012-A7, 2011-B-63, 2010-B-54 and 2009-C-20).	Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martin V, 2011, INT J SYST EVOL MICR, V61, P1048, DOI 10.1099/ijs.0.021642-0; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Glazunova OO, 2006, INT J SYST EVOL MICR, V56, P1127, DOI 10.1099/ijs.0.64099-0; Glazunova OO, 2009, INT J SYST EVOL MICR, V59, P2317, DOI [10.1099/ijs.0.005488-0, 10.1099/ijs-0.005488-0]; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Willcox MDP, 2001, INT J SYST EVOL MICR, V51, P1277; Zbinden A, 2012, INT J SYST EVOL MICR, V62, P2941, DOI 10.1099/ijs.0.038299-0; Camelo-Castillo A, 2014, INT J SYST EVOL MICR, V64, P60, DOI 10.1099/ijs.0.054098-0; HANDLEY P, 1991, INT J SYST BACTERIOL, V41, P543; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406; Tong HC, 2003, INT J SYST EVOL MICR, V53, P1101, DOI 10.1099/ijs.0.02493-0; Glazunova OO, 2010, INT J SYST EVOL MICR, V60, P2140, DOI 10.1099/ijs.0.018176-0; Woo PCY, 2002, J CLIN MICROBIOL, V40, P805, DOI 10.1128/JCM.40.3.805-810.2002; Argimon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056305; EZAKI T, 1990, FEMS MICROBIOL LETT, V67, P127, DOI 10.1016/0378-1097(90)90180-X; Geng JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034769; Huch M, 2013, INT J SYST EVOL MICR, V63, P4026, DOI 10.1099/ijs.0.048538-0; Kilian M., 2014, MBIO, V5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P3, DOI 10.1007/4-431-30248-4_1; Miyanohara M, 2013, MICROBIOL IMMUNOL, V57, P359, DOI 10.1111/1348-0421.12047; Okada M, 2001, J CLIN PERIODONTOL, V28, P576, DOI 10.1034/j.1600-051x.2001.028006576.x; Okamoto M, 2013, INT J SYST EVOL MICR, V63, P418, DOI 10.1099/ijs.0.039388-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sakamoto M, 2002, INT J SYST EVOL MICR, V52, P841, DOI 10.1099/ijs.0.01945-0; Teng J.L., 2014, GENOME BIOL EVOL, V6, P2930; Tomonaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009131; Zhang M, 2013, INT J SYST EVOL MICR, V63, P449, DOI 10.1099/ijs.0.038133-0	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	SEP	2015	59	9					526	532		10.1111/1348-0421.12290		7	Immunology; Microbiology	Immunology; Microbiology	CR3DS	WOS:000361211300004		
J	Narahara, C; Yasuda, J				Narahara, Chisato; Yasuda, Jiro			Roles of the three L-domains in -retrovirus budding	MICROBIOLOGY AND IMMUNOLOGY			English	Article						budding; L-domain; M-PMV; retrovirus	ROUS-SARCOMA-VIRUS; LATE ASSEMBLY DOMAIN; MATRIX PROTEIN; PARTICLE RELEASE; GAG PROTEIN; UBIQUITIN LIGASE; MOTIF; TSG101; NEDD4; HIV-1	Retroviral Gag protein plays a critical role during the late stage of virus budding and possesses a so-called L-domain containing PT/SAP, PPxY, YxxL or FPIV motifs that are critical for efficient budding. Mason-Pfizer monkey virus (M-PMV) contains PSAP, PPPY, and YADL sequences in Gag. This study was performed to investigate the roles of these three L-domain-like sequences in virus replication in three different cell lines, 293T, COS-7 and HeLa cells. It was found that the PPxY motif plays an essential role in progeny virus production as a major L-domain in all three cell lines. The PSAP sequence was shown to function as an additional L-domain in HeLa cells and to promote efficient release of M-PMV; however, this sequence was dispensable for M-PMV production in 293T and COS-7 cells, suggesting that the role of the PSAP motif as an L-domain in M-PMV budding is cell type-dependent. Viruses possessing multiple L-domains appear to change the L-domain usage to replicate in various cells. On the other hand, the YADL motif was required for M-PMV production as a transport signal of Gag to the plasma membrane, but not as an L-domain.	[Narahara, Chisato; Yasuda, Jiro] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Emerging Infect Dis, Nagasaki 8528523, Japan; [Narahara, Chisato; Yasuda, Jiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan	Yasuda, J (reprint author), Nagasaki Univ, Inst Trop Med, Dept Emerging Infect Dis, Nagasaki 8528523, Japan.	j-yasuda@nagasaki-u.ac.jp			Japan Society for the Promotion of Science; Nakajima Foundation	The authors would like to thank Dr. S. Urata, who is a member of our laboratory, for helpful discussions. This work was supported by grants from the Japan Society for the Promotion of Science and the Nakajima Foundation.	Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; WILLS JW, 1994, J VIROL, V68, P6605; Strecker T, 2003, J VIROL, V77, P10700, DOI 10.1128/JVI.77.19.10700-10705.2003; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Zhai QT, 2011, J VIROL, V85, P9222, DOI 10.1128/JVI.02653-10; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Schmitt AP, 2005, J VIROL, V79, P2988, DOI 10.1128/JVI.79.5.2988-2997.2005; Li M, 2009, J VIROL, V83, P7261, DOI 10.1128/JVI.00421-09; Gottwein E, 2003, J VIROL, V77, P9474, DOI 10.1128/JVI.77.17.9474-9485.2003; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; HUANG MJ, 1995, J VIROL, V69, P6810; Dorweiler IJ, 2006, J VIROL, V80, P3634, DOI 10.1128/JVI.80.7.3634-3643.2006; Irie T, 2004, J VIROL, V78, P7823, DOI 10.1128/JVI.78.14.7823-7827.2004; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; PARENT LJ, 1995, J VIROL, V69, P5455; Puffer BA, 1997, J VIROL, V71, P6541; RHEE SS, 1990, CELL, V63, P77, DOI 10.1016/0092-8674(90)90289-Q; RHEE SS, 1991, EMBO J, V10, P535; Sakurai A, 2004, MICROBES INFECT, V6, P150, DOI 10.1016/j.micinf.2003.10.011; Song CS, 2005, J VIROL, V79, P11569, DOI 10.1128/JVI.79.18.11569-11579.2005; Wang HT, 2004, J VIROL, V78, P1503, DOI 10.1128/JVI.78.3.1503-1512.2004; Xiang Y, 1996, J VIROL, V70, P5695; Yasuda J, 1998, J VIROL, V72, P4095; Yasuda J, 2002, EMBO REP, V3, P636, DOI 10.1093/embo-reports/kvf132; Yasuda J, 2000, VIROLOGY, V268, P533, DOI 10.1006/viro.1999.0179; Yuan B, 1999, EMBO J, V18, P4700, DOI 10.1093/emboj/18.17.4700	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	SEP	2015	59	9					545	554		10.1111/1348-0421.12285		10	Immunology; Microbiology	Immunology; Microbiology	CR3DS	WOS:000361211300006		
J	Gillich, N; Kuwata, R; Isawa, H; Horie, M				Gillich, Nadine; Kuwata, Ryusei; Isawa, Haruhiko; Horie, Masayuki			Persistent natural infection of a Culex tritaeniorhynchus cell line with a novel Culex tritaeniorhynchus rhabdovirus strain	MICROBIOLOGY AND IMMUNOLOGY			English	Article						Culex tritaeniorhynchus rhabdovirus; NIID-CTR; occult infection; persistent infection	BORNA-DISEASE VIRUS; RNA INTERFERENCE RESPONSE; P PROTEIN INTERACTS; PHOSPHOPROTEIN; ANTAGONIST; SUSCEPTIBILITY; IDENTIFICATION; ALPHAVIRUS; MOSQUITOS; DEFENSE	Culex tritaeniorhynchus rhabdovirus (CTRV) is a mosquito virus that establishes persistent infection without any obvious cell death. Therefore, occult infection by CTRV can be present in mosquito cell lines. In this study, it is shown that NIID-CTR cells, which were derived from Cx. tritaeniorhynchus, are persistently infected with a novel strain of CTRV. Complete genome sequencing of the infecting strain revealed that it is genetically similar but distinct from the previously isolated CTRV strain, excluding the possibility of contamination. These findings raise the importance of further CTRV studies, such as screening of CTRV in other mosquito cell lines.	[Gillich, Nadine; Horie, Masayuki] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Res Ctr, Kagoshima 8900065, Japan; [Gillich, Nadine] Univ Med Ctr Freiburg, Inst Virol, D-79104 Freiburg, Germany; [Kuwata, Ryusei; Isawa, Haruhiko] Natl Inst Infect Dis, Dept Med Entomol, Shinjuku Ku, Tokyo 1628640, Japan; [Horie, Masayuki] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi 7538511, Japan	Horie, M (reprint author), Kagoshima Univ, Joint Fac Vet Med, Anim Dis Res Ctr, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	mhorie@vet.kagoshima-u.ac.jp					BRIESE T, 1992, P NATL ACAD SCI USA, V89, P11486, DOI 10.1073/pnas.89.23.11486; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Li Z, 2005, J VIROL METHODS, V130, P154, DOI 10.1016/j.jviromet.2005.06.022; Kuwata R, 2011, J VIROL, V85, P6185, DOI 10.1128/JVI.00040-11; Kuwata R, 2012, IN VITRO CELL DEV-AN, V48, P369, DOI 10.1007/s11626-012-9520-1; Attarzadeh-Yazdi G, 2009, J VIROL, V83, P5735, DOI 10.1128/JVI.02440-08; CUBITT B, 1994, VIRUS RES, V34, P69, DOI 10.1016/0168-1702(94)90120-1; Vidy A, 2005, J VIROL, V79, P14411, DOI 10.1128/JVI.79.22.14411-14420.2005; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Lieu KG, 2013, J VIROL, V87, P8261, DOI 10.1128/JVI.00989-13; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Ito N, 2010, J VIROL, V84, P6699, DOI 10.1128/JVI.00011-10; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Prasad AN, 2013, VIRUSES-BASEL, V5, P3142, DOI 10.3390/v5123142; Brzozka K, 2005, J VIROL, V79, P7673, DOI 10.1128/JVI.79.12.7673-7681.2005; Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106; Wiltzer L, 2012, J VIROL, V86, P10194, DOI 10.1128/JVI.01249-12; Tomonaga K, 2000, P NATL ACAD SCI USA, V97, P12788, DOI 10.1073/pnas.97.23.12788; Vidy A, 2007, J VIROL, V81, P4255, DOI 10.1128/JVI.01930-06; Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12; SCHNEIDER PA, 1994, J VIROL, V68, P5007; Athawale SS, 2002, ACTA VIROL, V46, P237; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Chelbi-Alix MK, 2006, J INTERF CYTOK RES, V26, P271, DOI 10.1089/jir.2006.26.271; Fablet M, 2014, VIRUSES-BASEL, V6, P4447, DOI 10.3390/v6114447; Kuwata R, 2015, J MED ENTOMOL, V52, P222, DOI 10.1093/jme/tju059; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Schneider U, 2003, J VIROL, V77, P11781, DOI 10.1128/JVI.77.21.11781-11789.2003; Segura NA, 2012, MEM I OSWALDO CRUZ, V107, P89, DOI 10.1590/S0074-02762012000100013; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Wiltzer L, 2014, J INFECT DIS, V209, P1744, DOI 10.1093/infdis/jit829; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	SEP	2015	59	9					562	566		10.1111/1348-0421.12279		5	Immunology; Microbiology	Immunology; Microbiology	CR3DS	WOS:000361211300008		
J	Suzuki, Y				Suzuki, Yoshiyuki			A candidate packaging signal of human rotavirus differentiating Wa-like and DS-1-like genomic constellations	MICROBIOLOGY AND IMMUNOLOGY			English	Article						complementarity; human rotavirus; packaging signal; secondary structure	GROUP-A ROTAVIRUSES; STRANDED-RNA GENOME; RIBONUCLEOPROTEIN COMPLEXES; GENE CONSTELLATIONS; SEQUENCE; SEGMENTS; VACCINE; PROTEIN; VIRUS; REASSORTMENT	RotavirusA (RVA) possesses a genome of 11 segmented RNAs. In human RVA, two major genomic constellations are represented by prototype strains Wa and DS-1. Here packaging signals differentiating Wa-like and DS-1-like genomic constellations were searched for by analyzing genomic sequences of Wa-like and DS-1-like strains. One pair of 11 nucleotide sites in the coding regions of viral structural protein (VP) 2 and VP6 was found to be complementary specifically among Wa-like strains. These sites tended to be free from base-pairing in secondary structures of genomic segments, suggesting that they may serve as a packaging signal in Wa-like strains.	Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Nagoya, Aichi 4678501, Japan	Suzuki, Y (reprint author), Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, 1 Yamanohata,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	yossuzuk@nsc.nagoya-cu.ac.jp			JSPS KAKENHI [26650134]	The author thanks Dr. Osamu Nakagomi and Dr. Toyoko Nakagomi at Nagasaki University, Nagasaki, Japan for valuable discussion, and two anonymous reviewers for valuable comments. This work was supported by JSPS KAKENHI grant number 26650134 to Y.S.	Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Mathieu M, 2001, EMBO J, V20, P1485, DOI 10.1093/emboj/20.7.1485; HUNDLEY F, 1985, VIROLOGY, V143, P88, DOI 10.1016/0042-6822(85)90099-6; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Sugita Y, 2013, J VIROL, V87, P12879, DOI 10.1128/JVI.02096-13; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; WYATT RG, 1980, SCIENCE, V207, P189, DOI 10.1126/science.6243190; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; McClain B, 2010, J MOL BIOL, V397, P587, DOI 10.1016/j.jmb.2010.01.055; Ito H, 2001, VIRUS RES, V75, P123, DOI 10.1016/S0168-1702(01)00234-9; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Tortorici MA, 2006, RNA, V12, P133, DOI 10.1261/rna.2122606; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; McDonald SM, 2011, TRENDS MICROBIOL, V19, P136, DOI 10.1016/j.tim.2010.12.002; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Chen D, 1998, J VIROL, V72, P7387; Zhang S, 2014, J VIROL, V88, P9842, DOI 10.1128/JVI.01562-14; Charpilienne A, 2002, J VIROL, V76, P7822, DOI 10.1128/JVI.76.15.7822-7831.2002; Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Gavazzi C, 2013, P NATL ACAD SCI USA, V110, P16604, DOI 10.1073/pnas.1314419110; Attoui H, 2012, VIRUS TAXONOMY, P541; Estes M, 2007, FIELDS VIROLOGY, V2, P1917; JOKLIK WK, 1995, J BIOL CHEM, V270, P4181; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Noda T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1647; Pattron J. T., 1990, VIRUS RES, V17, P199; Schumann T, 2009, VIROLOGY, V386, P334, DOI 10.1016/j.virol.2009.01.040; Sokal RR, 1995, BIOMETRY; Suzuki Y, 2014, GENES GENET SYST, V89, P81; Trojnar E, 2009, VIROLOGY, V386, P325, DOI 10.1016/j.virol.2009.01.034; WARD RL, 1990, J VIROL, V64, P3219; Wentzel JF, 2013, INFECT GENET EVOL, V20, P276, DOI 10.1016/j.meegid.2013.09.007	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	SEP	2015	59	9					567	571		10.1111/1348-0421.12288		5	Immunology; Microbiology	Immunology; Microbiology	CR3DS	WOS:000361211300009		
J	Osman, OO; Shirai, A; Kawano, S				Osman, Osman Omran; Shirai, Atsushi; Kawano, Satoyuki			A numerical study on the performance of micro-vibrating flow pumps using the immersed boundary method	MICROFLUIDICS AND NANOFLUIDICS			English	Article						Micro-VFP; Numerical; Immersed boundary method; Micropump; Flow rate; Pumping head	ACTUATED ARTIFICIAL CILIA; BLOOD-FLOW; HEART; FLUID; PROPULSION; DEVICE	A micro-vibrating flow pump (micro-VFP) drives the fluid by the vibration of an elastic cantilever-like structure in the pump, which is actuated by a sinusoidal magnetic field. In the present study, we clarify the pumping mechanism of the micro-VFP through a numerical simulation. A two-dimensional simulation code based on the immersed boundary method was developed to obtain the flow field in the micro-VFP together with the vibration of the cantilever. The motion of the cantilever, which was imitated by the immersed body, was expressed as an external forcing term of the Navier-Stokes equations. Here, the magnetic force required to actuate the cantilever was calculated based on a two-dimensional magnetic model, and an integral approach was used to calculate the large deflection of the cantilever. The working conditions and length of the cantilever were numerically studied to determine their effects on the pumping performance. It was shown through the numerical simulations that the pumping mechanism could be explained as a result of elongation of the cantilever in the effective stroke induced by the actuating magnetic field. The pumping performance, which was characterized by the volumetric flow rate and the shut-off pressure, was enhanced by increasing the actuation frequency of the cantilever as has been found in previous experiments. It was also found that the cantilever has an optimum length to give the maximum flow rate. The mechanism was explained with respect to the kinetic energy transferred to the fluid by the vibrating cantilever and the choking level, which is determined by the clearance between the ceiling of the microchannel and the tip of the cantilever.	[Osman, Osman Omran; Kawano, Satoyuki] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Toyonaka, Osaka 5608531, Japan; [Shirai, Atsushi] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Osman, Osman Omran] Assiut Univ, Dept Mech Engn, Fac Engn, Assiut 71515, Egypt	Kawano, S (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	kawano@me.es.osaka-u.ac.jp	Kawano, Satoyuki/D-3028-2012				HARLOW FH, 1965, PHYS FLUIDS, V8, P2182, DOI 10.1063/1.1761178; Abramchuk S, 2007, POLYM ADVAN TECHNOL, V18, P883, DOI 10.1002/pat.924; Khaderi SN, 2011, J FLUID MECH, V688, P44, DOI 10.1017/jfm.2011.355; Gauger EM, 2009, EUR PHYS J E, V28, P231, DOI 10.1140/epje/i2008-10388-1; Shintaku H, 2007, MICROSYST TECHNOL, V13, P951, DOI [10.1007/s00542-006-0291-z, 10.1007/s00542-006-0291-x]; CHOI H, 1994, J COMPUT PHYS, V113, P1, DOI 10.1006/jcph.1994.1112; Hsieh YC, 2007, BIOSENS BIOELECTRON, V22, P2422, DOI 10.1016/j.bios.2006.08.044; Khaderi SN, 2011, LAB CHIP, V11, P2002, DOI 10.1039/c0lc00411a; Yang JM, 2006, J COMPUT PHYS, V215, P12, DOI 10.1016/j.jcp.2005.10.035; Wu MH, 2008, SENSOR ACTUAT B-CHEM, V129, P231, DOI 10.1016/j.snb.2007.07.145; Peng SL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2830620; Fahrni F, 2009, LAB CHIP, V9, P3413, DOI [10.1039/b908578e, 10.1039/b908578c]; Chen L, 2010, INT J NONLIN MECH, V45, P301, DOI 10.1016/j.ijnonlinmec.2009.12.004; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; PESKIN CS, 1977, J COMPUT PHYS, V25, P220, DOI 10.1016/0021-9991(77)90100-0; PERKINS TT, 1995, SCIENCE, V268, P83, DOI 10.1126/science.7701345; Hussong J, 2011, LAB CHIP, V11, P2017, DOI 10.1039/c0lc00722f; Evans BA, 2007, NANO LETT, V7, P1428, DOI 10.1021/nl070190c; Doi Kentaro, 2011, Journal of Computational Science and Technology, V5, DOI 10.1299/jcst.5.78; Dusenbery DB., 2009, LIVING MICRO SCALE U; Kato T, 2003, ARTIF ORGANS, V27, P41, DOI 10.1046/j.1525-1594.2003.07191.x; Kawano S, 2001, J PRESS VESS-T ASME, V123, P525, DOI 10.1115/1.1388009; Kawano S, 2003, ARTIF ORGANS, V27, P73, DOI 10.1046/j.1525-1594.2003.07186.x; Khaderi S, 2013, RSC ADV, V3, P12735, DOI 10.1039/c3ra42068j; Osman OO, 2012, MICROFLUID NANOFLUID, V13, P703, DOI 10.1007/s10404-012-0988-5; Shintaku H, 2008, EXP THERM FLUID SCI, V32, P1132, DOI 10.1016/j.expthermflusci.2008.01.004; Toonder Jd, 2008, LAB CHIP, V8, P533, DOI [10.1039/B717681C, DOI 10.1039/B717681C]; Yambe T, 1999, ARTIF ORGANS, V23, P747, DOI 10.1046/j.1525-1594.1999.06415.x; Yambe T, 2003, ARTIF ORGANS, V27, P2, DOI 10.1046/j.1525-1594.2003.07181.x	29	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1613-4982	1613-4990		MICROFLUID NANOFLUID	Microfluid. Nanofluid.	SEP	2015	19	3					595	608		10.1007/s10404-015-1586-0		14	Nanoscience & Nanotechnology; Instruments & Instrumentation; Physics, Fluids & Plasmas	Science & Technology - Other Topics; Instruments & Instrumentation; Physics	CR6PC	WOS:000361468600010		
J	Yamada, Y; Fukuda, Y; Harashima, H				Yamada, Yuma; Fukuda, Yutaka; Harashima, Hideyoshi			An analysis of membrane fusion between mitochondrial double membranes and MITO-Porter, mitochondrial fusogenic vesicles	MITOCHONDRION			English	Article						Mitochondria; Mitochondrial drug delivery; Nucleic acid delivery; Mitochondrial matrix; MITO-Porter; Membrane fusion	LIPOSOME-BASED CARRIER; NANO DEVICE; INTRACELLULAR TRAFFICKING; DRUG-DELIVERY; DISEASE; MACROMOLECULE; ENVELOPES; PEPTIDES; SYSTEMS	To achieve mitochondrial gene therapy, therapeutic molecules need to be transported through the outer and inner membranes of mitochondria into the innermost space (mitochondrial matrix), which contains the mtDNA pool. We previously reported on the construction of a MITO-Porter with a high fusogenic activity for the mitochondrial outer membrane for delivering molecules to the mitochondria of human cells. Here, we report on an investigation of a fusogenic lipid composition for the inner membrane, and an analysis of the fusogenic compositions for the outer and inner membranes. A significant relationship was found between fusion activity and the mitochondrial delivery of nucleic acids. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.	[Yamada, Yuma; Fukuda, Yutaka; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Harashima, H (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Mol Design Pharmaceut, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	harasima@pharm.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (MEXT) [26282131, 25560219]; A-step feasibility study program in Japan Science and Technology Agency (JST) [AS251Z00277Q]; Northern Advancement Center for Science & Technology (Noastec Foundation,. Hokkaido, Japan) [T-1-42]	We thank Dr. Y. Shinohara (University of Tokushima, Tokushima, Japan) for kindly supplying primary antibodies from rabbit against VDAC2. This work was supported, in part by, a Grant-in-Aid for Young Scientists (A) [Grant No. 26282131 (to Y.Y.)], a Grant-in Aid for Challenging Exploratory Research [Grant No. 25560219 (to Y.Y.)] and a Grant-in-Aid for Scientific Research (B) [Grant No. 26282131 (to Y.Y.)] from the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (MEXT), and A-step feasibility study program in Japan Science and Technology Agency (JST) [Grant No. AS251Z00277Q (to Y.Y.)], and a grant from the Northern Advancement Center for Science & Technology (Noastec Foundation,. Hokkaido, Japan) [Grant NoT-1-42 (to Y.Y.)]. We also thank Dr. Milton Feather for his helpful advice in writing the manuscript.	Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Yamada Y, 2012, BIOMATERIALS, V33, P1589, DOI 10.1016/j.biomaterials.2011.10.082; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Maier O, 2002, CHEM PHYS LIPIDS, V116, P3, DOI 10.1016/S0009-3084(02)00017-8; Miyata K, 2012, CHEM SOC REV, V41, P2562, DOI 10.1039/c1cs15258k; Kajimoto K, 2014, J CONTROL RELEASE, V190, P593, DOI 10.1016/j.jconrel.2014.03.058; Biswas S, 2014, ADV DRUG DELIVER REV, V66, P26, DOI 10.1016/j.addr.2013.11.004; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Zhang EL, 2011, DRUG DISCOV TODAY, V16, P140, DOI 10.1016/j.drudis.2010.12.006; Kogure K, 2004, J CONTROL RELEASE, V98, P317, DOI 10.1016/j.jconrel.2004.04.024; Yamada Y, 2012, METHOD ENZYMOL, V509, P301, DOI 10.1016/B978-0-12-391858-1.00015-0; Weissig V, 2011, PHARM RES-DORDR, V28, P2657, DOI 10.1007/s11095-011-0556-9; Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016; Nakamura T, 2012, ACCOUNTS CHEM RES, V45, P1113, DOI 10.1021/ar200254s; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Furukawa R, 2015, BIOMATERIALS, V57, P107, DOI 10.1016/j.biomaterials.2015.04.022; Greenawalt J W, 1974, Methods Enzymol, V31, P310; Kawamura E, 2013, MITOCHONDRION, V13, P610, DOI [10.1016/j.mito.2013.08.010, 10.1016/j.mito2013.08.010]; Yamada Y, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1013-3; Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99; Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002; Yamada Y, 2014, METHODS MOL BIOL, V1141, P57, DOI 10.1007/978-1-4939-0363-4_2; Yasuzaki Y, 2010, BIOCHEM BIOPH RES CO, V397, P181, DOI 10.1016/j.bbrc.2010.05.070	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1567-7249	1872-8278		MITOCHONDRION	Mitochondrion	SEP	2015	24						50	55		10.1016/j.mito.2015.07.003		6	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CR5YD	WOS:000361419400005		
J	Jashni, MK; Dols, IHM; Iida, Y; Boeren, S; Beenen, HG; Mehrabi, R; Collemare, J; de Wit, PJGM				Jashni, Mansoor Karimi; Dols, Ivo H. M.; Iida, Yuichiro; Boeren, Sjef; Beenen, Henriek G.; Mehrabi, Rahim; Collemare, Jerome; de Wit, Pierre J. G. M.			Synergistic Action of a Metalloprotease and a Serine Protease from Fusarium oxysporum f. sp lycopersici Cleaves Chitin-Binding Tomato Chitinases, Reduces Their Antifungal Activity, and Enhances Fungal Virulence	MOLECULAR PLANT-MICROBE INTERACTIONS			English	Article							PATHOGENESIS-RELATED PROTEINS; CLASS-I CHITINASE; CLADOSPORIUM-FULVUM; PLANT CHITINASES; INFECTED TOMATO; MOLECULAR CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; DISEASE RESISTANCE; GENE-EXPRESSION; PR PROTEINS	As part of their defense strategy against fungal pathogens, plants secrete chitinases that degrade chitin, the major structural component of fungal cell walls. Some fungi are not sensitive to plant chitinases because they secrete chitin-binding effector proteins that protect their cell wall against these enzymes. However, it is not known how fungal pathogens that lack chitin-binding effectors overcome this plant defense barrier. Here, we investigated the ability of fungal tomato pathogens to cleave chitin-binding domain (CBD)-containing chitinases and its effect on fungal virulence. Four tomato CBD chitinases were produced in Pichia pastoris and were incubated with secreted proteins isolated from seven fungal tomato pathogens. Of these, Fusarium oxyspontm f. sp. lycopersici, Verticillium dahliae, and Bohyds cinerea were able to cleave the extracellular tomato chitinases SIChil and SIChil3. Cleavage by F. oxysporum removed the CBD from the N-terminus, shown by mass spectrometry, and significantly reduced the chitinase and antifungal activity of both chitinases. Both secreted metalloprotease FoMep1 and serine protease FoSep1 were responsible for this cleavage. Double deletion mutants of FoMep1 and FoSep1 of F. oxysporum lacked chitinase cleavage activity on SIChil and SIChil3 and showed reduced virulence on tomato. These results demonstrate the importance of plant chitinase cleavage in fungal virulence.	[Jashni, Mansoor Karimi; Dols, Ivo H. M.; Iida, Yuichiro; Beenen, Henriek G.; Mehrabi, Rahim; Collemare, Jerome; de Wit, Pierre J. G. M.] Univ Wageningen & Res Ctr, Lab Phytopathol, NL-6708 PB Wageningen, Netherlands; [Jashni, Mansoor Karimi] Tarbiat Modares Univ, Dept Plant Pathol, Tehran 14115336, Iran; [Iida, Yuichiro] Natl Agr & Food Res Org, Tsu, Mie 5142392, Japan; [Boeren, Sjef] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands	de Wit, PJGM (reprint author), Univ Wageningen & Res Ctr, Lab Phytopathol, NL-6708 PB Wageningen, Netherlands.	Pierre.deWit@wur.nl			Ministry of Science, Research and Technology (MSRT) of Iran; Wageningen University	We are grateful for the financial assistance provided by the Ministry of Science, Research and Technology (MSRT) of Iran and Wageningen University (to M. K. Jashni) and Grant-in-Aid for Scientific Research, KAKENHI (to Y. Iida).	Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; Ham KS, 1997, PLANT J, V11, P169, DOI 10.1046/j.1365-313X.1997.11020169.x; Houterman PM, 2007, MOL PLANT PATHOL, V8, P215, DOI [10.1111/j.1364-3703.2007.00384.x, 10.1111/J.1364-3703.2007.00384.X]; Okmen B, 2013, NEW PHYTOL, V198, P1203, DOI 10.1111/nph.12208; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Iqbal MM, 2012, MOL BIOTECHNOL, V50, P129, DOI 10.1007/s12033-011-9426-2; JONGEDIJK E, 1995, EUPHYTICA, V85, P173; Aime S, 2013, MOL PLANT MICROBE IN, V26, P918, DOI 10.1094/MPMI-12-12-0290-R; Talavera G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Naumann TA, 2010, PHYTOPATHOLOGY, V100, P645, DOI 10.1094/PHYTO-100-7-0645; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Balasubramanian V, 2012, BIOTECHNOL LETT, V34, P1983, DOI 10.1007/s10529-012-1012-6; Rose JKC, 2002, PLANT CELL, V14, P1329, DOI 10.1105/tpc.002253; Suarez V, 2001, PLANT MOL BIOL, V45, P609, DOI 10.1023/A:1010619421524; Maximova SN, 2006, PLANTA, V224, P740, DOI 10.1007/s00425-005-0188-6; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wu SW, 2014, J INTEGR AGR, V13, P926, DOI 10.1016/S2095-3119(13)60570-5; ISELI B, 1993, PLANT PHYSIOL, V103, P221, DOI 10.1104/pp.103.1.221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; SELABUURLAGE MB, 1993, PLANT PHYSIOL, V101, P857; Naumann TA, 2011, MOL PLANT PATHOL, V12, P365, DOI 10.1111/j.1364-3703.2010.00677.x; Naumann TA, 2011, J BIOL CHEM, V286, P35358, DOI 10.1074/jbc.M111.279646; Cletus J, 2013, BIOTECHNOL LETT, V35, P1719, DOI 10.1007/s10529-013-1269-4; Sreedhar L, 1999, GENE, V235, P121, DOI 10.1016/S0378-1119(99)00201-2; Stergiopoulos I, 2010, P NATL ACAD SCI USA, V107, P7610, DOI 10.1073/pnas.1002910107; Lu J, 2011, J PROTEOMICS, V75, P34, DOI 10.1016/j.jprot.2011.07.031; NEUHAUS JM, 1991, P NATL ACAD SCI USA, V88, P10362, DOI 10.1073/pnas.88.22.10362; Dana MD, 2006, PLANT PHYSIOL, V142, P722, DOI 10.1104/pp.106.086140; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Truong NH, 2003, BIOSCI BIOTECH BIOCH, V67, P1063; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Li H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008654; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ARLORIO M, 1992, PROTOPLASMA, V171, P34, DOI 10.1007/BF01379278; BALL AM, 1991, PHYSIOL MOL PLANT P, V38, P147, DOI 10.1016/S0885-5765(05)80132-8; BENHAMOU N, 1990, PLANT PHYSIOL, V92, P1108, DOI 10.1104/pp.92.4.1108; Bindschedler LV, 2003, FUNGAL GENET BIOL, V38, P43, DOI 10.1016/S1087-1845(02)00517-0; Cota IE, 2007, SCI HORTIC-AMSTERDAM, V112, P42, DOI 10.1016/j.scienta.2006.12.005; DANHASH N, 1993, PLANT MOL BIOL, V22, P1017, DOI 10.1007/BF00028974; de Wit PJGM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003088; DEWIT PJGM, 1982, PHYSIOL PLANT PATHOL, V21, P1, DOI 10.1016/0048-4059(82)90002-9; Di Pietro A, 2001, MOL PLANT MICROBE IN, V14, P653, DOI 10.1094/MPMI.2001.14.5.653; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Godoy AV, 1996, POTATO RES, V39, P259, DOI 10.1007/BF02360917; Hamid Rifat, 2013, J Pharm Bioallied Sci, V5, P21, DOI 10.4103/0975-7406.106559; JOOSTEN MHAJ, 1995, PHYSIOL MOL PLANT P, V46, P45, DOI 10.1006/pmpp.1995.1004; JOOSTEN MHAJ, 1989, PLANT PHYSIOL, V89, P945, DOI 10.1104/pp.89.3.945; Kolosova N, 2014, PHYTOCHEMISTRY, V101, P32, DOI 10.1016/j.phytochem.2014.02.006; Kombrink A, 2012, METHODS MOL BIOL, V835, P209, DOI 10.1007/978-1-61779-501-5_13; Lange J, 1996, PLANT PHYSIOL, V111, P1135, DOI 10.1104/pp.111.4.1135; Lu SW, 2003, P NATL ACAD SCI USA, V100, P5980, DOI 10.1073/pnas.0931375100; MAUCH F, 1988, PLANT PHYSIOL, V88, P936, DOI 10.1104/pp.88.3.936; McGowan S, 2013, CURR OPIN STRUC BIOL, V23, P828, DOI 10.1016/j.sbi.2013.07.015; Mehrabi R, 2015, FUNGAL GENET BIOL, V79, P186, DOI 10.1016/j.fgb.2015.03.016; Michielse CB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r4; Murphy JM, 1996, MOL PLANT MICROBE IN, V9, P290, DOI 10.1094/MPMI-9-0290; Nagy NE, 2013, PLANT BIOLOGY, V15, P99, DOI 10.1111/j.1438-8677.2012.00596.x; Naumann TA, 2013, PHYSIOL MOL PLANT P, V82, P1, DOI 10.1016/j.pmpp.2012.12.001; Naumann TA, 2009, PHYSIOL MOL PLANT P, V74, P134, DOI 10.1016/j.pmpp.2009.10.004; Ohnuma T, 2011, PLANTA, V234, P123, DOI 10.1007/s00425-011-1390-3; Ohnuma T, 2012, FEBS J, V279, P3639, DOI 10.1111/j.1742-4658.2012.08723.x; Olivieri F, 2002, EUR J PLANT PATHOL, V108, P63, DOI 10.1023/A:1013920929965; Schickler H, 1997, J IND MICROBIOL BIOT, V19, P196, DOI 10.1038/sj.jim.2900447; Sela-Buurlage M. B., 1996, THESIS WAGENINGEN U; Sinha M, 2014, SCI WORLD J, DOI 10.1155/2014/543195; WUBBEN JP, 1992, PHYSIOL MOL PLANT P, V41, P23, DOI 10.1016/0885-5765(92)90046-X; Yamagami T, 1998, BIOSCI BIOTECH BIOCH, V62, P1253, DOI 10.1271/bbb.62.1253	76	2	2	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0894-0282	1943-7706		MOL PLANT MICROBE IN	Mol. Plant-Microbe Interact.	SEP	2015	28	9					996	1008		10.1094/MPM1-04-15-0074-R		13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Plant Sciences	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Plant Sciences	CR5XU	WOS:000361418500004		
J	Niimi, A; Hopkins, SR; Downs, JA; Masutani, C				Niimi, Atsuko; Hopkins, Suzanna R.; Downs, Jessica A.; Masutani, Chikahide			The BAH domain of BAF180 is required for PCNA ubiquitination	MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS			English	Article						Post replication repair; Chromatin remodeling; PCNA ubiquitination; BAF180; BAH domain	CHROMATIN-REMODELING COMPLEX; TRANSLESION DNA-SYNTHESIS; STRAND BREAK REPAIR; MONOUBIQUITINATED PCNA; POLYBROMO PROTEIN; DAMAGE RESPONSE; REPLICATION; SWI/SNF; BINDING; INO80	Monoubiquitination of proliferating cell nuclear antigen (PCNA) is a critical regulator of post replication repair (PRR). The depletion of BAF180, a unique subunit of the PBAF chromatin remodeling complex in human cells results in reduced PCNA ubiquitination leading to less efficient fork progression following DNA damage, but little is known about the mechanism. Here, we report that the expression of exogenous BAF180 in cells promotes PCNA ubiquitination during S-phase after UV irradiation and it persists for many hours. No correlation was observed between the protein level of ubiquitin-specific protease 1 (USP1) and ubiquitinated PCNA in BAF180 expressing cells. Analysis of cells expressing BAF180 deletion mutants showed that the bromo-adjacent homology (BAH) domains are responsible for this effect. Surprisingly, a deletion construct encoding only the BAH domain region is able to increase the level of ubiquitinated PCNA, even though it is unable to be assembled into the PBAF complex. These results suggest that the ATPase-dependent chromatin remodeling activity of PBAF is not necessary, but instead the BAH domains are sufficient to promote PCNA ubiquitination. (C) 2015 Elsevier B.V. All rights reserved.	[Niimi, Atsuko; Masutani, Chikahide] Nagoya Univ, Dept Genome Dynam, Environm Med Res Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hopkins, Suzanna R.; Downs, Jessica A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Masutani, C (reprint author), Nagoya Univ, Dept Genome Dynam, Environm Med Res Inst, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	masutani@riem.nagoya-u.ac.jp	Masutani, Chikahide/I-6160-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan [25241011, 22131008]; Takeda Science Foundation; Uehara Memorial Foundation	This work was supported by Grants-in-Aid for Scientific Research [25241011 to C.M.], and Scientific Research on Innovation Areas [22131008 to C.M.] from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Takeda Science Foundation and the Uehara Memorial Foundation [to C.M.].	Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Chambers AL, 2013, NUCLEIC ACIDS RES, V41, P9168, DOI 10.1093/nar/gkt662; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Lehmann AR, 2011, FEBS LETT, V585, P2772, DOI 10.1016/j.febslet.2011.06.005; Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kim H, 2014, MOL CELL, V54, P107, DOI 10.1016/j.molcel.2014.02.017; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Jiang YJ, 2010, P NATL ACAD SCI USA, V107, P17274, DOI 10.1073/pnas.1008388107; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Avkin S, 2006, MOL CELL, V22, P407, DOI 10.1016/j.molcel.2006.03.022; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Niimi A, 2012, NUCLEIC ACIDS RES, V40, P7393, DOI 10.1093/nar/gks453; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Brownlee PM, 2014, CELL REP, V6, P973, DOI 10.1016/j.celrep.2014.02.012; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Falbo KB, 2009, NAT STRUCT MOL BIOL, V16, P1167, DOI 10.1038/nsmb.1686; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gohler T, 2008, DNA REPAIR, V7, P775, DOI 10.1016/j.dnarep.2008.02.001; Goodwin GH, 2001, GENE, V268, P1, DOI 10.1016/S0378-1119(01)00428-0; Kakarougkas A, 2014, MOL CELL, V55, P723, DOI 10.1016/j.molcel.2014.06.028; Kent NA, 2007, J BIOL CHEM, V282, P27693, DOI 10.1074/jbc.M704707200; Lehmann AR, 2011, DNA REPAIR, V10, P730, DOI 10.1016/j.dnarep.2011.04.023; Norris A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000301; Oliver AW, 2005, BIOCHEM J, V389, P657; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Shaw A, 2010, CHROMOSOME RES, V18, P163, DOI 10.1007/s10577-010-9114-2; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Vincent JA, 2008, NAT STRUCT MOL BIOL, V15, P477, DOI 10.1038/nsmb.1419; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Wurster AL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-9; Yang XH, 2008, GENE DEV, V22, P1147, DOI 10.1101/gad.1632808; Zhang SF, 2008, CELL CYCLE, V7, P3399	60	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0027-5107	1873-135X		MUTAT RES-FUND MOL M	Mutat. Res.-Fundam. Mol. Mech. Mutagen.	SEP	2015	779						16	23		10.1016/j.mrfmmm.2015.06.006		8	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CR3RT	WOS:000361251500002		
J	Sunaoshi, M; Amasaki, Y; Hirano-Sakairi, S; Blyth, BJ; Morioka, T; Kaminishi, M; Shang, Y; Nishimura, M; Shimada, Y; Tachibana, A; Kakinuma, S				Sunaoshi, Masaaki; Amasaki, Yoshiko; Hirano-Sakairi, Shinobu; Blyth, Benjamin J.; Morioka, Takamitsu; Kaminishi, Mutsumi; Shang, Yi; Nishimura, Mayumi; Shimada, Yoshiya; Tachibana, Akira; Kakinuma, Shizuko			The effect of age at exposure on the inactivating mechanisms and relative contributions of key tumor suppressor genes in radiation-induced mouse T-cell lymphomas	MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS			English	Article						Ikaros; Pten; Radiation; Age; Lymphoma; Mitotic recombination	ACUTE LYMPHOBLASTIC-LEUKEMIA; ETHYL-N-NITROSOUREA; MURINE THYMIC LYMPHOMAS; ATOMIC-BOMB SURVIVORS; IONIZING-RADIATION; POINT MUTATIONS; TRANSCRIPTION FACTOR; THYROID CARCINOMAS; IKAROS ISOFORMS; X-RAYS	Children are considered more sensitive to radiation-induced cancer than adults, yet any differences in genomic alterations associated with age-at-exposure and their underlying mechanisms remain unclear. We assessed genome-wide DNA copy number and mutation of key tumor suppressor genes in T-cell lymphomas arising after weekly irradiation of female B6C3F1 mice with 1.2 Gy X-rays for 4 consecutive weeks starting during infancy (1 week old), adolescence (4 weeks old) or as young adults (8 weeks old). Although T-cell lymphoma incidence was similar, loss of heterozygosity at Cdkn2a on chromosome 4 and at Ikaros on chromosome 11 was more frequent in the two older groups, while loss at the Pten locus on chromosome 19 was more frequent in the infant-irradiated group. Cdkn2a and Ikaros mutation/loss was a common feature of the young adult-irradiation group, with Ikaros frequently (50%) incurring multiple independent hits (including deletions and mutations) or suffering a single hit predicted to result in a dominant negative protein (such as those lacking exon 4, an isoform we have designated Ikl 2, which lacks two DNA binding zinc-finger domains). Conversely, Pten mutations were more frequent after early irradiation (60%) than after young adult-irradiation (30%). Homozygous Pten mutations occurred without DNA copy number change after irradiation starting in infancy, suggesting duplication of the mutated allele by chromosome mis-segregation or mitotic recombination. Our findings demonstrate that while deletions on chromosomes 4 and II affecting Cdkn2a and Ikaros are a prominent feature of young adult irradiation-induced T-cell lymphoma, tumors arising after irradiation from infancy suffer a second hit in Pten by mis-segregation or recombination. This is the first report showing an influence of age-at-exposure on genomic alterations of tumor suppressor genes and their relative involvement in radiation-induced T-cell lymphoma. These data are important for considering the risks associated with childhood exposure to radiation. (C) 2015 Elsevier B.V. All rights reserved.	[Sunaoshi, Masaaki; Amasaki, Yoshiko; Hirano-Sakairi, Shinobu; Blyth, Benjamin J.; Morioka, Takamitsu; Kaminishi, Mutsumi; Shang, Yi; Nishimura, Mayumi; Shimada, Yoshiya; Kakinuma, Shizuko] Natl Inst Radiol Sci, Radiobiol Childrens Hlth Program, Inage Ku, Chiba 2638555, Japan; [Sunaoshi, Masaaki; Tachibana, Akira] Ibaraki Univ, Dept Biol Sci, Coll Sci, Mito, Ibaraki 3108512, Japan; [Morioka, Takamitsu; Shang, Yi; Nishimura, Mayumi; Shimada, Yoshiya; Kakinuma, Shizuko] Natl Inst Radiol Sci, Radiat Effect Accumulat & Prevent Project, Fukushima Project Headquarters, Inage Ku, Chiba 2638555, Japan	Kakinuma, S (reprint author), Natl Inst Radiol Sci, Radiobiol Childrens Hlth Program, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	skakinum@nirs.go.jp		Blyth, Benjamin/0000-0003-4754-6249	JSPS KAKENHI [22501002, 21610029, 24600029]; National Cancer Center Research and Development Fund;  [25-9922]	This work was supported in part by JSPS KAKENHI Grant Numbers 22501002 (SK), 21610029 (YS), and 24600029 (YS); and by National Cancer Center Research and Development Fund No. 3 (SK). MS is a recipient of a Grant-In-Aid for JSPS Fellows (Grant Number: 25-9922). The animals used in this experiment are part of the J-SHARE project (Japan-Storehouse of Animal Radiobiology Experiments) under construction by the National Institute of Radiological Sciences.	Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Lima J, 2004, J CLIN ENDOCR METAB, V89, P4267, DOI 10.1210/jc.2003-032224; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; KAPLAN HS, 1952, J NATL CANCER I, V13, P185; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Richardson D, 2009, RADIAT RES, V172, P368, DOI 10.1667/RR1801.1; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Guo W, 2011, P NATL ACAD SCI USA, V108, P1409, DOI 10.1073/pnas.1006937108; Denissova NG, 2011, MUTAT RES-FUND MOL M, V715, P1, DOI 10.1016/j.mrfmmm.2011.06.017; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Amant F, 2002, GYNECOL ONCOL, V85, P165, DOI 10.1006/gyno.2002.6601; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Jin G, 2010, LUNG CANCER, V69, P279, DOI 10.1016/j.lungcan.2009.11.012; Van Vlierberghe P, 2013, BLOOD, V122, P74, DOI 10.1182/blood-2013-03-491092; Peller S, 2003, HUM MUTAT, V21, P277, DOI 10.1002/humu.10190; Hess J, 2011, P NATL ACAD SCI USA, V108, P9595, DOI 10.1073/pnas.1017137108; Sun L, 1996, EMBO J, V15, P5358; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Rao CV, 2005, P NATL ACAD SCI USA, V102, P4365, DOI 10.1073/pnas.0407822102; BRATHWAITE O, 1992, CANCER RES, V52, P3791; Chan CY, 2007, NUCLEIC ACIDS RES, V35, P5051, DOI 10.1093/nar/gkm442; Hattori N, 1996, J EXP MED, V184, P1901, DOI 10.1084/jem.184.5.1901; Hirano S, 2013, INT J CANCER, V132, P259, DOI 10.1002/ijc.27668; HIROKAWA K, 1975, J IMMUNOL, V114, P1659; Kakinuma S, 2002, RADIAT RES, V157, P331, DOI 10.1667/0033-7587(2002)157[0331:SOZIIA]2.0.CO;2; Kakinuma S, 2012, MUTAT RES-FUND MOL M, V737, P43, DOI 10.1016/j.mrfmmm.2012.06.001; Kakinuma S, 2005, MUTAT RES-FUND MOL M, V572, P132, DOI 10.1016/j.mrfmmm.2005.01.010; LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350; Larson Gedman A, 2009, Leukemia, V23, P1417, DOI 10.1038/leu.2009.64; Liang L, 2007, DNA REPAIR, V6, P1380, DOI 10.1016/j.dnarep.2007.04.005; Nakase K, 2000, CANCER RES, V60, P4062; Ottaviani D, 2014, TRENDS GENET, V30, P85, DOI 10.1016/j.tig.2014.01.001; Sankaranarayanan K, 2013, MUTAT RES-REV MUTAT, V753, P114, DOI 10.1016/j.mrrev.2013.07.003; Santos J, 1996, ONCOGENE, V12, P669; Scuric Z, 2009, RADIAT RES, V171, P454, DOI 10.1667/RR1329.1; Shimada Y, 2000, RADIAT RES, V154, P293, DOI 10.1667/0033-7587(2000)154[0293:RALOHA]2.0.CO;2; SINGH J, 1979, CLIN EXP IMMUNOL, V37, P507; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Sun L, 1999, CLIN CANCER RES, V5, P2112; Sun L, 1999, J CLIN ONCOL, V17, P3753; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Williams D, 2008, Oncogene, V27 Suppl 2, pS9, DOI 10.1038/onc.2009.349; Yamaguchi Y, 2010, MUTAT RES-FUND MOL M, V686, P30, DOI 10.1016/j.mrfmmm.2009.12.011	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0027-5107	1873-135X		MUTAT RES-FUND MOL M	Mutat. Res.-Fundam. Mol. Mech. Mutagen.	SEP	2015	779						58	67		10.1016/j.mrfmmm.2015.06.004		10	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CR3RT	WOS:000361251500006		
J	Okamoto, M; Kobayashi, K; Hasegawa, E; Ohkawara, K				Okamoto, Misato; Kobayashi, Kazuya; Hasegawa, Eisuke; Ohkawara, Kyohsuke			Sexual and asexual reproduction of queens in a myrmicine ant, Vollenhovia emeryi (Hymenoptera: Formicidae)	MYRMECOLOGICAL NEWS			English	Article						Vollenhovia emeryi; clonal reproduction; wing morphology	CLONAL REPRODUCTION; PLURALIST APPROACH; SOCIAL INSECT; RECOMBINATION; SOCIETIES; DISPERSAL; EVOLUTION; MALES	Sexual reproduction is more common than asexual reproduction in eukaryotes. There are few species with obligate clonality, and most clonal organisms maintain sexual reproduction. Organisms tend to couple sexual reproduction with dispersal, or changes in the environment. These facultatively clonal species use both reproductive systems to reduce the costs of clonality, and to gain benefits of sexuality. In recent decades, clonal reproductive systems have been discovered in some eusocial insects. In the myrmicine ant Vollenhovia emeryi previous research has documented that new queens are produced clonally with complete, diploid, maternal genomes. Usually, new queens have short rudimentary wings and cannot fly, suggesting that dispersal of new colonies is limited. However, some new queens with functional long wings occur in natural colonies, in addition to short-winged queens. In this study, we analyzed the reproductive modes of long-winged queens and short-winged queens. In agreement with previous data, most short-winged queens were produced asexually. However, mature colonies and nutritionally rich colonies tend to produce long-winged queens sexually. Since long-winged queens may encounter different environments after dispersal, higher genetic diversity should be advantageous to increase adaptability. Thus, V. emeryi may have evolved a reproductive strategy to maximize advantages of both clonal and sexual reproduction, as in other facultatively clonal organisms.	[Okamoto, Misato] Grad Univ, Okinawa Inst Sci & Technol, Ecol & Evolut Unit, Kunigami Dist, Okinawa 9040495, Japan; [Kobayashi, Kazuya; Hasegawa, Eisuke] Hokkaido Univ, Anim Ecol Lab, Dept Systemat & Ecol, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Ohkawara, Kyohsuke] Kanazawa Univ, Ecol Lab, Div Biol Sci, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Okamoto, M (reprint author), Grad Univ, Okinawa Inst Sci & Technol, Ecol & Evolut Unit, Kunigami Dist, Okinawa 9040495, Japan.	m-okamoto@oist.jp			Japanese Ministry of Education, Science Sports, and Culture [20370030]; JSPS [23-1357]; Okinawa Institute of Science and Technology Graduate University	We especially thank Dr. Osamu Nakayachi for genotypic analysis, and Dr. Alexander Mikheyev for useful comments about this study. We thank Dr. Douglas B. Booher and Dr. Gilsang Jeong for their comments about populations of Vollenhovia emeryi. We especially thank Dr. Steven D. Aird for editing our manuscript. This study was supported by funding from the Japanese Ministry of Education, Science Sports, and Culture Grant for Overseas Research (No. 20370030) and a JSPS Research Fellowship for young scientists (23-1357). Lastly, we thank the Okinawa Institute of Science and Technology Graduate University for its research support.	Anderson Kirk E., 2008, Myrmecological News, V11, P119; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Schwander T, 2008, CURR BIOL, V18, P265, DOI 10.1016/j.cub.2008.01.024; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; West SA, 1999, J EVOLUTION BIOL, V12, P1003; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; FELSENSTEIN J, 1974, GENETICS, V78, P737; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Kobayashi K, 2008, ENTOMOL SCI, V11, P167, DOI 10.1111/j.1479-8298.2008.00272; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Ohkawara K, 2006, BIOL LETT-UK, V2, P359, DOI 10.1098/rsbl.2006.0491; Schmidt AM, 2011, ECOL ENTOMOL, V36, P751, DOI 10.1111/j.1365-2311.2011.01325.x; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; SCHEMSKE DW, 1985, EVOLUTION, V39, P41, DOI 10.2307/2408515; Schwander T, 2010, TRENDS ECOL EVOL, V25, P275, DOI 10.1016/j.tree.2009.12.001; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Pearcy M, 2011, P ROY SOC B-BIOL SCI, V278, P2677, DOI 10.1098/rspb.2010.2562; Applebaum SW, 1999, ANNU REV ENTOMOL, V44, P317, DOI 10.1146/annurev.ento.44.1.317; Bourke A, 1995, SOCIAL EVOLUTION ANT; de Menten L, 2005, BEHAV ECOL SOCIOBIOL, V58, P527, DOI 10.1007/s00265-005-0964-0; Gouyon PH, 1999, J EVOLUTION BIOL, V12, P1029; KOBAYASHI K., 2010, INSECT SOC, V58, P163; Libbrecht R, 2013, P NATL ACAD SCI USA, V110, P11050, DOI 10.1073/pnas.1221781110; Maynard Smith J, 1971, GROUP SELECTION, P163; MYRMECOLOGICAL SOCIETY OF JAPAN, 1992, GUID ID JAP ANTS 3 M; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Ohkawara K, 2002, P 14 INT C IUSSI, P206; Seeley TD, 2003, INSECT SOC, V50, P134, DOI 10.1007/s00040-003-0638-8; Smith CR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1479, DOI 10.1007/s00265-007-0380-8; Tschinkel WR, 2011, MYRMECOL NEWS, V14, P49; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1017/CBO9781139173179; Williams GC, 1975, SEX EVOLUTION	33	2	2	OESTERREICHISCHE GESELL ENTOMOFAUNISTIK, C/O NATURHISTOR MUSEUM WIEN	WIEN	ZWEITE ZOOLOGISCHE ABTEILUNG (INSEKTEN), BURGRING 7, WIEN, AUSTRIA	1994-4136			MYRMECOL NEWS	Myrmecol. News	SEP	2015	21						13	17				5	Entomology	Entomology	CR5YK	WOS:000361420100002		
J	Peeters, C; Ito, F				Peeters, Christian; Ito, Fuminori			Wingless and dwarf workers underlie the ecological success of ants (Hymenoptera: Formicidae)	MYRMECOLOGICAL NEWS			English	Review						Body size; miniaturisation; morphology; colony foundation; flight; caste; queen; wasps; bees; Ponerinae; review	SPERMATHECA MORPHOLOGY; COLONY COMPOSITION; METABOLIC-RATES; SOCIAL INSECTS; TROPHIC EGGS; EVOLUTION; CASTE; BEHAVIOR; QUEEN; SIZE	Ant colonies are organized similarly to those of wasps and bees: reproductive altruism, age polyethism, and complex communication. Yet ants exhibit more species, much higher total biomass, and their lifestyles and diet are more diverse. Hence, factors additional to sociality must be involved in this evolutionary diversification. We argue that loss of flight permitted extensive changes in body size of ant workers and queens. Wingless helpers revolutionized colonial economy because they are cheaper to manufacture. Flightlessness also removed constraints on the evolution of dwarf workers (head width 1 mm or less); these exist in 229 / 286 ant genera examined but not in social wasps and bees. Miniaturisation involves simplification of tissues and organs (compound eyes, sting apparatus, ovaries, exoskeleton), and dwarf workers are cheaper per capita. Comparison of ovariole numbers in 106 genera indicates reduction of ovaries in dwarf workers, and complete loss in six genera of Ponerinae and eight genera of Myrmicinae. Body size influences trophic ecology, but also the pattern in which a colony's finite energy budget is "packaged", allowing increases in colony size if adaptive. Dwarf workers together with big queens enabled the evolution of claustral independent colony foundation that is predominant in three large subfamilies (Dolichoderinae, Formicinae and Myrmicinae). Winglessness allows this divergence of costs between workers and queens, but also novel activity schedules and adaptations for defence. Highly dimorphic queens and workers promoted the evolution of mosaic phenotypes (soldiers and ergatoid queens), which added to colonial complexity (MoLET & al. 2012 The American Naturalist 180: 328-341). We speculate that cheaper workers caused a shift away from a carnivorous diet to carbohydrates such as honeydew. Wasp and bee workers infertile just as in ants need to fly and this constrained extensive divergence from queens, which prevented bigger colonies. The winglessness of ant helpers maximized the benefits of having two morphological castes.	[Peeters, Christian] Univ Paris 06, Inst Ecol & Environm Sci, CNRS, UMR 7618, F-75005 Paris, France; [Ito, Fuminori] Kagawa Univ, Fac Agr, Miki, Kagawa 7610795, Japan	Peeters, C (reprint author), Univ Paris 06, Inst Ecol & Environm Sci, CNRS, UMR 7618, F-75005 Paris, France.	christian.peeters@upmc.fr; ito@ag.kagawa-u.ac.jp			JSPS [24405010]; French National Research Agency (ANTEVO) [ANR-12-JSV7-0003-01]	We thank M. Deyrup, T. McGlynn, M. Molet, T. Monnin, and J. Shik for critical comments on different versions of our manuscript. Serge Aron, Mark Deyrup, Frances Duncan, Roberto Keller, Keiichi Masuko, Ajay Narendra, Jonathan Shik, and Lotta Sundstrom helped us with specific enquiries. CP is indebted to Roberto A. Keller for sharing many insights about functional morphology in Hymenoptera. FT is supported by a Grant-in-Aid for Scientific Research (B, 24405010) from JSPS, and CP is supported by the French National Research Agency (ANTEVO ANR-12-JSV7-0003-01). We acknowledge the tremendous value of AntWeb.org as a repository of high-quality images for ant species on earth.	Andersen Alan N., 2007, Memoirs of the American Entomological Institute (Gainesville), V80, P19; Warrant EJ, 2008, J EXP BIOL, V211, P1737, DOI 10.1242/jeb.015396; Reinhold K, 1999, FUNCT ECOL, V13, P217, DOI 10.1046/j.1365-2435.1999.00300.x; GEHRING WJ, 1995, P NATL ACAD SCI USA, V92, P2994, DOI 10.1073/pnas.92.7.2994; Polilov AA, 2015, ANNU REV ENTOMOL, V60, P103, DOI 10.1146/annurev-ento-010814-020924; Bourke AFG, 1999, J EVOLUTION BIOL, V12, P245, DOI 10.1046/j.1420-9101.1999.00028.x; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Gotoh A, 2013, APIDOLOGIE, V44, P133, DOI 10.1007/s13592-012-0165-6; Cronin AL, 2013, ANNU REV ENTOMOL, V58, P37, DOI 10.1146/annurev-ento-120811-153643; Kaspari M, 1999, FUNCT ECOL, V13, P530, DOI 10.1046/j.1365-2435.1999.00343.x; Boomsma JJ, 2009, PHILOS T R SOC B, V364, P3191, DOI 10.1098/rstb.2009.0101; Niven JE, 2005, BIOL LETTERS, V1, P346, DOI 10.1098/rsbl.2005.0311; Keller RA, 2011, B AM MUS NAT HIST, P1; Czaczkes TJ, 2013, MYRMECOL NEWS, V18, P1; Haight KL, 2012, J INSECT PHYSIOL, V58, P1568, DOI 10.1016/j.jinsphys.2012.09.011; Kaspari M, 2000, BIOTROPICA, V32, P703, DOI 10.1646/0006-3606(2000)032[0703:AAAMGI]2.0.CO;2; CALABI P, 1989, J INSECT PHYSIOL, V35, P643, DOI 10.1016/0022-1910(89)90127-3; Ward PS, 2014, ANNU REV ECOL EVOL S, V45, P23, DOI 10.1146/annurev-ecolsys-120213-091824; Federle W, 2001, P NATL ACAD SCI USA, V98, P6215, DOI 10.1073/pnas.111139298; Peeters C, 2012, MYRMECOL NEWS, V16, P75; Korb J, 2008, BIOL REV, V83, P295, DOI 10.1111/j.1469-185X.2008.00044.x; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Wilson EO, 2014, P NATL ACAD SCI USA, V111, P12585, DOI 10.1073/pnas.1405550111; Yamamoto A, 2009, J INSECT BEHAV, V22, P1, DOI 10.1007/s10905-008-9126-3; Narendra A, 2011, P ROY SOC B-BIOL SCI, V278, P1141, DOI 10.1098/rspb.2010.1378; Molet M, 2007, ETHOLOGY, V113, P721, DOI 10.1111/j.1439-0310.2007.01376.x; Kipyatkov VE, 2015, ENTOMOL SCI, V18, P174, DOI 10.1111/ens.12098; Billen J, 2011, INVERTEBR BIOL, V130, P277, DOI 10.1111/j.1744-7410.2011.00230.x; Buschinger B., 1984, DEFENSIVE MECH SOCIA, P95; Dietemann V, 2002, INSECT SOC, V49, P289, DOI 10.1007/s00040-002-8316-9; Evans H.E., 1978, MEM AM ENTOMOL I, V27, P1; Gobin B, 2008, NATURWISSENSCHAFTEN, V95, P1041, DOI 10.1007/s00114-008-0420-x; Gobin B, 1998, PHYSIOL ENTOMOL, V23, P329, DOI 10.1046/j.1365-3032.1998.00102.x; Gobin B, 2000, NATURWISSENSCHAFTEN, V87, P323, DOI 10.1007/s001140050731; Gotoh A, 2008, ARTHROPOD STRUCT DEV, V37, P199, DOI 10.1016/j.asd.2007.11.001; Gronenberg Wulfila, 2008, Myrmecological News, V11, P25; Gruter C, 2012, P NATL ACAD SCI USA, V109, P1182, DOI 10.1073/pnas.1113398109; Hashimoto Yoshiaki, 1996, Japanese Journal of Entomology, V64, P340; Heinrich B, 1993, HOT BLOODED INSECTS; Heinze J, 1996, INSECT SOC, V43, P319, DOI 10.1007/BF01242933; Helms JA, 2015, INSECT SOC, V62, P171, DOI 10.1007/s00040-015-0391-9; HIGASHI S, 1990, J AUST ENTOMOL SOC, V29, P327; Holldobler B., 1990, ANTS; HOLLDOBLER B, 1983, INSECT SOC, V30, P384, DOI 10.1007/BF02223970; Ito F, 1998, INSECT SOC, V45, P79, DOI 10.1007/s000400050070; Ito F, 2008, ASIAN MYRMECOL, V2, P103; Ito F, 1998, BELG J ZOOL, V128, P201; Iwata K., 1976, EVOLUTION INSTINCT C; Julian GE, 2002, BRAIN BEHAV EVOLUT, V60, P152, DOI 10.1159/000065936; Kaspari M, 2015, GLOBAL CHANGE BIOL, V21, P1092, DOI 10.1111/gcb.12750; KASPARI M, 1995, AM NAT, V145, P610, DOI 10.1086/285758; Keller R.A., 2008, THESIS CORNELL U ITH; Keller RA, 2014, ELIFE, V3, DOI 10.7554/eLife.01539; KUGLER C, 1979, EVOLUTION, V33, P117, DOI 10.2307/2407370; Masuko K, 2009, J KANSAS ENTOMOL SOC, V82, P109; Matsuura M, 1990, BIOL VESPINE WASPS; McGlynn TP, 1999, AM NAT, V154, P690, DOI 10.1086/303270; Michener C. D., 2007, BEES WORLD; Molet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084929; Molet M, 2008, AM NAT, V172, P75, DOI 10.1086/588079; Molet M, 2012, AM NAT, V180, P328, DOI 10.1086/667368; Monnin T, 2008, NATURWISSENSCHAFTEN, V95, P109, DOI 10.1007/s00114-007-0297-0; Moreau CS, 2009, MYRMECOL NEWS, V12, P201; Muscedere ML, 2011, NATURWISSENSCHAFTEN, V98, P783, DOI 10.1007/s00114-011-0828-6; Narendra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076015; Nielsen MG, 2001, PHYSIOL ENTOMOL, V26, P248, DOI 10.1046/j.0307-6962.2001.00242.x; Niven J.E., 2007, PLOS BIOL, V5, pel 16; Oster GF, 1978, CASTE ECOLOGY SOCIAL; Passera L., 2005, FOURMIS COMPORTEMENT; Paul J, 2001, COMP BIOCHEM PHYS A, V131, P7, DOI 10.1016/S1095-6433(01)00458-5; Peeters C, 2010, INSECT SOC, V57, P177, DOI 10.1007/s00040-010-0067-4; Peeters Christian, 1997, P372; Peeters C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047727; Peeters C, 2010, ANT ECOLOGY, P159; Polidori C, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-36; Powell S, 2008, FUNCT ECOL, V22, P902, DOI 10.1111/j.1365-2435.2008.01436.x; Ramirez-Esquivel F., 2012, THESIS AUSTR NATL U; Rifflet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028571; Ross KG, 1991, SOCIAL BIOL WASPS; ROUBIK D. W., 1989, ECOLOGY NATURAL HIST; Shik JZ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1981, DOI 10.1007/s00265-010-1009-x; Taniguchi K, 2005, INSECT SOC, V52, P320, DOI 10.1007/s00040-005-0813-1; Touyama Yoshifumi, 2004, Edaphologia, V74, P27; Tschinkel WR, 2011, MYRMECOL NEWS, V14, P49; VILLET MH, 1991, J NAT HIST, V25, P1603, DOI 10.1080/00222939100770991; Ward P.S., 2006, CURR BIOL, V16, P152; Wheeler Diana E., 1994, P245; Wilson E.O, 2003, PHEIDOLE NEW WORLD; Yamane S, 1996, RAFFLES B ZOOL, V44, P253; Yeo K, 2006, INSECT SOC, V53, P435, DOI 10.1007/s00040-005-0890-9	90	0	0	OESTERREICHISCHE GESELL ENTOMOFAUNISTIK, C/O NATURHISTOR MUSEUM WIEN	WIEN	ZWEITE ZOOLOGISCHE ABTEILUNG (INSEKTEN), BURGRING 7, WIEN, AUSTRIA	1994-4136			MYRMECOL NEWS	Myrmecol. News	SEP	2015	21						117	130				14	Entomology	Entomology	CR5YK	WOS:000361420100011		
J	Jacob, MV; Rawat, RS; Ouyang, B; Bazaka, K; Kumar, DS; Taguchi, D; Iwamoto, M; Neupane, R; Varghese, OK				Jacob, Mohan V.; Rawat, Rajdeep S.; Ouyang, Bo; Bazaka, Kateryna; Kumar, D. Sakthi; Taguchi, Dai; Iwamoto, Mitsumasa; Neupane, Ram; Varghese, Oomman K.			Catalyst-Free Plasma Enhanced Growth of Graphene from Sustainable Sources	NANO LETTERS			English	Article						graphene; PECVD; hydrophobic; memristor	2ND-HARMONIC GENERATION MEASUREMENT; RAMAN-SPECTROSCOPY; LINALYL ACETATE; CARBON-SOURCES; PECVD GROWTH; SURFACE; LAYER; FILMS; WETTABILITY; TEMPERATURE	Details of a fast and sustainable bottom-up process to grow large area high quality graphene films without the aid of any catalyst are reported in this paper. We used Melaleuca alternifolia, a volatile natural extract from tea tree plant as the precursor. The as-fabricated graphene films yielded a stable contact angle of 135 degrees, indicating their potential application in very high hydrophobic coatings. The electronic devices formed by sandwiching pentacene between graphene and aluminum films demonstrated memristive behavior, and hence, these graphene films could find use in nonvolatile memory devices also.	[Jacob, Mohan V.; Bazaka, Kateryna] James Cook Univ, Coll Sci Technol & Engn, Elect Mat Lab, Townsville, Qld 4811, Australia; [Rawat, Rajdeep S.; Ouyang, Bo] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore 637616, Singapore; [Kumar, D. Sakthi] Toyo Univ, Bio Nano Elect Res Ctr, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama 3508585, Japan; [Taguchi, Dai; Iwamoto, Mitsumasa] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Neupane, Ram; Varghese, Oomman K.] Univ Houston, Dept Phys, Nanomat & Devices Lab, Houston, TX 77204 USA	Jacob, MV (reprint author), James Cook Univ, Coll Sci Technol & Engn, Elect Mat Lab, Townsville, Qld 4811, Australia.	Mohan.Jacob@jcu.edu.au	Jacob, Mohan/B-9097-2009	Jacob, Mohan/0000-0002-2598-7193	ARC DECRA fellowship; NIE/NTU AcRF grant, National Institute of Education, Nanyang Technological University, Singapore [RI 7/11 RSR]; University of Houston	Authors are grateful to Ivy Ahiabu (XRD), University of Houston and P. Vivekanandan (XPS), Toyo University for the help in material characterization. K.B. also acknowledges the ARC DECRA fellowship. Part of this research was supported by NIE/NTU AcRF grant (RI 7/11 RSR) provided by National Institute of Education, Nanyang Technological University, Singapore. O.K.V. acknowledges the financial support from University of Houston.	Anderson LJ, 2012, MATER SCI ENG B-ADV, V177, P311, DOI 10.1016/j.mseb.2011.12.026; Hwang EH, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115432; Zhu CZ, 2010, ACS NANO, V4, P2429, DOI 10.1021/nn1002387; Rafiee J, 2012, NAT MATER, V11, P217, DOI [10.1038/nmat3228, 10.1038/NMAT3228]; Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020; Peng KJ, 2013, J MATER CHEM C, V1, P3862, DOI 10.1039/c3tc30332b; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Taherian F, 2013, LANGMUIR, V29, P1457, DOI 10.1021/la304645w; Ruan GD, 2011, ACS NANO, V5, P7601, DOI 10.1021/nn202625c; Zhang LC, 2011, NANO RES, V4, P315, DOI 10.1007/s12274-010-0086-5; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Li ZC, 2011, ACS NANO, V5, P3385, DOI 10.1021/nn200854p; Wang J, 2012, ANGEW CHEM INT EDIT, V51, P9297, DOI 10.1002/anie.201204381; Yang CY, 2013, J MATER CHEM A, V1, P770, DOI 10.1039/c2ta00234e; Borunda MF, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125415; Wang SR, 2009, LANGMUIR, V25, P11078, DOI 10.1021/la901402f; Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579; Eckmann A, 2012, NANO LETT, V12, P3925, DOI 10.1021/nl300901a; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8; Kim H, 2013, ANGEW CHEM INT EDIT, V52, P5997, DOI 10.1002/anie.201300896; Liu Y, 2014, RSC ADV, V4, P45389, DOI 10.1039/c4ra06051b; Son JY, 2010, ACS NANO, V4, P2655, DOI 10.1021/nn100234x; Rafiee J, 2010, ADV MATER, V22, P2151, DOI 10.1002/adma.200903696; Dong XC, 2012, CHEM COMMUN, V48, P10660, DOI 10.1039/c2cc35844a; Unarunotai S, 2010, ADV MATER, V22, P1072, DOI 10.1002/adma.200904095; Raj R, 2013, NANO LETT, V13, P1509, DOI 10.1021/nl304647t; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Yang W, 2013, NAT MATER, V12, P792, DOI [10.1038/nmat3695, 10.1038/NMAT3695]; Bo Z, 2015, CHEM SOC REV, V44, P2108, DOI 10.1039/c4cs00352g; Kim YS, 2014, ACS NANO, V8, P2230, DOI 10.1021/nn405477f; Hwang EH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115449; Berke K, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/25/255802; Basu S, 2014, PHYS CHEM CHEM PHYS, V16, P16701, DOI 10.1039/c3cp55440f; Bazaka K, 2010, BIOMACROMOLECULES, V11, P2016, DOI 10.1021/bm100369n; Dong J., 2013, SCI REP, V3, P3; Easton CD, 2009, POLYMER, V50, P3465, DOI 10.1016/j.polymer.2009.05.019; Liu G., 2009, APPL PHYS LETT, V95; Seo DH, 2013, ADV MATER, V25, P5638, DOI 10.1002/adma201301510; Shih C.-J., 2012, PHYS REV LETT, V109; Singh E, 2013, SMALL, V9, P75, DOI 10.1002/smll.201201176; Taguchi D, 2014, CHEM PHYS LETT, V593, P69, DOI 10.1016/j.cplett.2013.12.070; Taguchi D, 2013, CHEM PHYS LETT, V572, P150, DOI 10.1016/j.cplett.2013.04.030; Wang LH, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681366	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	SEP	2015	15	9					5702	5708		10.1021/acs.nanolett.5b01363		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CR3SF	WOS:000361252700006		
J	Sekiguchi, A; Tanaka, F; Saito, T; Kuwahara, Y; Sakurai, S; Futaba, DN; Yamada, T; Hata, K				Sekiguchi, Atsuko; Tanaka, Fumiaki; Saito, Takeshi; Kuwahara, Yuki; Sakurai, Shunsuke; Futaba, Don N.; Yamada, Takeo; Hata, Kenji			Robust and Soft Elastomeric Electronics Tolerant to Our Daily Lives	NANO LETTERS			English	Article						wearable electronics; conductive rubber; single-walled carbon nanotube; field effect transistor; flexible electronics	THIN-FILM TRANSISTORS; CARBON NANOTUBE TRANSISTORS; INTEGRATED-CIRCUITS; ELASTIC CONDUCTORS; GATE DIELECTRICS; SEMICONDUCTOR; DEVICES; SENSORS; SKIN	Clothes represent a unique textile, as they simultaneously provide robustness against our daily activities and comfort (i.e., softness). For electronic devices to be fully integrated into clothes, the devices themselves must be as robust and soft as the clothes themselves. However, to date, no electronic device has ever possessed these properties, because all contain components fabricated from brittle materials, such as metals. Here, we demonstrate robust and soft elastomeric devices where every component possesses elastomeric characteristics with two types of single-walled carbon nanotubes added to provide the necessary electronic properties. Our elastomeric field effect transistors could tolerate every punishment our clothes experience, such as being stretched (elasticity: similar to 110%), bent, compressed (>4.0 MPa, by a car and heels), impacted (>6.26 kg m/s, by a hammer), and laundered. Our electronic device provides a novel design principle for electronics and wide range applications even in research fields where devices cannot be used.	[Sekiguchi, Atsuko; Tanaka, Fumiaki; Saito, Takeshi; Kuwahara, Yuki; Sakurai, Shunsuke; Futaba, Don N.; Yamada, Takeo; Hata, Kenji] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Sekiguchi, Atsuko; Tanaka, Fumiaki; Futaba, Don N.; Yamada, Takeo; Hata, Kenji] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Hata, K (reprint author), Natl Inst Adv Ind Sci & Technol, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	kenji-hata@aist.go.jp	Futaba, Don /C-8294-2009		Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)	We thank S. Yamada, M. Nishimura, R. Hikosaka, M. Fujii, and M. Suzuki for assistance in making FETs, S. Chandramouli for assistance in making ion-gel, K. Kobashi for assistance in robust test by car. We also thank K. Hyung and D. Frisbie for discussions of ion-gel, I. Laszczyk for his contribution to photographs, 2D, and 3D figures. This work was partially supported by Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST).	Okimoto H, 2010, ADV MATER, V22, P3981, DOI 10.1002/adma.201000889; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Ata S, 2012, NANO LETT, V12, P2710, DOI 10.1021/nl204221y; Son D, 2014, NAT NANOTECHNOL, V9, P397, DOI [10.1038/nnano.2014.38, 10.1038/NNANO.2014.38]; Lau PH, 2013, NANO LETT, V13, P3864, DOI 10.1021/nl401934a; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Shin M, 2014, ADV MATER, V26, P3706, DOI 10.1002/adma.201400009; Xiao L, 2008, NANO LETT, V8, P4539, DOI 10.1021/nl802750z; Ihara K, 2011, J PHYS CHEM C, V115, P22827, DOI 10.1021/jp2071474; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Xu S, 2014, SCIENCE, V344, P70, DOI 10.1126/science.1250169; Toups MA, 2011, MOL BIOL EVOL, V28, P29, DOI 10.1093/molbev/msq234; Ha MJ, 2010, ACS NANO, V4, P4388, DOI 10.1021/nn100966s; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/nnano.2011.184, 10.1038/NNANO.2011.184]; Hu LB, 2010, NANO LETT, V10, P708, DOI 10.1021/nl903949m; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/nmat2459, 10.1038/NMAT2459]; Lee KH, 2012, ADV MATER, V24, P4457, DOI 10.1002/adma.201200950; Zhao JW, 2012, J MATER CHEM, V22, P2051, DOI 10.1039/c1jm14773k; Snow ES, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1854721; Chortos A, 2014, ADV MATER, V26, P4253, DOI 10.1002/adma.201305462; Chae SH, 2013, NAT MATER, V12, P403, DOI [10.1038/nmat3572, 10.1038/NMAT3572]; Brandrup J, 2003, POLYM HDB; Howatson A. M., 1991, ENG TABLES DATA, V2nd; Nobusa Y, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3657502; Rogers JA, 2014, MRS BULL, V39, P549, DOI 10.1557/mrs.2014.102; Saito T, 2005, J PHYS CHEM B, V109, P10647, DOI 10.1021/jp044200z; Sajed F, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824475; Sun DM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3302; Xu F, 2014, NANO LETT, V14, P682, DOI 10.1021/nl403941a; Zavodchikova MY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085201	31	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	SEP	2015	15	9					5716	5723		10.1021/acs.nanolett.5b01458		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CR3SF	WOS:000361252700008		
J	Saito, H; Yamamoto, N				Saito, Hikaru; Yamamoto, Naoki			Control of Light Emission by a Plasmonic Crystal Cavity	NANO LETTERS			English	Article						Surface plasmon-polariton; plasmonic crystal; plasmonic bandgap; cavity; cathodoluminescence; scanning transmission electron microscopy	SIZE DEPENDENCE; BAND-GAP; NANOLASER; LATTICE; SCALE; MODES	Surface plasmon-polaritons (SPPs) localized inside a plasmonic crystal (PIC) cavity are probed by STEM-CL technique to characterize the influence of the surface shape parameters on the cavity modes. The results elucidate the formation mechanism of the cavity mode in terms of the symmetry and quality factor, which provide a clear design guide for the PIC cavity to control the coupling between SPPs and photons in plasmonic devices and future integrated circuits.	[Saito, Hikaru; Yamamoto, Naoki] Tokyo Inst Technol, Quantum Nanoelect Reserch Ctr, Meguro Ku, Tokyo 1528551, Japan; [Yamamoto, Naoki] Tokyo Inst Technol, Dept Condensed Matter Phys, Meguro Ku, Tokyo 1528551, Japan; [Saito, Hikaru] Kyushu Univ, Ctr Adv Instrumental Anal, Kasuga, Fukuoka 8168580, Japan; [Yamamoto, Naoki] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Saito, H (reprint author), Tokyo Inst Technol, Quantum Nanoelect Reserch Ctr, Meguro Ku, Tokyo 1528551, Japan.	saito.hikaru.961@m.kyushu-u.ac.jp; yamamoto.n.ac@m.titech.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Nanotechnology Platform [12025014]	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Nanotechnology Platform 12025014.	Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Boudarham G, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245447; Bozhevolnyi SI, 2001, PHYS REV LETT, V86, P3008, DOI 10.1103/PhysRevLett.86.3008; Gong YY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2431450; Watanabe H, 2014, OPT EXPRESS, V22, P5155, DOI 10.1364/OE.22.005155; Ma RM, 2011, NAT MATER, V10, P110, DOI 10.1038/nmat2919; Kociak M, 2014, CHEM SOC REV, V43, P3865, DOI 10.1039/c3cs60478k; Le Thomas N, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155314; Barnes WL, 1996, PHYS REV B, V54, P6227, DOI 10.1103/PhysRevB.54.6227; Lu YJ, 2012, SCIENCE, V337, P450, DOI 10.1126/science.1223504; Takeuchi K, 2011, OPT EXPRESS, V19, P12365, DOI 10.1364/OE.19.012365; van Beijnum F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.206802; Gramotnev DK, 2010, NAT PHOTONICS, V4, P83, DOI 10.1038/nphoton.2009.282; Saito H, 2015, OPT EXPRESS, V23, P2524, DOI 10.1364/OE.23.002524; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; PURCELL EM, 1946, PHYS REV, V69, P681; Suzuki T, 2009, OPT EXPRESS, V17, P23664, DOI 10.1364/OE.17.023664; Lakhani AM, 2011, OPT EXPRESS, V19, P18237, DOI 10.1364/OE.19.018237; Yamamoto N, 2014, OPT EXPRESS, V22, P29761, DOI 10.1364/OE.22.029761; Knight MW, 2012, NANO LETT, V12, P6000, DOI 10.1021/nl303517v; Zhou W, 2013, NAT NANOTECHNOL, V8, P506, DOI [10.1038/nnano.2013.99, 10.1038/NNANO.2013.99]; Russell KJ, 2012, NAT PHOTONICS, V6, P459, DOI [10.1038/nphoton.2012.112, 10.1038/NPHOTON.2012.112]; Honda M, 2013, OPT EXPRESS, V21, P11973, DOI 10.1364/OE.21.011973; Sapienza R, 2012, NAT MATER, V11, P781, DOI [10.1038/nmat3402, 10.1038/NMAT3402]; de Abajo FJG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.106804; Kitson SC, 1996, PHYS REV LETT, V77, P2670, DOI 10.1103/PhysRevLett.77.2670; Kuttge M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.113405; Liu TL, 2014, OPT EXPRESS, V22, P8219, DOI 10.1364/OE.22.008219; Lozano G, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.22; Maier S. A., 2007, PLASMONICS FUNDAMENT; Palik E. D., 1985, HDB OPTICAL CONSTANT	31	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	SEP	2015	15	9					5764	5769		10.1021/acs.nanolett.5b01719		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CR3SF	WOS:000361252700015		
J	Karasawa, K				Karasawa, Kazutomo			THE MENOLOGIUM AND MAXIMS II IN THE MANUSCRIPT CONTEXT	NOTES AND QUERIES			English	Article									Komazawa Univ, Tokyo, Japan	Karasawa, K (reprint author), Komazawa Univ, Tokyo, Japan.						Bately J., 1980, EETS SS, V6; Bollard J. K., 1973, NEOPHILOLOGUS, Vlvii, P179, DOI 10.1007/BF01514330; Conner P. W., 1996, ANGLOSAXON CHRONICLE, V10, pxix; Dobbie Elliot V. K., 1942, ANGLOSAXON POETIC R, V6; Fulk R. D., 2003, HIST OLD ENGLISH LIT, P133; Gneuss H., 2001, HANDLIST ANGLOSAXON, P68; Harrison K., 1976, FRAMEWORK ANGLOSAXON, P124; Head Pauline, 1999, MEDIEVAL CHRONICLE, P155; Jorgensen A., 2010, READING ANGLOSAXON C, P1; Ker N. R., 1957, CATALOGUE MANUSCRIPT, P251; O'Keeffe K. O'Brien, 2001, ANGLOSAXON CHRONICLE, V5; O'Keeffe K. O'Brien, 1998, ANGLOSAXON MANUSCRIP, p[137, 138]; Plummer C., 1952, 2 SAXON CHRONICLES P, VII, P273; Robinson Fred C., 1980, OLD ENGLISH LIT CONT, P11; Shippey T., 1976, POEMS WISDOM LEARNIN, P15; Swanton M. J., 1996, ANGLOSAXON CHRONICLE, pxxiv; Whitbread L., 1947, STUDIA NEOPHILOLOGIC, Vxx, P192, DOI 10.1080/00393274708587010; Williams B. C., 1914, GNOMIC POETRY ANGLOS, P103	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0029-3970	1471-6941		NOTES QUERIES	Notes Queries	SEP	2015	62	3					353	356		10.1093/notesj/gjv114		4	Literature	Literature	CR4NI	WOS:000361309800001		
J	Taguchi, M				Taguchi, Mayumi			A HITHERTO UNIDENTIFIED MIDDLE ENGLISH TRANSLATION OF 'LES QUATRE REQUETES DE NOTRE-DAME A JESUS'	NOTES AND QUERIES			English	Article									Osaka Sangyo Univ, Daito, Osaka, Japan	Taguchi, M (reprint author), Osaka Sangyo Univ, Daito, Osaka, Japan.						[Anonymous], 1857, CATALOGUE MANUSCRIPT, VII, p[534, 171]; Bazire J., 1957, CHASTISING GODS CHIL, P104; Bordier J.-P., 1999, EC DIALOGUE ANCIEN T, P187; Bynum C. W., 1982, JESUS MOTHER STUDIES, P110; Darker William, 2011, MEDIEVAL MANUSCRIPTS, p[199, 200]; Doyle A. I., 1953, THESIS U CAMBRIDGE, VII, P240; DuBruck, 1986, MICHIGAN ACAD, Vxviii, P95; DuBruck Edelgard, 1990, PASSION ISABEAU EDIT; Feuillet A., 1984, STUDIES IN SCRIPTURE, P8; Fischer C., 1932, ARCH FRANCISCANUM HI, V25, P3; Fischer C., 1932, ARCH FRANCISCANUM HI, V25, P175; Fischer C., 1932, ARCH FRANCISCANUM HI, V25, P305; Fischer C., 1932, ARCH FRANCISCANUM HI, V25, P449; Hanna R., 2010, ENGLISH MANUSCRIPTS, P12; Hanna R., 2010, ENGLISH MANUSCRIPTS, P8; Hasenohr G., 1981, ROMANIA, Vcii, P353; Hasenohr G., 1992, REV LINGUIST ROMAN, Vlvi, P312; Horobin Simon, 2014, MIDDLE ENGLISH TEXTS, P177; Horrox R., 1994, 15TH-CENTURY ATTITUD, P188; Kinsley D., 1989, GODDESSES MIRROR VIS, P226; McKitterick R., 1992, CATALOGUE PEPYS LI 1, Vv, P54; Paris G., 1878, MYSTERE PASSION A GR, P215; Peltier A. C., 1868, MEDITATIONES VITAE C, VXII, P509; Pepysian The, 2014, DEVOTIONAL CULTURE L, P487; Ragusa I., 1961, MEDITATIONS LIFE CHR, P309; Roy Emile, 1904, MYSTERE PASSION FRAN, P251; Ruh K., 1950, THEOLOGISCHE Z, Viv, p[17, 32]; Spretnak C., 2004, MISSING MARY QUEEN H, P154; Towl Elizabeth, 2010, THESIS U OTAGO DUNED, P311; Waller G., 2011, VIRGIN MARY LATE MED, P190	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0029-3970	1471-6941		NOTES QUERIES	Notes Queries	SEP	2015	62	3					364	372		10.1093/notesj/gjv111		10	Literature	Literature	CR4NI	WOS:000361309800005		
J	Karasawa, T; Takahashi, S				Karasawa, Toshihiko; Takahashi, Shigeru			Introduction of various cover crop species to improve soil biological P parameters and P uptake of the following crops	NUTRIENT CYCLING IN AGROECOSYSTEMS			English	Article						Cover crop; Phosphorus; P-solubilizing fungi; Biomass P; Wheat; Soybean	MICROBIAL BIOMASS PHOSPHORUS; ARBUSCULAR MYCORRHIZAL FUNGI; GUINEA SAVANNA ZONE; GREEN MANURE; REPRESENTATIVE TOPOSEQUENCE; MANAGEMENT-PRACTICES; MINERAL NITROGEN; WEED SUPPRESSION; ORGANIC-MATTER; ROCK PHOSPHATE	Field experiments were conducted to clarify whether the introduction of several cover crop species increases P uptake of the following wheat and soybean. Four summer cover crops (sorghum, buckwheat, groundnut and crotalaria) and four winter cover crops (oat, rye, vetch and lupin) were tested. Growth and P uptake of succeeding wheat were significantly increased by P fertilizer application and tended to be increased by sorghum, groundnut or crotalaria incorporation, whereas buckwheat did not show positive effects. Growth and P uptake of succeeding soybean were significantly increased by oat or vetch incorporation and tended to be increased by P fertilizer or other cover crop incorporation. These positive effects of cover crops were attributed to the large amount of P incorporation, increase in the P-solubilizing fungal population and/or biomass P in soil. Sorghum, oat, rye and vetch were thought to be suitable cover crops to accelerate P uptake of the following crops since a large amount of P would be incorporated. Sorghum, groundnut and lupin were thought to be suitable cover crops because they increased the indigenous P-solubilizing fungal population in soil. Soil biomass P correlated with P uptake of wheat. Incorporation of suitable cover crops as a P source and activation of indigenous soil microorganisms by the carbon supply were thought to have accelerated P uptake of the following wheat and soybean. It is therefore thought that introduction of suitable cover crops could be an effective means to reduce P fertilizer application for the following crops.	[Karasawa, Toshihiko; Takahashi, Shigeru] NARO, Agr Res Ctr, Soil Sci & Plant Nutr Div, Tsukuba, Ibaraki 3058666, Japan	Karasawa, T (reprint author), NARO, Agr Res Ctr, Soil Sci & Plant Nutr Div, 3-1-1 Kannondai, Tsukuba, Ibaraki 3058666, Japan.	tkarasaw@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This work was partly supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Development of mitigation and adaptation techniques to global warming in the sectors of agriculture, forestry, and fisheries). We thank Ms. Noriko Tayama and Ms. Emi Doi for technical help with plant and soil analysis. We also thank Mr. Ichiro Ameta and Mr. Yuji Horiuchi for management of the experimental field. We thank Dr. Takayuki Mitsunaga for suggestions on statistical analysis.	Russelle MP, 2007, AGRON J, V99, P325, DOI 10.2134/agronj2006.0139; Larkin RP, 2011, PLANT DIS, V95, P568, DOI 10.1094/PDIS-09-10-0670; Fraser PM, 2013, SOIL SCI SOC AM J, V77, P1391, DOI 10.2136/sssaj2012.0256; MCCRACKEN DV, 1994, SOIL SCI SOC AM J, V58, P1476; BRAUM SM, 1995, PLANT SOIL, V176, P95, DOI 10.1007/BF00017679; Steenwerth K, 2008, APPL SOIL ECOL, V40, P359, DOI 10.1016/j.apsoil.2008.06.006; Stutter MI, 2012, ENVIRON SCI TECHNOL, V46, P1977, DOI 10.1021/es2044745; Hansen ZR, 2013, APPL SOIL ECOL, V63, P67, DOI [10.1016/j.apsoi1.2012.09.007, 10.1016/j.apsoil.2012.09.007]; Chabot R, 1996, PLANT SOIL, V184, P311, DOI 10.1007/BF00010460; Vassilev N, 2006, APPL MICROBIOL BIOT, V71, P137, DOI 10.1007/s00253-006-0380-z; Ruiz-Colmenero M, 2013, CATENA, V104, P153, DOI 10.1016/j.catena.2012.11.007; Abawi GS, 2000, APPL SOIL ECOL, V15, P37, DOI 10.1016/S0929-1393(00)00070-6; Kamh M, 1999, PLANT SOIL, V211, P19, DOI 10.1023/A:1004543716488; Karasawa T, 2012, PLANT SOIL, V353, P355, DOI 10.1007/s11104-011-1036-z; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; KOUNO K, 1995, SOIL BIOL BIOCHEM, V27, P1353, DOI 10.1016/0038-0717(95)00057-L; Kristensen HL, 2004, SOIL SCI SOC AM J, V68, P529; HUE NV, 1991, SOIL SCI, V152, P463, DOI 10.1097/00010694-199112000-00009; EARL KD, 1979, SOIL SCI SOC AM J, V43, P674; SHIPLEY PR, 1992, AGRON J, V84, P869; Unger PW, 1998, J SOIL WATER CONSERV, V53, P200; Elfstrand S, 2007, APPL SOIL ECOL, V36, P70, DOI 10.1016/j.apsoil.2006.11.001; Ding GW, 2006, GEODERMA, V130, P229, DOI 10.1016/j.geoderma.2005.01.019; Jokela WE, 2009, AGRON J, V101, P727, DOI 10.2134/agronj2008.0191; Kruidhof HM, 2011, WEED RES, V51, P177, DOI 10.1111/j.1365-3180.2010.00825.x; Lawley YE, 2012, AGRON J, V104, P205, DOI 10.2134/agronj2011.0128; Richardson AE, 2011, PLANT PHYSIOL, V156, P989, DOI 10.1104/pp.111.175448; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Horst WJ, 2001, PLANT SOIL, V237, P211, DOI 10.1023/A:1013353610570; Pearse SJ, 2007, NEW PHYTOL, V173, P181, DOI 10.1111/j.1469-8137.2006.01897.x; Gabriel JL, 2012, AGR ECOSYST ENVIRON, V155, P50, DOI 10.1016/j.agee.2012.03.021; Spohn M, 2013, SOIL BIOL BIOCHEM, V61, P69, DOI 10.1016/j.soilbio.2013.02.013; Randhawa PS, 2005, NUTR CYCL AGROECOSYS, V73, P181, DOI 10.1007/s10705-005-0593-z; Blanco-Canqui H, 2012, AGRON J, V104, P137, DOI 10.2134/agronj2011.0240; BLEVINS RL, 1990, AGRON J, V82, P769; Brozyna MA, 2013, AGR ECOSYST ENVIRON, V181, P115, DOI 10.1016/j.agee.2013.09.013; Cavigelli MA, 2003, SOIL SCI SOC AM J, V67, P1186; Cordell D, 2011, SUSTAINABILITY-BASEL, V3, P2027, DOI 10.3390/su3102027; Crow WT, 2001, J NEMATOL, V33, P285; Dao TH, 2015, NUTR CYCL AGROECOSYS, V101, P153, DOI 10.1007/s10705-014-9665-2; Goto S., 1997, Japanese Journal of Soil Science and Plant Nutrition, V68, P640; Fowler CJE, 2004, NEW ZEAL J AGR RES, V47, P95; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gu S, 2002, JPN J FARM WORK RES, V37, P13; Ishii T., 1974, Journal of the Science of Soil and Manure, Japan (Nippon Dojohiryogaku Zasshi), V45, P505; ILLMER P, 1995, SOIL BIOL BIOCHEM, V27, P265, DOI 10.1016/0038-0717(94)00205-F; Karasawa T, 2002, SOIL BIOL BIOCHEM, V34, P851, DOI 10.1016/S0038-0717(02)00017-2; Karasawa T, 2000, SOIL SCI PLANT NUTR, V46, P53; Kasuya Masahiro, 2010, Research Bulletin of the Aichi-ken Agricultural Research Center, P141; KUCEY RMN, 1983, CAN J SOIL SCI, V63, P671; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158; Pypers P, 2005, SOIL BIOL BIOCHEM, V37, P163, DOI 10.1016/j.soilbio.2004.06.018; Sharifi M, 2014, NUTR CYCL AGROECOSYS, V100, P135, DOI 10.1007/s10705-014-9633-x; Sugito T, 2010, SOIL SCI PLANT NUTR, V56, P390, DOI 10.1111/j.1747-0765.2010.00483.x; Takahashi S, 2007, FIELD CROP RES, V101, P160, DOI 10.1016/j.fcr.2006.11.003; Takeda M, 2009, APPL SOIL ECOL, V42, P86, DOI [10.1016/j.apsoi1.2009.02.003, 10.1016/j.apsoil.2009.02.003]; Thomsen IK, 2014, SOIL USE MANAGE, V30, P48, DOI 10.1111/sum.12083; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; Truog E., 1930, AGRON J, V22, P874, DOI DOI 10.2134/AGRONJ1930.00021962002200100008X; Vanlauwe B, 2000, SOIL BIOL BIOCHEM, V32, P2079, DOI 10.1016/S0038-0717(00)00150-4; Vanlauwe B, 2000, SOIL BIOL BIOCHEM, V32, P2063, DOI 10.1016/S0038-0717(00)00149-8; Wasaki J, 2008, SOIL SCI PLANT NUTR, V54, P95, DOI 10.1111/j.1747-0765.2007.00207.x; Wyland LJ, 1996, AGR ECOSYST ENVIRON, V59, P1, DOI 10.1016/0167-8809(96)01048-1	63	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-1314	1573-0867		NUTR CYCL AGROECOSYS	Nutr. Cycl. Agroecosyst.	SEP	2015	103	1					15	28		10.1007/s10705-015-9715-4		14	Soil Science	Agriculture	CR6DJ	WOS:000361433200002		
J	Nishina, K; Sudo, S; Yagi, K; Sano, T; Takata, Y; Obara, H; Eguchi, S; Oura, N; Yano, S; Ohkoshi, S; Fujita, Y; Shiratori, Y; Tsuji, M; Hasukawa, H; Suzue, Y; Yamada, Y; Mizukami, H; Uezono, I				Nishina, Kazuya; Sudo, Shigeto; Yagi, Kazuyuki; Sano, Tomohito; Takata, Yusuke; Obara, Hiroshi; Eguchi, Sadao; Oura, Noriko; Yano, Shinji; Ohkoshi, Satoru; Fujita, Yutaka; Shiratori, Yutaka; Tsuji, Masaki; Hasukawa, Hiroyuki; Suzue, Yasufumi; Yamada, Yasunao; Mizukami, Hiroyuki; Uezono, Ichiro			Multi-site monitoring for emission factors of synthetic fertilizer in various soils with different redoximorphic features across Japan	NUTRIENT CYCLING IN AGROECOSYSTEMS			English	Article						Nitrous oxide; Emission factor; Fertilizer induced emission factor; Synthetic fertilizer; Numerical soil classification	NITROUS-OXIDE EMISSIONS; AGRICULTURAL SOILS; N2O EMISSIONS; SUBSURFACE DRAINAGE; AVAILABLE DATA; FIELD; DENITRIFICATION; MANAGEMENT; REDUCTION; LYSIMETER	The use of N fertilizers for agricultural production acts as a sources of atmospheric . Fertilizer induced emission considerably varies in accordance with environmental factors. We conducted a flux measurement campaign across 10 different experimental sites with various soil types throughout Japan and investigated the fertilizer induced emission factors (FIEFs) of synthetic fertilizers (mainly urea) in multiple growing periods at each experimental site. FIEFs considerably varied among the 10 sites, and measurement periods ranged from 0.00 to 7.13 % in 40 total observations. Soil profile information divided the experimental sites into two major groups through cluster analysis, which are volcanic or non-volcanic soils. According to this classification, FIEFs were clearly differentiated into high and low FIEF groups (mean values: 2.67 and 0.59 %, respectively). Regression trees selected total soil carbon, the depth to the Fe mottling horizon, and mean air temperature as the key parameters to determine the strength of FIEFs out of 10 explanatory variables (e.g., N fertilizer application rates, fertilizer application times, clay content, total precipitation during measurement periods, pH, total soil carbon, and total soil nitrogen). The existence of shallow Fe mottling layer (up to 42.5 cm) induced high FIEFs in this model, suggesting that upward emissions derived from the intermediate Fe mottling layers presumably contributed high emissions in such soils. Our results suggest that the soil profile information associated with the water regime is an important index for synthetic fertilizer induced emissions.	[Nishina, Kazuya; Sudo, Shigeto; Yagi, Kazuyuki; Sano, Tomohito; Takata, Yusuke; Obara, Hiroshi; Eguchi, Sadao; Oura, Noriko] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Sano, Tomohito] NARO Inst Vegetable & Tea Sci, Shimada 4288501, Japan; [Yano, Shinji] Yamagata Integrated Agr Res Ctr, Yamagata, Yamagata 9902372, Japan; [Ohkoshi, Satoru] Fukushima Agr Technol Ctr, Koriyama, Fukushima 9630531, Japan; [Fujita, Yutaka] Ibaraki Agr Ctr, Inst Hort, Kasama, Ibaraki 3190292, Japan; [Shiratori, Yutaka] Niigata Agr Res Inst, Nagaoka, Niigata 9400826, Japan; [Tsuji, Masaki] Aichi Agr Res Ctr, Nagakute, Aichi 4801193, Japan; [Hasukawa, Hiroyuki] Shiga Prefecture Agr Technol Promot Ctr, Ohmihachiman, Shiga 5211301, Japan; [Suzue, Yasufumi] Tokushima Agr Forestry & Fisheries Technol Suppor, Tokushima 7793233, Japan; [Yamada, Yasunao] Nagasaki Agr & Forestry Tech Dev Ctr, Isahaya, Nagasaki 8540063, Japan; [Mizukami, Hiroyuki] Kumamoto Prefectural Agr Res Ctr, Koushi, Kumamoto 8611113, Japan; [Uezono, Ichiro] Kagoshima Prefectural Inst Agr Dev, Minami Satsuma, Kagoshima 8993401, Japan	Nishina, K (reprint author), Natl Inst Environm Studies, Tsukuba, Ibaraki 3058604, Japan.	kazuya.nishina@gmail.com		Nishina, Kazuya/0000-0002-8820-1282	project assessment and extension of technologies for mitigating greenhouse gas emissions from agricultural soil from the Ministry of Agriculture, Forestry and Fisheries, Japan;  [20780117];  [PD22-5033]	We appreciate all of the participants of the MAFF project. This work was supported by a grant under a project assessment and extension of technologies for mitigating greenhouse gas emissions from agricultural soil from the Ministry of Agriculture, Forestry and Fisheries, Japan and by Grants-in-Aid for Scientific Research (20780117, PD22-5033), Japan. We thank Professor K. Inubushi at Chiba University and Assistant Professor M. Ito at Kyoto University for valuable comments and support for flux measurement at many sites. We appreciate all support of T. Yoshida for this project. KN appreciates Dr. D. Beaudette at USDA-NRCS for developing and maintaining a great R package "aqp".	Rees RM, 2013, BIOGEOSCIENCES, V10, P2671, DOI 10.5194/bg-10-2671-2013; Jungkunst HF, 2006, J PLANT NUTR SOIL SC, V169, P341, DOI 10.1002/jpln.200521954; Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Beaudette DE, 2013, COMPUT GEOSCI-UK, V52, P258, DOI 10.1016/j.cageo.2012.10.020; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272; Akiyama H, 2006, SOIL SCI PLANT NUTR, V52, P774, DOI 10.1111/j.1747-0765.2006.00097.x; Aguilera E, 2013, AGR ECOSYST ENVIRON, V164, P32, DOI 10.1016/j.agee.2012.09.006; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Hayakawa A, 2009, SOIL BIOL BIOCHEM, V41, P521, DOI 10.1016/j.soilbio.2008.12.011; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Toma Y, 2007, SOIL SCI PLANT NUTR, V53, P692, DOI 10.1111/j.1747-0765.2007.00184.x; Shiratori Y, 2007, SOIL SCI PLANT NUTR, V53, P387, DOI 10.1111/j.1747-0765.2007.00171.x; Kampschreur MJ, 2011, WATER RES, V45, P5945, DOI 10.1016/j.watres.2011.08.056; Dobbie KE, 2003, GLOBAL CHANGE BIOL, V9, P204, DOI 10.1046/j.1365-2486.2003.00563.x; Minamikawa K, 2013, SOIL SCI PLANT NUTR, V59, P87, DOI 10.1080/00380768.2012.740606; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Henault C, 1998, BIOL FERT SOILS, V26, P199, DOI 10.1007/s003740050368; Beaudette D.E., 2012, ALGORITHMS QUANTITAT; Berdanier AB, 2012, GLOBAL CHANGE BIOL, V18, P928, DOI 10.1111/j.1365-2486.2011.02554.x; Bouma J, 1999, SOIL SCI SOC AM J, V63, P1763; Chesworth W, 2008, ENCY SOIL SCI, P363, DOI 10.1007/978-1-4020-3995-9_302; Freney J. R., 1983, Gaseous loss of nitrogen from plant-soil systems, P1; Gee G. W., 1986, METHODS SOIL ANAL, V1, P383; Hayatsu M, 2008, SOIL SCI PLANT NUTR, V54, P33, DOI 10.1111/j.1747-0765.2007.00195.x; Intergovernmental Panel for Climate Change (IPCC), 2006, 2006 IPCC GUIDELINES, V4; IPCC, 2013, CLIM CHANG 2013 PHYS; Minamikawa K, 2011, SOIL SCI PLANT NUTR, V57, P719, DOI 10.1080/00380768.2011.625556; Nishina K, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002157; Penman J, 2000, GOOD PRACTICE GUIDAN; Plummer M., 2013, RJAGS BAYESIAN GRAPH; Reay D.S., 2005, ENV SCI, V2, P153, DOI DOI 10.1080/15693430500415525; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258; Verheye W, 2009, LAND COVER LAND USE; Zheng XH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002167	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-1314	1573-0867		NUTR CYCL AGROECOSYS	Nutr. Cycl. Agroecosyst.	SEP	2015	103	1					87	99		10.1007/s10705-015-9723-4		13	Soil Science	Agriculture	CR6DJ	WOS:000361433200007		
J	Temporin, K; Namba, J; Okamoto, M; Yamamoto, K				Temporin, K.; Namba, J.; Okamoto, M.; Yamamoto, K.			Diagnostic arthroscopy in the treatment of minimally displaced lateral humeral condyle fractures in children	ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH			English	Article						Arthroscopy; Lateral humeral condyle fracture; Children; Plain radiography	ELBOW ARTHROSCOPY; STABILITY	Introduction: In minimally displaced pediatric lateral humeral condyle fractures, plain radiography cannot be used for accurate differential diagnosis of the cartilage lesion, and other imaging methods have demerits in their accuracy and their accessibility. The purpose of this study was to investigate the usefulness of arthroscopy to diagnose cartilage displacement in minimally displaced fractures. Materials and methods: Nine children with minimally displaced lateral humeral condyle fractures, an average of 6.6 years old, underwent combined arthroscopy and fixation surgery. Percutaneous fixation was performed with nondisplaced articular surface according to the arthroscopic findings, while in case of displaced fracture under arthroscopy, open fixation was preferred. The difference between the arthroscopic and radiographic findings was investigated. Results: Articular surface could be arthroscopically visualized in all patients. Under arthroscopy, cartilage hinges were maintained in seven cases and disrupted in two. Nondisplaced cartilage disruption was noted in one of these two cases, and percutaneous fixation was performed. A displaced articular surface was noted in the other one, where the patient underwent open surgery. At the last follow-up, an average of 14.7 months postoperatively, union and wide range of motion had been achieved without any complications. Conclusion: Diagnosis of fracture displacement by merely using plain radiography was considered to be insufficient for minimally displaced cases. Diagnostic arthroscopy aided in the appropriate selection of either a percutaneous or open fixation method. Level of evidence: Level IV, therapeutic case series. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Temporin, K.] Osaka Hosp, Japan Community Hlth Care Org, Dept Orthopaed Surg, Osaka, Osaka 5530003, Japan; [Namba, J.; Okamoto, M.; Yamamoto, K.] Toyonaka City Hosp, Dept Orthopaed Surg, Toyonaka, Osaka, Japan	Temporin, K (reprint author), Osaka Hosp, Japan Community Hlth Care Org, Dept Orthopaed Surg, 4-2-78 Fukushima,Fukushima Ward, Osaka, Osaka 5530003, Japan.	ko-tempo@umin.ac.jp					ANGELO RL, 1993, ORTHOPEDICS, V16, P1037; Micheli LJ, 2001, ARTHROSCOPY, V17, P694, DOI 10.1053/jars.2001.25338; FLYNN JC, 1975, J BONE JOINT SURG AM, V57, P1087; Marcheix PS, 2011, ORTHOP TRAUMATOL-SUR, V97, P304, DOI 10.1016/j.otsr.2010.10.007; Hausman MR, 2007, J PEDIATR ORTHOPED, V27, P739, DOI 10.1097/BPO.0b013e3181558ac5; Launay F, 2004, J PEDIATR ORTHOPED, V24, P385; Kelly EW, 2001, J BONE JOINT SURG AM, V83A, P25; SALTER RB, 1963, J BONE JOINT SURG AM, V45, P587; Chapman VM, 2005, J COMPUT ASSIST TOMO, V29, P842, DOI 10.1097/01.rct.0000175504.64707.e3; Dumonski ML, 2006, ARTHROSCOPY, V22, P705; FINNBOGASON T, 1995, J PEDIATR ORTHOPED, V15, P422; FLYNN JC, 1989, J PEDIATR ORTHOPED, V9, P691; Bast SC, 1998, J PEDIATR ORTHOPED, V18, P448; Horn BD, 2002, J PEDIATR ORTHOPED, V22, P8, DOI 10.1097/00004694-200201000-00003; JAKOB R, 1975, J BONE JOINT SURG BR, V57, P430; Kamegaya M, 1999, J Pediatr Orthop, V19, P570, DOI 10.1097/00004694-199909000-00002; Knutsen Ashleen, 2014, J Child Orthop, V8, P83, DOI 10.1007/s11832-014-0553-8; MARZO JM, 1990, J PEDIATR ORTHOPED, V10, P317; Perez Carro I, 2007, ARTHROSCOPY, V23, pe1; Rosenberg Brett M, 2007, Bull NYU Hosp Jt Dis, V65, P43; Song KS, 2007, J BONE JOINT SURG AM, V89A, P58, DOI 10.2106/JBJS.E.01387; Vocke-Hell AK, 2001, J PEDIATR ORTHOP B, V10, P138, DOI 10.1097/00009957-200104000-00011; Zhang Jing-dong, 2008, Chin J Traumatol, V11, P297, DOI 10.1016/S1008-1275(08)60060-7	23	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0568			ORTHOP TRAUMATOL-SUR	Orthop. Traumatol.-Surg. Res.	SEP	2015	101	5					593	596		10.1016/j.otsr.2015.04.003		4	Orthopedics; Surgery	Orthopedics; Surgery	CR3OG	WOS:000361242000014		
J	Ain, Q; Naveed, M; Mumtaz, AS; Farman, M; Ahmed, I; Khalid, N				Ain, Quratul; Naveed, Muhammad; Mumtaz, Abdul Samad; Farman, Muhammad; Ahmed, Iftikhar; Khalid, Nauman			Phytochemical analysis of Hibiscus caesius using high performance liquid chromatography coupled with mass spectrometry	PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						H. caesius; Phytochemicals; medicinal value; HPLC-MS	ANTIMICROBIAL ACTIVITY; PHENOLIC-ACIDS; DIABETIC-RATS; SABDARIFFA; ANTIOXIDANT; EXTRACTS; FLAVONOIDS; APIGENIN; CHOLESTEROL; GLYCOSIDES	Various species in genus Hibiscus are traditionally known for their therapeutic attributes. The present study focused on the phytochemical analysis of a rather unexplored species Hibiscus caesius (H. caesius), using high-pressure liquid chromatography coupled with mass spectrometry (HPLC-MS). The analysis revealed five major compounds in the aqueous extract, viz. vanillic acid, protocatechoic acid, quercetin, quercetin glucoside and apigenin, being reported for the first time in H. caesius. Literature suggests that these compounds have important pharmacological traits such as anticancer, anti-inflammatory, anti-bacterial and hepatoprotective etc. however, this requires further pharmacological investigations at in vitro and in vivo scale. The above study concluded the medicinal potential of H. caesius.	[Ain, Quratul; Naveed, Muhammad; Mumtaz, Abdul Samad] Quaid I Azam Univ, Dept Plant Sci, Islamabad, Pakistan; [Farman, Muhammad] Quaid I Azam Univ, Dept Chem, Islamabad, Pakistan; [Ahmed, Iftikhar] NARC, NIGAB, Islamabad, Pakistan; [Khalid, Nauman] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Khalid, N (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	asmumtaz@qau.edu.pk; nauman_khalid120@yahoo.com					Agoreyo FO, 2008, AFR J BIOTECHNOL, V7, P3949; Kong JM, 2003, PHYTOCHEMISTRY, V64, P923, DOI 10.1016/S0031-9422(03)00438-2; Mohd-Esa N, 2010, FOOD CHEM, V122, P1055, DOI 10.1016/j.foodchem.2010.03.074; Galati G, 1999, CHEM RES TOXICOL, V12, P521, DOI 10.1021/tx980271b; Gilani AH, 2005, J ETHNOPHARMACOL, V102, P289, DOI 10.1016/j.jep.2005.07.023; Akim A, 2011, AFR J PHARM PHARMACO, V5, P957; Prenesti E, 2007, FOOD CHEM, V100, P433, DOI 10.1016/j.foodchem.2005.09.063; Lepley DM, 1996, CARCINOGENESIS, V17, P2367, DOI 10.1093/carcin/17.11.2367; Sini JM, 2011, J MED PLANTS RES, V5, P2182; Chen HJ, 2012, INT J MOL SCI, V13, P260, DOI 10.3390/ijms13010260; Chao CY, 2009, FOODBORNE PATHOG DIS, V6, P201, DOI 10.1089/fpd.2008.0187; Lin WL, 2003, ARCH TOXICOL, V77, P42, DOI 10.1007/s00204-002-0404-0; Ali BH, 2005, PHYTOTHER RES, V19, P369, DOI 10.1002/ptr.1628; Lin TL, 2007, NUTR RES, V27, P140, DOI 10.1016/j.nutres.2007.01.007; Chiang LC, 2003, PLANTA MED, V69, P600, DOI 10.1055/s-2003-41113; Asolkar LV, 1992, CHOPRA GLOSSARY 1 S, P1965; Birt DF, 1997, ANTICANCER RES, V17, P85; Chen JJ, 2006, PLANTA MED, V72, P935, DOI 10.1055/s-2006-931604; Farombi EO, 2007, FUND CLIN PHARMACOL, V21, P601, DOI 10.1111/j.1472-8206.2007.00525.x; Fernandez MA, 1998, J PHARM PHARMACOL, V50, P1183; Fullerton M, 2011, J MED FOOD, V14, P950, DOI 10.1089/jmf.2010.0200; Gauthaman Karunakaran K, 2006, BMC Complement Altern Med, V6, P32, DOI 10.1186/1472-6882-6-32; Laikangbam R, 2012, UROL RES, V40, P211, DOI 10.1007/s00240-011-0433-3; Leal LKAM, 2011, PHYTOMEDICINE, V18, P230, DOI 10.1016/j.phymed.2010.05.012; Lin EH, 2012, FOOD CHEM, V132, P880; Mabary JJ, 1970, SYSTEMATIC IDENTIFIC; MOLYNEUX RJ, 1970, TETRAHEDRON, V26, P1409, DOI 10.1016/S0040-4020(01)92970-9; Narender K, 2009, INT J PHARM PHYTOCHE, V1, P15; Wooftisin S, 2011, J UROLOGY, V185, P323; Yadong QI, 2005, 604 AGR RES EXT CTR, P1; Yi JH, 2000, PHYTOCHEMISTRY, V53, P1001, DOI 10.1016/S0031-9422(99)00457-4; Zhang M, 2011, J MED PLANTS RES, V5, P6672, DOI 10.5897/JMPR11.621	32	0	0	UNIV KARACHI	KARACHI	UNIV CAMPUS, FAC PHARMACY, KARACHI, 75270, PAKISTAN	1011-601X			PAK J PHARM SCI	Pak. J. Pharm. Sci.	SEP	2015	28	5					1625	1629				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CR7BM	WOS:000361502900010		
J	Chishti, MA; Mohi-Ud-Din, E; Usmanghani, K; Nawaz, A; Nazar, H; Ahmad, I				Chishti, Muhammad Amjad; Mohi-Ud-Din, Ejaz; Usmanghani, Khan; Nawaz, Allah; Nazar, Halima; Ahmad, Irshad			Comparative clinical efficacy and safety of coded herbal medicine dermovix in the management of patients with atopic dermatitis versus allopathic medicine	PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						Atopic dermatitis; topical cream; clinical trials	QUALITY-OF-LIFE; HAY-FEVER; CHILDREN; ECZEMA; ASTHMA; PREVALENCE; GUIDELINES; CHILDHOOD; SYMPTOMS; CRITERIA	Atopic dermatitis (AD) is defined as a chronic, highly pruritic inflammatory condition of skin. It is estimated that this disease may lead significant morbidity and also adversely affects the quality of life. Atopic dermatitis responds well to home treatment. Proper skin care reduces the need for medicines. Topical creams and oral antihistamines can be used to suppress the symptoms. The clinical trial was conducted on 60 patients in which 30 are control and 30 are test by taking written consent from them. Dermovix significantly improved skin symptoms associated with AD. This Dermovix ointment was safe and well tolerated in specified age group patients. Overall results of individual group were analyzed by using Paired sample t-test and level of significance of all the symptoms was calculated. Both the drugs showed similar efficacy and the calculated p value was p<0.05. Except in case of dry skin the test drug had shown not significant p value i.e. 0.407. When we compare all these and their effects and patients' complaints then Test group have shown better results because of no side effects.	[Chishti, Muhammad Amjad; Mohi-Ud-Din, Ejaz; Usmanghani, Khan; Nawaz, Allah; Nazar, Halima] Hamdard Univ, Fac Eastern Med, Dept Basic Clin Sci, Karachi, Pakistan; [Usmanghani, Khan] Jinnah Univ Women, Karachi, Pakistan; [Nawaz, Allah] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Fac Med, Toyama 930, Japan; [Ahmad, Irshad] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Pakistan	Usmanghani, K (reprint author), Hamdard Univ, Fac Eastern Med, Dept Basic Clin Sci, Karachi, Pakistan.	ugk_2005@yahoo.com					Carlsten C, 2013, ANN ALLERG ASTHMA IM, V110, P24, DOI 10.1016/j.anai.2012.10.005; Kojima R, 2013, PEDIATR DERMATOL, V30, P29, DOI 10.1111/j.1525-1470.2012.01808.x; Weinmann S, 2003, PEDIATR ALLERGY IMMU, V14, P18, DOI 10.1034/j.1399-3038.2003.02085.x; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Barbeau M, 2006, INT J DERMATOL, V45, P31, DOI 10.1111/j.1365-4632.2004.02345.x; Weber TM, 2014, J DRUGS DERMATOL, V13, P589; STRACHAN DP, 1989, BRIT MED J, V299, P1259; Lawson V, 1998, BRIT J DERMATOL, V138, P107; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Boguniewicz M, 2010, J ALLERGY CLIN IMMUN, V125, P4, DOI 10.1016/j.jaci.2009.11.027; Krakowski AC, 2008, PEDIATRICS, V122, P812, DOI 10.1542/peds.2007-2232; Hon KLE, 2006, ACTA PAEDIATR, V95, P1451, DOI 10.1080/08035250600612298; von Mutius E, 1998, LANCET, V351, P862, DOI 10.1016/S0140-6736(97)10100-3; Ben-Gashir MA, 2004, BRIT J DERMATOL, V150, P284, DOI 10.1111/j.1365-2133.2004.05776.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Gu H, 2001, BRIT J DERMATOL, V145, P428, DOI 10.1046/j.1365-2133.2001.04379.x; Hanifin JM, 2004, J AM ACAD DERMATOL, V50, P391, DOI 10.1016/j.jaad.2003.08.003; McKenna SP, 2008, CURR OPIN ALLERGY CL, V8, P228, DOI 10.1097/ACI.0b013e3282ffd6cc; O'Connell EJ, 2004, ALLERGY, V59, P7, DOI 10.1111/j.1398-9995.2004.00563.x; Olesen AB, 1997, BRIT MED J, V314, P1003; Schultz LF, 1992, ACTA DERM-VENEREOL, V176, P7; Spergel JM, 2003, J ALLERGY CLIN IMMUN, V112, pS128; SVENSSON A, 1985, ACTA DERM-VENEREOL, P33	24	0	0	UNIV KARACHI	KARACHI	UNIV CAMPUS, FAC PHARMACY, KARACHI, 75270, PAKISTAN	1011-601X			PAK J PHARM SCI	Pak. J. Pharm. Sci.	SEP	2015	28	5					1655	1663				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CR7BM	WOS:000361502900014		
J	Kurotsu, M; Yajima, M; Takahashi, M; Ogawa, E; Arai, T				Kurotsu, Mariko; Yajima, Masahiro; Takahashi, Mei; Ogawa, Emiyu; Arai, Tsunenori			Evaluation of human and bovine serum albumin on oxidation characteristics by a photosensitization reaction under complete binding of talaporfin sodium	PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY			English	Article						Extra-cellular photosensitization reaction; Talaporfin sodium; Human serum albumin; Bovine serum albumin; Oxidation characteristics; Therapeutic interaction	PHOTODYNAMIC THERAPY; ACID; SITES	Background: In order to investigate the therapeutic interaction of an extra-cellular photosensitization reaction, we evaluated the oxidation characteristics of human and bovine serum albumin by this reaction with talaporfin sodium under complete binding with albumin by spectroscopic analysis in a cell-free solution. Methods: The solution was composed of 20 mu g/ml talaporfin sodium and 2.1 mg/ml human or bovine serum albumin. A 662 nm laser light was used to irradiate the solution. Visible absorbance spectra of solutions were measured to obtain the oxidized and non-oxidized relative densities of albumin and talaporfin sodium before and after the photosensitization reaction. The defined oxidation path ratio of talaporfin sodium to albumin reflected the oxidation of the solution. Absorbance wavelengths at approximately 240 and 660 nm were used to calculate normalized molecular densities of oxidized albumin and talaporfin sodium, respectively. Results and conclusions: The oxidation path ratio of talaporfin sodium to albumin when binding human serum albumin was approximately 1.8 times larger than that of bovine serum albumin during the photosensitization reaction from 1 to 50 J/cm(2). We hypothesized that the oxidation path ratio results might have been caused by talaporfin sodium binding affinity or binding location difference between the two albumins, because the fluorescence lifetimes of talaporfin sodium bound to human and bovine serum albumin were 7.0 and 4.9 ns, respectively. Therefore, the photodynamic therapeutic interaction might be stronger with human serum albumin than with bovine serum albumin in the case of extracellular photosensitization reaction. (C) 2015 Elsevier B.V. All rights reserved.	[Kurotsu, Mariko] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Yajima, Masahiro; Takahashi, Mei; Ogawa, Emiyu; Arai, Tsunenori] Keio Univ, Sch Fundamental Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Kurotsu, M (reprint author), Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	m.kurotsu@arai.appi.keio.ac.jp; m.yajima@arai.appi.keio.ac.jp; m.takahashi@arai.appi.keio.ac.jp; e.ogawa@arai.appi.kei.ac.jp; tsunearai@appi.keio.ac.jp					ALLISON BA, 1991, PHOTOCHEM PHOTOBIOL, V54, P709, DOI 10.1111/j.1751-1097.1991.tb02079.x; Magi B, 2004, CELL DEATH DIFFER, V11, P842, DOI 10.1038/sj.cdd.4401427; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Kimura T, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1025, DOI 10.1161/CIRCEP.113.000810; CISTOLA DP, 1987, J BIOL CHEM, V262, P10971; Tayyab S, 2000, BIOCHEM BIOPH RES CO, V277, P83, DOI 10.1006/bbrc.2000.3642; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; RADI R, 1991, J BIOL CHEM, V266, P4244; de Vries HE, 1999, J PHARMACOL EXP THER, V289, P528; Ni YN, 2009, SPECTROCHIM ACTA A, V71, P1865, DOI 10.1016/j.saa.2008.07.004; SPIKES JD, 1993, PHOTOCHEM PHOTOBIOL, V58, P346, DOI 10.1111/j.1751-1097.1993.tb09572.x; CISTOLA DP, 1987, J BIOL CHEM, V262, P10980; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3562, DOI 10.1021/bi00434a062; HAMILTON JA, 1984, P NATL ACAD SCI-BIOL, V81, P3718, DOI 10.1073/pnas.81.12.3718; Ishizumi T, 2004, PHOTODIAGN PHOTODYN, V1, P295, DOI 10.1016/S1572-1000(05)00002-5; Kato H, 2002, PDT HDB, V1, P1; Meiji Seika Pharma Co.  Ltd, 2014, INT FORM LAS INJ; Moore JV, 1997, PHYS MED BIOL, V42, P913, DOI 10.1088/0031-9155/42/5/012; MULLINS RJ, 1982, CIRC RES, V51, P305; Wiig H, 2000, AM J PHYSIOL-HEART C, V278, pH1627; Zhang Y, 2009, DYES PIGMENTS, V83, P174, DOI 10.1016/j.dyepig.2009.04.013	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1572-1000	1873-1597		PHOTODIAGN PHOTODYN	Photodiagnosis Photodyn. Ther.	SEP	2015	12	3					408	413		10.1016/j.pdpdt.2015.05.008		6	Oncology	Oncology	CR5SP	WOS:000361404600007		
J	Kageyama, A; Ishizaki, K; Kohchi, T; Matsuura, H; Takahashi, K				Kageyama, Akito; Ishizaki, Kimitsune; Kohchi, Takayuki; Matsuura, Hideyuki; Takahashi, Kosaku			Abscisic acid induces biosynthesis of bisbibenzyls and tolerance to UV-C in the liverwort Marchantia polymorpha	PHYTOCHEMISTRY			English	Article						Common liverwort; Marchantiophyta; Marchantia polymorpha; Abscisic acid; Bisbibenzyl; Secondary metabolite; UV-C irradiation	AGROBACTERIUM-MEDIATED TRANSFORMATION; CONSTITUENTS; MECHANISMS; EVOLUTION; THALLI; GENES; L.	Environmental stresses are effective triggers for the biosynthesis of various secondary metabolites in plants, and phytohormones such as jasmonic acid and abscisic acid are known to mediate such responses in flowering plants. However, the detailed mechanism underlying the regulation of secondary metabolism in bryophytes remains unclear. In this study, the induction mechanism of secondary metabolites in the model liverwort Marchantia polymorpha was investigated. Abscisic acid (ABA) and ultraviolet irradiation (UV-C) were found to induce the biosynthesis of isoriccardin C, marchantin C, and riccardin F, which are categorized as bisbibenzyls, characteristic metabolites of liverworts. UV-C led to the significant accumulation of ABA Overexpression of MpABI1, which encodes protein phosphatase 2C (PP2C) as a negative regulator of ABA signaling, suppressed accumulation of bisbibenzyls in response to ABA and UV-C irradiation and conferred susceptibility to UV-C irradiation. These data show that ABA plays a significant role in the induction of bisbibenzyl biosynthesis, which might confer tolerance against UV-C irradiation in M. polymorpha. (C) 2015 Elsevier Ltd. All rights reserved.	[Kageyama, Akito; Matsuura, Hideyuki; Takahashi, Kosaku] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Ishizaki, Kimitsune] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Kohchi, Takayuki] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan	Takahashi, K (reprint author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan.	kosaku@chem.agr.hokudai.ac.jp		Ishizaki, Kimitsune/0000-0003-0504-8196			Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Tougane K, 2010, PLANT PHYSIOL, V152, P1529, DOI 10.1104/pp.110.153387; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Markham KR, 1998, PHYTOCHEMISTRY, V48, P791, DOI 10.1016/S0031-9422(97)00875-3; Wolf L, 2010, PLANT PHYSIOL, V153, P1123, DOI 10.1104/pp.110.154658; Yoshida T, 1996, TETRAHEDRON, V52, P14487, DOI 10.1016/0040-4020(96)00889-7; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Friederich S, 1999, PHYTOCHEMISTRY, V52, P1195, DOI 10.1016/S0031-9422(99)00340-4; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Yamamoto Y, 2015, PHYTOCHEMISTRY, V116, P48, DOI 10.1016/j.phytochem.2015.03.008; Chiyoda S, 2008, PLANT CELL REP, V27, P1467, DOI 10.1007/s00299-008-0570-5; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Takezawa D, 2011, J PLANT RES, V124, P437, DOI 10.1007/s10265-011-0410-5; ASAKAWA Y, 1982, PROG CH ORG NAT PROD, V42, P1; Asakawa Yoshinori, 2013, Prog Chem Org Nat Prod, V95, P1; Asakawa Y, 2013, PHYTOCHEMISTRY, V91, P52, DOI 10.1016/j.phytochem.2012.04.012; ASAKAWA Y, 1987, PHYTOCHEMISTRY, V26, P1811, DOI 10.1016/S0031-9422(00)82294-3; Emiliani G, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-7; Harrowven DC, 2012, NAT PROD REP, V29, P223, DOI 10.1039/c1np00080b; Ishizaki K., 2013, SCI REP, V3; Kato-Noguchi H, 2011, J PLANT PHYSIOL, V168, P1511, DOI 10.1016/j.jplph.2011.03.014; Kobayashi Y, 2010, PLANT CELL PHYSIOL, V51, P1594, DOI 10.1093/pcp/pcq103; Komatsu K., 2013, NAT COMMUN, V4; LI XY, 1994, PHYTOCHEMISTRY, V37, P625, DOI 10.1016/S0031-9422(00)90328-5; Nascimento Naíla Cannes do, 2010, Methods Mol Biol, V643, P1, DOI 10.1007/978-1-60761-723-5_1; Okada S, 2000, PLANT J, V24, P421, DOI 10.1046/j.1365-313x.2000.00882.x; Roda AL, 2003, PHYTOCHEMISTRY, V62, P527, DOI 10.1016/S0031-9422(02)00608-8; Speicher A, 2010, TETRAHEDRON LETT, V51, P2986, DOI 10.1016/j.tetlet.2010.03.125; Takenaka M, 2000, TRANSGENIC RES, V9, P179, DOI 10.1023/A:1008963410465; Zhang F., 2013, PLOS ONE, V8	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	SEP	2015	117						547	553		10.1016/j.phytochem.2015.05.009		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CR3SL	WOS:000361253300057		
J	Iwahashi, N; Yahata, T; Mizoguchi, M; Nanjyo, S; Yamamoto, M; Tanizaki, Y; Kobayashi, A; Shiro, M; Ota, N; Mabuchi, Y; Yagi, S; Minami, S; Ino, K				Iwahashi, Naoyuki; Yahata, Tamaki; Mizoguchi, Mika; Nanjyo, Sakiko; Yamamoto, Madoka; Tanizaki, Yuko; Kobayashi, Aya; Shiro, Michihisa; Ota, Nami; Mabuchi, Yasushi; Yagi, Shigetaka; Minami, Sawako; Ino, Kazuhiko			IMMUNOHISTOCHEMICAL EXPRESSION OF ANGIOGENIC AND IMMUNOLOGICAL FACTORS IN PLACENTA WITH PREECLAMPSIA AND/OR FETAL GROWTH RESTRICTION	PLACENTA			English	Meeting Abstract									[Iwahashi, Naoyuki; Yahata, Tamaki; Mizoguchi, Mika; Nanjyo, Sakiko; Yamamoto, Madoka; Tanizaki, Yuko; Kobayashi, Aya; Shiro, Michihisa; Ota, Nami; Mabuchi, Yasushi; Yagi, Shigetaka; Minami, Sawako; Ino, Kazuhiko] Wakayama Med Univ, Wakayama, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P2.59	A55	A56				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500183		
J	Kotani, T; Moroi, H; Nakano, T; Tsuda, H; Sumigama, S; Yamamoto, E; Kikkawa, F				Kotani, Tomomi; Moroi, Hiroaki; Nakano, Tomoko; Tsuda, Hiroyuki; Sumigama, Seiji; Yamamoto, Eiko; Kikkawa, Fumitaka			THE MANAGEMENT OF PLACENTAL ABRUPTION	PLACENTA			English	Meeting Abstract									[Kotani, Tomomi; Moroi, Hiroaki; Nakano, Tomoko; Tsuda, Hiroyuki; Sumigama, Seiji; Yamamoto, Eiko; Kikkawa, Fumitaka] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P237	A49	A49				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500161		
J	Moriyama, Y; Kotani, T; Sawada, M; Miki, R; Kikkawa, F				Moriyama, Yoshinori; Kotani, Tomomi; Sawada, Masako; Miki, Rika; Kikkawa, Fumitaka			ATYPICAL E2F CONTRIBUTES TO PATHOPHYSIOLOGY OF PREECLAMPSIA	PLACENTA			English	Meeting Abstract									[Moriyama, Yoshinori; Kotani, Tomomi; Sawada, Masako; Kikkawa, Fumitaka] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Miki, Rika] Bell Res Ctr, Nagoya, Aichi, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P2.69	A58	A59				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500193		
J	Motomura, K; Okada, N; Matsuda, A; Sago, H; Saito, H; Matsumoto, K				Motomura, Kenichiro; Okada, Naoko; Matsuda, Akio; Sago, Haruhiko; Saito, Hirohisa; Matsumoto, Kenji			INDUCTION OF APOPTOSIS IN HUMAN TERM SYNCYTIOTROPHOBLAST BY STIMULATION VIA TLR3	PLACENTA			English	Meeting Abstract									[Motomura, Kenichiro; Okada, Naoko; Matsuda, Akio; Saito, Hirohisa; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Motomura, Kenichiro; Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.40	A24	A25				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500086		
J	Nakano, T; Kotani, T; Tsuda, H; Sumigama, S; Kikkawa, F				Nakano, Tomoko; Kotani, Tomomi; Tsuda, Hiroyuki; Sumigama, Seiji; Kikkawa, Fumitaka			MATERNAL ADMINISTRATION OF HYDROGEN WATER MIGHT BE PROTECTIVE FOR THE LPS-INDUCED PRETERM LABOUR IN MICE	PLACENTA			English	Meeting Abstract									[Nakano, Tomoko; Kotani, Tomomi; Tsuda, Hiroyuki; Sumigama, Seiji; Kikkawa, Fumitaka] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.39	A24	A24				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500085		
J	Okubo, T; Tamura, K; Yoshie, M; Ishikawa, G; Nakai, A; Takeshita, T; Matsutani, T; Ohneda, W; Kuwabara, N; Tachikawa, E				Okubo, Takanori; Tamura, Kazuhiro; Yoshie, Mikihiro; Ishikawa, Gen; Nakai, Akihito; Takeshita, Toshiyuki; Matsutani, Takeshi; Ohneda, Wakana; Kuwabara, Naoko; Tachikawa, Eiichi			INHIBITORY ACTION OF LIPOPOLYSACCHARIDE-INDUCED CASPASE-1 EXPRESSION BY ALPHA-1-ANTITRYPSIN IN HUMAN TROPHOBLASTS	PLACENTA			English	Meeting Abstract									[Okubo, Takanori; Tamura, Kazuhiro; Yoshie, Mikihiro; Ohneda, Wakana; Kuwabara, Naoko; Tachikawa, Eiichi] Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neutral Pharmacol, Tokyo, Japan; [Ishikawa, Gen; Nakai, Akihito; Takeshita, Toshiyuki] Nippon Med Sch, Div Reprod Med Perinatol & Gynecol Oncol, Tokyo 113, Japan; [Matsutani, Takeshi] Nippon Med Sch, Dept Gastrointestinal & Hepatobiliary Pancreat Su, Tokyo 113, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.37	A24	A24				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500083		
J	Onda, K; Tong, S; Binder, N; Beard, S; Kaitu'u-Lino, T; Muto, M; Ikawa, M; Dilworth, M; Renshal, L; Senadheera, S; Parry, L; Hastie, R; Brownfoot, F; Tuohey, L; Palmer, K; Hannan, N				Onda, Kenji; Tong, Stephen; Binder, Natalie; Beard, Sally; Kaitu'u-Lino, Tu'uhevaha; Muto, Masanaga; Ikawa, Masahito; Dilworth, Mark; Renshal, Lewis; Senadheera, Sevvandi; Parry, Laura; Hastie, Roxanne; Brownfoot, Fiona; Tuohey, Laura; Palmer, Kirsten; Hannan, Natalie			PROTON PUMP INHIBITORS QUENCH THE PATHOPHYSIOLOGICAL CHARACTERISTICS OF PREECLAMPSIA IN BOTH HUMAN AND MOUSE MODELS AND REPRESENT AN EXCITING NOVEL CANDIDATE THERAPEUTIC	PLACENTA			English	Meeting Abstract									[Onda, Kenji; Tong, Stephen; Binder, Natalie; Beard, Sally; Kaitu'u-Lino, Tu'uhevaha; Hastie, Roxanne; Brownfoot, Fiona; Tuohey, Laura; Palmer, Kirsten; Hannan, Natalie] Univ Melbourne, Dept Obstet & Gynaecol, Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia; [Onda, Kenji] Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Hachioji, Tokyo 19203, Japan; [Muto, Masanaga; Ikawa, Masahito] Osaka Univ, Inst Microbial Dis, Anim Resource Ctr Infect Dis Res, Osaka, Japan; [Dilworth, Mark; Renshal, Lewis] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Senadheera, Sevvandi; Parry, Laura] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				O4.1	A10	A11				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500046		
J	Sato, T; Matsuoka, K; Ito, Y; Umehara, N; Okamoto, A; Sago, H				Sato, Taisuke; Matsuoka, Kentaro; Ito, Yuki; Umehara, Nagayoshi; Okamoto, Aikou; Sago, Haruhiko			PATHOGENESIS OF TWIN REVERSED ARTERIAL PERFUSION SEQUENCE IS DIFFERENT FROM THAT OF TWIN-TO-TWIN TRANSFUSION SYNDROME: CLINICOPATHOLOGICAL ASSESSMENT OF 32 CASES OF MULTIPLE PREGNANCIES WITH ACARDIA	PLACENTA			English	Meeting Abstract									[Sato, Taisuke; Matsuoka, Kentaro; Ito, Yuki] Natl Ctr Children Hlth & Dev, Dept Pathol, Tokyo, Japan; [Umehara, Nagayoshi; Sago, Haruhiko] Natl Ctr Children Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan; [Sato, Taisuke; Ito, Yuki; Umehara, Nagayoshi; Okamoto, Aikou] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.03	A12	A13				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500050		
J	Shiro, M; Iwahashi, N; Noguchi, T; Yahata, T; Yamamoto, M; Tanizaki, Y; Kobayashi, A; Ota, N; Yagi, S; Minami, S; Ino, K				Shiro, Michihisa; Iwahashi, Naoyuki; Noguchi, Tomoko; Yahata, Tamaki; Yamamoto, Madoka; Tanizaki, Yuko; Kobayashi, Aya; Ota, Nami; Yagi, Shigetaka; Minami, Sawako; Ino, Kazuhiko			SEVERE DISCORDANCY IN DICHORIONIC DIAMNIOTIC TWIN POTENTIALLY SHOWS PRETERM LABOR AND POOR PERINATAL OUTCOME	PLACENTA			English	Meeting Abstract									[Shiro, Michihisa; Iwahashi, Naoyuki; Noguchi, Tomoko; Yahata, Tamaki; Yamamoto, Madoka; Tanizaki, Yuko; Kobayashi, Aya; Ota, Nami; Yagi, Shigetaka; Minami, Sawako; Ino, Kazuhiko] Wakayama Med Univ, Wakayama, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P2.18	A43	A43				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500142		
J	Sumigama, S; Moriyama, Y; Nakano, T; Tsuda, H; Kotaki, T; Ito, Y; Hirako, S; Moroi, H; Imai, K; Kikkawa, F				Sumigama, Seiji; Moriyama, Yoshinori; Nakano, Tomoko; Tsuda, Hiroyuki; Kotaki, Tomomi; Ito, Yumiko; Hirako, Shima; Moroi, Hiroaki; Imai, Kenji; Kikkawa, Fumitaka			VARIATIONS IN SUTURE TECHNIQUES AT CESAREAN SECTION AND ITS RELATION TO COMPLICATIONS IN SUBSEQUENT PREGNANCIES	PLACENTA			English	Meeting Abstract									[Sumigama, Seiji; Moriyama, Yoshinori; Nakano, Tomoko; Tsuda, Hiroyuki; Kotaki, Tomomi; Ito, Yumiko; Hirako, Shima; Moroi, Hiroaki; Imai, Kenji; Kikkawa, Fumitaka] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.29	A21	A22				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500075		
J	Suzuki, M				Suzuki, Michiko			HEPARIN IS STRONGLY RECOMMENDED FOR JUVENILE WOMEN WITH RECURRENT PREGNANCY LOSS CAUSED BY ANTI-PHOSPHOLIPID ANTIBODIES COMPARED WITH THROMBOPHILIA	PLACENTA			English	Meeting Abstract									[Suzuki, Michiko] Jikei Univ, Sch Med, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.31	A22	A22				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500077		
J	Takahashi, H; Zhao, DW; Ohkuchi, A; Matsubara, S; Takizawa, T				Takahashi, Hironori; Zhao, Dongwei; Ohkuchi, Akihide; Matsubara, Shigeki; Takizawa, Toshihiro			THE EXPRESSION OF ADAM (A DISINTEGRIN AND METALLOPROTEINASE) GENES IN HUMAN FIRST-TRIMESTER VILLOUS AND EXTRAVILLOUS TROPHOBLAST CELLS	PLACENTA			English	Meeting Abstract									[Takahashi, Hironori; Ohkuchi, Akihide; Matsubara, Shigeki] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Takahashi, Hironori; Zhao, Dongwei; Takizawa, Toshihiro] Nippon Med Sch, Tokyo 113, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.32	A22	A22				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500078		
J	Tamura, K; Yoshie, M; Kusama, K; Imakawa, K; Sakurai, T; Bai, H; Nishi, H; Kuwabara, N; Isaka, K; Tachikawa, E				Tamura, Kazuhiro; Yoshie, Mikihiro; Kusama, Kazuya; Imakawa, Kazuhiko; Sakurai, Toshihiro; Bai, Hanako; Nishi, Hirotaka; Kuwabara, Naoko; Isaka, Keiichi; Tachikawa, Eiichi			EPAC SIGNAL ENHANCES DECIDUAL PROLACTIN EXPRESSION VIA C/EBP beta EXPRESSION IN HUMAN ENDOMETRIAL STROMAL CELLS	PLACENTA			English	Meeting Abstract									[Tamura, Kazuhiro; Yoshie, Mikihiro; Kusama, Kazuya; Kuwabara, Naoko; Tachikawa, Eiichi] Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neural Pharmacol, Tokyo, Japan; [Kusama, Kazuya; Imakawa, Kazuhiko; Sakurai, Toshihiro; Bai, Hanako] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Theriogenol & Anim Breeding, Tokyo, Japan; [Nishi, Hirotaka; Isaka, Keiichi] Tokyo Med Univ, Dept Obstet & Gynecol, Tokyo 1608402, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.26	A20	A20				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500072		
J	Tanizaki, Y; Yamamoto, M; Yagi, S; Iwahashi, N; Yahata, T; Nanjo, S; Mizoguchi, M; Kobayashi, A; Shiro, M; Ota, N; Mabuchi, Y; Minami, S; Ino, K				Tanizaki, Yuko; Yamamoto, Madoka; Yagi, Shigetaka; Iwahashi, Naoyuki; Yahata, Tamaki; Nanjo, Sakiko; Mizoguchi, Mika; Kobayashi, Aya; Shiro, Michihisa; Ota, Nami; Mabuchi, Yasushi; Minami, Sawako; Ino, Kazuhiko			TWO CASES OF GESTATIONAL TROPHOBLASTIC NEOPLASIA WITH MULTIPLE MOLAR EMBOLI-LIKE LUNG LESIONS AFTER EVACUATION OF HYDATID WORM MOLE	PLACENTA			English	Meeting Abstract									[Tanizaki, Yuko; Yamamoto, Madoka; Yagi, Shigetaka; Iwahashi, Naoyuki; Yahata, Tamaki; Nanjo, Sakiko; Mizoguchi, Mika; Kobayashi, Aya; Shiro, Michihisa; Ota, Nami; Mabuchi, Yasushi; Minami, Sawako; Ino, Kazuhiko] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.30	A22	A22				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500076		
J	Tomi, M; Akashi, T; Takaki, Y; Nishimura, T; Nakashima, E				Tomi, Masatoshi; Akashi, Tomoya; Takaki, Yoshiya; Nishimura, Tomohiro; Nakashima, Emi			SYNCYTIOTROPHOBLAST LAYER 2 EXPRESSES MDR1 AND BCRP EFFLUX TRANSPORTERS IN RODENT PLACENTA	PLACENTA			English	Meeting Abstract									[Tomi, Masatoshi; Akashi, Tomoya; Takaki, Yoshiya; Nishimura, Tomohiro; Nakashima, Emi] Keio Univ, Fac Pharm, Tokyo 108, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.57	A30	A30				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500103		
J	Ujita, M; Kondoh, E; Kawasaki, K; Chigusa, Y; Sato, M; Takai, H; Kiyokawa, H; Mogami, H; Konishi, I				Ujita, Mari; Kondoh, Eiji; Kawasaki, Kaoru; Chigusa, Yoshitsugu; Sato, Mai; Takai, Hiroshi; Kiyokawa, Hikaru; Mogami, Haruta; Konishi, Ikuo			WNT5A CAN BE INVOLVED IN THE PATHOGENESIS OF PREECLAMPSIA THROUGH MODULATION OF SPIRAL ARTERY REMODELLING AND PRO-AND ANTI-ANGIOGENIC FACTORS	PLACENTA			English	Meeting Abstract									[Ujita, Mari; Kondoh, Eiji; Kawasaki, Kaoru; Chigusa, Yoshitsugu; Sato, Mai; Takai, Hiroshi; Kiyokawa, Hikaru; Mogami, Haruta; Konishi, Ikuo] Kyoto Univ, Kyoto, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P2.57	A55	A55				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500181		
J	Yoshie, M; Tamakoshi, R; Tamura, K; Ishikawa, G; Nakai, A; Takeshita, T; Kuwabara, N; Tachikawa, E				Yoshie, Mikihiro; Tamakoshi, Rinna; Tamura, Kazuhiro; Ishikawa, Gen; Nakai, Akihito; Takeshita, Toshiyuki; Kuwabara, Naoko; Tachikawa, Eiichi			REGULATORY ACTION OF AN INTRACELLULAR CA(2+) IN CAMP-INDUCED FUNCTIONAL AND MORPHOLOGICAL DIFFERENTIATION IN TROPHOBLASTS	PLACENTA			English	Meeting Abstract									[Yoshie, Mikihiro; Tamakoshi, Rinna; Tamura, Kazuhiro; Kuwabara, Naoko; Tachikawa, Eiichi] Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neural Pharmacol, Tokyo, Japan; [Ishikawa, Gen; Nakai, Akihito; Takeshita, Toshiyuki] Nippon Med Sch, Div Reprod Med Perinatol & Gynecol Oncol, Tokyo 113, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	SEP	2015	36	9				P1.70	A34	A34				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CR3UV	WOS:000361259500116		
J	Mizuno, T; Kitayama, M; Takayama, C; Yamashino, T				Mizuno, Takeshi; Kitayama, Miki; Takayama, Chieko; Yamashino, Takafumi			Insight into a Physiological Role for the EC Night-Time Repressor in the Arabidopsis Circadian Clock	PLANT AND CELL PHYSIOLOGY			English	Article						Arabidopsis thaliana; Circadian clock; Light response; Temperature response; Transcriptional regulation	COINCIDENCE MECHANISM; PHOTOPERIODIC CONTROL; FLOWERING TIME; THALIANA; GROWTH; ELF4; COMPONENTS; RHYTHMS; COMPLEX; SYSTEM	Life cycle adaptation to seasonal variation in photoperiod and temperature is a major determinant of ecological success of widespread domestication of Arabidopsis thaliana. The circadian clock plays a role in the underlying mechanism for adaptation. Nevertheless, the mechanism by which the circadian clock tracks seasonal changes in photoperiod and temperature is a longstanding subject of research in the field. We previously showed that a set of the target genes (i.GI, LNK1. PRR9 and PRR7) of the Evening Complex (EC) consisting of LUX-ELF3-ELF4 is synergistically induced in response to both warm-night and night-light signals. Here, we further show that the responses occur within a wide range of growth-compatible temperatures (16-28A degrees C) in response to a small change in temperature (Delta 4A degrees C). A dim light pulse (< 1 A mu mol m(-2) s(-1)) causes the enhanced effect on the transcription of EC targets. The night-light pulse antagonizes against a positive effect of the cool-night signal on the EC activity. The mechanism of double-checking external temperature and light signals through the EC nighttime repressor might enable plants to ignore (or tolerate) daily fluctuation of ambient temperature within a short time interval in their natural habitats. Taken together, the EC night-time repressor might play a physiological role in tracking seasonal variation in photoperiod and temperature by conservatively double-checking both the light and temperature conditions. Another EC target output gene PIF4 regulating plant morphologies is also regulated by both the temperature and light stimuli during the night. Hence, the EC night-time repressor is also implicated in a physiological output of the PIF4-mediated regulation of morphologies in response to seasonal variation in photoperiod and ambient temperature.	[Mizuno, Takeshi; Kitayama, Miki; Takayama, Chieko; Yamashino, Takafumi] Nagoya Univ, Sch Agr, Lab Mol & Funct Genom, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Yamashino, T (reprint author), Nagoya Univ, Sch Agr, Lab Mol & Funct Genom, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	yamasino@agr.nagoya-u.ac.jp			Japan Society for Promotion of Science [26292051, Vo. 24380046]; Naito Foundation under Grant (The Naito Foundation Subsidy for Promotion of Specific Research Projects)	This work was supported by the Japan Society for Promotion of Science [No. 26292051 to T.Y. and Vo. 24380046 to T.M.] and Naito Foundation under Grant (The Naito Foundation Subsidy for Promotion of Specific Research Projects).	Song YH, 2015, ANNU REV PLANT BIOL, V66, P441, DOI 10.1146/annurev-arplant-043014-115555; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Nagel DH, 2012, CURR BIOL, V22, pR648, DOI 10.1016/j.cub.2012.07.025; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Box MS, 2015, CURR BIOL, V25, P194, DOI 10.1016/j.cub.2014.10.076; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Kunihiro A, 2011, PLANT CELL PHYSIOL, V52, P1315, DOI 10.1093/pcp/pcr076; Thines B, 2010, P NATL ACAD SCI USA, V107, P3257, DOI 10.1073/pnas.0911006107; Kolmos E, 2009, HFSP J, V3, P350, DOI 10.2976/1.3218766; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Mizuno T, 2014, PLANT CELL PHYSIOL, V55, P958, DOI 10.1093/pcp/pcu030; Nomoto Y, 2012, PLANT CELL PHYSIOL, V53, P1965, DOI 10.1093/pcp/pcs141; Dixon LE, 2011, CURR BIOL, V21, P120, DOI 10.1016/j.cub.2010.12.013; Niwa Y, 2009, PLANT CELL PHYSIOL, V50, P838, DOI 10.1093/pcp/pcp028; Kikis EA, 2005, PLANT J, V44, P300, DOI 10.1111/j.1365-313X.2005.02531.x; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; McClung CR, 2011, ADV GENET, V74, P105, DOI 10.1016/B978-0-12-387690-4.00004-0; Yu JW, 2008, MOL CELL, V32, P617, DOI 10.1016/j.molcel.2008.09.026; Carre I, 2013, SEMIN CELL DEV BIOL, V24, P393, DOI 10.1016/j.semcdb.2013.03.011; Kolmos E, 2011, PLANT CELL, V23, P3230, DOI 10.1105/tpc.111.088195; Hsu PY, 2014, TRENDS PLANT SCI, V19, P240, DOI 10.1016/j.tplants.2013.11.007; Chow Brenda Y, 2012, Plant Signal Behav, V7, P170, DOI 10.4161/psb.18766; Fogelmark K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003705; Johansson M., 2014, J EXP BOT, V66, P719; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Mizuno T., 2014, PLANT SIGNAL BEHAV, V9; Mizuno T., 2014, PLANT CELL PHYSL, V55, P2139; Nomoto Yuji, 2013, Plant Signal Behav, V8, pe22863, DOI 10.4161/psb.22863; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Pokhilko A., 2013, BMC SYST BIOL, V7, P1, DOI DOI 10.1186/1752-0509-7-23; Pokhilko A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.69; Sanchez SE, 2013, ELIFE, V2, DOI 10.7554/eLife.00791	35	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	SEP	2015	56	9					1738	1747		10.1093/pcp/pcv094		10	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CR4OD	WOS:000361312600005		
J	Nguyen, AH; Matsui, A; Tanaka, M; Mizunashi, K; Nakaminami, K; Hayashi, M; Iida, K; Toyoda, T; Nguyen, DV; Seki, M				Anh Hai Nguyen; Matsui, Akihiro; Tanaka, Maho; Mizunashi, Kayoko; Nakaminami, Kentaro; Hayashi, Makoto; Iida, Kei; Toyoda, Tetsuro; Dong Van Nguyen; Seki, Motoaki			Loss of Arabidopsis 5'aEuro"3' Exoribonuclease AtXRN4 Function Enhances Heat Stress Tolerance of Plants Subjected to Severe Heat Stress	PLANT AND CELL PHYSIOLOGY			English	Article						Arabidopsis; AtXRN4; Heat stress tolerance; RNA degradation	GENOME-WIDE ANALYSIS; MESSENGER-RNA STABILITY; TRANSCRIPTION FACTOR; GENE-EXPRESSION; HIGH-TEMPERATURE; KEY REGULATOR; THALIANA; THERMOTOLERANCE; ACCLIMATION; RESPONSES	mRNA degradation plays an important role in the rapid and dynamic alteration of gene expression in response to environmental stimuli. Arabidopsis 5'aEuro"3' exoribonuclease (AtXRN4), a homolog of yeast Xrn1p, functions after a de-capping step in the degradation of uncapped RNAs. While Xrn1p-dependent degradation of mRNA is the main process of mRNA decay in yeast, information pertaining to the targets of XRN4-based degradation in plants is limited. In order to better understand the biological function of AtXRN4, the current study examined the survivability of atxrn4 mutants subjected to heat stress. The results indicated that atxrn4 mutants, compared with wild-type plants, exhibited an increased survival rate when subjected to a short-term severe heat stress. A microarray and mRNA decay assay showed that loss of AtXRN4 function caused a reduction in the degradation of heat shock factor A2 (HSFA2) and ethylene response factor 1 (ERF1) mRNA. The heat stress tolerance phenotype of atxrn4 mutants was significantly reduced or lost by mutation of HSFA2, a known key regulator of heat acclimation, thus indicating that HSFA2 is a target gene of AtXRN4-mediated mRNA degradation both under non-stress conditions and during heat acclimation. These results demonstrate that AtXRN4-mediated mRNA degradation is linked to the suppression of heat acclimation.	[Anh Hai Nguyen; Matsui, Akihiro; Tanaka, Maho; Mizunashi, Kayoko; Nakaminami, Kentaro; Seki, Motoaki] RIKEN Ctr Sustainable Resource Sci, Plant Genom Network, Res Team, Yokohama, Kanagawa 2300045, Japan; [Anh Hai Nguyen; Hayashi, Makoto] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama 5260829, Japan; [Iida, Kei] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Toyoda, Tetsuro] RIKEN, ACCC, Integrated Database Unit, Wako, Saitama 3510198, Japan; [Dong Van Nguyen] Agr Genet Inst, Natl Key Lab Plant Cell Technol, Hanoi, Vietnam; [Seki, Motoaki] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan; [Seki, Motoaki] Japan Sci & Technol, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Seki, M (reprint author), RIKEN Ctr Sustainable Resource Sci, Plant Genom Network, Res Team, Yokohama, Kanagawa 2300045, Japan.	motoaki.seki@riken.jp			RIKEN; Japan Science and Technology Agency (JST) [Core Research for Evolutionary Science and Technology (CREST)]	This project was supported by RIKEN; the Japan Science and Technology Agency (JST) [Core Research for Evolutionary Science and Technology (CREST) to M.S.].	Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Narsai R, 2007, PLANT CELL, V19, P3418, DOI 10.1105/tpc.107.055046; Kawaguchi S, 2012, BIOINFORMATICS, V28, P929, DOI 10.1093/bioinformatics/bts065; Ogawa D, 2007, J EXP BOT, V58, P3373, DOI 10.1093/jxb/erm184; Chiba Y, 2009, J PLANT BIOL, V52, P114, DOI 10.1007/s12374-009-9021-2; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Hayashi M, 2012, PLANT CELL PHYSIOL, V53, P1310, DOI 10.1093/pcp/pcs078; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Potuschak T, 2006, PLANT CELL, V18, P3047, DOI 10.1105/tpc.106.046508; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Okamoto M, 2010, PLANT J, V62, P39, DOI 10.1111/j.1365-313X.2010.04135.x; Merret R, 2013, CELL REP, V5, P1279, DOI 10.1016/j.celrep.2013.11.019; Shim J, 2002, MOL CELLS, V14, P323; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Rymarquis LA, 2011, RNA, V17, P501, DOI 10.1261/rna.2467911; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x; Lim CJ, 2006, J PLANT RES, V119, P373, DOI 10.1007/s10265-006-0285-z; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; Zhou YP, 2012, PLANT MOL BIOL, V79, P333, DOI 10.1007/s11103-012-9915-0; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Nakaminami K, 2012, BBA-GENE REGUL MECH, V1819, P149, DOI 10.1016/j.bbagrm.2011.07.015; Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011; Crawford AJ, 2012, CURR BIOL, V22, pR396, DOI 10.1016/j.cub.2012.03.044; Kastenmayer JP, 2000, P NATL ACAD SCI USA, V97, P13985, DOI 10.1073/pnas.97.25.13985; Castells-Roca L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017272; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014	38	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	SEP	2015	56	9					1762	1772		10.1093/pcp/pcv096		11	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CR4OD	WOS:000361312600007		
J	Hauvermale, AL; Tuttle, KM; Takebayashi, Y; Seo, M; Steber, CM				Hauvermale, Amber L.; Tuttle, Keiko M.; Takebayashi, Yumiko; Seo, Mitsunori; Steber, Camille M.			Loss of Arabidopsis thaliana Seed Dormancy is Associated with Increased Accumulation of the GID1 GA Hormone Receptors	PLANT AND CELL PHYSIOLOGY			English	Article						After-ripening; DELLA; Dormancy; Gibberellin; GID1; Seed	ENDOGENOUS ABSCISIC-ACID; GIBBERELLIN RECEPTOR; DELLA REPRESSION; L HEYNH; INSENSITIVE DWARF1A; FLORAL DEVELOPMENT; DEFICIENT MUTANTS; RGL2 PROTEIN; GERMINATION; LIGHT	Dormancy prevents seeds from germinating under favorable conditions until they have experienced dormancy-breaking conditions, such as after-ripening through a period of dry storage or cold imbibition. Abscisic acid (ABA) hormone signaling establishes and maintains seed dormancy, whereas gibberellin (GA) signaling stimulates germination. ABA levels decrease and GA levels increase with after-ripening and cold stratification. However, increasing GA sensitivity may also be critical to dormancy loss since increasing seed GA levels are detectable only with long periods of after-ripening and imbibition. After-ripening and cold stratification act additively to enhance GA hormone sensitivity in ga1-3 seeds that cannot synthesize GA. Since the overexpression of the GA receptoGID1 GIBBERELLIN-INSENSITIVE DWARF1) enhanced this dormancy loss, and becausgid1a gid1b gid1c triple mutants show decreased germination, the effects of dormancy-breaking treatments on GID1 mRNA and protein accumulation were examined. Partial after-ripening resulted in increasedGID1b, but notGID1a or GID1c mRNA levels. Cold imbibition stimulated the accumulation of all three GID1 transcripts, but resulted in no increase in GA sensitivity during ga1-3 seed germination unless seeds were also partially after-ripened. This is probably because after-ripening was needed to enhance GID1 protein accumulation, independently of transcript abundance. The rise in GID1b transcript with after-ripening was not associated with decreased ABA levels, suggesting there is ABA-independent GID1b regulation by after-ripening and the 26S proteasome. GA and the DELLA RGL2 repressor of GA responses differentially regulated the three GID1 transcripts. Moreover, DELLA RGL2 appeared to switch between positive and negative regulation of GID1 expression in response to dormancy-breaking treatments.	[Hauvermale, Amber L.; Steber, Camille M.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Tuttle, Keiko M.; Steber, Camille M.] Washington State Univ, Mol Plant Sci Program, Pullman, WA 99164 USA; [Takebayashi, Yumiko; Seo, Mitsunori] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Steber, Camille M.] Washington State Univ, USDA ARS, Wheat Genet Qual Physiol & Dis Res Unit, Pullman, WA 99164 USA	Steber, CM (reprint author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	csteber@wsu.edu	Seo, Mitsunori/N-9603-2015		National Science Foundation (NSF) [0850981]; National Science Foundation-Eastern Asian Pacific Summer Internship Program (NSF-EAPSI); Japanese Society for the Promotion of Science [1209878]	This research was supported by an National Science Foundation (NSF) Award [0850981 to C.M.S.]; National Science Foundation-Eastern Asian Pacific Summer Internship Program (NSF-EAPSI) in collaboration with the Japanese Society for the Promotion of Science [1209878 to K.M.T.].	de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; KARSSEN CM, 1989, ANN BOT-LONDON, V63, P71; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; DERKX MPM, 1993, PHYSIOL PLANTARUM, V89, P360, DOI 10.1034/j.1399-3054.1993.890218.x; Fukazawa J, 2014, PLANT CELL, V26, P2920, DOI 10.1105/tpc.114.125690; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; Seo M, 2009, PLANT MOL BIOL, V69, P463, DOI 10.1007/s11103-008-9429-y; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Ariizumi T, 2013, PLANT PHYSIOL, V162, P2125, DOI 10.1104/pp.113.219451; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Steber CM, 1998, GENETICS, V149, P509; Lee KP, 2010, P NATL ACAD SCI USA, V107, P19108, DOI 10.1073/pnas.1012896107; Ali-Rachedi S, 2004, PLANTA, V219, P479, DOI 10.1007/s00425-004-1251-4; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Yoshida H, 2014, P NATL ACAD SCI USA, V111, P7861, DOI 10.1073/pnas.1321669111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Cao DN, 2005, PLANTA, V223, P105, DOI 10.1007/s00425-005-0057-3; Jacobsen JV, 2013, PLANTA, V238, P121, DOI 10.1007/s00425-013-1878-0; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Cheminant S, 2011, PLANT CELL, V23, P1849, DOI 10.1105/tpc.111.085233; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; GROOT SPC, 1987, PLANTA, V171, P525, DOI 10.1007/BF00392302; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Liu XD, 2013, P NATL ACAD SCI USA, V110, P15485, DOI 10.1073/pnas.1304651110; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; DERKX MPM, 1994, PLANT GROWTH REGUL, V15, P223, DOI 10.1007/BF00029895; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; KARSSEN CM, 1983, PLANTA, V157, P158, DOI 10.1007/BF00393650; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc010827; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Hussain A, 2005, PLANT J, V44, P88, DOI 10.1111/j.1365-313X.2005.02512.x; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Yamamoto Y, 2010, PLANT CELL, V22, P3589, DOI 10.1105/tpc.110.074542; Ariizumi T, 2008, PLANT CELL, V20, P2447, DOI 10.1105/tpc.108.058487; KOORNNEEF M, 1982, THEOR APPL GENET, V61, P385, DOI 10.1007/BF00272861; Layat E, 2014, NEW PHYTOL, V204, P864, DOI 10.1111/nph.13002; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Ariizumi T, 2007, PLANT CELL, V19, P791, DOI 10.1105/tpc.106.048009; Bewley D. J., 2013, SEEDS PHYSL DEV GERM; Chen LY, 2013, PLANT CELL, V25, P2253, DOI 10.1105/tpc.112.107292; Footitt S, 2011, P NATL ACAD SCI USA, V108, P20236, DOI 10.1073/pnas.1116325108; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Iuchi S, 2007, PLANT J, V50, P958, DOI 10.1111/j.1365-313X.2007.03098.x; Jacobsen J.V., 2002, PHYSIOL PLANTARUM, V115, P429; Karssen C. M., 1986, Plant growth substances 1985. Proceedings of the 12th international conference on plant growth substances., P315; Livne S, 2014, PLANT CELL PHYSIOL, V55, P1727, DOI 10.1093/pcp/pcu104; Pandord J.A., 1988, J AM OIL CHEM SOC, V65, P1627, DOI 10.1007/BF02912567; Ueguchi-Tanaka M, 2010, CURR OPIN PLANT BIOL, V13, P503, DOI 10.1016/j.pbi.2010.08.004; Voegele A, 2011, J EXP BOT, V62, P5131, DOI 10.1093/jxb/err214; Wang XP, 2002, MOL BIOL CELL, V13, P646, DOI 10.1091/mbc.01-08-0427	62	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	SEP	2015	56	9					1773	1785		10.1093/pcp/pcv084		13	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CR4OD	WOS:000361312600008		
J	Utsugi, S; Shibasaka, M; Maekawa, M; Katsuhara, M				Utsugi, Shigeko; Shibasaka, Mineo; Maekawa, Masahiko; Katsuhara, Maki			Control of the Water Transport Activity of Barley HvTIP3;1 Specifically Expressed in Seeds	PLANT AND CELL PHYSIOLOGY			English	Article						Aquaporin; Barley; Seed; TIP; Water transport activity	TONOPLAST INTRINSIC PROTEINS; MEMBRANE AQUAPORIN NTAQP1; PLASMA-MEMBRANE; FUNCTIONAL-ANALYSIS; GAMMA-TIP; RICE; ARABIDOPSIS; CHANNELS; MERCURY; ROOTS	Tonoplast intrinsic proteins (TIPs) are involved in the transport and storage of water, and control intracellular osmotic pressure by transporting material related to the water potential of cells. In the present study, we focused on HvTIP3;1 during the periods of seed development and desiccation in barley. HvTIP3;1 was specifically expressed in seeds. An immunochemical analysis showed that HvTIP3;1 strongly accumulated in the aleurone layers and outer layers of barley seeds. The water transport activities of HvTIP3;1 and HvTIP1;2, which also accumulated in seeds, were measured in the heterologous expression system of Xenopus oocytes. When they were expressed individually, HvTIP1;2 transported water, whereas HvTIP3;1 did not. However, HvTIP3;1 exhibited water transport activity when co-expressed with HvTIP1;2 in oocytes, and this activity was higher than when HvTIP1;2 was expressed alone. This is the first report to demonstrate that the water permeability of a TIP aquaporin was activated when co-expressed with another TIP. The split-yellow fluorescent protein (YFP) system in onion cells revealed that HvTIP3;1 interacted with HvTIP1;2 to form a heterotetramer in plants. These results suggest that HvTIP3;1 functions as an active water channel to regulate water movement through tissues during the periods of seed development and desiccation.	[Utsugi, Shigeko; Shibasaka, Mineo; Maekawa, Masahiko; Katsuhara, Maki] Okayama Univ, IPSR, Kurashiki, Okayama 7100046, Japan	Utsugi, S (reprint author), Okayama Univ, IPSR, Kurashiki, Okayama 7100046, Japan.	utsugi@okayama-u.ac.jp			Wesco Scientific Promotion Foundation; Ohara Foundation for Agricultural Science; Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported by the Wesco Scientific Promotion Foundation [to S.U.]; Ohara Foundation for Agricultural Science [to S.U., M.S., M.M. and M.K.]; the Program for Promotion of Basic Research Activities for Innovative Biosciences [a grant to M.K.].	Hukin D, 2002, PLANTA, V215, P1047, DOI 10.1007/s00425-002-0841-2; Nguyen MX, 2013, PLANTA, V238, P669, DOI 10.1007/s00425-013-1918-9; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Takahashi H, 2004, BIOSCI BIOTECH BIOCH, V68, P1728, DOI 10.1271/bbb.68.1728; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Klebl F, 2003, FEBS LETT, V547, P69, DOI 10.1016/S0014-5793(03)00671-9; Azad AK, 2004, PLANT CELL PHYSIOL, V45, P608, DOI 10.1093/pcp/pch069; Suga S, 2002, PLANT CELL PHYSIOL, V43, P1229, DOI 10.1093/pcp/pcf148; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; ESPELUND M, 1992, PLANT J, V2, P241; Liu CW, 2013, PLANT PHYSIOL BIOCH, V63, P151, DOI 10.1016/j.plaphy.2012.11.018; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Vander Willigen C, 2006, PLANT CELL PHYSIOL, V47, P1241, DOI 10.1093/pcp/pcj094; Gattolin S, 2011, MOL PLANT, V4, P180, DOI 10.1093/mp/ssq051; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Yaneff A, 2014, P NATL ACAD SCI USA, V111, P231, DOI 10.1073/pnas.1316537111; MAUREL C, 1993, EMBO J, V12, P2241; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; Siefritz F, 2004, PLANT J, V37, P147, DOI 10.1046/j.1365-313X.2003.01947.x; Chen W, 2013, PLANT MOL BIOL, V83, P219, DOI 10.1007/s11103-013-0084-6; Chrispeels M., 1994, PLANT PHYSIOL, V100, P9; Hayashi H, 2015, BIOSCI BIOTECH BIOCH, V79, P1422, DOI 10.1080/09168451.2015.1032882; Ibl V, 2014, J EXP BOT, V65, P3249, DOI 10.1093/jxb/eru175; Jang Ji Young, 2012, Plant Signal Behav, V7, P1180, DOI 10.4161/psb.21178; Katsuhara M, 2002, PLANT CELL PHYSIOL, V43, P885, DOI 10.1093/pcp/pcf102; Kawakami N, 1997, J EXP BOT, V48, P1415, DOI 10.1093/jxb/48.7.1415; Kondo H, 2013, J VIROL, V87, P7423, DOI 10.1128/JVI.00270-13; Manfre AJ, 2006, PLANT PHYSIOL, V140, P140, DOI 10.1104/pp.105.072967; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Ohshima Y, 2001, PLANT CELL PHYSIOL, V42, P1119, DOI 10.1093/pcp/pce141; Rivers RL, 1997, J BIOL CHEM, V272, P16256, DOI 10.1074/jbc.272.26.16256; Schuurmans Jolanda A M J, 2003, Plant Mol Biol, V53, P633, DOI 10.1023/B:PLAN.0000019070.60954.77; Takano Junpei, 2010, Proc Natl Acad Sci U S A, V107, P5220, DOI 10.1073/pnas.0910744107; Uemura T, 2002, GENES CELLS, V7, P743, DOI 10.1046/j.1365-2443.2002.00550.x; Utsugi S., 2006, PLANT BIOTECHNOLOGY, V23, P413, DOI 10.5511/plantbiotechnology.23.413; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	SEP	2015	56	9					1831	1840		10.1093/pcp/pcv104		10	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CR4OD	WOS:000361312600013		
J	Miyata, K; Ikeda, H; Nakaji, M; Kanel, DR; Terashima, I				Miyata, Kazunori; Ikeda, Hiroshi; Nakaji, Masayoshi; Kanel, Dhana Raj; Terashima, Ichiro			Rate Constants of PSII Photoinhibition and its Repair, and PSII Fluorescence Parameters in Field Plants in Relation to their Growth Light Environments	PLANT AND CELL PHYSIOLOGY			English	Article						Chlorophyll fluorescence; Excess energy hypothesis; Jaljale Himal; Non-regulated energy dissipation; Photoinhibition; Two-step hypothesis	PHOTOSYNTHETIC ELECTRON-TRANSPORT; CHENOPODIUM-ALBUM LEAVES; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; FLUCTUATING LIGHT; ARABIDOPSIS-THALIANA; D1 PROTEIN; PHOTOINACTIVATION; CHLOROPLASTS; DISSIPATION	The extent of photoinhibition of PSII is determined by a balance between the rate of photodamage to PSII and that of repair of the damaged PSII. It has already been indicated that the rate constants of photodamage (k(pi)) and repair (k(rec)) of the leaves differ depending on their growth light environment. However, there are no studies using plants in the field. We examined these rate constants and fluorescence parameters of several field-grown plants to determine inter-relationships between these values and the growth environment. The k(pi) values were strongly related to the excess energy, E-Y, of the puddle model and non-regulated energy dissipation, Y(NO), of the lake model, both multiplied by the photosynthetically active photon flux density (PPFD) level during the photoinhibitory treatment. In contrast, the k(rec) values corrected against in situ air temperature were very strongly related to the daily PPFD level. The plants from the fields showed higher NPQ than the chamber-grown plants, probably because these field plants acclimated to stronger lightflecks than the averaged growth PPFD. Comparing chamber-grown plants and the field plants, we showed that k(pi) is determined by the incident light level and the photosynthetic capacities such as in situ rate of PSII electron transport and non-photochemical quenching (NPQ) [e.g. Y(NO)xPPFD] and that k(rec) is mostly determined by the growth light and temperature levels.	[Miyata, Kazunori; Terashima, Ichiro] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Hiroshi] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Nakaji, Masayoshi] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Makino Herbarium, Hachioji, Tokyo 1920397, Japan; [Kanel, Dhana Raj] Dept Plant Resources, Natl Herbarium & Plant Labs, Godawari, Nepal	Terashima, I (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	itera@bs.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology-Japan [23255005, 26291055]	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology-Japan [23255005, 26291055].	GREER DH, 1986, PLANTA, V168, P253, DOI 10.1007/BF00402971; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Oguchi R, 2009, PLANT CELL PHYSIOL, V50, P1815, DOI 10.1093/pcp/pcp123; Lazar D, 1999, BBA-BIOENERGETICS, V1412, P1, DOI 10.1016/S0005-2728(99)00047-X; CALLAHAN FE, 1986, PLANT PHYSIOL, V82, P261, DOI 10.1104/pp.82.1.261; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; Takahashi S, 2009, PLANT PHYSIOL, V149, P1560, DOI 10.1104/pp.108.134122; Lee HY, 2001, PLANTA, V212, P332, DOI 10.1007/s004250000398; Cazzaniga S, 2013, PLANT J, V76, P568, DOI 10.1111/tpj.12314; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Kono M, 2014, PLANT CELL PHYSIOL, V55, P990, DOI 10.1093/pcp/pcu033; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; ANDERSON JM, 1994, PHOTOSYNTH RES, V41, P315, DOI 10.1007/BF00019409; Alter P, 2012, PHOTOSYNTH RES, V113, P221, DOI 10.1007/s11120-012-9757-2; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Kasajima I, 2009, PLANT CELL PHYSIOL, V50, P1600, DOI 10.1093/pcp/pcp102; He J, 2003, PHYSIOL PLANTARUM, V118, P297, DOI 10.1034/j.1399-3054.2003.00107.x; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; Hendrickson L, 2004, PHOTOSYNTH RES, V82, P73, DOI 10.1023/B:PRES.0000040446.87305.f4; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Tu WF, 2012, J PLANT PHYSIOL, V169, P1463, DOI 10.1016/j.jplph.2012.05.027; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Murata N, 2012, BBA-BIOENERGETICS, V1817, P1127, DOI 10.1016/j.bbabio.2012.02.020; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; Kato MC, 2003, PLANT CELL PHYSIOL, V44, P318, DOI 10.1093/pcp/pcg045; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87; Kono M, 2014, J PHOTOCH PHOTOBIO B, V137, P89, DOI 10.1016/j.jphotobiol.2014.02.016; Tikkanen M, 2010, PLANT PHYSIOL, V152, P723, DOI 10.1104/pp.109.150250; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; ARO EM, 1993, PLANT PHYSIOL, V103, P835; BASSHAM JA, 1977, SCIENCE, V197, P630, DOI 10.1126/science.197.4304.630; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Campbell G.S., 1998, INTRO ENV BIOPHYS, V2nd, P147; Dall'Osto L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0221; Kato MC, 2002, FUNCT PLANT BIOL, V29, P787, DOI 10.1071/PP01162; Kato MC, 2002, PHOTOSYNTH RES, V72, P65, DOI 10.1023/A:1016097312036; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Laisk A, 2012, PHOTOSYNTH RES, V113, P145, DOI 10.1007/s11120-012-9751-8; Miyata K, 2012, PHOTOSYNTH RES, V113, P165, DOI 10.1007/s11120-012-9767-0; OGREN E, 1984, PHYSIOL PLANTARUM, V62, P181, DOI 10.1111/j.1399-3054.1984.tb00368.x; Schreiber U, 1994, SERIES ECOLOGICAL ST, V100, P49; Stefanov D, 2008, PHYSIOL PLANTARUM, V133, P327, DOI 10.1111/j.1399-3054.2008.01077.x; TERASHIMA I, 1993, OECOLOGIA, V95, P194, DOI 10.1007/BF00323490; Tholen D, 2008, PLANT CELL ENVIRON, V31, P1688, DOI 10.1111/j.1365-3040.2008.01875.x; Tsonev TD, 2003, PLANT CELL PHYSIOL, V44, P828, DOI 10.1093/pcp/pcg107; TYYSTJARVI E, 1992, PLANT PHYSIOL, V100, P1310, DOI 10.1104/pp.100.3.1310; Vass Imre, 2011, Physiol Plant, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x	54	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	SEP	2015	56	9					1841	1854		10.1093/pcp/pcv107		14	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CR4OD	WOS:000361312600014		
J	Koike, S; Kuo, TC; Paunescu, L				Koike, Satoshi; Kuo, Tzee-Char; Paunescu, Laurentiu			A'Campo curvature bumps and the Dirac phenomenon near a singular point	PROCEEDINGS OF THE LONDON MATHEMATICAL SOCIETY			English	Article							MORSE STABILITY	The level curves of an analytic function germ can have bumps (maxima of Gaussian curvature) at unexpected points near the singularity. This phenomenon is fully explored for f(z, w) is an element of C{z, w}, using the Newton-Puiseux infinitesimals and the notion of gradient canyon. Equally unexpected is the Dirac phenomenon: as c -> 0, the total Gaussian curvature of f = c accumulates in the minimal gradient canyons, and nowhere else. Our approach mimics the introduction of polar coordinates in Analytic Geometry.	[Koike, Satoshi] Hyogo Univ Teachers Educ, Dept Math, Kato, Hyogo 6731494, Japan; [Kuo, Tzee-Char; Paunescu, Laurentiu] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia	Koike, S (reprint author), Hyogo Univ Teachers Educ, Dept Math, Kato, Hyogo 6731494, Japan.	koike@hyogo-u.ac.jp; tzeechar@gmail.com; laurent@maths.usyd.edu.au			ARC Discovery Project [DP1096073]	The authors were partially supported by the ARC Discovery Project: DP1096073.	KUO TC, 1977, TOPOLOGY, V16, P299, DOI 10.1016/0040-9383(77)90037-4; Carmo MD, 1976, DIFFERENTIAL GEOMETR; Eisenbud D., 1985, ANN MATH STUDIES, V110; GARCIA BAROSSO E., 1999, COMMENT MATH HELV, V74, P398; KOIKE S., 2011, SEVERAL TOPICS REAL, P115; Koike S, 2012, P JPN ACAD A-MATH, V88, P70, DOI 10.3792/pjaa.88.70; Kuo TC, 2012, J LOND MATH SOC, V85, P382, DOI 10.1112/jlms/jdr049; Kuo TC, 2005, P JPN ACAD A-MATH, V81, P115; Kuo TC, 2000, CH CRC RES NOTES, V412, P76; LANGEVIN R, 1979, COMMENT MATH HELV, V54, P6, DOI 10.1007/BF02566253; Milnor J., 1968, ANN MATH STUDIES, V61; NESS L, 1977, COMPOS MATH, V35, P57; NISHIMURA S., 1991, REP FS KOGOSHIMA U M, V24, P33; REEVE J. E., 1954, REND SEM MAT TORINO, V51, P159; Siersma D, 2006, B SCI MATH, V130, P110, DOI 10.1016/j.bulsci.2005.08.003; WALKER R. J., 1962, ALGEBRAIC CURVES; WALL C. T. C., 2004, LONDON MATH SOC STUD, V63	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0024-6115	1460-244X		P LOND MATH SOC	Proc. London Math. Soc.	SEP	2015	111		3				717	748		10.1112/plms/pdv036		32	Mathematics	Mathematics	CR4OF	WOS:000361313000006		
J	Salem, NM; Lin, YH; Moriguchi, T; Lim, SY; Salem, N; Hibbeln, JR				Salem, N. M.; Lin, Y. H.; Moriguchi, T.; Lim, S. Y.; Salem, N., Jr.; Hibbeln, J. R.			Distribution of omega-6 and omega-3 polyunsaturated fatty acids in the whole rat body and 25 compartments	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Alpha-linolenic acid; Linoleic acid; Docosahaexenoic acid; Arachidonic acid; n-3; n-6	ALPHA-LINOLENIC-ACID; DOCOSAHEXAENOIC ACID; LIPID-COMPOSITION; ARACHIDONIC-ACID; BRAIN; METABOLISM; DIET; DEFICIENCY; LIVER	The steady state compositions of omega-6 and omega-3 polyunsaturated fatty acids (PUFA) throughout the various viscera and tissues within the whole body of rats have not previously been described in a comprehensive manner. Dams consumed diets containing 10 wt% fat (15% linoleate and 3% alpha-linolenate). Male offspring (n=9) at 7-week of age were euthanized and dissected into 25 compartments. Total lipid fatty acids for each compartment were quantified by GC/FID and summed for the rat whole body; total n-6 PUFA was 12 wt% and total n-3 PUFA was 2.1% of total fatty acids. 18:2n-6 accounted for 84% of the total n-6 PUFA, 20:4n-6 was 12%, 18:3n-3 was 59% of the total n-3 PUFA, 20:5n-3 was 2.1%, and 22:6n-3 was 32%. The white adipose tissue contained the greatest amounts of 18:2n-6 (1.5 g) and 18:3n-3 (0.2 g). 20:4n-6 was highest in muscle (60 mg) and liver (57 mg), while 22:6n-3 was greatest in muscle (46 mg), followed by liver (27 mg) and carcass (20 mg). In terms of fatty acid composition expressed as a percentage, 18:2n-6 was the highest in the heart (13 wt%), while 18:3n-3 was about 13 wt% for skin, white adipose tissue and fur. 20:4n-6 was highest (21-25 wt%) in the circulation, kidney, and spleen, while 22:6n-3 was highest in the brain (12 wt%), followed by the heart (7.9 wt%), liver (5.9 wt%), and spinal cord (5.1 wt%). Selectivity was greatest when comparing 22:6n-3 in brain (12%) to white adipose (0.08%) (68-fold) and 22:5n-6 in testes (15.6%) compared to white adipose (0.02%), 780-fold. Published by Elsevier Ltd.	[Salem, N. M.; Lin, Y. H.; Hibbeln, J. R.] NIAAA, Sect Nutr Neurosci, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA; [Moriguchi, T.] Azabu Univ, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan; [Lim, S. Y.] Korea Maritime & Ocean Univ, Div Marine Environm & Biosci, Busan, South Korea; [Salem, N., Jr.] DSM Nutr Prod Inc, Nutr Lipids, Columbia, MD USA	Lin, YH (reprint author), NIAAA, NIH, Lab Membrane Biochem & Biophys, 5625 Fishers Lane,Rm 3N-07, Bethesda, MD 20892 USA.	yuhong.lin@nih.gov			Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health	This project was supported by the Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health.	REEVES PG, 1993, J NUTR, V123, P1939; Fu Z, 2000, PEDIATR RES, V47, P414, DOI 10.1203/00006450-200003000-00021; HANDELMAN GJ, 1988, LIPIDS, V23, P598, DOI 10.1007/BF02535604; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Chen CT, 2015, PROSTAG LEUKOTR ESS, V92, P33, DOI 10.1016/j.plefa.2014.05.007; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; OBRIEN JS, 1965, J LIPID RES, V6, P537; Carver JD, 2001, BRAIN RES BULL, V56, P79, DOI 10.1016/S0361-9230(01)00551-2; Cunnane SC, 1997, J NUTR, V127, P146; Lin YH, 2007, J LIPID RES, V48, P2709, DOI 10.1194/jlr.M700369-JLR200; Moriguchi T, 2004, J LIPID RES, V45, P1437, DOI 10.1194/jlr.M400087; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9; Salem N, 1999, PROSTAG LEUKOTR ESS, V60, P407, DOI 10.1016/S0952-3278(99)80021-0; Burr GO, 1929, J BIOL CHEM, V82, P345; Gibson RA, 2013, PROSTAG LEUKOTR ESS, V88, P139, DOI 10.1016/j.plefa.2012.04.003; BIERI JG, 1965, COMP BIOCHEM PHYSIOL, V15, P275, DOI 10.1016/0010-406X(65)90131-3; Cunnane SC, 2001, LIPIDS, V36, P975, DOI 10.1007/s11745-001-0808-3; Demar JC, 2008, J LIPID RES, V49, P1963, DOI 10.1194/jlr.M800117-JLR200; Domenichiello AF, 2014, J LIPID RES, V55, P62, DOI 10.1194/jlr.M042275; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu Z, 2001, LIPIDS, V36, P255, DOI 10.1007/s11745-001-0715-7; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; MORRISON WR, 1964, J LIPID RES, V5, P600; Salem Jr N., 1989, CURRENT TOPICS NUTR, P109; Salem N, 1996, LIPIDS, V31, pS153, DOI 10.1007/BF02637068; Stark KD, 2007, J LIPID RES, V48, P2471, DOI 10.1194/jlr.M700317-JLR200; TINOCO J, 1979, LIPIDS, V14, P166, DOI 10.1007/BF02533868; U.S. Government, 2010, DIET GUID AM, V7th; YANG JL, 1994, METABOLISM, V43, P940, DOI 10.1016/0026-0495(94)90171-6	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	SEP	2015	100						13	20		10.1016/j.plefa.2015.06.002		8	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	CR5TD	WOS:000361406100003		
J	Prak, K; Naka, M; Tandang-Silvas, MRG; Kriston-Vizi, J; Maruyama, N; Utsumi, S				Prak, Krisna; Naka, Masashi; Tandang-Silvas, Mary Rose Gecolea; Kriston-Vizi, Janos; Maruyama, Nobuyuki; Utsumi, Shigeru			Polypeptide modification: an improved proglycinin design to stabilise oil-in-water emulsions	PROTEIN ENGINEERING DESIGN & SELECTION			English	Article						emulsion; glycinin; polypeptide properties; protein interface; protein engineering	SOYBEAN BETA-CONGLYCININ; PHYSICOCHEMICAL FUNCTION RELATIONSHIPS; EMULSIFYING PROPERTIES; FUNCTIONAL-PROPERTIES; 11S GLOBULIN; CRYSTAL-STRUCTURES; SUBUNIT LEVELS; PROTEIN; GLYCININ; SOLUBILITY	beta-Conglycinin and glycinin are soybean major seed storage proteins. Previous studies have shown that adding the extension region of beta-conglycinin alpha subunit improves the emulsifying properties of proglycinin and confers more favourable characteristics than fusing the extension region of beta-conglycinin alpha' subunit or the hypervariable regions (A4IV) of glycinin A1aB1b subunit. To evaluate the polypeptide properties, we designed mutants of A1aB1b subunits fused with truncated versions of A4IV (A4IVcut), alpha (alpha cut) or alpha' (alpha'cut) extension regions lacking the C-terminus 25 or 31 residues (A4IVC25, alpha C25 or alpha'C31), and also A4IVcut and alpha'cut with alpha C25 residues added (A4IVcut-alpha C25 and alpha'cut-alpha C25). All the modified proteins displayed conformations similar to the wild type. With good solubilities, the emulsion properties of the modified proteins were much better at ionic strength mu = 0.08 than at mu = 0.5. The modified A1aB1b alpha cut and A1aB1b alpha'cut showed poorer emulsion properties than those of A1aB1b alpha and A1aB1b alpha'. Replacing the hydrophobic A4IVC25 region of A1aB1bA4IV with hydrophilic alpha C25 created A1aB1bA4IVcut-alpha C25, which had the best emulsion stability among these proglycinin mutants. We found that addition of alpha C25 improves the emulsifying properties of two C-terminally truncated proglycinin variants, thereby illustrating its potential general utility. Our investigation showed that in order to improve the emulsifying ability and emulsion stability of a globular protein, the introduced polypeptide should (i) be highly hydrophilic, (ii) consist of multiple hydrophobic-strong hydrophilic regions comprising at least two alpha helixes, (iii) harbour a terminal alpha-helix at the end of the C-terminus and (iv) have properties similar to those of alpha C25.	[Prak, Krisna; Naka, Masashi; Tandang-Silvas, Mary Rose Gecolea; Maruyama, Nobuyuki; Utsumi, Shigeru] Kyoto Univ, Grad Sch Agr, Lab Food Qual Design & Dev, Uji, Kyoto 6110011, Japan; [Prak, Krisna; Kriston-Vizi, Janos] UCL, Mol Cell Biol Lab, MRC, London WC1E 6BT, England	Maruyama, N (reprint author), Kyoto Univ, Grad Sch Agr, Lab Food Qual Design & Dev, Uji, Kyoto 6110011, Japan.	marunobu@kais.kyoto-u.ac.jp	Kriston-Vizi, Janos/L-6021-2013	Kriston-Vizi, Janos/0000-0002-0149-145X	Ministry of Education, Culture, Sports, Science and Technology of Japan; MRC/UCL Confidence in Concept; Medical Research Council	This work was supported by a grant to S.U. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The Ministry of Education, Culture, Sports, Science and Technology of Japan and the MRC/UCL Confidence in Concept funding supported K.P. The Medical Research Council supported J.K.-V.	Adachi M, 2003, J AGR FOOD CHEM, V51, P4633, DOI 10.1021/jf026065y; Anderson J.W., 1999, FED REG, V64; Angelia MRN, 2010, FOOD SCI TECHNOL RES, V16, P225, DOI 10.3136/fstr.16.225; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Prak K, 2005, J AGR FOOD CHEM, V53, P3650, DOI 10.1021/jf047811x; GREEN AA, 1955, METHOD ENZYMOL, V1, P67, DOI 10.1016/0076-6879(55)01014-8; KINSELLA JE, 1979, J AM OIL CHEM SOC, V56, P242, DOI 10.1007/BF02671468; NIELSEN NC, 1989, PLANT CELL, V1, P313, DOI 10.1105/tpc.1.3.313; Romero A, 2011, J AGR FOOD CHEM, V59, P9466, DOI 10.1021/jf2019853; Utsumi S, 1992, Adv Food Nutr Res, V36, P89, DOI 10.1016/S1043-4526(08)60105-9; Zhai JL, 2012, LANGMUIR, V28, P2357, DOI 10.1021/la203281c; Tang CH, 2011, J AGR FOOD CHEM, V59, P4071, DOI 10.1021/jf104834m; Lee SH, 2007, J AGR FOOD CHEM, V55, P10924, DOI 10.1021/jf0726076; Maruyama N, 2002, J AGR FOOD CHEM, V50, P4323, DOI 10.1021/jf0117053; PENG IC, 1984, CEREAL CHEM, V61, P480; Maruyama N, 2004, J AGR FOOD CHEM, V52, P8197, DOI 10.1021/jf048786y; Adachi M, 2001, J MOL BIOL, V305, P291, DOI 10.1006/jmbi.2000.4310; Puppo MC, 2011, FOOD HYDROCOLLOID, V25, P389, DOI 10.1016/j.foodhyd.2010.07.005; ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; Palazolo GG, 2003, FOOD SCI TECHNOL INT, V9, P409, DOI 10.1177/1082013203040899; Wang YL, 1999, MACROMOLECULES, V32, P7128, DOI 10.1021/ma990972v; Bilgi B, 2004, EUR FOOD RES TECHNOL, V218, P437, DOI 10.1007/s00217-004-0895-4; CAREY KB, 1994, FOOD CHEM, V50, P83, DOI 10.1016/0308-8146(94)90097-3; DAMODARAN S, 1997, FOOD PROTEINS THEIR, P57; Dexter A.F., 2010, LANGMUIR, V23, P17997; DICKINSON CD, 1989, PLANT CELL, V1, P459; DICKINSON E, 1988, J CHEM SOC FARAD T 1, V84, P871, DOI 10.1039/f19888400871; Dickinson E, 1992, INTRO FOOD COLLOIDS; Enserm M.B., 1994, United States Patent, Patent No. [5,330,682, 5330682]; FDA, 1999, FED REGISTER, V64, P57699; Fukuda T, 2007, J AGR FOOD CHEM, V55, P3667, DOI 10.1021/jf063205l; Graham D.E., 1976, THEORY PRACTICE EMUL, P75; Huang PH, 2011, J AGR FOOD CHEM, V59, P9623, DOI 10.1021/jf202020t; Jung R, 1997, PLANT CELL, V9, P2037; Karaca AC, 2011, J AGR FOOD CHEM, V59, P13203, DOI 10.1021/jf203028n; Kimura A, 2010, J AGR FOOD CHEM, V58, P2923, DOI 10.1021/jf9042997; Kinsella J, 1985, NEW PROTEIN FOODS, V5, P107; KOLAR CW, 1979, J AM OIL CHEM SOC, V56, P389, DOI 10.1007/BF02671512; Liu MX, 1999, J AGR FOOD CHEM, V47, P4970, DOI 10.1021/jf9902200; Maruyama N, 1998, EUR J BIOCHEM, V258, P854, DOI 10.1046/j.1432-1327.1998.2580854.x; Maruyama N, 2001, EUR J BIOCHEM, V268, P3595, DOI 10.1046/j.1432-1327.2001.02268.x; PHILLIPS MC, 1981, FOOD TECHNOL-CHICAGO, V35, P50; Prak K, 2006, PEPTIDES, V27, P1179, DOI 10.1016/j.peptides.2005.11.007; Prak K, 2007, PROTEIN ENG DES SEL, V20, P433, DOI 10.1093/protein/gzm039; Prak K, 2009, J AGR FOOD CHEM, V57, P3792, DOI 10.1021/jf8034258; Burgess D J, 1998, Pharm Dev Technol, V3, P21, DOI 10.3109/10837459809028476; Steitz R, 2001, LANGMUIR, V17, P4471, DOI 10.1021/la010168d; Tandang MRG, 2005, J AGR FOOD CHEM, V53, P8736, DOI 10.1021/jf050871y; Torio MAO, 2011, FOOD RES INT, V44, P2984, DOI 10.1016/j.foodres.2011.07.010; Tsumura K, 2005, FOOD SCI TECHNOL RES, V11, P46, DOI 10.3136/fstr.11.46; Utsumi S, 1997, FOOD PROTEINS THEIR, P257	52	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1741-0126	1741-0134		PROTEIN ENG DES SEL	Protein Eng. Des. Sel.	SEP	2015	28	9					281	291		10.1093/protein/gzv031		11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CR4OR	WOS:000361315000002		
J	Okamuraa, T; Kondola, R				Okamuraa, Takahiko; Kondola, Ryuji			Suigetsumonas clinomigrationis gen. et sp nov., a Novel Facultative Anaerobic Nanoflagellate Isolated from the Meromictic Lake Suigetsu, Japan	PROTIST			English	Article						Anaerobic; Nanoflagellate; Placididea; Stramenopiles; Ultrastructure	HETEROTROPHIC FLAGELLATE; ELECTRON-MICROSCOPY; SEQUENCE DATA; COASTAL LAKE; STRAMENOPILES; EUKARYOTES; WATER; ULTRASTRUCTURE; BICOSOECIDA; METABOLISM	A novel facultative anaerobic bacterivorous nanoflagellate was isolated from the water just below the permanent oxic-anoxic interface of the meromictic Lake Suigetsu, Japan. We characterized the isolate using light and transmission electron microscopy and molecular phylogenetic analyses inferred from 18S rDNA sequences. The phylogenetic analyses showed that the isolate belonged to class Placididea (stramenopiles). The isolate showed key ultrastructural features of the Placididea, such as flagellar hairs with two unequal terminal filaments, microtubular root 2 changing in shape from an arced to an acute-angled shape, and a lack of an x-fiber in root 2. However, the isolate had a single helix in the flagellar transition region, which is a double helix in the two known placidid nanoflagellates Placidia cafeteriopsis and Wobblia lunata. Moreover, the isolate had different intracellular features compared with these two genera, such as the arrangement of basal bodies, the components of the flagellar apparatus, the number of mitochondria, and the absence (or presence) of paranuclear bodies. The 18S rDNA sequence was also phylogenetically distant from the clades of the known Placididae W. lunata and P. cafeteriopsis. Consequently, the newly isolated nanoflagellate was described as Suigetsumonas clinomigrationis gen. et sp. nov. (C) 2015 Elsevier GmbH. All rights reserved.	[Okamuraa, Takahiko] Fukui Prefectural Univ, Grad Sch Biosci & Biotechnol, Obama, Fukui 9170003, Japan; [Kondola, Ryuji] Fukui Prefectural Univ, Dept Marine Biosci, Obama, Fukui 9170003, Japan	Kondola, R (reprint author), Fukui Prefectural Univ, Dept Marine Biosci, Obama, Fukui 9170003, Japan.	rykondo@fpu.ac.jp			JSPS KAKENHI Grant [25.8636, 25450261]	We are grateful for constructive comments on an earlier draft by Dr. Akinori Yabuki at the Japan Agency for Marine-Earth Science and Technology. We also gratefully acknowledge useful comments by anonymous reviewers and the monitoring editor. This work was supported by JSPS KAKENHI Grant Number 25.8636 from Grant-in-Aid for JSPS Fellows to TO and by JSPS KAKENHI Grant Number 25450261 from Grant-in-Aid for Scientific Research to RK.	Al-Qassab S, 2002, ACTA PROTOZOOL, V41, P91; ANDERSEN RA, 1987, AM J BOT, V74, P337, DOI 10.2307/2443810; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; CARON DA, 1983, APPL ENVIRON MICROB, V46, P491; VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407; Nakano S, 1998, AQUAT MICROB ECOL, V16, P153, DOI 10.3354/ame016153; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sacca A, 2008, HYDROBIOLOGIA, V600, P89, DOI 10.1007/s10750-007-9179-x; Zhou ZM, 2002, J BIOL CHEM, V277, P1892, DOI 10.1074/jbc.M109096200; Cavalier-Smith T, 2013, EUR J PROTISTOL, V49, P328, DOI 10.1016/j.ejop.2012.09.002; Inaga S, 2007, ARCH HISTOL CYTOL, V70, P43, DOI 10.1679/aohc.70.43; Takano Y, 2006, J PHYCOL, V42, P251, DOI 10.1111/j.1529-8817.2006.00177.x; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Yubuki N, 2013, PLANT J, V75, P230, DOI 10.1111/tpj.12145; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Fenchel T, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P47; FENCHEL T, 1990, FEMS MICROBIOL ECOL, V74, P269, DOI 10.1111/j.1574-6968.1990.tb04073.x; Harder CB, 2014, PROTIST, V165, P144, DOI 10.1016/j.protis.2014.01.004; Karpov Serguei A., 2001, Protistology, V2, P34; Kondo R, 2000, FISHERIES SCI, V66, P1076, DOI 10.1046/j.1444-2906.2000.00171.x; Kopylov Alexander I., 2002, Aquatic Ecology, V36, P179, DOI 10.1023/A:1015678918611; MATSUYAMA M, 1973, Journal of the Oceanographical Society of Japan, V29, P131, DOI 10.1007/BF02109088; Moestrup O, 2000, SYST ASSOC SPEC VOL, V59, P69; Moriya M, 2002, PROTIST, V153, P143, DOI 10.1078/1434-4610-00093; Moriya M, 2000, PROTIST, V151, P41, DOI 10.1078/1434-4610-00006; Okamura T, 2012, AQUAT MICROB ECOL, V66, P149, DOI 10.3354/ame01565; Okamura T, 2014, THESIS FUKUI PREFECT; Park JS, 2010, ENVIRON MICROBIOL, V12, P1173, DOI 10.1111/j.1462-2920.2010.02158.x; Patterson D. J., 1989, SYSTEMATICS ASS, V38, P357; Sacca A, 2009, FEMS MICROBIOL ECOL, V70, P42, DOI 10.1111/j.1574-6941.2009.00735.x; SANDERS RW, 1989, LIMNOL OCEANOGR, V34, P673; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Tong SM, 1997, OPHELIA, V47, P71; TONG SM, 1995, EUR J PROTISTOL, V31, P24; Wylezich C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-271; Yubuki N, J EUKARYOT IN PRESS; Yubuki N, 2010, PROTIST, V161, P264, DOI 10.1016/j.protis.2009.10.004	38	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1434-4610			PROTIST	Protist	SEP	2015	166	4					409	421		10.1016/j.protis.2015.06.003		13	Microbiology	Microbiology	CR6ZD	WOS:000361496200002		
J	Inamura, K; Shinagawa, S; Nagata, T; Tagai, K; Nukariya, K; Nakayama, K				Inamura, Keisuke; Shinagawa, Shunichiro; Nagata, Tomoyuki; Tagai, Kenji; Nukariya, Kazutaka; Nakayama, Kazuhiko			Cognitive Dysfunction in Patients With Late-Life Somatic Symptom Disorder: A Comparison According to Disease Severity	PSYCHOSOMATICS			English	Article							SOMATOFORM DISORDERS; ANXIETY; DEPRESSION; POPULATION; IMPAIRMENT; PREVALENCE; QUALITY; SCALES	Background: Late-lift somatic symptom disorder (SSD) is characterized by various aging-associated factors, such as a,functional decline, psychosocatl problems, and cognitive dysfunction. However, the details of the cognitive dysfunction that occur in late-lift SSD are still unknown. Objective: The aims of this study were to reveal the cognitive profile of patients with late-life SSD and to evaluate how cognitive dysfunction affects disease severity. Methods: We compared the cognitive profiles of patients with late-life SSD (n = 40) with those of normal control subjects (n = 21). In addition, we divided the patients with late-life SSD into mild-to-moderate (n = 24) and severe (n = 16) groups and compared the cognitive profiles of the 3 groups. Results: Patients with late-life SSD exhibited a lower Mini-Mental State Examination total score and attention decline. In the 3-group comparison, the severe group had a lower Mini-Mental State Examination score and Frontal Assessment Battery score than the normal control group, it no significant difference was seen between the mild-to-moderate and the normal control groups. Conclusions: Our data suggest that different cognitive patterns may exist depending on disease severity, possibly indicating differences in pathogenesis.	[Inamura, Keisuke; Nagata, Tomoyuki; Nukariya, Kazutaka] Jikei Univ, Sch Med, Kashiwa Hosp, Dept Psychiat, Kashiwa, Chiba 2778567, Japan; [Shinagawa, Shunichiro; Tagai, Kenji; Nakayama, Kazuhiko] Jikei Univ, Sch Med, Dept Psychiat, Tokyo, Japan	Inamura, K (reprint author), Jikei Univ, Sch Med, Kashiwa Hosp, Dept Psychiat, 163-1 Kashiwashita, Kashiwa, Chiba 2778567, Japan.	inamura@jikei.ac.jp			 [23791354]	This research was supported by a Grant-in-Aid for Scientific Research (No. 23791354) to S. Shinagawa.	Altamura AC, 1998, EUR ARCH PSY CLIN N, V248, P267, DOI 10.1007/s004060050048; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Beaudreau SA, 2008, AM J GERIAT PSYCHIAT, V16, P790, DOI 10.1097/JGP.0b013e31817945c3; Harwood RH, 1998, AGE AGEING, V27, P707, DOI 10.1093/ageing/27.6.707; Onofrj M, 2011, J NEUROL SCI, V310, P166, DOI 10.1016/j.jns.2011.07.010; Muller JE, 2008, INT CLIN PSYCHOPHARM, V23, P43; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Dubois B, 2000, NEUROLOGY, V55, P1621; Rief W, 2005, PSYCHONEUROENDOCRINO, V30, P996, DOI 10.1016/j.psyneuen.2005.03.018; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Rosas HD, 2002, NEUROLOGY, V58, P695; Kashyap H, 2012, ACTA PSYCHIAT SCAND, V126, P106, DOI 10.1111/j.1600-0447.2012.01845.x; Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50; Henderson M, 2005, J PSYCHOSOM RES, V59, P181, DOI 10.1016/j.jpsychores.2004.04.374; Inagaki A, 1999, DOSE EQUIVALENCE PSY; Inamura K, 2014, AGING MENT HLTH; Luo YL, 2014, PSYCHOL HLTH MED; Matsuda O, 2004, MANUAL JAPANESE VERS; Murata T, 2001, INT J GERIATR PSYCH, V16, P1129, DOI 10.1002/gps.501; Segal M, 1988, COMP EVALUATION RATI; Sheehan B, 2005, INT J GERIATR PSYCH, V20, P967, DOI 10.1002/gps.1387; Zhang YY, 2014, J PSYCHOSOM RES, V77, P187, DOI 10.1016/j.jpsychores.2014.06.005	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	SEP-OCT	2015	56	5					486	494				9	Psychiatry; Psychology	Psychiatry; Psychology	CR0KD	WOS:000361006500006		
J	Hasegawa, T; Saito, S; Sato, I				Hasegawa, Takehiro; Saito, Seiken; Sato, Iwao			A GENERALIZATION OF A GRAPH THEORY MERTENS' THEOREM: ABELIAN COVERING CASE	QUARTERLY JOURNAL OF MATHEMATICS			English	Article								In 1874, Franz Mertens proved the so-called Mertens' third theorem in number theory, and after just 100 years, Kenneth S. Williams generalized it. In the previous papers, the first and the second authors presented a graph-theoretic analogue to the Mertens' third theorem. In this paper, we generalize it along the lines of Williams.	[Hasegawa, Takehiro] Shiga Univ, Otsu, Shiga 5200862, Japan; [Saito, Seiken] Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan; [Sato, Iwao] Oyama Natl Coll Technol, Oyama, Tochigi 3230806, Japan	Saito, S (reprint author), Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan.	seiken.saitou@gmail.com; isato@oyama-ct.ac.jp			JSPS KAKENHI [15K17508, 15K04985]	The first author was partially supported by JSPS KAKENHI Grant Number 15K17508. The third author was partially supported by JSPS KAKENHI Grant Number 15K04985.	Hardy G.H., 2008, INTRO THEORY NUMBERS; Hasegawa T., 2014, ARXIV150700498; Jameson G. J. O., 2003, LONDON MATH SOC STUD, V53; Knopp K., 1956, INFINITE SEQUENCES S; Languasco A, 2007, J NUMBER THEORY, V127, P37, DOI 10.1016/j.jnt.2006.12.015; Murty M. R., 1997, PROGR MATH, V157; Hasegawa T, 2015, PAC J MATH, V273, P123, DOI 10.2140/pjm.2015.273.123; Terras A, 2011, CAMBRIDGE STUDIES AD, V128; Terras A., 1999, LONDON MATH SOC STUD, V43; Williams K. S., 1974, J NUMBER THEORY, V6, P353, DOI 10.1016/0022-314X(74)90032-8	10	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0033-5606	1464-3847		Q J MATH	Q. J. Math.	SEP	2015	66	3					809	836		10.1093/qmath/hav024		28	Mathematics	Mathematics	CR4PJ	WOS:000361318000003		
J	Kawai, K				Kawai, Kotaro			SOME ASSOCIATIVE SUBMANIFOLDS OF THE SQUASHED 7-SPHERE	QUARTERLY JOURNAL OF MATHEMATICS			English	Article								The squashed 7-sphere S-7 is a 7-sphere with an Einstein metric given by the canonical variation and its cone R-8 - {0} has full holonomy Spin(7). There is a canonical calibrating 4-form Phi on R-8 - {0}. A minimal 3-submanifold in S-7 is called associative if its cone is calibrated by Phi. In this paper, we classify two types of fundamental associative submanifolds in the squashed S-7. One is obtained by the intersection with a 4-plane and the other is homogeneous. Then we study their infinitesimal associative deformations and explicitly show that all of them are integrable.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Kawai, K (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	kkawai@ms.u-tokyo.ac.jp			 [26-7067]	The author is supported by Grant-in-Aid for JSPS fellows (26-7067).	HARVEY R, 1982, ACTA MATH-DJURSHOLM, V148, P47, DOI 10.1007/BF02392726; BAR C, 1993, COMMUN MATH PHYS, V154, P509, DOI 10.1007/BF02102106; Besse A.L., 1987, EINSTEIN MANIFOLDS; Bolton J, 2000, GEOMETRIAE DEDICATA, V80, P231, DOI 10.1023/A:1005259413135; Friedrich T, 1997, J GEOM PHYS, V23, P259, DOI 10.1016/S0393-0440(97)80004-6; Kawai K., 2014, MATHDG14078046; Lotay JD, 2012, P LOND MATH SOC, V105, P1183, DOI 10.1112/plms/pds029; Marshall S. P., 1999, THESIS U OXFORD; Mashimo K., 1985, TSUKUBA J MATH, V9, P185; Ohnita Y., 2009, P 13 INT WORKSH DIFF, V13, P71; Salamon S. M., 1989, PITMAN RES NOTES MAT, V201; Xu F, 2010, DIFFER GEOM APPL, V28, P107, DOI 10.1016/j.difgeo.2009.05.005; Yano K., 1957, THEORY LIE DERIVATIV	13	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0033-5606	1464-3847		Q J MATH	Q. J. Math.	SEP	2015	66	3					861	893		10.1093/qmath/hav021		33	Mathematics	Mathematics	CR4PJ	WOS:000361318000005		
J	Kessar, R; Koshitani, S; Linckelmann, M				Kessar, Radha; Koshitani, Shigeo; Linckelmann, Markus			ON THE BRAUER INDECOMPOSABILITY OF SCOTT MODULES	QUARTERLY JOURNAL OF MATHEMATICS			English	Article							PERMUTATION MODULES; BLOCKS; CONSTRUCTION; EQUIVALENCES; ALGEBRAS; BIMODULE	Let k be an algebraically closed field of prime characteristic p, and let P be a p-subgroup of a finite group G. We give sufficient conditions for the kG-Scott module Sc(G, P) with vertex P to remain indecomposable under the Brauer construction with respect to any subgroup of P. This generalizes similar results for the case where P is abelian. The background motivation for this note is the fact that the Brauer indecomposability of a p-permutation bimodule is a key step towards showing that the module under consideration induces a stable equivalence of Morita type, which then may possibly be lifted to a derived equivalence.	[Kessar, Radha; Linckelmann, Markus] City Univ London, Dept Math, London EC1V 0HB, England; [Koshitani, Shigeo] Chiba Univ, Grad Sch Sci, Dept Math, Inage Ku, Chiba 2638522, Japan	Koshitani, S (reprint author), Chiba Univ, Grad Sch Sci, Dept Math, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	radha.kessar.1@city.ac.uk; koshitan@math.s.chiba-u.ac.jp; markus.linckelmann.1@city.ac.uk			Japan Society for Promotion of Science (JSPS) [23540007]	S.K. was supported by the Japan Society for Promotion of Science (JSPS) Grant-in-Aid for Scientific Research(C) 23540007, 2011-2014.	Alperin JL, 2001, J ALGEBRA, V239, P262, DOI 10.1006/jabr.2000.8625; PUIG L, 1981, MATH Z, V176, P265, DOI 10.1007/BF01261873; Hendren S, 2005, J ALGEBRA, V291, P457, DOI 10.1016/j.jalgebra.2005.05.002; BROUE M, 1994, NATO ADV SCI INST SE, V424, P1; BROUE M, 1985, P AM MATH SOC, V93, P401, DOI 10.2307/2045600; Aschbacher M., 2011, LONDON MATH SOC LECT, V391; Fan Y., 1998, ALGEBR REPRESENT TH, V1, P27, DOI 10.1023/A:1009964332013; KAWAI H, 1986, OSAKA J MATH, V23, P201; Kessar R, 2011, J ALGEBRA, V340, P90, DOI 10.1016/j.jalgebra.2011.04.029; Koshitani S, 2005, J ALGEBRA, V285, P726, DOI 10.1016/j.jalgebra.2004.08.031; Linckelmann M, 2009, T AM MATH SOC, V361, P1279; Linckelmann M., 2007, GROUP REPRESENTATION, P79; Mazza N, 2003, J GROUP THEORY, V6, P477, DOI 10.1515/jgth.2003.033; Thevenaz J., 1995, G ALGEBRAS MODULAR R; Tsushima Y., 1988, REPRESENTATIONS FINI; Tuvay I, 2014, J GROUP THEORY, V17, P1071, DOI 10.1515/jgt-2014-0018	16	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0033-5606	1464-3847		Q J MATH	Q. J. Math.	SEP	2015	66	3					895	903		10.1093/qmath/hav010		9	Mathematics	Mathematics	CR4PJ	WOS:000361318000006		
J	Nakajima, T; Roggia, MF; Noda, Y; Ueta, T				Nakajima, Takuya; Roggia, Murilo F.; Noda, Yasuo; Ueta, Takashi			EFFECT OF INTERNAL LIMITING MEMBRANE PEELING DURING VITRECTOMY FOR DIABETIC MACULAR EDEMA Systematic Review and Meta-analysis	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Review							PARS-PLANA VITRECTOMY; POSTERIOR HYALOID MEMBRANE; VISUAL-ACUITY; VITREOUS DETACHMENT; SURGICAL-PROCEDURES; REMOVAL; RETINOPATHY; EYES; OUTCOMES; RANIBIZUMAB	Purpose: To evaluate the effect of internal limiting membrane (ILM) peeling during vitrectomy for diabetic macular edema. Methods: MEDLINE, EMBASE, and CENTRAL were systematically reviewed. Eligible studies included randomized or nonrandomized studies that compared surgical outcomes of vitrectomy with or without ILM peeling for diabetic macular edema. The primary and secondary outcome measures were postoperative best-corrected visual acuity and central macular thickness. Meta-analysis on mean differences between vitrectomy with and without ILM peeling was performed using inverse variance method in random effects. Results: Five studies (7 articles) with 741 patients were eligible for analysis. Superiority (95% confidence interval) in postoperative best-corrected visual acuity in ILM peeling group compared with nonpeeling group was 0.04 (-0.05 to 0.13) logMAR (equivalent to 2.0 ETDRS letters, P = 0.37), and superiority in best-corrected visual acuity change in ILM peeling group was 0.04 (-0.02 to 0.09) logMAR (equivalent to 2.0 ETDRS letters, P = 0.16). There was no significant difference in postoperative central macular thickness and central macular thickness reduction between the two groups. Conclusion: The visual acuity outcomes using pars plana vitrectomy with ILM peeling versus no ILM peeling were not significantly different. A larger randomized prospective study would be necessary to adequately address the effectiveness of ILM peeling on visual acuity outcomes.	Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo 1138655, Japan; Univ Tokyo, Fac Med, Tokyo 1138655, Japan	Ueta, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ueta-tky@umin.ac.jp					Aboutable T, 2006, KLIN MONATSBL AUGENH, V223, P681, DOI 10.1055/s-2006-926606; Yamamoto T, 2001, AM J OPHTHALMOL, V132, P369, DOI 10.1016/S0002-9394(01)01050-9; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Hikichi T, 1997, OPHTHALMOLOGY, V104, P473; Stefansson E, 2006, SURV OPHTHALMOL, V51, P364, DOI 10.1016/j.survophthal.2006.04.005; Kumagai K, 2009, RETINA-J RET VIT DIS, V29, P464, DOI 10.1097/IAE.0b013e31819c632f; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; KISHI S, 1986, INT OPHTHALMOL, V9, P253, DOI 10.1007/BF00137539; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; LEWIS H, 1992, OPHTHALMOLOGY, V99, P753; Rajendram R, 2012, ARCH OPHTHALMOL-CHIC, V130, P972, DOI 10.1001/archophthalmol.2012.393; Kamura Y, 2005, JPN J OPHTHALMOL, V49, P297, DOI 10.1007/s10384-005-0199-7; Pendergast SD, 2000, AM J OPHTHALMOL, V130, P178, DOI 10.1016/S0002-9394(00)00472-4; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Simunovic MP, 2014, CAN J OPHTHALMOL, V49, P188, DOI 10.1016/j.jcjo.2013.11.012; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Gandorfer A, 2000, RETINA-J RET VIT DIS, V20, P126, DOI 10.1097/00006982-200003000-00003; Hartley KL, 2008, RETINA-J RET VIT DIS, V28, P410, DOI 10.1097/IAE.0b013e31816102f2; Massin P, 2003, AM J OPHTHALMOL, V135, P169, DOI 10.1016/S0002-9394(02)01837-8; Ljubimov AV, 1996, J HISTOCHEM CYTOCHEM, V44, P1469; Harbour JW, 1996, AM J OPHTHALMOL, V121, P405; NASRALLAH FP, 1988, OPHTHALMOLOGY, V95, P1335; Bhagat N, 2009, SURV OPHTHALMOL, V54, P1, DOI 10.1016/j.survophthal.2008.10.001; Bahadir Mehmet, 2005, International Ophthalmology, V26, P3; Christoforidis John B., 2004, International Ophthalmology Clinics, V44, P139, DOI 10.1097/00004397-200404410-00015; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Figueroa MS, 2008, RETINA-J RET VIT DIS, V28, P420, DOI 10.1097/IAE.0b013e318159e7d2; Flaxel CJ, 2010, RETINA-J RET VIT DIS, V30, P1488, DOI 10.1097/IAE.0b013e3181e7974f; Haller JA, 2010, OPHTHALMOLOGY, V117, P1087, DOI 10.1016/j.ophtha.2009.10.040; Hoerauf H, 2011, GRAEF ARCH CLIN EXP, V249, P997, DOI 10.1007/s00417-010-1610-8; Ikeda T, 1999, BRIT J OPHTHALMOL, V83, P12, DOI 10.1136/bjo.83.1.12; Jahn CE, 2004, OPHTHALMOLOGICA, V218, P378, DOI 10.1159/000080940; Kadonosono K, 2000, AM J OPHTHALMOL, V130, P740, DOI 10.1016/S0002-9394(00)00575-4; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P515; Kumagai Kazuyuki, 2002, Nippon Ganka Gakkai Zasshi, V106, P590; Matsunaga N, 2005, RETINA-J RET VIT DIS, V25, P311, DOI 10.1097/00006982-200504000-00010; Mochizuki Y, 2006, RETINA-J RET VIT DIS, V26, P143, DOI 10.1097/00006982-200602000-00003; Patel JI, 2006, RETINA-J RET VIT DIS, V26, P5, DOI 10.1097/00006982-200601000-00002; Shiba T, 2009, JPN J OPHTHALMOL, V53, P120, DOI 10.1007/s10384-008-0639-2; Stefaniotou M, 2004, EUR J OPHTHALMOL, V14, P137; Stolba U, 2005, AM J OPHTHALMOL, V140, P295, DOI 10.1016/j.ajo.2005.03.045; The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6; Yamakoshi T, 2009, OPHTHAL RES, V41, P203, DOI 10.1159/000217724; Yamamoto T, 2005, OPHTHALMOLOGICA, V219, P206, DOI 10.1159/000085729; Yanagida Y, 2014, RETINA-J RET VIT DIS, V34, P629, DOI 10.1097/IAE.0000000000000116	46	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	SEP	2015	35	9					1719	1725		10.1097/IAE.0000000000000622		7	Ophthalmology	Ophthalmology	CR2YK	WOS:000361196600002		
J	Manabe, A; Shimada, H; Hattori, T; Nakashizuka, H; Yuzawa, M				Manabe, Ayumu; Shimada, Hiroyuki; Hattori, Takayuki; Nakashizuka, Hiroyuki; Yuzawa, Mitsuko			RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article							ENDOTHELIAL GROWTH-FACTOR; PREOPERATIVE ADJUNCT; MACULAR DEGENERATION; PLASMA-LEVELS; VITREOUS HEMORRHAGE; RETINAL-DETACHMENT; PRIMATE EYE; VITRECTOMY; AVASTIN; RANIBIZUMAB	Purpose: To investigate the usefulness of 0.16 mg/0.05 mL intravitreal bevacizumab (IVB) injection 1 day before vitrectomy for proliferative diabetic retinopathy. Methods: Sixty-two patients with proliferative diabetic retinopathy (66 eyes) with an indication for primary vitrectomy were randomized to IVB group (34 eyes) or sham control group (32 eyes). Intravitreal bevacizumab group received intravitreal injection of 0.16 mg/0.05 mL bevacizumab, and sham control group received sham injection 1 day before vitrectomy. Vitreous fluid was sampled before vitrectomy was started. Results: Frequency of reoperation due to recurrent vitreous hemorrhage within 4 weeks after surgery was significantly lower (P = 0.033) in IVB group (3.1%, 1/32) than in sham control group (20.6%, 7/34). The number of intraoperative endodiathermy spots (0.63 +/- 1.0 vs. 1.3 +/- 1.4, P = 0.025) and frequency of postoperative recurrent vitreous hemorrhage (3.1%, 1/32 vs. 23.5%, 8/34, P = 0.017) were significantly lower in IVB group than in sham control group. Vitreous vascular endothelial growth factor concentrations were 1315.3 +/- 1153.4 pg/mL in sham control group and 25.0 +/- 13.6 pg/mL in IVB group (P < 0.0001). Conclusion: Intravitreal injection of 0.16 mg/0.05 mL bevacizumab 1 day before vitrectomy blocked vascular endothelial growth factor production in vitreous and significantly reduced the incidence of reoperation due to early postoperative recurrent vitreous hemorrhage.	[Manabe, Ayumu; Shimada, Hiroyuki; Hattori, Takayuki; Nakashizuka, Hiroyuki; Yuzawa, Mitsuko] Nihon Univ, Sch Med, Dept Ophthalmol, Chiyoda Ku, Tokyo 1018309, Japan	Shimada, H (reprint author), Nihon Univ, Surugadai Hosp, Dept Ophthalmol, Chiyoda Ku, 1-8-13 Surugadai, Tokyo 1018309, Japan.	sshimada@olive.ocn.ne.jp					Rizzo S, 2008, GRAEF ARCH CLIN EXP, V246, P837, DOI 10.1007/s00417-008-0774-y; Carneiro AM, 2011, OPHTHALMOLOGICA, V225, P211, DOI 10.1159/000323943; Hattori T, 2010, RETINA-J RET VIT DIS, V30, P761, DOI 10.1097/IAE.0b013e3181c70168; Ahn J, 2011, OPHTHALMOLOGY, V118, P2218, DOI 10.1016/j.ophtha.2011.03.036; Zehetner C, 2013, BRIT J OPHTHALMOL, V97, P454, DOI 10.1136/bjophthalmol-2012-302451; Arevalo JF, 2008, BRIT J OPHTHALMOL, V92, P213, DOI 10.1136/bjo.2007.127142; Zhang ZH, 2013, AM J OPHTHALMOL, V156, P106, DOI 10.1016/j.ajo.2013.02.008; Ahmadieh H, 2009, OPHTHALMOLOGY, V116, P1943, DOI 10.1016/j.ophtha.2009.07.001; Inan UU, 2007, INVEST OPHTH VIS SCI, V48, P1773, DOI 10.1167/iovs.06-0828; Hernandez-Da Mota SE, 2010, EUR J OPHTHALMOL, V20, P1047; Shimomura Y, 2009, GRAEF ARCH CLIN EXP, V247, P1089, DOI 10.1007/s00417-009-1054-1; Modarres M, 2009, EUR J OPHTHALMOL, V19, P848; Zhao LQ, 2011, BRIT J OPHTHALMOL, V95, P1216, DOI 10.1136/bjo.2010.189514; Farahvash MS, 2011, RETINA-J RET VIT DIS, V31, P1254, DOI 10.1097/IAE.0b013e31820a68e5; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Carneiro AM, 2012, ACTA OPHTHALMOL, V90, pE25, DOI 10.1111/j.1755-3768.2011.02240.x; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Matsuyama K, 2011, J OCUL PHARMACOL TH, V27, P379, DOI 10.1089/jop.2010.0194; Oshima Y, 2009, OPHTHALMOLOGY, V116, P927, DOI 10.1016/j.ophtha.2008.11.005; di Lauro R, 2010, GRAEF ARCH CLIN EXP, V248, P785, DOI 10.1007/s00417-010-1303-3; Avery L, 2006, OPHTHALMOLOGY, V113; Brown David M, 2010, Ophthalmology, V117, P1124, DOI 10.1016/j.ophtha.2010.02.022; da R Lucena D, 2009, Br J Ophthalmol, V93, P688, DOI 10.1136/bjo.2008.151233; El-Batarny Ashraf M, 2008, Clin Ophthalmol, V2, P709; Heiduschka P, 2007, INVEST OPHTH VIS SCI, V48, P2814, DOI 10.1167/iovs.06-1171; Julien S, 2008, BRIT J OPHTHALMOL, V92, P1424, DOI 10.1136/bjo.2008.141317; LEWIS H, 1987, AM J OPHTHALMOL, V104, P607; Matsuyama K, 2010, BRIT J OPHTHALMOL, V94, P1215, DOI 10.1136/bjo.2008.156810; NOVAK MA, 1984, OPHTHALMOLOGY, V91, P1485; SCHACHAT AP, 1983, OPHTHALMOLOGY, V90, P522; Shimada H, 2013, GRAEFES ARCH CLIN EX, V251, P1185; TOLENTINO FI, 1980, OPHTHALMOLOGY, V87, P1078	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	SEP	2015	35	9					1800	1807		10.1097/IAE.0000000000000577		8	Ophthalmology	Ophthalmology	CR2YK	WOS:000361196600013		
J	Tanaka, N; Miyatake, N; Kinoshita, H; Fukunaga, T				Tanaka, Naoko; Miyatake, Nobuyuki; Kinoshita, Hiroshi; Fukunaga, Tatsushige			Correlation between death while bathing and meteorological parameters in the 23 wards of Tokyo	ROMANIAN JOURNAL OF LEGAL MEDICINE			English	Article						death during bathing; air temperature; 23 wards of Tokyo; ecological study	AIR-TEMPERATURE; SUDDEN-DEATH; MORTALITY	Study's Objectives. Japanese people bathe every day and every home has a bathtub. The number of deaths while bathing increases during colder months. The present ecological study aimed to determine whether or not low air temperature is associated with death while bathing in Japan. Materials and Methods. The monthly numbers of deaths while bathing in the 23 wards of Tokyo were obtained from the Tokyo Medical Examiner's Office and data on air temperature and humidity were obtained from the Japan Meteorological Agency. Results. The monthly numbers of deaths while bathing significantly and negatively correlated with air temperature and humidity (mean air temperature, r = -0.943; p < 0.0001). A single regression line showed that a decrease in mean air temperature of 1 degrees C corresponded to a monthly increase of 0.095 deaths per 100,000 persons. Conclusions. Lower air temperature is closely associated with higher rates of death while bathing in the 23 wards of Tokyo, Japan.	[Tanaka, Naoko; Kinoshita, Hiroshi] Kagawa Univ, Fac Med, Dept Forens Med, Miki, Kagawa, Japan; [Miyatake, Nobuyuki] Kagawa Univ, Dept Hyg, Fac Med, Miki, Kagawa, Japan; [Fukunaga, Tatsushige] Tokyo Metropolitan Govt, Tokyo Med Examiners Off, Bunkyo Ku, Tokyo, Tokyo, Japan	Kinoshita, H (reprint author), Kagawa Univ, Fac Med, Dept Forens Med, 1750-1,Miki, Kagawa 7610793, Japan.	kinochin@med.kagawa-u.ac.jp					KUNST AE, 1993, AM J EPIDEMIOL, V137, P331; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; Martens WJM, 1998, SOC SCI MED, V46, P331, DOI 10.1016/S0277-9536(97)00162-7; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Chiba T, 2005, FORENSIC SCI INT, V149, P151, DOI 10.1016/j.forsciint.2004.04.085; Hashimoto Yoshihiro, 2008, Journal of  the Japanese Society of Balneology Climatology and Physical Medicine, V72, P25; Japan Meteorological Agency, MONTHL DAT CLIM PAR; Miyatake N, 2013, OPEN J EPIDEMIOL, V3, P220; Nagahara Yousuke, 2011, Medical Journal of Kagoshima University, V63, P23; Statistics Division Bureau of General Affairs Tokyo Japan, POP TOK; Takahashi R, 2007, J AM GERIATR SOC, V55, P1305, DOI 10.1111/j.1532-5415.2007.01255.x; Tokyo Medical Examiner's Office, CHANG DEATH BATH 23	12	0	0	ROMANIAN LEGAL MED SOC	BUCHAREST	SOS VITAN-BIRZESTI 9, BUCHAREST, 75669, ROMANIA	1221-8618			ROM J LEG MED	Rom. J. Leg. Med.	SEP	2015	23	3					167	170		10.4323/rjlm.2015.167		4	Medicine, Legal	Legal Medicine	CR3ZW	WOS:000361272600003		
J	Kinoshita, H; Tanaka, N; Takakura, A; Kumihashi, M; Jamal, M; Ito, A; Tsutsui, K; Kimura, S; Matsubara, S; Ameno, K				Kinoshita, Hiroshi; Tanaka, Naoko; Takakura, Ayaka; Kumihashi, Mitsuru; Jamal, Mostofa; Ito, Asuka; Tsutsui, Kunihiko; Kimura, Shoji; Matsubara, Shuji; Ameno, Kiyoshi			Multiple drug poisoning case caused by a pharmacokinetic interaction involving paroxetine	ROMANIAN JOURNAL OF LEGAL MEDICINE			English	Article						multiple drug; pharmacokinetic drug interaction; poisoning; paroxetine		A fatal poisoning case involving multiple psychotropic drugs is presented. Quantitative toxicological analysis showed that the concentrations of diphenhydramine, paroxetine, phenobarbital, diazepam and its metabolites (nordiazepam and temazepam) in the femoral blood were 9.19 mu g/ml, 1.02 mu g/ml, 19.9 mu g/ml, 0.26 mu g/ml, 8.55 mu g/ml and 2.69 mu g/ml, respectively. We concluded that the cause of death was due to multiple drug ingestion. As diphenhydramine metabolism is mediated by CYP2D6, and paroxetine inhibits its enzymatic activity, a pharmacokinetic interaction may have induced the high concentration of diphenhydramine in the present case. Pharmacokinetic drug interactions need to be evaluated in cases involving paroxetine drug overdoses.	[Kinoshita, Hiroshi; Tanaka, Naoko; Takakura, Ayaka; Kumihashi, Mitsuru; Jamal, Mostofa; Ito, Asuka; Kimura, Shoji; Ameno, Kiyoshi] Kagawa Univ, Dept Forens Med, Fac Med, Kagawa 7610793, Japan; [Tsutsui, Kunihiko] Kagawa Univ, Dept Hlth Sci, Fac Med, Kagawa 7610793, Japan; [Matsubara, Shuji] Kagawa Univ Hosp, Community Hlth Care Educ Support Ctr, Kagawa, Japan	Kinoshita, H (reprint author), Kagawa Univ, Dept Forens Med, Fac Med, 1750-1,Miki, Kagawa 7610793, Japan.	kinochin@med.kagawa-u.ac.jp					Akutsu T, 2007, DRUG METAB DISPOS, V35, P72, DOI 10.1124/dmd.106.012088; Andresen H, 2013, INT J LEGAL MED, V127, P395, DOI 10.1007/s00414-012-0759-6; Bourin M, 2001, CNS DRUG REV, V7, P25; Kudo K, 2009, FORENSIC TOXICOL, V27, P21, DOI 10.1007/s11419-009-0066-1; Winek CL, 2001, FORENSIC SCI INT, V122, P107, DOI 10.1016/S0379-0738(01)00483-2; Vermeulen T, 1998, J ANAL TOXICOL, V22, P541; Goeringer KE, 2000, J FORENSIC SCI, V45, P633; Baselt RC, 2008, DISPOSITION TOXIC DR; Skidgel RA, 2006, GOODMAN GILMANS PHAR, V11'h; Takahashi M, 2010, SOUD LEK, V55, P2	10	0	0	ROMANIAN LEGAL MED SOC	BUCHAREST	SOS VITAN-BIRZESTI 9, BUCHAREST, 75669, ROMANIA	1221-8618			ROM J LEG MED	Rom. J. Leg. Med.	SEP	2015	23	3					208	210		10.4323/rjlm.2015.208		3	Medicine, Legal	Legal Medicine	CR3ZW	WOS:000361272600010		
J	Sheehan, AF; Gusman, AR; Heidarzadeh, M; Satake, K				Sheehan, Anne F.; Gusman, Aditya Riadi; Heidarzadeh, Mohammad; Satake, Kenji			Array Observations of the 2012 Haida Gwaii Tsunami Using Cascadia Initiative Absolute and Differential Seafloor Pressure Gauges	SEISMOLOGICAL RESEARCH LETTERS			English	Article							INFRAGRAVITY WAVES; PLATE BOUNDARY; DEEP-OCEAN; PACIFIC; EARTHQUAKE		[Sheehan, Anne F.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Sheehan, Anne F.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Gusman, Aditya Riadi; Heidarzadeh, Mohammad; Satake, Kenji] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Sheehan, AF (reprint author), Univ Colorado, Dept Geol Sci, UCB 399, Boulder, CO 80309 USA.	anne.sheehan@colorado.edu	Satake, Kenji/E-2312-2011; Heidarzadeh, Mohammad/A-1354-2016	Heidarzadeh, Mohammad/0000-0002-1112-1276	United States National Science Foundation [EAR-0552316]; National Science Foundation [1333025]; University of Colorado College Scholar Award; Japan Society for the Promotion of Science	The authors are grateful to the Cascadia Initiative (CI) Expedition Team for acquiring the Amphibious Array Ocean Bottom Seismograph data and appreciate the open data policy that made the data available shortly after they were acquired. The Scripps, Lamont, and Woods Hole National Ocean Bottom Seismograph Instrument Pool (OBSIP) institutional instrument centers are thanked for building, deploying, and servicing the seafloor instruments of the CI. The facilities of the Incorporated Research Institutions for Seismology (IRIS) Data Management System were used to access the data used in this study. The IRIS DMS is funded through the United States National Science Foundation under Cooperative Agreement EAR-0552316. We thank Jessica Lodewyk for answering our OBSIP and CI data questions and Justin Ball for help with the coherence measurements. We thank the guest editors of the SRL special issue on CI initial results and data quality control, Haiying Gao and Susan Schwartz, and an anonymous reviewer for comments that improved the article. Some of the figures were made using the public domain Generic Mapping Tools (Wessel and Smith, 1998). Partial support for this work came from National Science Foundation Grant Number 1333025 and a University of Colorado College Scholar Award. A. F. S. gratefully acknowledges a visiting professorship at the Earthquake Research Institute, University of Tokyo. M. H. was supported by the Japan Society for the Promotion of Science.	EBLE MC, 1991, J ATMOS OCEAN TECH, V8, P221, DOI 10.1175/1520-0426(1991)008<0221:DOBPMI>2.0.CO;2; Kanamori H, 2008, GEOPHYS J INT, V175, P222, DOI 10.1111/j.1365-246X.2008.03887.x; Thomson R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046728; SATAKE K, 1995, PURE APPL GEOPHYS, V144, P455, DOI 10.1007/BF00874378; Watada S, 2014, J GEOPHYS RES-SOL EA, V119, P4287, DOI 10.1002/2013JB010841; Toomey DR, 2014, OCEANOGRAPHY, V27, P138; Rabinovich A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047026; Lay T, 2013, EARTH PLANET SC LETT, V375, P57, DOI 10.1016/j.epsl.2013.05.005; Baba T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019397; Mungov G, 2013, PURE APPL GEOPHYS, V170, P1369, DOI 10.1007/s00024-012-0477-5; Takeo A, 2014, GEOPHYS J INT, V199, P11, DOI 10.1093/gji/ggu240; Araki E., 2009, JAMSTEC R, V9, P141; Bernard E. N., 2001, INT TSUN S 2001 ITS; Chadwick WW, 2012, NAT GEOSCI, V5, P474, DOI 10.1038/ngeo1464; Cox C., 1984, Journal of Atmospheric and Oceanic Technology, V1, DOI 10.1175/1520-0426(1984)001<0237:ADSDPG>2.0.CO;2; Drushka K, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004662; Fine IV, 2015, PURE APPL GEOPHYS, V172, P699, DOI 10.1007/s00024-014-1012-7; Gonzalez F. I., 1998, P INT WORKSH TSUN DI; Houston MH, 1998, PROCEEDINGS OF THE 1998 INTERNATIONAL SYMPOSIUM ON UNDERWATER TECHNOLOGY, P307, DOI 10.1109/UT.1998.670113; Ito Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048355; James TS, 2015, B SEISMOL SOC AM, V105, P1053, DOI 10.1785/0120150044; Leonard LJ, 2015, B SEISMOL SOC AM, V105, P1280, DOI 10.1785/0120140193; Lin FC, 2015, J GEOPHYS RES-SOL EA, V120, P3350, DOI 10.1002/2014JB011524; Meinig C., 2005, REAL TIME DEEP OCEAN; Mofjeld H. O., 2009, THE SEA TSUNAMI, P201; Polster A, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002532; Rabinovich AB, 2015, PURE APPL GEOPHYS, V172, P3281, DOI 10.1007/s00024-015-1058-1; Rawat A, 2014, GEOPHYS RES LETT, V41, P7957, DOI 10.1002/2014GL061604; Saito T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045290; Sheehan A. F., 2011, EOS T AGU S; Tian Y, 2013, GEOCHEM GEOPHY GEOSY, V14, P3221, DOI 10.1002/ggge.20206; WEBB SC, 1991, J GEOPHYS RES-OCEANS, V96, P2723, DOI 10.1029/90JC02212; WESSEL P, 1998, EOS T AGU, V0079	33	2	2	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0895-0695			SEISMOL RES LETT	Seismol. Res. Lett.	SEP-OCT	2015	86	5					1278	1286		10.1785/0220150108		9	Geochemistry & Geophysics	Geochemistry & Geophysics	CR3TR	WOS:000361256500008		
J	Okada, S; Ishimura, D; Niwa, Y; Toda, S				Okada, Shinsuke; Ishimura, Daisuke; Niwa, Yuichi; Toda, Shinji			The First Surface-Rupturing Earthquake in 20 Years on a HERP Active Fault is Not Characteristic: The 2014 M-W, 6.2 Nagano Event along the Northern Itoigawa-Shizuoka Tectonic Line	SEISMOLOGICAL RESEARCH LETTERS			English	Article							CRUSTAL DEFORMATION; CENTRAL JAPAN; FAILURE		[Okada, Shinsuke; Ishimura, Daisuke; Niwa, Yuichi; Toda, Shinji] Tohoku Univ, Int Res Inst Disaster Sci IRIDeS, Aoba Ku, Sendai, Miyagi 9800845, Japan	Okada, S (reprint author), Tohoku Univ, Int Res Inst Disaster Sci IRIDeS, Aoba Ku, 468-1 Aoba, Sendai, Miyagi 9800845, Japan.	sokada@irides.tohoku.ac.jp; toda@irides.tohoku.ac.jp			International Research Institute of Disaster Science (IRIDeS), Tohoku University	The thoughtful comments from Mike Oskin, an anonymous reviewer, Associate Editor Taka'aki Taira, and Editor-in-Chief Zhigang Peng improved the document. We thank Masashi Omata and Nobuhisa Matsuta for providing us with information on several rupture locations. We also thank Toshifumi Imaizumi for helpful discussions. This study was supported by a special emergency grant to study the 2014 Nagano earthquake from the International Research Institute of Disaster Science (IRIDeS), Tohoku University.	Matthews MV, 2002, B SEISMOL SOC AM, V92, P2233, DOI 10.1785/0120010267; SCHWARTZ DP, 1984, J GEOPHYS RES, V89, P5681, DOI 10.1029/JB089iB07p05681; Okada S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008355; Scharer K, 2014, GEOPHYS RES LETT, V41, P4527, DOI 10.1002/2014GL060318; Woessner J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003961; Toda S, 2011, EARTH PLANETS SPACE, V63, P725, DOI 10.5047/eps.2011.05.010; Okumura K, 2001, J SEISMOL, V5, P411, DOI 10.1023/A:1011483811145; Stein RS, 1997, GEOPHYS J INT, V128, P594, DOI 10.1111/j.1365-246X.1997.tb05321.x; Geological Survey of Japan National Institute of Advanced Industrial Science and Technology (AIST), 2005, ACT FAULT DAT JAP GO; Geospatial Information Authority of Japan, 2014, INF 2014 NAG KEN HOK; Headquarters for Earthquake Research and Promotion (HERP), 1996, SURV RES EV IT SHIZ; Headquarters for Earthquake Research and Promotion (HERP), 2014, SCEN EARTHQ SHAK MAP, P128; Ikeda Y., 2002, ATLAS QUATERNARY THR; Imaizumi T., 1997, ACTIVE FAULT RES, V16, P35; Japan Meteorological Agency (JMA), 2014, NOV 22 2014 22 08 JS; Koketsu K., 2010, UNDERGROUND EXPLORAT, P255; Kosaka T, 1992, J FS SHINSHU U, V26, P75; Maruyama T., 2010, HIST PALEOSEISMIC IN, P230; Matsuda T., 1975, ZISIN 2, V28, P269; Matsuta N., 2001, ACTIVE FAULT RES, V20, P59; Miura D., 2002, ZISIN, V255, P33; Nakata T., 2002, DIGITAL ACTIVE FAULT; National Research Institute for Earth Science and Disaster Prevention, 2014, STRONG MOT DUE 22 NO; Okumura K., 1998, ZISIN APPENDIX, V50, P35; Okumura K., 1994, ZISIN, V2, P425; Okumura K., 2007, EOS T AGU, V87; Research Group for Active Faults of Japan, 1980, ACT FAULTS JAP SHEET; Research Group for Active Faults of Japan, 1991, ACT FAULTS JAP SHEET, VSecond; SAGIYA T., 2000, PURE APPL GEOPHYS, V157, P2302; Sagiya T, 2003, ZISIN, V56, P199; Sagiya T, 2002, EARTH PLANETS SPACE, V54, P1059; Sagiya T, 2004, EARTH PLANETS SPACE, V56, P1247; Shimokawa K., 1987, ANN M JAP ASS QUAT R, P92; Suzuki Y., 2010, ACTIVE FAULT RES, V33, P1; Takemura M., 1998, ZISIN 2, V51, P211; Toda S., 2000, ZISIN, V2, P445; Toda S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047834; Tsuji Y., 2004, HIST EARTHQUAKES ITO, P77; Ueno H., 2002, Q J SEISMOL, V65, P123; Usami T., 2013, MAT COMPREHENSIVE LI; Yoshinaga Y., 2009, THESIS OSAKA CITY U	41	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0895-0695			SEISMOL RES LETT	Seismol. Res. Lett.	SEP-OCT	2015	86	5					1287	1300		10.1785/0220150052		14	Geochemistry & Geophysics	Geochemistry & Geophysics	CR3TR	WOS:000361256500009		
J	Thompson, DA; Kendall, JM; Helffrich, GR; Bastow, ID; Wookey, J; Snyder, DB				Thompson, D. A.; Kendall, J. -M.; Helffrich, G. R.; Bastow, I. D.; Wookey, J.; Snyder, D. B.			CAN-HK: An a Priori Crustal Model for the Canadian Shield	SEISMOLOGICAL RESEARCH LETTERS			English	Article							TELESEISMIC RECEIVER FUNCTIONS; TRANSITION ZONE BENEATH; UPPER-MANTLE; SEISMIC VELOCITIES; NOISE TOMOGRAPHY; WAVE DISPERSION; SLAVE CRATON; HUDSON-BAY; LITHOSPHERE; DISCONTINUITY		[Thompson, D. A.] Univ Aberdeen, Kings Coll, Sch Geosci, Aberdeen AB24 3UE, Scotland; [Thompson, D. A.; Kendall, J. -M.; Wookey, J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Helffrich, G. R.] Tokyo Inst Technol, Earth & Life Sci Inst, Meguro Ku, Tokyo 1528550, Japan; [Bastow, I. D.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Snyder, D. B.] Nat Resources Canada, Geol Survey Canada, Ottawa, ON K1A 0E9, Canada; [Thompson, D. A.; Helffrich, G. R.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	Thompson, DA (reprint author), Univ Aberdeen, Kings Coll, Sch Geosci, Aberdeen AB24 3UE, Scotland.	david.thompson@abdn.ac.uk	Geophysical Equipment Facility, NERC/G-5260-2010		Natural Environment Research Council (NERC) [NE/F007337/1]; Geological Survey of Canada (GSC); Canada-Nunavut Geoscience Office (CNGO); SEIS-UK (the seismic node of NERC);  [RPG-2013-332]	The United Kingdom component of the Hudson Bay Lithospheric Experiment (HuBLE) was supported by the Natural Environment Research Council (NERC) Grant Number NE/F007337/1, with financial and logistical support from the Geological Survey of Canada (GSC), Canada-Nunavut Geoscience Office (CNGO), SEIS-UK (the seismic node of NERC), and the First Nations communities of Nunavut. J. Beauchesne and J. Kendall provided invaluable assistance in the field. I. D. B. was funded by the Leverhulme Trust and acknowledges support through Grant Number RPG-2013-332. The authors thank three anonymous reviewers for their constructive comments.	Abt D. L., 2010, J GEOPHYS RES, V115, P1; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Postlethwaite B, 2014, TECTONOPHYSICS, V633, P256, DOI 10.1016/j.tecto.2014.07.024; Thompson DA, 2010, EARTH PLANET SC LETT, V297, P655, DOI 10.1016/j.epsl.2010.07.021; Bank CG, 2000, TECTONOPHYSICS, V319, P151, DOI 10.1016/S0040-1951(00)00034-2; Ritsema J, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002610; Eaton DW, 2006, TECTONOPHYSICS, V420, P223, DOI 10.1016/j.tecto.2006.01.023; Eaton DW, 2009, LITHOS, V109, P1, DOI 10.1016/j.lithos.2008.05.009; Mooney WD, 1998, J GEOPHYS RES-SOL EA, V103, P727, DOI 10.1029/97JB02122; Frederiksen AW, 2001, PHYS EARTH PLANET IN, V124, P175, DOI 10.1016/S0031-9201(01)00194-7; Waldhauser F, 2002, GEOPHYS J INT, V150, P403, DOI 10.1046/j.1365-246X.2002.01690.x; HALES AL, 1969, EARTH PLANET SC LETT, V7, P44, DOI 10.1016/0012-821X(69)90009-0; Zhu LP, 2000, J GEOPHYS RES-SOL EA, V105, P2969, DOI 10.1029/1999JB900322; Bastow ID, 2011, GEOLOGY, V39, P91, DOI 10.1130/G31396.1; Angus DA, 2009, PHYS EARTH PLANET IN, V177, P206, DOI 10.1016/j.pepi.2009.09.002; Steffen R, 2012, GEOPHYS J INT, V189, P1741, DOI 10.1111/j.1365-246X.2012.05452.x; Darbyshire FA, 2003, GEOPHYS J INT, V152, P372, DOI 10.1046/j.1365-246X.2003.01840.x; Lebedev S, 2009, LITHOS, V109, P96, DOI 10.1016/j.lithos.2008.06.010; Nair SK, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003802; Thompson DA, 2011, EARTH PLANET SC LETT, V312, P28, DOI 10.1016/j.epsl.2011.09.037; Ferreira AMG, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006716; Bastow ID, 2011, ASTRON GEOPHYS, V52, P21, DOI 10.1111/j.1468-4004.2011.52621.x; Kao H, 2013, J GEOPHYS RES-SOL EA, V118, P5865, DOI 10.1002/2013JB010535; Levin V, 2000, TECTONOPHYSICS, V323, P131, DOI 10.1016/S0040-1951(00)00105-0; Helffrich G, 2006, B SEISMOL SOC AM, V96, P344, DOI 10.1785/0120050098; Davis WJ, 2003, LITHOS, V71, P575, DOI 10.1016/S0024-4937(03)00131-2; Pawlak A, 2011, GEOPHYS J INT, V184, P65, DOI 10.1111/j.1365-246X.2010.04828.x; Panning MP, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007520; Artemieva I.M., 2011, LITHOSPHERE INTERDIS; Bassin C, 2000, EOS T AGU, V81, pF897, DOI DOI 10.1007/S00015-005-1168-3; Bastow I. D., 2015, SPECIAL PUBLICATIONS, V389, P41, DOI [10.1144/SP389.7, DOI 10.1144/SP389.7]; Christensen NI, 1996, J GEOPHYS RES-SOL EA, V101, P3139, DOI 10.1029/95JB03446; Crotwell H.P., 1999, SEISMOL RES LETT, V70, P154, DOI DOI 10.1785/GSSRL.70.2.154; Darbyshire FA, 2007, GEOPHYS J INT, V169, P1043, DOI 10.1111/j.1365-246X.2006.03259.x; Eaton D.W., 2005, EOS T AGU, V86, P169, DOI [10.1029/2005EO170001, DOI 10.1029/2005E0170001]; Laske G., 2013, GEOPH RES ABSTR, V15; Marone F, 2007, GEOPHYS J INT, V170, P460, DOI 10.1111/j.1365-246X.2007.03399.x; Perry HKC, 2002, GEOPHYS J INT, V150, P285, DOI 10.1046/j.1365-246X.2002.01712.x; Tesauro M, 2014, TECTONOPHYSICS, V631, P65, DOI 10.1016/j.tecto.2014.04.016; Wessel P., 1995, EOS T AM GEOPHYS UN, V76, P329, DOI DOI 10.1029/95EO00198	40	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0895-0695	1938-2057		SEISMOL RES LETT	Seismol. Res. Lett.	SEP-OCT	2015	86	5					1374	1382		10.1785/0220150015		9	Geochemistry & Geophysics	Geochemistry & Geophysics	CR3TR	WOS:000361256500018		
J	Qin, D				Qin, Dan			On justifiable choice functions over opportunity sets	SOCIAL CHOICE AND WELFARE			English	Article							RATIONALITY	A choice function over opportunity sets is justifiable if there exists a choice function over alternatives such that an opportunity set (menu) is chosen from a collection of menus if and only if the former contains alternatives which reach the highest instrumentalist value, in terms of the choice function over alternatives, of all menus combined. This article explores necessary and sufficient conditions for justifiable choice function by general choice function, Chernoff consistent choice function, and path-independent choice function. This article also considers the condition under which the underlying choice function is binary, which leads to characterizations for binary-justifiability by acyclic, quasi-transitive, and transitive preferences.	Waseda Univ, Grad Sch Econ, Shinjuku Ku, Tokyo 1698050, Japan	Qin, D (reprint author), Waseda Univ, Grad Sch Econ, Shinjuku Ku, 1-104 Totsukamachi, Tokyo 1698050, Japan.	Lucifier1031@foxmail.com					KREPS DM, 1979, ECONOMETRICA, V47, P565, DOI 10.2307/1910406; Chernoff H, 1954, ECONOMETRICA, V22, P422, DOI 10.2307/1907435; ARROW KJ, 1959, ECONOMICA, V26, P121, DOI 10.2307/2550390; BLAIR DH, 1976, J ECON THEORY, V13, P361, DOI 10.1016/0022-0531(76)90047-8; Bossert W, 2011, SOC CHOICE WELFARE, V37, P729, DOI 10.1007/s00355-011-0568-8; Bossert W, 2009, ECON PHILOS, V25, P139, DOI 10.1017/S0266267109990010; Dowding K, 2009, HDB RATIONAL SOCIAL, P374; Kreps DM, 1988, NOTES THEORY CHOICE, V2; Lahiri S, 2003, SOC CHOICE WELFARE, V21, P117, DOI 10.1007/s00355-003-0205-2; Luce R. D., 1957, GAMES DECISIONS; PLOTT CR, 1973, ECONOMETRICA, V41, P1075, DOI 10.2307/1914037; QUINN WS, 1990, PHILOS STUD, V59, P79, DOI 10.1007/BF00368392; Richter MK, 1971, PREFERENCES UTILITY, P29; Ryan M, 2014, SOC CHOICE WELFARE, V42, P193, DOI 10.1007/s00355-012-0719-6; SEN A, 1993, ECONOMETRICA, V61, P495, DOI 10.2307/2951715	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0176-1714	1432-217X		SOC CHOICE WELFARE	Soc Choice Welf.	SEP	2015	45	2					269	285		10.1007/s00355-015-0890-7		17	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	CR7QB	WOS:000361544400002		
J	van den Brink, R; Funaki, Y				van den Brink, Rene; Funaki, Yukihiko			Implementation and axiomatization of discounted Shapley values	SOCIAL CHOICE AND WELFARE			English	Article							COOPERATIVE GAMES; TU-GAMES; SURPLUS; FAMILY	In this paper we introduce discounting in the bidding mechanism of P,rez-Castrillo and Wettstein (J Econ Theory 100:274-294, 2001) who implemented the Shapley value for cooperative transferable utility games. This modification of the mechanism yields the corresponding discounted Shapley value as the payoff distribution in every subgame perfect equilibrium. The class of discounted Shapley values contains the Shapley value and equal division solution as its extreme cases. Interestingly, we obtain axiomatizations of each solution in this class by generalizing the null player property (of the Shapley value) and nullifying player property (of the equal division solution) to the so-called -reducing player property.	[van den Brink, Rene] Vrije Univ Amsterdam, Dept Econometr, NL-1081 HV Amsterdam, Netherlands; [van den Brink, Rene] Vrije Univ Amsterdam, Tinbergen Inst, NL-1081 HV Amsterdam, Netherlands; [Funaki, Yukihiko] Waseda Univ, Fac Polit Sci & Econ, Shinjuku Ku, Tokyo 1698050, Japan	van den Brink, R (reprint author), Vrije Univ Amsterdam, Dept Econometr, Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands.	jrbrink@feweb.vu.nl; funaki@waseda.jp			NWO [B 45-299]; JSPS KAKENHI [26380247]	Financial supports from NWO-Grant B 45-299 and JSPS KAKENHI Grant Number 26380247 are gratefully acknowledged. We thank anonymous referees for their valuable comments.	Ju Y, 2007, SOC CHOICE WELFARE, V28, P685, DOI 10.1007/s00355-006-0192-1; van den Brink R, 2007, J ECON THEORY, V136, P767, DOI 10.1016/j.jet.2006.09.008; van den Brink R, 2009, THEOR DECIS, V67, P303, DOI 10.1007/s11238-007-9083-x; HART S, 1989, ECONOMETRICA, V57, P589, DOI 10.2307/1911054; Perez-Castrillo D, 2001, J ECON THEORY, V100, P274, DOI 10.1006/jeth.2000.2704; GUL F, 1989, ECONOMETRICA, V57, P81, DOI 10.2307/1912573; DRIESSEN TSH, 1991, OR SPEKTRUM, V13, P15; Nash J, 1953, ECONOMETRICA, V21, P128, DOI 10.2307/1906951; Hart S, 1996, ECONOMETRICA, V64, P357, DOI 10.2307/2171787; RUBINSTEIN A, 1982, ECONOMETRICA, V50, P97, DOI 10.2307/1912531; CHUN Y, 1991, INT J GAME THEORY, V20, P183, DOI 10.1007/BF01240278; Radzik T, 2013, MATH SOC SCI, V65, P105, DOI 10.1016/j.mathsocsci.2012.10.002; Ju Y, 2009, ECON THEOR, V39, P307, DOI 10.1007/s00199-008-0335-y; Nembua CC, 2012, GAME ECON BEHAV, V74, P431, DOI 10.1016/j.geb.2011.07.003; Deegan J., 1978, International Journal of Game Theory, V7, DOI 10.1007/BF01753239; Driessen TSH, 2002, INT T OPER RES, V9, P1; Harsanyi J. C., 1959, CONTRIBUTIONS THEORY, P325; Hart S, 1988, SHAPLEY VALUE ESSAYS, P127, DOI 10.1017/CBO9780511528446.010; Joosten R, 1996, THESIS MAASTRICHT U; Malawski M, 2013, INT J GAME THEORY, V42, P305, DOI 10.1007/s00182-012-0361-7; MASCHLER M, 1989, INT J GAME THEORY, V18, P389, DOI 10.1007/BF01358800; Myerson R. B., 1980, International Journal of Game Theory, V9, DOI 10.1007/BF01781371; Ruiz LM, 1998, GAME ECON BEHAV, V24, P109, DOI 10.1006/game.1997.0622; Shapley L.S., 1953, CONTRIBUTIONS THEORY, P307; Sobolev AI, 1973, ADV GAME THEORY, P151; van den Brink R., 2013, SOC CHOICE WELFARE, V40, P693; van den Brink R, 2001, INT J GAME THEORY, V30, P309; Young H. P., 1985, International Journal of Game Theory, V14, DOI 10.1007/BF01769885	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0176-1714	1432-217X		SOC CHOICE WELFARE	Soc Choice Welf.	SEP	2015	45	2					329	344		10.1007/s00355-015-0899-y		16	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	CR7QB	WOS:000361544400005		
J	Pramanik, A				Pramanik, Anup			Further results on dictatorial domains	SOCIAL CHOICE AND WELFARE			English	Article								This paper generalizes the results in Aswal et al. (Econ Theory 22:45-62, 2003) on dictatorial domains. This is done in two ways. In the first, the notion of connections between pairs of alternatives in Aswal et al. (2003) is weakened to weak connectedness. This notion requires the specification of four preference orderings for every alternative pair. Domains that are linked in the sense of Aswal et al. (2003) with weak connectedness replacing connectedness, are shown to be dictatorial. In the second, the notion of connections for alternative pairs is strengthened relative to its counterpart in Aswal et al. (2003). However, a domain is shown to be dictatorial if the induced graph is merely connected rather than linked. This result generalizes the result in Sato (Rev Econ Design 14:331-342, 2010) on circular domains.	Osaka Univ, Inst Social & Econ Res, Osaka, Japan	Pramanik, A (reprint author), Osaka Univ, Inst Social & Econ Res, Osaka, Japan.	anup.isid@gmail.com					GIBBARD A, 1973, ECONOMETRICA, V41, P587, DOI 10.2307/1914083; Aswal N, 2003, ECON THEOR, V22, P45, DOI 10.1007/s00199-002-0285-8; Chatterji S, 2011, ECON THEOR, V46, P255, DOI 10.1007/s00199-009-0509-2; Dogan E, 2007, ECON LETT, V96, P140, DOI 10.1016/j.econlet.2006.12.022; Sato S, 2010, REV ECON DES, V14, P331, DOI 10.1007/s10058-010-0102-y; SATTERTHWAITE MA, 1975, J ECON THEORY, V10, P187, DOI 10.1016/0022-0531(75)90050-2; West D. B., 2001, INTRO GRAPH THEORY	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0176-1714	1432-217X		SOC CHOICE WELFARE	Soc Choice Welf.	SEP	2015	45	2					379	398		10.1007/s00355-015-0889-0		20	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	CR7QB	WOS:000361544400007		
J	Liu, Q; Chen, YJ; Wang, HS; Zeng, Q; Ozaki, Y				Liu Qing; Chen Yu-jing; Wang Hai-shui; Zeng Qiang; Ozaki, Yukihiro			A Method to Obtain a Good Infrared Spectrum of the Wet Acetone Gas Sample without Any Drying Pretreatment	SPECTROSCOPY AND SPECTRAL ANALYSIS			English	Article						Water vapor interference; Elimination; Infrared spectrum; High resolution; Gas sample	SPECTROSCOPY	Water vapor in the beam of a Fourier transform infrared (FTIR) spectrometer or/and in a gas cell is a major source of interference in the infrared measurement of a gas sample. In general, in order to eliminate the effect of water vapor, we have to completely remove these molecules before the measurement of any spectrum. Herein, we provide an approach to collect an IR spectrum of a gas (wet acetone) sample free from water vapor interference without any drying pretreatment. After dozens of scans, the air atmosphere in the sample compartment of the FTIR spectrometer will be slightly adjusted by small amounts of dry air or wet air (room air) depending on the property of water vapor lines (absorbance> 0 or absorbance <0). Water vapor lines will then gradually disappear when the ensuing collection process is continued. The experiment results demonstrated that this method is a facile and very effective way to remove water vapor interference. Moreover, this method works still well for the measurement at 0.5 cm(-1) resolution, typically used in the gas infrared measurement.	[Liu Qing; Chen Yu-jing; Wang Hai-shui; Zeng Qiang] S China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510640, Guangdong, Peoples R China; [Ozaki, Yukihiro] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Chem, Sanda, Hyogo 6691337, Japan	Wang, HS (reprint author), S China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510640, Guangdong, Peoples R China.	wanghsh@scut.edu.cn; ceqzeng@scut.edu.cn			Natural Science Foundation of China [20873136]	Foundation item: Natural Science Foundation of China (20873136)	Weis DD, 1998, ANAL CHEM, V70, P3175, DOI 10.1021/ac971174a; Chen Y, 2014, TALANTA, V119, P105, DOI 10.1016/j.talanta.2013.10.058; Griffiths P. R., 2007, FOURIER TRANSFORM IN; Miljkovic M, 2012, ANALYST, V137, P3954, DOI 10.1039/c2an35582e; Wang XF, 2008, J AM CHEM SOC, V130, P1972, DOI 10.1021/ja077322o	5	0	0	OFFICE SPECTROSCOPY & SPECTRAL ANALYSIS	BEIJING	NO 76 COLLAGE SOUTH RD BEIJING, BEIJING 100081, PEOPLES R CHINA	1000-0593			SPECTROSC SPECT ANAL	Spectrosc. Spectr. Anal.	SEP	2015	35	9					2540	2543		10.3964/j.issn.1000-0593(2015)09-2540-04		4	Spectroscopy	Spectroscopy	CR3YF	WOS:000361268300030		
J	Prudencio, J; Ibanez, JM; Del Pezzo, E; Marti, J; Garcia-Yeguas, A; De Siena, L				Prudencio, J.; Ibanez, J. M.; Del Pezzo, E.; Marti, J.; Garcia-Yeguas, A.; De Siena, L.			3D Attenuation Tomography of the Volcanic Island of Tenerife (Canary Islands)	SURVEYS IN GEOPHYSICS			English	Review						Attenuation; Scattering; Tomography; Tenerife; Canary Islands	WESTERN ANATOLIA TURKEY; TEIDE-VOLCANO; CALDERA TENERIFE; SEISMIC ATTENUATION; SOUTHERN SPAIN; MAGNETIC-ANOMALIES; STRUCTURAL CONTROL; NORTH-ATLANTIC; MAGMA STORAGE; MT. VESUVIUS	This paper shows a new multidisciplinary interpretation approach to the internal structure of Tenerife Island. The central core of this work is the determination of the three-dimensional attenuation structure of the region using P-waves and the coda normalization method. This study has been performed using 45,303 seismograms recorded at 85 seismic stations from an active experiment (air gun shots) conducted in January 2007. The interpretation of these new results is done combining the new images with previous studies performed in the area such as seismic velocity tomography, magnetic structure, magnetotelluric surveys or gravimetric models. Our new 3D images indicate the presence of seismic attenuation contrasts, with areas of high and low seismic attenuation patterns. High seismic attenuation zones are observed both in shallow and in deeper areas. The shallowest area of Las Caadas caldera complex (1-3 km thick) is dominated by high attenuation behavior, and it is interpreted as the combined effect of sedimentary and volcanoclastic deposits, multifracture systems and the presence of shallow aquifers. At the same time, the deeper analyzed area, more than 8 km below sea level, is dominated by a high attenuation pattern, and it is interpreted as the consequence of the effect of high-temperature rocks in the crustal-mantle boundary. This interpretation is compatible and confirmed by previous models that indicate the presence of underplating magma in this region. On the contrary, some low attenuation bodies and structures have been identified at different depths. A deep low attenuation central body is interpreted as the original central structure associated with the early stage of Tenerife Island. At shallower depths, some low attenuation bodies are compatible with old intermediate magmatic chambers postulated by petrological studies. Finally, in the north of the island (La Orotava valley) we can interpret the low attenuation structure as the headwall of this valley, supporting the idea that Las Caadas caldera and this valley resulted from two different destructive processes.	[Prudencio, J.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Prudencio, J.; Ibanez, J. M.; Del Pezzo, E.; Garcia-Yeguas, A.] Univ Granada, Inst Andaluz Geofis, E-18071 Granada, Spain; [Ibanez, J. M.] Univ Granada, Dept Fis Teor & Cosmos, E-18001 Granada, Spain; [Ibanez, J. M.] Ist Nazl Geofis & Vulcanol, Sez Catania Osservatorio Etneo, I-95125 Catania, Italy; [Del Pezzo, E.] Ist Nazl Geofis & Vulcanol, Sez Napoli Osservatorio Vesuviano, I-80124 Naples, Italy; [Marti, J.] CSIC, Inst Ciencias Tierra Jaume Almera, E-08028 Barcelona, Spain; [Garcia-Yeguas, A.] Univ Cadiz, Dept Fis Aplicada, Cadiz 11002, Spain; [Garcia-Yeguas, A.] INVOLCAN, Antiguo Hotel Taoro, Tenerife 38400, Spain; [De Siena, L.] Univ Aberdeen, Kings Coll, Sch Geosci Geol & Petr Geol, Aberdeeen AB24 3UE, Scotland	Prudencio, J (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1 Yayoi, Tokyo 1130032, Japan.	janire@ugr.es			Grupo de Investigacion en Geofisica y Sismologia from the Andalusian Regional Program, APASVO Spanish project [TEC2012-31551]; EU project MED-SUV (EC-FP7 MEDiterranean SUpersite Volcanoes); European Union's Seventh Program for research, technological development and demonstration [308665]; International Research Promotion Office from ERI (University of Tokyo); V2-Precursori project from DPC-INGV	This work was funded by several projects as Grupo de Investigacion en Geofisica y Sismologia from the Andalusian Regional Program, APASVO (TEC2012-31551) Spanish project and by the EU project MED-SUV (EC-FP7 MEDiterranean SUpersite Volcanoes). MED-SUV has received funding from the European Union's Seventh Program for research, technological development and demonstration under grant agreement No 308665. We also want to acknowledge the very useful contribution of the Editor-in-Chief and an anonymous reviewer that helped us to improve the present paper. The first author is funded by the International Research Promotion Office from ERI (University of Tokyo), and Edoardo Del Pezzo was partially funded by the V2-Precursori project from DPC-INGV.	ABDELMON.A, 1972, AM J SCI, V272, P805; Ablay G, 1997, THESIS U BRISTOL; AKINCI A, 1995, TECTONOPHYSICS, V250, P47, DOI 10.1016/0040-1951(95)00046-1; Almendros J, 2000, J VOLCANOL GEOTH RES, V103, P439, DOI 10.1016/S0377-0273(00)00236-5; ANCOCHEA E, 1990, J VOLCANOL GEOTH RES, V44, P231, DOI 10.1016/0377-0273(90)90019-C; Andujar J, 2010, B VOLCANOL, V72, P381, DOI 10.1007/s00445-009-0325-3; Alparone S, 2012, J VOLCANOL GEOTH RES, V229, P50, DOI 10.1016/j.jvolgeores.2012.04.001; [Anonymous], 2005, J GEOPHYS RES-SOL EA, DOI DOI 10.1029/2004JB003102; Watts AB, 1997, EARTH PLANET SC LETT, V146, P431, DOI 10.1016/S0012-821X(96)00249-X; AKI K, 1980, PHYS EARTH PLANET IN, V21, P50, DOI 10.1016/0031-9201(80)90019-9; Marti J, 1997, GEOLOGY, V25, P879, DOI 10.1130/0091-7613(1997)025<0879:VALCOT>2.3.CO;2; Pina-Varas P, 2014, SURV GEOPHYS, V35, P1045, DOI 10.1007/s10712-014-9280-4; Geyer A, 2010, TECTONOPHYSICS, V483, P310, DOI 10.1016/j.tecto.2009.11.002; Danobeitia JJ, 2000, J VOLCANOL GEOTH RES, V103, P27, DOI 10.1016/S0377-0273(00)00214-6; Carracedo JC, 2007, GEOL SOC AM BULL, V119, P1027, DOI 10.1130/B26087.1; Almendros J, 2007, J VOLCANOL GEOTH RES, V160, P285, DOI 10.1016/j.jvolgeores.2006.10.002; Ohlendorf SJ, 2014, J VOLCANOL GEOTH RES, V278, P103, DOI 10.1016/j.jvolgeores.2014.04.002; De Gori P, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2003JB002875; MARTI J, 1994, GEOL MAG, V131, P715; AKINCI A, 1995, GEOPHYS J INT, V121, P337, DOI 10.1111/j.1365-246X.1995.tb05715.x; Schurr B, 2003, EARTH PLANET SC LETT, V215, P105, DOI 10.1016/S0012-821X(03)00441-2; DASH BP, 1969, EARTH PLANET SC LETT, V7, P169, DOI 10.1016/0012-821X(69)90033-8; MEZCUA J, 1992, TECTONOPHYSICS, V208, P447, DOI 10.1016/0040-1951(92)90440-H; Marti J, 2008, J VOLCANOL GEOTH RES, V178, P529, DOI 10.1016/j.jvolgeores.2008.07.011; Gottsmann J, 2008, PHYS EARTH PLANET IN, V168, P212, DOI 10.1016/j.pepi.2008.06.020; Lodge A, 2012, PHYS EARTH PLANET IN, V212, P44, DOI 10.1016/j.pepi.2012.09.004; BOSSHARD E, 1970, J GEOPHYS RES, V75, P4901, DOI 10.1029/JB075i026p04901; Del Pezzo E, 2006, PHYS EARTH PLANET IN, V157, P257, DOI 10.1016/j.pepi.2006.04.009; YOSHIMOTO K, 1993, GEOPHYS J INT, V114, P165, DOI 10.1111/j.1365-246X.1993.tb01476.x; Ablay GJ, 2000, J GEOPHYS RES-SOL EA, V105, P5783, DOI 10.1029/1999JB900404; Pous J, 2002, EARTH PLANET SC LETT, V204, P249, DOI 10.1016/S0012-821X(02)00956-1; Cerdena ID, 2011, J VOLCANOL GEOTH RES, V206, P15, DOI 10.1016/j.jvolgeores.2011.06.005; Arana V, 1971, ESTUD GEOL, V27, P95; Blanco-Montenegro I, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007646; Block LV, 1991, THESIS MIT CAMBRIGE; Coppo N, 2008, J VOLCANOL GEOTH RES, V170, P153, DOI 10.1016/j.jvolgeores.2007.09.013; Coppo N, 2010, GEOL ACTA, V8, P67, DOI 10.1344/105.000001516; De Siena L, 2013, NATURE GEOSCIE UNPUB; De Siena L, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006938; De Barros L, 2012, GEOPHYS J INT, V191, P695, DOI 10.1111/j.1365-246X.2012.05637.x; de Lorenzo S, 2001, J GEODYN, V32, P467; Del Pezzo E, 2008, ADV GEOPHYS, V50, P353, DOI 10.1016/S0065-2687(08)00013-7; Del Pezzo E, 1997, B SEISMOL SOC AM, V87, P1637; De Siena L, 2014, J VOLCANOL GEOTH RES, V277, P22, DOI 10.1016/j.jvolgeores.2014.03.009; De Siena L, 2009, PHYS EARTH PLANET IN, V173, P17, DOI 10.1016/j.pepi.2008.10.015; Eberhart-Phillips D, 2005, GEOPHYS J INT, V162, P270, DOI 10.1111/j.1365-246X.2005.02500.x; Fullea J, 2015, EARTH PLANET SC LETT, V409, P71, DOI 10.1016/j.epsl.2014.10.038; Fuster JM, 1968, GEOLOGIA VOLCANOLOGI, P218; Garcia O, 2014, J GEOL SOC LONDON, V171, P375, DOI 10.1144/jgs2013-086; Garcia-Yeguas A, 2012, GEOPHYS J INT, V117, P970, DOI [10.1029/2011JB008, DOI 10.1029/2011JB008,970]; Gudmundsson O, 2004, J VOLCANOL GEOTH RES, V130, P77, DOI 10.1016/S0377-0273(03)00282-8; Ibanez J, 2008, EOS T AGU, V89, P289, DOI DOI 10.1029/2008EO320001; IBANEZ JM, 1993, PHYS EARTH PLANET IN, V80, P25, DOI 10.1016/0031-9201(93)90070-P; Iribarren I, 2014, THESIS U BARCELONA, P234; Koulakov I, 2009, CODE ATOM 3D 3D TOMO; La Rocca M, 2001, B SEISMOL SOC AM, V91, P219, DOI 10.1785/0120000028; Mantovani E, 2007, ANN GEOPHYS-ITALY, V50, P341; Marti J, 2000, J VOLCANOL GEOTH RES, V103, P161, DOI 10.1016/S0377-0273(00)00221-3; Marti J, 2012, B VOLCANOL, V74, P767, DOI 10.1007/s00445-011-0569-6; Marti J, 1996, J VOLCANOL GEOTH RES, V72, P143, DOI 10.1016/0377-0273(95)00079-8; Martinez-Arevalo C, 2005, GEOPHYS RESLETT, V32, P309; Morozov IB, 2011, ANN GEOPHYS-ITALY, V54, P235, DOI 10.4401/ag-4780; Neumann ER, 1999, J PETROL, V40, P1089; Nolet G, 2008, BREVIARY SEISMIC TOM, P360; Pittari A, 2008, DEV VOLCANO, V10, P97, DOI 10.1016/S1871-644X(07)00003-4; Prudencio J, 2013, GEOPHYS J INT, V195, P1957, DOI 10.1093/gji/ggt360; Prudencio J, 2013, GEOPHYS J INT, V195, P1942, DOI 10.1093/gji/ggt361; Prudencio J, 2015, SURV GEOPHYS, V36, P371, DOI 10.1007/s10712-015-9322-6; ROEST WR, 1992, MAR GEOPHYS RES, V14, P1, DOI 10.1007/BF01674063; Romero-Ruiz C, 1991, MANIFESTACIONES VOLC, P1463; Sato H, 2012, SEISMIC WAVE PROPAGA; Soler-Javaloyes V, 2013, GEOPHYS INVESTIGATIO; Thrilwall M, 2000, J VOLCANOL GEOTHERM, V103, P247; Tramelli A, 2009, B SEISMOL SOC AM, V99, P1962, DOI 10.1785/0120080273; UM J, 1987, B SEISMOL SOC AM, V77, P972; VERHOEF J, 1991, MAR GEOPHYS RES, V13, P81; Villasante-Marcos V, 2014, J VOLCANOL GEOTH RES, V272, P59, DOI 10.1016/j.jvolgeores.2013.12.007; Zandomeneghi D, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006119	78	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0169-3298	1573-0956		SURV GEOPHYS	Surv. Geophys.	SEP	2015	36	5					693	716		10.1007/s10712-015-9333-3		24	Geochemistry & Geophysics	Geochemistry & Geophysics	CR6YV	WOS:000361495400004		
J	Murashita, T; Okada, Y; Kanemitsu, H; Fukunaga, N; Konishi, Y; Nakamura, K; Koyama, T				Murashita, Takashi; Okada, Yukikatsu; Kanemitsu, Hideo; Fukunaga, Naoto; Konishi, Yasunobu; Nakamura, Ken; Koyama, Tadaaki			Efficacy of Stentless Aortic Bioprosthesis Implantation for Aortic Stenosis with Small Aortic Annulus	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						aortic valve and root; heart valve surgery; clinical outcomes	PROSTHESIS-PATIENT MISMATCH; VALVES HEMODYNAMICALLY SUPERIOR; PROSPECTIVE RANDOMIZED TRIAL; STENTED VALVES; SURVIVAL ADVANTAGE; ROOT BIOPROSTHESIS; AFFECT MORTALITY; FOLLOW-UP; REPLACEMENT; HYPOPLASIA	BackgroundIn patients with small aortic annulus, sufficient size of stented aortic bioprosthesis cannot be implanted without additional procedures. In such cases, we use stentless aortic bioprosthesis to obtain sufficient effective orifice area. In this study, we investigated long-term impact of stentless aortic bioprosthesis on clinical outcomes, compared with stented aortic bioprosthesis. Materials and MethodsWe retrospectively investigated 140 patients who underwent aortic valve replacement (AVR) with porcine bioprosthesis for severe aortic stenosis between 1999 and 2010. Patients who had moderate or more aortic regurgitation and who underwent concomitant mitral procedures were excluded. A total of 69 patients (49%) were implanted stentless bioprosthesis (Freestyle group; Medtronic Inc, Minneapolis, Minnesota, United States) and 71 patients (51%) were implanted stented bioprosthesis (Mosaic group; Medtronic Inc). Follow-up was complete in 97.9% patients. Median follow-up period was 4.2 years. ResultsPatients in Freestyle group had smaller body surface area, smaller aortic annulus diameter, smaller aortic valve area, larger mean pressure gradient, higher peak velocity across aortic valve, larger left ventricular mass index (LVMI), and lower left ventricular ejection fraction (LVEF). Mean size of implanted prosthesis was larger in Freestyle group. In-hospital mortality was 1.4% in Freestyle group and 2.8% in Mosaic group (p=0.980). Five-year survival rate was not different between two groups (5-year survival rate was 87.54.7% in Freestyle group and 84.1 +/- 7.5% in Mosaic group; log rank, p=0.619). Late New York Heart Association functional class was lower in Freestyle group. Late LVMI and LVEF became similar between two groups. ConclusionStentless aortic bioprosthesis is superior in left ventricular remodeling after AVR for aortic stenosis and is especially effective for small aortic annulus.	[Murashita, Takashi; Okada, Yukikatsu; Kanemitsu, Hideo; Fukunaga, Naoto; Konishi, Yasunobu; Nakamura, Ken; Koyama, Tadaaki] Kobe City Med Ctr, Gen Hosp, Dept Cardiovasc Surg, Kobe, Hyogo 6500047, Japan	Murashita, T (reprint author), Kobe City Med Ctr, Gen Hosp, Dept Cardiovasc Surg, Chuo Ku, 2-1-1 Minatozimaminami, Kobe, Hyogo 6500047, Japan.	tmurashita@gmail.com					RAHIMTOOLA SH, 1978, CIRCULATION, V58, P20; KONNO S, 1975, J THORAC CARDIOV SUR, V70, P909; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Bach DS, 2005, ANN THORAC SURG, V80, P480, DOI 10.1016/j.athoracsur.2005.03.027; Cohen G, 2002, ANN THORAC SURG, V73, P767, DOI 10.1016/S0003-4975(01)03338-0; Mohammadi S, 2012, CIRCULATION, V126, pS198, DOI 10.1161/CIRCULATIONAHA.111.084806; Borger MA, 2005, ANN THORAC SURG, V80, P2180, DOI 10.1016/j.athoracsur.2005.05.055; Kon ND, 2002, ANN THORAC SURG, V73, P775; Doty DB, 1998, J CARDIAC SURG, V13, P369, DOI 10.1111/j.1540-8191.1998.tb01099.x; Dumesnil JG, 2005, ANN THORAC SURG, V80, P486; Fries R, 2000, ANN THORAC SURG, V69, P817, DOI 10.1016/S0003-4975(99)01409-5; Macgillivray TE, 2011, ANN THORAC SURG, V92, P888; LaPar DJ, 2011, ANN THORAC SURG, V92, P880, DOI 10.1016/j.athoracsur.2011.04.105; MANOUGUIAN S, 1979, J THORAC CARDIOV SUR, V78, P402; Mazzola A, 2012, ANN THORAC SURG, V94, P1185, DOI 10.1016/j.athoracsur.2012.05.015; Morsy S, 2001, Semin Thorac Cardiovasc Surg, V13, P129; NICKS R, 1970, THORAX, V25, P339, DOI 10.1136/thx.25.3.339; Ruel M, 2006, J THORAC CARDIOV SUR, V131, P1036, DOI 10.1016/j.jtcvs.2005.10.028; Tasca G, 2006, CIRCULATION, V113, P570, DOI 10.1161/CIRCULATIONAHA.105.587022; Westaby S, 2000, ANN THORAC SURG, V70, P785, DOI 10.1016/S0003-4975(00)01736-7; Cohen LH, 2000, ANN THORAC SURG, V70, P790	21	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	SEP	2015	63	6					446	451		10.1055/s-0034-1389106		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CR5LE	WOS:000361382900002		
J	Tsubokawa, N; Harada, H; Takenaka, C; Misumi, K; Yamashita, Y				Tsubokawa, Norifumi; Harada, Hiroaki; Takenaka, Chie; Misumi, Keizo; Yamashita, Yoshinori			Comparison of Postoperative Pain after Different Thoracic Surgery Approaches as Measured by Electrical Stimulation	THORACIC AND CARDIOVASCULAR SURGEON			English	Article						surgery; complications; video-assisted thoracic surgery; postoperative care	QUALITY-OF-LIFE; LUNG-CANCER; THORACOSCOPIC LOBECTOMY; INTENSITY SCALES; NERVE INJURY; THORACOTOMY; YOUNGER	BackgroundPostoperative pain is commonly evaluated using the numerous rating scale (NRS), visual analogue scale, or pain scale; however, these assessments are easily affected by various subjective factors. We measured the degree of postoperative chest pain among different thoracic surgery approaches using NRS and electrical stimulation measurements. MethodsSeventy patients who underwent lobectomy or segmentectomy were enrolled. Concomitant with NRS, pain scores were quantitatively measured on postoperative day 2 using an electrical neurostimulator to compare the degree of pain among three different surgical approaches: pure video-assisted thoracic surgery (VATS), hybrid VATS, and conventional thoracotomy. The risk factors associated with postoperative pain were also analyzed. ResultsThirty patients underwent lung resection with pure VATS, while 30 had hybrid VATS, and 10 had conventional thoracotomy. Among the three surgical approaches, analyzing the pain score indicated statistically significant differences (pure, 159.5026.22; hybrid, 269.36 +/- 30.49; thoracotomy, 589.40 +/- 141.11; p=0.003); however, NRS did not obtain a statistically significant difference between the three approaches (pure, 4.26 +/- 0.27; hybrid, 4.96 +/- 0.30; thoracotomy, 5.50 +/- 0.68; p=0.105). A multivariate analysis showed that the surgical approach was an independent risk factor for postoperative pain as determined by the pain score (pure vs. hybrid, p=0.076; pure vs. thoracotomy, p<0.001). ConclusionFor lung surgery, the differences in surgical approach were an independent risk factor for postoperative pain. In the early postoperative period, pure VATS was shown to be the least painful of the three surgical approaches.	[Tsubokawa, Norifumi; Harada, Hiroaki; Takenaka, Chie; Misumi, Keizo; Yamashita, Yoshinori] Natl Hosp Org, Kure Med Ctr, Dept Resp Surg, Kure, Hiroshima 7370023, Japan; [Tsubokawa, Norifumi; Harada, Hiroaki; Takenaka, Chie; Misumi, Keizo; Yamashita, Yoshinori] Chugoku Canc Ctr, Kure, Hiroshima 7370023, Japan	Yamashita, Y (reprint author), Natl Hosp Org, Kure Med Ctr, Dept Resp Surg, 3-1 Aoyama Cho, Kure, Hiroshima 7370023, Japan.	yamashitay@kure-nh.go.jp			Japanese Foundation for Research and Promotion of Endoscopy	This study was supported by the Japanese Foundation for Research and Promotion of Endoscopy. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Wallace MS, 1996, PAIN, V66, P69, DOI 10.1016/0304-3959(96)02980-6; Herr K, 2007, PAIN MED, V8, P585, DOI 10.1111/j.1526-4637.2007.00316.x; Soto RG, 2003, ANN THORAC SURG, V75, P1349, DOI 10.1016/S0003-4975(02)04647-7; Swanson SJ, 2007, J CLIN ONCOL, V25, P4993, DOI 10.1200/JCO.2007.12.6649; Sugiura H, 1999, SURG LAPARO ENDO PER, V9, P403, DOI 10.1097/00019509-199912000-00007; Roviaro G, 2004, SURG ENDOSC, V18, P1551, DOI 10.1007/s00464-004-6006-6; Rogers ML, 2002, EUR J CARDIO-THORAC, V21, P298, DOI 10.1016/S1010-7940(01)01104-6; Cerfolio RJ, 2008, ANN THORAC SURG, V85, P1901, DOI 10.1016/j.athoracsur.2008.01.041; Sakai T, 2008, J ANESTH, V22, P242, DOI 10.1007/s00540-008-0616-4; Herr KA, 2004, CLIN J PAIN, V20, P207, DOI 10.1097/00002508-200407000-00002; Gagliese L, 2005, PAIN, V117, P412, DOI 10.1016/j.pain.2005.07.004; Gottschalk A, 2006, ANESTHESIOLOGY, V104, P594, DOI 10.1097/00000542-200603000-00027; Cerfolio RJ, 2008, ANN THORAC SURG, V85, P1906; Demmy TL, 2008, ANN THORAC SURG, V85, pS719, DOI 10.1016/j.athoracsur.2007.09.056; Koop O, 2013, EUR J CARDIO-THORAC, V43, P808, DOI 10.1093/ejcts/ezs453; LANDRENEAU RJ, 1994, J THORAC CARDIOV SUR, V107, P1079; Landreneau RJ, 1994, J THORAC CARDIOVASC, V107, P1085; MASSON EA, 1991, DIABETIC MED, V8, pS63; Miyazaki T, 2011, EUR J CARDIO-THORAC, V39, P1033, DOI 10.1016/j.ejcts.2010.10.015; Nomori H, 2001, ANN THORAC SURG, V72, P879, DOI 10.1016/S0003-4975(01)02891-0; Ochroch E Andrew, 2005, Thorac Surg Clin, V15, P105, DOI 10.1016/j.thorsurg.2004.08.004; Okada M, 2005, CHEST, V128, P2696, DOI 10.1378/chest.128.4.2696; Sakai T, 2006, CLIN J PAIN, V22, P359, DOI 10.1097/01.ajp.0000178222.85636.00; Shiraishi T, 2004, SURG ENDOSC, V18, P1657, DOI 10.1007/s00464-003-9269-4; Wildgaard K, 2012, EUR J CARDIO-THORAC, V41, P1072, DOI 10.1093/ejcts/ezr151; Yamashita T, 2002, SPINE, V27, P1567, DOI 10.1097/01.BRS.0000018483.20260.6B; Yamashita Y, 2013, EUR J CARDIO-THORAC, V44, pE71, DOI 10.1093/ejcts/ezt107	27	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0171-6425	1439-1902		THORAC CARDIOV SURG	Thorac. Cardiovasc. Surg.	SEP	2015	63	6					519	525		10.1055/s-0035-1546427		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CR5LE	WOS:000361382900015		
J	Sugiyama, T; Nagasawa, T				Sugiyama, Tatsuki; Nagasawa, Takashi			CXCL12 catches T-ALL at the entrance of the bone marrow	TRENDS IN IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; NICHES; MAINTENANCE	A fraction of patients with T-cell acute lymphoblastic leukemias (T-ALLs) relapse and have a dismal prognosis. Two recent papers in Cancer Cell reveal that endothelial cell-derived CXCL12 is essential for bone marrow involvement and tumor progression in T-ALL patients, suggesting that this chemokine axis presents a potential therapeutic target for the treatment of T-ALL.	[Sugiyama, Tatsuki; Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto, Japan; [Sugiyama, Tatsuki; Nagasawa, Takashi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Sakyo Ku, Kyoto 6068507, Japan	Nagasawa, T (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto, Japan.	tnagasa@frontier.kyoto-u.ac.jp					Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Passaro D, 2015, CANCER CELL, V27, P769, DOI 10.1016/j.ccell.2015.05.003; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Omatsu Y, 2014, NATURE, V508, P536, DOI 10.1038/nature13071; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Pitt L.A., 2015, CANCER CELL, V27, P755	10	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4906	1471-4981		TRENDS IMMUNOL	Trends Immunol.	SEP	2015	36	9					504	506		10.1016/j.it.2015.08.001		3	Immunology	Immunology	CR5TI	WOS:000361406600002		
J	Fujita, Y; Kosaka, N; Araya, J; Kuwano, K; Ochiya, T				Fujita, Yu; Kosaka, Nobuyoshi; Araya, Jun; Kuwano, Kazuyoshi; Ochiya, Takahiro			Extracellular vesicles in lung microenvironment and pathogenesis	TRENDS IN MOLECULAR MEDICINE			English	Review						extracellular vesicle; exosome; microRNA; COPD; lung cancer; mesenchymal stem cell	OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; MESENCHYMAL STEM-CELLS; CIRCULATING ENDOTHELIAL MICROPARTICLES; EXOSOME SECRETION; AIRWAY EPITHELIUM; CIGARETTE-SMOKE; ADENOCARCINOMA CELLS; CANCER-THERAPY; TOBACCO-SMOKE	Increasing attention is being paid to the role of extracellular vesicles (EVs) in various lung diseases. EVs are released by a variety of cells, including respiratory cells and immune cells, and they encapsulate various molecules, such as proteins and microRNAs, as modulators of intercellular communication. Cancer cell-derived EVs play crucial roles in promoting tumor progression and modifying their microenvironment. By contrast, noncancerous cell-derived EVs demonstrate protective functions against injury, such as tissue recovery and repair, to maintain physiological homeostasis. Airway cells in contact with harmful substances may alter their EV composition and modify the balanced reciprocal interactions with surrounding mesenchymal cells. We summarize the novel findings of EV function in various lung diseases, primarily chronic obstructive pulmonary disease (COPD) and lung cancer.	[Fujita, Yu; Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Res Inst, Chuo Ku, Tokyo 1040045, Japan; [Fujita, Yu; Araya, Jun; Kuwano, Kazuyoshi] Jikei Univ, Sch Med, Dept Internal Med, Div Resp Dis,Minato Ku, Tokyo 1058471, Japan; [Fujita, Yu] Univ Calif San Diego, Dept Pathol & Moores, Ctr Canc, La Jolla, CA 92093 USA; [Kosaka, Nobuyoshi] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Ochiya, T (reprint author), Natl Canc Ctr, Div Mol & Cellular Med, Res Inst, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tochiya@ncc.go.jp			Foundation for Promotion of Cancer Research (Japan); Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio)	This work was supported in part by a Grant-in-Aid for the Third-Term Comprehensive 10 Year Strategy for Cancer Control of Japan, including Awardee of Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan); a Grant-in-Aid for scientific research on priority areas in cancer from the Ministry of Education, Culture, Sports, Science and Technology; the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) initiated by the Council for Science and Technology Policy; and the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio).	Anand PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010136; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Fujita Y, 2014, CLIN THER, V36, P873, DOI 10.1016/j.clinthera.2014.05.006; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Li MZ, 2010, ARTERIOSCL THROM VAS, V30, P1818, DOI 10.1161/ATVBAHA.110.209577; Griffin MD, 2013, IMMUNOL CELL BIOL, V91, P40, DOI 10.1038/icb.2012.67; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Rani S, 2015, MOL THER, V23, P812, DOI 10.1038/mt.2015.44; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Jung JH, 2015, PROTEOMICS, V15, P824, DOI 10.1002/pmic.201400243; Bastarache JA, 2009, AM J PHYSIOL-LUNG C, V297, pL1035, DOI 10.1152/ajplung.00214.2009; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Shannon JM, 1998, DEV DYNAM, V212, P482, DOI 10.1002/(SICI)1097-0177(199808)212:4<482::AID-AJA2>3.0.CO;2-D; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Kosaka N, 2013, ADV DRUG DELIVER REV, V65, P376, DOI 10.1016/j.addr.2012.07.011; Castellana D, 2009, CANCER RES, V69, P785, DOI 10.1158/0008-5472.CAN-08-1946; Beyer C, 2010, NAT REV RHEUMATOL, V6, P21, DOI 10.1038/nrrheum.2009.229; Qazi KR, 2010, THORAX, V65, P1016, DOI 10.1136/thx.2009.132027; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Choi DY, 2014, PROTEOMICS, V14, P1845, DOI 10.1002/pmic.201400008; Li CJ, 2013, AM J PATHOL, V182, P1552, DOI 10.1016/j.ajpath.2013.01.035; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Cazzoli R, 2013, J THORAC ONCOL, V8, P1156, DOI 10.1097/JTO.0b013e318299ac32; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Moon HG, 2014, AM J PHYSIOL-LUNG C, V307, pL326, DOI 10.1152/ajplung.00102.2014; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JC132526; Araya J, 2006, AM J PATHOL, V169, P405, DOI 10.2353/ajpath.2006.060049; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Huang SH, 2013, CANCER INVEST, V31, P330, DOI 10.3109/07357907.2013.789905; Fujita Y, 2015, INT J MOL SCI, V16, P5254, DOI 10.3390/ijms16035254; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Cordazzo C, 2014, INFLAMM RES, V63, P539, DOI 10.1007/s00011-014-0723-7; Kulshreshtha A, 2013, J ALLERGY CLIN IMMUN, V131, P1194, DOI 10.1016/j.jaci.2012.12.1565; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Evans MJ, 1999, AM J RESP CELL MOL, V21, P655; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Park JO, 2013, PROTEOMICS, V13, P2125, DOI 10.1002/pmic.201200323; Yamashita T, 2013, PHARMAZIE, V68, P969, DOI 10.1691/ph.2013.3599; Li WH, 2014, APMIS, V122, P1080, DOI 10.1111/apm.12261; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Holgate ST, 2000, CLIN EXP ALLERGY, V30, P37; Liu H, 2014, J THORAC DIS, V6, P649, DOI 10.3978/j.issn.2072-1439.2014.06.26; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Li YY, 2011, ELECTROPHORESIS, V32, P1976, DOI 10.1002/elps.201000598; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Fujii S, 2012, ONCOIMMUNOLOGY, V1, P630, DOI 10.4161/onci.20297; Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403; Beninson LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108748; Beninson LA, 2014, SEMIN IMMUNOL, V26, P394, DOI 10.1016/j.smim.2013.12.001; Cui H, 2015, ONCOGENE, V34, P3640, DOI 10.1038/onc.2014.300; Demayo F, 2002, AM J PHYSIOL-LUNG C, V283, pL510, DOI 10.1152/ajplung.00144.2002; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Eltom S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101087; Fontana Simona, 2013, Proteomics, V13, P1581, DOI 10.1002/pmic.201200398; Fujita Y, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/486413; Fujita Yu, 2013, Pharmaceuticals (Basel), V6, P223, DOI 10.3390/ph6020223; Gould Stephen J, 2013, J Extracell Vesicles, V2, DOI 10.3402/jev.v2i0.20389; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jakobsen KR, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26659; Kesimer M., 2015, METHODS; Kosaka Nobuyoshi, 2013, Methods Mol Biol, V1024, P1, DOI 10.1007/978-1-62703-453-1_1; Letsiou E, 2015, AM J RESP CELL MOL, V52, P193, DOI 10.1165/rcmb.2013-0347OC; Li JY, 2014, LUNG CANCER, V86, P144, DOI 10.1016/j.lungcan.2014.08.015; Lockett AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093979; Marleau AM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-134; Matthay Michael A, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS54, DOI 10.1513/AnnalsATS.201406-254MG; Moon HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068199; Novelli F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095013; Porro C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-94; Schutze N, 2001, J CLIN PATHOL-MOL PA, V54, P170; Takahashi T, 2014, INT J CHRONIC OBSTR, V9, P303, DOI 10.2147/COPD.S38931; Ueda K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06232; Witwer K. W., 2013, J EXTRACELL VESICLES, V2, P20360, DOI DOI 10.3402/JEV.V2I0.20360; Xiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089534; Yoshioka Y, 2013, J EXTRACELL VESICLES, V2, P20424, DOI DOI 10.3402/JEV.V2I0.20424	93	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4914	1471-499X		TRENDS MOL MED	Trends Mol. Med	SEP	2015	21	9					533	542		10.1016/j.molmed.2015.07.004		10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CR5TP	WOS:000361407500004		
J	Franca, C; Hostetler, J; He, W; Robinson, LJ; Lin, E; Li, CSN; Suen, W; Sharma, S; Gruszczyk, J; Malhotra, I; Frato, G; Siba, P; Galinski, M; Kazura, J; Schofield, L; Wright, G; Tham, WH; Takashima, E; Tsuboi, T; Fairhurst, RM; Rayner, J; King, CL; Mueller, I				Franca, C.; Hostetler, J.; He, W.; Robinson, L. J.; Lin, E.; Li, C. S. N.; Suen, Wai; Sharma, S.; Gruszczyk, J.; Malhotra, I.; Frato, G.; Siba, P.; Galinski, M.; Kazura, J.; Schofield, L.; Wright, G.; Tham, W. H.; Takashima, E.; Tsuboi, T.; Fairhurst, R. M.; Rayner, J.; King, C. L.; Mueller, I.			Identification of potential novel P. vivax vaccine candidates: naturally-acquired immune responses to a panel of P. vivax blood-stage antigens are associated with reduced risk of clinical malaria episodes in Papua New Guinean children	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Franca, C.; Robinson, L. J.; Li, C. S. N.; Schofield, L.; Mueller, I.] Univ Melbourne, Walter & Eliza Hall Inst, Div Populat Hlth & Immun, Melbourne, Vic, Australia; [Franca, C.; He, W.; Robinson, L. J.; Li, C. S. N.; Gruszczyk, J.; Schofield, L.; Tham, W. H.; Mueller, I.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Hostetler, J.; Sharma, S.; Wright, G.; Rayner, J.] Wellcome Trust Sanger Inst, Malaria Programme, Hinxton, Cambs, England; [Hostetler, J.; Fairhurst, R. M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [He, W.; Gruszczyk, J.; Tham, W. H.] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Melbourne, Vic, Australia; [Robinson, L. J.; Lin, E.; Siba, P.] PNG Inst Med Res, Malaria Immunoepidemiol Unit, Madang, Papua N Guinea; [Malhotra, I.; Frato, G.; Kazura, J.; King, C. L.] Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA; [Galinski, M.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; [Schofield, L.] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld 4811, Australia; [Takashima, E.; Tsuboi, T.] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan; [Mueller, I.] Inst Global Hlth ISGLOBAL, Barcelona, Spain								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		105	105				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800255		
J	Wiese, S; Feldmeier, H; Elson, L; Larson, PS; Mambo, B				Wiese, S.; Feldmeier, H.; Elson, L.; Larson, P. S.; Mambo, B.			Household-related risk factors of tungiasis and severe disease in Kilifi County, Kenya	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Wiese, S.; Feldmeier, H.] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Elson, L.] Wajimida Jigger Campaign, Watamu, Kenya; [Larson, P. S.] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Larson, P. S.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Mambo, B.] Kilifi Cty Hosp, Mombasa, Kenya								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		114	115				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800279		
J	Massavon, W; Nannini, M; Wilunda, C; Agaro, C; De Vivo, E; Lochoro, P; Putoto, G				Massavon, W.; Nannini, M.; Wilunda, C.; Agaro, C.; De Vivo, E.; Lochoro, P.; Putoto, G.			How effective are demand-side incentives in improving utilisation of delivery services in the Oyam district of northern Uganda? A quasi-experimental study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Massavon, W.; De Vivo, E.] Africa CUAMM, Aber, Uganda; [Nannini, M.] Univ Florence, Sch Econ & Dev, Florence, Italy; [Wilunda, C.] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan; [Wilunda, C.; Putoto, G.] Africa CUAMM, Padua, Italy; [Agaro, C.] Oyam Dist Local Govt, Dist Hlth Off, Oyam, Uganda; [Lochoro, P.] Africa CUAMM, Kampala, Uganda								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		138	138				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800337		
J	Saijuntha, W; Tantrawatpan, C; Agatsuma, T				Saijuntha, W.; Tantrawatpan, C.; Agatsuma, T.			Novel DNA marker for population genetic study of lung fluke, Paragonimus spp. in Japan	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Saijuntha, W.] Mahasarakham Univ, WRBRI, Maha Sarakham, Thailand; [Tantrawatpan, C.] Thammasat Univ, Preclin Sci, Fac Med, Pathum Thani, Thailand; [Agatsuma, T.] Kochi Univ, Kochi Med Sch, Div Environm Hlth Sci, Nankoku, Kochi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.026	313	313				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802018		
J	Tantrawatpan, C; Saijuntha, W; Agatsuma, T				Tantrawatpan, C.; Saijuntha, W.; Agatsuma, T.			Genetic variation of Indoplanorbis exustus (Gastropoda: Plaorbidae), intermediate host of foodborne trematodes in Southeast Asia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Tantrawatpan, C.] Thammasat Univ, Fac Med, Dept Preclin Sci, Pathum Thani, Thailand; [Saijuntha, W.] Mahasarakham Univ, WRBRI, Maha Sarakham, Thailand; [Agatsuma, T.] Kochi Univ, Kochi Med Sch, Div Environm Hlth Sci, Nankoku, Kochi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.057	324	325				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802049		
J	Aiga, H; Sasagawa, E; Soriano, EYC; Marroquin, BLC; Ramirez, MAH; de Aguilar, AVG; Chevez, JER; Hernandez, HMR; Cedillos, RA; Misago, C; Kita, K				Aiga, H.; Sasagawa, E.; Soriano, E. Y. C.; Marroquin, B. L. C.; Ramirez, M. A. H.; de Aguilar, A. V. G.; Chevez, J. E. R.; Hernandez, H. M. R.; Cedillos, R. A.; Misago, C.; Kita, K.			Neglected route of transmission of a neglected tropical disease: mother-to-child transmission of chagas disease in El Salvador	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Aiga, H.] JICA, Dept Human Dev, Tokyo, Japan; [Aiga, H.] George Washington Univ, Dept Global Hlth, Washington, DC USA; [Sasagawa, E.; Kita, K.] Univ Tokyo, Dept Biomed Chem, Tokyo, Japan; [Soriano, E. Y. C.] Minist Salud, SIBASI Sonsonate, Secc Epidemiol, Sonsonate, El Salvador; [Marroquin, B. L. C.] Minist Salud, Direcc Reg Salud Zona Occidente, Programa Materno Infantil, Santa Ana, El Salvador; [Ramirez, M. A. H.; de Aguilar, A. V. G.] Unidad Vigilancia Lab, San Salvador, El Salvador; [Chevez, J. E. R.] Unidad Vigilancia Enfermedades Vectorizadas, San Salvador, El Salvador; [Hernandez, H. M. R.] Minist Salud, Direcc Vigilancia Sanitaria, San Salvador, El Salvador; [Cedillos, R. A.] Univ El Salvador, Consejo Invest Cient CIC UES, San Salvador, El Salvador; [Misago, C.] Tsuda Coll, Dept Int & Cultural Studies, Kodaira, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.074	331	332				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802065		
J	Aiga, H; Sasagawa, E; Soriano, EYC; Marroquin, BLC; Ramirez, MAH; de Aguilar, AVG; Chevez, JER; Hernandez, HMR; Cedillos, RA; Misago, C; Kita, K				Aiga, H.; Sasagawa, E.; Soriano, E. Y. C.; Marroquin, B. L. C.; Ramirez, M. A. H.; de Aguilar, A. V. G.; Chevez, J. E. R.; Hernandez, H. M. R.; Cedillos, R. A.; Misago, C.; Kita, K.			Risk factors for transmission of Chagas disease among pregnant women in El Salvador	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Aiga, H.] JICA, Dept Human Dev, Tokyo, Japan; [Aiga, H.] George Washington Univ, Dept Global Hlth, Washington, DC USA; [Sasagawa, E.; Kita, K.] Univ Tokyo, Dept Biomed Chem, Tokyo, Japan; [Soriano, E. Y. C.] Minist Salud, SIBASI Sonsonate, Secc Epidemiol, Sonsonate, El Salvador; [Marroquin, B. L. C.] Minist Salud, Direcc Reg Salud Zona Occidente, Programa Materno Infantil, Santa Ana, El Salvador; [Ramirez, M. A. H.; de Aguilar, A. V. G.] Unidad Vigilancia Lab, San Salvador, El Salvador; [Chevez, J. E. R.] Unidad Vigilancia Enfermedades Vectorizadas, San Salvador, El Salvador; [Hernandez, H. M. R.] Minist Salud, Direcc Vigilancia Sanitaria, San Salvador, El Salvador; [Cedillos, R. A.] Univ El Salvador, Consejo Invest Cient CIC UES, San Salvador, El Salvador; [Misago, C.] Tsuda Coll, Dept Int & Cultural Studies, Kodaira, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.075	332	332				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802066		
J	Jaiteh, F; Dierickx, S; O'Neill, S; Alessandro, UD; Balen, J; Grietens, KP				Jaiteh, F.; Dierickx, S.; O'Neill, S.; Alessandro, U. D'; Balen, J.; Grietens, K. P.			Socio-cultural factors influencing pregnant women's adherence to anti-malarial treatment in rural Gambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jaiteh, F.; Alessandro, U. D'] MRC, Gambia Unit, Banjul, Gambia; [Dierickx, S.; O'Neill, S.; Grietens, K. P.] Insitute Trop Med Antwerp, Med Anthropol Unit, Antwerp, Belgium; [Alessandro, U. D'] London Sch Hyg & Trop Med, London WC1, England; [Balen, J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Grietens, K. P.] Nagasaki Univ, Sch Hlth Dev, Nagasaki 852, Japan; [Grietens, K. P.] Partners Appl Social Sci PASS Int, Antwerp, Belgium								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.159	362	362				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802142		
J	Sinh, DX; Hung, NV; Phuc, PD; Ngan, TT; Thanh, NT; Fred, U; Kohei, M; Delia, G				Sinh, D. X.; Hung, N. V.; Phuc, P. D.; Ngan, T. T.; Thanh, N. T.; Fred, U.; Kohei, M.; Delia, G.			Hygiene and microbial contamination along the pork value chain in Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sinh, D. X.; Hung, N. V.; Phuc, P. D.; Ngan, T. T.] Hanoi Sch Publ Hlth, Ctr Publ Hlth & Ecosyst Res, Hanoi, Vietnam; [Hung, N. V.; Fred, U.] Int Livestock Res Inst ILRI, Hanoi, Vietnam; [Hung, N. V.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Thanh, N. T.] Natl Inst Vet Res, Hanoi, Vietnam; [Kohei, M.] Rakuno Gakuen Univ, Sapporo, Hokkaido, Japan; [Delia, G.] Int Livestock Res Inst ILRI, Nairobi, Kenya								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.243	394	394				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802224		
J	Angeles, JMM; Leonardo, LR; Goto, Y; Kirinoki, M; Moendeg, KJ; Villacorte, EA; Inoue, N; Chigusa, Y; Kawazu, SI				Angeles, J. M. M.; Leonardo, L. R.; Goto, Y.; Kirinoki, M.; Moendeg, K. J.; Villacorte, E. A.; Inoue, N.; Chigusa, Y.; Kawazu, S. -I.			Epidemiological study of zoonotic schistosomiasis among water buffaloes in different endemic areas in the Philippines	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Angeles, J. M. M.; Moendeg, K. J.; Inoue, N.; Kawazu, S. -I.] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Leonardo, L. R.; Villacorte, E. A.] Univ Philippines, Coll Publ Hlth, Dept Parasitol, Manila, Philippines; [Goto, Y.] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Mol Immunol, Tokyo, Japan; [Kirinoki, M.; Chigusa, Y.] Dokkyo Med Univ, Dept Trop Med & Parasitol, Mibu, Tochigi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.245	395	395				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802226		
J	Kohno, A; Farid, NDN; Aziz, NA; Dahlui, M				Kohno, A.; Farid, N. D. Nik; Aziz, N. Abudul; Dahlui, M.			Healthcare service utilization of Japanese retirees in Malaysia: results of in-depth interviews and focus group discussions	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kohno, A.; Farid, N. D. Nik; Aziz, N. Abudul; Dahlui, M.] Univ Malaya, Dept Social & Prevent Med, Selangor, Malaysia; [Kohno, A.] Kyoto Univ, Sch Publ Hlth, Dept Hlth Infomat, Kyoto, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.366.LB	440	441				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802343		
J	Satoh, S; Matsuura, K; Asano, S				Satoh, Shigeru; Matsuura, Kenjirou; Asano, Satoshi			The study of urban form in Japan	URBAN MORPHOLOGY			English	Article						Japan; morphology; castle town; overpopulated district; Machizukuri; modernization		Five aspects of urban morphology in Japan are reviewed First, the study of castle towns is considered in terms of both the compositional principles and generative processes of these towns. Secondly, research on historical Machinami and Machiya is examined with a view to establishing a set of guidelines and theories for urban conservation. Thirdly, a revision of perspectives on the modernization of urban form and spaces between the late-nineteenth century and the middle of the twentieth century is proposed Fourthly, investigations are described of over-populated urban areas, including those on the periphery of large cities, in relation to the potential of the Machizukuri movement as a method of upgrading such areas. Finally, the particularities of Japanese methods in designing and planning are examined with a view to overcoming the sterile view that to modernize is necessarily to Westernize.	[Satoh, Shigeru] Waseda Univ, Dept Architecture Urban Design & Planning, Shinjuku Ku, Tokyo 1698555, Japan; [Matsuura, Kenjirou; Asano, Satoshi] Mie Univ, Dept Architecture, Grad Sch Engn, Tsu, Mie 5148705, Japan	Satoh, S (reprint author), Waseda Univ, Dept Architecture Urban Design & Planning, Shinjuku Ku, 55N-7F-10,Okubo 3-4-1, Tokyo 1698555, Japan.	gerusato@waseda.jp; matsuura@arch.mie-u.ac.jp; asano@arch.mie-u.ac.jp					Asano J., 2008, SENZENKI TIHOU TOSHI; Asano S., 1999, BUILT ENV, V25, P236; Fujimori T., 2004, MEIJI TOKYO KEIKAKU; Hatsuda K., 2011, TOSHI SENGO ZATTOU N; Hatsuda T., 2001, HANKAGAI NIMIRU TOSH; Hatsuda T., 2004, HANKAGAI KINDAI TOSH; Higuchi T., 1983, VISUAL SPATIAL STRUC; Ishida Y., 2004, NIHON KINDAI TOSHIKE; Jinnai H., 1981, TOKYO MACHI WO YOMU; Jinnai Hidenobu, 1995, TOKYO SPATIAL ANTHR; Kon W., 1971, KON WAJIROU SHUU ZEN; Kubo K., 2014, J CITY PLANNING I JA, V49, P759; Maki F., 1980, MIEGAKURE SURU TOSHI; MAKI F, 1979, JPN ARCHIT, V54, P50; Matsuura K., 2007, J CITY PLANNING I JA, V42, P445; Matsuura K., 2009, 16 INT SEM URB UNPUB; Matsuura K., 2009, P C INT PLANN HIST S, V1, P329; Matsuura K., 2006, J CITY PLANNING I JA, V41, P917; Matsuura K., 2004, J ARCHITECTURE PLANN, V581, P67; Matsuura K., 2006, J ARCHITECTURE PLANN, V602, P105; Matsuura K., 2005, J ARCHITECTURE PLANN, V588, P87; Matsuura K., 2006, J ARCHITECTURE PLANN, V608, P89; Matsuura K., 2002, J CITY PLANNING I JA, V37, P499; Meiji University Kamishiro Laboratory and Hosei University Miyawaki Seminar, 2012, HUKKOKU DESIGN SURVE; Miyamoto M., 1986, KENCHIKUSHIGAKU, V6, P72; Miyamoto M., 2005, TOSHI KUKAN KINNSEI; Noguchi T., 1988, CHUSSEI KYOTO MACHIY; Noguchi T., 1992, NIHON KINSEI TOSHI T; Nonaka K., 2013, J JAPANESE I LANDSCA, P427; Nonaka K., 1980, J CITY PLANNING I JA, P1053; Nonaka K., 2014, J JAPANESE I LANDSCA, P419; Ota H., 1981, REKISHITEKIFUDO HOZO; Satoh K., 2005, JYUKANKYO SEIBI MACH; Satoh S, 2008, URBAN MORPHOL, V12, P5; Satoh S., 2003, INT URBAN FORM STUDY, P149; Satoh S., 2004, SUSTAINABLE CITIES E, P239; Satoh S., 1999, BUILT ENV, V24, P217; Satoh S., 1990, GENDAINI IKIRU MACHI; Satoh S., 2014, J CITY PLANNING I JA, V49, P71; Satoh S., 2015, SHIN PAN ZUSETU JOUK; Shelton B., 2012, LEARNING JAPANESE CI, V2nd; Shimamura N., 1971, KYO MACHIYA; Sugano K., 2014, NEW URBAN CONFIGURAT, P695; Takahashi Y, 1993, ZUSHU NIHON TOSHISHI; Takami K., 2008, KINSEI JOKAMACHI SEK; Tatsumi K., 1999, MACHIYA GATA SYUGOU; Taut B. J. F., 1962, NIHONBINO SAIHAKKENN; Toshi design kenkyuutai, 1973, NIHON HIROBA; Toshi design kenkyuutai, 1968, NIHON TOSHI KUUKAN; Ueda A., 1975, MACHIYA KYOUDOU KENK; Ueda A., 1976, KYOU MACHIYA COMMUNI; Yamori K., 1970, TOSHI PLAN KENKYU; Yoshisaka T., 1975, HAKKENTEKI HOUHOU; Yoshisaka T., 1980, SEIKATU KATACHI YOU; Yoshisaka T., 1976, MORINO MIYAKO SENDAI	55	0	0	INT SEMINAR URBAN FORM	CHICAGO	UNIV CHICAGO, COMMITTEE GEOGRAPHICAL STUDIES, 5828 S UNIVERSITY AVE, 60637-1583 CHICAGO, IL USA	1027-4278			URBAN MORPHOL	Urb. Morphol.	SEP	2015	19	2					157	166				10	Architecture	Architecture	CR3ZV	WOS:000361272500005		
J	Agrimi, G; Mena, MC; Izumi, K; Pisano, I; Germinario, L; Fukuzaki, H; Blank, LM; Kitagaki, H; Palmieri, L				Agrimi, Gennaro; Mena, Maria C.; Izumi, Kazuki; Pisano, Isabella; Germinario, Lucrezia; Fukuzaki, Hisashi; Blank, Lars M.; Kitagaki, Hiroshi; Palmieri, Luigi			Increased mitochondrial metabolism in sake yeast	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Agrimi, Gennaro; Mena, Maria C.; Pisano, Isabella; Germinario, Lucrezia; Palmieri, Luigi] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Izumi, Kazuki; Fukuzaki, Hisashi] Saga Univ, Fac Agr, Dept Environm Sci, Saga 8408502, Japan; [Blank, Lars M.] Rhein Westfal TH Aachen, ABBt Aachen Biol & Biotechnol Dept, Inst Appl Microbiol IAMB, D-52074 Aachen, Germany; [Kitagaki, Hiroshi] Kagoshima Univ, United Grad Sch Agr Sci, Dept Biochem & Appl Biosci, Kagoshima 890, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS14-2	S230	S230				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200395		
J	Akada, R; Misumi, Y; Nakagawa, T; Iwakiri, R; Nakamura, M; Hoshida, H				Akada, Rinji; Misumi, Yukie; Nakagawa, Takaaki; Iwakiri, Ryo; Nakamura, Mikiko; Hoshida, Hisashi			A synthetic medium optimized for growth and a minimal medium for fermentation in yeasts	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Akada, Rinji; Nakagawa, Takaaki; Hoshida, Hisashi] Yamaguchi Univ, Dept Appl Mol Biosci, Ube, Yamaguchi 755, Japan; [Akada, Rinji; Misumi, Yukie; Hoshida, Hisashi] Yamaguchi Univ, Res Ctr Thermotolerant Microbial Resources, Yamaguchi, Japan; [Akada, Rinji; Nakamura, Mikiko; Hoshida, Hisashi] Yamaguchi Univ, Biomed Engn Ctr, Ube, Yamaguchi 755, Japan; [Iwakiri, Ryo] Kohjin Life Sci Co Ltd, Saiki, Japan; [Nakamura, Mikiko] Yamaguchi Univ, Innovat Ctr, Ube, Yamaguchi 755, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS13-1	S228	S228				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200391		
J	Altaf-Ul-Amin, M; Chandra, DF; Wijaya, SH; Kanaya, S				Altaf-Ul-Amin, Md.; Chandra, Dodi Fitra; Wijaya, Sony Hartono; Kanaya, Shigehiko			Relation of essentiality and functionality of yeast proteins with their centrality values in a PPI network	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Altaf-Ul-Amin, Md.; Chandra, Dodi Fitra; Wijaya, Sony Hartono; Kanaya, Shigehiko] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		W3-6	S64	S64				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200070		
J	Barberis, M; Mondeel, TDGA; Linke, C; Supady, A; Chasapi, A; Liebermeister, W; Loog, M; Xenarios, I; Kitano, H				Barberis, Matteo; Mondeel, Thierry D. G. A.; Linke, Christian; Supady, Adriana; Chasapi, Anastasia; Liebermeister, Wolfram; Loog, Mart; Xenarios, Ioannis; Kitano, Hiroaki			Deciphering the design principles of dynamic cell cycle control	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Barberis, Matteo; Mondeel, Thierry D. G. A.; Linke, Christian] Univ Amsterdam, Synthet Syst Biol & Nucl Org, Amsterdam, Netherlands; [Chasapi, Anastasia] Max Planck Gesell, Fritz Haber Inst, Theory Dept, Berlin, Germany; [Chasapi, Anastasia; Xenarios, Ioannis] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Liebermeister, Wolfram] Charite, Inst Biochem, D-13353 Berlin, Germany; [Loog, Mart] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Kitano, Hiroaki] Syst Biol Inst, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		W3-1	S62	S62				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200065		
J	Celaj, A; Yachie, N; Gebbia, M; Musa, L; Zhou, S; Ko, MJ; Roth, FP				Celaj, Albi; Yachie, Nozomu; Gebbia, Marinella; Musa, Louai; Zhou, Shijie; Ko, Minjeong; Roth, Frederick P.			Using engineered populations to study the genetic basis of drug resistance in Saccharomyces cerevisiae	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Celaj, Albi; Gebbia, Marinella; Zhou, Shijie; Roth, Frederick P.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Celaj, Albi; Yachie, Nozomu; Musa, Louai; Ko, Minjeong; Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Celaj, Albi; Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Yachie, Nozomu] Univ Tokyo, Res Ctr Adv Sci & Technol, Synthet Biol Div, Tokyo, Japan; [Ko, Minjeong; Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS16-5	S261	S261				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200459		
J	Csikasz-Nagy, A; Vaggi, F; Dodgson, J; Chessel, A; Geymonat, M; Giordan, M; Arai, K; Sato, M; Salas, REC				Csikasz-Nagy, Attila; Vaggi, Federico; Dodgson, James; Chessel, Anatole; Geymonat, Marco; Giordan, Marco; Arai, Kunio; Sato, Masamitsu; Salas, Rafael Edgardo Carazo			Systems level understanding of cell polarity regulation	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Csikasz-Nagy, Attila; Vaggi, Federico; Giordan, Marco] Fdn Edmund Mach, Dept Computat Biol, Res & Innovat Ctr, San Michele All Adige, Italy; [Csikasz-Nagy, Attila] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Dodgson, James; Chessel, Anatole; Geymonat, Marco; Salas, Rafael Edgardo Carazo] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Arai, Kunio; Sato, Masamitsu] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS15-6	S247	S247				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200431		
J	Gebre, AA; Okada, H; Kim, C; Kubo, K; Ohnuki, S; Ohya, Y				Gebre, Abraham Abera; Okada, Hiroki; Kim, Cholgwang; Kubo, Karen; Ohnuki, Shinsuke; Ohya, Yoshikazu			Phenotypic profiling of antifungal agents using multiparametric yeast signatures	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Gebre, Abraham Abera; Okada, Hiroki; Kim, Cholgwang; Kubo, Karen; Ohnuki, Shinsuke; Ohya, Yoshikazu] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778561, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS7-12	S178	S179				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200294		
J	Hoshida, H; Yarimizu, T; Nakamura, M; Akada, R				Hoshida, Hisashi; Yarimizu, Tohru; Nakamura, Mikiko; Akada, Rinji			Selected talk: A synthetic model of secretion signal sequence in the yeast Kluyveromyces marxianus	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Hoshida, Hisashi; Yarimizu, Tohru; Akada, Rinji] Yamaguchi Univ, Dept Appl Mol Biosci, Ube, Yamaguchi 755, Japan; [Hoshida, Hisashi; Akada, Rinji] Yamaguchi Univ, Res Ctr Thermotolerant Microbial Resources, Yamaguchi, Japan; [Hoshida, Hisashi; Akada, Rinji] Yamaguchi Univ, Ctr Biomed Engn, Ube, Yamaguchi 755, Japan; [Nakamura, Mikiko] Yamaguchi Univ, Innovat Ctr, Ube, Yamaguchi 755, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PL8-4	S45	S45				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200034		
J	Kasumi, T; Kobayashi, Y; Iwata, H; Mizushima, D; Ogihara, J				Kasumi, Takafumi; Kobayashi, Yosuke; Iwata, Hisashi; Mizushima, Daiki; Ogihara, Jun			Erythritol production using non-refined glycerol as a carbon source	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Kasumi, Takafumi; Kobayashi, Yosuke; Iwata, Hisashi; Mizushima, Daiki; Ogihara, Jun] Nihon Univ, Coll Bioresource Sci, Lab Appl Microbiol & Biotechnol, Fujisawa, Kanagawa 2520880, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS6-23	S154	S155				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200245		
J	Kawai, S				Kawai, Shigeyuki			Acquisition of the ability to assimilate mannitol by Saccharomyces cerevisiae by spontaneous mutation in the genes encoding the general corepressor Tup1-Cyc8	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Kawai, Shigeyuki] Kyoto Univ, Div Food & Biol Sci, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Uji, Kyoto, Japan							Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; Chujo M, 2015, APPL ENVIRON MICROB, V81, P9, DOI 10.1128/AEM.02906-14; Lin YP, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0126-6	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS16-13	S264	S265				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200466		
J	Li, SN; Piotrowski, J; Simpkins, S; Nelson, J; Deshpande, R; Barber, J; Okada, H; Gebre, AA; Ohya, Y; Yoshida, M; Myers, CL; Boone, C				Li, Sheena; Piotrowski, Jeff; Simpkins, Scott; Nelson, Justin; Deshpande, Raamesh; Barber, Jacqueline; Okada, Hiroki; Gebre, Abraham Abera; Ohya, Yoshikazu; Yoshida, Minoru; Myers, Chad L.; Boone, Charles			Functional annotation of biological processes targeted by chemical libraries	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Li, Sheena; Barber, Jacqueline; Yoshida, Minoru; Boone, Charles] RIKEN, CSRS, Saitama, Japan; [Piotrowski, Jeff] Univ Wisconsin, GLBRC, Madison, WI 53706 USA; [Simpkins, Scott; Nelson, Justin; Deshpande, Raamesh; Myers, Chad L.] Univ Minnesota, Comp Sci & Engn, Minneapolis, MN 55455 USA; [Okada, Hiroki; Gebre, Abraham Abera; Ohya, Yoshikazu] Univ Tokyo, Integrated Biosci, Chiba, Japan; [Boone, Charles] Univ Toronto, Donnelly CCBR, Toronto, ON M5S 1A1, Canada								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		W8-4	S78	S78				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200098		
J	Mizushima, D; Iwata, H; Ishimaki, Y; Kato, J; Ogihara, J; Kasumi, T				Mizushima, Daiki; Iwata, Hisashi; Ishimaki, Yuki; Kato, Jun; Ogihara, Jun; Kasumi, Takafumi			Two glycerol 3-phosphate dehydrogenases play an important role in glycerol production of Candida versatilis SN-18 under high glucose concentration	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Mizushima, Daiki; Iwata, Hisashi; Ishimaki, Yuki; Kato, Jun; Ogihara, Jun; Kasumi, Takafumi] Nihon Univ, Dept Chem & Lifesci, Lab Appl Microbiol & Biotechnol, Fujisawa, Kanagawa 2520880, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS3-21	S124	S125				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200186		
J	Obara, K; Nishino, K; Kihara, A				Obara, Keisuke; Nishino, Kanako; Kihara, Akio			Mechanism for sensing lipid asymmetry of the plasma membrane and external alkalization	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Obara, Keisuke; Kihara, Akio] Hokkaido Univ, Fac Pharm Sci, Sapporo, Hokkaido, Japan; [Obara, Keisuke; Nishino, Kanako; Kihara, Akio] Hokkaido Univ, Sch Pharm Sci, Sapporo, Hokkaido, Japan							Kihara, 2014, MOL CELL BIOL, V34, P3525; Obara, 2012, J BIOL CHEM, V287, P38473	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS8-10	S195	S195				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200327		
J	Ohnuki, S; Yang, M; Ohya, Y				Ohnuki, Shinsuke; Yang, Ming; Ohya, Yoshikazu			Application of generalized linear model to reveal nonessential genes of deletion mutants with significant morphological phenotypes beyond natural yeast strains	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Ohnuki, Shinsuke; Yang, Ming; Ohya, Yoshikazu] Univ Tokyo, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS16-19	S267	S267				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200472		
J	Ohsumi, Y				Ohsumi, Yoshinori			Molecular dissection of autophagy-intracellular recycling system	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Ohsumi, Yoshinori] Tokyo Inst Technol, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PL6-3	S41	S41				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200025		
J	Oku, M; Sakai, Y				Oku, Masahide; Sakai, Yasuyoshi			Induction of microautophagy during diauxic shift	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Oku, Masahide; Sakai, Yasuyoshi] Kyoto Univ, Kyoto 6068501, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		W4-4	S66	S67				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200074		
J	Oomuro, M; Kato, T; Yamagishi, H; Motoyama, Y; Aizawa, M; Zhou, Y; Watanabe, D; Akao, T; Goto, N				Oomuro, Mayu; Kato, Taku; Yamagishi, Hiromi; Motoyama, Yasuo; Aizawa, Masayuki; Zhou, Yan; Watanabe, Daisuke; Akao, Takeshi; Goto, Nami			Fermentation ability of bottom fermenting yeast exhibiting defective entry into the quiescent state	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Oomuro, Mayu; Kato, Taku; Yamagishi, Hiromi; Motoyama, Yasuo; Aizawa, Masayuki] Asahi Brewery Co Ltd, Tokyo, Japan; [Zhou, Yan; Akao, Takeshi; Goto, Nami] Natl Res Inst Brewing, Tokyo, Japan; [Watanabe, Daisuke] Nara Inst Sci & Technol, Nara, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS6-41	S162	S163				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200263		
J	Pizzolante, G; Pontieri, P; De Stefano, M; Romano, R; Alifano, P; Gunge, N; Miyakawa, I; Sando, N; Del Giudice, L				Pizzolante, Graziano; Pontieri, Paola; De Stefano, Mario; Romano, Roberta; Alifano, Pietro; Gunge, Norio; Miyakawa, Isamu; Sando, Nobundo; Del Giudice, Luigi			The prokaryotic origin of mitochondria studied by the metalloid tellurium as a valuable tool	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Pizzolante, Graziano] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Pontieri, Paola; Romano, Roberta; Alifano, Pietro; Del Giudice, Luigi] CNR, Inst Biosci & Bioresources UOS Portici, Dipartimento Biol, Sez Igiene, I-80125 Naples, Italy; [De Stefano, Mario] Univ Naples 2, Dept Environm Sci, I-81100 Caserta, Italy; [Gunge, Norio] Sojo Univ, Kumamoto 8600082, Japan; [Miyakawa, Isamu; Sando, Nobundo] Yamaguchi Univ, Dept Biol, Fac Sci, Yamaguchi 7538512, Japan							Gray, 2004, ANNU REV GENET, V38, P477; NAGAI S, 1965, J BACTERIOL, V90, P220; Taylor, 1999, TRENDS MICROBIOL, V7, P111	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS16-21	S268	S268				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200474		
J	Sasano, Y; Nagasawa, K; Kaboli, S; Sugiyama, M; Harashima, S				Sasano, Yu; Nagasawa, Koki; Kaboli, Saeed; Sugiyama, Minetaka; Harashima, Satoshi			CRISPR-PCS: An efficient and versatile chromosome splitting technology in yeast	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Sasano, Yu; Nagasawa, Koki; Kaboli, Saeed; Sugiyama, Minetaka; Harashima, Satoshi] Osaka Univ, Suita, Osaka 565, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS15-22	S255	S255				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200447		
J	Sheykhkarimli, D; Yachie, N; Petsalaki, E; Cote, A; Knapp, J; Roth, FP				Sheykhkarimli, Dayag; Yachie, Nozomu; Petsalaki, Evangelia; Cote, Atina; Knapp, Jennifer; Roth, Frederick P.			Towards a platform for global mapping of binary protein interactions under diverse conditions	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Sheykhkarimli, Dayag; Petsalaki, Evangelia; Cote, Atina; Knapp, Jennifer; Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Sheykhkarimli, Dayag; Petsalaki, Evangelia; Cote, Atina; Knapp, Jennifer; Roth, Frederick P.] Univ Toronto, Donelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Sheykhkarimli, Dayag; Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Yachie, Nozomu] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan; [Yachie, Nozomu] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Yachie, Nozomu] Japan Sci & Technol Agcy JST, PRESTO, Tokyo, Japan; [Roth, Frederick P.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS1-13	S99	S99				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200137		
J	Shintani, T; Fujita, S; Gomi, K				Shintani, Takahiro; Fujita, Shoki; Gomi, Katsuya			Identification of regions in monocarboxylic acid transporter Jen1 requisite for its glucose-induced degradation and recognition by arrestin-related protein Rod1	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Shintani, Takahiro; Fujita, Shoki; Gomi, Katsuya] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS9-9	S201	S201				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200340		
J	Sing, TL; Hung, M; Ohnuki, S; San Luis, BJ; Costanzo, M; Boone, C; Ohya, Y; Brown, G				Sing, Tina L.; Hung, Minnie; Ohnuki, Shinsuke; San Luis, Bryan-Joseph; Costanzo, Michael; Boone, Charles; Ohya, Yoshikazu; Brown, Grant			The RSC complex functions to maintain ploidy in Saccharomyces cerevisiae	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Sing, Tina L.; Hung, Minnie; Brown, Grant] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Sing, Tina L.; Hung, Minnie; San Luis, Bryan-Joseph; Costanzo, Michael; Boone, Charles; Brown, Grant] Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Ohnuki, Shinsuke; Ohya, Yoshikazu] Univ Tokyo, Dept Integrated Biosci, Tokyo, Japan; [San Luis, Bryan-Joseph; Costanzo, Michael; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		W1-5	S58	S58				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200057		
J	Takagi, H				Takagi, Hiroshi			Nitric oxide-mediated antioxidative mechanism in Saccharomyces cerevisiae and its application to baker's yeast	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach		STRESS TOLERANCE; PROLINE		[Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan							Nishimura A, 2010, FEMS YEAST RES, V10, P687, DOI 10.1111/j.1567-1364.2010.00650.x; Nasuno R, 2013, P NATL ACAD SCI USA, V110, P11821, DOI 10.1073/pnas.1300558110; Nishimura A, 2013, BIOCHEM BIOPH RES CO, V430, P137, DOI 10.1016/j.bbrc.2012.11.023; Nasuno R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113788; Sasano Y, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-40	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PL3-3	S34	S34				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200013		
J	Yokota, H; Gomi, K; Shintani, T				Yokota, Hiroto; Gomi, Katsuya; Shintani, Takahiro			Non-selective autophagy induced by phosphate starvation requires Atg11 and Is regulated by TORC1 signaling pathway in Saccharomyces cerevisiae	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Yokota, Hiroto; Gomi, Katsuya; Shintani, Takahiro] Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS9-13	S203	S203				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200344		
J	Yoshikawa, Y; Nasuno, R; Takagi, H				Yoshikawa, Yuki; Nasuno, Ryo; Takagi, Hiroshi			Regulatory mechanism and physiological role of the flavoprotein Tah18-dependent Nitric Oxide synthesis in yeast	YEAST			English	Meeting Abstract	27th International Conference on Yeast Genetics and Molecular Biology (ICYGMB)	SEP 06-12, 2015	Fondazione Edmund Mach, Levico Terme, ITALY	Inst Cell Biol Nas Ukraine, Roche, Singer Instruments, Tema Ric, EMBO, Wiley Blackwell, Federat European Microbiol Soc, Assoc Genetica Italiana, Stanford Univ, DSB, Athesina Studiorum Univ, Soc Italiana Microbiologia Generale & Biotecnologie Microbiche, Saccharomyces Genome Database, Fondazione Bruno Kessler, Prov Autonoma Trento	Fondazione Edmund Mach				[Yoshikawa, Yuki; Nasuno, Ryo; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-503X	1097-0061		YEAST	Yeast	SEP	2015	32			1		PS3-35	S131	S132				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	CR6OF	WOS:000361466200200		
J	Iwai, T; Sawamura, M				Iwai, Tomohiro; Sawamura, Masaya			Transition-Metal-Catalyzed Site-Selective C-H Functionalization of Quinolines beyond C2 Selectivity	ACS CATALYSIS			English	Review						quinolines; quinoline N-oxides; C-H activation; transition metal catalysts; site-selectivity	RH(I)-CATALYZED DIRECT ARYLATION; LATE-STAGE FUNCTIONALIZATION; NICKEL/LEWIS ACID CATALYSIS; N-OXIDES; HETEROAROMATIC-COMPOUNDS; BOND ACTIVATION; C-8 POSITION; OXIDATIVE OLEFINATION; ORGANOZINC REAGENTS; HETEROARENES SCOPE	Quinoline is an important scaffold in many natural products, biologically active compounds, and functional materials. The C-H functionalization of quinoline scaffolds by transition metal catalysis provides an efficient method for rapidly obtaining substituted quinolines. This review summarizes recently reported transition-metal-catalyzed site-selective C-H functionalization of quinolines, excluding C2 selective reactions. A review of direct functionalization of quinoline N-oxides at the C8 position also is provided.	[Iwai, Tomohiro; Sawamura, Masaya] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan	Sawamura, M (reprint author), Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan.	sawamura@sci.hokudai.ac.jp	Sawamura, Masaya/G-1428-2012		CREST; JST; JSPS [25810056]	This work was supported in part by CREST and ACT-C from JST, and a Grant-in-Aid for Young Scientists (B) (No. 25810056) from JSPS.	Zhang XY, 2014, ANGEW CHEM INT EDIT, V53, P10794, DOI 10.1002/anie.201406747; Yamamoto S, 2014, ADV SYNTH CATAL, V356, P401, DOI 10.1002/adsc.201300991; Wasa M, 2010, ANGEW CHEM INT EDIT, V49, P1275, DOI 10.1002/anie.200906104; Tobisu M, 2009, J AM CHEM SOC, V131, P12070, DOI 10.1021/ja9053509; Haag B, 2011, ANGEW CHEM INT EDIT, V50, P9794, DOI 10.1002/anie.201101960; Seiple IB, 2010, J AM CHEM SOC, V132, P13194, DOI 10.1021/ja1066459; Li YZ, 2015, CHEM-EUR J, V21, P10131, DOI 10.1002/chem.201500290; Berman AM, 2010, J ORG CHEM, V75, P7863, DOI 10.1021/jo101793r; Sharma U, 2014, J ORG CHEM, V79, P9899, DOI 10.1021/jo501995c; Stephens DE, 2015, CHEM COMMUN, V51, P9507, DOI 10.1039/c5cc02227d; Harrisson P, 2009, ORG LETT, V11, P3586, DOI 10.1021/ol901306m; Prajapati SM, 2014, RSC ADV, V4, P24463, DOI 10.1039/c4ra01814a; Fujiwara Y, 2012, NATURE, V492, P95, DOI 10.1038/nature11680; Yan GB, 2014, ADV SYNTH CATAL, V356, P2375, DOI 10.1002/adsc.201400203; MINISCI F, 1989, HETEROCYCLES, V28, P489; Konishi S, 2014, CHEM-ASIAN J, V9, P434, DOI 10.1002/asia.201301423; Suess AM, 2013, J AM CHEM SOC, V135, P9797, DOI 10.1021/ja4026424; Shang YP, 2014, ORG LETT, V16, P416, DOI 10.1021/ol403311b; Li BJ, 2011, CHEM SCI, V2, P488, DOI 10.1039/c0sc00419g; Chen CH, 1998, COORDIN CHEM REV, V171, P161, DOI 10.1016/S0010-8545(98)90027-3; Hyodo I, 2012, CHEM-ASIAN J, V7, P1357, DOI 10.1002/asia.201100971; Shin K, 2015, J AM CHEM SOC, V137, P8584, DOI 10.1021/jacs.5b04043; Campeau LC, 2009, J AM CHEM SOC, V131, P3291, DOI 10.1021/ja808332k; Kwak J, 2011, J AM CHEM SOC, V133, P3780, DOI 10.1021/ja111670s; Fier PS, 2013, SCIENCE, V342, P956, DOI 10.1126/science.1243759; Nakao Y, 2010, J AM CHEM SOC, V132, P13666, DOI 10.1021/ja106514b; Engle KM, 2013, J ORG CHEM, V78, P8927, DOI 10.1021/jo400159y; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Takagi J, 2002, TETRAHEDRON LETT, V43, P5649, DOI 10.1016/S0040-4039(02)01135-8; Zaitsev VG, 2005, J AM CHEM SOC, V127, P13154, DOI 10.1021/ja054549f; Song GY, 2011, J ORG CHEM, V76, P7583, DOI 10.1021/jo201266u; Ye MC, 2011, J AM CHEM SOC, V133, P6964, DOI 10.1021/ja2021075; Hartwig JF, 2011, CHEM SOC REV, V40, P1992, DOI 10.1039/c0cs00156b; Larsen MA, 2014, J AM CHEM SOC, V136, P4287, DOI 10.1021/ja412563e; Manske RH, 1942, CHEM REV, V30, P113, DOI 10.1021/cr60095a006; Chinchilla R, 2004, CHEM REV, V104, P2667, DOI 10.1021/cr020101a; Shen K, 2007, TETRAHEDRON, V63, P1568, DOI 10.1016/j.tet.2006.12.032; Michael JP, 2008, NAT PROD REP, V25, P166, DOI 10.1039/b612168n; Guo PF, 2011, J AM CHEM SOC, V133, P16338, DOI 10.1021/ja206022p; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; MCGILL CK, 1988, ADV HETEROCYCL CHEM, V44, P1, DOI 10.1016/S0065-2725(08)60261-5; Kouznetsov VV, 2005, CURR ORG CHEM, V9, P141, DOI 10.2174/1385272053369196; MINISCI F, 1990, J HETEROCYCLIC CHEM, V27, P79; Shibata T, 2014, ADV SYNTH CATAL, V356, P1516, DOI 10.1002/adsc.201400223; Hwang H, 2014, J AM CHEM SOC, V136, P10770, DOI 10.1021/ja5053768; Sadler SA, 2014, ORG BIOMOL CHEM, V12, P7318, DOI 10.1039/c4ob01565g; Oshima K, 2011, J AM CHEM SOC, V133, P7324, DOI 10.1021/ja2020229; Makosza M, 2004, CHEM REV, V104, P2631; Muniz K, 2009, ANGEW CHEM INT EDIT, V48, P9412, DOI 10.1002/anie.200903671; Roger J, 2010, CHEMCATCHEM, V2, P20, DOI 10.1002/cctc.200900074; Stephens DE, 2015, ACS CATAL, V5, P167, DOI 10.1021/cs501813v; Tsai CC, 2010, J AM CHEM SOC, V132, P11887, DOI 10.1021/ja1061246; Ren XY, 2013, ORG LETT, V15, P5194, DOI 10.1021/ol402262c; Nakao Y, 2008, J AM CHEM SOC, V130, P2448, DOI 10.1021/ja710766j; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Cong XF, 2014, ORG LETT, V16, P3716, DOI 10.1021/ol501534z; Andou T, 2013, ANGEW CHEM INT EDIT, V52, P3213, DOI 10.1002/anie.201208666; Guan BT, 2011, J AM CHEM SOC, V133, P18086, DOI 10.1021/ja208129t; Wang C, 2011, ORG LETT, V13, P4024, DOI 10.1021/ol201539d; Ros A, 2014, CHEM SOC REV, V43, P3229, DOI 10.1039/c3cs60418g; Chen Q, 2013, J AM CHEM SOC, V135, P4958, DOI 10.1021/ja401146v; Zhou J, 2014, ADV SYNTH CATAL, V356, P1038, DOI 10.1002/adsc.201300895; Jeong J, 2014, ORG LETT, V16, P4598, DOI 10.1021/ol502173d; Klatt T, 2014, J ORG CHEM, V79, P4253, DOI 10.1021/jo500297r; Rouquet G, 2013, ANGEW CHEM INT EDIT, V52, P11726, DOI 10.1002/anie.201301451; Tajuddin H, 2012, CHEM SCI, V3, P3505, DOI 10.1039/c2sc20776a; Ye MC, 2011, J AM CHEM SOC, V133, P19090, DOI 10.1021/ja209510q; Zhou J, 2013, ORG LETT, V15, P3460, DOI 10.1021/ol401540k; Ishiyama T, 2002, ANGEW CHEM INT EDIT, V41, P3056, DOI 10.1002/1521-3773(20020816)41:16<3056::AID-ANIE3056>3.0.CO;2-#; Berman AM, 2008, J AM CHEM SOC, V130, P14926, DOI 10.1021/ja8059396; Fier PS, 2014, J AM CHEM SOC, V136, P10139, DOI 10.1021/ja5049303; O'Hara F, 2013, J AM CHEM SOC, V135, P12122, DOI 10.1021/ja406223k; Duncton MAJ, 2011, MEDCHEMCOMM, V2, P1135, DOI 10.1039/c1md00134e; Eicher T., 2003, CHEM HETEROCYCLES, V6, P316; Gros P, 2002, EUR J ORG CHEM, P3375; Gros PC, 2009, EUR J ORG CHEM, P4199, DOI 10.1002/ejoc.200900324; Kwak J, 2012, J AM CHEM SOC, V134, P17778, DOI 10.1021/ja308205d; McAteer C. H., 2008, COMPREHENSIVE HETERO, V7, P309; Nakao Y, 2011, SYNTHESIS-STUTTGART, P3209, DOI 10.1055/s-0030-1260212; Schlosser M, 2005, ANGEW CHEM INT EDIT, V44, P376, DOI 10.1002/anie.200300645; Wei XH, 2012, ORG BIOMOL CHEM, V10, P5521, DOI 10.1039/c2ob25773d	81	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	SEP	2015	5	9					5031	5040		10.1021/acscatal.5b01143		10	Chemistry, Physical	Chemistry	CR1MT	WOS:000361089700009		
J	Hase, S; Kayaki, Y; Ikariya, T				Hase, Shun; Kayaki, Yoshihito; Ikariya, Takao			Mechanistic Aspects of the Carboxylative Cyclization of Propargylamines and Carbon Dioxide Catalyzed by Gold(I) Complexes Bearing an N-Heterocyclic Carbene Ligand	ACS CATALYSIS			English	Article						gold catalysis; carbon dioxide; carboxylative cyclization; alkenyl complex; cyclic urethane	INTRAMOLECULAR HYDROARYLATION; REGIOSELECTIVE SYNTHESIS; FUSED PYRIDOCOUMARINS; SELECTIVE SYNTHESIS; ATMOSPHERIC CO2; AMINO-ALCOHOLS; SYN-INSERTION; CYCLIC UREAS; ALKYNES; DERIVATIVES	The carboxylative cyclization of a range of propargylic amines using carbon dioxide (CO2) is promoted by IPr-gold(I) (IPr = 1,3-bis(2,6-diisopropyl-phenyl)-imidazol-2-ylidene) complexes to afford (Z)-5-alkylidene-2-oxazolidones in methanol under mild conditions, even in the absence of additives such as silver salts and bases. Investigation of the substrate scope shows that the catalytic performance is markedly retarded by the introduction of aromatic substituents at the alkyne terminus. The formation of alkenylgold(I) complexes as catalytic intermediate models is demonstrated by the treatment of methyl- and phenyl-substituted propargylamines with AuOH(IPr) under a CO2 atmosphere. A comparison of the reactivity of the alkenylgold(I) complexes clearly indicates that the alkenyl ligand attached to an alkyl group at the alpha position is more susceptible to protonolysis compared with that attached to a phenyl group. These results and kinetic experiments corroborate a catalytic cycle that involves the nucleophilic attack of carbamate at the C-C triple bond bound to the Au center and its subsequent protodeauration to release the cyclic urethane products.	[Hase, Shun; Kayaki, Yoshihito; Ikariya, Takao] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, Meguro Ku, Tokyo 1528552, Japan	Kayaki, Y (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, Meguro Ku, O Okayama 2-12-1-E4-1, Tokyo 1528552, Japan.	ykayaki@o.cc.titech.ac.jp; tikariya@apc.titech.ac.jp			JSPS KAKENHI [24350079, 26621043]	This work was financially supported by JSPS KAKENHI grant nos. 24350079 and 26621043. We thank the Material Analysis Suzukake-dai Center, Technical Department, Tokyo Institute of Technology, for the HRMS analysis.	Alfonsi M, 2011, TETRAHEDRON LETT, V52, P5145, DOI 10.1016/j.tetlet.2011.07.115; Arcadi A, 2012, ORG BIOMOL CHEM, V10, P9700, DOI 10.1039/c2ob26763b; Ihata O, 2005, MACROMOLECULES, V38, P6429, DOI 10.1021/ma050549o; Yoshida S, 2009, CHEM LETT, V38, P786, DOI 10.1246/cl.2009.786; Fructos MR, 2005, ANGEW CHEM INT EDIT, V44, P5284, DOI 10.1002/anie.200501056; Fujita K, 2014, TETRAHEDRON LETT, V55, P3013, DOI 10.1016/j.tetlet.2014.03.074; Hashmi ASK, 2012, ANGEW CHEM INT EDIT, V51, P4456, DOI 10.1002/anie.201109183; Paz J, 2010, J ORG CHEM, V75, P3037, DOI 10.1021/jo100268n; Joost M, 2014, J AM CHEM SOC, V136, P10373, DOI 10.1021/ja504024h; MITSUDO T, 1987, TETRAHEDRON LETT, V28, P4417, DOI 10.1016/S0040-4039(00)96526-2; GATTOW G, 1972, ANGEW CHEM INT EDIT, V11, P534, DOI 10.1002/anie.197205342; Nale DB, 2014, APPL CATAL A-GEN, V469, P340, DOI 10.1016/j.apcata.2013.10.011; Zhu YG, 2011, ANGEW CHEM INT EDIT, V50, P8329, DOI 10.1002/anie.201103409; Egorova OA, 2011, ANGEW CHEM INT EDIT, V50, P11446, DOI 10.1002/anie.201106132; Kikuchi S, 2011, B CHEM SOC JPN, V84, P698, DOI 10.1246/bcsj.20110078; Yoshida M, 2012, CHEM-EUR J, V18, P15578, DOI 10.1002/chem.201203366; Hu JY, 2015, ANGEW CHEM INT EDIT, V54, P5399, DOI 10.1002/anie.201411969; Dibenedetto A, 2006, EUR J INORG CHEM, P908, DOI 10.1002/ejic.200500622; Riduan SN, 2010, DALTON T, V39, P3347, DOI 10.1039/b920163g; Kayaki Y, 2007, J ORG CHEM, V72, P647, DOI 10.1021/jo062094m; Ma TY, 2014, ACS CATAL, V4, P3847, DOI 10.1021/cs501124d; Yoshida M, 2008, ORG LETT, V10, P2083, DOI 10.1021/ol800663v; Hase S, 2013, ORGANOMETALLICS, V32, P5285, DOI 10.1021/om400949m; Shi M, 2002, J ORG CHEM, V67, P16, DOI 10.1021/jo0014966; Kayaki Y, 2008, CHEM-ASIAN J, V3, P1865, DOI 10.1002/asia.200800204; Hashmi ASK, 2010, ADV SYNTH CATAL, V352, P971, DOI 10.1002/adsc.201000011; Tang Y, 2013, J AM CHEM SOC, V135, P18396, DOI 10.1021/ja4064316; Dinsmore CJ, 2004, ORG LETT, V6, P2885, DOI 10.1021/ol0491080; Ishida T, 2013, ORG LETT, V15, P848, DOI 10.1021/ol303534w; Gaillard S, 2010, CHEM COMMUN, V46, P2742, DOI 10.1039/c0cc00018c; Liu LP, 2008, J AM CHEM SOC, V130, P17642, DOI 10.1021/ja806685j; Yang ZZ, 2012, ENERG ENVIRON SCI, V5, P6602, DOI 10.1039/c2ee02774g; Zeng XM, 2010, ANGEW CHEM INT EDIT, V49, P942, DOI 10.1002/anie.200905341; Zhang X, 2012, J ORG CHEM, V77, P501, DOI 10.1021/jo202087j; Cai R, 2014, CHEM COMMUN, V50, P7303, DOI 10.1039/c4cc03175j; Gohres JL, 2009, IND ENG CHEM RES, V48, P1302, DOI 10.1021/ie8011227; Maggi R, 2007, TETRAHEDRON LETT, V48, P2131, DOI 10.1016/j.tetlet.2007.01.116; Kayaki Y, 2009, ANGEW CHEM INT EDIT, V48, P4194, DOI 10.1002/anie.200901399; Hashmi ASK, 2011, ORGANOMETALLICS, V30, P6328, DOI 10.1021/om2009556; Zhdanko A, 2014, CHEM-EUR J, V20, P1918, DOI 10.1002/chem.201303795; Miller KM, 2003, TETRAHEDRON-ASYMMETR, V14, P3619, DOI 10.1016/j.tetasy.2003.07.010; Arai M., 2014, TRANSFORMATION AND U, P39, DOI DOI 10.1007/978-3-642-44988-8_2; Bhanage BM, 2003, GREEN CHEM, V5, P340, DOI 10.1039/b300778b; Boddien A., 2012, ORGANIC CHEM BREAKTH, P685; Chaturvedi D, 2012, CURR ORG CHEM, V16, P1609; Chen YF, 2010, CHEM COMMUN, V46, P6147, DOI 10.1039/c0cc01338b; Cornell TP, 2012, ORGANOMETALLICS, V31, P5990, DOI 10.1021/om300639h; Costa M, 1996, CHEM COMMUN, P1699, DOI 10.1039/cc9960001699; Costa M., 1998, J CHEM SOC PERK T, V1, P1541; Darensbourg DJ, 2010, INORG CHEM, V49, P10765, DOI 10.1021/ic101800d; Dimroth P., 1964, DE Pat, Patent No. [1164411, 1,164,411]; Dopp R, 2011, ORGANOMETALLICS, V30, P5894, DOI 10.1021/om200735c; Foo SW, 2013, TETRAHEDRON LETT, V54, P4717, DOI 10.1016/j.tetlet.2013.06.100; Fujita S, 2006, INT J MOL SCI, V7, P438, DOI 10.3390/i7100438; Gomez-Suarez A, 2012, DALTON T, V41, P5461, DOI 10.1039/c2dt30294b; Hashmi ASK, 2009, ANGEW CHEM INT EDIT, V48, P8247, DOI 10.1002/anie.200903134; Ihata O., 2004, ANGEW CHEM INT EDIT, V43, P717; Ihata O, 2005, CHEM COMMUN, P2268, DOI 10.1039/b418850k; Johnson A, 2014, J AM CHEM SOC, V136, P12812, DOI 10.1021/ja5055675; Joost M, 2013, ANGEW CHEM INT EDIT, V52, P7160, DOI 10.1002/anie.201303450; Kayaki Y, 2002, CHEM LETT, P424, DOI 10.1246/cl.2002.424; Kayaki Y, 2009, TETRAHEDRON LETT, V50, P6491, DOI 10.1016/j.tetlet.2009.09.015; KODAKA M, 1989, J CHEM SOC CHEM COMM, P1479, DOI 10.1039/c39890001479; Majumdar KC, 2011, SYNLETT, P116, DOI 10.1055/s-0030-1259097; MATSUDA H, 1985, IND ENG CHEM PROD RD, V24, P239, DOI 10.1021/i300018a013; Omae I, 2012, COORDIN CHEM REV, V256, P1384, DOI 10.1016/j.ccr.2012.03.017; Patil YP, 2008, J MOL CATAL A-CHEM, V289, P14, DOI 10.1016/j.molcata.2008.03.019; Pulla S, 2013, ACS SUSTAIN CHEM ENG, V1, P309, DOI 10.1021/sc300077m; Quaranta E., 2010, CARBON DIOXIDE CHEM, P121, DOI 10.1002/9783527629916.ch6; Shi Y, 2009, ORGANOMETALLICS, V28, P1275, DOI 10.1021/om801206g; Symeonidis TS, 2014, J HETEROCYCLIC CHEM, V51, P642, DOI 10.1002/jhet.1791; Symeonidis TS, 2013, TETRAHEDRON, V69, P4612, DOI 10.1016/j.tet.2013.04.026; Takada Y, 2014, RSC ADV, V4, P50851, DOI 10.1039/c4ra09609f; Tamura M, 2013, J CATAL, V305, P191, DOI 10.1016/j.jcat.2013.05.013; Tanimoto R, 2014, CHEM LETT, V43, P678, DOI 10.1246/cl.131162; Tominaga K., 2002, SYNLETT, V2002, P0307; Ueno A, 2013, GREEN CHEM, V15, P425, DOI 10.1039/c2gc36414j; Weber D, 2009, ANGEW CHEM INT EDIT, V48, P5733, DOI 10.1002/anie.200902049; Kayaki Y, 2006, GREEN CHEM, V8, P1019, DOI 10.1039/b603700c; Yamashita K, 2015, ORG LETT, V17, P2334, DOI 10.1021/acs.orglett.5b00809; Yuan RM, 2015, ACS CATAL, V5, P2866, DOI 10.1021/acscatal.5b00252	81	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	SEP	2015	5	9					5135	5140		10.1021/acscatal.5b01335		6	Chemistry, Physical	Chemistry	CR1MT	WOS:000361089700020		
J	Song, FZ; Zhu, QL; Tsumori, N; Xu, Q				Song, Fu-Zhan; Zhu, Qi-Long; Tsumori, Nobuko; Xu, Qiang			Diamine-Alkalized Reduced Graphene Oxide: Immobilization of Sub-2 nm Palladium Nanoparticles and Optimization of Catalytic Activity for Dehydrogenation of Formic Acid	ACS CATALYSIS			English	Article						dehydrogenation; formic acid; heterogeneous catalysis; nanoparticles; alkalized reduced graphene oxide	OXYGEN REDUCTION REACTION; METAL-ORGANIC FRAMEWORK; NITROGEN-DOPED GRAPHENE; HYDROGEN GENERATION; ROOM-TEMPERATURE; HIGH-PERFORMANCE; FACILE SYNTHESIS; EFFICIENT CATALYST; AMBIENT CONDITIONS; PD NANOPARTICLES	An efficient strategy to downsize metal nanoparticles (NPs) and provide basic sites located nearby for optimizing the catalytic performance of reduced graphene oxide (rGO)-supported metal catalysts has been explored, for the first time, by potent alkalization of rGO with diamine. By virtue of the coordination effects between the metal ions and the amine groups ligated to rGO, monodispersed Pd nanoparticles (diameter <= 1.5 nm) can be facilely anchored on the diamine-alkalized rGO by a simple reduction approach. The turnover frequency (TOF) for heterogeneously catalyzed decomposition of formic acid reaches 3810 h(-1) at 323 K, the highest value ever reported under ambient conditions compared with the other heterogeneous catalysts.	[Song, Fu-Zhan; Zhu, Qi-Long; Tsumori, Nobuko; Xu, Qiang] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan; [Song, Fu-Zhan; Xu, Qiang] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Tsumori, Nobuko] Toyama Natl Coll Technol, Toyama 9398630, Japan	Xu, Q (reprint author), Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan.	q.xu@aist.go.jp	Zhu, Qi-Long/B-9257-2012		AIST; METI; MEXT	The authors are thankful to Dr. Yanying Zhao for Raman, Dr. Yasuyuki Matsumura for XPS, and Dr. Takeyuki Uchida for SEM and TEM measurements, and AIST and METI for financial support. F.-Z.S. thanks MEXT for a government scholarship.	Liu MM, 2014, CHEM REV, V114, P5117, DOI 10.1021/cr400523y; Zhu QL, 2014, CHEM SCI, V5, P195, DOI 10.1039/c3sc52448e; Hull JF, 2012, NAT CHEM, V4, P383, DOI [10.1038/nchem.1295, 10.1038/NCHEM.1295]; Mori K, 2013, ACS CATAL, V3, P1114, DOI 10.1021/cs400148n; Shin SI, 2013, ENERG ENVIRON SCI, V6, P608, DOI 10.1039/c2ee22739h; Loges B, 2008, ANGEW CHEM INT EDIT, V47, P3962, DOI 10.1002/anie.200705972; Boddien A, 2011, SCIENCE, V333, P1733, DOI 10.1126/science.1206613; Grasemann M, 2012, ENERG ENVIRON SCI, V5, P8171, DOI 10.1039/c2ee21928j; Gan WJ, 2013, CHEMCATCHEM, V5, P1126, DOI 10.1002/cctc.201200782; Wang ZL, 2013, ANGEW CHEM INT EDIT, V52, P4406, DOI 10.1002/anie.201301009; Ojeda M, 2009, ANGEW CHEM INT EDIT, V48, P4800, DOI 10.1002/anie.200805723; Martis M, 2013, J PHYS CHEM C, V117, P22805, DOI 10.1021/jp4069027; Yu WY, 2014, J AM CHEM SOC, V136, P11070, DOI 10.1021/ja505192v; Li PZ, 2012, ANGEW CHEM INT EDIT, V51, P6753, DOI 10.1002/anie.201202055; Yin HJ, 2012, ACS NANO, V6, P8288, DOI 10.1021/nn302984x; Guo SJ, 2010, ACS NANO, V4, P547, DOI 10.1021/nn9014483; Gu XJ, 2011, J AM CHEM SOC, V133, P11822, DOI 10.1021/ja200122f; Loges B, 2010, TOP CATAL, V53, P902, DOI 10.1007/s11244-010-9522-8; Ping Y, 2013, J MATER CHEM A, V1, P12188, DOI 10.1039/c3ta12724a; Sponholz P, 2013, CHEMSUSCHEM, V6, P1172, DOI 10.1002/cssc.201300186; Yadav M, 2012, J MATER CHEM, V22, P12582, DOI 10.1039/c2jm31309j; Hu CQ, 2014, INT J HYDROGEN ENERG, V39, P381, DOI 10.1016/j.ijhydene.2013.10.067; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Shang L, 2014, ANGEW CHEM INT EDIT, V53, P250, DOI 10.1002/anie.201306863; Farmer JA, 2010, SCIENCE, V329, P933, DOI 10.1126/science.1191778; Bi QY, 2012, J AM CHEM SOC, V134, P8926, DOI 10.1021/ja301696e; Tan CL, 2013, MATER TODAY, V16, P29, DOI 10.1016/j.mattod.2013.01.021; Fellay C, 2008, ANGEW CHEM INT EDIT, V47, P3966, DOI 10.1002/anie.200800320; Himeda Y, 2009, GREEN CHEM, V11, P2018, DOI 10.1039/b914442k; Hu H, 2013, ADV MATER, V25, P2219, DOI 10.1002/adma.201204530; Parvez K, 2012, ACS NANO, V6, P9541, DOI 10.1021/nn302674k; Aijaz A, 2012, J AM CHEM SOC, V134, P13926, DOI 10.1021/ja3043905; Thevenon A, 2014, CHEMCATCHEM, V6, P3146, DOI 10.1002/cctc.201402410; Chen RJ, 2013, NANO LETT, V13, P4642, DOI 10.1021/nl4016683; Chen Y, 2015, J AM CHEM SOC, V137, P106, DOI 10.1021/ja511511q; Guo ZY, 2014, ACS CATAL, V4, P1340, DOI 10.1021/cs400982n; Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y; Kuo CH, 2012, J AM CHEM SOC, V134, P14345, DOI 10.1021/ja306869j; Lee CW, 2015, J MATER CHEM A, V3, P2314, DOI 10.1039/c4ta05863a; Moret S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5017; Tiwari JN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3221; Wang ZY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6002; Wang ZL, 2014, NANOSCALE, V6, P3073, DOI 10.1039/c3nr05809c; Zhu QL, 2015, ENERG ENVIRON SCI, V8, P478, DOI 10.1039/c4ee03690e	44	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	SEP	2015	5	9					5141	5144		10.1021/acscatal.5b01411		4	Chemistry, Physical	Chemistry	CR1MT	WOS:000361089700021		
J	Muthukrishnan, A; Nabae, Y; Okajima, T; Ohsaka, T				Muthukrishnan, Azhagumuthu; Nabae, Yuta; Okajima, Takeyoshi; Ohsaka, Takeo			Kinetic Approach to Investigate the Mechanistic Pathways of Oxygen Reduction Reaction on Fe-Containing N-Doped Carbon Catalysts	ACS CATALYSIS			English	Article						nitrogen-doped carbon; oxygen reduction reaction; XPS; electrochemical reduction; mechanism of the ORB	RING-DISK ELECTRODE; PEM FUEL-CELLS; HIGH-PERFORMANCE FE; HYDROGEN-PEROXIDE; ELECTROCATALYTIC ACTIVITY; PHENOLIC RESIN; O-2 REDUCTION; ACTIVE-SITES; ACIDIC MEDIA; C CATALYSTS	The mechanism of the oxygen reduction reaction (ORR) on polyimide-based N-doped carbon catalysts with and without Fe (i.e., Fe-N-C and N-C) in acidic media was studied, using a rotating ring-disk electrode voltammetry, based on the estimation of the rate constants of the ORB, i.e., k(1), k(2), and k(3) corresponding to the 4-electron direct reduction of O-2 to H2O, the 2-electron reduction of O-2 to H2O2, and the 2-electron reduction of H2O2 to H2O, respectively as functions of the loading density of Fe-N-C or N-C and the electrode potential, in which two different kinetic models for the ORR, i.e., Damjanovic and Wroblowa models were used to estimate the values of the k(1), k(2), and k(3). The H2O2 disproportionation reaction rate constants (k(4)) of the Fe-N-C and N-C catalysts were also estimated. For both catalysts, the ORR follows, as a whole, a 4-electron pathway (k(1) >> k(2)) when the loading density is high (>ca. 200 mu g/cm(2)), whereas at the lower loading density the 2-electron reduction of O-2 becomes more dominant (k(1) < k(2)). The value of k(4) was found to be negligible compared with that of k(1), k(2), and k(3). In addition, the individual rate constants estimated by extrapolating rate constant vs loading density plots to the zero loading density demonstrate that in the case of the Fe-N-C catalyst, 2-electron and 4-electron reduction sites coexist with a higher population of the former, whereas in the case of the N-C catalyst, only 2-electron active sites exist. The kinetic analysis strongly suggests that the Fe in the Fe-N-C catalyst plays a crucial role in making the 4-electron active sites as well as it may catalyze the H2O2 reduction to H2O, resulting in the enhanced ORR performance.	[Muthukrishnan, Azhagumuthu; Okajima, Takeyoshi; Ohsaka, Takeo] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Nabae, Yuta] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan	Ohsaka, T (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, G1-5,4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	ohsaka@echem.titech.ac.jp	AZHAGUMUTHU, MUTHUKRISHNAN/I-9728-2014	AZHAGUMUTHU, MUTHUKRISHNAN/0000-0001-9971-0093	New Energy and Industrial Technology and Development Organization (NEDO), Japan	This work was financially supported by the New Energy and Industrial Technology and Development Organization (NEDO), Japan. We thank Dr. Fuchigami for helpful discussions.	ANASTASIJEVIC NA, 1987, J ELECTROANAL CHEM, V229, P305, DOI 10.1016/0022-0728(87)85148-3; ANASTASIJEVIC NA, 1987, J ELECTROANAL CHEM, V229, P317, DOI 10.1016/0022-0728(87)85149-5; WIESENER K, 1986, ELECTROCHIM ACTA, V31, P1073, DOI 10.1016/0013-4686(86)80022-6; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Nabae Y, 2014, J MATER CHEM A, V2, P11561, DOI 10.1039/c4ta01828a; Niwa H, 2009, J POWER SOURCES, V187, P93, DOI 10.1016/j.jpowsour.2008.10.064; Ganesan S, 2014, PHYS CHEM CHEM PHYS, V16, P4576, DOI 10.1039/c3cp54751e; Yan XH, 2013, CHINESE J CATAL, V34, P1992, DOI 10.1016/S1872-2067(12)60714-1; Singh D, 2014, J CATAL, V317, P30, DOI 10.1016/j.jcat.2014.05.025; Robson MH, 2013, ELECTROCHIM ACTA, V90, P656, DOI 10.1016/j.electacta.2012.11.025; Gojkovic SL, 1999, ELECTROCHIM ACTA, V45, P889, DOI 10.1016/S0013-4686(99)00294-7; Matter PH, 2006, J PHYS CHEM B, V110, P18374, DOI 10.1021/jp062206d; Sun J, 2014, PHYS CHEM CHEM PHYS, V16, P13733, DOI 10.1039/c4cp00037d; Nabae Y, 2014, CATAL SCI TECHNOL, V4, P1400, DOI 10.1039/c4cy00119b; Chen Z, 2010, ELECTROCHIM ACTA, V55, P4799, DOI 10.1016/j.electacta.2010.03.057; Lefevre M, 2003, ELECTROCHIM ACTA, V48, P2749, DOI 10.1016/S0013-4686(03)00393-1; Li XG, 2010, J POWER SOURCES, V195, P6373, DOI 10.1016/j.jpowsour.2010.04.019; Liu G, 2011, CATAL SCI TECHNOL, V1, P207, DOI 10.1039/c0cy00053a; Lefevre M, 2000, J PHYS CHEM B, V104, P11238, DOI 10.1021/jp002444n; Bonakdarpour A, 2008, ELECTROCHEM SOLID ST, V11, pB105, DOI 10.1149/1.2904768; WROBLOWA HS, 1976, J ELECTROANAL CHEM, V69, P195, DOI 10.1016/S0022-0728(76)80250-1; Liu G, 2010, ELECTROCHIM ACTA, V55, P2853, DOI 10.1016/j.electacta.2009.12.055; Claude E, 1998, J APPL ELECTROCHEM, V28, P57; Matter PH, 2006, J CATAL, V239, P83, DOI 10.1016/j.jcat.2006.01.022; Lefevre M, 2002, J PHYS CHEM B, V106, P8705, DOI 10.1021/jp020267f; Subramanian NP, 2009, J POWER SOURCES, V188, P38, DOI 10.1016/j.jpowsour.2008.11.087; Park J, 2014, ACS CATAL, V4, P3749, DOI 10.1021/cs5008206; OGRADY WE, 1982, J ELECTROANAL CHEM, V132, P137, DOI 10.1016/0022-0728(82)85013-4; HSUEH KL, 1983, J ELECTROANAL CHEM, V153, P79, DOI 10.1016/S0022-0728(83)80007-2; Geng DS, 2011, J POWER SOURCES, V196, P1795, DOI 10.1016/j.jpowsour.2010.09.084; Wang HB, 2012, ACS CATAL, V2, P781, DOI 10.1021/cs200652y; Rao CV, 2010, J PHYS CHEM LETT, V1, P2622, DOI 10.1021/jz100971v; Paulus UA, 2001, J ELECTROANAL CHEM, V495, P134, DOI 10.1016/S0022-0728(00)00407-1; Inaba M, 2004, ELECTROCHEM SOLID ST, V7, pA474, DOI 10.1149/1.1814595; MORCOS I, 1970, ELECTROCHIM ACTA, V15, P953, DOI 10.1016/0013-4686(70)80037-8; APPLEBY AJ, 1978, J ELECTROANAL CHEM, V92, P15, DOI 10.1016/S0022-0728(78)80113-2; Zhu YS, 2014, ANGEW CHEM INT EDIT, V53, P10673, DOI 10.1002/anie.201405314; Li H, 2011, INT J HYDROGEN ENERG, V36, P2258, DOI 10.1016/j.ijhydene.2010.11.025; Wu JJ, 2015, LANGMUIR, V31, P5529, DOI 10.1021/acs.langmuir.5b00310; FRANKE R, 1989, J ELECTROANAL CHEM, V260, P63, DOI 10.1016/0022-0728(89)87099-8; Jaouen F, 2009, J PHYS CHEM C, V113, P15422, DOI 10.1021/jp900837e; Bron M, 2002, FUEL CELLS, V2, P137, DOI 10.1002/fuce.200290012; Chen JY, 2015, CATAL COMMUN, V60, P37, DOI 10.1016/j.catcom.2014.11.012; DAMJANOV.A, 1966, J CHEM PHYS, V45, P4057, DOI 10.1063/1.1727457; DAVIES MO, 1959, J ELECTROCHEM SOC, V106, P56, DOI 10.1149/1.2427266; Easton EB, 2008, J ELECTROCHEM SOC, V155, pB547, DOI 10.1149/1.2899013; FISCHER P, 1980, J ELECTROANAL CHEM, V112, P231, DOI 10.1016/S0022-0728(80)80404-9; Muthukrishnan A, 2015, CATAL SCI TECHNOL, V5, P1764, DOI 10.1039/c4cy01429d; Muthukrishnan A, 2015, CATAL SCI TECHNOL, V5, P475, DOI 10.1039/c4cy01001a; Peng HL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01765; Yang RZ, 2007, J ELECTROCHEM SOC, V154, pA275, DOI 10.1149/1.2435670	51	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	SEP	2015	5	9					5194	5202		10.1021/acscatal.5b00397		9	Chemistry, Physical	Chemistry	CR1MT	WOS:000361089700027		
J	AlOtaibi, B; Fan, SZ; Wang, DF; Ye, JH; Mi, ZT				AlOtaibi, Bandar; Fan, Shizhao; Wang, Defa; Ye, Jinhua; Mi, Zetian			Wafer-Level Artificial Photosynthesis for CO2 Reduction into CH4 and CO Using GaN Nanowires	ACS CATALYSIS			English	Article						carbon dioxide photoreduction; artificial photosynthesis; solar fuels; methane; gallium nitride; nanowires	MOLECULAR-BEAM EPITAXY; IN-SITU FTIR; P-TYPE GAN; CARBON-DIOXIDE; VISIBLE-LIGHT; PHOTOCATALYTIC REDUCTION; GALLIUM NITRIDE; SEMICONDUCTOR NANOWIRES; ELECTRONIC-STRUCTURE; SURFACE INTERACTION	We report on the first demonstration of high-conversion-rate photochemical reduction of carbon dioxide (CO2) on gallium nitride (GaN) nanowire arrays into methane (CH4) and carbon monoxide (CO). It was observed that the reduction of CO2 to CO dominates on as-grown GaN nanowires under ultraviolet light irradiation. However, the production of CH4 is significantly increased by using the Rh/Cr2O3 core/shell cocatalyst, with an average rate of similar to 3.5 mu mol g(cat)(-1) h(-1) in 24 h. In this process, the rate of CO2 to CO conversion is suppressed by nearly an order of magnitude. The rate of photoreduction of CO2 to CH4 can be further enhanced and can reach similar to 14.8 mu mol gcat(-1) h(-1) by promoting Pt nanoparticles on the lateral m-plane surfaces of GaN nanowires, which is nearly an order of magnitude higher than that measured on as-grown GaN nanowire arrays. This work establishes the potential use of metal-nitride nanowire arrays as a highly efficient photocatalyst for the direct photoreduction of CO2 into chemical fuels. It also reveals the potential of engineered core/shell cocatalysts in improving the selectivity toward more valuable fuels.	[AlOtaibi, Bandar; Fan, Shizhao; Mi, Zetian] McGill Univ, Dept Elect & Comp Engn, Montreal, PQ H3A 0E9, Canada; [Wang, Defa; Ye, Jinhua] Tianjin Univ, TU NIMS Joint Res Ctr, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China; [Wang, Defa] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China; [Ye, Jinhua] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Ye, Jinhua] Natl Inst Mat Sci, Environm Remediat Mat Unit, Tsukuba, Ibaraki 3050044, Japan	Mi, ZT (reprint author), McGill Univ, Dept Elect & Comp Engn, 3480 Univ St, Montreal, PQ H3A 0E9, Canada.	zetian.mi@mcgill.ca			Natural Sciences and Engineering Research Council of Canada; Climate Change and Emissions Management (CCEMC) Corporation	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the Climate Change and Emissions Management (CCEMC) Corporation. B.A. acknowledges King Abdullah foreign scholarship program.	Abee MW, 2001, J PHYS CHEM B, V105, P7755, DOI 10.1021/jp011223u; Maeda K, 2007, J PHYS CHEM C, V111, P7554, DOI 10.1021/jp071056j; Zhang N, 2011, CHEM COMMUN, V47, P2041, DOI 10.1039/c0cc04687f; SALADIN F, 1995, J CHEM SOC CHEM COMM, P533, DOI 10.1039/c39950000533; Maeda K, 2007, J PHYS CHEM C, V111, P7851, DOI 10.1021/jp070911w; Li XK, 2012, APPL CATAL A-GEN, V413, P103, DOI 10.1016/j.apcata.2011.10.044; Wang SB, 2014, PHYS CHEM CHEM PHYS, V16, P14656, DOI 10.1039/c4cp02173h; Arunajatesan V, 2007, CHEM ENG SCI, V62, P5062, DOI 10.1016/j.ces.2007.01.010; Maeda K, 2010, CHEM MATER, V22, P612, DOI 10.1021/cm901917a; Liu Q, 2012, J MATER CHEM, V22, P2033, DOI 10.1039/c1jm14122h; Pan J, 2011, CHEM COMMUN, V47, P8361, DOI 10.1039/c1cc13034j; Tran PD, 2012, ENERG ENVIRON SCI, V5, P5902, DOI 10.1039/c2ee02849b; AlOtaibi B, 2013, NANO LETT, V13, P4356, DOI 10.1021/nl402156e; Habisreutinger SN, 2013, ANGEW CHEM INT EDIT, V52, P7372, DOI 10.1002/anie.201207199; Lekse JW, 2012, J PHYS CHEM C, V116, P1865, DOI 10.1021/jp2087225; TUNG RT, 1992, PHYS REV B, V45, P13509, DOI 10.1103/PhysRevB.45.13509; AlOtaibi B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/17/175401; KOPPENOL WH, 1987, J PHYS CHEM-US, V91, P4429, DOI 10.1021/j100300a045; Fan HJ, 2006, SMALL, V2, P700, DOI 10.1002/smll.200500495; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; FORESI JS, 1993, APPL PHYS LETT, V62, P2859, DOI 10.1063/1.109207; INOUE T, 1979, NATURE, V277, P637, DOI 10.1038/277637a0; Chen XB, 2012, CHEM SOC REV, V41, P7909, DOI 10.1039/c2cs35230c; ANPO M, 1992, J MOL CATAL, V74, P207, DOI 10.1016/0304-5102(92)80238-C; Liu Q, 2012, RSC ADV, V2, P3247, DOI 10.1039/c2ra20186k; Li P, 2012, J PHYS CHEM C, V116, P7621, DOI 10.1021/jp210106b; Zhao S, 2013, NANOSCALE, V5, P5283, DOI 10.1039/c3nr00387f; Sarusi I, 2011, CATAL TODAY, V171, P132, DOI 10.1016/j.cattod.2011.03.075; Zhou Y, 2011, ACS APPL MATER INTER, V3, P3594, DOI 10.1021/am2008147; Amirav L, 2013, J AM CHEM SOC, V135, P13049, DOI 10.1021/ja404918z; Mori K, 2012, RSC ADV, V2, P3165, DOI 10.1039/c2ra01332k; RASKO J, 1994, J PHYS CHEM-US, V98, P7147, DOI 10.1021/j100080a009; Tollefson J, 2011, NATURE, V473, P134, DOI 10.1038/473134a; Caccamo L, 2014, ACS APPL MATER INTER, V6, P2235, DOI 10.1021/am4058937; Roy SC, 2010, ACS NANO, V4, P1259, DOI 10.1021/nn9015423; SOLYMOSI F, 1980, J CATAL, V65, P428, DOI 10.1016/0021-9517(80)90319-X; Maeda K, 2007, B CHEM SOC JPN, V80, P1004, DOI 10.1246/bcsj.80.1004; Moustakas TD, 2013, PHYS STATUS SOLIDI A, V210, P169, DOI 10.1002/pssa.201200561; Guan GQ, 2003, APPL CATAL B-ENVIRON, V41, P387, DOI 10.1016/S0926-3373(02)00174-1; Varghese OK, 2009, NANO LETT, V9, P731, DOI 10.1021/nl803258p; Wang WN, 2012, J AM CHEM SOC, V134, P11276, DOI 10.1021/ja304075b; Xie YP, 2012, J MATER CHEM, V22, P6746, DOI 10.1039/c2jm16178h; TANAKA K, 1984, J PHYS CHEM-US, V88, P3504, DOI 10.1021/j150660a026; AURIANBLAJENI B, 1980, SOL ENERGY, V25, P165, DOI 10.1016/0038-092X(80)90472-7; Gotz W, 1996, APPL PHYS LETT, V68, P3144; Wang WN, 2011, CATAL SCI TECHNOL, V1, P593, DOI 10.1039/c0cy00091d; Kubacka A, 2012, CHEM REV, V112, P1555, DOI 10.1021/cr100454n; Park JN, 2009, J CATAL, V266, P92, DOI 10.1016/j.jcat.2009.05.018; Kibria MG, 2013, ACS NANO, V7, P7886, DOI 10.1021/nn4028823; Van de Walle CG, 2007, J APPL PHYS, V101, DOI 10.1063/1.2722731; Wang DF, 2011, NANO LETT, V11, P2353, DOI 10.1021/nl2006802; Zhang N, 2012, CHEM COMMUN, V48, P1269, DOI 10.1039/c2cc16900b; Kamat PV, 2012, J PHYS CHEM LETT, V3, P663, DOI 10.1021/jz201629p; Park HA, 2012, J MATER CHEM, V22, P5304, DOI 10.1039/c2jm30337j; Glas F, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.121302; SOLYMOSI F, 1981, J CHEM SOC FARAD T 1, V77, P2645, DOI 10.1039/f19817702645; Uner D, 2012, CATAL TODAY, V181, P82, DOI 10.1016/j.cattod.2011.06.019; TANAKA K, 1982, J PHYS CHEM-US, V86, P3977, DOI 10.1021/j100217a018; Nguyen HPT, 2011, NANO LETT, V11, P1919, DOI 10.1021/nl104536x; Yoshida M, 2009, J AM CHEM SOC, V131, P13218, DOI 10.1021/ja904991p; Izumi Y, 2013, COORDIN CHEM REV, V257, P171, DOI 10.1016/j.ccr.2012.04.018; Maeda K, 2006, NATURE, V440, P295, DOI 10.1038/440295a; Goguet A, 2004, J PHYS CHEM B, V108, P20240, DOI 10.1021/jp047242w; Ebaid M, 2015, RSC ADV, V5, P23303, DOI 10.1039/c5ra01374g; Wang CJ, 2010, J PHYS CHEM LETT, V1, P48, DOI 10.1021/jz9000032; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Duan XF, 2003, NATURE, V425, P274, DOI 10.1038/nature01996; Beach JD, 2003, J ELECTROCHEM SOC, V150, pA899, DOI 10.1149/1.1577542; Chen YG, 1997, APPL CATAL A-GEN, V165, P335, DOI 10.1016/S0926-860X(97)00216-0; Elvins OC, 1926, NATURE, V118, P154, DOI 10.1038/118154a0; ERDOHELYI A, 1982, ACTA CHIM HUNG, V111, P591; Fujii K, 2005, JPN J APPL PHYS 2, V44, pL909, DOI 10.1143/JJAP.44.L909; GALUSZKA J, 1994, CATAL TODAY, V21, P321, DOI 10.1016/0920-5861(94)80153-3; Huygens IM, 2000, J ELECTROCHEM SOC, V147, P1797, DOI 10.1149/1.1393436; Kibria MG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4825; Kibria MG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7797; Kohno Y, 1999, J PHOTOCH PHOTOBIO A, V126, P117, DOI 10.1016/S1010-6030(99)00113-6; KUHLENBECK H, 1992, BER BUNSEN PHYS CHEM, V96, P15; Liliental-Weber Z, 2004, OPTO-ELECTRON REV, V12, P339; Luo WJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2955828; MARCOS ML, 1989, J ELECTROANAL CHEM, V270, P205, DOI 10.1016/0022-0728(89)85037-5; NIKOLIC BZ, 1990, J ELECTROANAL CHEM, V295, P415, DOI 10.1016/0022-0728(90)85033-2; Rasko J, 1998, CATAL LETT, V56, P11, DOI 10.1023/A:1019072021006; RISSMANN EF, 1992, CATAL LETT, V16, P159, DOI 10.1007/BF00764366; ROSTRUPNIELSEN JR, 1993, J CATAL, V38, P144; Schafer S, 2013, CHEMCATCHEM, V5, P3224, DOI 10.1002/cctc.201300070; SERPONE N, 1984, J CHEM SOC CHEM COMM, P342, DOI 10.1039/c39840000342; Smol JP, 2012, NATURE, V483, pS12, DOI 10.1038/483S12a; SOLYMOSI F, 1994, CATAL LETT, V27, P61, DOI 10.1007/BF00806978; TANAKA K, 1983, J CATAL, V79, P81, DOI 10.1016/0021-9517(83)90291-9; Van de Walle CG, 1998, J CRYST GROWTH, V189, P505, DOI 10.1016/S0022-0248(98)00340-6; Wang SB, 2015, CHEM COMMUN, V51, P1517, DOI 10.1039/c4cc07225a; Yotsuhashi S, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.117101; Yotsuhashi S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BP07	94	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	SEP	2015	5	9					5342	5348		10.1021/acscatal.5b00776		7	Chemistry, Physical	Chemistry	CR1MT	WOS:000361089700042		
J	Wang, WH; Ertem, MZ; Xu, SA; Onishi, N; Manaka, Y; Suna, Y; Kambayash, H; Muckerman, JT; Fujita, E; Himeda, Y				Wang, Wan-Hui; Ertem, Mehmed Z.; Xu, Shaoan; Onishi, Naoya; Manaka, Yuichi; Suna, Yuki; Kambayash, Hide; Muckerman, James T.; Fujita, Etsuko; Himeda, Yuichiro			Highly Robust Hydrogen Generation by Bioinspired Ir Complexes for Dehydrogenation of Formic Acid in Water: Experimental and Theoretical Mechanistic Investigations at Different pH	ACS CATALYSIS			English	Article						formic acid dehydrogenation; Ir complexes; mechanism; kinetic isotope effect; pH dependence	CARBON-DIOXIDE; REVERSIBLE HYDROGENATION; AMBIENT-TEMPERATURE; LIGAND COOPERATION; IRIDIUM CATALYST; STORAGE; DECOMPOSITION; H-2; CO2; OXIDATION	Hydrogen generation from formic acid (FA), one of the most promising hydrogen storage materials, has attracted much attention due to the demand for the development of renewable energy carriers. Catalytic dehydrogenation of FA in an efficient and green manner remains challenging. Here, we report a series of bioinspired Ir complexes for highly robust and selective hydrogen production from FA in aqueous solutions without organic solvents or additives. One of these complexes bearing an imidazoline moiety (complex 6) achieved a turnover frequency (TOF) of 322 000 h(-1) at 100 degrees C, which is higher than ever reported. The novel catalysts are very stable and applicable in highly concentrated FA. For instance, complex 3 (1 mu mol) affords an unprecedented turnover number (TON) of 2 050 000 at 60 degrees C. Deuterium kinetic isotope effect experiments and density functional theory (DFT) calculations employing a "speciation" approach demonstrated a change in the rate-determining step with increasing solution pH. This study provides not only more insight into the mechanism of dehydrogenation of FA but also offers a new principle for the design of effective homogeneous organometallic catalysts for H-2 generation from FA.	[Wang, Wan-Hui] Dalian Univ Technol, Sch Petr & Chem Engn, Panjin 124221, Peoples R China; [Ertem, Mehmed Z.; Muckerman, James T.; Fujita, Etsuko] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; [Xu, Shaoan; Onishi, Naoya; Manaka, Yuichi; Suna, Yuki; Kambayash, Hide; Himeda, Yuichiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Manaka, Yuichi; Himeda, Yuichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Muckerman, JT (reprint author), Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA.	muckerma@bnl.gov; fujita@bnl.gov; himeda.y@aist.go.jp	Wang, Wan-Hui/J-8773-2012; 	Wang, Wan-Hui/0000-0002-5943-4589; Manaka, Yuichi/0000-0001-5872-3365	Japan Science and Technology Agency (JST), CREST; Dalian University of Technology (Fundamental Research Funds for Central Universities) [DUT14RC(3)082, 844401]; National Natural Science Foundation of China [21402019]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC00112704]	Y.H. and Y.M. thank the Japan Science and Technology Agency (JST), CREST for financial support. W.-H.W. is thankful for the financial support from Dalian University of Technology (the Fundamental Research Funds for the Central Universities, Grant No. DUT14RC(3)082; Grant No. 844401) and National Natural Science Foundation of China (Grant No. 21402019). The work at BNL was carried out under contract DE-SC00112704 with the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, and utilized resources at the BNL Center for Functional Nanomaterials.	Hsu SF, 2014, ANGEW CHEM INT EDIT, V53, P7074, DOI 10.1002/anie.201310972; Bielinski EA, 2014, J AM CHEM SOC, V136, P10234, DOI 10.1021/ja505241x; Wang N, 2013, DALTON T, V42, P12059, DOI 10.1039/c3dt51371h; Vogt M, 2014, CHEM SCI, V5, P2043, DOI 10.1039/c4sc00130c; DIXON HBF, 1973, BIOCHEM J, V131, P149; Hull JF, 2012, NAT CHEM, V4, P383, DOI [10.1038/nchem.1295, 10.1038/NCHEM.1295]; Zell T, 2013, CHEM-EUR J, V19, P8068, DOI 10.1002/chem.201301383; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Fukuzumi S, 2008, CHEMSUSCHEM, V1, P827, DOI 10.1002/cssc.200800147; Loges B, 2008, ANGEW CHEM INT EDIT, V47, P3962, DOI 10.1002/anie.200705972; Liu TB, 2013, NAT CHEM, V5, P228, DOI 10.1038/NCHEM.1571; Preti D, 2010, ANGEW CHEM INT EDIT, V49, P2581, DOI 10.1002/anie.200906054; Bullock RM, 2014, CHEM COMMUN, V50, P3125, DOI 10.1039/c3cc46135a; Boddien A, 2011, SCIENCE, V333, P1733, DOI 10.1126/science.1206613; Askevold B, 2012, CHEMCATCHEM, V4, P307, DOI 10.1002/cctc.201100347; Grasemann M, 2012, ENERG ENVIRON SCI, V5, P8171, DOI 10.1039/c2ee21928j; Johnson TC, 2010, CHEM SOC REV, V39, P81, DOI 10.1039/b904495g; Papp G, 2011, ANGEW CHEM INT EDIT, V50, P10433, DOI 10.1002/anie.201104951; Gan WJ, 2013, CHEMCATCHEM, V5, P1126, DOI 10.1002/cctc.201200782; Boddien A, 2011, ANGEW CHEM INT EDIT, V50, P6411, DOI 10.1002/anie.201101995; Eberle U, 2009, ANGEW CHEM INT EDIT, V48, P6608, DOI 10.1002/anie.200806293; Oldenhof S, 2015, CHEM SCI, V6, P1027, DOI 10.1039/c4sc02555e; Wang WH, 2014, CHEMSUSCHEM, V7, P1976, DOI 10.1002/cssc.201301414; Joo F, 2008, CHEMSUSCHEM, V1, P805, DOI 10.1002/cssc.200800133; Gan WJ, 2013, CHEMCATCHEM, V5, P3124, DOI 10.1002/cctc.201300246; Bi QY, 2014, ANGEW CHEM INT EDIT, V53, P13583, DOI 10.1002/anie.201409500; Gordon JC, 2010, ORGANOMETALLICS, V29, P4682, DOI 10.1021/om100436c; Myers TW, 2014, CHEM SCI, V5, P2771, DOI 10.1039/c4sc01035c; Enthaler S, 2010, ENERG ENVIRON SCI, V3, P1207, DOI 10.1039/b907569k; Loges B, 2010, TOP CATAL, V53, P902, DOI 10.1007/s11244-010-9522-8; Maenaka Y, 2012, ENERG ENVIRON SCI, V5, P7360, DOI 10.1039/c2ee03315a; Sponholz P, 2013, CHEMSUSCHEM, V6, P1172, DOI 10.1002/cssc.201300186; Boddien A, 2012, ENERG ENVIRON SCI, V5, P8907, DOI 10.1039/c2ee22043a; Makowski P, 2009, ENERG ENVIRON SCI, V2, P480, DOI 10.1039/b822279g; Tanaka R, 2011, ORGANOMETALLICS, V30, P6742, DOI 10.1021/om2010172; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Wang WH, 2013, ACS CATAL, V3, P856, DOI 10.1021/cs400172j; Shima S, 2011, EUR J INORG CHEM, P963, DOI 10.1002/ejic.201000955; Yadav M, 2012, ENERG ENVIRON SCI, V5, P9698, DOI 10.1039/c2ee22937d; Barnard JH, 2013, CHEM SCI, V4, P1234, DOI 10.1039/c2sc21923a; Fellay C, 2009, CHEM-EUR J, V15, P3752, DOI 10.1002/chem.200801824; Manaka Y, 2014, CATAL SCI TECHNOL, V4, P34, DOI 10.1039/c3cy00830d; DuBois MR, 2009, CHEM SOC REV, V38, P62, DOI 10.1039/b801197b; Wang WH, 2012, ENERG ENVIRON SCI, V5, P7923, DOI 10.1039/c2ee21888g; Fellay C, 2008, ANGEW CHEM INT EDIT, V47, P3966, DOI 10.1002/anie.200800320; Armaroli N, 2011, CHEMSUSCHEM, V4, P21, DOI 10.1002/cssc.201000182; Himeda Y, 2009, GREEN CHEM, V11, P2018, DOI 10.1039/b914442k; Filonenko GA, 2014, CHEMCATCHEM, V6, P1526, DOI 10.1002/cctc.201402119; Himeda Y, 2011, CHEMSUSCHEM, V4, P487, DOI 10.1002/cssc.201000327; Oldenhof S, 2013, CHEM-EUR J, V19, P11507, DOI 10.1002/chem.201302230; Wang WH, 2013, NEW J CHEM, V37, P1860, DOI 10.1039/c3nj41146j; Wang WH, 2012, CHEM-EUR J, V18, P9397, DOI 10.1002/chem.201200576; Chen Y, 2015, J AM CHEM SOC, V137, P106, DOI 10.1021/ja511511q; Bavykina AV, 2015, CHEMSUSCHEM, V8, P809, DOI 10.1002/cssc.201403173; Bulushev DA, 2010, CATAL TODAY, V154, P7, DOI 10.1016/j.cattod.2010.03.050; Kubas G. J., 2007, J CHEM REV, V107, P4152; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Neary MC, 2015, CHEM SCI, V6, P1859, DOI 10.1039/c4sc03128h; Zuttel A., 2008, HYDROGEN FUTURE ENER, P1	59	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	SEP	2015	5	9					5496	5504		10.1021/acscatal.5b01090		9	Chemistry, Physical	Chemistry	CR1MT	WOS:000361089700058		
J	Uneyama, H				Uneyama, Hisayuki			Physiological Benefits of the Umami Taste Substance, Monosodium Glutamate (MSG) for Healthier Life	ACTA PHYSIOLOGICA			English	Meeting Abstract									[Uneyama, Hisayuki] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	SEP	2015	215			704	SI	S3.4	9	9				1	Physiology	Physiology	CQ7UL	WOS:000360810100022		
J	Tamada, Y; Seno, T				Tamada, Yasuaki; Seno, Takeharu			Roles of Size, Position, and Speed of Stimulus in Vection with Stimuli Projected on a Ground Surface	AEROSPACE MEDICINE AND HUMAN PERFORMANCE			English	Article						self-motion; body sway; optic flow properties	SELF-MOTION PERCEPTION; CIRCULAR VECTION; POSTURAL SWAY; VISUAL SCENES; OPTICAL-FLOW; DEPTH; READJUSTMENTS; ECCENTRICITY	INTRODUCTION: Although the induction of vection (perception of illusory self-motion) has been studied for some decades, the effect of ground surface properties on vection remains to be assessed quantitatively. This study will be helpful for designing helicopter or airplane flight simulation, because pilots often perceive optic flow on the ground surface and perceive self-motion from such flows. METHOD: Vection stimuli of variable position, size, and optic flow speed were presented in a trapezoidal area on a ground surface. Body sway was also measured. RESULTS: Substantial vection was induced by stimuli on a ground surface. Increases in stimulus speed and size were each associated with stronger vection (e.g., the subjective strength increased by 50% as the speed increased from 0.375 m.s(-1) to 1.5 m.s(-1)). When the stimulus occupied a more distant section of the visual field, vection was more efficiently induced than when the nearer section was occupied (e.g., the subjective strength decreased by 50% when the nearer half section of optical flow was removed). These properties of vection were similar to vection induced by upright vertical stimuli. Speed, size, and position of vection stimuli modified both length and direction of body sway significantly. Vection and body sway showed some correlations (e.g., r = 0.55). CONCLUSION: Stimuli on ground surfaces can induce substantial vection and vection strength can be modified by the stimulus properties of the ground surfaces.	Paris Miki Inc, R&D Div, Himeji, Hyogo 6728048, Japan; Kyushu Univ, Fac Design, Fukuoka 812, Japan; Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan; Kyushu Univ, Res Ctr Appl Perceptual Sci, Fukuoka 812, Japan	Tamada, Y (reprint author), Paris Miki Inc, R&D Div, Shikama Ku, 1-138 Miyake, Himeji, Hyogo 6728048, Japan.	y-tamada@kitakyu-u.ac.jp			Program to Disseminate the Tenure Tracking System, MEXT	We thank Dr. Stephen Palmisano for his kind and useful suggestions and instructions. This work is supported by the Program to Disseminate the Tenure Tracking System, MEXT, and also by a Grant-in-Aid for Young Scientists (A), Japan, to T. Seno.	JOHANSSON G, 1977, PERCEPTION, V6, P365, DOI 10.1068/p060365; Baumberger B, 2004, EXP BRAIN RES, V159, P33, DOI 10.1007/s00221-004-1930-1; Bian Z, 2005, PERCEPT PSYCHOPHYS, V67, P802, DOI 10.3758/BF03193534; Palmisano S, 2009, PERCEPTION, V38, P442, DOI 10.1068/p6159; DEGRAAF B, 1990, VISION RES, V30, P637, DOI 10.1016/0042-6989(90)90074-U; HELD R, 1975, VISION RES, V15, P357, DOI 10.1016/0042-6989(75)90083-8; Bubka A, 2010, PERCEPTION, V39, P627, DOI 10.1068/p6315; OHMI M, 1988, PERCEPTION, V17, P5, DOI 10.1068/p170005; Ito H, 2005, VISION RES, V45, P397, DOI 10.1016/j.visres.2004.11.009; Rushton SK, 1999, PERCEPTION, V28, P255, DOI 10.1068/p2780; Nakamura S, 2006, VISION RES, V46, P2344, DOI 10.1016/j.visres.2006.01.016; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; Seno T, 2009, VISION RES, V49, P2973, DOI 10.1016/j.visres.2009.09.017; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; BRANDT T, 1973, EXP BRAIN RES, V16, P476; Palmisano S, 2014, EXP BRAIN RES, V232, P1185, DOI 10.1007/s00221-014-3835-y; Apthorp D, 2013, FRONT HUM NEUR C ACN; Dichgans J, 1978, HDB SENSORY PHYSL, P79; Fischer MH, 1930, J PSYCHOL NEUROL, V41, P273; FLUCKIGER M, 1988, PERCEPTION, V17, P633, DOI 10.1068/p170633; Gibson J. J., 1966, SENSES CONSIDERED PE; Gibson J. J., 1979, ECOLOGICAL APPROACH; Japan Society for Equilibrium Research. Juusindouyou no Q&A, 1996, EQUILIB RES, V55, P64; Kanazawa M, 2012, VISION, V24, P137; Kim J, 2010, J VISION, V10, DOI 10.1167/10.12.7; Kitabayashi Tamotsu, 2003, Journal of Physiological Anthropology and Applied Human Science, V22, P265, DOI 10.2114/jpa.22.265; Mach E., 1875, GRUNDLINIEN LEHRE BE; McCarley JS, 2000, PERCEPT PSYCHOPHYS, V62, P540, DOI 10.3758/BF03212105; MELCHER GA, 1981, PERCEPT PSYCHOPHYS, V30, P552, DOI 10.3758/BF03202009; Ogawa M, 2014, PERCEPTION, V43, P605, DOI 10.1068/p7639; Ohsawa I, 2012, GERODONTOLOGY, V29, pE780, DOI 10.1111/j.1741-2358.2011.00559.x; POST RB, 1988, PERCEPTION, V17, P737, DOI 10.1068/p170737; Riecke BE, 2006, ACM T APPL PERCEPT, V3, P194, DOI [10.1145/1166087.1166091, DOI 10.1145/1166087.1166091]; Sato T., 2007, P ASIAGRAPH 2007 SHA, P103; Seno T, 2012, SEEING PERCEIVING, V25, P631, DOI 10.1163/18784763-00002394; Seno T, 2010, ATTEN PERCEPT PSYCHO, V72, P1642, DOI 10.3758/APP.72.6.1642; Trutoiu LC, 2009, COMPUT GRAPH-UK, V33, P47, DOI 10.1016/j.cag.2008.11.008; Wei KL, 2010, J VISION, V10, DOI 10.1167/10.14.4	38	0	0	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	2375-6314	2375-6322		AEROSP MED HUM PERF	Aerosp. Med.Hum. Perform.	SEP	2015	86	9					794	802		10.3357/AMHP.4206.2015		9	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	CQ9FW	WOS:000360919200004		
J	Hiraguchi, Y; Hirayama, A; Kainuma, K; Nagao, M; Tokuda, R; Fujisawa, T				Hiraguchi, Yukiko; Hirayama, Atsuya; Kainuma, Keigo; Nagao, Mizuho; Tokuda, Reiko; Fujisawa, Takao			Semaphorin 4D is expressed constitutively by human eosinophils	ALLERGOLOGY INTERNATIONAL			English	Letter							SEMA4A; CELLS; IL-5; LUNG; 7A		[Hiraguchi, Yukiko; Hirayama, Atsuya; Kainuma, Keigo; Nagao, Mizuho; Tokuda, Reiko; Fujisawa, Takao] Mie Natl Hosp, Inst Clin Res, Tsu, Mie 5140125, Japan; [Hiraguchi, Yukiko] Osaka Saiseikai Nakatsu Hosipital, Dept Pediat, Ctr Allergy & Clin Immunol, Osaka, Japan	Fujisawa, T (reprint author), Mie Natl Hosp, Inst Clin Res, 357 Osato Kubota, Tsu, Mie 5140125, Japan.	fujisawa@mie-m.hosp.go.jp					Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Hiraguchi Y, 2008, INT ARCH ALLERGY IMM, V146, P16, DOI 10.1159/000126055; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Esnault S, 2014, CLIN IMMUNOL, V150, P90, DOI 10.1016/j.clim.2013.11.009; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Kumanogoh A, 2005, IMMUNITY, V22, P305, DOI 10.1016/j.immuni.2005.01.014; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Kumanogoh A, 2003, J CELL SCI, V116, P3463, DOI 10.1242/jcs.00674; Bartemes KR, 1999, J IMMUNOL, V162, P2982; Shanks K, 2013, MOL IMMUNOL, V56, P480, DOI 10.1016/j.molimm.2013.05.228; Smith EP, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-30	12	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S77	S79		10.1016/j.alit.2015.04.011		3	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500013		
J	Izuhara, K; Matsumoto, H; Ohta, S; Ono, J; Arima, K; Ogawa, M				Izuhara, Kenji; Matsumoto, Hisako; Ohta, Shoichiro; Ono, Junya; Arima, Kazuhiko; Ogawa, Masahiro			Recent developments regarding periostin in bronchial asthma	ALLERGOLOGY INTERNATIONAL			English	Review						Biomarker; Bronchial asthma; Companion diagnostic; Periostin; Stratified medicine	EXACERBATED RESPIRATORY-DISEASE; EXHALED NITRIC-OXIDE; SERUM PERIOSTIN; EOSINOPHILIC ASTHMA; ALLERGIC-ASTHMA; AIRWAY HYPERRESPONSIVENESS; INSENSITIVE ASTHMA; PULMONARY-FUNCTION; INFLAMMATION; INTERLEUKIN-5	Although it is currently recognized that bronchial asthma is not a single disease but a syndrome, we have not yet made use of our new understanding of this heterogeneity as we treat asthma patients. To increase the efficacy of anti-asthma drugs and to decrease costs, it is important to stratify asthma patients into subgroups and to develop therapeutic strategies for each subgroup. Periostin has recently emerged as a biomarker for bronchial asthma, unique in that it is useful not in diagnosis but in categorizing asthma patients. We first found that periostin is a novel component of subepithelial fibrosis in bronchial asthma downstream of IL-13 signals. Thereafter, it was shown that periostin can be a surrogate biomarker of type 2 immune responses, the basis of the notion that a detection system of serum periostin is potentially a companion diagnostic for type 2 antagonists. Furthermore, we have recently shown that serum periostin can predict resistance or hyporesponsiveness to inhaled corticosteroids, based on its contribution to tissue remodeling or fibrosis in bronchial asthma. Thus, serum periostin has two characteristics as a biomarker for bronchial asthma: it is both a surrogate biomarker of type 2 immune responses and a biomarker reflecting tissue remodeling or fibrosis. We can take advantage of these characteristics to develop stratified medicine in bronchial asthma. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Izuhara, Kenji; Arima, Kazuhiko; Ogawa, Masahiro] Saga Med Sch, Div Med Biochem, Dept Biomol Sci, Saga 8498501, Japan; [Matsumoto, Hisako] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Ohta, Shoichiro] Saga Med Sch, Dept Lab Med, Saga 8498501, Japan; [Ono, Junya] Shinotest Corp, Sagamihara, Kanagawa, Japan	Izuhara, K (reprint author), Saga Med Sch, Div Med Biochem, Dept Biomol Sci, 5-1-1 Nabeshima, Saga 8498501, Japan.	kizuhara@cc.saga-u.ac.jp			Japan Society for the Promotion of Science; Adaptable and Seamless Technology Transfer Program Through Target-Driven RD, JST [AS2414004P]	We thank our collaborators contributing to the present article: Drs. Yoshihiro Kanemitsu and Tadao Nagasaki at Kyoto University; Prof. Hae-Sim Park at Ajou University; Dr. Mi-Ae Kim at CHA University; Prof. Koichiro Asano at Tokai University; Prof. Tomoko Betsuyaku and Drs. Masako Matsusaka, Hiroki Kabata, and Koichi Fukunaga at Keio University; Drs. Go Takayama, Go Kato, Koichiro Takahashi, and Shinichiro Hayashi at Saga Medical School; and Dr. Noriko Yuyama at Genox Research Institute. We also thank Dr. Dovie R. Wylie for the critical review of this manuscript. This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and Adaptable and Seamless Technology Transfer Program (AS2414004P) Through Target-Driven R&D, JST.	Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Bousquet J, 2007, RESP MED, V101, P1483, DOI 10.1016/j.rmed.2007.01.011; Kanemitsu Y, 2014, AM J RESP CRIT CARE, V190, P472, DOI 10.1164/rccm.201403-0562LE; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Chung KF, 1999, EUR RESPIR J, V13, P1198; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Gordon ED, 2012, CLIN EXP ALLERGY, V42, P144, DOI 10.1111/j.1365-2222.2011.03840.x; Donohue JF, 2013, RESP MED, V107, P943, DOI 10.1016/j.rmed.2013.02.018; Kanemitsu Y, 2013, J ALLERGY CLIN IMMUN, V132, P305, DOI 10.1016/j.jaci.2013.04.050; Izuhara K, 2014, ALLERGOL INT, V63, P143, DOI 10.2332/allergolint.13-RAI-0663; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Wenzel S, 2005, AM J RESP CRIT CARE, V172, P149, DOI 10.1164/rccm.200409-1181PP; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Kim MA, 2014, ANN ALLERG ASTHMA IM, V113, P314, DOI 10.1016/j.anai.2014.06.014; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Matsumoto H, 2014, ALLERGOL INT, V63, P153, DOI 10.2332/allergolint.13-RAI-0678; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Sehra S, 2011, J IMMUNOL, V186, P4959, DOI 10.4049/jimmunol.1002359; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Sorkness RL, 2008, J APPL PHYSIOL, V104, P394, DOI 10.1152/japplphysiol.00329.2007; Piper E, 2013, EUR RESPIR J, V41, P330, DOI 10.1183/09031936.00223411; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Matsusaka M, 2015, ALLERGOL INT, V64, P175, DOI 10.1016/j.alit.2014.07.003; Kim MA, 2014, CURR OPIN ALLERGY CL, V14, P49, DOI 10.1097/ACI.0000000000000028; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Arron JR, 2015, THORAX, V70, P105, DOI 10.1136/thoraxjnl-2014-206069; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Bentley JK, 2014, J ALLERGY CLIN IMMUN, V134, P1433, DOI 10.1016/j.jaci.2014.05.029; Choi JH, 2014, CURR OPIN ALLERGY CL, V14, P1, DOI 10.1097/ACI.0000000000000021; Gauvreau GM, 2011, AM J RESP CRIT CARE, V183, P1007, DOI 10.1164/rccm.201008-1210OC; Global Initiative for Asthma (GINA), 2014, GLOB STRAT ASTHM MAN; Izuhara K, 2006, CURR MED CHEM, V13, P2291, DOI 10.2174/092986706777935140; Kato Go, 2013, Biomark Insights, V8, P97, DOI 10.4137/BMI.S12537; Kips JC, 2003, AM J RESP CRIT CARE, V167, P1655, DOI 10.1164/rccm.200206-525OC; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Nagasaki T, 2014, J ALLERGY CLIN IMMUN, V133, P1474, DOI 10.1016/j.jaci.2013.12.1084; Nagasaki T, 2014, AM J RESP CRIT CARE, V190, P1449, DOI 10.1164/rccm.201407-1290LE; Nakamura Y, 2015, ALLERGOL INT, V64, P209, DOI 10.1016/j.alit.2015.01.001; Shoda T, 2013, ALLERGY, V68, P1467, DOI 10.1111/all.12240; Takatsu K, 2011, P JPN ACAD B-PHYS, V87, P463, DOI 10.2183/pjab.87.463; Wagener AH, 2015, THORAX, V70, P115, DOI 10.1136/thoraxjnl-2014-205634; Yuyama N, 2002, CYTOKINE, V19, P287, DOI 10.1006/cyto.2002.1972; Zhu Zhou, 1999, Journal of Clinical Investigation, V103, P779, DOI 10.1172/JCI5909	56	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S3	S10		10.1016/j.alit.2015.04.012		8	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500002		
J	Kanda, A; Fleury, S; Kobayashi, Y; Tomoda, K; Julia, V; Dombrowicz, D				Kanda, Akira; Fleury, Sebastien; Kobayashi, Yoshiki; Tomoda, Koichi; Julia, Valerie; Dombrowicz, David			Th2-activated eosinophils release Th1 cytokines that modulate allergic inflammation	ALLERGOLOGY INTERNATIONAL			English	Letter							INTERFERON-GAMMA; IFN-GAMMA		[Kanda, Akira; Kobayashi, Yoshiki; Tomoda, Koichi] Kansai Med Univ, Dept Otolaryngol Head & Neck Surg, Hirakata, Osaka 5731010, Japan; [Kanda, Akira; Fleury, Sebastien; Dombrowicz, David] INSERM, U1011, F-59045 Lille, France; [Kanda, Akira; Fleury, Sebastien; Dombrowicz, David] Inst Pasteur, Lille, France; [Kanda, Akira; Fleury, Sebastien; Dombrowicz, David] Univ Lille 2, Lille, France; [Julia, Valerie] INSERM, U924, Valbonne, France; [Julia, Valerie] Univ Nice, Valbonne, France	Kanda, A (reprint author), Kansai Med Univ, Dept Otolaryngol Head & Neck Surg, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	akanda@hirakata.kmu.ac.jp					Steinke JW, 2013, J ALLERGY CLIN IMMUN, V132, P856, DOI 10.1016/j.jaci.2013.05.008; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Li XN, 2013, J ALLERGY CLIN IMMUN, V132, P313, DOI 10.1016/j.jaci.2013.01.051; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945; Kumar RK, 2004, AM J RESP CRIT CARE, V170, P1043, DOI 10.1164/rccm.200405-681OC; Vale-Pereira S, 2011, CLIN EXP ALLERGY, V41, P490, DOI 10.1111/j.1365-2222.2010.03640.x; Driss V, 2009, BLOOD, V113, P3235, DOI 10.1182/blood-2008-07-166595; Ishihara C, 1997, CLIN EXP IMMUNOL, V110, P524, DOI 10.1046/j.1365-2249.1997.4511469.x; Kanda A, 2009, J ALLERGY CLIN IMMUN, V124, P573, DOI 10.1016/j.jaci.2009.04.031; Kobayashi T, 2003, J IMMUNOL, V170, P5756; Woerly G, 1999, J EXP MED, V190, P487, DOI 10.1084/jem.190.4.487	11	1	1	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S71	S73		10.1016/j.alit.2015.03.006		3	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500011		
J	Kato, M; Suzuki, K; Yamada, Y; Maruyama, K; Hayashi, Y; Mochizuki, H				Kato, Masahiko; Suzuki, Kazuo; Yamada, Yoshiyuki; Maruyama, Kenichi; Hayashi, Yasuhide; Mochizuki, Hiroyuki			Virus detection and cytokine profile in relation to age among acute exacerbations of childhood asthma	ALLERGOLOGY INTERNATIONAL			English	Article						Age; Asthma; Childhood; Cytokine; Virus detection	RESPIRATORY-SYNCYTIAL-VIRUS; CHEMOKINE RECEPTOR EXPRESSION; VIRAL-INFECTIONS; RHINOVIRUS INFECTION; YOUNG-CHILDREN; EARLY-LIFE; IN-VITRO; INFANCY; IP-10; BRONCHIOLITIS	Background: Little information is available regarding eosinophil activation and cytokine profiles in relation to age in virus-induced bronchial asthma. We therefore explored the association between age, respiratory viruses, serum eosinophil cationic protein (ECP), and cytokines/chemokines in acute exacerbations of childhood asthma. Methods: We investigated viruses in nasal secretions from 88 patients with acute exacerbation of childhood asthma by using antigen detection kits and/or RT-PCR, followed by direct DNA sequencing analysis. We also measured peripheral eosinophil counts, and the serum levels of ECP and 27 types of cytokines/chemokines in 71 virus-induced acute asthma cases and 13 controls. Results: Viruses were detected in 71(80.7%) of the 88 samples. The three major viruses detected were rhinoviruses, RS viruses, and enteroviruses; enteroviruses were found to be dominant in patients aged >= 3 years. There was no change in the levels of rhinoviruses and RS viruses between the two age groups, defined as children aged <3 years and children aged >= 3 years. Serum concentrations of ECP, IL-5, and IP-10 were significantly elevated in virus-induced acute asthma cases compared with controls. Serum ECP values were significantly higher in patients with virus-induced asthma at age >= 3 years compared with those aged <3 years. Among the 27 cytokines/chemokines, serum IP-10 was significantly higher in virus-induced asthma in patients <3 years than in those >= 3 years. Serum ECP and IL-5 production correlated significantly with age, whereas serum IP-10 showed an inverse correlation with age. Conclusions: Age-related differences in cytokine profiles and eosinophil activation may be related to virus-induced acute exacerbations of childhood asthma. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Kato, Masahiko; Suzuki, Kazuo; Mochizuki, Hiroyuki] Tokai Univ, Sch Med, Dept Pediat, Isehara, Kanagawa 259193, Japan; [Kato, Masahiko; Yamada, Yoshiyuki] Gunma Childrens Med Ctr, Dept Allergy & Immunol, Gunma, Japan; [Maruyama, Kenichi] Gunma Childrens Med Ctr, Dept Nephrol, Gunma, Japan; [Hayashi, Yasuhide] Gunma Red Cross Blood Ctr, Gunma, Japan	Kato, M (reprint author), Tokai Univ, Sch Med, Dept Pediat, 143 Shimokasuya, Isehara, Kanagawa 259193, Japan.	mkato@tokai-u.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology and Gunma Prefecture, Japan [24591565]	This study was supported in part by Grants-in-Aid for Scientific Research (C) (#24591565) from the Japanese Ministry of Education, Culture, Sports, Science and Technology and Gunma Prefecture, Japan.	Annunziato F, 1999, J LEUKOCYTE BIOL, V65, P691; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Yuan YH, 2001, INFLAMM BOWEL DIS, V7, P281, DOI 10.1097/00054725-200111000-00001; Kneyber M, 2000, ACTA PAEDIATR, V89, P654, DOI 10.1080/080352500750043945; Heymann PW, 2004, J ALLERGY CLIN IMMUN, V114, P239, DOI 10.1016/j.jaci.2004.04.006; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501; JOHNSTON SL, 1995, BRIT MED J, V310, P1225; Dufour JH, 2002, J IMMUNOL, V168, P3195; Kawamoto N, 2006, PEDIATR ALLERGY IMMU, V17, P125, DOI 10.1111/j.1399-3038.2005.00363.x; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Roe MFE, 2011, PEDIAT ALLERG IMM-UK, V22, P229, DOI 10.1111/j.1399-3038.2010.01032.x; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; Rabin RL, 1999, J IMMUNOL, V162, P3840; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Quint JK, 2010, CHEST, V137, P812, DOI 10.1378/chest.09-1541; Black Craig Patrick, 2003, Respir Care, V48, P209; Burrell A., 2011, BIOTECHNOL RES INT, V2011; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Japanese Society of Pediatric Allergy and Clinical Immunology, JAP PED GUID TREATM; Kato M, 2011, PEDIAT ALLERG IMM-UK, V22, pe87, DOI 10.1111/j.1399-3038.2010.01026.x; Kotaniemi-Syrjanen A, 2002, PEDIATR ALLERGY IMMU, V13, P418, DOI 10.1034/j.1399-3038.2002.02091.x; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Lemanske Jr RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lemanske RF, 2004, J ALLERGY CLIN IMMUN, V114, P1023, DOI 10.1016/j.jaci.2004.08.031; NICHOLSON KG, 1993, BRIT MED J, V307, P982; Singleton RJ, 2003, PEDIATRICS, V112, P285, DOI 10.1542/peds.112.2.285; Smart JM, 2001, PEDIATR ALLERGY IMMU, V12, P181, DOI 10.1034/j.1399-3038.2001.012004181.x; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x	34	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S64	S70		10.1016/j.alit.2015.06.008		7	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500010		
J	Kobayashi, T; Soma, T; Noguchi, T; Nakagome, K; Nakamoto, H; Kita, H; Nagata, M				Kobayashi, Takehito; Soma, Tomoyuki; Noguchi, Toru; Nakagome, Kazuyuki; Nakamoto, Hidetomo; Kita, Hirohito; Nagata, Makoto			ATP drives eosinophil effector responses through P2 purinergic receptors	ALLERGOLOGY INTERNATIONAL			English	Article						ATP; Danger signal; Eosinophils; P2Y(2) receptor; Uric acids	SUPEROXIDE ANION GENERATION; OXYGEN RADICAL PRODUCTION; URIC-ACID; ADHESION MOLECULES; LUNG INFLAMMATION; DENDRITIC CELLS; ACTIVATION; CYTOKINES; DANGER; LEUKOTRIENE-D-4	Background: Eosinophils recognize various stimuli, such as cytokines, chemokines, immunoglobulins, complement, and external pathogens, resulting in their accumulation in mucosal tissues and the progression of inflammation. Eosinophils are also involved in innate Th2-type immune responses mediated through endogenous danger signals, including IL-33, uric acid (UA), or ATP, in non-sensitized mice exposed to environmental allergens. However, the mechanism involved in eosinophil responses to these danger signals remains insufficiently understood. Methods: We examined migration, adhesion, superoxide production and degranulation of human eosinophils. Isolated eosinophils were incubated with monosodium urate (MSU) crystals and ATP gamma S, a non-hydrolysable ATP analogue. To determine the involvement of P2 or P2Y(2) receptors in eosinophil responses to UA and ATP, eosinophils were preincubated with a pan-P2 receptor inhibitor, oxidized ATP (oATP), or anti-P2Y(2) antibody before incubation with MSU crystals or ATP gamma S. Results: MSU crystals induced adhesion of eosinophils to recombinant human (rh)-ICAM-1 and induced production of superoxide. oATP abolished eosinophil responses to MSU crystals, suggesting involvement of endogenous ATP and its receptors. Furthermore, exogenous ATP, as ATP gamma S, induced migration of eosinophils through a model basement membrane, adhesion to rh-ICAM-1, superoxide generation, and degranulation of eosinophil-derived neurotoxin (EDN). oATP and anti-P2Y(2) significantly reduced these eosinophil responses. Conclusions: ATP serves as an essential mediator of functional responses in human eosinophils. Eosinophil responses to ATP may be implicated in airway inflammation in patients with asthma. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Kobayashi, Takehito; Soma, Tomoyuki; Noguchi, Toru; Nakagome, Kazuyuki; Nagata, Makoto] Saitama Med Univ, Allergy Ctr, Iruma, Saitama 3500495, Japan; [Kobayashi, Takehito; Noguchi, Toru; Nakamoto, Hidetomo] Saitama Med Univ, Dept Gen Internal Med, Iruma, Saitama 3500495, Japan; [Kobayashi, Takehito; Soma, Tomoyuki; Nakagome, Kazuyuki; Nagata, Makoto] Saitama Med Univ, Dept Resp Med, Iruma, Saitama 3500495, Japan; [Kita, Hirohito] Mayo Clin, Div Allerg Dis, Dept Immunol, Dept Internal Med, Rochester, MN USA	Soma, T (reprint author), Saitama Med Univ, Allergy Ctr, Dept Resp Med, Iruma, Saitama 3500495, Japan.	tsoma@saitama-med.ac.jp			National Institutes of Health in Japan [24791004]; Saitama Medical University Foundation [24-C-1-11]; National Institutes of Health in USA [AI34486]; Mayo Foundation for Medical Education and Research, United States [AI34486]	We greatly thank Ms. Akemi Yokote for her excellent technical assistance. This work was supported in part by Grant 24791004 from the National Institutes of Health in Japan, by Saitama Medical University Foundation (24-C-1-11), by Grant AI34486 from the National Institutes of Health in USA and by the Mayo Foundation for Medical Education and Research (AI34486), United States.	Ferrari D, 2006, J LEUKOCYTE BIOL, V79, P7, DOI 10.1189/jlb.0505286; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Lacy P, 2000, CHEM IMMUNOL, V76, P134; Kikuchi I, 2006, AM J RESP CELL MOL, V34, P760, DOI 10.1165/rcmb.2005-0303OC; Horie S, 1996, J ALLERGY CLIN IMMUN, V98, P371, DOI 10.1016/S0091-6749(96)70161-6; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177, DOI 10.1016/S0065-2776(08)60351-X; Jacobsen EA, 2007, J ALLERGY CLIN IMMUN, V119, P1313, DOI 10.1016/j.jaci.2007.03.043; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathol.3.121806.151456; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Willart MAM, 2009, CLIN EXP ALLERGY, V39, P12, DOI 10.1111/j.1365-2222.2008.03118.x; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Idzko M, 2001, J CELL PHYSIOL, V188, P329, DOI 10.1002/jcp.1129; Idzko M, 2003, BRIT J PHARMACOL, V138, P1244, DOI 10.1038/sj,bjp.0705145; Dichmann S, 2000, BLOOD, V95, P973; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kobayashi T, 2010, J IMMUNOL, V184, P6350, DOI 10.4049/jimmunol.0902673; Grunberg K, 1997, AM J RESP CRIT CARE, V156, P609; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Vanderstocken G, 2010, J IMMUNOL, V185, P3702, DOI 10.4049/jimmunol.0903908; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; BOCHNER BS, 1994, J ALLERGY CLIN IMMUN, V94, P427, DOI 10.1016/0091-6749(94)90195-3; Ferrari D, 2000, FEBS LETT, V486, P217, DOI 10.1016/S0014-5793(00)02306-1; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.med.44.1.85; Hara K, 2014, J IMMUNOL, V192, P4032, DOI 10.4049/jimmunol.1400110; IDE M, 1994, J IMMUNOL METHODS, V168, P187, DOI 10.1016/0022-1759(94)90054-X; Mohanty JG, 2001, J ALLERGY CLIN IMMUN, V107, P849, DOI 10.1067/mai.2001.114658; Mori M, 2009, INT ARCH ALLERGY IMM, V149, P31, DOI 10.1159/000210651; Nagata M, 2002, J ALLERGY CLIN IMMUN, V109, P676, DOI 10.1067/mai.2002.122841; Nagata M, 1998, AM J RESP CELL MOL, V19, P158; NAGATA M, 1995, J IMMUNOL, V155, P2194; Saito K, 2004, ANN ALLERG ASTHMA IM, V93, P594; Schauer C, 2014, NAT MED, V20, P515, DOI 10.1038/nm.3547; Song ZL, 2007, AM J PHYSIOL-REG I, V292, pR423, DOI 10.1152/ajpregu.00495.2006; Takaku Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-138	39	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S30	S36		10.1016/j.alit.2015.04.009		7	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500006		
J	Koyama, D; Maruoka, S; Gon, Y; Shintani, Y; Sekiyama, T; Hiranuma, H; Shikano, S; Kuroda, K; Takeshita, I; Tsuboi, E; Soda, K; Hashimoto, S				Koyama, Daisuke; Maruoka, Shuichiro; Gon, Yasuhiro; Shintani, Yoshitaka; Sekiyama, Tadataka; Hiranuma, Hisato; Shikano, Sotaro; Kuroda, Kazumichi; Takeshita, Ikuko; Tsuboi, Eriko; Soda, Kaori; Hashimoto, Shu			Myeloid differentiation-2 is a potential biomarker for the amplification process of allergic airway sensitization in mice	ALLERGOLOGY INTERNATIONAL			English	Article						Asthma; House dust mite; Microarray analysis; Myeloid differentiation-2; Sensitization	HOUSE-DUST-MITE; ENDOTOXIN EXPOSURE; SOLUBLE MD-2; RECEPTOR 4; ASTHMA; LIPOPOLYSACCHARIDE; INNATE; RESPONSIVENESS; RESPONSES; CELLS	Background: Allergic sensitization is a key step in the pathogenesis of asthma. However, little is known about the molecules that are critical regulators for establishing allergic sensitization of the airway. Thus, we conducted global gene expression profiling to identify candidate genes and signaling pathways involved in house dust mite (HDM)-induced allergic sensitization in the murine airway. Methods: We sensitized and challenged mice with HDM or saline as a control through the airway on days 1 and 8. We evaluated eosinophilia in bronchoalveolar lavage fluid (BALF), airway inflammation, and mucus production on days 7 and 14. We extracted total RNA from lung tissues of HDM- and saline-sensitized mice on days 7 and 14. Microarray analyses were performed to identify up-regulated genes in the lungs of HDM-sensitized mice compared to the control mice. Data analyses were performed using GeneSpring software and gene networks were generated using Ingenuity Pathways Analysis (IPA). Results: We identified 50 HDM-mediated, stepwise up-regulated genes in response to allergic sensitization and amplification of allergic airway inflammation. The highest expressed gene was myeloid differentiation-2 (MD-2), a lipopolysaccharide (LPS)-binding component of Toll-like receptor (TLR) 4 signaling complex. MD-2 protein was expressed in lung vascular endothelial cells and was increased in the serum of HDM-sensitized mice, but not in the control mice. Conclusions: Our data suggest MD-2 is a critical regulator of the establishment of allergic airway sensitization to HDM in mice. Serum MD-2 may represent a potential biomarker for the amplification of allergic sensitization and allergic inflammation. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Koyama, Daisuke; Maruoka, Shuichiro; Gon, Yasuhiro; Shintani, Yoshitaka; Sekiyama, Tadataka; Hiranuma, Hisato; Shikano, Sotaro; Takeshita, Ikuko; Tsuboi, Eriko; Soda, Kaori; Hashimoto, Shu] Nihon Univ, Sch Med, Div Resp Med, Dept Internal Med, Tokyo 1738610, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan	Gon, Y (reprint author), Nihon Univ, Sch Med, Div Resp Med, Dept Internal Med,Itabashi Ku, 30-1 Oyagutikami Cho, Tokyo 1738610, Japan.	gon.yasuhiro@nihon-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25461200]; Strategic Research Foundation for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan [S1091023]	This work was supported in part by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (C) Grant Number 25461200 and the Strategic Research Foundation for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S1091023).	Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Nelson RP, 1996, J ALLERGY CLIN IMMUN, V98, P258, DOI 10.1016/S0091-6749(96)70148-3; Kelada SNP, 2011, AM J RESP CELL MOL, V45, P817, DOI 10.1165/rcmb.2010-0315OC; Wilson RH, 2012, NAT MED, V18, P1705, DOI 10.1038/nm.2920; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Wittke A, 2004, J IMMUNOL, V173, P3432; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P79; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Park SH, 2012, PHARMACOL THERAPEUT, V133, P291, DOI 10.1016/j.pharmthera.2011.11.001; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Feruglio SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069896; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P843, DOI DOI 10.1016/IJACI.2012.06.03; Kljaic-Bukvic B, 2014, PEDIAT ALLERG IMM-UK, V25, P552, DOI 10.1111/pai.12258; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Sahu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011348; Smit LAM, 2011, OCCUP ENVIRON MED, V68, P826, DOI 10.1136/oem.2010.060038; Tissieres P, 2008, BLOOD, V111, P2122, DOI 10.1182/blood-2007-06-097782; Troseid M, 2013, INNATE IMMUN-LONDON, V19, P290, DOI 10.1177/1753425912461042; Vamadevan AS, 2010, INNATE IMMUN, V16, P93, DOI 10.1177/1753425909339231; Wolfs TGAM, 2008, MOL IMMUNOL, V45, P3268, DOI 10.1016/j.molimm.2008.02.014; Zhang J, 2009, IMMUNOL CELL BIOL, V87, P141, DOI 10.1038/icb.2008.75	35	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S37	S45		10.1016/j.alit.2015.05.011		9	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500007		
J	Matsumoto, K				Matsumoto, Kenji			Preface to the Proceedings of the Workshop on Eosinophils in Allergy and Related Diseases 2014	ALLERGOLOGY INTERNATIONAL			English	Editorial Material							AIRWAY		Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan	Matsumoto, K (reprint author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan.	matsumoto-k@ncchd.go.jp					Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Castro M, 2015, LANCET RESP MED, V3, P355, DOI 10.1016/S2213-2600(15)00042-9; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; FRIGAS E, 1980, LAB INVEST, V42, P35; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Petsky HL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005603.pub2; WASSERMAN SI, 1975, J IMMUNOL, V114, P645	8	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S1	S2		10.1016/j.alit.2015.07.008		2	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500001		
J	Nagase, H; Takano, H; Inoue, K; Yamaguchi, M; Ohta, K				Nagase, Hiroyuki; Takano, Hirohisa; Inoue, Ken-ichiro; Yamaguchi, Masao; Ohta, Ken			Diesel exhaust particles suppress pathogen-associated molecular pattern-induced cytokine generation from bronchial epithelial cells	ALLERGOLOGY INTERNATIONAL			English	Letter							INTERCELLULAR-ADHESION MOLECULE-1; MURINE MODEL; EXPRESSION; ACTIVATION; INFECTION		[Nagase, Hiroyuki; Yamaguchi, Masao] Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Tokyo 1738605, Japan; [Takano, Hirohisa] Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Div Environm Hlth, Kyoto, Japan; [Inoue, Ken-ichiro] Int Univ Hlth & Welf, Ctr Med Sci, Otawara, Tochigi, Japan; [Ohta, Ken] Natl Hosp Org, Tokyo Natl Hosp, Tokyo, Japan	Nagase, H (reprint author), Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol,Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	nagaseh@med.teikyo-u.ac.jp					Takano H, 2002, AM J RESP CRIT CARE, V165, P1329, DOI 10.1164/rccm20108122; Ciencewicki J, 2006, AM J PHYSIOL-LUNG C, V290, pL1154, DOI 10.1152/ajplung.00318.2005; Yanagisawa R, 2006, CLIN EXP ALLERGY, V36, P386, DOI 10.1111/j.1365-2222.2006.02452.x; Park SY, 2009, J BIOL CHEM, V284, P20099, DOI 10.1074/jbc.M109.010017; Yin XJJ, 2004, TOXICOL SCI, V77, P263, DOI 10.1093/toxsci/kfh035; Sekiya T, 2000, J IMMUNOL, V165, P2205; Nagase H, 2003, J IMMUNOL, V171, P3977; Hiramatsu K, 2005, EXP LUNG RES, V31, P405, DOI 10.1080/01902140590918786; Finkelman FD, 2004, J IMMUNOL, V172, P3808; Ohta K, 1999, J ALLERGY CLIN IMMUN, V104, P1024; Salvi S, 1999, AM J RESP CELL MOL, V20, P984; Takizawa H, 2000, CLIN EXP IMMUNOL, V120, P356, DOI 10.1046/j.1365-2249.2000.01213.x	12	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S74	S76		10.1016/j.alit.2015.04.010		3	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500012		
J	Noguchi, T; Nakagome, K; Kobayashi, T; Ueda, Y; Soma, T; Nakamoto, H; Nagata, M				Noguchi, Toru; Nakagome, Kazuyuki; Kobayashi, Takehito; Ueda, Yutaka; Soma, Tomoyuki; Nakamoto, Hidetomo; Nagata, Makoto			Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation	ALLERGOLOGY INTERNATIONAL			English	Article						Adhesion molecule; Beta2-adrenergic agonist; Chemokine; Cysteinyl leukotrienes; Eosinophils	BRONCHIAL EPITHELIAL-CELLS; ASTHMA EXACERBATIONS; RHINOVIRUS INFECTION; HUMAN NEUTROPHILS; DOUBLE-BLIND; IFN-GAMMA; FLUTICASONE PROPIONATE; CYSTEINYL LEUKOTRIENES; AIRWAY INFLAMMATION; MONONUCLEAR-CELLS	Background: Eosinophils play important roles in the development of asthma exacerbation. Viral infection is a major cause of asthma exacerbation, and the expression of IFN-gamma-inducible protein of 10 kDa (IP-10) and cysteinyl leukotrienes (cysLTs) is up-regulated in virus-induced asthma. As beta 2-adrenergic agonists, such as formoterol or salbutamol, are used to treat asthma exacerbation, we examined whether formoterol or salbutamol could modify eosinophil functions such as adhesiveness, particularly those activated by cysLTs or IP-10. Methods: Eosinophils were isolated from the blood of healthy subjects and were pre-incubated with either formoterol or salbutamol, and subsequently stimulated with IL-5, LTD4, or IP-10. Adhesion of eosinophils to intercellular cell adhesion molecule (ICAM)-1 was measured using eosinophil peroxidase assays. The generation of eosinophil superoxide anion (O-2(-)) was examined based on the superoxide dismutase-inhibitable reduction of cytochrome C. Eosinophil-derived neurotoxin (EDN) release was evaluated by ELISA as a marker of degranulation. Results: Neither formoterol nor salbutamol suppressed the spontaneous adhesion of eosinophils to ICAM-1. However, when eosinophils were activated by IL-5, LTD4, or IP-10, formoterol, but not salbutamol, suppressed the adhesion to ICAM-1. Formoterol also suppressed IL-5, LTD4, or IP-10 induced eosinophil O-2(-) generation or EDN release. Conclusions: These findings suggest that formoterol, but not salbutamol, suppresses eosinophil functions enhanced by IL-5, LTD4, or IP-10. As these factors are involved in the development of asthma exacerbation, our results strongly support the hypothesis that administration of formoterol is a novel strategy for treating asthma exacerbation. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Noguchi, Toru; Nakagome, Kazuyuki; Kobayashi, Takehito; Ueda, Yutaka; Soma, Tomoyuki; Nagata, Makoto] Saitama Med Univ, Allergy Ctr, Moroyama, Saitama 3500495, Japan; [Noguchi, Toru; Nakagome, Kazuyuki; Kobayashi, Takehito; Soma, Tomoyuki; Nagata, Makoto] Saitama Med Univ, Dept Resp Med, Moroyama, Saitama 3500495, Japan; [Noguchi, Toru; Kobayashi, Takehito; Nakamoto, Hidetomo] Saitama Med Univ, Dept Gen Internal Med, Moroyama, Saitama 3500495, Japan; [Ueda, Yutaka] Saitama Med Univ, Dept Pediat, Moroyama, Saitama 3500495, Japan	Nakagome, K (reprint author), Saitama Med Univ, Dept Resp Med, Allergy Ctr, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	nakagomek-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (Japan) [205591191, 21790783, 24791004]	The authors thank Ms. Akemi Yokote for her excellent technical assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (Japan, Grant nos. 205591191, 21790783, and 24791004).	Anderson R, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/105420; Rabe KF, 2006, LANCET, V368, P744, DOI 10.1016/S0140-6736(06)69284-2; Reddel HK, 2011, EUR RESPIR J, V38, P584, DOI 10.1183/09031936.00186510; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; van Schaik SM, 1999, J ALLERGY CLIN IMMUN, V103, P630, DOI 10.1016/S0091-6749(99)70235-6; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Swystun VA, 2000, J ALLERGY CLIN IMMUN, V106, P57; Kelly MM, 2010, J ALLERGY CLIN IMMUN, V125, P349, DOI 10.1016/j.jaci.2009.09.011; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; FREYSSBEGUIN M, 1983, BRIT J PHARMACOL, V78, P717; BARNES PJ, 1993, LIFE SCI, V52, P2101, DOI 10.1016/0024-3205(93)90725-I; WHELAN CJ, 1993, BRIT J PHARMACOL, V110, P613; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Ezeamuzie CI, 1998, J PHARMACOL EXP THER, V284, P25; Hanania NA, 2002, AM J RESP CRIT CARE, V165, P1353, DOI 10.1164/rccm.2109060; Bisgaard H, 2005, AM J RESP CRIT CARE, V171, P315, DOI 10.1164/rccm.200407-894OC; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Bjermer L, 2003, BRIT MED J, V327, P891, DOI 10.1136/bmj.327.7420.891; Bloemen PGM, 1997, AM J PHYSIOL-LUNG C, V272, pL580; BOWDEN JJ, 1994, J APPL PHYSIOL, V77, P397; BUTCHERS PR, 1991, BRIT J PHARMACOL, V104, P672; Campestrini J, 1997, J CHROMATOGR B, V704, P221, DOI 10.1016/S0378-4347(97)00425-8; Currie GP, 2003, AM J RESP CRIT CARE, V167, P1232, DOI 10.1164/rccm.200209-11160C; EDA R, 1993, INT ARCH ALLERGY IMM, V102, P391; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Gauvreau GM, 1997, AM J RESP CRIT CARE, V156, P1738; Gravett CM, 2010, EUR RESPIR J, V36, P1417, DOI 10.1183/09031936.00157409; Grunberg K, 2000, CLIN EXP ALLERGY, V30, P1015; Hashimoto T, 2007, INT ARCH ALLERGY IMM, V143, P106, DOI 10.1159/000101415; Johnson Malcolm, 2002, Journal of Allergy and Clinical Immunology, V110, pS282, DOI 10.1067/mai.2002.129430; JOHNSON M, 1995, ANN ALLERG ASTHMA IM, V75, P177; Kawashima A, 2013, INT ARCH ALLERGY IMM, V161, P10, DOI 10.1159/000350335; KITA H, 1991, J IMMUNOL, V146, P2712; Kobayashi T, 2008, EUR RESPIR J, V32, P1540, DOI 10.1183/09031936.00059507; Lindqvist A, 2003, J ALLERGY CLIN IMMUN, V112, P23, DOI 10.1067/mai.2003.1500; Machida K, 2005, AM J PHYSIOL-LUNG C, V288, pL860, DOI 10.1152/ajplung.00131.2004; Maneechotesuwan K, 2005, CHEST, V128, P1936, DOI 10.1378/chest.128.4.1936; Matsuse H, 2005, INT ARCH ALLERGY IMM, V138, P267, DOI 10.1159/000088728; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; MUNOZ NM, 1995, J PHARMACOL EXP THER, V273, P850; Myo S, 2004, EUR RESPIR J, V23, P511, DOI 10.1183/09031936.04.00065904; Nagata M, 2002, J ALLERGY CLIN IMMUN, V109, P676, DOI 10.1067/mai.2002.122841; Nagata M, 1998, AM J RESP CELL MOL, V19, P158; NAGATA M, 1995, J IMMUNOL, V155, P2194; Ottonello L, 1996, CLIN EXP IMMUNOL, V106, P97, DOI 10.1046/j.1365-2249.1996.d01-804.x; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Saito K, 2004, ANN ALLERG ASTHMA IM, V93, P594; Soma T, 2008, INT ARCH ALLERGY IMM, V146, P22, DOI 10.1159/000126056; TAI PC, 1991, CLIN EXP IMMUNOL, V85, P312; Takaku Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-138; Teran LM, 1999, CLIN EXP ALLERGY, V29, P287; Tintinger GR, 2000, INFLAMMATION, V24, P239, DOI 10.1023/A:1007013530072; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Weller PF, 1997, J ALLERGY CLIN IMMUN, V100, P283, DOI 10.1016/S0091-6749(97)70237-9; Yamaguchi T, 2010, INT ARCH ALLERGY IMM, V152, P32, DOI 10.1159/000312123; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737; YUKAWA T, 1990, AM REV RESPIR DIS, V141, P1446	63	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S46	S53		10.1016/j.alit.2015.05.009		8	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500008		
J	Nunomura, S; Okayama, Y; Matsumoto, K; Hashimoto, N; Endo-Umeda, K; Terui, T; Makishima, M; Ra, C				Nunomura, Satoshi; Okayama, Yoshimichi; Matsumoto, Kenji; Hashimoto, Noriko; Endo-Umeda, Kaori; Terui, Tadashi; Makishima, Makoto; Ra, Chisei			Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells	ALLERGOLOGY INTERNATIONAL			English	Article						Cell degranulation; Cytokines; IgE receptor; Liver X receptor; Mast cells	LIVER-X-RECEPTOR; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; CHOLESTEROL ACYLTRANSFERASE; RHEUMATOID-ARTHRITIS; REDUCTASE-ACTIVITY; EXPRESSION; GAMMA; MACROPHAGES; OXYSTEROL; IL-6	Background: The activation of liver X receptor (LXR) alpha or LXR beta negatively regulates the expression of pro-inflammatory genes in mammalian cells. We recently reported that 25-hydroxycholesterol, a representative LXR-activating oxysterol, suppresses IL-6 production in mouse mast cells (MCs) following its engagement of the high-affinity IgE receptor (Fc epsilon RI). This finding suggests that murine MCs express functional LXRs; however, the mechanisms underlying the LXR-dependent repression of the MC-mediated production of pro-inflammatory cytokines, including IL-6, are poorly understood. Therefore, we employed the synthetic LXR ligand GW3965 to examine the functions of LXR alpha and LXR beta in the production of pro-inflammatory cytokines by murine bone marrow-derived MCs (BMMCs). Methods: We prepared BMMCs from wild-type (WT), LXR alpha(-/-), and LXR alpha/beta(-/-) mice. Each group of BMMCs was pretreated with GW3965 and then stimulated with IgE+antigen (Ag) or lipopolysaccharide (LPS). Cytokine production was then analyzed using specific ELISA kits. Results: The activation of LXRs by GW3965 significantly attenuated the production of IL-1 alpha and IL-1 beta, but not of IL-6, in the WT and LXR alpha(-/-) BMMCs stimulated with IgE+Ag. However, GW3965 treatment decreased the production of IL-1 alpha, IL-1 beta, and IL-6 in WT and LXR alpha(-/-) BMMCs upon stimulation with LPS, while the GW3965-mediated suppression of cytokine production was nearly absent from the LXR alpha/beta(-/-) BMMCs. Conclusions: These findings demonstrate, for the first time, that the activation of LXRs by GW3965 attenuates the antigen-or LPS-induced production of pro-inflammatory cytokines, such as IL-1 alpha and IL-1 beta, in murine MCs and that LXR beta plays an important role in the LXR-mediated repression of cytokine production. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Nunomura, Satoshi; Terui, Tadashi] Nihon Univ, Sch Med, Dept Dermatol, Tokyo 1738610, Japan; [Nunomura, Satoshi; Okayama, Yoshimichi; Ra, Chisei] Nihon Univ, Sch Med, Res Inst Med Sci, Allergy & Immunol Grp, Tokyo 1738610, Japan; [Matsumoto, Kenji; Hashimoto, Noriko] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Endo-Umeda, Kaori; Makishima, Makoto] Nihon Univ, Sch Med, Dept Biomed Sci, Tokyo 1738610, Japan; [Ra, Chisei] Nihon Univ, Sch Med, Dept Microbiol, Tokyo 1738610, Japan; [Ra, Chisei] Asahi Hosp, Chiba, Japan	Nunomura, S (reprint author), Nihon Univ, Sch Med, Res Inst Med Sci, Dept Dermatol,Allergy & Immunol Grp,Itabashi Ku, 30-1 Oyaguchikami Cho, Tokyo 1738610, Japan.	nunomura.satoshi@nihon-u.ac.jp			MEXT KAKENHI [22790946]	The authors thank Dr. Mangelsdorf (University of Texas Southwestern Medical Center) for providing the LXR alpha- and beta-null mice. This work was supported by MEXT KAKENHI (Grant Number 22790946 to SN).	Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; CHENG D, 1995, J BIOL CHEM, V270, P685; Oldford SA, 2010, J IMMUNOL, V185, P7067, DOI 10.4049/jimmunol.1001137; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Supajatura V, 2001, J IMMUNOL, V167, P2250; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Hatano Y, 2010, J ALLERGY CLIN IMMUN, V125, P160, DOI 10.1016/j.jaci.2009.06.049; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Ninomiya Y, 2007, J STEROID BIOCHEM, V103, P44, DOI 10.1016/j.jsbmb.2006.07.009; Pascual-Garcia M, 2013, J IMMUNOL, V190, P6520, DOI 10.4049/jimmunol.1201393; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Torocsik D, 2009, MOL ASPECTS MED, V30, P134, DOI 10.1016/j.mam.2009.02.002; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Kovarova M, 2006, J EXP MED, V203, P1161, DOI 10.1084/jem.20051701; Ganeshan K, 2013, J IMMUNOL, V190, P5731, DOI 10.4049/jimmunol.1203362; Yoon CH, 2013, J CLIN IMMUNOL, V33, P190, DOI 10.1007/s10875-012-9799-4; Bhuvaneswaran C, 1997, BIOCHEM PHARMACOL, V53, P27, DOI 10.1016/S0006-2952(96)00649-1; Delvecchio CJ, 2007, MOL ENDOCRINOL, V21, P1324, DOI 10.1210/me.2007.0017; Fukunaga M, 2010, EXP CELL RES, V316, P3272, DOI 10.1016/j.yexcr.2010.09.002; Guma M, 2010, P NATL ACAD SCI USA, V107, P22122, DOI 10.1073/pnas.1016401107; Hatano Y, 2010, J ALLERGY CLIN IMMUN, V125, pe1; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; Lee H, 2013, ARTHRITIS RHEUM-US, V65, P109, DOI 10.1002/art.37741; Lundequist A, 2011, MOL IMMUNOL, V48, P1753, DOI 10.1016/j.molimm.2011.04.017; Nakamura Y, 2012, IMMUNITY, V37, P85, DOI 10.1016/j.immuni.2012.04.013; Nunomura S, 2010, FEBS LETT, V584, P1143, DOI 10.1016/j.febslet.2010.02.006; Nunomura S, 2012, J IMMUNOL, V188, P4052, DOI 10.4049/jimmunol.1102796; PANINI SR, 1986, J LIPID RES, V27, P1190; PARISH EJ, 1995, LIPIDS, V30, P247, DOI 10.1007/BF02537828; Shi Y, 2014, PLOS ONE, V9; Sutherland RE, 2008, J IMMUNOL, V181, P5598; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600	40	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S11	S17		10.1016/j.alit.2015.03.001		7	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500003		
J	Ogawa, R; Suzuki, Y; Kagawa, S; Masaki, K; Fukunaga, K; Yoshimura, A; Fujishima, S; Terashima, T; Betsuyaku, T; Asano, K				Ogawa, Rika; Suzuki, Yusuke; Kagawa, Shizuko; Masaki, Katsunori; Fukunaga, Koichi; Yoshimura, Akihiko; Fujishima, Seitaro; Terashima, Takeshi; Betsuyaku, Tomoko; Asano, Koichiro			Distinct effects of endogenous interleukin-23 on eosinophilic airway inflammation in response to different antigens	ALLERGOLOGY INTERNATIONAL			English	Article						Asthma; Eosinophils; Interleukin-17A; Interleukin-23; Th17	ALLERGIC-ASTHMA; AUTOIMMUNE INFLAMMATION; MOUSE MODEL; T-CELLS; IL-23; IL-17A; MICE; TH17; HYPERRESPONSIVENESS; DISEASE	Background: The role of interleukin (IL)-23 in asthma pathophysiology is still controversial. We examined its role in allergic airway inflammation in response to two distinct antigens using IL-23-deficient mice. Methods: Allergic airway inflammation was evaluated in wild-type and IL-23p19(-/-) mice. Mice were sensitized to ovalbumin (OVA) or house dust mite (HDM) by intraperitoneal injection of antigen and their airways were then exposed to the same antigen. Levels of antigen-specific immunoglobulins in serum as well as cytokines in bronchoalveolar or peritoneal lavage fluid and lung tissue were determined by enzyme-linked immunosorbent assay and/or quantitative polymerase chain reaction. Results: Deficiency of IL-23p19 decreased eosinophils and Th2 cytokines in bronchoalveolar lavage fluid (BALF) of OVA-treated mice, while it increased BALF eosinophils of HDM-treated mice. Peritoneal injection of OVA with alum, but not of HDM, induced local synthesis of IL-6, IL-10, and IL-23. Systemic production of antigen-specific IgG(1) was partially dependent on IL-23. In contrast, airway exposure to HDM, but not to OVA, induced IL-23p19 mRNA expression in the lungs. In IL-23p19-deficient mice, HDM-exposed lungs did not exhibit the induction of IL-17A, which negatively regulates eosinophilic inflammation. Conclusions: Different antigens induced IL-23 at different part of the body in our similar asthma models. Endogenous IL-23 production at the site of antigen sensitization facilitates type-2 immune responses, whereas IL-23 production and subsequent IL-17A synthesis in the airways suppresses allergic inflammation. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Ogawa, Rika; Suzuki, Yusuke; Kagawa, Shizuko; Masaki, Katsunori; Fukunaga, Koichi; Betsuyaku, Tomoko; Asano, Koichiro] Keio Univ, Sch Med, Div Pulm Med, Dept Med, Tokyo 1608582, Japan; [Suzuki, Yusuke; Kagawa, Shizuko] Keio Univ, Sch Med, MSD Endowed Program Allergy Res, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Fujishima, Seitaro] Keio Univ, Sch Med, Ctr Gen Med & Educ, Tokyo 1608582, Japan; [Terashima, Takeshi] Tokyo Dent Coll, Dept Internal Med, Div Pulm Med, Chiba, Japan; [Asano, Koichiro] Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Hiratsuka, Kanagawa 25912, Japan	Suzuki, Y (reprint author), Keio Univ, Sch Med, Div Pulm Med, Dept Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yu_ske_suzuki@yahoo.co.jp			Merck, Sharp, and Dohme (MSD); Astellas Pharma; GlaxoSmithKline (GSK)	YS received research funding from Merck, Sharp, and Dohme (MSD). KA received research funding from Astellas Pharma; honoraria as lecture fees from Astellas Pharma, GlaxoSmithKline (GSK) and MSD. The rest of the authors have no conflict of interest.	Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Moreira AP, 2011, J CLIN INVEST, V121, P4420, DOI 10.1172/JCI44999; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Mintz-Cole RA, 2012, J IMMUNOL, V189, P3609, DOI 10.4049/jimmunol.1200589; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Kinyanjui MW, 2013, J IMMUNOL, V190, P3859, DOI 10.4049/jimmunol.1200506; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Peng J, 2010, CELL RES, V20, P62, DOI 10.1038/cr.2009.128; Guan Q, 2012, CLIN EXP ALLERGY, V42, P1397, DOI 10.1111/j.1365-2222.2012.04022.x; Li YC, 2011, EXP MOL MED, V43, P197, DOI 10.3858/emm.2011.43.4.024; Aujla Shean J, 2007, Semin Immunol, V19, P377, DOI 10.1016/j.smim.2007.10.009; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Ciprandi G, 2012, INT ARCH ALLERGY IMM, V159, P183, DOI 10.1159/000336418; Kay AB, 2001, NEW ENGL J MED, V344, P30; Masaki K, 2014, ALLERGOL INT, V63, P13, DOI 10.2332/allergolint.13-OA-0632; Nakada EM, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0090-5; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Tian BP, 2014, AM J RESP CELL MOL B, V52, P459	29	1	1	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S24	S29		10.1016/j.alit.2015.04.005		6	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500005		
J	Shintani, Y; Maruoka, S; Gon, Y; Koyama, D; Yoshida, A; Kozu, Y; Kuroda, K; Takeshita, I; Tsuboi, E; Soda, K; Hashimoto, S				Shintani, Yoshitaka; Maruoka, Shuichiro; Gon, Yasuhiro; Koyama, Daisuke; Yoshida, Akiko; Kozu, Yutaka; Kuroda, Kazumichi; Takeshita, Ikuko; Tsuboi, Eriko; Soda, Kaori; Hashimoto, Shu			Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates airway epithelial barrier integrity	ALLERGOLOGY INTERNATIONAL			English	Article						AOX1; Asthma; Corticosteroid; Nrf2; Microarray analysis	INHALED CORTICOSTEROIDS; ASTHMA; CELLS; CULTURE; PERMEABILITY; SULFORAPHANE; INFLAMMATION; RECEPTOR; PATHWAY; ENZYMES	Background: Inhaled corticosteroids enhance airway epithelial barrier integrity. However, the mechanism by which they accomplish this is unclear. Therefore, we investigated steroid-inducible genes and signaling pathways that were involved in enhancing airway epithelial barrier integrity. Methods: A human bronchial epithelial cell line (16HBE cells) was cultured with 10 (6) M dexamethasone (DEX) for 3 days to enhance epithelial barrier integrity. After measuring transepithelial electrical resistance (TER) and paracellular permeability, we extracted total RNA from 16HBE cells and performed microarray and pathway analysis. After we identified candidate genes and a canonical pathway, we measured TER and immunostained for tight junction (TJ) and adherent junction (AJ) proteins in cells that had been transfected with specific small interfering RNAs (siRNAs) for these genes. Results: We identified a nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated oxidative stress response pathway which was primarily involved in the steroid-induced enhancement of airway epithelial barrier integrity. Transfecting cells with Nrf2 specific siRNA reduced the steroid-induced enhancement of airway epithelial barrier integrity and the accumulation of TJ and AJ proteins at sites of cell-cell contact. Moreover, based on pathway analysis, aldehyde oxidase 1 (AOX1) was identified as a downstream enzyme of Nrf2. Transfecting cells with AOX1-specific siRNA also reduced the steroid-induced enhancement of airway epithelial barrier integrity. Conclusions: Our results indicated that the Nrf2/AOX1 pathway was important for enhancing airway epithelial barrier integrity. Because the airway epithelium of asthmatics is susceptible to reduced barrier integrity, this pathway might be a new therapeutic target for asthma. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Shintani, Yoshitaka; Maruoka, Shuichiro; Gon, Yasuhiro; Koyama, Daisuke; Yoshida, Akiko; Kozu, Yutaka; Takeshita, Ikuko; Tsuboi, Eriko; Soda, Kaori; Hashimoto, Shu] Nihon Univ, Sch Med, Div Resp Med, Dept Internal Med, Tokyo 1738610, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Div Microbiol, Dept Pathol & Microbiol, Tokyo 1738610, Japan	Gon, Y (reprint author), Nihon Univ, Sch Med, Div Resp Med, Dept Internal Med,Itabashi Ku, 30-1 Oyaguchikamicho, Tokyo 1738610, Japan.	gon.yasuhiro@nihon-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25461200]; Strategic Research Foundation for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan [S1091023]	This work was supported in part by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (C) Grant Number 25461200 and the Strategic Research Foundation for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan Grant Number S1091023.	Terakado M, 2011, AM J PHYSIOL-LUNG C, V300, pL56, DOI 10.1152/ajplung.00159.2010; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Kitamura S, 2006, DRUG METAB PHARMACOK, V21, P83, DOI 10.2133/dmpk.21.83; Ganan-Gomez I, 2013, FREE RADICAL BIO MED, V65, P750, DOI 10.1016/j.freeradbiomed.2013.06.041; Ohta K, 2014, ALLERGOL INT, V63, P293, DOI [10.2332/allergolint. 14-RAI-0766, 10.2332/allergolint.14-RAI-0766]; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Park JH, 2012, BMB REP, V45, P311, DOI 10.5483/BMBRep.2012.45.5.311; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V102, P531, DOI 10.1016/S0091-6749(98)70268-4; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Sekiyama A, 2012, INT IMMUNOPHARMACOL, V12, P350, DOI 10.1016/j.intimp.2011.12.006; Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Ferrell N, 2010, BIOTECHNOL BIOENG, V107, P707, DOI 10.1002/bit.22835; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Fahey JW, 1999, FOOD CHEM TOXICOL, V37, P973, DOI 10.1016/S0278-6915(99)00082-4; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Forbes B, 2005, EUR J PHARM BIOPHARM, V60, P193, DOI 10.1016/j.ejpb.2005.02.010; Trevor JL, 2014, ALLERGY, V69, P817, DOI 10.1111/all.12412; ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988; Claude P, 1978, J MEMBRANE BIOL, V39, P219; Fan Xian, 2013, Am J Physiol Lung Cell Mol Physiol, V305, pL267, DOI 10.1152/ajplung.00288.2012; Geys J, 2007, TOXICOL IN VITRO, V21, P1215, DOI 10.1016/j.tiv.2007.05.012; Grainger CI, 2006, PHARM RES, V23, P1482, DOI 10.1007/s11095-006-0255-0; Maeda K, 2012, GENE, V505, P374, DOI 10.1016/j.gene.2012.06.010; McGarvey LP, 2014, J ALLERGY CLIN IMMUN, V133, P704, DOI 10.1016/j.jaci.2013.09.016; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755	32	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S54	S63		10.1016/j.alit.2015.06.004		10	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500009		
J	Tanaka, Y; Yamaguchi, M; Suzukawa, M; Arai, H; Nagase, H; Ohta, K				Tanaka, Yusuke; Yamaguchi, Masao; Suzukawa, Maho; Arai, Hidenori; Nagase, Hiroyuki; Ohta, Ken			Modulation of human basophil activation by resveratrol	ALLERGOLOGY INTERNATIONAL			English	Letter							ALLERGIC-ASTHMA; MOUSE MODEL; DEGRANULATION; MICE		[Tanaka, Yusuke; Yamaguchi, Masao; Arai, Hidenori; Nagase, Hiroyuki; Ohta, Ken] Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Tokyo 1738605, Japan; [Suzukawa, Maho; Ohta, Ken] Natl Hosp Org, Tokyo Natl Hosp, Tokyo, Japan	Yamaguchi, M (reprint author), Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol,Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	myama@med.teikyo-u.ac.jp					Hayashi Y, 2012, BIOCHEM BIOPH RES CO, V417, P169, DOI 10.1016/j.bbrc.2011.11.078; Ichikawa T, 2013, RESPIROLOGY, V18, P332, DOI 10.1111/j.1440-1843.2012.02284.x; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Lee M, 2009, INT IMMUNOPHARMACOL, V9, P418, DOI 10.1016/j.intimp.2009.01.005; Aich J, 2012, INT IMMUNOPHARMACOL, V14, P438, DOI 10.1016/j.intimp.2012.08.017; Han SY, 2013, J NUTR, V143, P632, DOI 10.3945/jn.112.173302; Koketsu R, 2013, INT ARCH ALLERGY IMM, V161, P23, DOI 10.1159/000350339; Okada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044338; Royce SG, 2011, PATHOBIOLOGY AGING A, V1, P7134; Tan Y, 2008, BRIT J PHARMACOL, V155, P995, DOI 10.1038/bjp.2008.330	10	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S80	S82		10.1016/j.alit.2015.05.003		3	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500014		
J	Uchimizu, H; Matsuwaki, Y; Kato, M; Otori, N; Kojima, H				Uchimizu, Hirotaka; Matsuwaki, Yoshinori; Kato, Masahiko; Otori, Nobuyosi; Kojima, Hiromi			Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media	ALLERGOLOGY INTERNATIONAL			English	Article						Cytokine profile; Elastase; Eosinophil-derived neurotoxin; Eosinophilic otitis media; Secretory otitis media	CHRONIC RHINOSINUSITIS; NASAL POLYPOSIS; HOST-DEFENSE; INTERLEUKIN-5; DISEASES; ASTHMA; RANTES; INHIBITION; ANTAGONIST; ACTIVATION	Background: Eosinophilic otitis media (EOM) is an intractable disease characterized by a remarkably viscous effusion and accumulation of numerous eosinophils in both the middle ear effusion and the mucosa. The key factors in EOM pathogenesis remain unclear. The purpose of this study is to identify the important factors involved in EOM pathogenesis. Methods: Middle ear effusion samples were collected from 12 patients with EOM and 9 patients with secretory otitis media (SOM), as controls. Multiple cytokines in the effusion were measured using a Bio-Plex (TM) Human Cytokine 27-Plex panel. Eosinophil-derived neurotoxin (EDN) and elastase were measured by ELISA. The concentrations of EDN, elastase, and each cytokine were compared between the EOM and SOM groups. Furthermore, in the EOM group, each cytokine was examined for correlation with EDN and elastase. Results: EDN and elastase concentrations were significantly higher in the EOM group than in the SOM group (p < 0.05). IL-5, IL-1 beta, MIP-1 alpha, G-CSF, IL-1ra, IL-4, IFN-gamma, MIP-1 beta, IL-10, TNF-alpha, VEGF, and IL-2 concentration was significantly higher in the EOM group than in the SOM group (p < 0.05). Significant positive correlations were found between EDN and IL-1ra, IL-2, IL-5, IL-9, IL-13, eotaxin, MIP-1 alpha, PDGF-BB, and RANTES in the EOM group (p < 0.05). Conclusions: Our study showed that IL-5, IL-2, MIP-1 alpha, and IL-1ra are the important factors involved in EOM pathogenesis. Furthermore, not only eosinophil, but also neutrophil are involved in middle ear inflammation of EOM. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.	[Uchimizu, Hirotaka; Matsuwaki, Yoshinori; Otori, Nobuyosi; Kojima, Hiromi] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo 1058461, Japan; [Kato, Masahiko] Tokai Univ, Sch Med, Dept Pediat, Hiratsuka, Kanagawa 25912, Japan	Uchimizu, H (reprint author), Jikei Univ, Sch Med, Dept Otorhinolaryngol, Minato Ku, 3-25-8 Nishishimbashi, Tokyo 1058461, Japan.	uchimizu@jikei.ac.jp					Iwasaki S, 2006, EUR ARCH OTO-RHINO-L, V263, P365, DOI 10.1007/s00405-005-1006-2; Nagamine H, 2002, AURIS NASUS LARYNX, V29, P19, DOI 10.1016/S0385-8146(01)00124-9; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Allen JN, 1996, J ALLERGY CLIN IMMUN, V97, P1366, DOI 10.1016/S0091-6749(96)70206-3; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Otto BA, 2008, CURR OPIN OTOLARYNGO, V16, P270, DOI 10.1097/MOO.0b013e3282fb2885; Liu MT, 2001, J IMMUNOL, V166, P1790; Iino Y, 2008, OTOL NEUROTOL, V29, P949, DOI 10.1097/MAO.0b013e318185fb0d; Holgate ST, 1997, AM J RESP CRIT CARE, V156, P1377; Corren J, 2011, CURR OPIN ALLERGY CL, V11, P565, DOI 10.1097/ACI.0b013e32834c3d30; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; Iino Y, 2005, CLIN EXP ALLERGY, V35, P1370, DOI 10.1111/j.1365-2222.205.02330.x; Iino Y, 2011, AURIS NASUS LARYNX, V38, P456, DOI 10.1016/j.anl.2010.11.016; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Bachert Claus, 2002, Curr Allergy Asthma Rep, V2, P481, DOI 10.1007/s11882-002-0088-9; Bachert C, 2000, AM J RHINOL, V14, P279, DOI 10.2500/105065800781329573; Cain BS, 1998, J AM COLL SURGEONS, V186, P337, DOI 10.1016/S1072-7515(98)00036-2; Corren J, 2012, DISCOV MED, V71, P305; Danielsen A, 2006, EUR ARCH OTO-RHINO-L, V263, P282, DOI 10.1007/S00405-005-1031-1; Doyle WJ, 2003, CURR ALLERGY ASTHM R, V3, P326, DOI 10.1007/s11882-003-0093-7; Goldbach-Mansky R, 2009, ANN NY ACAD SCI, V1182, P111, DOI 10.1111/j.1749-6632.2009.05159.x; Iino Y, 2009, OTOL NEUROTOL, V31, P100; Kato M, 2011, PEDIAT ALLERG IMM-UK, V22, pe87, DOI 10.1111/j.1399-3038.2010.01026.x; Lamblin C, 2001, AM J RESP CRIT CARE, V163, P1226; Liu MT, 2000, J IMMUNOL, V165, P2327; Lukacs NW, 1996, J LEUKOCYTE BIOL, V60, P573; Matsutani S, 2004, OTOL JPN, V14, P108; Molfino NA, 2012, EXPERT OPIN BIOL TH, V12, P807, DOI 10.1517/14712598.2012.674938; SANZ MJ, 1995, J IMMUNOL, V154, P1364	30	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S18	S23		10.1016/j.alit.2015.03.007		6	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500004		
J	Yamada, Y; Toki, F; Yamamoto, H; Nishi, A; Kato, M				Yamada, Yoshiyuki; Toki, Fumiaki; Yamamoto, Hideki; Nishi, Akira; Kato, Masahiko			Proton pump inhibitor treatment decreased duodenal and esophageal eosinophilia in a case of eosinophilic gastroenteritis	ALLERGOLOGY INTERNATIONAL			English	Letter									[Yamada, Yoshiyuki; Kato, Masahiko] Gunma Childrens Med Ctr, Div Allergy & Immunol, Gunma 3778577, Japan; [Toki, Fumiaki; Yamamoto, Hideki; Nishi, Akira] Gunma Childrens Med Ctr, Div Surg, Gunma 3778577, Japan; [Kato, Masahiko] Tokai Univ, Sch Med, Dept Pediat, Isehara, Kanagawa 25911, Japan	Yamada, Y (reprint author), Gunma Childrens Med Ctr, Div Allergy & Immunol, 779 Shimohakoda Hokkitsu, Gunma 3778577, Japan.	yamaday@gcmc.pref.gunma.jp					Dellon ES, 2013, AM J GASTROENTEROL, V108, P679, DOI 10.1038/ajg.2013.71; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Yamada Y, 2012, INT ARCH ALLERGY IMM, V158, P83, DOI 10.1159/000337797; Yamada Y, 2014, ALLERGOL INT, V63, P53, DOI 10.2332/allergolint.13-LE-0633; Cortes JR, 2009, J ALLERGY CLIN IMMUN, V124, P607, DOI 10.1016/j.jaci.2009.06.023; Benias Petros C, 2013, Gastroenterol Hepatol (N Y), V9, P607; Rothenberg ME, 2008, MIDDLETONS ALLERGY P, V7th, P879; Takenaka M, 2010, NIHON SHONI ARERUGI, V24, P305, DOI 10.3388/jspaci.24.305; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050037	10	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	SEP	2015	64			S			S83	S85		10.1016/j.alit.2015.06.002		3	Allergy; Immunology	Allergy; Immunology	CQ9IN	WOS:000360927500015		
J	Omori, K; Jitsuiki, K; Ohsaka, H; Mishima, K; Ishikawa, K; Obinata, M; Oode, Y; Yanagawa, Y				Omori, Kazuhiko; Jitsuiki, Kei; Ohsaka, Hiromichi; Mishima, Kentaro; Ishikawa, Kouhei; Obinata, Mariko; Oode, Yasumasa; Yanagawa, Youichi			Recurrent idiopathic ventricular fibrillation induced by high fever	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							INDUCED QTC PROLONGATION; BRUGADA-SYNDROME	A 75-year-old man became unconscious while taking a bath and drowned. His family found him and called an ambulance, and he was transported to our department. On arrival, his consciousness had improved. The results of his physical examination and an electrocardiogram were negative for abnormalities. After starting to eat, he developed a high fever at greater than 39 degrees C, which was followed by pulseless ventricular tachycardia and ventricular fibrillation (Vf). Immediate coronary angiography showed no remarkable findings. After the reinitiation of tube feeding, he again developed a high fever, which was followed by Vf. When he maintained a normal body temperature or had a low-grade fever, the lethal arrhythmia did not occur. An electrophysiological study on the 62nd hospital day failed to induce the ventricular tachycardia or Vf.	[Omori, Kazuhiko; Jitsuiki, Kei; Ohsaka, Hiromichi; Mishima, Kentaro; Ishikawa, Kouhei; Obinata, Mariko; Oode, Yasumasa; Yanagawa, Youichi] Juntendo Univ, Shizuoka Hosp, Dept Acute Crit Care Med, Shizuoka, Japan	Yanagawa, Y (reprint author), 1129 Nagaoka Izunokuni City, Shizuoka 4102295, Japan.	yyanaga@juntendo.ac.jp					Amin AS, 2008, J CLIN INVEST, V118, P2552, DOI 10.1172/JCI35337; Amin AS, 2008, ANN INTERN MED, V149, P216; Keller DI, 2006, CARDIOVASC RES, V70, P521, DOI 10.1016/j.cardiores.2006.02.030; Adler A, 2013, HEART RHYTHM, V10, P1375, DOI 10.1016/j.hrthm.2013.07.030; Lebreiro A, 2010, CARDIOLOGY, V115, P232, DOI 10.1159/000297686; Lim SM, 2011, YONSEI MED J, V52, P1025, DOI 10.3349/ymj.2011.52.6.1025; Ozben Beste, 2010, Turk Kardiyol Dern Ars, V38, P35; Pasquie JL, 2004, J CARDIOVASC ELECTR, V15, P1271, DOI 10.1046/j.1540-8167.2004.04388.x; Pasquié Jean Luc, 2005, Indian Pacing Electrophysiol J, V5, P139	9	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2015	33	9							1331.e1	10.1016/j.ajem.2015.03.021		3	Emergency Medicine	Emergency Medicine	CQ9GG	WOS:000360920700074		
J	Ogura, T; Nakano, M; Izawa, Y; Nakamura, M; Fujizuka, K; Lefor, AT				Ogura, Takayuki; Nakano, Minoru; Izawa, Yoshimitsu; Nakamura, Mitsunobu; Fujizuka, Kenji; Lefor, Alan T.			Analysis of risk classification for massive transfusion in severe trauma using the gray zone approach	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							MAJOR TRAUMA; COMBAT CASUALTIES; HEMORRHAGE; BLOOD; COAGULOPATHY; VALIDATION; MANAGEMENT; TRIGGERS; PROMMTT; TESTS	Background: The Traumatic Bleeding Severity Score (TBSS) was developed to predict the need for massive transfusion (MT). The aim of this study is evaluation of clinical thresholds for activation of a MT protocol using the gray zone approach based on TBSS. Methods: This is a single-center retrospective study of trauma patients, admitted from 2010 to 2013. The TBSS on admission was calculated, and the accuracy of predicting MT was analyzed using area under the receiver operating characteristic curve. Risk classification for MT was made using sensitivity/specificity. The gray zone (indeterminate risk) was defined from a sensitivity of 95% to a specificity of 95%, patients were separated into MT and non-MT groups, and their clinical characteristics were compared. Results: A total of 264 patients were enrolled, with an area under the TBSS curve of 0.967 (95% confidence interval, 0.94-0.99). A TBSS of 10 points or less resulted in a sensitivity of 96.5% with 146 patients in this group, and 3.4% (5/146) of them received MT. A TBSS of 17 points or higher had a specificity of 97.8%, which included 72 patients, and 94.4% (68/72) of them received MT. Forty-six patients had a TBSS from 11 to 16 points (gray zone), and 26.1% (12/46) of them received MT. Comparing the MT group (12/46) and non-MT group (34/46), coagulopathy and extravasation on computed tomographic scan were more prevalent in the MT group. Conclusion: The TBSS is highly accurate in predicting the need for MT, and a risk classification for needing MT was created based on TBSS. (C) 2015 Elsevier Inc. All rights reserved.	[Ogura, Takayuki; Nakano, Minoru; Nakamura, Mitsunobu; Fujizuka, Kenji] Japan Red Cross Maebashi Hosp, Adv Med Emergency Dept, Maebashi, Tochigi, Japan; [Ogura, Takayuki; Nakano, Minoru; Nakamura, Mitsunobu; Fujizuka, Kenji] Japan Red Cross Maebashi Hosp, Crit Care Ctr, Maebashi, Tochigi, Japan; [Ogura, Takayuki; Izawa, Yoshimitsu] Jichi Med Univ, Dept Emergency Med, Shimotsuke, Tochigi, Japan; [Lefor, Alan T.] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan	Ogura, T (reprint author), 371-0014 Asahi Cho 3-21-36, Maebashi, Gunma, Japan.	alongthelongestway2003@yahoo.co.jp; icuqq@maebashi.jrc.or.jp; yizawa@ms2.jichi.ac.jp; mi-nakamura@maebashi.jrc.or.jp; fujiken_sanjo_4138@yahoo.co.jp; alefor@jichi.ac.jp		Lefor, Alan/0000-0001-6673-5630			Schuster KM, 2010, TRANSFUSION, V50, P1545, DOI 10.1111/j.1537-2995.2010.02587.x; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Schreiber MA, 2007, J AM COLL SURGEONS, V205, P541, DOI 10.1016/j.jamcollsurg.2007.05.007; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Callcut RA, 2011, J TRAUMA, V70, P794, DOI 10.1097/TA.0b013e3182127e40; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; Yucel N, 2006, J TRAUMA, V60, P1228, DOI 10.1097/01.ta.0000220386.84012.bf; Davenport R, 2011, BRIT J HAEMATOL, V155, P537, DOI 10.1111/j.1365-2141.2011.08885.x; Ogura T, 2014, J TRAUMA ACUTE CARE, V76, P1243, DOI 10.1097/TA.0000000000000200; Ho AMH, 2005, AM J SURG, V190, P479, DOI 10.1016/j.amjsurg.2005.03.034; Vandromme MJ, 2011, AM SURGEON, V77, P155; Coste J, 2003, INT J EPIDEMIOL, V32, P304, DOI 10.1093/ije/dyg054; Rainer TH, 2011, RESUSCITATION, V82, P724, DOI 10.1016/j.resuscitation.2011.02.016; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Bouillon B, 2010, J TRAUMA, V68, P225, DOI 10.1097/TA.0b013e3181c42815; Brockamp T, 2012, CRIT CARE, V16, DOI 10.1186/cc11432; Callcut RA, 2013, J TRAUMA ACUTE CARE, V74, P59, DOI 10.1097/TA.0b013e3182788b34; Holcomb JB, 2008, ANN SURG, V95, P112; Larson CR, 2010, J TRAUMA, V69, pS26, DOI 10.1097/TA.0b013e3181e423f4; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Yucel N, 2006, J TRAUMA, V60, P1236	22	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2015	33	9					1146	1151		10.1016/j.ajem.2015.05.007		6	Emergency Medicine	Emergency Medicine	CQ9GG	WOS:000360920700006		
J	Oda, S; Shimoda, M; Hirayama, A; Imai, M; Komatsu, F; Shigematsu, H; Nishiyama, J; Matsumae, M				Oda, S.; Shimoda, M.; Hirayama, A.; Imai, M.; Komatsu, F.; Shigematsu, H.; Nishiyama, J.; Matsumae, M.			Neuroradiologic Diagnosis of Minor Leak prior to Major SAH: Diagnosis by T1-FLAIR Mismatch	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; RUPTURED INTRACRANIAL ANEURYSM; SENTINEL HEADACHE; MR-ANGIOGRAPHY; WARNING LEAK; FLUID; APPEARANCE; MANAGEMENT; VASOSPASM; SUBACUTE	BACKGROUND AND PURPOSE: In major SAH, the only method to diagnose a preceding minor leak is to ascertain the presence of a warning headache by interview; however, poor clinical condition and recall bias can cause inaccuracy. We devised a neuroradiologic method to diagnose previous minor leak in patients with SAH and attempted to determine whether warning (sentinel) headaches were associated with minor leaks before major SAH. MATERIALS AND METHODS: We retrospectively evaluated 127 patients who were admitted with SAH within 48 hours of ictus. Previous minor leak before major SAH was defined as T1WI-detected clearly bright hyperintense subarachnoid blood accompanied by SAH blood on FLAIR images that was distributed over a larger area than bright hyperintense subarachnoid blood on T1WI (T1-FLAIR mismatch). RESULTS: The incidence of warning headache before SAH was 11.0% (14 of 127 patients, determined by interview). The incidence of T1-FLAIR mismatch (neuroradiologic diagnosis of minor leak before major SAH) was 33.9% (43 of 127 patients). Of the 14 patients with warning headache, 13 had a minor leak diagnosed by T1-FLAIR mismatch at the time of admission. Variables identified by multivariate analysis as significantly associated with minor leak diagnosed by T1-FLAIR mismatch included 80 years of age or older, rebleeding after admission, intracerebral hemorrhage on CT, and mRS scores of 3-6. CONCLUSIONS: We conclude that warning headaches diagnosed by interview are not a product of recall bias but are the result of actual leaks from aneurysms.	[Oda, S.; Shimoda, M.; Hirayama, A.; Imai, M.; Komatsu, F.; Shigematsu, H.; Nishiyama, J.] Tokai Univ, Hachioji Hosp, Dept Neurosurg, Hachioji, Tokyo 1920032, Japan; [Matsumae, M.] Tokai Univ, Sch Med, Dept Neurosurg, Hiratsuka, Kanagawa 25912, Japan	Shimoda, M (reprint author), Tokai Univ, Hachioji Hosp, Dept Neurosurg, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.	mashimoda-nsu@umin.ac.jp					Grandin CB, 2000, AM J NEURORADIOL, V21, P1611; ROBERTSON EG, 1949, BRAIN, V72, P150, DOI 10.1093/brain/72.2.150; BRADLEY WG, 1993, RADIOLOGY, V189, P15; Mitchell P, 2001, J NEUROL NEUROSUR PS, V70, P205, DOI 10.1136/jnnp.70.2.205; Noguchi K, 1997, RADIOLOGY, V203, P257; DRAKE CG, 1988, J NEUROSURG, V68, P985; OGAWA T, 1995, AM J ROENTGENOL, V165, P1257; FISHER CM, 1980, NEUROSURGERY, V6, P1; CROMPTON MR, 1962, J NEUROL NEUROSUR PS, V25, P378, DOI 10.1136/jnnp.25.4.378; Imaizumi T, 2003, STROKE, V34, P1693, DOI 10.1161/01.STR.0000075771.88719.CE; Mizutani T, 2011, J NEUROSURG, V114, P1037, DOI 10.3171/2010.9.JNS10668; OKAWARA SH, 1973, J NEUROSURG, V38, P575, DOI 10.3171/jns.1973.38.5.0575; Beck J, 2006, STROKE, V37, P2733, DOI 10.1161/01.STR.0000244762.51326.e7; BRADLEY WG, 1985, RADIOLOGY, V156, P99; DRAKE CG, 1981, STROKE, V12, P273; GILLINGHAM F. J., 1967, SCOT MED J, V12, P377; Guresir E, 2008, NEUROSURGERY, V63, P1088, DOI 10.1227/01.NEU.0000335170.76722.B9; Guresir E, 2008, NEUROSURGERY, V63, P1093; HAUERBERG J, 1991, ACTA NEUROL SCAND, V83, P61; Ida M, 1997, AM J NEURORADIOL, V18, P1025; Jakobsson KE, 1996, J NEUROSURG, V85, P995, DOI 10.3171/jns.1996.85.6.0995; JUVELA S, 1992, NEUROSURGERY, V30, P7; LINN FHH, 1994, LANCET, V344, P590, DOI 10.1016/S0140-6736(94)91970-4; Linn FHH, 2000, J NEUROL NEUROSUR PS, V68, P332, DOI 10.1136/jnnp.68.3.332; Naidech AM, 2005, ARCH NEUROL-CHICAGO, V62, P410, DOI 10.1001/archneur.62.3.410; Noguchi K, 2000, AM J NEURORADIOL, V21, P923; OGAWA T, 1993, RADIOLOGY, V186, P345; Shimoda M, 2010, NEUROL MED-CHIR, V50, P530; Shimoda M, 2010, ACTA NEUROCHIR, V152, P1197, DOI 10.1007/s00701-010-0640-7; Shinohara Y, 2006, CEREBROVASC DIS, V21, P271, DOI 10.1159/000091226; SPICKLER E, 1990, COMPUT MED IMAG GRAP, V14, P67, DOI 10.1016/0895-6111(90)90142-X; TOMLINSON BE, 1959, J CLIN PATHOL, V12, P391, DOI 10.1136/jcp.12.5.391; WAHLGREN NG, 1987, EUR NEUROL, V26, P216, DOI 10.1159/000116339	33	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2015	36	9					1616	1622		10.3174/ajnr.A4325		7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CR0WO	WOS:000361044500010		
J	Kitajima, M; Hirai, T; Yoneda, T; Iryo, Y; Azuma, M; Tateishi, M; Morita, K; Komi, M; Yamashita, Y				Kitajima, M.; Hirai, T.; Yoneda, T.; Iryo, Y.; Azuma, M.; Tateishi, M.; Morita, K.; Komi, M.; Yamashita, Y.			Visualization of the Medial and Lateral Geniculate Nucleus on Phase Difference Enhanced Imaging	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							WHITE-MATTER CONTRAST; IN-VIVO; BRAIN; IDENTIFICATION; RESPONSES; GLAUCOMA; THALAMUS; ATROPHY; BODY; GRAY	BACKGROUND AND PURPOSE: The precise identification and measurement of the medial geniculate nucleus and lateral geniculate nucleus on MR imaging remain technically challenging because the thalamic nuclei are small structures. We compared the visualization of the medial geniculate nucleus and lateral geniculate nucleus on phase difference enhanced imaging with 3D high-resolution phase imaging, 2D-T2WI, STIR, proton attenuation-weighted imaging, and DTI acquired at 3T. We also measured the volume and height of the medial geniculate nucleus and lateral geniculate nucleus on phase difference enhanced imaging. MATERIALS AND METHODS: Phase difference enhanced, 2D-T2-weighted, STIR, proton attenuation-weighted, and DTI were acquired on a 3T MR imaging unit in 10 healthy volunteers. Two neuroradiologists recorded the qualitative visualization scores of the medial geniculate nucleus and lateral geniculate nucleus, specifically the identification of their boundaries, for all images. Measurement differences were assessed with the Wilcoxon signed rank test. The volume and height of the medial geniculate nucleus and lateral geniculate nucleus were measured on phase difference enhanced imaging and compared with previously reported values. RESULTS: The qualitative visualization scores of the lateral geniculate nucleus and medial geniculate nucleus were significantly higher on phase difference enhanced images than on T2-weighted, proton attenuation-weighted, STIR, or DTI (P < .05). On phase difference enhanced imaging, the medial geniculate nucleus and lateral geniculate nucleus were bordered by low-intensity structures: the cerebral peduncle, the origin of the optic radiation, and the superior and inferior quadrigeminal brachia. The volume of the medial geniculate nucleus and lateral geniculate nucleus varied from 74.0 to 183.75 mm(3) (mean, 129.0 +/- 34.7 mm(3)) and from 96.5 to 173.75 mm(3) (mean, 135.2 +/- 28.0 mm(3)), respectively. CONCLUSIONS: For the depiction of the medial geniculate nucleus and lateral geniculate nucleus on 3T MR imaging, phase difference enhanced imaging is superior to conventional MR imaging. The medial geniculate nucleus and lateral geniculate nucleus volumes vary among individuals.	[Kitajima, M.; Hirai, T.; Iryo, Y.; Azuma, M.; Tateishi, M.; Yamashita, Y.] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, Kumamoto, Kumamoto 8600811, Japan; [Yoneda, T.] Kumamoto Univ, Fac Life Sci, Dept Med Phys Adv Biomed Sci, Kumamoto, Kumamoto 8600811, Japan; [Morita, K.; Komi, M.] Kumamoto Univ Hosp, Dept Radiol, Kumamoto, Japan	Kitajima, M (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, Chuo Ku, 1-1-1 Honjo, Kumamoto, Kumamoto 8600811, Japan.	mkitaji@kumamoto-u.ac.jp			Philips Healthcare	Tetsuya Yoneda-RELATED: Grant: Philips Healthcare,<SUP>star</SUP> Comments: joint research; UNRELATED: Royalties: Philips Healthcare,<SUP>star</SUP> Comments: development of SWI with phase enhancement. <SUP>star</SUP> Money paid to the institution.	Selemon LD, 2007, PSYCHIAT RES, V151, P1, DOI 10.1016/j.psychres.2006.11.003; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Li W, 2012, NEUROIMAGE, V59, P2088, DOI 10.1016/j.neuroimage.2011.10.038; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; Hess RF, 2009, EUR J NEUROSCI, V29, P1064, DOI 10.1111/j.1460-9568.2009.06650.x; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Marques JP, 2009, NEUROIMAGE, V46, P345, DOI 10.1016/j.neuroimage.2009.02.023; Zhong K, 2008, NEUROIMAGE, V40, P1561, DOI 10.1016/j.neuroimage.2008.01.061; Devlin JT, 2006, NEUROIMAGE, V30, P1112, DOI 10.1016/j.neuroimage.2005.11.025; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Li M, 2012, AM J NEURORADIOL, V33, P915, DOI 10.3174/ajnr.A2884; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fujita N, 2001, AM J NEURORADIOL, V22, P1719; Dai H, 2011, AM J NEURORADIOL, V32, P1347, DOI 10.3174/ajnr.A2486; Abduljalil AM, 2003, J MAGN RESON IMAGING, V18, P284, DOI 10.1002/jmri.10362; HORTON JC, 1990, ARCH NEUROL-CHICAGO, V47, P1201; Ide S, 2012, ACAD RADIOL, V19, P1283, DOI 10.1016/j.acra.2012.05.018; Kakeda S, 2011, EUR RADIOL, V21, P2202, DOI 10.1007/s00330-011-2158-7; Naidich TP, 2009, DUVERNOYS ATLAS HUMA, P53; Schaltenbrand G, 2005, ATLAS STEREOTAXY HUM, V2nd, P51; WINER JA, 1984, HEARING RES, V15, P225, DOI 10.1016/0378-5955(84)90031-5; Yoneda T, 2009, P ANN M INT SOC MAGN	22	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2015	36	9					1669	1674		10.3174/ajnr.A4356		6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CR0WO	WOS:000361044500019		
J	Kiyosue, H; Tanoue, S; Hongo, N; Sagara, Y; Mori, H				Kiyosue, H.; Tanoue, S.; Hongo, N.; Sagara, Y.; Mori, H.			Artery of the Superior Orbital Fissure: An Undescribed Branch from the Pterygopalatine Segment of the Maxillary Artery to the Orbital Apex Connecting with the Anteromedial Branch of the Inferolateral Trunk	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							INTERNAL CAROTID-ARTERY; FOSSA; ANATOMY	BACKGROUND AND PURPOSE: Some branches of the internal maxillary artery have anastomoses with the inferolateral trunk that are important as intracranial-extracranial collateral pathways and as dangerous anastomoses for transarterial embolization of these branches. We present here an undescribed branch potentially anastomosing with the anteromedial branch of the inferolateral trunk, which is provisionally named the artery of the superior orbital fissure, defined as an arterial branch from the pterygopalatine segment of the maxillary artery to the orbital apex at the superior orbital fissure. MATERIALS AND METHODS: Two neuroradiologists reviewed 3D and MPR images of the external and/or common carotid artery with particular interest paid to the artery of the superior orbital fissure in 54 patients who underwent 3D angiography with a field of view covering the pterygopalatine fossa and the cavernous sinus. The underlying diseases in these patients were 17 parasellar hypervascular lesions (including 13 cavernous sinus dural arteriovenous fistulas and 4 meningiomas), 18 internal carotid artery stenoses/occlusions, and 19 other diseases. RESULTS: The artery of the superior orbital fissure was identified in 20 of 54 patients; it arose at the pterygopalatine segment of the maxillary artery, either singly or from a common trunk with the artery of the foramen rotundum, and ran upward to reach the superior orbital fissure. It anastomosed with the anteromedial branch of the inferolateral trunk at the superior orbital fissure with blood flow toward the cavernous sinus (n = 14) and/or the ophthalmic artery (n = 2). It was more prominent in parasellar hypervascular lesions and internal carotid artery stenoses/occlusions than in other diseases. CONCLUSIONS: The artery of the superior orbital fissure, a remnant of the anastomotic artery, was often identified, especially in patients with parasellar hypervascular lesions.	[Kiyosue, H.; Tanoue, S.; Hongo, N.; Sagara, Y.; Mori, H.] Oita Univ, Fac Med, Dept Radiol, Oita 87011, Japan	Kiyosue, H (reprint author), 1-1 Idaigaoka, Yufu City, Oita 8795963, Japan.	hkiyosue@oita-u.ac.jp					Rusu MC, 2013, SURG RADIOL ANAT, V35, P143, DOI 10.1007/s00276-012-1009-9; LASJAUNIAS P, 1977, NEURORADIOLOGY, V13, P215; Hiu T, 2009, AM J NEURORADIOL, V30, P487, DOI 10.3174/ajnr.A1395; Daniels DL, 1998, AM J NEURORADIOL, V19, P1423; DANIELS DL, 1983, RADIOLOGY, V149, P511; DELATORRE E, 1960, AM J ANAT, V106, P185, DOI 10.1002/aja.1001060302; Djindjian R, 1978, SUPER SELECTIVE ARTE, P22; Ginsberg LE, 1998, AM J NEURORADIOL, V19, P1417; Kim HS, 1996, NEURORADIOLOGY, V38, pS120; Kiyosue H, 2013, AM J NEURORADIOL, V34, P1612, DOI 10.3174/ajnr.A3428; Lasjaunias P, 2001, CLIN VASCULAR ANATOM, P15; Oomen KP, 2011, AM J RHINOL ALLERGY, V25, P50, DOI 10.2500/ajra.2011.25.3550; OSBORN AG, 1979, AM J ROENTGENOL, V132, P389; Tanoue S, 2013, RADIOGRAPHICS, V33, pE209, DOI 10.1148/rg.337125173; Williams PL, 1999, GRAYS ANATOMY ANATOM; WILLINSKY R, 1987, SURG RADIOL ANAT, V9, P201, DOI 10.1007/BF02109631	16	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2015	36	9					1741	1747		10.3174/ajnr.A4331		7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CR0WO	WOS:000361044500030		
J	Niimi, Y; Matsukawa, H; Uchiyama, N; Berenstein, A				Niimi, Y.; Matsukawa, H.; Uchiyama, N.; Berenstein, A.			The Preventive Effect of Endovascular Treatment for Recurrent Hemorrhage in Patients with Spinal Cord Arteriovenous Malformations	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CONSECUTIVE PATIENTS; POOLED ANALYSIS; FISTULAS; EMBOLIZATION; ANEURYSMS; SHUNTS; SERIES; RISK	BACKGROUND AND PURPOSE: Spinal cord AVMs represent rare and insufficiently studied pathologic entities. Embolization is thought to play an important role in the management of spinal cord AVMs. Factors for recurrent hemorrhage and the impact of endovascular treatment on prevention of recurrent hemorrhage remain to be confirmed. We aimed to assess recurrent hemorrhagic incidence of spinal cord AVMs and its prevention by endovascular treatment. MATERIALS AND METHODS: We reviewed 80 patients with spinal cord AVMs by spinal cord angiography who had hemorrhage before the first endovascular treatment at New York University Medical Center, Beth Israel Medical Center, or Roosevelt Hospital in New York. We compared the baseline and radiologic characteristics of patients with and without recurrent hemorrhage by the log-rank test and the Cox proportional hazards model. RESULTS: We observed recurrent hemorrhage in 35 (44%) patients (1/41 patients with endovascular treatment and 34/39 patients without endovascular treatment). The median length of total follow-up was 659 days (interquartile range, 129-2640 days), and the median length from first-to-recurrent hemorrhage was 369 days (interquartile range, 30 - 1596 days). The log-rank test revealed that endovascular treatment and venous thrombosis reduced recurrent hemorrhage, and associated aneurysm was related to recurrent hemorrhage. Even in multivariate analysis, the endovascular treatment reduced (hazard ratio, 0.027; P < .0001) and associated aneurysm increased (hazard ratio, 3.4; P = .044) the risk of recurrent hemorrhage. CONCLUSIONS: Endovascular embolization is the first choice of treatment for spinal cord AVMs and is effective in preventing recurrent hemorrhage.	[Niimi, Y.] St Lukes Int Hosp, Dept Neuroendovasc Therapy, Tokyo 1048560, Japan; [Matsukawa, H.] St Lukes Int Hosp, Dept Neurosurg, Tokyo 1048560, Japan; [Uchiyama, N.] Kanazawa Univ, Dept Neurosurg, Kanazawa, Ishikawa, Japan; [Berenstein, A.] St Lukes Roosevelt Hosp, Ctr Endovasc Surg, New York, NY 10025 USA	Niimi, Y (reprint author), St Lukes Int Hosp, Dept Neuroendovasc Therapy, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	yasunm@luke.ac.jp					Gross BA, 2013, NEUROSURGERY, V73, P141, DOI 10.1227/01.neu.0000429848.91707.73; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Niimi Y, 2004, AM J NEURORADIOL, V25, P1131; Berenstein A, 2004, SURG NEUROANGIOGRAPH, P737, DOI DOI 10.1007/978-3-642-18888-6_11; BIONDI A, 1992, AM J NEURORADIOL, V13, P923; BIONDI A, 1990, RADIOLOGY, V177, P651; Gross BA, 2013, NEUROSURGERY, V72, P25, DOI 10.1227/NEU.0b013e318276b5d3; Inagawa S, 2013, JPN J RADIOL, V31, P455, DOI 10.1007/s11604-013-0216-6; Kim Louis J, 2006, Neurosurgery, V59, pS195; Kim LJ, 2006, NEUROSURGERY S3, V59, pS3, DOI 10.1227/01.NEU.0000237335.82234.CE; Konan AV, 1999, J NEUROSURG, V90, P148, DOI 10.3171/spi.1999.90.1.0148; Lasjaunias P, 1997, Interv Neuroradiol, V3, P275; MOURIER KL, 1993, NEUROSURGERY, V32, P885; Rodesch G, 2003, NEUROSURGERY, V53, P49; Rodesch G, 2004, ACTA NEUROCHIR WIEN, V146, P226; Rodesch G, 2003, NEUROSURGERY, V53, P40, DOI 10.1227/01.NEU.0000068701.25600.A1; Rodesch G, 2005, NEUROSURGERY, V57, P973, DOI 10.1227/01.NEU.0000181314.94000.CD; Rodesch G, 2004, ACTA NEUROCHIR, V146, P217, DOI 10.1007/s00701-003-0192-1; ROSENBLUM B, 1987, J NEUROSURG, V67, P795, DOI 10.3171/jns.1987.67.6.0795; Veznedaroglu Erol, 2006, Neurosurgery, V59, pS202; Veznedaroglu E, 2006, NEUROSURGERY S3, V59, pS3, DOI 10.1227/01.NEU.0000244419.91488.44; Zozulya Yuri P, 2006, Neurosurg Focus, V20, pE7	22	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2015	36	9					1763	1768		10.3174/ajnr.A4396		6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CR0WO	WOS:000361044500033		
J	Oda, S; Shimoda, M; Hirayama, A; Imai, M; Komatsu, F; Shigematsu, H; Nishiyama, J; Matsumae, M				Oda, S.; Shimoda, M.; Hirayama, A.; Imai, M.; Komatsu, F.; Shigematsu, H.; Nishiyama, J.; Matsumae, M.			Sentinel Headache: A Warning Sign Preceding Every Fourth Aneurysmal Subarachnoid Hemorrhage REPLY	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Letter									[Oda, S.; Shimoda, M.; Hirayama, A.; Imai, M.; Komatsu, F.; Shigematsu, H.; Nishiyama, J.] Tokai Univ, Hachioji Hosp, Dept Neurosurg, Tokyo 151, Japan; [Matsumae, M.] Tokai Univ, Sch Med, Dept Neurosurg, Hiratsuka, Kanagawa 25912, Japan	Oda, S (reprint author), Tokai Univ, Hachioji Hosp, Dept Neurosurg, Tokyo 151, Japan.						Jakobsson KE, 1996, J NEUROSURG, V85, P995, DOI 10.3171/jns.1996.85.6.0995; Oda S, 2015, AJNR AM J NEURORADIO	2	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2015	36	9					E64	E64		10.3174/ajnr.A4480		1	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CR0WO	WOS:000361044500004		
J	Toyoda, S; Inami, S; Kato, T; Tsukada, K; Nakamoto, A; Kikegawa, Y; Suzuki, A; Anraku, Y; Node, K; Inoue, T				Toyoda, Shigeru; Inami, Shu; Kato, Toru; Tsukada, Kinji; Nakamoto, Akiya; Kikegawa, Yoshinobu; Suzuki, Akihiro; Anraku, Yukitaka; Node, Koichi; Inoue, Teruo			Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake	AMERICAN JOURNAL OF THE MEDICAL SCIENCES			English	Article							CALCIUM-CHANNEL BLOCKER; II RECEPTOR ANTAGONIST; HIGH BLOOD-PRESSURE; ESSENTIAL-HYPERTENSION; JAPANESE SOCIETY; PLUS AMLODIPINE; KIDNEY-DISEASE; RENAL-FUNCTION; DIETARY SALT; PREVENTION	Background: It is unclear whether thiazide diuretics (TZs) or calcium channel blockers (CCBs) are more effective as add-on therapy to angiotensin receptor blockers (ARBs) in controlling hypertension. Because TZs are a rational choice in salt-sensitive hypertension, patients with high salt intake might preferentially benefit from ARB/TZ over ARB/CCB combination therapy. Methods: Hypertensive patients who failed to reach blood pressure goals despite treatment with ARBs alone were randomly assigned to receive either ARB/TZ or ARB/CCB combination therapy. Estimated daily sodium intake was calculated from spot urine values of sodium and creatinine. Results: Blood pressure was measured at baseline, and at 4, 8 and 12 weeks after starting combination therapy. For all study patients (n = 87), diastolic blood pressure reduction was greater in patients receiving ARB/CCB treatment. However, in the 37 patients with a baseline estimated daily salt intake greater than 10 g and baseline systolic blood pressure (SBP) ranging from 150 to 200 mm Hg, SBP was lower (P < 0.05) and SBP reduction was greater (P < 0.05) 4 weeks after starting combination therapy in those receiving ARB/TZ treatment. In the 31 patients whose estimated daily salt intake increased at 12 weeks compared with baseline, SBP at 12 weeks was lower in those receiving ARB/TZ treatment (P < 0.05). Conclusions: Estimated daily salt intake is a useful tool for guiding antihypertensive therapy and should be measured repeatedly during the therapeutic course.	[Toyoda, Shigeru; Inami, Shu; Inoue, Teruo] Dokkyo Med Univ, Dept Cardiovasc Med, Mibu, Tochigi 3210293, Japan; [Kato, Toru] Natl Hosp Org, Tochigi Med Ctr, Dept Clin Res, Utsunomiya, Tochigi, Japan; [Toyoda, Shigeru; Tsukada, Kinji; Nakamoto, Akiya; Kikegawa, Yoshinobu; Suzuki, Akihiro; Anraku, Yukitaka; Inoue, Teruo] Tochigi Med Assoc, Utsunomiya, Tochigi, Japan; [Node, Koichi] Saga Univ, Dept Cardiovasc Med, Saga 840, Japan	Toyoda, S (reprint author), Dokkyo Med Univ, Dept Cardiovasc Med, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	s-toyoda@dokkyomed.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; Matsui Y, 2009, HYPERTENSION, V54, P716, DOI 10.1161/HYPERTENSIONAHA.109.131466; Solomon SD, 2006, CIRCULATION, V114, P26, DOI 10.1161/CIRCULATIONAHA.105.592733; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Shimosawa T, 2007, HYPERTENS RES, V30, P831, DOI 10.1291/hypres.30.831; Ishimitsu T, 2009, HYPERTENS RES, V32, P962, DOI 10.1038/hr.2009.133; Sanada H, 2011, CURR HYPERTENS REP, V13, P55, DOI 10.1007/s11906-010-0167-6; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Engeli S, 2005, HYPERTENSION, V45, P356, DOI 10.1161/01.HYP.0000154361.47683.d3; Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236; Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Hoffmann IS, 2007, J HUM HYPERTENS, V21, P438, DOI 10.1038/sj.jhh.1002153; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Hasegawa H, 2013, HYPERTENS RES, V36, P776, DOI 10.1038/hr.2013.41; Ibuki Chikao, 2014, J Clin Med Res, V6, P8, DOI 10.4021/jocmr1649w; Ishimitsu T, 2011, CLIN EXP HYPERTENS, V33, P366, DOI 10.3109/10641963.2010.503299; Jamerson KA, 2011, HYPERTENSION, V57, P174, DOI 10.1161/HYPERTENSIONAHA.110.159939; Kato J, 2011, HYPERTENS RES, V34, P331, DOI 10.1038/hr.2010.233; Kawano Y, 2007, HYPERTENS RES, V30, P887, DOI 10.1291/hypres.30.887; Kim-Mitsuyama S, 2012, KIDNEY INT, V83, P167; Nishiwaki M, 2013, CLIN THER, V35, P461, DOI 10.1016/j.clinthera.2013.02.021; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218; Siragy H M, 1999, Curr Hypertens Rep, V1, P289, DOI 10.1007/s11906-999-0036-3; Siragy HM, 2000, AM J KIDNEY DIS, V36, pS4, DOI 10.1053/ajkd.2000.9684; Uzu T, 2006, J HYPERTENS, V24, P1627, DOI 10.1097/01.hjh.0000239299.71001.77; Weir MR, 1999, AM J HYPERTENS, V12, p205S, DOI DOI 10.1016/S0895-7061(99)00103-X; Zhou MS, 2006, J CARDIOVASC PHARM, V48, P857, DOI 10.1097/01.fjc.0000238598.09152.30	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0002-9629	1538-2990		AM J MED SCI	Am. J. Med. Sci.	SEP	2015	350	3					160	166		10.1097/MAJ.0000000000000529		7	Medicine, General & Internal	General & Internal Medicine	CQ7WW	WOS:000360817700002		
J	Sasaki, Y; Iwama, R; Shimamura, S; Katayama, M; Uzuka, Y; Yabe, K; Takasuna, K; Satoh, H; Furuhama, K				Sasaki, Yui; Iwama, Ryosuke; Shimamura, Shunsuke; Katayama, Masaaki; Uzuka, Yuji; Yabe, Koichi; Takasuna, Kiyoshi; Satoh, Hiroshi; Furuhama, Kazuhisa			Estimation of glomerular filtration rate in dogs by a single-blood sample method involving iodixanol	AMERICAN JOURNAL OF VETERINARY RESEARCH			English	Article							PLASMA-CLEARANCE; CONTRAST-MEDIA; IOHEXOL; CATS; CR-51-EDTA; CREATININE; AGREEMENT	OBJECTIVE To establish a simplified single-blood-sample method (SBSM) involving iodixanol to estimate glomerular filtration rate (GFR) in dogs and compare data provided by that procedure with data provided by a conventional multiple-blood-sample method (MBSM) involving inulin. ANIMALS 26 healthy dogs and 36 dogs with naturally occurring renal disease. PROCEDURES Dogs were used in various preliminary experiments to establish protocols for the SBSM and the MBSM of GFR estimation. To evaluate the relationship between GFRs obtained by the SBSM and the MBSM each involving iodixanol, iodixanol (40 mg of I/kg) was administered IV to 26 healthy dogs and 36 dogs with renal disease; blood sample collection was performed before and at 60, 90, and 120 minutes after the injection. To evaluate the relationship between GFRs obtained by the SBSM involving iodixanol and the MBSM involving inulin, iodixanol (40 mg of I/kg) and inulin (50 mg/kg) were coadministered IV to 22 healthy dogs and 3 dogs with renal disease, followed by blood sample collection 30, 60, 90, and 120 minutes later. Serum iodixanol and inulin concentrations were separately determined by reverse-phase high-performance liquid chromatography. RESULTS Findings revealed a correlation (r = 0.99) between GFR estimated by the SBSM and MBSM each involving iodixanol. Likewise, GFR estimated by the SBSM involving iodixanol was correlated (r = 0.89) with that estimated by the MBSM involving inulin. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that the SBSM involving iodixanol can be applied to estimate GFR in dogs, instead of use of an MBSM.	[Sasaki, Yui; Iwama, Ryosuke; Satoh, Hiroshi; Furuhama, Kazuhisa] Iwate Univ, Cooperat Dept Vet Basic Med, Morioka, Iwate 020, Japan; [Shimamura, Shunsuke; Katayama, Masaaki; Uzuka, Yuji] Iwate Univ, Vet Clin Med, Morioka, Iwate 020, Japan; [Yabe, Koichi; Takasuna, Kiyoshi] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo, Japan	Satoh, H (reprint author), Iwate Univ, Cooperat Dept Vet Basic Med, Morioka, Iwate 020, Japan.	satohsss@iwate-u.ac.jp					Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Varona JL, 2002, MATH INTELL, V24, P37; Katayama R, 2010, J PHARMACOL TOX MET, V61, P59, DOI 10.1016/j.vascn.2009.10.002; Heiene RD, 1998, J VET INTERN MED, V12, P401; Price GS, 1998, J VET INTERN MED, V12, P267; McCullough PA, 2006, J AM COLL CARDIOL, V48, P692, DOI 10.1016/j.jacc.2006.02.073; Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833; Bexfield NH, 2008, J VET INTERN MED, V22, P66, DOI 10.1111/j.1939-1676.2007.0035.x; BLAND JM, 1986, LANCET, V1, P307; Deming W E, 1964, STAT ADJUSTMENT DATA; Finco DR, 1995, J VET PHARMACOL THER, V18, P418, DOI 10.1111/j.1365-2885.1995.tb00619.x; Goy-Thollot I, 2006, J VET INTERN MED, V20, P52, DOI 10.1892/0891-6640(2006)20[52:SMFEOP]2.0.CO;2; GROTH S, 1981, CLIN PHYSIOL, V1, P417, DOI 10.1111/j.1475-097X.1981.tb00909.x; HARVEY JN, 1988, DIABETES RES CLIN EX, V9, P67; Heglund I F, 1995, Acta Radiol Suppl, V399, P69; Heiene R, 2009, AM J VET RES, V70, P176, DOI 10.2460/ajvr.70.2.176; Jacobsen PB, 1995, ACTA RADIOL, V36, P61; JACOBSSON L, 1983, CLIN PHYSIOL, V3, P297, DOI 10.1111/j.1475-097X.1983.tb00712.x; Japanese Association for Laboratory Animal Science, 1987, EXP ANIM, V3, P285; Karlsberg RP, 2010, J NEPHROL, V23, P658; Michigoshi Y, 2011, J AM ASSOC LAB ANIM, V50, P702; Miyamoto K, 2001, AM J VET RES, V62, P572, DOI 10.2460/ajvr.2001.62.572; Polzin D. J., 2005, TXB VET INTERNAL MED, VII, P1756; Ritschel WA, 1986, HDB BASIC PHARMACOKI, V3rd, P193; SMALE S, 1985, B AM MATH SOC, V13, P87, DOI 10.1090/S0273-0979-1985-15391-1; SVALAND MG, 1992, INVEST RADIOL, V27, P130, DOI 10.1097/00004424-199202000-00007; Tanaka T, 1992, INVEST RADIOL S1, V23, P195; Von Hendy-Willson VE, 2011, VET J, V188, P156, DOI 10.1016/j.tvjl.2010.05.006	28	0	0	AMER VETERINARY MEDICAL ASSOC	SCHAUMBURG	1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA	0002-9645	1943-5681		AM J VET RES	Am. J. Vet. Res.	SEP	2015	76	9					828	835				8	Veterinary Sciences	Veterinary Sciences	CQ9ZN	WOS:000360976800010		
J	Anazawa, T; Yokoi, T; Uchiho, Y				Anazawa, Takashi; Yokoi, Takahide; Uchiho, Yuichi			Side-Entry Laser-Beam Zigzag Irradiation of Multiple Channels in a Microchip for Simultaneous and Highly Sensitive Detection of Fluorescent Analytes	ANALYTICAL CHEMISTRY			English	Article							CAPILLARY-ARRAY ELECTROPHORESIS; FLOW-CYTOMETRY; CHIPS; MICROFLUIDICS; IMMUNOASSAY	A simple and highly sensitive technique for laser-induced fluorescence detection on multiple channels in a plastic microchip was developed, and its effectiveness was demonstrated by laser-beam ray-trace simulations and experiments. In the microchip, with refractive index n(C), A channels and B channels are arrayed alternately and respectively filled with materials with refractive indexes n(A) for electrophoresis analysis and n(B) for laser-beam control. It was shown that a laser beam entering from the side of the channel array traveled straight and irradiated all A channels simultaneously and effectively because the refractive actions by the A and B channels were counterbalanced according to the condition n(A) < n(C) < n(B). This technique is thus called "side-entry laser-beam zigzag irradiation". As a demonstration of the technique, when n(C) = 1.53, n(A) = 1.41, n(B) = 1.66, and the cross sections of both eight A channels and seven B channels were the same isosceles trapezoids with 97 degrees base angle, laser-beam irradiation efficiency on the eight A channels by the simulations was 89% on average and coefficient of variation was 4.4%. These results are far superior to those achieved by other conventional methods such as laser-beam expansion and scanning. Furthermore, fluorescence intensity on the eight A channels determined by the experiments agreed well with that determined by the simulations. Therefore, highly sensitive and uniform fluorescence detection on eight A channels was achieved. It is also possible to fabricate the microchips at low cost by plastic-injection molding and to make a simple and compact detection system, thereby promoting actual use of the proposed side-entry laser-beam zigzag irradiation in various fields.	[Anazawa, Takashi; Yokoi, Takahide; Uchiho, Yuichi] Hitachi Ltd, Res & Dev Grp, Kokubunji, Tokyo 1858601, Japan	Anazawa, T (reprint author), Hitachi Ltd, Res & Dev Grp, 1-280 Higashi Koigakubo, Kokubunji, Tokyo 1858601, Japan.	takashi.anazawa.rc@hitachi.com					Anazawa T, 1996, ANAL CHEM, V68, P2699, DOI 10.1021/ac9601831; Anazawa T, 1999, ELECTROPHORESIS, V20, P539, DOI 10.1002/(SICI)1522-2683(19990301)20:3<539::AID-ELPS539>3.0.CO;2-3; Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060; Huang NT, 2014, LAB CHIP, V14, P1230, DOI 10.1039/c3lc51211h; Dang FQ, 2005, ANAL CHEM, V77, P2140, DOI 10.1021/ac0485031; Skommer J, 2013, BIOSENS BIOELECTRON, V42, P586, DOI 10.1016/j.bios.2012.11.008; Tung YC, 2012, LAB CHIP, V12, P3552, DOI 10.1039/c2lc40509a; Scherer JR, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3502457; Ban E, 2013, J CHROMATOGR B, V929, P180, DOI 10.1016/j.jchromb.2013.04.028; Okagbare PI, 2009, ANALYST, V134, P97, DOI 10.1039/b816383a; Cheng SB, 2001, ANAL CHEM, V73, P1472, DOI 10.1021/ac0007938; Dang F, 2005, LAB CHIP, V5, P472, DOI 10.1039/b417398h; Emory JM, 2008, ANAL CHEM, V80, P3897, DOI 10.1021/ac800447x; Fredlake CP, 2008, P NATL ACAD SCI USA, V105, P476, DOI 10.1073/pnas.0705093105; Gai HW, 2011, TOP CURR CHEM, V304, P171, DOI 10.1007/128_2011_144; HUANG XHC, 1992, ANAL CHEM, V64, P2149, DOI 10.1021/ac00042a021; Huang Y, 2011, ANAL CHIM ACTA, V694, P162, DOI 10.1016/j.aca.2011.03.036; Huang Z, 1999, ANAL CHEM, V71, P5309, DOI 10.1021/ac990740u; KAMBARA H, 1988, BIO-TECHNOL, V6, P816, DOI 10.1038/nbt0788-816; Liu ZY, 2011, SENSORS-BASEL, V11, P10038, DOI 10.3390/s111110038; Nikcevic I, 2010, ELECTROPHORESIS, V31, P2796, DOI 10.1002/elps.201000030; Piyasena ME, 2014, LAB CHIP, V14, P1044, DOI 10.1039/c3lc51152a; Shi YN, 1999, ANAL CHEM, V71, P5354, DOI 10.1021/ac990518p; Shi YN, 2006, ELECTROPHORESIS, V27, P3703, DOI 10.1002/elps.200600129	24	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	SEP 1	2015	87	17					8623	8628		10.1021/acs.analchem.5b02222		6	Chemistry, Analytical	Chemistry	CQ7HH	WOS:000360773100006		
J	Rosenberg, BL; Shozugawa, K; Steinhauser, G				Rosenberg, Brett L.; Shozugawa, Katsumi; Steinhauser, Georg			Detection of Fuel Release in a Nuclear Accident: A Method for Preconcentration and Isolation of Reactor-Borne Np-239 Using Ion-Specific Extraction Chromatography	ANALYTICAL CHEMISTRY			English	Article							POWER-PLANT ACCIDENT; CHEMICAL-COMPOSITION; PLUTONIUM ISOTOPES; RAPID-DETERMINATION; PU ISOTOPES; FUKUSHIMA; RADIONUCLIDES; ACTINIDES; SAMPLES; ENVIRONMENT	Although actinides are the most informative, elements with respect to the nature of a nuclear accident, plutonium analysis is complicated by the background created by fallout from atmospheric nuclear explosions. Therefore, we propose Np-239, a short-lived actinide that emits several gamma rays, as a preferred proxy. The aim of this study was to screen ion specific extraction chromatography resins (RE-, TEVA-, UTEVA-, TRU-, and Actinide-Resin) for the highest possible recovery and separation of trace amounts of Np-239 from samples with large activities of fission products such as radiocesium, radioiodine, and, most importantly, radiotellurium, the latter of which causes spectral interference in gamma spectrometry through overlapping peaks with Np-239. The investigated environmental media for these separations were aqueous solutions simulating rainwater and soil. Spiked samples containing Np-239 and the aforementioned volatile radionuclides were separated through extraction chromatographic columns to ascertain the most effective means of separating Np-239 from other fission products for detection by gamma spectroscopy. We propose a method for nuclear accident preparedness based on the use of Eichrom's RE-Resin. The proposed method was found most effective for isolating Np-239 from interfering radionuclides in both aqueous solution and soil using 8 M HNO3 as the loading solution and H2O as the eluent. The RE-Resin outperforms the more commonly used TEVA-Resin because the TEVA-Resin showed a higher affinity for interfering radiotellurium and radioiodine.	[Rosenberg, Brett L.; Steinhauser, Georg] Colorado State Univ, Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Shozugawa, Katsumi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Steinhauser, G (reprint author), Leibniz Univ Hannover, Inst Radioecol & Radiat Protect, D-30419 Hannover, Germany.	georg.steinhauser@colostate.edu	Steinhauser, Georg/O-7283-2014	Steinhauser, Georg/0000-0002-6114-5890	CDC NIOSH Mountain and Plains Education and Research Center [T42OH009229-07]; U.S. Nuclear Regulatory Commission (NRC) [NRC-HQ-12-G-38-0044]	This study was supported by Grant Number T42OH009229-07 from the CDC NIOSH Mountain and Plains Education and Research Center. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC NIOSH and MAP ERC. The authors also gratefully acknowledges funding by the U.S. Nuclear Regulatory Commission (NRC), Grant Number NRC-HQ-12-G-38-0044. We thank James Self from the CSU Soil Testing Lab for the analysis of the deionized water.	Shaw G, 2007, RADIOACTIV ENVIRONM, V10, P127, DOI 10.1016/S1569-4860(06)10006-6; Evrard O, 2014, ENVIRON SCI TECHNOL, V48, P9334, DOI 10.1021/es501890n; Zhang NN, 2014, J ATMOS CHEM, V71, P157, DOI 10.1007/s10874-014-9288-7; Dai XX, 2012, J ANAL ATOM SPECTROM, V27, P126, DOI 10.1039/c1ja10264h; Maxwell SL, 2014, J RADIOANAL NUCL CH, V300, P1175, DOI 10.1007/s10967-014-3079-0; Bisinger T, 2010, NUCL INSTRUM METH B, V268, P1269, DOI 10.1016/j.nimb.2009.10.150; Hirose K, 2008, APPL RADIAT ISOTOPES, V66, P1675, DOI 10.1016/j.apradiso.2007.09.019; Steinhauser G, 2014, SCI TOTAL ENVIRON, V470, P800, DOI 10.1016/j.scitotenv.2013.10.029; Zheng J, 2013, J ANAL ATOM SPECTROM, V28, P1676, DOI 10.1039/c3ja50217a; Shozugawa K, 2012, ENVIRON POLLUT, V163, P243, DOI 10.1016/j.envpol.2012.01.001; Steinhauser G, 2014, ENVIRON SCI TECHNOL, V48, P4649, DOI 10.1021/es405654c; Bu WT, 2015, J RADIOANAL NUCL CH, V303, P1151, DOI 10.1007/s10967-014-3437-y; Bu WT, 2014, ENVIRON SCI TECHNOL, V48, P9070, DOI 10.1021/es502480y; Bu WT, 2013, BIOGEOSCIENCES, V10, P2497, DOI 10.5194/bg-10-2497-2013; Cagno S, 2014, ENVIRON SCI-PROC IMP, V16, P306, DOI 10.1039/c3em00531c; Dai XX, 2014, ANAL CHEM, V86, P5441, DOI 10.1021/ac500572g; Eichrom, 2001, EICHR METH NEPT THOR; Eichrom, 2006, AM NEPT PLUT THOR CU; Krey P. W., 1976, MASS ISOTOPIC COMPOS, P671; Marsac R, 2015, GEOCHIM COSMOCHIM AC, V152, P39, DOI 10.1016/j.gca.2014.12.021; Maxwell SL, 2015, J RADIOANAL NUCL CH, V305, P599, DOI 10.1007/s10967-015-3992-x; Maxwell SL, 2014, J RADIOANAL NUCL CH, V299, P1891, DOI 10.1007/s10967-013-2885-0; Mullaugh KM, 2013, ATMOS CHEM PHYS, V13, P2321, DOI 10.5194/acp-13-2321-2013; Paatero J, 2010, BOREAL ENVIRON RES, V15, P19; Perkins R. W., 1980, TRANSURANIC ELEMENTS, P53; Qiao JX, 2013, ANAL CHEM, V85, P11026, DOI 10.1021/ac402673p; Quinto F, 2015, ANAL CHEM, V87, P5766, DOI 10.1021/acs.analchem.5b00980; Reboul SH, 2002, ANAL BIOANAL CHEM, V374, P1096, DOI 10.1007/s00216-002-1566-6; Rosenberg B. L., J RADIOANAL NUCL CHE, DOI [10.1007/s10967-015-4376-y, DOI 10.1007/S10967-015-4376-Y]; Schneider S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02988; Tuerler A., 1988, RADIOCHIM ACTA, V43, P149; Wang ZT, 2015, ANAL CHEM, V87, P5511, DOI 10.1021/acs.analchem.5b01472; Xu ZF, 2015, ATMOS RES, V164, P278, DOI 10.1016/j.atmosres.2015.05.009; Zheng J, 2013, ENVIRON SCI TECHNOL, V47, P9584, DOI 10.1021/es402212v; Zheng J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00304	35	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	SEP 1	2015	87	17					8651	8656		10.1021/acs.analchem.5b02265		6	Chemistry, Analytical	Chemistry	CQ7HH	WOS:000360773100011		
J	Hirabayshi, K; Hanaoka, K; Takayanagi, T; Toki, Y; Egawa, T; Kamiya, M; Komatsu, T; Ueno, T; Terai, T; Yoshida, K; Uchiyama, M; Nagano, T; Urano, Y				Hirabayshi, Kazuhisa; Hanaoka, Kenjiro; Takayanagi, Toshio; Toki, Yuko; Egawa, Takahiro; Kamiya, Mako; Komatsu, Toni; Ueno, Tasuku; Terai, Takuya; Yoshida, Kengo; Uchiyama, Masanobu; Nagano, Tetsuo; Urano, Yasuteru			Analysis of Chemical Equilibrium of Silicon-Substituted Fluorescein and Its Application to Develop a Scaffold for Red Fluorescent Probes	ANALYTICAL CHEMISTRY			English	Article							CAPILLARY-ZONE-ELECTROPHORESIS; PROTOTROPIC EQUILIBRIA; IONIZATION-CONSTANTS; REPORTER GENES; DERIVATIVES; ABSORPTION; VALUES; ACID; PHOSPHATASES; INDICATORS	Fluorescein is a representative green fluorophore that has been widely used as a scaffold of practically useful green fluorescent probes. Here, we report synthesis and characterization of a silicon-substituted fluorescein, i.e., 2-COOH TokyoMagenta (2-COOH TM), which is a fluorescein analogue in which the 0 atom at the 10' position of the xanthene moiety of fluorescein is replaced with a Si atom. This fluorescein analogue forms a spirolactone ring via intramolecular nucleophilic attack of the carboxylic group in a pH-dependent manner. Consequently, 2-COOH TM exhibits characteristic large pH-dependent absorption and fluorescence spectral changes: (1) 2-COOH TM is colorless at acidic pH, whereas fluorescein retains observable absorption and fluorescence even at acidic pH, and the absorption maximum is also shifted; (2) the absorption spectral change occurs above pH 7.0 for 2-COOH TM and below pH 7.0 for fluorescein; (3) 2-COOH TM shows a much sharper pH response than fluorescein because of its pK(a) inversion, i.e., pK(a1) > pK(a2). These features are also different from those of a compound without the carboxylic group, 2-Me TokyoMagenta (2-Me TM). Analysis of the chemical equilibrium between pH 3.0 and 11.0 disclosed that 2-COOH TM favors the colorless and nonfluorescent lactone form, compared with fluorescein. Substitution of Cl atoms at the 4' and 5' positions of the xanthene moiety of 2-COOH TM to obtain 2-COOH DCTM shifted the equilibrium so that the new derivative exists predominantly in the strongly fluorescent open form at physiological pH (pH 7.4). To demonstrate the practical utility of 2-COOH DCTM as a novel scaffold for red fluorescent probes, we employed it to develop a probe for beta-galactosidase.	[Hirabayshi, Kazuhisa; Hanaoka, Kenjiro; Toki, Yuko; Egawa, Takahiro; Komatsu, Toni; Ueno, Tasuku; Terai, Takuya; Uchiyama, Masanobu; Urano, Yasuteru] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kamiya, Mako; Urano, Yasuteru] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Takayanagi, Toshio] Univ Tokushima, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan; [Nagano, Tetsuo] Univ Tokyo, Drug Discovery Initiat, Tokyo 1130033, Japan; [Yoshida, Kengo; Uchiyama, Masanobu] RIKEN, Riken Ctr Sustainable Resource Sci, Elements Chem Lab, Wako, Saitama 3510198, Japan; [Yoshida, Kengo; Uchiyama, Masanobu] RIKEN, Riken Ctr Sustainable Resource Sci, Adv Elements Chem Res Team, Wako, Saitama 3510198, Japan; [Kamiya, Mako; Komatsu, Toni] Japan Sci & Technol Agcy, PREST, Saitama 3320012, Japan; [Urano, Yasuteru] Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan	Hanaoka, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	khanaoka@mol.fu-tokyo.ac.jp; uranokun@m.u-tokyo.ac.jp			MEXT [22000006, 24689003, 24659042, 26104509, 24655147]; SENTAN, JST; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Asahi Glass Foundation; Takeda Science Foundation; Cosmetology Research Foundation	This work was supported in parts by MEXT (Specially Promoted Research Grant Nos. 22000006 to T.N., Grant Nos. 24689003, 24659042, and 26104509 to K. Hanaoka, and Grant Nos. 24655147 to T.K.), and SENTAN, JST to K. Hanaoka. K. Hanaoka was also supported by grants from Mochida Memorial Foundation for Medical and Pharmaceutical Research, The Naito Foundation, The Asahi Glass Foundation, Takeda Science Foundation and The Cosmetology Research Foundation. K. Hirabayashi was supported by a Grant-in-Aid for JSPS Fellows.	Ueno T, 2004, J AM CHEM SOC, V126, P14079, DOI 10.1021/ja048241k; Lavis LD, 2007, ANAL CHEM, V79, P6775, DOI 10.1021/ac070907g; Zhou KJ, 2012, J AM CHEM SOC, V134, P7803, DOI 10.1021/ja300176w; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Egawa T, 2013, ANGEW CHEM INT EDIT, V52, P3874, DOI 10.1002/anie.201210279; MINTA A, 1989, J BIOL CHEM, V264, P8171; Chen W, 2013, CHEM SCI, V4, P2892, DOI 10.1039/c3sc50754h; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Grimm JB, 2013, ACS CHEM BIOL, V8, P1303, DOI 10.1021/cb4000822; Jang YH, 2002, CHEM RES TOXICOL, V15, P1023, DOI 10.1021/tx010146r; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; BECKERS JL, 1991, J CHROMATOGR, V537, P407, DOI 10.1016/S0021-9673(01)88914-7; Naylor LH, 1999, BIOCHEM PHARMACOL, V58, P749, DOI 10.1016/S0006-2952(99)00096-9; Hirano T, 2000, J AM CHEM SOC, V122, P12399, DOI 10.1021/ja002467f; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; CHEN SC, 1979, CHEM PHARM BULL, V27, P475; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; ROTMAN B, 1966, P NATL ACAD SCI USA, V55, P134, DOI 10.1073/pnas.55.1.134; Mottram LF, 2006, ORG LETT, V8, P581, DOI 10.1021/ol052655g; Egawa T, 2011, CHEM COMMUN, V47, P4162, DOI 10.1039/c1cc00078k; TAMURA Z, 1994, BUNSEKI KAGAKU, V43, P339; Baeyer A., 1871, BER DTSCH CHEM GES, V4, P555, DOI 10.1002/cber.18710040209; Best QA, 2013, J AM CHEM SOC, V135, P13365, DOI 10.1021/ja401426s; Crovetto L, 2007, J PHYS CHEM A, V111, P13311, DOI 10.1021/jp077249o; Dean J., 1985, LANGES HDB CHEM; Fu MY, 2008, CHEM COMMUN, P1780, DOI 10.1039/b718544h; Huang Z, 1999, J BIOMOL SCREEN, V4, P327, DOI 10.1177/108705719900400608; Johnson I., 2010, MOL PROBES HDB GUIDE; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Klonis N, 1996, J Fluoresc, V6, P147, DOI 10.1007/BF00732054; Liu C. R., 2011, ANGEW CHEM, V123, P10511; MAEDA H, 1969, J BIOCHEM-TOKYO, V65, P777; MAURICE D. M., 1967, INVEST OPHTHALMOL, V6, P464; MCHEDLOVPETROSSYAN NO, 1992, J CHEM SOC FARADAY T, V88, P3025, DOI 10.1039/ft9928803025; Mchedlov-Petrossyan NO, 2010, J PHYS CHEM B, V114, P4551, DOI 10.1021/jp909854s; Mchedlov-Petrossyan NO, 2006, J PHYS ORG CHEM, V19, P365, DOI 10.1002/poc.1087; Mchedlov-Petrosyan NO, 2002, RUSS J GEN CHEM+, V72, P785, DOI 10.1023/A:1019524722318; Nanjiani M., 1991, FLUORESCEIN ANGIOGRA; PARKER CA, 1960, ANALYST, V85, P3, DOI 10.1039/an9608500003; POLYAKOVA IN, 1984, J STRUCT CHEM+, V25, P752; ROTMAN B, 1963, P NATL ACAD SCI USA, V50, P1; Schroder CR, 2005, ANALYST, V130, P907, DOI 10.1039/b501306b; SOUCHIER C, 1995, CYTOMETRY, V20, P203, DOI 10.1002/cyto.990200303; Spergel DJ, 2001, PROG NEUROBIOL, V63, P673, DOI 10.1016/S0301-0082(00)00038-1; Takayanagi T, 2001, CHEM LETT, P14, DOI 10.1246/cl.2001.14; Tamura A., 1996, ANAL SCI, V12, P927; Uchiyama S., 2009, CHEM COMMUN, V19, P2646; Yamaguchi S, 1998, J CHEM SOC DALTON, P3693, DOI 10.1039/a804491k; Zhang XF, 2008, PHOTOCH PHOTOBIO SCI, V7, P1079, DOI 10.1039/b801883a	50	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	SEP 1	2015	87	17					9061	9069		10.1021/acs.analchem.5b02331		9	Chemistry, Analytical	Chemistry	CQ7HH	WOS:000360773100064		
J	Tanaka, A; Suzuki, S; Ohta, S; Manabe, R; Furukawa, H; Kuwahara, N; Fukuda, Y; Kimura, T; Jinno, M; Hirai, K; Miyata, Y; Yamaguchi, M; Homma, T; Watanabe, Y; Yamamoto, M; Yokoe, T; Sagara, H				Tanaka, Akihiko; Suzuki, Shintaro; Ohta, Shin; Manabe, Ryo; Furukawa, Hitomi; Kuwahara, Naota; Fukuda, Yosuke; Kimura, Tomoyuki; Jinno, Megumi; Hirai, Kuniaki; Miyata, Yoshito; Yamaguchi, Munehiro; Homma, Tetsuya; Watanabe, Yoshio; Yamamoto, Mayumi; Yokoe, Takuya; Sagara, Hironori			Association between specific IgE to Staphylococcus aureus enterotoxins A and B and asthma control	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY			English	Article							SEVERE ATOPIC-DERMATITIS; ALLERGIC RHINITIS; IMMUNOGLOBULIN-E; AIRWAY DISEASE; SENSITIZATION; SUPERANTIGENS; ANTIBODIES; POPULATION; EXPOSURE; NASAL	Background: Recent studies have found that serum levels of Staphylococcus aureus enterotoxin (SE) eIgE are higher in patients with severe asthma compared with patients with nonsevere asthma. However, the association between SE-IgE and asthma control is not fully understood. Furthermore, SEA and SEB were the first reported SEs and subdivided into different groups. The influences of SEA-IgE and SEB-IgE on asthma control have not been elucidated. Objective: To determine the relevance of SEA-and SEB-IgE in patients with adult asthma and to investigate the association of SEA-IgE, SEB-IgE, and asthma control, respectively. Methods: The serum concentrations of SEA-and SEB-IgE in 172 adults with asthma were measured with a fluorescent enzyme immunoassay. Results: The prevalence of SEA-and SEB-IgE was 16.2% and 22.1%, respectively. Total IgE levels and the prevalence of atopic dermatitis were higher in SEA-IgE- and SEB-IgE-positive patients than in SEA-IgE- and SEB-IgE-negative patients, respectively; more SEA-IgE- and SEB-IgE-positive patients owned pets. Sensitization to SEA was associated with a younger mean age and a younger mean age at asthma onset. Multiple regression analysis indicated an association between total IgE levels and SEB-IgE. The prevalence of poorly uncontrolled asthma was significantly higher in SEA-IgE-positive patients than in SEA-IgE-negative patients. In addition, fractional exhaled nitric oxide levels were higher in SEA-IgE-positive patients than in SEA-IgE-negative patients. Logistic regression analysis also identified an association between SEA-IgE and poor asthma control. Conclusion: Our findings indicate that sensitization to SE, in particular SEA rather than SEB, is associated with poor asthma control in adults with asthma. (C) 2015 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.	[Tanaka, Akihiko; Suzuki, Shintaro; Ohta, Shin; Manabe, Ryo; Furukawa, Hitomi; Kuwahara, Naota; Fukuda, Yosuke; Kimura, Tomoyuki; Jinno, Megumi; Hirai, Kuniaki; Miyata, Yoshito; Yamaguchi, Munehiro; Homma, Tetsuya; Watanabe, Yoshio; Yamamoto, Mayumi; Yokoe, Takuya; Sagara, Hironori] Showa Univ, Div Resp Med & Allergol, Dept Med, Tokyo 1428666, Japan	Tanaka, A (reprint author), Showa Univ, Div Resp Med & Allergol, Dept Med, Sch Med,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	tanakaa@med.showa-u.ac.jp					American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P1107; Omoe K, 2013, INFECT IMMUN, V81, P3627, DOI 10.1128/IAI.00550-13; Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; Laouini D, 2003, J ALLERGY CLIN IMMUN, V112, P981, DOI 10.1067/mai.2003.1789; Song WJ, 2014, CLIN EXP ALLERGY, V44, P553, DOI 10.1111/cea.12239; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Bachert C, 2003, CURR ALLERGY ASTHM R, V3, P523, DOI 10.1007/s11882-003-0065-y; Huvenne W, 2013, INT ARCH ALLERGY IMM, V161, P304, DOI 10.1159/000350329; Semic-Jusufagic A, 2007, J ALLERGY CLIN IMMUN, V119, P930, DOI 10.1016/j.jaci.2006.12.639; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Hu DL, 2014, EUR J PHARMACOL, V722, P95, DOI 10.1016/j.ejphar.2013.08.050; Rohde G, 2004, RESP MED, V98, P858, DOI 10.1016/j.rmed.2004.02.012; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Huvenne W, 2010, ALLERGY, V65, P1013, DOI 10.1111/j.1398-9995.2009.02313.x; Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Herz U, 1999, EUR J IMMUNOL, V29, P1021, DOI 10.1002/(SICI)1521-4141(199903)29:03<1021::AID-IMMU1021>3.0.CO;2-3; Fokkens W, 2007, RHINOLOGY, P1; [Anonymous], 2004, NIHON KOKYUKI GAKK S, P1; Bernal A, 1999, J CLIN IMMUNOL, V19, P149, DOI 10.1023/A:1020547509410; Breuer K, 2000, ALLERGY, V55, P551, DOI 10.1034/j.1398-9995.2000.00432.x; Hellings PW, 2006, CLIN EXP ALLERGY, V36, P1063, DOI 10.1111/j.1365-2222.2006.02527.x; Huvenne W, 2010, CLIN EXP ALLERGY, V40, P1079, DOI 10.1111/j.1365-2222.2010.03464.x; Ide F, 2004, PEDIATR INT, V46, P337, DOI 10.1111/j.1442-200x.2004.01880.x; KAPPLER J, 1994, P NATL ACAD SCI USA, V91, P8462, DOI 10.1073/pnas.91.18.8462; Kowalski ML, 2011, ALLERGY, V66, P32, DOI 10.1111/j.1398-9995.2010.02379.x; Lee JH, 2005, INT ARCH ALLERGY IMM, V138, P305, DOI 10.1159/000088868; Leung AD, 2008, CLIN EXP ALLERGY, V38, P789, DOI 10.1111/j.1365-2222.2008.02964.x; Liu JN, 2014, ALLERGY ASTHMA IMMUN, V6, P263, DOI 10.4168/aair.2014.6.3.263; Nomura I, 1999, J ALLERGY CLIN IMMUN, V104, P441, DOI 10.1016/S0091-6749(99)70390-8; Okano M, 2001, AM J RHINOL, V15, P417; Roll Antonie, 2004, Curr Opin Allergy Clin Immunol, V4, P373, DOI 10.1097/00130832-200410000-00008; Rossi RE, 2004, INT ARCH ALLERGY IMM, V133, P261, DOI 10.1159/000076833; Saloga J, 1996, J INVEST DERMATOL, V106, P982, DOI 10.1111/1523-1747.ep12338479; Sundstrom M, 1996, EMBO J, V15, P6832; Tomassen P, 2013, ALLERGY, V68, P1289, DOI 10.1111/all.12230; WALSH GA, 1981, J CLIN MICROBIOL, V13, P1046	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1081-1206	1534-4436		ANN ALLERG ASTHMA IM	Ann. Allergy Asthma Immunol.	SEP	2015	115	3					191	+		10.1016/j.anai.2015.06.017		9	Allergy; Immunology	Allergy; Immunology	CQ9KS	WOS:000360934100009		
J	Yoneyama, M; Nomura, T; Kato, T; Sobajima, T; Tanida, H; Morishita, T; Sugiura, S; Suda, Y; Hirabayashi, Y; Misawa, C; Kamioka, N; Tanaka, H; Mizuno, M; Terada, A; Kanda, Y; Saitoh, S				Yoneyama, Mizuki; Nomura, Takayasu; Kato, Taisuke; Sobajima, Takehiro; Tanida, Hisashi; Morishita, Takehiro; Sugiura, Shiro; Suda, Yuichiro; Hirabayashi, Yasutaka; Misawa, Chieko; Kamioka, Naomi; Tanaka, Hidenori; Mizuno, Mihoko; Terada, Akihiko; Kanda, Yasushi; Saitoh, Shinji			Probability curves for predicting symptom severity during oral food challenge with milk	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY			English	Letter							IGE CONCENTRATIONS; ALLERGY; MANAGEMENT; EGG		[Yoneyama, Mizuki; Kamioka, Naomi] Nagoya City Univ, Nagoya City West Med Ctr, Dept Pediat, Nagoya, Aichi, Japan; [Nomura, Takayasu; Tanida, Hisashi; Kamioka, Naomi; Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan; [Kato, Taisuke] Gamagori City Hosp, Dept Pediat, Gamagori, Japan; [Sobajima, Takehiro] Seirei Mikatahara Gen Hosp, Dept Pediat, Hamamatsu, Shizuoka, Japan; [Tanida, Hisashi] Holy Spirit Hosp, Dept Pediat, Nagoya, Aichi, Japan; [Morishita, Takehiro] Shizuoka Saiseikai Gen Hosp, Dept Pediat, Shizuoka, Japan; [Sugiura, Shiro] Toyohashi Municipal Hosp, Dept Pediat, Toyohashi, Aichi, Japan; [Suda, Yuichiro] Miyoshi Municipal Hosp, Dept Pediat, Miyoshi, Japan; [Hirabayashi, Yasutaka] Hibarigaoka Kids Allergy Clin, Nagoya, Aichi, Japan; [Misawa, Chieko] Gifu Prefectural Tajimi Hosp, Dept Pediat, Tajimi, Japan; [Tanaka, Hidenori] Komaki City Hosp, Dept Pediat, Komaki, Japan; [Mizuno, Mihoko] Daido Hosp, Dept Pediat, Nagoya, Aichi, Japan; [Terada, Akihiko] Japanese Red Cross Nagoya Daini Hosp, Terada Kids Allergy & Asthma Clin, Nagoya, Aichi, Japan; [Kanda, Yasushi] Japanese Red Cross Nagoya Daini Hosp, Dept Pediat, Nagoya, Aichi, Japan	Yoneyama, M (reprint author), Nagoya City Univ, Nagoya City West Med Ctr, Dept Pediat, Nagoya, Aichi, Japan.	tnomura@med.nagoya-cu.ac.jp					Sampson HA, 2003, PEDIATRICS, V111, P1601; Komata T, 2007, J ALLERGY CLIN IMMUN, V119, P1272, DOI 10.1016/j.jaci.2007.01.038; Leonard SA, 2015, J ALLER CL IMM-PRACT, V3, P13, DOI 10.1016/j.jaip.2014.10.001; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Bird JA, 2015, J ALLER CL IMM-PRACT, V3, P1, DOI 10.1016/j.jaip.2014.06.008; Urisu A, 2014, ALLERGOL INT, V63, P399, DOI 10.2332/allergolint.14-RAI-0770; Nomura T, 2014, ANN ALLERG ASTHMA IM, V112, P556, DOI 10.1016/j.anai.2014.04.001; Santos AF, 2015, J ALLERGY CLIN IMMUN, V135, P179, DOI 10.1016/j.jaci.2014.09.001; Wood RA, 2011, PEDIATRICS, V129, P193	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1081-1206	1534-4436		ANN ALLERG ASTHMA IM	Ann. Allergy Asthma Immunol.	SEP	2015	115	3					251	253				4	Allergy; Immunology	Allergy; Immunology	CQ9KS	WOS:000360934100023		
J	Rylski, B; Siepe, M; Beyersdorf, F; Kari, FA; Grun, L; Desai, ND; Szeto, WY; Milewski, RK; Adachi, H; Kimura, N; Bavaria, JE				Rylski, Bartosz; Siepe, Matthias; Beyersdorf, Friedhelm; Kari, Fabian A.; Gruen, Linda; Desai, Nimesh D.; Szeto, Wilson Y.; Milewski, Rita K.; Adachi, Hideo; Kimura, Naoyuki; Bavaria, Joseph E.			Bicuspid Aortic Valve Resuspension in Acute Type A Aortic Dissection Patients	ANNALS OF THORACIC SURGERY			English	Article; Proceedings Paper	51st Annual Meeting of the Society-of-Thoracic-Surgeons	JAN 24-28, 2015	San Diego, CA	Soc Thorac Surg			SURGICAL APPROACH; FALSE LUMEN; REPAIR; DISEASE; SURGERY; ROOT; REPLACEMENT; VALSALVA; FATE	Background. There are no data on the fate of the preserved bicuspid aortic valve (BAV) in patients with acute type A aortic dissection. We investigated surgical outcomes in BAV patients who had undergone aortic valve resuspension versus replacement for dissection type A. Methods. Among 1,500 consecutive patients operated on for acute type A dissection between 1993 and 2013 at 3 tertiary centers, 66 had BAV (68% males, median age 60 +/- 15 years). Thirteen BAV resuspension patients were compared with 53 BAV replacement patients. Median follow-up was 5.0 +/- 4.7 years. Results. The ages of both groups were similar (resuspension 62 +/- 13 vs replacement 57 +/- 15 years, p = 0.62), and both presented similar risk-factor profiles. Moderate-to-severe aortic valve regurgitation was observed in 15% of the resuspension and 45% of the replacement patients (p = 0.06). Resuspension patients required shorter cardiopulmonary bypass and cross-clamp times (153 +/- 48 vs 224 +/- 76 min, p < 0.01; 106 +/- 33 vs 172 +/- 57 min, p < 0.01, respectively). In-hospital mortality was observed in 15.4% of the resuspension and 15.1% of the replacement patients (p = 1). One replacement patient underwent a proximal reoperation. The resuspension group experienced no severe aortic regurgitation, nor any need for proximal reintervention. Overall survival was 68% +/- 13% vs 65% +/- 7% at 5 years in resuspension and replacement groups, respectively (log-rank, p = 0.97). Conclusions. The BAV resuspension in type A dissection patients showed good short-and mid-term results. It is doable with acceptable results, and full root replacement is not always necessary. (C) 2015 by The Society of Thoracic Surgeons	[Rylski, Bartosz] Univ Freiburg, Ctr Heart, Dept Cardiovasc Surg, D-79106 Freiburg, Germany; Hosp Univ Penn, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; Saitama Med Ctr, Dept Cardiovasc Surg, Saitama, Japan	Rylski, B (reprint author), Univ Freiburg, Ctr Heart, Dept Cardiovasc Surg, Hugstetter Str 55, D-79106 Freiburg, Germany.	bartosz.rylski@universitaets-herzzentrum.de					Tanaka M, 2012, ANN THORAC CARDIOVAS, V18, P18, DOI 10.5761/atcs.oa.11.01704; Rylski B, 2014, J THORAC CARDIOV SUR, V148, P949, DOI 10.1016/j.jtcvs.2014.05.051; Akutsu K, 2004, EUR J CARDIO-THORAC, V26, P359, DOI 10.1016/j.ejcts.2004.03.026; Pape LA, 2007, CIRCULATION, V116, P1120, DOI 10.1161/CIRCULATIONAHA.107.702720; Braverman AC, 2005, CURR PROB CARDIOLOGY, V30, P470, DOI 10.1016/j.cpcardiol.2005.06.002; Park CB, 2011, J THORAC CARDIOV SUR, V142, P278, DOI 10.1016/j.jtcvs.2010.08.055; Rylski B, 2014, ANN THORAC SURG, V97, P1582, DOI 10.1016/j.athoracsur.2013.12.064; Dell'Aquila AM, 2013, J THORAC CARDIOV SUR, V146, P1456, DOI 10.1016/j.jtcvs.2012.09.049; Doss M, 2010, EUR J CARDIO-THORAC, V38, P523, DOI 10.1016/j.ejcts.2010.03.006; Etz CD, EUR J CARDIOTHORAC S; Kimura N, 2011, CIRC J, V75, P2135, DOI 10.1253/circj.CJ-10-1222; MAZZUCOTELLI JP, 1993, ANN THORAC SURG, V55, P1513; Nardi P, 2013, ANN THORAC SURG, V96, P1648, DOI 10.1016/j.athoracsur.2013.06.039; Park KH, 2009, ANN THORAC SURG, V87, P103, DOI 10.1016/j.athoracsur.2008.09.032; Rylski B, 2014, ANN THORAC SURG, V97, P1991, DOI 10.1016/j.athoracsur.2013.12.090; Rylski B, 2013, J THORAC CARDIOV SUR, V146, P285, DOI 10.1016/j.jtcvs.2012.07.013; Rylski B, 2014, EUR J CARDIO-THORAC, V46, P156, DOI 10.1093/ejcts/ezu251; Rylski B, 2014, J THORAC CARDIOV SUR, V148, P2981, DOI 10.1016/j.jtcvs.2014.05.093; Rylski B, 2014, ANN THORAC SURG, V98, P582, DOI 10.1016/j.athoracsur.2014.04.050; Wang YS, 2013, EUR J CARDIO-THORAC, V44, P172, DOI 10.1093/ejcts/ezs613	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					827	832		10.1016/j.athoracsur.2015.03.102		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600017		
J	Miyahara, S; Matsueda, T; Izawa, N; Yamanaka, K; Sakamoto, T; Nomura, Y; Morimoto, N; Inoue, T; Matsumori, M; Okada, K; Okita, Y				Miyahara, Shunsuke; Matsueda, Takashi; Izawa, Naoto; Yamanaka, Katsuhiro; Sakamoto, Toshihito; Nomura, Yoshikatsu; Morimoto, Naoto; Inoue, Takeshi; Matsumori, Masamichi; Okada, Kenji; Okita, Yutaka			Mid-Term Results of Valve-Sparing Aortic Root Replacement in Patients With Expanded Indications	ANNALS OF THORACIC SURGERY			English	Article; Proceedings Paper	51st Annual Meeting of the Society-of-Thoracic-Surgeons	JAN 24-28, 2015	San Diego, CA	Soc Thorac Surg			REIMPLANTATION TECHNIQUE; REPAIR; CUSP; RECONSTRUCTION; REGURGITATION; EXPERIENCE; OPERATION; PROLAPSE	Background. The mid-term results of valve-sparing aortic root reimplantation (VSRR) for various indications were investigated. Methods. From 2000 to 2013, 183 consecutive patients undergoing VSRR were enrolled. Expanded indications, defined as a patient on the marginal operative indication, included age 65 years or older (n = 33), age 15 years or younger (n = 4), acute type A aortic dissection (AAAD) (n = 21), aortitis (n = 8), reoperative root replacement (n = 11), cusp prolapse (n = 67), large aortoventricular junction of greater than 28 mm (AVJ) (n = 42), preoperative severe aortic regurgitation (AR) (n = 89), left ventricular ejection fraction 0.40 or less (n = 12), LV dilation (n = 66), New York Heart Association class III or greater (n = 5), need for total arch replacement (n = 29), and concomitant mitral valve repair (n = 12). Results. The overall survival at 5 years was 96.6%. Freedom from greater than mild AR and reoperation at 5 years was 85.8% and 92.9%, respectively. Cox proportional hazard model revealed that AAAD, cusp prolapse, AVJ 28 mm or greater, and operation before 2009 were at risk for late AR recurrence (p = 0.015, p = 0.0041, p = 0.032, and p = 0.014, respectively). After 2009, freedom from late AR in the cusp prolapse group improved (p = 0.055, versus control). Both freedom from recurrent AR and reoperation were worse as the number of expanded indications increased (log-rank trend p = 0.00017 and p = 0.00067, respectively). Conclusions. Surgical outcomes of VSRR in these patient cohorts were satisfactory with some room for improvement in patients with cusp prolapse. Although the indications for VSRR are being expanded, a larger number of expanded indications were associated with poor outcomes in terms of longevity of valve function. (C) 2015 by The Society of Thoracic Surgeons	[Miyahara, Shunsuke; Matsueda, Takashi; Izawa, Naoto; Yamanaka, Katsuhiro; Sakamoto, Toshihito; Nomura, Yoshikatsu; Morimoto, Naoto; Inoue, Takeshi; Matsumori, Masamichi; Okada, Kenji; Okita, Yutaka] Kobe Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Kobe, Hyogo 6500017, Japan	Okita, Y (reprint author), Kobe Univ, Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yokita@med.kobe-u.ac.jp					Amano Jun, 2013, Gen Thorac Cardiovasc Surg, V61, P578, DOI 10.1007/s11748-013-0289-2; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Schafers HJ, 2013, J THORAC CARDIOV SUR, V146, P269, DOI 10.1016/j.jtcvs.2012.06.053; Kvitting JPE, 2013, J THORAC CARDIOV SUR, V145, P117, DOI 10.1016/j.jtcvs.2012.09.013; Sharma V, 2014, J THORAC CARDIOV SUR, V147, P100, DOI 10.1016/j.jtcvs.2013.08.015; Subramanian S, 2012, ANN THORAC SURG, V94, P1230, DOI 10.1016/j.athoracsur.2012.04.094; de Kerchove L, 2011, ANN THORAC SURG, V92, P749, DOI 10.1016/j.athoracsur.2011.03.015; David TE, 2006, J THORAC CARDIOV SUR, V132, P347, DOI 10.1016/j.jtcvs.2006.03.053; David TE, 2011, J THORAC CARDIOV SUR, V141, P613, DOI 10.1016/j.jtcvs.2010.11.039; David TE, 2013, J THORAC CARDIOV SUR, V145, pS22, DOI 10.1016/j.jtcvs.2012.11.075; de Kerchove L, 2013, CIRCULATION S, V120, pS120; El Khoury G, 2004, EUR J CARDIO-THORAC, V26, P628, DOI 10.1016/j.ejcts.2004.05.027; Langer F, 2001, J THORAC CARDIOV SUR, V122, P270, DOI 10.1067/mtc.2001.114635; Liebrich M, 2013, ANN THORAC SURG, V95, P71, DOI 10.1016/j.athoracsur.2012.08.010; Matsumori Masamichi, 2007, Interact Cardiovasc Thorac Surg, V6, P177; Miyahara S, 2013, J HEART VALVE DIS, V22, P509; Oka T, 2011, ANN THORAC SURG, V92, P1639, DOI 10.1016/j.athoracsur.2011.06.080; Okita Y, 2012, J THORAC CARDIOV SUR, V144, P981, DOI 10.1016/j.jtcvs.2012.05.002; Patel ND, 2011, ANN THORAC SURG, V92, P556, DOI 10.1016/j.athoracsur.2011.04.003; Schafers HJ, 2006, J THORAC CARDIOV SUR, V132, P436, DOI 10.1016/j.jtcvs.2006.04.032; Schafers HJ, 2010, J THORAC CARDIOV SUR, V139, P660, DOI 10.1016/j.jtcvs.2009.06.025; Suzuki Shinichi, 2006, Ann Thorac Cardiovasc Surg, V12, P333; Tanaka H, 2011, ANN THORAC SURG, V92, P1646, DOI 10.1016/j.athoracsur.2011.06.090; Valo J, 2013, ANN THORAC SURG, V95, P579, DOI 10.1016/j.athoracsur.2012.08.079	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					845	852		10.1016/j.athoracsur.2014.09.091		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600020		
J	Omori, T; Tajiri, M; Baba, T; Ogura, T; Iwasawa, T; Okudela, K; Takemura, T; Oba, MS; Maehara, T; Nakayama, H; Tsuboi, M; Masuda, M				Omori, Takahiro; Tajiri, Michihiko; Baba, Tomohisa; Ogura, Takashi; Iwasawa, Tae; Okudela, Koji; Takemura, Tamiko; Oba, Mari S.; Maehara, Takamitsu; Nakayama, Haruhiko; Tsuboi, Masahiro; Masuda, Munetaka			Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia	ANNALS OF THORACIC SURGERY			English	Article							CRYPTOGENIC FIBROSING ALVEOLITIS; PROGNOSTIC-SIGNIFICANCE; SURVIVAL; MORTALITY; EXACERBATION; PIRFENIDONE; PREVALENCE; PREDICTORS; DIAGNOSIS; MORBIDITY	Background. After pulmonary resection, patients with lung cancer who have idiopathic pulmonary fibrosis (IPF) have been reported to have higher pulmonary morbidity and mortality and poorer outcomes than patients without IPF. However, whether morbidity, mortality, and outcomes differ according to the subtype of idiopathic interstitial pneumonia (IIP) remains unclear. Methods. The clinical records of 678 patients with non-small cell lung cancer who underwent pulmonary resection were reviewed retrospectively. A total of 103 patients had IIP and were classified into an IPF group and a non-IPF group in accordance with the 2011 statement. Results. The IPF group comprised 46 patients, and the non-IPF group comprised 57. The 5-year survival rate was significantly higher in the non-IPF group (53.2%) than in the IPF group (22.1%; p = 0.0093). Cause of death was IIP-related respiratory failure in 26.1% (12 of 46) of the patients in the IPF group as compared with 7.0% (4 of 57) of patients in the non-IPF group (p = 0.008). Multivariate Cox analysis indicated that IPF was a significant predictor of long-term survival (hazard ratio 1.910, 95% confidence interval: 1.102 to 3.313; p = 0.021). Conclusions. Idiopathic pulmonary fibrosis is independently associated with poorer overall survival in patients with lung cancer who undergo pulmonary resection. The decision whether to perform surgery in patients who have lung cancer with IIP should therefore take into account the subtype of IIP and the poorer outcomes associated with IPF. (C) 2015 by The Society of Thoracic Surgeons	Kanagawa Cardiovasc & Resp Ctr, Dept Thorac Surg, Yokohama, Kanagawa 2360051, Japan; Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa 2360051, Japan; Kanagawa Cardiovasc & Resp Ctr, Dept Radiol, Yokohama, Kanagawa 2360051, Japan; Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan; Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 232, Japan; Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan; Yokohama Rosai Hosp, Dept Thorac Surg, Yokohama, Kanagawa, Japan; Kanagawa Canc Ctr, Dept Thorac Surg, Yokohama, Kanagawa 2410815, Japan; Natl Canc Ctr Hosp East, Div Thorac Surg & Oncol, Kashiwa, Chiba, Japan	Omori, T (reprint author), Kanagawa Cardiovasc & Resp Ctr, Dept Thorac Surg, Kanazawa Ku, 6-16-1 Tomiokahiga Shi, Yokohama, Kanagawa 2360051, Japan.	taka-ohmori@cocoa.plala.or.jp					American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Flaherty KR, 2002, EUR RESPIR J, V19, P275, DOI 10.1183/09031936.02.00182002; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Perez ERF, 2010, CHEST, V137, P129, DOI 10.1378/chest.09-1002; Minegishi Y, 2009, INTERNAL MED, V48, P665, DOI 10.2169/internalmedicine.48.1650; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199; Kawasaki H, 2002, J SURG ONCOL, V81, P33, DOI 10.1002/jso.10145; Flaherty KR, 2003, THORAX, V58, P143, DOI 10.1136/thorax.58.2.143; King TE, 2001, AM J RESP CRIT CARE, V164, P1171; Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Ozawa Y, 2009, RESPIROLOGY, V14, P723, DOI 10.1111/j.1440-1843.2009.01547.x; Kumar P, 2003, J THORAC CARDIOV SUR, V125, P1321, DOI 10.1016/S0022-5223(03)00028-X; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P459, DOI 10.1164/rccm.201011-1790OC; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Nicholson AC, 2000, AM J RESP CRIT CARE, V162, P2213; Sato T, 2014, J THORAC CARDIOV SUR, V147, P1604, DOI 10.1016/j.jtcvs.2013.09.050; Rudd RM, 2007, THORAX, V62, P62, DOI 10.1136/thx.2005.045591; Watanabe A, 2008, J THORAC CARDIOV SUR, V136, P1357, DOI 10.1016/j.jtcvs.2008.07.016; Yokoyama A, 2006, RESPIROLOGY, V11, P164, DOI 10.1111/j.1440-1843.2006.00834.x; Saito Y, 2011, ANN THORAC SURG, V92, P1812, DOI 10.1016/j.athoracsur.2011.06.055; Fujimoto T, 2003, ANN THORAC SURG, V76, P1674, DOI 10.1016/S0003-4975(03)00966-4; Goto T, 2014, INT J CLIN ONCOL, V19, P266, DOI 10.1007/s10147-013-0566-1; Chiyo M, 2003, J THORAC CARDIOV SUR, V126, P1141, DOI 10.1016/S0022-5223(03)00791-8; Hiraki T, 2011, J THORAC CARDIOV SUR, V142, P24, DOI 10.1016/j.jtcvs.2011.02.036; Iwata T, 2014, SURG TODAY; Koizumi Kiyoshi, 2004, Ann Thorac Cardiovasc Surg, V10, P340; Omori T, 2015, ANN THORAC SURG, V100, P954, DOI 10.1016/j.athoracsur.2015.03.094; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL	32	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					954	960		10.1016/j.athoracsur.2015.03.094		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600035		
J	Yamada, Y; Yoshino, I; Nakajima, J; Miyoshi, S; Ohnuki, T; Suzuki, M; Nagayasu, T; Iwasaki, A; Okumura, M				Yamada, Yoshito; Yoshino, Ichiro; Nakajima, Jun; Miyoshi, Shinichiro; Ohnuki, Takamasa; Suzuki, Makoto; Nagayasu, Takeshi; Iwasaki, Akinori; Okumura, Meinoshin		Japanese Assoc Res Thymus	Surgical Outcomes of Patients With Stage III Thymoma in the Japanese Nationwide Database	ANNALS OF THORACIC SURGERY			English	Article							THYMIC TUMORS; ADJUVANT RADIATION; PROGNOSTIC-FACTORS; PHRENIC-NERVE; RECURRENCE; RESECTION; CHEMORADIOTHERAPY; PREDICTORS; INVASION; SURGERY	Background. To investigate the clinical characteristics and therapeutic outcomes of patients who underwent surgery for stage III thymoma in Japan. Methods. Using the Japanese nationwide database, which contains the records of 2,835 patients with thymic epithelial tumors who underwent treatment between 1991 and 2010, we extracted and analyzed the records of those who underwent surgery for stage III thymoma. Results. A total of 310 patients (170 males, 140 females; median age, 58 years) were analyzed. Involved sites were the lung in 194 (62.6%), the (pericardium in 151 (48.7%), the great vessels in 126 (40.6%), the phrenic nerve in 84 (27.1%), and the chest wall in 7 (2.3%). Complete resection (R0) was achieved in 247 (79.7%) cases. Induction therapies were administered to 42 (13.5%) patients, and postoperative therapies were administered to 147 (47.4%). In R0 cases, 68 (27.5%) experienced recurrence. The pleural space was the most frequent site of recurrence (46; 18.6%). The 10-year overall and disease-free (in R0) survival rates were 80.2% and 51.6%, respectively. Multivariate analyses revealed that age (p = 0.002), male sex (p = 0.017), induction therapy (p < 0.001), and type B histology (p = 0.037) were independent adverse predictors for overall survival. Chest wall invasion was the only independent adverse predictor for disease-free survival, although the factor analysis was marginal for overall survival. Conclusions. The outcomes of surgery for patients with stage III thymoma were favorable unless chest wall invasion was present; however, the role of complete resection and appropriate multimodal treatment plan require further investigation. (C) 2015 by The Society of Thoracic Surgeons	Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan; Univ Tokyo, Dept Cardiothorac Surg, Tokyo, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Thorac Surg, Okayama, Japan; Tokyo Womens Med Univ, Sch Med, Dept Surg 1, Tokyo, Japan; Kumamoto Univ, Grad Sch Med Sci, Dept Thorac Surg, Kumamoto, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki 852, Japan; Fukuoka Univ, Sch Med, Dept Gen Thorac Breast & Pediat Surg, Fukuoka 81401, Japan; Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan	Yamada, Y (reprint author), Univ Zurich Hosp, Div Thorac Surg, CH-8091 Zurich, Switzerland.	yoshito.yamada@usz.ch					Korst RJ, 2014, J THORAC CARDIOV SUR, V147, P36, DOI 10.1016/j.jtcvs.2013.08.061; Regnard JF, 1996, J THORAC CARDIOV SUR, V112, P376, DOI 10.1016/S0022-5223(96)70265-9; Utsumi T, 2008, J THORAC CARDIOV SUR, V136, P1481, DOI 10.1016/j.jtcvs.2008.05.012; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Venuta F, 2003, ANN THORAC SURG, V76, P1866, DOI 10.1016/S0003-4975(03)01020-8; Mangi AA, 2005, ANN THORAC SURG, V79, P1834, DOI 10.1016/j.athoracsur.2004.12.051; Haniuda M, 2001, J SURG ONCOL, V78, P183, DOI 10.1002/jso.1146; Margaritora S, 2010, ANN THORAC SURG, V89, P245, DOI 10.1016/j.athoracsur.2009.08.074; Wu KL, 2009, CANCER INVEST, V27, P1008, DOI 10.3109/07357900802563002; Wright CD, 2008, ANN THORAC SURG, V85, P385, DOI 10.1016/j.athoracsur.2007.08.051; Wright CD, 2005, J THORAC CARDIOV SUR, V130, P1413, DOI 10.1016/j.jtcvs.2005.07.026; Okumura M, 1999, J THORAC CARDIOV SUR, V117, P605; Filosso PL, 2014, EUR J CARDIO-THORAC, V45, P1020, DOI 10.1093/ejcts/ezt567; Hamaji M, 2013, ASIAN CARDIOVASC THO, V22, P712; Hamdi S, 2014, EUR J CARDIO-THORAC, V45, pE151, DOI 10.1093/ejcts/ezu025; Korst RJ, 2014, J THORAC CARDIOVASC, V147; Marulli Giuseppe, 2011, Eur J Cardiothorac Surg, V39, pe1, DOI 10.1016/j.ejcts.2010.11.026; Marx A, 2004, PATHOLOGY GENETICS T, P152; Okereke IC, 2010, ANN THORAC SURG, V89, P1071, DOI 10.1016/j.athoracsur.2010.01.026; Omasa M, 2015, CANCER-AM CANCER SOC, V121, P1008, DOI 10.1002/cncr.29166; Ruffini E, 2014, EUR J CARDIO-THORAC, V46, P361, DOI 10.1093/ejcts/ezt649; Weksler B, 2012, ANN THORAC SURG, V93, P1822, DOI 10.1016/j.athoracsur.2012.03.004; Yano M, 2010, ANN THORAC SURG, V89, P1612, DOI 10.1016/j.athoracsur.2010.01.057	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					961	967		10.1016/j.athoracsur.2015.04.059		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600036		
J	Motoishi, M; Okamoto, K; Kaku, R; Sawai, S; Hanaoka, J				Motoishi, Makoto; Okamoto, Keigo; Kaku, Ryosuke; Sawai, Satoru; Hanaoka, Jun			Thymoma-Associated Graft-Versus-Host-Like Disease With Skin Manifestations Improved by Complete Resection of Thymoma	ANNALS OF THORACIC SURGERY			English	Editorial Material							MALIGNANT THYMOMA; COLITIS	A 69-year-old woman with refractory skin eruptions, which had first appeared 3 years previously, was examined, and an anterior mediastinal tumor was detected. The tumor was resected, and a diagnosis of type B2 thymoma, stage III disease (according to the World Health Organization classification), was made. Retrospectively, histologic findings of the skin before the operation were consistent with graft-versus-host disease. The final diagnosis of her skin lesions was thymoma-associated graft-versus-host-like disease. The skin lesions improved gradually during the 1-month period after resection with only a topical steroid, and further improvement was seen at 3 months. (C) 2015 by The Society of Thoracic Surgeons	Natl Hosp Org, Kyoto Med Ctr, Dept Thorac Surg, Kyoto, Japan; Shiga Univ Med Sci, Dept Thorac Surg, Shiga, Japan	Motoishi, M (reprint author), 1-1 Fukakusamukaihata Cho,Fushimi Ku, Kyoto 6128555, Japan.	mmotoish@kyotolan.hosp.go.jp					Holder J, 1997, CLIN EXP DERMATOL, V22, P287, DOI 10.1046/j.1365-2230.1997.2750703.x; Fujii Y, 2013, SURG TODAY, V43, P461, DOI 10.1007/s00595-012-0318-2; Wadhera A, 2007, J AM ACAD DERMATOL, V57, P683, DOI 10.1016/j.jaad.2007.02.027; Sader C, 2002, ANN THORAC SURG, V73, P1947, DOI 10.1016/S0003-4975(01)03505-6; KORNACKI S, 1995, AM J SURG PATHOL, V19, P224, DOI 10.1097/00000478-199502000-00011	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					1078	1080		10.1016/j.athoracsur.2014.10.080		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600051		
J	Cho, T; Tokunaga, S; Yasuda, S; Izubuchi, R; Masuda, M				Cho, Tomoki; Tokunaga, Shigehiko; Yasuda, Shota; Izubuchi, Ryo; Masuda, Munetaka			Exophytic Atheroma Mimicking Papillary Fibroelastoma Adjacent to the Aortic Valve	ANNALS OF THORACIC SURGERY			English	Editorial Material							ASCENDING AORTA; THORACIC AORTA; THROMBUS; ARCH	Follow-up echocardiography in a 69-year-old man with alcoholic cardiomyopathy showed a mass above the aortic valve near the left coronary ostium. Transesophageal echocardiography and computed tomography suggested a papillary fibroelastoma with a high risk of embolism. At operation we found an exophytic atheroma adjacent to the left coronary artery orifice. The atheroma was removed, and the patient made an uneventful recovery. We describe this very rare case of an exophytic atheroma mimicking a papillary fibroelastoma situated at the left coronary orifice. (C) 2015 by The Society of Thoracic Surgeons	Kanagawa Cardiovasc & Resp Ctr, Dept Cardiovasc Surg, Yokohama, Kanagawa, Japan; Yokohama City Univ, Med Ctr, Dept Cardiovasc Ctr, Yokohama, Kanagawa 232, Japan; Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan	Tokunaga, S (reprint author), Kanagawa Cardiovasc & Resp Ctr, Kanazawa Ku, 6-16-1 Tomioka Higashi, Yokohama, Kanagawa, Japan.	tokunaga@kanagawa-junko.jp					Tunick PA, 2000, J AM COLL CARDIOL, V35, P545, DOI 10.1016/S0735-1097(99)00604-X; Hisagi Motoyuki, 2007, Gen Thorac Cardiovasc Surg, V55, P38; Montgomery DH, 1996, J AM COLL CARDIOL, V27, P95, DOI 10.1016/0735-1097(95)00431-9; Roth M, 2001, EUR J CARDIO-THORAC, V19, P534, DOI 10.1016/S1010-7940(01)00636-4; Sabetai MM, 2013, INTERACT CARDIOV TH, V16, P389, DOI 10.1093/icvts/ivs490; Sodian R, 2002, ANN THORAC SURG, V74, P588, DOI 10.1016/S0003-4975(02)03628-7; SWANSON SJ, 1995, ANN THORAC SURG, V60, P457, DOI 10.1016/0003-4975(95)00166-I	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					1080	1082		10.1016/j.athoracsur.2014.11.057		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600052		
J	Kikuchi, K; Une, D; Endo, Y; Matsuyama, T; Fukada, Y; Kurata, A				Kikuchi, Keita; Une, Dai; Endo, Yoshiki; Matsuyama, Takayoshi; Fukada, Yasuhisa; Kurata, Atsushi			Minimally Invasive Coronary Artery Bypass Grating Using Bilateral In Situ Internal Thoracic Arteries	ANNALS OF THORACIC SURGERY			English	Editorial Material								When performing minimally invasive coronary artery bypass grafting (MICS CABG), it is difficult to access the right internal thoracic artery (ITA) under direct vision. We successfully performed off-pump MICS CABG using the bilateral in situ ITAs through a 8-cm left thoracotomy under direct vision for a 76-year-old man. His postoperative course was uneventful and all the grafts were patent. This novel, minimally invasive approach safely preserves the sternum and delivers the benefits of bilateral in situ ITA grafting, providing an alternative to conventional CABG and off-pump CABG. (C) 2015 by The Society of Thoracic Surgeons	[Kikuchi, Keita; Une, Dai; Endo, Yoshiki; Matsuyama, Takayoshi; Fukada, Yasuhisa; Kurata, Atsushi] Yamato Seiwa Hosp, Div Cardiovasc Surg, Yamato, Kanagawa 2420006, Japan	Kikuchi, K (reprint author), Yamato Seiwa Hosp, Div Cardiovasc Surg, 9-8-2 Minami Rinkan, Yamato, Kanagawa 2420006, Japan.	k-kikuchi@seiwa.or.jp					Kinoshita T, 2011, CIRCULATION, V124, pS130, DOI 10.1161/CIRCULATIONAHA.110.010892; Ruel M, 2013, CURR OPIN CARDIOL, V28, P639, DOI 10.1097/HCO.0b013e3283653fd1; Bonaros N, 2013, ANN THORAC SURG, V95, P803, DOI 10.1016/j.athoracsur.2012.09.071; McGinn JT, 2009, CIRCULATION, V120, pS78, DOI 10.1161/CIRCULATIONAHA.108.840041; Une Dai, 2013, Innovations (Phila), V8, P403, DOI 10.1097/IMI.0000000000000019	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					1082	1084		10.1016/j.athoracsur.2014.11.056		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600053		
J	Takahashi, Y; Sasaki, Y; Kato, Y; Motoki, M; Bito, Y; Morisaki, A; Miyabe, M; Inno, G				Takahashi, Yosuke; Sasaki, Yasuyuki; Kato, Yasuyuki; Motoki, Manabu; Bito, Yasuyuki; Morisaki, Akimasa; Miyabe, Makoto; Inno, Gouki			Less-Invasive Endovascular Treatment of Arch Aneurysm With Aberrant Right Subclavian Artery	ANNALS OF THORACIC SURGERY			English	Editorial Material							CHIMNEY	We report a patient with an arch aneurysm with an aberrant right subclavian artery who underwent successful endovascular treatment with the chimney technique and bilateral carotid artery-to-subclavian artery bypasses. We used a chimney graft in the left carotid artery to preserve its flow. The bilateral carotid-to-subclavian artery bypasses preserved perfusion of the bilateral vertebral arteries. A thoracic stent graft was subsequently deployed in the aortic arch over the chimney graft of the left carotid artery. There have been few reports about less-invasive treatment for arch aneurysm with aberrant right subclavian artery. This technique was an effective strategy to avoid a high-risk open operation. (C) 2015 by The Society of Thoracic Surgeons	[Takahashi, Yosuke; Sasaki, Yasuyuki; Kato, Yasuyuki; Motoki, Manabu; Bito, Yasuyuki; Morisaki, Akimasa; Miyabe, Makoto; Inno, Gouki] Osaka City Gen Hosp, Dept Cardiovasc Surg, Osaka 5640021, Japan	Takahashi, Y (reprint author), Osaka City Gen Hosp, Dept Cardiovasc Surg, Miyakojima Ku, 2-13-22 Hondori Miyakojima, Osaka 5640021, Japan.	ysk@msic.med.osaka-cu.ac.jp					Bisognano JD, 1997, CHEST, V112, P1693, DOI 10.1378/chest.112.6.1693; Corral JS, 2003, J VASC INTERV RADIOL, V14, P789, DOI 10.1097/01.RVI.0000079990.80153.FE; Davidian M, 1998, J VASC SURG, V28, P335, DOI 10.1016/S0741-5214(98)70169-7; Hata H, 2012, ANN THORAC SURG, V94, P1362, DOI 10.1016/j.athoracsur.2012.05.126; Kiokawa K, 2007, ANN THORAC SURG, V83, pE3, DOI 10.1016/j.athoracsur.2006.10.045; Lacroix V, 2003, J ENDOVASC THER, V10, P190, DOI 10.1583/1545-1550(2003)010<0190:ETOAAA>2.0.CO;2; Samura M, 2014, ANN THORAC SURG, V97, P315, DOI 10.1016/j.athoracsur.2013.05.094; Vicente S, 2014, J ENDOVASC THER, V21, P123, DOI 10.1583/13-4434R.1	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					1089	1091		10.1016/j.athoracsur.2014.10.081		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600056		
J	Wakida, K; Watanabe, Y; Kumasaka, T; Seyama, K; Mitani, K; Hiraki, T; Kamimura, G; Nagata, T; Nakamura, Y; Sato, M				Wakida, Kazuhiro; Watanabe, Yui; Kumasaka, Toshio; Seyama, Kuniaki; Mitani, Keiko; Hiraki, Tsubasa; Kamimura, Go; Nagata, Toshiyuki; Nakamura, Yoshihiro; Sato, Masami			Lymphangioleiomyomatosis in a Male	ANNALS OF THORACIC SURGERY			English	Editorial Material							TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOLEIOMYOMATOSIS	We report a 17-year-old male with a histopathologic diagnosis of lymphangioleiomyomatosis after surgery for a pneumothorax. In general, lymphangioleiomyomatosis has been considered a female-specific disease. However, there are a few lymphangioleiomyomatosis cases reported in males, and our patient is the youngest case reported. Spontaneous pneumothorax occurs most commonly in males in their late teens and early twenties. Histopathologic diagnosis cannot always be performed in young males with pneumothorax. However, simple diagnosis should be avoided, and lymphangioleiomyomatosis should be considered as an underlying disease. This remarkable case provides new and valuable clinical insights into young male pneumothorax. (C) 2015 by The Society of Thoracic Surgeons	[Watanabe, Yui] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Gen Thorac Surg, Kagoshima 8908570, Japan; Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan; Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan; Juntendo Univ, Grad Sch Med, Div Resp Med, Tokyo, Japan; Juntendo Univ, Fac Med, Dept Human Pathol, Tokyo, Japan; Juntendo Univ, Grad Sch Med, Dept Human Pathol, Tokyo, Japan; Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Kagoshima 8908570, Japan	Watanabe, Y (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Gen Thorac Surg, 8-35-1 Sakuragaoka, Kagoshima 8908570, Japan.	yuiw@mac.com					McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Adriaensen MEAPM, 2011, CLIN RADIOL, V66, P625, DOI 10.1016/j.crad.2011.02.009; Schiavina M, 2007, AM J RESP CRIT CARE, V176, P96, DOI 10.1164/rccm.200610-1408CR; Aubry MC, 2000, AM J RESP CRIT CARE, V162, P749; Kim NR, 2003, PATHOL INT, V53, P231, DOI 10.1046/j.1320-5463.2003.01460.x; Miyake Mototaka, 2005, Radiat Med, V23, P525; Pigula FA, 1997, ANN THORAC SURG, V64, P1630, DOI 10.1016/S0003-4975(97)00930-2; Taveira-DaSilva Angelo M, 2006, Cancer Control, V13, P276	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					1105	1107		10.1016/j.athoracsur.2014.11.069		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600063		
J	Watanabe, Y; Shibuya, J; Handa, M; Watanabe, T; Notsuda, H; Saito, R; Hatanaka, K; Okada, Y; Sato, M; Kondo, T				Watanabe, Yui; Shibuya, Jotaro; Handa, Masashi; Watanabe, Tatsuaki; Notsuda, Hirotsugu; Saito, Ryoko; Hatanaka, Kazuhito; Okada, Yoshinori; Sato, Masami; Kondo, Takashi			Unilateral Absence of the Right Pulmonary Artery Accompanied by Right Lung Cancer	ANNALS OF THORACIC SURGERY			English	Editorial Material									Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Sendai, Miyagi 9808575, Japan; Iwate Prefectural Isawa Hosp, Dept Thorac Surg, Oshu, Japan; Tohoku Univ, Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Pathol, Kagoshima 890, Japan; Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Gen Thorac Surg, Kagoshima 890, Japan	Watanabe, Y (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yuiw@mac.com					Ito M, 2010, ANN THORAC SURG, V90, pE6, DOI 10.1016/j.athoracsur.2010.03.097	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					1113	1113		10.1016/j.athoracsur.2015.05.106		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600067		
J	Kimura, S; Yonekura, R; Umesue, M				Kimura, Satoshi; Yonekura, Ryusuke; Umesue, Masayoshi			Angiosarcoma Mimicking an Infected Pseudoaneurysm After Graft Replacement	ANNALS OF THORACIC SURGERY			English	Editorial Material									[Kimura, Satoshi; Yonekura, Ryusuke; Umesue, Masayoshi] Matsuyama Red Cross Hosp, Dept Cardiovasc Surg, Matsuyama, Ehime 7908524, Japan	Kimura, S (reprint author), Matsuyama Red Cross Hosp, Dept Cardiovasc Surg, 1 Bunkyo Cho, Matsuyama, Ehime 7908524, Japan.	sakimura@heart.med.kyushu-u.ac.jp					FEHRENBACHER JW, 1981, ANN THORAC SURG, V32, P297; Okada M, 2004, J THORAC CARDIOV SUR, V127, P1843, DOI 10.1016/j.jtcvs.2004.01.021	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					1114	1114		10.1016/j.athoracsur.2015.05.084		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600068		
J	Fujiwara, H; Shiozaki, A; Konishi, H; Kosuga, T; Komatsu, S; Ichikawa, D; Okamoto, K; Otsuji, E				Fujiwara, Hitoshi; Shiozaki, Atsushi; Konishi, Hirotaka; Kosuga, Toshiyuki; Komatsu, Shuhei; Ichikawa, Daisuke; Okamoto, Kazuma; Otsuji, Eigo			Single-Port Mediastinoscopic Lymphadenectomy Along the Left Recurrent Laryngeal Nerve	ANNALS OF THORACIC SURGERY			English	Editorial Material							TRANSHIATAL ESOPHAGECTOMY; CANCER	We herein describe a single-port mediastinoscopic method for upper mediastinal dissection in esophageal cancer surgery. After the left cervical incision and lymphadenectomy, a Lap-Protector (Hakko, Tokyo, Japan) was inserted into the wound and an EZ Access port (Hakko) was attached. Esophageal mobilization with en bloc lymphadenectomy along the left recurrent laryngeal nerve was then performed using a port-in-port technique with conventional flexible laparoscopy. Carbon dioxide insufflation expanded the intramediastinal space, and minute structures in the deep mediastinum around the aortic arch, such as nerves, bronchial arteries, and lymphatic vessels, were clearly visualized, allowing lymphadenectomy to be safely and carefully performed along the nerve. (C) 2015 by The Society of Thoracic Surgeons	[Fujiwara, Hitoshi; Shiozaki, Atsushi; Konishi, Hirotaka; Kosuga, Toshiyuki; Komatsu, Shuhei; Ichikawa, Daisuke; Okamoto, Kazuma; Otsuji, Eigo] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto 6028566, Japan	Fujiwara, H (reprint author), Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	hfuji@koto.kpu-m.ac.jp					Feng MX, 2012, SURG ENDOSC, V26, P1573, DOI 10.1007/s00464-011-2073-7; Froghi F, 2010, SURG LAPARO ENDO PER, V20, P191, DOI 10.1097/SLE.0b013e3181ed86c6; BUMM R, 1993, ANN SURG, V218, P97, DOI 10.1097/00000658-199307000-00015; Fujiwara H, 2014, DIS ESOPHAGUS; Leschber G, 2003, EUR J CARDIO-THORAC, V24, P192, DOI 10.1016/S1010-7940(03)00253-7; Sobin LH, 2009, TNM CLASSIFICATION M; Tangoku A, 2004, SURG ENDOSC, V18, P383, DOI 10.1007/s00464-003-8181-2; Udagawa H, 2012, J SURG ONCOL, V106, P742, DOI 10.1002/jso.23122	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					1115	1117		10.1016/j.athoracsur.2015.03.122		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600069		
J	Fuchigami, T; Nishioka, M; Akashige, T; Nagata, N				Fuchigami, Tai; Nishioka, Masahiko; Akashige, Toru; Nagata, Nobuhiro			A Surgical Integration Technique for Right-Sided and Left-Sided Superior Venae Cavae	ANNALS OF THORACIC SURGERY			English	Article							LEFT ATRIUM	The treatment of some subsets of patients having both right-sided superior vena cava (SVC) and left-sided SVC may be very challenging. We performed the SVC integration (SVCI) technique with end-to-side anastomoses between the two SVCs on 4 such patients (age, 5 to 11 months; body weight, 5.4 to 10.2 kg) with excellent outcomes. In 2 patients, we performed intrapulmonary artery septation with SVCI; in 1 patient, pulmonary artery sling repair with SVCI; and in 1 patient with supramitral stenosis related to persistent left-sided SVC, repeated Blalock-Taussig shunt (BTS) with SVCI. Our SVCI technique is very useful in specific cases (eg, in candidates for the Fontan procedure. (C) 2015 by The Society of Thoracic Surgeons	[Fuchigami, Tai] Okinawa Prefectural Nanbu Med Ctr, Dept Pediat Cardiovasc Surg, Haebaru, Okinawa 9011193, Japan; [Fuchigami, Tai] Childrens Med Ctr, Haebaru, Okinawa 9011193, Japan	Fuchigami, T (reprint author), Okinawa Prefectural Nanbu Med Ctr, Dept Pediat Cardiovasc Surg, Arakawa 118-1, Haebaru, Okinawa 9011193, Japan.	taifuchigami@yahoo.co.jp					Reddy VM, 1997, ANN THORAC SURG, V63, P1800, DOI 10.1016/S0003-4975(97)83867-2; Sakamoto Kisaburo, 2007, Interact Cardiovasc Thorac Surg, V6, P150; van Son JAM, 1998, ANN THORAC SURG, V65, P280, DOI 10.1016/S0003-4975(97)01267-8; Zimand S, 1999, ANN THORAC SURG, V68, P1869, DOI 10.1016/S0003-4975(99)01037-1	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					E63	E65		10.1016/j.athoracsur.2015.05.042		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600006		
J	Tabata, M; Hiraiwa, N; Kawano, Y; Nakatsuka, D; Hoshino, S				Tabata, Minoru; Hiraiwa, Nobuhiko; Kawano, Yuji; Nakatsuka, Daisuke; Hoshino, Satoshi			A Simple, Effective, and Inexpensive Technique for Exposure of Papillary Muscles in Minimally Invasive Mitral Valve Repair: Wakka Technique	ANNALS OF THORACIC SURGERY			English	Article								Obtaining excellent exposure of the papillary muscles is challenging in minimally invasive mitral valve repair. We have developed a simple and effective technique using a sterile paper ruler. The ruler is cut to the proper length (8 to 12 cm) depending on the valve size, then rolled and sutured. The rolled ruler, 7 to 11 cm in circumference, is placed inside the mitral leaflets. This technique provides excellent exposure of the papillary muscles without damaging the leaflets and prevents chordal injury during artificial chordal implantation. (C) 2015 by The Society of Thoracic Surgeons	[Tabata, Minoru; Hiraiwa, Nobuhiko; Kawano, Yuji; Nakatsuka, Daisuke; Hoshino, Satoshi] Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Cardiovasc Surg, Urayasu, Chiba 2790001, Japan	Tabata, M (reprint author), Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Cardiovasc Surg, 3-4-32 Todaijima, Urayasu, Chiba 2790001, Japan.	mtabata@post.harvard.edu					Ito T., 2015, GEN THORAC CARDIOVAS; Tabata M, 2014, J THORAC CARDIOV SUR, V148, P2033, DOI 10.1016/j.jtcvs.2014.03.045; Yozu R, 2012, J THORAC CARDIOV SUR, V143, pS82, DOI 10.1016/j.jtcvs.2011.05.026	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2015	100	3					E59	E61		10.1016/j.athoracsur.2015.05.044		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CQ9VF	WOS:000360962600005		
J	Kimura, H; Nakashima, A; Takahashi, S; Tsuchida, A; Kurosaka, K				Kimura, Hiroshi; Nakashima, Aya; Takahashi, Shinya; Tsuchida, Akira; Kurosaka, Keiichi			Changes of viscosity in stevensite aqueous dispersions with application of an electric field of the order of a few V/mm	APPLIED CLAY SCIENCE			English	Article						Reversible viscosity change; Stevensite; Deionization; Aqueous dispersion; Alternating current electric field	LIQUID-CRYSTALS; SUSPENSIONS	A change in the viscosity of a deionized stevensite aqueous dispersion under an electric field of the order of a few V/mm was recently discovered. The dispersion shows a reversible change of viscosity with the application and removal of an AC electric field. Regarding the mechanism of the reversible viscosity change, it can be considered that the by applying an electric field, the stevensite forms some flocs and a weak network structure, which leads to the increased viscosity, while it returns to a well-dispersed state and its original viscosity by removing the electric field. The viscosity response of the stevensite dispersion for an AC electric field was faster than that of the hectorite dispersion in the same measuring condition. It is speculated that the quick viscosity change would be related to the unique charge distribution on the stevensite, which is known to form a finer network structure than hectorite, beyond a critical concentration of salt. This finding offers great potential for controlling the dispersion state and sedimentation/floatation velocity, by an electric field, of various colloidal particles dispersed in the clay mineral dispersions. (C) 2015 Elsevier B.V. All rights reserved.	[Kimura, Hiroshi; Nakashima, Aya; Takahashi, Shinya; Tsuchida, Akira] Gifu Univ, Grad Sch Mat Sci, Dept Chem, Gifu 5011193, Japan; [Kurosaka, Keiichi] Kunimine Ind Co Ltd, Lwaki Labs, Div Chem, Iwaki, Fukushima 9728312, Japan	Kimura, H (reprint author), Gifu Univ, Grad Sch Mat Sci, Dept Chem, Gifu 5011193, Japan.	kimurah@gifu-u.ac.jp			Japan Society for the Promotion of Science [25550055]	The authors are appreciative of Instrumental Analysis, Life Science Research Center, Gifu University, for sample characterizations. This work was supported by Grant-in-Aid for Challenging Exploratory Research (No. 25550055) from the Japan Society for the Promotion of Science.	Dozov I, 2011, J PHYS CHEM B, V115, P7751, DOI 10.1021/jp201201x; Shen TZ, 2014, NAT MATER, V13, P394, DOI [10.1038/nmat3888, 10.1038/NMAT3888]; WINSLOW WM, 1949, J APPL PHYS, V20, P1137, DOI 10.1063/1.1698285; Nakato T, 2014, PHYS CHEM CHEM PHYS, V16, P955, DOI 10.1039/c3cp54140a; Ishijima H, 2000, NIHON REOROJI GAKK, V28, P79; Kimura H, 2011, RHEOL ACTA, V50, P159, DOI 10.1007/s00397-011-0532-7; Kimura H, 2013, RHEOL ACTA, V52, P139, DOI 10.1007/s00397-013-0682-x; Kimura H, 2014, APPL CLAY SCI, V99, P160, DOI 10.1016/j.clay.2014.06.026; KLINGENBERG DJ, 1990, LANGMUIR, V6, P15, DOI 10.1021/la00091a003; MARSHALL L, 1989, J CHEM SOC FARAD T 1, V85, P2785, DOI 10.1039/f19898502785; Masuko T, 2001, J SOC RHEOL JPN, V29, P139; Masuko T, 2006, NIHON REOROJI GAKK, V34, P259, DOI 10.1678/rheology.34.259; Nakato T, 2011, J PHYS CHEM C, V115, P8934, DOI 10.1021/jp201056q; Paineau E, 2009, J PHYS CHEM B, V113, P15858, DOI 10.1021/jp908326y; Tanaka H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031404; van Olphen H., 1977, INTRO CLAY COLLOID C	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1317	1872-9053		APPL CLAY SCI	Appl. Clay Sci.	SEP	2015	114						120	123		10.1016/j.clay.2015.05.015		4	Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy	Chemistry; Materials Science; Mineralogy	CQ7GW	WOS:000360772000015		
J	Luo, WH; Sasaki, K; Hirajima, T				Luo, Wuhui; Sasaki, Keiko; Hirajima, Tsuyoshi			Effect of surfactant molecular structure on perchlorate removal by various organo-montmorillonites	APPLIED CLAY SCIENCE			English	Article						Montmorillonite; Surfactant structure; Perchlorate removal; Adsorption capacity; Kinetics; Selectivity	CATIONIC SURFACTANT; CLAY-MINERALS; LAYERED SILICATES; ADSORPTION; SORPTION; WATER; ION; CETYLTRIMETHYLAMMONIUM; GROUNDWATER; BENTONITE	A series of organo-montmorillonites (organo-Mt) was synthesized using various cationic surfactants with different alkyl-chain lengths, head groups, and alkyl-chain numbers, which were systematically examined for perchlorate adsorption. The products were characterized by the specific surface area, field-emission scanning electron microscopy, X-ray diffraction, Fourier transform infrared spectroscopy, and X-ray photoelectron spectroscopy. In addition, the surfactant loadings and surface charges were investigated by CHN analysis and zeta potential measurements. The greatest adsorption capacity of 0.95 mmol/g-composite was obtained on benzyloctadecyldimethylammonium-modified Mt. Increasing the alkyl-chain length significantly enhanced the capacity and selectivity for perchlorate adsorption, but resulted in decrease of adsorption rate. Compared with trimethylammonium and pyridinium with the same alkyl-chain length, the benzyldimethylammonium as a head group showed better performance in terms of adsorption capacity and selectivity of perchlorate because of higher hydrophobicity. Moreover, increasing the alkyl-chain number decreased adsorption rate, but enhanced adsorption capacity, because of dense packing of alkyl chains and high driving force for entrapment of counter ion-accompanying surfactant. The perchlorate adsorption performance of organo-Mt was synergistically influenced by the alkyl-chain length, head group and alkyl-chain number of the surfactants used for modification. (C) 2015 Elsevier B.V. All rights reserved.	[Luo, Wuhui; Sasaki, Keiko; Hirajima, Tsuyoshi] Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Fukuoka 8190395, Japan	Luo, WH (reprint author), Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Fukuoka 8190395, Japan.	luo070221@gmail.com			funding program "Progress 100" (World Premier International Researcher Invitation Program) through Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Financial support was provided to KS by the funding program "Progress 100" (World Premier International Researcher Invitation Program) through operating expense grants of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). FESEM observation and XPS measurement were conducted on the Advanced Analytical Center in Kyushu University.	Bors J, 1999, ENG GEOL, V54, P195, DOI 10.1016/S0013-7952(99)00074-5; Sanchez CA, 2005, ENVIRON SCI TECHNOL, V39, P9391, DOI 10.1021/es050804k; He HP, 2006, CLAY CLAY MINER, V54, P689, DOI 10.1346/CCMN.2006.0540604; Kwolek T, 2003, J COLLOID INTERF SCI, V264, P14, DOI 10.1016/S0021-9797(03)00414-4; Zhang R, 2006, ADV COLLOID INTERFAC, V123, P213, DOI 10.1016/j.cis.2006.07.004; He HP, 2006, APPL CLAY SCI, V31, P262, DOI 10.1016/j.clay.2005.10.011; Xi YF, 2010, APPL CLAY SCI, V48, P92, DOI 10.1016/j.clay.2009.11.047; Naranjo PM, 2013, CLAY CLAY MINER, V61, P98, DOI 10.1346/CCMN.2013.0610208; Gu BH, 2007, ENVIRON SCI TECHNOL, V41, P6277, DOI 10.1021/es0706910; Vimonses V, 2009, APPL CLAY SCI, V43, P465, DOI 10.1016/j.clay.2008.11.008; Lin SY, 2013, COLLOID SURFACE A, V434, P236, DOI 10.1016/j.colsurfa.2013.05.048; Xi YF, 2005, LANGMUIR, V21, P8675, DOI 10.1021/la051454i; Zhu JX, 2012, J THERM ANAL CALORIM, V109, P301, DOI 10.1007/s10973-011-1761-9; Shi YL, 2007, ENVIRON INT, V33, P955, DOI 10.1016/j.envint.2007.05.007; Praus P, 2006, J COLLOID INTERF SCI, V304, P29, DOI 10.1016/j.jcis.2006.08.038; Wang CC, 2004, J COLLOID INTERF SCI, V280, P27, DOI 10.1016/j.jcis.2004.07.009; Wolff J, 1998, PHARMACOL REV, V50, P89; Baidas S, 2011, J HAZARD MATER, V189, P54, DOI 10.1016/j.jhazmat.2011.01.124; Zadaka D, 2010, J COLLOID INTERF SCI, V352, P171, DOI 10.1016/j.jcis.2010.08.010; HAGGERTY GM, 1994, ENVIRON SCI TECHNOL, V28, P452, DOI 10.1021/es00052a017; Kadar F, 2006, LANGMUIR, V22, P7848, DOI 10.1021/la060144c; Lv L, 2014, J ENVIRON SCI-CHINA, V26, P792, DOI 10.1016/S1001-0742(13)60519-7; Atia AA, 2008, APPL CLAY SCI, V41, P73, DOI 10.1016/j.clay.2007.09.011; Behnsen J, 2008, APPL GEOCHEM, V23, P2746, DOI 10.1016/j.apgeochem.2008.06.019; Chitrakar R, 2012, CHEM ENG J, V191, P141, DOI 10.1016/j.cej.2012.02.085; Custelcean R, 2007, EUR J INORG CHEM, P1321, DOI 10.1002/ejic.200700018; Droge STJ, 2013, ENVIRON SCI TECHNOL, V47, P14224, DOI 10.1021/es403187w; Fang QL, 2013, ENVIRON SCI TECHNOL, V47, P11013, DOI 10.1021/es402490k; He HP, 2007, SPECTROCHIM ACTA A, V66, P1180, DOI 10.1016/j.saa.2006.06.005; Kannan K, 2009, CHEMOSPHERE, V76, P22, DOI 10.1016/j.chemosphere.2009.02.054; Kim JY, 2011, APPL CLAY SCI, V51, P158, DOI 10.1016/j.clay.2010.11.025; Lim YH, 2015, J THERM ANAL CALORIM, V120, P67, DOI 10.1007/s10973-015-4413-7; Logan B.E., 2001, ENVIRON SCI TECHNOL, V35, P483; Okada T, 2015, LANGMUIR, V31, P180, DOI 10.1021/la503708t; Othmani-Assmann H, 2007, J PHYS CHEM C, V111, P10869, DOI 10.1021/jp068814a; VAIA RA, 1994, CHEM MATER, V6, P1017, DOI 10.1021/cm00043a025; Xi Y., 2007, J COLLOID INTERF SCI, V350, P150; Xiong Z, 2007, IND ENG CHEM RES, V46, P9213, DOI 10.1021/ie0702025; Xu X, 2013, CARBOHYD POLYM, V98, P132, DOI 10.1016/j.carbpol.2013.05.058; Yariv S, 2004, APPL CLAY SCI, V24, P225, DOI 10.1016/j.clay.2003.04.002; Zhu JX, 2011, COLLOID SURFACE A, V384, P401, DOI 10.1016/j.colsurfa.2011.04.023	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1317	1872-9053		APPL CLAY SCI	Appl. Clay Sci.	SEP	2015	114						212	220		10.1016/j.clay.2015.06.003		9	Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy	Chemistry; Materials Science; Mineralogy	CQ7GW	WOS:000360772000027		
J	Kawada, T				Kawada, Tomoyuki			Sleep Problems in Patients With Traumatic Brain Injury by Actigraphy	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Letter									Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, 1-1-5 Sendagi, Tokyo 113, Japan.						Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	5	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2015	96	9					1741	1742		10.1016/j.apmr.2015.06.016		2	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CR1JT	WOS:000361081700025		
J	Bebenroth, R; Hemmert, M				Bebenroth, Ralf; Hemmert, Martin			Country-level antecedents of target firms' post-acquisition business performance: A study of inbound Japanese and Korean M&As	ASIAN BUSINESS & MANAGEMENT			English	Article						cross-border M&As; emerging-market multinationals (EMMs); post-acquisition business performance; Japan; Korea	CROSS-BORDER ACQUISITIONS; FOREIGN DIRECT-INVESTMENT; EMERGING-MARKET; OWNERSHIP STRATEGIES; CHINESE FIRMS; ENTRY MODE; PERSPECTIVE; MERGERS; DISTANCE; CHOICE	In contrast to most previous studies on cross-border M&A performance, which have focused on financial outcomes for acquiring firms, we examine the post-acquisition business performance of target firms. For 109 Japanese and South Korean acquisition targets, we find negative effects of managerial distance on target firms' post-acquisition return-on-assets (ROA) development and of cultural distance on their asset growth. Furthermore, firms acquired by emerging-market multinationals recorded relatively higher ROA development and lower asset growth than other target firms. Our findings suggest that multiple performance dimensions should be considered to assess the outcomes of international M&As accurately.	[Bebenroth, Ralf] Kobe Univ, Res Inst Econ & Business Adm, Nada Ku, Kobe, Hyogo 6578501, Japan; [Hemmert, Martin] Korea Univ, Sch Business, Seoul 136701, South Korea	Hemmert, M (reprint author), Korea Univ, Sch Business, 145 Anam Ro, Seoul 136701, South Korea.	rbeben@rieb.kobe-u.ac.jp; mhemmert@korea.ac.kr					Cartwright S, 2006, BRIT J MANAGE, V17, pS1, DOI 10.1111/j.1467-8551.2006.00475.x; Froese FJ, 2008, J WORLD BUS, V43, P97, DOI 10.1016/j.jwb.2007.10.002; Tan XM, 2013, ENERG ECON, V36, P750, DOI 10.1016/j.eneco.2012.11.019; Cui L, 2012, J INT BUS STUD, V43, P264, DOI 10.1057/jibs.2012.1; Marks ML, 2001, ACAD MANAGE EXEC, V15, P80; Zollo M, 2008, ACAD MANAGE PERSPECT, V22, P55; Berry H, 2010, J INT BUS STUD, V41, P1460, DOI 10.1057/jibs.2010.28; Deng P, 2015, INT BUS REV, V24, P157, DOI 10.1016/j.ibusrev.2014.07.005; KOGUT B, 1988, J INT BUS STUD, V19, P411, DOI 10.1057/palgrave.jibs.8490394; Jacoby W, 2014, ASIA EUR J, V12, P199, DOI 10.1007/s10308-014-0380-z; Luo YD, 2007, J INT BUS STUD, V38, P481, DOI 10.1057/palgrave.jibs.8400275; Igarashi T, 2008, ASIAN J SOC PSYCHOL, V11, P88, DOI 10.1111/j.1467-839X.2007.00246.x; Rui HC, 2008, J WORLD BUS, V43, P213, DOI 10.1016/j.jwb.2007.11.006; Barkema HG, 1996, STRATEGIC MANAGE J, V17, P151, DOI 10.1002/(SICI)1097-0266(199602)17:2<151::AID-SMJ799>3.0.CO;2-Z; Birkinshaw J, 2000, J MANAGE STUD, V37, P395, DOI 10.1111/1467-6486.00186; Stahl GK, 2008, ORGAN SCI, V19, P160, DOI 10.1287/orsc.1070.0270; Demirbag M, 2007, J WORLD BUS, V42, P418, DOI 10.1016/j.jwb.2007.06.004; Li J, 2010, J INT BUS STUD, V41, P1550, DOI 10.1057/jibs.2010.25; Haleblian J, 2009, J MANAGE, V35, P469, DOI 10.1177/0149206308330554; Buckley PJ, 2007, J INT BUS STUD, V38, P499, DOI 10.1057/palgrave.jibs.8400277; Yiu D, 2002, ORGAN SCI, V13, P667, DOI 10.1287/orsc.13.6.667.494; Denis DJ, 2002, J FINANC, V57, P1951, DOI 10.1111/0022-1082.00485; Froese FJ, 2007, ASIAN BUS MANAG, V6, P95, DOI 10.1057/palgrave.abm.9200208; King DR, 2004, STRATEGIC MANAGE J, V25, P187, DOI 10.1002/smj.371; Morosini P, 1998, J INT BUS STUD, V29, P137, DOI 10.1057/palgrave.jibs.8490029; Davis PS, 2000, J INT BUS STUD, V31, P239, DOI 10.1057/palgrave.jibs.8490904; Sun SL, 2012, J WORLD BUS, V47, P4, DOI 10.1016/j.jwb.2010.10.015; Aybar B, 2009, J INT BUS STUD, V40, P1317, DOI 10.1057/jibs.2009.15; Beamish P., 2004, MANAGE INT REV, V44, P285; Bebenroth R., 2012, KOKUMINKEIZAI ZASHI, V206, P49; Boateng A., 2008, THUNDERBIRD INT BUSI, V50, P259, DOI 10.1002/tie.20203; Buckley P.J., 1976, FUTURE MULTINATIONAL; Chattopadhyay A., 2012, NEW EMERGING MARKET; Cherry J, 2006, PAC AFF, V79, P9; Das Arindam, 2012, Journal of Strategy and Management, V5, DOI 10.1108/17554251211247580; Dickson M. W., 2004, CULTURE LEADERSHIP O, P74; Drifte R, 2010, CURRENT ISSUES IN ECONOMIC INTEGRATION: CAN ASIA INSPIRE THE WEST?, P137; Dunning J. H., 2000, INT BUSINESS REV, V9, P163, DOI DOI 10.1016/S0969-5931(99)00035-9; Edamura K, 2014, CHINA ECON REV, V30, P169, DOI 10.1016/j.chieco.2014.06.011; Froese F.J., 2010, GLOBAL BUSINESS ORG, V30, P50; Fukao K., 2008, NBER EASE, V17, P347; Gupta A.K., 2008, QUEST GLOBAL DOMINAN; Haghirian P., 2010, UNDERSTANDING JAPANE; Hemmert M., 2014, ASIAN BUSINESS MANAG, V2nd, P219; Hemmert M., 2012, TIGER MANAGEMENT KOR; House Robert J., 2004, CULTURE LEADERSHIP O; JEMISON DB, 1986, ACAD MANAGE REV, V11, P145; Kwon O.Y., 2000, ASIAN STUDIES REV, V24, P25, DOI 10.1080/10357820008713258; Lawrence R.Z., 1993, FOREIGN DIRECT INVES, P85; Lee Y, 2014, ASIAN BUS MANAG, V13, P197, DOI 10.1057/abm.2014.5; Lu JW, 2002, J INT BUS STUD, V33, P19, DOI 10.1057/palgrave.jibs.8491003; Milhaupt C.J., 2003, GLOBAL MARKETS DOMES, P295; Nicholson R.R., 2012, INT BUSINESS REV, V22, P963; Nielsen L., 2011, WP1131 IMF; North D.C., 1990, I I CHANGE EC PERFOR; North Douglass C., 1996, EMPIRICAL STUDIES I, P342; Porter M E, 1990, COMPETITIVE ADVANTAG; RECOF, 2006, MERG ACQ RES REP; Scott R.W., 2000, I CHANGE HEALTHCARE; Shimizu K., 2004, J INT MANAG, V10, P307, DOI 10.1016/j.intman.2004.05.005; Stahl G.K., 2005, ADV MERGERS ACQUISIT, V4, P401; United Nations Conference on Trade and Development (UNCTAD), 2014, WORLD INV REP 2014; Vaara E, 2014, STRATEGIC MANAGE J, V35, P1302, DOI 10.1002/smj.2163; Williamson P.J., 2013, COMPETITIVE ADVANTAG, P260; Witt M., 2014, ASIAN BUSINESS MANAG, V2nd, P161; World Economic Forum, 2011, GLOB COMP REP 2011 2; Xu LP, 2012, ASIAN CASE RES J, V16, P1, DOI 10.1142/S0218927512500010; Yoshida H., 2006, KOKUMINKEIZAI ZASHI, V194, P75; ZAHEER S, 1995, ACAD MANAGE J, V38, P341, DOI 10.2307/256683; ZUCKER LG, 1977, AM SOCIOL REV, V42, P726, DOI 10.2307/2094862	70	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	1472-4782	1476-9328		ASIAN BUS MANAG	Asian. Bus. Manag.	SEP	2015	14	4			SI		303	325		10.1057/abm.2015.10		23	Business; Management	Business & Economics	CQ9PI	WOS:000360946700004		
J	Thao, NGM; Uchida, K				Nguyen Gia Minh Thao; Uchida, Kenko			Active and Reactive Power Control Techniques Based on Feedback Linearization and Fuzzy Logic for Three-Phase Grid-Connected Photovoltaic Inverters	ASIAN JOURNAL OF CONTROL			English	Article						Grid-connected photovoltaic inverter; active and reactive power control; feedback linearization; fuzzy logic; per-unit system	DC/AC CONVERTERS; PWM CONVERTERS	This paper discusses two techniques based on the feedback linearization (FBL) method to control the active and reactive output powers of three-phase grid-connected photovoltaic (PV) inverters. The first control scheme is an application of the direct FBL approach. The other is an appropriate combination of the FBL and fuzzy logic (FBL-FL), and is the main proposed method of this study. Wherein, a unique fuzzy logic controller (FLC) is designed to enhance effectiveness of the linear control method used in the direct FBL. In detail, its major objectives are to improve the transient response and reduce steady-state oscillations in the output powers. In this research, the illustrative PV inverter utilizes a three-level DC-AC converter, an R-L filter and a 250V/10kV wye-wye transformer to inject the energy, obtained from PV array with a nominal power of 100kW, into the 10kV/60Hz three-phase grid. Numerical simulations in MATLAB and PSIM illustrate that the two FBL-based structures perform very well in independently regulating the active and reactive output powers to the reference values, even within the parametric uncertainties and the unbalanced grid voltage condition. Moreover, comparisons of simulation results, obtained from the traditional proportional-integral (PI) control and the two FBL-based structures, show advantages of the proposed FBL-FL hybrid technique in terms of fast response, small overshoot, acceptable steady-state fluctuation and high robustness.	[Nguyen Gia Minh Thao; Uchida, Kenko] Waseda Univ, Dept Elect Engn & Biosci, Tokyo, Japan	Thao, NGM (reprint author), Waseda Univ, Dept Elect Engn & Biosci, Tokyo, Japan.	thao@uchi.elec.waseda.ac.jp; kuchida@uchi.elec.waseda.ac.jp			JST-CREST	This work was partially supported by JST-CREST.	Bao XW, 2013, IEEE T POWER ELECTR, V28, P2739, DOI 10.1109/TPEL.2012.2225076; Gahinet P, 1996, IEEE T AUTOMAT CONTR, V41, P436, DOI 10.1109/9.486646; Yang B, 2010, IEEE T POWER ELECTR, V25, P992, DOI 10.1109/TPEL.2009.2036432; Zhi DW, 2009, IEEE T POWER ELECTR, V24, P1280, DOI 10.1109/TPEL.2009.2012497; Hu JB, 2011, IEEE T POWER ELECTR, V26, P210, DOI 10.1109/TPEL.2010.2057518; Noguchi T, 1998, IEEE T IND APPL, V34, P473, DOI 10.1109/28.673716; Kazmierkowski MP, 1998, IEEE T IND ELECTRON, V45, P691, DOI 10.1109/41.720325; [Anonymous], 1993, 5191992 IEEE SM; Benchagra M, 2012, 2012 INTERNATIONAL CONFERENCE ON MULTIMEDIA COMPUTING AND SYSTEMS (ICMCS), P1049, DOI 10.1109/ICMCS.2012.6320130; Chien TL, 2010, CONTROL CYBERN, V39, P1069; Cortes P, 2008, IEEE T POWER ELECTR, V23, P2516, DOI 10.1109/TPEL.2008.2002065; Dupont FH, 2013, ASIAN J CONTROL, V15, P861, DOI 10.1002/asjc.561; Gahinet P., 1995, LMI CONTROL TOOLBOX; Giroux P., 2012, 2 DEMONSTRATIONS GRI; Jirutitijaroen P., 2012, EE2022 ELECT ENERGY; Kim DE, 2009, J POWER ELECTRON, V9, P288; Marino Riccardo, 1995, NONLINEAR CONTROL DE; Meah K., 2007, P IEEE REG 5 TECHN C, P226; Raducu G. A., 2008, THESIS AALBORG U AAL; Ross T. L., 2010, FUZZY LOGIC ENG APPL; Scherer C., 2009, COURSE LINEAR MATRIX; Strzelecki R, 2008, POWER SYST, P1, DOI 10.1007/978-1-84800-318-7; Tanaka M. C., 2012, P ABCM S SERIES MECH, V5, P438; Thao N. G. M., 2010, P 2010 IEEE INT FOR, P140; Thao N. G. M., 2013, P 9 AS CONTR C, P1; THAO NGM, 2013, P 3 IEEE AUSTR CONTR, P133; Zhou X., 2012, P 7 IPEMC, P1859	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1561-8625	1934-6093		ASIAN J CONTROL	Asian J. Control	SEP	2015	17	5					1522	1546		10.1002/asjc.998		25	Automation & Control Systems	Automation & Control Systems	CR2UR	WOS:000361186700005		
J	Sawaki, H				Sawaki, Hisashi			Horizontal Mergers Under Asymmetric Information About Synergies	AUSTRALIAN ECONOMIC PAPERS			English	Article							INTERNATIONAL MERGERS; SIGNALING GAMES; EQUILIBRIUM; INCENTIVES	This paper analyses a situation in which there are three quantity-setting firms, two of which are considering whether or not to merge. When these two firms have private information about the potential cost-saving synergies of the merger, they may have an incentive to overstate them. This is because if they succeed in making the non-merging rival firm believe that the synergies are high, the rival firm reduces output and the merger becomes more profitable. Under some conditions, anticipating that the rival will form such a belief, low-synergy firms that would never merge under complete information will mimic high-synergy firms by merging. Such pooling behaviour by the merging firms can have a negative impact on social welfare.	[Sawaki, Hisashi] Okayama Univ, Okayama 7008530, Japan	Sawaki, H (reprint author), Okayama Univ, Dept Econ, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	sawaki-h@cc.okayama-u.ac.jp					Kartik N, 2009, REV ECON STUD, V76, P1359, DOI 10.1111/j.1467-937X.2009.00559.x; Feltovich N, 2002, RAND J ECON, V33, P630, DOI 10.2307/3087478; DENECKERE R, 1985, RAND J ECON, V16, P473, DOI 10.2307/2555507; Banal-Estanol A, 2007, INT J IND ORGAN, V25, P31, DOI 10.1016/j.ijindorg.2005.12.002; Austen-Smith D, 2005, Q J ECON, V120, P551, DOI 10.1162/0033553053970205; BERNHEIM BD, 1994, J POLIT ECON, V102, P841, DOI 10.1086/261957; Bruner R. F., 2004, APPL MERGERS ACQUISI; CHO IK, 1990, J ECON THEORY, V50, P381, DOI 10.1016/0022-0531(90)90009-9; CHO IK, 1987, Q J ECON, V102, P179, DOI 10.2307/1885060; Das SP, 2001, J ECON MANAGE STRAT, V10, P565, DOI 10.1162/105864001753356105; DOJ/FTC (Department of Justice and Federal Trade Commission), 1997, 1997 REV EFF PROV 19; FARRELL J, 1990, AM ECON REV, V80, P107; GALOR E, 1988, INT ECON REV, V29, P639, DOI 10.2307/2526826; Lommerud KE, 1997, INT J IND ORGAN, V16, P21, DOI 10.1016/S0167-7187(96)01042-9; Perry P. K., 1985, AM ECON REV, V75, P219; Qiu LD, 2006, J INT ECON, V68, P38, DOI 10.1016/j.jinteco.2004.12.005; SALANT SW, 1983, Q J ECON, V98, P185, DOI 10.2307/1885620; Spence M., 1974, MARKET SIGNALING	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-900X	1467-8454		AUST ECON PAP	Aust. Econ. Pap.	SEP	2015	54	3					167	184		10.1111/1467-8454.12049		18	Economics	Business & Economics	CR2GE	WOS:000361143700003		
J	Lu, FC; Karlen, SD; Regner, M; Kim, H; Ralph, SA; Sun, RC; Kuroda, K; Augustin, MA; Mawson, R; Sabarez, H; Singh, T; Jimenez-Monteon, G; Zakaria, S; Hill, S; Harris, PJ; Boerjan, W; Wilkerson, CG; Mansfield, SD; Ralph, J				Lu, Fachuang; Karlen, Steven D.; Regner, Matt; Kim, Hoon; Ralph, Sally A.; Sun, Run-Cang; Kuroda, Ken-ichi; Augustin, Mary Ann; Mawson, Raymond; Sabarez, Henry; Singh, Tanoj; Jimenez-Monteon, Gerardo; Zakaria, Sarani; Hill, Stefan; Harris, Philip J.; Boerjan, Wout; Wilkerson, Curtis G.; Mansfield, Shawn D.; Ralph, John			Naturally p-Hydroxybenzoylated Lignins in Palms	BIOENERGY RESEARCH			English	Article						Lignin acylation; Transferase; NMR; DFRC method; Poplar; p-Hydroxybenzoic acid; Monolignol	FRUIT-BUNCH FIBERS; O-METHYLTRANSFERASE ACTIVITY; OIL PALM; STRUCTURAL-CHARACTERIZATION; CELL-WALLS; 2D NMR; FERULATE 5-HYDROXYLASE; FRACTIONAL ISOLATION; ERYTHRO/THREO RATIO; TRANSGENIC POPLARS	The industrial production of palm oil concurrently generates a substantial amount of empty fruit bunch (EFB) fibers that could be used as a feedstock in a lignocellulose-based biorefinery. Lignin byproducts generated by this process may offer opportunities for the isolation of value-added products, such as p-hydroxybenzoate (pBz), to help offset operating costs. Analysis of the EFB lignin by nuclear magnetic resonance (NMR) spectroscopy clearly revealed the presence of bound acetate and pBz, with saponification revealing that 1.1 wt% of the EFB was pBz; with a lignin content of 22.7 %, 4.8 % of the lignin is pBz that can be obtained as a pure component for use as a chemical feedstock. Analysis of EFB lignin by NMR and derivatization followed by reductive cleavage (DFRC) showed that pBz selectively acylates the gamma-hydroxyl group of S units. This selectivity suggests that pBz, analogously with acetate in kenaf, p-coumarate in grasses, and ferulate in a transgenic poplar augmented with a feruloyl-CoA monolignol transferase (FMT), is incorporated into the growing lignin chain via its gamma-p-hydroxybenzoylated monolignol conjugate. Involvement of such conjugates in palm lignification is proven by the observation of novel p-hydroxybenzoylated non-resinol beta-beta-coupled units in the lignins. Together, the data implicate the existence of p-hydroxybenzoyl-CoA:monolignol transferases that are involved in lignification in the various willows (Salix spp.), poplars and aspen (Populus spp., family Salicaceae), and palms (family Arecaceae) that have p-hydroxybenzoylated lignins. Even without enhancing the levels by breeding or genetic engineering, current palm oil EFB 'wastes' should be able to generate a sizeable stream of p-hydroxybenzoic acid that offers opportunities for the development of value-added products derived from the oil palm industry.	[Lu, Fachuang; Karlen, Steven D.; Regner, Matt; Kim, Hoon; Ralph, Sally A.] Univ Wisconsin, Wisconsin Energy Inst, Dept Energys, Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA; [Lu, Fachuang; Regner, Matt; Kim, Hoon; Ralph, Sally A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ralph, Sally A.] USDA, Forest Serv, US Forest Prod Lab, Madison, WI 53726 USA; [Sun, Run-Cang] Beijing Forestry Univ, Beijing Key Lab Lignocellulos Chem, Beijing 100083, Peoples R China; [Kuroda, Ken-ichi] Kyushu Univ, Fac Agr, Dept Forest & Forest Prod Sci, Fukuoka 8128581, Japan; [Augustin, Mary Ann; Mawson, Raymond; Sabarez, Henry; Singh, Tanoj] CSIRO Food Nutr & Bioprod Flagship, Werribee, Vic 3030, Australia; [Jimenez-Monteon, Gerardo] USA ARS Dairy Forage Res Ctr, Madison, WI 53706 USA; [Zakaria, Sarani] Univ Kebangsaan Malaysia, Bioresources & Biorefinery Lab, Bangi 43600, Malaysia; [Hill, Stefan] Scion, Rotorua 3046, New Zealand; [Harris, Philip J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Boerjan, Wout] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Boerjan, Wout] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Wilkerson, Curtis G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Wilkerson, Curtis G.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Wilkerson, Curtis G.] Michigan State Univ, Dept Energys, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Mansfield, Shawn D.] Univ British Columbia, Dept Wood Sci, Vancouver, BC V6T 1Z4, Canada; [Ralph, John] Univ Wisconsin, Wisconsin Energy Inst, Dept Biochem, Madison, WI 53726 USA; [Ralph, John] Univ Wisconsin, Wisconsin Energy Inst, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA	Ralph, J (reprint author), Univ Wisconsin, Wisconsin Energy Inst, Dept Biochem, 1552 Univ Ave, Madison, WI 53726 USA.	jralph@wisc.edu	Singh, Tanoj/H-5705-2013	Singh, Tanoj/0000-0002-0413-1935	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE Energy Biosciences program [DE-AI02-00ER15067, DE-FG02-03ER15442]; USDA-CSREES National Research Initiatives (Improved Utilization of Wood and Wood Fiber) [2001-02176]; NSF [CHE9974839]	We gratefully acknowledge partial funding through the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494), DOE Energy Biosciences program (#DE-AI02-00ER15067, #DE-FG02-03ER15442), USDA-CSREES National Research Initiatives (Improved Utilization of Wood and Wood Fiber #2001-02176), and, for the reported ESI-MS data, the purchase of the Waters LCT (R) in 2000 that was partially funded by NSF Award #CHE9974839 to the University of Wisconsin Department of Chemistry. WB acknowledges the Multidisciplinary Research Partnership (01MRB510W) 'Biotechnology for a Sustainable Economy.'	Akiyama T, 2015, J WOOD CHEM TECHNOL, V35, P8, DOI 10.1080/02773813.2014.892992; Lu FC, 2002, CHEM COMMUN, P90, DOI 10.1039/b109876d; Morreel K, 2004, PLANT PHYSIOL, V136, P3537, DOI 10.1104/pp.104.049304; Fukushima RS, 2001, J AGR FOOD CHEM, V49, P3133, DOI 10.1021/jf010449r; Akiyama T, 2002, J WOOD SCI, V48, P210, DOI 10.1007/BF00771369; Isahak WNRW, 2012, RENEW SUST ENERG REV, V16, P5910, DOI 10.1016/j.rser.2012.05.039; Lu FC, 2008, ORG BIOMOL CHEM, V6, P3681, DOI 10.1039/b809464k; Sun RC, 1998, J AGR FOOD CHEM, V46, P718, DOI 10.1021/jf9705532; Kuroda K, 2001, J AGR FOOD CHEM, V49, P1840, DOI 10.1021/jf001126i; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Grabber JH, 1996, PHYTOCHEMISTRY, V43, P1189, DOI 10.1016/S0031-9422(96)00431-1; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Lu FC, 1999, J AGR FOOD CHEM, V47, P1988, DOI 10.1021/jf981140j; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Hatfield RD, 1999, J AGR FOOD CHEM, V47, P628, DOI 10.1021/jf9808776; Meyermans H, 2000, J BIOL CHEM, V275, P36899, DOI 10.1074/jbc.M006915200; Ralph J, 1996, J NAT PROD, V59, P341, DOI 10.1021/np960143s; LANDUCCI LL, 1992, HOLZFORSCHUNG, V46, P505, DOI 10.1515/hfsg.1992.46.6.505; Kim H, 2008, BIOENERG RES, V1, P56, DOI 10.1007/s12155-008-9004-z; Bardet M, 1998, MAGN RESON CHEM, V36, P597, DOI 10.1002/(SICI)1097-458X(199808)36:8<597::AID-OMR345>3.0.CO;2-G; Lu FC, 2004, ORG BIOMOL CHEM, V2, P2888, DOI 10.1039/b411428k; Hedenstrom M, 2009, MOL PLANT, V2, P933, DOI 10.1093/mp/ssp047; Martinez AT, 2008, PHYTOCHEMISTRY, V69, P2831, DOI 10.1016/j.phytochem.2008.09.005; RALPH J, 1994, J AM CHEM SOC, V116, P9448, DOI 10.1021/ja00100a006; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; CHANG HM, 1975, HOLZFORSCHUNG, V29, P153, DOI 10.1515/hfsg.1975.29.5.153; Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161; Sumathi S, 2008, RENEW SUST ENERG REV, V12, P2404, DOI 10.1016/j.rser.2007.06.006; Akiyama T, 2005, HOLZFORSCHUNG, V59, P276, DOI 10.1515/HF.2005.045; Sun RC, 1999, J WOOD CHEM TECHNOL, V19, P335, DOI 10.1080/02773819909349616; HIBINO T, 1994, PHYTOCHEMISTRY, V37, P445, DOI 10.1016/0031-9422(94)85076-3; Rencoret J, 2013, J AGR FOOD CHEM, V61, P2434, DOI 10.1021/jf304686x; BJORKMAN A, 1954, NATURE, V174, P1057, DOI 10.1038/1741057a0; Lu FC, 1997, J AGR FOOD CHEM, V45, P2590, DOI 10.1021/jf970258h; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Ralph J, 1998, J AGR FOOD CHEM, V46, P4616, DOI 10.1021/jf980680d; [Anonymous], 2014, DISTRIBUTION PALM PL; Withers S, 2012, J BIOL CHEM, V287, P8347, DOI 10.1074/jbc.M111.284497; Del Rio JC, 2007, J AGR FOOD CHEM, V55, P5461, DOI 10.1021/jf0705264; Marita JM, 1999, P NATL ACAD SCI USA, V96, P12328, DOI 10.1073/pnas.96.22.12328; Petrik DL, 2014, PLANT J, V77, P713, DOI 10.1111/tpj.12420; Crestini C, 1997, J AGR FOOD CHEM, V45, P1212, DOI 10.1021/jf960568k; del Rio JC, 2008, J AGR FOOD CHEM, V56, P9525, DOI 10.1021/jf800806h; GALLACHER J, 1994, J SCI FOOD AGR, V64, P487, DOI 10.1002/jsfa.2740640415; Hatfield R, 2008, PLANTA, V228, P919, DOI 10.1007/s00425-008-0791-4; Hatfield RD, 2008, J SCI FOOD AGR, V88, P2529, DOI 10.1002/jsfa.3376; HELM RF, 1992, J AGR FOOD CHEM, V40, P2167, DOI 10.1021/jf00023a025; JARVIS MC, 1994, PHYTOCHEMISTRY, V35, P485, DOI 10.1016/S0031-9422(00)94787-3; Jouanin L, 2000, PLANT PHYSIOL, V123, P1363, DOI 10.1104/pp.123.4.1363; Kratzl K, 1959, MONATSH CHEM, V90, P771, DOI 10.1007/BF00905664; Lu F, 2014, LIGNIN STRUCTURAL AN, P27; Lu F, 2005, 13 INT S WOOD FIB PU, P233; LUNDQUIST K, 1987, ACTA CHEM SCAND B, V41, P499, DOI 10.3891/acta.chem.scand.41b-0499; Marita JM, 2001, J CHEM SOC PERK T 1, P2939, DOI 10.1039/b107219f; Marita JM, 2014, PLANT J, V78, P850, DOI 10.1111/tpj.12510; MONTIES B, 1981, PHYSIOL VEG, V19, P327; Nakamura Y, 1978, CELL CHEM TECHNOL, V12, P199; Ralph J., 2010, LIGNIN LIGNANS ADV C, P137, DOI DOI 10.1201/EBK1574444865; Ralph J., 2007, COMPR WOOD WORKSH 20, P85; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ralph J, 2004, ORG BIOMOL CHEM, V2, P2714, DOI 10.1039/b412633e; Rasidi Roslan, 2014, Industrial Crops and Products, V62, P119, DOI 10.1016/j.indcrop.2014.08.024; SARKANEN KV, 1967, TAPPI, V50, P587; Sun RC, 1998, WOOD FIBER SCI, V30, P301; Sun RC, 1999, J AGR FOOD CHEM, V47, P2930; Sun RC, 1999, HOLZFORSCHUNG, V53, P253, DOI 10.1515/HF.1999.043; TOMIMURA Y, 1992, Bulletin of the Forestry and Forest Products Research Institute, P133; TOMIMURA Y, 1992, JARQ-JPN AGR RES Q, V25, P283; VENVERLO.CJ, 1971, HOLZFORSCHUNG, V25, P18, DOI 10.1515/hfsg.1971.25.1.18; Wanasuria S, 1999, BETTER CROPS INT, V13, P33; Zakaria S, 2013, BIOREMEDIATION BIODE, P1, DOI [10.4172/2155-6199.S4-001, DOI 10.4172/2155-6199.S4-001]; Zhu YM, 2013, RSC ADV, V3, P21964, DOI 10.1039/c3ra42818d	73	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1939-1234	1939-1242		BIOENERG RES	BioEnergy Res.	SEP	2015	8	3					934	952		10.1007/s12155-015-9583-4		19	Energy & Fuels; Environmental Sciences	Energy & Fuels; Environmental Sciences & Ecology	CQ7GG	WOS:000360770400005		
J	Yasuda, M; Takenouchi, Y; Nitta, Y; Ishii, Y; Ohta, K				Yasuda, Masahide; Takenouchi, Yuka; Nitta, Yui; Ishii, Yasuyuki; Ohta, Kazuyoshi			Italian ryegrass (Lolium multiflorum Lam) as a High-Potential Bio-Ethanol Resource	BIOENERGY RESEARCH			English	Article						Bio-ethanol; Lignocellulosic raw material; Italian ryegrass; Simultaneous saccharification and co-fermentation (SSCF)	SACCHAROMYCES-CEREVISIAE 424A(LNH-ST); ESCHERICHIA-COLI KO11; SIMULTANEOUS SACCHARIFICATION; CORN STOVER; LIGNOCELLULOSIC MATERIALS; XYLOSE FERMENTATION; COMMERCIAL ENZYMES; AQUEOUS-AMMONIA; RICE STRAW; PRETREATMENT	Cellulosic bioethanol production from lignocellulosic biomass has been recognized as one of the promising sustainable energy source alternatives to petroleum-based fuels, since the lignocelluloses are not directly in competition with food sources. In order to develop a lignocellulosic raw material with high energy crops for bio-ethanol production, we selected Italian ryegrass (Lolium multiflorum Lam). Bio-ethanol production from Italian ryegrass through a low-moisture anhydrous ammonia (LMAA) pretreatment and simultaneous saccharification and co-fermentation (SSCF) was examined. At first, Italian ryegrass was subjected to LMAA pretreatment, which was performed by keeping the moist powdered Italian ryegrass under NH3 gas atmosphere at room temperature for 4 weeks. The effect of LMAA pretreatment was examined for bio-ethanol production through simultaneous saccharification and fermentation (SSF) which was performed at 34 A degrees C using Saccharomyces cerevisiae, cellulase, and xylanase. The yields of ethanol and xylose in SSF were enhanced by LMAA-pretreatment. The SSCF of the LMAA-retreated Italian ryegrass was performed at 36 A degrees C using Escherichia coli KO11, S. cerevisiae, cellulase, and xylanase. The SSCF of LMAA-pretreated Italian ryegrass produced ethanol in higher yield (84.6 %) compared with those of LMAA-pretreated bamboo, rice straw, Napier grass, and silvergrass.	[Yasuda, Masahide; Takenouchi, Yuka; Nitta, Yui] Miyazaki Univ, Fac Engn, Dept Appl Chem, Miyazaki 8892192, Japan; [Ishii, Yasuyuki] Miyazaki Univ, Fac Agr, Dept Anim & Grassland Sci, Miyazaki 8892192, Japan; [Ohta, Kazuyoshi] Miyazaki Univ, Fac Agr, Dept Biochem & Appl Biosci, Miyazaki 8892192, Japan	Yasuda, M (reprint author), Miyazaki Univ, Fac Engn, Dept Appl Chem, Miyazaki 8892192, Japan.	yasuda@cc.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24610055]	This study was supported by a Grant-in-Aid for Scientific Research (C) No 24610055 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Dien BS, 2011, BIORESOURCE TECHNOL, V102, P6479, DOI 10.1016/j.biortech.2011.03.022; Guo GL, 2008, BIORESOURCE TECHNOL, V99, P6046, DOI 10.1016/j.biortech.2007.12.047; Teymouri F, 2005, BIORESOURCE TECHNOL, V96, P2014, DOI 10.1016/j.biortech.2005.01.016; OHTA K, 1990, APPL ENVIRON MICROB, V56, P463; Taherzadeh MJ, 2007, BIORESOURCES, V2, P707; Lau MW, 2008, BIOTECHNOL BIOENG, V99, P529, DOI 10.1002/bit.21609; Kim TH, 2005, APPL BIOCHEM BIOTECH, V121, P1119; Xu F, 2007, PROCESS BIOCHEM, V42, P913, DOI 10.1016/j.procbio.2007.02.001; Galbe M, 2007, ADV BIOCHEM ENG BIOT, V108, P41, DOI 10.1007/10_2007_070; Jin MJ, 2010, BIORESOURCE TECHNOL, V101, P8171, DOI 10.1016/j.biortech.2010.06.026; Ko JK, 2009, BIORESOURCE TECHNOL, V100, P4374, DOI 10.1016/j.biortech.2009.04.026; Yoo CG, 2011, BIORESOURCE TECHNOL, V102, P10028, DOI 10.1016/j.biortech.2011.08.057; Jin MJ, 2012, BIORESOURCE TECHNOL, V110, P587, DOI 10.1016/j.biortech.2012.01.150; Attala R. H., 1984, SCIENCE, V223, P283; Erdei B, 2011, BIOMASS BIOENERG, V56, P506; ROUSSELLE MA, 1976, TEXT RES J, V46, P304; Shao T, 2002, ASIAN AUSTRAL J ANIM, V15, P1606; Sluiter A., 2010, NRELTP51042618; Sun ZY, 2011, BIORESOURCE TECHNOL, V102, P10929, DOI 10.1016/j.biortech.2011.09.071; Underwood SA, 2002, APPL ENVIRON MICROB, V68, P1071, DOI 10.1128/AEM.68.3.1071-1081.2002; Yasuda M, 2014, BIOTECHNOL BIOPROC E, V19, P945; Yasuda M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-333; Yasuda M, 2012, J BIOSCI BIOENG, V114, P188, DOI 10.1016/j.jbiosc.2012.03.011; Yasuda M., 2013, J SUSTAIN BIOENERGY, V3, P179; Yasuda M, 2011, J PHOTOCH PHOTOBIO A, V220, P195, DOI 10.1016/j.jphotochem.2011.04.019; Zhang J, 2014, J AGR FOOD CHEM, V62, P7486, DOI 10.1021/jf501703j	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1939-1234	1939-1242		BIOENERG RES	BioEnergy Res.	SEP	2015	8	3					1303	1309		10.1007/s12155-015-9582-5		7	Energy & Fuels; Environmental Sciences	Energy & Fuels; Environmental Sciences & Ecology	CQ7GG	WOS:000360770400036		
J	Kurihara, K; Kawaguchi, H; Obata, T; Ito, H; Okada, E				Kurihara, Kazuki; Kawaguchi, Hiroshi; Obata, Takayuki; Ito, Hiroshi; Okada, Eiji			Magnetic resonance imaging appropriate for construction of subject-specific head models for diffuse optical tomography	BIOMEDICAL OPTICS EXPRESS			English	Article							NEAR-INFRARED SPECTROSCOPY; LIGHT-PROPAGATION; BRAIN; IMAGES; SEGMENTATION; TOPOGRAPHY; TISSUE; ADULT	Subject-specific head models of which their geometry is based on structural magnetic resonance images are essential to accurately estimate the spatial sensitivity profiles for image reconstruction in diffuse optical tomography. T1-weighted magnetic resonance images, which are commonly used for structural imaging, are not sufficient for the threshold-based segmentation of the superficial tissues. Two types of pulse sequences, which provide a high contrast among the superficial tissues, are introduced to complement the segmentation to construct the subject-specific head models. The magnetic resonance images acquired by the proposed pulse sequences are robust to the threshold level and adequate for the threshold-based segmentation of the superficial tissues compared to the T1- and T2-weighted images. The total scan time of the proposed pulse sequences is less than one-fourth of that for the T2-weighted pulse sequence. (C) 2015 Optical Society of America	[Kurihara, Kazuki; Okada, Eiji] Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Kawaguchi, Hiroshi] Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Cent 6, Tsukuba, Ibaraki 3058566, Japan; [Kawaguchi, Hiroshi; Obata, Takayuki; Ito, Hiroshi] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 2638555, Japan; [Obata, Takayuki] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan; [Ito, Hiroshi] Fukushima Med Univ, Adv Clin Res Ctr, Fukushima 9601295, Japan	Kurihara, K (reprint author), Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	okada@elec.keio.ac.jp			JSPS KAKENHI [26.5906]	A part of this work was supported by JSPS KAKENHI Grant Number 26.5906.	KELLER PJ, 1987, RADIOLOGY, V164, P539; Kurihara K, 2012, BIOMED OPT EXPRESS, V3, P2121; Schmitz B, 2003, EUR RADIOL, V13, P1577, DOI 10.1007/s00330-003-1846-3; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Ashburner J, 2012, NEUROIMAGE, V62, P791, DOI 10.1016/j.neuroimage.2011.10.025; HIRAOKA M, 1993, PHYS MED BIOL, V38, P1859, DOI 10.1088/0031-9155/38/12/011; Simpson CR, 1998, PHYS MED BIOL, V43, P2465, DOI 10.1088/0031-9155/43/9/003; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; Eggebrecht AT, 2012, NEUROIMAGE, V61, P1120, DOI 10.1016/j.neuroimage.2012.01.124; White BR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3368999; Bamett Alex H, 2003, Appl Opt, V42, P3095; FIRBANK M, 1993, PHYS MED BIOL, V38, P503, DOI 10.1088/0031-9155/38/4/002; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Jenkinson S., 2005, 11 ANN M ORG HUM BRA; Jermyn M, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086007; Kawaguchi H, 2007, APPL OPTICS, V46, P1658, DOI 10.1364/AO.46.001658; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Perdue KL, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.2.026011; VANDERZEE P, 1993, P SOC PHOTO-OPT INS, V1888, P454, DOI 10.1117/12.154665; Zhan Yuxuan, 2012, Front Neuroenergetics, V4, P6, DOI 10.3389/fnene.2012.00006	22	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	SEP 1	2015	6	9					3197	3209		10.1364/BOE.6.003197		13	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CQ8VR	WOS:000360888400007		
J	Miyazaki, J; Tsurui, H; Kobayashi, T				Miyazaki, Jun; Tsurui, Hiromichi; Kobayashi, Takayoshi			Reduction of distortion in photothermal microscopy and its application to the high-resolution three-dimensional imaging of nonfluorescent tissues	BIOMEDICAL OPTICS EXPRESS			English	Article							THERMAL-LENS MICROSCOPE; CYTOCHROME-C; DIFFRACTION; PARTICLE; CELLS	A scheme for reducing image distortion in photothermal microscopy is presented. In photothermal microscopy, the signal shape exhibits twin peaks corresponding to the focusing or defocusing of the probe beam when a sample is scanned in the axial direction. This causes a distortion when imaging a structured sample in the axial plane. Here, we demonstrate that image distortion caused by the twin peaks is effectively suppressed by providing a small offset between two the focal planes of the pump and the probe beams. Experimental results demonstrate improvement in resolution, especially in the axial direction, over conventional optical microscopy-even with the focal offset. When a dry objective lens with a numerical aperture of 0.95 is used, the full width at half the maximum of the axial point spread function is 0.6 mu m, which is 50% (62%) smaller than the focal spot sizes of the pump (probe) beam. Herein, we present high-resolution three-dimensional imaging of thick biological tissues based on the present scheme. (C) 2015 Optical Society of America	[Miyazaki, Jun; Kobayashi, Takayoshi] Univ Electrocommun, Adv Ultrafast Laser Res Ctr, Chofu, Tokyo 1828585, Japan; [Miyazaki, Jun; Kobayashi, Takayoshi] JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Tsurui, Hiromichi] Juntendo Univ, Dept Pathol, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Kobayashi, Takayoshi] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu 300, Taiwan; [Kobayashi, Takayoshi] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650971, Japan	Miyazaki, J (reprint author), Univ Electrocommun, Adv Ultrafast Laser Res Ctr, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	kobayashi@isl.uec.ac.jp			Japan Society for the Promotion of Science [15K17735]; joint research project at the Institute of Laser Engineering, Osaka University [B1-27]	This study was financially supported by a Grant-in-Aid for Scientific Research (No. 15K17735) received from the Japan Society for the Promotion of Science and a joint research project at the Institute of Laser Engineering, Osaka University, under contract number B1-27.	Miyazaki J, 2014, OPT EXPRESS, V22, P9024, DOI 10.1364/OE.22.009024; Leduc C, 2011, ACS NANO, V5, P2587, DOI 10.1021/nn1023285; Tamaki E, 2002, ANAL CHEM, V74, P1560, DOI 10.1021/ac011092t; Moreau J, 2004, OPT LETT, V29, P1488, DOI 10.1364/OL.29.001488; Uchiyama K, 2000, JPN J APPL PHYS 1, V39, P5316, DOI 10.1143/JJAP.39.5316; Brusnichkin AV, 2010, J BIOPHOTONICS, V3, P791, DOI 10.1002/jbio.201000012; Cognet L, 2003, P NATL ACAD SCI USA, V100, P11350, DOI 10.1073/pnas.1534635100; Leduc C, 2013, NANO LETT, V13, P1489, DOI 10.1021/nl304561g; Selmke M, 2012, ACS NANO, V6, P2741, DOI 10.1021/nn300181h; Lu SJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3308485; Miyazaki J, 2015, OPT LETT, V40, P479, DOI 10.1364/OL.40.000479; Miyazaki J, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4895832; Miyazaki J, 2015, OPT EXPRESS, V23, P3647, DOI 10.1364/OE.23.003647; Moreau J, 2006, JPN J APPL PHYS 1, V45, P7141, DOI 10.1143/JJAP.45.7141; Nedosekin DA, 2012, BIOPHYS J, V102, P672, DOI 10.1016/j.bpj.2011.12.035; Selmke M, 2012, OPT EXPRESS, V20, P8055, DOI 10.1364/OE.20.008055	16	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	SEP 1	2015	6	9					3217	3224	242711	10.1364/BOE.6.003217		8	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CQ8VR	WOS:000360888400009		
J	Ochi, K; Kamiura, M				Ochi, Kento; Kamiura, Moto			Overtaking method based on sand-sifter mechanism: Why do optimistic value functions find optimal solutions in multi-armed bandit problems?	BIOSYSTEMS			English	Article						Exploration-exploitation dilemma; Multi-armed bandit problem; Confidence interval; UCB algorithm; Optimism	CONFIDENCE-INTERVALS; PROPORTION; VARIANCE	A multi-armed bandit problem is a search problem on which a learning agent must select the optimal arm among multiple slot machines generating random rewards. UCB algorithm is one of the most popular methods to solve multi-armed bandit problems. It achieves logarithmic regret performance by coordinating balance between exploration and exploitation. Since UCB algorithms, researchers have empirically known that optimistic value functions exhibit good performance in multi-armed bandit problems. The terms optimistic or optimism might suggest that the value function is sufficiently larger than the sample mean of rewards. The first definition of UCB algorithm is focused on the optimization of regret, and it is not directly based on the optimism of a value function. We need to think the reason why the optimism derives good performance in multi-armed bandit problems. In the present article, we propose a new method, which is called Overtaking method, to solve multi-armed bandit problems. The value function of the proposed method is defined as an upper bound of a confidence interval with respect to an estimator of expected value of reward: the value function asymptotically approaches to the expected value of reward from the upper bound. If the value function is larger than the expected value under the asymptote, then the learning agent is almost sure to be able to obtain the optimal arm. This structure is called sand-sifter mechanism, which has no regrowth of value function of suboptimal arms. It means that the learning agent can play only the current best arm in each time step. Consequently the proposed method achieves high accuracy rate and low regret and some value functions of it can outperform UCB algorithms. This study suggests the advantage of optimism of agents in uncertain environment by one of the simplest frameworks. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Ochi, Kento; Kamiura, Moto] Tokyo Denki Univ, Grad Sch Sci & Engn, Hiki, Saitama, Japan; [Kamiura, Moto] Tokyo Denki Univ, Sch Sci & Engn, Hiki, Saitama, Japan; [Kamiura, Moto] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan	Kamiura, M (reprint author), Tokyo Denki Univ, Sch Sci & Engn, Hiki, Saitama, Japan.	kamiura@mail.dendai.c.jp					Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Wallis S, 2013, J QUANT LINGUIST, V20, P178, DOI 10.1080/09296174.2013.799918; ROBBINS H, 1952, B AM MATH SOC, V58, P527, DOI 10.1090/S0002-9904-1952-09620-8; Audibert JY, 2009, THEOR COMPUT SCI, V410, P1876, DOI 10.1016/j.tcs.2009.01.016; Babaioff M, 2009, 10TH ACM CONFERENCE ON ELECTRONIC COMMERCE - EC 2009, P79; Bubeck S, 2011, THEOR COMPUT SCI, V412, P1832, DOI 10.1016/j.tcs.2010.12.059; Bubeck Sebastien, 2012, Foundations and Trends in Machine Learning, V5, DOI 10.1561/2200000024; Devanur NR, 2009, 10TH ACM CONFERENCE ON ELECTRONIC COMMERCE - EC 2009, P99; Fox E., 2012, RAINY BRAIN SUNNY BR; Gelly S., 2006, ON LIN TRAD EXPL EXP; Gelly S., 2006, 6062 INRIA; Oyo K, 2013, PROCEDIA COMPUT SCI, V24, P194, DOI 10.1016/j.procs.2013.10.043; LAI TL, 1985, ADV APPL MATH, V6, P4, DOI 10.1016/0196-8858(85)90002-8; Ochi K, 2013, PROCEDIA COMPUT SCI, V24, P126, DOI 10.1016/j.procs.2013.10.035; Ross TD, 2003, COMPUT BIOL MED, V33, P509, DOI 10.1016/S0010-4825(03)00019-2; Salomon A, 2014, THEOR COMPUT SCI, V519, P46, DOI 10.1016/j.tcs.2013.09.019; Sauro J., 2005, P HUM FACT ERG SOC A, V49, P2100; Shepperd JA, 2002, PSYCHOL BELG, V42, P65; Shinohara S, 2007, T JAPANESE SOC ARTIF, V22, P58, DOI 10.1527/tjsai.22.58; Sturtevant NR, 2008, LECT NOTES COMPUT SC, V5131, P37, DOI 10.1007/978-3-540-87608-3_4; Sutton R., 1998, REINFORCEMENT LEARNI; Takahashi T., 2010, SYMMETRY CULTURE SCI, V21, P275; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0303-2647	1872-8324		BIOSYSTEMS	Biosystems	SEP	2015	135						55	65		10.1016/j.biosystems.2015.06.009		11	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CR3SS	WOS:000361254000006		
J	Nemoto, MW; Nozaki-Taguchi, N; Togasaki, G; Kanazawa, A; Kurokawa, M; Harada, R; Kobayashi, H; Isono, S; Uno, T				Nemoto, Miho Watanabe; Nozaki-Taguchi, Natsuko; Togasaki, Gentaro; Kanazawa, Aid; Kurokawa, Marie; Harada, Rintarou; Kobayashi, Hiroki; Isono, Shiroh; Uno, Takashi			New approach to relieving pain and distress during high-dose-rate intracavitary irradiation for cervical cancer	BRACHYTHERAPY			English	Article						Anesthesia; Intravenous; Cervical cancer; High-dose-rate intracavitary irradiation	PROCEDURAL SEDATION; RATE BRACHYTHERAPY; RADIOTHERAPY; ANESTHESIA; ANALGESIA; CARCINOMA; PATTERNS; JAPAN; CARE	BACKGROUND AND PURPOSE: To relieve the pain and distress experienced by women who undergo high-dose-rate intracavitary radiotherapy (HDR-ICRT) for cervical cancer and to improve the current status of gynecologic brachytherapy in Japan, a new intravenous anesthetic protocol involving the administration of a combination of propofol and ketamine was developed. The primary aim of this study is to investigate the efficacy and safety of this new anesthetic protocol during HDR-ICRT for cervical cancer. METHODS AND MATERIALS: All the patients who were diagnosed with cervical cancer between December 2008 and February 2011, treated with three-channel brachytherapy and subjected to the new sedation protocol, were evaluated. A visual analog scale (VAS) was used to assess the pain during brachytherapy, and we collected VAS score at the next HDR-ICRT. Toxicities were graded using the Common Toxicity Criteria, version 3. RESULTS: A total of 178 sessions of HDR-ICRT were delivered to 57 patients. The patients' median VAS pain score was 0 (range, 0-10). The most frequent side effect was Grade 1-2 nausea, which occurred in 33 sessions (34%). However, 13 of 14 patients received concurrent cisplatin chemotherapy. None of the patients experienced Grade 3 or 4 adverse events. CONCLUSIONS: We have demonstrated that our new intravenous anesthetic protocol produces appropriate effects and can be performed by radiation oncologists who were required to finish training in basic life support and the cooperative system of emergency according to in-house guideline. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.	[Nemoto, Miho Watanabe; Kobayashi, Hiroki; Uno, Takashi] Chiba Univ, Dept Radiol & Radiat Oncol, Grad Sch Med, Chiba 2608677, Japan; [Nemoto, Miho Watanabe; Togasaki, Gentaro; Kanazawa, Aid; Kurokawa, Marie; Harada, Rintarou; Kobayashi, Hiroki; Uno, Takashi] Chiba Univ Hosp, Dept Radiol, Chiba, Japan; [Nozaki-Taguchi, Natsuko; Isono, Shiroh] Chiba Univ Hosp, Dept Anesthesiol, Chiba, Japan	Nemoto, MW (reprint author), Chiba Univ, Dept Radiol & Radiat Oncol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	mwatanabe@hospital.chiba-u.jp			JSPS KAKENHI [25861073]	This work was supported by JSPS KAKENHI (grant number, 25861073).	RAMSAY MAE, 1974, BRIT MED J, V2, P656; CORN BW, 1994, GYNECOL ONCOL, V53, P294, DOI 10.1006/gyno.1994.1137; Nag S, 2000, INT J RADIAT ONCOL, V48, P201, DOI 10.1016/S0360-3016(00)00497-1; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Willman EV, 2007, ANN EMERG MED, V49, P23, DOI 10.1016/j.annemergmed.2006.08.002; Toita T, 2008, INT J RADIAT ONCOL, V70, P788, DOI 10.1016/j.ijrobp.2007.10.045; Arora Sanjay, 2008, West J Emerg Med, V9, P20; Benrath J, 2006, BRIT J ANAESTH, V96, P195, DOI 10.1093/bja/aei301; Borker A, 2006, INDIAN PEDIATR, V43, P309; Chen HC, 1998, INT J RADIAT ONCOL, V42, P541, DOI 10.1016/S0360-3016(98)00243-0; Cooper NA, 2010, BMJ-BRIT MED J, V23, pc1130, DOI DOI 10.1136/BMI.C1130; Kwekkeboom Kristine L, 2009, J Support Oncol, V7, P108; Lim KHC, 2004, AM J CLIN ONCOL-CANC, V27, P449, DOI 10.1097/01.coc.0000128723.00352.ad; Mayr NA, 1998, INT J RADIAT ONCOL, V42, P1049, DOI 10.1016/S0360-3016(98)00286-7; Smith MD, 2002, BRIT J ANAESTH, V88, P270, DOI 10.1093/bja/88.2.270; Toita T, 2005, JPN J CLIN ONCOL, V35, P139, DOI 10.1093/jjcolhyi047	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1538-4721	1873-1449		BRACHYTHERAPY	Brachytherapy	SEP-OCT	2015	14	5					642	647		10.1016/j.brachy.2015.04.009		6	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CR1JG	WOS:000361080400008		
J	Laakso, I; Tanaka, S; Koyama, S; De Santis, V; Hirata, A				Laakso, Ilkka; Tanaka, Satoshi; Koyama, Soichiro; De Santis, Valerio; Hirata, Akimasa			Inter-subject Variability in Electric Fields of Motor Cortical tDCS	BRAIN STIMULATION			English	Article						tDCS; Inter-subject variability; Electric field; Finite-element method; Motor cortex	DIRECT-CURRENT STIMULATION; NONINVASIVE BRAIN-STIMULATION; CORTEX; EXCITABILITY; DETERMINANTS; MONTAGES; SURFACE; HUMANS; ADULTS	Background: The sources of inter-subject variability in the efficacy of transcranial direct current stimulation (tDCS) remain unknown. One potential source of variations is the brain's electric field, which varies according to each individual's anatomical features. Objective: We employed an approach that combines imaging and computational modeling to quantitatively study the extent and primary causes of inter-subject variation in tDCS electric fields. Methods: Anatomically-accurate models of the head and brain of 24 males (age: 38.63 +/- 11.24 years) were constructed from structural MRI. Finite-element method was used to computationally estimate the electric fields for tDCS of the motor cortex. Surface-based inter-subject registration of the electric field and functional MRI data was used for group level statistical analysis. Results: We observed large differences in each individual's electric field patterns. However, group level analysis revealed that the average electric fields concentrated in the vicinity of the primary motor cortex. The variations in the electric fields in the hand motor area could be characterized by a normal distribution with a standard deviation of approximately 20% of the mean. The cerebrospinal fluid (CSF) thickness was the primary factor influencing an individual's electric field, thereby explaining 50% of the inter-individual variability, a thicker layer of CSF decreasing the electric field strength. Conclusions: The variability in the electric fields is related to each individual's anatomical features and can only be controlled using detailed image processing. Age was found to have a slight negative effect on the electric field, which might have implications on tDCS studies on aging brains. (C) 2015 Elsevier Inc. All rights reserved.	[Laakso, Ilkka; De Santis, Valerio; Hirata, Akimasa] Nagoya Inst Technol, Dept Comp Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tanaka, Satoshi] Hamamatsu Univ Sch Med, Psychol Lab, Hamamatsu, Shizuoka 4313192, Japan; [Koyama, Soichiro] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 4448585, Japan; [Koyama, Soichiro] Grad Univ Adv Studies, Sch Life Sci, Miura, Kanagawa 2400193, Japan	Laakso, I (reprint author), Nagoya Inst Technol, Dept Comp Sci & Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	laakso.ilkka@nitech.ac.jp	Hirata, Akimasa/I-8245-2012; 	Hirata, Akimasa/0000-0001-8336-1140; De Santis, Valerio/0000-0001-6223-744X	Konica Minolta Science and Technology Foundation	This work was partly supported by Konica Minolta Science and Technology Foundation.	Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Truong DQ, 2013, NEUROIMAGE-CLIN, V2, P759, DOI 10.1016/j.nicl.2013.05.011; Nitsche MA, 2001, NEUROLOGY, V57, P1899; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Kim JH, 2014, NEUROSCI LETT, V564, P6, DOI 10.1016/j.neulet.2014.01.054; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Opitz A, 2015, NEUROIMAGE, V109, P140, DOI 10.1016/j.neuroimage.2015.01.033; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Laakso I, 2012, PHYS MED BIOL, V57, P7753, DOI 10.1088/0031-9155/57/23/7753; Datta A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036018; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Bai SW, 2014, NEUROIMAGE, V87, P332, DOI 10.1016/j.neuroimage.2013.11.015; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Parazzini M, 2011, IEEE T BIO-MED ENG, V58, P1773, DOI 10.1109/TBME.2011.2116019; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Suh HS, 2012, PHYS MED BIOL, V57, P6961, DOI 10.1088/0031-9155/57/21/6961; Furubayashi T, 2008, EXP BRAIN RES, V185, P279, DOI 10.1007/s00221-007-1149-z; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hummel FC, 2008, BRAIN STIMUL, V1, P370, DOI 10.1016/j.brs.2008.09.003; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Friston KJ, 1994, HUM BRAIN MAPP, V2, P5678; Fujiyama H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00115; Heise KF, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00146; Krause Beatrix, 2014, Front Syst Neurosci, V8, P25, DOI 10.3389/fnsys.2014.00025; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Neuling Toralf, 2012, Front Psychiatry, V3, P83; Noetscher GM, 2014, IEEE T BIO-MED ENG, V61, P2488, DOI 10.1109/TBME.2014.2322774; Parazzini M, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S012906571430006X; Shahid SS, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036002; Tanaka Satoshi, 2009, Brain and Nerve (Tokyo), V61, P53; Tremblay S, 2014, BRAIN STIMUL, V7, P773, DOI 10.1016/j.brs.2014.10.003; Wagner S, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016002; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003	37	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	SEP-OCT	2015	8	5					906	913		10.1016/j.brs.2015.05.002		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CR0ME	WOS:000361012000010		
J	Inoue, S; Abe, R; Tanaka, Y; Kawaguchi, M				Inoue, S.; Abe, R.; Tanaka, Y.; Kawaguchi, M.			Tracheal intubation by trainees does not alter the incidence or duration of postoperative sore throat and hoarseness: a teaching hospital-based propensity score analysis	BRITISH JOURNAL OF ANAESTHESIA			English	Article						airway, complications; complications, tracheal intubation; education, untrained personnel	ADVERSE EVENTS; SURGERY; ANESTHESIA; COMPLAINTS; LIDOCAINE; CUFF	Background: Postoperative throat complications, such as sore throat and hoarseness, are frequent complications of tracheal intubation. To assess whether severity of throat complications is related to the experience of physicians performing tracheal intubation, we compared the incidence and duration of postoperative sore throat and hoarseness and patient satisfaction between tracheal intubation performed by trainees and experienced consultant anaesthetists. Methods: This is a retrospective review of an institutional registry containing records of 21 606 patients undergoing general anaesthesia and was conducted with ethics board approval. All tracheal intubations by trainees were performed under the supervision of consultant anaesthetists. To avoid channel bias, the propensity score analysis was used to generate a set of matched cases (intubations by trainees) and controls (intubations by anaesthetists), yielding 3465 (sore throat) and 3267 (hoarseness) matched patient pairs. The incidence and sustained rate of symptoms were compared as primary outcomes. We also compared patient satisfaction with perioperative care. Results: After propensity score matching, there was no difference between tracheal intubation by trainees and tracheal intubation by consultant anaesthetists in the incidences of sore throat (32.9 vs 32.6%, P=0.84) or hoarseness (35.8 vs 35.2%, P=0.60). Odds ratios and 95% confidence intervals for tracheal intubation by trainees were 1.01 (0.91-1.12) for sore throat and 1.03 (0.93-1.14) for hoarseness. The rates of sustained sore throat and hoarseness over the course were low (P=0.85 and P=0.67, respectively). Hazard ratios and 95% confidence intervals for tracheal intubation by trainees were 0.99 (0.94-1.05) for sustained sore throat and 0.99 (0.93-1.05) for sustained hoarseness. Patient satisfaction did not differ between matched groups (P=0.66 and P=0.83). Conclusions: Tracheal intubation by trainees under the supervision of consultant anaesthetists did not worsen the postoperative airway outcomes, such as sore throat and hoarseness.	[Inoue, S.] Nara Med Univ, Div Intens Care, Kashihara, Nara 6348522, Japan; [Abe, R.; Tanaka, Y.; Kawaguchi, M.] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara 6348522, Japan	Inoue, S (reprint author), Nara Med Univ, Div Intens Care, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	seninoue@naramed-u.ac.jp					CHRISTENSEN AM, 1994, BRIT J ANAESTH, V73, P786, DOI 10.1093/bja/73.6.786; Hirsch-Allen AJ, 2010, CAN J ANESTH, V57, P823, DOI 10.1007/s12630-010-9345-x; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Higgins PP, 2002, BRIT J ANAESTH, V88, P582, DOI 10.1093/bja/88.4.582; Biro P, 2005, EUR J ANAESTH, V22, P307, DOI 10.1017/S0265021505000529; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Weingart SN, 2005, J GEN INTERN MED, V20, P830, DOI 10.1111/j.1525-1497.2005.0180.x; McHardy FE, 1999, ANAESTHESIA, V54, P444, DOI 10.1046/j.1365-2044.1999.00780.x; Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956; Combes X, 2001, ANESTHESIOLOGY, V95, P1120, DOI 10.1097/00000542-200111000-00015; Hara K, 2005, ACTA ANAESTH SCAND, V49, P463, DOI 10.1111/j.1399-6576.2005.00632.x; Jaensson M, 2012, ACTA ANAESTH SCAND, V56, P1306, DOI 10.1111/j.1399-6576.2012.02771.x; Kloub Rula, 2001, Middle East Journal of Anesthesiology, V16, P29; Navarro RM, 1997, J CLIN ANESTH, V9, P394, DOI 10.1016/S0952-8180(97)00068-8; Orandi Amirali, 2013, Anesth Pain Med, V3, P243, DOI 10.5812/aapm.11416; Schmidt UH, 2008, ANESTHESIOLOGY, V109, P973, DOI 10.1097/ALN.0b013e31818ddb90; Taylor BB, 2008, MED CARE, V46, P224, DOI 10.1097/MLR.0b013e3181589ba4; Tazeh-kand NF, 2010, ANESTH ANALG, V111, P895, DOI 10.1213/ANE.0b013e3181c8a5a2	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	SEP	2015	115	3					463	469		10.1093/bja/aev234		7	Anesthesiology	Anesthesiology	CR2WL	WOS:000361191400021		
J	Feilchenfeldt, J; Varga, Z; Siano, M; Grabsch, HI; Held, U; Schuknecht, B; Trip, A; Hamaguchi, T; Gut, P; Balague, O; Khanfir, K; Diebold, J; Jochum, W; Shoji, H; Kushima, R; Wagner, D; Shimada, Y; Cats, A; Knuth, A; Moch, H; Aebi, S; Hofer, S				Feilchenfeldt, J.; Varga, Z.; Siano, M.; Grabsch, H. I.; Held, U.; Schuknecht, B.; Trip, A.; Hamaguchi, T.; Gut, P.; Balague, O.; Khanfir, K.; Diebold, J.; Jochum, W.; Shoji, H.; Kushima, R.; Wagner, D.; Shimada, Y.; Cats, A.; Knuth, A.; Moch, H.; Aebi, S.; Hofer, S.			Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)	BRITISH JOURNAL OF CANCER			English	Article						HER2; gastro-oesophageal adenocarcinoma; CNS metastases; lepto-meningeal carcinomatosis; brain; ethnicity	GASTRIC-CANCER; MICROSATELLITE INSTABILITY; E-CADHERIN; RECURRENCE; EXPRESSION; PROGNOSIS; CARCINOMA; SURVIVAL; SYSTEM; SITES	Background: Gastro-oesophageal adenocarcinomas rarely metastasize to the central nervous system (CNS). The role of the human epidermal growth factor receptor 2 (HER2) in patients with these cancers and CNS involvement is presently unknown. Patients and Methods: A multicentre registry was established to collect data from patients with gastro-oesophageal adenocarcinomas and CNS involvement both retrospectively and prospectively. Inclusion in the study required a predefined clinical data set, a central neuro-radiological or histopathological confirmation of metastatic CNS involvement and central assessment of HER2 by immunohistochemistry (IHC) and in situ hybridisation (ISH). In addition, expression of E-cadherin and DNA mismatch repair (MMR) proteins were assessed by IHC. Results: One hundred patients fulfilled the inclusion criteria. The population's median age was 59 years (interquartile range: 54-68), of which 85 (85%) were male. Twenty-five patients were of Asian and 75 of Caucasian origin. HER2 status was positive in 36% (95% CI: 26.6-46.2) of cases. Median time from initial diagnosis to the development of brain metastases (BMets) or leptomeningeal carcinomatosis (LC) was 9.9 months (95% CI: 8.5-15.0). Median overall survival from diagnosis was 16.9 months (95% CI: 14.0-20.7) and was not related to the HER2 status. E-cadherin loss was observed in 9% of cases and loss of expression in at least one DNA MMR proteins in 6%. Conclusions: The proportion of a positive HER2 status in patients with gastro-oesophageal adenocarcinoma and CNS involvement was higher than expected. The impact of anti-HER2 therapies should be studied prospectively.	[Feilchenfeldt, J.] Hop Valais, Serv Oncol Med, CH-1951 Sion, Switzerland; [Feilchenfeldt, J.; Knuth, A.] Hamad Med Corp, NCCCR, Doha, Qatar; [Varga, Z.; Moch, H.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Siano, M.] Kantonsspital St Gallen, Dept Oncol & Hematol, CH-9700 St Gallen, Switzerland; [Grabsch, H. I.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pathol, NL-6229 HX Maastricht, Netherlands; [Held, U.] Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, CH-8091 Zurich, Switzerland; [Schuknecht, B.] MRI Med Radiol Inst, Neuroradiol, CH-8001 Zurich, Switzerland; [Trip, A.] Netherlands Canc Inst, Dept Radiat Oncol, NL-1066 Amsterdam, Netherlands; [Hamaguchi, T.; Shoji, H.; Shimada, Y.] Natl Canc Ctr Hosp Tokyo, Gastrointestinal Med Oncol Div, Tokyo 1040045, Japan; [Gut, P.] Luzerner Kantonsspital, Dept Radiooncol, CH-6000 Luzern, Switzerland; [Balague, O.] Netherlands Canc Inst, Dept Pathol, NL-1066 Amsterdam, Netherlands; [Khanfir, K.] Hopl Valais, Dept Radiooncol, CH-1951 Sion, Switzerland; [Diebold, J.] Luzerner Kantonsspital, Inst Pathol, CH-6000 Luzern, Switzerland; [Jochum, W.] Kantonsspital, Inst Pathol, CH-9700 St Gallen, Switzerland; [Kushima, R.] Shiga Univ Med Sci, Dept Clin Lab Med & Pathol, Otsu, Shiga 5202192, Japan; [Wagner, D.] CHU Vaudois, Dept Oncol, CH-1011 Lausanne, Switzerland; [Cats, A.] Netherlands Canc Inst, Dept Gastroenterol, NL-1066 Amsterdam, Netherlands; [Knuth, A.; Hofer, S.] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland; [Aebi, S.; Hofer, S.] Luzerner Kantonsspital, Dept Oncol, CH-6000 Luzern, Switzerland	Hofer, S (reprint author), Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland.	silvia.hofer@luks.ch	Aebi, Stefan/F-2004-2010	Aebi, Stefan/0000-0002-3383-9449	Netherlands Cancer Institute Core Facility Molecular Pathology and Biobanking (CFMPM); ROCHE Pharma, Switzerland	We would like to acknowledge the Netherlands Cancer Institute Core Facility Molecular Pathology and Biobanking (CFMPM) for support. This work was supported in part by an unrestricted grant from ROCHE Pharma, Switzerland (SH).	Abu Hejleh T, 2012, WORLD J GASTROINTEST, V4, P103; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Bang YJ, 2010, LANCET, V376, P1302; Varga Z, 2012, BREAST CANCER RES TR, V132, P925, DOI 10.1007/s10549-011-1642-8; Bozzetti C, 2011, BRIT J CANCER, V104, P1372, DOI 10.1038/bjc.2011.121; Giglio P, 2005, CANCER, V103, P2355, DOI 10.1002/cncr.21082; Janjigian YY, 2012, ANN ONCOL, V23, P2656, DOI 10.1093/annonc/mds104; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Pestalozzi BC, 2006, ANN ONCOL, V17, P935, DOI 10.1093/annonc/mdl064; Lee HS, 2002, MODERN PATHOL, V15, P632, DOI 10.1038/modpathol.3880578; Al-Refaie WB, 2008, CANCER, V113, P461, DOI 10.1002/cncr.23572; Corso G, 2013, J CLIN ONCOL, V31, P868, DOI 10.1200/JCO.2012.44.4612; Kunz PL, 2012, J CLIN ONCOL, V30, P3507, DOI 10.1200/JCO.2011.35.8028; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Warneke VS, 2013, ANN ONCOL, V24, P725, DOI 10.1093/annonc/mds528; D'Angelica M, 2004, ANN SURG, V240, P808, DOI 10.1097/01.sla.0000143245.28656.15; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Warneke VS, 2013, DIAGN MOL PATHOL, V22, P127, DOI 10.1097/PDM.0b013e318284188e; Choi YY, 2014, J SURG ONCOL, V110, P129, DOI 10.1002/jso.23618; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Musolino A, 2011, CANCER-AM CANCER SOC, V117, P1837, DOI 10.1002/cncr.25771; Go PH, 2011, CANCER-AM CANCER SOC, V117, P3630, DOI 10.1002/cncr.25940; York JE, 1999, ANN SURG ONCOL, V6, P771, DOI 10.1007/s10434-999-0771-3; Maehara Y, 2000, BRIT J SURG, V87, P353, DOI 10.1046/j.1365-2168.2000.01358.x; Blay C, 2015, ACTA ONCOL, V1, P3; Bosman FT, 2010, IARC WHO CLASSIFICAT, V43, P3; CI5, 2015, CANC INC 5 CONT EL V; Kafka A, 2014, INT J MOL SCI, V15, P10635, DOI 10.3390/ijms150610635; Preusser M, 2013, ANTICANCER RES, V33, P1065; R Core Team, 2015, R LANG ENV STAT COMP; Shibata R, 2014, MOL CLIN ONCOL, V2, P751; Uchikado Y, 2011, GASTRIC CANCER, V14, P41, DOI 10.1007/s10120-011-0004-x; Van Cutsem E, 2014, GASTRIC CANCER, V18, P476; Wadhwa R, 2013, ONCOLOGY-BASEL, V85, P204, DOI 10.1159/000354736	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0007-0920	1532-1827		BRIT J CANCER	Br. J. Cancer	SEP 1	2015	113	5					716	721		10.1038/bjc.2015.279		6	Oncology	Oncology	CQ6PU	WOS:000360727200004		
J	Nagle, CM; Dixon, SC; Jensen, A; Kjaer, SK; Modugno, F; deFazio, A; Fereday, S; Hung, J; Johnatty, SE; Fasching, PA; Beckmann, MW; Lambrechts, D; Vergote, I; Van Nieuwenhuysen, E; Lambrechts, S; Risch, HA; Rossing, MA; Doherty, JA; Wicklund, KG; Chang-Claude, J; Goodman, MT; Ness, RB; Moysich, K; Heitz, F; du Bois, A; Harter, P; Schwaab, I; Matsuo, K; Hosono, S; Goode, EL; Vierkant, RA; Larson, MC; Fridley, BL; Hogdall, C; Schildkraut, JM; Weber, RP; Cramer, DW; Terry, KL; Bandera, EV; Paddock, L; Rodriguez-Rodriguez, L; Wentzensen, N; Yang, HP; Brinton, LA; Lissowska, J; Hogdall, E; Lundvall, L; Whittemore, A; McGuire, V; Sieh, W; Rothstein, J; Sutphen, R; Anton-Culver, H; Ziogas, A; Pearce, CL; Wu, AH; Webb, PM				Nagle, C. M.; Dixon, S. C.; Jensen, A.; Kjaer, S. K.; Modugno, F.; deFazio, A.; Fereday, S.; Hung, J.; Johnatty, S. E.; Fasching, P. A.; Beckmann, M. W.; Lambrechts, D.; Vergote, I.; Van Nieuwenhuysen, E.; Lambrechts, S.; Risch, H. A.; Rossing, M. A.; Doherty, J. A.; Wicklund, K. G.; Chang-Claude, J.; Goodman, M. T.; Ness, R. B.; Moysich, K.; Heitz, F.; du Bois, A.; Harter, P.; Schwaab, I.; Matsuo, K.; Hosono, S.; Goode, E. L.; Vierkant, R. A.; Larson, M. C.; Fridley, B. L.; Hogdall, C.; Schildkraut, J. M.; Weber, R. P.; Cramer, D. W.; Terry, K. L.; Bandera, E. V.; Paddock, L.; Rodriguez-Rodriguez, L.; Wentzensen, N.; Yang, H. P.; Brinton, L. A.; Lissowska, J.; Hogdall, E.; Lundvall, L.; Whittemore, A.; McGuire, V.; Sieh, W.; Rothstein, J.; Sutphen, R.; Anton-Culver, H.; Ziogas, A.; Pearce, C. L.; Wu, A. H.; Webb, P. M.		Australian Ovarian Canc Study Grp; Ovarian Canc Assoc Consortium	Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium	BRITISH JOURNAL OF CANCER			English	Article						ovarian cancer; obesity; overall survival; progression-free survival; ovarian cancer-specific survival	PROTEIN EXPRESSION; HORMONE-THERAPY; CELL-GROWTH; IN-VITRO; RISK; ESTROGEN; IMPACT; MORTALITY; GENE; TIME	Background: Observational studies have reported a modest association between obesity and risk of ovarian cancer; however, whether it is also associated with survival and whether this association varies for the different histologic subtypes are not clear. We undertook an international collaborative analysis to assess the association between body mass index (BMI), assessed shortly before diagnosis, progression-free survival (PFS), ovarian cancer-specific survival and overall survival (OS) among women with invasive ovarian cancer. Methods: We used original data from 21 studies, which included 12 390 women with ovarian carcinoma. We combined study-specific adjusted hazard ratios (HRs) using random-effects models to estimate pooled HRs (pHR). We further explored associations by histologic subtype. Results: Overall, 6715 (54%) deaths occurred during follow-up. A significant OS disadvantage was observed for women who were obese (BMI: 30-34.9, pHR: 1.10 (95% confidence intervals (CIs): 0.99-1.23); BMI: >= 35, pHR: 1.12 (95% CI: 1.01-1.25)). Results were similar for PFS and ovarian cancer-specific survival. In analyses stratified by histologic subtype, associations were strongest for women with low-grade serous (pHR: 1.12 per 5 kg m(-2)) and endometrioid subtypes (pHR: 1.08 per 5 kg m(-2)), and more modest for the high-grade serous (pHR: 1.04 per 5 kg m(-2)) subtype, but only the association with high-grade serous cancers was significant. Conclusions: Higher BMI is associated with adverse survival among the majority of women with ovarian cancer.	[Nagle, C. M.; Dixon, S. C.; Webb, P. M.] QIMR Berghofer Med Res Inst, Populat Hlth Dept, Brisbane, Qld, Australia; [Dixon, S. C.; Webb, P. M.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Jensen, A.; Kjaer, S. K.; Hogdall, E.] Danish Canc Soc Res Ctr, Virus Lifestyle & Genes, Copenhagen, Denmark; [Kjaer, S. K.; Hogdall, C.; Lundvall, L.] Univ Copenhagen, Rigshosp, Dept Gynecol, DK-2100 Copenhagen, Denmark; [Modugno, F.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Modugno, F.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Modugno, F.] Magee Womens Res Inst, Womens Canc Res Program, Philadelphia, PA USA; [Modugno, F.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [deFazio, A.; Hung, J.] Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW 2145, Australia; [deFazio, A.; Hung, J.] Univ Sydney, Westmead Millennium Inst, Ctr Canc Res, Westmead, NSW 2145, Australia; [Fereday, S.; Australian Ovarian Canc Study Grp] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Johnatty, S. E.] QIMR Berghofer Med Res Inst, Genet & Computat Biol Dept, Brisbane, Qld, Australia; [Fasching, P. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fasching, P. A.; Beckmann, M. W.] Univ Erlangen Nurnberg, Comprehens Canc Ctr Erlangen EMN, Dept Gynecol & Obstet, Univ Hosp Erlangen, D-91054 Erlangen, Germany; [Lambrechts, D.] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, D.] Univ Leuven, Dept Oncol, Leuven, Belgium; [Vergote, I.; Van Nieuwenhuysen, E.; Lambrechts, S.] Univ Hosp Leuven, Leuven Canc Inst, Dept Obstet & Gynecol, Leuven, Belgium; [Risch, H. A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Rossing, M. A.; Wicklund, K. G.] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA; [Doherty, J. A.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH USA; [Chang-Claude, J.] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Goodman, M. T.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Ness, R. B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Moysich, K.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Heitz, F.; du Bois, A.; Harter, P.] Knappschaft GmbH, Evang Huyssens Stiftung, Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Heitz, F.; du Bois, A.; Harter, P.] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany; [Schwaab, I.] Inst Humangenet Wiesbaden, Wiesbaden, Germany; [Matsuo, K.] Kyushu Univ, Dept Prevent Med, Fac Med Sci, Nagoya, Aichi, Japan; [Hosono, S.] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Goode, E. L.; Vierkant, R. A.; Larson, M. C.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Fridley, B. L.] Univ Kansas, Dept Biostat, Kansas City, KS USA; [Schildkraut, J. M.; Weber, R. P.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Cramer, D. W.; Terry, K. L.] Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Bandera, E. V.; Rodriguez-Rodriguez, L.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Paddock, L.] New Jersey State Canc Registry, Trenton, NJ USA; [Wentzensen, N.; Yang, H. P.; Brinton, L. A.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Lissowska, J.] M Sklodowska Curie Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Hogdall, E.] Univ Copenhagen, Herlev Hosp, Dept Pathol, Mol Unit, Copenhagen, Denmark; [Whittemore, A.; McGuire, V.; Sieh, W.; Rothstein, J.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Sutphen, R.] Univ S Florida, Coll Med, Epidemiol Ctr, Tampa, FL USA; [Anton-Culver, H.; Ziogas, A.] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Pearce, C. L.; Wu, A. H.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	Nagle, CM (reprint author), QIMR Berghofer Med Res Inst, Populat Hlth Dept, Brisbane, Qld, Australia.	christina.nagle@qimrberghofer.edu.au		Kjaer, Susanne/0000-0002-8347-1398	Ovarian Cancer Association Consortium; Ovarian Cancer Research Fund; National Institutes of Health [R01-CA61107, R01-CA95023, R01-CA126841, P01-CA17054, NIH-K07 CA095666, R01-CA83918, NIH-K22-CA138563, P30-CA072720, R01-CA074850, R01-CA080742, R01-CA112523, R01-CA087538, R01-CA058598, N01-CN-55424, N01-PC-67001, R01-CA122443, P50-CA136393, P30-CA15083, R01-CA076016, R01-CA054419, P50-CA105009, U01-CA71966, R01-CA016056, K07-CA143047, R01-CA106414, R01CA058860, R01CA092044, PSA042205]; Department of Defense [DAMD17-02-1-0666, W81XWH-10-1-02802, DAMD17-02-1-0669, DAMD17-01-1-0729, DAMD17-98-1-8659]; National Cancer Institute [K07-CA80668]; NIH/National Center for Research Resources/General Clinical Research Center [MO1-RR000056, P50-CA159981]; National Health and Medical Research Council of Australia; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Council of Queensland; Cancer Council of South Australia; Cancer Council of Tasmania; Cancer Foundation of Western Australia; National Health and Medical Research Council of Australia [199600, 400281]; Danish Cancer Society, Copenhagen, Denmark [94 222 52]; Mermaid I project; California Cancer Research Program [00-01389V-20170, R03-CA113148, R03-CA115195, N01-CN25403, 2II0200]; ELAN Funds of the University of Erlangen-Nuremberg; Nationaal Kankerplan; German Federal Ministry of Education and Research; Programme of Clinical Biomedical Research [01 GB 9401]; Ministry of Education, Science, Sports, Culture and Technology of Japan; Ministry Health, Labour and Welfare of Japan; Takeda Science Foundation; Mayo Foundation; Minnesota Ovarian Cancer Alliance; Fred C. and Katherine B. Andersen Foundation; Cancer Institute of New Jersey; Intramural Research Program of the National Cancer Institute; Cancer Prevention Institute of California [U01-CA69417]; American Cancer Society [CRTG-00-196-01-CCE]; Celma Mastry Ovarian Cancer Foundation; Lon V Smith Foundation [LVS-39420]; NHMRC; NHMRC Program [552429]; University of Sydney Cancer Research Fund; Cancer Institute NSW through the Sydney-West Translational Cancer Research Centre;  [K07-CA080668]	We are grateful to the family and friends of Kathryn Sladek Smith for their generous support of Ovarian Cancer Association Consortium through their donations to the Ovarian Cancer Research Fund. The Australian Ovarian Cancer Study Management Group (D Bowtell, G Chenevix-Trench, A deFazio, D Gertig, A Green and PM Webb) and ACS Investigators (A Green, P Parsons, N Hayward, PM Webb and D Whiteman) thank all the clinical and scientific collaborators (see http://www.aocstudy.org/) and the women who participated in these studies for their contribution. We thank Gilian Peuteman, Thomas Van Brussel and Dominiek Smeets for technical assistance (for BEL). The cooperation of the 32 Connecticut hospitals, including Stamford Hospital, in allowing patient access, is gratefully acknowledged. This study was approved by the State of Connecticut Department of Public Health Human Investigation Committee. Certain data used in this study were obtained from the Connecticut Tumor Registry in the Connecticut Department of Public Health. We assume full responsibility for analyses and interpretation of these data (for CON). The German Ovarian Cancer Study (GER) thank Ursula Eilber for competent technical assistance (for GER). Funding: The Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund. This work was supported by the following: National Institutes of Health (R01-CA61107 (for MAL); R01-CA95023 and R01-CA126841 (for HOP); P01-CA17054 (for USC); NIH-K07 CA095666, R01-CA83918, NIH-K22-CA138563 and P30-CA072720 (for NJO); (R01-CA074850 and R01-CA080742 (for CON); R01-CA112523 and R01-CA087538 (for DOV); R01-CA058598, N01-CN-55424 and N01-PC-67001 (for HAW); R01-CA122443, P50-CA136393 and P30-CA15083 (for MAC and MAY); R01-CA076016 (for NCO); R01-CA054419 and P50-CA105009 (for NEC); U01-CA71966, R01-CA016056 and K07-CA143047 (for STA); R01-CA106414 (for TBO); R01CA058860, R01CA092044 and PSA042205 (for UCI); Department of Defense (DAMD17-02-1-0666 (for NCO); W81XWH-10-1-02802 (for NEC); DAMD17-02-1-0669 (for HOP); DAMD17-01-1-0729 (for AUS); DAMD17-98-1-8659 (for TBO); National Cancer Institute K07-CA80668 (for HOP); NIH/National Center for Research Resources/General Clinical Research Center grant MO1-RR000056 and P50-CA159981 (for HOP); National Health and Medical Research Council of Australia, Cancer Councils of New South Wales, Victoria, Queensland, South Australia and Tasmania, Cancer Foundation of Western Australia; National Health and Medical Research Council of Australia (199600 and 400281) (for AUS); Danish Cancer Society, Copenhagen, Denmark (94 222 52) and the Mermaid I project (for MAL); FM supported by funding from K07-CA080668 (for HOP); California Cancer Research Program (00-01389V-20170, R03-CA113148, R03-CA115195, N01-CN25403 and 2II0200) (for USC); ELAN Funds of the University of Erlangen-Nuremberg (for BAV); Nationaal Kankerplan (for BEL); German Federal Ministry of Education and Research, Programme of Clinical Biomedical Research (01 GB 9401) and data management by the German Cancer Research Center (for GER); Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, Culture and Technology of Japan, by a Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from Ministry Health, Labour and Welfare of Japan, and by a grant from Takeda Science Foundation (for JPN); Mayo Foundation, Minnesota Ovarian Cancer Alliance, Fred C. and Katherine B.; Andersen Foundation (for MAC and MAY); Cancer Institute of New Jersey (for NJO); Intramural Research Program of the National Cancer Institute (for POL); Cancer Prevention Institute of California (U01-CA69417) (for STA); American Cancer Society (CRTG-00-196-01-CCE), Celma Mastry Ovarian Cancer Foundation (for TBO); and Lon V Smith Foundation grant LVS-39420 (for UCI). PW is supported by a Fellowship from NHMRC and CN is supported by NHMRC Program grant 552429 (for AUS). AdF is supported by the University of Sydney Cancer Research Fund and the Cancer Institute NSW through the Sydney-West Translational Cancer Research Centre (for AUS).	Merritt MA, 2008, INT J CANCER, V122, P170, DOI 10.1002/ijc.23017; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; Ramus SJ, 2008, INT J CANCER, V123, P380, DOI 10.1002/ijc.23448; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Lurie G, 2008, EPIDEMIOLOGY, V19, P237, DOI 10.1097/EDE.0b013e31816334c5; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Modugno F, 2012, ENDOCR-RELAT CANCER, V19, pR255, DOI 10.1530/ERC-12-0175; Modesitt SC, 2005, OBSTET GYNECOL SURV, V60, P683, DOI 10.1097/01.ogx.0000180866.62409.01; Pavelka JC, 2006, CANCER, V107, P1520, DOI 10.1002/cncr.22194; Merritt MA, 2013, HUM REPROD, V28, P1406, DOI 10.1093/humrep/des466; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Harter P, 2011, GYNECOL ONCOL, V121, P615, DOI 10.1016/j.ygyno.2011.02.014; Olsen CM, 2013, ENDOCR-RELAT CANCER, V20, P251, DOI 10.1530/ERC-12-0395; KARLAN BY, 1995, AM J OBSTET GYNECOL, V173, P97, DOI 10.1016/0002-9378(95)90176-0; Makowski L, 2014, GYNECOL ONCOL, V133, P90, DOI [10.1016/j.ygyno.2013.12.026, 10.1016/j.ygyno2013.12.026]; Parekh N, 2012, ANNU REV NUTR, V32, P311, DOI 10.1146/annurev-nutr-071811-150713; Goode EL, 2011, CANCER EPIDEM BIOMAR, V20, P1638, DOI 10.1158/1055-9965.EPI-11-0455; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Diaz ES, 2013, GYNECOL ONCOL, V129, P353, DOI 10.1016/j.ygyno.2013.02.006; Pike MC, 2004, FERTIL STERIL, V82, P186, DOI 10.1016/j.fertnstert.2004.03.013; Barb D, 2007, AM J CLIN NUTR, V86, p858S; Royar J, 2001, INT J CANCER, V95, P370, DOI 10.1002/1097-0215(20011120)95:6<370::AID-IJC1065>3.0.CO;2-T; du Bois A, 2003, J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Protani MM, 2012, CANCER PREV RES, V5, P901, DOI 10.1158/1940-6207.CAPR-12-0048; Sieh W, 2013, LANCET ONCOL, V14, P853, DOI 10.1016/S1470-2045(13)70253-5; Griggs JJ, 2012, J CLIN ONCOL, V30, P1553, DOI 10.1200/JCO.2011.39.9436; Terry KL, 2005, CANCER RES, V65, P5974, DOI 10.1158/0008-5472.CAN-04-3885; Goode EL, 2010, CLIN CANCER RES, V16, P995, DOI 10.1158/1078-0432.CCR-09-2553; Pal T, 2005, CANCER, V104, P2807, DOI 10.1002/cncr.21536; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; LANGDON SP, 1994, J STEROID BIOCHEM, V50, P131, DOI 10.1016/0960-0760(94)90019-1; Ziogas A, 2000, CANCER EPIDEM BIOMAR, V9, P103; Rossing MA, 2007, CANCER EPIDEM BIOMAR, V16, P2548, DOI 10.1158/1055-9965.EPI-07-0550; Risch HA, 2006, CANCER EPIDEM BIOMAR, V15, P1738, DOI 10.1158/1055-9965.EPI-06-0272; Wu AH, 2009, INT J CANCER, V124, P1409, DOI 10.1002/ijc.24091; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Au-Yeung G, 2014, GYNECOL ONCOL, V133, P16, DOI 10.1016/j.ygyno.2014.01.030; Bandera EV, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-40; Bodelon C, 2012, CANCER CAUSE CONTROL, V23, P1985, DOI 10.1007/s10552-012-0076-x; Chandran U, 2011, CANCER CAUSE CONTROL, V22, P563, DOI 10.1007/s10552-011-9728-5; Chen CC, 2013, INT J ONCOL, V42, P1113, DOI 10.3892/ijo.2013.1789; *COLL GROUP EP STU, 2012, PLOS MED, V0009; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Field Kathryn M, 2008, J Oncol Pract, V4, P108, DOI 10.1200/JOP.0832001; GALTIERDEREURE F, 1992, J CLIN ENDOCR METAB, V75, P1497, DOI 10.1210/jc.75.6.1497; Garcia-Closas M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-60; Gifkins D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-211; Goodman MT, 2008, ENDOCR-RELAT CANCER, V15, P1055, DOI 10.1677/ERC-08-0104; Hamajima N, 2001, ASIAN PAC J CANCER P, V2, P99; Hogdall E, 2010, PROTEOM CLIN APPL, V4, P940, DOI 10.1002/prca.200900171; Hua KQ, 2008, INT J ONCOL, V33, P959, DOI 10.3892/ijo_00000083; Lacour RA, 2011, GYNECOL ONCOL, V121, P358, DOI 10.1016/j.ygyno.2010.12.354; Lo-Ciganic WH, 2012, EPIDEMIOLOGY, V23, P311, DOI 10.1097/EDE.0b013e3182456ad3; McGuire V, 2004, AM J EPIDEMIOL, V160, P613, DOI 10.1093/aje/kwh284; Pal T, 2007, FAM CANCER, V6, P113, DOI 10.1007/s10689-006-9112-x; Poniewierski MS, 2008, J CLIN ONCOL S, V26; Ptak A, 2013, ENDOCRINE, V43, P394, DOI 10.1007/s12020-012-9788-7; Risum S, 2011, ACTA ONCOL, V50, P415, DOI 10.3109/0284186X.2010.500296; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schildkraut JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010061; Schildkraut JM, 2008, CANCER EPIDEM BIOMAR, V17, P585, DOI 10.1158/1055-9965.EPI-07-0596; Soegaard M, 2007, CANCER EPIDEM BIOMAR, V16, P1160, DOI 10.1158/1055-9965.EPI-07-0089; World Health Organization (WHO), 1995, PHYS STAT US INT ANT; Zhu J, 2012, ARCH GYNECOL OBSTET, V286, P729, DOI 10.1007/s00404-012-2368-5	66	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0007-0920	1532-1827		BRIT J CANCER	Br. J. Cancer	SEP 1	2015	113	5					817	826		10.1038/bjc.2015.245		10	Oncology	Oncology	CQ6PU	WOS:000360727200016		
J	Toda, T; Watanabe, M; Kawato, J; Kadin, ME; Higashihara, M; Kunisada, T; Umezawa, K; Horie, R				Toda, Takashi; Watanabe, Mariko; Kawato, Junji; Kadin, Marshall E.; Higashihara, Masaaki; Kunisada, Takao; Umezawa, Kazuo; Horie, Ryouichi			Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						anaplastic large cell lymphoma; classical Hodgkin lymphoma; anaplastic lymphoma kinase; STAT3; Brefeldin A	REED-STERNBERG CELLS; KAPPA-B ACTIVATION; ARF ACTIVATION; CD30; EXPRESSION; INHIBITOR; DISEASE; GENES; JUNB	To obtain further insights into the biological differences of anaplastic lymphoma kinase positive anaplastic large cell lymphoma (ALK+ ALCL) and classical Hodgkin lymphoma (HL), we screened microbial culture filtrates to search for compounds that would exert a significantly greater effect on the viability of ALK+ ALCL cell lines compared to HL cell lines and identified Brefeldin A (BFA) as a suitable candidate. BFA inhibited phosphorylation of ALK and its downstream molecule, signal transducer and activator of transcription 3 (STAT3), one of the central pathways for the survival of ALK+ ALCL cells. In HL cell lines BFA did not affect CD30 expression orconstitutive nuclear factor (NF)-B activity, both of which are critical forHL cell survival. BFA induced disruption of the Golgi apparatus in ALK+ ALCL cell lines, which was accompanied by a decrease in active ADP-ribosylation factor 1 (ARF1), whereas BFA had no significant effect on these parameters in HL cell lines. These results add extra insights into the biological distinction between ALK+ ALCL and HL cells and highlight the Golgi apparatus as a target for the treatment of ALK+ ALCL.	[Toda, Takashi; Kawato, Junji] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Tokyo 108, Japan; [Watanabe, Mariko; Higashihara, Masaaki; Horie, Ryouichi] Kitasato Univ, Sch Med, Dept Haematol, Sagamihara, Kanagawa 2520374, Japan; [Kadin, Marshall E.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Kadin, Marshall E.] Roger Williams Med Ctr, Dept Dermatol & Skin Surg, Providence, RI USA; [Kunisada, Takao] Meiji Seika Pharma Co Ltd, Biosci Inst, Odawara, Kanagawa, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med, Aichi, Japan	Horie, R (reprint author), Kitasato Univ, Sch Med, Dept Haematol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	rhorie@med.kitasato-u.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1101027];  [23590433];  [23590432];  [B23310163]	This work was supported in part by Grants-in-Aid for Scientific Research of Japan (23590433) (R.H.), (23590432) (M.W.) and (B23310163) (K.U.). This work was also supported in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, which is for Aichi Medical University 2011-2015 (S1101027) (K.U.).	Agostinelli C, 2008, J CLIN PATHOL, V61, P1160, DOI 10.1136/jcp.2008.055335; SU IJ, 1989, AM J PATHOL, V135, P439; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Bai RY, 2000, BLOOD, V96, P4319; Horie R, 2003, DRUG NEWS PERSPECT, V16, P649, DOI 10.1358/dnp.2003.16.10.829295; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Horie R, 2002, ONCOGENE, V21, P2493, DOI 10.1038/sj/onc/1205337; Marzec M, 2007, ONCOGENE, V26, P813, DOI 10.1038/sj.onc.1209843; Stein H, 2000, BLOOD, V96, P3681; Medeiros LJ, 2007, AM J CLIN PATHOL, V127, P707, DOI 10.1309/R2Q9CCUVTLRYC3H; Horie R, 2007, MICROBES INFECT, V9, P721, DOI 10.1016/j.micinf.2007.02.017; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Drexler HG, 2004, LEUKEMIA, V18, P1569, DOI 10.1038/sj.leu.2403465; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Horie R, 2004, CANCER CELL, V5, P353, DOI 10.1016/S1535-6108(04)00084-4; Johnson S., 2013, ASSESSMENT CELL VIAB; Ohashi Y, 2012, J BIOL CHEM, V287, P3885, DOI 10.1074/jbc.M111.316125; Pan HL, 2008, J BIOL CHEM, V283, P31087, DOI 10.1074/jbc.M806592200; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Takeiri M, 2012, ONCOL RES, V20, P7, DOI 10.3727/096504012X13425470196056; Watanabe M, 2012, AM J PATHOL, V180, P831, DOI 10.1016/j.ajpath.2011.10.007; Watanabe M, 2005, CANCER RES, V65, P7628, DOI 10.1158/0008-5472.CAN-05-0925; WEISS LM, 1995, BLOOD, V85, P2845	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	SEP	2015	170	6					837	846		10.1111/bjh.13508		10	Hematology	Hematology	CQ7BG	WOS:000360757200011		
J	Mizutani, S; Yoshida, T; Zhao, XY; Nimer, SD; Taniwaki, M; Okuda, T				Mizutani, Shinsuke; Yoshida, Tatsushi; Zhao, Xinyang; Nimer, Stephen D.; Taniwaki, Masafumi; Okuda, Tsukasa			Loss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasis	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						RUNX1; methylation; lymphocyte differentiation; transgenic mice models; leukaemia	ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM-CELLS; CORE-BINDING-FACTOR; TRANSCRIPTION-FACTOR; POINT MUTATIONS; AML1 GENE; CHROMOSOMAL TRANSLOCATIONS; THYMOCYTE DIFFERENTIATION; DEFINITIVE HEMATOPOIESIS	RUNX1 (previously termed AML1) is a frequent target of human leukaemia-associated gene aberrations, and it encodes the DNA-binding subunit of the Core-Binding Factor transcription factor complex. RUNX1 expression is essential for the initiation of definitive haematopoiesis, for steady-state thrombopoiesis, and for normal lymphocytes development. Recent studies revealed that protein arginine methyltransferase 1 (PRMT1), which accounts for the majority of the type I PRMT activity in cells, methylates two arginine residues in RUNX1 (R206 and R210), and these modifications inhibit corepressor-binding to RUNX1 thereby enhancing its transcriptional activity. In order to elucidate the biological significance of these methylations, we established novel knock-in mouse lines with non-methylable, double arginine-to-lysine (RTAMR-to-KTAMK) mutations in RUNX1. Homozygous Runx1(KTAMK/KTAMK) mice are born alive and appear normal during adulthood. However, Runx1(KTAMK/KTAMK) mice showed a reduction in CD3(+) T lymphoid cells and a decrease in CD4(+) T cells in peripheral lymphoid organs, in comparison to their wild-type littermates, leading to a reduction in the CD4(+) to CD8(+) T-cell ratio. These findings suggest that arginine-methylation of RUNX1 in the RTAMR-motif is dispensable for the development of definitive haematopoiesis and for steady-state platelet production, however this modification affects the role of RUNX1 in the maintenance of the peripheral CD4(+) T-cell population.	[Mizutani, Shinsuke; Yoshida, Tatsushi; Okuda, Tsukasa] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Biochem & Mol Biol, Kyoto 6028566, Japan; [Mizutani, Shinsuke; Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Dept Med, Div Haematol & Oncol, Kyoto 6028566, Japan; [Zhao, Xinyang] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Nimer, Stephen D.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	Okuda, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Biochem & Mol Biol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	okuda@koto.kpu-m.ac.jp			Ministry of Education, Sports, Culture, Science and Technology, Japan; NIH [CA166835]; Shimizu Foundation for the Promotion of Immunology Research, Kyoto, Japan	We wish to thank all past and present members of Okuda Laboratory, Kyoto Prefectural University of Medicine, for their encouragement and helpful discussions. This work was supported by grants from the Ministry of Education, Sports, Culture, Science and Technology, Japan to TO and NIH R01 grant CA166835 to SDN. TO also received a research grant from the Shimizu Foundation for the Promotion of Immunology Research, Kyoto, Japan.	Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Abe N, 2005, J IMMUNOL, V175, P4475; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Putz G, 2006, ONCOGENE, V25, P929, DOI 10.1038/sj.onc.1209136; Okuda T, 1998, BLOOD, V91, P3134; Shang Y, 2009, BIOCHEM BIOPH RES CO, V386, P242, DOI 10.1016/j.bbrc.2009.06.043; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Shia WJ, 2012, BLOOD, V119, P4953, DOI 10.1182/blood-2011-04-347476; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303; Osato M, 1999, BLOOD, V93, P1817; Okuda T, 2001, INT J HEMATOL, V74, P252, DOI 10.1007/BF02982057; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Sun W, 2004, BLOOD, V104, P3565, DOI 10.1182/blood-2003-12-4349; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085; Yamaguchi Y, 2004, J BIOL CHEM, V279, P15630, DOI 10.1074/jbc.M400355200; Goyama S, 2004, BLOOD, V104, P3558, DOI 10.1182/blood-2004-04-1535; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608; Huang H, 2012, GENE DEV, V26, P1587, DOI 10.1101/gad.192054.112; Vu LP, 2013, CELL REP, V5, P1625, DOI 10.1016/j.celrep.2013.11.025; Preudhomme C, 2000, BLOOD, V96, P2862; Imai Y, 2000, BLOOD, V96, P3154; Tani-ichi S, 2013, P NATL ACAD SCI USA, V110, P612, DOI 10.1073/pnas.1219242110; ERICKSON P, 1992, BLOOD, V80, P1825; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Hassan H, 2011, P NATL ACAD SCI USA, V108, P18330, DOI 10.1073/pnas.1105835108; North T, 1999, DEVELOPMENT, V126, P2563; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Song WJ, 1999, NAT GENET, V23, P166; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; Seo W, 2012, J EXP MED, V209, P1255, DOI 10.1084/jem.20112745; Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Chakraborty S, 2003, ONCOGENE, V22, P5229, DOI 10.1038/sj.onc.1206600; Nagamachi A, 2010, DEV BIOL, V345, P226, DOI 10.1016/j.ydbio.2010.07.015; Dowdy C. R., 2013, EXPT HEMATOLOGY, V41, pe981; Frank R, 1995, ONCOGENE, V11, P2667; Fukushima-Nakase Y, 2005, BLOOD, V105, P4298, DOI 10.1182/blood-2004-08-3372; Gilliland DG, 2001, CURR OPIN HEMATOL, V8, P189, DOI 10.1097/00062752-200107000-00001; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Kitabayashi I, 1998, MOL CELL BIOL, V18, P846; Komeno Y, 2014, BLOOD, V123, P3760, DOI 10.1182/blood-2013-08-521252; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; McNerney ME, 2014, BRIT J HAEMATOL, V166, P550, DOI 10.1111/bjh.12964; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; MIYOSHI H, 1993, EMBO J, V12, P2715; Nakao M, 2004, BRIT J HAEMATOL, V125, P709, DOI 10.1111/j.1365-2141.2004.04966.x; Nguyen LA, 2005, BLOOD, V105, P292, DOI 10.1182/blood-2004-03-1185; Nishimura M, 2004, BLOOD, V103, P562, DOI 10.1182/blood-2003-06-2109; Okuda T, 2000, MOL CELL BIOL, V20, P319; Parry RV, 2010, TRENDS IMMUNOL, V31, P164, DOI 10.1016/j.it.2010.01.006; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Speck NA, 2001, CURR OPIN HEMATOL, V8, P192, DOI 10.1097/00062752-200107000-00002; Tachibana M, 2008, BIOCHEM BIOPH RES CO, V368, P536, DOI 10.1016/j.bbrc.2008.01.124; Wang L, 2009, BLOOD CELL MOL DIS, V43, P30, DOI 10.1016/j.bcmd.2009.03.005; WANG SW, 1993, MOL CELL BIOL, V13, P3324; Wee HJ, 2008, BLOOD, V112, P3777, DOI 10.1182/blood-2008-01-134122; Yoshimi M, 2012, EUR J IMMUNOL, V42, P1044, DOI 10.1002/eji.201040746; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; Zhang YH, 2004, J BIOL CHEM, V279, P53116, DOI 10.1074/jbc.M405502200	78	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	SEP	2015	170	6					859	873		10.1111/bjh.13499		15	Hematology	Hematology	CQ7BG	WOS:000360757200013		
J	Muromachi, S; Kida, M; Takeya, S; Yamamoto, Y; Ohmura, R				Muromachi, Sanehiro; Kida, Masato; Takeya, Satoshi; Yamamoto, Yoshitaka; Ohmura, Ryo			Characterization of the ionic clathrate hydrate of tetra-n-butylammonium acrylate	CANADIAN JOURNAL OF CHEMISTRY			English	Article						ionic clathrate hydrate; tetra-n-butylammonium acrylate; single-crystal X-ray structural analysis; nuclear magnetic resonance	SEMICLATHRATE HYDRATE; BROMIDE; CHLORIDE	The ionic clathrate hydrate of tetra-n-butylammonium (TBA) acrylate was characterized using single-crystal X-ray diffraction, elemental analysis, and nuclear magnetic resonance (NMR) spectroscopy. The crystal structure of TBA acrylate was Jeffrey's type III and tetragonal P4(2)/n, with a 33.076(7) x 33.076(7) x 12.170(2) angstrom(3) unit cell. The volume of the unit cell was 13315(5) angstrom(3), which is almost twice that of the ideal structure. The TBA cation was disordered and located in two types of fused cages. Although the acrylate anion was located in a pentagonal dodecahedral cage neighboring the TBA cation, there is a residual acrylate anion that could be around the other TBA cation in the unit cell. Solid-state C-13 NMR spectra showed that the TBA cation was clearly disordered at 173 K, but not at 239 K. NMR peaks from the acrylate anion were not observed at either temperature. This is probably because of the strong restriction on the acrylate anion by hydrogen bonding with the lattice water. Some of the characteristics of the anion and cation of the ionic guest incorporated in the hydrate structure have yet to be defined. Further research is needed to clarify complexation of the ionic clathrate hydrate and the ionic guest, and the resulting structure.	[Muromachi, Sanehiro; Kida, Masato; Takeya, Satoshi; Yamamoto, Yoshitaka] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; [Ohmura, Ryo] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan	Muromachi, S (reprint author), Natl Inst Adv Ind Sci & Technol, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	s-muromachi@aist.go.jp			Japan Society for the Promotion of Science (JSPS) [26820069]	SM thanks the Japan Society for the Promotion of Science (JSPS) for a Grant-in-Aid for Young Scientists (Grant No. 26820069). We thank Drs. Gotoh Midori, Shibasaki Shizuko, and Kobashi Hiroko for their help and valuable discussions concerning the analytical experiments.	Aladko EY, 2010, J INCL PHENOM MACRO, V67, P13, DOI 10.1007/s10847-009-9662-2; Aladko LS, 1996, MENDELEEV COMMUN, P198; HAYASHI S, 1991, B CHEM SOC JPN, V64, P685, DOI 10.1246/bcsj.64.685; Sakamoto J, 2008, CHEM ENG SCI, V63, P5789, DOI 10.1016/j.ces.2008.08.026; Muromachi S, 2014, CHEM COMMUN, V50, P11476, DOI 10.1039/c4cc02111h; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Sato K, 2013, FLUID PHASE EQUILIBR, V337, P115, DOI 10.1016/j.fluid.2012.09.016; Alavi S, 2010, CHEM-EUR J, V16, P1017, DOI 10.1002/chem.200902351; Oyama H, 2005, FLUID PHASE EQUILIBR, V234, P131, DOI 10.1016/j.fluid.2005.06.005; Sakamoto H, 2011, RSC ADV, V1, P315, DOI 10.1039/c1ra00108f; Davidson DW., 1973, WATER COMPREHENSIVE; Dyadin Y. A., 1987, J STRUCT CHEM, V28, P75; Dyadin Y. A., 1984, J INCLUSION PHENOM, V2, P259, DOI 10.1007/BF00663264.; Jeffrey G. A., 1984, INCLUSION COMPOUNDS, V1; Komarov VY, 2012, J STRUCT CHEM+, V53, P768, DOI 10.1134/S002247661204021X; Lee S, 2011, LANGMUIR, V27, P10597, DOI 10.1021/la202143t; Muromachi S, 2014, PHYS CHEM CHEM PHYS, V16, P21467, DOI 10.1039/c4cp03444a; Muromachi S, 2014, CRYSTENGCOMM, V16, P2056, DOI 10.1039/c3ce41942h; NAKAYAMA H, 1984, B CHEM SOC JPN, V57, P171, DOI 10.1246/bcsj.57.171; NAKAYAMA H, 1981, B CHEM SOC JPN, V54, P3717, DOI 10.1246/bcsj.54.3717; Rodionova T, 2010, NEW J CHEM, V34, P432, DOI 10.1039/b9nj00530g; Sheldrick G. M., 1993, ACTA CRYSTALLOGR A S, V49, pC53, DOI 10.1107/S0108767378098451; Shimada W, 2005, ACTA CRYSTALLOGR C, V61, pO65, DOI 10.1107/S0108270104032743; Udachin K. A., 2002, J SUPRAMOL CHEM, V2, P405, DOI 10.1016/S1472-7862(03)00049-2; Udachin KA, 1999, ANGEW CHEM INT EDIT, V38, P1983, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1983::AID-ANIE1983>3.3.CO;2-A	25	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	SEP	2015	93	9	2		SI		954	959		10.1139/cjc-2014-0539		6	Chemistry, Multidisciplinary	Chemistry	CQ8VS	WOS:000360888500006		
J	Takeya, S; Gotoh, Y; Yoneyama, A; Hyodo, K; Takeda, T				Takeya, Satoshi; Gotoh, Yoshito; Yoneyama, Akio; Hyodo, Kazuyuki; Takeda, Tohoru			Observation of the growth process of icy materials in interparticle spaces: phase-contrast X-ray imaging of clathrate hydrate	CANADIAN JOURNAL OF CHEMISTRY			English	Article						gas hydrate; memory effect; X-ray absorption contrast; X-ray CT; X-ray interferometry	METHANE HYDRATE; GAS HYDRATE; MEMORY; SEDIMENTS; NUCLEATION; WATER; SYSTEM	The visualization of temperature-controlled crystal growth and dissociation of tetrahydrofuran clathrate hydrates and ice in the interparticle spaces between beads is presented. Phase-contrast X-ray imaging using synchrotron X-ray radiation is a unique technique to study clathrate hydrates coexisting with both ice and liquid water and is used here to observe tetrahydrofuran hydrate and ice formation in situ. The nondestructive images obtained reveal a morphology change of tetrahydrofuran clathrate hydrate grown under isothermal temperature conditions at 253 K, which may be caused by the thermal history of crystallization of the clathrate hydrate. In addition, the water freezing process in the interparticle spaces between is observed using phase-contrast X-ray imaging. This method is useful for understanding the kinetics of clathrate hydrates in interparticle spaces.	[Takeya, Satoshi; Gotoh, Yoshito] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Yoneyama, Akio] Hitachi Ltd, Hatoyama, Saitama 3500395, Japan; [Hyodo, Kazuyuki] High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; [Takeda, Tohoru] Kitasato Univ, Sagamihara, Kanagawa 2288555, Japan	Takeya, S (reprint author), Natl Inst Adv Ind Sci & Technol, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	s.takeya@aist.go.jp			Japan Society for the Promotion of Science KAKENHI [40357421, 26410032]	This study was carried out with the approval of the High Energy Accelerator Research Organization (proposal No. 2012G148). This study was supported by the Japan Society for the Promotion of Science KAKENHI 40357421 and 26410032.	Abegg F, 2007, GEO-MAR LETT, V27, P269, DOI 10.1007/s00367-007-0080-4; Ribeiro CP, 2008, CHEM ENG SCI, V63, P2007, DOI 10.1016/j.ces.2008.01.014; Takeya S, 2000, J PHYS CHEM B, V104, P4164, DOI 10.1021/jp993759+; Sefidroodi H, 2013, CHEM ENG SCI, V87, P133, DOI 10.1016/j.ces.2012.10.018; VYSNIAUSKAS A, 1983, CHEM ENG SCI, V38, P1061, DOI 10.1016/0009-2509(83)80027-X; Sum AK, 2009, IND ENG CHEM RES, V48, P7457, DOI 10.1021/ie900679m; Ohmura R, 2003, J PHYS CHEM B, V107, P5289, DOI 10.1021/jp027094e; Takeya S, 2011, J PHYS CHEM C, V115, P16193, DOI 10.1021/jp202569r; Buchanan P, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2074927; Takeya S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709645; Ohmura R, 2004, PHILOS MAG, V84, P1, DOI 10.1080/14786430310001623542; Hawtin RW, 2008, PHYS CHEM CHEM PHYS, V10, P4853, DOI 10.1039/b807455k; English NJ, 2015, CHEM ENG SCI, V121, P133, DOI 10.1016/j.ces.2014.07.047; Rees EVL, 2011, MAR PETROL GEOL, V28, P1283, DOI 10.1016/j.marpetgeo.2011.03.015; Zeng H, 2006, J AM CHEM SOC, V128, P2844, DOI 10.1021/ja0548182; Rodger PM, 2000, ANN NY ACAD SCI, V912, P474; Kerkar P, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3120544; Bagherzadeh SA, 2011, ENERG FUEL, V25, P3083, DOI 10.1021/ef200399a; Bisnoi P. R., 1996, FLUID PHASE EQUILIBR, V117, P168, DOI [10.1016/0378-3812(95)02950-8, DOI 10.1016/0378-3812(95)02950-8]; Jin S, 2004, JPN J APPL PHYS 1, V43, P5673, DOI 10.1143/JJAP.43.5673; Jones KW, 2007, J PETROL SCI ENG, V56, P136, DOI 10.1016/j.petrol.2006.03.029; Klapp SA, 2012, GEO-MAR LETT, V32, P555, DOI 10.1007/s00367-012-0276-0; Max M. D., 2000, NATURAL GAS HYDRATE; Menzel MI, 2000, J MAGN RESON, V143, P376, DOI 10.1006/jmre.1999.1999; Moudrakovski I. L., 2012, EMAGRES, V1, P863, DOI [10.1002/9780470034590.emrstm1289, DOI 10.1002/9780470034590.EMRSTM1289]; Moudrakovski I. L., 1999, J PHYS CHEM A, V103, P4970, DOI 10.1021/jp9839854; Murshed MM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035460; Ripmeester JA, 2000, ANN NY ACAD SCI, V912, P1; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Takeya S, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2200751; Takeya S, 2012, J SYNCHROTRON RADIAT, V19, P1038, DOI 10.1107/S0909049512033857; Tse J. S, 1987, J PHYSL S3, V48, pCl, DOI [10.1051/jphyscol:1987174, DOI 10.1051/JPHYSCOL:1987174]; Wilson PW, 2010, CHEM ENG J, V161, P146, DOI 10.1016/j.cej.2010.04.047; Yoneyama A, 2004, AIP CONF PROC, V705, P1299; Yoneyama A, 2005, APPL OPTICS, V44, P3258, DOI 10.1364/AO.44.003258; Yoneyama A., 2008, MED PHYS, V35, P4724, DOI 10.1118/1.2977543; Zhao JF, 2011, MAGN RESON IMAGING, V29, P281, DOI 10.1016/j.mri.2010.08.012	37	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	SEP	2015	93	9	2		SI		983	987		10.1139/cjc-2014-0544		5	Chemistry, Multidisciplinary	Chemistry	CQ8VS	WOS:000360888500010		
J	Jitsuyama, Y				Jitsuyama, Yutaka			Morphological root responses of soybean to rhizosphere hypoxia reflect waterlogging tolerance	CANADIAN JOURNAL OF PLANT SCIENCE			English	Article						Hypoxia; soybean; root; temperature; waterlogging tolerance	FLOODING TOLERANCE; NITROGEN-FIXATION; WATER-TABLE; YIELD; PHOTOSYNTHESIS; IMPROVEMENT; CULTIVARS; GROWTH; SYSTEM	Excess soil moisture induces hypoxia, causing waterlogging injury in soybeans [Glycine max (L.) Merr.]. Twelve Japanese soybean cultivars with varying hypoxia tolerance were used. Of these, 11 (all but Hayahikari) were evaluated for waterlogging tolerance using a scaled index with data from previous studies. To investigate hypoxic responses, cultivars were grown under hydroponic conditions for 2 wk a year for 2 yr, with aerobic or hypoxic oxygen concentrations artificially maintained in the rhizosphere. Hypoxic responses (measured as plant dry weight and root morphology) were assessed at the early vegetative stage. The effects of hypoxic treatment on root dry weight were significant, and the effect of year on soybean dry weight was not significant. The change in root dry weight, and particularly, in coarse root length, was significantly correlated with waterlogging tolerance index at the 0.001 probability level. This study showed that root responses to rhizosphere hypoxia might reflect waterlogging tolerance in soybeans.	Hokkaido Univ, Div Bioresources & Prod Sci, Res Grp Hort Sci & Landscape Architecture, Sapporo, Hokkaido 0608589, Japan	Jitsuyama, Y (reprint author), Hokkaido Univ, Div Bioresources & Prod Sci, Res Grp Hort Sci & Landscape Architecture, Sapporo, Hokkaido 0608589, Japan.	y-jitsu@res.agr.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [22688002, 26450015]	This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 22688002 and 26450015. I extend my appreciation to Dr. F. Kousaka of the Hokkaido Central Agricultural Experiment Station (HCAES) for providing Shokukei32 (#25164) seeds and helpful suggestions and to Prof. J. Abe of the Research Faculty of Agriculture, Hokkaido University, for advice on the experimental progress. I also thank Mr. S. Ichikawa of the Field Science Center for the Northern Biosphere, Hokkaido University, for helping me with the construction of the experimental system.	SUNG FJM, 1993, FIELD CROP RES, V35, P183, DOI 10.1016/0378-4290(93)90152-D; Kokubun M, 2013, FIELD CROP RES, V152, P3, DOI 10.1016/j.fcr.2012.09.022; Shimada S, 2012, PLANT PROD SCI, V15, P132, DOI 10.1626/pps.15.132; FEHR WR, 1971, CROP SCI, V11, P929; OOSTERHUIS DM, 1990, ENVIRON EXP BOT, V30, P85, DOI 10.1016/0098-8472(90)90012-S; Bacanamwo M, 1999, J EXP BOT, V50, P689, DOI 10.1093/jexbot/50.334.689; Board JE, 2008, J PLANT NUTR, V31, P828, DOI 10.1080/01904160802043122; e- STAT, 2014, PORT SIT OFF STAT JA; Hokkaido Research Organization Agriculture Research De- partment Central Agricultural Experiment Station, 2014, FIELD SURV SOYB WAT; Jitsuyama Y., 2013, American Journal of Plant Sciences, V4, P1297, DOI 10.4236/ajps.2013.46161; Jitsuyama Y, 2014, SEED SCI RES, V24, P37, DOI 10.1017/S0960258513000378; Jung G, 2008, PLANT PROD SCI, V11, P291, DOI 10.1626/pps.11.291; Kim H, 2006, POLICY REFORM AND ADJUSTMENT IN THE AGRICULTURAL SECTORS OF DEVELOPED COUNTRIES, P123, DOI 10.1079/9781845930332.0123; Kousaka F., 2013, 11 C INT SOC PLANT A; Kramer P. J., 1995, WATER RELATIONS PLAN, P9; Matsukawa I., 1983, B HOKKAIDO PREF AGR, V49, P32; National Institute of Agrobiological Sciences, 2008, BUS PERF REP AGR BIO; SHIMADA S, 1995, JPN J CROP SCI, V64, P294; Shimamura S, 2010, ANN BOT-LONDON, V106, P277, DOI 10.1093/aob/mcq123; Takahashi M., 2006, SOIL SCI PLANT NUTR, V52, P291; Thomas AL, 2005, ANN BOT-LONDON, V96, P1191, DOI 10.1093/aob/mci272; Tian XH, 2005, PLANT PROD SCI, V8, P157, DOI 10.1626/pps.8.157; Yoshinaga S, 2012, JARQ-JPN AGR RES Q, V46, P115	23	0	0	AGRICULTURAL INST CANADA	OTTAWA	280 ALBERT ST, SUITE 900, OTTAWA, ONTARIO K1P 5G8, CANADA	0008-4220	1918-1833		CAN J PLANT SCI	Can. J. Plant Sci.	SEP	2015	95	5					999	1005		10.4141/CJPS-2014-370		7	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CR0GO	WOS:000360996700021		
J	Yoshida, K; Tsujimoto, H; Matsumura, K; Kinoshita, M; Takahata, R; Matsumoto, Y; Hiraki, S; Ono, S; Seki, S; Yamamoto, J; Hase, K				Yoshida, Kazumichi; Tsujimoto, Hironori; Matsumura, Kouji; Kinoshita, Manabu; Takahata, Risa; Matsumoto, Yusuke; Hiraki, Shuichi; Ono, Satoshi; Seki, Shuhji; Yamamoto, Junji; Hase, Kazuo			CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer	CANCER MEDICINE			English	Article						CD44; CD47; gastric cancer; phagocytosis	COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; MONOCYTE SURVIVAL; PROTEIN CD47; EXPRESSION; MACROPHAGES; LEUKEMIA; ANTIBODY; TUMOR; DIFFERENTIATION	CD47 is an antiphagocytic molecule that acts via ligation to signal regulatory protein alpha on phagocytes; its enhanced expression and therapeutic targeting have recently been reported for several malignancies. However, CD47 expression in gastric cancer is not well documented. Immunohistochemical expression of CD47 in surgical specimens was investigated. Expression of CD47 and CD44, a known gastric cancer stem cell marker, were investigated in gastric cancer cell lines by flow cytometry. MKN45 and MKN74 gastric cancer cells were sorted by fluorescence-activated cell sorting according to CD44 and CD47 expression levels, and their in vitro proliferation, spheroid-forming capacity, and in vivo tumorigenicity were studied. In vitro phagocytosis of cancer cells by human macrophages in the presence of a CD47 blocking monoclonal antibody (B6H12) and the survival of immunodeficient mice intraperitoneally engrafted with MKN45 cells and B6H12 were compared to experiments using control antibodies. Immunohistochemistry of the clinical specimens indicated that CD47 was positive in 57 out of 115 cases, and its positivity was an independent adverse prognostic factor. Approximately 90% of the MKN45 and MKN74 cells expressed CD47 and CD44. CD47(hi) gastric cancer cells showed significantly higher proliferation and spheroid colony formation than CD47(lo), and CD44(hi)CD47(hi) cells showed the highest proliferation in vitro and tumorigenicity in vivo. B6H12 significantly enhanced in vitro phagocytosis of cancer cells by human macrophages and prolonged the survival of intraperitoneal cancer dissemination in mice compared to control antibodies. In conclusion, CD47 is an adverse prognostic factor and promising therapeutic target in gastric cancer.	[Yoshida, Kazumichi; Tsujimoto, Hironori; Takahata, Risa; Matsumoto, Yusuke; Hiraki, Shuichi; Yamamoto, Junji; Hase, Kazuo] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Matsumura, Kouji] Natl Def Med Coll, Lab Ctr, Tokorozawa, Saitama 3598513, Japan; [Kinoshita, Manabu; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 3598513, Japan; [Hiraki, Shuichi; Ono, Satoshi] Natl Def Med Coll, Div Traumatol, Tokorozawa, Saitama 3598513, Japan	Tsujimoto, H (reprint author), Natl Def Med Coll, Dept Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	tsujihi@ndmc.ac.jp			JSPS KAKENHI [26670612]	This work was supported in part by JSPS KAKENHI (grant number 26670612).	Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; REINHOLD MI, 1995, J CELL SCI, V108, P3419; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Mateo V, 1999, NAT MED, V5, P1277; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Yamaguchi A, 2002, J SURG ONCOL, V79, P230, DOI 10.1002/jso.10082; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Zhou JC, 2003, J MOL BIOL, V332, P901, DOI 10.1016/S0022-2836(03)00952-5; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Wakamatsu Y, 2012, PATHOL INT, V62, P112, DOI 10.1111/j.1440-1827.2011.02760.x; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Sick E, 2011, GLIA, V59, P308, DOI 10.1002/glia.21102; WASHINGTON K, 1994, HUM PATHOL, V25, P1043, DOI 10.1016/0046-8177(94)90063-9; Okazawa H, 2005, J IMMUNOL, V174, P2004; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Uno S, 2007, ONCOL REP, V17, P1189; Chan KS, 2010, CURR OPIN UROL, V20, P393, DOI 10.1097/MOU.0b013e32833cc9df; BRUGGER W, 1991, J LEUKOCYTE BIOL, V49, P483; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108; BECKER S, 1987, J IMMUNOL, V139, P3703; Kaczorowski DJ, 2007, CIRC RES, V100, P602, DOI 10.1161/01.RES.0000261609.44977.25; Kaur S, 2011, CELL CYCLE, V10, P10, DOI 10.4161/cc.10.1.14324; Muller W, 1997, J PATHOL, V183, P222, DOI 10.1002/(SICI)1096-9896(199710)183:2<222::AID-PATH923>3.0.CO;2-C; Sobin LH, 2010, TNM CLASSIFICATION M; Tsujimoto H., 2011, GASTRIC CANCER, V13, P212; Way KJ, 2009, J LEUKOCYTE BIOL, V85, P766, DOI 10.1189/jlb.1108689; Wenqi Du, 2009, J Cancer Res Clin Oncol, V135, P1277, DOI 10.1007/s00432-009-0569-5; Zhao X. W., 2012, P NATL ACAD SCI USA, V109, P2844	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	SEP	2015	4	9					1322	1333		10.1002/cam4.478		12	Oncology	Oncology	CR0KM	WOS:000361007400002		
J	Kanematsu, M; Futamura, M; Takata, M; Gaowa, S; Yamada, A; Morimitsu, K; Morikawa, A; Mori, R; Hara, H; Yoshida, K				Kanematsu, Masako; Futamura, Manabu; Takata, Masafumi; Gaowa, Siqin; Yamada, Atsuko; Morimitsu, Kasumi; Morikawa, Akemi; Mori, Ryutaro; Hara, Hideaki; Yoshida, Kazuhiro			Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer	CANCER MEDICINE			English	Article						Biomarker; breast cancer; cross talk; GPNMB; HER2	ANTIBODY-DRUG CONJUGATE; THERAPEUTIC TARGET; GLEMBATUMUMAB VEDOTIN; TRANSMEMBRANE PROTEIN; PROGNOSTIC INDICATOR; ESTROGEN-RECEPTOR; ENDOCRINE THERAPY; PHASE I/II; TRASTUZUMAB; MELANOMA	Glycoprotein nonmetastatic B (GPNMB) is a potential oncogene that is particularly expressed in melanoma and breast cancer (BC). To clarify its clinical significance in BC, we measured serum GPNMB invivo and investigated its cross talk with human epidermal growth factor 2 (HER2). GPNMB was expressed in four of six breast cell lines (SK-BR-3, BT-474, MDA-MD-231, and MDA-MD-157), two of six colorectal cell lines, and two of four gastric cancer (GC) cell lines. We established a GPNMB quantification system using enzyme-linked immunosorbent assay (ELISA) for these cell lines. We measured serum GPNMB invivo in 162 consecutive BC patients and in 88 controls (50 colorectal cancer [CC] and 38 GC patients). The GPNMB concentration in BC, CC and GC was 8.163, 5.751 and 6.55ng/mL, respectively. The GPNMB level was significantly higher in BC patients than in CC patients (P=0.021). The HER2-rich subtype of BC patients had significantly higher GPNMB levels than other subtypes (vs. Luminal; P=0.038; vs. DCIS; P=0.0195). These high GPNMB levels decreased after treatment (surgery/chemotherapy). Next, we examined the relationship between GPNMB and HER2 invitro using SK-BR3 and BT-474 (HER2-positive/GPNMB-positive) cells. GPNMB depletion by small interfering RNA (siRNA) increased both HER2 expression and phosphorylation. Trastuzumab (Tra) in combination with docetaxel promoted cell growth inhibition, and treatment with Tra or an Extracellular signal-related kinase (ERK) inhibitor enhanced GPNMB expression. These results indicate that GPNMB might be a surrogate marker for BC and may cross talk with the HER2 signal pathway. GPNMB may therefore emerge as an important player in anti-HER2 therapy.	[Kanematsu, Masako; Gaowa, Siqin; Yamada, Atsuko; Morikawa, Akemi; Mori, Ryutaro; Yoshida, Kazuhiro] Gifu Univ, Grad Sch Med, Dept Surg Oncol, Gifu 5011194, Japan; [Futamura, Manabu; Morimitsu, Kasumi] Gifu Univ, Grad Sch Med, Dept Breast & Mol Oncol, Gifu 5011194, Japan; [Takata, Masafumi; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, Gifu, Japan	Futamura, M (reprint author), Gifu Univ, Grad Sch Med, Dept Breast & Mol Oncol, Yanagido 1-1, Gifu 5011194, Japan.	mfutamur@gifu-u.ac.jp			Gifu University; Gifu Pharmaceutical University	This study was supported by a grant for clinical research promotion of Gifu University and Gifu Pharmaceutical University.	Ott PA, 2014, J CLIN ONCOL, V32, P3659, DOI 10.1200/JCO.2013.54.8115; Johnston SRD, 2010, CLIN CANCER RES, V16, P1979, DOI 10.1158/1078-0432.CCR-09-1823; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Kostler WJ, 2004, CLIN CANCER RES, V10, P1618, DOI 10.1158/1078-0432.CCR-0385-3; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Cameron D, 2010, ONCOLOGIST, V15, P924, DOI 10.1634/theoncologist.2009-0181; Bartlett JMS, 2011, J CLIN ONCOL, V29, P1531, DOI 10.1200/JCO.2010.30.3677; Lavaud P, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0132-3; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Pegram MD, 2004, J NATL CANCER I, V96, P739, DOI 10.1093/jnci/djh131; Bandari PS, 2003, REGUL PEPTIDES, V111, P169, DOI 10.1016/S0167-0115(02)00288-4; Hayashi N, 2012, INT J CLIN ONCOL, V17, P55, DOI 10.1007/s10147-011-0253-z; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Bendell J, 2014, J CLIN ONCOL, V32, P3619, DOI 10.1200/JCO.2013.52.5683; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Ludovini V, 2008, ANN ONCOL, V19, P883, DOI 10.1093/annonc/mdm585; Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Dawood S, 2009, J CLIN ONCOL, V28, P92; Dowsett M, 2005, ENDOCR-RELAT CANCER, V12, pS113, DOI 10.1677/erc.1.01044; Futamura M, 2007, CANCER RES, V67, P1451, DOI 10.1158/0008-5472.CAN-06-2485; Gijsen M., 2010, PLOS ONE, V12; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Li YN, 2014, APMIS, V122, P140, DOI 10.1111/apm.12107; Luftner D, 2004, INT J BIOL MARKER, V19, P175; Ohnishi S, 2010, INT J ONCOL, V37, P1133, DOI 10.3892/ijo_00000765; Qian XZ, 2008, MOL ONCOL, V2, P81, DOI 10.1016/j.molonc.2008.02.002; Rho HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-240; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Safadi Fayez. F., 2001, Journal of Cellular Biochemistry, V84, P12; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	SEP	2015	4	9					1344	1355		10.1002/cam4.480		12	Oncology	Oncology	CR0KM	WOS:000361007400004		
J	Nishioka, C; Ikezoe, T; Yokoyama, A				Nishioka, Chie; Ikezoe, Takayuki; Yokoyama, Akihito			Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo	CANCER MEDICINE			English	Article						AML; AraC; bone marrow microenvironment; CD82	ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; CELL-ADHESION; STEM-CELLS; EXPRESSION; CXCR4; MICROENVIRONMENT; ENGRAFTMENT; RECEPTOR; CANCER	We recently found that CD82 inhibits matrix metalloproteinase 9 and augments adhesion of CD34(+)/CD38(-) acute myelogenous leukemia (AML) cells to the bone marrow (BM) microenvironment. The present study found that the use of an anti-CD82 monoclonal antibody (CD82 mAb) mobilized CD34(+) leukemia cells from BM into the peripheral blood in a humanized AML murine model. The use of CD82 mAb in combination with cytarabine (AraC) significantly prolonged survival of immunodeficient mice-bearing human AML cells than did treatment with either AraC or CD82 mAb alone. Taken together, the combination of an anti-leukemic agent and the mobilizing agent CD82 mAb may be a promising treatment strategy to treat patients with AML.	[Nishioka, Chie; Ikezoe, Takayuki; Yokoyama, Akihito] Kochi Univ, Dept Hematol & Resp Med, Kochi Med Sch, Nankoku, Kochi 7838505, Japan	Ikezoe, T (reprint author), Kochi Univ, Dept Hematol & Resp Med, Oko Cho, Nankoku, Kochi 7838505, Japan.	ikezoet@kochi-u.ac.jp			Takeda Science Foundation; JSPS KAKENHI [14446690]	This work was supported in part by a grant from the Takeda Science Foundation (to C. N.) and JSPS KAKENHI grant number 14446690 (to C. N.).	NAGIRA M, 1994, CELL IMMUNOL, V157, P144, DOI 10.1006/cimm.1994.1212; Nishioka C, 2014, INT J CANCER, V134, P55, DOI 10.1002/ijc.28348; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Dai WQ, 2014, BIOCHEM BIOPH RES CO, V446, P541, DOI 10.1016/j.bbrc.2014.03.006; Rombouts EJC, 2004, BLOOD, V104, P550, DOI 10.1182/blood-2004-02-0566; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Larochelle A, 2012, BLOOD, V119, P1848, DOI 10.1182/blood-2011-08-371583; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Konopleva M, 2007, CURR DRUG TARGETS, V8, P685, DOI 10.2174/138945007780830827; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590; Termini CM, 2014, MOL BIOL CELL, V25, P1560, DOI 10.1091/mbc.E13-11-0660; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Ruseva Z, 2009, EXP CELL RES, V315, P1759, DOI 10.1016/j.yexcr.2009.01.007; Spoo AC, 2007, BLOOD, V109, P786, DOI 10.1182/blood-2006-05-024844; Fragoso Rita, 2014, Advances in Biological Regulation, V56, P22, DOI 10.1016/j.jbior.2014.05.005; Nishioka C., 2014, INT J CANCER, V132, P2006; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; REUSSBORST MA, 1995, LEUKEMIA, V9, P869	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	SEP	2015	4	9					1426	1431		10.1002/cam4.482		6	Oncology	Oncology	CR0KM	WOS:000361007400012		
J	Yamato, K; Iwase, A; Kudo, A				Yamato, Kohei; Iwase, Akihide; Kudo, Akihiko			Photocatalysis using a Wide Range of the Visible Light Spectrum: Hydrogen Evolution from Doped AgGaS2	CHEMSUSCHEM			English	Article						doping; heterogeneous catalysis; hydrogen; nickel; photocatalysis	AQUEOUS-METHANOL SOLUTION; H-2 EVOLUTION; SOLID-SOLUTION; NOBLE-METAL; SULFIDE; SRTIO3; IRRADIATION; ANTIMONY; CHROMIUM; RHODIUM	Doping of nickel into AgGaS2 yields a new absorption band, at a wavelength longer than the intrinsic absorption band of the AgGaS2 host. The doped nickel forms an electron donor level in a forbidden band of AgGaS2. The nickel-doped AgGaS2 with rhodium co-catalyst shows photocatalytic activity for sacrificial H-2 evolution under the light of up to 760 nm due to the transition from the electron donor level consisting of Ni2+ to the conduction band of AgGaS2. Apparent quantum yields for the sacrificial H-2 evolution at 540-620 nm are about 1%. Moreover, the nickel-doped AgGa0.75In0.25S2 also responds to near-IR light, up to 900 nm.	[Yamato, Kohei; Iwase, Akihide; Kudo, Akihiko] Tokyo Univ Sci, Dept Appl Chem, Fac Sci, Shinjyuku Ku, Tokyo 1628601, Japan; [Iwase, Akihide; Kudo, Akihiko] Tokyo Univ Sci, Res Inst Sci & Technol, Photocatalysis Int Res Ctr, Noda, Chiba 2788510, Japan	Kudo, A (reprint author), Tokyo Univ Sci, Dept Appl Chem, Fac Sci, Shinjyuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	a-kudo@rs.kagu.tus.ac.jp	Iwase, Akihide/E-9218-2010	Iwase, Akihide/0000-0002-6395-9556	Ministry of Education, Culture, Sports, Science & Technology in Japan [24107001, 24107004, 2406, 26820354]	This work was supported by a Grant-in-Aid (24107001 and 24107004) for Scientific Research on Innovative Areas (2406) and a Grant-in-Aid for Young Scientists (B) (26820354) from the Ministry of Education, Culture, Sports, Science & Technology in Japan.	Kudo A, 2007, CHEM PHYS, V339, P104, DOI 10.1016/j.chemphys.2007.07.024; Kudo A, 2004, CHEM LETT, V33, P1534, DOI 10.1246/cl.2004.1534; MATSUMURA M, 1983, J PHYS CHEM-US, V87, P3807, DOI 10.1021/j100243a005; Konta R, 2004, J PHYS CHEM B, V108, P8992, DOI 10.1021/jp049556p; Tsuji I, 2005, ANGEW CHEM INT EDIT, V44, P3565, DOI 10.1002/anie.200500314; Yan HJ, 2009, J CATAL, V266, P165, DOI 10.1016/j.jcat.2009.06.024; Kato T, 2015, J PHYS CHEM LETT, V6, P1042, DOI 10.1021/acs.jpclett.5b00137; KAKUTA N, 1985, J PHYS CHEM-US, V89, P732, DOI 10.1021/j100251a002; [Anonymous], 2005, ANGEW CHEM, V117, P3631; Kudo A, 2006, INT J HYDROGEN ENERG, V31, P197, DOI 10.1016/j.ijhydene.2005.04.050; Huang D, 2014, CHEM PHYS LETT, V591, P189, DOI 10.1016/j.cplett.2013.11.042; Asai R, 2014, CHEM COMMUN, V50, P2543, DOI 10.1039/c3cc49279f; Bao NZ, 2008, CHEM MATER, V20, P110, DOI 10.1021/cm7029344; REBER JF, 1984, J PHYS CHEM-US, V88, P5903, DOI 10.1021/j150668a032; Ishii T, 2004, J PHOTOCH PHOTOBIO A, V163, P181, DOI 10.1016/S1010-6030(03)00442-8; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Kato H, 2002, J PHYS CHEM B, V106, P5029, DOI 10.1021/jp0255482; Luo M, 2012, ACS APPL MATER INTER, V4, P1813, DOI 10.1021/am3000903; Kato H, 2013, J MATER CHEM A, V1, P12327, DOI 10.1039/c3ta12803b; Kudo A, 1999, CATAL LETT, V58, P241, DOI 10.1023/A:1019067025917; Zhang K, 2013, CATAL SCI TECHNOL, V3, P1672, DOI 10.1039/c3cy00018d; Jang JS, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2900984; Jang JS, 2007, J SOLID STATE CHEM, V180, P1110, DOI 10.1016/j.jssc.2007.01.008; Kudo A, 2000, CHEM COMMUN, P1371, DOI 10.1039/b003297m; Niishiro R, 2014, APPL CATAL B-ENVIRON, V150, P187, DOI 10.1016/j.apcatb.2013.12.015; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Wu M, 1995, STUD SURF SCI CATAL, V92, P257	27	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	SEP	2015	8	17			SI		2902	2906		10.1002/cssc.201500540		5	Chemistry, Multidisciplinary	Chemistry	CQ9ET	WOS:000360915800013		
J	Atanda, L; Shrotri, A; Mukundan, S; Ma, Q; Konarova, M; Beltramini, J				Atanda, Luqman; Shrotri, Abhijit; Mukundan, Swathi; Ma, Qing; Konarova, Muxina; Beltramini, Jorge			Direct Production of 5-Hydroxymethylfurfural via Catalytic Conversion of Simple and Complex Sugars over Phosphated TiO2	CHEMSUSCHEM			English	Article						biphasic systems; heterogeneous catalysis; mesoporous materials; solvents; sugars	NEUTRON FIBER DIFFRACTION; LEVULINIC ACID FORMATION; HYDROGEN-BONDING SYSTEM; HIGH-YIELD PRODUCTION; SYNCHROTRON X-RAY; IONIC LIQUID; SUPERCRITICAL WATER; SOLID ACID; MICROCRYSTALLINE CELLULOSE; LIGNOCELLULOSIC BIOMASS	A water-THF biphasic system containing N-methyl-2-pyrrolidone (NMP) was found to enable the efficient synthesis of 5-hydroxymethylfurfural (HMF) from a variety of sugars (simple to complex) using phosphated TiO2 as a catalyst. Fructose and glucose were selectively converted to HMF resulting in 98% and 90% yield, respectively, at 175 degrees C. Cellobiose and sucrose also gave rise to high HMF yields of 94% and 98%, respectively, at 180 degrees C. Other sugar variants such as starch (potato and rice) and cellulose were also investigated. The yields of HMF from starch (80-85%) were high, whereas cellulose resulted in a modest yield of 33%. Direct transformation of cellulose to HMF in significant yield (86%) was assisted by mechanocatalytic depolymerization-ball milling of acid-impregnated cellulose. This effectively reduced cellulose crystallinity and particle size, forming soluble cello-oligomers; this is responsible for the enhanced substrate-catalytic sites contact and subsequent rate of HMF formation. During catalyst recyclability, P-TiO2 was observed to be reusable for four cycles without any loss in activity. We also investigated the conversion of the cello-oligomers to HMF in a continuous flow reactor. Good HMF yield (53%) was achieved using a water-methyl isobutyl ketone+NMP biphasic system.	[Atanda, Luqman; Shrotri, Abhijit; Mukundan, Swathi; Ma, Qing; Konarova, Muxina; Beltramini, Jorge] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Nanomat Ctr, St Lucia, Qld 4072, Australia; [Atanda, Luqman; Shrotri, Abhijit; Mukundan, Swathi; Ma, Qing; Konarova, Muxina; Beltramini, Jorge] Univ Queensland, Sch Chem Engn, St Lucia, Qld 4072, Australia; [Shrotri, Abhijit] Hokkaido Univ, Catalysis Res Ctr, Kita Ku, Sapporo, Hokkaido 0010021, Japan	Beltramini, J (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Nanomat Ctr, St Lucia, Qld 4072, Australia.	j.beltramini@uq.edu.au			Nanomaterials center at The University of Queensland, Australia; International Postgraduate Research Scholarship (IPRS); UQ Centennial Scholarship (UQ Cent)	The authors gratefully acknowledge the financial support of the Nanomaterials center at The University of Queensland, Australia. The authors also acknowledge the facilities, scientific, and technical assistance of the Australian Microscopy and Microanalysis Research Facility at The University of Queensland. The first author sincerely appreciates the sponsorship from the International Postgraduate Research Scholarship (IPRS) and UQ Centennial Scholarship (UQ Cent).	Koriakin A, 2014, J SUPERCRIT FLUID, V95, P175, DOI 10.1016/j.supflu.2014.08.017; Zhang YT, 2010, ENERG FUEL, V24, P2410, DOI 10.1021/ef1000198; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Cao Y, 2009, CHEM ENG J, V147, P13, DOI 10.1016/j.cej.2008.11.011; Sasaki M, 2000, IND ENG CHEM RES, V39, P2883, DOI 10.1021/ie990690j; Zhao HB, 2007, SCIENCE, V316, P1597, DOI 10.1126/science.1141199; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Mascal M, 2010, GREEN CHEM, V12, P370, DOI 10.1039/b918922j; Tan KT, 2011, RENEW SUST ENERG REV, V15, P2452, DOI 10.1016/j.rser.2011.02.012; Chareonlimkun A, 2010, FUEL, V89, P2873, DOI 10.1016/j.fuel.2010.03.015; Alonso DM, 2013, GREEN CHEM, V15, P584, DOI 10.1039/c3gc37065h; El Seoud OA, 2007, BIOMACROMOLECULES, V8, P2629, DOI 10.1021/bm070062i; KUSTER BFM, 1990, STARCH-STARKE, V42, P314, DOI 10.1002/star.19900420808; McNeff CV, 2010, APPL CATAL A-GEN, V384, P65, DOI 10.1016/j.apcata.2010.06.008; Chheda JN, 2007, ANGEW CHEM INT EDIT, V46, P7164, DOI 10.1002/anie.200604274; Wang P, 2011, BIORESOURCE TECHNOL, V102, P4179, DOI 10.1016/j.biortech.2010.12.073; Qi XH, 2008, GREEN CHEM, V10, P799, DOI 10.1039/b801641k; Bucharsky EC, 2009, J EUR CERAM SOC, V29, P1955, DOI 10.1016/j.jeurceramsoc.2008.12.007; Peng WH, 2012, J MATER CHEM, V22, P23181, DOI 10.1039/c2jm35391a; Roman-Leshkov Y, 2007, NATURE, V447, P982, DOI 10.1038/nature05923; Huang RL, 2010, CHEM COMMUN, V46, P1115, DOI 10.1039/b921306f; Centi G, 1996, APPL CATAL A-GEN, V147, P267, DOI 10.1016/S0926-860X(96)00179-2; Su Y, 2011, APPL CATAL A-GEN, V391, P436, DOI 10.1016/j.apcata.2010.09.021; Kumar S, 2008, IND ENG CHEM RES, V47, P9321, DOI 10.1021/ie801102j; Damyanova S, 1999, J MOL CATAL A-CHEM, V142, P85, DOI 10.1016/S1381-1169(98)00279-9; HORVAT J, 1986, CROAT CHEM ACTA, V59, P429; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Mascal M, 2008, ANGEW CHEM INT EDIT, V47, P7924, DOI 10.1002/anie.200801594; Kuo CH, 2014, GREEN CHEM, V16, P785, DOI 10.1039/c3gc40909k; Tong XL, 2010, APPL CATAL A-GEN, V385, P1, DOI 10.1016/j.apcata.2010.06.049; Gandini A, 2009, J POLYM SCI POL CHEM, V47, P295, DOI 10.1002/pola.23130; Fang Z, 2000, P COMBUST INST, V28, P2717; Dutta S, 2011, APPL CATAL A-GEN, V409, P133, DOI 10.1016/j.apcata.2011.09.037; Atanda L, 2015, CHEMCATCHEM, V7, P781, DOI 10.1002/cctc.201402794; Shi N, 2013, GREEN CHEM, V15, P1967, DOI 10.1039/c3gc40667a; Yong G, 2008, ANGEW CHEM INT EDIT, V47, P9345, DOI 10.1002/anie.200803207; Chheda JN, 2007, GREEN CHEM, V9, P342, DOI 10.1039/b611568c; Horvath IT, 2008, GREEN CHEM, V10, P238, DOI 10.1039/b712863k; DEPERO LE, 1994, J SOLID STATE CHEM, V111, P247, DOI 10.1006/jssc.1994.1224; Hilgert J, 2013, ENERG ENVIRON SCI, V6, P92, DOI 10.1039/c2ee23057g; Dornath P, 2015, GREEN CHEM, V17, P769, DOI 10.1039/c4gc02187h; Casanova O, 2009, CHEMSUSCHEM, V2, P1138, DOI 10.1002/cssc.200900137; Mascal M, 2009, CHEMSUSCHEM, V2, P859, DOI 10.1002/cssc.200900136; Wang JJ, 2011, GREEN CHEM, V13, P2678, DOI 10.1039/c1gc15306d; Ishikawa Y, 2001, CELLULOSE, V8, P189, DOI 10.1023/A:1013170020469; EMEIS CA, 1993, J CATAL, V141, P347, DOI 10.1006/jcat.1993.1145; Binder JB, 2009, J AM CHEM SOC, V131, P1979, DOI 10.1021/ja808537j; Asghari FS, 2010, CARBOHYD RES, V345, P124, DOI 10.1016/j.carres.2009.10.006; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Dutta A, 2012, J MATER CHEM, V22, P14094, DOI 10.1039/c2jm30623a; HORVAT J, 1985, TETRAHEDRON LETT, V26, P2111, DOI 10.1016/S0040-4039(00)94793-2; Dhepe PL, 2008, CHEMSUSCHEM, V1, P969, DOI 10.1002/cssc.200800129; Moreau C, 2004, TOP CATAL, V27, P11, DOI 10.1023/B:TOCA.0000013537.13540.0e; Zhang ZH, 2011, CHEMSUSCHEM, V4, P131, DOI 10.1002/cssc.201000279; Tolonen LK, 2015, CARBOHYD RES, V401, P16, DOI 10.1016/j.carres.2014.10.012; De S, 2012, APPL CATAL A-GEN, V435, P197, DOI 10.1016/j.apcata.2012.06.002; Hick SM, 2010, GREEN CHEM, V12, P468, DOI 10.1039/b923079c; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; Meine N, 2012, CHEMSUSCHEM, V5, P1449, DOI 10.1002/cssc.201100770; Roman-Leshkov Y, 2009, TOP CATAL, V52, P297, DOI 10.1007/s11244-008-9166-0; Shrotri A, 2013, GREEN CHEM, V15, P2761, DOI 10.1039/c3gc40945g; Banares MA, 1996, J SOLID STATE CHEM, V124, P69, DOI 10.1006/jssc.1996.0209; Bereczky A, 2014, NAT RESOUR, V05, P177; BUDNEVA AA, 1987, REACT KINET CATAL L, V34, P63, DOI 10.1007/BF02069202; Carrasquillo-Flores R, 2013, ACS CATAL, V3, P993, DOI 10.1021/cs4001333; Chheda J. N., 2007, ANGEW CHEM, V119, P7298, DOI 10.1002/ange.200604274; Dalai AK, 1998, IND ENG CHEM RES, V37, P3869, DOI 10.1021/ie980091x; De S, 2011, J MATER CHEM, V21, P17505, DOI 10.1039/c1jm13229f; Foley M. P., 2014, AM J BIOMASS BIOENER, V3, P68; Kaldstrom M, 2014, GREEN CHEM, V16, P3528, DOI 10.1039/c4gc00004h; Klein-Marcuschamer D, 2011, BIOFUEL BIOPROD BIOR, V5, P562, DOI 10.1002/bbb.303; Klemm D., 2005, ANGEW CHEM, V117, P3422, DOI DOI 10.1002/ANGE.200460587; Mascal M., 2008, ANGEW CHEM, V120, P8042, DOI 10.1002/ange.200801594; Nakajima K, 2014, J MOL CATAL A-CHEM, V388, P100, DOI 10.1016/j.molcata.2013.09.012; Nandiwale KY, 2014, ACS SUSTAIN CHEM ENG, V2, P1928, DOI 10.1021/sc500270z; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Ohno E, 2014, J WOOD SCI, V60, P428, DOI 10.1007/s10086-014-1421-3; Stocker M, 2008, ANGEW CHEM INT EDIT, V47, P9200, DOI 10.1002/anie.200801476; Stocker M., 2008, ANGEW CHEM, V120, P9340, DOI 10.1002/ange.200801476; SU Y., 2009, APPL CATAL A-GEN, V361, P117, DOI DOI 10.1016/J.APCATA.2009.04.002; Yong G, 2008, ANGEW CHEM, V120, P9485, DOI 10.1002/ange.200803207	81	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	SEP	2015	8	17			SI		2907	2916		10.1002/cssc.201500395		10	Chemistry, Multidisciplinary	Chemistry	CQ9ET	WOS:000360915800014		
J	Ishida, M; Hwang, D; Zhang, Z; Choi, YJ; Oh, J; Lynch, VM; Kim, DY; Sessler, JL; Kim, D				Ishida, Masatoshi; Hwang, Daesub; Zhang, Zhan; Choi, Yung Ji; Oh, Juwon; Lynch, Vincent M.; Kim, Dong Young; Sessler, Jonanthan L.; Kim, Dongho			beta-Functionalized Push-Pull Porphyrin Sensitizers in Dye-Sensitized Solar Cells: Effect of pi-Conjugated Spacers	CHEMSUSCHEM			English	Article						cross-coupling; density functional calculations; donor-acceptor systems; porphyrins; solar cells	ELECTRON-TRANSFER DYNAMICS; HIGHLY EFFICIENT; PHOTOVOLTAIC PROPERTIES; MOLECULAR DESIGN; ANCHORING GROUP; ORGANIC-DYES; TIO2; DONOR; PERFORMANCE; ABSORPTIVITY	A series of new beta-functionalized push-pull-structured porphyrin dyes were synthesized so as to investigate the effect of the p-conjugated spacer on the performance of dye-sensitized solar cells (DSSCs). Suzuki-and Heck-type palladium-catalyzed coupling methodologies were used to obtain various beta-functionalized porphyrins and beta-benzoic acid (ZnPHn) and beta-vinylbenzoic acid (ZnPVn) derivatives from beta-borylated porphyrin precursors. Photophysical studies of the resulting porphyrins revealed a clear dependence on the nature of the beta linker. In particular, it was found that a beta-vinylene linkage perturbs the electronic structure of the porphyrin core; this is less true for a beta-phenyl linkage. Theoretical analyses provided support for the intrinsic intramolecular charge-transfer character of the beta-functionalized, push-pull porphyrins of this study. The extent of charge transfer depends on the nature of the beta-conjugated linkage. The photovoltaic performances of the cells sensitized with beta-phenylenevinylene ZnPVn exhibited higher power conversion efficiency values than those bearing beta-phenyl linkages (ZnPHn). This was ascribed to differences in light-harvesting efficiency. Furthermore, compared to the use of a standard iodine-based electrolyte, the DSSC performance of cells made from the present porphyrins was improved by more than 1% upon using a cobalt(II/III)-based electrolyte. Under standard AM 1.5 illumination, the highest efficiency, 8.2 %, was obtained by using cells made from the doubly beta-butadiene-linked porphyrin.	[Ishida, Masatoshi; Hwang, Daesub; Choi, Yung Ji; Oh, Juwon; Sessler, Jonanthan L.; Kim, Dongho] Yonsei Univ, Dept Chem, Seoul 120749, South Korea; [Ishida, Masatoshi] Kyushu Univ, Educ Ctr Global Leaders Mol Syst Devices, Fukuoka 8190395, Japan; [Hwang, Daesub; Kim, Dong Young] Korea Inst Sci & Technol, Optoelect Mat Lab, Seoul 130650, South Korea; [Zhang, Zhan; Lynch, Vincent M.; Sessler, Jonanthan L.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	Ishida, M (reprint author), Yonsei Univ, Dept Chem, Seoul 120749, South Korea.	sessler@cm.utexas.edu; dongho@yonsei.ac.kr			Global Frontier R&D Program on Center for Multiscale Energy System - National Research Foundation under the Ministry of Science, ITC Future, Korea [2012-8-2081]; United States National Science Foundation [CHE-1402004]; Korea Institute of Science and Technology Institutional Program [2E25371]; Robert A. Welch Foundation [F-1018]; Japan Society for the Promotion of Science [26810024]	This work was supported by the Global Frontier R&D Program on Center for Multiscale Energy System funded by the National Research Foundation under the Ministry of Science, ITC & Future, Korea (2012-8-2081; D.K.), the United States National Science Foundation (CHE-1402004; J.L.S.), the Korea Institute of Science and Technology Institutional Program (2E25371; D.Y.K), the Robert A. Welch Foundation (F-1018 to J.L.S.), and a Grant-in-Aid from the Japan Society for the Promotion of Science (26810024; M.I.). The authors thank Prof. Shunichi Fukuzumi (Osaka University, Japan) for allowing access to his single-crystal X-ray diffractometer.	Wang Q, 2005, J PHYS CHEM B, V109, P15397, DOI 10.1021/jp052877w; Kurotobi K, 2013, CHEM-EUR J, V19, P17075, DOI 10.1002/chem.201303460; Ren XM, 2012, CHEM MATER, V24, P3493, DOI 10.1021/cm302250y; Asbury JB, 2001, J PHYS CHEM B, V105, P4545, DOI 10.1021/jp003485m; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Preat J, 2009, J PHYS CHEM C, V113, P16821, DOI 10.1021/jp904946a; Li LL, 2013, CHEM SOC REV, V42, P291, DOI 10.1039/c2cs35257e; Chang S, 2013, J MATER CHEM A, V1, P11553, DOI 10.1039/c3ta12714a; Gu X, 2013, PHYS CHEM CHEM PHYS, V15, P15434, DOI 10.1039/c3cp51200b; Nazeeruddin MK, 2004, LANGMUIR, V20, P6514, DOI 10.1021/la0496082; Gao F, 2008, J AM CHEM SOC, V130, P10720, DOI 10.1021/ja801942j; Ishida M, 2011, J PHYS CHEM C, V115, P19343, DOI 10.1021/jp202307b; Ambre RB, 2013, CHEM-ASIAN J, V8, P2144, DOI 10.1002/asia.201300328; Hsieh CP, 2010, J MATER CHEM, V20, P1127, DOI 10.1039/b919645e; Campbell WM, 2007, J PHYS CHEM C, V111, P11760, DOI 10.1021/jp0750598; KAY A, 1993, J PHYS CHEM-US, V97, P6272, DOI 10.1021/j100125a029; Imahori H, 2011, J PHYS CHEM A, V115, P3679, DOI 10.1021/jp103747t; O'Boyle NM, 2008, J COMPUT CHEM, V29, P839, DOI 10.1002/jcc.20823; Heredia D, 2010, ORG LETT, V12, P12, DOI 10.1021/ol902314z; Walter MG, 2010, J PORPHYR PHTHALOCYA, V14, P759, DOI 10.1142/S1088424610002689; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Hayashi S, 2008, J PHYS CHEM C, V112, P15576, DOI 10.1021/jp805122z; Luo J, 2014, J AM CHEM SOC, V136, P265, DOI 10.1021/ja409291g; Pastore M, 2010, J PHYS CHEM C, V114, P22742, DOI 10.1021/jp1088965; Imahori H, 2006, LANGMUIR, V22, P11405, DOI 10.1021/la061527d; Clifford JN, 2011, CHEM SOC REV, V40, P1635, DOI 10.1039/b920664g; Ning ZJ, 2010, ENERG ENVIRON SCI, V3, P1170, DOI 10.1039/c003841e; Urbani M, 2014, CHEM REV, V114, P12330, DOI 10.1021/cr5001964; Kroeze JE, 2006, J AM CHEM SOC, V128, P16376, DOI 10.1021/ja065653f; Reddy NM, 2013, PHYS CHEM CHEM PHYS, V15, P8409, DOI 10.1039/c3cp51327k; Meng S, 2011, J PHYS CHEM C, V115, P9276, DOI 10.1021/jp201646q; Seo KD, 2013, J MATER CHEM A, V1, P9947, DOI 10.1039/c3ta11832k; Wang YQ, 2014, ANGEW CHEM INT EDIT, V53, P10779, DOI 10.1002/anie.201406190; Kira A, 2010, J PHYS CHEM C, V114, P11293, DOI 10.1021/jp1004049; Ooyama Y, 2013, CHEM COMMUN, V49, P2548, DOI 10.1039/c3cc40498f; Gratzel M, 2005, INORG CHEM, V44, P6841, DOI 10.1021/ic0508371; Yoo KS, 2006, J AM CHEM SOC, V128, P16384, DOI 10.1021/ja063710z; Wang P, 2003, J PHYS CHEM B, V107, P14336, DOI 10.1021/jp0365965; Park JK, 2009, J PHYS CHEM C, V113, P21956, DOI 10.1021/jp905675x; Santhanamoorthi N, 2013, J PHYS CHEM LETT, V4, P524, DOI 10.1021/jz302101j; Bai Y, 2011, J AM CHEM SOC, V133, P11442, DOI 10.1021/ja203708k; Campbell WM, 2004, COORDIN CHEM REV, V248, P1363, DOI 10.1016/j.ccr.2004.01.007; Imahori H, 2009, ACCOUNTS CHEM RES, V42, P1809, DOI 10.1021/ar900034t; Mathew S, 2014, NAT CHEM, V6, P242, DOI [10.1038/nchem.1861, 10.1038/NCHEM.1861]; Han LY, 2012, ENERG ENVIRON SCI, V5, P6057, DOI 10.1039/c2ee03418b; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Imahori H, 2010, J PHYS CHEM C, V114, P10656, DOI 10.1021/jp102486b; Yamaguchi S, 2007, J AM CHEM SOC, V129, P6392, DOI 10.1021/ja072218s; Song J, 2008, ANGEW CHEM INT EDIT, V47, P6004, DOI 10.1002/anie.200802026; Higashino T, 2015, DALTON T, V44, P448, DOI 10.1039/c4dt02756f; Wang CL, 2011, ENERG ENVIRON SCI, V4, P1788, DOI 10.1039/c0ee00767f; Feldt SM, 2010, J AM CHEM SOC, V132, P16714, DOI 10.1021/ja1088869; Hardin BE, 2012, NAT PHOTONICS, V6, P162, DOI [10.1038/nphoton.2012.22, 10.1038/NPHOTON.2012.22]; Martinson ABF, 2008, CHEM-EUR J, V14, P4458, DOI 10.1002/chem.200701667; Kang MS, 2012, CHEM COMMUN, V48, P9349, DOI 10.1039/c2cc31384g; Wang XF, 2010, ENERG ENVIRON SCI, V3, P94, DOI 10.1039/b918464c; Rochford J, 2007, J AM CHEM SOC, V129, P4655, DOI 10.1021/ja068218u; De Angelis F, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/42/424002; Gratzel M, 2009, ACCOUNTS CHEM RES, V42, P1788, DOI 10.1021/ar900141y; Cao YM, 2009, J PHYS CHEM C, V113, P6290, DOI 10.1021/jp9006872; Imahori H, 2009, J PHYS CHEM C, V113, P18406, DOI 10.1021/jp907288h; Yamamoto J, 2011, J PORPHYR PHTHALOCYA, V15, P534, DOI 10.1142/S1088424611002908; Hagfeldt A, 2004, COORDIN CHEM REV, V248, P1501, DOI 10.1016/j.ccr.2004.04.012; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Park JK, 2008, J PHYS CHEM C, V112, P16691, DOI 10.1021/jp804258q; Dean J. A., 1992, LANGES HDB CHEM; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hwang D, 2013, J MATER CHEM A, V1, P1228, DOI 10.1039/c2ta00418f; Hwang D, 2013, J MATER CHEM A, V1, P1359, DOI 10.1039/c2ta00292b; Hwang D, 2011, ACS APPL MATER INTER, V3, P2719, DOI 10.1021/am200517v; Ishida M, 2013, CHEM COMMUN, V49, P9164, DOI 10.1039/c3cc44847a; Panda MK, 2012, COORDIN CHEM REV, V256, P2601, DOI 10.1016/j.ccr.2012.04.041; Park SW, 2010, J CHIN CHEM SOC-TAIP, V57, P1111; Rehm JM, 1996, J PHYS CHEM-US, V100, P9577, DOI 10.1021/jp960155m; Sirithip K, 2013, TETRAHEDRON LETT, V54, P2435, DOI 10.1016/j.tetlet.2013.03.037; Song J., 2008, ANGEW CHEM, V120, P6093, DOI 10.1002/ange.200802026; Sun X, 2014, CHEM COMMUN, V50, P15609, DOI 10.1039/c4cc07963a; Tachibana Y., 2000, J PHYS CHEM B, V104, P1198, DOI 10.1021/jp992774b; Wang CL, 2012, ENERG ENVIRON SCI, V5, P6933, DOI 10.1039/c2ee03308a; WANG Y, 2014, ANGEW CHEM, V126, P10955; Yella A., 2014, ANGEW CHEM, V126, P3017; Yella A, 2014, ANGEW CHEM INT EDIT, V53, P2973, DOI 10.1002/anie.201309343; Yum JH, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/42/424005	83	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	SEP	2015	8	17			SI		2967	2977		10.1002/cssc.201500085		11	Chemistry, Multidisciplinary	Chemistry	CQ9ET	WOS:000360915800021		
J	Kadota, K; Yeh, YC; Villena-Vargas, J; Cherkassky, L; Drill, EN; Sima, CS; Jones, DR; Travis, WD; Adusumilli, PS				Kadota, Kyuichi; Yeh, Yi-Chen; Villena-Vargas, Jonathan; Cherkassky, Leonid; Drill, Esther N.; Sima, Camelia S.; Jones, David R.; Travis, William D.; Adusumilli, Prasad S.			Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma	CHEST			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REGULATORY T-CELLS; CANCER STEM-CELLS; IASLC/ATS/ERS HISTOLOGIC CLASSIFICATION; INTERNATIONAL ASSOCIATION; COLORECTAL-CANCER; GRADING SYSTEM; COMPETING RISK; C-MET; IMPACT	BACKGROUND: Immune cell infiltration associated with tumor capsule disruption and tumor budding has been shown to reflect invasiveness, metastasis, and unfavorable prognosis in colorectal cancer. We investigated the influence of tumor budding on prognosis and its association with the immune microenvironment in lung adenocarcinoma. METHODS: Tumor slides from resected stage I lung adenocarcinomas were reviewed (n = 524 and n = 514, for training and validation cohorts, respectively) for assessment of tumor budding. CD3(+) and forkhead box P3(+) (FoxP3(+)) lymphocytes, CD68(+) macrophages, IL-7 receptor, and IL-12 receptor beta 2 were analyzed using tissue microarrays constructed from tumor and stroma. Probability of recurrence was calculated using the competing risks method. RESULTS: In the training cohort, risk of recurrence for high-grade tumor budding was higher than it was for low-grade tumor budding (32% vs 12%, P<.001), which was confirmed in the validation cohort (P=.005). Tumor budding stratified the risk of recurrence for acinar-predominant (22% vs 9%, P<.001), papillary-predominant (22% vs 13%, P=.045), and solid-predominant (39% vs 19%, P=.022) tumors. Tumor budding was associated with higher stromal FoxP3(+) lymphocyte infiltration, higher stromal FoxP3/CD3 risk index, higher tumoral and stromal CD68(+) macrophage infiltration, and IL-7 receptor overexpression (P<.001, all associations). Tumor budding remained independently associated with recurrence on multivariate analysis (hazard ratio, 1.61; P=.008). CONCLUSIONS: Tumor budding is an independent prognostic factor of stage I lung adenocarcinoma and correlates with the protumor immune microenvironment. Our findings advocate investigating tumor-immune cell interactions at the invading edge as a biologic driver of tumor aggressiveness.	[Kadota, Kyuichi; Yeh, Yi-Chen; Villena-Vargas, Jonathan; Cherkassky, Leonid; Jones, David R.; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, New York, NY 10065 USA; [Kadota, Kyuichi; Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Drill, Esther N.; Sima, Camelia S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA; [Kadota, Kyuichi] Kagawa Univ, Fac Med, Dept Diagnost Pathol, Takamatsu, Kagawa 760, Japan	Adusumilli, PS (reprint author), Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10065 USA.	adusumip@mskcc.org			National Institutes of Health [R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P50 CA086438-13, P30 CA008748]; US Department of Defense [PR101053, LC110202]; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center	This work was supported by grants from the National Institutes of Health [R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P50 CA086438-13, and P30 CA008748], the US Department of Defense [PR101053 and LC110202], Mr William H. Goodwin and Mrs Alice Goodwin, the Commonwealth Foundation for Cancer Research, and the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center.	Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Kadota K, 2012, ANN SURG ONCOL, V19, P3598, DOI 10.1245/s10434-012-2414-3; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Kadota K, 2012, MODERN PATHOL, V25, P1117, DOI 10.1038/modpathol.2012.58; Man YG, 2011, J CELL BIOCHEM, V112, P1154, DOI 10.1002/jcb.23035; Tsuta K, 2013, LUNG CANCER, V81, P371, DOI 10.1016/j.lungcan.2013.06.012; Kadota K, 2013, CANCER-AM CANCER SOC, V119, P931, DOI 10.1002/cncr.27863; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Mansuet-Lupo A, 2014, CHEST, V146, P633, DOI 10.1378/chest.13-2499; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Zlobec I, 2011, HISTOPATHOLOGY, V59, P482, DOI 10.1111/j.1365-2559.2011.03975.x; Karamitopoulou E, 2013, MODERN PATHOL, V26, P295, DOI 10.1038/modpathol.2012.155; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Helm O, 2014, INT J CANCER, V135, P843, DOI 10.1002/ijc.28736; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Yamaguchi Y, 2010, J THORAC ONCOL, V5, P1361, DOI 10.1097/JTO.0b013e3181eaf2f3; Koga K, 2013, LUNG CANCER, V82, P413, DOI 10.1016/j.lungcan.2013.09.005; Kadota K, 2012, MODERN PATHOL, V25, P260, DOI 10.1038/modpathol.2011.146; Byrne WL, 2011, CANCER RES, V71, P6915, DOI 10.1158/0008-5472.CAN-11-1156; Puppa G, 2012, HISTOPATHOLOGY, V61, P562, DOI 10.1111/j.1365-2559.2012.04270.x; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; McShane LM, 2005, NAT CLIN PRACT ONCOL, V2, P416, DOI 10.1038/ncponc0252; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Kadota K, 2014, MODERN PATHOL, V27, P690, DOI 10.1038/modpathol.2013.188; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Taira T, 2012, LUNG CANCER, V76, P423, DOI 10.1016/j.lungcan.2011.11.010; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Kadota K, 2014, AM J SURG PATHOL, V38, P1118, DOI 10.1097/PAS.0000000000000246; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Nitadori J, 2013, JNCI-J NATL CANCER I, V105, P1212, DOI 10.1093/jnci/djt166; Benevides L, 2013, EUR J IMMUNOL, V43, P1518, DOI 10.1002/eji.201242951; Mitrovic B, 2012, MODERN PATHOL, V25, P1315, DOI 10.1038/modpathol.2012.94; Chappell R, 2012, CLIN CANCER RES, V18, P2127, DOI 10.1158/1078-0432.CCR-12-0455; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Edge SB, 2009, AJCC CANC STAGING MA, P253; Jiang B, 2013, INT J MED SCI, V10, P475, DOI 10.7150/ijms.5798; Lewis DR, 2014, CANCER-AM CANCER SOC, V120, P2883, DOI 10.1002/cncr.28749; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Reiman JM, 2010, CANCER RES, V70, P3005, DOI 10.1158/0008-5472.CAN-09-4041; Satoh K, 2014, CANCER SCI, V105, P1487, DOI 10.1111/cas.12530	46	1	1	AMER COLL CHEST PHYSICIANS	GLENVIEW	2595 PATRIOT BLVD, GLENVIEW, IL 60026 USA	0012-3692			CHEST	Chest	SEP	2015	148	3					711	721		10.1378/chest.14-3005		11	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CQ9ZY	WOS:000360978500035		
J	Uchida, J; Kato, K; Kukita, Y; Kumagai, T; Nishino, K; Daga, H; Nagatomo, I; Inoue, T; Kimura, M; Oba, S; Ito, Y; Takeda, K; Imamura, F				Uchida, Junji; Kato, Kikuya; Kukita, Yoji; Kumagai, Toru; Nishino, Kazumi; Daga, Haruko; Nagatomo, Izumi; Inoue, Takako; Kimura, Madoka; Oba, Shigeyuki; Ito, Yuri; Takeda, Koji; Imamura, Fumio			Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA	CLINICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; CIRCULATING TUMOR DNA; TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; GEFITINIB; MUTATIONS; ADENOCARCINOMAS; HETEROGENEITY; GENE; PCR	BACKGROUND: Genotyping of EGFR (epidermal growth factor receptor) mutations is indispensable for making therapeutic decisions regarding whether to use EGFR tyrosine kinase inhibitors (TKIs) for lung cancer. Because some cases might pose challenges for biopsy, noninvasive genotyping of EGFR in circulating tumor DNA (ctDNA) would be beneficial for lung cancer treatment. METHODS: We developed a detection system for EGFR mutations in ctDNA by use of deep sequencing of plasma DNA. Mutations were searched in >100000 reads obtained from each exon region. Parameters corresponding to the limit of detection and limit of quantification were used as the thresholds for mutation detection. We conducted a multi-institute prospective study to evaluate the detection system, enrolling 288 non-small cell lung cancer (NSCLC) patients. RESULTS: In evaluating the performance of the detection system, we used the genotyping results from biopsy samples as a comparator: diagnostic sensitivity for exon 19 deletions, 50.9% (95% CI 37.9%-63.9%); diagnostic specificity for exon 19 deletions, 98.0% (88.5%-100%); sensitivity for the L858R mutation, 51.9% (38.7%-64.9%); and specificity for L858R, 94.1% (83.5%-98.6%). The overall sensitivities were as follows: all cases, 54.4% (44.8%-63.7%); stages IA-IIIA, 22.2% (11.5%-38.3%); and stages II-IB-IV, 72.7% (60.9%-82.1%). CONCLUSIONS: Deep sequencing of plasma DNA can be used for genotyping of EGFR in lung cancer patients. In particular, the high specificity of the system may enable a direct recommendation for EGFR-TKI on the basis of positive results with plasma DNA. Because sensitivity was low in early-stage NSCLC, the detection system is preferred for stage IIIB-IV NSCLC. (C) 2015 American Association for Clinical Chemistry	[Uchida, Junji; Kumagai, Toru; Nishino, Kazumi; Inoue, Takako; Kimura, Madoka; Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Osaka 5378511, Japan; [Kato, Kikuya; Kukita, Yoji] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol & Med Genet, Res Inst, Osaka 5378511, Japan; [Ito, Yuri] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka 5378511, Japan; [Daga, Haruko; Takeda, Koji] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; [Nagatomo, Izumi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Osaka, Japan; [Oba, Shigeyuki] Kyoto Univ, Grad Sch Informat, Japan Sci & Technol, Kyoto, Japan	Kato, K (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Higasninari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	katou-ki@mc.pref.osaka.jp			Osaka Foundation for the Prevention of Cancer and Cardiovascular Diseases	This work was supported by the Osaka Foundation for the Prevention of Cancer and Cardiovascular Diseases.	Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Qiu MT, 2015, CANCER EPIDEM BIOMAR, V24, P206, DOI 10.1158/1055-9965.EPI-14-0895; Chen ZY, 2012, ONCOLOGIST, V17, P978, DOI 10.1634/theoncologist.2011-0385; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Kimura H, 2007, BRIT J CANCER, V97, P778, DOI 10.1038/sj.bjc.6603949; Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Douillard JY, 2014, J THORAC ONCOL, V9, P1345, DOI 10.1097/JTO.0000000000000263; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Brevet M, 2011, LUNG CANCER, V73, P96, DOI 10.1016/j.lungcan.2010.10.014; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Kukita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081468; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073	23	0	0	AMER ASSOC CLINICAL CHEMISTRY	WASHINGTON	2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA	0009-9147	1530-8561		CLIN CHEM	Clin. Chem.	SEP	2015	61	9					1191	1196		10.1373/clinchem.2015.241414		6	Medical Laboratory Technology	Medical Laboratory Technology	CR1TD	WOS:000361107000012		
J	Takeda, Y; Fujita, S; Ikemoto, T; Okada, Y; Sohmiya, K; Hoshiga, M; Ishizaka, N				Takeda, Yoshihiro; Fujita, Shu-ichi; Ikemoto, Toshiyuki; Okada, Yoshikatsu; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu			The relationship of fibroblast growth factors 21 and 23 and alpha-Klotho with platelet activity measured by platelet volume indices	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						fibroblast growth factor 21 (FGF21); FGF23; platelet activity; alpha-Klotho	CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; ATRIAL-FIBRILLATION; FGF23; INTERVENTION; HYPERTROPHY; BIOMARKER; OUTCOMES; EVENTS; STROKE	Background: Subjects with high fibroblast growth factor 21(FGF21) and 23 (FGF23), endocrine hormones that regulate insulin sensitivity and phosphate metabolism, respectively, are reported to have a higher risk for adverse cardiovascular outcome. Therefore, the relationship of FGF21, FGF23, and alpha-Klotho (co-receptor for FGF23 signaling) with mean platelet volume (MPV) and platelet distribution width (PDW), two platelet volume indices that reflect platelet activity, was investigated. Methods: Data from 156 patients admitted to the cardiology department were analyzed. MPV and PDW were measured by an automatic blood counter, and serum FGF21, FGF23, and alpha-Klotho concentrations were measured by an enzyme-linked immunoassay. Results: Log(FGF21) was significantly correlated with serum triglycerides but did not differ according to the use of non-use of antidiabetic or lipid-lowering drugs. MPV and PDW were significantly correlated (R = 0.475, p < 0.001). MPV was significantly correlated with log(FGF21) (R = -0.167, p < 0.05) and log(FGF23) (R = 0.351, p < 0.001) but not with log(alpha-Klotho). Linear regression analysis showed a negative and positive association of log(FGF21) and log(FGF23), respectively, with MPV that was independent of possible confounders including sex, age, renal function, and antithrombotic drug use. In addition, log(FGF23) was found to have a significant independent positive association with PDW. Conclusions: Among cardiac patients, FGF21 had a negative association with MPV, whereas FGF23 had a positive association. Future studies of serum FGF23/FGF21 concentrations and the incidence of thromboembolic disorders are warranted.	[Takeda, Yoshihiro; Fujita, Shu-ichi; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Osaka 5698686, Japan; [Ikemoto, Toshiyuki; Okada, Yoshikatsu] Osaka Med Coll, Cent Clin Lab, Osaka 5698686, Japan	Ishizaka, N (reprint author), Osaka Med Coll, Dept Cardiol, Takatsuki Shi Daigaku Machi 2-7, Osaka 5698686, Japan.	ishizaka@poh.osaka-med.ac.jp					Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Lenart-Lipinska M, 2013, DIABETES RES CLIN PR, V101, P194, DOI 10.1016/j.diabres.2013.04.010; Zuberi BF, 2008, SINGAP MED J, V49, P114; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Park Y, 2002, PLATELETS, V13, P301, DOI 10.1080/095371002220148332; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Xie J, 2015, J AM SOC NEPHROL, V26, P1150, DOI 10.1681/ASN.2014040325; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Ki YJ, 2014, PLATELETS, V25, P427, DOI 10.3109/09537104.2013.835393; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Wright CB, 2014, NEUROLOGY, V82, P1700, DOI 10.1212/WNL.0000000000000410; Kralisch S, 2011, CURR OPIN CLIN NUTR, V14, P354, DOI 10.1097/MCO.0b013e328346a326; Li XS, 2012, J BONE MINER METAB, V30, P660, DOI 10.1007/s00774-012-0362-4; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Asher E, 2014, THROMB HAEMOSTASIS, V112, P137, DOI 10.1160/TH13-10-0845; Schafer K, 2011, CLIN EXP PHARMACOL P, V38, P864, DOI 10.1111/j.1440-1681.2011.05589.x; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Arik OZ, 2014, PLATELETS, V25, P311, DOI 10.3109/09537104.2013.821603; Bisgaard Amalie, 2014, Int J Pediatr Endocrinol, V2014, P7, DOI 10.1186/1687-9856-2014-7; Breart G, 2010, OSTEOPOROSIS INT, V21, P1181, DOI 10.1007/s00198-009-1050-7; Carnevale R, 2014, MEDIAT INFLAMM, V2014; El-Hodhod MAA, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-44; Heilbronn LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078864; Itoh N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00247; Ju HY, 2015, PLATELETS, V26, P143, DOI 10.3109/09537104.2014.890179; Li B, 2014, INTERN MED J, V44, P653, DOI 10.1111/imj.12454; Lutsey PL, 2014, J AM HEART ASSOC, V3, DOI [10.1161/JAHA.114.000936, DOI 10.1161/JAHA.114.000936]; Marsell R, 2009, OSTEOPOROSIS INT, V20, P1167, DOI 10.1007/s00198-008-0780-2; Okamoto Y, 2014, HEART VESSELS, DOI [10.1007/s00380-014-0581-9, DOI 10.1007/S00380-014-0581-9]; Ong KL, 2015, DIABETOLOGIA, V58, P464, DOI 10.1007/s00125-014-3458-7; Ozeki M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-147; Ozkan B, 2014, BLOOD COAGUL FIBRIN, DOI [10.1097/MBC.0000000000000108, DOI 10.1097/MBC.0000000000000108]; Patel V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087102; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Poelzl G, 2014, EUR J CLIN INVEST, V44, P1150, DOI 10.1111/eci.12349; Shibata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073184; Wang WQ, 2011, PHYSIOL RES, V60, P347	41	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	SEP	2015	53	10					1569	1574		10.1515/cclm-2014-1251		6	Medical Laboratory Technology	Medical Laboratory Technology	CQ8IT	WOS:000360851500022		
J	Suzuki, K; Saito, K; Yoshimura, N; Ohno, Y; Nakashima, J; Oshiro, H; Akata, S; Tachibana, M; Tokuuye, K				Suzuki, Kunihito; Saito, Kazuhiro; Yoshimura, Nobutaka; Ohno, Yoshio; Nakashima, Jun; Oshiro, Hisashi; Akata, Soichi; Tachibana, Masaaki; Tokuuye, Koichi			Ureteral intussusception associated with a fibroepithelial polyp: a case report	CLINICAL IMAGING			English	Article						Ureteral intussusception; Fibroepithelial polyp; MDCT; MRI		We present a case of a 67-year-old man with intussusception of the right ureter associated with a fibroepithelial polyp. The concentric sign and line sign are characteristic radiological findings in intussusception, and these findings could be seen in the present case. Although this entity is rare, its radiological findings are specific. Multidetector row computed tomography and its multiplanar reconstruction make the diagnosis feasible, although the qualitative diagnosis of the tumor was difficult. (C) 2015 Elsevier Inc. All rights reserved.	[Suzuki, Kunihito; Saito, Kazuhiro; Yoshimura, Nobutaka; Akata, Soichi; Tokuuye, Koichi] Tokyo Med Univ, Dept Radiol, Tokyo 1608402, Japan; [Ohno, Yoshio; Nakashima, Jun; Tachibana, Masaaki] Tokyo Med Univ, Dept Urol, Tokyo 1608402, Japan; [Oshiro, Hisashi] Tokyo Med Univ, Dept Diagnost Pathol, Tokyo 1608402, Japan	Saito, K (reprint author), 6-7-1 Nishishinjuku,Shinjuku Ku, Tokyo 1600023, Japan.	saito-k@tokyo-med.ac.jp					Chao CH, 2012, J COMPUT ASSIST TOMO, V36, P261, DOI 10.1097/RCT.0b013e31824677a5; Harvin Howard J, 2006, AJR Am J Roentgenol, V187, pW434, DOI 10.2214/AJR.05.1631; Lai Thomas K. K., 2008, Hong Kong Medical Journal, V14, P408; MAZER MJ, 1979, UROL RADIOL, V1, P63; Patheyar V, 2011, Singapore Med J, V52, pe45; Wang ZJ, 2008, J ULTRAS MED, V27, P1647; Xu W, 2007, ABDOM IMAGING, V32, P675, DOI 10.1007/s00261-006-9163-3	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-7071	1873-4499		CLIN IMAG	Clin. Imaging	SEP-OCT	2015	39	5					901	903		10.1016/j.clinimag.2015.05.009		3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CQ7IT	WOS:000360776900033		
J	Tokunaga, K; Hishikawa, T; Sugiu, K; Date, I				Tokunaga, K.; Hishikawa, T.; Sugiu, K.; Date, I.			Combined Transarterial and Transvenous Approach for Curative Obliteration of Klippel-Trenaunay-Weber Syndrome-Associated Spinal Perimedullary Arteriovenous Fistulas	CLINICAL NEURORADIOLOGY			English	Article							MALFORMATIONS		[Tokunaga, K.] Okayama City Hosp, Dept Neurosurg, Kita Ku, Okayama 7008557, Japan; [Hishikawa, T.; Sugiu, K.; Date, I.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Okayama, Japan	Tokunaga, K (reprint author), Okayama City Hosp, Dept Neurosurg, Kita Ku, 6-10 Amase, Okayama 7008557, Japan.	kojitoku@md.okayama-u.ac.jp					Alomari AI, 2010, AM J NEURORADIOL, V31, P1608, DOI 10.3174/ajnr.A2167; Casasco A, 2012, NEUROSURGERY, V70, P141, DOI 10.1227/NEU.0b013e31822ec19e; Casasco A, 2012, NEUROSURGERY, V70, P149; HALBACH VV, 1993, NEUROSURGERY, V33, P972; Halbach VV, 1993, NEUROSURGERY, V33, P979; NAKSTAD PH, 1993, NEURORADIOLOGY, V35, P163; Rohany M, 2007, AM J NEURORADIOL, V28, P584	7	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.	SEP	2015	25	3					291	294		10.1007/s00062-014-0319-1		4	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CQ8FL	WOS:000360841800010		
